Citrus Sinensis ID: 005875
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 672 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LVM0 | 654 | Probable inactive recepto | yes | no | 0.918 | 0.943 | 0.709 | 0.0 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.927 | 0.973 | 0.619 | 0.0 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.906 | 0.951 | 0.576 | 0.0 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.891 | 0.910 | 0.551 | 1e-178 | |
| Q9SUQ3 | 638 | Probable inactive recepto | no | no | 0.886 | 0.934 | 0.503 | 1e-166 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.857 | 0.879 | 0.468 | 1e-146 | |
| Q9SH71 | 587 | Putative inactive recepto | no | no | 0.848 | 0.971 | 0.443 | 1e-141 | |
| Q9FK10 | 601 | Probable inactive recepto | no | no | 0.831 | 0.930 | 0.461 | 1e-140 | |
| Q9FL63 | 614 | Inactive leucine-rich rep | no | no | 0.843 | 0.923 | 0.444 | 1e-138 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.877 | 0.880 | 0.465 | 1e-136 |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 886 bits (2290), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/627 (70%), Positives = 519/627 (82%), Gaps = 10/627 (1%)
Query: 50 LCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVF 109
L V + A ADLNSDRQALL FA +VPHLR+LNW+STN IC+SWVG+ CT D T V
Sbjct: 31 LFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGVTCTSDGTSVH 90
Query: 110 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 169
LRLPGIGL+GPIP NTLGKL++L +LSLRSN+L+G LP +I SLPSL Y+YLQHNNFSG
Sbjct: 91 ALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSG 150
Query: 170 KIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 229
++PS S QL +LDLSFNSFTG IP + QNL QLTGLSLQ+N LSG +PN D LR LN
Sbjct: 151 EVPSFVSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVSLRRLN 210
Query: 230 LSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPS--PTYSPPPF--IPRK 285
LS N L GSIPS+L FP+SSF GN+LLCG PL+ C +P PS P S PP P K
Sbjct: 211 LSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPLPPFPHK 270
Query: 286 QSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKPK 345
+ SK+KL + II IA GG+A+LLL+ ++ILC C+KKKD + + K K +EK K
Sbjct: 271 EGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKT----LTEKAK 326
Query: 346 EEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK 405
+EFGSGVQEPEKNKLVFF GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK
Sbjct: 327 QEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK 386
Query: 406 RLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGN 465
RLKEV GKR+FEQQMEI+ RVG HP+VVPLRAYYYSKDEKL+V DY+ +G+LS+LLHGN
Sbjct: 387 RLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGN 446
Query: 466 RGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 525
RG+ +TPLDW++RVKI L A+G+AH+H+ GGPKF+HGNIK+SNV++ Q+ D CISDFGL
Sbjct: 447 RGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGL 506
Query: 526 TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
TPLM VP P R AGYRAPEV+ETRKH+HKSDVYSFGVL+LEMLTGK+P+QSP+RDDMVD
Sbjct: 507 TPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMVD 566
Query: 586 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645
LPRWVQSVVREEWT+EVFD+ELMRFQNIEEEMVQMLQI MACVA+VP++RP MD+VVRMI
Sbjct: 567 LPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMI 626
Query: 646 EEVRQSDSE-NRPSSEEN-KSKDSNVQ 670
EE+R SDSE RPSS++N K KDSNVQ
Sbjct: 627 EEIRVSDSETTRPSSDDNSKPKDSNVQ 653
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 758 bits (1956), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/639 (61%), Positives = 469/639 (73%), Gaps = 16/639 (2%)
Query: 43 AAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCT 102
AA LF + VS AD+ SD+QALL+FA VPH RKLNW+ST PIC SW GI C+
Sbjct: 6 AAFLFLLVTTFVSRC--LSADIESDKQALLEFASLVPHSRKLNWNSTIPICASWTGITCS 63
Query: 103 QDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYL 162
++ RV LRLPG GL GP+P T KLDAL ++SLRSN L G +PS I SLP +R LY
Sbjct: 64 KNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYF 123
Query: 163 QHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI 222
NNFSG IP S +LV LDLS NS +GNIP S+QNLTQLT LSLQ+N+LSG IPN
Sbjct: 124 HENNFSGTIPPVLSHRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNLP- 182
Query: 223 PKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFI 282
P+L++LNLS+N L GS+PSS++ FP SSF GNSLLCG PL C +PSP+ + P
Sbjct: 183 PRLKYLNLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPLTPCPENTTAPSPSPTTPTEG 242
Query: 283 PR-----KQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASS 337
P + ++K+ L GAI+ IAVGGS +L ++ +I C KK+D G + + KA
Sbjct: 243 PGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKAKP 302
Query: 338 GGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLE 397
G RS+ EEFGSGVQE EKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGT YKA+LE
Sbjct: 303 G-RSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILE 361
Query: 398 ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457
E TTVVVKRLKEV GKR+FEQQME VGR+ H NV PLRAYY+SKDEKLLVYDY+ G+
Sbjct: 362 EGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGN 421
Query: 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 517
S LLHGN GR LDWETR++I L ARG++HIHS G K HGNIK+ NVL+ Q+L
Sbjct: 422 FSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELH 481
Query: 518 GCISDFGLTPLMNVPA-TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
C+SDFG+ PLM+ PSRS GYRAPE IETRKH+ KSDVYSFGVLLLEMLTGKA +
Sbjct: 482 VCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGK 541
Query: 577 SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ-NIEEEMVQMLQIGMACVAKVPDMR 635
+ +++VDLP+WVQSVVREEWT EVFDVEL++ Q N+EEEMVQMLQI MACV+K PD R
Sbjct: 542 TTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSR 601
Query: 636 PNMDEVVRMIEEVRQS----DSENRPSSEEN-KSKDSNV 669
P+M+EVV M+EE+R S S NR SS E +S DS V
Sbjct: 602 PSMEEVVNMMEEIRPSGSGPGSGNRASSPEMIRSSDSPV 640
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 708 bits (1827), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/633 (57%), Positives = 457/633 (72%), Gaps = 24/633 (3%)
Query: 43 AAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCT 102
AA FF L ++L ADL SD QALL+FA +VPH KLNW+ +C SW+GI C
Sbjct: 10 AASFFFLLLAATAVL--VSADLASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITCD 67
Query: 103 QDR--TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYL 160
+ +RV +RLPG+GL G IP TLGKLDAL+VLSLRSN L G LPS+I SLPSL YL
Sbjct: 68 ESNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYL 127
Query: 161 YLQHNNFSGKIPS----SFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS 216
YLQHNNFSG++ + S S QLVVLDLS+NS +GNIP ++NL+Q+T L LQ+N+ G
Sbjct: 128 YLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGP 187
Query: 217 IPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTY 276
I + D+P ++ +NLSYN L G IP L+K P SF+GNSLLCGPPL AC A SPS
Sbjct: 188 IDSLDLPSVKVVNLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPSSNL 247
Query: 277 SPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKG-KA 335
P P +++ IIAI VG S +L + +V L CL KK G +G +
Sbjct: 248 -PRPLTENLHPVRRRQSKAYIIAIVVGCSVAVLFLGIVFLV-CLVKKTKKEEGGGEGVRT 305
Query: 336 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 395
GG + K ++FGSGVQ+PEKNKL FFE C++NFDLEDLL+ASAEVLGKGS+GTAYKAV
Sbjct: 306 QMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAV 365
Query: 396 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455
LE++T VVVKRL+EVV K++FEQQMEIVG++ QH N VPL AYYYSKDEKLLVY Y
Sbjct: 366 LEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTK 425
Query: 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 515
GSL ++HGNRG +DWETR+KI GT++ ++++HS+ KF HG+IK+SN+L+ +D
Sbjct: 426 GSLFGIMHGNRG--DRGVDWETRMKIATGTSKAISYLHSL---KFVHGDIKSSNILLTED 480
Query: 516 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
L+ C+SD L L N+P R+ GY APEVIETR+ S +SDVYSFGV++LEMLTGK PL
Sbjct: 481 LEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPL 540
Query: 576 QSPTRDD---MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 632
P +D ++DLPRWV+SVVREEWTAEVFDVEL++FQNIEEEMVQMLQ+ +ACVA+ P
Sbjct: 541 TQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNP 600
Query: 633 DMRPNMDEVVRMIEEVRQSD-----SENRPSSE 660
+ RP M+EV RMIE+VR+ D +NR SSE
Sbjct: 601 ESRPKMEEVARMIEDVRRLDQSQQLQQNRTSSE 633
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1614), Expect = e-178, Method: Compositional matrix adjust.
Identities = 346/627 (55%), Positives = 448/627 (71%), Gaps = 28/627 (4%)
Query: 66 SDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNN 125
+++QALL F +PH +L W+ ++ C +WVG+ C +++ + LRLPG GLVG IP+
Sbjct: 27 AEKQALLTFLQQIPHENRLQWNESDSAC-NWVGVECNSNQSSIHSLRLPGTGLVGQIPSG 85
Query: 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QLVVLD 183
+LG+L L VLSLRSN L+G +PS+ ++L LR LYLQHN FSG+ P+SF+ L+ LD
Sbjct: 86 SLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRLD 145
Query: 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 243
+S N+FTG+IP S+ NLT LTGL L +N SG++P+ + L N+S N L GSIPSSL
Sbjct: 146 ISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISL-GLVDFNVSNNNLNGSIPSSL 204
Query: 244 QKFPNSSFVGNSLLCGPPLKAC--FPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIA 301
+F SF GN LCG PLK C F V+PSPSP+ P R S K KL AI+AI
Sbjct: 205 SRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLINPS--NRLSSKKSKLSKAAIVAII 262
Query: 302 VGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSG----------GRSEKPKEEFG-- 349
V + V LL+ ++L CL+K+ + +K +G G S +E G
Sbjct: 263 VASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTS 322
Query: 350 SGVQ-EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLK 408
SG+ E E+NKLVF EG Y+FDLEDLLRASAEVLGKGS GT+YKAVLEE TTVVVKRLK
Sbjct: 323 SGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLK 382
Query: 409 EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA 468
+V+ K++FE QME+VG++ +HPNV+PLRAYYYSKDEKLLV+D+ +GSLS LLHG+RG+
Sbjct: 383 DVMASKKEFETQMEVVGKI-KHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGS 441
Query: 469 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528
GRTPLDW+ R++I + ARG+AH+H K HGNIKASN+L++ + D C+SD+GL L
Sbjct: 442 GRTPLDWDNRMRIAITAARGLAHLHVSA--KLVHGNIKASNILLHPNQDTCVSDYGLNQL 499
Query: 529 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 588
+ + P+R AGY APEV+ETRK + KSDVYSFGVLLLE+LTGK+P Q+ ++ +DLPR
Sbjct: 500 FSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPR 559
Query: 589 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648
WV SVVREEWTAEVFDVELMR+ NIEEEMVQ+LQI MACV+ VPD RP M EV+RMIE+V
Sbjct: 560 WVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDV 619
Query: 649 RQSDSEN---RPSSEENKSKDSNVQTP 672
+S++ + R SS++ SK S QTP
Sbjct: 620 NRSETTDDGLRQSSDD-PSKGSEGQTP 645
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 584 bits (1505), Expect = e-166, Method: Compositional matrix adjust.
Identities = 314/624 (50%), Positives = 416/624 (66%), Gaps = 28/624 (4%)
Query: 60 AFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLV 119
A +D D++ALL+F + R LNW+ T+ +C W G+ C QD +R+ +RLPG+GL
Sbjct: 22 ANSDPLEDKRALLEFLTIMQPTRSLNWNETSQVCNIWTGVTCNQDGSRIIAVRLPGVGLN 81
Query: 120 GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--P 177
G IP NT+ +L AL VLSLRSN+++G P + L L +LYLQ NN SG +P FS
Sbjct: 82 GQIPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVWK 141
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-PKLRHLNLSYN-GL 235
L ++LS N F G IP S+ L ++ L+L +N LSG IP+ + L+H++LS N L
Sbjct: 142 NLTSVNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQHIDLSNNYDL 201
Query: 236 KGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLG 295
G IP L++FP SS+ G ++ PP V P P P +K S + LGL
Sbjct: 202 AGPIPDWLRRFPFSSYTGIDII--PPGGNYTLVTPPP-----PSEQTHQKPSKARFLGLS 254
Query: 296 AIIAI----AVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGK-ASSGGRSEKPKEEFGS 350
+ + AV + L ++ +CY +K G +S K GG S E+F S
Sbjct: 255 ETVFLLIVIAVSIVVITALAFVLTVCYVRRKLRRGDGVISDNKLQKKGGMS---PEKFVS 311
Query: 351 GVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEV 410
+++ N+L FFEGC+Y+FDLEDLLRASAEVLGKG++GT YKAVLE++T+V VKRLK+V
Sbjct: 312 RMEDV-NNRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDV 370
Query: 411 VVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR 470
GKRDFEQQMEI+G + +H NVV L+AYYYSKDEKL+VYDYF+ GS+++LLHGNRG R
Sbjct: 371 AAGKRDFEQQMEIIGGI-KHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENR 429
Query: 471 TPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530
PLDWETR+KI +G A+G+A IH K HGNIK+SN+ +N + +GC+SD GLT +M+
Sbjct: 430 IPLDWETRMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMS 489
Query: 531 VPATP-SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW 589
A P SR AGYRAPEV +TRK S SDVYSFGV+LLE+LTGK+P+ + D+++ L RW
Sbjct: 490 PLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRW 549
Query: 590 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV- 648
V SVVREEWTAEVFD+EL+R+ NIEEEMV+MLQI M+CV K D RP M ++VR+IE V
Sbjct: 550 VHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVG 609
Query: 649 --RQS---DSENRPSSEENKSKDS 667
R S + E +P SE S+ S
Sbjct: 610 NRRTSIEPEPELKPKSENGASETS 633
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1339), Expect = e-146, Method: Compositional matrix adjust.
Identities = 292/623 (46%), Positives = 388/623 (62%), Gaps = 47/623 (7%)
Query: 63 DLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPI 122
DLN+DR ALL AV R W+ +W G+ C + RV LRLPG+ L G I
Sbjct: 32 DLNADRTALLSLRSAVGG-RTFRWNIKQTSPCNWAGVKC--ESNRVTALRLPGVALSGDI 88
Query: 123 PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS-PQLV 180
P G L L LSLR N L+G LP ++++ +LR+LYLQ N FSG+IP FS LV
Sbjct: 89 PEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLV 148
Query: 181 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 240
L+L+ NSFTG I NLT+L L L++N LSGSIP+ D+P L N+S N L GSIP
Sbjct: 149 RLNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLP-LVQFNVSNNSLNGSIP 207
Query: 241 SSLQKFPNSSFVGNSLLCGPPLKAC-----FPVAPSPSPTYSPPPFI-PRKQSSKQKLGL 294
+LQ+F + SF+ SL CG PLK C P P+ +PP ++ K KL
Sbjct: 208 KNLQRFESDSFLQTSL-CGKPLKLCPDEETVPSQPTSGGNRTPPSVEGSEEKKKKNKLSG 266
Query: 295 GAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKP-----KEEFG 349
GAI I +G L+ L+++ C KK SN S+ S + ++P KE
Sbjct: 267 GAIAGIVIGCVVGFALIVLILMVLCRKK----SNKRSRAVDISTIKQQEPEIPGDKEAVD 322
Query: 350 SGV---------------------QEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSY 388
+G P KLVFF + FDLEDLLRASAEVLGKG++
Sbjct: 323 NGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTF 382
Query: 389 GTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 448
GTAYKAVL+ T V VKRLK+V++ ++F++++E+VG + H N+VPLRAYY+S+DEKLL
Sbjct: 383 GTAYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAM-DHENLVPLRAYYFSRDEKLL 441
Query: 449 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKAS 508
VYD+ GSLS LLHGNRGAGR+PL+W+ R +I +G ARG+ ++HS G +HGNIK+S
Sbjct: 442 VYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQG-TSTSHGNIKSS 500
Query: 509 NVLINQDLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLE 567
N+L+ + D +SDFGL L+ AT P+R+ GYRAPEV + ++ S K DVYSFGV+LLE
Sbjct: 501 NILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLE 560
Query: 568 MLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMV-QMLQIGMA 626
++TGKAP S ++ VDLPRWV+SV R+EW EVFD EL+ EEEM+ +M+Q+G+
Sbjct: 561 LITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLE 620
Query: 627 CVAKVPDMRPNMDEVVRMIEEVR 649
C ++ PD RP M EVVR +E +R
Sbjct: 621 CTSQHPDQRPEMSEVVRKMENLR 643
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SH71|Y1421_ARATH Putative inactive receptor-like protein kinase At1g64210 OS=Arabidopsis thaliana GN=At1g64210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 503 bits (1294), Expect = e-141, Method: Compositional matrix adjust.
Identities = 276/622 (44%), Positives = 389/622 (62%), Gaps = 52/622 (8%)
Query: 46 LFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDR 105
LFF +I+ + ++ L D++ALL F + R L+W+ ++ +C SW G+ C ++
Sbjct: 5 LFF-FSLILCFVLISSQTLEDDKKALLHFLSSFNSSR-LHWNQSSDVCHSWTGVTCNENG 62
Query: 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 165
R+ +RLP +G G IP T+ +L +L+ LSLR N TG PS+ T+L SL +LYLQHN
Sbjct: 63 DRIVSVRLPAVGFNGLIPPFTISRLSSLKFLSLRKNHFTGDFPSDFTNLKSLTHLYLQHN 122
Query: 166 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP 223
+ SG + + FS L VLDLS N F G+IP S+ LT L L+L +N+ SG IPN +P
Sbjct: 123 HLSGPLLAIFSELKNLKVLDLSNNGFNGSIPTSLSGLTSLQVLNLANNSFSGEIPNLHLP 182
Query: 224 KLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIP 283
KL +NLS N L G+IP SLQ+F +S+F GN+L
Sbjct: 183 KLSQINLSNNKLIGTIPKSLQRFQSSAFSGNNL-------------------------TE 217
Query: 284 RKQSSKQKLGLGAIIAIAVGGSAVLLLVA----LVILCYCLKKKDNGSNGVSKGKASSGG 339
RK+ K GL + + + +A +L V+ ++I C+ G +S GK
Sbjct: 218 RKKQRKTPFGLSQLAFLLILSAACVLCVSGLSFIMITCF-------GKTRIS-GKLRKRD 269
Query: 340 RSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEES 399
S P E K++FF G ++ FDL+DLL +SAEVLGKG++GT YK +E+
Sbjct: 270 SSSPPGNWTSRDDNTEEGGKIIFFGGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDM 329
Query: 400 TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459
+TVVVKRLKEVVVG+R+FEQQMEI+G + +H NV L+AYYYSKD+KL VY Y+ GSL
Sbjct: 330 STVVVKRLKEVVVGRREFEQQMEIIGMI-RHENVAELKAYYYSKDDKLAVYSYYNHGSLF 388
Query: 460 TLLHGNRGA-GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 518
+LHGNRG R PLDW+ R++I G ARG+A IH KF HGNIK+SN+ ++ G
Sbjct: 389 EILHGNRGRYHRVPLDWDARLRIATGAARGLAKIHE---GKFIHGNIKSSNIFLDSQCYG 445
Query: 519 CISDFGLTPLM-NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 577
CI D GLT +M ++P T ++GY APE+ +TR+ + SDVYSFGV+LLE+LTGK+P+
Sbjct: 446 CIGDVGLTTIMRSLPQTTCLTSGYHAPEITDTRRSTQFSDVYSFGVVLLELLTGKSPVSQ 505
Query: 578 ----PTRDDMVDLPRWVQSVVREEWTAEVFDVELM-RFQNIEEEMVQMLQIGMACVAKVP 632
PT + +DL W++SVV +EWT EVFD+E++ + EEEMV+MLQIG+ACVA
Sbjct: 506 AELVPTGGENMDLASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMVEMLQIGLACVALKQ 565
Query: 633 DMRPNMDEVVRMIEEVRQSDSE 654
RP++ +V+++IE++R D+E
Sbjct: 566 QERPHIAQVLKLIEDIRSVDAE 587
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FK10|Y5332_ARATH Probable inactive receptor kinase At5g53320 OS=Arabidopsis thaliana GN=At5g53320 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1283), Expect = e-140, Method: Compositional matrix adjust.
Identities = 278/603 (46%), Positives = 368/603 (61%), Gaps = 44/603 (7%)
Query: 50 LCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVF 109
L V++ + + + D+ LL F + + H LNWS + IC W G+ C D + V
Sbjct: 9 LIVVIFNVCIEAETIKEDKHTLLQFVNNINHSHSLNWSPSLSICTKWTGVTCNSDHSSVD 68
Query: 110 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 169
L L GL G I + + +L L L L SN ++G P+ + +L +L L L N FSG
Sbjct: 69 ALHLAATGLRGDIELSIIARLSNLRFLILSSNNISGTFPTTLQALKNLTELKLDFNEFSG 128
Query: 170 KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH 227
+PS S +L VLDLS N F G+IP SI LT L L+L N SG IP+ IP L+
Sbjct: 129 PLPSDLSSWERLQVLDLSNNRFNGSIPSSIGKLTLLHSLNLAYNKFSGEIPDLHIPGLKL 188
Query: 228 LNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQS 287
LNL++N L G++P SLQ+FP S+FVGN +L PV S RK +
Sbjct: 189 LNLAHNNLTGTVPQSLQRFPLSAFVGNKVLA--------PVHSSL-----------RKHT 229
Query: 288 SKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKPKEE 347
++ IA L V IL + + + SS + K +++
Sbjct: 230 KHHN---HVVLGIA-------LSVCFAILALLAILLVIIIHNREEQRRSSKDKPSKRRKD 279
Query: 348 FGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRL 407
V E + NK+VFFEG + FDLEDLLRASAEVLGKG +GT YK LE+S T+VVKR+
Sbjct: 280 SDPNVGEGD-NKIVFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYKVDLEDSATIVVKRI 338
Query: 408 KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG 467
KEV V +R+FEQQ+E +G + +H NV LR Y+YSKDEKL+VYDY+ GSLSTLLHG +G
Sbjct: 339 KEVSVPQREFEQQIENIGSI-KHENVATLRGYFYSKDEKLVVYDYYEHGSLSTLLHGQKG 397
Query: 468 -AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 526
R L+WETR+ ++ GTARGVAHIHS G K HGNIK+SN+ +N GCIS G+
Sbjct: 398 LRDRKRLEWETRLNMVYGTARGVAHIHSQSGGKLVHGNIKSSNIFLNGKGYGCISGTGMA 457
Query: 527 PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586
LM+ + P + GYRAPE+ +TRK + SDVYSFG+L+ E+LTGK+ ++ +L
Sbjct: 458 TLMH--SLPRHAVGYRAPEITDTRKGTQPSDVYSFGILIFEVLTGKS--------EVANL 507
Query: 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646
RWV SVVREEWT EVFD EL+R +EEEMV+MLQ+GM C A++P+ RPNM EVVRM+E
Sbjct: 508 VRWVNSVVREEWTGEVFDEELLRCTQVEEEMVEMLQVGMVCTARLPEKRPNMIEVVRMVE 567
Query: 647 EVR 649
E+R
Sbjct: 568 EIR 570
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FL63|Y5410_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At5g24100 OS=Arabidopsis thaliana GN=At5g24100 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 492 bits (1266), Expect = e-138, Method: Compositional matrix adjust.
Identities = 270/608 (44%), Positives = 378/608 (62%), Gaps = 41/608 (6%)
Query: 62 ADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGP 121
DL DRQALLDF + + H R L W++++P+C +W G+ C D TRV L LPG L+G
Sbjct: 28 GDLAGDRQALLDFLNNIIHPRSLAWNTSSPVCTTWPGVTCDIDGTRVTALHLPGASLLGV 87
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
IP T+ +L L++LSLRSN L G P + L L+ + L +N FSG +PS ++ L
Sbjct: 88 IPPGTISRLSELQILSLRSNGLRGPFPIDFLQLKKLKAISLGNNRFSGPLPSDYATWTNL 147
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 239
VLDL N F G+IP NLT L L+L N+ SG IP+ ++P LR LN S N L GSI
Sbjct: 148 TVLDLYSNRFNGSIPAGFANLTGLVSLNLAKNSFSGEIPDLNLPGLRRLNFSNNNLTGSI 207
Query: 240 PSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLG--AI 297
P+SL++F NS+F GN+L+ F AP PP + K+ K + + AI
Sbjct: 208 PNSLKRFGNSAFSGNNLV--------FENAP-------PPAVVSFKEQKKNGIYISEPAI 252
Query: 298 IAIAVGGSAVLLLVALVILCYCLKKKDNGSNGV---SKGKASSGGRSEKPKEEFGSGVQ- 353
+ IA+ V+ V V++ C K+ S K K + SEK + G
Sbjct: 253 LGIAISVCFVIFFVIAVVIIVCYVKRQRKSETEPKPDKLKLAKKMPSEKEVSKLGKEKNI 312
Query: 354 -----EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLK 408
+ E NK++FFEG + F+LEDLL ASAE LGKG +G YKAVLE+S + VKRLK
Sbjct: 313 EDMEDKSEINKVMFFEGSNLAFNLEDLLIASAEFLGKGVFGMTYKAVLEDSKVIAVKRLK 372
Query: 409 EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHG-NRG 467
++VV ++DF+ QMEIVG + +H NV PLRAY SK+EKL+VYDY ++GSLS LHG N
Sbjct: 373 DIVVSRKDFKHQMEIVGNI-KHENVAPLRAYVCSKEEKLMVYDYDSNGSLSLRLHGKNAD 431
Query: 468 AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527
G PL+WETR++ ++G A+G+ HIH+ HGNIK+SNV +N + GCIS+ GL P
Sbjct: 432 EGHVPLNWETRLRFMIGVAKGLGHIHTQ---NLAHGNIKSSNVFMNSEGYGCISEAGL-P 487
Query: 528 LMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 582
L+ P + S+ YRAPEV +TR+ + +SD+YSFG+L+LE LTG++ + R +
Sbjct: 488 LLTNPVVRADSSARSVLRYRAPEVTDTRRSTPESDIYSFGILMLETLTGRSIMDD--RKE 545
Query: 583 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 642
+DL WV V+ ++WT EVFD+EL++ N+E +++QMLQ+G +C A VP RP+M +VV
Sbjct: 546 GIDLVVWVNDVISKQWTGEVFDLELVKTPNVEAKLLQMLQLGTSCTAMVPAKRPDMVKVV 605
Query: 643 RMIEEVRQ 650
+EE+ +
Sbjct: 606 ETLEEIER 613
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 485 bits (1248), Expect = e-136, Method: Compositional matrix adjust.
Identities = 300/645 (46%), Positives = 406/645 (62%), Gaps = 55/645 (8%)
Query: 66 SDRQALLDFADAVPHLRKLN-WSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPN 124
+D + LL+F KLN W++T CQ W G++C +R RV L L I L G I +
Sbjct: 30 TDSETLLNFKLTADSTGKLNSWNTTTNPCQ-WTGVSC--NRNRVTRLVLEDINLTGSISS 86
Query: 125 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182
T L +L VLSL+ N L+G +P+ +++L +L+ L+L +N FSG P+S + +L L
Sbjct: 87 LT--SLTSLRVLSLKHNNLSGPIPN-LSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRL 143
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 242
DLSFN+F+G IP + +LT L L L+SN SG IPN ++ L+ N+S N G IP+S
Sbjct: 144 DLSFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPNS 203
Query: 243 LQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSP----------PPFIPR-------- 284
L +FP S F N LCG PL C ++ P+ P P +P
Sbjct: 204 LSQFPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGG 263
Query: 285 -KQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEK 343
K ++ ++ ++IAI +G +L V+L +L YC ++ V+K K S EK
Sbjct: 264 DKSNNTSRISTISLIAIILGDFIILSFVSL-LLYYCFWRQ----YAVNKKKHSKILEGEK 318
Query: 344 --------PKEEFGSGVQEP---EKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAY 392
P + Q +K K+VFFEG + F+LEDLLRASAE+LGKG +GTAY
Sbjct: 319 IVYSSNPYPTSTQNNNNQNQQVGDKGKMVFFEG-TRRFELEDLLRASAEMLGKGGFGTAY 377
Query: 393 KAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450
KAVLE+ V VKRLK+ V GK++FEQQME++GR+ +H N+V L+AYY++++EKLLVY
Sbjct: 378 KAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRL-RHTNLVSLKAYYFAREEKLLVY 436
Query: 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-SMGGPKFTHGNIKASN 509
DY +GSL LLHGNRG GRTPLDW TR+KI G ARG+A IH S K THG+IK++N
Sbjct: 437 DYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTN 496
Query: 510 VLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEML 569
VL+++ + +SDFGL+ + T ++S GYRAPE+I+ RKH+ KSDVYSFGVLLLE+L
Sbjct: 497 VLLDRSGNARVSDFGLS-IFAPSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEIL 555
Query: 570 TGKAP--LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMAC 627
TGK P +++ VDLPRWVQSVVREEWTAEVFD+ELMR+++IEEEMV +LQI MAC
Sbjct: 556 TGKCPNMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMAC 615
Query: 628 VAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 672
A D RP M VV++IE++R SE P N +S V +P
Sbjct: 616 TAVAADHRPKMGHVVKLIEDIRGGGSEASPC---NDGINSAVDSP 657
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 672 | ||||||
| 224145409 | 636 | predicted protein [Populus trichocarpa] | 0.943 | 0.996 | 0.803 | 0.0 | |
| 297745748 | 656 | unnamed protein product [Vitis vinifera] | 0.971 | 0.995 | 0.792 | 0.0 | |
| 359478866 | 637 | PREDICTED: probable inactive receptor ki | 0.944 | 0.996 | 0.802 | 0.0 | |
| 255586379 | 635 | Nodulation receptor kinase precursor, pu | 0.941 | 0.996 | 0.802 | 0.0 | |
| 224126989 | 635 | predicted protein [Populus trichocarpa] | 0.940 | 0.995 | 0.788 | 0.0 | |
| 356537708 | 664 | PREDICTED: probable inactive receptor ki | 0.964 | 0.975 | 0.759 | 0.0 | |
| 449444334 | 630 | PREDICTED: probable inactive receptor ki | 0.934 | 0.996 | 0.773 | 0.0 | |
| 356500954 | 654 | PREDICTED: probable inactive receptor ki | 0.959 | 0.986 | 0.753 | 0.0 | |
| 356570023 | 631 | PREDICTED: probable inactive receptor ki | 0.938 | 1.0 | 0.770 | 0.0 | |
| 356553186 | 656 | PREDICTED: probable inactive receptor ki | 0.961 | 0.984 | 0.749 | 0.0 |
| >gi|224145409|ref|XP_002325632.1| predicted protein [Populus trichocarpa] gi|222862507|gb|EEF00014.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1050 bits (2716), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/637 (80%), Positives = 560/637 (87%), Gaps = 3/637 (0%)
Query: 38 MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 97
MK + ++F ++ + P AFADL SD+QALLDFA AVPHLRKLNW+ + +C SWV
Sbjct: 1 MKIFLGSVIYF-FIILTIIFPFAFADLKSDKQALLDFATAVPHLRKLNWNPASSVCNSWV 59
Query: 98 GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 157
G+ C +RTRV LRLPG+GLVG IP NTLGKLDAL VLSLRSNVL G LPS+ITSLPSL
Sbjct: 60 GVTCNSNRTRVSQLRLPGVGLVGHIPPNTLGKLDALRVLSLRSNVLEGDLPSDITSLPSL 119
Query: 158 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 217
L+LQHNNFSG IP+SFS QL VLDLSFNSFTGNIPQ++ NLTQL GLSLQ+N LSG I
Sbjct: 120 TNLFLQHNNFSGGIPTSFSLQLNVLDLSFNSFTGNIPQTLANLTQLIGLSLQNNTLSGPI 179
Query: 218 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVA--PSPSPT 275
P+ + +++ LNLSYN L GSIP SLQ FPNSSF+GNSLLCGPPL C PV PSPSP
Sbjct: 180 PDLNHTRIKRLNLSYNHLNGSIPVSLQNFPNSSFIGNSLLCGPPLNPCSPVIRPPSPSPA 239
Query: 276 YSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 335
Y PPP +PRK+SSK KL +GAIIAIAVGGSAVL LV L ILC CLKKKDNG + V KGKA
Sbjct: 240 YIPPPTVPRKRSSKVKLTMGAIIAIAVGGSAVLFLVVLTILCCCLKKKDNGGSSVLKGKA 299
Query: 336 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 395
S GR EKPKEEFGSGVQE EKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 300 VSSGRGEKPKEEFGSGVQEHEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 359
Query: 396 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455
LEESTTVVVKRL+EVV+GKRDFEQQME VGRVGQHPN+VPLRAYYYSKDEKLLVYDY
Sbjct: 360 LEESTTVVVKRLREVVMGKRDFEQQMENVGRVGQHPNIVPLRAYYYSKDEKLLVYDYIPG 419
Query: 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 515
GSLSTLLH NRGAGRTPLDW++RVKI LGTARG++H+HS+GGPKFTHGNIK++NVL++QD
Sbjct: 420 GSLSTLLHANRGAGRTPLDWDSRVKIALGTARGISHLHSVGGPKFTHGNIKSTNVLLSQD 479
Query: 516 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
DGCISDFGLTPLMNVPAT SRSAGYRAPEVIETRKH+HKSDVYSFGV+LLEMLTGKAP+
Sbjct: 480 HDGCISDFGLTPLMNVPATSSRSAGYRAPEVIETRKHTHKSDVYSFGVVLLEMLTGKAPI 539
Query: 576 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 635
QSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQIGM CVAKVPDMR
Sbjct: 540 QSPGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMTCVAKVPDMR 599
Query: 636 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 672
PNM+EVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 600 PNMEEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 636
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745748|emb|CBI15804.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1046 bits (2706), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/655 (79%), Positives = 575/655 (87%), Gaps = 2/655 (0%)
Query: 20 LHFCYSSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVP 79
+ F Y H IPC +QL MK S + + L VI LLPLA ADL++D+QALLDFADAVP
Sbjct: 2 VQFYYYGHSHIPCARQLPMKLFSTSLVLLFLFVIAILLPLAIADLDADKQALLDFADAVP 61
Query: 80 HLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLR 139
H RKLNW+S+ P+C SWVGINCT D +RV LRLPGIGL G IP TLGKLDALE+LSLR
Sbjct: 62 HRRKLNWNSSTPVCTSWVGINCTGDGSRVRALRLPGIGLTGSIPATTLGKLDALEILSLR 121
Query: 140 SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQN 199
SN+LTG LPS+I SLPSL+YL+LQHNNFSG IP+SFSPQL VLDLSFNSFTGNIP +I N
Sbjct: 122 SNLLTGKLPSDIPSLPSLQYLFLQHNNFSGDIPASFSPQLTVLDLSFNSFTGNIPLTIWN 181
Query: 200 LTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCG 259
LTQLTGL+LQ+N+LSG+IP+ + KL+HLNLSYN L GSIPSSLQ+FPNSSFVGNSLLCG
Sbjct: 182 LTQLTGLNLQNNSLSGAIPDVNPSKLKHLNLSYNNLNGSIPSSLQRFPNSSFVGNSLLCG 241
Query: 260 PPLKAC--FPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILC 317
PPL C P++PSP+P++ PP KQ SK+KL +G IIAIAVGG+ VL LV L+I
Sbjct: 242 PPLNNCSLTPLSPSPAPSFPSPPMASEKQGSKKKLSMGIIIAIAVGGAVVLFLVVLMIFL 301
Query: 318 YCLKKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLR 377
CL+KKD+ +GV+KGKAS GGRSEKPKEEFGSGVQEP+KNKLVFFEGCSYNFDLEDLLR
Sbjct: 302 CCLRKKDSEGSGVAKGKASGGGRSEKPKEEFGSGVQEPDKNKLVFFEGCSYNFDLEDLLR 361
Query: 378 ASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
ASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM+IVGRVGQHPNVVPLR
Sbjct: 362 ASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMDIVGRVGQHPNVVPLR 421
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
AYYYSKDEKLLVYDY + GSLS LLHGNR GR+PLDW RVKI LG ARG+ HIHS+GG
Sbjct: 422 AYYYSKDEKLLVYDYVSGGSLSALLHGNRPTGRSPLDWNARVKISLGIARGITHIHSVGG 481
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSD 557
KFTHGNIK+SNVL+NQD +GCISDFGLTPLMN PAT SR+AGYRAPEVIE+RKH+HKSD
Sbjct: 482 GKFTHGNIKSSNVLLNQDFEGCISDFGLTPLMNFPATSSRNAGYRAPEVIESRKHTHKSD 541
Query: 558 VYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 617
VYSFGVLLLEMLTGKAPLQSP RDDMVDLPRWVQSVVREEWTAEVFD+ELMR+QNIEEEM
Sbjct: 542 VYSFGVLLLEMLTGKAPLQSPGRDDMVDLPRWVQSVVREEWTAEVFDIELMRYQNIEEEM 601
Query: 618 VQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 672
VQMLQ+ MACVAKVPDMRP+MDEVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 602 VQMLQLAMACVAKVPDMRPSMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 656
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478866|ref|XP_002276162.2| PREDICTED: probable inactive receptor kinase At5g58300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1032 bits (2668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/637 (80%), Positives = 565/637 (88%), Gaps = 2/637 (0%)
Query: 38 MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 97
MK S + + L VI LLPLA ADL++D+QALLDFADAVPH RKLNW+S+ P+C SWV
Sbjct: 1 MKLFSTSLVLLFLFVIAILLPLAIADLDADKQALLDFADAVPHRRKLNWNSSTPVCTSWV 60
Query: 98 GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 157
GINCT D +RV LRLPGIGL G IP TLGKLDALE+LSLRSN+LTG LPS+I SLPSL
Sbjct: 61 GINCTGDGSRVRALRLPGIGLTGSIPATTLGKLDALEILSLRSNLLTGKLPSDIPSLPSL 120
Query: 158 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 217
+YL+LQHNNFSG IP+SFSPQL VLDLSFNSFTGNIP +I NLTQLTGL+LQ+N+LSG+I
Sbjct: 121 QYLFLQHNNFSGDIPASFSPQLTVLDLSFNSFTGNIPLTIWNLTQLTGLNLQNNSLSGAI 180
Query: 218 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKAC--FPVAPSPSPT 275
P+ + KL+HLNLSYN L GSIPSSLQ+FPNSSFVGNSLLCGPPL C P++PSP+P+
Sbjct: 181 PDVNPSKLKHLNLSYNNLNGSIPSSLQRFPNSSFVGNSLLCGPPLNNCSLTPLSPSPAPS 240
Query: 276 YSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 335
+ PP KQ SK+KL +G IIAIAVGG+ VL LV L+I CL+KKD+ +GV+KGKA
Sbjct: 241 FPSPPMASEKQGSKKKLSMGIIIAIAVGGAVVLFLVVLMIFLCCLRKKDSEGSGVAKGKA 300
Query: 336 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 395
S GGRSEKPKEEFGSGVQEP+KNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 301 SGGGRSEKPKEEFGSGVQEPDKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 360
Query: 396 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455
LEESTTVVVKRLKEVVVGKRDFEQQM+IVGRVGQHPNVVPLRAYYYSKDEKLLVYDY +
Sbjct: 361 LEESTTVVVKRLKEVVVGKRDFEQQMDIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYVSG 420
Query: 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 515
GSLS LLHGNR GR+PLDW RVKI LG ARG+ HIHS+GG KFTHGNIK+SNVL+NQD
Sbjct: 421 GSLSALLHGNRPTGRSPLDWNARVKISLGIARGITHIHSVGGGKFTHGNIKSSNVLLNQD 480
Query: 516 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
+GCISDFGLTPLMN PAT SR+AGYRAPEVIE+RKH+HKSDVYSFGVLLLEMLTGKAPL
Sbjct: 481 FEGCISDFGLTPLMNFPATSSRNAGYRAPEVIESRKHTHKSDVYSFGVLLLEMLTGKAPL 540
Query: 576 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 635
QSP RDDMVDLPRWVQSVVREEWTAEVFD+ELMR+QNIEEEMVQMLQ+ MACVAKVPDMR
Sbjct: 541 QSPGRDDMVDLPRWVQSVVREEWTAEVFDIELMRYQNIEEEMVQMLQLAMACVAKVPDMR 600
Query: 636 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 672
P+MDEVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 601 PSMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 637
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586379|ref|XP_002533837.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223526229|gb|EEF28551.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1024 bits (2648), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/637 (80%), Positives = 556/637 (87%), Gaps = 4/637 (0%)
Query: 38 MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 97
MKF A+ F L V+ +L LA ADLNSD+QALL+F+ A+PH R LNW+ + IC+SWV
Sbjct: 1 MKFFPASS--FRLIVLFTLFSLAIADLNSDKQALLNFSAAIPHYRLLNWNPASSICKSWV 58
Query: 98 GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 157
G+ C +TRV LRLPG+G +G IP NTLGKLDAL VLSLRSN+L G LPS++TSLPSL
Sbjct: 59 GVTCNPSQTRVLELRLPGVGFIGQIPANTLGKLDALRVLSLRSNLLYGNLPSDVTSLPSL 118
Query: 158 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 217
R LYLQHNNFS IP+SFS QL VLDLSFNSF+G+IPQ+I NLTQLTGLSLQ+N LSG+I
Sbjct: 119 RNLYLQHNNFSSTIPTSFSSQLNVLDLSFNSFSGSIPQTIANLTQLTGLSLQNNTLSGAI 178
Query: 218 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYS 277
P+ + +LRHLNLSYN L GS+P SLQKFPNSSF GNSLLCG PL C P+ PSP+ +
Sbjct: 179 PDLNQSRLRHLNLSYNHLNGSVPFSLQKFPNSSFTGNSLLCGLPLNPCSPILSPPSPSPA 238
Query: 278 PPPFIP--RKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 335
P K+ SK KL LGAIIAIAVGG AVL L+ ++ILC CLKKKDNG + V KGKA
Sbjct: 239 SSPPPEMPHKKGSKAKLTLGAIIAIAVGGFAVLFLIVVIILCCCLKKKDNGGSSVLKGKA 298
Query: 336 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 395
S GR EKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 299 VSSGRGEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 358
Query: 396 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455
LEESTTVVVKRLKEVVVGKR+FEQQMEIVGRVGQH NVVPLRAYYYSKDEKLLVYDY
Sbjct: 359 LEESTTVVVKRLKEVVVGKREFEQQMEIVGRVGQHQNVVPLRAYYYSKDEKLLVYDYIQG 418
Query: 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 515
GSLSTLLHGNR AGRTPLDW+ RVKI LGTARG+AH+HS GGPKFTHGNIK+SNVL+NQD
Sbjct: 419 GSLSTLLHGNRQAGRTPLDWDNRVKIALGTARGIAHLHSAGGPKFTHGNIKSSNVLLNQD 478
Query: 516 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
DGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKH+HKSDVYSFGVLLLEMLTGKAPL
Sbjct: 479 HDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHTHKSDVYSFGVLLLEMLTGKAPL 538
Query: 576 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 635
QSP+RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQIGMACVAKVPDMR
Sbjct: 539 QSPSRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMACVAKVPDMR 598
Query: 636 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 672
PNMDEVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 599 PNMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 635
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126989|ref|XP_002319979.1| predicted protein [Populus trichocarpa] gi|222858355|gb|EEE95902.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2593), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/638 (78%), Positives = 552/638 (86%), Gaps = 6/638 (0%)
Query: 38 MKF--SSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQS 95
MKF +S LF L +I P A +DL SD+QALLDFA VPH RKLNW+ + +C+S
Sbjct: 1 MKFFRASVIHLFIILTII---FPFAISDLKSDKQALLDFAAVVPHSRKLNWNPASLVCKS 57
Query: 96 WVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP 155
WVG+ C + TRV LRLPG+GL+G +P NTLGKLDAL LSLRSNVL G LPS++TSLP
Sbjct: 58 WVGVTCNSNDTRVVELRLPGVGLLGHVPPNTLGKLDALNTLSLRSNVLEGDLPSDVTSLP 117
Query: 156 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
SL+ L+LQHNNFSG +P+SFS +L VLDLSFNSFTGNIPQ+I NLTQLTGLSLQ+N LSG
Sbjct: 118 SLQNLFLQHNNFSGGVPTSFSLKLNVLDLSFNSFTGNIPQTIANLTQLTGLSLQNNALSG 177
Query: 216 SIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPV-APSPSP 274
IP+ + +++HLNLSYN L GSIP SLQKFPNSSF+GNSLLCGPPL C V P PSP
Sbjct: 178 PIPDLNHTRIKHLNLSYNHLNGSIPVSLQKFPNSSFIGNSLLCGPPLNPCSIVLPPPPSP 237
Query: 275 TYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGK 334
Y+PPP K+SSK KL +GAIIAIAVGGSAVL LV L++ C CLKKKDN GV KGK
Sbjct: 238 AYTPPPATSHKRSSKLKLTMGAIIAIAVGGSAVLFLVVLIVFCCCLKKKDNEGPGVLKGK 297
Query: 335 ASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA 394
A S GR EKPKE+FGSGVQE EKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA
Sbjct: 298 AVSSGRGEKPKEDFGSGVQESEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA 357
Query: 395 VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454
VLEESTTVVVKRLKEVVVGKRDFEQQMEI GRVGQHPNVVPLRAYYYSKDE+LLVYDY
Sbjct: 358 VLEESTTVVVKRLKEVVVGKRDFEQQMEIAGRVGQHPNVVPLRAYYYSKDERLLVYDYIP 417
Query: 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 514
GSLSTLLH NRGAGRTPLDW++RVKI LGTARG++H+HS GGPKFTHGNIK+SNVL++Q
Sbjct: 418 GGSLSTLLHANRGAGRTPLDWDSRVKIALGTARGISHLHSAGGPKFTHGNIKSSNVLLSQ 477
Query: 515 DLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
D DGCISDFGLTPLMNVPA+ SRSAGYRAPEVIET KHSHKSDVYSFGV+LLEMLTGKAP
Sbjct: 478 DHDGCISDFGLTPLMNVPASSSRSAGYRAPEVIETSKHSHKSDVYSFGVILLEMLTGKAP 537
Query: 575 LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDM 634
+QSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQIGM CVAKVPDM
Sbjct: 538 IQSPRRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMTCVAKVPDM 597
Query: 635 RPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 672
RPNM+EVVRMIEE+RQSDSENRPSSE NKSKDSNV TP
Sbjct: 598 RPNMEEVVRMIEEIRQSDSENRPSSEGNKSKDSNVHTP 635
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537708|ref|XP_003537367.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 996 bits (2574), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/649 (75%), Positives = 557/649 (85%), Gaps = 1/649 (0%)
Query: 24 YSSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRK 83
++ LIP KQL MKF S + F L VIV PLA ADL+SD+QALL+FA+AVPH R
Sbjct: 17 FNCRYLIPFSKQLSMKFCSTSVASF-LFVIVIFFPLAIADLSSDKQALLNFANAVPHRRN 75
Query: 84 LNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVL 143
L W+ + +C SWVGI C ++RTRV +RLPG+GLVG IP+NTLGKLDA++++SLRSN+L
Sbjct: 76 LMWNPSTSVCSSWVGITCNENRTRVVKVRLPGVGLVGTIPSNTLGKLDAVKIISLRSNLL 135
Query: 144 TGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQL 203
+G LP++I SLPSL+YLYLQHNN SG IP+S SPQL+VLDLS+NSFTG IP++ QN++ L
Sbjct: 136 SGNLPADIGSLPSLQYLYLQHNNLSGDIPASLSPQLIVLDLSYNSFTGVIPKTFQNMSVL 195
Query: 204 TGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLK 263
T L+LQ+N+LSG IPN ++ L+ LNLSYN L GSIP +L+ FPNSSF GNSLLCGPPLK
Sbjct: 196 TSLNLQNNSLSGQIPNLNVTLLKLLNLSYNHLNGSIPKALEIFPNSSFEGNSLLCGPPLK 255
Query: 264 ACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKK 323
C V P+PSP +PPP +QSSK KL AII IAVGG+ VL +ALV + CLKK+
Sbjct: 256 PCSAVPPTPSPASTPPPSTTGRQSSKNKLSKIAIIVIAVGGAVVLFFIALVFVICCLKKE 315
Query: 324 DNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVL 383
DN + V KGK SGGR EKPKEEFGSGVQEPEKNKLVFFEG SYNFDLEDLLRASAEVL
Sbjct: 316 DNRGSNVIKGKGPSGGRGEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVL 375
Query: 384 GKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK 443
GKGSYGTAYKA+LEES TVVVKRLKEVVVGK+DFEQQMEI+GRVGQH NVVPLRAYYYSK
Sbjct: 376 GKGSYGTAYKAILEESMTVVVKRLKEVVVGKKDFEQQMEIMGRVGQHTNVVPLRAYYYSK 435
Query: 444 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHG 503
DEKLLVYDY G+L TLLHG R GRTPLDW++R+KI LGTA+G+AHIHS+GGPKFTHG
Sbjct: 436 DEKLLVYDYVPGGNLHTLLHGGRTGGRTPLDWDSRIKISLGTAKGLAHIHSVGGPKFTHG 495
Query: 504 NIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 563
NIK+SNVL+NQD DGCISDFGL PLMNVPATPSR+AGYRAPEVIETRKHSHKSDVYSFGV
Sbjct: 496 NIKSSNVLLNQDNDGCISDFGLAPLMNVPATPSRAAGYRAPEVIETRKHSHKSDVYSFGV 555
Query: 564 LLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQI 623
LLLEMLTGKAPLQSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI
Sbjct: 556 LLLEMLTGKAPLQSPGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQI 615
Query: 624 GMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 672
MACVAK+PDMRP+MDE VRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 616 AMACVAKMPDMRPSMDEAVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 664
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444334|ref|XP_004139930.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Cucumis sativus] gi|449475802|ref|XP_004154555.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 974 bits (2518), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/637 (77%), Positives = 551/637 (86%), Gaps = 9/637 (1%)
Query: 38 MKFSSAA--PLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQS 95
MKF SA+ PLFF VI++LL LA ADL SD+QALLDFA +VPH R LNW+ T PIC S
Sbjct: 1 MKFCSASVLPLFF---VIINLLHLAIADLESDKQALLDFASSVPHRRSLNWNDTTPICTS 57
Query: 96 WVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP 155
WVG+ C+ D T V LRLPGIGLVG IP++TLGKLD L++LSLRSN+L+G +PS+ITSLP
Sbjct: 58 WVGVTCSADGTHVLTLRLPGIGLVGSIPSDTLGKLDGLKILSLRSNLLSGIIPSDITSLP 117
Query: 156 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
SL+YLYLQHNN SG +PSS SP LVVL+LSFN G IP+++QNLTQLTGL+LQ+NNLSG
Sbjct: 118 SLQYLYLQHNNLSGDVPSSLSPTLVVLNLSFNLLEGKIPKTVQNLTQLTGLNLQNNNLSG 177
Query: 216 SIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPT 275
SIP+ ++PKL+HLN+SYN L GSIP+ FPNSSF+GN LCG PLKAC + SP+P
Sbjct: 178 SIPDINLPKLKHLNISYNHLNGSIPTFFNTFPNSSFIGNPSLCGSPLKAC-SIVLSPAPH 236
Query: 276 YSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 335
P P I +KQSSK KL +G IIAIAVGG VL LV L ++ CLKKK+ G G KGK
Sbjct: 237 APPSPAISQKQSSK-KLKMGVIIAIAVGGFFVLFLVVLFVVLCCLKKKEGGDAGTRKGKV 295
Query: 336 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 395
S GGRSEKPKEEFGSGVQEPEKNKLVFFEGCS+NFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 296 SGGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSFNFDLEDLLRASAEVLGKGSYGTAYKAV 355
Query: 396 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455
LEE TTVVVKRLKEVVVGKR+FEQQM+IVGRVGQHPNV+PLRAYYYSKDEKLLVYDY
Sbjct: 356 LEEPTTVVVKRLKEVVVGKREFEQQMDIVGRVGQHPNVMPLRAYYYSKDEKLLVYDYVPG 415
Query: 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 515
GSLS+LLHGNRG RTPLDW++RVKI L TA+G+AHIH+MGGPKFTHGNIKASNVL+ QD
Sbjct: 416 GSLSSLLHGNRGGERTPLDWDSRVKIALATAKGIAHIHAMGGPKFTHGNIKASNVLLIQD 475
Query: 516 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
++ C+SDFGLTPLMNVP SR+AGYRAPEVIE RKH+HKSDVYSFGVLLLEMLTGKAPL
Sbjct: 476 VNACVSDFGLTPLMNVPT--SRTAGYRAPEVIEARKHTHKSDVYSFGVLLLEMLTGKAPL 533
Query: 576 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 635
QSP RD+MVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI M CVAK+PDMR
Sbjct: 534 QSPGRDEMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMTCVAKLPDMR 593
Query: 636 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 672
PNMDEVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 594 PNMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 630
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500954|ref|XP_003519295.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 966 bits (2498), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/649 (75%), Positives = 553/649 (85%), Gaps = 4/649 (0%)
Query: 25 SSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKL 84
S ++L K++ MKF S+ F L +IV L PLA ADL+SD+QALLDFA AVPH R L
Sbjct: 9 SVNILYHTTKKISMKFYSSQVHRF-LFIIVILFPLAIADLSSDKQALLDFAAAVPHRRNL 67
Query: 85 NWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT 144
W+ PIC SWVGI C + TRV +RLPGIGLVG IP NTLGK+D+L +SLR+N+L+
Sbjct: 68 KWNPATPICSSWVGITCNPNGTRVVSVRLPGIGLVGTIPANTLGKIDSLRNISLRANLLS 127
Query: 145 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 204
G LP +ITSLPSL+YLYLQHNN SG +P+S S +L VLDLS+NSF+G IP+++QN+TQL
Sbjct: 128 GSLPPDITSLPSLQYLYLQHNNLSGSVPTSLSTRLNVLDLSYNSFSGAIPKTLQNITQLI 187
Query: 205 GLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKA 264
L+LQ+N+LSG IPN ++ KLRHLNLSYN L GSIP +LQ FPNSSF GNSL CG PLK+
Sbjct: 188 KLNLQNNSLSGQIPNLNVTKLRHLNLSYNHLNGSIPDALQIFPNSSFEGNSL-CGLPLKS 246
Query: 265 CFPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKD 324
C V+ +P P+ P P + SSK KL AIIAIAVGG +LLLVAL+I+ CLKKKD
Sbjct: 247 CSVVSSTP-PSTPVSPSTPARHSSKSKLSKAAIIAIAVGGGVLLLLVALIIVLCCLKKKD 305
Query: 325 NGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLG 384
+ S V+KGK SGGRSEKPKEEFGSGVQEPEKNKLVFFEG SYNFDLEDLLRASAEVLG
Sbjct: 306 DRSPSVTKGKGPSGGRSEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLG 365
Query: 385 KGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD 444
KGSYGTAYKA+LEESTTVVVKRLKEVVVGKR+FEQQMEIVGRVG HPNVVPLRAYYYSKD
Sbjct: 366 KGSYGTAYKAILEESTTVVVKRLKEVVVGKREFEQQMEIVGRVGHHPNVVPLRAYYYSKD 425
Query: 445 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 504
EKLLVYDY SG+LSTLLHGNR +GRTPLDW +R+KI +G ARG+AHIHS+GGPKFTHGN
Sbjct: 426 EKLLVYDYIPSGNLSTLLHGNRASGRTPLDWNSRIKISVGIARGIAHIHSVGGPKFTHGN 485
Query: 505 IKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVL 564
+K+SNVL+N D DGCISDFGLTPLMNVPATPSR+AGYRAPEVIETRKH+HKSDVYSFG+L
Sbjct: 486 VKSSNVLLNHDNDGCISDFGLTPLMNVPATPSRAAGYRAPEVIETRKHTHKSDVYSFGIL 545
Query: 565 LLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIG 624
LLEMLTGKAP QSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI
Sbjct: 546 LLEMLTGKAPQQSPGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIA 605
Query: 625 MACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSK-DSNVQTP 672
MACVAKVPDMRP+MDEVVRMIEE+R SDSENRPSSEEN+SK +S QTP
Sbjct: 606 MACVAKVPDMRPSMDEVVRMIEEIRLSDSENRPSSEENRSKEESAAQTP 654
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570023|ref|XP_003553192.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2483), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/632 (77%), Positives = 546/632 (86%), Gaps = 1/632 (0%)
Query: 38 MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 97
MKF S + F L VIV L PLA ADL+SD+QALLDFA+AVPH R L W+ + +C SWV
Sbjct: 1 MKFHSTSVASF-LFVIVILFPLAIADLSSDKQALLDFANAVPHRRNLMWNPSTSVCTSWV 59
Query: 98 GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 157
GI C ++RTRV +RLPG+GLVG IP+NTLGKL A++++SLRSN+L+G LP++I SLPSL
Sbjct: 60 GITCNENRTRVVKVRLPGVGLVGTIPSNTLGKLGAVKIISLRSNLLSGNLPADIGSLPSL 119
Query: 158 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 217
+YLYLQHNN SG IP+S S QLVVLDLS+NSFTG IP + QNL++LT L+LQ+N+LSG I
Sbjct: 120 QYLYLQHNNLSGDIPASLSLQLVVLDLSYNSFTGVIPTTFQNLSELTSLNLQNNSLSGQI 179
Query: 218 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYS 277
PN ++ L+ LNLSYN L GSIP +LQ FPNSSF GNSLLCGPPLK C V P+PSP+ +
Sbjct: 180 PNLNVNLLKLLNLSYNQLNGSIPKALQIFPNSSFEGNSLLCGPPLKPCSVVPPTPSPSST 239
Query: 278 PPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASS 337
PP P +QSSK KL AIIAIAVGG+ VL VALV CLKK+D+ + V KGK S
Sbjct: 240 PPQSTPGRQSSKNKLSKIAIIAIAVGGAVVLFFVALVFFICCLKKEDDRGSNVIKGKGPS 299
Query: 338 GGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLE 397
GGR EKPKEEFGSGVQEPEKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGTAYKA+LE
Sbjct: 300 GGRGEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTAYKAILE 359
Query: 398 ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457
ES TVVVKRLKEVVVGK+DFEQQMEI+GRVGQH NVVPLRAYYYSKDEKLLVYDY G+
Sbjct: 360 ESMTVVVKRLKEVVVGKKDFEQQMEIMGRVGQHTNVVPLRAYYYSKDEKLLVYDYVPGGN 419
Query: 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 517
L TLLHG R GRTPLDW++R+KI LGTA+G+AH+HS+GGPKFTHGNIK+SNVL+NQD D
Sbjct: 420 LHTLLHGGRTGGRTPLDWDSRIKISLGTAKGLAHVHSVGGPKFTHGNIKSSNVLLNQDND 479
Query: 518 GCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 577
GCISDFGL PLMNVPATPSR+AGYRAPEVIE RKHSHKSDVYSFGVLLLEMLTGKAPLQS
Sbjct: 480 GCISDFGLAPLMNVPATPSRTAGYRAPEVIEARKHSHKSDVYSFGVLLLEMLTGKAPLQS 539
Query: 578 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN 637
P RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI MACVAK+PDMRP+
Sbjct: 540 PGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMACVAKMPDMRPS 599
Query: 638 MDEVVRMIEEVRQSDSENRPSSEENKSKDSNV 669
MDEVVRMIEE+RQSDSENRPSSEENKSKDSNV
Sbjct: 600 MDEVVRMIEEIRQSDSENRPSSEENKSKDSNV 631
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553186|ref|XP_003544939.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 945 bits (2443), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/650 (74%), Positives = 550/650 (84%), Gaps = 4/650 (0%)
Query: 25 SSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKL 84
S ++L K++ MKF S F L +IV L PL ADL+SD+QALLDFA AVPH R L
Sbjct: 9 SVNILYHTAKKISMKFYSLQAHRF-LFIIVILCPLVIADLSSDKQALLDFAAAVPHRRNL 67
Query: 85 NWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT 144
W+ PIC SWVGI C + TRV +RLPGIGLVG IP NTLGK+D+L +SLR+N+L+
Sbjct: 68 KWNPATPICSSWVGITCNLNDTRVVSVRLPGIGLVGTIPANTLGKIDSLRNISLRANLLS 127
Query: 145 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 204
G LP++ITSLPSL+YLYLQHNN SG IP+S S +L VLDLS+NSFTG IP+++QNLTQL
Sbjct: 128 GSLPADITSLPSLQYLYLQHNNLSGNIPTSLSTRLNVLDLSYNSFTGAIPKTLQNLTQLI 187
Query: 205 GLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKA 264
L+LQ+N+LSG IPN ++ KLR LNLSYN L GSIP++LQ FPNSSF GNSL CG PLK+
Sbjct: 188 KLNLQNNSLSGLIPNLNVTKLRRLNLSYNHLNGSIPAALQIFPNSSFEGNSL-CGLPLKS 246
Query: 265 CFPVAPSPSPTYSPPPFIPR-KQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKK 323
C V +P P+ +P P + SSK KL AIIAIAVGG +LLLVAL+I+ C KKK
Sbjct: 247 CPVVPSTPPPSSTPAPPSTPARHSSKSKLSKAAIIAIAVGGGVLLLLVALIIVLCCFKKK 306
Query: 324 DNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVL 383
D+GS +KGK SGGRSEKPKEEFGSGVQEPEKNKLVFFEG SYNFDLEDLLRASAEVL
Sbjct: 307 DDGSPRATKGKGPSGGRSEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVL 366
Query: 384 GKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK 443
GKGSYGTAYKA+LEESTTVVVKRLKE VVGKR+FEQQMEIVGRVG HPNVVPLRAYYYSK
Sbjct: 367 GKGSYGTAYKAILEESTTVVVKRLKEAVVGKREFEQQMEIVGRVGHHPNVVPLRAYYYSK 426
Query: 444 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHG 503
DEKLLVYDY SG+LSTLLHGNR +GRTPLDW +R+KI +G ARG+AHIHS+GGPKF HG
Sbjct: 427 DEKLLVYDYIPSGNLSTLLHGNRASGRTPLDWNSRIKISVGIARGIAHIHSVGGPKFAHG 486
Query: 504 NIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 563
N+K+SNVL+NQD DGCISDFGLTPLMNVP+TPSR+AGYRAPEVIETRKH+HKSDVYSFGV
Sbjct: 487 NVKSSNVLLNQDNDGCISDFGLTPLMNVPSTPSRAAGYRAPEVIETRKHTHKSDVYSFGV 546
Query: 564 LLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQI 623
LLLEMLTGKAP QSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI
Sbjct: 547 LLLEMLTGKAPQQSPGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQI 606
Query: 624 GMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSK-DSNVQTP 672
MACVAKVPDMRP+M+EVVRMIEE+R SDSENRPSSEEN+SK +S QTP
Sbjct: 607 AMACVAKVPDMRPSMEEVVRMIEEIRLSDSENRPSSEENRSKEESTAQTP 656
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 672 | ||||||
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.931 | 0.957 | 0.634 | 8e-211 | |
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.520 | 0.546 | 0.648 | 2.7e-178 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.501 | 0.526 | 0.589 | 3e-168 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.900 | 0.919 | 0.494 | 2.3e-151 | |
| TAIR|locus:2128414 | 638 | AT4G23740 [Arabidopsis thalian | 0.514 | 0.542 | 0.568 | 7.8e-144 | |
| TAIR|locus:2198090 | 655 | RKL1 "receptor-like kinase 1" | 0.476 | 0.488 | 0.518 | 5e-125 | |
| TAIR|locus:2154227 | 601 | AT5G53320 [Arabidopsis thalian | 0.452 | 0.505 | 0.542 | 4.5e-122 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.464 | 0.465 | 0.563 | 7.4e-122 | |
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.437 | 0.454 | 0.556 | 5.9e-120 | |
| TAIR|locus:2024517 | 587 | AT1G64210 [Arabidopsis thalian | 0.482 | 0.551 | 0.476 | 5.9e-120 |
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2038 (722.5 bits), Expect = 8.0e-211, P = 8.0e-211
Identities = 404/637 (63%), Positives = 471/637 (73%)
Query: 40 FSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGI 99
F S + F L V + A ADLNSDRQALL FA +VPHLR+LNW+STN IC+SWVG+
Sbjct: 22 FLSTCLVSF-LFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGV 80
Query: 100 NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRY 159
CT D T V LRLPGIGL+GPIP NTLGKL++L +LSLRSN+L+G LP +I SLPSL Y
Sbjct: 81 TCTSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDY 140
Query: 160 LYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTXXXXXXXXXXXXXXXIPN 219
+YLQHNNFSG++PS S QL +LDLSFNSFTG IP + QNL +PN
Sbjct: 141 IYLQHNNFSGEVPSFVSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPN 200
Query: 220 FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFXXXXXXXXXXXXX 279
D LR LNLS N L GSIPS+L FP+SSF GN+LLCG PL+ C
Sbjct: 201 LDTVSLRRLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHIS 260
Query: 280 XXXX----RKQSSKQKXXXXXXXXXXXXXXXXXXXXXXXXXCYCLKKKDNGSNGVSKGKA 335
K+ SK+K C C+KKKD + + K K
Sbjct: 261 TPPLPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKT 320
Query: 336 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 395
+ EK K+EFGSGVQEPEKNKLVFF GCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 321 LT----EKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 376
Query: 396 LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455
LEESTT R+FEQQMEI+ RVG HP+VVPLRAYYYSKDEKL+V DY+ +
Sbjct: 377 LEESTTVVVKRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPA 436
Query: 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 515
G+LS+LLHGNRG+ +TPLDW++RVKI L A+G+AH+H+ GGPKF+HGNIK+SNV++ Q+
Sbjct: 437 GNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQE 496
Query: 516 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
D CISDFGLTPLM VP P R AGYRAPEV+ETRKH+HKSDVYSFGVL+LEMLTGK+P+
Sbjct: 497 SDACISDFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPV 556
Query: 576 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 635
QSP+RDDMVDLPRWVQSVVREEWT+EVFD+ELMRFQNIEEEMVQMLQI MACVA+VP++R
Sbjct: 557 QSPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVR 616
Query: 636 PNMDEVVRMIEEVRQSDSEN-RPSSEEN-KSKDSNVQ 670
P MD+VVRMIEE+R SDSE RPSS++N K KDSNVQ
Sbjct: 617 PTMDDVVRMIEEIRVSDSETTRPSSDDNSKPKDSNVQ 653
|
|
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1151 (410.2 bits), Expect = 2.7e-178, Sum P(2) = 2.7e-178
Identities = 232/358 (64%), Positives = 268/358 (74%)
Query: 319 CLKKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRA 378
C KK+D G + + KA G RS+ EEFGSGVQE EKNKLVFFEG SYNFDLEDLLRA
Sbjct: 284 CAKKRDGGQDSTAVPKAKPG-RSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRA 342
Query: 379 SAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRA 438
SAEVLGKGSYGT YKA+LEE TT R+FEQQME VGR+ H NV PLRA
Sbjct: 343 SAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRA 402
Query: 439 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 498
YY+SKDEKLLVYDY+ G+ S LLHGN GR LDWETR++I L ARG++HIHS G
Sbjct: 403 YYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGA 462
Query: 499 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETRKHSHKSD 557
K HGNIK+ NVL+ Q+L C+SDFG+ PLM+ PSRS GYRAPE IETRKH+ KSD
Sbjct: 463 KLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSD 522
Query: 558 VYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ-NIEEE 616
VYSFGVLLLEMLTGKA ++ +++VDLP+WVQSVVREEWT EVFDVEL++ Q N+EEE
Sbjct: 523 VYSFGVLLLEMLTGKAAGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEE 582
Query: 617 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE----NRPSSEEN-KSKDSNV 669
MVQMLQI MACV+K PD RP+M+EVV M+EE+R S S NR SS E +S DS V
Sbjct: 583 MVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIRPSGSGPGSGNRASSPEMIRSSDSPV 640
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1058 (377.5 bits), Expect = 3.0e-168, Sum P(2) = 3.0e-168
Identities = 207/351 (58%), Positives = 261/351 (74%)
Query: 319 CLKKKDNGSNGVSKG-KASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLR 377
CL KK G +G + GG + K ++FGSGVQ+PEKNKL FFE C++NFDLEDLL+
Sbjct: 288 CLVKKTKKEEGGGEGVRTQMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLK 347
Query: 378 ASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLR 437
ASAEVLGKGS+GTAYKAVLE++T ++FEQQMEIVG++ QH N VPL
Sbjct: 348 ASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLL 407
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
AYYYSKDEKLLVY Y GSL ++HGNRG +DWETR+KI GT++ ++++HS+
Sbjct: 408 AYYYSKDEKLLVYKYMTKGSLFGIMHGNRGD--RGVDWETRMKIATGTSKAISYLHSL-- 463
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSD 557
KF HG+IK+SN+L+ +DL+ C+SD L L N+P R+ GY APEVIETR+ S +SD
Sbjct: 464 -KFVHGDIKSSNILLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSD 522
Query: 558 VYSFGVLLLEMLTGKAPLQSPTRDD---MVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614
VYSFGV++LEMLTGK PL P +D ++DLPRWV+SVVREEWTAEVFDVEL++FQNIE
Sbjct: 523 VYSFGVVILEMLTGKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIE 582
Query: 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS-----ENRPSSE 660
EEMVQMLQ+ +ACVA+ P+ RP M+EV RMIE+VR+ D +NR SSE
Sbjct: 583 EEMVQMLQLALACVARNPESRPKMEEVARMIEDVRRLDQSQQLQQNRTSSE 633
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1477 (525.0 bits), Expect = 2.3e-151, P = 2.3e-151
Identities = 311/629 (49%), Positives = 404/629 (64%)
Query: 62 ADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGP 121
++ +++QALL F +PH +L W+ ++ C +WVG+ C +++ + LRLPG GLVG
Sbjct: 23 SESTAEKQALLTFLQQIPHENRLQWNESDSAC-NWVGVECNSNQSSIHSLRLPGTGLVGQ 81
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QL 179
IP+ +LG+L L VLSLRSN L+G +PS+ ++L LR LYLQHN FSG+ P+SF+ L
Sbjct: 82 IPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNL 141
Query: 180 VVLDLSFNSFTGNIPQSIQNLTXXXXXXXXXXXXXXXIPNFDIPKLRHLNLSYNGLKGSI 239
+ LD+S N+FTG+IP S+ NLT +P+ + L N+S N L GSI
Sbjct: 142 IRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISLG-LVDFNVSNNNLNGSI 200
Query: 240 PSSLQKFPNSSFVGNSLLCGPPLKACFXXXXXXXXXXXXXXXXXRKQSSKQKXXXXXXXX 299
PSSL +F SF GN LCG PLK C R S K K
Sbjct: 201 PSSLSRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLINPSNRLSSKKSKLSKAAIVA 260
Query: 300 XXXXXXXXXXXXXXXXXCYCLKKKDNGSNGVSKGKASSG----------GRSEKPKEEFG 349
CL+K+ + +K +G G S +E G
Sbjct: 261 IIVASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTG 320
Query: 350 --SGVQ-EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXX 406
SG+ E E+NKLVF EG Y+FDLEDLLRASAEVLGKGS GT+YKAVLEE TT
Sbjct: 321 TSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKR 380
Query: 407 XXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR 466
++FE QME+VG++ +HPNV+PLRAYYYSKDEKLLV+D+ +GSLS LLHG+R
Sbjct: 381 LKDVMASKKEFETQMEVVGKI-KHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSR 439
Query: 467 GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 526
G+GRTPLDW+ R++I + ARG+AH+H K HGNIKASN+L++ + D C+SD+GL
Sbjct: 440 GSGRTPLDWDNRMRIAITAARGLAHLHVSA--KLVHGNIKASNILLHPNQDTCVSDYGLN 497
Query: 527 PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586
L + + P+R AGY APEV+ETRK + KSDVYSFGVLLLE+LTGK+P Q+ ++ +DL
Sbjct: 498 QLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDL 557
Query: 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646
PRWV SVVREEWTAEVFDVELMR+ NIEEEMVQ+LQI MACV+ VPD RP M EV+RMIE
Sbjct: 558 PRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIE 617
Query: 647 EVRQSDSEN---RPSSEENKSKDSNVQTP 672
+V +S++ + R SS++ SK S QTP
Sbjct: 618 DVNRSETTDDGLRQSSDD-PSKGSEGQTP 645
|
|
| TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1019 (363.8 bits), Expect = 7.8e-144, Sum P(2) = 7.8e-144
Identities = 204/359 (56%), Positives = 259/359 (72%)
Query: 317 CYCLKKKDNGSNGVSKGKASS-GGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDL 375
CY +K G +S K GG S P E+F S +++ N+L FFEGC+Y+FDLEDL
Sbjct: 280 CYVRRKLRRGDGVISDNKLQKKGGMS--P-EKFVSRMEDVN-NRLSFFEGCNYSFDLEDL 335
Query: 376 LRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVP 435
LRASAEVLGKG++GT YKAVLE++T+ RDFEQQMEI+G + +H NVV
Sbjct: 336 LRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDVAAGKRDFEQQMEIIGGI-KHENVVE 394
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
L+AYYYSKDEKL+VYDYF+ GS+++LLHGNRG R PLDWETR+KI +G A+G+A IH
Sbjct: 395 LKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENRIPLDWETRMKIAIGAAKGIARIHKE 454
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP-SRSAGYRAPEVIETRKHSH 554
K HGNIK+SN+ +N + +GC+SD GLT +M+ A P SR AGYRAPEV +TRK S
Sbjct: 455 NNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLAPPISRQAGYRAPEVTDTRKSSQ 514
Query: 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614
SDVYSFGV+LLE+LTGK+P+ + D+++ L RWV SVVREEWTAEVFD+EL+R+ NIE
Sbjct: 515 LSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRWVHSVVREEWTAEVFDIELLRYTNIE 574
Query: 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV---RQS---DSENRPSSEENKSKDS 667
EEMV+MLQI M+CV K D RP M ++VR+IE V R S + E +P SE S+ S
Sbjct: 575 EEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVGNRRTSIEPEPELKPKSENGASETS 633
|
|
| TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 843 (301.8 bits), Expect = 5.0e-125, Sum P(2) = 5.0e-125
Identities = 170/328 (51%), Positives = 227/328 (69%)
Query: 324 DNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVL 383
DNG N S A++ + K G+G P KLVFF + FDLEDLLRASAEVL
Sbjct: 322 DNG-NVYSVSAAAAAAMTGNGKASEGNG---PATKKLVFFGNATKVFDLEDLLRASAEVL 377
Query: 384 GKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSK 443
GKG++GTAYKAVL+ T ++F++++E+VG + H N+VPLRAYY+S+
Sbjct: 378 GKGTFGTAYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAM-DHENLVPLRAYYFSR 436
Query: 444 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHG 503
DEKLLVYD+ GSLS LLHGNRGAGR+PL+W+ R +I +G ARG+ ++HS G +HG
Sbjct: 437 DEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQG-TSTSHG 495
Query: 504 NIKASNVLINQDLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETRKHSHKSDVYSFG 562
NIK+SN+L+ + D +SDFGL L+ AT P+R+ GYRAPEV + ++ S K DVYSFG
Sbjct: 496 NIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFG 555
Query: 563 VLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMV-QML 621
V+LLE++TGKAP S ++ VDLPRWV+SV R+EW EVFD EL+ EEEM+ +M+
Sbjct: 556 VVLLELITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMV 615
Query: 622 QIGMACVAKVPDMRPNMDEVVRMIEEVR 649
Q+G+ C ++ PD RP M EVVR +E +R
Sbjct: 616 QLGLECTSQHPDQRPEMSEVVRKMENLR 643
|
|
| TAIR|locus:2154227 AT5G53320 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 851 (304.6 bits), Expect = 4.5e-122, Sum P(2) = 4.5e-122
Identities = 172/317 (54%), Positives = 221/317 (69%)
Query: 334 KASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYK 393
+ SS + K +++ V E + NK+VFFEG + FDLEDLLRASAEVLGKG +GT YK
Sbjct: 266 RRSSKDKPSKRRKDSDPNVGEGD-NKIVFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYK 324
Query: 394 AVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453
LE+S T R+FEQQ+E +G + +H NV LR Y+YSKDEKL+VYDY+
Sbjct: 325 VDLEDSATIVVKRIKEVSVPQREFEQQIENIGSI-KHENVATLRGYFYSKDEKLVVYDYY 383
Query: 454 ASGSLSTLLHGNRGA-GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 512
GSLSTLLHG +G R L+WETR+ ++ GTARGVAHIHS G K HGNIK+SN+ +
Sbjct: 384 EHGSLSTLLHGQKGLRDRKRLEWETRLNMVYGTARGVAHIHSQSGGKLVHGNIKSSNIFL 443
Query: 513 NQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 572
N GCIS G+ LM+ + P + GYRAPE+ +TRK + SDVYSFG+L+ E+LTGK
Sbjct: 444 NGKGYGCISGTGMATLMH--SLPRHAVGYRAPEITDTRKGTQPSDVYSFGILIFEVLTGK 501
Query: 573 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 632
+ ++ +L RWV SVVREEWT EVFD EL+R +EEEMV+MLQ+GM C A++P
Sbjct: 502 S--------EVANLVRWVNSVVREEWTGEVFDEELLRCTQVEEEMVEMLQVGMVCTARLP 553
Query: 633 DMRPNMDEVVRMIEEVR 649
+ RPNM EVVRM+EE+R
Sbjct: 554 EKRPNMIEVVRMVEEIR 570
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 875 (313.1 bits), Expect = 7.4e-122, Sum P(2) = 7.4e-122
Identities = 181/321 (56%), Positives = 234/321 (72%)
Query: 353 QEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXX 412
Q +K K+VFFEG + F+LEDLLRASAE+LGKG +GTAYKAVLE+
Sbjct: 339 QVGDKGKMVFFEG-TRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVT 397
Query: 413 XX--RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR 470
++FEQQME++GR+ +H N+V L+AYY++++EKLLVYDY +GSL LLHGNRG GR
Sbjct: 398 VAGKKEFEQQMEVLGRL-RHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGR 456
Query: 471 TPLDWETRVKILLGTARGVAHIH-SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529
TPLDW TR+KI G ARG+A IH S K THG+IK++NVL+++ + +SDFGL+ +
Sbjct: 457 TPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLS-IF 515
Query: 530 NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP--LQSPTRDDMVDLP 587
T ++S GYRAPE+I+ RKH+ KSDVYSFGVLLLE+LTGK P +++ VDLP
Sbjct: 516 APSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLP 575
Query: 588 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647
RWVQSVVREEWTAEVFD+ELMR+++IEEEMV +LQI MAC A D RP M VV++IE+
Sbjct: 576 RWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIED 635
Query: 648 VRQSDSENRPSSEE-NKSKDS 667
+R SE P ++ N + DS
Sbjct: 636 IRGGGSEASPCNDGINSAVDS 656
|
|
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 832 (297.9 bits), Expect = 5.9e-120, Sum P(2) = 5.9e-120
Identities = 167/300 (55%), Positives = 215/300 (71%)
Query: 359 KLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFE 418
KLVFF + FDLEDLLRASAEVLGKG++GTAYKAVL+ T R+F+
Sbjct: 347 KLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKDVTMADREFK 406
Query: 419 QQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR 478
+++E+VG + H N+VPLRAYYYS DEKLLVYD+ GSLS LLHGN+GAGR PL+WE R
Sbjct: 407 EKIEVVGAM-DHENLVPLRAYYYSGDEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVR 465
Query: 479 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-PSR 537
I LG ARG+ ++HS P +HGN+K+SN+L+ D +SDFGL L++ +T P+R
Sbjct: 466 SGIALGAARGLDYLHSQD-PLSSHGNVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNR 524
Query: 538 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 597
+ GYRAPEV + R+ S K+DVYSFGV+LLE+LTGKAP S ++ +DL RWV SV REE
Sbjct: 525 ATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGMDLARWVHSVAREE 584
Query: 598 WTAEVFDVELMRFQ---NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654
W EVFD ELM + ++EEEM +MLQ+G+ C + PD RP M EVVR I+E+RQS ++
Sbjct: 585 WRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELRQSGAD 644
|
|
| TAIR|locus:2024517 AT1G64210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 781 (280.0 bits), Expect = 5.9e-120, Sum P(2) = 5.9e-120
Identities = 160/336 (47%), Positives = 221/336 (65%)
Query: 326 GSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGK 385
G +S GK S P E K++FF G ++ FDL+DLL +SAEVLGK
Sbjct: 257 GKTRIS-GKLRKRDSSSPPGNWTSRDDNTEEGGKIIFFGGRNHLFDLDDLLSSSAEVLGK 315
Query: 386 GSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE 445
G++GT YK +E+ +T R+FEQQMEI+G + +H NV L+AYYYSKD+
Sbjct: 316 GAFGTTYKVTMEDMSTVVVKRLKEVVVGRREFEQQMEIIGMI-RHENVAELKAYYYSKDD 374
Query: 446 KLLVYDYFASGSLSTLLHGNRGA-GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 504
KL VY Y+ GSL +LHGNRG R PLDW+ R++I G ARG+A IH G KF HGN
Sbjct: 375 KLAVYSYYNHGSLFEILHGNRGRYHRVPLDWDARLRIATGAARGLAKIHE-G--KFIHGN 431
Query: 505 IKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 563
IK+SN+ ++ GCI D GLT +M ++P T ++GY APE+ +TR+ + SDVYSFGV
Sbjct: 432 IKSSNIFLDSQCYGCIGDVGLTTIMRSLPQTTCLTSGYHAPEITDTRRSTQFSDVYSFGV 491
Query: 564 LLLEMLTGKAPLQS----PTRDDMVDLPRWVQSVVREEWTAEVFDVELM-RFQNIEEEMV 618
+LLE+LTGK+P+ PT + +DL W++SVV +EWT EVFD+E++ + EEEMV
Sbjct: 492 VLLELLTGKSPVSQAELVPTGGENMDLASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMV 551
Query: 619 QMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654
+MLQIG+ACVA RP++ +V+++IE++R D+E
Sbjct: 552 EMLQIGLACVALKQQERPHIAQVLKLIEDIRSVDAE 587
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LVM0 | Y5830_ARATH | No assigned EC number | 0.7097 | 0.9181 | 0.9434 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_XIX2581 | hypothetical protein (636 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 672 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-39 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-33 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-11 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 4e-43
Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQ-MEI-VGRVGQHPNVVPLR 437
LG GS+GT YKA V VK LK+ + + EI + R HPN+V L
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ KD LV +Y G L L PL + KI L RG+ ++HS G
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVI-ETRKH 552
H ++K N+L++++ I+DFGL + ++ + Y APEV+ +
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 553 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 583
K DV+S GV+L E+LTGK P D
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQ 207
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 3e-42
Identities = 161/608 (26%), Positives = 251/608 (41%), Gaps = 125/608 (20%)
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 170
+RL G +P+ KL + L + +N L G + S +PSL+ L L N F G
Sbjct: 409 VRLQDNSFSGELPSE-FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467
Query: 171 IPSSF-SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRH 227
+P SF S +L LDLS N F+G +P+ + +L++L L L N LSG IP+ KL
Sbjct: 468 LPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS 527
Query: 228 LNLSYNGLKGSIPSSLQKFP---------------------------------------- 247
L+LS+N L G IP+S + P
Sbjct: 528 LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587
Query: 248 ---------NSSFV-GNSLLCG----PPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLG 293
N+S V GN LCG L C V +PS +
Sbjct: 588 PSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWF----------------- 630
Query: 294 LGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQ 353
I +G VL LVA + ++ ++N E + E G
Sbjct: 631 ---YITCTLGAFLVLALVAFGFV--FIRGRNN---------------LELKRVENEDGTW 670
Query: 354 EPEKNKLVFFEG-CSYNFDLEDLLRASAE--VLGKGSYGTAYKA-VLEESTTVVVKRLKE 409
E L FF+ S + + D+L + E V+ +G G +YK ++ VVK + +
Sbjct: 671 E-----LQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIND 725
Query: 410 VVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG 469
V M QHPN+V L S+ L+++Y +LS +L
Sbjct: 726 VNSIPSSEIADM----GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----- 776
Query: 470 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPL 528
L WE R KI +G A+ + +H P GN+ ++I+ +D L L
Sbjct: 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR--LSLPGL 831
Query: 529 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP--LQSPTRDDMVDL 586
+ S+ Y APE ET+ + KSD+Y FG++L+E+LTGK+P + +V+
Sbjct: 832 LCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891
Query: 587 PRWVQSVVR-EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645
R+ S + W ++ QN E+V+++ + + C A P RP ++V++ +
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQN---EIVEVMNLALHCTATDPTARPCANDVLKTL 948
Query: 646 EEVRQSDS 653
E +S S
Sbjct: 949 ESASRSSS 956
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-39
Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 17/195 (8%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
LG+G +GT Y A + V +K +K + + +++EI+ ++ HPN+V L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+ ++ LV +Y GSL LL N G L + ++ILL G+ ++HS G
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLHSNG--- 112
Query: 500 FTHGNIKASNVLINQDLDGC-ISDFGL----TPLMNVPATPSRSAGYRAPEVIETR-KHS 553
H ++K N+L++ D ++DFGL T ++ T + Y APEV+ + +S
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 554 HKSDVYSFGVLLLEM 568
KSD++S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 6e-39
Identities = 79/287 (27%), Positives = 132/287 (45%), Gaps = 46/287 (16%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVV 434
+ LG+G++G YK L ++T V VK LKE ++DF ++ ++ ++G HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVV 59
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA----GRTPLDWETRVKILLGTARGVA 490
L ++ LV +Y G L L +R ++ L + + + A+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------AP 544
++ S KF H ++ A N L+ +DL ISDFGL+ + + G + AP
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 545 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 599
E ++ + KSDV+SFGVLL E+ T G P P + ++ +++ R E
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY--PGLSN-EEVLEYLRKGYRLPKPEYCP 233
Query: 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646
E++++ ML C P+ RP E+V +E
Sbjct: 234 DELYEL--------------MLS----CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 63/270 (23%), Positives = 119/270 (44%), Gaps = 29/270 (10%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
E LG+GS+G Y A + V +K +K ++ + ++++I+ ++ +HPN+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNIVRLY 63
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ +D+ LV +Y G L LL L + L + ++HS G
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFYLRQILSALEYLHSKG- 117
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHSH 554
H ++K N+L+++D ++DFGL ++ + G Y APEV+ + +
Sbjct: 118 --IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614
D++S GV+L E+LTGK P L + + + + +I
Sbjct: 176 AVDIWSLGVILYELLTGKPPF-----PGDDQLLELFKKIGKPKPP------FPPPEWDIS 224
Query: 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644
E +++ + K P+ R +E ++
Sbjct: 225 PEAKDLIR---KLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 78/286 (27%), Positives = 128/286 (44%), Gaps = 53/286 (18%)
Query: 381 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 433
+ LG+G++G YK L T V VK LKE + +F ++ I+ ++ HPN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
V L + +V +Y G L L + L + +++ L A+G+ ++
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLE 119
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGYR-----APEVI 547
S F H ++ A N L+ ++L ISDFGL+ + R G APE +
Sbjct: 120 SK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 548 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-------LPRWVQSVVREEWT 599
+ K + KSDV+SFGVLL E+ T G+ P + +++++ LPR E
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR------PENCP 230
Query: 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645
E++++ MLQ C A P+ RP E+V +
Sbjct: 231 DELYEL--------------MLQ----CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 55/287 (19%)
Query: 381 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNV 433
+ LG+G++G YK L + V VK LKE +F ++ I+ ++ HPN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
V L ++ ++V +Y G L L NR L + L ARG+ ++
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE 120
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-----------PLMNVPATPSRSAGYR 542
S F H ++ A N L+ ++L ISDFGL+ +P R
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP--------IR 169
Query: 543 --APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599
APE ++ K + KSDV+SFGVLL E+ T G+ P ++ +++ R
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP---YPGMSNAEVLEYLKKGYR---- 222
Query: 600 AEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMI 645
L + N E+ + MLQ C A+ P+ RP E+V ++
Sbjct: 223 -------LPKPPNCPPELYKLMLQ----CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 80/287 (27%), Positives = 128/287 (44%), Gaps = 56/287 (19%)
Query: 381 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 433
+ LG+G++G YK L+ + V VK LKE + +F ++ I+ ++ HPNV
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
V L ++ +V +Y G L + L NR L + L ARG+ ++
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEYLE 119
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-----------PLMNVPATPSRSAGYR 542
S F H ++ A N L+ ++L ISDFGL+ +P R
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP--------IR 168
Query: 543 --APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599
APE ++ K + KSDV+SFGVLL E+ T G+ P ++ ++++ R
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEVLEYLKNGYR---- 221
Query: 600 AEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMI 645
L + N E+ MLQ C A+ P+ RP E+V ++
Sbjct: 222 -------LPQPPNCPPELYDLMLQ----CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-27
Identities = 72/201 (35%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 56 LLPLAFADLNSDR-QALLDFA----DAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFG 110
L L F+ L+++ + LL F D + +L NW+S+ +C W GI C + +RV
Sbjct: 18 FLFLNFSMLHAEELELLLSFKSSINDPLKYLS--NWNSSADVCL-WQGITCN-NSSRVVS 73
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSG 169
+ L G + G I + L ++ ++L +N L+G +P +I T+ SLRYL L +NNF+G
Sbjct: 74 IDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132
Query: 170 KIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRH 227
IP P L LDLS N +G IP I + + L L L N L G IPN ++ L
Sbjct: 133 SIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEF 192
Query: 228 LNLSYNGLKGSIPSSLQKFPN 248
L L+ N L G IP L + +
Sbjct: 193 LTLASNQLVGQIPRELGQMKS 213
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 43/217 (19%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 435
E+LG+GS+G+ Y A+ +++ ++ +K V + E+ + + QHPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMA--VKSVELSGDSEEELEALEREIRILSSLQHPNIV- 62
Query: 436 LRAYYYSKDEK----LLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGT 485
YY S+ ++ L ++ +Y + GSLS+LL G+ P E ++ IL
Sbjct: 63 --RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF---GKLP---EPVIRKYTRQIL--- 111
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGL------TPLMNVPATPSR 537
G+A++HS G H +IK +N+L+ D DG ++DFG +
Sbjct: 112 -EGLAYLHSNG---IVHRDIKGANILV--DSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 538 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ + APEVI ++ +D++S G ++EM TGK P
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 381 EVLGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
E +GKG +G YKA V +K +K K++ + + +HPN+V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
Y KDE +V ++ + GSL LL L + +G+ ++HS G
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQ----TLTESQIAYVCKELLKGLEYLHSNG--- 118
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIETRKHSH 554
H +IKA+N+L+ D + + DFGL+ ++ T +R + + APEVI + + +
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 555 KSDVYSFGVLLLEMLTGKAPL 575
K+D++S G+ +E+ GK P
Sbjct: 177 KADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (277), Expect = 3e-26
Identities = 68/280 (24%), Positives = 114/280 (40%), Gaps = 30/280 (10%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVPL 436
LG+GS+G Y A + V +K L + + K F ++++I+ + PN+V L
Sbjct: 6 RKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
++ + LV +Y GSL LL G + IL + ++HS G
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE--ALFILAQILSALEYLHSKG 121
Query: 497 GPKFTHGNIKASNVLINQDLDGC-ISDFGL----------TPLMNVPATPSRSAGYRAPE 545
H +IK N+L+++D + DFGL + + +P+T + GY APE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 546 VIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602
V+ S SD++S G+ L E+LTG P + ++ E T +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ---TLKIILELPTPSL 235
Query: 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 642
+ N E + +AK P R + +
Sbjct: 236 A--SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-24
Identities = 64/142 (45%), Positives = 82/142 (57%), Gaps = 5/142 (3%)
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 170
L L G LVG IPN +L L +LE L+L SN L G +P E+ + SL+++YL +NN SG+
Sbjct: 169 LDLGGNVLVGKIPN-SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227
Query: 171 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLR 226
IP L LDL +N+ TG IP S+ NL L L L N LSG IP F + KL
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLI 287
Query: 227 HLNLSYNGLKGSIPSSLQKFPN 248
L+LS N L G IP + + N
Sbjct: 288 SLDLSDNSLSGEIPELVIQLQN 309
|
Length = 968 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 22/204 (10%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRAY 439
E LG+GSYG+ YKA+ +E+ VV +K V V + E EI + + P +V
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVA--IKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
Y+ + +V +Y +GS+S ++ + +T L E IL T +G+ ++HS K
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIM---KITNKT-LTEEEIAAILYQTLKGLEYLHSN---K 119
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLTPLMN--------VPATPSRSAGYRAPEVIETRK 551
H +IKA N+L+N++ ++DFG++ + V TP + APEVI+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF----WMAPEVIQEIG 175
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPL 575
+++K+D++S G+ +EM GK P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 435
+++G+G++G YK + E+ V +K++ + K E I+ + +HPN+V
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVA--IKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 494
+ D ++ +Y +GSL ++ G P E+ V + + +G+A++H
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKF---GPFP---ESLVAVYVYQVLQGLAYLHE 117
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPATPSRSAG---YRAPEVIETR 550
G H +IKA+N+L +D ++DFG+ T L +V + G + APEVIE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 551 KHSHKSDVYSFGVLLLEMLTGKAP 574
S SD++S G ++E+LTG P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 3e-23
Identities = 59/284 (20%), Positives = 127/284 (44%), Gaps = 52/284 (18%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRL-------KEVVVGKRDFEQQMEIVGRVGQHPN 432
+ +GKGS+G Y + V+K + KE + D +++I+ ++ HPN
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE----REDALNEVKILKKL-NHPN 60
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
++ + K + +V +Y G LS + + P E + + + ++
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--------VPATPSRSAGYRAP 544
HS K H +IK N+ + + + DFG++ +++ V TP Y +P
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPY----YLSP 172
Query: 545 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA--EV 602
E+ + + +++KSD++S G +L E+ T K P + +++++L +++ ++
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG---ENLLEL---ALKILKGQYPPIPSQ 226
Query: 603 FDVELMRFQNIEEEMV-QMLQIGMACVAKVPDMRPNMDEVVRMI 645
+ EL +V +LQ K P+ RP++ ++++
Sbjct: 227 YSSEL-------RNLVSSLLQ-------KDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 79/279 (28%), Positives = 123/279 (44%), Gaps = 38/279 (13%)
Query: 373 EDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEV-VVGKRDFEQQ----MEIVGRV 427
DL R VLG+GS G YK + + + LK++ V G +F +Q ++ + R
Sbjct: 1 SDLERVK--VLGQGSSGVVYKVRHKPTGKIYA--LKKIHVDGDEEFRKQLLRELKTL-RS 55
Query: 428 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 487
+ P VV +Y + E +V +Y GSL+ LL L + R +IL G
Sbjct: 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QILKG--- 111
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFG----LTPLMNVPATPSRSAGY 541
+ ++H+ H +IK SN+LIN G I+DFG L ++ T + Y
Sbjct: 112 -LDYLHTK--RHIIHRDIKPSNLLINSK--GEVKIADFGISKVLENTLDQCNTFVGTVTY 166
Query: 542 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601
+PE I+ +S+ +D++S G+ LLE GK P P + +L + + AE
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE 226
Query: 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 640
F E F + AC+ K P RP+ E
Sbjct: 227 EFSPEFRDFIS-------------ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 434
+V+G G +G + L ++ V +K LK K DF + I+G+ HPN++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNII 68
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
L +++ +Y +GSL L N G V +L G A G+ ++
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSE 124
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG-----YRAPEVIE 548
M + H ++ A N+L+N +L +SDFGL+ L + AT + G + APE I
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 549 TRKHSHKSDVYSFGVLLLEMLT-GKAP 574
RK + SDV+SFG+++ E+++ G+ P
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 30/219 (13%)
Query: 383 LGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQME---IVGRVGQHPNVVPLR 437
LGKGS+G +++ + +K L K+ ++ +++ E + I+ R+ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKL- 58
Query: 438 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAH 491
Y + +EKL LV +Y G L + L GR E R + I+L + +
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS---EERARFYAAEIVLA----LEY 108
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPA---TPSRSAGYRAPEVI 547
+HS+G + ++K N+L++ D ++DFGL L + + T + Y APEV+
Sbjct: 109 LHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL 165
Query: 548 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586
+ + D +S GVLL EMLTGK P + R ++ +
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK 204
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 51/297 (17%)
Query: 383 LGKGSYGTAYKAVLE---ESTT--VVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVVP 435
LG+G +G + ++T V VK L + DFE+++EI+ + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVK 70
Query: 436 LRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+ + L+ +Y SGSL L +R ++ + + +G+ ++
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG 126
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-------APEV 546
S ++ H ++ A N+L+ + ISDFGL ++ APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606
+ T K S SDV+SFGV L E+ T P QSP + + +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-------------------MIG 224
Query: 607 LMRFQNIEEEMVQMLQIG--MACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 661
+ + Q I ++++L+ G + P DEV +++ +++ ++RPS +
Sbjct: 225 IAQGQMIVTRLLELLKEGERLPRPPSCP------DEVYDLMKLCWEAEPQDRPSFAD 275
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 69/267 (25%), Positives = 119/267 (44%), Gaps = 32/267 (11%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLR 437
LGKGSYG+ YK LKEV +G +++ + V + HPN++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYA--LKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ ++ +V +Y G LS + R R + + +I + RG+ +H
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-- 122
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIETRKHSHK 555
K H ++K++N+L+ + I D G++ ++ N+ T + Y APEV + R +S+K
Sbjct: 123 -KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYK 181
Query: 556 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 615
SD++S G LL EM T P ++ M DL VQ ++ I
Sbjct: 182 SDIWSLGCLLYEMATFAPPFEA---RSMQDLRYKVQR---------------GKYPPIPP 223
Query: 616 EMVQ-MLQIGMACVAKVPDMRPNMDEV 641
Q + + + P +RPN D++
Sbjct: 224 IYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 6e-20
Identities = 59/151 (39%), Positives = 77/151 (50%), Gaps = 5/151 (3%)
Query: 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 165
++ L L L G IP + +L LE+L L SN TG +P +TSLP L+ L L N
Sbjct: 284 QKLISLDLSDNSLSGEIPE-LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 166 NFSGKIPSSFSPQ--LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--D 221
FSG+IP + L VLDLS N+ TG IP+ + + L L L SN+L G IP
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 222 IPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252
LR + L N G +PS K P F+
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433
|
Length = 968 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 77/290 (26%), Positives = 131/290 (45%), Gaps = 57/290 (19%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
EV+G+G+YG YKA +++ +V +K + + + + +++ I+ + HPN+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 440 YYSK------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+ K D+ LV + GS++ L+ G R G+ L E IL T RG+A++H
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGLAYLH 130
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------A 543
K H +IK N+L+ ++ + + DFG V A + G R A
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFG------VSAQLDSTLGRRNTFIGTPYWMA 181
Query: 544 PEVI-----ETRKHSHKSDVYSFGVLLLEMLTGKAPL--QSPTRDDMVDLPRWVQSVVR- 595
PEVI + +SDV+S G+ +E+ GK PL P R + +PR ++
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRNPPPTLKS 240
Query: 596 -EEWTAEVFDVELMRFQN-IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
E W+ + F + I E C+ K + RP M+E++
Sbjct: 241 PENWSKK--------FNDFISE-----------CLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+GKG +G V VK LK+ + F + ++ + +HPN+V L
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVV 69
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
+ +V +Y A GSL L R GR + ++ L G+ ++ F
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-SAGYRAPEVIETRKHSHKSDVY 559
H ++ A NVL+++DL +SDFGL + + + APE + +K S KSDV+
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 560 SFGVLLLEMLT-GKAP 574
SFG+LL E+ + G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442
+G G +G + E V +K ++E + + DF ++ +++ ++ HP +V L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTE 70
Query: 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 502
+ LV+++ G LS L RG ET + + L G+A++ S H
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLES---SNVIH 123
Query: 503 GNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAGY----RAPEVIETRKHSHKSD 557
++ A N L+ ++ +SDFG+T ++ T S + +PEV K+S KSD
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 558 VYSFGVLLLEMLT-GKAPLQSPTRDDMVD 585
V+SFGVL+ E+ + GK P ++ + ++V+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVE 212
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 52/281 (18%)
Query: 382 VLGKGSYGTA--YKAVLEESTTVVVK-----RLKEVVVGKRDFEQQMEIVGRVGQHPNVV 434
VLGKG++G A Y+ E+ + VV K RL E +RD ++ I+ + QHPN++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEK--ERRDALNEIVILSLL-QHPNII 62
Query: 435 PLRAYY--YSKDEKLLV-YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 491
AYY + D LL+ +Y G+L + +G + E + L V++
Sbjct: 63 ---AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSY 116
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--------VPATPSRSAGYRA 543
IH G H +IK N+ + + + DFG++ ++ V TP Y +
Sbjct: 117 IHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY----YMS 169
Query: 544 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603
PE+ + K++ KSD+++ G +L E+LT K D + V +V+ +T V
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTF------DATNPLNLVVKIVQGNYTPVV- 222
Query: 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644
E++ ++ + + + P+ RP DEV+
Sbjct: 223 -------SVYSSELISLVH---SLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442
LG G +G + +T V VK LK + F Q+ +I+ ++ +H +V L A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSE 72
Query: 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 502
++ +V +Y + GSL L G G+ L V + A G+A++ S + H
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKS--GEGKK-LRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 503 GNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAGY----RAPEVIETRKHSHKSD 557
++ A N+L+ ++L I+DFGL L + T A + APE + + KSD
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 558 VYSFGVLLLEMLT-GKAP 574
V+SFG+LL E++T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 435
+GKGS+G +K V + V +K++ + K + ++ E + ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYA--MKQIDLSKMNRREREEAIDEARVLAKLDSSYII- 62
Query: 436 LRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLD--WETRVKILLGTARGVA 490
YY S KL +V +Y +G L LL RG P D W ++ILLG +A
Sbjct: 63 --RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLG----LA 115
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEV 546
H+HS K H +IK+ N+ ++ + I D G L+ N T + Y +PE+
Sbjct: 116 HLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAP 574
E + ++ KSDV++ GV+L E TGK P
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 70/245 (28%), Positives = 117/245 (47%), Gaps = 22/245 (8%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442
LG G +G + ST V VK LK + + F ++ ++ + QH +V L A
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLM-KTLQHDKLVRLYAVVTK 72
Query: 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPL----DWETRVKILLGTARGVAHIHSMGGP 498
++ ++ +Y A GSL L + G G+ L D+ ++ A G+A+I
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQI------AEGMAYIER---K 122
Query: 499 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 553
+ H +++A+NVL+++ L I+DFGL ++ +R + APE I +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 554 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDD-MVDLPRWVQSVVREEWTAEVFDVELMRFQ 611
KSDV+SFG+LL E++T GK P + D M L R + E E++D+ ++
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWK 242
Query: 612 NIEEE 616
EE
Sbjct: 243 EKAEE 247
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442
LG G +G ++ + +T V VK LK + +DF + +I+ ++ +HP ++ L A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTL 72
Query: 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 502
++ +V + GSL L G GAGR L + + A G+A++ + + H
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQG--GAGRA-LKLPQLIDMAAQVASGMAYLEAQ---NYIH 126
Query: 503 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 557
++ A NVL+ ++ ++DFGL ++ +R + APE + S KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 558 VYSFGVLLLEMLT-GKAP 574
V+SFG+LL E++T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 62/234 (26%), Positives = 95/234 (40%), Gaps = 35/234 (14%)
Query: 385 KGSYGTAYKA------------VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN 432
KG++G+ Y A VL++S + ++ V + Q G+ P
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQ-------GESPY 58
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
V L + SKD LV +Y G ++L+ + G P DW + + GV +
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDL 113
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKH 552
H G H +IK N+LI+Q ++DFGL+ + Y APE I
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGD 170
Query: 553 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--LPRWVQSVVREEWTAEVFD 604
SD +S G ++ E L G P + T D + D L R + W EV +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN------WPEEVKE 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 37/214 (17%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 437
+ +G G+YG YKA + V +K +K + DFE Q EI + + +HPN+V
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHPNIV--- 63
Query: 438 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
AY+ Y + +KL +V +Y GSL + RG PL + T +G+A++H
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHE 119
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------AP 544
G H +IK +N+L+ +D D ++DFG V A + + R AP
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFG------VSAQLTATIAKRKSFIGTPYWMAP 170
Query: 545 EVIETRKHS---HKSDVYSFGVLLLEMLTGKAPL 575
EV + K D+++ G+ +E+ + P+
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-18
Identities = 60/221 (27%), Positives = 111/221 (50%), Gaps = 24/221 (10%)
Query: 381 EVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 434
EV+G G +G + L+ V +K LK K RDF + I+G+ HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNII 68
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
L +++ ++ +G+L + L N G T + V +L G A G+ ++
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQL---VGMLRGIAAGMKYLSE 124
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG--------YRAPE 545
M + H ++ A N+L+N +L +SDFGL+ L + + P+ ++ + APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 585
I RK + SDV+S+G+++ E+++ G+ P + D+++
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-17
Identities = 52/144 (36%), Positives = 72/144 (50%), Gaps = 6/144 (4%)
Query: 104 DRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQ 163
+F L L L G IP +LG +L + L+ N +G LPSE T LP + +L +
Sbjct: 378 SSGNLFKLILFSNSLEGEIPK-SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 164 HNNFSGKIPSSF--SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-- 219
+NN G+I S P L +L L+ N F G +P S + +L L L N SG++P
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKL 495
Query: 220 FDIPKLRHLNLSYNGLKGSIPSSL 243
+ +L L LS N L G IP L
Sbjct: 496 GSLSELMQLKLSENKLSGEIPDEL 519
|
Length = 968 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 57/208 (27%), Positives = 107/208 (51%), Gaps = 22/208 (10%)
Query: 381 EVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVV 434
+V+G G +G ++ +L+ + V +K LK K+ DF + I+G+ H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH-NII 69
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
L +++ +Y +G+L L + G + V +L G A G+ ++
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQL---VGMLRGIAAGMKYLSD 125
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAG-----YRAPEVI 547
M + H ++ A N+L+N +L+ +SDFGL+ ++ + T + S G + APE I
Sbjct: 126 M---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 548 ETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
RK + SDV+SFG+++ E+++ G+ P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 381 EVLGKGSYGTAY---KAVLEESTTV-VVKRLKEVVVGKRD-FEQQME--IVGRVGQHPNV 433
+VLG+GS+G + K ++ + +K LK+ + RD +ME I+ V HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFI 60
Query: 434 VPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAH 491
V L Y + + KL L+ D+ G L T L + + E VK L A + H
Sbjct: 61 VKLH-YAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDH 113
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT--PLMNVPATPS--RSAGYRAPEVI 547
+HS+G + ++K N+L++++ ++DFGL+ + + S + Y APEV+
Sbjct: 114 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170
Query: 548 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586
R H+ +D +SFGVL+ EMLTG P Q R + + +
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 32/220 (14%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPN 432
LG+G++G + + V VK LKE ++DFE++ E++ QH N
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHEN 69
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HG-------NRGAGRTPLDWETRVKILL 483
+V D ++V++Y G L+ L HG + + L ++I +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-RSAGYR 542
A G+ + + F H ++ N L+ DL I DFG++ +V T R G+
Sbjct: 130 QIASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMS--RDVYTTDYYRVGGHT 184
Query: 543 -------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
PE I RK + +SDV+SFGV+L E+ T GK P
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 79/288 (27%), Positives = 134/288 (46%), Gaps = 46/288 (15%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 432
+ LG+G++G KA E++TV VK LK+ K D +ME++ +G+H N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--------RTPLDWETRVKIL-- 482
++ L + +V +Y A G+L L R G R P + T+ ++
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 483 -LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG 540
ARG+ + S K H ++ A NVL+ +D I+DFGL + ++ + G
Sbjct: 138 AYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 541 -----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 594
+ APE + R ++H+SDV+SFGVLL E+ T G +P +++ L +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL-------L 247
Query: 595 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 642
+E + E + QN +E+ ++ C +VP RP ++V
Sbjct: 248 KEGYRME-------KPQNCTQELYHLM---RDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-17
Identities = 70/235 (29%), Positives = 98/235 (41%), Gaps = 70/235 (29%)
Query: 96 WVGINCTQDRTR----VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI 151
W G +C D T+ + GL L GL G IPN + KL L+ ++L N + G +P +
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSL 462
Query: 152 TSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 211
S+ SL VLDLS+NSF G+IP+S+ LT L L+L N
Sbjct: 463 GSITSL----------------------EVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500
Query: 212 NLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCG-PPLKACFPVAP 270
+LSG +P G F +F N+ LCG P L+AC P
Sbjct: 501 SLSGRVP---------------AALGGRLLHRASF---NFTDNAGLCGIPGLRACGP--- 539
Query: 271 SPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDN 325
L +GA I IA G S L + + +C+ K++ N
Sbjct: 540 --------------------HLSVGAKIGIAFGVSVAFLFLVICAMCWW-KRRQN 573
|
Length = 623 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 382 VLGKGSYGTAYKAV---LEESTT--VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVV 434
VLG G++GT YK V E V +K L+E ++ + ++ V HP+VV
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVV 72
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHI 492
L S + L+ G L + ++ + L+W ++ A+G++++
Sbjct: 73 RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------APEV 546
H ++ A NVL+ I+DFGL L++V + G + A E
Sbjct: 126 EEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 547 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS-PTRD 581
I R ++HKSDV+S+GV + E++T G P + P +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 382 VLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVVP 435
V+G G +G L+ V +K LK K RDF + I+G+ HPN++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIH 69
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
L ++V +Y +GSL L + G V +L G A G+ ++ M
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ----FTVIQLVGMLRGIASGMKYLSDM 125
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVIE 548
G + H ++ A N+L+N +L +SDFGL+ ++ + P + G + APE I
Sbjct: 126 G---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 549 TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 584
RK + SDV+S+G+++ E+++ G+ P + D++
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 40/218 (18%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ---QMEIVGRVGQ------H 430
EV+G G+ Y A+ L + V +KR+ D E+ ++ + + Q H
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI--------DLEKCQTSVDELRKEVQAMSQCNH 58
Query: 431 PNVVPLRAYYYS---KDEKLLVYDYFASGSLSTLL-HGNRGAGRTPLDWETRVKILLGTA 486
PNVV YY S DE LV Y + GSL ++ G LD +L
Sbjct: 59 PNVV---KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG---LDEAIIATVLKEVL 112
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 540
+G+ ++HS G H +IKA N+L+ +D I+DFG++ + +R
Sbjct: 113 KGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 541 --YRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPL 575
+ APEV+E + K+D++SFG+ +E+ TG AP
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-16
Identities = 54/130 (41%), Positives = 71/130 (54%), Gaps = 5/130 (3%)
Query: 118 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 176
L GPIP + L L L L N L+G +P + L +L L+L NNF+GKIP + +
Sbjct: 272 LSGPIPPSIFS-LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330
Query: 177 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYN 233
P+L VL L N F+G IP+++ LT L L +NNL+G IP L L L N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390
Query: 234 GLKGSIPSSL 243
L+G IP SL
Sbjct: 391 SLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQ------- 429
E++GKG+YG Y A+ TT + +K+V + R +Q ++V +
Sbjct: 7 ELIGKGTYGRVYLAL--NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 430 --HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TA 486
H N+V + +++ + +Y GS+ + L R GR E V+
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFE---EQLVRFFTEQVL 118
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDG-C-ISDFGLTP-----LMNVPATPSR-S 538
G+A++HS G H ++KA N+L+ D DG C ISDFG++ N + S
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLV--DADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 539 AGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAP 574
+ APEVI + + +S K D++S G ++LEM G+ P
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 72/283 (25%), Positives = 119/283 (42%), Gaps = 60/283 (21%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRA 438
E +GKG++G YK VL+ +T V VK + + KR F Q+ EI+ + HPN+V L
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIG 59
Query: 439 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 498
K +V + GSL T L + + +++ L A G+ ++ S
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV----KKLLQMSLDAAAGMEYLESK--- 112
Query: 499 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---------SAGYR------- 542
H ++ A N L+ ++ ISDFG+ SR S G +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGM----------SREEEGGIYTVSDGLKQIPIKWT 162
Query: 543 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602
APE + +++ +SDV+S+G+LL E + P RE
Sbjct: 163 APEALNYGRYTSESDVWSYGILLWETFSLGD----------TPYPGMSNQQTRER----- 207
Query: 603 FDVE----LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 641
+E + Q EE+ +++ + C A P+ RP+ E+
Sbjct: 208 --IESGYRMPAPQLCPEEIYRLM---LQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 52/230 (22%), Positives = 103/230 (44%), Gaps = 41/230 (17%)
Query: 381 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVP 435
+++G+GS+ T A E + +K L + + K + + E++ R+ HP ++
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 436 LRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
L YY +DE+ L V +Y +G L + G+ LD + + ++H
Sbjct: 67 L--YYTFQDEENLYFVLEYAPNGELLQYIR-KYGS----LDEKCTRFYAAEILLALEYLH 119
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS--------------- 538
S G H ++K N+L+++D+ I+DFG +++ ++P +
Sbjct: 120 SKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 539 ---------AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579
A Y +PE++ + SD+++ G ++ +MLTGK P +
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442
LG G +G + V +K ++E + + DF ++ +++ ++ HPN+V L
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTK 70
Query: 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 502
+ +V +Y A+G L L +G T E + + + ++ S G F H
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGT----EWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 503 GNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGY----RAPEVIETRKHSHKSD 557
++ A N L+ +D +SDFGL +++ T S+ + PEV + + S KSD
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 558 VYSFGVLLLEMLT-GKAPLQSPTRDDMVD 585
V+SFGVL+ E+ + GK P + + ++V+
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEVVE 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-16
Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442
LG+G +G + +T V +K LK + F Q+ +++ ++ +H +V L A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 71
Query: 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 502
++ +V +Y + GSL L G G L V + A G+A++ M + H
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERM---NYVH 125
Query: 503 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 557
+++A+N+L+ ++L ++DFGL L+ +R + APE + + KSD
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 558 VYSFGVLLLEMLT-GKAPLQSPTRDDMVD 585
V+SFG+LL E+ T G+ P +++D
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLD 214
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 72/262 (27%), Positives = 118/262 (45%), Gaps = 53/262 (20%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 432
E LG+G++G YK L +T+V +K LKE K ++F Q+ E++ + QHPN
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPN 69
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAG------RTPLDWETRVKI 481
+V L + ++++Y A G L L H + GA ++ LD + I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRS 538
+ A G+ ++ S F H ++ A N L+ + L ISDFGL+ + + S+S
Sbjct: 130 AIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 539 ---AGYRAPEVIETRKHSHKSDVYSFGVLL-------------------LEMLTGKAPLQ 576
+ PE I K + +SD++SFGV+L +EM+ + L
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
Query: 577 SPTRDDMVDLPRWVQSVVREEW 598
P D P V +++ E W
Sbjct: 247 CP-----EDCPARVYALMIECW 263
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 31/273 (11%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+ LG G +G + T V +K LK+ + F + ++ ++ QHP +V L A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVV 70
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
+++ ++ +Y +GSL L G L + + A G+A I +
Sbjct: 71 -TQEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERK---NY 123
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 555
H +++A+N+L+++ L I+DFGL L+ +R + APE I + K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 556 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614
SDV+SFG+LL E++T G+ P T P +Q++ R + R N
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTN------PEVIQNLER--------GYRMPRPDNCP 229
Query: 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647
EE+ +++ C + P+ RP + + ++E+
Sbjct: 230 EELYELM---RLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 34/274 (12%)
Query: 371 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ---QMEIVGRV 427
DLE L LG G+ G K + + ++ + + + + +Q +++I+ +
Sbjct: 2 DLEYL-----GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC 56
Query: 428 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 487
P +V +Y+ + + +Y GSL +L GR P KI + +
Sbjct: 57 -NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPER--ILGKIAVAVLK 111
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPA-TPSRSAGYRAPE 545
G+ ++H K H ++K SN+L+N + DFG+ L+N A T ++ Y APE
Sbjct: 112 GLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE 169
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE---WTAEV 602
I+ +S KSD++S G+ L+E+ TG+ P +Q +V E +
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVNEPPPRLPSGK 228
Query: 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 636
F + F N C+ K P RP
Sbjct: 229 FSPDFQDFVN-------------LCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442
LG+G +G + +T V +K LK + F Q+ +I+ ++ +H +VPL A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVV-S 71
Query: 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 502
++ +V ++ GSL L G G+ L V + A G+A+I M + H
Sbjct: 72 EEPIYIVTEFMGKGSLLDFL--KEGDGKY-LKLPQLVDMAAQIADGMAYIERM---NYIH 125
Query: 503 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 557
+++A+N+L+ +L I+DFGL L+ +R + APE + + KSD
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 558 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 616
V+SFG+LL E++T G+ P P V V E+ + Q E
Sbjct: 186 VWSFGILLTELVTKGRVP-----------YPGMVNREVLEQVER---GYRMPCPQGCPES 231
Query: 617 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647
+ +++++ C K PD RP + + +E+
Sbjct: 232 LHELMKL---CWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 6e-16
Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 31/210 (14%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVG--RVGQHPNVVPLR 437
+ LG G++G+ Y A +E+ +V +K++K+ + E+ ++ +HPN+V L+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHIHSMG 496
+ DE V++Y G+L L+ +G P E+ ++ I+ +G+AHIH G
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKG---KPFS-ESVIRSIIYQILQGLAHIHKHG 119
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----------YRAPEV 546
F H ++K N+L++ I+DFGL A RS YRAPE+
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGL-------AREIRSRPPYTDYVSTRWYRAPEI 169
Query: 547 I-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
+ + +S D+++ G ++ E+ T + PL
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR-PL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442
LG G +G + +T V VK LK + F ++ +I+ ++ +H +V L A S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVV-S 71
Query: 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 502
++ +V +Y + GSL L G GR L V + A G+A+I M + H
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL--KDGEGRA-LKLPNLVDMAAQVAAGMAYIERM---NYIH 125
Query: 503 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 557
+++++N+L+ L I+DFGL L+ +R + APE + + KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 558 VYSFGVLLLEMLT-GKAP 574
V+SFG+LL E++T G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 61/242 (25%), Positives = 112/242 (46%), Gaps = 34/242 (14%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLK-EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 441
LG G +G ++ + + V +K LK + ++ ++DF+++++ + R+ +H +++ L A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCS 72
Query: 442 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG----TARGVAHIHSMGG 497
+ ++ + GSL L R+P V L+ A G+A++
Sbjct: 73 VGEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--ATPSRSAGYR--APEVIETRKHS 553
H ++ A N+L+ +DL ++DFGL L+ + + Y+ APE S
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 554 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL-------------PRWVQSVVREEWT 599
KSDV+SFG+LL EM T G+ P ++ D P+ + ++ E W
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWA 242
Query: 600 AE 601
AE
Sbjct: 243 AE 244
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ------MEI-VGRVGQHPNV 433
E +G+G+ G YKA KEV + K +Q EI + + +HPN+
Sbjct: 25 EKIGEGASGEVYKAT-------DRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 492
V Y DE +V +Y GSL+ ++ N ++ E ++ + +G+ ++
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF----VRMN-EPQIAYVCREVLQGLEYL 132
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA--G---YRAPEVI 547
HS H +IK+ N+L+++D ++DFG + R++ G + APEVI
Sbjct: 133 HSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSVVGTPYWMAPEVI 188
Query: 548 ETRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ + + K D++S G++ +EM G+ P
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 34/208 (16%)
Query: 383 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EIVG-RVGQHPNV 433
+G+G+YG YKA + + +V +K++K FE + EI + HPN+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK------LRFESEGIPKTALREIKLLKELNHPNI 60
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 492
+ L + K + LV+++ + L + + L E+ +K L +G+A
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDR-QRGLP-ESLIKSYLYQLLQGLAFC 114
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------SRSAGYRAPEV 546
HS G H ++K N+LIN + ++DFGL P P +R YRAPE+
Sbjct: 115 HSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR--WYRAPEL 169
Query: 547 IET-RKHSHKSDVYSFGVLLLEMLTGKA 573
+ + +S D++S G + E+L+ +
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 383 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 441
LG G YG Y+ V ++ S TV VK LKE + +F ++ ++ + +HPN+V L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT 72
Query: 442 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 501
+ ++ ++ G+L L R R ++ + + + + ++ F
Sbjct: 73 REPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 502 HGNIKASNVLINQDLDGCISDFGLTPLM-----NVPATPSRSAGYRAPEVIETRKHSHKS 556
H ++ A N L+ ++ ++DFGL+ LM A + APE + K S KS
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 557 DVYSFGVLLLEMLT-GKAP 574
DV++FGVLL E+ T G +P
Sbjct: 187 DVWAFGVLLWEIATYGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 383 LGKGSYGTAYKAV---LEEST--TVVVKRLKEVVVGK-RDFEQQMEIVGRVGQHPNVVPL 436
LGKG++G+ L+++T V VK+L+ RDFE+++EI+ + QH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEIL-KSLQHDNIVKY 70
Query: 437 RAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
+ YS + LV +Y GSL L +R K+LL ++ +
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR-------KLLLYASQICKGMEY 123
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM------NVPATPSRSAGY-RAPEVI 547
+G ++ H ++ N+L+ + I DFGLT ++ P S + APE +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 548 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 583
K S SDV+SFGV+L E+ T SP + M
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 29/228 (12%)
Query: 382 VLGKGSYGTAYKAVLEESTTV-VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNVVPL 436
VLGKGS+G A L+ + +K LK +VV+ D E M ++ +HP + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHIHS 494
+ +K+ V +Y G L + + +GR +I+ G + +H
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICG----LQFLHK 114
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETR 550
G + ++K NVL+++D I+DFG+ MN S G Y APE+++ +
Sbjct: 115 KG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 551 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--------LPRWV 590
K++ D +SFGVLL EML G++P D++ D PRW+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 383 LGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGKR-DFEQQMEIVGRVGQHPNVVP 435
LG+G++G + A ++ V VK LKE R DF+++ E++ V QH ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL-TVLQHQHIVR 71
Query: 436 LRAYYYSKDEKLLVYDYFASGSL----------STLLHGNRGAGRTPLDWETRVKILLGT 485
L+V++Y G L + +L G L + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRA-- 543
A G+ ++ S+ F H ++ N L+ Q L I DFG++ ++ +T G R
Sbjct: 132 ASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMS--RDIYSTDYYRVGGRTML 186
Query: 544 ------PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
PE I RK + +SD++SFGV+L E+ T GK P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 34/271 (12%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRLK--EVVVGK--RDFEQQMEIVGRVGQHPNVVPLR 437
+GKG + YKA+ L + V +K+++ E++ K +D ++++++ ++ HPNV+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYL 68
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
A + +E +V + +G LS ++ + R + T K + + H+HS
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQLCSALEHMHSK-- 125
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-AG---YRAPEVIETRKHS 553
+ H +IK +NV I + D GL + T + S G Y +PE I ++
Sbjct: 126 -RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 554 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT---AEVFDVELMRF 610
KSD++S G LL EM A LQSP D ++L + + + ++ A+ + EL
Sbjct: 185 FKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL--- 237
Query: 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 641
++V C+ P+ RP++ V
Sbjct: 238 ----RDLVSR------CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 7e-15
Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 62/236 (26%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-------------QQMEIVGRV 427
E LG+G+YG YKA +++ +V LK++ + + E +++
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVA--LKKIRLDNEE-EGIPSTALREISLLKEL------ 55
Query: 428 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTA 486
+HPN+V L +++ + LV++Y L L G PL +K I+
Sbjct: 56 -KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG----PLS-PNLIKSIMYQLL 108
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG---- 540
RG+A+ HS + H ++K N+LIN DG ++DFGL +R+ G
Sbjct: 109 RGLAYCHSH---RILHRDLKPQNILIN--RDGVLKLADFGL----------ARAFGIPLR 153
Query: 541 ----------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
YRAPE++ ++ +S D++S G + EM+TGK + D +
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 383 LGKGSYGTAYKAVL--------EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 432
LG+G +G A +E+ TV VK LK+ K D +ME++ +G+H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRVKI 481
++ L ++ +Y + G+L L R G + ++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG 540
ARG+ ++ S K H ++ A NVL+ ++ I+DFGL + N+ + G
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 541 -----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
+ APE + R ++H+SDV+SFGVL+ E+ T G +P
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 31/211 (14%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ---QMEIVG----RVGQHPNV 433
E++G+G+YG Y+ + VV LK + + D + Q E+ R Q PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVA--LKIINLDTPDDDVSDIQREVALLSQLRQSQPPNI 64
Query: 434 VPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
YY Y K +L ++ +Y GS+ TL+ AG P+ + I+ +
Sbjct: 65 T---KYYGSYLKGPRLWIIMEYAEGGSVRTLMK----AG--PIAEKYISVIIREVLVALK 115
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS--AG---YRAPE 545
+IH +G H +IKA+N+L+ + + DFG+ L+N + RS G + APE
Sbjct: 116 YIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ-NSSKRSTFVGTPYWMAPE 171
Query: 546 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
VI E + + K+D++S G+ + EM TG P
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 27/203 (13%)
Query: 383 LGKGSYGTAYKAVLEE----STTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVVPL 436
LG G++G+ K V V VK LK+ + GK++F ++ ++ ++ HP +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV-- 59
Query: 437 RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHS 494
R K E L LV + G L L R + +V A G+A++ S
Sbjct: 60 RLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES 113
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSRSAG-----YRAPEVI 547
F H ++ A NVL+ ISDFG++ + + + +AG + APE I
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 548 ETRKHSHKSDVYSFGVLLLEMLT 570
K S KSDV+S+GV L E +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 63/241 (26%), Positives = 111/241 (46%), Gaps = 46/241 (19%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRD-FEQQM--EI-VGRVGQHPNVVPLR 437
+G+G+YG YKA + V +K+++ + +++ F EI + + +HPN+V L+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 438 AYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHIHS 494
SK + +V++Y L+ LL + T E+++K + G+ ++HS
Sbjct: 65 EIVTSKGKGSIYMVFEYM-DHDLTGLLD-SPEVKFT----ESQIKCYMKQLLEGLQYLHS 118
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVI-- 547
G H +IK SN+LIN D ++DFGL + + YR PE++
Sbjct: 119 NG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 548 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ----------------SPTRDD---MVDLPR 588
TR + + D++S G +L E+ GK Q SPT ++ + LP
Sbjct: 176 ATR-YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234
Query: 589 W 589
+
Sbjct: 235 F 235
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 35/220 (15%)
Query: 381 EVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVP 435
+V+G+G++G +A++++ +K LKE RDF ++E++ ++G HPN++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 436 L------RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP-----------LDWETR 478
L R Y Y + +Y G+L L +R P L +
Sbjct: 68 LLGACENRGYLY------IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 479 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT--PLMNVPATPS 536
++ A G + + +F H ++ A NVL+ ++L I+DFGL+ + V T
Sbjct: 122 LQFASDVATG---MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178
Query: 537 R-SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
R + A E + ++ KSDV+SFGVLL E+++ G P
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 65/245 (26%), Positives = 119/245 (48%), Gaps = 23/245 (9%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442
LG G +G + A + T V VK +K + F + ++ + QH +V L A +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVV-T 71
Query: 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPL----DWETRVKILLGTARGVAHIHSMGGP 498
K+ ++ ++ A GSL L + G + PL D+ ++ A G+A I
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQI------AEGMAFIEQR--- 121
Query: 499 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 553
+ H +++A+N+L++ L I+DFGL ++ +R + APE I +
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 554 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV-DLPRWVQSVVREEWTAEVFDVELMRFQ 611
KSDV+SFG+LL+E++T G+ P + +++ L R + E E++++ + ++
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWK 241
Query: 612 NIEEE 616
N EE
Sbjct: 242 NRPEE 246
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 80/301 (26%), Positives = 131/301 (43%), Gaps = 55/301 (18%)
Query: 382 VLGKGSYGTAYKAVLEE------STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNV 433
LG+G +G KA TTV VK LKE RD + ++ +V HP+V
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHV 65
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRT---------------PLDWETR 478
+ L LL+ +Y GSL + L +R G + P +
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 479 VKILLGTA----RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPA 533
+ L+ A RG+ ++ M K H ++ A NVL+ + ISDFGL+ + +
Sbjct: 126 MGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 534 TPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLP 587
RS G + A E + ++ +SDV+SFGVLL E++T G P + + +L
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL- 241
Query: 588 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647
+++ R E R +N EEM ++ + C + PD RP ++ + +E+
Sbjct: 242 --LKTGYRME-----------RPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEK 285
Query: 648 V 648
+
Sbjct: 286 M 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 50/223 (22%), Positives = 97/223 (43%), Gaps = 52/223 (23%)
Query: 382 VLGKGSYGTAYKAVLEESTTVV-VKRL----KEVVVGKRDFEQQMEIVGRVGQHPNVVPL 436
+G G+YG AV + + V +K++ +++ KR ++++++ + +H N++ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHL-RHENIIGL 64
Query: 437 RAYYYSKD----EKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVA 490
+ +V + + L ++ + PL + ++ L RG+
Sbjct: 65 LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ-----PLT-DDHIQYFLYQILRGLK 117
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---------- 540
++HS H ++K SN+L+N + D I DFGL +R
Sbjct: 118 YLHSAN---VIHRDLKPSNILVNSNCDLKICDFGL----------ARGVDPDEDEKGFLT 164
Query: 541 -------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 575
YRAPE++ + K+ D++S G + E+LT K PL
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+ +GKG +G V VK +K + F + ++ ++ +H N+V L
Sbjct: 12 QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQA-FLAEASVMTQL-RHSNLVQLLGVI 68
Query: 441 YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+ L +V +Y A GSL L R GR+ L + +K L + ++
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANN 122
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGYRAPEVIETRKHSHKSDV 558
F H ++ A NVL+++D +SDFGLT + T + APE + +K S KSDV
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 559 YSFGVLLLEMLT-GKAP 574
+SFG+LL E+ + G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ--------QMEI-VGRVGQHP 431
E +GKGS+G YKA+ + + VV +K + D E+ Q EI + P
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVA--IKVI-----DLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 432 NVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 488
+ YY + K KL ++ +Y GS LL LD IL G
Sbjct: 60 YIT---KYYGSFLKGSKLWIIMEYCGGGSCLDLLK------PGKLDETYIAFILREVLLG 110
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS---AG---YR 542
+ ++H G K H +IKA+N+L++++ D ++DFG++ + +T S+ G +
Sbjct: 111 LEYLHEEG--KI-HRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRNTFVGTPFWM 165
Query: 543 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 577
APEVI+ + K+D++S G+ +E+ G+ PL
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 82/319 (25%), Positives = 138/319 (43%), Gaps = 48/319 (15%)
Query: 344 PKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV 403
P +++PE +L F E D E L E+ G GS+G Y A + T V
Sbjct: 1 PSTSRAGSLKDPEIAELFFKE------DPEKLFTDLREI-GHGSFGAVYFA-RDVRTNEV 52
Query: 404 VKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458
V K GK+ E+ +I+ V +HPN + + Y + LV +Y GS
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSA 111
Query: 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 518
S LL + PL I G +G+A++HS H +IKA N+L+ +
Sbjct: 112 SDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQV 164
Query: 519 CISDFGLTPLMNVPATPSRSAGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
++DFG + + + + + APEVI + ++ K DV+S G+ +E+ K PL
Sbjct: 165 KLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
Query: 576 QSPTRDDMVDLPRWVQ----SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKV 631
+ + M L Q ++ EW+ F+N + +C+ K+
Sbjct: 225 FN--MNAMSALYHIAQNESPTLQSNEWSD--------YFRNFVD----------SCLQKI 264
Query: 632 PDMRPNMDEVVRMIEEVRQ 650
P RP +E+++ + +R+
Sbjct: 265 PQDRPTSEELLKHMFVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 383 LGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVPL 436
+G+GS+G KA+L E+ V+K + + ++ E+ + V + HPN+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRG---AGRTPLDWETRVKILLGTARGVAHIH 493
+ + +V DY G L ++ RG LDW V+I L + H+H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW--FVQICLA----LKHVH 118
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVIET 549
K H +IK+ N+ + +D + DFG+ ++N +R+ Y +PE+ E
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 584
R +++KSD+++ G +L EM T K ++ ++V
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 30/210 (14%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGK------RDFEQQMEIVGRVGQHPNV 433
E+LG GS+G+ Y+ + L++ VK + G+ + EQ++ ++ ++ QHPN+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNI 64
Query: 434 VPLRAYYYSK--DEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
V Y ++ ++ L ++ + GSL+ LL G+ P+ +ILLG +
Sbjct: 65 V---QYLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTRQILLG----LE 116
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSR---SAGYRAPE 545
++H H +IK +N+L+ D +G + +DFG+ + + S + APE
Sbjct: 117 YLHDRN---TVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171
Query: 546 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAP 574
VI + + +D++S G +LEM TGK P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD-FEQQMEIVGRVG-----QHPNVV 434
E +GKGS+GT K + ++V KE+ G E+Q +V V +HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILV--WKEIDYGNMTEKEKQQ-LVSEVNILRELKHPNIV 62
Query: 435 PLRAYYYSKD---EKLLVY---DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 488
YY + +Y +Y G L+ L+ + R ++ E +IL
Sbjct: 63 R----YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLA 117
Query: 489 VAHIH--SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-AG---YR 542
+ H S G H ++K +N+ ++ + + + DFGL ++ ++ +++ G Y
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYM 177
Query: 543 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
+PE + + KSD++S G L+ E+ P
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 67/277 (24%), Positives = 125/277 (45%), Gaps = 38/277 (13%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLR 437
LG G+ G+ K + TV+ K K V +G + + +I+ + + P +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAK--KVVHIGAKS-SVRKQILRELQIMHECRSPYIVSFY 69
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ +++ + ++ GSL + + G P+ E KI + G+ +++++
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIY---KKGG--PIPVEILGKIAVAVVEGLTYLYNV-- 122
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN-VPATPSRSAGYRAPEVIETRKHSHK 555
+ H +IK SN+L+N + DFG++ L+N + T ++ Y +PE I+ K++ K
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 556 SDVYSFGVLLLEMLTGKAPLQSPTRDD--------MVDLPRWVQSVVREEWTAEVFDVEL 607
SDV+S G+ ++E+ GK P DD ++DL +Q +V+E
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL---LQQIVQEPPPRLPSS--- 236
Query: 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644
F + V AC+ K P RP ++ M
Sbjct: 237 -DFPEDLRDFVD------ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 73/298 (24%), Positives = 135/298 (45%), Gaps = 58/298 (19%)
Query: 381 EVLGKGSYGTAYKAVLEES---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVP 435
+V+G+G++G KA +++ +KR+KE RDF ++E++ ++G HPN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 436 L------RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP-----------LDWETR 478
L R Y Y L +Y G+L L +R P L +
Sbjct: 73 LLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 479 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT--PLMNVPATPS 536
+ ARG+ ++ +F H ++ A N+L+ ++ I+DFGL+ + V T
Sbjct: 127 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 183
Query: 537 R-SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-LPRWVQSV 593
R + A E + ++ SDV+S+GVLL E+++ G P T ++ + LP+
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----- 238
Query: 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV----RMIEE 647
L + N ++E+ +++ C + P RP+ +++ RM+EE
Sbjct: 239 ----------GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 74/303 (24%), Positives = 122/303 (40%), Gaps = 77/303 (25%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ---QMEIVGRVGQHPNVVPLRA 438
+G G++G Y AV L+ + VK ++ + ++ +M+++ + +HPN+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVK--- 63
Query: 439 YYYS---KDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWE-TRV--KILLGTARGVAH 491
YY EK+ ++ +Y + G+L LL R LD RV LL G+A+
Sbjct: 64 -YYGVEVHREKVYIFMEYCSGGTLEELLEHGR-----ILDEHVIRVYTLQLL---EGLAY 114
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSRSAG--------Y 541
+HS G H +IK +N+ + D +G I DFG + T Y
Sbjct: 115 LHSHG---IVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169
Query: 542 RAPEVIETRKHSHK---SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 598
APEVI K +D++S G ++LEM TGK P
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP------------------------ 205
Query: 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS 658
+ ++ E M +G +PD E ++ +SD + RP+
Sbjct: 206 -----------WSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPT 254
Query: 659 SEE 661
+ E
Sbjct: 255 ASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 75/300 (25%), Positives = 134/300 (44%), Gaps = 48/300 (16%)
Query: 383 LGKGSYGTAYKAVL--------EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 432
LG+G +G +A +++ TV VK LK+ K D +ME++ +G+H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRVKI 481
++ L + ++ +Y A G+L L R G L ++ V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG 540
ARG+ ++ S + H ++ A NVL+ +D I+DFGL + ++ S G
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 541 -----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 594
+ APE + R ++H+SDV+SFG+L+ E+ T G +P +++ L +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL-------L 249
Query: 595 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654
RE + + N E+ +++ C VP RP ++V +++V + SE
Sbjct: 250 REGHRMD-------KPSNCTHELYMLMR---ECWHAVPTQRPTFKQLVEALDKVLAAVSE 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 18/199 (9%)
Query: 381 EVLGKGSYGTAYKAVLEESTT---VVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
E++G+G +G AVL+ T V VK +K V + F ++ ++ ++ H N+V L
Sbjct: 12 EIIGEGEFG----AVLQGEYTGQKVAVKNIKCDVTAQA-FLEETAVMTKL-HHKNLVRLL 65
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+V + + G+L L R GR + ++ L A G+ ++ S
Sbjct: 66 GVILHNG-LYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLES--- 118
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-SAGYRAPEVIETRKHSHKS 556
K H ++ A N+L+++D +SDFGL + ++ S+ + APE ++ +K S KS
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKS 178
Query: 557 DVYSFGVLLLEMLT-GKAP 574
DV+S+GVLL E+ + G+AP
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 383 LGKGSYGTAY--------KAVLEESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 432
LG+G +G K + TV VK LK+ K D +ME++ +G+H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--------RTP---LDWETRVKI 481
++ L ++ +Y + G+L L R G + P L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG 540
ARG+ ++ S K H ++ A NVL+ +D I+DFGL + N+ + G
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 541 -----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
+ APE + R ++H+SDV+SFGVLL E+ T G +P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 64/288 (22%), Positives = 121/288 (42%), Gaps = 46/288 (15%)
Query: 382 VLGKGSYGTAYKAVLEES------TTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 433
LG+G +G + A + T V+VK L++ +F +++++ ++ H NV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNV 70
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRT----PLDWETRVKILLGTARGV 489
V L + ++ +Y G L L + PL + +V + A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT---------PLMNVPATPSRSAG 540
H+ + +F H ++ A N L++ + +S L+ L N P R
Sbjct: 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLR--- 183
Query: 541 YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599
+ APE ++ S KSDV+SFGVL+ E+ T G+ P + +++++
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN-------------R 230
Query: 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647
+ +EL + + +++ C A P RP+ E+V + E
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMT---RCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 371 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKR---LKEVVVGKRDFEQQMEIVGRV 427
D E+L E +GKGS+G +K + + VV + L+E D +Q++ ++ +
Sbjct: 1 DPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 428 GQHPNVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 484
P V YY Y KD KL ++ +Y GS LL PLD IL
Sbjct: 60 -DSPYVT---KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILRE 109
Query: 485 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG--- 540
+G+ ++HS K H +IKA+NVL+++ + ++DFG+ L + + G
Sbjct: 110 ILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 166
Query: 541 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ APEVI+ + K+D++S G+ +E+ G+ P
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 60/211 (28%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 381 EVLGKGSYGTAYKAVLEEST----TVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 434
+ LG GS+G + S V VK LK + DF ++ I+ + H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLI 59
Query: 435 PLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLD--WETRVKILLGTARGVAH 491
R Y L +V + GSL L G + + V+I A G+ +
Sbjct: 60 --RLYGVVLTHPLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQI----ANGMRY 112
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-------AP 544
+ S +F H ++ A N+L+ D I DFGL + + AP
Sbjct: 113 LES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
Query: 545 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
E + TR SH SDV+ FGV L EM T G+ P
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
E +G+G+ GT Y A+ + V +K++ K++ +V R ++PN+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
Y DE +V +Y A GSL+ ++ T +D + + + +HS +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLHS---NQ 135
Query: 500 FTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHSHK 555
H +IK+ N+L+ D ++DFG +TP + +T + + APEV+ + + K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 556 SDVYSFGVLLLEMLTGKAPL--QSPTR 580
D++S G++ +EM+ G+ P ++P R
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLR 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 64/250 (25%), Positives = 117/250 (46%), Gaps = 26/250 (10%)
Query: 381 EVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVP 435
+V+G+G++G KA +++ +KR+KE RDF ++E++ ++G HPN++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP-----------LDWETRVKILLG 484
L + L +Y G+L L +R P L + +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 485 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT--PLMNVPATPSR-SAGY 541
ARG+ ++ +F H ++ A N+L+ ++ I+DFGL+ + V T R +
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 542 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-LPRWVQSVVREEWT 599
A E + ++ SDV+S+GVLL E+++ G P T ++ + LP+ +
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237
Query: 600 AEVFDVELMR 609
EV+ +LMR
Sbjct: 238 DEVY--DLMR 245
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 61/212 (28%), Positives = 87/212 (41%), Gaps = 24/212 (11%)
Query: 382 VLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVPLRA 438
VLGKG+YG Y A L + +K + E R + E + H N+V
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 439 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA--RGVAHIHSMG 496
+ + GSLS LL G PL + I G+ ++H
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHDN- 127
Query: 497 GPKFTHGNIKASNVLINQDLDGC-ISDFG----LTPLMNVPATPSRSAGYRAPEVIE--T 549
+ H +IK NVL+N ISDFG L + T + + Y APEVI+
Sbjct: 128 --QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAP---LQSP 578
R + +D++S G ++EM TGK P L P
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPFIELGEP 217
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 27/226 (11%)
Query: 382 VLGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 436
VLGKGS+G A L+ + + VK L K+V++ D E M ++ G+HP + L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHSM 495
+ + +KD V +Y G L + H R +GR E R + G+ +H
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDL--MFHIQR-SGRFD---EPRARFYAAEIVLGLQFLHER 115
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRK 551
G + ++K NVL++ + I+DFG+ + T S G Y APE++ +
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP 172
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRW 589
+ D ++ GVLL EML G++P + D++ V PRW
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW 218
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHPN 432
E +G+G+ GT Y A+ + +T +EV + + + +QQ + +V R +HPN
Sbjct: 25 EKIGQGASGTVYTAI-DVATG------QEVAIKQMNLQQQPKKELIINEILVMRENKHPN 77
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
+V Y DE +V +Y A GSL+ ++ T +D + + + +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFL 131
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIE 548
HS H +IK+ N+L+ D ++DFG +TP + +T + + APEV+
Sbjct: 132 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ + K D++S G++ +EM+ G+ P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQME-------IVGRVGQHPN 432
+ LG G++ + Y+A ++ T + VK++ V + E+ +E ++ R+ HP+
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPH 64
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
++ + L ++ A GS+S LL G + RG++++
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYG----AFKEAVIINYTEQLLRGLSYL 119
Query: 493 HSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVPATPSR--------SAGY 541
H + H ++K +N+LI+ Q L I+DFG + T + + +
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 542 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
APEV+ ++ DV+S G +++EM T K P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNVVP 435
+VLGKGS+G A L+ + VK LK +VV+ D E M ++ ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHIH 493
L + +K+ V ++ G L + H + GR L T +I+ G + +H
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL--MFH-IQDKGRFDLYRATFYAAEIVCG----LQFLH 113
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPATPSRSAGYRAPEVIET 549
S G + ++K NV++++D I+DFG+ N +T + Y APE+++
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--------LPRWV 590
K++ D +SFGVLL EML G++P D++ + PRW+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 62/270 (22%), Positives = 121/270 (44%), Gaps = 31/270 (11%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442
LG G +G V +K +KE + + +F ++ +++ ++ H +V L
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTK 70
Query: 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 502
+ +V +Y ++G L L R G+ + +++ G+A++ S +F H
Sbjct: 71 QRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQL-LEMCKDVCEGMAYLES---KQFIH 123
Query: 503 GNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGY----RAPEVIETRKHSHKSD 557
++ A N L++ +SDFGL+ +++ T S + + PEV+ K S KSD
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 558 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 616
V++FGVL+ E+ + GK P + + V+ V +R L R E+
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVEK---VSQGLR-----------LYRPHLASEK 229
Query: 617 MVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646
+ ++ +C + + RP +++ IE
Sbjct: 230 VYAIM---YSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 16/211 (7%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442
LG G +G + V +K + E + + DF ++ +++ ++ HP +V L
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQ 70
Query: 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGPKFT 501
+ +V ++ +G L L +G + +LL + V + + F
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 502 HGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGY----RAPEVIETRKHSHKS 556
H ++ A N L++ +SDFG+T +++ T S A + PEV K+S KS
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 557 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 586
DV+SFGVL+ E+ T GK P + + ++V++
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 383 LGKGSYG---TAYKAVLEESTTVVVKRL----KEVVVGKRDFEQQMEIVGRVGQHPNVVP 435
+G G++G +A + V +K++ V+ KR + ++++++ + +H N++
Sbjct: 18 VGMGAFGLVCSARDQL--TGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHL-RHENIIS 73
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
L + S E + YF + L T LH R PL+ + L RG+ ++HS
Sbjct: 74 LSDIFISPLEDI----YFVTELLGTDLH--RLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-YRAPEVIET-RKHS 553
G H ++K SN+LIN++ D I DFGL + + T S YRAPE++ T +K+
Sbjct: 128 G---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 554 HKSDVYSFGVLLLEMLTGKAPLQSPTRD 581
+ D++S G + EML GK PL P +D
Sbjct: 185 VEVDIWSAGCIFAEMLEGK-PL-FPGKD 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD-FEQQMEIVGRVGQHPNVVPLRAY 439
E++G G+YG YK ++ + ++ +V + + +Q++ ++ + H N+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 440 YYSK------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+ K D+ LV ++ +GS++ L+ +G L E I RG++H+H
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH 128
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------A 543
K H +IK NVL+ ++ + + DFG V A R+ G R A
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFG------VSAQLDRTVGRRNTFIGTPYWMA 179
Query: 544 PEVIETRK-----HSHKSDVYSFGVLLLEMLTGKAPL 575
PEVI + + KSD++S G+ +EM G PL
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 38/219 (17%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD-FEQQMEIVGRVGQHPNVVPLRAY 439
EV+G G+YG YK ++ + ++ +V + + + ++ ++ + H N+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 440 YYSK------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV--KILLGTARGVAH 491
+ K D+ LV ++ +GS++ L+ +G DW + +IL RG+AH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-DWIAYICREIL----RGLAH 136
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR--------- 542
+H+ K H +IK NVL+ ++ + + DFG V A R+ G R
Sbjct: 137 LHAH---KVIHRDIKGQNVLLTENAEVKLVDFG------VSAQLDRTVGRRNTFIGTPYW 187
Query: 543 -APEVIETRK-----HSHKSDVYSFGVLLLEMLTGKAPL 575
APEVI + + ++SD++S G+ +EM G PL
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-------VGRVGQHPNV 433
E+LGKG++G +K L++ T V VK KE D Q+++I + + HPN+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKE------DLPQELKIKFLSEARILKQYDHPNI 54
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
V L + +V + G + L + +T + VK L A G+A++
Sbjct: 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKT----KQLVKFALDAAAGMAYLE 110
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-----------LMNVPATPSRSAGYR 542
S H ++ A N L+ ++ ISDFG++ L +P +
Sbjct: 111 S---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK------WT 161
Query: 543 APEVIETRKHSHKSDVYSFGVLLLEMLT 570
APE + ++S +SDV+S+G+LL E +
Sbjct: 162 APEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 70/293 (23%), Positives = 131/293 (44%), Gaps = 47/293 (16%)
Query: 383 LGKGSYGTAYKAVL------EESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVP 435
LG+G++G + A ++ V VK LK+ ++DF ++ E++ + QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVK 71
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLL--HG------NRGAGRTPLDWETRVKILLGTAR 487
D ++V++Y G L+ L HG G L + I A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------- 540
G+ ++ S F H ++ N L+ ++L I DFG++ +V +T G
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMS--RDVYSTDYYRVGGHTMLPI 186
Query: 541 -YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW 598
+ PE I RK + +SDV+S GV+L E+ T GK P + +++++ Q V
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC--ITQGRV---- 240
Query: 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
L R + +E+ ++ + C + P MR N+ E+ +++ + ++
Sbjct: 241 --------LQRPRTCPKEVYDLM---LGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 65/271 (23%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLR 437
+G+G + Y+A L + V +K+++ + + D ++++++ ++ HPNV+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYY 68
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
A + +E +V + +G LS ++ + R + +T K + + H+HS
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEHMHSR-- 125
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRKHS 553
+ H +IK +NV I + D GL + T + S Y +PE I ++
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 554 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613
KSD++S G LL EM A LQSP D ++L + + E D + +
Sbjct: 185 FKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKI-------EQCDYPPLPSDHY 233
Query: 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644
EE+ Q++ + C+ P+ RP++ V +
Sbjct: 234 SEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 53/291 (18%)
Query: 383 LGKGSYGTAYKAVL------EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 434
LG+GS+G Y+ + E T V +K + E + + +F + ++ H +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-HVV 72
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 489
L + L+V + A G L + L R G P + +++ A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------- 542
A++ + KF H ++ A N ++ +DL I DFG+T + + YR
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY------ETDYYRKGGKGLL 183
Query: 543 -----APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVRE 596
APE ++ + KSDV+SFGV+L EM T + P Q + ++++
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF---------- 233
Query: 597 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647
V D + E ++L++ C P MRP E+V +++
Sbjct: 234 -----VIDGGHLDLP--ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 56/214 (26%), Positives = 104/214 (48%), Gaps = 30/214 (14%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHPN 432
E +G+G+ GT Y T + V +EV + + + +QQ + +V R ++PN
Sbjct: 26 EKIGQGASGTVY-------TAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
+V Y DE +V +Y A GSL+ ++ T +D + + + +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFL 132
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIE 548
HS + H +IK+ N+L+ D ++DFG +TP + +T + + APEV+
Sbjct: 133 HS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPL--QSPTR 580
+ + K D++S G++ +EM+ G+ P ++P R
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 64/246 (26%), Positives = 112/246 (45%), Gaps = 52/246 (21%)
Query: 383 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKR-------DFEQQMEI-VGRVGQHPNV 433
LG+G+Y YKA +E+ +V +K++K +G+R +F EI + + +HPN+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 492
+ L + K LV++ F L ++ ++ TP D +K +L T RG+ ++
Sbjct: 65 IGLLDVFGHKSNINLVFE-FMETDLEKVIK-DKSIVLTPAD----IKSYMLMTLRGLEYL 118
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YRAPE 545
HS H ++K +N+LI D ++DFGL +P+R YRAPE
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF---GSPNRKMTHQVVTRWYRAPE 172
Query: 546 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ----------------SPTRD---DMVD 585
++ R + D++S G + E+L L +PT + +
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 586 LPRWVQ 591
LP +V+
Sbjct: 233 LPDYVE 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 382 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK-------RDFEQQMEIVGRVGQHPNVV 434
V+GKG++G ++++ T + +K + K R+ + I+ + HP +V
Sbjct: 7 VIGKGAFGKVC--IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLV 63
Query: 435 PLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHI 492
L Y + +E + LV D G L H ++ + E +VK + + ++
Sbjct: 64 NLW-YSFQDEENMYLVVDLLLGGDLR--YHLSQKVKFS----EEQVKFWICEIVLALEYL 116
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIE 548
HS G H +IK N+L+++ I+DF +TP +T S + GY APEV+
Sbjct: 117 HSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST-SGTPGYMAPEVLC 172
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ +S D +S GV E L GK P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKR---LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
E +GKGS+G YK + + VV + L+E D +Q++ ++ + P +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYY 68
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
Y + ++ +Y GS LL PL+ IL +G+ ++HS
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHS--- 119
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHS 553
+ H +IKA+NVL+++ D ++DFG LT T + + APEVI+ +
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 554 HKSDVYSFGVLLLEMLTGKAP 574
K+D++S G+ +E+ G+ P
Sbjct: 180 FKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 371 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKR---LKEVVVGKRDFEQQMEIVGRV 427
D E+L E +GKGS+G +K + + VV + L+E D +Q++ ++ +
Sbjct: 1 DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 428 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 487
P V Y + ++ +Y GS LL P D +L +
Sbjct: 60 -DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILK 112
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRA 543
G+ ++HS K H +IKA+NVL+++ D ++DFG LT T + + A
Sbjct: 113 GLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 544 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMVDLPRWVQSVVREEWTAE 601
PEVI+ + K+D++S G+ +E+ G+ P P R + +P+ + E++
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-VLFLIPKNNPPTLTGEFSKP 228
Query: 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
F+ + AC+ K P RP E+++
Sbjct: 229 --------FKEFID----------ACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
E +GKG+YG YK ++ + VK L + + E + I+ + HPNVV
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 440 YYSKDEKL-----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
+Y D+ + LV + GS++ L+ G G+ LD IL G G+ H+H+
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLHN 146
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG---YRAPEVIETR 550
+ H ++K +N+L+ + + DFG++ L + + S G + APEVI
Sbjct: 147 ---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203
Query: 551 K-----HSHKSDVYSFGVLLLEMLTGKAPL 575
+ + + DV+S G+ +E+ G PL
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 382 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK-----RDFEQQMEIVGRVGQHPNVVPL 436
V+G+GS+G A S +KE+ + K D ++ ++ ++ +HPN+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYA--MKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAF 63
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRG---AGRTPLDWETRVKILLGTARGVAHIH 493
+ + + +V +Y G L + RG T L W ++ + GV HIH
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH 117
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----TPSRSAGYRAPEVIET 549
+ H +IK+ N+ + Q+ + DFG L+ P T + Y PE+ E
Sbjct: 118 E---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQS 577
+++KSD++S G +L E+ T K P Q+
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 18/156 (11%)
Query: 429 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 488
QH N+V D + +Y GS++ LL+ N GA L +IL +G
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQIL----KG 118
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------ 542
+ ++H+ G H +IK +N+L++ ISDFG++ + + +++ G R
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 543 ----APEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
APEV++ ++ K+D++S G L++EMLTGK P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ--------QMEIVGRVGQHPN 432
E LG+G+Y T YK TT + LKE+ D E+ ++ ++ + +H N
Sbjct: 6 EKLGEGTYATVYKG--RNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKEL-KHEN 59
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTARGVA 490
+V L +++++ +LV++Y L + HG RGA LD T +G+A
Sbjct: 60 IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGA----LDPNTVKSFTYQLLKGIA 114
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEV 546
H + H ++K N+LIN+ + ++DFGL +P + YRAP+V
Sbjct: 115 FCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDV 171
Query: 547 I-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 582
+ +R +S D++S G ++ EM+TG+ +D
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 67/276 (24%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRLK--EVVVGK--RDFEQQMEIVGRVGQHPNVVPLR 437
+G+G + Y+A L + V +K+++ E++ K +D ++++++ ++ HPNV+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYL 68
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ +E +V + +G LS ++ + R + T K + V H+HS
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-IPERTVWKYFVQLCSAVEHMHSR-- 125
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRKHS 553
+ H +IK +NV I + D GL + T + S Y +PE I ++
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 554 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613
KSD++S G LL EM A LQSP D ++L Q + E D + ++
Sbjct: 185 FKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQKI-------EQCDYPPLPTEHY 233
Query: 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649
E++ +++ + C+ PD RP++ V ++ +++
Sbjct: 234 SEKLRELVSM---CIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 54/297 (18%)
Query: 383 LGKGSYGTAYKAVLEES-----------TTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQ 429
LG+G +G + V+ E+ T V VK LK K D +ME++ +G+
Sbjct: 26 LGEGCFG---QVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--------RTP---LDWETR 478
H N++ L ++ +Y + G+L L R G + P L ++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 479 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSR 537
V ARG+ ++ S K H ++ A NVL+ +D I+DFGL + ++
Sbjct: 143 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 538 SAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 591
+ G + APE + R ++H+SDV+SFGVLL E+ T G +P +++ L +
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 259
Query: 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648
+ + N E+ M++ C VP RP ++V ++ +
Sbjct: 260 RMDKP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 71/279 (25%), Positives = 118/279 (42%), Gaps = 51/279 (18%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPN 432
E LG+ +G YK L E++ V +K LK+ G + +F+ + + R+ QHPN
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPN 69
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAG------RTPLDWETRVKI 481
+V L + +++ Y + L L H + G+ ++ L+ V I
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL---------TPLMNVP 532
+ A G+ + S H ++ NVL+ L+ ISD GL LM
Sbjct: 130 VTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 533 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV------- 584
P R + +PE I K S SD++S+GV+L E+ + G P + D++
Sbjct: 187 LLPIR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243
Query: 585 ------DLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 617
D P WV +++ E W F RF++I +
Sbjct: 244 VLPCPDDCPAWVYTLMLECWNE--FPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 29/235 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTV-VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNVVP 435
++LGKGS+G + A L+ + +K LK +VV+ D E M ++ +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHIH 493
L + +K+ V +Y G L + + + L T +I+ G + +H
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICG----LQFLH 113
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIET 549
S G + ++K N+L++ D I+DFG+ M A G Y APE++
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAP--------LQSPTRDDMVDLPRWVQSVVRE 596
+K++ D +SFGVLL EML G++P L R D PRW+ ++
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKD 225
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 24/243 (9%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
E +GKG+YG +K + +++ + VK L + + E + I+ + HPNVV
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 440 YYSKDEK-----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
YY KD K LV + GS++ L+ G G ++ IL G+ H+H
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPIIAYILHEALMGLQHLHV 142
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG---YRAPEVIETR 550
K H ++K +N+L+ + + DFG++ L + + S G + APEVI
Sbjct: 143 ---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 551 K-----HSHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMVDLPRWVQSVVR--EEWTAE 601
+ + + DV+S G+ +E+ G PL P R + +PR + E W+ E
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKIPRNPPPTLHQPELWSNE 258
Query: 602 VFD 604
D
Sbjct: 259 FND 261
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 30/234 (12%)
Query: 381 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNV 433
E LG+ ++G YK L + + V +K LK++ ++ +F+Q+ ++ + HPN+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNI 69
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAG-------RTPLDWETRVKI 481
V L + ++++Y G L L H + G ++ LD + I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT------PLMNVPATP 535
+ A G+ ++ S F H ++ A N+LI + L ISD GL+ V
Sbjct: 130 AIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 536 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR 588
+ PE I K S SD++SFGV+L E+ + G P + +++++ R
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 52/208 (25%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 381 EVLGKGSYGTAYKAVLE-ESTTVVVKR--LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
+ +G+GS+G Y A + +S V+K L ++ V +++ ++ I+ +HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP---LDWETRVKILLGTARGVAHIHS 494
A + +V +Y G L ++ RG + L W ++ + G+ HIH
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119
Query: 495 MGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVPATPSRS-AG---YRAPEVIET 549
K H +IK+ N+ ++++ + + DFG+ +N + + G Y +PE+ +
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQS 577
R +++K+D++S G +L E+ T K P +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 54/294 (18%)
Query: 368 YNFDLEDLLRASAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGR 426
D E L E+ G GS+G Y A + + V +K++ GK+ E+ +I+
Sbjct: 9 SKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKE 65
Query: 427 VG-----QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKI 481
V +HPN + + Y + LV +Y GS S +L + PL I
Sbjct: 66 VRFLQQLRHPNTIEYKGCYLREHTAWLVMEY-CLGSASDILE----VHKKPLQEVEIAAI 120
Query: 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----TPS 536
G +G+A++HS + H +IKA N+L+ + ++DFG L++ PA TP
Sbjct: 121 CHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS-PANSFVGTPY 176
Query: 537 RSAGYRAPEVIETRKHSH---KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ-- 591
+ APEVI K DV+S G+ +E+ K PL + + M L Q
Sbjct: 177 ----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYHIAQND 230
Query: 592 --SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
++ +W+ + + +C+ K+P RP+ +E+++
Sbjct: 231 SPTLSSNDWS---------------DYFRNFVD---SCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD--FEQQM--EI-VGRVGQHPNVVPLR 437
+G+G++G +KA E+ V LK+V + + + Q EI + QHP VV L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVA--LKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ +LV +Y S LS +L R + + + + +GVA++H+ G
Sbjct: 66 DVFPHGSGFVLVMEYMPS-DLSEVLRDEE---RPLPEAQVK-SYMRMLLKGVAYMHANG- 119
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVI-ETRK 551
H ++K +N+LI+ D I+DFGL L + S YRAPE++ RK
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 588
+ D+++ G + E+L G +PL P +D+ L
Sbjct: 178 YDPGVDLWAVGCIFAELLNG-SPL-FPGENDIEQLAI 212
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 8e-12
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 47/225 (20%)
Query: 383 LGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQ-------MEIVGRVGQHPNVV 434
LG G +G V ++ T +K +K+ + + ++ +E HP +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC----NHPFIV 56
Query: 435 PLRAYYYSKDEKLLVY---DYFASGSLSTLLHGNRGAGRTPLDWETR---VKILLGTARG 488
L + KD+K +Y +Y G L T+L R G ++ R ++L
Sbjct: 57 KLYRTF--KDKKY-IYMLMEYCLGGELWTIL---RDRGLFD-EYTARFYIACVVLAFE-- 107
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTPLMNVPA-------TPSRSA 539
++H+ G + ++K N+L+ D +G + DFG + TP
Sbjct: 108 --YLHNRG---IIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP---- 156
Query: 540 GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 584
Y APE+I + + D +S G+LL E+LTG+ P D M
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME 201
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 55/291 (18%)
Query: 381 EVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVVGKRDFEQQME-----IVGRVGQHP 431
V+GKG +G Y L +S VK L + D E+ + I+ + HP
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT----DLEEVEQFLKEGIIMKDFSHP 56
Query: 432 NVVPLRAYYYSKD-EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG----TA 486
NV+ L + L+V Y G L + R P VK L+G A
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNP-----TVKDLIGFGLQVA 108
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--TPSRSAGYRAP 544
+G+ ++ S KF H ++ A N ++++ ++DFGL + + G + P
Sbjct: 109 KGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 545 ------EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD-DMVDLPRWVQSVVREE 597
E ++T+K + KSDV+SFGVLL E++T AP P D D D+ ++ R
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVDSFDITVYLLQGRR-- 220
Query: 598 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648
L++ + + + +++ +C P+MRP E+V IE++
Sbjct: 221 ---------LLQPEYCPDPLYEVML---SCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 9e-12
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 44/223 (19%)
Query: 383 LGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQM---------EIVGRVGQHP 431
+ KG+YG + A ++ST +K V+ K D ++ +I+ + Q P
Sbjct: 1 ISKGAYGRVFLAK-KKSTGDIYAIK-----VIKKADMIRKNQVDQVLTERDILSQA-QSP 53
Query: 432 NVVPLRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 488
VV L YYS + L LV +Y G L++LL N G+ LD + +
Sbjct: 54 YVVKL---YYSFQGKKNLYLVMEYLPGGDLASLLE-NVGS----LDEDVARIYIAEIVLA 105
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL---------TPLMNVPATPSRSA 539
+ ++HS G H ++K N+LI+ + ++DFGL L + R
Sbjct: 106 LEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 540 G---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579
G Y APEVI + HS D +S G +L E L G P T
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 79/292 (27%), Positives = 122/292 (41%), Gaps = 50/292 (17%)
Query: 368 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV 427
Y D E++ E+ G GS+G Y A T VV K GK+ E+ +I+ V
Sbjct: 15 YKDDPEEIFVGLHEI-GHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEV 72
Query: 428 G-----QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 482
+HPN + + Y + LV +Y GS S LL + PL I
Sbjct: 73 KFLQQLKHPNTIEYKGCYLKEHTAWLVMEY-CLGSASDLLE----VHKKPLQEVEIAAIT 127
Query: 483 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRS 538
G +G+A++HS H +IKA N+L+ + ++DFG +P + TP
Sbjct: 128 HGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY-- 182
Query: 539 AGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ---- 591
+ APEVI + ++ K DV+S G+ +E+ K PL + + M L Q
Sbjct: 183 --WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYHIAQNDSP 238
Query: 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
++ EWT F + C+ K+P RP E++R
Sbjct: 239 TLQSNEWTD-----SFRGFVDY-------------CLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 71/288 (24%), Positives = 114/288 (39%), Gaps = 48/288 (16%)
Query: 383 LGKGSYGTAYKAVLEE------STTVVVKRLKEVVVGKRD--FEQQMEIVGRVGQHPNVV 434
+G G +G K +L E VVVK L+ F Q+++ R HPNV+
Sbjct: 3 IGNGWFG---KVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPY-RELNHPNVL 58
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
LLV ++ G L L NRG + ++ A G+ +H
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----------ATPSRSAGYRAP 544
F H ++ N + DL I D+GL L P A P R + AP
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLR---WLAP 171
Query: 545 EVIETR-------KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 597
E++E R + KS+++S GV + E+ T D+ V ++ VVRE+
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-----LKQVVREQ 226
Query: 598 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645
D++L + Q + + ++ C P+ RP +EV ++
Sbjct: 227 ------DIKLPKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 38/223 (17%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRL----KEVVVGKRDFEQQMEIVG--RVGQHPNVV 434
EVLGKG+YGT Y + + + VK++ V+ ++++E+ E V + +H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHIH 493
+ + ++ GS+S++L NR G P+ + +IL GVA++H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQIL----DGVAYLH 119
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTP--------------LMNVPATPSR 537
+ H +IK +NV++ + G I DFG L ++ TP
Sbjct: 120 N---NCVVHRDIKGNNVMLMPN--GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY- 173
Query: 538 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR 580
+ APEVI + KSD++S G + EM TGK PL S R
Sbjct: 174 ---WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 30/220 (13%)
Query: 378 ASAEVLGKGSYGTAYKAVLEESTT---VVVKRLKEVVVGKRDFEQQME--IVGRVGQHPN 432
A + LG+G +G+ + L + + V VK +K + + + E + + + HPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 433 VVPLRAYYYSKDEK------LLVYDYFASGSLSTLLHGNRGAGRTP--LDWETRVKILLG 484
V+ L E +++ + G L + L +R G P L + VK +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR-LGDCPQYLPTQMLVKFMTD 120
Query: 485 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATP 535
A G+ ++ S F H ++ A N ++N++++ C++DFGL+ + + P
Sbjct: 121 IASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 536 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
+ + A E + R ++ KSDV+SFGV + E+ T G+ P
Sbjct: 178 VK---WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 381 EVLGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQMEI------VGRVGQHPNV 433
V+G+G+YG K V +K+ KE D E + V R +H N+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKES----EDDEDVKKTALREVKVLRQLRHENI 62
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
V L+ + K LV++Y +L LL + G L + + + +A+ H
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG----LPPDAVRSYIWQLLQAIAYCH 117
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEV-I 547
S H +IK N+L+++ + DFG + + YRAPE+ +
Sbjct: 118 SH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 548 ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
+ DV++ G ++ E+L G+ PL
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE-PL 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 376 LRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QH 430
L + +G GS+G Y A ++ VV + K GK+ E+ +I+ V +H
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIK-KMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 431 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
PN + R Y + LV +Y GS S LL + PL + G +G+A
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEY-CLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLA 129
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVI--- 547
++HS H ++KA N+L+++ + DFG +M + + APEVI
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAM 186
Query: 548 ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
+ ++ K DV+S G+ +E+ K PL
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 45/240 (18%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVP 435
+ LG GS+G + S +K L K +V + E + I+ + +HP +V
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLV- 64
Query: 436 LRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRV---KILLGTARGVA 490
Y +D+ L V +Y G L + L R +GR P R +++L +
Sbjct: 65 -NLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPV-ARFYAAQVVLA----LE 115
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPL-----MNVPATPSRSAGYRA 543
++HS+ + ++K N+L+ D DG I +DFG + TP Y A
Sbjct: 116 YLHSLD---IVYRDLKPENLLL--DSDGYIKITDFGFAKRVKGRTYTLCGTPE----YLA 166
Query: 544 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVR 595
PE+I ++ + D ++ G+L+ EML G P + V P + +
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAK 226
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 50/217 (23%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTT----VVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVV 434
++LG+G +G+ + L + V VK +K + + E+ + + HPNV+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 435 PLRAYYYSKDEK------LLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTAR 487
L + +++ + G L + L +R G L +T +K ++ A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATPSRS 538
G+ ++ + F H ++ A N ++ +D+ C++DFGL+ + + P +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 180
Query: 539 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
+ A E + R ++ KSDV++FGV + E+ T G+ P
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 387 SYGTAYKAVLEESTTVVV-----KRLKEVVVGKRDFEQQME--------IVGRVGQHPNV 433
SY + + E ST +V ++V V K D +Q ++ R QHPN+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
V + + Y DE +V ++ G+L+ ++ R ++ E + L + ++ +H
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLAVLKALSFLH 132
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-AG---YRAPEVIET 549
+ G H +IK+ ++L+ D +SDFG ++ +S G + APEVI
Sbjct: 133 AQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPL 575
+ + D++S G++++EM+ G+ P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 47/292 (16%)
Query: 371 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGK--RDFEQQMEIVGRV 427
DL+DL +G+G++GT K + + S T++ VKR++ V K + +++V R
Sbjct: 5 DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS 59
Query: 428 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 487
P +V + + + + + SL ++ + E KI + T +
Sbjct: 60 SDCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLT-PLMNVPATPSRSAG---Y 541
+ ++ K H ++K SN+L+ D +G I DFG++ L++ A +R AG Y
Sbjct: 119 ALNYLKEE--LKIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVDSIAK-TRDAGCRPY 173
Query: 542 RAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE- 597
APE I+ + +SDV+S G+ L E+ TGK P P + + D + VV+ +
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFD---QLTQVVKGDP 228
Query: 598 -----WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644
F + F N+ C+ K RP E++
Sbjct: 229 PILSNSEEREFSPSFVNFINL-------------CLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 383 LGKGSYGTAYKA------VLEESTTVVVKRLKE-VVVGKRDFEQQMEIVGRVGQHPNVVP 435
LG+G++G + A ++ V VK LK+ + ++DF+++ E++ + QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVK 71
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR-----------VKILLG 484
D ++V++Y G L+ L + +D + R + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 485 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---- 540
A G+ ++ S F H ++ N L+ +L I DFG++ +V +T G
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS--RDVYSTDYYRVGGHTM 186
Query: 541 ----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
+ PE I RK + +SDV+SFGV+L E+ T GK P
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 30/205 (14%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHPNVV 434
+G+GS G A + + K+V V K D +Q ++ R H NVV
Sbjct: 30 IGEGSTGIVCIATEKHTG-------KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVV 82
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
+ Y DE +V ++ G+L+ ++ R ++ E + L R ++++H+
Sbjct: 83 DMYNSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSYLHN 136
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIET 549
G H +IK+ ++L+ D +SDFG ++ P R + + APEVI
Sbjct: 137 QG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISR 192
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAP 574
+ + D++S G++++EM+ G+ P
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 47/227 (20%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG------------- 428
LG+G+YG KA V +K++K ++ D + ++VG G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 429 --QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGT 485
+H N++ L Y D LV D AS L ++ + L E++VK ILL
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDR-----KIRLT-ESQVKCILLQI 128
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT------PLMNVPATPSRSA 539
G+ +H F H ++ +N+ IN I+DFGL P + +
Sbjct: 129 LNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 540 G------------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKA 573
YRAPE++ K+ D++S G + E+LTGK
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 46/254 (18%)
Query: 363 FEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFE-- 418
F GCS D E L LG+G++G YKA ++ VV LK++++ K F
Sbjct: 1 FYGCSKLRDYEIL-----GKLGEGTFGEVYKARQIKTGRVVA--LKKILMHNEKDGFPIT 53
Query: 419 --QQMEIVGRVGQHPNVVPL--RAYYYSKDEK------LLVYDYFASGSLSTLLHGNRGA 468
++++I+ ++ +HPNVVPL A K +V Y LS LL
Sbjct: 54 ALREIKILKKL-KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS-V 110
Query: 469 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528
T + + LL G+ ++H H +IKA+N+LI+ I+DFGL
Sbjct: 111 KLTESQIKCYMLQLL---EGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARP 164
Query: 529 MNVPATPSRSAG---------------YRAPE-VIETRKHSHKSDVYSFGVLLLEMLTGK 572
+ P + G YR PE ++ R+++ D++ G + EM T +
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
Query: 573 APLQSPTRDDMVDL 586
LQ + D + L
Sbjct: 225 PILQGKSDIDQLHL 238
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 3e-11
Identities = 51/207 (24%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
E +G+G+ GT + A+ + V +K++ K++ +V + ++PN+V
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+ DE +V +Y A GSL+ ++ T +D + + + +H+ +
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLHA---NQ 135
Query: 500 FTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHSHK 555
H +IK+ NVL+ D ++DFG +TP + +T + + APEV+ + + K
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 556 SDVYSFGVLLLEMLTGKAPL--QSPTR 580
D++S G++ +EM+ G+ P ++P R
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLR 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 50/197 (25%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 383 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 441
+G+GS G A ++ S +V VK++ +R+ ++ R QH NVV + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 442 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 501
DE +V ++ G+L+ ++ R ++ E + L + ++ +H+ G
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLKALSVLHAQG---VI 138
Query: 502 HGNIKASNVLINQDLDGCISDFGLTPLMN--VPATPSR--SAGYRAPEVIETRKHSHKSD 557
H +IK+ ++L+ D +SDFG ++ VP S + + APE+I + + D
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 558 VYSFGVLLLEMLTGKAP 574
++S G++++EM+ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 31/204 (15%)
Query: 383 LGKGSYGTAY-----KAVLEESTTVVVKRLKEVVVGKRD------FEQQMEIVGRVGQHP 431
LGKGS+GT Y KAV EE +K LKE+ VG+ + Q+ +++ ++ HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEER----LKVLKEIPVGELNPNETVQANQEAQLLSKL-DHP 62
Query: 432 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRT---PLDWETRVKILLGTARG 488
+V A + +D ++ +Y L L + G+T E +++LLG
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG---- 118
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPATPSRSAGYRAP 544
+H M + H ++KA N+ + +L I DFG++ L+ ++ T + + Y +P
Sbjct: 119 ---VHYMHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 545 EVIETRKHSHKSDVYSFGVLLLEM 568
E ++ + + KSD++S G +L EM
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 382 VLGKGSYGTA----YKAVLEESTTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNVVP 435
++GK K +T V VK++ K D + QQ I R QHPN++P
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+ E +V A GS LL H G + + IL + +IH
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIH 118
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCIS-----------DFGLTPLMNVPATPSRSAGYR 542
S G F H ++KAS++L++ D +S + + P + ++ +
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 543 APEVIETRKHSH--KSDVYSFGVLLLEMLTGKAPLQ 576
+PEV++ + KSD+YS G+ E+ G P +
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 27/229 (11%)
Query: 381 EVLGKGSYGTAYKAVLEESTTV-VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNVVP 435
VLGKGS+G A L+ES + VK LK +V++ D E M I+ HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 494
L + + D V ++ G L + +R D E R + + +H
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-----RFD-EARARFYAAEITSALMFLHD 114
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP--LMN--VPATPSRSAGYRAPEVIETR 550
G + ++K NVL++ + ++DFG+ + N +T + Y APE+++
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 551 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQ 591
+ D ++ GVLL EML G AP ++ DD+ V P W+
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 42/218 (19%)
Query: 382 VLGKGSYGTAYKA---------------VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGR 426
VLG G+YG + VL+++T V + E +R +++
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTER------QVLEA 60
Query: 427 VGQHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG- 484
V + P +V L Y + D KL L+ DY G L T L+ R E+ V++ +
Sbjct: 61 VRRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLY-QREHFT-----ESEVRVYIAE 113
Query: 485 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---- 540
+ H+H +G + +IK N+L++ + ++DFGL+ + R+
Sbjct: 114 IVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGT 169
Query: 541 --YRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAP 574
Y APEVI H D +S GVL E+LTG +P
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 42/226 (18%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR-DFEQQMEIVGRVG----------QHP 431
+G+G+YG Y+A ++T+ E+V K+ + + + + +HP
Sbjct: 15 IGEGTYGIVYRA--RDTTS------GEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 432 NVVPLRAYYYSK--DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARG 488
N+V L+ K D LV +Y L++LL TP E++VK ++L RG
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEY-CEQDLASLLDNMP----TPFS-ESQVKCLMLQLLRG 120
Query: 489 VAHIHSMGGPKFT-HGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR----SAGY 541
+ ++H F H ++K SN+L+ GC I+DFGL +PA P + Y
Sbjct: 121 LQYLHE----NFIIHRDLKVSNLLLTDK--GCLKIADFGLARTYGLPAKPMTPKVVTLWY 174
Query: 542 RAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586
RAPE++ ++ D+++ G +L E+L K L + + +DL
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 55/206 (26%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVVPLRAYY 440
LG G++G YKA +E+ + ++ E + D+ ++EI+ HP +V L +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAF 78
Query: 441 YSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHIHSMGGP 498
Y + ++ ++ G++ + +L +RG E +++++ + ++HSM
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLT------EPQIQVICRQMLEALQYLHSM--- 129
Query: 499 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVI--ETRK 551
K H ++KA NVL+ D D ++DFG++ NV R + + APEV+ ET K
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 552 ---HSHKSDVYSFGVLLLEMLTGKAP 574
+ +K+D++S G+ L+EM + P
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 19/166 (11%)
Query: 424 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 483
V ++ HPN+VP RA + + +E +V + A GS L+ + G + L IL
Sbjct: 52 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL---AIAYILQ 108
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLTP-------LMNVP 532
G + + +IH MG + H ++KAS++LI+ D L G S+ + + + P
Sbjct: 109 GVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFP 165
Query: 533 ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
+ + +PEV++ + + KSD+YS G+ E+ G P +
Sbjct: 166 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTV----VVKRLKEVVVGKRDFEQQME-IVGRVGQHPNVV 434
+VLG G++GT YK + + E TV +K L E K + E E ++ HP++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAHI 492
L S +L V G L +H ++ + L+W ++ A+G+ ++
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EV 546
+ H ++ A NVL+ I+DFGL L+ + G + P E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 547 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS-PTRD 581
I RK +H+SDV+S+GV + E++T G P PTR+
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 378 ASAEVLGKGSYGTAYKAVLEES-TTVVVKRL----KEVVVGKRDFEQQMEIVGRVGQHPN 432
S + +G G+YG+ A+ + + V +K+L + + KR + +++ ++ + QH N
Sbjct: 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHM-QHEN 75
Query: 433 VVPLRAYYYSKDEKLLVYD-YFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVA 490
V+ L + S D Y + T L G PL E +V+ L+ G+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG---HPLS-EDKVQYLVYQMLCGLK 131
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP-SRSAGYRAPEVIET 549
+IHS G H ++K N+ +N+D + I DFGL + T + YRAPEVI
Sbjct: 132 YIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILN 188
Query: 550 RKHSHKS-DVYSFGVLLLEMLTGK 572
H +++ D++S G ++ EMLTGK
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 383 LGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVV 434
+G+G++G ++A E T V VK LKE + DF+++ ++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIV 71
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----------------GAGRTPLDWET 477
L L+++Y A G L+ L G PL
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 478 RVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----- 532
++ I A G+A++ KF H ++ N L+ +++ I+DFGL+ +
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 533 ----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 570
A P R + PE I +++ +SDV+++GV+L E+ +
Sbjct: 189 SENDAIPIR---WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 382 VLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNVV 434
VLG G++GT YK + V +K L+E K + E + ++ VG P V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PYVC 72
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAHI 492
L + +L V G L + N+ + L+W ++ A+G++++
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EV 546
+ + H ++ A NVL+ I+DFGL L+++ T + G + P E
Sbjct: 126 EEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 547 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS-PTRD 581
I R+ +H+SDV+S+GV + E++T G P P R+
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 382 VLGKGSYGTAYKAVLEES----TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVP 435
+LGKG +G+ +A L+ V VK LK + D E+ + + + HPNV+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 436 LRAYYYSKDEK------LLVYDYFASGSLSTLLHGNRGAGRTP--LDWETRVKILLGTAR 487
L K +++ + G L T L +R G P L +T V+ ++ A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR-IGEEPFTLPLQTLVRFMIDIAS 124
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP--- 544
G+ ++ S F H ++ A N ++N+++ C++DFGL+ + + + P
Sbjct: 125 GMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 545 ---EVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
E + ++ SDV++FGV + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-------QQMEIVGRVGQHPNV 433
E +G+G+YG YKA + T + LK+ + + D E +++ ++ + + +
Sbjct: 7 EKIGEGTYGKVYKA--RDKNTGKLVALKKTRL-EMDEEGIPPTALREISLLQMLSESIYI 63
Query: 434 VPLRAYYYSKDEK-----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 488
V L + +++ LV++Y S L + N PL +T + +G
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR----SAGYRA 543
VAH H G H ++K N+L+++ I+D GL ++P + YRA
Sbjct: 123 VAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179
Query: 544 PEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
PEV + + +S D++S G + EM K PL
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 41/213 (19%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKE----VVVGKRDFE-----QQMEIVGRVGQH 430
+G G+YG A ++ V +K+L + KR + + M H
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-------DH 73
Query: 431 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHG---NRGAGRTPLDWETRVKILL-GTA 486
NV+ L + + L + F L T L G N L + ++ L+
Sbjct: 74 ENVIGLLDVF-TPASSL---EDFQDVYLVTHLMGADLNNIVKCQKLS-DDHIQFLVYQIL 128
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 540
RG+ +IHS G H ++K SN+ +N+D + I DFGL + T G
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-----GYVATRW 180
Query: 541 YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 572
YRAPE++ H +++ D++S G ++ E+LTGK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 41/239 (17%)
Query: 381 EVLGKGSYGTAYKAVLEESTT-VVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVV 434
E LG GS+G A + + +K LK+ + K +Q + HP +V
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK--MKQVQHVAQEKSILMELSHPFIV 81
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHI 492
+ + ++ + ++ G L T L R AGR P D +++L ++
Sbjct: 82 NMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLA----FEYL 134
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-------ATPSRSAGYRAPE 545
HS + ++K N+L++ ++DFG VP TP Y APE
Sbjct: 135 HSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFTLCGTPE----YLAPE 185
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPL--QSPTR------DDMVDLPRWVQSVVRE 596
VI+++ H D ++ GVLL E + G P +P R + P W R+
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244
|
Length = 329 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 69/287 (24%), Positives = 122/287 (42%), Gaps = 45/287 (15%)
Query: 383 LGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVV 434
LG+GS+G Y+ E T V VK + E + +F + ++ H +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 489
L L+V + A G L + L R GR P + +++ A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 541
A++++ KF H ++ A N ++ D I DFG+T ++ T G +
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 187
Query: 542 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601
APE ++ + SD++SFGV+L E+ + + + P Q + E+
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS------------LAEQP--YQGLSNEQVLKF 233
Query: 602 VFD-VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647
V D L + N E + ++++ C P MRP E+V ++++
Sbjct: 234 VMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 383 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVPLR 437
+G+G YG + A +++ +V +KR+K+ ++ K + + +I+ + +V L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDIL-TTTKSEWLVKL- 66
Query: 438 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
Y + DE L L +Y G TLL+ N G + R + V +H +G
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLS---EDHARFYMAEMFE-AVDALHELG 121
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPATPSRSAGYRAPEVIETRKHSHK 555
+ H ++K N LI+ ++DFGL ++ + S Y APEV+ + +
Sbjct: 122 ---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 556 SDVYSFGVLLLEMLTGKAPLQSPTRDD-MVDLPRWVQSVVREEWTAEVFDV 605
D +S G +L E L G P T ++ +L W +++ R + F++
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRA 438
LG G++G YKA T + K + + DF +++I+ +HPN+V L
Sbjct: 13 LGDGAFGKVYKAQ--HKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYE 69
Query: 439 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 498
Y+ +++ ++ ++ G+L +++ L + + +HS
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIML----ELERGLTEPQIRYVCRQMLEALNFLHSH--- 122
Query: 499 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVI--ETRK 551
K H ++KA N+L+ D D ++DFG++ N R + APEV+ ET K
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 552 ---HSHKSDVYSFGVLLLEMLTGKAPLQ--SPTR 580
+ +K+D++S G+ L+E+ + P +P R
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 35/211 (16%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVVPLRAYY 440
LG G++G YKA +E+ + ++ + + D+ +++I+ HPN+V L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAF 71
Query: 441 YSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHSMGGP 498
Y ++ ++ ++ A G++ + +L R PL E +++++ T + ++H
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELER-----PLT-EPQIRVVCKQTLEALNYLHE---N 122
Query: 499 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------APEVI- 547
K H ++KA N+L D D ++DFG V A +R+ R APEV+
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFG------VSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 548 -ET---RKHSHKSDVYSFGVLLLEMLTGKAP 574
ET R + +K+DV+S G+ L+EM + P
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ-------MEI-VGRVGQHPN 432
E +G+G+YG YKA + + VV LK++ + D E + EI + + HPN
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVA--LKKI---RLDTETEGVPSTAIREISLLKELNHPN 60
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVK-ILLGTARGVA 490
+V L +++++ LV+++ L + + +G PL +K L +G+A
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPL-----IKSYLFQLLQGLA 114
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YRA 543
HS + H ++K N+LIN + ++DFGL VP R+ YRA
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRA 168
Query: 544 PEV-IETRKHSHKSDVYSFGVLLLEMLTGKA 573
PE+ + + +S D++S G + EM+T +A
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 384 GKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM--------EI-VGRVGQHPNVV 434
G+G+YG YKA + +K+ K D EQ EI + R +H NVV
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKF---KGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 435 PLRAYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
L + +K L++DY A L ++ +R A R + +L GV ++
Sbjct: 66 SLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGC----ISDFGLTPLMNVPATPSRSAG-------Y 541
HS H ++K +N+L+ + I D GL L N P P Y
Sbjct: 125 HSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 542 RAPEVIETRKHSHKS-DVYSFGVLLLEMLT 570
RAPE++ +H K+ D+++ G + E+LT
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 8e-10
Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 54/221 (24%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE--------QQM--EIV--GRVGQH 430
LGKG+YG +KA+ +R KEVV K+ F+ Q+ EI+ +G H
Sbjct: 15 LGKGAYGIVWKAI--------DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 431 PNVVPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTAR 487
PN+V L ++++K LV++Y + T LH A + + + I+ +
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRAN---ILEDVHKRYIMYQLLK 118
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGL----TPLMNVPATP----- 535
+ +IHS H ++K SN+L+N D C ++DFGL + L P P
Sbjct: 119 ALKYIHSGN---VIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 536 --SRSAGYRAPEV-IETRKHSHKSDVYSFGVLLLEMLTGKA 573
+R YRAPE+ + + +++ D++S G +L EML GK
Sbjct: 173 VATR--WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 61/285 (21%), Positives = 120/285 (42%), Gaps = 43/285 (15%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----GK---------RDFEQQMEIVGR 426
E LG G++G YK V +++ + LKE+ V GK D ++ I+
Sbjct: 6 EHLGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 427 VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD---WETRVKILL 483
+HPN+V + D +V D L + + + + W V+++L
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 540
+ ++H + H ++ +N+++ +D I+DFGL + + G
Sbjct: 125 A----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 541 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 600
Y PE+++ + K+DV++FG +L +M T + P S +M+ L + V E
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS---TNMLSLATKIVEAVYEPLPE 235
Query: 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645
++ E + ++ +C+ + RP++ +V MI
Sbjct: 236 GMYS-EDVTD------VIT------SCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 382 VLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVVP 435
+LG G +G + L+ V + L+ K R F + +G+ H N+V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVR 70
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
L + ++V +Y ++G+L + L + G L + +L G A G+ ++ M
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEM 126
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETR 550
G + H + A VL+N DL IS F A + +G + APE I+
Sbjct: 127 G---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 551 KHSHKSDVYSFGVLLLEMLT-GKAP 574
S SDV+SFG+++ E+++ G+ P
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 67/280 (23%), Positives = 118/280 (42%), Gaps = 44/280 (15%)
Query: 383 LGKGSYGTAYKAVL-------EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 433
LG G++G Y+ V VK L++ K++F ++ ++ HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP--LDWETRVKILLGTARGVAH 491
V L + + ++ + G L + L R P L + + I L A+G +
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGC-----ISDFGLT-PLMNVPATPSRSAG----- 540
+ M F H ++ A N L+++ I DFGL + G
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 541 YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599
+ APE + K + +SDV+SFGVL+ E+LT G+ P P ++ ++ + V + R
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY--PALNNQ-EVLQHVTAGGR---- 231
Query: 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMD 639
L + +N +++ Q++ C A+ P RP D
Sbjct: 232 -------LQKPENCPDKIYQLMTN---CWAQDPSERPTFD 261
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 381 EVLGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVP 435
+VLGKGS+G A L+ + V +K L K+V++ D + M I+ +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 494
L + +KD V +Y G L + +R D E R + + +H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-----KFD-EPRSRFYAAEVTLALMFLHR 114
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETR 550
G + ++K N+L++ + ++DFG+ + T + G Y APE+++
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 551 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
++ D ++ GVL+ EM+ G+ P ++ DD+ +
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 20/203 (9%)
Query: 382 VLGKGSYG-----TAYKAVLEEST-TVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNV 433
LG G++G TAY ++ V VK LK + +++I+ +G H N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
V L L++ +Y G L L R + L E + A+G+A +
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN-----VPATPSRSAGYRAPEVI 547
S H ++ A NVL+ I DFGL +MN V + APE I
Sbjct: 159 S---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 548 ETRKHSHKSDVYSFGVLLLEMLT 570
++ +SDV+S+G+LL E+ +
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 52/224 (23%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQ--HPNVV 434
++LG G +GT +K + + E ++ + + + G++ F++ + + +G H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHI 492
L +L V GSL + +R + + L+W ++ A+G+ ++
Sbjct: 73 RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATPSRSAGYRA 543
H N+ A N+L+ D I+DFG+ L+ + TP + + A
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK---WMA 179
Query: 544 PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 586
E I +++H+SDV+S+GV + EM++ G P ++ DL
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 37/227 (16%)
Query: 370 FDLEDLLRASAEVLGKGSYGTAYKAVLEESTT---VVVKRL----KEVVVGKRDFEQQME 422
FD+ + E +G G+YG A+ ++ + V +K++ + KR E
Sbjct: 1 FDVGSRYKPI-ENIGSGAYGVVCSAI--DTRSGKKVAIKKIPHAFDVPTLAKRTLR---E 54
Query: 423 I-VGRVGQHPNVVPLRAYYYSKDEKL----LVYDYFASGSLSTLLHGNRGAGRTPLDWET 477
+ + R +H N++ +R +V D S L ++H ++ PL E
Sbjct: 55 LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQ-----PLTEEH 108
Query: 478 RVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPS 536
L RG+ +IHS H ++K SN+L+N+D + I DFG+ L + P
Sbjct: 109 IRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165
Query: 537 R-------SAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPL 575
+ YRAPE++ + +++ D++S G + EML G+ L
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVG------KRDFEQQMEIVGRVGQHPNVVPL 436
+G G+ GT YK + + + LK V+ G +R +++EI+ R HPNVV
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYA--LK-VIYGNHEDTVRRQICREIEIL-RDVNHPNVVKC 137
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
+ E ++ ++ GSL G A L R +IL G+A++H
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLE----GTHIADEQFLADVAR-QIL----SGIAYLHRR- 187
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVIET--- 549
H +IK SN+LIN + I+DFG++ ++ P S+ Y +PE I T
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN 245
Query: 550 --RKHSHKSDVYSFGVLLLEMLTGKAPL 575
+ D++S GV +LE G+ P
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 43/153 (28%), Positives = 79/153 (51%), Gaps = 13/153 (8%)
Query: 431 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
P +V +YS E + ++ GSL +L + AGR P + ++ I RG+
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISI--AVLRGLT 113
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP---SRSAGYRAPEV 546
++ K H ++K SN+L+N + + DFG++ L++ A +RS Y +PE
Sbjct: 114 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPER 169
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579
++ ++ +SD++S G+ L+EM G+ P+ P
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 382 VLGKGSYGTAYKAVLEESTTV----VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNV 433
VLGKGS+G K +L E +K LK +VV+ D E M ++ G+ P +
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
L + + + D V +Y G L + G + P +I A G+ +H
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEI----AIGLFFLH 118
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIET 549
S G + ++K NV+++ + I+DFG+ ++ + Y APE+I
Sbjct: 119 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 583
+ + D ++FGVLL EML G+AP + D++
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 40/221 (18%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 400 TTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL----LVYD 451
V+++ K+ G E +++ + R+ N++ + + + L L+ +
Sbjct: 44 KEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-SMGGPKFTHGNIKASNV 510
Y G L +L + L ++T++ + + +G+ +++ P + N+ + +
Sbjct: 103 YCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSF 154
Query: 511 LINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPEVIET--RKHSHKSDVYSFGVLLLE 567
L+ ++ I GL +++ P + + Y + +++ +++ K D+YS GV+L E
Sbjct: 155 LVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWE 214
Query: 568 MLTGKAPLQSPTRDDMVDL--------------PRWVQSVV 594
+ TGK P ++ T ++ DL P ++ +V
Sbjct: 215 IFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIV 255
|
Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 382 VLGKGSYGTAYKAVLEESTTV----VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNV 433
VLGKGS+G K +L E +K LK +V++ D E M ++ G+ P +
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHI 492
L + + + D V +Y G L + H + G + P +I A G+ +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEI----AIGLFFL 117
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIE 548
HS G + ++K NV+++ + I+DFG+ +R + Y APE+I
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA 174
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 583
+ + D ++FGVLL EML G+ P D++
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 46/201 (22%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 382 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ--QMEI-VGRVGQHPNVVPLRA 438
V+G+G++G + + +V+ + V +D Q E V ++ HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---E 63
Query: 439 YYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
YY + +D+ L +V +Y G+L+ + + LD +T + + + H+H+
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHT- 119
Query: 496 GGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK 551
H ++K N+L+++ I DFG++ +++ + G Y +PE+ E +
Sbjct: 120 --KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP 177
Query: 552 HSHKSDVYSFGVLLLEMLTGK 572
++ KSD+++ G +L E+ + K
Sbjct: 178 YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNVVPLRAYY 440
+G G+YG YKA + + ++ ++ G DF QQ + + +H N+V Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
S+++ + +Y GSL + H PL + T +G+A++HS G
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRK---HS 553
H +IK +N+L+ + D ++DFG+ + +S + APEV K ++
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 554 HKSDVYSFGVLLLEMLTGKAPLQSPTRD 581
D+++ G+ +E+ A LQ P D
Sbjct: 188 QLCDIWAVGITAIEL----AELQPPMFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 58/291 (19%), Positives = 106/291 (36%), Gaps = 73/291 (25%)
Query: 398 ESTTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455
V VK L+ + DF ++++I+ R+ PN+ L ++ +Y +
Sbjct: 45 APVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 456 GSLSTLLH------GNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASN 509
G L+ L L + T + + A G+ ++ S+ F H ++ N
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160
Query: 510 VLINQDLDGCISDFGLTPLMNVPATPSRSAGY---------RAP--------EVIETRKH 552
L+ ++ I+DFG+ SR+ Y RAP E + K
Sbjct: 161 CLVGKNYTIKIADFGM----------SRNL-YSSDYYRVQGRAPLPIRWMAWESVLLGKF 209
Query: 553 SHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610
+ KSDV++FGV L E+LT + P + T ++
Sbjct: 210 TTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI-------------------------- 243
Query: 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 661
+N + + P P ++ ++ E + D E+RP+ E
Sbjct: 244 ENAGH--FFRDDGRQIYLPR-PPNCP--KDIYELMLECWRRDEEDRPTFRE 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 66/245 (26%), Positives = 99/245 (40%), Gaps = 63/245 (25%)
Query: 382 VLGKGSYGTAYKAVLEESTTVVV--KRLKEVVVGKRDFEQ----QMEIVGRVGQHPNVVP 435
V+G+G++G + V ++ T V K L++ + KR+ + +I+ P +V
Sbjct: 8 VIGRGAFGEVW-LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-ADSPWIVK 65
Query: 436 LRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETR---VKILLGTARGVA 490
L YY +DE+ L V +Y G L LL R P + R +++L +
Sbjct: 66 L--YYSFQDEEHLYLVMEYMPGGDLMNLL--IR-KDVFPEET-ARFYIAELVLA----LD 115
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGL------------------TPLMN 530
+H +G F H +IK N+LI D DG I +DFGL L
Sbjct: 116 SVHKLG---FIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 531 VPATPSRSA---------------GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
R Y APEV+ + + D +S GV+L EML G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 576 QSPTR 580
S T
Sbjct: 231 YSDTL 235
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 383 LGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQ----QMEIVGRVGQHPNVVPL 436
LGKG +G A ++T K+L + + KR EQ + +I+ +V +V L
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSL 58
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTAR---GVAH 491
+ +KD+ LV G L + G G E R + A+ G+ H
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP------EARA--IFYAAQIICGLEH 110
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIE 548
+H + ++K NVL++ + ISD GL + AG Y APEV++
Sbjct: 111 LHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
+ D ++ G L EM+ G++P +
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 65/298 (21%), Positives = 115/298 (38%), Gaps = 64/298 (21%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVV 434
+G+G +G Y+ V E V VK K + F Q+ I+ R HP++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM-RQFDHPHIV 70
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
L +++ +V + G L + L N+ LD + + + +A++ S
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLES 125
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIET 549
+F H +I A NVL++ + DFGL+ + + S G + APE I
Sbjct: 126 K---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 550 RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV-------------DLPRWVQSVVR 595
R+ + SDV+ FGV + E+L G P Q +D++ + P + S++
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 242
Query: 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653
+ W + P RP E+ + ++ Q +
Sbjct: 243 KCWAYD------------------------------PSKRPRFTELKAQLSDILQEEK 270
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 382 VLGKGSYGTAYKAVLEESTTVV--VKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 435
++G+G +G + V E++T + +K +K+ V+ ++ FE++ +I+ P +
Sbjct: 8 LVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI-SNSPWIPQ 65
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
L+ + KD LV +Y G L +LL NR D E + L A V IHS+
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYED--QFD-EDMAQFYL--AELVLAIHSV 118
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN-----VPATPSRSAGYRAPEVIETR 550
+ H +IK NVLI++ ++DFG + P + Y APEV+ T
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 551 KHSHKS------DVYSFGVLLLEMLTGKAPLQSPT 579
K D +S GV+ EM+ G++P T
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVPLR 437
++G+GSYG K +E+ +V +K+ E K + M + + Q H N+V L
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ K LV+++ L L G LD K L RG+ HS
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH-- 119
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--------ATPSRSAGYRAPE-VIE 548
H +IK N+L++Q + DFG + P AT YRAPE ++
Sbjct: 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVAT----RWYRAPELLVG 174
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPL 575
K+ D+++ G L+ EMLTG+ PL
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGE-PL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNVVPLRAYY 440
+G G+YG YKA + + ++ ++ G+ DF QQ I+ + +H N+V Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
+D+ + ++ GSL + H PL + T +G+ ++HS G
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKGK--- 127
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRK---HS 553
H +IK +N+L+ + ++DFG++ + +S + APEV + ++
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 554 HKSDVYSFGVLLLEMLTGKAPLQSPTRD 581
D+++ G+ +E+ A LQ P D
Sbjct: 188 QLCDIWAVGITAIEL----AELQPPMFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLR 437
E +G+G++G + L ++T V VK +E + K F Q+ I+ + HPN+V L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLI 59
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
K +V + G T L G L + ++++ A G+ ++ S
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLR-TEGP---RLKVKELIQMVENAAAGMEYLES--- 112
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-------APEVIETR 550
H ++ A N L+ + ISDFG++ + + G + APE +
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 551 KHSHKSDVYSFGVLLLEMLT-GKAP 574
++S +SDV+SFG+LL E + G P
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 383 LGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
LG G++G K V + + V +K LK K ++ M + Q N +R
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLK-NENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 440 YYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-- 496
+ E L LV + + G L+ L G + +I + + H SMG
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFLSGKKD------------EITVSNVVELMHQVSMGMK 109
Query: 497 ---GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSRSAG-----YRAPEV 546
G F H ++ A NVL+ ISDFGL+ + + +RSAG + APE
Sbjct: 110 YLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 547 IETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
I RK S +SDV+S+G+ + E + G+ P
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 30/177 (16%)
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 542
G+A++HS + H ++ A NVL++ D I DFGL A P YR
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEYYRVREDG 170
Query: 543 -------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR--DDMVDLPRWVQSV 593
A E ++ K S+ SDV+SFGV L E+LT QSP + ++M+ + +V
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230
Query: 594 VREEWTAEVFD--VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648
VR E+ + + L +N +E+ +++ C RP ++ +++E+
Sbjct: 231 VR---LIELLERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 64/287 (22%), Positives = 123/287 (42%), Gaps = 45/287 (15%)
Query: 383 LGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVV 434
LG+GS+G Y+ + E T V +K + E + +F + ++ H +VV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 72
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 489
L L++ + G L + L R + P + +++ A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 541
A++++ KF H ++ A N ++ +D I DFG+T ++ T G +
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 187
Query: 542 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 600
+PE ++ + SDV+SFGV+L E+ T + P Q + + V+R
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----------EQVLRFVMEG 237
Query: 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647
+ D + N + + +++++ C P MRP+ E++ I+E
Sbjct: 238 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 383 LGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 441
+G+GS G A + S V VK + +R+ ++ R QH NVV + Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 442 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 501
+E ++ ++ G+L+ ++ R L+ E + + + ++HS G
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 502 HGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSR--SAGYRAPEVIETRKHSHKSD 557
H +IK+ ++L+ D +SDFG + +VP S + + APEVI + + D
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 558 VYSFGVLLLEMLTGKAPLQSPT 579
++S G++++EM+ G+ P S +
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDS 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 65/257 (25%), Positives = 109/257 (42%), Gaps = 37/257 (14%)
Query: 429 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTAR 487
+HPN++ + + ++ + A GS ++LL G + E + IL G R
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMS----EALIGNILFGALR 112
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-------------MNVPAT 534
G+ ++H G + H NIKAS++LI+ D G +S GL+ L + P
Sbjct: 113 GLNYLHQNG---YIHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167
Query: 535 PSRSAGYRAPEVIETRKHSH--KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS 592
+ + +PE++ + + KSD+YS G+ E+ TG+ P Q R M L + ++
Sbjct: 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKG 225
Query: 593 VVREEWTAEVFDVELMRFQN--------IEEEMV--QMLQIGMACVAKVPDMRPNMDEVV 642
F E R +N I E +V M Q + + P +
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ 285
Query: 643 RMIEEVRQSDSENRPSS 659
++E Q D E RPS+
Sbjct: 286 NLVELCLQQDPEKRPSA 302
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD----FEQQMEI-VGRVGQHPNVVP 435
E +G+G+YGT +KA E+ +V LK V + D EI + + +H N+V
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVA--LKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
L +S + LV++Y L G +D E + +G+A HS
Sbjct: 64 LYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGD----IDPEIVKSFMFQLLKGLAFCHSH 118
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETR 550
H ++K N+LIN++ + ++DFGL +P SA YR P+V+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGA 174
Query: 551 K-HSHKSDVYSFGVLLLEMLTGKAPL 575
K +S D++S G + E+ PL
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 383 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 441
L GS G + A + VV+K +G++ ++ + HP+V+ ++
Sbjct: 74 LTPGSEGRVFVATKPGQPDPVVLK------IGQKGTTLIEAMLLQNVNHPSVIRMKDTLV 127
Query: 442 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 501
S +V +++S L T L PL + + I G+ ++H+ +
Sbjct: 128 SGAITCMVLPHYSS-DLYTYLTKRSR----PLPIDQALIIEKQILEGLRYLHAQ---RII 179
Query: 502 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY---RAPEVIETRKHSHKSDV 558
H ++K N+ IN CI D G V AG APEV+ K++ K+D+
Sbjct: 180 HRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADI 239
Query: 559 YSFGVLLLEML 569
+S G++L EML
Sbjct: 240 WSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 21/231 (9%)
Query: 382 VLGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFE----QQMEIVGRVGQHPNVVPL 436
VLGKG +G V K+L++ + KR E + +I+ +V VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVSL 65
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
Y +KD LV G L ++ AG + V G+ +H
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG---FEEGRAVFYAAEICCGLEDLHQ-- 120
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-----RSAGYRAPEVIETRK 551
+ + ++K N+L++ ISD GL ++VP + + GY APEV++ +
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNER 177
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRD-DMVDLPRWVQSVVREEWTAE 601
++ D ++ G LL EM+ G++P Q + ++ R V+ V+EE++ +
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 51/203 (25%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAY 439
LG G+ G +K + S ++ ++L + + + ++++++ P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGA 71
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+YS E + ++ GSL +L + AGR P +V I +G+ ++ K
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI--AVIKGLTYLREKH--K 124
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP---SRSAGYRAPEVIETRKHSHK 555
H ++K SN+L+N + + DFG++ L++ A +RS Y +PE ++ +S +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPERLQGTHYSVQ 182
Query: 556 SDVYSFGVLLLEMLTGKAPLQSP 578
SD++S G+ L+EM G+ P+ P
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPP 205
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 76/311 (24%), Positives = 127/311 (40%), Gaps = 65/311 (20%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQ-----MEIVGRVGQHPNVV 434
E LG+G+YG K + T++ VKR++ V EQ+ ++I R P V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
+ + + + + + SL G T + + KI + + + ++HS
Sbjct: 64 TFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLT-IPEDILGKIAVSIVKALEYLHS 121
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVI---- 547
H ++K SNVLIN++ + DFG++ + + AG Y APE I
Sbjct: 122 K--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 179
Query: 548 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW------VQSVVRE---EW 598
+ + KSDV+S G+ ++E+ TG+ P S W ++ VV E +
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WKTPFQQLKQVVEEPSPQL 228
Query: 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS 658
AE F E F N C+ K RPN E+++ P
Sbjct: 229 PAEKFSPEFQDFVN-------------KCLKKNYKERPNYPELLQH------------PF 263
Query: 659 SEENKSKDSNV 669
E + SK+++V
Sbjct: 264 FELHLSKNTDV 274
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 50/208 (24%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAY 439
LG G+ G K + S ++ ++L + + + ++++++ P +V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGA 71
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+YS E + ++ GSL +L + A R P E K+ + RG+A++ +
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVL---KEAKRIP--EEILGKVSIAVLRGLAYLREKH--Q 124
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP---SRSAGYRAPEVIETRKHSHK 555
H ++K SN+L+N + + DFG++ L++ A +RS Y +PE ++ +S +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPERLQGTHYSVQ 182
Query: 556 SDVYSFGVLLLEMLTGKAPLQSPTRDDM 583
SD++S G+ L+E+ G+ P+ P ++
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 47/200 (23%), Positives = 87/200 (43%), Gaps = 33/200 (16%)
Query: 417 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL-VYDYFASGSLSTLLHGNRGAGRTPLDW 475
F ++ + R+ HPN+V L + L V++Y +L +L A L
Sbjct: 25 FRRETALCARL-YHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL-----AADGALPA 78
Query: 476 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGC--ISDFGLTPLM--- 529
+++L +A H+ G H ++K N++++Q + + DFG+ L+
Sbjct: 79 GETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGV 135
Query: 530 --NVPATPSR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 581
AT +R + Y APE + + SD+Y++G++ LE LTG+ +Q +
Sbjct: 136 RDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVA 195
Query: 582 DM---------VDLPRWVQS 592
++ V LP W+
Sbjct: 196 EILYQQLSPVDVSLPPWIAG 215
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 10/109 (9%)
Query: 473 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 527
LD E +L G+ H+HS G H ++K SN+++ D I DFGL T
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176
Query: 528 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
M P +R YRAPEVI + D++S G ++ E++ G Q
Sbjct: 177 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV---VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
E+LG G+ GT YKA + ++ V L V ++ ++EI+ + P ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFY 65
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
++ ++ + ++ GSL + P R I + +G+ ++ S+
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGR--IAVAVVKGLTYLWSL-- 114
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGL-TPLMN-VPATPSRSAGYRAPEVIETRKHSHK 555
K H ++K SN+L+N + DFG+ T L+N + T + Y APE I ++
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 556 SDVYSFGVLLLEMLTGKAP 574
SDV+S G+ +E+ G+ P
Sbjct: 174 SDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRDFEQQM--EIVGRVGQHPNVVPL 436
++LGKG++G + S ++ KEV++ K + + V + +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
+ + +KD V +Y G L H R + E R + A V+ + +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGEL--FFH----LSRERVFSEDRTRFY--GAEIVSALDYLH 112
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGL--------TPLMNVPATPSRSAGYRAPEVIE 548
K + ++K N+++++D I+DFGL + TP Y APEV+E
Sbjct: 113 SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE----YLAPEVLE 168
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586
+ D + GV++ EM+ G+ P + + + +L
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 37/209 (17%)
Query: 383 LGKGSYGTAYKAVLEES-TTVVVKRL----KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
+G G+YGT A+ + V +K+L + + KR + +++ ++ + +H NV+ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHM-KHENVIGL- 79
Query: 438 AYYYSKDEKLLVY-DY-----FASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVA 490
++ D L + D+ F L L+ + + E R++ L+ +G+
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-------EDRIQFLVYQMLKGLK 132
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAP 544
+IH+ G H ++K N+ +N+D + I DFGL T S G YRAP
Sbjct: 133 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA-----RQTDSEMTGYVVTRWYRAP 184
Query: 545 EVIETRKH-SHKSDVYSFGVLLLEMLTGK 572
EVI H + D++S G ++ EMLTGK
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 63/223 (28%), Positives = 93/223 (41%), Gaps = 58/223 (26%)
Query: 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETR---VKILLGTARGVAHIHSMGGPKFTHGN 504
LV DY +G L + RT + E +++LL V H+HS H +
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA----VHHVHSK---HMIHRD 168
Query: 505 IKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------YRAPEVIETRKHSHKS 556
IK++N+L+ + + DFG + + AT S G Y APE+ + +S K+
Sbjct: 169 IKSANILLCSNGLVKLGDFGFSKMYA--ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKA 226
Query: 557 DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 616
D++S GVLL E+LT K P FD E N+EE
Sbjct: 227 DMFSLGVLLYELLTLKRP----------------------------FDGE-----NMEEV 253
Query: 617 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 659
M + L + P + P M E+V + SD + RPSS
Sbjct: 254 MHKTLAGRYDPLP--PSISPEMQEIVTAL---LSSDPKRRPSS 291
|
Length = 496 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 382 VLGKGSYGTAYKAVLEESTTV-VVKRLKEVVVGKRDFE----QQMEIVGRVGQHPNVVPL 436
VLGKG +G + + + K+L++ + KR E + +I+ +V VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSL 65
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV-----KILLGTARGVAH 491
Y +KD LV G L ++ N G E R +I G +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFD---EERAVFYAAEITCG----LED 117
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-ATPSR----SAGYRAPEV 546
+H + + ++K N+L++ ISD GL + +P R + GY APEV
Sbjct: 118 LHR---ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEV 172
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
++ +++ D + G L+ EM+ GK+P +
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 46/200 (23%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 383 LGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRD--FEQQMEIVGRVGQHPNVVPLR 437
+G G++G + + E + V + EV+ K++ + ++ V HP ++ R
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFII--R 65
Query: 438 AYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
++ D++ L + +Y G L + L R +GR + L + V + +
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYL---RNSGRF-----SNSTGLFYASEIVCALEYL 117
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGYRAPEVIETRKHSH 554
+ + ++K N+L++++ ++DFG L + T + Y APEVI+++ H+
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNK 177
Query: 555 KSDVYSFGVLLLEMLTGKAP 574
D ++ G+L+ EML G P
Sbjct: 178 AVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----------Q 429
E +G+G+YG YKA V +K+++ E + E V
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIR--------LETEDEGVPSTAIREISLLKELN 56
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
HPN+V L +S+++ LV+++ L + T LD L +G+
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFLDL----DLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YR 542
A+ HS + H ++K N+LI+++ ++DFGL VP R+ YR
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV---RTYTHEVVTLWYR 166
Query: 543 APEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
APE+ + +R++S D++S G + EM+ + PL
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 382 VLGKGSYGTAYKAVLEESTTV-VVKRLKEVVVGKRDFE----QQMEIVGRVGQHPNVVPL 436
VLGKG +G + + + KRL++ + KR E + +I+ +V VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNL 65
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
Y +KD LV G L ++ GN G + E + G+ +H
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FEEERALFYAAEILCGLEDLHR 120
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-----RSAGYRAPEVIET 549
+ ++K N+L++ ISD GL + +P S + GY APEV+
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNN 175
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQS 577
++++ D + G L+ EM+ G++P +
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 40/219 (18%)
Query: 381 EVLGKGSYGTAY---------------KAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVG 425
+VLG G+YG + VL+++T V + E +R +++
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTER------QVLE 59
Query: 426 RVGQHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 484
+ Q P +V L Y + D KL L+ DY G L T L + R E V+I G
Sbjct: 60 HIRQSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHL-----SQRERFK-EQEVQIYSG 112
Query: 485 -TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----S 538
+ H+H +G + +IK N+L++ + ++DFGL+ + +
Sbjct: 113 EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 539 AGYRAPEVIETRKHSHKS--DVYSFGVLLLEMLTGKAPL 575
Y AP+++ H D +S GVL+ E+LTG +P
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 381 EVLGKGSYGTAYKAVLEES-----TTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNV 433
+VLG G++GT YK + V +K L+E K + E + ++ V +P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 71
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTARGVAH 491
L + +L + G L + H + + L+W ++ A+G+ +
Sbjct: 72 CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 124
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------E 545
+ + H ++ A NVL+ I+DFGL L+ + G + P E
Sbjct: 125 LEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
I R ++H+SDV+S+GV + E++T G P
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 379 SAEVLGKGSYGTAYKAVLEESTT-----VVVKRLK----EVVVGKRDFEQQMEIVGRVGQ 429
+++L +G++G + +L + V VK +K E+ V ++ + G
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQV-TLLLQESCLLYGL--S 66
Query: 430 HPNVVP-LRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGT-- 485
H N++P L + ++Y Y G+L L R G P T+ + +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-------TPSRS 538
A G++++H G H +I A N +I+++L I+D L+ + P +R
Sbjct: 127 ACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDL-FPMDYHCLGDNENRP 182
Query: 539 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
+ A E + +++S SDV+SFGVLL E++T G+ P
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 383 LGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDF-----EQQMEIVGRVGQHPNVVP 435
+GKG++G Y+ +++ + +K L K+ +V K++ E+ + + + + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHS 494
L+ + + + LV DY + G L L GR E R K + + H+H
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKE---GRFS---EDRAKFYIAELVLALEHLHK 114
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG---YRAPEVI-ET 549
+ ++K N+L++ + DFGL+ + T + G Y APEV+ +
Sbjct: 115 Y---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 583
+ ++ D +S GVL+ EM G +P + M
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM 205
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 382 VLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 436
VLGKGS+G A + + + ++ K+VV+ D E M ++ + P + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHIHSM 495
+ + + D V +Y G L + H + G + P +I + G+ +H
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEI----SVGLFFLHRR 120
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRK 551
G + ++K NV+++ + I+DFG+ V +R+ Y APE+I +
Sbjct: 121 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 583
+ D +++GVLL EML G+ P D++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 383 LGKGSYGTAYKAVLEESTTV-VVKRLKEVVVGKRDFEQ----QMEIVGRVGQHPNVVPLR 437
LGKG +G ++ + + K+L + + K+ E+ + EI+ +V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
+ SK LV G L ++ G RG L+ E + G+ H+HSM
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-----LEMERVIHYSAQITCGILHLHSM 114
Query: 496 GGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK 551
+ ++K NVL++ D C +SD GL + T ++ AG Y APE+++
Sbjct: 115 D---IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPLQ 576
+S+ D ++ G + EM+ G+ P +
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD--FEQ---QMEIVGRVGQHPNVVPLR 437
LGKG+YG+ YK + T V +KE+ + + F Q +++I+ + P +V
Sbjct: 9 LGKGNYGSVYKVL--HRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFY 65
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
++ + + +Y +GSL L G P D +L V G
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPED------VLRRITYAVVK-----G 114
Query: 498 PKF-------THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEV 546
KF H ++K +NVL+N + + DFG++ N+ A+ +++ Y APE
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPER 172
Query: 547 IETR------KHSHKSDVYSFGVLLLEMLTGKAP 574
I++ ++ +SDV+S G+ +LEM G+ P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 35/216 (16%)
Query: 383 LGKGSYG---TAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHP 431
+G G+ G AY A+LE + V +K+L R F+ Q ++ + H
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLS------RPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 432 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVA 490
N++ L + + D + + L+ N + LD E +L G+
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYI---VMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAGYRAPE 545
H+HS G H ++K SN+++ D I DFGL T M P +R YRAPE
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPE 195
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 581
VI + D++S G ++ EM+ G P D
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVP 435
+V+GKGS+G A + + VK L K++V+ +++ + M ++ + +HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 494
L + + ++ V D+ G L L R E R + A + ++HS
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP------EPRARFYAAEIASALGYLHS 114
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGL----TPLMNVPATPSRSAGYRAPEVIETR 550
+ + ++K N+L++ ++DFGL + T + Y APEVI +
Sbjct: 115 I---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 551 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
+ + D + G +L EML G P +M D
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 381 EVLGKGSYGTAY---KAVLEESTTV-VVKRLKEVVVGKRDFEQQ-----MEIVGRVGQHP 431
+VLG G+YG + K ++ + +K L++ + ++ + ++ V Q P
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 432 NVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGV 489
+V L Y + + KL L+ DY + G + T L+ E V+ G +
Sbjct: 66 FLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS------EDEVRFYSGEIILAL 118
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRA 543
H+H +G + +IK N+L++ + ++DFGL+ + R+ Y A
Sbjct: 119 EHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYMA 174
Query: 544 PEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPL 575
PE+I + H D +S G+L+ E+LTG +P
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 23/151 (15%)
Query: 439 YYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
+Y +DE LV DY+ G L TLL ++ R P E + + V IHS+
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLP---EDMARFYIAEM--VLAIHSIH 119
Query: 497 GPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSRSAG-----YRAPEVIET 549
+ H +IK NVL+ D++G I +DFG MN T S Y +PE+++
Sbjct: 120 QLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 550 R-----KHSHKSDVYSFGVLLLEMLTGKAPL 575
K+ + D +S GV + EML G+ P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 20/101 (19%)
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 540
RG+ +IHS H ++K SN+L+N + D I DFGL + A P
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI----ADPEHDHTGFLTEY 169
Query: 541 -----YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 575
YRAPE++ K K+ D++S G +L EML+ + PL
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 60/244 (24%)
Query: 382 VLGKGSYGTAYKAVLEESTTV----VVKRLK-EVVVGKRDFEQQM------EIVGRVGQH 430
VLG+G +G K +L E +K LK ++ + + E M E +H
Sbjct: 6 VLGRGHFG---KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RH 61
Query: 431 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGT 485
P +V L A + ++D V +Y A G L +H + + E R ++LG
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-------EPRAVFYAACVVLGL 114
Query: 486 ARGVAHIHSMGGPKFTHGN------IKASNVLINQDLDGC--ISDFGLTPL-MNVPATPS 536
++ H N +K N+L+ D +G I+DFGL M S
Sbjct: 115 -------------QYLHENKIVYRDLKLDNLLL--DTEGFVKIADFGLCKEGMGFGDRTS 159
Query: 537 RSAG---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 593
G + APEV+ ++ D + GVL+ EML G++P +++ D S+
Sbjct: 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SI 213
Query: 594 VREE 597
V +E
Sbjct: 214 VNDE 217
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAGYR 542
G+ H+HS G H ++K SN+++ D I DFGL T M P +R YR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YR 184
Query: 543 APEVIETRKHSHKSDVYSFGVLLLEMLTGK 572
APEVI + D++S G ++ EM+ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 382 VLGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 436
V+GKGS+G A + VK L K+ ++ K++ + M ++ + +HP +V L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHSM 495
+ + D+ V DY G L L R P E R + A + ++HS+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRER---SFP---EPRARFYAAEIASALGYLHSL 115
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRK 551
+ ++K N+L++ ++DFGL + T S G Y APEV+ +
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
+ D + G +L EML G P S +M D
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 37/110 (33%), Positives = 60/110 (54%), Gaps = 8/110 (7%)
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-YRAPE 545
RG+ +IHS G H ++K SNV +N+D + I DFGL + T + YRAPE
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPE 185
Query: 546 VIETRKHSHKS-DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 594
++ H +++ D++S G ++ E+L GKA +D +D + + VV
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG---NDYIDQLKRIMEVV 232
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 35/216 (16%)
Query: 383 LGKGSYG---TAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHP 431
+G G+ G AY AVL+ + V +K+L R F+ Q ++ + H
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLS------RPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 432 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVA 490
N++ L + + D + + L+ N + LD E +L G+
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYL---VMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAGYRAPE 545
H+HS G H ++K SN+++ D I DFGL T M P +R YRAPE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPE 188
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 581
VI + D++S G ++ EM+ K + P RD
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVP 435
+V+GKGS+G A + E VK L++ + K+ E+ + ++ + +HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 494
L + + D+ V DY G L L R E R + A + ++HS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCF------LEPRARFYAAEIASALGYLHS 114
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-ATPSRSAG---YRAPEVIETR 550
+ + ++K N+L++ ++DFGL T S G Y APEV+ +
Sbjct: 115 L---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 551 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
+ D + G +L EML G P S +M D
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 36/223 (16%)
Query: 376 LRASAE------VLGKGSYGTAYKAVLEESTTVV--VKRLKEVVVGKRD----FEQQMEI 423
LR AE V+G+G++G + V +ST V +K L + + KR F ++ +I
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 424 VGRVGQHPNVVPLRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKI 481
+ P VV L +Y +D++ L V +Y G L L+ + + V +
Sbjct: 97 MA-FANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 153
Query: 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----TPS 536
L IHSMG F H ++K N+L+++ ++DFG MN T
Sbjct: 154 ALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204
Query: 537 RSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPL 575
+ Y +PEV++++ + + D +S GV L EML G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV--VKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVV 434
+V+G+G++G + V +S+ V +K L + + KR F ++ +I+ +V
Sbjct: 49 KVIGRGAFG-EVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANSEWIV 106
Query: 435 PLRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVA 490
L +Y +D+K L V +Y G L L+ P W +++L +
Sbjct: 107 QL--HYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFYTAEVVLA----LD 156
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN-----VPATPSRSAGYRAPE 545
IHSMG F H ++K N+L+++ ++DFG M+ T + Y +PE
Sbjct: 157 AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213
Query: 546 VIETRKHS----HKSDVYSFGVLLLEMLTGKAP 574
V++++ + D +S GV L EML G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 47/214 (21%)
Query: 386 GSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVG---------------Q 429
G+YG Y+A +++ +V +K+LK E++ E G Q
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLK--------MEKEKE-----GFPITSLREINILLKLQ 62
Query: 430 HPNVVPLRAYYYSK--DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTA 486
HPN+V ++ D+ +V +Y L +L+ + VK ++L
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS-----EVKCLMLQLL 116
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYR 542
GVAH+H H ++K SN+L+N I DFGL P P YR
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173
Query: 543 APEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
APE++ +++S D++S G + E+LT K PL
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK-PL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 51/227 (22%)
Query: 382 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ-------MEI-VGRVGQHPNV 433
+G+G+YG YKA +++ +V LK+V + D E++ EI + R H N+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVA--LKKV---RLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 434 VPLRAYYYSKDEKL----------LVYDYFAS---GSL-STLLHGNRGAGRTPLDWETRV 479
V L+ K + L LV++Y G L S L+H + ++ +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM------ 122
Query: 480 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-- 537
K LL G+ + H F H +IK SN+L+N ++DFGL L N + SR
Sbjct: 123 KQLL---EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPY 174
Query: 538 -----SAGYRAPEVI--ETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 577
+ YR PE++ E R + DV+S G +L E+ T K Q+
Sbjct: 175 TNKVITLWYRPPELLLGEER-YGPAIDVWSCGCILGELFTKKPIFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 49/219 (22%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRL----------KEVVVGKRDFEQQMEIVGRVGQHP 431
LG+G++G Y ++ + VK++ KEV E +++++ + QH
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV----NALECEIQLLKNL-QHE 64
Query: 432 NVVPLRAYY--YSKDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 488
+V YY DE L ++ +Y GS+ L T TR +IL G
Sbjct: 65 RIV---QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QIL----EG 116
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFG-----------LTPLMNVPATP 535
V ++HS H +IK +N+L +D G + DFG T + +V TP
Sbjct: 117 VEYLHS---NMIVHRDIKGANIL--RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 536 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ +PEVI + K+DV+S G ++EMLT K P
Sbjct: 172 Y----WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 39/215 (18%)
Query: 381 EVLGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--------- 428
E +G+G+YG YKA V E T+ +K+++ EQ+ E V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNE--TIALKKIR--------LEQEDEGVPSTAIREISLLKE 57
Query: 429 -QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTA 486
QH N+V L+ +S+ LV++Y L + + + P +K L
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNP----RLIKTYLYQIL 112
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR----SAGY 541
RG+A+ HS + H ++K N+LI++ + ++DFGL +P + Y
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWY 169
Query: 542 RAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 575
RAPE++ +H S D++S G + EM+ K PL
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK-PL 203
|
Length = 294 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVP 435
+V+GKGS+G A + + + VK L K+ ++ K++ M ++ + +HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 436 LRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIH 493
L Y + EKL V DY G L H R R L E R + A + ++H
Sbjct: 61 LH-YSFQTAEKLYFVLDYVNGGEL--FFHLQRE--RCFL--EPRARFYAAEVASAIGYLH 113
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIET 549
S+ + ++K N+L++ ++DFGL + T S G Y APEV+
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
+ D + G +L EML G P S M D
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 29/82 (35%), Positives = 47/82 (57%), Gaps = 11/82 (13%)
Query: 502 HGNIKASNVLINQDLDGCIS--DFGLTPLMNVPATPSRSAG---YRAPEVIE----TRKH 552
H ++K SN+L+ D G + DFG++ + +RSAG Y APE I+ K+
Sbjct: 138 HRDVKPSNILL--DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKY 195
Query: 553 SHKSDVYSFGVLLLEMLTGKAP 574
++DV+S G+ L+E+ TG+ P
Sbjct: 196 DIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 382 VLGKGSYGTAYKAVLEEST----TVVVKRLKE--VVVGKRDF---EQQMEIVGRVGQHPN 432
VLGKG YG ++ +K LK+ +V ++D + + I+ V +HP
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPF 61
Query: 433 VVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVA 490
+V L Y + KL L+ +Y + G L L R + E L + +
Sbjct: 62 IVDL-IYAFQTGGKLYLILEYLSGGELFMHLE------REGIFMEDTACFYLSEISLALE 114
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP----LMNVPATPSRSAGYRAPEV 546
H+H G + ++K N+L++ ++DFGL V T + Y APE+
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
+ H D +S G L+ +MLTG P + R +D
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRAYYY 441
+G+G+YG YKA ++ LK++ EI + R +HPNV+ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 442 SKDEK--LLVYDYFASGSLSTLLHGNRG--AGRTPLDW-ETRVKILLGTARGVAHIHSMG 496
S ++ L++DY A L ++ +R A + P+ + VK LL + + IH +
Sbjct: 69 SHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL--YQILDGIHYLH 125
Query: 497 GPKFTHGNIKASNVLINQDLDG----CISDFGLTPLMNVPATPSRSAG-------YRAPE 545
H ++K +N+L+ + I+D G L N P P YRAPE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 546 VIETRKHSHKS-DVYSFGVLLLEMLTGK 572
++ +H K+ D+++ G + E+LT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-----VGRVGQHPNVVPLR 437
LG+G+ G+ K L+ + + + + + + Q +I + + + P +V
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALK---TITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 438 AYYYSKDEKLL--VYDYFASGSLSTLL-----HGNRGAGRTPLDWETRVKILLGTARGVA 490
+ + + +Y GSL ++ G R G L KI +G++
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLG-----KIAESVLKGLS 119
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN-VPATPSRSAGYRAPEVIE 548
++HS K H +IK SN+L+ + + DFG++ L+N + T + ++ Y APE I+
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQ 176
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ +S SDV+S G+ LLE+ + P
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 36/135 (26%), Positives = 57/135 (42%), Gaps = 17/135 (12%)
Query: 122 IPNNTLGKLDALEVLSLR--------SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 173
+ + + LD E L + SE+ L +L L L +NN + IP
Sbjct: 75 LSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPP 133
Query: 174 S---FSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHL 228
L LDLS N ++P ++NL L L L N+LS +P ++ L +L
Sbjct: 134 LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191
Query: 229 NLSYNGLKGSIPSSL 243
+LS N + +P +
Sbjct: 192 DLSGNKIS-DLPPEI 205
|
Length = 394 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 64/237 (27%), Positives = 98/237 (41%), Gaps = 38/237 (16%)
Query: 375 LLRASAEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGKR--DFEQQMEIVGR 426
LLRA LG G++G Y+ + V VK L E + DF + I+ +
Sbjct: 10 LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 427 VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 486
H N+V L + + + ++ + A G L + L NR P +K LL A
Sbjct: 66 F-NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS--SLTMKDLLFCA 122
Query: 487 RGVAH-IHSMGGPKFTHGNIKASNVLINQDLDG---CISDFGLTPLMNVPATPSRSAGYR 542
R VA + F H +I A N L+ G I+DFG+ + R++ YR
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI------YRASYYR 176
Query: 543 ------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 586
PE + K+DV+SFGVLL E+ + G P T ++++
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTV--VVKRL-KEVVVGKRDFEQQMEIVGRVGQ---HPNVV 434
++LGKG++G V E++T +K L KEV++ K + + RV Q HP +
Sbjct: 1 KLLGKGTFGKVI-LVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRHPFLT 58
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
L+ + + D V +Y G L H +R T E R + A V+ +
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT----EERARFY--GAEIVSALEY 110
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGL--------TPLMNVPATPSRSAGYRAPEV 546
+ + +IK N+++++D I+DFGL + TP Y APEV
Sbjct: 111 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE----YLAPEV 166
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586
+E + D + GV++ EM+ G+ P + + + +L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 383 LGKGSYGT---AYKAVLEESTTVVVKRLKEV----VVGKRDFEQQMEIVGRVGQHPNVVP 435
LG+G+YG A A E TV +K++ V ++ KR ++++++ H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNITC 66
Query: 436 L---RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
L + +L +Y+ L ++ + PL + G+ +I
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYI 121
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----------YR 542
HS H ++K N+L+N D + I DFGL + P +AG YR
Sbjct: 122 HS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFS--ENPGENAGFMTEYVATRWYR 176
Query: 543 APEVIETRKHSHKS-DVYSFGVLLLEMLTGK 572
APE++ + + K+ DV+S G +L E+L K
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-YRAPE 545
RG+ +IHS H ++K SN+ +N+D + I DFGL + T + YRAPE
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 187
Query: 546 VIETRKHSHKS-DVYSFGVLLLEMLTGK 572
++ H +++ D++S G ++ E+LTG+
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 383 LGKGSYGTAYKAVLEESTTVV-VKRLKEV----VVGKRDF-EQQMEIVGRVGQHPNVVPL 436
+G+GSYG +K E+ +V +K+ E V+ K E +M + +HPN+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRML---KQLKHPNLVNL 65
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
+ K + LV++Y L+ L RG + KI+ T + V H
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNFCHKH- 119
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--------ATPSRSAGYRAPEVI- 547
H ++K N+LI + + DFG ++ P AT YRAPE++
Sbjct: 120 --NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT----RWYRAPELLV 173
Query: 548 -ETRKHSHKSDVYSFGVLLLEMLTGKA 573
+T ++ DV++ G + E+LTG+
Sbjct: 174 GDT-QYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 51/232 (21%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKR--------------LKEVVVGKRDFEQQMEIVGRV 427
+G+G+YGT YKA L V +K+ L+E+ + K+ E
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQ-LESF------- 58
Query: 428 GQHPNVVPLR----AYYYSKDEKL-LVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVK 480
+HPN+V L ++ KL LV+++ L+T L G + R +
Sbjct: 59 -EHPNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMR-Q 115
Query: 481 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-------PLMNVPA 533
+L RGV +HS + H ++K N+L+ D I+DFGL L +V
Sbjct: 116 LL----RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV 168
Query: 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
T YRAPEV+ ++ D++S G + E+ + + + D +D
Sbjct: 169 T----LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 382 VLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRDF---EQQMEIVGRVGQHPNVVPL 436
V+G+GSY L+++ + ++ KE+V D + + + + HP +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
+ + ++ V +Y G L + H R + L E + + ++H G
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLALNYLHERG 116
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAPEVIETRKH 552
+ ++K NVL++ + ++D+G+ P T S G Y APE++ +
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 553 SHKSDVYSFGVLLLEMLTGKAPL 575
D ++ GVL+ EM+ G++P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 50/225 (22%), Positives = 99/225 (44%), Gaps = 17/225 (7%)
Query: 382 VLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRDF---EQQMEIVGRVGQHPNVVPL 436
V+G+GSY L+++ + ++ KE+V D + + + + +P +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
+ + + LV +Y G L + H R + L E + +H G
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL--MFHMQR---QRKLPEEHARFYAAEICIALNFLHERG 116
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAPEVIETRKH 552
+ ++K NVL++ D ++D+G+ P T S G Y APE++ ++
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 553 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 597
D ++ GVL+ EM+ G++P T + ++ ++ V+ E+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 381 EVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVVGKRDF-EQQMEIVGRVGQ-- 429
E LG+G++ +K + E T V++K L + R++ E E + Q
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS 57
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
H ++V DE ++V +Y GSL T L N+ + W+ V L A
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL--INISWKLEVAKQLAWA--- 112
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGC--------ISDFGLTPLMNVPATPSRSAGY 541
+H + THGN+ A NVL+ ++ D +SD G++ + +
Sbjct: 113 --LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPW 170
Query: 542 RAPEVIETRKH-SHKSDVYSFGVLLLEMLTG 571
PE IE ++ S +D +SFG L E+ +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 1e-06
Identities = 22/60 (36%), Positives = 30/60 (50%), Gaps = 2/60 (3%)
Query: 156 SLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL 213
+L+ L L +N + +F P L VLDLS N+ T P++ L L L L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-06
Identities = 14/42 (33%), Positives = 21/42 (50%), Gaps = 3/42 (7%)
Query: 64 LNSDRQALLDFADAV---PHLRKLNWSSTNPICQSWVGINCT 102
LN DR ALL F ++ P +W+ ++ SW G+ C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 2e-06
Identities = 24/60 (40%), Positives = 32/60 (53%), Gaps = 4/60 (6%)
Query: 133 LEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSF 189
L+ L L +N LT +P LP+L+ L L NN + P +FS P L LDLS N+
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 70/303 (23%), Positives = 134/303 (44%), Gaps = 54/303 (17%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-----QQMEIVGRVGQHPNVVP 435
E LG+G+Y T +K + + +V LKE+ + + +++ ++ + +H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVA--LKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVT 68
Query: 436 LRAYYYSKDEKLLVYDYFAS---------GSLSTLLHGNRGAGRTPLDWETRVKILL-GT 485
L ++ LV++Y G++ ++ VKI L
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM---------------HNVKIFLYQI 113
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----ATPSRSAGY 541
RG+A+ H K H ++K N+LIN+ + ++DFGL +VP + + Y
Sbjct: 114 LRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWY 170
Query: 542 RAPEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-RWVQSVVREEWT 599
R P+V + + ++S + D++ G + EM +G+ T +D + L R + + E W
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230
Query: 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVRMIEEVRQSDSENRPS 658
+ + + N + Q L I A P +D E + ++ + Q +S+ R S
Sbjct: 231 G-ISSNDEFKNYNFPKYKPQPL-INHA---------PRLDTEGIELLTKFLQYESKKRIS 279
Query: 659 SEE 661
+EE
Sbjct: 280 AEE 282
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVG--RVGQHPNVVPLR 437
EV+GKGSYG A+ V +K++ +V D + + + R+ +HP++V ++
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR--TPLDWETRVKILLGTARGVAHIHSM 495
+ Y + + LH A TP + + LL R + +IH+
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL---RALKYIHTA 122
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-------RSAGYRAPEVIE 548
H ++K N+L N D I DFGL + + + YRAPE+
Sbjct: 123 N---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 549 T--RKHSHKSDVYSFGVLLLEMLTGKAPL 575
+ K++ D++S G + E+LTGK PL
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK-PL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRAYYY 441
+G+G+YG YKA ++ LK++ EI + R +HPNV+ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 442 SK-DEKL-LVYDYFASGSLSTLLHGNRG--AGRTPLDW-ETRVKILLGTARGVAHIHSMG 496
S D K+ L++DY A L ++ +R A + P+ VK LL + + IH +
Sbjct: 69 SHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL--YQILDGIHYLH 125
Query: 497 GPKFTHGNIKASNVLINQDLDG----CISDFGLTPLMNVPATPSRSAG-------YRAPE 545
H ++K +N+L+ + I+D G L N P P YRAPE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 546 VIETRKHSHKS-DVYSFGVLLLEMLTGK 572
++ +H K+ D+++ G + E+LT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 402 VVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK--LLVYDYFASGS 457
V VK LK G D ++++EI+ R H N+V + L+ ++ SGS
Sbjct: 36 VAVKSLKPESGGNHIADLKKEIEIL-RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94
Query: 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 517
L L N+ ++ + ++K + +G+ + +G ++ H ++ A NVL+ +
Sbjct: 95 LKEYLPRNKNK----INLKQQLKYAVQICKGMDY---LGSRQYVHRDLAARNVLVESEHQ 147
Query: 518 GCISDFGLTPLM-------NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 570
I DFGLT + V + APE + K SDV+SFGV L E+LT
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTT--VVVKRLKEVVVGKRDFEQQMEIVGRVGQ---HPNVVP 435
++LGKG++G V E++T +K LK+ V+ +D RV Q HP +
Sbjct: 1 KLLGKGTFGKVI-LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 494
L+ + + D V +Y G L L R + E R + + ++HS
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHS 113
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGL--------TPLMNVPATPSRSAGYRAPEV 546
+ ++K N+++++D I+DFGL + TP Y APEV
Sbjct: 114 E--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE----YLAPEV 167
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586
+E + D + GV++ EM+ G+ P + + + +L
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 48/193 (24%), Positives = 68/193 (35%), Gaps = 64/193 (33%)
Query: 440 YYS---KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHSM 495
YYS KD V DY G + +LL R + E + + + +H M
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLI------RLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 496 GGPKFTHGNIKASNVLINQDLDGCI--SDFGL---------------------------- 525
G F H +IK N+LI D DG I +DFGL
Sbjct: 121 G---FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 526 --TPLMNVPATPSR-----------------SAGYRAPEVIETRKHSHKSDVYSFGVLLL 566
+ + P + Y APEV+ ++ D +S GV+L
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 567 EMLTGKAPLQSPT 579
EML G+ P + T
Sbjct: 236 EMLVGQPPFLADT 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV---VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
E LG+GSY T YK + + +V V RL+E ++ ++ + +H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLH 69
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVAHIHSMG 496
++K+ LV++Y + L + + G G P VK+ L RG+++IH
Sbjct: 70 DIIHTKETLTLVFEYVHT-DLCQYMDKHPG-GLHP----ENVKLFLFQLLRGLSYIHQR- 122
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR---SAGYRAPEV-IETRK 551
H ++K N+LI+ + ++DFGL +VP+ T S + YR P+V + + +
Sbjct: 123 --YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
+S D++ G + +EM+ G A P D+ D
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAF--PGMKDIQD 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 381 EVLGKGSYGTAYKAVL-EESTT---VVVKRLKEVVVGKRDFEQQMEIVGRVGQ---HPNV 433
++LGKG++G K +L E T +K LK+ V+ +D RV Q HP +
Sbjct: 1 KLLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR---VKILLGTARGVA 490
L+ + + D V +Y G L H +R R + R +I+ +
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARFYGAEIVSA----LG 109
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEV 546
++HS + ++K N+++++D I+DFGL ++ AT G Y APEV
Sbjct: 110 YLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586
+E + D + GV++ EM+ G+ P + + + +L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 33/212 (15%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----------QH 430
E +G+G+YG YK +++ +V + K E + E V QH
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMK-------KIRLESEEEGVPSTAIREISLLKELQH 58
Query: 431 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
PN+V L+ + L+++ F S L L +D E L +G+
Sbjct: 59 PNIVCLQDVLMQESRLYLIFE-FLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGIL 115
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSR----SAGYRAP 544
HS + H ++K N+LI+ G I +DFGL +P + YRAP
Sbjct: 116 FCHSR---RVLHRDLKPQNLLIDN--KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAP 170
Query: 545 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
EV+ + ++S D++S G + EM T K PL
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 36/212 (16%)
Query: 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLR 437
AE LG+G+ + VL V VK L+ V + DF ++++I+ R+ ++PN++ L
Sbjct: 30 AEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLL 83
Query: 438 AYYYSKDEKLLVYDYFASGSL----------STLLHGNRGAGRTPLDWETRVKILLGTAR 487
S D ++ +Y +G L ST H N + + +L +
Sbjct: 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN------IPSVSIANLLYMAVQ 137
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP---------LMNVPATPSRS 538
+ + + F H ++ N L+ I+DFG++ + P R
Sbjct: 138 IASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR- 196
Query: 539 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 570
+ A E I K + SDV++FGV L EM T
Sbjct: 197 --WMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 4e-06
Identities = 23/60 (38%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGL 235
L LDLS N T + + L L L L NNL+ P +P LR L+LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-----QQMEIVGRVGQHPNVVPLR 437
LG+G+Y T +K + + +V LKE+ + + +++ ++ + +H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVA--LKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLH 69
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLH-GNRGAGRTPLDWETRVKILL-GTARGVAHIHSM 495
+++ LV++Y S L + GN L VKI + RG+++ H
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGN-------LMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR---SAGYRAPEV-IETR 550
K H ++K N+LIN+ + ++DFGL +VP T S + YR P+V + +
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 551 KHSHKSDVYSFGVLLLEMLTGK 572
++S D++ G +L EM TG+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 52/221 (23%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 383 LGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVV 434
LG+G++ YK VL +S +V +EV V RD E + Q +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 435 PLRAYYYS-KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
++ Y +DE ++V +Y G L LH + L W ++ + A + ++
Sbjct: 63 LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNN--VSLHW--KLDVAKQLASALHYLE 118
Query: 494 SMGGPKFTHGNIKASNVLINQD-------LDGCISDFGL-TPLMNVPATPSRSAGYRAPE 545
K HGN+ N+L+ + +SD G+ +++ R + APE
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-WIAPE 174
Query: 546 VIE--TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDM 583
I + +D +SFG LLE+ + G+ PL + + +
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 21/206 (10%)
Query: 382 VLGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN---VVPLR 437
VLGKG +G V K+L++ + KR E R+ + N VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
Y +KD LV G L ++ GN G D + + G+ +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FDEQRAIFYAAELCCGLEDLQR- 120
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-----RSAGYRAPEVIETR 550
+ + ++K N+L++ ISD GL + +P + + GY APEVI
Sbjct: 121 --ERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNE 176
Query: 551 KHSHKSDVYSFGVLLLEMLTGKAPLQ 576
K++ D + G L+ EM+ G++P +
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 48/215 (22%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 382 VLGKGSYG-TAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPNVVPLR 437
V+GKGSYG + + V+K+L +R+ EQ+ +++ ++ +HPN+V R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYR 65
Query: 438 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGA---GRTPLDWETRVKILLGTARGVAHIH 493
+ +D L +V + G L L +G ++W ++ A + ++H
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLH 119
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPATPSRSAGYRAPEVIET 549
H ++K NV + + + D G+ ++ ++ +T + Y +PE+
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 584
+ +++KSDV++ G + EM T K + + +V
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 62/245 (25%), Positives = 103/245 (42%), Gaps = 41/245 (16%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--------QHPNV 433
+G+G+YG +KA L+ V LK V V + + + V +HPNV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 434 VPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 488
V L ++ KL LV+++ L+T L G ET ++ RG
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRG 122
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---SAGYRAPE 545
+ +HS + H ++K N+L+ ++DFGL + + + + YRAPE
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD--------DMVDLPRWVQSVVREE 597
V+ ++ D++S G + EM K PL + D D++ LP E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPG------EED 232
Query: 598 WTAEV 602
W +V
Sbjct: 233 WPRDV 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 43/201 (21%), Positives = 79/201 (39%), Gaps = 12/201 (5%)
Query: 376 LRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP 435
LRAS E + + ++ KR+K E ++ +GR+ H N++
Sbjct: 169 LRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILK 227
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
+ S+ ++ + S + PL +TR I+ V +IH
Sbjct: 228 IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHD- 285
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY------RAPEVIET 549
K H +IK N+ +N D + DFG G+ +PE++
Sbjct: 286 --KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAG 342
Query: 550 RKHSHKSDVYSFGVLLLEMLT 570
+ +D++S G++LL+ML+
Sbjct: 343 DGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 6e-06
Identities = 20/46 (43%), Positives = 23/46 (50%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF 167
IP+ L L+VL L N LT P + LPSLR L L NN
Sbjct: 15 IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTV-VVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 435
+V+G+G++G L+ + V +K L + + KR F ++ +++ G + +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDNQWITT 65
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
L + ++ LV DY+ G L TLL ++ R P E + L A V I S+
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLP---EDMARFYL--AEMVIAIDSV 118
Query: 496 GGPKFTHGNIKASNVLINQDLDGCI--SDFG--LTPLMNVPATPSRSAG---YRAPEVIE 548
+ H +IK N+L+ D++G I +DFG L + + S + G Y +PE+++
Sbjct: 119 HQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 549 TR-----KHSHKSDVYSFGVLLLEMLTGKAPL 575
K+ + D +S GV + EML G+ P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 39/150 (26%), Positives = 76/150 (50%), Gaps = 12/150 (8%)
Query: 442 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVAHIHSMGGPKF 500
S D+ LL+ +Y + G L+ + R P E V +L + +HS K
Sbjct: 136 SDDKLLLIMEYGSGGDLNKQIK-QRLKEHLPFQ-EYEVGLLFYQIVLALDEVHSR---KM 190
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPL------MNVPATPSRSAGYRAPEVIETRKHSH 554
H ++K++N+ + + DFG + ++V ++ + Y APE+ E +++S
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSK 250
Query: 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 584
K+D++S GV+L E+LT P + P++ +++
Sbjct: 251 KADMWSLGVILYELLTLHRPFKGPSQREIM 280
|
Length = 478 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 8/83 (9%)
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YRAPEVIETRKH 552
F H ++ A NVL+ ISDFGL+ + ++ + APE + K
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 553 SHKSDVYSFGVLLLEMLT-GKAP 574
S KSDV+SFGVL+ E + G+ P
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 58/248 (23%), Positives = 97/248 (39%), Gaps = 63/248 (25%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ---------QMEIVGRVGQHP 431
++LGKG G + ++ T + LK V+ K++ + + EI+ + HP
Sbjct: 7 KLLGKGDVGRVF--LVRLKGTGKLFALK--VLDKKEMIKRNKVKRVLTEQEILATL-DHP 61
Query: 432 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTA 486
+ L A + ++ LV DY G L LL G E + +LL
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG-KCLS---EEVARFYAAEVLLA-- 115
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-PATPSRSAG----- 540
+ ++H +G + ++K N+L+++ +SDF L+ +V P S++
Sbjct: 116 --LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 541 ---------------------------YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 573
Y APEVI H D ++ G+LL EML G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 574 PLQSPTRD 581
P + RD
Sbjct: 231 PFKGSNRD 238
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 1e-05
Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 10/158 (6%)
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
+PN + L + +L+ DY G L LL L KI+ +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEAL 122
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAGYRAPEVIE 548
+H H +IK NVL ++ D + D+GL ++ P+ + Y +PE I+
Sbjct: 123 NDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIK 179
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586
+ D ++ GVL E+LTGK P + D+ +DL
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKE-DEDEELDL 216
|
Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 469 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528
+ PL E + ARG+ + S K H ++ A N+L++++ I DFGL
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARD 222
Query: 529 MNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 582
+ R R APE I + ++ +SDV+SFGVLL E+ + A SP
Sbjct: 223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA---SPYPGV 279
Query: 583 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 642
+D EE+ + + MR E ++ I + C P+ RP E+V
Sbjct: 280 QID----------EEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHNNPEDRPTFSELV 327
Query: 643 RMIEEVRQSD 652
++ ++ Q +
Sbjct: 328 EILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 23/101 (22%)
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 540
RG+ +IHS H ++K SN+L+N + D I DFGL A + G
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL-------ARTTSEKGDFMTEY 168
Query: 541 -----YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
YRAPE++ +++ DV+S G + E+L K PL
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK-PL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 26/188 (13%)
Query: 470 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529
++PL E + ARG+ + S K H ++ A N+L++++ I DFGL +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 530 NVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDD 582
R R APE I + ++ +SDV+SFGVLL E+ + G +P
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG----- 279
Query: 583 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 642
VQ + EE+ + D MR E ++ +I +AC P RP +V
Sbjct: 280 -------VQ--INEEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERPTFSALV 328
Query: 643 RMIEEVRQ 650
++ ++ Q
Sbjct: 329 EILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 35/210 (16%)
Query: 382 VLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
++G GS+G Y+A+ ++ S V +K+ V+ ++ + ++ + H N++ L+ YY
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 441 YS----KDEKLL----VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL-LGTARGVAH 491
Y+ K+EK + V ++ + H R PL VK+ R +A+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL---FLVKLYSYQLCRALAY 185
Query: 492 IHSMGGPKFT-HGNIKASNVLIN---QDLDGCISDFG-----LTPLMNVPATPSRSAGYR 542
IHS KF H ++K N+LI+ L C DFG L +V SR YR
Sbjct: 186 IHS----KFICHRDLKPQNLLIDPNTHTLKLC--DFGSAKNLLAGQRSVSYICSRF--YR 237
Query: 543 APEV-IETRKHSHKSDVYSFGVLLLEMLTG 571
APE+ + ++ D++S G ++ EM+ G
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 32/204 (15%)
Query: 383 LGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQMEI--VGRVGQHPNVVPLRAY 439
+G+G++ KA + +K +K+ EI + R+ HPN++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 440 YYSKDEKLLVYDYFASGSLS---TLLHGN-----RGAGRTPLDWETRVK-ILLGTARGVA 490
+ D K +G L+ L+ N +G + PL E RVK + + +
Sbjct: 67 LF--DRK--------TGRLALVFELMDMNLYELIKGR-KRPLP-EKRVKSYMYQLLKSLD 114
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--PATPSRSAG-YRAPEVI 547
H+H G H +IK N+LI D+ ++DFG + P T S YRAPE +
Sbjct: 115 HMHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTRWYRAPECL 170
Query: 548 ETR-KHSHKSDVYSFGVLLLEMLT 570
T + K D+++ G + E+L+
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRD---FEQQMEIVGRVGQHPNVVP 435
+V+G+G++G + S V +L K ++ + D F ++ +I+ P VV
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQ 107
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHIH 493
L + +V +Y G L L+ P W +++L + IH
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTAEVVLA----LDAIH 159
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----TPSRSAGYRAPEVIE 548
SMG H ++K N+L+++ ++DFG M+ T + Y +PEV++
Sbjct: 160 SMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 549 TRK----HSHKSDVYSFGVLLLEMLTGKAPL 575
++ + + D +S GV L EML G P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEI-VGRVGQHPNVVPL 436
+ LG+GSY T YK + + +V LKE+ + + F E + + +H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVA--LKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILL-GTARGVAHIH 493
++K LV++Y + L + G G + V++ L RG+A+ H
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG---GLSM----HNVRLFLFQLLRGLAYCH 120
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR---SAGYRAPEVI-E 548
+ H ++K N+LI++ + ++DFGL +VP+ T S + YR P+V+
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG 177
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKA 573
+ ++S D++ G + EM TG+
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 23/150 (15%)
Query: 439 YYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
+Y +DE LV DY+ G L TLL ++ R P E + L A V I S+
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLP---EDMARFYL--AEMVLAIDSVH 119
Query: 497 GPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSRSAG-----YRAPEVIE- 548
+ H +IK NVL+ D +G I +DFG + T + Y +PE+++
Sbjct: 120 QLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 549 ----TRKHSHKSDVYSFGVLLLEMLTGKAP 574
++ + D +S GV + EML G+ P
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVPATPS-------RS 538
RG+ +IHS H ++K +NV IN DL I DFGL +++ + +
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 539 AGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 572
YR+P ++ + + K+ D+++ G + EMLTGK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVG--KRDFE----QQMEIVGRVGQHPNVVPL 436
+G+G++G +KA +++ +V LK+V++ K F ++++I+ + +H NVV L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVA--LKKVLMENEKEGFPITALREIKILQLL-KHENVVNL 76
Query: 437 RAYYYSKDEK--------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 488
+K LV++ F L+ LL N+ T + + +K+LL G
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFE-FCEHDLAGLLS-NKNVKFTLSEIKKVMKMLLN---G 131
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--------SAG 540
+ +IH K H ++KA+N+LI +D ++DFGL ++ +
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 541 YRAPEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579
YR PE+ + R + D++ G ++ EM T +Q T
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 51/225 (22%), Positives = 85/225 (37%), Gaps = 37/225 (16%)
Query: 383 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLR 437
+GKG G Y A S V +K+++E + K+ F ++ +I + HP +VP+
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVY 68
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE--TRVKILLG----TARGVAH 491
+ D Y +L +LL + T V L + +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL----------------------M 529
+HS G H ++K N+L+ + I D+G M
Sbjct: 129 VHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 530 NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
+P + Y APE + S +D+Y+ GV+L +MLT P
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 24/94 (25%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRA 543
G+ H+H + + ++K NVL++ D + ISD GL + + ++ + G+ A
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165
Query: 544 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 577
PE+++ ++ D ++ GV L EM+ + P ++
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-----QQMEIVGRVGQHPNVVPLR 437
LG+G+Y T YK + + +V LKE+ + + +++ ++ + +H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVA--LKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLH 70
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
+++ LV++Y L L GN ++ L RG+ + H
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNS------INMHNVKLFLFQLLRGLNYCHRR 123
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----ATPSRSAGYRAPEV-IETR 550
K H ++K N+LIN+ + ++DFGL ++P + + YR P++ + +
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 551 KHSHKSDVYSFGVLLLEMLTGKAPL 575
+S + D++ G + EM TG+ PL
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR-PL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----Y 541
RG+ ++HS G H +IK N+L+N + I DFGL + + + Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 542 RAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQS 577
RAPE++ +H + D++S G + E+L + Q+
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 44/197 (22%), Positives = 89/197 (45%), Gaps = 32/197 (16%)
Query: 414 KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL----------H 463
+ DF ++++I+ R+ + PN++ L +D ++ +Y +G L+ L +
Sbjct: 63 RNDFLKEVKILSRL-KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 464 GNRGAGRT----PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 519
GN + + + + + L A G+ ++ S+ F H ++ N L+ ++L
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIK 178
Query: 520 ISDFGLTP---------LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 570
I+DFG++ + P R + A E I K + SDV++FGV L E+L
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIR---WMAWECILMGKFTTASDVWAFGVTLWEILM 235
Query: 571 --GKAPLQSPTRDDMVD 585
+ P T + +++
Sbjct: 236 LCKEQPYGELTDEQVIE 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 31/116 (26%), Positives = 53/116 (45%), Gaps = 11/116 (9%)
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY----- 541
R + ++H + H +IKA N+ IN D C+ DFG V ++ G+
Sbjct: 193 RAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIA 248
Query: 542 -RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL-QSPTRDDMVDLPRWVQSVVR 595
APE++ + D++S G++L EM T L + D D R ++ ++R
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304
|
Length = 391 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 18/98 (18%)
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----------TPLMNVPATPS 536
GV+++HS H +IK +N+L + + + DFG T + +V TP
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 537 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ +PEVI + K+D++S G ++EMLT K P
Sbjct: 175 ----WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 46/139 (33%), Positives = 64/139 (46%), Gaps = 5/139 (3%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184
L L L L L N ++ LP EI L +L L L NN ++ SS S L L+L
Sbjct: 182 LSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDL-SNNSIIELLSSLSNLKNLSGLEL 239
Query: 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ 244
S N ++P+SI NL+ L L L +N +S + LR L+LS N L ++P
Sbjct: 240 SNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIAL 298
Query: 245 KFPNSSFVGNSLLCGPPLK 263
+ N LL L+
Sbjct: 299 LLLLLELLLNLLLTLKALE 317
|
Length = 394 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 383 LGKGSYGTAYKAVLEESTTV-VVKRLKEV-VVGKRDFEQQME---IVGRVGQHPNVVPLR 437
+GKGS+G + ++ + +K +++ +V + + + ++ +V P +VPL+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR-GVAHIHSMG 496
+ S ++ LV + G L H + GR +R + + ++H
Sbjct: 60 FSFQSPEKLYLVLAFINGGEL---FHHLQREGRFD---LSRARFYTAELLCALENLHKF- 112
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRKH 552
+ ++K N+L++ + DFGL L M + G Y APE++ +
Sbjct: 113 --NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 553 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 583
+ D ++ GVLL EMLTG P ++M
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNEM 201
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 52/242 (21%), Positives = 105/242 (43%), Gaps = 36/242 (14%)
Query: 345 KEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVL--EESTTV 402
K++ S + KNK+ + + +NF LG GS+G A E+ V
Sbjct: 12 KKDSDSTKEPKRKNKMKYED---FNF---------IRTLGTGSFGRVILATYKNEDFPPV 59
Query: 403 VVKRL-KEVVVGKRDFEQ---QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458
+KR K ++ ++ + + +I+ + HP V L + + LV ++ G
Sbjct: 60 AIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 459 STLLHGNRGAGRTPLD----WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 514
T L N+ R P D + ++ ++ ++ S+ + ++K N+L+++
Sbjct: 119 FTFLRRNK---RFPNDVGCFYAAQIVLIF------EYLQSL---NIVYRDLKPENLLLDK 166
Query: 515 DLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 573
D ++DFG +++ T + Y APE++ H +D ++ G+ + E+L G
Sbjct: 167 DGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226
Query: 574 PL 575
P
Sbjct: 227 PF 228
|
Length = 340 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 18/98 (18%)
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----------TPLMNVPATPS 536
G++++H H +IK +N+L + + + DFG T + +V TP
Sbjct: 118 GMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 537 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ +PEVI + K+DV+S G ++EMLT K P
Sbjct: 175 ----WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVG-QHPNVVPL 436
E LG+GSY T YK + + +V LK + + + F E G +H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVA--LKVISMKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
++K+ V++Y + L+ + + G G P + + LL RG+A+IH
Sbjct: 69 HDIIHTKETLTFVFEYMHT-DLAQYMIQHPG-GLHPYNVRLFMFQLL---RGLAYIH--- 120
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVI-ETRK 551
G H ++K N+LI+ + ++DFGL ++P+ S YR P+V+
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 552 HSHKSDVYSFGVLLLEMLTGK 572
+S D++ G + +EML G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 72/290 (24%), Positives = 116/290 (40%), Gaps = 53/290 (18%)
Query: 383 LGKGSYGTAYKAVLEESTT------VVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVV 434
+G G +G K +L E T VVVK LK K +F QQ + R+ QHPN++
Sbjct: 3 IGNGWFG---KVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPY-RILQHPNIL 58
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGN---RGAGRTPLDWETRVKILLGTARGVAH 491
LLV++Y G L + L R + L +I A GV H
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI----AAGVTH 114
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATPSRSAGYR 542
+H F H ++ N + DL + D+G+ P + P R +
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR---WL 168
Query: 543 APEVIETR-------KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 595
APE++ + + S+V++ GV L E+ A S D V + V++
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-----LNHVIK 223
Query: 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645
++ ++F +L E ++LQ C P+ R +EV R++
Sbjct: 224 DQQV-KLFKPQLE--LPYSERWYEVLQF---CWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 49/189 (25%), Positives = 80/189 (42%), Gaps = 24/189 (12%)
Query: 470 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529
+ L E + A+G+ + S K H ++ A N+L++++ I DFGL +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 530 NVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 583
R R APE I R ++ +SDV+SFGVLL E+ + A SP
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---SPYPGVK 286
Query: 584 VDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
+D EE+ + E R + + +M Q + C P RP E+V
Sbjct: 287 ID----------EEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334
Query: 644 MIEEVRQSD 652
+ + Q++
Sbjct: 335 HLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 37/170 (21%)
Query: 429 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TAR 487
++P VV + + +K +V +Y G +TLL + G P+D ++ T
Sbjct: 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL---KNIGALPVD---MARMYFAETVL 112
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP--LMN--------------- 530
+ ++H+ G H ++K N+LI ++DFGL+ LM+
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 531 ------VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
V TP Y APEVI + + D ++ G++L E L G P
Sbjct: 170 EFLDKQVCGTPE----YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 18/99 (18%)
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----------TPLMNVPATP 535
+GV+++HS H +IK +N+L + + + DFG T + +V TP
Sbjct: 117 QGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 536 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ +PEVI + K+DV+S ++EMLT K P
Sbjct: 174 Y----WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 402 VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459
V VK L+E + DF ++++I+ R+ + PN++ L A + D ++ +Y +G L+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 460 TLL--HGNRGAG----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN 513
L H + A + + T + + A G+ ++ S+ F H ++ N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG 164
Query: 514 QDLDGCISDFGLTP---------LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVL 564
++ I+DFG++ + P R + + E I K + SDV++FGV
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR---WMSWESILLGKFTTASDVWAFGVT 221
Query: 565 LLEMLT 570
L E+LT
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 55/197 (27%), Positives = 76/197 (38%), Gaps = 60/197 (30%)
Query: 430 HPNVVPLRAYYYS-KDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 486
+P VV L YYS +DE L+ +Y G + TLL T + ETR I A
Sbjct: 60 NPWVVKL---YYSFQDENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYI----A 108
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGL-TPL--------------- 528
+ I S+ + H +IK N+L+ D G I SDFGL T L
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 529 -----MNVPATPSRSAG---------------------YRAPEVIETRKHSHKSDVYSFG 562
++ + P S Y APEV ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 563 VLLLEMLTGKAPLQSPT 579
V++ EML G P S
Sbjct: 227 VIMYEMLVGYPPFCSDN 243
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 62/291 (21%)
Query: 383 LGKGSYGTAYKAVLEE------STTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPNVV 434
+G G +G K +L E VVVK L+ V + F ++ + R QH N++
Sbjct: 3 IGNGWFG---KVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPY-RSLQHSNLL 58
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
LLV ++ G L L R A D T ++ A G+ H+H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSR---SAGYRAPEVIE 548
F H ++ N L+ DL I D+GL+ + TP + + APE+++
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 549 -------TRKHSHKSDVYSFGVLLLEMLT-GKAP---------LQSPTRDDMVDLPR-WV 590
+ +S+V+S GV + E+ G P L R+ + LP+ +
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235
Query: 591 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 641
+ + + W E+M+F ++ P+ RP+ +EV
Sbjct: 236 KLPLSDRW------YEVMQFCWLQ-----------------PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 41/169 (24%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 418 EQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET 477
E+ M + G P +V + +++ D+ + D G L L + + +
Sbjct: 44 ERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYA 103
Query: 478 RVKILLGTARGVAHIHSMGGPKFT-HGNIKASNVLINQDLDGCISDFGLTPLMN--VPAT 534
IL G+ H+H+ +F + ++K +N+L+++ ISD GL + P
Sbjct: 104 TEIIL-----GLEHMHN----RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 154
Query: 535 PSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPL-QSPTRD 581
+ GY APEV++ + +D +S G +L ++L G +P Q T+D
Sbjct: 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 46/202 (22%), Positives = 83/202 (41%), Gaps = 23/202 (11%)
Query: 383 LGKGSYGTAYKAVL---EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
L GS G + E+ V+VK V G + ++++I+ + H ++ L
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVK----AVTGGKTPGREIDILKTI-SHRAIINLIHA 154
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
Y K +V + L T + PL E + I +A++H G
Sbjct: 155 YRWKSTVCMVMPKYKC-DLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG--- 205
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP-----SRSAGYRAPEVIETRKHS 553
H ++K N+ +++ + + DFG L P TP S + +PE++ +
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265
Query: 554 HKSDVYSFGVLLLEMLTGKAPL 575
K+D++S G++L EM L
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 55/214 (25%), Positives = 76/214 (35%), Gaps = 62/214 (28%)
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
VV L + KD V DY G + +LL G P D L A V +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRMGIFPEDLARFYIAELTCA--VESV 117
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG---------------------------- 524
H MG F H +IK N+LI++D ++DFG
Sbjct: 118 HKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 525 --------------LTPLMNVPATPSR---------SAGYRAPEVIETRKHSHKSDVYSF 561
L PL A + + Y APEV+ ++ D +S
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 562 GVLLLEMLTGKAPL--QSPTRDDMVDLPRWVQSV 593
GV+L EML G+ P Q+P M + W S+
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQM-KVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 47/205 (22%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 382 VLGKGSYGTAYKAVLEESTTV----VVKRLKEVVVGKRDF---EQQMEIVGRVGQHPNVV 434
V+G+GSY L+++ + V+K KE+V D + + + HP +V
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIK--KELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 493
L + + ++ V ++ + G L + H R + P E + + +H
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDL--MFHMQR-QRKLP---EEHARFYSAEISLALNFLH 113
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAPEVIET 549
G + ++K NVL++ + ++D+G+ P T S G Y APE++
Sbjct: 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAP 574
+ D ++ GVL+ EM+ G++P
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 472 PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN 530
PLD + ++ A+G+ + S H ++ A NVL+ I DFGL +MN
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 531 -----VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
V + APE I ++ +SDV+S+G+LL E+ + GK+P
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 17/104 (16%)
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY------- 541
+ +IH G H +IK NVL+N D C+ DFG A S S +
Sbjct: 273 IDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF----ARGSWSTPFHYGIAGT 325
Query: 542 ---RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 582
APEV+ ++ D++S G+++ E A L S +R D
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369
|
Length = 461 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 383 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--------QHPNVV 434
+G G+YGT YKA S V LK V V + + V V HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVA--LKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 435 PLRAYYYS----KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
L + ++ K+ LV+++ L T L G L ET ++ RG+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPG---LPAETIKDLMRQFLRGL 121
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--VPATPSR-SAGYRAPEV 546
+H+ H ++K N+L+ ++DFGL + + + TP + YRAPEV
Sbjct: 122 DFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
+ ++ D++S G + EM K PL
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK-PL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 61/249 (24%)
Query: 379 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP--- 435
S +V+G+G++G ++++ T V +K ++ K D ++ E VG + +++
Sbjct: 5 SLKVIGRGAFGEV--RLVQKKDTGHVYAMK--ILRKADMLEK-EQVGHIRAERDILVEAD 59
Query: 436 ---LRAYYYSKDEKL---LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
+ +YS +KL L+ ++ G + TLL + L E + T +
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL-----MKKDTLTEEETQFYIAETVLAI 114
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPAT----------PS-- 536
IH +G F H +IK N+L++ +SDFGL T L T PS
Sbjct: 115 DSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 537 --------RSA------------------GYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 570
R A Y APEV ++ D +S GV++ EML
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 571 GKAPLQSPT 579
G P S T
Sbjct: 232 GYPPFCSET 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 27/109 (24%), Positives = 54/109 (49%), Gaps = 6/109 (5%)
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--PATPSRSAGYRAPE 545
G+ H+H+ + ++K +N+L+++ ISD GL + P + GY APE
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 165
Query: 546 VIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 593
V++ + +D +S G +L ++L G +P + D ++ R ++
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 38/132 (28%), Positives = 51/132 (38%), Gaps = 24/132 (18%)
Query: 129 KLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSF--------- 175
KL L+VL L N L L S + PSL+ L L N +G+IP
Sbjct: 21 KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCL-SLNETGRIPRGLQSLLQGLTK 79
Query: 176 SPQLVVLDLSFNSFTGNIPQSIQNLTQ---LTGLSLQSNNLSGSIPNFDI-------PKL 225
L LDLS N+ + +++L + L L L +N L P L
Sbjct: 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL 139
Query: 226 RHLNLSYNGLKG 237
L L N L+G
Sbjct: 140 EKLVLGRNRLEG 151
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 17/39 (43%), Positives = 25/39 (64%)
Query: 541 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579
Y APEV+ + ++ D +S GV+L EML G+ P +PT
Sbjct: 214 YIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPT 252
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 672 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.45 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.35 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.33 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.3 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.23 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.21 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.09 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.09 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.05 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.91 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.85 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.8 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.78 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.77 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.75 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.67 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.66 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.66 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.66 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.64 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.62 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.57 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.42 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.37 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.29 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.24 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.17 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.15 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.13 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.12 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.09 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.08 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.07 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.06 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-59 Score=565.17 Aligned_cols=492 Identities=28% Similarity=0.477 Sum_probs=308.9
Q ss_pred EEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecc
Q 005875 108 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLS 185 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls 185 (672)
+..|+|++|.+.|.+|. .+ .+++|+.|+|++|+++|.+|..|.++++|+.|+|++|+++|.+|..+. ++|++|+|+
T Consensus 454 L~~L~L~~n~~~~~~p~-~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 531 (968)
T PLN00113 454 LQMLSLARNKFFGGLPD-SF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS 531 (968)
T ss_pred CcEEECcCceeeeecCc-cc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECC
Confidence 33444444444444443 12 334555555555555555555555566666666666666655555554 456666666
Q ss_pred cccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcc--cCCCCCCccccCCCCCCCC
Q 005875 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS--LQKFPNSSFVGNSLLCGPP 261 (672)
Q Consensus 186 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~--~~~~~~l~~~~n~~~~~~~ 261 (672)
+|+++|.+|..|+++++|+.|+|++|+++|.+|.. .+++|+.|++++|+++|.+|.. +..+....+.||+.+||.+
T Consensus 532 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~ 611 (968)
T PLN00113 532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGD 611 (968)
T ss_pred CCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCc
Confidence 66666666666666666666666666666655553 5556666666666666666542 3344444555666665532
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCcccccccccccceeeeeeechhHHHHHHHHHhhhhhccccCCCCCCCcCCCCCCCCCC
Q 005875 262 LKACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRS 341 (672)
Q Consensus 262 l~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~ivv~~~~~~llv~~~i~~~~~~rk~~~~~~~~~~~~~~~~~~ 341 (672)
...-. ++............++++++++++ ++++++++++++++|+........ ... +..
T Consensus 612 ~~~~~----------------~~c~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~ 670 (968)
T PLN00113 612 TTSGL----------------PPCKRVRKTPSWWFYITCTLGAFL-VLALVAFGFVFIRGRNNLELKRVE---NED-GTW 670 (968)
T ss_pred cccCC----------------CCCccccccceeeeehhHHHHHHH-HHHHHHHHHHHHHhhhcccccccc---ccc-ccc
Confidence 11000 000000011111122222222222 222222222223322211111000 000 000
Q ss_pred CCCccccCCCCCCcccCceeeec-cCCCCCCHHHHHHHH--hccccccCcEEEEEEEE-CCCcEEEEEEecccccChhhH
Q 005875 342 EKPKEEFGSGVQEPEKNKLVFFE-GCSYNFDLEDLLRAS--AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDF 417 (672)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~--~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~ 417 (672)
+ ...+. .....++.+++.... .+.||+|+||.||+|+. .++..||||+++.... ..
T Consensus 671 ~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~ 730 (968)
T PLN00113 671 E-----------------LQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IP 730 (968)
T ss_pred c-----------------ccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---cc
Confidence 0 00000 001123444443333 35799999999999997 4688999999865432 22
Q ss_pred HHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005875 418 EQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497 (672)
Q Consensus 418 ~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~ 497 (672)
..|+++++++ +|||||+++++|.+++..++||||+++|+|.++++. ++|..+.+++.|+++||+|||+.+.
T Consensus 731 ~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~ 801 (968)
T PLN00113 731 SSEIADMGKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCS 801 (968)
T ss_pred HHHHHHHhhC-CCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCC
Confidence 3457888888 999999999999999999999999999999999962 8899999999999999999997655
Q ss_pred CCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 005875 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 577 (672)
Q Consensus 498 ~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~ 577 (672)
++|+||||||+||+++.++..++. ||.+..........+++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 802 ~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CCeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 669999999999999999988875 6766554444445678899999999999999999999999999999999999964
Q ss_pred CCCCCCCChhHHHHHhhhhccccccchhhhhcc-cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 578 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF-QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.. .....+.+|.+............|+..... ....++...+.+++.+||+.+|++||||+|+++.|+++.+..+
T Consensus 881 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 881 EF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred cc-CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 32 223456667665444433334444443221 2234566788999999999999999999999999999977544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-51 Score=429.15 Aligned_cols=281 Identities=38% Similarity=0.680 Sum_probs=249.1
Q ss_pred CCCCCHHHHHHHH-----hccccccCcEEEEEEEECCCcEEEEEEecccccC-hhhHHHHHHHHHHHcCCCceeceEEEE
Q 005875 367 SYNFDLEDLLRAS-----AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVVPLRAYY 440 (672)
Q Consensus 367 ~~~~~~~~l~~~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~ 440 (672)
...|+++++..+| .+.||+|+||.||+|.+.+++.||||++...... ..+|..|++++.++ +|||+|+++|||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYC 140 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEE
Confidence 4568999999999 3689999999999999999999999988876554 67799999999999 799999999999
Q ss_pred EeCC-eeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeE
Q 005875 441 YSKD-EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 519 (672)
Q Consensus 441 ~~~~-~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 519 (672)
.+.+ +.+||||||++|+|.++++..... .++|..|++||.++|+||+|||+...|+|||||||++|||||+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9998 599999999999999999865432 689999999999999999999999888999999999999999999999
Q ss_pred EeecCCCCCCCC-CCC---C-CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh
Q 005875 520 ISDFGLTPLMNV-PAT---P-SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 594 (672)
Q Consensus 520 l~DfGla~~~~~-~~~---~-~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 594 (672)
|+|||+|+.... ... . .||.+|+|||++..+..+.|+|||||||++.|++||+.+.+.........+..|.....
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999976654 222 1 78999999999999999999999999999999999999988766555566899999888
Q ss_pred hhccccccchhhhhcccCh-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 595 REEWTAEVFDVELMRFQNI-EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 595 ~~~~~~~~~d~~~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.+....+++|+.+...... .+++..+.+++.+|++.+|++||+|.||+++|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 8888999999998643333 26888899999999999999999999999999776644
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=388.15 Aligned_cols=261 Identities=31% Similarity=0.494 Sum_probs=212.8
Q ss_pred CCCHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCC-
Q 005875 369 NFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD- 444 (672)
Q Consensus 369 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~- 444 (672)
..+..++. ..+.||+|+||+||+|.+.+...||||++.....+ .++|.+|+.++.++ +|||||+++|+|.+..
T Consensus 37 ~i~~~~l~--~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELP--IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhh--hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC
Confidence 34455543 34569999999999999996666999999876543 34899999999998 9999999999999887
Q ss_pred eeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-CeEEeec
Q 005875 445 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDF 523 (672)
Q Consensus 445 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~Df 523 (672)
..++||||+++|+|.++++.. ....+++..+++++.|||+||.|||+++ + |||||||++|||++.++ ++||+||
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCC
Confidence 789999999999999999863 2345999999999999999999999986 3 99999999999999998 9999999
Q ss_pred CCCCCCCC---CCC-CCCCCcccCccccc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhc
Q 005875 524 GLTPLMNV---PAT-PSRSAGYRAPEVIE--TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 597 (672)
Q Consensus 524 Gla~~~~~---~~~-~~~~~~y~aPE~~~--~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 597 (672)
|+++.... ..+ ..||+.|||||++. ...|+.|+||||||+++|||+||+.||......+ ....+....
T Consensus 189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~~~v~~~~ 262 (362)
T KOG0192|consen 189 GLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VASAVVVGG 262 (362)
T ss_pred ccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcC
Confidence 99976653 223 56899999999999 5689999999999999999999999998654311 111111111
Q ss_pred cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 598 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 598 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.+..+ ...+...+..++.+||+.||+.||++.|++..|+.+.....
T Consensus 263 ~Rp~~----------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 263 LRPPI----------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCC----------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 11111 12245667778889999999999999999999999977554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=390.97 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=218.1
Q ss_pred CCCHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEE
Q 005875 369 NFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 448 (672)
Q Consensus 369 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 448 (672)
.++.+++ ...+.||+|.||+||.|+++....||+|.++......++|.+|+++|++| +|+|||+++|+|..++..||
T Consensus 202 ei~r~~l--~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 202 EIPREEL--KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred eecHHHH--HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecCCceEE
Confidence 4455555 44678999999999999999888999999998888889999999999999 99999999999999889999
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 449 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
|||||+.|+|.++|+... +..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+.
T Consensus 279 VtE~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEEecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccc
Confidence 999999999999998622 345889999999999999999999998 99999999999999999999999999995
Q ss_pred CCCCCCCC-----CCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 529 MNVPATPS-----RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 529 ~~~~~~~~-----~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
........ -...|.|||.+....++.|||||||||+||||+| |+.||.+....+.+ ..+..+.
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~-------~~le~Gy---- 421 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL-------ELLERGY---- 421 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH-------HHHhccC----
Confidence 44332211 2345999999999999999999999999999999 99999876644432 1222222
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
+...+..+...+.++|..||+.+|++|||++.+...|+++....
T Consensus 422 ------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 422 ------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 12223446667888999999999999999999999999887643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=363.15 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=205.6
Q ss_pred CCHHHHHHHHhccccccCcEEEEEEEECC-CcEEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCC-e
Q 005875 370 FDLEDLLRASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-E 445 (672)
Q Consensus 370 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~ 445 (672)
....+++ ..+.||+|..|+|||++++. ++.+|+|.+.... ...+++.+|++++.+. +||+||.++|.|+.+. .
T Consensus 76 i~~~dle--~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 76 ISLSDLE--RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cCHHHhh--hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCce
Confidence 4455553 35789999999999999875 5678899884332 2356789999999999 9999999999999998 5
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEEecCCCCeEEeecC
Q 005875 446 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFG 524 (672)
Q Consensus 446 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 524 (672)
..++||||++|+|.+++... +.+++....+|+.+|++||.|||+ .+ ||||||||+|||++..|.+||||||
T Consensus 153 isI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccc
Confidence 99999999999999999743 349999999999999999999996 54 9999999999999999999999999
Q ss_pred CCCCCCCC--CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 525 LTPLMNVP--ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 525 la~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
.++..... .+..||..|||||.+.+..|+.++||||||++++|+.+|+.||.... ....+....+..++.+....
T Consensus 225 VS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv~~ppP~-- 301 (364)
T KOG0581|consen 225 VSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIVDEPPPR-- 301 (364)
T ss_pred ccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHhcCCCCC--
Confidence 99876543 46779999999999999999999999999999999999999998752 22233333343433322211
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+. .. ....+|..++..|+++||.+||+++|++++
T Consensus 302 ----lP--~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 ----LP--EG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ----CC--cc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 10 01 234456667779999999999999999984
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=396.87 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=214.4
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|+.. +.+.||||.+++.... ..+|++|++++..+ +|||||+++|+|.+++..++|+|
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCCeeEEEEE
Confidence 467999999999999843 3567999999987554 57899999999999 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEee
Q 005875 452 YFASGSLSTLLHGNRGAG---------RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 522 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 522 (672)
||..|||.+||....... ..+++..+.+.||.|||.||+||-++. +|||||..+|+||.++..|||+|
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecc
Confidence 999999999997543211 334899999999999999999999987 99999999999999999999999
Q ss_pred cCCCCCCCCCCCCC------CCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhh
Q 005875 523 FGLTPLMNVPATPS------RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 595 (672)
Q Consensus 523 fGla~~~~~~~~~~------~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 595 (672)
||+++.....+.+. -..+|||||.+..++|+++||||||||+|||+++ |+.||.+...++.+..++
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~------- 719 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR------- 719 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH-------
Confidence 99998654433222 2457999999999999999999999999999999 999999887766543221
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
... .....+.+...+.+||..||+..|++||+++||-..|+...+..+
T Consensus 720 ~g~----------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 720 AGQ----------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred cCC----------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 111 123345677889999999999999999999999999998876654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=379.62 Aligned_cols=238 Identities=25% Similarity=0.462 Sum_probs=202.6
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
+++||+|||+.||+++. ..|..||+|++.+.. ...+...+|+++.+++ +|||||+++++|++.++.|+|.|+|+
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYivLELC~ 101 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIVLELCH 101 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEEEEecC
Confidence 57899999999999997 779999999998743 2356788999999999 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+++|.++++. ++++++.+++.++.||+.||.|||+.+ |+|||||..|++++++.++||+|||||......
T Consensus 102 ~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 102 RGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred CccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999973 456999999999999999999999998 999999999999999999999999999887643
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.+.+|||.|.|||++....++..+||||+||+||-|+.|++||+.....+.. .++...++.
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety------~~Ik~~~Y~----------- 236 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY------NKIKLNEYS----------- 236 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH------HHHHhcCcc-----------
Confidence 4678999999999999999999999999999999999999999865433321 122111111
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.+........+||.++|+.+|.+|||+++|+.+
T Consensus 237 -~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 -MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111222344566679999999999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=358.90 Aligned_cols=243 Identities=24% Similarity=0.403 Sum_probs=195.2
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc--------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.+.||+|+||.|-+|.. ++++.||||++.+... ...+..+|+++|++| +|||||++.++|+..+..|+||
T Consensus 177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecCCceEEEE
Confidence 57899999999999985 4688999999976532 123457999999999 9999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC---CCeEEeecCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTP 527 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DfGla~ 527 (672)
||++||+|.+.+-.++ .+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+
T Consensus 256 E~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999997543 3777788999999999999999999 9999999999999866 779999999999
Q ss_pred CCCC---CCCCCCCCcccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccc
Q 005875 528 LMNV---PATPSRSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601 (672)
Q Consensus 528 ~~~~---~~~~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (672)
.... ..+.+|||.|.|||++.+.. +..++|+||+||++|-+++|.+||.+...+.. ...++.+..+.-
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----l~eQI~~G~y~f- 401 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----LKEQILKGRYAF- 401 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----HHHHHhcCcccc-
Confidence 8754 35778999999999997654 33488999999999999999999986543321 112222221110
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 602 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
-+ ....+...+.+++|.+|+..||++|||++|++++
T Consensus 402 --~p-----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 402 --GP-----LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --cC-----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 00 0112333455667779999999999999999983
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=355.16 Aligned_cols=193 Identities=27% Similarity=0.428 Sum_probs=172.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
+.||+|+||+||+|+++ ++..||||.+...... .+-...|+++++.+ +|||||++++++++++..|+|||||+||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 45999999999999975 4788999999766432 34567899999999 8999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC------CCeEEeecCCCCCCC
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD------LDGCISDFGLTPLMN 530 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~------~~~kl~DfGla~~~~ 530 (672)
||.+|++... .+++..+..++.|+|.||++||+++ ||||||||.||||+.+ -.+||+|||+|+...
T Consensus 95 DLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 95 DLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999998543 4999999999999999999999998 9999999999999865 458999999999887
Q ss_pred CC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 005875 531 VP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 582 (672)
Q Consensus 531 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~ 582 (672)
.. .+.+|++-|||||++...+|+.|+|+||+|+++|+|++|+.||...+..+
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 54 35679999999999999999999999999999999999999998665443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=341.65 Aligned_cols=238 Identities=23% Similarity=0.375 Sum_probs=195.0
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.++||+|+||+||.++.++ ++.+|+|++++... ..+...+|..++.++ +||+||+++..|++.+..|+|+||+.
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEEEEeccC
Confidence 4789999999999999664 67899999987643 234577899999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
||+|..+|++.. .+++..+.-++..|+.||.|||+++ ||||||||+|||||++|+++|+|||+++....
T Consensus 109 GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 109 GGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred CccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999997433 4899999999999999999999999 99999999999999999999999999985432
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
..+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||.+.+.. .+.+++..+... ...
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~k~~--------~~p 246 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKGKLP--------LPP 246 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcCcCC--------CCC
Confidence 33568999999999999999999999999999999999999999876433 333344333300 001
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRP----NMDEVVR 643 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~evl~ 643 (672)
..... ...+++.+.++.||++|. ++.+|.+
T Consensus 247 ~~ls~---~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 247 GYLSE---EARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred ccCCH---HHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 11233 345566699999999995 4555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=331.41 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=199.8
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
..++|+|+||.||+++.++ |+.||||++.....+ ++-..+|+++++++ +|+|+|.++++|......++|+|||+.
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEEeeecch
Confidence 3579999999999999775 788999999876543 45678999999999 999999999999999999999999988
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++.+-+.... ..++.....+++.|+++|+.|+|+++ +|||||||+|||++.+|.+|+||||+|+....+.
T Consensus 86 -TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 86 -TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred -HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 4444454332 23889999999999999999999998 9999999999999999999999999999887433
Q ss_pred --CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC--------hhHHHHHhhhhcc-ccc
Q 005875 534 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--------LPRWVQSVVREEW-TAE 601 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~--------~~~~~~~~~~~~~-~~~ 601 (672)
.+..|.+|+|||.+.+ ..|+..+||||+||++.||++|.+-|.+...-+.+. +...-++++..+. ...
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 2446889999999987 679999999999999999999999998876443321 1111222222221 111
Q ss_pred cchhhhhcccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 602 VFDVELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 602 ~~d~~~~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
+.-+.....+. .......++++++.|++.||.+|++.+|++.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111111 2223346789999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=330.36 Aligned_cols=249 Identities=23% Similarity=0.403 Sum_probs=202.3
Q ss_pred HhccccccCcEEEEEEE-ECCCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEE-EEEeCCe-eEEEEEe
Q 005875 379 SAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRA-YYYSKDE-KLLVYDY 452 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~-~~~~~~~-~~lV~e~ 452 (672)
+.++||+|.||+||++. ..++..+|.|.++-... ..++...|+.++++| +|||||++++ .+.++.+ .+|||||
T Consensus 23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evlnivmE~ 101 (375)
T KOG0591|consen 23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLNIVMEL 101 (375)
T ss_pred HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhHHHHHh
Confidence 35789999999999998 56788999998873322 245678899999999 9999999998 4545555 7899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK--FTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
+..|||...++..+. .++.+++..+.+++.|++.||+++|++- ++ |+||||||.||+++.+|.+|++|||+++...
T Consensus 102 c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 102 CDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred hcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999986654 3556999999999999999999999842 44 9999999999999999999999999999876
Q ss_pred CCC----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhh
Q 005875 531 VPA----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606 (672)
Q Consensus 531 ~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 606 (672)
... ...|||.||+||++.+..|+.|+||||+||++|||+.-.+||.+. .+.....++...+. ..+.
T Consensus 180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qgd~-~~~p--- 249 (375)
T KOG0591|consen 180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQGDY-PPLP--- 249 (375)
T ss_pred chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcCCC-CCCc---
Confidence 543 457999999999999999999999999999999999999999875 33344444433321 1111
Q ss_pred hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 607 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.+.....+..++..|+..||+.||+...++..+.
T Consensus 250 ------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 250 ------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1345567888889999999999998544444433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=350.02 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=202.8
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 378 ASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 378 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
..++.||+|.||+||+|++. ..||||.++-.... .+.|+.|+.++++- +|.||+-+.|+|..+.. .||+.+|+
T Consensus 395 ~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~~-AIiTqwCe 470 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPPL-AIITQWCE 470 (678)
T ss_pred hccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCce-eeeehhcc
Confidence 45789999999999999997 46999999765433 35799999999998 99999999999988877 99999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
|-+|+.++|-.+ ..++....+.|+.|||+||.|||.++ |||||||..||++.+++.|||+|||++..-..
T Consensus 471 GsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 471 GSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred Cchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999998544 44888999999999999999999998 99999999999999999999999999865432
Q ss_pred ---CCCCCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 532 ---PATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 532 ---~~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.....+...|||||++.. ..|++++||||||+|+|||+||..||.....+.++-.+ ...+. ..|.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV-------GrG~l--~pd~ 614 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV-------GRGYL--MPDL 614 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-------ccccc--Cccc
Confidence 122345667999999964 46899999999999999999999999955544432211 11110 0111
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
. .....+.+++.+|+..||..++++||.+.+|+..|+++...
T Consensus 615 s----~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 615 S----KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred h----hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1 11234556777788899999999999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=382.86 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=209.8
Q ss_pred hccccccCcEEEEEEEECC--C----cEEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE--S----TTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~--~----~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|.||.||.|.+.+ + ..||||.+++.. ....+|.+|..+|+.+ +|||||+++|++.+....+|++|
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCCCcEEEeh
Confidence 5789999999999999654 3 248999998763 3457899999999999 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAG--RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
||++|||..||++.+... ...++..+.+.++.|||+|+.||++++ +|||||.++|+||+....+||+|||+|+..
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhh
Confidence 999999999998764322 345889999999999999999999998 999999999999999999999999999843
Q ss_pred CCC-CCCC-----CCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 530 NVP-ATPS-----RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 530 ~~~-~~~~-----~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
... .... -...|||||.+.++.++.|+|||||||++||++| |..||...+..+.... .....
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~------~~~gg----- 921 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD------VLEGG----- 921 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH------HHhCC-----
Confidence 222 1111 1346999999999999999999999999999999 9999987665443210 01111
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
+...++.+...+.++|..||+.+|++||++..+++++.++.+...
T Consensus 922 ------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 922 ------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 233445667788899999999999999999999999999876653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=368.14 Aligned_cols=248 Identities=26% Similarity=0.515 Sum_probs=213.3
Q ss_pred hccccccCcEEEEEEEECC----CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.++||.|.||+||+|+++- ...||||.+|.... .+.+|..|+.||.+. .||||++|.|+....+..+||+|||
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeEEEhhhh
Confidence 6799999999999999763 34699999997654 356899999999999 9999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++|+|+.||+.+.+ ++++.+...|+.+||.||+||-+++ +|||||.++|||++.+..+||+|||+++...+..
T Consensus 713 ENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999987653 3999999999999999999999998 9999999999999999999999999999875443
Q ss_pred -CCCC------CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 534 -TPSR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 534 -~~~~------~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.... ...|.|||.+..++++.++||||||++|||.++ |..||+.+...+.+. .+.+.+
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk-------aIe~gy------- 851 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK-------AIEQGY------- 851 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH-------HHHhcc-------
Confidence 2111 246999999999999999999999999999776 999999887665422 122221
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
+...+.++...+.+||..||++|-.+||.+.||+..|+++....
T Consensus 852 ---RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 852 ---RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ---CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 23344577888999999999999999999999999999997654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=345.74 Aligned_cols=248 Identities=20% Similarity=0.330 Sum_probs=203.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
++.||+|+|++|++|+.. .++++|||++.+... ..+....|-++|.+|.+||.|++|+..|+++...|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 578999999999999954 578999999976532 234567788899999899999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.++|++.. .+++.....++.+|+.|++|||+.| ||||||||+|||||.||++||+|||.|+.+...
T Consensus 158 nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 158 NGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred CCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999998643 4999999999999999999999999 999999999999999999999999999876421
Q ss_pred ---------------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhc
Q 005875 533 ---------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 597 (672)
Q Consensus 533 ---------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 597 (672)
...+||..|.+||++.+...+..+|+|||||++|.|+.|++||.+.++.-. .+++.
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli------FqkI~--- 300 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI------FQKIQ--- 300 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH------HHHHH---
Confidence 224578889999999999999999999999999999999999987653211 11211
Q ss_pred cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH-------HHHhhhcCC
Q 005875 598 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM-------IEEVRQSDS 653 (672)
Q Consensus 598 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~-------L~~i~~~~~ 653 (672)
+.......++. ....+|+.+.+..||.+|+|.+||-++ .+.+++..+
T Consensus 301 ------~l~y~fp~~fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~P 354 (604)
T KOG0592|consen 301 ------ALDYEFPEGFP---EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTP 354 (604)
T ss_pred ------HhcccCCCCCC---HHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCC
Confidence 11111222333 345566679999999999999999885 355555544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=344.16 Aligned_cols=259 Identities=20% Similarity=0.367 Sum_probs=203.1
Q ss_pred HHhccccccCcEEEEEEEE-CCCcEEEEEEecccccChhh--HHHHHHHHHHHcCCCceeceEEEEEeCC-eeEEEEEec
Q 005875 378 ASAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRD--FEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVYDYF 453 (672)
Q Consensus 378 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~--~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lV~e~~ 453 (672)
.+.+.||.|.||.||+|+. ..+..||||++++.....++ -.+|++.++++..||||+++.+++.+.+ ..++|||||
T Consensus 13 ~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M 92 (538)
T KOG0661|consen 13 TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM 92 (538)
T ss_pred HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh
Confidence 3457899999999999994 45788999999988766554 4579999999944999999999999888 899999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
+. +|+++++.. ...+++..+..|+.||++||+|+|++| +.|||+||+|||+..+..+||+|||+|+......
T Consensus 93 d~-NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 93 DC-NLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred hh-hHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCC
Confidence 76 999999854 456999999999999999999999999 9999999999999999999999999999875433
Q ss_pred ---CCCCCCcccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHHHHhhhhcccc-----ccc
Q 005875 534 ---TPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-DLPRWVQSVVREEWTA-----EVF 603 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~-----~~~ 603 (672)
.+..|.+|+|||++. ...|+.+.||||+||+++|+.+-++-|.+..+.|.+ .+...+..-..+.|.. ..+
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 345688999999985 566899999999999999999999999987654421 1111111111112211 001
Q ss_pred hhhhhcc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+... .-......+.++++.+|+..||.+|||++|++++
T Consensus 245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111000 0122355678889999999999999999999984
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=349.26 Aligned_cols=239 Identities=22% Similarity=0.369 Sum_probs=198.7
Q ss_pred hccccccCcEEEEEEE-ECCCcEEEEEEecccccCh-hhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGK-RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~-~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+.|.||.++ ...++.||||++......+ +-..+|+.+|+.. +|+|||.+++.|..+++.|+|||||++|+
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 3579999999999998 4567889999998776554 4577899999998 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----CC
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----PA 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----~~ 533 (672)
|.+.+... .+++.++..|+.++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..... ..
T Consensus 357 LTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 357 LTDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred hhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 99999744 3899999999999999999999999 99999999999999999999999999876643 34
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
+..|||.|||||+.....|++|+||||||++++||+.|.+||-..+.-. .... +..+.. + .....
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------AlyL-Ia~ng~-----P---~lk~~ 492 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYL-IATNGT-----P---KLKNP 492 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH------HHHH-HhhcCC-----C---CcCCc
Confidence 5679999999999999999999999999999999999999997532211 1111 111111 1 12222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
+.....|.+++.+||+.|+++|+++.|+++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 333445556666999999999999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=335.36 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=197.3
Q ss_pred HHhccccccCcEEEEEEEECC-CcEEEEEEecccccC-hhhHHHHHHHHHHHcCCCceeceEEEEEeCC--eeEEEEEec
Q 005875 378 ASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYF 453 (672)
Q Consensus 378 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e~~ 453 (672)
...+.||+|+||+||++...+ |...|||........ .+..++|+.++.++ +|||||+++|.....+ ..++.|||+
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeeeecc
Confidence 346889999999999999765 788999988765221 35689999999999 6999999999855554 588999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-CCCeEEeecCCCCCCCC-
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNV- 531 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~~- 531 (672)
++|+|.+++.+..+ .+++..++.++.||++||+|||++| ||||||||+|||++. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred CCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999986543 4999999999999999999999998 999999999999999 79999999999876552
Q ss_pred ------CCCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 532 ------PATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 532 ------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
.....||+.|||||++..+ ....++||||+||++.||+||+.||... .....+.-.+..+.....+
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~i-- 244 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEI-- 244 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCC--
Confidence 2235689999999999863 3345899999999999999999999853 1222223333322211111
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
...+.++. .+++.+|++.+|++||||+|++++---....
T Consensus 245 -----p~~ls~~a---~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 245 -----PDSLSDEA---KDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred -----CcccCHHH---HHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 11233344 4555699999999999999999976554433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=312.49 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=202.3
Q ss_pred HhccccccCcEEEEEEEE-CCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 379 SAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
+.+++|+|.||.||+|+. +.|+.||||+++..... .....+|++.++.+ +|+||+.++++|...+...+|+|||+
T Consensus 6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lVfEfm~ 84 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLVFEFMP 84 (318)
T ss_pred hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEEEEecc
Confidence 457899999999999995 46889999999866433 35678999999999 89999999999999999999999998
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 534 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 534 (672)
. ||...++.. ...++-.++..++.++.+|++|||++. |+||||||.|+|++++|.+||+|||+|+.......
T Consensus 85 t-dLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 85 T-DLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred c-cHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 7 999999753 345888999999999999999999998 99999999999999999999999999998765443
Q ss_pred C----CCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh-hHHHHHhhhhcccccc--chhh
Q 005875 535 P----SRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL-PRWVQSVVREEWTAEV--FDVE 606 (672)
Q Consensus 535 ~----~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~d~~ 606 (672)
. ..|.+|+|||.+.+ +.|+..+||||.||++.||+-|.+-|.+.+.-+.+.. .+....-..+.|..-. .|..
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 2 35788999998876 5699999999999999999999999987654332211 1111111122232111 1110
Q ss_pred h-------hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 607 L-------MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 607 ~-------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. ....-+..+....++++..++.++|.+|+|+.|++++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 0011233445567899999999999999999999985
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.90 Aligned_cols=255 Identities=17% Similarity=0.340 Sum_probs=203.2
Q ss_pred CCHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEecccccCh----hhHHHHHHHHHHHcCCCceeceEEEEEe---
Q 005875 370 FDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYS--- 442 (672)
Q Consensus 370 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----~~~~~e~~~l~~l~~h~niv~l~~~~~~--- 442 (672)
++.+++.......||+|++|.||+|.+ +++.||||+++...... +.+.+|++++.++ +||||+++++++.+
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVD 92 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEeccc
Confidence 455555444456899999999999998 48899999997654332 5677999999999 99999999999877
Q ss_pred -CCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEecCCCCeEE
Q 005875 443 -KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCI 520 (672)
Q Consensus 443 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl 520 (672)
....++||||+++|+|.+++... ..+++.....++.|++.|+.|||+. + ++||||||+||++++++.+||
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl 164 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKI 164 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEE
Confidence 34678999999999999999743 3488999999999999999999985 5 889999999999999999999
Q ss_pred eecCCCCCCCCC-CCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhc
Q 005875 521 SDFGLTPLMNVP-ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 597 (672)
Q Consensus 521 ~DfGla~~~~~~-~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 597 (672)
+|||+++..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+....
T Consensus 165 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~~i~~~~ 238 (283)
T PHA02988 165 ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYDLIINKN 238 (283)
T ss_pred cccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcC
Confidence 999998765433 23457788999999976 678999999999999999999999998643221 112221111
Q ss_pred cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 598 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 598 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
.... . .......+.+++.+||+.||++|||++|+++.|++++.
T Consensus 239 ~~~~-~---------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 239 NSLK-L---------PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCC-C---------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1110 0 01223456778889999999999999999999998764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=349.82 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=204.1
Q ss_pred hccccccCcEEEEEEEECCC----cE-EEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEES----TT-VVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~----~~-vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.++||+|+||+||+|++..+ .. ||||..+... ....+|.+|+++++.+ +|||||+++|++..++..|+||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCccEEEE
Confidence 47899999999999996532 23 8999988522 2356799999999998 9999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
|+|+||+|.++|++..+ .++..++..++.+.|.||+|||+++ ++||||.++|+|++.++.+||+|||+++...
T Consensus 241 El~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999986553 4999999999999999999999998 9999999999999999999999999987664
Q ss_pred CCCC----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 531 VPAT----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 531 ~~~~----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.-.. ..-...|+|||.+....|+.++|||||||++||+++ |..||.+....+ ....+....+......
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~------v~~kI~~~~~r~~~~~- 386 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE------VKAKIVKNGYRMPIPS- 386 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH------HHHHHHhcCccCCCCC-
Confidence 2111 123457999999999999999999999999999999 888998765332 1222223333332211
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.....+..++.+||..+|+.||+|.++.+.++.+.....
T Consensus 387 ---------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 387 ---------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ---------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 223445566669999999999999999999999986654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.46 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=197.4
Q ss_pred hccccccCcEEEEEEEE------CCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC-eeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lV~ 450 (672)
.+.||+|+||.||+|.. .+++.||+|+++.... ..+.+.+|++++..+.+||||+++++++...+ ..++||
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 57899999999999974 2246799999875432 23468889999999988999999999987654 578999
Q ss_pred EecCCCchhhhhccCCCC---------------------------------------------------------CCCCC
Q 005875 451 DYFASGSLSTLLHGNRGA---------------------------------------------------------GRTPL 473 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~---------------------------------------------------------~~~~l 473 (672)
||+++|+|.+++...... ....+
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 999999999999753210 02347
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC------CCCCCCcccCcccc
Q 005875 474 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVI 547 (672)
Q Consensus 474 ~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~ 547 (672)
++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...+++.|+|||++
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 88899999999999999999998 9999999999999999999999999997653221 12245679999999
Q ss_pred cCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHH
Q 005875 548 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMA 626 (672)
Q Consensus 548 ~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~ 626 (672)
.+..++.++|||||||++|||++ |..||......+. ............ ........+.+++.+
T Consensus 249 ~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~~----------~~~~~~~~l~~li~~ 312 (338)
T cd05102 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRMR----------APENATPEIYRIMLA 312 (338)
T ss_pred hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCCC----------CCCCCCHHHHHHHHH
Confidence 99999999999999999999997 9999976432210 111111111100 011223457788889
Q ss_pred cccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 627 CVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 627 Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
||+.||++|||+.|+++.|+++.+.
T Consensus 313 cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 313 CWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=339.15 Aligned_cols=239 Identities=25% Similarity=0.409 Sum_probs=198.2
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+-||.|+.|.||+|+++ +..||||+++. --+.+++-+++| +||||+.|.|+|...-.++||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~e------lkETdIKHLRkL-kH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRE------LKETDIKHLRKL-KHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhh------hhhhhHHHHHhc-cCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 367999999999999998 67899998753 235567788898 9999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---CCCC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---ATPS 536 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---~~~~ 536 (672)
++|+. ...+.-...+.+..+||.||.|||.+. |||||||.-||||..+..+||+|||-++..... ....
T Consensus 201 ~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 201 EVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred HHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhh
Confidence 99984 334788888999999999999999987 999999999999999999999999988766543 3456
Q ss_pred CCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHH
Q 005875 537 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 616 (672)
Q Consensus 537 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 616 (672)
||..|||||++.....++|+||||||||||||+||..||..-....++ |. +-.+.....-.+.+
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wG------------VGsNsL~LpvPstc 336 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WG------------VGSNSLHLPVPSTC 336 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----Ee------------ccCCcccccCcccC
Confidence 899999999999999999999999999999999999999753321110 00 00011122233455
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 617 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 617 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
..-|.-|++.||+..|.+||++.+++.+|+-...
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 6667777889999999999999999999986654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.38 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=196.5
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 453 (672)
.+.||+|.||.||+|+. .+|+.||+|++.-.... .....+|+.+++++ +||||+++.+...+. ...|+|+|||
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEEEEEecc
Confidence 36799999999999994 56889999998754322 34567899999999 999999999999876 6899999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
+. ||.-++... .-.+++.++..++.|++.||+|||.+| |+|||||.+|||||.+|.+||+|||+|+++....
T Consensus 201 dh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 201 DH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred cc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 88 898888642 234999999999999999999999999 9999999999999999999999999999776543
Q ss_pred C-----CCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC-hhHHHHHhhhhcccc------
Q 005875 534 T-----PSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-LPRWVQSVVREEWTA------ 600 (672)
Q Consensus 534 ~-----~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~------ 600 (672)
. .+.|.+|+|||.+.+. .|+.++|+||.||||.||++|++.|.+.++-+.+. +.+.+.....+.|..
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 2 2347889999999875 59999999999999999999999999876543322 122222222222321
Q ss_pred ccchhhhhcccChHH----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 601 EVFDVELMRFQNIEE----EMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 601 ~~~d~~~~~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
..+.+...-...+.+ -....++|+..+|..||.+|.|+.++++
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 011110000001111 1234567777999999999999999987
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.32 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=207.2
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.++||+|-||+|.++....+..||||+++.... ...+|..|+++|.++ +|||||+++|+|..++..++|+|||++|+
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 689999999999999999889999999987644 347899999999999 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCCCC-
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS- 536 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~~- 536 (672)
|.+|+.++.... +......+|+.|||.||+||.+.. +|||||.++|+|+|.++++||+|||+++.+.......
T Consensus 622 LnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 622 LNQFLSAHELPT---AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 999998654221 455667889999999999999987 9999999999999999999999999998654333222
Q ss_pred -----CCCcccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 537 -----RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 537 -----~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
-...|||+|.+.-++++.++|||+||+++||+++ ...||...+.++. .+.............+
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~------- 765 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVV------- 765 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCccee-------
Confidence 2467999999999999999999999999999876 7889987665443 2222222322222111
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
...+..+...+.++|.+||+.|.++||+++++...|++.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112234556778999999999999999999999998864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.67 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=199.9
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHc-CCCceeceEEEEEeCC----eeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-QHPNVVPLRAYYYSKD----EKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~----~~~lV~e~~~ 454 (672)
.++||+|+||.||||++. ++.||||++... .++.|..|-+|..... +|+||++++++-.... +++||+||.+
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 467999999999999998 489999999753 3677888888877542 8999999999987665 8899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG------GPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
.|+|.++|..+ .++|.+..+|+..+++||+|||+.. +|+|+|||||++|||+..|+.+.|+|||+|..
T Consensus 292 kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 292 KGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred CCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999854 3999999999999999999999743 57899999999999999999999999999976
Q ss_pred CCCC------CCCCCCCcccCcccccCCCC------CCccchhhHHHHHHHHHhCCCCCCCCCCCC--------CC--Ch
Q 005875 529 MNVP------ATPSRSAGYRAPEVIETRKH------SHKSDVYSFGVLLLEMLTGKAPLQSPTRDD--------MV--DL 586 (672)
Q Consensus 529 ~~~~------~~~~~~~~y~aPE~~~~~~~------~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~--------~~--~~ 586 (672)
+... ....||.+|||||++.+... -.+.||||+|.|+|||+++..-+......+ .- ..
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 6432 23568999999999976432 236899999999999999765553211111 10 11
Q ss_pred hHHHHHh-hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 587 PRWVQSV-VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 587 ~~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.+.++.. ++++.+..+ ...... ...+..+.+.+..||+.||+.|.|+.-|.+.+.++....+
T Consensus 446 ~e~mq~~VV~kK~RP~~-p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKI-PDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHHHhhccCCCC-hhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1222222 222222222 212211 1445678888899999999999999999999999886654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.62 Aligned_cols=239 Identities=24% Similarity=0.390 Sum_probs=192.7
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+-++ |..+|+|++++...- -+....|-.+|... .+|+||+++..|++.+..||||||++
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEEEEEecC
Confidence 4789999999999999654 778999999887542 24566788888885 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
|||+..+|.+ ...|++..+..++.+++.|+..||+.| +|||||||+|+|||..|++||+||||++....
T Consensus 225 GGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 225 GGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred CccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 9999999974 345999999999999999999999999 99999999999999999999999999842210
Q ss_pred ----------------------C--------------------------CCCCCCCcccCcccccCCCCCCccchhhHHH
Q 005875 532 ----------------------P--------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 563 (672)
Q Consensus 532 ----------------------~--------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gv 563 (672)
. ....|||-|||||++.+..|+..+|+||+||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0 1123688899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCC-CChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCC---HH
Q 005875 564 LLLEMLTGKAPLQSPTRDDM-VDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN---MD 639 (672)
Q Consensus 564 vl~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ 639 (672)
|||||+.|.+||.+.++.+. ..+..|-..+... ...... .+..+||.+|+. ||++|.- ++
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP------------~~~~~s---~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP------------EEVDLS---DEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC------------CcCccc---HHHHHHHHHHhc-CHHHhcCcccHH
Confidence 99999999999998776554 2233333221110 011112 445667779999 9999975 66
Q ss_pred HHHH
Q 005875 640 EVVR 643 (672)
Q Consensus 640 evl~ 643 (672)
||-+
T Consensus 441 EIK~ 444 (550)
T KOG0605|consen 441 EIKK 444 (550)
T ss_pred HHhc
Confidence 6655
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.85 Aligned_cols=239 Identities=23% Similarity=0.380 Sum_probs=195.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc------cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+|+.|... .+..||+|++.... ...+...+|+.+++++..||||++++.++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 468999999999999854 57899999766531 12345668999999995599999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC-CCeEEeecCCCCCCC-
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMN- 530 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~- 530 (672)
+.+|+|.+++.. . ..+.+.++..++.|++.|++|||+.| |+||||||+|||++.+ +++||+|||++....
T Consensus 102 ~~gGdL~~~i~~-~----g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 102 CSGGDLFDYIVN-K----GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred cCCccHHHHHHH-c----CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999985 2 34888999999999999999999999 9999999999999999 999999999998772
Q ss_pred ---CCCCCCCCCcccCcccccCCC-CC-CccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 531 ---VPATPSRSAGYRAPEVIETRK-HS-HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 531 ---~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
...+.+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... .+.....+......
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~ki~~~~~~------ 241 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRKIRKGEFK------ 241 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHHHhcCCcc------
Confidence 345778999999999999977 86 67999999999999999999998632 22222222222111
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
...... ...+..++.+|+..+|.+|+|+.|++.
T Consensus 242 ---~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 242 ---IPSYLL--SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---CCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 011110 345667778999999999999999994
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.79 Aligned_cols=240 Identities=25% Similarity=0.371 Sum_probs=200.5
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
++.||+|+.|.|-+|++ ..|+.+|||++.+... ....+++|+-+|+.+ .||||++++++|++..+.|+|.||++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEEEecC
Confidence 67899999999999995 4689999999976622 245688899888877 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|.|++++-. +.++++.++++++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|......
T Consensus 96 gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 96 GGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred CchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 9999999963 345999999999999999999999998 999999999999999999999999999776543
Q ss_pred -CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 -ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.+.+|+|.|.|||++.+..| +.++||||+|||||-|+||+.||++.+ +-....++.+..+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LLlKV~~G~f------------ 229 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLLLKVQRGVF------------ 229 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHHHHHHcCcc------------
Confidence 47889999999999999998 568999999999999999999998433 2222222222211
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
+.......+..+|+++|+..||++|.|++||+++--
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 112233345667788999999999999999999643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=341.25 Aligned_cols=232 Identities=25% Similarity=0.353 Sum_probs=194.5
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.++||+|.||+|+++..+. ++.+|||.+++... +-+....|..|+....+||.++.++++|+..++.|.||||+.
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~ 452 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA 452 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence 5789999999999999764 67799999998743 234567788888888789999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC----
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN---- 530 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~---- 530 (672)
|||+..+.+. ..+++..+.-++..|+.||+|||+++ |||||||.+|||||.+|.+||+|||+++..-
T Consensus 453 Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 453 GGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred CCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 9996666552 34999999999999999999999999 9999999999999999999999999997642
Q ss_pred CCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 531 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 531 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
...+.+|||.|||||++.+..|+.++|+|||||+||||+.|..||.+.++++..+ .++.++....
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd------sI~~d~~~yP--------- 588 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD------SIVNDEVRYP--------- 588 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHhcCCCCCC---------
Confidence 3456789999999999999999999999999999999999999999887665432 2333322211
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNM 638 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 638 (672)
.-...+.+.++++++..+|++|.-+
T Consensus 589 ---~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 589 ---RFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CcccHHHHHHHHHHhccCcccccCC
Confidence 1223455677779999999999876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=320.29 Aligned_cols=253 Identities=21% Similarity=0.351 Sum_probs=198.8
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||.|..++||+|+. ..+..||||++.-... +-+...+|+..++.+ +||||++++..|..+...|+||.||.+|
T Consensus 31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWvVmpfMa~G 109 (516)
T KOG0582|consen 31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWVVMPFMAGG 109 (516)
T ss_pred EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEEeehhhcCC
Confidence 46899999999999994 4578899999976543 236788899888887 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
++.++++..-.. .+++..+..|+.++++||.|||++| .||||||+.||||+.+|.|||+|||.+..+...
T Consensus 110 S~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 110 SLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999865433 3899999999999999999999999 999999999999999999999999976443221
Q ss_pred ----CCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccc--cch
Q 005875 533 ----ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE--VFD 604 (672)
Q Consensus 533 ----~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~d 604 (672)
.+..+++.|||||++.. ..|+.|+||||||++..||.+|..||....+.+++ ...+-....... ..+
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTLQNDPPTLLTSGLD 258 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHhcCCCCCcccccCC
Confidence 34568999999999644 45899999999999999999999999854433221 111111111111 111
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR 649 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~ 649 (672)
. .......+.|.+++..|+++||++|||++++++ +++..+
T Consensus 259 ~-----d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 259 K-----DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred h-----HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 1 111222346788888999999999999999997 444443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=308.37 Aligned_cols=192 Identities=22% Similarity=0.336 Sum_probs=172.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||.|+||.|.+++.+ ++..+|+|++.+...- .+...+|..+++.+ .||+++++++.+.+.+..|+||||++
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeEEEEEeccC
Confidence 578999999999999965 4677899999765331 24466788899998 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-C
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-~ 533 (672)
||.|..++++.+ .+++..+..++.||+.|++|||+.+ |++|||||+|||+|.+|.+||+|||.|+..... .
T Consensus 128 GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~ 199 (355)
T KOG0616|consen 128 GGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTW 199 (355)
T ss_pred CccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCcEE
Confidence 999999998543 4999999999999999999999998 999999999999999999999999999877554 4
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR 580 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~ 580 (672)
+.+|||.|+|||++.+..|..++|+|||||++|||+.|.+||...++
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 67899999999999999999999999999999999999999987654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.68 Aligned_cols=237 Identities=22% Similarity=0.386 Sum_probs=198.8
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccCh---hhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|.||.||||+.+. .+.||+|.+.+....+ +...+|+++++++ +|||||.++++|+...+.++|+||+.|
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEEehhhhh
Confidence 4679999999999999664 5778999987765444 3478899999999 999999999999999999999999987
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
+|..++... ..++++.+..++.+++.||.|||+.+ |.|||+||.|||++..|.+|++|||+|+.+....
T Consensus 86 -~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 86 -DLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred -hHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 999999743 34999999999999999999999998 9999999999999999999999999999886543
Q ss_pred --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 534 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
...|||.|||||+..+..|+..+|+||+||++|||++|++||.... +...+..+..+....
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~v~~----------- 219 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDPVKP----------- 219 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCCCCC-----------
Confidence 3468999999999999999999999999999999999999997432 233333433332211
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+......+..++...+.+||..|.++.+++.+
T Consensus 220 -p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 220 -PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11334456667779999999999999999873
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=327.12 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=194.5
Q ss_pred hccccccCcEEEEEEEECC-----------------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-----------------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYY 440 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~ 440 (672)
.+.||+|+||.||+|.+++ +..||+|.+..... ...++.+|++++.++ +||||+++++++
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 88 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNIIRLLGVC 88 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEE
Confidence 4679999999999998543 23699998875432 245788999999998 999999999999
Q ss_pred EeCCeeEEEEEecCCCchhhhhccCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCC
Q 005875 441 YSKDEKLLVYDYFASGSLSTLLHGNRG--------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 506 (672)
Q Consensus 441 ~~~~~~~lV~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk 506 (672)
.+.+..++||||+++|+|.+++..... .....+++....+++.||+.||+|||+.+ |+|||||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlk 165 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLA 165 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcc
Confidence 999999999999999999999864321 11234788999999999999999999998 9999999
Q ss_pred CCCEEecCCCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCCC
Q 005875 507 ASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSP 578 (672)
Q Consensus 507 ~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t--g~~pf~~~ 578 (672)
|+|||++.++.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ +..||...
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 999999999999999999987653321 2234667999999998899999999999999999987 56677654
Q ss_pred CCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 579 TRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
...+ .............. ... ..........+.+++.+||+.+|++|||++||.+.|++
T Consensus 246 ~~~~---~~~~~~~~~~~~~~-~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 246 TDEQ---VIENAGEFFRDQGR-QVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CHHH---HHHHHHHHhhhccc-ccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 3222 11111111111100 000 00011233567888899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=344.14 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=204.6
Q ss_pred HhccccccCcEEEEEEEECCC-cEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEE-EEEe------CCeeEEE
Q 005875 379 SAEVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRA-YYYS------KDEKLLV 449 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~-~~~~------~~~~~lV 449 (672)
..+.|.+|||+.||.|+...+ ..+|+|++-.... .-+..++|+++|+.|.+|+|||.+++ .... ..+.+|+
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 357899999999999998776 9999999875532 34568899999999988999999999 3321 1367899
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
||||.+|.|-+++..... ..|++.++++|+.|+++|+++||... |+|||||||.+||||+.++..||||||.|...
T Consensus 121 mEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred hhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 999999999999975432 22999999999999999999999985 88999999999999999999999999988543
Q ss_pred CCCC-------------CCCCCCcccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHh
Q 005875 530 NVPA-------------TPSRSAGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 593 (672)
Q Consensus 530 ~~~~-------------~~~~~~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 593 (672)
-... ....|+.|+|||.+ .+...++|+|||||||+||-|+....||+....-.
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----------- 265 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----------- 265 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----------
Confidence 2211 12358889999988 46678999999999999999999999998653222
Q ss_pred hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 594 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
|.+... .+.........|.+||+.||+.+|++||++.||+..+-++.....
T Consensus 266 --------Ilng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 266 --------ILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred --------EEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 111111 222335667788889999999999999999999999999986654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.91 Aligned_cols=244 Identities=23% Similarity=0.282 Sum_probs=193.3
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||++.. .+++.||+|.+..... ....+.+|++++..+ +|+||+++++++.+++..++||||++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEEecC
Confidence 36799999999999996 4688999999865422 234577899999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 84 ~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 84 GGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred CCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999998875322 234899999999999999999999998 999999999999999999999999998765332
Q ss_pred -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
....++..|+|||++.+..++.++|||||||++|||++|+.||......... ........... ....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------~~~~- 225 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ--------EEYS- 225 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc--------ccCC-
Confidence 2345788999999999999999999999999999999999999865432211 11111110000 0000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 644 (672)
......+.+++.+||+.||++||+ ++|++++
T Consensus 226 --~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 226 --EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 112235667888999999999997 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=315.73 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=198.6
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHH-cCCCceeceEEEEEeCC----eeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV-GQHPNVVPLRAYYYSKD----EKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~~----~~~lV~e~~~ 454 (672)
.+.||+|.||+||+|+++ |..||||++... +++.+.+|.++++.+ .+|+||..+++.-..++ +.|||++|.+
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 578999999999999998 788999999754 356778888887643 39999999998865443 6789999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-----MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-----~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
.|+|+|||.. ..++....++++..+|.||++||. +|+|.|+|||||+.|||+..++.+.|+|+|+|-..
T Consensus 293 ~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 293 HGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred CCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 9999999974 349999999999999999999994 67899999999999999999999999999999554
Q ss_pred CC--------CCCCCCCCcccCcccccCCC------CCCccchhhHHHHHHHHHhC----------CCCCCCCCCCCCCC
Q 005875 530 NV--------PATPSRSAGYRAPEVIETRK------HSHKSDVYSFGVLLLEMLTG----------KAPLQSPTRDDMVD 585 (672)
Q Consensus 530 ~~--------~~~~~~~~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~el~tg----------~~pf~~~~~~~~~~ 585 (672)
.. .....||.+|||||++...- ....+||||||.|+||+..+ +.||.+.-+.+-
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP-- 444 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP-- 444 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC--
Confidence 32 23456899999999996532 12358999999999998763 456654322211
Q ss_pred hhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 586 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
-.+.+++++-.+.. .|.....-...+.+..+.++|+.||..+|..|.|+--+-+.|.++.+.
T Consensus 445 s~eeMrkVVCv~~~----RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 445 SFEEMRKVVCVQKL----RPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CHHHHhcceeeccc----CCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 01111222211111 122222223357888999999999999999999999999999999864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=332.45 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=213.9
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
..+||-|.||.||.|.|+. .-.||||.++.....-++|..|..+|+.+ +|||+|+++|+|..+-..|||+|||..|+|
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiTEfM~yGNL 350 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIITEFMCYGNL 350 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEEecccCccH
Confidence 5689999999999999876 45799999999888899999999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCCC---
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP--- 535 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~--- 535 (672)
.+||+... +..++.-..+.|+.||+.||+||..++ +|||||.++|+|+.++..+||+|||+++.+......
T Consensus 351 LdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 351 LDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred HHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 99998755 345777888999999999999999987 999999999999999999999999999988654322
Q ss_pred --CCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 536 --SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 536 --~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
.-...|.|||.+....++.|+|||+|||+|||+.| |..||.+.+... +..++.+.+++ ..
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEkgyRM----------~~ 487 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEKGYRM----------DG 487 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhccccc----------cC
Confidence 12456999999999999999999999999999988 899998654222 22233333322 23
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.+.|...+.+||+.||+..|..||+++|+-+.++.|-...+
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 34566788899999999999999999999999999876543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.46 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=196.9
Q ss_pred HhccccccCcEEEEEEEE------CCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 379 SAEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
..+.||+|+||+||+|+. ..+..||||+++.... ..+.+.+|+.++..+.+||||+++++++...+..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 368899999999999973 2355799999875432 23567889999999878999999999999999999999
Q ss_pred EecCCCchhhhhccCCCC--------------------------------------------------------------
Q 005875 451 DYFASGSLSTLLHGNRGA-------------------------------------------------------------- 468 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~-------------------------------------------------------------- 468 (672)
||+++|+|.++++.....
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 999999999999643210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC------
Q 005875 469 --------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT------ 534 (672)
Q Consensus 469 --------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~------ 534 (672)
....+++..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 275 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence 0124788999999999999999999998 99999999999999999999999999876543221
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||++.+..++.++|||||||++|||++ |..||....... . ......+...... .
T Consensus 276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~----~~~~~~~~~~~~~----------~ 339 (375)
T cd05104 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K----FYKMIKEGYRMLS----------P 339 (375)
T ss_pred CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H----HHHHHHhCccCCC----------C
Confidence 223456999999999999999999999999999998 889987543221 1 1111111111100 0
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
......+.+++.+||+.||++||++.|+++.|++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11124577888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=325.01 Aligned_cols=238 Identities=24% Similarity=0.407 Sum_probs=197.1
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
++||+|.||.||+|... .++.||+|++.-... ..++.++|+.++..+ +++||.+++|.|..+...+++||||.||+
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 67999999999999965 467799999875543 346889999999999 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----CC
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----PA 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----~~ 533 (672)
+.+.++.. ..+++.+..-++.++..|+.|||.++ .+|||||+.|||+..+|.+|++|||.+..+.. ..
T Consensus 98 v~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 98 VLDLLKSG-----NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred hhhhhccC-----CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999742 23478888889999999999999998 99999999999999999999999999876543 35
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
+..||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+...+.+ +.+.. -|. .++
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------Ipk~~-----PP~---L~~- 233 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------IPKSA-----PPR---LDG- 233 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------ccCCC-----CCc---ccc-
Confidence 67899999999999999999999999999999999999999986654332211 11110 111 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.....+.+++..|++++|+.||++.+++++
T Consensus 234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 -DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 233456677779999999999999999873
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=326.53 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=213.2
Q ss_pred CCCHHHHHHHHhccccccCcEEEEEEEECC---C--cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEE
Q 005875 369 NFDLEDLLRASAEVLGKGSYGTAYKAVLEE---S--TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYY 441 (672)
Q Consensus 369 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~---~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 441 (672)
++.+..-.....++||.|.||.||+|.+.+ | -.||||.-+.... +.+.|.+|..+++.+ +||||++++|+|.
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~ 461 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCV 461 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeee
Confidence 344333333557899999999999999643 2 2488998876432 457799999999998 9999999999996
Q ss_pred eCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEe
Q 005875 442 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 521 (672)
Q Consensus 442 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 521 (672)
+ ...|||||.++-|.|..|++.++. .++......++.||+.+|+|||+.. +|||||..+|||+.....+|++
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred c-cceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeec
Confidence 4 578999999999999999987654 3888999999999999999999987 9999999999999999999999
Q ss_pred ecCCCCCCCCCCCCCC-----CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhh
Q 005875 522 DFGLTPLMNVPATPSR-----SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 595 (672)
Q Consensus 522 DfGla~~~~~~~~~~~-----~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 595 (672)
|||+++.+.....+.. ...|||||.+.-++++.++|||.|||.+||++. |..||.+-...+.+...+
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE------- 606 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE------- 606 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-------
Confidence 9999998876554433 335999999999999999999999999999877 999999876665432110
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
. ..+...++.+...+..++.+||.++|.+||.+.|+...|.++.+.+.
T Consensus 607 n----------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 607 N----------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred C----------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 0 11233345677788899999999999999999999999999987543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=312.12 Aligned_cols=241 Identities=24% Similarity=0.403 Sum_probs=197.3
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||.||++.++++..+|+|.+.......+++.+|++++.++ +||||+++++++..++..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 467999999999999998888999999876655677899999999999 9999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC-----
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----- 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~----- 534 (672)
++++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.++.......
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 88 NYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9987432 24889999999999999999999998 99999999999999999999999999876532221
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+...... ..+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~~~~i~~~~~~---~~~-------- 223 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EVVEMISRGFRL---YRP-------- 223 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHCCCCC---CCC--------
Confidence 123456999999998889999999999999999999 89999754321 111111111110 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
......+.+++.+||+.+|++||+++|+++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11224578888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=305.78 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=193.8
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEe--CCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~ 453 (672)
.+.|++|.||.||+|+.+. +..||+|+++-.... .-...+|+.++.+. +|||||.+-.+..- -+..|+|||||
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceeeeeHHHH
Confidence 4789999999999999764 677999999755321 12467899999999 89999999887753 45799999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
+. ||..+++..+ +++...++..++.|+++|++|||... |+|||||++|+|++..|.+||+|||+|+.+..+.
T Consensus 160 Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 160 EH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred Hh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 87 9999998644 45889999999999999999999998 9999999999999999999999999999987763
Q ss_pred CC----CCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh--hhccccccchh-
Q 005875 534 TP----SRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV--REEWTAEVFDV- 605 (672)
Q Consensus 534 ~~----~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~- 605 (672)
.. ..|.+|+|||.+.+. .|++++|+||+|||+.||+++++-|.+..+-+.++ ..++-.. .+.........
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~--~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD--KIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH--HHHHHhCCCccccCCCccccc
Confidence 32 357889999999774 58999999999999999999999999876544322 1111110 01100000000
Q ss_pred -------------hhh-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 606 -------------ELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 606 -------------~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.+. .+.... ....-++++...+.+||.+|.|++|.+++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhcc
Confidence 000 011111 11344667779999999999999999884
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.44 Aligned_cols=237 Identities=20% Similarity=0.289 Sum_probs=191.0
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||.||+++.. +++.||+|+++.... ....+.+|++++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999965 578899999875422 124567788999988 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 80 GELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence 9999998743 24899999999999999999999998 99999999999999999999999999875322
Q ss_pred CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 532 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..... .. .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~-------~~--p- 215 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEEI-------RF--P- 215 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCCC-------CC--C-
Confidence 123457899999999999999999999999999999999999997543211 1111111110 00 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
......+.+++.+||+.||++|| ++.|++++
T Consensus 216 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 --RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred --CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 11223466778899999999999 79999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.81 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=196.7
Q ss_pred HhccccccCcEEEEEEEEC------CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 379 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
..+.||+|+||.||+|... ++..||+|+++..... ...+.+|++++..+.+|+||+++++++...+..++||
T Consensus 42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ 121 (374)
T cd05106 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT 121 (374)
T ss_pred ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence 3678999999999998842 2357999999754322 3457889999998878999999999999999999999
Q ss_pred EecCCCchhhhhccCCC---------------------------------------------------------------
Q 005875 451 DYFASGSLSTLLHGNRG--------------------------------------------------------------- 467 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~--------------------------------------------------------------- 467 (672)
||+++|+|.++++....
T Consensus 122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (374)
T cd05106 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201 (374)
T ss_pred hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence 99999999999864211
Q ss_pred --CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC------CCCCCC
Q 005875 468 --AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSA 539 (672)
Q Consensus 468 --~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~ 539 (672)
.....+++..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...++.
T Consensus 202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 278 (374)
T cd05106 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278 (374)
T ss_pred ccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcc
Confidence 01124788999999999999999999998 9999999999999999999999999987653322 112345
Q ss_pred cccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHH
Q 005875 540 GYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMV 618 (672)
Q Consensus 540 ~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 618 (672)
.|+|||++.+..++.++|||||||++|||++ |+.||........ ............. . .....
T Consensus 279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~~~~~-------~---~~~~~ 342 (374)
T cd05106 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGYQMSR-------P---DFAPP 342 (374)
T ss_pred ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcccCccC-------C---CCCCH
Confidence 7999999998899999999999999999997 9999975432210 1111111110000 0 01124
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 619 QMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 619 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
.+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 5678888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=314.95 Aligned_cols=245 Identities=27% Similarity=0.450 Sum_probs=199.7
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.++||+|+||.||+|...+++.||+|.+.......+.+.+|+.++..+ +|+||+++++++..++..+++|||+++|+|.
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEecCCCCcHH
Confidence 468999999999999988888999999876555567889999999998 9999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----C
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 534 (672)
++++... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++....... .
T Consensus 90 ~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05072 90 DFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163 (261)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence 9997532 234888999999999999999999988 9999999999999999999999999997654322 1
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||++....++.++|||||||++|||+| |+.||......+ ............ ..
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~-------~~--- 226 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYRMP-------RM--- 226 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCCC-------CC---
Confidence 223457999999998889999999999999999998 999997543221 111111111100 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
......+.+++.+|++.+|++||+++++.+.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11224567788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.95 Aligned_cols=238 Identities=22% Similarity=0.345 Sum_probs=186.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+.. +++.||+|++..... ....+.+|++++..+ +|+||+++++++..++..++||||+++|
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 578999999999999965 578999999865432 245688999999998 8999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+... .++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 158 ~L~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 158 SLEGTHI---------ADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred ccccccc---------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 9865432 567788899999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 533 ATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
....++..|+|||++.. ...+.++|||||||++|||++|+.||......+.. ...........
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------- 293 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA---SLMCAICMSQP--------- 293 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH---HHHHHHhccCC---------
Confidence 23457889999998853 23456899999999999999999999843322211 11111100000
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..........+.+++.+||+.||++||+++|++++
T Consensus 294 --~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 --PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011223457788889999999999999999985
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=317.00 Aligned_cols=244 Identities=24% Similarity=0.421 Sum_probs=194.6
Q ss_pred hccccccCcEEEEEEEEC----CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||.||+|.++ .+..||+|.++..... ...+.+|+.++..+ +||||+++++++..++..++||||+
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCcEEEEEeC
Confidence 568999999999999854 3567999998765322 34688899999888 9999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+.......
T Consensus 89 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 89 SNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999997432 24899999999999999999999998 9999999999999999999999999875532211
Q ss_pred -----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 534 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 534 -----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
...++..|+|||++.+..++.++|||||||++||+++ |+.||......+ .... ..+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~~~~-~~~~~~~------- 227 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIKA-VEDGFRL------- 227 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHH-HHCCCCC-------
Confidence 1123467999999999999999999999999999775 999997643221 1111 1111110
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
.........+.+++.+||+.+|++||+++|+.+.|+.+
T Consensus 228 ---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01122334577788899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=317.64 Aligned_cols=247 Identities=27% Similarity=0.477 Sum_probs=197.0
Q ss_pred hccccccCcEEEEEEEECCC------cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEES------TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~------~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||+|..... ..|++|.++.... ...++.+|++++..+ +||||+++++++.+.+..+++||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e 88 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQPTCMLFE 88 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCCceEEEEe
Confidence 56799999999999986432 4689998875432 235688899999998 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEE
Q 005875 452 YFASGSLSTLLHGNRGAG-----------RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 520 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl 520 (672)
|+++|+|.+++....... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEE
Confidence 999999999997543211 145889999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHh
Q 005875 521 SDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 593 (672)
Q Consensus 521 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 593 (672)
+|||++....... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+. ...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~------~~~- 238 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV------IEM- 238 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHH-
Confidence 9999987543221 2234677999999998899999999999999999998 9999976443221 111
Q ss_pred hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 594 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
+....... ........+.+++.+||+.+|.+||+++||+++|+.
T Consensus 239 i~~~~~~~----------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRSRQLLP----------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcCC----------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111100 112334567788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=324.86 Aligned_cols=245 Identities=19% Similarity=0.292 Sum_probs=191.9
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||.||+++.. +++.||+|+++.... ..+.+..|..++..+.+||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999965 578899999976432 1234678888888887899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence 9999888642 24899999999999999999999998 99999999999999999999999999865321
Q ss_pred CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC--CCChhHHHHHhhhhccccccchhhhhc
Q 005875 532 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD--MVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ......+......+... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--------RI 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--------CC
Confidence 223457889999999999999999999999999999999999997433222 11111222222111110 00
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPN------MDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~ 644 (672)
... ....+.+++.+|++.||++||+ ++|++++
T Consensus 225 p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRS---LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCC---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 011 1234667888999999999997 6777653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.29 Aligned_cols=238 Identities=17% Similarity=0.242 Sum_probs=193.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|... +++.||+|++..... ..+.+.+|++++..+ +||||+++++++.+++..++||||++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 467999999999999976 578899999864321 234678899999999 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-C
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-~ 533 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 85 ~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~ 156 (291)
T cd05612 85 GGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW 156 (291)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCcc
Confidence 99999999743 24889999999999999999999998 999999999999999999999999998765433 2
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+++.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+...... . .
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~~-------~--~--- 218 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKILAGKLE-------F--P--- 218 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCcC-------C--C---
Confidence 3457889999999999899999999999999999999999997643211 11111111100 0 0
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 644 (672)
......+.+++.+||+.||.+||+ ++|++++
T Consensus 219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011234667888999999999995 8888875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=318.66 Aligned_cols=256 Identities=20% Similarity=0.315 Sum_probs=190.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|... +++.||+|+++.... ....+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~- 87 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYLDS- 87 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEeCCCc-
Confidence 467999999999999965 578899999865432 234677899999999 999999999999999999999999985
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 88 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 88 DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 8998886432 24788999999999999999999998 999999999999999999999999998654322
Q ss_pred CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhH-HHHHhhhhcccc--------cc
Q 005875 533 ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR-WVQSVVREEWTA--------EV 602 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~--------~~ 602 (672)
....+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+...... .......+.+.. ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 22346788999999865 568999999999999999999999998654332211000 000000000000 00
Q ss_pred chhhhhc---ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 603 FDVELMR---FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 603 ~d~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+.... ............+++.+|++.||.+|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00000112346788889999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=308.29 Aligned_cols=244 Identities=22% Similarity=0.371 Sum_probs=203.2
Q ss_pred HHhccccccCcEEEEEEEE-CCCcEEEEEEeccccc-Chh---hHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 378 ASAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-GKR---DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 378 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~---~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.+.||+|.||.|-+|.. ..|+.||||.+++... +++ .+.+|++||..| +||||+..+.+|++.+...|||||
T Consensus 56 E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIvivMEY 134 (668)
T KOG0611|consen 56 EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIVIVMEY 134 (668)
T ss_pred HHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEEEEEEe
Confidence 3457899999999999985 6799999999976643 333 477899999999 999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
..+|.|++|+.. ...+++.++..++.||..|+.|+|.++ ++|||||.+|||+|+++++||+|||++-.+...
T Consensus 135 aS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 135 ASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred cCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999974 335999999999999999999999998 999999999999999999999999999877554
Q ss_pred ---CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 533 ---ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
.+.+|+|-|.+||++.+..| ++.+|-||+||+||-++.|..||++.+ .-..++++....+. .+.
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs~GaYr----EP~-- 274 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQISRGAYR----EPE-- 274 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhhccccc----CCC--
Confidence 36789999999999999998 567999999999999999999998653 22333333333222 111
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
. .....-||++|+..+|++|-|+.+|..+..-=+
T Consensus 275 ---~----PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 275 ---T----PSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred ---C----CchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 1 112345777999999999999999999876433
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=322.81 Aligned_cols=235 Identities=20% Similarity=0.295 Sum_probs=188.4
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 383 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 383 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
||+|+||+||+|+.. +++.||+|+++... .....+.+|++++.++ +||||+++++++.+++..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999976 46789999987532 1234567888999998 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 533 (672)
|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .
T Consensus 80 L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 80 LFHHLQRE-----GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence 99999742 24899999999999999999999998 999999999999999999999999998754221 2
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ............. ..
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~~~---------~~--- 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEPLR---------FP--- 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCC---------CC---
Confidence 34578899999999999999999999999999999999999975432 1222222211100 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPN---MDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 644 (672)
......+.+++.+||+.||++||+ +.|++.+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 112234567778999999999975 5666653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=311.96 Aligned_cols=245 Identities=26% Similarity=0.442 Sum_probs=200.3
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||.||+|...+++.||+|.++......+++.+|++++.++ +|+||+++++++...+..++||||+++++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 478999999999999988888899999876655667899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC--CCC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSR 537 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~--~~~ 537 (672)
+++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.++|+|||++........ ..+
T Consensus 90 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 90 EYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred HHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 9997533 234899999999999999999999998 99999999999999999999999999876543211 112
Q ss_pred ---CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 538 ---SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 538 ---~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
+..|+|||++.+..++.++||||||+++|||++ |+.||.+....+. .. ........ ...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~-~~~~~~~~----------~~~ 226 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV------LQ-QVDQGYRM----------PCP 226 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH------HH-HHHcCCCC----------CCC
Confidence 346999999999899999999999999999999 9999975432111 11 11111100 001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
......+.+++.+|++.+|++||+++++++.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 12335678888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=326.53 Aligned_cols=246 Identities=19% Similarity=0.285 Sum_probs=195.5
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|+..+ ++.||+|+++.... ....+..|++++..+ +||||+++++++.+++..++||||++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLAMEYVP 84 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEEEeCCC
Confidence 4679999999999999764 78899999975432 234577899999988 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-CC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-PA 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-~~ 533 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..... ..
T Consensus 85 g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~ 156 (333)
T cd05600 85 GGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN 156 (333)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccccccC
Confidence 99999999642 24889999999999999999999998 99999999999999999999999999976543 23
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+++.|+|||++.+..++.++|||||||++|||++|..||......+.. ..+.... .....+.. ....
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~--~~~~~~~~--~~~~ 226 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW------ENLKYWK--ETLQRPVY--DDPR 226 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH------HHHHhcc--ccccCCCC--Cccc
Confidence 456889999999999999999999999999999999999999765432211 1111000 00000000 0000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+|++.+|++||+++|++++
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1223456677889999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=294.68 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=204.2
Q ss_pred CCCHHHHHHHHhccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeC
Q 005875 369 NFDLEDLLRASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK 443 (672)
Q Consensus 369 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~ 443 (672)
.++++++ ..++.||+|-||.||.|+.+. +-.||+|++.+.+. ....+.+|+++-..| +||||.+++++|.+.
T Consensus 18 ~~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 18 TWTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDS 94 (281)
T ss_pred ccchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheecc
Confidence 3445554 347899999999999999654 66799999977643 346788899999999 999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeec
Q 005875 444 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 523 (672)
Q Consensus 444 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~Df 523 (672)
...|+++||..+|++...|+..+. ..+++.....+..|+|.|+.|+|..+ |+||||||+|+|++.++.+||+||
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence 999999999999999999985442 34888889999999999999999987 999999999999999999999999
Q ss_pred CCCCCC--CCCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccc
Q 005875 524 GLTPLM--NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601 (672)
Q Consensus 524 Gla~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (672)
|-+... +...+.+||.-|.+||...+..++..+|+|++|+++||++.|.+||......+... ++.. .+
T Consensus 169 GwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk------rI~k----~~ 238 (281)
T KOG0580|consen 169 GWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK------RIRK----VD 238 (281)
T ss_pred CceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH------HHHH----cc
Confidence 987554 33456789999999999999999999999999999999999999998765333211 1110 11
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 602 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
+.++ +.......++|.+|+.++|.+|.+..|++++-
T Consensus 239 ~~~p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 239 LKFP--------STISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred ccCC--------cccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1111 22233456777799999999999999998864
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.89 Aligned_cols=242 Identities=29% Similarity=0.527 Sum_probs=187.7
Q ss_pred hccccccCcEEEEEEEEC-----CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||.|.||.||+|.+. .+..|+||.++.... ..+.+.+|++.+.++ +||||++++|++...+..++||||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEEEE-
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccccccccccccc
Confidence 357999999999999977 256799999965432 246889999999999 999999999999988889999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.++++... ...+++..+..|+.||+.||+|||+.+ ++|+||+++||+++.++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999998652 234899999999999999999999987 999999999999999999999999998766221
Q ss_pred ------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 ------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
........|+|||.+.+..++.++||||||+++||+++ |+.||..... ......+ .+.....
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~-~~~~~~~---- 225 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL-KQGQRLP---- 225 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH-HTTEETT----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-cccccce----
Confidence 12234567999999999889999999999999999999 7888864421 1222222 1111111
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
........+.+++.+||+.+|++|||++|+++.|
T Consensus 226 ------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112234567888899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=324.07 Aligned_cols=192 Identities=22% Similarity=0.368 Sum_probs=166.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||+++.. ++..+|+|.+..... ..+.+.+|++++..+ +||||+++++++..++..++||||+++|
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 367999999999999976 467788888765422 235688999999999 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--CC
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--AT 534 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 534 (672)
+|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++...... ..
T Consensus 89 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (331)
T cd06649 89 SLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (331)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccccccc
Confidence 999999743 24889999999999999999999853 3999999999999999999999999998765332 23
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~ 579 (672)
..+++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 457889999999999999999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=322.80 Aligned_cols=245 Identities=19% Similarity=0.298 Sum_probs=190.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||+||+++.. +++.+|+|+++.... ....+..|+.++.++.+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 467899999876432 1234667888888777899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence 9999888643 24899999999999999999999998 99999999999999999999999999875322
Q ss_pred CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC--CChhHHHHHhhhhccccccchhhhhc
Q 005875 532 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--VDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+. .....+.......... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-------~ 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-------I 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-------C
Confidence 1234578899999999999999999999999999999999999964322211 1112222221111100 0 0
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPN------MDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~ 644 (672)
. ......+.+++.+||+.||++||+ ++|++++
T Consensus 225 p---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 P---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred C---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 0 112234667888999999999998 4677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=318.45 Aligned_cols=256 Identities=17% Similarity=0.224 Sum_probs=192.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+++.. +++.||+|+++.... ..+.+.+|++++..+ +|+||+++++++..++..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEEEecCCC
Confidence 467999999999999976 467899999875432 235678899999998 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
+.+..+... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 85 NMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 877655432 224889999999999999999999998 9999999999999999999999999997654321
Q ss_pred ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhH---------HHHHhhhhccccc
Q 005875 534 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR---------WVQSVVREEWTAE 601 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 601 (672)
...+++.|+|||++.+..++.++|||||||++|||++|+.||.+....+...... +............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 2346888999999998889999999999999999999999998654322110000 0000000000000
Q ss_pred cchhhhhcccC-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 602 VFDVELMRFQN-----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 602 ~~d~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+....... .......+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 01123457889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=322.35 Aligned_cols=245 Identities=20% Similarity=0.290 Sum_probs=192.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||+||+|+.. +++.+|+|+++.... ..+.+..|+.++.++.+|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 467899999976432 1234678888888887899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 9999888642 24899999999999999999999998 99999999999999999999999999875321
Q ss_pred CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 532 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.............+........... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~p~ 224 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR--------IPR 224 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC--------CCC
Confidence 123457889999999999999999999999999999999999997544333222222222222111100 001
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~ 644 (672)
. ....+.+++.+|++.||++|+++ ++++++
T Consensus 225 ~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 225 F---LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred C---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1 12345677889999999999984 566553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=324.32 Aligned_cols=238 Identities=20% Similarity=0.260 Sum_probs=193.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|+.. +++.||+|+++.... ..+.+.+|+.++.++ +||||+++++++.+++..++||||++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 101 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFLLEFVV 101 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEEEcCCC
Confidence 468999999999999976 478899999875421 235678899999999 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-C
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-~ 533 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...... .
T Consensus 102 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 102 GGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred CChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 99999999743 24788999999999999999999998 999999999999999999999999999765433 2
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+++.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+...... ....
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~---------~p~~- 237 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKILAGRLK---------FPNW- 237 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHhcCCcC---------CCCC-
Confidence 345788999999999999999999999999999999999999754321 111111111100 0001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 644 (672)
....+.+++.+||+.||++||+ ++|++.+
T Consensus 238 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 238 --FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1234567888999999999997 6888765
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.66 Aligned_cols=261 Identities=21% Similarity=0.332 Sum_probs=200.3
Q ss_pred ccccccCcEEEEEEEE-CCCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCc-eeceEEEEEeCC------eeEEE
Q 005875 381 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPN-VVPLRAYYYSKD------EKLLV 449 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~------~~~lV 449 (672)
++||+|+||+||+|+. .+|+.||+|++..... ......+|+.++.++ +|+| ||++++++...+ ..++|
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccccceEEEE
Confidence 5699999999999995 4578999999976544 235678999999999 8999 999999999877 78899
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
+||++. +|..++....... ..++...+..++.||+.||+|||+++ |+||||||.|||++++|.+||+|||+|+..
T Consensus 96 fe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred EEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHh
Confidence 999977 9999998654321 34777889999999999999999998 999999999999999999999999999876
Q ss_pred CCCC----CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHh---hhhccccc
Q 005875 530 NVPA----TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV---VREEWTAE 601 (672)
Q Consensus 530 ~~~~----~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~ 601 (672)
..+. ....|..|+|||++.+. .|+..+||||+||+++||++++.-|.+..+.+. +....+.. -.+.|...
T Consensus 171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHHHHHHcCCCCccCCCCc
Confidence 5433 23467889999999876 689999999999999999999999988765222 11111111 11233222
Q ss_pred cchh----hhhc---ccChHHHH----HHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005875 602 VFDV----ELMR---FQNIEEEM----VQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 649 (672)
Q Consensus 602 ~~d~----~~~~---~~~~~~~~----~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~ 649 (672)
..-+ .... ........ ....+++.+|++++|.+|.|++.++.+ +.++.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1111 1111 11111111 357788889999999999999999986 55443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=323.06 Aligned_cols=237 Identities=21% Similarity=0.287 Sum_probs=190.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||.||+++.. +++.||+|+++.... ....+.+|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 36999999999999965 578999999875422 223566788899888 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 80 GELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence 9999888643 24899999999999999999999998 999999999999999999999999998753221
Q ss_pred -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+. .......... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~~~~~~~~---------~p- 215 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILMEEIR---------FP- 215 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHhcCCCC---------CC-
Confidence 234578899999999999999999999999999999999999975432211 1111111100 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
......+.+++.+||+.||++|| ++.+++++
T Consensus 216 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 --RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred --CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 11223456777899999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=322.84 Aligned_cols=237 Identities=21% Similarity=0.303 Sum_probs=190.9
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||.||+++.. +++.||+|++..... ....+.+|++++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999965 578899999975422 234567788888888 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 80 GELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151 (328)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence 9999888642 24899999999999999999999998 999999999999999999999999998753221
Q ss_pred -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..... .. .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~~~~~~~-------~~--p- 215 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEDI-------KF--P- 215 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHHhccCCc-------cC--C-
Confidence 23457889999999999899999999999999999999999997543221 1111111110 00 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
......+.+++.+||+.||++|| ++.|++++
T Consensus 216 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 --RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11223456777899999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.63 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=198.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||.||+|... .++.|++|.++.......++.+|++++..+ +|+||+++++++..++..++||||+++++|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 89 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence 467999999999999965 477899999876555556788999999998 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC----
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---- 534 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 534 (672)
.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 90 ~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 90 LDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred HHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 99996432 234899999999999999999999998 99999999999999999999999999876543221
Q ss_pred -CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 535 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 535 -~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...+..|+|||++.+..++.++|||||||++|||++ |..||.+....+ ..... ....... .
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~-~~~~~~~----------~ 226 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELL-EKGYRME----------R 226 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHH-HCCCCCC----------C
Confidence 123457999999999999999999999999999998 999987543221 11111 1111000 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
.......+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111234577788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.72 Aligned_cols=236 Identities=24% Similarity=0.331 Sum_probs=187.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||.||+|+.. +++.||+|.++... ........|..++....+||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999976 46789999987642 12344566777777666899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence 9999998642 24889999999999999999999998 99999999999999999999999999864321
Q ss_pred CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 532 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+.... +... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~------~~~~~~~~~-------~~~~--~ 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE------LFESIRVDT-------PHYP--R 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------CCCC--C
Confidence 223457889999999999999999999999999999999999997543221 111111000 0000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMD-EVV 642 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 642 (672)
.....+.+++.+||+.||++||++. ++.
T Consensus 218 ---~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 ---WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1123456777899999999999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=322.28 Aligned_cols=237 Identities=24% Similarity=0.364 Sum_probs=187.9
Q ss_pred ccccccCcEEEEEEEECC-CcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||+||+|+..+ ++.||+|+++... .....+..|..++....+||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 368999999999999764 6789999987642 12344566777777666899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 9999999642 24889999999999999999999998 99999999999999999999999999865321
Q ss_pred CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 532 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..... .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~i~~~~~---~~~------- 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE------LFQSIRMDNP---CYP------- 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC---CCC-------
Confidence 123457889999999999899999999999999999999999997543221 1111111100 000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVR 643 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 643 (672)
......+.+++.+||+.+|++||++. ++.+
T Consensus 217 --~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 --RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01123456778899999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.66 Aligned_cols=246 Identities=25% Similarity=0.440 Sum_probs=197.1
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||+|...+ +..||+|.++..... .+.+.+|++++..+ +|+||+++++++......++|||
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 88 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEGDPPIMVFE 88 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCCCeEEEEe
Confidence 4679999999999998643 467999998765433 46789999999998 89999999999999999999999
Q ss_pred ecCCCchhhhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEee
Q 005875 452 YFASGSLSTLLHGNRG---------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 522 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 522 (672)
|+++|+|.++++.... .....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d 165 (280)
T cd05049 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGD 165 (280)
T ss_pred cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECC
Confidence 9999999999975431 12344889999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhh
Q 005875 523 FGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 595 (672)
Q Consensus 523 fGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 595 (672)
||++...... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+.
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------~~~~~~- 238 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VIECIT- 238 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHH-
Confidence 9998754221 12224567999999999999999999999999999998 999997543221 111111
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
...... ........+.+++.+||+.+|++||+++|+++.|+
T Consensus 239 ~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 QGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred cCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 110000 00122345778888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.39 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=197.8
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.++||+|+||.||+|.... ...||||+++.... ..+.+.+|++++.++..||||+++++++.+....++|||
T Consensus 42 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (400)
T cd05105 42 GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITE 121 (400)
T ss_pred hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEE
Confidence 5789999999999998532 23699999975432 245688999999999569999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC---------------------------------------------------------------
Q 005875 452 YFASGSLSTLLHGNRGA--------------------------------------------------------------- 468 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~--------------------------------------------------------------- 468 (672)
|+++|+|.++++.....
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (400)
T cd05105 122 YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYS 201 (400)
T ss_pred ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhh
Confidence 99999999998653210
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEE
Q 005875 469 ----------------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 520 (672)
Q Consensus 469 ----------------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl 520 (672)
....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL 278 (400)
T cd05105 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKI 278 (400)
T ss_pred hcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEE
Confidence 0124788889999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHh
Q 005875 521 SDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 593 (672)
Q Consensus 521 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 593 (672)
+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||......+. ....
T Consensus 279 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~------~~~~ 352 (400)
T cd05105 279 CDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST------FYNK 352 (400)
T ss_pred EeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH------HHHH
Confidence 9999987643221 2234567999999999899999999999999999997 9999975432211 1111
Q ss_pred hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 594 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
....... .........+.+++.+||+.+|++||++.++.++|+++.+
T Consensus 353 ~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 353 IKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111100 0011233567788889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=321.48 Aligned_cols=237 Identities=25% Similarity=0.357 Sum_probs=186.8
Q ss_pred ccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||+||+|+..+ ++.||+|+++.... ..+.+..|.+++....+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999754 67899999875432 2234556666776666899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence 9999998642 24889999999999999999999998 99999999999999999999999999875422
Q ss_pred CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 532 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+...... + .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~~---~------~- 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILNDRPH---F------P- 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCC---C------C-
Confidence 123457889999999999899999999999999999999999998654221 11111111100 0 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVR 643 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 643 (672)
......+.+++.+||+.+|++||++. ++++
T Consensus 217 --~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 --RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred --CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11123456777899999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.17 Aligned_cols=241 Identities=24% Similarity=0.416 Sum_probs=196.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||.||++.++++..+|+|.+........++.+|++++..+ +|+||+++++++...+..++||||+++++|.
T Consensus 9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (256)
T cd05059 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87 (256)
T ss_pred hhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence 567999999999999988778899999876555667788999999998 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC-----
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----- 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~----- 534 (672)
+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 88 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 88 NYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred HHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9997432 24899999999999999999999998 99999999999999999999999999876543221
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . .. ....... ...
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~---~~-~~~~~~~----------~~~ 223 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---V---ES-VSAGYRL----------YRP 223 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---H---HH-HHcCCcC----------CCC
Confidence 112346999999999899999999999999999999 8999975432211 1 11 1111000 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
......+.+++.+||+.+|++|||+.|+++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11334677888899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=321.04 Aligned_cols=237 Identities=24% Similarity=0.348 Sum_probs=189.6
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||+||+|+.. +++.||+|+++... ...+.+..|.+++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 47889999987542 12345667888887776899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence 9999988743 24889999999999999999999998 99999999999999999999999999875322
Q ss_pred CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 532 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+...... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~----~-----~- 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDEVV----Y-----P- 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhcCCCC----C-----C-
Confidence 123457889999999999999999999999999999999999997643221 11122111110 0 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVR 643 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 643 (672)
......+.+++.+|++.||++||++ +++++
T Consensus 217 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 217 --TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred --CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 0122356678889999999999998 66665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.82 Aligned_cols=238 Identities=23% Similarity=0.353 Sum_probs=190.8
Q ss_pred ccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
++||+|+||+||+|+..+ ++.||+|+++.... ..+.+..|.+++..+.+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999999764 67899999875422 2345667888888776899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 9999988643 24889999999999999999999998 99999999999999999999999999875322
Q ss_pred CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 532 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+...... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~~~~~----~p------ 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILHDDVL----YP------ 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCC----CC------
Confidence 123347889999999999899999999999999999999999998654221 11122111110 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRP-------NMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~~ 644 (672)
......+.+++.+|++.||++|| ++++++++
T Consensus 217 --~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 --VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01123566788899999999999 78888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=323.45 Aligned_cols=238 Identities=18% Similarity=0.271 Sum_probs=192.0
Q ss_pred hccccccCcEEEEEEEECC--CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE--STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||.||+|...+ +..||+|++..... ..+.+.+|++++..+ +||||+++++++.+++..++||||+
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~Ey~ 113 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLYLVLEFV 113 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEEEEEeCC
Confidence 4689999999999998643 35799999865421 234677899999998 9999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 532 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~- 532 (672)
++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 114 ~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 114 IGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence 999999999743 24889999999999999999999998 999999999999999999999999999765432
Q ss_pred CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 533 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
....|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...... + ...
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i~~~~~~---~------p~~ 250 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKILEGIIY---F------PKF 250 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHHhcCCCC---C------CCC
Confidence 24458889999999999889999999999999999999999997543211 11111111100 0 011
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
.. ..+.+++.+|++.||++|+ +++|++++
T Consensus 251 ~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 LD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 12 2356777899999999995 89998875
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=306.77 Aligned_cols=242 Identities=23% Similarity=0.356 Sum_probs=196.8
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|+..++..+|+|.++......+++.+|+.++.++ +||||+++++++.+.+..++||||+.+|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence 467999999999999988777899999876655667899999999999 8999999999999888899999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----C
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 534 (672)
+++.... ..+++..+..++.||+.|++|||+.+ ++|+||||+||++++++.+||+|||.++...... .
T Consensus 88 ~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 88 NYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9997432 24899999999999999999999998 9999999999999999999999999987553322 1
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||++.+..++.++||||||+++|||++ |..||......+ ........... . ..
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~-~----------~~ 223 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKVSQGLRL-Y----------RP 223 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHhcCCCC-C----------CC
Confidence 123456999999998889999999999999999999 999987543211 11111111110 0 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
......+.+++.+||+.+|++||++.++++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112356778888999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=310.96 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=193.4
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCe-----eEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----KLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lV~e~~ 453 (672)
.+++|+|+||.||+|...+ +..||||+.-.. ++.-.+|+++|+.+ .|||||++..+|..... ..+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d---~r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD---KRYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCC---CCcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 4689999999999999654 588999987543 23445788899977 99999999998875432 34899999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC-CCeEEeecCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVP 532 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~~~ 532 (672)
+. +|.++++.... ....++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.....
T Consensus 105 P~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred hH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 88 99999975321 1334788888899999999999999988 9999999999999976 99999999999987654
Q ss_pred CC---CCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccc-------
Q 005875 533 AT---PSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE------- 601 (672)
Q Consensus 533 ~~---~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------- 601 (672)
.. +.-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+..+.+. . .-+++.-....+
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~--e-Iik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLV--E-IIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHH--H-HHHHhCCCCHHHHhhcCcc
Confidence 43 234678999999876 458999999999999999999999999865433211 1 111111000000
Q ss_pred ---cchhhhhcc----cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhhc
Q 005875 602 ---VFDVELMRF----QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQS 651 (672)
Q Consensus 602 ---~~d~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 651 (672)
.-.+..... -.......+.++++.++++++|.+|.++.|++. ..++++..
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 000111000 011233456788888999999999999999997 56666655
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.42 Aligned_cols=244 Identities=25% Similarity=0.443 Sum_probs=197.5
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|+..++..||+|+++......+.+.+|++++..+ +|+||+++++++. ....++||||+++|+|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (262)
T cd05071 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (262)
T ss_pred eeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEEC-CCCcEEEEEcCCCCcHH
Confidence 467999999999999988777899999986555567889999999998 8999999999874 45679999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----C
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 534 (672)
+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.+....... .
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 89 DFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred HHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 9997432 234789999999999999999999998 9999999999999999999999999987654322 1
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||+..+..++.++||||||+++|||+| |..||......+. ..... .... ....
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------~~~~~-~~~~----------~~~~ 225 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVE-RGYR----------MPCP 225 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------HHHHh-cCCC----------CCCc
Confidence 224557999999988889999999999999999999 8888875432211 11110 0000 0011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
.+....+.+++.+|++.+|++||+++++++.|++.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 23345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=312.41 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=196.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---------------ChhhHHHHHHHHHHHcCCCceeceEEEEEeC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK 443 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~ 443 (672)
.+.||+|.||.|-+|+.. +++.||||++.+... ..+...+|+.+++++ +|||||+|+++..+.
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~LiEvLDDP 180 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLIEVLDDP 180 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEEEeecCc
Confidence 467999999999999954 688899999965421 124678999999999 999999999999764
Q ss_pred --CeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEe
Q 005875 444 --DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 521 (672)
Q Consensus 444 --~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 521 (672)
+..|||+|||..|.+...=. ....+++.++.+++.++..||+|||.+| ||||||||+|+||+++|++||+
T Consensus 181 ~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 181 ESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred ccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEee
Confidence 57899999999988754432 1223899999999999999999999999 9999999999999999999999
Q ss_pred ecCCCCCCCCC---------CCCCCCCcccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 005875 522 DFGLTPLMNVP---------ATPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 588 (672)
Q Consensus 522 DfGla~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~ 588 (672)
|||.+...... ....|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-+....+
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~------ 326 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE------ 326 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH------
Confidence 99988655221 2356899999999997733 3567899999999999999999998654322
Q ss_pred HHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 589 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 589 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
...+++.+ .+ .+...++....+.+|+.++|++||+.|.+..+|..+..-.+..+.
T Consensus 327 l~~KIvn~---------pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 327 LFDKIVND---------PL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred HHHHHhcC---------cc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 12222211 11 112223455677788889999999999999999998887766544
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=319.32 Aligned_cols=254 Identities=27% Similarity=0.403 Sum_probs=197.1
Q ss_pred HhccccccCcEEEEEEEEC------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeC-CeeEEE
Q 005875 379 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLV 449 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV 449 (672)
..+.||+|+||.||+|... .++.||+|+++.... ..+.+..|++++.++.+|+||+++++++... ...+++
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence 3578999999999999743 246799999875432 2245678999999987899999999988654 567899
Q ss_pred EEecCCCchhhhhccCCCC--------------------------------------------------------CCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGA--------------------------------------------------------GRTPL 473 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~--------------------------------------------------------~~~~l 473 (672)
|||+++|+|.+++...... ....+
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 9999999999998643210 01258
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC------CCCCCCcccCcccc
Q 005875 474 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVI 547 (672)
Q Consensus 474 ~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~ 547 (672)
++..+..++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||++....... ...++..|+|||++
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 247 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence 99999999999999999999998 9999999999999999999999999997653221 12235679999999
Q ss_pred cCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHH
Q 005875 548 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMA 626 (672)
Q Consensus 548 ~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~ 626 (672)
.+..++.++|||||||++|||++ |..||.+....+. ............ ........+.+++.+
T Consensus 248 ~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~----------~~~~~~~~~~~l~~~ 311 (337)
T cd05054 248 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRMR----------APEYATPEIYSIMLD 311 (337)
T ss_pred cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCCC----------CCccCCHHHHHHHHH
Confidence 99999999999999999999998 9999976432211 111111111100 011223467888899
Q ss_pred cccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 627 CVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 627 Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
||+.+|++||++.|++++|+++.+.
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=311.63 Aligned_cols=243 Identities=20% Similarity=0.283 Sum_probs=190.5
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 383 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 383 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
||+|+||+||++... +++.+|+|.+..... ..+.+..|++++..+ +|+||+++.+++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 699999999999965 578899999865432 124567788999998 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC----
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 533 (672)
|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 80 L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 80 LRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred HHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 9988754322 2335899999999999999999999998 9999999999999999999999999987553322
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+++.|+|||++.+..++.++|||||||++|||++|+.||........ ............ . ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~---------~---~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILNDS---------V---TYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcccC---------C---CCc
Confidence 23578899999999999999999999999999999999999975432211 000011111000 0 001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
......+.+++.+||+.||++|| +++|++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 12234567788899999999999 77788764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.80 Aligned_cols=243 Identities=20% Similarity=0.307 Sum_probs=190.2
Q ss_pred hccccccCcEEEEEEEEC----CCcEEEEEEeccccc-----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.+.||+|+||+||+++.. +++.||+|++.+... ..+.+..|++++..+.+|+||+++++++..++..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 468999999999999853 578899999875321 23457788999999877999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 85 DYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999998642 34889999999999999999999998 9999999999999999999999999987643
Q ss_pred CC-----CCCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 531 VP-----ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 531 ~~-----~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
.. ....|++.|+|||++.+.. ++.++|||||||++|||++|+.||......... ......+....
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~------- 227 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILKCD------- 227 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhcCC-------
Confidence 22 1235788999999998654 788999999999999999999999754322211 11111111110
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
+.. . ......+.+++.+||+.||++|| +++|++++
T Consensus 228 ~~~--~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 PPF--P---SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCC--C---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 000 0 11223456778899999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.40 Aligned_cols=237 Identities=22% Similarity=0.348 Sum_probs=189.9
Q ss_pred ccccccCcEEEEEEEEC----CCcEEEEEEeccccc-----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 381 EVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
+.||+|+||.||+++.. .++.||+|+++.... ....+..|++++..+ +||||+++++++..++..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEEe
Confidence 57999999999999853 477899999875421 234567899999998 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 81 YLSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999998642 24788889999999999999999998 99999999999999999999999999864322
Q ss_pred C----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 532 P----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 532 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
. ....+++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..... .
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~~--~------ 218 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGKL--N------ 218 (323)
T ss_pred CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC--C------
Confidence 1 2235788999999999988999999999999999999999999754321 11111111110 0
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
.. ......+.+++.+||+.+|++|| ++++++++
T Consensus 219 -~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 -LP---PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -CC---CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 00 11123566788899999999999 88888773
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=307.81 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=195.0
Q ss_pred ccccccCcEEEEEEEECCC-c--EEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLEES-T--TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~-~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||.||+|...++ . .+++|.++.... ..+.+.+|++++.++.+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 3689999999999997643 3 468888764322 3457888999999998899999999999999999999999999
Q ss_pred CchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecC
Q 005875 456 GSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 524 (672)
Q Consensus 456 g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 524 (672)
|+|.++++.... .....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999975431 11234789999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhcccc
Q 005875 525 LTPLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 600 (672)
Q Consensus 525 la~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (672)
++...... .....+..|+|||++....++.++|||||||++|||++ |..||......+ ...... .....
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~-~~~~~ 230 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLP-QGYRL 230 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHHh-CCCCC
Confidence 98543211 11123456999999988889999999999999999997 999996543211 111111 11111
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 601 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
+. .......+.+++.+||+.+|.+|||+.|++..|+++.
T Consensus 231 ~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 EK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC----------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 0112245678889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=304.54 Aligned_cols=241 Identities=24% Similarity=0.358 Sum_probs=197.1
Q ss_pred hccccccCcEEEEEEEECCC-cEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|.-|+||++++.+. ..+|+|++.+.... ..+.+.|.+|+..+ +||.++.+++.++.++..|+|||||+
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEEEecCC
Confidence 46899999999999998764 78999999876432 23567788899998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
||+|..++++..+ ..+++..+..++..++-||+|||-.| ||+|||||+||||.++|++.|+||.++.....
T Consensus 161 GGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 161 GGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred CccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 9999999987653 45999999999999999999999999 99999999999999999999999998632100
Q ss_pred ------------------------------C-C--------------------------CCCCCCcccCcccccCCCCCC
Q 005875 532 ------------------------------P-A--------------------------TPSRSAGYRAPEVIETRKHSH 554 (672)
Q Consensus 532 ------------------------------~-~--------------------------~~~~~~~y~aPE~~~~~~~~~ 554 (672)
. . ..+||-.|+|||++.+..++.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 012445599999999999999
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCC
Q 005875 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDM 634 (672)
Q Consensus 555 ~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~ 634 (672)
++|+|+|||++|||+.|..||.+.+..+... .++.+ .+ .+....+......+||++.|.+||++
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~------NIv~~---------~l-~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLR------NIVGQ---------PL-KFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHH------HHhcC---------CC-cCCCCCcchhHHHHHHHHHhccChhh
Confidence 9999999999999999999999987665421 11111 11 12222244566778888999999999
Q ss_pred CCC----HHHHHH
Q 005875 635 RPN----MDEVVR 643 (672)
Q Consensus 635 RPs----~~evl~ 643 (672)
|.- +.||-+
T Consensus 379 Rlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 379 RLGSKRGAAEIKR 391 (459)
T ss_pred hhccccchHHhhc
Confidence 998 888876
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.05 Aligned_cols=246 Identities=23% Similarity=0.422 Sum_probs=200.9
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 379 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
..+.||+|+||.||+|...+++.+++|.+..... ....+..|+.++..+ +|+||+++++++.+.+..++||||+++|+
T Consensus 10 ~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (261)
T cd05148 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYIITELMEKGS 88 (261)
T ss_pred HhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEEEEeecccCC
Confidence 3578999999999999998889999999876544 456788999999999 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC----
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 533 (672)
|.++++... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||.+.......
T Consensus 89 L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 89 LLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred HHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 999997543 234899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...++..|+|||++....++.++||||||+++|+|++ |+.||......+. ..... ..... ..
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~------~~~~~-~~~~~----------~~ 225 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV------YDQIT-AGYRM----------PC 225 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH------HHHHH-hCCcC----------CC
Confidence 1224567999999998889999999999999999998 8999975432211 11111 11000 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
.......+.+++.+||+.+|++|||++++++.|+.+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 112234577888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=326.86 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=200.6
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCC-----ceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-----NVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-----niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.++||+|+||.|-+|.... ++.||||+++....-..+-..|+.++..+.+|. |+|+++++|...++.|||+|.+
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL 270 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL 270 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh
Confidence 4789999999999999654 788999999876554556677888999885343 8999999999999999999998
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC--CCeEEeecCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD--LDGCISDFGLTPLMNV 531 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~--~~~kl~DfGla~~~~~ 531 (672)
.. +|+++++.++- ..++...++.|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.|.....
T Consensus 271 ~~-NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 271 ST-NLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred hh-hHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 65 99999987663 44999999999999999999999998 9999999999999764 4799999999987654
Q ss_pred CC-CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChh--------HHHH-------Hhhh
Q 005875 532 PA-TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP--------RWVQ-------SVVR 595 (672)
Q Consensus 532 ~~-~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~--------~~~~-------~~~~ 595 (672)
.. ++..+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+.++.+.+..+ .++- +.+.
T Consensus 344 ~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~ 423 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFT 423 (586)
T ss_pred cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehh
Confidence 33 555678899999999999999999999999999999999999987665442110 1110 0011
Q ss_pred h-cccc------c-----------------cch---h-hhhccc-ChH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 596 E-EWTA------E-----------------VFD---V-ELMRFQ-NIE-EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 596 ~-~~~~------~-----------------~~d---~-~~~~~~-~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. .+.. + ..+ + ...... ... ..-..|++++.+|+..||.+|+|+.|++++
T Consensus 424 ~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 424 SLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred ccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 1 0000 0 000 0 000000 111 334568999999999999999999999984
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=320.45 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=200.9
Q ss_pred CCCHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeccc----ccChhhHHHHHHHHHHHcCCCceeceEEEEEeC
Q 005875 369 NFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEV----VVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK 443 (672)
Q Consensus 369 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~ 443 (672)
.-|.+.++... +.||+|+||.||-++.. +...||||++.-. .....++..|+.++..+ +|||++.+-|+|..+
T Consensus 21 k~DPEklf~dL-rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre 98 (948)
T KOG0577|consen 21 KDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLRE 98 (948)
T ss_pred cCCHHHHHHHH-HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeecc
Confidence 34666665554 45999999999999965 4677899998533 12346788999999999 999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeec
Q 005875 444 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 523 (672)
Q Consensus 444 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~Df 523 (672)
...|+|||||-| +-.|++.-. ++++-+.++..|+.+.+.||+|||+.+ .||||||+.|||+++.|.||++||
T Consensus 99 ~TaWLVMEYClG-SAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDF 170 (948)
T KOG0577|consen 99 HTAWLVMEYCLG-SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADF 170 (948)
T ss_pred chHHHHHHHHhc-cHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccc
Confidence 999999999965 666666422 345888999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccc
Q 005875 524 GLTPLMNVPATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 600 (672)
Q Consensus 524 Gla~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (672)
|.|..........|||.|||||++. .+.|+-++||||+|+++.|+...++|+..++. ......+...+.
T Consensus 171 GSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQNes-- 242 (948)
T KOG0577|consen 171 GSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES-- 242 (948)
T ss_pred cchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHhcCC--
Confidence 9999999999999999999999984 57899999999999999999999999875432 112222221111
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 601 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
|.+ . -.+....|.+++..|+++-|.+|||.++++++
T Consensus 243 ----PtL-q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 ----PTL-Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ----CCC-C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 001 1 12334456666679999999999999998875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=305.60 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=195.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEe-----CCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-----KDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-----~~~~~lV~ 450 (672)
.+.||+|+||.|+.+... ++..||||++..... ..++..+|+++++.+ +|+||+.+.+++.. -+..|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccccccceeEEeh
Confidence 367999999999999965 578899999985543 356778899999999 79999999999865 35789999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
|+|+ .||...++.. +.++......++.|+++|++|+|+.+ |+||||||+|++++.+..+||+|||+|+...
T Consensus 106 elMe-tDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 106 ELME-TDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred hHHh-hHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecc
Confidence 9995 4999999743 34999999999999999999999998 9999999999999999999999999999875
Q ss_pred CC------CCCCCCCcccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHH--------HHhhh
Q 005875 531 VP------ATPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV--------QSVVR 595 (672)
Q Consensus 531 ~~------~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~--------~~~~~ 595 (672)
.. .....|.+|+|||++. ...|+.+.||||.||++.||++|++-|.+.+.-+.+.++-.. ...+.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 31 2344688899999985 467899999999999999999999999986543332211111 00011
Q ss_pred hccccccchhhhh-cccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005875 596 EEWTAEVFDVELM-RFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 649 (672)
Q Consensus 596 ~~~~~~~~d~~~~-~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~ 649 (672)
.......+..... .... +.......++|+.+|+..||.+|+|++|++++ |....
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 0000000000000 0001 11222446777779999999999999999985 44443
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=318.33 Aligned_cols=241 Identities=22% Similarity=0.373 Sum_probs=202.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCe-eEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-KLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-~~lV~e~~~ 454 (672)
.+.+|+|+||.++.++.+ +++.+++|.+.-... .++..++|+.+++++ +|||||.+.+.|.+++. .+|||+|++
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCIVMEYCE 87 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEEEEeecC
Confidence 467999999999999854 567899998875543 234678999999998 99999999999999988 899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
||++.+.+.+.+ ...++++.+.+++.|++.|+.|||++. |+|||||+.||+++.++.|||+|||+|+.+....
T Consensus 88 Gg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 88 GGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred CCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999998765 345899999999999999999999887 9999999999999999999999999999887653
Q ss_pred ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 534 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
+..||+.||.||++.+..|..|+||||+||++|||++-+++|.+.+. ...+.++.... ..+
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~~Li~ki~~~~-----~~P----- 225 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM------SELILKINRGL-----YSP----- 225 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch------HHHHHHHhhcc-----CCC-----
Confidence 45699999999999999999999999999999999999999986542 22233333222 111
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
-.......+..++..|++.+|+.||++.+++.+
T Consensus 226 -lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 -LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 112344567777889999999999999999985
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=306.40 Aligned_cols=244 Identities=25% Similarity=0.450 Sum_probs=197.3
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 379 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
..+.||+|+||.||+|...++..+|+|.+.......+.+.+|+.++.++ +|+|++++++++. ....+++|||+++++|
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (260)
T ss_pred hhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcEEEEEecCCCcH
Confidence 3578999999999999988888999999987666667899999999999 9999999999875 4568999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC----
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---- 534 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 534 (672)
.++++... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 88 LDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 99997532 234899999999999999999999998 99999999999999999999999999876543221
Q ss_pred -CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 535 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 535 -~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
..++..|+|||++.+..++.++||||||+++|||++ |..||......+ ....+. ...... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~-~~~~~~----------~ 224 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------VLEQVE-RGYRMP----------C 224 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHH-cCCCCC----------C
Confidence 123456999999988889999999999999999999 899997543211 111111 110000 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
.......+.+++.+|++.+|++|||++++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11223457788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=307.57 Aligned_cols=239 Identities=21% Similarity=0.331 Sum_probs=187.0
Q ss_pred ccccccCcEEEEEEEECC-------------CcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCee
Q 005875 381 EVLGKGSYGTAYKAVLEE-------------STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK 446 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~ 446 (672)
+.||+|+||.||+|+... ...|++|.+..... ....+.+|+.++..+ +||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCC
Confidence 368999999999998532 22478888765432 234677788888888 999999999999999999
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC-------eE
Q 005875 447 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-------GC 519 (672)
Q Consensus 447 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~-------~k 519 (672)
++||||+++|+|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. ++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeE
Confidence 99999999999998886432 34899999999999999999999998 999999999999987664 89
Q ss_pred EeecCCCCCCCCCCCCCCCCcccCccccc-CCCCCCccchhhHHHHHHHHH-hCCCCCCCCCCCCCCChhHHHHHhhhhc
Q 005875 520 ISDFGLTPLMNVPATPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEML-TGKAPLQSPTRDDMVDLPRWVQSVVREE 597 (672)
Q Consensus 520 l~DfGla~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~el~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 597 (672)
++|||++..........++..|+|||++. +..++.++|||||||++|||+ +|..||......+. .......
T Consensus 153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~~~~ 225 (262)
T cd05077 153 LSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFYEGQ 225 (262)
T ss_pred eCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHHhcC
Confidence 99999987765555556788899999986 566899999999999999997 58888865322111 0000000
Q ss_pred cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 598 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 598 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
. .. .......+.+++.+||+.||++||++.|+++.++
T Consensus 226 ~--~~----------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 226 C--ML----------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred c--cC----------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 00 0111245678888999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=288.04 Aligned_cols=253 Identities=19% Similarity=0.338 Sum_probs=198.4
Q ss_pred hccccccCcEEEEEEE-ECCCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCC-----eeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lV~e~ 452 (672)
.+.+|+|||+-||+++ ..++..+|+|++.-.. .+.+...+|++..+++ +||||++++++...+. ..|++++|
T Consensus 26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~~~yll~Py 104 (302)
T KOG2345|consen 26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKHEAYLLLPY 104 (302)
T ss_pred eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCceeEEEEeeh
Confidence 4689999999999999 5667889999987554 4566788999999998 9999999998875433 48999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+..|+|.+.+...+.. +..+++.+.+.|+.+|++||++||+.. |+++||||||.|||+.+++.+++.|||.++.....
T Consensus 105 y~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~ 182 (302)
T KOG2345|consen 105 YKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQ 182 (302)
T ss_pred hccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceE
Confidence 9999999999865543 446999999999999999999999986 68999999999999999999999999998765422
Q ss_pred C-------------CCCCCCcccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh
Q 005875 533 A-------------TPSRSAGYRAPEVIETR---KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE 596 (672)
Q Consensus 533 ~-------------~~~~~~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 596 (672)
. ...-|..|+|||.+.-. ..++++|||||||++|+|+.|..||+..-... ..+
T Consensus 183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-gSl---------- 251 (302)
T KOG2345|consen 183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-GSL---------- 251 (302)
T ss_pred eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-CeE----------
Confidence 1 11236779999999644 46889999999999999999999997432211 000
Q ss_pred ccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 597 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 597 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
...+....+. ...-......+.+++.+|++.||.+||++.|++..++++.
T Consensus 252 --aLAv~n~q~s-~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 --ALAVQNAQIS-IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --EEeeeccccc-cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0111111110 1111124456778888999999999999999999998764
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=309.53 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=194.1
Q ss_pred hccccccCcEEEEEEEE-----CCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 450 (672)
.+.||+|+||+||++.+ .++..||+|.++.... ....+.+|++++..+ +||||+++++++... ...++||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCceEEEEe
Confidence 46799999999988753 3467899999875432 345788899999998 999999999988754 3578999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++|+|.+++... .+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 88 e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 88 EYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred cCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999642 3899999999999999999999998 9999999999999999999999999987654
Q ss_pred CCCC-------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 531 VPAT-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 531 ~~~~-------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
.... ..++..|+|||.+.+..++.++||||||+++|||+||..||...... ..................+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhh
Confidence 3221 12345699999998888999999999999999999999998653321 000000000000000000000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
+... ...........+.+++.+||+.+|++|||++++++.|+++.
T Consensus 238 ~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000 00001123356778888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=316.07 Aligned_cols=192 Identities=21% Similarity=0.375 Sum_probs=165.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||++... ++..+|+|.+..... ....+.+|++++..+ +|+||+++++++.+++..++||||+++|
T Consensus 10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (333)
T cd06650 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 88 (333)
T ss_pred eccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEEEEecCCCC
Confidence 468999999999999976 467788888765422 235688999999999 8999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--CC
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--AT 534 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 534 (672)
+|.+++... ..+++.....++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 89 ~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 161 (333)
T cd06650 89 SLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (333)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcccc
Confidence 999999742 24788999999999999999999752 3999999999999999999999999998755332 23
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~ 579 (672)
..++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 457889999999998889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.67 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=188.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+.. +++.||+|++..... ....+.+|+.+++.+ +||||+++++++.+++..++||||+. +
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLVFEYVH-T 87 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence 467999999999999976 578899999875432 234577899999998 99999999999999999999999996 5
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 88 DLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 8888776432 34888999999999999999999998 999999999999999999999999998654322
Q ss_pred CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh----hcccc----ccc
Q 005875 533 ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA----EVF 603 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~ 603 (672)
....+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ............ ..+.. ..+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhcccc
Confidence 23446788999999865 45788999999999999999999999864221 000111100000 00000 000
Q ss_pred hhh-h--hcccChHH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 604 DVE-L--MRFQNIEE------EMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 604 d~~-~--~~~~~~~~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
++. . ........ ....+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 0 00000111 1234667888999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.16 Aligned_cols=238 Identities=25% Similarity=0.349 Sum_probs=190.7
Q ss_pred ccccccCcEEEEEEEECC-CcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||+||+++... ++.||+|+++... .....+..|.+++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999764 6789999987542 12345667888888776899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence 9999988643 24899999999999999999999998 999999999999999999999999998653221
Q ss_pred -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+...... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~~~i~~~~~~---------~~- 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LFQSILEDEVR---------YP- 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCC---------CC-
Confidence 22347889999999999999999999999999999999999997543211 11111111100 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 644 (672)
......+.+++.+||+.||++||++ .+++++
T Consensus 217 --~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 --RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1122456778889999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.06 Aligned_cols=241 Identities=24% Similarity=0.375 Sum_probs=192.0
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
+.||+|+||.||+|... +++.+|+|.+..... ....+.+|++++..+ +|+||+++++++...+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36999999999999975 678899998764432 245688999999998 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC---
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--- 534 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 534 (672)
|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 80 L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99999642 234889999999999999999999998 99999999999999999999999999875432211
Q ss_pred ---CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 535 ---PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 535 ---~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
...+..|+|||.+.+..++.++||||||+++|||++ |..||......+ ...........
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~~---------- 215 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVRL---------- 215 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCC----------
Confidence 112345999999999889999999999999999998 888886432211 11111111000
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.........+.+++.+|++.+|++|||++|+.+.|+
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 001122346778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=305.15 Aligned_cols=243 Identities=25% Similarity=0.452 Sum_probs=198.0
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.++||+|+||.||+|..++++.||+|.+........++.+|+++++++ +|+||+++++++. ++..+++|||+++|+|.
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPIYIITEYMENGSLV 88 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCcEEEEEcCCCCCHH
Confidence 468999999999999998899999999987666677899999999999 8999999999874 56789999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----C
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 534 (672)
+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... .
T Consensus 89 ~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 89 DFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 9986533 234899999999999999999999988 9999999999999999999999999987654221 1
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||++....++.++||||||+++|||++ |+.||.+....+ ..... ........ .
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~-~~~~~~~~----------~ 225 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------VIQNL-ERGYRMPR----------P 225 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------HHHHH-HcCCCCCC----------C
Confidence 223567999999998889999999999999999999 999997543221 11111 11110000 0
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
......+.+++.+|++.+|++||++++++..|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1122457788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=307.41 Aligned_cols=244 Identities=26% Similarity=0.484 Sum_probs=196.2
Q ss_pred hccccccCcEEEEEEEECC----CcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||+||+|.+.. ...|++|.++..... ..++..|+.++..+ +|+||+++++++...+..++||||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCceEEEEEcC
Confidence 4689999999999999753 357899988754332 35688899999998 8999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++++|.+++.... ..+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 88 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 88 ENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred CCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999997533 24899999999999999999999988 9999999999999999999999999998764211
Q ss_pred C------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhh
Q 005875 534 T------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606 (672)
Q Consensus 534 ~------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 606 (672)
. ..++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .... ....+...
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~------~~~~-~~~~~~~~----- 228 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD------VIKA-VEDGYRLP----- 228 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH------HHHH-HHcCCCCC-----
Confidence 1 123457999999998899999999999999999998 999986533211 1111 11111000
Q ss_pred hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 607 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
........+.+++.+||+.+|++||+++|++++|+++
T Consensus 229 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 -----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112334677888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.11 Aligned_cols=237 Identities=20% Similarity=0.279 Sum_probs=189.0
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||+||+++.. +++.||+|+++.... ....+..|++++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999964 578899999875422 124566788888887 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 80 GELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 9999988642 248999999999999999999997 66 999999999999999999999999998653221
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+...... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~~i~~~~~~---------~p 216 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEEIR---------FP 216 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------HHHHHhcCCCC---------CC
Confidence 23457889999999999999999999999999999999999997543221 11111111100 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
......+.+++.+|++.||++|+ ++.|++++
T Consensus 217 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 ---RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11123466778899999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.42 Aligned_cols=257 Identities=21% Similarity=0.312 Sum_probs=187.5
Q ss_pred hccccccCcEEEEEEEEC--CCcEEEEEEecccccC---hhhHHHHHHHHHHHc--CCCceeceEEEEEe-----CCeeE
Q 005875 380 AEVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVG--QHPNVVPLRAYYYS-----KDEKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~--~h~niv~l~~~~~~-----~~~~~ 447 (672)
.+.||+|+||+||+|+.. +++.||+|+++..... ...+.+|+.++..+. +||||+++++++.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 367999999999999863 3678999988654322 235667887777664 69999999999853 34678
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
+||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred EEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 9999997 58999886433 234899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHHHHhhhhcccccc-
Q 005875 528 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-DLPRWVQSVVREEWTAEV- 602 (672)
Q Consensus 528 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~- 602 (672)
..... ....+++.|+|||++.+..++.++|||||||++|||++|++||.+....+.. .+.........+.+....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 65432 2334688899999999889999999999999999999999999865432211 000000000001110000
Q ss_pred -chhhh--hcccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 603 -FDVEL--MRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 603 -~d~~~--~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
..... ...... ......+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 000000 112244567888999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.33 Aligned_cols=251 Identities=24% Similarity=0.441 Sum_probs=198.7
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||++... ++..+|+|.+..... ..+.+.+|++++.++ +|+||+++++++...+..++||||
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEc
Confidence 467999999999999842 245588888865432 345788999999999 899999999999999999999999
Q ss_pred cCCCchhhhhccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecC
Q 005875 453 FASGSLSTLLHGNRG--------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 524 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 524 (672)
+++++|.+++..... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg 165 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFG 165 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCC
Confidence 999999999974321 12234899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhc
Q 005875 525 LTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 597 (672)
Q Consensus 525 la~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 597 (672)
++....... ...++..|+|||++.+..++.++|||||||++|||++ |..||......+. ...+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~------~~~i~~~~ 239 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------IECITQGR 239 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCC
Confidence 987553221 1223567999999998899999999999999999998 8999875432211 11111111
Q ss_pred cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 598 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 598 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
... .. ......+.+++.+||+.+|.+|||++|+.+.|+++...
T Consensus 240 -~~~-------~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 240 -VLQ-------RP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -cCC-------CC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000 00 11224578888899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=321.15 Aligned_cols=249 Identities=20% Similarity=0.297 Sum_probs=188.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||.||++... .++.||+|... ...+.+|++++.++ +||||+++++++..+...++|+|++. ++|
T Consensus 97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred EEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 468999999999999965 46789998643 34578899999999 99999999999999999999999995 688
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-----CC
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-----PA 533 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-----~~ 533 (672)
..++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..... ..
T Consensus 170 ~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 170 YCYLAAK-----RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 8888642 24889999999999999999999998 99999999999999999999999999865322 12
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC-CCChhHHHHHhhhh------ccc-------
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD-MVDLPRWVQSVVRE------EWT------- 599 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~------~~~------- 599 (672)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..+.......+... .+.
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 3458899999999999999999999999999999999998875432211 10100001111000 000
Q ss_pred cccc---------hhhh-hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 600 AEVF---------DVEL-MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 600 ~~~~---------d~~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
...+ .+.. ............+.+++.+||+.||++|||++|+++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0000 000011223456788899999999999999999997
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=312.03 Aligned_cols=251 Identities=24% Similarity=0.436 Sum_probs=199.3
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||.||+|+.. ++..+++|.+..... ..+.+.+|++++.++ +|+||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCceEEEEec
Confidence 367999999999999843 345688888865433 235788999999998 899999999999999999999999
Q ss_pred cCCCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEe
Q 005875 453 FASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 521 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 521 (672)
+++++|.+++..... .....+++..++.++.||+.|++|||+++ |+||||||+||+++.++.++|+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEEC
Confidence 999999999965321 11234899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhh
Q 005875 522 DFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 594 (672)
Q Consensus 522 DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 594 (672)
|||++....... ...++..|+|||++.+..++.++||||||+++|||+| |+.||......+ .....
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~- 238 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VIECI- 238 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH-
Confidence 999987543321 2234567999999999999999999999999999999 999987543221 11111
Q ss_pred hhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 595 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 595 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
....... ........+.+++.+||+.+|++||+++++++.|+++...
T Consensus 239 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 TQGRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred hCCCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111100 0111234577888899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.14 Aligned_cols=247 Identities=22% Similarity=0.372 Sum_probs=194.5
Q ss_pred hccccccCcEEEEEEEECC-Cc----EEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|.+.. +. .||+|.++.... ..+++.+|+.++..+ +||||+++++++... ..++|+||
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-Cceeeeec
Confidence 4679999999999998642 33 389999875432 245688899999888 999999999999764 56799999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.+++.... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 90 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred CCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999997533 24889999999999999999999998 999999999999999999999999999876432
Q ss_pred CC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 AT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ~~------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.. ...+..|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ...........
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~----- 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERL----- 230 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCCCC-----
Confidence 22 122457999999999999999999999999999998 999997543211 11111111100
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
.....+...+.+++.+||+.+|++||++.+++..+.++....
T Consensus 231 -----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 000112345678888999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.84 Aligned_cols=259 Identities=23% Similarity=0.360 Sum_probs=189.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC-----eeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lV~ 450 (672)
.+.||+|+||.||+|... +++.||+|++..... ....+.+|++++..+ +||||+++++++.... ..++||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceEEEEE
Confidence 468999999999999965 578999999875322 234678899999998 9999999999886432 479999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 84 ELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred ecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9995 6899888642 24899999999999999999999998 9999999999999999999999999987542
Q ss_pred CC-------CCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh---------hHHHHH
Q 005875 531 VP-------ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL---------PRWVQS 592 (672)
Q Consensus 531 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~---------~~~~~~ 592 (672)
.. ....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+......... ..+...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 21 12357888999999876 6789999999999999999999999976432111000 000000
Q ss_pred hhhhccccccchhhhh-cccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005875 593 VVREEWTAEVFDVELM-RFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 649 (672)
Q Consensus 593 ~~~~~~~~~~~d~~~~-~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~ 649 (672)
+.... .......-.. ..... ......+.+++.+||+.+|++|||++|++++ ++.+.
T Consensus 235 i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 235 VRNEK-ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhhhh-HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 00000 0000000000 00000 0112346788889999999999999999984 44443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=314.16 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=199.7
Q ss_pred HhccccccCcEEEEEEEECC--------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEE
Q 005875 379 SAEVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 448 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 448 (672)
..+.||+|+||.||+++..+ ...+|+|.++.... ...++.+|++++..+.+|+||+++++++..++..++
T Consensus 22 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (307)
T cd05098 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 101 (307)
T ss_pred EeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 35789999999999998532 34699999875422 234677899999988789999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC
Q 005875 449 VYDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 517 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~ 517 (672)
||||+++|+|.+++...... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 102 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~ 178 (307)
T cd05098 102 IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNV 178 (307)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCc
Confidence 99999999999999754321 1234889999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCCCCCCCC----CC--CCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 005875 518 GCISDFGLTPLMNVPA----TP--SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 590 (672)
Q Consensus 518 ~kl~DfGla~~~~~~~----~~--~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~ 590 (672)
+||+|||++....... .. .++..|+|||++.+..++.++|||||||++|||++ |..||......+ ..
T Consensus 179 ~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~------~~ 252 (307)
T cd05098 179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LF 252 (307)
T ss_pred EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HH
Confidence 9999999987653221 11 12357999999998889999999999999999998 888886433211 11
Q ss_pred HHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 591 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 591 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
. ........+ ........+.+++.+||+.+|++|||+.|+++.|+++.+..
T Consensus 253 ~-~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 253 K-LLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred H-HHHcCCCCC----------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1 111111111 11122346677888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=313.90 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=200.8
Q ss_pred HhccccccCcEEEEEEEEC--------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEE
Q 005875 379 SAEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 448 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 448 (672)
..+.||+|+||.||+|+.. ++..||+|.+..... ..+++.+|+.++..+.+||||+++++++......++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 98 (304)
T cd05101 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 98 (304)
T ss_pred ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence 4578999999999999742 234689998875432 245688899999988789999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC
Q 005875 449 VYDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 517 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~ 517 (672)
||||+++|+|.+++...... ....+++..++.++.||+.||+|||+.+ ++||||||+||++++++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~ 175 (304)
T cd05101 99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNV 175 (304)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCc
Confidence 99999999999999754321 1235788999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 005875 518 GCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 590 (672)
Q Consensus 518 ~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~ 590 (672)
+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..||.+....+ ..
T Consensus 176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~ 249 (304)
T cd05101 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LF 249 (304)
T ss_pred EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------HH
Confidence 9999999987654321 1223467999999998889999999999999999998 788886543221 11
Q ss_pred HHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 591 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 591 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
... ....... ........+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 250 ~~~-~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 250 KLL-KEGHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHH-HcCCcCC----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 111 1111100 011233567778889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.25 Aligned_cols=191 Identities=25% Similarity=0.379 Sum_probs=166.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+++.. +++.||+|++..... ....+.+|+.++..+ +|+||+++++.+.++...++||||++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEEEcCCC
Confidence 467999999999999865 478899999875422 224567788899888 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 85 GGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999742 34899999999999999999999998 999999999999999999999999998654211
Q ss_pred -------------------------------------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCC
Q 005875 533 -------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575 (672)
Q Consensus 533 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf 575 (672)
....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 1235788999999999999999999999999999999999999
Q ss_pred CCCC
Q 005875 576 QSPT 579 (672)
Q Consensus 576 ~~~~ 579 (672)
.+..
T Consensus 237 ~~~~ 240 (363)
T cd05628 237 CSET 240 (363)
T ss_pred CCCC
Confidence 7654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=305.81 Aligned_cols=238 Identities=22% Similarity=0.368 Sum_probs=190.2
Q ss_pred ccccccCcEEEEEEEECCCc-----------EEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEE
Q 005875 381 EVLGKGSYGTAYKAVLEEST-----------TVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 449 (672)
+.||+|+||.||+|...+.. .+++|.+.........+.+|+.+++.+ +|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec-CCcEEE
Confidence 36899999999999976543 477787765443367788999999988 89999999999988 778999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-------CeEEee
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-------DGCISD 522 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-------~~kl~D 522 (672)
|||+++|+|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999975331 4889999999999999999999988 99999999999999888 799999
Q ss_pred cCCCCCCCCCCCCCCCCcccCcccccCC--CCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 523 FGLTPLMNVPATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 523 fGla~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
||++..........++..|+|||++.+. .++.++||||||+++|||++ |..||......+.. .+. .....
T Consensus 152 fg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~----~~~~~ 224 (259)
T cd05037 152 PGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFY----QDQHR 224 (259)
T ss_pred CCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHH----hcCCC
Confidence 9999876554455567789999999876 78999999999999999999 57777654322110 000 00000
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
... .....+.+++.+||..+|++|||+.|+++.|+
T Consensus 225 --~~~----------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 --LPM----------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --CCC----------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00156778889999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=322.23 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=197.8
Q ss_pred HhccccccCcEEEEEEEEC------CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 379 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
..+.||+|+||.||+|++. .+..||+|+++..... .+.+.+|++++.++..||||+++++++...+..++||
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 4678999999999999864 2457999999765322 3468889999999955999999999999999999999
Q ss_pred EecCCCchhhhhccCCC---------------------------------------------------------------
Q 005875 451 DYFASGSLSTLLHGNRG--------------------------------------------------------------- 467 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~--------------------------------------------------------------- 467 (672)
||+++|+|.++++..+.
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 99999999999975421
Q ss_pred ------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC
Q 005875 468 ------------------------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 517 (672)
Q Consensus 468 ------------------------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~ 517 (672)
.....+++...+.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~ 277 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKL 277 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCE
Confidence 01124678889999999999999999987 999999999999999999
Q ss_pred eEEeecCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 005875 518 GCISDFGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 590 (672)
Q Consensus 518 ~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~ 590 (672)
+||+|||+++..... ....++..|+|||.+....++.++|||||||++|||++ |..||......+ ..
T Consensus 278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~~ 351 (401)
T cd05107 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------QF 351 (401)
T ss_pred EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------HH
Confidence 999999998754321 12234677999999998889999999999999999998 899987543221 11
Q ss_pred HHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 591 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 591 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
........... ........+.+++.+||+.+|++||+++|+++.|+++.
T Consensus 352 ~~~~~~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 YNAIKRGYRMA----------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111100 01112345777888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=310.28 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=193.6
Q ss_pred hccccccCcEEEEEEEE-----CCCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|.. .++..+++|.++..... ..++.+|++++..+ +|+||+++++++..++..++||||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 88 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQPVCMLFEY 88 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCceEEEEEc
Confidence 46799999999999984 24578999998754322 24688899999999 999999999999999999999999
Q ss_pred cCCCchhhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEE
Q 005875 453 FASGSLSTLLHGNRG------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 520 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl 520 (672)
+++|+|.+++..... .....+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (283)
T cd05090 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKI 165 (283)
T ss_pred CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEe
Confidence 999999999853221 11234788999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHh
Q 005875 521 SDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 593 (672)
Q Consensus 521 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 593 (672)
+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..||.+....+ ....
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-------~~~~ 238 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-------VIEM 238 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 9999997653221 2224557999999998889999999999999999998 999997543211 1111
Q ss_pred hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 594 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
........ ........+.+++.+||+.+|++||++.++.++|..
T Consensus 239 ~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRKRQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111000 001122456778889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.02 Aligned_cols=251 Identities=22% Similarity=0.376 Sum_probs=199.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|+.. +++.||+|.++.... ....+.+|+++++.+ +||||+++++++...+..++||||++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIVLELAD 85 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEEEEecC
Confidence 467999999999999964 678999998764322 234678899999999 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 86 AGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999998864322 2334889999999999999999999998 9999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 534 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
...+++.|+|||.+.+..++.++||||||+++|||++|+.||..... +...+...+...... .
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~-~--------- 227 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCDYP-P--------- 227 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCCCC-C---------
Confidence 23467789999999988899999999999999999999999964322 111222211111100 0
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
.........+.+++.+||+.+|++||+++|+++.+++++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 011223356778888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=309.12 Aligned_cols=237 Identities=21% Similarity=0.313 Sum_probs=184.5
Q ss_pred cccccCcEEEEEEEECC-------------------------CcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceec
Q 005875 382 VLGKGSYGTAYKAVLEE-------------------------STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVP 435 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~ 435 (672)
.||+|+||.||+|.+.. ...|++|.+..... ....+.+|+.++..+ +||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 59999999999997521 13488888865432 234577788888887 8999999
Q ss_pred eEEEEEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC
Q 005875 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 515 (672)
Q Consensus 436 l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~ 515 (672)
+++++.++...++||||+++|+|..++.... ..+++..++.++.||++||+|||+.+ |+||||||+||+++.+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~ 153 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEecc
Confidence 9999999999999999999999999986432 34889999999999999999999988 9999999999999865
Q ss_pred C-------CeEEeecCCCCCCCCCCCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHH-HhCCCCCCCCCCCCCCCh
Q 005875 516 L-------DGCISDFGLTPLMNVPATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEM-LTGKAPLQSPTRDDMVDL 586 (672)
Q Consensus 516 ~-------~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el-~tg~~pf~~~~~~~~~~~ 586 (672)
+ .+|++|||++..........++..|+|||.+.+ ..++.++|||||||++||| ++|+.||......+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--- 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--- 230 (274)
T ss_pred CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---
Confidence 4 379999998865544444456778999998865 5688999999999999998 479999975433221
Q ss_pred hHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 587 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
.. ....... . . ......+.+++.+||+.+|++|||++++++.|
T Consensus 231 ~~----~~~~~~~-------~--~---~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ER----FYEKKHR-------L--P---EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HH----HHHhccC-------C--C---CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 01 1111000 0 0 01123567888899999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=310.79 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=197.7
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||++...+ ...+|+|.+...... ..++.+|++++.++.+|+||+++++++..++..+++||
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 5689999999999998643 357899988754322 24577899999888789999999999999999999999
Q ss_pred ecCCCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEE
Q 005875 452 YFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 520 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl 520 (672)
|+++|+|.++++.... .....+++..++.++.|++.|++|||+.+ |+||||||+||++++++.+||
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEe
Confidence 9999999999964321 12345899999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHh
Q 005875 521 SDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 593 (672)
Q Consensus 521 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 593 (672)
+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||......+. .. .
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~-~ 246 (293)
T cd05053 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL------FK-L 246 (293)
T ss_pred CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH------HH-H
Confidence 9999997654321 1123457999999998899999999999999999998 9999875432211 11 1
Q ss_pred hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 594 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
........ ........+.+++.+||+.+|++|||++|+++.|+++.
T Consensus 247 ~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 LKEGYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111000 01122346778889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.97 Aligned_cols=248 Identities=23% Similarity=0.393 Sum_probs=191.8
Q ss_pred hccccccCcEEEEEEEECCCc---EEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeC------CeeE
Q 005875 380 AEVLGKGSYGTAYKAVLEEST---TVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~---~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~ 447 (672)
++.||+|+||.||+|.+.++. .+|+|.++.... ..+.+..|++++..+ +|+||+++++++... ...+
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCCcE
Confidence 467999999999999976543 588998865432 235678899999998 999999999987532 2468
Q ss_pred EEEEecCCCchhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCC
Q 005875 448 LVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 526 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 526 (672)
++|||+++|+|.+++...+. .....+++.....++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988743221 12344899999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 527 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 527 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
+...... ....++.|+|||+..+..++.++||||||+++|||++ |+.||......+ .... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~-~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------IYDY-LRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH-HHcCCC
Confidence 8654322 1224567999999999999999999999999999999 889997533211 1111 111111
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
.. ........+.+++.+||+.+|++|||++|+++.|+++
T Consensus 233 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0112234567888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=313.15 Aligned_cols=254 Identities=23% Similarity=0.409 Sum_probs=197.9
Q ss_pred hccccccCcEEEEEEEECC-Cc--EEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-ST--TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|.+.+ +. .+++|.++.... ....+.+|++++.++.+|+||+++++++..++..++||||++
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 4679999999999999653 33 457777664322 235688899999999889999999999999999999999999
Q ss_pred CCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeec
Q 005875 455 SGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 523 (672)
Q Consensus 455 ~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~Df 523 (672)
+|+|.++++.... .....+++..++.++.|++.|++|||+.+ ++||||||+|||+++++.+||+||
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~df 168 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 168 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCcc
Confidence 9999999975431 11235889999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 524 GLTPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 524 Gla~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
|++....... ....+..|+|||++.+..++.++|||||||++|||+| |..||......+ ..... .....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~-~~~~~ 241 (303)
T cd05088 169 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKL-PQGYR 241 (303)
T ss_pred ccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHHHH-hcCCc
Confidence 9986432111 1123456999999988889999999999999999998 999997543221 11111 11100
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.. .. ......+.+++.+||+.+|++||++++++..|+.+.+...
T Consensus 242 ~~-------~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 242 LE-------KP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred CC-------CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 00 00 1122356788889999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=309.64 Aligned_cols=244 Identities=24% Similarity=0.311 Sum_probs=193.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||++... +++.||+|++..... ....+.+|+.++..+ +|+||+++++++..++..++||||++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEEeccC
Confidence 367999999999999965 578899999865422 224567899999999 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 84 GGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred CCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999998886432 234899999999999999999999998 9999999999999999999999999987654322
Q ss_pred --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 534 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
...+++.|+|||++.+..++.++||||+||++|||++|+.||.+...... .......+.... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~-----------~~ 223 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKEDQ-----------EE 223 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhcc-----------cc
Confidence 23568899999999988899999999999999999999999986432211 011111111000 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
........+.+++.+||+.||++|| ++++++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0112234567788899999999999 78888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=294.31 Aligned_cols=242 Identities=22% Similarity=0.346 Sum_probs=194.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc---cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|.|+.||++... .|+.+|+|++.... .+.++.++|+.|.+.+ +|||||++...+.+....|+|+|+|+|
T Consensus 16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcccceeEEEEecccc
Confidence 467999999999998854 57788888775432 3567888999999999 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC---CCCeEEeecCCCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~~ 532 (672)
++|..-+-. +...++..+-..+.||+.++.|+|.++ |||||+||+|+++.. ...+|++|||+|......
T Consensus 95 ~dl~~eIV~-----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 95 GELFEDIVA-----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred hHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 999654431 234788888999999999999999998 999999999999954 356899999999887743
Q ss_pred C---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 533 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 533 ~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
. ...|||+|||||++...+|+..+|||+.||+||-++.|.+||++.+... ....+... .+|...+.
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r------lye~I~~g-----~yd~~~~~ 235 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYEQIKAG-----AYDYPSPE 235 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH------HHHHHhcc-----ccCCCCcc
Confidence 3 3558999999999999999999999999999999999999999754332 12222222 22322333
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+.++.+.++ ++|+..||.+|.|+.|++++
T Consensus 236 w~~is~~Ak~Lv---rrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 236 WDTVTPEAKSLI---RRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cCcCCHHHHHHH---HHHhccChhhhccHHHHhCC
Confidence 444555555554 59999999999999998764
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=323.71 Aligned_cols=242 Identities=24% Similarity=0.349 Sum_probs=187.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|++..... ....+.+|++++..+ +|+||+++++++.+++..++||||++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEEecCC
Confidence 367999999999999865 467899999975432 134578899999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 85 GGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999743 24888999999999999999999998 99999999999999999999999998753210
Q ss_pred ------------------------------------------------CCCCCCCCcccCcccccCCCCCCccchhhHHH
Q 005875 532 ------------------------------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 563 (672)
Q Consensus 532 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gv 563 (672)
.....||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 01235788999999999988999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHH--cccCCCCCCCCHHHH
Q 005875 564 LLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMA--CVAKVPDMRPNMDEV 641 (672)
Q Consensus 564 vl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~ev 641 (672)
++|||++|+.||......+. ...+.... ... .......... .+.+++.+ |+..+|..||+++|+
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~~--~~~---~~~~~~~~s~---~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET------QLKVINWE--NTL---HIPPQVKLSP---EAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH------HHHHHccc--ccc---CCCCCCCCCH---HHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999976432211 11111000 000 0001111223 34445555 556677779999999
Q ss_pred HHH
Q 005875 642 VRM 644 (672)
Q Consensus 642 l~~ 644 (672)
+++
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 885
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.37 Aligned_cols=242 Identities=21% Similarity=0.362 Sum_probs=193.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---------hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 449 (672)
.+.+|+|..++|-++..+ .+++.|+|++...... .+...+|+.+++++..||+|+++.++|+.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 356999999999988855 5788999998644221 134567899999999999999999999999999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
+|.|+.|.|.+++.. ...+++....+|+.|+..|++|||... ||||||||+|||+|++.++||+|||.|+..
T Consensus 102 Fdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeecc
Confidence 999999999999973 445999999999999999999999987 999999999999999999999999999988
Q ss_pred CCCC---CCCCCCcccCcccccC------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccc
Q 005875 530 NVPA---TPSRSAGYRAPEVIET------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 600 (672)
Q Consensus 530 ~~~~---~~~~~~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (672)
.... ..+|||+|+|||.+.. ..|+..+|+||+||+||-++.|.+||+.....-+ .+.+...++
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM------LR~ImeGky-- 245 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM------LRMIMEGKY-- 245 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH------HHHHHhccc--
Confidence 7655 4579999999999853 4578889999999999999999999984321110 111111111
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 601 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
........ +......+|+.+|++.||++|.|++|+++
T Consensus 246 ---qF~speWa---dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 246 ---QFRSPEWA---DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ---ccCCcchh---hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11111122 22334556777999999999999999998
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=305.89 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=186.6
Q ss_pred cccccCcEEEEEEEECC---CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 382 VLGKGSYGTAYKAVLEE---STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.||+|+||.||+|...+ +..+++|.++.... ....+.+|+.++.++ +||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999998653 35689998865432 234678899999999 9999999999999989999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.++++..........++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997544322334677888899999999999999998 9999999999999999999999999986543221
Q ss_pred ---CCCCCCcccCcccccCC-------CCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 534 ---TPSRSAGYRAPEVIETR-------KHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~-------~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
...++..|+|||++... .++.++||||||+++|||++ |+.||......+. . ...... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~---~~~~~~-~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---L---TYTVRE-QQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---H---HHHhhc-ccCCC
Confidence 22346679999998642 35789999999999999996 9999975432221 0 000100 00111
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.++... .. ....+.+++.+|| .+|++|||++||++.|+
T Consensus 231 ~~~~~~--~~---~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK--LP---LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC--CC---CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111110 01 1234566777999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=306.98 Aligned_cols=241 Identities=23% Similarity=0.334 Sum_probs=188.7
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 383 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 383 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
||+|+||+||+++.. +++.+|+|++..... ....+..|++++.++ +||||+++++++.++...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 699999999999965 478899999864322 233456688999999 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---T 534 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 534 (672)
|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 80 L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 80 LKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred HHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence 998886432 234889999999999999999999998 9999999999999999999999999987654322 2
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChH
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 614 (672)
..++..|+|||++.+..++.++||||+||++|||++|+.||....... .............. .. ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~-----~~---~~~--- 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDEV-----KF---EHQ--- 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhcccc-----cc---ccc---
Confidence 457889999999998889999999999999999999999997543211 11111111111110 00 001
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 615 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.....+.+++.+||+.||++||+++|+++
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 12334677888999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=311.28 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=198.2
Q ss_pred hccccccCcEEEEEEEECCC---cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEES---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|...++ ..+++|.++.... ..+.+.+|++++.++.+||||+++++++......++||||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 46799999999999987543 2468888764322 245688899999999789999999999999999999999999
Q ss_pred CCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeec
Q 005875 455 SGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 523 (672)
Q Consensus 455 ~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~Df 523 (672)
+|+|.++++..... ....+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+||
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~df 163 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADF 163 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCc
Confidence 99999999753211 1234889999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCC-C--CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 524 GLTPLMNVPA-T--PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 524 Gla~~~~~~~-~--~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
|++....... . ...+..|+|||++.+..++.++|||||||++|||++ |..||......+ ....... ...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~~~~~-~~~ 236 (297)
T cd05089 164 GLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYEKLPQ-GYR 236 (297)
T ss_pred CCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHhc-CCC
Confidence 9986433211 1 112446999999998889999999999999999997 999997543221 1111111 110
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.. ........+.+++.+||+.+|.+||+++++++.|+.+.+...
T Consensus 237 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 237 ME----------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 001123456788889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=304.54 Aligned_cols=242 Identities=26% Similarity=0.394 Sum_probs=193.1
Q ss_pred ccccccCcEEEEEEEECC----CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 381 EVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
+.||+|+||.||+|.+.. +..+|+|.+..... ..+++.+|++++..+ .|+||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 369999999999998543 25799999876554 356788899999998 8999999999875 456899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 534 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 534 (672)
+|+|.+++.... .+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999997432 4899999999999999999999998 99999999999999999999999999876543322
Q ss_pred C-------CCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhh
Q 005875 535 P-------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606 (672)
Q Consensus 535 ~-------~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 606 (672)
. .++..|+|||.+.+..++.++||||||+++|||++ |..||......+ +..+. .......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~----~~~~~~~----- 218 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAML----ESGERLP----- 218 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH----HcCCcCC-----
Confidence 1 12346999999998899999999999999999998 999997543211 11111 1111100
Q ss_pred hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 607 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
........+.+++.+||+.+|++||++.++++.|+++.
T Consensus 219 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 -----RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01122346778888999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=304.93 Aligned_cols=240 Identities=25% Similarity=0.367 Sum_probs=190.4
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 382 VLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.||+|+||.||+|.++ ++..+|+|+++..... .+++..|+.++..+ +|+||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 5899999999999753 4678999998654322 35678889999998 9999999999875 4567899999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC-
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT- 534 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~- 534 (672)
|+|.+++... ..+++..+..++.|++.|++|||+.+ |+||||||.||++++++.+||+|||++........
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 80 GPLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999999632 24889999999999999999999998 99999999999999999999999999876543221
Q ss_pred ------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 535 ------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 535 ------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
..++..|+|||.+....++.++|||||||++|||++ |+.||......+ +... +........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~-i~~~~~~~~----- 219 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE------VTQM-IESGERMEC----- 219 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HHCCCCCCC-----
Confidence 112467999999988889999999999999999998 999997543221 1111 111111110
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
.......+.+++.+||+.+|++||++++|.+.|++.
T Consensus 220 -----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 -----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 011234567788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.26 Aligned_cols=241 Identities=26% Similarity=0.424 Sum_probs=194.2
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
++||+|+||.||+|...+++.+|+|.+...... ...+.+|++++..+ +||||+++++++...+..++||||+++|+|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 368999999999999888899999988754322 34688899999998 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----- 533 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----- 533 (672)
.+++.... ..+++..+..++.|++.|+.|+|+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 80 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 80 LSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 99986432 24789999999999999999999998 9999999999999999999999999986543221
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
....+..|+|||++.+..++.++||||||+++||+++ |..||......+ .............
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~---------- 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRMSC---------- 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCCCCC----------
Confidence 1123456999999998889999999999999999998 999997543211 1111111111100
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.......+.+++.+|++.+|++||++.|+++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1122356778888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=308.65 Aligned_cols=247 Identities=23% Similarity=0.384 Sum_probs=193.9
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||+|...+ ++.||+|+++..... .+.+.+|+.++..+ +||||+++++++...+..++++|
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~~~~e 88 (283)
T cd05091 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQPLSMIFS 88 (283)
T ss_pred HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCceEEEEE
Confidence 5689999999999998643 467999998754332 34577888888888 89999999999999999999999
Q ss_pred ecCCCchhhhhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEE
Q 005875 452 YFASGSLSTLLHGNR-----------GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 520 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl 520 (672)
|+.+++|.+++.... ......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl 165 (283)
T cd05091 89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEe
Confidence 999999999985321 011234888999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHh
Q 005875 521 SDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 593 (672)
Q Consensus 521 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 593 (672)
+|||+++...... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... .+...+
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~i 239 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DVIEMI 239 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH
Confidence 9999987653322 2234568999999988889999999999999999998 88888754321 112221
Q ss_pred hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 594 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
..... ... .......+.+++.+||+.+|++||+++|++..|+.
T Consensus 240 ~~~~~-~~~----------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 RNRQV-LPC----------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HcCCc-CCC----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111 000 11233456788889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.64 Aligned_cols=243 Identities=26% Similarity=0.446 Sum_probs=195.7
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||.||++...++..+|+|++.......+.+.+|++++..+ +|+|++++++++. .+..++||||+++|+|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence 467999999999999988777899998876555567788999999998 8999999999875 45688999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----C
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 534 (672)
++++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... .
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 89 DFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred HHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 9997532 234789999999999999999999998 9999999999999999999999999987653322 1
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||+..+..++.++||||||+++|||++ |..||.+....+. .... ....... ..
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~~-~~~~~~~----------~~ 225 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV------LEQV-ERGYRMP----------CP 225 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHH-HcCCCCC----------CC
Confidence 224557999999998889999999999999999999 8999975432211 1111 1111100 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
......+.+++.+||+.+|++||+++++++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1223567788889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.32 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=199.6
Q ss_pred HhccccccCcEEEEEEEEC--------CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEE
Q 005875 379 SAEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 448 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 448 (672)
..+.||+|+||.||+++.. ....+|+|.++..... ..++..|++++.++.+||||+++++++..+...++
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence 4678999999999999742 2346889988754332 34678899999888679999999999999889999
Q ss_pred EEEecCCCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC
Q 005875 449 VYDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 517 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~ 517 (672)
||||+++|+|.+++..... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~ 172 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNV 172 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCc
Confidence 9999999999999975321 11235899999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCCCCCCCC----C--CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 005875 518 GCISDFGLTPLMNVPA----T--PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 590 (672)
Q Consensus 518 ~kl~DfGla~~~~~~~----~--~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~ 590 (672)
+||+|||+++...... . ..++..|+|||++.+..++.++||||||+++|||++ |..||......+ .
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-------~ 245 (314)
T cd05099 173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-------L 245 (314)
T ss_pred EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 9999999997654321 1 112356999999998889999999999999999999 889986543221 1
Q ss_pred HHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 591 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 591 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
............ .......+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 246 ~~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 246 FKLLREGHRMDK----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HHHHHcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 111111111110 11223456678889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=308.83 Aligned_cols=246 Identities=22% Similarity=0.383 Sum_probs=192.3
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||+|... .+..||+|++..... ...++.+|+.++..+ +|+||+++++++.++...++|||
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCeEEEEe
Confidence 467999999999999854 245799998864322 234678899999888 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCC
Q 005875 452 YFASGSLSTLLHGNRGA-----GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 526 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 526 (672)
|+++|+|.++++..... ....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCc
Confidence 99999999998653211 1234678899999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 527 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 527 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
+...... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+ ......... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-~ 239 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------VLRFVMEGG-L 239 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHcCC-c
Confidence 7543221 1223567999999998889999999999999999999 788987543221 111111111 0
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
... .......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 240 ~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 240 LDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 000 0112345778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=315.16 Aligned_cols=242 Identities=23% Similarity=0.374 Sum_probs=201.4
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|.||.||+++.+. |+.+|+|.+++... ......+|+.+++++..|||||.+.+.|++....++|||++.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 3679999999999999765 88999999987643 235899999999999669999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC----CCeEEeecCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLTPLMN 530 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~----~~~kl~DfGla~~~~ 530 (672)
||.|.+.+... .+++..+..++.|++.+++|||+.| |+||||||+|+|+... +.+|++|||++....
T Consensus 120 GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 120 GGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred CchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999754 2899999999999999999999998 9999999999999643 479999999998876
Q ss_pred CC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 531 VP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 531 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
.. ....||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+..+... .+...++ +...
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~-----~f~~ 259 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF-----DFTS 259 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-----CCCC
Confidence 52 34579999999999999999999999999999999999999999876543211 1222221 1111
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+..+.+ ...+++.+++..||.+|+|+.+++++
T Consensus 260 ~~w~~is~---~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 260 EPWDDISE---SAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCccccCH---HHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22333334 44555569999999999999999996
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.91 Aligned_cols=238 Identities=23% Similarity=0.315 Sum_probs=187.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHc--CCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||.||+|... +++.||+|+++.... ..+.+..|++++..+. +||||+++++++..++..|+||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 367999999999999965 578899999975421 1234566666554322 799999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV- 531 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~- 531 (672)
+++|+|..+++. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 84 AAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred CCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999988863 24899999999999999999999998 99999999999999999999999999865322
Q ss_pred ---CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 532 ---PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 532 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+......
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~~~~~~--------- 219 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVNDEVR--------- 219 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC---------
Confidence 123457889999999999999999999999999999999999997653221 11111111110
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
.. ......+.+++.+||+.||++|| ++++++++
T Consensus 220 ~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 YP---RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CC---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 00 11224456788899999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=304.24 Aligned_cols=244 Identities=27% Similarity=0.458 Sum_probs=199.7
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||.||+|..++++.+++|.+.......+++.+|+++++++ +|+||+++++++..+...++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence 468999999999999988888999999987666678899999999998 8999999999999888999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----C
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 534 (672)
+++.... ...+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.++++|||++....... .
T Consensus 90 ~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (261)
T cd05034 90 DFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163 (261)
T ss_pred HHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence 9997533 234899999999999999999999998 9999999999999999999999999987654321 1
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+..|+|||.+.+..++.++||||||+++||+++ |+.||.+....+ ....... ..... ..
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~~-~~~~~-------~~--- 226 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE------VLEQVER-GYRMP-------RP--- 226 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHc-CCCCC-------CC---
Confidence 223457999999998889999999999999999998 999996543211 1111111 00000 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
......+.+++.+|++.+|++||+++|+++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1113457788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=332.46 Aligned_cols=242 Identities=20% Similarity=0.283 Sum_probs=191.7
Q ss_pred hccccccCcEEEEEEEECC--CcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEE--STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||+|.... +..||+|.+..... ....+..|++++..+ +|||||++++++..++..++||||+++|
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 4689999999999998543 46678886643322 234567799999998 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.++++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 151 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 151 DLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 99998864321 2345889999999999999999999998 999999999999999999999999999765432
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....||++|+|||++.+..++.++|||||||++|||++|+.||...... ............ +
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~-----~----- 290 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLYGKYD-----P----- 290 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-----C-----
Confidence 2335789999999999999999999999999999999999999754321 111111111110 0
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
........+.+++.+||+.+|++||+++|++.
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00112245677888999999999999999875
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.10 Aligned_cols=233 Identities=25% Similarity=0.389 Sum_probs=187.3
Q ss_pred ccccccCcEEEEEEEE----CCCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
+.||+|+||+||+++. .+++.+|+|+++.... ....+..|++++.++ +||||+++++++.+++..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcCC
Confidence 4699999999999985 3578899999976432 234567788999998 9999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 532 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~- 532 (672)
++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 81 RGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999998642 34899999999999999999999998 999999999999999999999999998765433
Q ss_pred ---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 533 ---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+...... .
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~i~~~~~~---------~ 217 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTMILKAKLG---------M 217 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHHHHcCCCC---------C
Confidence 22357889999999998889999999999999999999999997543211 11111111100 0
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 640 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 640 (672)
. ......+.+++.+||+.||++||++.+
T Consensus 218 p---~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 P---QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C---CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0 111234567788999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.32 Aligned_cols=241 Identities=23% Similarity=0.373 Sum_probs=193.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|+++.... ....+..|++++..+ +|+||+++++++.+++..++||||++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLVMEYMP 84 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEEEcCCC
Confidence 467999999999999976 578999999875432 234678889999988 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 85 GGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999743 34899999999999999999999988 9999999999999999999999999987654322
Q ss_pred --------------------------------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 005875 534 --------------------------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 581 (672)
Q Consensus 534 --------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~ 581 (672)
...+++.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 234788899999999999999999999999999999999999865421
Q ss_pred CCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 005875 582 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN-MDEVVRM 644 (672)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 644 (672)
+ ....+.. +..... ...... ....+.+++.+|++ +|++||+ ++|++++
T Consensus 237 ~------~~~~i~~--~~~~~~---~p~~~~---~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E------TYNKIIN--WKESLR---FPPDPP---VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H------HHHHHhc--cCCccc---CCCCCC---CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 1111111 000000 000011 23456677779997 9999999 9999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=299.02 Aligned_cols=245 Identities=29% Similarity=0.481 Sum_probs=198.5
Q ss_pred ccccccCcEEEEEEEECC----CcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 381 EVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
+.||+|+||.||+|...+ +..+++|.++..... .+.+.+|++.+..+ +|+||+++++++.++...++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999999764 778999998766443 56788999999999 79999999999999999999999999
Q ss_pred CCchhhhhccCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 455 SGSLSTLLHGNRGA----GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 455 ~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
+++|.+++...... ....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999754211 0245899999999999999999999998 9999999999999999999999999997765
Q ss_pred CCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 531 VPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 531 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
... ...++..|+|||.+....++.++||||+|+++|||++ |..||......+ ....... ....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~-~~~~--- 226 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VLEYLRK-GYRL--- 226 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHc-CCCC---
Confidence 432 2345678999999988889999999999999999999 699997652211 1111111 1100
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.........+.+++.+||+.+|++|||+.|++++|+
T Consensus 227 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122456778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=315.54 Aligned_cols=232 Identities=22% Similarity=0.302 Sum_probs=182.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHH-HHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIV-GRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l-~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
+.||+|+||+||+|+.. +++.||+|++..... ....+..|...+ ..+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 36999999999999975 578899999875422 123344555544 445 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 80 ~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 80 GGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 99999998742 24889999999999999999999998 999999999999999999999999998753221
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~---------~~~ 216 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILNKPL---------RLK 216 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCCC---------CCC
Confidence 2234788999999999999999999999999999999999999754321 11112111110 001
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMD 639 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 639 (672)
.. ....+.+++.+|++.||++||++.
T Consensus 217 ~~---~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PN---ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC---CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11 134566788899999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=307.63 Aligned_cols=246 Identities=21% Similarity=0.324 Sum_probs=189.5
Q ss_pred hccccccCcEEEEEEEECC-Cc----EEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|.+.. +. .+++|.+..... ...++..|+..+.++ +||||+++++++. +...++++||
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEEC-CCccEEEEEe
Confidence 4689999999999999643 33 367777654322 124566666677777 8999999999875 4567899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 90 SPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred CCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999997432 34899999999999999999999998 999999999999999999999999999754322
Q ss_pred C------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
. ...++..|+|||++.+..++.++|||||||++||+++ |..||.+....+. .......... ..+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~--~~~ 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERL--AQP 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcC--CCC
Confidence 1 1234567999999998899999999999999999998 9999976432211 1111111100 000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
..+...+.+++.+||..+|++|||+.|+++.|+.+.+.
T Consensus 234 --------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 234 --------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred --------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 01223456788899999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.44 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=200.7
Q ss_pred HHHhccccccCcEEEEEEEECC--------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCee
Q 005875 377 RASAEVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK 446 (672)
Q Consensus 377 ~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~ 446 (672)
....+.||+|+||.||+++..+ ...||+|.++.... ..+++.+|++++.++.+|+||+++++++..++..
T Consensus 14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (334)
T cd05100 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 93 (334)
T ss_pred eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCce
Confidence 3446789999999999997421 23689998875432 2357888999999987899999999999999999
Q ss_pred EEEEEecCCCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC
Q 005875 447 LLVYDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 515 (672)
Q Consensus 447 ~lV~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~ 515 (672)
+++|||+++|+|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 94 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~ 170 (334)
T cd05100 94 YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTED 170 (334)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCC
Confidence 999999999999999975321 11234889999999999999999999998 9999999999999999
Q ss_pred CCeEEeecCCCCCCCCCCC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhH
Q 005875 516 LDGCISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR 588 (672)
Q Consensus 516 ~~~kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~ 588 (672)
+.+||+|||+++....... ..++..|+|||++.+..++.++||||||+++|||++ |..||.+....+
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------ 244 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------ 244 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence 9999999999876543211 112356999999999999999999999999999998 888987543221
Q ss_pred HHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 589 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 589 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
....+. ....... .......+.+++.+||+.+|++||++.|+++.|+++....
T Consensus 245 ~~~~~~-~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 LFKLLK-EGHRMDK----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHH-cCCCCCC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 111111 1111110 1122346778888999999999999999999999998544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.69 Aligned_cols=248 Identities=22% Similarity=0.412 Sum_probs=194.7
Q ss_pred hccccccCcEEEEEEEECC----CcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCe------e
Q 005875 380 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE------K 446 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~ 446 (672)
.+.||+|+||.||+|.... +..||+|+++..... ...+.+|++.+..+ +|+||+++++++...+. .
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccCccc
Confidence 4679999999999998643 367999998754332 24678899998888 99999999999876554 6
Q ss_pred EEEEEecCCCchhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCC
Q 005875 447 LLVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 525 (672)
Q Consensus 447 ~lV~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 525 (672)
++||||+++|+|..++..... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccc
Confidence 899999999999999854321 12345899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCCC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 526 TPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 526 a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
++....... ...+..|+|||++.+..++.++|||||||++|||++ |..||.+....+ ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~------~~~~~~~~~~ 233 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE------IYDYLRHGNR 233 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC
Confidence 876543321 123457999999988889999999999999999999 889987543221 1111111110
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
.. ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 234 -~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 -LK----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -CC----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0112345678888899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.72 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=197.1
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||+|.... ...+++|.+..... ..+.+.+|+.++..+ +||||+++++.+..++..++|||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCCcEEEEE
Confidence 4679999999999998532 24688888765432 235688899999998 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe
Q 005875 452 YFASGSLSTLLHGNRG-------------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 512 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl 512 (672)
|+.+|+|.+++..... .....+++..+..++.|++.|++|||+.+ ++||||||+||++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEE
Confidence 9999999999864321 11234889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 005875 513 NQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 585 (672)
Q Consensus 513 ~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~ 585 (672)
++++.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..||.+....+
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--- 237 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--- 237 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence 999999999999987543221 1224567999999988889999999999999999999 999997543221
Q ss_pred hhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 586 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
............ ........+.+++.+||+.+|++||+++|+++.|+++...
T Consensus 238 ----~~~~~~~~~~~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 ----LFNLLKTGYRME----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred ----HHHHHhCCCCCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 111111111100 0112234677888899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.89 Aligned_cols=251 Identities=21% Similarity=0.375 Sum_probs=199.7
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||++.. .+++.+++|.+..... ...++.+|+++++.+ +|+||+++++++..++..+++|||++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELAD 85 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEEEEecC
Confidence 46799999999999995 4688999998765322 234678899999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+++|.+++..... ....+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 86 AGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 9999999864322 2345899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 534 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
...++..|+|||++.+..++.++||||||+++|||++|..||.+.... ............. +..
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~------~~~--- 228 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQCDY------PPL--- 228 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhcCCC------CCC---
Confidence 234677899999999888999999999999999999999999754321 1111111110000 000
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
........+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 -PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01123345777888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.76 Aligned_cols=255 Identities=27% Similarity=0.382 Sum_probs=196.1
Q ss_pred HHhccccccCcEEEEEEEE------CCCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeC-CeeEE
Q 005875 378 ASAEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLL 448 (672)
Q Consensus 378 ~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~l 448 (672)
...+.||+|+||.||+|.. .+++.||||+++..... ...+.+|+.++.++.+|+||+++++++... ...++
T Consensus 10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l 89 (343)
T cd05103 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 89 (343)
T ss_pred cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEE
Confidence 3467899999999999974 34678999998754322 345778999999998899999999988654 46789
Q ss_pred EEEecCCCchhhhhccCCCC------------------------------------------------------------
Q 005875 449 VYDYFASGSLSTLLHGNRGA------------------------------------------------------------ 468 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~~------------------------------------------------------------ 468 (672)
||||+++|+|.++++.....
T Consensus 90 v~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (343)
T cd05103 90 IVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQE 169 (343)
T ss_pred EEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhh
Confidence 99999999999998643210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC------CCCCCCc
Q 005875 469 --GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAG 540 (672)
Q Consensus 469 --~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~ 540 (672)
....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++....... ...++..
T Consensus 170 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 170 DLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 0123788889999999999999999998 9999999999999999999999999987643221 1223457
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHH
Q 005875 541 YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ 619 (672)
Q Consensus 541 y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 619 (672)
|+|||++.+..++.++||||||+++|||++ |..||......+ .......+...... . ......
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~-------~---~~~~~~ 310 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA-------P---DYTTPE 310 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCCC-------C---CCCCHH
Confidence 999999998899999999999999999997 999997543211 01111111111000 0 011235
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 620 MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 620 l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
+.+++.+||+.+|++|||+.|++++|+.+.+.
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 67888899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=314.23 Aligned_cols=238 Identities=25% Similarity=0.336 Sum_probs=188.5
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+..+ ++.||+|++..... ..+.+..|..++..+.+|++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 4679999999999999764 67899999875432 123456677777777679999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 85 GGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 99999998643 24889999999999999999999998 99999999999999999999999999875432
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+...... ..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~~~~i~~~~~~---------~p 221 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHNVA---------YP 221 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC---------CC
Confidence 123457889999999999999999999999999999999999997643221 11111111100 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVR 643 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 643 (672)
......+.+++.+|++.+|++|++. .++.+
T Consensus 222 ---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 222 ---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ---CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 1122355678889999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=321.50 Aligned_cols=241 Identities=20% Similarity=0.329 Sum_probs=189.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||||++..... ....+.+|++++..+ +|+||+++++++.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEEECCCC
Confidence 468999999999999975 578899999975421 234567899999998 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 85 ~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 85 GGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999742 24899999999999999999999998 999999999999999999999999998643211
Q ss_pred ----------------------------------------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCC
Q 005875 533 ----------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 572 (672)
Q Consensus 533 ----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~ 572 (672)
....||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0134788999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 005875 573 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN---MDEVVRM 644 (672)
Q Consensus 573 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 644 (672)
.||......+ ....+.... .... ........ ..+.+++.+|+. +|.+|++ ++|++++
T Consensus 237 ~Pf~~~~~~~------~~~~i~~~~--~~~~---~~~~~~~s---~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQE------TYRKIINWK--ETLQ---FPDEVPLS---PEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHH------HHHHHHcCC--CccC---CCCCCCCC---HHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9997543221 111111100 0000 00011122 344566668886 8999998 9998874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.86 Aligned_cols=241 Identities=24% Similarity=0.387 Sum_probs=190.0
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 382 VLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.++.++ +|+||+++++++. .+..++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999864 345689998875532 235688999999998 9999999999885 45789999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC--
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-- 534 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 534 (672)
+|.+++.... ..+++..+.+++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 80 ~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 80 PLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9999986432 34899999999999999999999998 99999999999999999999999999875433211
Q ss_pred -----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 535 -----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 535 -----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
..++..|+|||.+....++.++|||||||++||+++ |..||......+ .. ..+.......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~-~~~~~~~~~~------- 218 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VM-SFIEQGKRLD------- 218 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HH-HHHHCCCCCC-------
Confidence 112457999999988889999999999999999996 999997543211 11 1111111000
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
........+.+++.+||..+|++||++.+|.+.|+.+
T Consensus 219 ---~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 ---CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0112235667788899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=303.44 Aligned_cols=243 Identities=22% Similarity=0.376 Sum_probs=190.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeC------CeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV~e~ 452 (672)
.+.||+|+||+||+|... +++.||+|++.........+.+|+.++.++.+|+||+++++++... ...++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 467999999999999965 4678999998766555677889999999987899999999998753 357899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+.+|+|.+++.... ...+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 91 ~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 91 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 99999999987532 234889999999999999999999998 999999999999999999999999998754322
Q ss_pred ----CCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 533 ----ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 533 ----~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
....++..|+|||++. ...++.++|||||||++|||++|+.||....... ... . ..........
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~-~-~~~~~~~~~~ 237 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF-L-IPRNPAPRLK 237 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHH-H-HhcCCCCCCC
Confidence 2344678899999986 3457889999999999999999999996432111 000 0 0000000000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. ......+.+++.+||..+|++|||++|++++
T Consensus 238 ------~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 238 ------S---KKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ------C---CCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 1122456788889999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.60 Aligned_cols=239 Identities=24% Similarity=0.325 Sum_probs=188.3
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|+..+ ++.||+|++.... ...+.+..|.+++..+.+|++|+++++++.+.+..|+||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 4679999999999999764 5789999987542 1234567788888888556779999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 85 GGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 99999998642 24889999999999999999999998 99999999999999999999999999864321
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.....|++.|+|||++.+..++.++||||+||++|||+||+.||.+....+. ...+..... . ..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~~i~~~~~-------~--~~ 221 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQSIMEHNV-------S--YP 221 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHcCCC-------C--CC
Confidence 1233578899999999999999999999999999999999999975432211 111111110 0 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 644 (672)
. .....+.+++.+|++.+|++|++. +++.++
T Consensus 222 ~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 222 K---SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred C---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 112346678889999999999986 566553
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.14 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=208.9
Q ss_pred HHHHHHHhccccccCcEEEEEEEE-CCC----cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCe
Q 005875 373 EDLLRASAEVLGKGSYGTAYKAVL-EES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE 445 (672)
Q Consensus 373 ~~l~~~~~~~lG~G~fg~Vy~~~~-~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~ 445 (672)
+|.+....++||+|+||+||+|.+ .++ -+||+|++..... ...++..|+.+|.++ +|||+++++|+|....
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-
Confidence 334444578999999999999985 333 3588998876543 356889999999999 9999999999998766
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCC
Q 005875 446 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 525 (672)
Q Consensus 446 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 525 (672)
..||++||+.|+|.++++..++ .+-....+.+..|||+||.|||++. +|||||.++|||+..-..+||+|||+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgl 844 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGL 844 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecch
Confidence 8899999999999999987654 3778899999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCCCC------CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 526 TPLMNVPATPSR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 526 a~~~~~~~~~~~------~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
++.......... .+.|||-|.+....|+.++|||||||++||++| |..||++...+++-++.+ ...
T Consensus 845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~ge 917 (1177)
T KOG1025|consen 845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KGE 917 (1177)
T ss_pred hhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------ccc
Confidence 988765543322 345999999999999999999999999999999 999999877665433221 110
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
+....+.+..++..++.+||..|+..||+++++...+.++...
T Consensus 918 ----------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 ----------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ----------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 2233445667788899999999999999999999999887643
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=307.87 Aligned_cols=194 Identities=23% Similarity=0.416 Sum_probs=158.8
Q ss_pred hccccccCcEEEEEEEEC---CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe--CCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~~ 454 (672)
+++||+|+||+||+|+.. +++.+|+|.+..... ...+.+|++++.++ +||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999965 457899999865432 34578899999999 99999999999864 456789999986
Q ss_pred CCchhhhhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe----cCCCCeEEeecCCC
Q 005875 455 SGSLSTLLHGNRG----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLT 526 (672)
Q Consensus 455 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DfGla 526 (672)
+ +|.+++..... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 88887753321 11235889999999999999999999998 9999999999999 45688999999999
Q ss_pred CCCCCC-------CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005875 527 PLMNVP-------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579 (672)
Q Consensus 527 ~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~ 579 (672)
+..... ....+|+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 765432 12346888999999976 458899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.22 Aligned_cols=242 Identities=26% Similarity=0.358 Sum_probs=194.1
Q ss_pred ccccccCcEEEEEEEECC--C--cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 381 EVLGKGSYGTAYKAVLEE--S--TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
+.||+|+||.||+|.+.+ + ..||+|.+..... ..+.+.+|+.++.++ +|+||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999999643 2 2589999876644 345788999999999 99999999999988 88899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++..... ..+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999975431 35899999999999999999999998 9999999999999999999999999987654321
Q ss_pred ------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhh
Q 005875 534 ------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606 (672)
Q Consensus 534 ------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 606 (672)
...++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+ ............
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~------ 220 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGERL------ 220 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCcC------
Confidence 1234567999999999899999999999999999999 999996543221 111111111000
Q ss_pred hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 607 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.........+.+++.+|++.+|++||+++|+++.|.
T Consensus 221 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011122356778888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=303.79 Aligned_cols=242 Identities=21% Similarity=0.367 Sum_probs=190.4
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+.+|++++.++ +||||+++++++..++..++||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 36799999999999986 4578899998865422 235688899999888 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--CC
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--AT 534 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 534 (672)
+|..+.. +++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++...... ..
T Consensus 85 ~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 152 (279)
T cd06619 85 SLDVYRK---------IPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT 152 (279)
T ss_pred ChHHhhc---------CCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccC
Confidence 9976532 788889999999999999999998 999999999999999999999999998765432 23
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh-hHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL-PRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||++.+..++.++||||||+++|||++|+.||......+.... ............ +.. ..
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~----~~ 222 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------PVL----PV 222 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC------CCC----CC
Confidence 4578889999999998999999999999999999999999975432221111 111111111100 000 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+|++.+|++||+++|++++
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1122356788889999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.05 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=184.0
Q ss_pred cccccCcEEEEEEEECC---CcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 382 VLGKGSYGTAYKAVLEE---STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.||+|+||+||+|...+ ...+++|.+...... ...+.+|++.+..+ +|+||+++++++......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999998543 346788876543322 34577899888888 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++...........++.....++.||+.|++|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997654333334567888999999999999999998 999999999999999999999999998653221
Q ss_pred --CCCCCCCcccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 533 --ATPSRSAGYRAPEVIET-------RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
....++..|+|||++.. ..++.++|||||||++|||++ |..||......+ .......... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccC-ccC
Confidence 12234567999998743 356789999999999999999 788886543211 0111111110 011
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.++.. .......+.+++..|| .||++|||++||++.|.
T Consensus 231 ~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 0112234455667888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.53 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=192.2
Q ss_pred hccccccCcEEEEEEEEC-----CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e 451 (672)
.+.||+|+||+||++... ++..|++|++..... ..+.+.+|++++..+ +||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCceEEEEE
Confidence 467999999999999853 477899999875432 245788999999998 999999999987543 46789999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 88 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 88 YLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999996432 24899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCC-------CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC---------CChhHHHHHhhh
Q 005875 532 PATP-------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM---------VDLPRWVQSVVR 595 (672)
Q Consensus 532 ~~~~-------~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~---------~~~~~~~~~~~~ 595 (672)
.... .++..|+|||++.+..++.++|||||||++|||++|..|+......-. ............
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 2211 123359999999988899999999999999999998877643321100 000000000010
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
... ...........+.+++.+||+.+|++|||++|+++.|++++
T Consensus 241 ~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 241 NNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cCC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000 00011122345778888999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=315.07 Aligned_cols=234 Identities=21% Similarity=0.289 Sum_probs=182.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHH-HHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
+.||+|+||+||+|+.. +++.||+|++..... ....+..|... +..+ +|+||+++++++..++..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36999999999999976 467799999875422 12234444444 3445 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 80 GGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 99999999742 23778888899999999999999998 99999999999999999999999999875322
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~---------~~~ 216 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNKPL---------QLK 216 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHhCCc---------CCC
Confidence 123457889999999999999999999999999999999999997543221 1111111110 001
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 641 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 641 (672)
. .....+.+++.+|++.+|.+||++.+.
T Consensus 217 ~---~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 217 P---NITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred C---CCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 1 122345677779999999999997743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=297.16 Aligned_cols=251 Identities=22% Similarity=0.397 Sum_probs=200.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|... +++.|++|.++.... ..+.+.+|+++++++ +|+|++++++++..++..++||||++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIVLELAD 85 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEEEecCC
Confidence 367999999999999976 688999998864221 245788999999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++..... ....+++..+..++.+++.|++|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 86 AGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 9999999865332 2344899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 534 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
...++..|+|||++.+..++.++|||||||++|||++|+.||.... .+............. ..
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~-~~--------- 227 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKCDY-PP--------- 227 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcCCC-CC---------
Confidence 2346778999999998889999999999999999999999996433 111111111111100 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
...+.....+.+++.+||+.+|++||++.++++.|+++.
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 001123346778888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=323.08 Aligned_cols=191 Identities=27% Similarity=0.392 Sum_probs=164.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|++..... ....+.+|++++..+ +|+||+++++++.+++..++||||++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999965 467899999875422 234677899999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 85 GGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999998643 24788999999999999999999998 99999999999999999999999999753210
Q ss_pred ------------------------------------------------CCCCCCCCcccCcccccCCCCCCccchhhHHH
Q 005875 532 ------------------------------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 563 (672)
Q Consensus 532 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gv 563 (672)
.....||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 01124788899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 005875 564 LLLEMLTGKAPLQSPT 579 (672)
Q Consensus 564 vl~el~tg~~pf~~~~ 579 (672)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=298.98 Aligned_cols=244 Identities=26% Similarity=0.440 Sum_probs=199.0
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||.||+|... ++.|++|.++......+.+.+|+.++..+ +|+||+++++++.+.+..++||||+++++|.
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 578999999999999976 78899999987655566788999999999 8999999999999989999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC-CCCC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-PSRS 538 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~ 538 (672)
+++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.++|+|||.+........ ...+
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 162 (256)
T cd05039 89 DYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP 162 (256)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccccCCCc
Confidence 9997432 224899999999999999999999998 99999999999999999999999999987643322 2234
Q ss_pred CcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHH
Q 005875 539 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 617 (672)
Q Consensus 539 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 617 (672)
..|+|||++.+..++.++||||||+++|||++ |..||......+ ............. .....
T Consensus 163 ~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~----------~~~~~ 225 (256)
T cd05039 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRMEA----------PEGCP 225 (256)
T ss_pred ccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCCCC----------ccCCC
Confidence 56999999998889999999999999999997 999997543211 1111111111100 11123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 618 VQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 618 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
..+.+++.+||+.+|++||+++|+++.|+.+
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 5677888899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=334.44 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=199.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.++||+|+||.||+|... .++.||+|++..... ..+++.+|++++.++ +||||+++++++.+++..++||||++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 468999999999999975 478899999875422 135688899999999 89999999999999999999999999
Q ss_pred CCchhhhhccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 455 SGSLSTLLHGNRG------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 455 ~g~L~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
+|+|.+++..... ......++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||+++.
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCccee
Confidence 9999999864211 11233667788999999999999999998 99999999999999999999999999875
Q ss_pred CCC----------------------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 005875 529 MNV----------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586 (672)
Q Consensus 529 ~~~----------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~ 586 (672)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+...
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~- 241 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY- 241 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh-
Confidence 511 011347889999999999999999999999999999999999997633221100
Q ss_pred hHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhhcCCC
Q 005875 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDSE 654 (672)
Q Consensus 587 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~~ 654 (672)
.. ...++.. .....+....+.+++.+|++.||++|| +++++.+.|+...+..+.
T Consensus 242 ---------~~---~i~~P~~--~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 242 ---------RD---VILSPIE--VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred ---------hh---hccChhh--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 00 0000000 000112234566788899999999996 577888889888776544
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=316.00 Aligned_cols=234 Identities=21% Similarity=0.307 Sum_probs=183.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||+||+|+.. +++.+|+|++..... ....+..|..++.+..+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999965 578899999875422 2234555555544434999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence 9999888642 34899999999999999999999998 99999999999999999999999999875322
Q ss_pred CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 532 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ .......... .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~~~~---~~------~~ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILHKPL---VL------RP 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHcCCc---cC------CC
Confidence 123457889999999999999999999999999999999999997543221 1111111110 00 01
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDE 640 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 640 (672)
.....+.+++.+|++.+|++||++.+
T Consensus 218 ---~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 218 ---GASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred ---CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 12234567788999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=323.35 Aligned_cols=241 Identities=22% Similarity=0.346 Sum_probs=187.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+++.. +++.||+|++..... ....+.+|++++.++ +|+||+++++.+.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 467999999999999965 478899999865321 235577899999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|.....
T Consensus 85 ~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 85 GGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999742 24788899999999999999999998 99999999999999999999999999753210
Q ss_pred --------------------------------------------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHH
Q 005875 532 --------------------------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLE 567 (672)
Q Consensus 532 --------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~e 567 (672)
.....||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 012357889999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 005875 568 MLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP---NMDEVVRM 644 (672)
Q Consensus 568 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~ 644 (672)
|++|+.||.+....+. ...+.. +..... ........ ..+.+++.+|+ .+|++|+ ++.|++++
T Consensus 237 ll~G~~Pf~~~~~~~~------~~~i~~--~~~~~~---~~~~~~~s---~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAET------QLKVIN--WETTLH---IPSQAKLS---REASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHH------HHHHhc--cCcccc---CCCCCCCC---HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999986543211 111110 000000 00011122 23445555665 4999999 89999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.22 Aligned_cols=246 Identities=24% Similarity=0.394 Sum_probs=192.9
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||+|.+.+ +..|++|.+..... ....+.+|+.++..+ +|+||+++++++.+.+..++|||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCcEEEEe
Confidence 4679999999999999754 45688888764432 235688899999998 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC---CeEEeecCCC
Q 005875 452 YFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLT 526 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGla 526 (672)
|+++|+|.+++...... ....+++..++.++.||+.|++|||+.+ ++||||||+||+++.++ .+||+|||++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccc
Confidence 99999999999754321 1235899999999999999999999998 99999999999998765 5899999998
Q ss_pred CCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 527 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 527 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
+...... ....+..|+|||++.+..++.++|||||||++|||++ |..||......+. ...+.... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~-~ 239 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV------MEFVTGGG-R 239 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHcCC-c
Confidence 7653221 1122457999999998899999999999999999997 9999976443221 11111110 0
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.. ........+.+++.+|++.+|++||++.||+++|+
T Consensus 240 ~~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 LD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 01112346778888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.25 Aligned_cols=241 Identities=24% Similarity=0.457 Sum_probs=196.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||.||++.+.+++.+++|.+........++.+|++++..+ +|||++++++++......++||||+++++|.
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 467999999999999987788999999887666677899999999998 9999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----C
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 534 (672)
+++.... ..++++.+..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 88 DYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9987433 24789999999999999999999998 9999999999999999999999999986543221 1
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+.+|+|||++.+..++.++||||||+++|||++ |..||......+ ..... .+... ...+
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~-~~~~~--~~~~-------- 223 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETI-NAGFR--LYKP-------- 223 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHH-hCCCC--CCCC--------
Confidence 223467999999998889999999999999999998 999997533211 11111 11100 0011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
......+.+++.+||+.+|++|||+.|++++|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 01234678889999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.88 Aligned_cols=241 Identities=21% Similarity=0.291 Sum_probs=190.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+++..++||||++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEcCCC
Confidence 468999999999999975 47789999986532 1234567888998888 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 127 gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 127 GGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999998632 3788889999999999999999998 999999999999999999999999998765432
Q ss_pred ---CCCCCCCcccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 ---ATPSRSAGYRAPEVIETR----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
....|++.|+|||++.+. .++.++|||||||++|||++|+.||.+.... .....+........
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~~---- 267 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSLT---- 267 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcCC----
Confidence 234578999999998653 3788999999999999999999999864321 11112211110000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM 644 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 644 (672)
.... ......+.+++.+|++.+|++ ||+++|++++
T Consensus 268 -~~~~---~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 -FPDD---IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -CCCc---CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000 112345667778999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.91 Aligned_cols=247 Identities=25% Similarity=0.392 Sum_probs=196.4
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||++... .+..+|+|.++.... ..+.+.+|++++.++.+|+||+++++++...+..++|||
T Consensus 40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 119 (302)
T cd05055 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119 (302)
T ss_pred cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence 578999999999999742 234689998875432 235688899999999789999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|+++|+|.++++.... ..+++.++..++.|++.|++|||+.+ |+|+||||+||+++.++.++++|||++.....
T Consensus 120 ~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 120 YCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred cCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 9999999999974332 23899999999999999999999998 99999999999999999999999999876533
Q ss_pred CC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 532 PA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 532 ~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
.. ...++..|+|||.+.+..++.++|||||||++|||++ |..||......+. ........+...
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~--- 264 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEGYRMA--- 264 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcCCcCC---
Confidence 22 1234567999999999899999999999999999998 9999975432211 111111111100
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
........+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 265 -------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 -------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0011224577888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=301.52 Aligned_cols=244 Identities=21% Similarity=0.323 Sum_probs=190.8
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||.||+|+. .+++.||+|++..... ....+.+|+.++..+ +|+||+++++++..++..++||||+++++
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~iv~e~~~~~~ 92 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWICMEYCGGGS 92 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEEeCCCCCc
Confidence 46799999999999996 4578899998865432 334677899999888 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 533 (672)
|.++++.. ..+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++...... .
T Consensus 93 L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 93 LQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99998632 24889999999999999999999998 999999999999999999999999998765322 2
Q ss_pred CCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 534 TPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
...++..|+|||.+. ...++.++|||||||++|||++|+.||......+... ......... + ..
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~~----~---~~ 231 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKSNFQP----P---KL 231 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecCCCCC----C---CC
Confidence 234677899999984 3447889999999999999999999986443221100 000000000 0 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
.........+.+++.+||+.+|++||+++++++++
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01112234677888899999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=298.88 Aligned_cols=243 Identities=26% Similarity=0.403 Sum_probs=193.5
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEE-eCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY-SKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~-~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||.||++... +..+++|.++... ..+.+.+|+.++.++ +|+|++++++++. .++..++||||+++|+|
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 468999999999999876 6778999886432 346788999999998 9999999999765 45578999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-CCCC
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR 537 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~ 537 (672)
.++++... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++....... ....
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 161 (256)
T cd05082 88 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 161 (256)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCCCCcc
Confidence 99997533 234889999999999999999999998 9999999999999999999999999987654322 2234
Q ss_pred CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHH
Q 005875 538 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 616 (672)
Q Consensus 538 ~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 616 (672)
+..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+ ........ ....
T Consensus 162 ~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~-~~~~~~~~----------~~~~ 224 (256)
T cd05082 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRV-EKGYKMDA----------PDGC 224 (256)
T ss_pred ceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-hcCCCCCC----------CCCC
Confidence 567999999998889999999999999999998 9999874321 1111111 11111110 0122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 617 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 617 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
...+.+++.+|++.+|++|||++++++.|+++
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 34667888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=305.45 Aligned_cols=239 Identities=24% Similarity=0.395 Sum_probs=186.5
Q ss_pred ccccccCcEEEEEEEECC--------CcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 381 EVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
+.||+|+||+||+|.... ...+++|.+..... ..+.+.+|+.++..+ +||||+++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEEEEe
Confidence 369999999999998643 22477777754332 235677888888887 89999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC--------eEEeec
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--------GCISDF 523 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~--------~kl~Df 523 (672)
|+++|+|.++++... ..+++..++.++.||+.|++|||+.+ |+||||||+||+++.++. ++++||
T Consensus 80 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 80 YVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred cCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999997533 24889999999999999999999998 999999999999988765 599999
Q ss_pred CCCCCCCCCCCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHHhhhhccccc
Q 005875 524 GLTPLMNVPATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVDLPRWVQSVVREEWTAE 601 (672)
Q Consensus 524 Gla~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (672)
|++..........++..|+|||++.+ ..++.++||||||+++|||++|. .||....... .. ...... ..
T Consensus 153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~~~~--~~ 223 (258)
T cd05078 153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFYEDR--HQ 223 (258)
T ss_pred ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHHHcc--cc
Confidence 99877665555667888999999986 45789999999999999999985 5554322111 00 001100 00
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 602 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
. .......+.+++.+||+.+|++|||++|+++.|+
T Consensus 224 ~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 L----------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred C----------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0111245678888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=304.64 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=192.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||++... +++.||+|.+...... ...+.+|+.++.++ +|+||+.+++.+.+++..++||||++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEEecC
Confidence 367999999999999965 5788999988654321 23466789999988 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 84 g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 84 GGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred CCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999886432 234889999999999999999999988 9999999999999999999999999987653322
Q ss_pred --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 534 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
...++..|+|||++.+..++.++|||||||++|||++|+.||.......... ....... .....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~~~~-~~~~~---------- 223 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVK-EVQEE---------- 223 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHhhhh-hhhhh----------
Confidence 2357888999999999999999999999999999999999997643211100 0011100 00000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 644 (672)
........+.+++.+||+.||++||| ++|++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00112234677888999999999999 8888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.24 Aligned_cols=255 Identities=18% Similarity=0.277 Sum_probs=185.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHc-----CCCceeceEEEEEeC-CeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLRAYYYSK-DEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~~~~-~~~~lV~e~ 452 (672)
.+.||+|+||+||+|... .++.||||+++.......+...|++++..+. +|.+++++++++..+ ...++|||+
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~ 213 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK 213 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence 468999999999999965 4678999998754333455667777777662 345688999988765 467899998
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEEecCCC---------------
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDL--------------- 516 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~--------------- 516 (672)
+ +++|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 214 ~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 214 Y-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred c-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 8 67888888642 248999999999999999999997 47 99999999999998765
Q ss_pred -CeEEeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh
Q 005875 517 -DGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 594 (672)
Q Consensus 517 -~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 594 (672)
.+||+|||.+...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+....+............
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 4999999987654332 23468899999999999999999999999999999999999998654322211110000000
Q ss_pred hhccc--------cccc----------hhh-hh---cccChH--HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 595 REEWT--------AEVF----------DVE-LM---RFQNIE--EEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 595 ~~~~~--------~~~~----------d~~-~~---~~~~~~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
...+. .+.+ ++. +. ...... .....+.+|+.+||+.||++|||++|+++
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00000 0000 000 00 000000 11245779999999999999999999998
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.26 Aligned_cols=242 Identities=22% Similarity=0.343 Sum_probs=190.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+++.. +++.||+|+++.... ..+.+.+|++++..+ +|+||+++++++.+++..++||||++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEECCCC
Confidence 467999999999999965 578899999976533 234577788888877 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 85 GGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999997542 24899999999999999999999998 9999999999999999999999999997654322
Q ss_pred ----CCCCCCcccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 534 ----TPSRSAGYRAPEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 534 ----~~~~~~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
...+++.|+|||++. ...++.++|||||||++|||++|+.||......+ ....+........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~-- 229 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLK-- 229 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccC--
Confidence 235788999999986 4567899999999999999999999997543211 1112111110000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..........+.+++..|++ +|++||++++++++
T Consensus 230 ------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 ------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00001122345667779997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=298.72 Aligned_cols=243 Identities=24% Similarity=0.452 Sum_probs=196.0
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||.||++...++..+++|.+.......+.+.+|+++++.+ +|+||+++++++.+ ...+++|||+++|+|.
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 468999999999999988888899998876544556788999999998 89999999999887 7789999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC-----
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----- 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~----- 534 (672)
+++.... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.+........
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 89 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred HHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 9997533 234788999999999999999999988 99999999999999999999999999875543221
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||++....++.++|+|||||++||+++ |+.||......+ . .. ......... ..
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~---~~-~~~~~~~~~----------~~ 225 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V---IR-ALERGYRMP----------RP 225 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H---HH-HHhCCCCCC----------Cc
Confidence 123456999999998889999999999999999999 999997543211 1 11 111111100 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1223457788889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.88 Aligned_cols=246 Identities=23% Similarity=0.397 Sum_probs=192.7
Q ss_pred hccccccCcEEEEEEEEC-CCc----EEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-EST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|++. ++. .||+|.++.... ..+++.+|+.++..+ +|+||+++++++.. ...+++|||
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-~~~~l~~~~ 89 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT-STVQLVTQL 89 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC-CCcEEEEEc
Confidence 468999999999999854 333 478998865432 245677888888888 89999999999875 457799999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 90 MPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred CCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999997432 24899999999999999999999998 999999999999999999999999998765432
Q ss_pred CC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 AT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ~~------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.. ..++..|+|||.+.+..++.++|||||||++|||++ |..||......+ +..+. .......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~~~---- 231 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLL----EKGERLP---- 231 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----HCCCcCC----
Confidence 21 123467999999998899999999999999999998 899987543211 11111 1110000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
........+.+++.+||+.||++||++.|+++.|+++...
T Consensus 232 ------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 232 ------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0012234567888899999999999999999999888544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=321.50 Aligned_cols=241 Identities=19% Similarity=0.334 Sum_probs=187.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||++... +++.||+|++..... ..+.+.+|++++..+ +||||+++++++.+++..|+||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 367999999999999864 578899999865422 124577899999888 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 85 GGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999643 34888999999999999999999998 999999999999999999999999998532110
Q ss_pred -------------------------------------------------CCCCCCCcccCcccccCCCCCCccchhhHHH
Q 005875 533 -------------------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 563 (672)
Q Consensus 533 -------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gv 563 (672)
....||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0134788899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCC---CCHHH
Q 005875 564 LLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR---PNMDE 640 (672)
Q Consensus 564 vl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~e 640 (672)
++|||++|..||......+. ...+.. +..... ..... .....+.+++.+|++ +|.+| +++.|
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~--~~~~~~---~p~~~---~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET------YRKIIN--WRETLY---FPDDI---HLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH------HHHHHc--cCCccC---CCCCC---CCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 99999999999975432211 111111 000000 00000 112345667778987 66665 69999
Q ss_pred HHHH
Q 005875 641 VVRM 644 (672)
Q Consensus 641 vl~~ 644 (672)
++++
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 9885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.26 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=195.3
Q ss_pred hccccccCcEEEEEEEECC-----------------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-----------------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYY 440 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~ 440 (672)
.+.||+|+||.||++...+ +..||+|.+..... ..+.+.+|++++.++ +|+||+++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 88 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIARLLGVC 88 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEeEEEEEE
Confidence 4689999999999998653 24578998875432 245788899999999 899999999999
Q ss_pred EeCCeeEEEEEecCCCchhhhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC
Q 005875 441 YSKDEKLLVYDYFASGSLSTLLHGNRGA------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 514 (672)
Q Consensus 441 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~ 514 (672)
..++..++||||+++++|.+++...... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~ 165 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecC
Confidence 9999999999999999999999754421 1235899999999999999999999998 999999999999999
Q ss_pred CCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCCCCCCh
Q 005875 515 DLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDL 586 (672)
Q Consensus 515 ~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t--g~~pf~~~~~~~~~~~ 586 (672)
++.++|+|||++....... ...++..|+|||++.+..++.++|||||||++|||++ +..||......+ .
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~ 242 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ---V 242 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH---H
Confidence 9999999999987543221 2234567999999988889999999999999999998 777886443211 1
Q ss_pred hHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 587 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
................. .........+.+++.+||+.+|++|||+.|+++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 243 IENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111110000000 011122356788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.12 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=194.4
Q ss_pred HHhccccccCcEEEEEEEEC-----CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEE
Q 005875 378 ASAEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLL 448 (672)
Q Consensus 378 ~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~l 448 (672)
...+.||+|+||.||++++. ++..||+|.++.... ....+.+|+++++.+ +|+||+++.+++... ...++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCceEE
Confidence 34578999999999999842 467899999875432 235788999999998 999999999998875 56789
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 449 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.
T Consensus 86 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999986432 24899999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC---------CCChhHHHHH
Q 005875 529 MNVPA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD---------MVDLPRWVQS 592 (672)
Q Consensus 529 ~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~---------~~~~~~~~~~ 592 (672)
..... ...++..|+|||++.+..++.++||||||+++|||++++.|+....... ......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 54322 2234556999999988889999999999999999999887654321100 0001111111
Q ss_pred hhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 593 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 593 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
...... ..........+.+++.+||+.+|++|||++++++.|+++
T Consensus 239 -~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 -LEEGKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHcCcc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111100 000112345678888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.49 Aligned_cols=244 Identities=24% Similarity=0.488 Sum_probs=194.7
Q ss_pred hccccccCcEEEEEEEECC-C---cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE-S---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||.||+|.... + ..+++|.++.... ..+++.+|++++..+ +|+||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCcEEEEEcC
Confidence 4689999999999999753 2 2688998865432 245688899999888 9999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 89 ENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999996432 34899999999999999999999998 9999999999999999999999999987553321
Q ss_pred CC-------CCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 534 TP-------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 534 ~~-------~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.. ..+..|+|||++....++.++|||||||++|||++ |+.||...... .....+. ...
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~-~~~------- 227 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAIN-DGF------- 227 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHh-cCC-------
Confidence 11 12346999999998889999999999999999998 99999754321 1111111 110
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
......+....+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0001112335678888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.09 Aligned_cols=255 Identities=20% Similarity=0.345 Sum_probs=189.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+.. +++.||+|.++.... ....+.+|++++.++ +|+||+++++++..++..++||||+++
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~- 88 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLVFEYLDK- 88 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence 467999999999999965 467899999875432 234577899999998 999999999999999999999999975
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 89 DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 8888876432 34788999999999999999999998 9999999999999999999999999987543221
Q ss_pred -CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH-Hhhhhcccc-----ccchh
Q 005875 534 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ-SVVREEWTA-----EVFDV 605 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~d~ 605 (672)
...+++.|+|||++.+ ..++.++|||||||++|||+||+.||.+.+..+......... ....+.|.. ...+.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 2346788999999865 457899999999999999999999998654332211100000 000000000 00000
Q ss_pred hhhcc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 606 ELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 606 ~~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
..... .........+.+++.+|++.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 000112234678888999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.37 Aligned_cols=233 Identities=24% Similarity=0.329 Sum_probs=186.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|++..... ..+.+..|.+++..+.+|++|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 367999999999999965 578899999875421 224566788888877677889999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 85 GGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99999998642 34899999999999999999999998 999999999999999999999999998754221
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+......
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~~~~~----------- 219 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LFQSIMEHNVS----------- 219 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC-----------
Confidence 23347889999999999899999999999999999999999997643221 11111111100
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNM 638 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 638 (672)
........+.+++.+|++.+|++|++.
T Consensus 220 -~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 -YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 001122356678889999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.15 Aligned_cols=241 Identities=20% Similarity=0.297 Sum_probs=186.6
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+++... ++.+|+|.+.+... ....+.+|+.++..+ +||||+++++++.+++..++||||++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEcCCC
Confidence 4679999999999999764 67899999865321 234567788888887 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 127 gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 127 GGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 99999999632 3788999999999999999999998 999999999999999999999999999765432
Q ss_pred ---CCCCCCCcccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 ---ATPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
....||+.|+|||++.+.. ++.++||||+||++|||++|+.||...... .....+........
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~---- 267 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSLN---- 267 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcccC----
Confidence 2345889999999997543 788999999999999999999999754321 11112211111000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM 644 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 644 (672)
..... .....+.+++.+|++.++.+ |++++|++++
T Consensus 268 -~p~~~---~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 -FPEDV---EISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -CCCcc---cCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00011 11234456666888755544 8999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=297.06 Aligned_cols=245 Identities=25% Similarity=0.402 Sum_probs=187.5
Q ss_pred ccccccCcEEEEEEEECC----CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEe-CCeeEEEEEec
Q 005875 381 EVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDYF 453 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lV~e~~ 453 (672)
+.||+|+||.||+|.+.+ ...+|+|++..... ..+.+.+|+.+++.+ +||||+++++++.. +...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEecC
Confidence 368999999999998642 35689998754322 235677888888888 99999999998764 55678999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
.+|+|.+++.... ...++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 9999999997432 23677888999999999999999988 9999999999999999999999999987543211
Q ss_pred --------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 534 --------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 534 --------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
...++..|+|||++.+..++.++|||||||++|||++| .+||..... .............
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~~----- 221 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQGRRL----- 221 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhcCCCC-----
Confidence 12235579999999888899999999999999999995 556653321 1111111111000
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
.........+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 222 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 ------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0001122457788889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=305.02 Aligned_cols=254 Identities=22% Similarity=0.372 Sum_probs=194.5
Q ss_pred hccccccCcEEEEEEEECC-----------------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-----------------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYY 440 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~ 440 (672)
.+.||+|+||+||+++..+ ...+|+|++..... ...++.+|++++..+ +|+||+++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~ 88 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIRLLAVC 88 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Confidence 4679999999999986432 33588998875432 245788999999999 999999999999
Q ss_pred EeCCeeEEEEEecCCCchhhhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC
Q 005875 441 YSKDEKLLVYDYFASGSLSTLLHGNRGA------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 514 (672)
Q Consensus 441 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~ 514 (672)
..++..++||||+++|+|.+++...... ....+++..+..++.|++.|++|||+.+ ++||||||+||+++.
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~ 165 (296)
T cd05095 89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcC
Confidence 9999999999999999999999754321 1234788899999999999999999998 999999999999999
Q ss_pred CCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCCCCCCh
Q 005875 515 DLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDL 586 (672)
Q Consensus 515 ~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t--g~~pf~~~~~~~~~~~ 586 (672)
++.++|+|||+++...... ....+..|+|||+..+..++.++|||||||++|||++ |..||......+..
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~-- 243 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI-- 243 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH--
Confidence 9999999999987653221 1223467999999888889999999999999999998 77888754332211
Q ss_pred hHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 587 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
................ .....+...+.+++.+||+.||++||++.||++.|++
T Consensus 244 -~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 244 -ENTGEFFRDQGRQVYL-------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -HHHHHHHhhccccccC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111110000 0011223567788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=303.77 Aligned_cols=250 Identities=22% Similarity=0.376 Sum_probs=197.7
Q ss_pred hccccccCcEEEEEEEECC-----CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEe-CCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lV~e 451 (672)
.+.||+|+||.||+|...+ +..|++|+++.... ..+.+.+|+.++.++ +|+||+++++++.. +...++++|
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCCEEEEE
Confidence 4689999999999999765 67889998875432 245678899999998 99999999998876 467899999
Q ss_pred ecCCCchhhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 452 YFASGSLSTLLHGNRGA---GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 99999999998654321 1245899999999999999999999988 99999999999999999999999999976
Q ss_pred CCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccc
Q 005875 529 MNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601 (672)
Q Consensus 529 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (672)
+.... ...++..|+|||++.+..++.++||||||+++||+++ |+.||......+ +... .......
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~-~~~~~~~- 238 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------MAAY-LKDGYRL- 238 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH------HHHH-HHcCCCC-
Confidence 53221 2234567999999998889999999999999999999 999997543211 1111 1111100
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 602 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
.........+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 239 ---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0001123456788889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=325.26 Aligned_cols=243 Identities=23% Similarity=0.312 Sum_probs=191.4
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCC--------eeE
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--------EKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~ 447 (672)
.+.||+|+||+||+|+. .+++.||||++...... ...+.+|+..+..+ +|+||+++.+.+...+ ..+
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcccceEEE
Confidence 46899999999999985 46889999998754332 34567788888887 8999999988775432 357
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
+||||+++|+|.++++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 99999999999999974332 2345899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCC------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccc
Q 005875 528 LMNV------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601 (672)
Q Consensus 528 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (672)
.... .....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~~~~~~~-- 263 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKTLAGRYD-- 263 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHhcCCCC--
Confidence 6432 12345788999999999999999999999999999999999999754321 122222211110
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 602 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+ ........+.+++.+||+.+|++||++.+++++
T Consensus 264 ---~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 ---P------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---C------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 001123456778889999999999999999874
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=302.24 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=194.6
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||+|...+ +..|++|.+..... ....+.+|+.++..+ +|+||+++++++......++|||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCCCCcEEEEe
Confidence 4689999999999998653 35799999865432 234678889999888 89999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCC
Q 005875 452 YFASGSLSTLLHGNRGA-----GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 526 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 526 (672)
|+++|+|.+++...... ....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccc
Confidence 99999999999653321 1234788999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 527 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 527 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
+...... ...++..|+|||.+.+..++.++|||||||++||+++ |..||......+. .. .......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------~~-~~~~~~~ 239 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV------LK-FVIDGGH 239 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH------HH-HHhcCCC
Confidence 7543221 2234667999999988889999999999999999998 9999975432221 11 1111111
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
... .......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 240 ~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 240 LDL----------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCC----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 0112456778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.07 Aligned_cols=232 Identities=21% Similarity=0.310 Sum_probs=181.5
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHH-HHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
+.||+|+||+||+|+.. +++.||+|++..... ....+..|... +..+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999975 477899999875422 12334555544 4455 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 80 GGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 99999888632 34788899999999999999999998 999999999999999999999999998753221
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....+++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..... . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~--~-------~- 215 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNILHKPL--Q-------L- 215 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHhcCCC--C-------C-
Confidence 2234788999999999989999999999999999999999999754321 11111111110 0 0
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMD 639 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 639 (672)
.......+.+++.+|++.+|.+||++.
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 --PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 011233567788899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.28 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=206.4
Q ss_pred CHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEE
Q 005875 371 DLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 371 ~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 449 (672)
..+++.. ..++||+|+||.||++.++ .|..+|||.+.- ..+-+++..|+.++.+. +.++||+++|.|......|+|
T Consensus 30 ~PEEVFD-i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 30 PPEEVFD-IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred ChHHHHH-HHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEee
Confidence 3444443 3567999999999999865 478889998754 34567788899999998 999999999999999999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
||||..|++.+.++. +.+++++.++..++...++||+|||... -+|||||+.|||++.+|.+|++|||.|..+
T Consensus 107 MEYCGAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQL 179 (502)
T ss_pred hhhcCCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchh
Confidence 999999999999974 3456999999999999999999999987 899999999999999999999999999776
Q ss_pred CC----CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 530 NV----PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 530 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.. ..+-.|||.|||||++..-.|+.++||||+|++..||..|++||....+...+-+ +...
T Consensus 180 TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---------------IPT~ 244 (502)
T KOG0574|consen 180 TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---------------IPTK 244 (502)
T ss_pred hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---------------ccCC
Confidence 53 3455689999999999999999999999999999999999999975432211100 0011
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
....+...++....+-+++++|+-+.|++|-|+-+++++
T Consensus 245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 112345566777888999999999999999999988764
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=297.68 Aligned_cols=241 Identities=27% Similarity=0.431 Sum_probs=194.3
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
++||+|+||.||++...+++.|++|.+..... ....+.+|+++++++ +|+||+++++++.+.+..++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36899999999999987789999998876543 245788899999998 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC----
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---- 534 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 534 (672)
.+++.... ..+++..+..++.+++.|++|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 80 ~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99996432 24789999999999999999999998 99999999999999999999999999875542111
Q ss_pred --CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 535 --PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 535 --~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
...+..|+|||.+.+..++.++||||||+++|||+| |..||....... ... ....... ..
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~~~-~~~~~~~----------~~ 215 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRE-RIESGYR----------MP 215 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------HHH-HHhcCCC----------CC
Confidence 112446999999998889999999999999999999 888886543211 111 1111100 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
........+.+++.+|++.+|++|||+.|+++.|+
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 01122346788888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.55 Aligned_cols=246 Identities=24% Similarity=0.407 Sum_probs=193.4
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||.||++... ++..+++|.++.... ..+.+.+|++++..+ +|+||+++++++.+....+++|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCCceEEEEec
Confidence 468999999999999742 355788888765432 345788999999998 999999999999999999999999
Q ss_pred cCCCchhhhhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEee
Q 005875 453 FASGSLSTLLHGNRG----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 522 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 522 (672)
+++|+|.+++..... .....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECC
Confidence 999999999975431 11134889999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhh
Q 005875 523 FGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 595 (672)
Q Consensus 523 fGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 595 (672)
||++....... ...+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ .......
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~ 239 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AIECITQ 239 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HHHHHHc
Confidence 99986543221 2223567999999999999999999999999999998 999986543221 1111111
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.. ... ........+.+++.+||+.||++||+++|+++.|+
T Consensus 240 ~~-~~~----------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 GR-ELE----------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred Cc-cCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 10 000 00112245667888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.76 Aligned_cols=245 Identities=27% Similarity=0.453 Sum_probs=192.6
Q ss_pred cccccCcEEEEEEEECC-------CcEEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 382 VLGKGSYGTAYKAVLEE-------STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.||+|+||.||+|+..+ +..+++|.+.... .....+.+|++++..+ +||||+++++++...+..++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998653 2468889876543 2345788899999998 999999999999999999999999
Q ss_pred cCCCchhhhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-----CeEEeecCC
Q 005875 453 FASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-----DGCISDFGL 525 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-----~~kl~DfGl 525 (672)
+++|+|.+++...... ....+++..++.++.|++.|++|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999753221 1234789999999999999999999988 99999999999999887 899999999
Q ss_pred CCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 526 TPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 526 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
+....... ....+..|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~------~~~~~-~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE------VLQHV-TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH------HHHHH-hcCC
Confidence 86543221 2234567999999999999999999999999999998 999997443211 11111 1100
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
. ..........+.+++.+||+.+|++||+++++++.|++
T Consensus 231 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 R----------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred c----------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 00111223466788889999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=303.89 Aligned_cols=240 Identities=23% Similarity=0.349 Sum_probs=192.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||.||+|... +++.|++|.+..... ..+.+.+|+.++..+ +|+||+++++++..+...++||||+++++
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 367999999999999864 578899998875433 345688899998887 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 533 (672)
|.+++... .+++.++..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++...... .
T Consensus 104 L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred HHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence 99998632 3788999999999999999999998 999999999999999999999999998754322 1
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+++.|+|||.+.+..++.++|||||||++|||++|+.||......+. +.. ..... ... ....
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~~~-~~~~~-~~~--------~~~~ 239 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYL-IATNG-TPE--------LQNP 239 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----HHH-HhcCC-CCC--------CCCc
Confidence 23567789999999988899999999999999999999999975432111 000 00000 000 0011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||..+|++||++.|++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1223456778889999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.54 Aligned_cols=244 Identities=25% Similarity=0.487 Sum_probs=193.9
Q ss_pred hccccccCcEEEEEEEECC-C---cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE-S---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||.||+|.... + ..|++|.++.... ...++..|+.++..+ +||||+++++++.+++..++||||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCceEEEEecC
Confidence 5689999999999999653 2 3599999875422 245788999999998 9999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++|+|.+++.... ..+++.+++.++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||++.......
T Consensus 88 ~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 88 ENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred CCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999997432 34899999999999999999999998 9999999999999999999999999987653321
Q ss_pred CC------CC---CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 534 TP------SR---SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 534 ~~------~~---~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
.. .+ +..|+|||++.+..++.++|||||||++|||++ |..||......+ ...+. ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i----~~~~~~--- 230 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI----EQDYRL--- 230 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH----HcCCcC---
Confidence 10 11 246999999999999999999999999999887 999997543211 11111 111100
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
....+....+.+++.+||+.+|++||++++++..|+++
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 -------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00112234567888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=305.93 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=192.3
Q ss_pred hccccccCcEEEEEEEECCC---------------cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEES---------------TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~---------------~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~ 442 (672)
.+.||+|+||.||+++..+. ..||+|.+..... ....+.+|++++.++ +|+|++++++++..
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~ 88 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLLGVCVS 88 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEcC
Confidence 46799999999999986432 2488998865422 235688999999999 99999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhccCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC
Q 005875 443 KDEKLLVYDYFASGSLSTLLHGNRGA-------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 515 (672)
Q Consensus 443 ~~~~~lV~e~~~~g~L~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~ 515 (672)
++..++||||+++++|.+++...... ....+++..+..++.|++.|++|||+.+ ++||||||+||+++++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~ 165 (295)
T cd05097 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNH 165 (295)
T ss_pred CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCC
Confidence 99999999999999999998643210 1123788999999999999999999998 9999999999999999
Q ss_pred CCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCCCCCChh
Q 005875 516 LDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDLP 587 (672)
Q Consensus 516 ~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t--g~~pf~~~~~~~~~~~~ 587 (672)
+.+||+|||++....... ...++..|+|||++....++.++|||||||++|||++ +..||......+. .
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~---~ 242 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV---I 242 (295)
T ss_pred CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH---H
Confidence 999999999987543221 1223557999999998889999999999999999998 6677765432221 1
Q ss_pred HHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 588 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 588 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
................. ........+.+++.+||+.+|++||++++|++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 243 ENTGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111100000000 001122467888899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.01 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=186.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeC--------CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--------DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~lV~ 450 (672)
.+.||+|+||.||+|... .++.||||++... .....+|+.++..+ +|+||+++++++... ...++||
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 578999999999999975 5788999988543 23456789999998 999999999887532 1356899
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-CeEEeecCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLM 529 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~ 529 (672)
||+++ +|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+..
T Consensus 147 E~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred ecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 99985 67776643221 2335899999999999999999999998 99999999999999765 7999999999765
Q ss_pred CCC---CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh---------
Q 005875 530 NVP---ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE--------- 596 (672)
Q Consensus 530 ~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--------- 596 (672)
... ....+++.|+|||++.+ ..++.++|||||||++|||++|.+||.+....+. +..... ....
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~-~~~~p~~~~~~~~ 298 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQ-VLGTPTEDQLKEM 298 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-HhCCCCHHHHHHh
Confidence 432 23457888999999865 4689999999999999999999999986543221 111110 0000
Q ss_pred --cccc----ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhh
Q 005875 597 --EWTA----EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQ 650 (672)
Q Consensus 597 --~~~~----~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~~ 650 (672)
.+.. .+....+.. .........+.+++.+||+.||++|||+.|+++ .++++..
T Consensus 299 ~~~~~~~~~~~~~~~~l~~-~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKK-VFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred chhhhcccCCccCchhHHH-HhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0000 000000000 000012245778888999999999999999997 4555543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=296.12 Aligned_cols=241 Identities=25% Similarity=0.406 Sum_probs=195.3
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|+++++++ +|+||+++++++.++...++++||+++++|
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 4579999999999999775 78899999875433 67899999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC----C
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----T 534 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----~ 534 (672)
.+++.... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||++....... .
T Consensus 86 ~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 86 SDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 99986432 34899999999999999999999998 9999999999999999999999999987654332 2
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChH
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 614 (672)
..++..|+|||++.+..++.++||||||+++|||++|+.||......+... . ...... .......
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~------~-~~~~~~--------~~~~~~~ 223 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF------M-IPNKPP--------PTLSDPE 223 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh------h-hccCCC--------CCCCchh
Confidence 235778999999999899999999999999999999999997543221100 0 000000 0011111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 615 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.....+.+++.+||+.+|++|||+.|++++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 223457788889999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.20 Aligned_cols=241 Identities=24% Similarity=0.393 Sum_probs=194.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc---cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||+|... +++.|++|.+.... ...+.+.+|+++++.+ +||||+++++++.+++..++||||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEEEeCCC
Confidence 357999999999999975 57889999886432 2345688899999998 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++|.++++... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 84 ~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 84 GDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 99999997542 235889999999999999999999988 9999999999999999999999999987654332
Q ss_pred --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 534 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
...+++.|+|||++.+..++.++|+||||+++|||++|+.||......+ ........ .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~~~--------- 221 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA------LILKIIRG-VFPPV--------- 221 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcC-CCCCC---------
Confidence 2246778999999999889999999999999999999999997543211 11111111 00000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.+|++||++.|++++
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 -SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01233467788889999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=302.30 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=190.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||++... +++.+|+|.+...... ...+.+|++++..+ +|+||+.+.+++..++..++||||++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEEecc
Confidence 367999999999999965 5788999998654321 23467899999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 84 GGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred CccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 999998886432 234899999999999999999999998 999999999999999999999999998654322
Q ss_pred -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
....++..|+|||++.+..++.++|+|||||++|||++|+.||......... ........... ..+ .
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~--~~~------~- 225 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETE--EVY------S- 225 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccc--ccc------C-
Confidence 2235688899999999889999999999999999999999999754321110 00010000000 000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 644 (672)
......+.+++.+|++.+|++||+ ++|++.+
T Consensus 226 --~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 226 --AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 112234567788999999999999 6676664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=303.13 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=194.2
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||+|..++ +..||+|.+...... ...+.+|+.++..+ +|+||+++++++.+.+..++|||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 89 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKGQPTLVVME 89 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEe
Confidence 4689999999999997542 457999987644322 34577888889888 89999999999999999999999
Q ss_pred ecCCCchhhhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCC
Q 005875 452 YFASGSLSTLLHGNRG-----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 526 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 526 (672)
|+++|+|.++++.... .+....++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCcc
Confidence 9999999999975321 12344677888999999999999999998 999999999999999999999999998
Q ss_pred CCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 527 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 527 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
+...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+ ...........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~~ 240 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------VLKFVMDGGYL 240 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCC
Confidence 7543211 1123557999999998889999999999999999998 788987543221 11111111100
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
. ........+.+++.+|++.+|++|||+.|+++.|++..
T Consensus 241 -~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 241 -D----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -C----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 00122356788888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.61 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=197.9
Q ss_pred hccccccCcEEEEEEEEC-----CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEe--CCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~ 450 (672)
.+.||+|+||.||++.+. .+..+|+|.++..... .+.+.+|+++++.+ +|+||+++++++.. ....++||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCceEEEE
Confidence 367999999999999864 3578999999866553 56799999999998 99999999999887 55789999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+....
T Consensus 88 e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 88 EYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999997533 24899999999999999999999998 9999999999999999999999999987765
Q ss_pred CCCC-------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC--------ChhHHHHHhhh
Q 005875 531 VPAT-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV--------DLPRWVQSVVR 595 (672)
Q Consensus 531 ~~~~-------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~--------~~~~~~~~~~~ 595 (672)
.... ...+..|+|||.+.+..++.++||||||+++|||++|+.|+......... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 3211 12344599999998888999999999999999999999998654322111 00000000111
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
... ...........+.+++.+||+.+|++|||+.|++++|+.+.
T Consensus 241 ~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 241 EGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 000 00011122356788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=305.73 Aligned_cols=194 Identities=23% Similarity=0.402 Sum_probs=158.0
Q ss_pred hccccccCcEEEEEEEECC---CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe--CCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~~ 454 (672)
+.+||+|+||+||+|+..+ +..||+|.+.... ....+.+|++++..+ +||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999653 4679999886543 234678899999998 99999999999854 456789999987
Q ss_pred CCchhhhhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe----cCCCCeEEeecCCC
Q 005875 455 SGSLSTLLHGNRG----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLT 526 (672)
Q Consensus 455 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DfGla 526 (672)
+ +|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 77777753221 12235889999999999999999999998 9999999999999 56789999999999
Q ss_pred CCCCCCC-------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005875 527 PLMNVPA-------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579 (672)
Q Consensus 527 ~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~ 579 (672)
+...... ...+++.|+|||++.+ ..++.++|||||||++|||+||++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 7654321 2345788999999876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=297.41 Aligned_cols=240 Identities=20% Similarity=0.277 Sum_probs=191.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||.||++... +++.+++|.+..... ..+.+.+|++++.++ +||||+++++++.+++..++||||
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEEEEEEE
Confidence 468999999999999864 578899998864322 124578899999998 999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++++|.+++... ..+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||+++.....
T Consensus 86 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 86 MPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred CCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999998743 24888999999999999999999998 999999999999999999999999998654321
Q ss_pred -------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 -------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
....++..|+|||++.+..++.++||||||+++|||++|+.||......+ .............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~---- 227 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA------AIFKIATQPTNPQ---- 227 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH------HHHHHhccCCCCC----
Confidence 12335678999999999889999999999999999999999997532111 0111111110000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+.+++.+||..+|++|||+.|++++
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 ------LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011223456778889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=303.06 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=187.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHc--CCCceeceEEEEEeC-----CeeEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSK-----DEKLL 448 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~-----~~~~l 448 (672)
.+.||+|+||+||+|+.. +++.||+|.++.... ....+.+|++++..+. +||||+++++++... ...++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 367999999999999976 577899998875422 1235667887777664 699999999988642 35789
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 449 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
||||+.+ +|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 v~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 85 VFEHVDQ-DLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEccccc-CHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 9999985 8888886432 234899999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHHHHhhhhcccccc--
Q 005875 529 MNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-DLPRWVQSVVREEWTAEV-- 602 (672)
Q Consensus 529 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~-- 602 (672)
..... ...++..|+|||++.+..++.++||||+||++|||++|++||......+.. .+...........+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 54322 234678899999999889999999999999999999999999754322110 000000000001111000
Q ss_pred ----chhhhh-c-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 603 ----FDVELM-R-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 603 ----~d~~~~-~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+.+... . .....+....+.+++.+|++.||++|||+.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 0 00001123456788889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=314.36 Aligned_cols=251 Identities=17% Similarity=0.246 Sum_probs=189.4
Q ss_pred hccccccCcEEEEEEEECC---CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||++...+ +..|++|.+... ....+|++++..+ +||||+++++++......++|||++. +
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 170 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTI-SHRAIINLIHAYRWKSTVCMVMPKYK-C 170 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhc-CCCCccceeeeEeeCCEEEEEehhcC-C
Confidence 4689999999999998543 467888887542 3467899999999 99999999999999999999999996 5
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 171 ~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 171 DLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 88888842 234899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc---c-c--cch
Q 005875 534 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT---A-E--VFD 604 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~-~--~~d 604 (672)
...+++.|+|||++.+..++.++|||||||++|||++|+.||.+............+......... . . .+.
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 235788999999999999999999999999999999999999875443211111111111100000 0 0 000
Q ss_pred hhh-------hcccChH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 VEL-------MRFQNIE------EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~~~-------~~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+ ....... .....+.+++.+|++.||++|||+.|++.+
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000000 112346678889999999999999999985
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=299.32 Aligned_cols=244 Identities=26% Similarity=0.508 Sum_probs=194.2
Q ss_pred hccccccCcEEEEEEEEC----CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||.||+|... ++..+|+|.++.... ..+.+..|+.++.++ +||||+++++++..++..++||||+
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYM 87 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEcC
Confidence 468999999999999864 233689998865432 235688899999998 8999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++++|.+++.... ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.++++|||++.......
T Consensus 88 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 88 ENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999997432 34899999999999999999999998 9999999999999999999999999987654322
Q ss_pred C-------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 534 T-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 534 ~-------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
. ..++..|+|||++.+..++.++|+||||+++||+++ |..||......+ .. ..+ .+....
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~---~~~-~~~~~~----- 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI---KAI-EEGYRL----- 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH---HHH-hCCCcC-----
Confidence 1 112356999999998889999999999999999886 999997543221 11 111 111100
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
.........+.+++.+|++.+|++||++.++++.|+++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00112234567888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.79 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=197.4
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 379 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
..+.||+|+||+||++... +++.+|+|++..... ..+.+.+|++++..+ +||||+++++++......++||||+++
T Consensus 9 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (284)
T cd06620 9 TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMCMEFMDC 87 (284)
T ss_pred HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEEEecCCC
Confidence 3578999999999999965 477889998764422 246788999999998 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
++|.+++... ..+++..+..++.+++.|+.|||+ .+ ++||||||+||++++++.++|+|||++......
T Consensus 88 ~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 88 GSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred CCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 9999998642 248999999999999999999997 45 999999999999999999999999998654322
Q ss_pred CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC-----CChhHHHHHhhhhccccccchhhh
Q 005875 533 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-----VDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
....++..|+|||++.+..++.++|||||||++||+++|+.||......+. ..+..+......+...
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 231 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP-------- 231 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC--------
Confidence 233578889999999888899999999999999999999999986543211 1112222222211100
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
.. ...+....+.+++.+|++.||++|||++|++++..-
T Consensus 232 -~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 232 -RL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred -CC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 00 001233457788889999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=299.09 Aligned_cols=245 Identities=27% Similarity=0.488 Sum_probs=192.3
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhh---HHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~---~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+++... ++.+|+|++......... ..+|+.++.++ +|+||+++++++.+....++||||+++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-ccccccccccccccccccccccccccc
Confidence 4689999999999999775 457999999876543332 34588999999 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC----CC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NV 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~----~~ 531 (672)
++|.+++.. ...+++..+..++.|++.||++||+.+ ++|+||||+||++++++.++|+|||.+... ..
T Consensus 83 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 83 GSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred ccccccccc-----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999972 234899999999999999999999998 999999999999999999999999998643 11
Q ss_pred CCCCCCCCcccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 PATPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.....++..|+|||++. +..++.++||||+|+++|+|++|..||......+. ........... . ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~----~-~~~~--- 223 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILKRP----L-PSSS--- 223 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHHTH----H-HHHT---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhccccc----c-cccc---
Confidence 22345678899999998 88899999999999999999999999986511111 00111110000 0 0000
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.........+.+++.+||+.||++||++.|++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112677888889999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=314.49 Aligned_cols=255 Identities=20% Similarity=0.300 Sum_probs=189.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC-----eeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lV~ 450 (672)
.+.||+|+||+||++... +++.||+|++..... ..+.+.+|++++..+ +|+||+++++++...+ ..++||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceEEEEe
Confidence 467999999999999964 688999999865422 235678899999998 9999999999998776 789999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 84 ELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred eccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9997 578887753 234899999999999999999999998 9999999999999999999999999987543
Q ss_pred CCC-----CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhH---------HHHHhh-
Q 005875 531 VPA-----TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR---------WVQSVV- 594 (672)
Q Consensus 531 ~~~-----~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~---------~~~~~~- 594 (672)
... ...+++.|+|||++.+. .++.++|||||||++|||++|+.||.+....+...... ......
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 221 23457789999998774 47899999999999999999999998654322111000 000000
Q ss_pred --hhccccccch-hhhh-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 595 --REEWTAEVFD-VELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 595 --~~~~~~~~~d-~~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......... +... ...........+.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 0000 000001123456788889999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.34 Aligned_cols=236 Identities=20% Similarity=0.287 Sum_probs=181.8
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeccccc-C---hhhHHHHHHHHHHHc--CCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 383 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-G---KRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 383 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~---~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
||+|+||+||+|+.. +++.||+|++..... . ......|..++.... +||||+++++++.+++..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 478899999865322 1 123344556666554 799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 9999988642 24899999999999999999999998 99999999999999999999999999865322
Q ss_pred CCCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 PATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.....|++.|+|||++.+. .++.++|||||||++|||++|+.||......+ ....+...... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~-------~~~- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNIAFGKVR-------FPK- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHHHcCCCC-------CCC-
Confidence 1234578899999998764 47899999999999999999999997543221 11111111100 000
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRP----NMDEVVR 643 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~evl~ 643 (672)
. .....+.+++.+||+.||++|| +++|+++
T Consensus 219 ~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 1123456777899999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.14 Aligned_cols=243 Identities=24% Similarity=0.356 Sum_probs=201.6
Q ss_pred HHhccccccCcEEEEEEEECC--C--cEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 378 ASAEVLGKGSYGTAYKAVLEE--S--TTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 378 ~~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
...++||+|.||.|++|.|.. | ..||||.++..... -.+|.+|+.+|.++ +|+|++++||+..+ ...++|||
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc-chhhHHhh
Confidence 346889999999999999763 3 35899999876543 57899999999999 99999999999877 77889999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
+++.|+|.+.|++. ....+.....-.++.|||.||+||..++ +|||||.++|+|+.....+||+|||+.+.+..
T Consensus 191 LaplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hcccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999862 2345778888899999999999999998 99999999999999999999999999988765
Q ss_pred CCCCC-------CCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 532 PATPS-------RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 532 ~~~~~-------~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
..... -...|.|||.+....++.++|||+|||++|||+| |..||.+-...+++ ..+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----------------~~i 328 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----------------KNI 328 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------Hhc
Confidence 54332 2345999999999999999999999999999999 78888765432221 112
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
| .-.+....+.+.+.+++++..||..+|++|||+..+.+.+
T Consensus 329 D-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 D-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred c-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2 1223444567788899999999999999999999998543
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=303.62 Aligned_cols=247 Identities=23% Similarity=0.413 Sum_probs=194.4
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||++... ++..||+|.+..... ...++.+|+.++..+ +||||+++++++.+++..++|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCccEEEEe
Confidence 367999999999999864 357899998875432 245688899999998 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC
Q 005875 452 YFASGSLSTLLHGNRG-----------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 514 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~ 514 (672)
|+++|+|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~ 165 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGE 165 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecC
Confidence 9999999999974321 11234788999999999999999999998 999999999999999
Q ss_pred CCCeEEeecCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChh
Q 005875 515 DLDGCISDFGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLP 587 (672)
Q Consensus 515 ~~~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~ 587 (672)
++.++|+|||++...... .....+..|+|||++.+..++.++|||||||++|||++ |..||.+....+
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~----- 240 (288)
T cd05050 166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE----- 240 (288)
T ss_pred CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 999999999998654322 11223556999999998899999999999999999998 888886543221
Q ss_pred HHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 588 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 588 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
....+...... . ........+.+++.+||+.+|++|||+.|+++.|++
T Consensus 241 -~~~~~~~~~~~-~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -VIYYVRDGNVL-S----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HHHHHhcCCCC-C----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111111100 0 001223467788889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.30 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=190.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEE-----eCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY-----SKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~-----~~~~~~lV~e~~ 453 (672)
.+.||+|+||.||++... +++.+++|++.........+..|+.++.++.+|+||+++++++. .++..++||||+
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 102 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC 102 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence 367999999999999865 46789999876544445678889999999877999999999884 345689999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 532 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~- 532 (672)
++++|.++++.... ....+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 103 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 103 NGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred CCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 99999998864321 1235889999999999999999999988 999999999999999999999999998765332
Q ss_pred ---CCCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 533 ---ATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
....+++.|+|||++.. ..++.++|||||||++|||++|+.||........ ..... ........+
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------~~~~~-~~~~~~~~~ 251 (286)
T cd06638 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------LFKIP-RNPPPTLHQ 251 (286)
T ss_pred CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------Hhhcc-ccCCCcccC
Confidence 22347788999999853 4478899999999999999999999975432111 00000 000000000
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
.......+.+++.+||+.+|++|||+.|++++.
T Consensus 252 --------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 252 --------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 011223577888899999999999999999763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.75 Aligned_cols=183 Identities=25% Similarity=0.354 Sum_probs=156.2
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||.||+|+... ++.||+|.... .....|+.++.++ +|+||+++++++......++||||+. |+|
T Consensus 71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 143 (357)
T PHA03209 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----GTTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMVLPHYS-SDL 143 (357)
T ss_pred EEEecCCCCeEEEEEEECCCCceEEEEeCCc-----cccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence 4689999999999999764 56788886433 2345688899998 99999999999999999999999995 588
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---CCC
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---ATP 535 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---~~~ 535 (672)
.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 144 ~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 144 YTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCcccccc
Confidence 8888642 234899999999999999999999998 999999999999999999999999998754322 234
Q ss_pred CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 005875 536 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576 (672)
Q Consensus 536 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~ 576 (672)
.+++.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 57889999999999999999999999999999998655543
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.04 Aligned_cols=254 Identities=20% Similarity=0.303 Sum_probs=192.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||++... ++..+++|.++.... ....+.+|++++.++ +||||+++++++.+++..++||||++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 467999999999999965 466788887764322 234578899999999 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--C
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--A 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--~ 533 (672)
+|.++++.. ..+++..+..++.|++.||.|||+. + ++||||||+||++++++.+||+|||++...... .
T Consensus 85 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 85 SLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence 999999743 3488999999999999999999984 5 999999999999999999999999998765332 2
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccc-------------
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA------------- 600 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------- 600 (672)
...++..|+|||++.+..++.++||||||+++|||++|+.||......+... +...........
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA---MFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH---hhcCccccccccCCcccccCCCCCc
Confidence 3456788999999988889999999999999999999999997543222110 000000000000
Q ss_pred -------ccchhhhh---cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 601 -------EVFDVELM---RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 601 -------~~~d~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
+..+.... ...........+.+++.+||+.+|++|||++|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000 0000001223577888899999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.36 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=186.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC------eeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 449 (672)
.+.||+|+||.||++... .+..||+|++..... ....+.+|+.++..+ +||||+++++++...+ ..++|
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccccceeEEE
Confidence 468999999999999964 478899999875422 235677899999888 9999999999986543 46899
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||+++ +|.+.++. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 105 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 105 MELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred EeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 999976 56666541 2788899999999999999999998 999999999999999999999999998764
Q ss_pred CCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC------------ChhHHH----
Q 005875 530 NVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV------------DLPRWV---- 590 (672)
Q Consensus 530 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~------------~~~~~~---- 590 (672)
... ....+++.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.. ......
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 332 2235688899999999999999999999999999999999999865321100 000000
Q ss_pred HHhhhhccccc--cchhhhhcc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 591 QSVVREEWTAE--VFDVELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 591 ~~~~~~~~~~~--~~d~~~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........... .+....... .........+.+++.+||+.||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 000000000 0000112456788889999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=295.90 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=182.9
Q ss_pred cccccCcEEEEEEEECCCc---EEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 382 VLGKGSYGTAYKAVLEEST---TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~~~---~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.||+|+||+||+|+..++. .+++|.+..... ..+.+.+|+.++..+ +||||+++++.+.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999854433 455666554322 345788888888888 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----- 531 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----- 531 (672)
+|.++++..... ....++.....++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999754321 234677788899999999999999988 99999999999999999999999999764321
Q ss_pred -CCCCCCCCcccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 532 -PATPSRSAGYRAPEVIET-------RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... ........+. ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-~~~~ 229 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIKDQ-QVKL 229 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhhc-cccc
Confidence 123346778999999853 235788999999999999997 56787643221 1222222211 1112
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.++... .. ....+.+++..|| .+|++||+++|+++.|.
T Consensus 230 ~~~~~~--~~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLE--LP---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccC--CC---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222211 11 1234566777899 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=313.94 Aligned_cols=251 Identities=21% Similarity=0.274 Sum_probs=187.1
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||.||++.... ++.||||... ...+.+|+++++++ +|+|||++++++..++..++|||++. ++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 4679999999999999764 6789998532 23467899999999 99999999999999999999999995 688
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC------
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP------ 532 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~------ 532 (672)
.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 247 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 247 YTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 88886432 24899999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC-CChhHHHHHhhhhcc------cccc---
Q 005875 533 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-VDLPRWVQSVVREEW------TAEV--- 602 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~------~~~~--- 602 (672)
....||..|+|||++.+..++.++|||||||++|||++|..|+........ ......+..++.... ....
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 123478899999999999999999999999999999998876543322111 111111111111100 0000
Q ss_pred chhhh------------h--cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 603 FDVEL------------M--RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 603 ~d~~~------------~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..... . ...........+.+|+.+||+.||.+|||+.|++++
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0 000000111256778889999999999999999975
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=297.31 Aligned_cols=243 Identities=21% Similarity=0.322 Sum_probs=189.5
Q ss_pred HhccccccCcEEEEEEEECC-CcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 379 SAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
..+.||+|+||.||+|.... +..+++|.+..... ..+.+.+|++++..+ +|+||+++++++..++..++||||+++|
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 45779999999999999765 56778888754332 245678899999998 8999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 88 ~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 88 AVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 999888642 234899999999999999999999998 999999999999999999999999998654322
Q ss_pred CCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 533 ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
....++..|+|||++. ...++.++|||||||++|||++|+.||......+ ............ .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~~~-~----- 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSEPPT-L----- 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhcCCCC-C-----
Confidence 2334678899999984 3457789999999999999999999997543211 111111111000 0
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... ......+.+++.+||+.+|++||++++++++
T Consensus 229 ~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 AQP---SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 1122456778889999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=314.16 Aligned_cols=237 Identities=24% Similarity=0.381 Sum_probs=188.2
Q ss_pred hccccccCcEEEEEEEECC-CcEEE---EEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCe--eEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVV---VKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE--KLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~va---vK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~--~~lV~e 451 (672)
..+||+|+|-+||+|.+.. |.+|| ||.-+-.... -++|..|+++++.| +|+||++++.+|.+... .-+|+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeeeee
Confidence 3579999999999999753 55665 3322222222 36799999999999 99999999999988765 668999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-CCCeEEeecCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMN 530 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~ 530 (672)
.+..|+|..|+++.+ ..+......|+.||++||.|||++. |||+|||||.+||+|+. .|.|||+|+|+|+...
T Consensus 124 L~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999998654 3788899999999999999999985 89999999999999986 4899999999998877
Q ss_pred CCCC--CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc---ccccchh
Q 005875 531 VPAT--PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW---TAEVFDV 605 (672)
Q Consensus 531 ~~~~--~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~ 605 (672)
.... -.|||.|||||+.. ..|++.+||||||+.|.||+|+..||..= ..-....+++..... ...+-|
T Consensus 198 ~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~SGiKP~sl~kV~d- 270 (632)
T KOG0584|consen 198 KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVTSGIKPAALSKVKD- 270 (632)
T ss_pred ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHHcCCCHHHhhccCC-
Confidence 6543 35999999999997 78999999999999999999999999732 122222222222211 111112
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
..+.++|.+|+.. .++|||+.|+++
T Consensus 271 ------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 ------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 2355677799999 999999999997
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=313.35 Aligned_cols=191 Identities=25% Similarity=0.388 Sum_probs=166.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||++... +++.||+|++..... ....+.+|++++..+ +|+||+++++.+.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 367999999999999975 478899999875321 234577788889888 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 85 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 85 GGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999642 34889999999999999999999998 999999999999999999999999998643211
Q ss_pred -------------------------------------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCC
Q 005875 533 -------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575 (672)
Q Consensus 533 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf 575 (672)
....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 1235788999999999999999999999999999999999999
Q ss_pred CCCC
Q 005875 576 QSPT 579 (672)
Q Consensus 576 ~~~~ 579 (672)
....
T Consensus 237 ~~~~ 240 (360)
T cd05627 237 CSET 240 (360)
T ss_pred CCCC
Confidence 7654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.44 Aligned_cols=239 Identities=24% Similarity=0.364 Sum_probs=192.2
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||.||++.. .+++.||+|.+..... ..+.+.+|+.++..+ +|+||+++++++..++..++||||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 46799999999999996 4688999999875433 345677888888887 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC----
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 533 (672)
|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 103 L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 103 LTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred HHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 9999863 23788999999999999999999998 9999999999999999999999999987553322
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+++.|+|||.+.+..++.++|||||||++|+|++|+.||........... ..... .. .....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~-~~--------~~~~~ 238 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-TP--------ELQNP 238 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC-CC--------CCCCc
Confidence 23467789999999988899999999999999999999999976443221100 00000 00 00011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
......+.+++.+||+.+|++||+++++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122344667888999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=298.61 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=194.7
Q ss_pred hccccccCcEEEEEEEECCC----cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||.||+|...+. ..|++|....... ..+.+.+|+.++..+ +|+||+++++++.+ +..++||||+
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC-CCcEEEEEcC
Confidence 56899999999999986532 4688898765432 245788899999998 89999999999865 5678999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++|+|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 89 PLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999997432 24899999999999999999999988 9999999999999999999999999987654322
Q ss_pred C-----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 534 T-----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 534 ~-----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
. ..++..|+|||.+....++.++||||||+++||+++ |..||......+. ...+...... .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~-~------ 228 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGRIENGERL-P------ 228 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHcCCcC-C------
Confidence 1 123457999999988889999999999999999986 9999975542211 1111111000 0
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
........+.+++.+|+..+|++|||+.|+++.|+++....
T Consensus 229 ----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 229 ----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 01122346777888999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=284.86 Aligned_cols=262 Identities=21% Similarity=0.351 Sum_probs=203.7
Q ss_pred CHHHHHHHHhccccccCcEEEEEEE-ECCCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEE
Q 005875 371 DLEDLLRASAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 448 (672)
Q Consensus 371 ~~~~l~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 448 (672)
.++++.+-+.+.||+|+|+.|--+. +..+.++|||++.+.. ....+..+|++++.....|+||++++++|++++..|+
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 4788888899999999999999887 6678999999997653 2456788999999999899999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC---CeEEeecCC
Q 005875 449 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGL 525 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGl 525 (672)
|||-|.||.|..+|++. ..+++.++.++..+|+.||.|||.+| |.|||+||+|||-.... .+||+||.+
T Consensus 154 VfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999853 34999999999999999999999999 99999999999997654 479999998
Q ss_pred CCCCCC-----------CCCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC----CC
Q 005875 526 TPLMNV-----------PATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM----VD 585 (672)
Q Consensus 526 a~~~~~-----------~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~----~~ 585 (672)
...... -.+++|+..|||||+.. ...|+.++|.||+|||+|-|+.|.+||.+....+- -.
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 744321 12345677799999873 34588999999999999999999999987643321 12
Q ss_pred hhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 586 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
..+..++.+-+......+...-..+..++.+.+. ++...+..|+..|.++.+++.
T Consensus 306 ~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakd---lisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKD---LISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHH---HHHHHHhccHHhhhhhhhccC
Confidence 2333333332322222222111223334444444 445777899999999999987
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=311.82 Aligned_cols=242 Identities=21% Similarity=0.302 Sum_probs=186.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+++.. +++.+|+|++..... ....+.+|+.++..+ +||||+++++++.+++..++||||++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMP 126 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 468999999999999976 467889999864321 234466788888877 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 127 gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 127 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 99999998632 3788889999999999999999998 999999999999999999999999998765432
Q ss_pred ---CCCCCCCcccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 ---ATPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
....||+.|+|||++.... ++.++|||||||++|||++|+.||...... .....+.........
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~--- 268 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLTF--- 268 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCcccC---
Confidence 2345889999999997543 788999999999999999999999854321 111222111110000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRMI 645 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L 645 (672)
.... .....+.+++.+|+...+.+ |++++|++++.
T Consensus 269 --~~~~---~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 --PDDN---DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred --CCcC---CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0111 12334556667899844433 78999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=303.65 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=190.1
Q ss_pred hcccccc--CcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKG--SYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.++||+| +||+||++... +++.||+|++...... .+.+.+|+++++.+ +||||+++++++..++..++||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEecc
Confidence 3579999 78999999864 5788999998754322 23566788888888 9999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC--
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-- 531 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-- 531 (672)
++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+.....
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999996432 224899999999999999999999998 99999999999999999999999986433211
Q ss_pred ---------CCCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh-----
Q 005875 532 ---------PATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----- 595 (672)
Q Consensus 532 ---------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----- 595 (672)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~ 233 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCccccccc
Confidence 111234567999999976 45889999999999999999999999754321110 000000000
Q ss_pred -----hcc----ccccchhhhh----------------cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHh
Q 005875 596 -----EEW----TAEVFDVELM----------------RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEV 648 (672)
Q Consensus 596 -----~~~----~~~~~d~~~~----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i 648 (672)
+.. .....+.... ...........+.+++.+||+.||++|||++|+++ .++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 000 0000000000 00001122346778899999999999999999998 35554
Q ss_pred h
Q 005875 649 R 649 (672)
Q Consensus 649 ~ 649 (672)
.
T Consensus 314 ~ 314 (327)
T cd08227 314 K 314 (327)
T ss_pred c
Confidence 4
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=297.89 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=190.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeC-----CeeEEEEEecC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVYDYFA 454 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~e~~~ 454 (672)
+.||+|+||.||++... +++.+|+|.+.........+.+|+.++.++.+|||++++++++... +..++||||++
T Consensus 28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~ 107 (291)
T cd06639 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCN 107 (291)
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECC
Confidence 57999999999999974 5778999998765444567788999999887899999999998754 35799999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.++++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 108 ~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 183 (291)
T cd06639 108 GGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183 (291)
T ss_pred CCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc
Confidence 9999998864321 1234899999999999999999999998 999999999999999999999999998764322
Q ss_pred --CCCCCCCcccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 --ATPSRSAGYRAPEVIETR-----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
....++..|+|||++... .++.++|||||||++|||++|+.||......+. ...... ......
T Consensus 184 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~------~~~~~~-~~~~~~--- 253 (291)
T cd06639 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT------LFKIPR-NPPPTL--- 253 (291)
T ss_pred cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH------HHHHhc-CCCCCC---
Confidence 233467789999998643 267899999999999999999999975432110 111100 000011
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+.....+.+++.+||+.+|++||++.|++++
T Consensus 254 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 -----LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1112233457788899999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=299.86 Aligned_cols=239 Identities=23% Similarity=0.357 Sum_probs=192.3
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||.|+||.||+|.. .+++.|++|.+..... ..+.+.+|++++..+ +|+||+++++++...+..++|+||+++++
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 35799999999999985 4678999998865433 345678899999988 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC----
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 533 (672)
|.+++.. ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 103 L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 103 LTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred HHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 9999863 23899999999999999999999998 9999999999999999999999999887543321
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...++..|+|||.+.+..++.++|||||||++|||++|+.||......+. ..... ...... ....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~-~~~~~~--------~~~~ 238 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIA-TNGTPE--------LQNP 238 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hcCCcc--------cCCc
Confidence 23467789999999988899999999999999999999999976432110 11110 000000 0011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
......+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 122345667888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.72 Aligned_cols=238 Identities=26% Similarity=0.373 Sum_probs=190.3
Q ss_pred ccccccCcEEEEEEEECCC-cEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
-+||+|.||+||.|+..++ ..+|||-+..... ..+....|+...+.+ +|.|||+++|.+.+++..-|.||-++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 3799999999999997654 4689998876533 345577888888888 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec-CCCCeEEeecCCCCCCC----C
Q 005875 459 STLLHGNRGAGRTPL--DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMN----V 531 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla~~~~----~ 531 (672)
.++++.. ..++ .+...-.+..||++||.|||+.. |||||||-+|||++ -.|.+||+|||-++... -
T Consensus 660 SsLLrsk----WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 660 SSLLRSK----WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred HHHHHhc----cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 9999742 3345 67778889999999999999997 99999999999996 57999999999776543 3
Q ss_pred CCCCCCCCcccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh-
Q 005875 532 PATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM- 608 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~- 608 (672)
..+..||..|||||++..+ .|+.++|||||||++.||.||++||.......- .++...+.
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-----------------AMFkVGmyK 795 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-----------------AMFKVGMYK 795 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-----------------hhhhhccee
Confidence 4566789999999999764 488999999999999999999999975543211 11111110
Q ss_pred -cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 609 -RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 609 -~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
...-+++...+...++.+|+.+||..||++.++++
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11122344455666778999999999999999987
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.52 Aligned_cols=242 Identities=22% Similarity=0.377 Sum_probs=189.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe------CCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS------KDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|... +++.+|+|.+........++..|+.++.++.+|+||+++++++.. .+..+++|||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 468999999999999974 467899998865544456788899999998789999999999853 4577999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV- 531 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~- 531 (672)
+++|+|.+++.... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 101 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~ 174 (282)
T cd06636 101 CGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174 (282)
T ss_pred CCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence 99999999997543 234788889999999999999999998 99999999999999999999999999875432
Q ss_pred ---CCCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 532 ---PATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 532 ---~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
.....++..|+|||.+. ...++.++|||||||++|||++|+.||......+... . ........
T Consensus 175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------~-~~~~~~~~-- 245 (282)
T cd06636 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------L-IPRNPPPK-- 245 (282)
T ss_pred ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------h-HhhCCCCC--
Confidence 22344678899999985 3457889999999999999999999996543211110 0 00000000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
. ........+.+++.+||+.+|++||++.|+++
T Consensus 246 ---~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 246 ---L----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---C----cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00122346778888999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=290.88 Aligned_cols=241 Identities=22% Similarity=0.366 Sum_probs=193.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||++... +++.+++|.++... ...+.+.+|+.++..+ +|+||+++++++..++..++||||+++|
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 468999999999999965 57889999886432 2345678899999888 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.+++.... ...+++.....++.|++.||.|||+.+ |+|+||||+||++++++.++++|||.+.......
T Consensus 84 ~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 84 DLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 9999886433 234789999999999999999999998 9999999999999999999999999987654322
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...+++.|+|||++.+..++.++|+||||+++|+|++|+.||...... .......... ....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~---------- 220 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKVCQGS-YKPL---------- 220 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHHhcCC-CCCC----------
Confidence 234677899999999988999999999999999999999999753211 1111111111 0000
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.+|++||++.|++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01122356778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=295.09 Aligned_cols=244 Identities=19% Similarity=0.302 Sum_probs=189.8
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 379 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
..+.||+|+||.||+|+.. +++.||+|.++.... ....+.+|+.++..+ +||||+++++++..++..++||||++++
T Consensus 13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 91 (267)
T cd06645 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWICMEFCGGG 91 (267)
T ss_pred HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence 3567999999999999965 577899998865432 234577888888888 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++... ..+++.++..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 92 ~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 92 SLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 999998642 24899999999999999999999998 999999999999999999999999998654322
Q ss_pred CCCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 533 ATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
....++..|+|||++. ...++.++|||||||++|||++|+.||......... .............. .
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~~~~~~~~~~----~ 233 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTKSNFQPPKLK----D 233 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------HhhhccCCCCCccc----c
Confidence 2335788899999974 455888999999999999999999998654321110 00000110000000 0
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. .....+.+++.+|++.+|++||++++++++
T Consensus 234 ~~---~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 KM---KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cC---CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 112346678889999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.63 Aligned_cols=252 Identities=19% Similarity=0.344 Sum_probs=188.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||+|+.. +++.||+|.++.... ....+.+|+.++..+ +|+||+++++++..++..++||||++ +
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 367999999999999875 467899998864432 234677899999999 99999999999999999999999997 5
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 89 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 89 DLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 8988886432 24889999999999999999999998 9999999999999999999999999987543222
Q ss_pred -CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh----hhcccccc-----
Q 005875 534 -TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV----REEWTAEV----- 602 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~----- 602 (672)
...+++.|+|||++.+. .++.++|||||||++|||++|+.||...+..+.. ....... ...|....
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChhhchhhhccccc
Confidence 23457789999998654 4788999999999999999999999865432111 0000000 00000000
Q ss_pred chhhhhccc------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 603 FDVELMRFQ------NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 603 ~d~~~~~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
......... ........+.+++.+|++.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 00011234667888999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=293.57 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=191.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|++++..+ +|+||+++++++..+...++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLVFEYCDH 84 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence 357999999999999976 478899998865432 235678899999998 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
+.|..++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 85 TVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred cHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 9888877532 24899999999999999999999988 9999999999999999999999999987664432
Q ss_pred --CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC-hhHHHHHhhh--------hccccc
Q 005875 534 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-LPRWVQSVVR--------EEWTAE 601 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~--------~~~~~~ 601 (672)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+... +......... ..+...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 2335678999999876 557889999999999999999999998654322110 0000000000 000000
Q ss_pred cchhhhhcccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 602 VFDVELMRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 602 ~~d~~~~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+........ ......+.+++.+||+.+|++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000000 1123457788889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=294.12 Aligned_cols=240 Identities=24% Similarity=0.352 Sum_probs=190.6
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC-------hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|...+++.+|+|.++..... ...+.+|++++.++ +|+||+++++++.+.+..++||||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEEEEEec
Confidence 4679999999999999888899999988643221 24577899999999 899999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV- 531 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~- 531 (672)
+++++|.+++... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 84 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 84 VPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999642 24789999999999999999999998 99999999999999999999999998865421
Q ss_pred ---------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 532 ---------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 532 ---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
.....++..|+|||++.+..++.++||||||+++|||++|+.||........ ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~--- 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA------MFYIGAHRGL--- 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH------HHHhhhccCC---
Confidence 1123467789999999998899999999999999999999999975321110 0000000000
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.+.. .......+.+++.+||+.+|++||++.|+++
T Consensus 227 -~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 -MPRL-----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCC-----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0112345677888999999999999999876
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=297.23 Aligned_cols=242 Identities=21% Similarity=0.328 Sum_probs=189.2
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||.||+|+... ++.+++|.+..... ..+.+.+|++++..+ +|+||+++++++..+...++||||+++++
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 4679999999999999764 78899999865432 235678899999888 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 533 (672)
|..++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++...... .
T Consensus 96 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 96 VDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 988875432 24899999999999999999999988 999999999999999999999999988654322 2
Q ss_pred CCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 534 TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
...++..|+|||++. ...++.++|||||||++|||++|..||...... ............ .
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~-~------- 234 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEPP-T------- 234 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcCCCc-c-------
Confidence 234677899999985 344678999999999999999999999753321 111111111000 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..........+.+++.+||+.+|++||+++|++++
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 -LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00111223456778889999999999999999873
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=304.06 Aligned_cols=244 Identities=18% Similarity=0.301 Sum_probs=184.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+++.. +++.||+|++.+.. ...+.+.+|..++..+ +|+||+++++++.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEEEecCC
Confidence 467999999999999965 47889999986432 1234577888888887 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999996422 24889999999999999999999998 9999999999999999999999999986543322
Q ss_pred ----CCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 534 ----TPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 534 ----~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
...+++.|+|||++.. ..++.++|||||||++|||++|+.||...... .....+......... .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~-~ 230 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQF-P 230 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccC-C
Confidence 1347889999999863 45788999999999999999999999754321 111122111110000 0
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAK--VPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~ 644 (672)
. ......+ .+.+++.+|+.. ++..||++++++++
T Consensus 231 ~---~~~~~~~---~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 P---DVTDVSE---EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C---ccCCCCH---HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0011223 344555566654 44448899999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.79 Aligned_cols=244 Identities=18% Similarity=0.293 Sum_probs=192.1
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 376 LRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 376 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
+....+.||+||.+.||++...+.+.+|+|++.....+ -..|.+|+..+.++.+|.+||++++|-..++..|+||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 34456789999999999999998899999988765443 356999999999999999999999999999999999997
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
=+ .||..+|+.... ..+...++.+..|++.++.++|++| |||.||||.|+|+- .|.+||+|||+|......
T Consensus 442 Gd-~DL~kiL~k~~~----~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 442 GD-IDLNKILKKKKS----IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred cc-ccHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 64 599999975432 2332377889999999999999999 99999999999985 578999999999877654
Q ss_pred C------CCCCCCcccCcccccCCC-----------CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh
Q 005875 533 A------TPSRSAGYRAPEVIETRK-----------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 595 (672)
Q Consensus 533 ~------~~~~~~~y~aPE~~~~~~-----------~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 595 (672)
. ...||+.||+||.+.... .++++||||+||++|+|+.|+.||..- .....+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--------~n~~aK--- 581 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--------INQIAK--- 581 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--------HHHHHH---
Confidence 3 456999999999985332 567899999999999999999999731 111111
Q ss_pred hccccccchhhhh-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 596 EEWTAEVFDVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 596 ~~~~~~~~d~~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
...+.++.-. .+.... ....++++|+.||..||.+||++.|+++
T Consensus 582 ---l~aI~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 ---LHAITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ---HHhhcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1222233211 111111 1123889999999999999999999997
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=324.90 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=209.5
Q ss_pred CCCCHHHHHHHHhccccccCcEEEEEEEEC--------CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceE
Q 005875 368 YNFDLEDLLRASAEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLR 437 (672)
Q Consensus 368 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~ 437 (672)
+.++.+.+ ...+.||+|.||.|++|... ....||||.++..... .+.+..|++++..++.|+||+.++
T Consensus 291 ~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 44555555 34569999999999999843 1456999999876543 567999999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCchhhhhccCC---C------CCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCC
Q 005875 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNR---G------AGR--TPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 506 (672)
Q Consensus 438 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---~------~~~--~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk 506 (672)
|+|..++..++|+||+..|+|.++++..+ . ... ..++..+...++.|||.||+||++.. ++||||.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA 445 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA 445 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence 99999999999999999999999998766 1 111 23889999999999999999999987 9999999
Q ss_pred CCCEEecCCCCeEEeecCCCCCCCCCCCC--C---C--CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 005875 507 ASNVLINQDLDGCISDFGLTPLMNVPATP--S---R--SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSP 578 (672)
Q Consensus 507 ~~NILl~~~~~~kl~DfGla~~~~~~~~~--~---~--~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~ 578 (672)
++|||++++..+||+|||+|+.......+ . + ...|||||.+....|+.++|||||||+|||++| |..||.+.
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999864432221 1 1 234999999999999999999999999999999 89999762
Q ss_pred CCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 579 TRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
... .. +.+.+++... ...+..+..++.++|+.||+.+|++||++.|+.+.++....
T Consensus 526 ~~~-----~~-l~~~l~~G~r----------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 526 PPT-----EE-LLEFLKEGNR----------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CcH-----HH-HHHHHhcCCC----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 211 11 1112222222 22234456678899999999999999999999999998643
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=296.73 Aligned_cols=238 Identities=24% Similarity=0.379 Sum_probs=191.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|++++.++ +|+||+++++++..++..++||||++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEEEEccCCC
Confidence 467999999999999865 467899998764432 235688899999998 8999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++++|||++.......
T Consensus 88 ~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 88 SALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 99999863 23889999999999999999999988 9999999999999999999999999987654322
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...++..|+|||++.+..++.++|||||||++|||++|+.||......+.. .. ...... +. .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~-~~~~~~-----~~-----~ 221 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------FL-IPKNSP-----PT-----L 221 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------hh-hhcCCC-----CC-----C
Confidence 223577899999999988999999999999999999999998754322111 00 000000 00 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.+|++||++.|++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11233457788889999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=302.16 Aligned_cols=244 Identities=18% Similarity=0.298 Sum_probs=185.8
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+++.++ ++.+|+|++.+... ....+.+|+.++..+ +|+||+++++++.+.+..++||||++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ey~~ 84 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLVMDYYV 84 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEEEeccC
Confidence 3679999999999999764 66789999864321 223477788888777 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 85 ~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999997432 24889999999999999999999998 999999999999999999999999998654322
Q ss_pred ---CCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 533 ---ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
....|++.|+|||++. ...++.++|||||||++|||++|+.||..... ......+........ +
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~-~- 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQ-F- 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCcccc-C-
Confidence 1235788999999986 34578899999999999999999999975432 122222221111000 0
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM 644 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 644 (672)
..........+.+++.+|++.++.+ |++++|++++
T Consensus 230 -----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 -----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0011122344556666877554444 7899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.42 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=187.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCC------eeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 449 (672)
.+.||+|+||.||++... .++.||+|++...... ...+.+|+.+++.+ +||||+++++++.... ..++|
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccccceeEEE
Confidence 468999999999999864 5788999998754322 34567888888888 9999999999986443 46899
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||+++ ++.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 101 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 101 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred hhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 999976 66666642 3788999999999999999999998 999999999999999999999999999765
Q ss_pred CCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHH-------H
Q 005875 530 NVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------LPRW-------V 590 (672)
Q Consensus 530 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~---------~~~~-------~ 590 (672)
.... ...+++.|+|||++.+..++.++|||||||++|||++|+.||.+....+... ...+ .
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 4332 2357888999999999899999999999999999999999997643211100 0000 0
Q ss_pred HHhhhhccc-cccchhhh------hc-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 591 QSVVREEWT-AEVFDVEL------MR-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 591 ~~~~~~~~~-~~~~d~~~------~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......... .....+.. .. ..........+.+++.+|++.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00000000 00 00001123456788899999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.72 Aligned_cols=244 Identities=19% Similarity=0.299 Sum_probs=186.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+++.. +++.||+|.+..... ....+.+|..++..+ +|+||+++++++.+++..|+||||++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 467999999999999975 467899999865321 223467777777777 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 85 GGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999997432 24889999999999999999999998 9999999999999999999999999987654322
Q ss_pred ----CCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 534 ----TPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 534 ----~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
...|++.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+........ +
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~-~- 229 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERFQ-F- 229 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCccc-C-
Confidence 2357889999999875 46788999999999999999999999754321 11111111110000 0
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM 644 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 644 (672)
..........+.+++.+|++.++.+ |+++++++++
T Consensus 230 -----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 -----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0111122345566777888765544 5689988875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=294.15 Aligned_cols=256 Identities=21% Similarity=0.336 Sum_probs=189.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||+|+.. ++..||+|+++.... ..+.+.+|+.++.++ +||||+++++++.+++..++||||++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 357999999999999975 578899999865432 235678899999999 89999999999999999999999997
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 83 MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 588888864331 245899999999999999999999998 9999999999999999999999999987553321
Q ss_pred --CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHh---hhhccc--ccc--c
Q 005875 534 --TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV---VREEWT--AEV--F 603 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~---~~~~~~--~~~--~ 603 (672)
...+++.|+|||++.+. .++.++|||||||++|||+||+.||.+....+. ........ ....|. ... +
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhHHH
Confidence 22357789999988654 478899999999999999999999986432110 00000000 000000 000 0
Q ss_pred hhhhhc--cc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMR--FQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~--~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...... .. ........+.+++.+||+.||++|||++|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00 000122455678889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=292.21 Aligned_cols=238 Identities=24% Similarity=0.371 Sum_probs=193.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||+|... ++..||+|.+..... ....+.+|++++..+ +|+||+++++++.++...++||||+++|
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 467999999999999975 477899998875432 245688899999988 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.+++.. ..+++.....++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 88 SALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 99999863 23788999999999999999999988 9999999999999999999999999986554322
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...++..|+|||++.+..++.++|+|||||++|||++|+.||.......... . ...... ...
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~-~~~~~~----------~~~ 221 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------L-IPKNNP----------PTL 221 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------h-hhcCCC----------CCC
Confidence 2235677999999988889999999999999999999999997543222110 0 000000 011
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.+|++||+++|++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12344567788899999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=309.21 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=186.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeC------CeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 449 (672)
.+.||+|+||+||+|... +++.||||++..... ..+.+.+|++++..+ +|+||+++++++... ...+++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccccCcEEEE
Confidence 468999999999999964 567899999875432 234577899999999 899999999987543 346899
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
+|++ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 99 ~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 99 TNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred eecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence 9988 7799888753 23899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhc---cccccch
Q 005875 530 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE---WTAEVFD 604 (672)
Q Consensus 530 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d 604 (672)
.... ...+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.. .......... ....+..
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL---KRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHhCCCCHHHHHhcch
Confidence 4432 3457888999999876 56889999999999999999999999754321110 0000000000 0000000
Q ss_pred -------hhhhcc--cCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 -------VELMRF--QNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 -------~~~~~~--~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+... ... ......+.+++.+|++.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000 0011246788899999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=296.24 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=194.8
Q ss_pred hccccccCcEEEEEEEECC-Cc----EEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|...+ +. .+++|.++.... ....+.+|+.++.++ +|+||+++++++.. ...++||||
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~ 89 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQVQLITQL 89 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-CceEEEEec
Confidence 4789999999999998643 22 588888765533 235678899999998 99999999999987 788999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 90 MPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred CCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999997543 23899999999999999999999988 999999999999999999999999999765432
Q ss_pred CCC------CCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 ATP------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ~~~------~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
... ..+..|+|||.+....++.++|+||||+++||+++ |+.||......+ ....+......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~------ 230 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IPDLLEKGERL------ 230 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhCCCCC------
Confidence 211 12456999999988889999999999999999999 999997643221 11111111000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.........+.+++.+||..+|.+||++.++++.|+++...
T Consensus 231 -----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 -----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00011224567888899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.84 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=192.1
Q ss_pred hccccccCcEEEEEEEEC-CCc----EEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-EST----TVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||.||+|.+. ++. .+|+|.+...... ..++.+|+.++..+ +||||+++++++... ..++++||
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-Cceeeehh
Confidence 467999999999999864 333 4688887654322 23677888888888 999999999998754 46799999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 90 MPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999987432 24889999999999999999999998 999999999999999999999999999765432
Q ss_pred CC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 AT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ~~------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.. ..++..|+|||++.+..++.++||||||+++|||++ |+.||.+....+ .. .........
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~----- 230 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IP----DLLEKGERL----- 230 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHCCCCC-----
Confidence 21 223567999999998899999999999999999997 999997543211 11 111111000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
.........+.+++.+||..+|++||+++|+++.|+++....
T Consensus 231 -----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 231 -----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 000112345678888999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=294.92 Aligned_cols=245 Identities=22% Similarity=0.383 Sum_probs=191.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||++... .++.||+|.++..... ...+.+|++++.++ +|+||+++++++..++..++||||++++
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMCMEYMDAG 84 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEEEeecCCC
Confidence 568999999999999976 6788999988654222 35688899999998 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--C
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--A 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--~ 533 (672)
+|.++++... ....+++..+..++.|++.|+.|||+. + |+||||||+||+++.++.++|+|||++...... .
T Consensus 85 ~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 85 SLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred CHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 9999987432 123589999999999999999999974 5 999999999999999999999999998765332 2
Q ss_pred CCCCCCcccCcccccCCC------CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 534 TPSRSAGYRAPEVIETRK------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
...+++.|+|||++.+.. ++.++|||||||++|||++|+.||....... ........... ....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~-~~~~------ 229 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIVDG-DPPT------ 229 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHhhc-CCCC------
Confidence 334677899999986543 4789999999999999999999997532211 11111111110 0000
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+.+++.+||+.+|++||++++++.+
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 ----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ----CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111234456778889999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.23 Aligned_cols=247 Identities=20% Similarity=0.346 Sum_probs=192.3
Q ss_pred hccccccCcEEEEEEEECC--CcEEEEEEeccccc-----------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCee
Q 005875 380 AEVLGKGSYGTAYKAVLEE--STTVVVKRLKEVVV-----------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK 446 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~-----------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~ 446 (672)
.+.||+|+||.||+|.... ++.+|+|.+..... ...++.+|+.++.+..+|+||+++++++..++..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 4679999999999999765 67899998753211 1234566777777655899999999999999999
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEEecCCCCeEEeecCC
Q 005875 447 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGL 525 (672)
Q Consensus 447 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 525 (672)
++||||+++++|.+++..... ....+++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||.
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999998854221 13348999999999999999999996 55 99999999999999999999999999
Q ss_pred CCCCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 526 TPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 526 a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
+....... ...++..|+|||.+.+..++.++||||||+++|||++|+.||..... ............. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~~~~~~-~~ 233 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIVEAVYE-PL 233 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHhhccCC-cC
Confidence 87654332 33467789999999988899999999999999999999999964321 1111111111110 00
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
........+.+++.+||+.||++||++.|+..+++
T Consensus 234 ---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 234 ---------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00112345778888999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=292.29 Aligned_cols=238 Identities=23% Similarity=0.375 Sum_probs=190.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC----------hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 448 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 448 (672)
.+.||+|+||.||+|... +++.+++|.+...... .+.+.+|++++..+ +||||+++++++.+.+..++
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCccEE
Confidence 467999999999999864 5788999988654321 13577888999999 99999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 449 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.++.
T Consensus 84 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 84 FLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999643 34888999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCC----------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 529 MNVPA----------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 529 ~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
..... ...++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~- 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKIG-EN- 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHHh-cc-
Confidence 54211 1235678999999998889999999999999999999999997542111 011100 00
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
..+. ........+.+++.+||+.+|++||++.|+++
T Consensus 228 ----~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ----ASPE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----CCCc-----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000 01122345677888999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=296.83 Aligned_cols=238 Identities=23% Similarity=0.342 Sum_probs=190.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
++||+|+||.||-++.. .|+.+|.|++.+... ++.-...|-.++.++ +.+.||.+-..|+..+..++|+..|+|
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEEEEeecC
Confidence 58999999999999965 478899998866543 344567788899999 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
|||.-+|.+.. ...+++..++.++.+|+.||++||..+ ||+|||||+|||+|+.|+++|+|+|+|..+....
T Consensus 270 GDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 270 GDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred CceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999987554 345999999999999999999999998 9999999999999999999999999998776543
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...||.||||||++..+.|+...|+||+||++|||+.|+.||....+... .++....+......-...
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----------~eEvdrr~~~~~~ey~~k 412 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----------REEVDRRTLEDPEEYSDK 412 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----------HHHHHHHHhcchhhcccc
Confidence 34689999999999999999999999999999999999999975332211 001111111111111233
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMD 639 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 639 (672)
++++.+.+.+ ..+++||++|.-..
T Consensus 413 FS~eakslc~---~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 413 FSEEAKSLCE---GLLTKDPEKRLGCR 436 (591)
T ss_pred cCHHHHHHHH---HHHccCHHHhccCC
Confidence 4555666555 77889999996544
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=294.77 Aligned_cols=237 Identities=20% Similarity=0.322 Sum_probs=198.5
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
+.||+|.|+.|-+|++- .|..||||++.+... ......+|++-|+.+ +|||||++|++.......|+|+|+=++|
T Consensus 24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKlyLiLELGD~G 102 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKLYLILELGDGG 102 (864)
T ss_pred hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcccceEEEEEEecCCc
Confidence 56999999999999843 688999999987654 345678899998888 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec-CCCCeEEeecCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla~~~~~~--- 532 (672)
+|++||.+... .+.++-+.+++.||+.|+.|+|+.. +|||||||+||.+- .-|-+|++|||++-.+...
T Consensus 103 Dl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 103 DLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred hHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence 99999976542 3899999999999999999999998 99999999998775 5689999999998766544
Q ss_pred CCCCCCCcccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 ATPSRSAGYRAPEVIETRKHS-HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
.+.+|+..|-|||++.+..|+ +++||||+||+||-++.|++||+..+..+.+.+ +.|-.. .
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImDCKY---t 237 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMDCKY---T 237 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhcccc---c
Confidence 356788899999999999986 568999999999999999999998776654332 222211 1
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
-+.....+..+||.+|+..||.+|-+.+||..
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 22344556667778999999999999999987
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=289.29 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=193.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+++++++ +||||+++++++.+.+..+++|||+++++
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 367999999999999975 467899998875432 346788899999998 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 533 (672)
|.+++.... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++...... .
T Consensus 87 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 87 LQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 999987532 34889999999999999999999998 999999999999999999999999998765432 2
Q ss_pred CCCCCCcccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 534 TPSRSAGYRAPEVIETR---KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
...++..|+|||.+... .++.++||||||+++|||++|+.||......+. ............ ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~~~~~~~~~~-------~~ 226 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFLISKSNFPPP-------KL 226 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCCCc-------cc
Confidence 23467789999999776 788999999999999999999999975432111 000001100000 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.........+.+++.+||+.+|.+|||+.+++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1112234567788899999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=292.23 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=187.1
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
..||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++..+ +|+||+++++++..++..++|+||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 47999999999999965 467799998865432 345788999999998 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-CCCeEEeecCCCCCCCCC---
Q 005875 459 STLLHGNRGAGRTPL--DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~~~--- 532 (672)
.+++.... ..+ ++..+..++.||+.|++|||+.+ |+||||||+||+++. ++.++|+|||++......
T Consensus 93 ~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 93 SALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred HHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 99997432 124 78888999999999999999998 999999999999986 679999999998654321
Q ss_pred -CCCCCCCcccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 533 -ATPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
....+++.|+|||++.... ++.++||||||+++|||++|+.||........ ..+....... .+..
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~~-------~~~~-- 233 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFKI-------HPEI-- 233 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhcc-------CCCC--
Confidence 1234678899999986543 78899999999999999999999975322110 0000000000 0000
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.+|++|||+.|++++
T Consensus 234 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 ---PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 01123456677889999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=294.50 Aligned_cols=243 Identities=22% Similarity=0.347 Sum_probs=191.1
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 379 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
..+.||+|+||+||++... ++..+|+|.+..... ..+.+..|++++.++ +|+||+++++++..+...++||||++++
T Consensus 9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd06611 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWILIEFCDGG 87 (280)
T ss_pred HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEEEeeccCCC
Confidence 3567999999999999975 578899998865432 235688899999999 7999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++.... ..+++..+..++.|++.|++|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 88 ~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 88 ALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred cHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999986432 34899999999999999999999998 999999999999999999999999987654322
Q ss_pred CCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 533 ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
....+++.|+|||++. ...++.++||||||+++|||++|+.||......+ ........... ..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~------~~ 228 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKILKSEPP------TL 228 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHhcCCCC------Cc
Confidence 1234678899999975 3446789999999999999999999997543211 11111111000 00
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.........+.+++.+||+.+|++||++++++++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 ---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011122356678889999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.73 Aligned_cols=241 Identities=24% Similarity=0.385 Sum_probs=194.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||.++.. ++..+++|.+..... ..+++.+|+++++++ +|+||+++++++.+.+..+++|||+++
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 468999999999999854 478899998765432 245688899999998 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
|+|.+++.... ...+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 84 GTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred CcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 99999997542 234889999999999999999999998 9999999999999999999999999987654322
Q ss_pred --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 534 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
...+++.|+|||++.+..++.++||||||+++|||++|..||...... .....+....... .
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~-~--------- 221 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQGNYTP-V--------- 221 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCCC-C---------
Confidence 344678899999999888999999999999999999999999753321 1122222111110 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.+|++||+++|++++
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 01223456778889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=292.95 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=192.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCC------eeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV~e~ 452 (672)
.+.||+|+||.||+|... +++.+++|++.......+.+.+|+++++++.+|+||+++++++.... ..++||||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 90 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL 90 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence 467999999999999975 46789999987665556788999999999878999999999997644 47999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 91 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 91 CGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred CCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 999999999864331 1245899999999999999999999998 999999999999999999999999998654322
Q ss_pred ----CCCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 533 ----ATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 533 ----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
....++..|+|||++.. ..++.++||||||+++|||++|+.||....... ........ ....
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~~-- 237 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFKIPRN-PPPT-- 237 (275)
T ss_pred hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHHhhcc-CCCC--
Confidence 23346778999998853 346789999999999999999999997432111 01111110 0000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..........+.+++.+||..||++|||++|++++
T Consensus 238 ------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 238 ------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11112234567788889999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.74 Aligned_cols=239 Identities=21% Similarity=0.322 Sum_probs=191.0
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
..||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++..+ +||||+++++++..++..++||||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 46999999999999864 57899999986432 2345678899998888 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----CC
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----AT 534 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 534 (672)
.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 106 ~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 106 TDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred HHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 998753 23889999999999999999999998 999999999999999999999999998654322 22
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChH
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 614 (672)
..++..|+|||++.+..++.++|||||||++|||++|+.||......+ ..... ...... ..... .
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~-~~~~~~-----~~~~~---~ 241 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKRL-RDSPPP-----KLKNA---H 241 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-hccCCC-----Ccccc---C
Confidence 346788999999998889999999999999999999999997533211 11111 110000 00000 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 615 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.....+.+++.+|++.+|++||+++|++++
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 122346678889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=291.43 Aligned_cols=241 Identities=24% Similarity=0.432 Sum_probs=191.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||.||++.. .++.+|+|.++... ..+.+.+|+.++.++ +|+|++++++++..+ ..++||||+++|+|.
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~ 86 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIVMELMSKGNLV 86 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEEEECCCCCCHH
Confidence 57899999999999985 46789999886532 346788899999998 999999999998654 579999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-CCCCC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRS 538 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~ 538 (672)
+++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++....... ....+
T Consensus 87 ~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (254)
T cd05083 87 NFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160 (254)
T ss_pred HHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCC
Confidence 9997432 234789999999999999999999988 9999999999999999999999999987643322 22235
Q ss_pred CcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHH
Q 005875 539 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 617 (672)
Q Consensus 539 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 617 (672)
..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .... ........ ......
T Consensus 161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~-~~~~~~~~----------~~~~~~ 223 (254)
T cd05083 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKEC-VEKGYRME----------PPEGCP 223 (254)
T ss_pred ceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHH-HhCCCCCC----------CCCcCC
Confidence 57999999998889999999999999999998 999997543221 1111 11111100 011223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 618 VQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 618 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
..+.+++.+||+.+|++||+++++++.|++
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 456788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=292.00 Aligned_cols=239 Identities=23% Similarity=0.379 Sum_probs=193.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||.|+||.||+|... +++.+++|.+..... ....+.+|+++++.+ +|+||+++++++.++...++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWIIMEYCGGG 84 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence 467999999999999965 578899998865432 235678899999999 8999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 85 ~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 85 SCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred cHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 999999742 4899999999999999999999998 999999999999999999999999998766533
Q ss_pred CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 533 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
....++..|+|||++.+..++.++||||||+++|||+||+.||......+. ... ..........+ .
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~-~~~~~~~~~~~-----~-- 221 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFL-IPKNNPPSLEG-----N-- 221 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHH-hhhcCCCCCcc-----c--
Confidence 233467789999999988899999999999999999999999975432211 111 11111111000 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.....+.+++.+||..+|++|||+++++++
T Consensus 222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 --KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 022356778889999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=293.11 Aligned_cols=247 Identities=23% Similarity=0.409 Sum_probs=192.9
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|+.+. .+.+++|.+...... .+++.+|++++.++ +|+||+++++++.+.+..++|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCCcceEEEE
Confidence 3579999999999999642 456888887654332 35789999999999 99999999999999889999999
Q ss_pred ecCCCchhhhhccCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 452 YFASGSLSTLLHGNRGAG----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
|+++|+|.+++....... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++.
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccccccc
Confidence 999999999997544211 125899999999999999999999998 9999999999999999999999999986
Q ss_pred CCCCCC-----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccc
Q 005875 528 LMNVPA-----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601 (672)
Q Consensus 528 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (672)
...... ...++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .............
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~~~~~~~~~~~ 239 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNRLQAGKLELP 239 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHHHHHcCCcCCC
Confidence 543211 1223566999999988888999999999999999999 888986433211 1111111110000
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 602 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
........+.+++.+||+.+|++||++.|+++.|+
T Consensus 240 ----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 ----------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00112246777888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=305.34 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=187.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeC------CeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 449 (672)
.+.||+|+||.||++... .++.||||++..... ....+.+|+.++..+ +||||+++++++... ...++|
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccccCeEEEE
Confidence 468999999999999965 477899999875432 234677888888888 999999999987543 356999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 108 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 108 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred EeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 999975 67776642 2788899999999999999999998 999999999999999999999999999765
Q ss_pred CCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHHH-----
Q 005875 530 NVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------LPRWVQS----- 592 (672)
Q Consensus 530 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~---------~~~~~~~----- 592 (672)
... ....++..|+|||++.+..++.++|||||||++|||++|+.||.+.+..+... .+.+...
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 443 23457888999999999999999999999999999999999997654221100 0000000
Q ss_pred --hhhhccc-cc-cchhhhhc--c----cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 593 --VVREEWT-AE-VFDVELMR--F----QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 593 --~~~~~~~-~~-~~d~~~~~--~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
....... .. .+...... . .........+.+++.+|++.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00 00000000 0 0000112456788899999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=297.67 Aligned_cols=240 Identities=21% Similarity=0.333 Sum_probs=190.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
...||+|+||.||++... ++..||+|.+..... ..+.+.+|+.++..+ +|+||+++++.+..++..++||||+++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 456999999999999964 578899998865432 345678899998888 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 533 (672)
|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++...... .
T Consensus 106 L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 106 LTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 9998853 23889999999999999999999998 999999999999999999999999998654322 2
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...++..|+|||++.+..++.++||||||+++|||++|+.||......+ .... ..... ...... .
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~-~~~~~-----~~~~~~---~ 241 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ------AMRR-IRDNL-----PPRVKD---S 241 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhcC-----CCcccc---c
Confidence 2346778999999988889999999999999999999999997533211 0111 10000 000000 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.+|++|||++|++++
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122345667779999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=288.13 Aligned_cols=235 Identities=21% Similarity=0.313 Sum_probs=185.2
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchhhh
Q 005875 383 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTL 461 (672)
Q Consensus 383 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~ 461 (672)
||+|+||.||++..+ ++..+|+|.+....... .|......+.+|+||+++++++..++..++||||+++|+|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 699999999999965 46778888876543221 1222222233799999999999999999999999999999999
Q ss_pred hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-CeEEeecCCCCCCCCCCCCCCCCc
Q 005875 462 LHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVPATPSRSAG 540 (672)
Q Consensus 462 l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~ 540 (672)
+.... .+++..+..++.|+++|++|||+.+ ++||||||+||+++.++ .++|+|||++..........++..
T Consensus 100 l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 171 (267)
T PHA03390 100 LKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD 171 (267)
T ss_pred HHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCc
Confidence 97432 5899999999999999999999998 99999999999999998 999999999987766666678889
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHH
Q 005875 541 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQM 620 (672)
Q Consensus 541 y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 620 (672)
|+|||++.+..++.++||||||+++|||++|+.||......+ .+...+.... .. . ..........+
T Consensus 172 y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~----~--------~~~~~~~~~~~ 237 (267)
T PHA03390 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QK----K--------LPFIKNVSKNA 237 (267)
T ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cc----c--------CCcccccCHHH
Confidence 999999999899999999999999999999999998543322 2222222211 00 0 00111233456
Q ss_pred HHHHHHcccCCCCCCCC-HHHHHH
Q 005875 621 LQIGMACVAKVPDMRPN-MDEVVR 643 (672)
Q Consensus 621 ~~l~~~Cl~~dP~~RPs-~~evl~ 643 (672)
.+++.+||+.+|++||+ ++|+++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhc
Confidence 77788999999999996 688875
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=293.16 Aligned_cols=244 Identities=24% Similarity=0.352 Sum_probs=187.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||++... +++.||+|+++.... ...++..|+.++.+..+|+||+++++++..++..++||||++ |
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 357999999999999975 588999999876533 234566677766666699999999999999999999999997 5
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
+|.+++...... ...+++..+..++.|++.||+|||++ + ++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 85 SLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred cHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 888887643322 24589999999999999999999986 6 9999999999999999999999999987654322
Q ss_pred -CCCCCCcccCcccccC----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 534 -TPSRSAGYRAPEVIET----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
...++..|+|||++.+ ..++.++|+|||||++|||++|+.||...... ........... .....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~----- 229 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVEEP-SPQLP----- 229 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHhcC-CCCCC-----
Confidence 2346778999998865 44688999999999999999999999642211 01111111110 00000
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.......+.+++.+||..+|++||+++++++
T Consensus 230 ----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 ----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112345778888999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.19 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=191.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|... +++.||+|.+..... ..+++.+|++++..+ +||||+++.+++.+++..++||||++
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHTAWLVMEYCL 98 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence 467999999999999965 578899998864322 124577899999998 89999999999999999999999997
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 534 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 534 (672)
|++.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 99 -g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 99 -GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170 (307)
T ss_pred -CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence 57777765322 24899999999999999999999998 99999999999999999999999999987665555
Q ss_pred CCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 535 PSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 535 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
..++..|+|||++. ...++.++||||||+++|||++|+.||....... ........ .... .
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~~~~-~~~~-----~---- 234 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN-DSPT-----L---- 234 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHHhcC-CCCC-----C----
Confidence 66788899999984 4568889999999999999999999997543111 11111100 0000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
........+.+++.+||+.+|++||++.+++.+.
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0112345678888899999999999999998853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.95 Aligned_cols=242 Identities=21% Similarity=0.348 Sum_probs=194.9
Q ss_pred hccccccCcEEEEEEEECCCcEE-EEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTV-VVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~v-avK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
...||-|+||.||+|..++.... |.|++.... ..-++|.-|++|+..+ .||+||++++.|+.++..|++.|||.||.
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwiliEFC~GGA 115 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWILIEFCGGGA 115 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEEEEeecCCch
Confidence 34589999999999998876554 455554332 2346889999999998 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC----CCC
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----VPA 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~----~~~ 533 (672)
+...+-... .++++.++.-++.|++.||.|||++. |||||||+.|||++-+|.++++|||.+.... ...
T Consensus 116 VDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 116 VDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred HhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 988876433 34999999999999999999999997 9999999999999999999999999875432 345
Q ss_pred CCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 534 TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
...|||+|||||+.. ..+|+.++||||||++|.||..+.+|....+.. +.+-++...+. .
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKiaKSeP---------P 253 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEP---------P 253 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHHhhcCC---------C
Confidence 677999999999874 567999999999999999999999998754322 22222221111 1
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
....++.....|.+++.+|+.++|..||++++++++
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 122334556677888889999999999999999863
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.42 Aligned_cols=242 Identities=29% Similarity=0.487 Sum_probs=194.0
Q ss_pred hccccccCcEEEEEEEECC-----CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEE-----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||.||++...+ +..||+|.+..... ..+.+.+|++++..+ +|+||+++++++.+.+..+++|||
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEEEEec
Confidence 4679999999999999764 37799999876543 356788999999999 999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++++|.+++..... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 83 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 83 MEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred cCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999974331 12899999999999999999999998 999999999999999999999999998765433
Q ss_pred CC-----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhh
Q 005875 533 AT-----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606 (672)
Q Consensus 533 ~~-----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 606 (672)
.. ..+++.|+|||.+.+..++.++||||+|+++|||++ |..||...... .......... ...
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~------~~~~~~~~~~-~~~----- 224 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE------EVLEYLKKGY-RLP----- 224 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHhcCC-CCC-----
Confidence 11 224578999999988889999999999999999998 78888753211 1111111111 000
Q ss_pred hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 607 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
........+.+++.+|++.+|++|||+.|+++.|
T Consensus 225 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111334677788899999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=292.30 Aligned_cols=248 Identities=23% Similarity=0.423 Sum_probs=191.7
Q ss_pred hccccccCcEEEEEEEEC----CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCC------ee
Q 005875 380 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EK 446 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~ 446 (672)
.+.||+|+||+||+|.+. .++.||+|+++..... .+++.+|++++..+ +||||+++++++...+ ..
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcccce
Confidence 467999999999999854 3578999998764332 34677899999998 8999999999886542 24
Q ss_pred EEEEEecCCCchhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCC
Q 005875 447 LLVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 525 (672)
Q Consensus 447 ~lV~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 525 (672)
++++||+++|+|.+++..... .....+++.....++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccc
Confidence 789999999999988753221 11234788999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 526 TPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 526 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
++...... ...+++.|++||.+....++.++|||||||++|||++ |+.||......+ + .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~---~~~~~~~~~ 233 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I---YNYLIKGNR 233 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H---HHHHHcCCc
Confidence 87654321 1223467999999998889999999999999999999 889987543211 1 111111110
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
.. ........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 234 ~~-----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LK-----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0012234678888999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=275.84 Aligned_cols=257 Identities=21% Similarity=0.352 Sum_probs=194.5
Q ss_pred cCCCCCCHHHHHHHHhccccccCcEEEEEEEECC-CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEE
Q 005875 365 GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYY 441 (672)
Q Consensus 365 ~~~~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 441 (672)
|..+..|+.|+.. ...||.|..|.|++++... +...|||.+..... +.+++...+.++..-...|+||+.+|||.
T Consensus 84 g~r~~~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 84 GQRYQADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred CcccccChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 4556677777743 5679999999999999764 67889999976532 23445556666666546899999999999
Q ss_pred eCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEe
Q 005875 442 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 521 (672)
Q Consensus 442 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 521 (672)
.+...++.||.|.. -+..+++..+ .++++...-++...+++||.||.++. .|+|||+||+|||+|+.|++|+|
T Consensus 162 ~n~dV~IcMelMs~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 162 TNTDVFICMELMST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred eCchHHHHHHHHHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence 99999999999854 4555555332 34888888899999999999998865 59999999999999999999999
Q ss_pred ecCCCCCCCCCCC---CCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh
Q 005875 522 DFGLTPLMNVPAT---PSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 595 (672)
Q Consensus 522 DfGla~~~~~~~~---~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 595 (672)
|||++..+..+.. ..|-+.|||||.+.- ..|+.++||||||++++|+.||..||.+-..+ . +....+..
T Consensus 235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--F---e~ltkvln 309 (391)
T KOG0983|consen 235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--F---EVLTKVLN 309 (391)
T ss_pred cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--H---HHHHHHHh
Confidence 9999987755443 345667999999953 46899999999999999999999999864321 0 11122222
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
++. +.+....+ -...|.+++..|+++|+.+||...+++++
T Consensus 310 ~eP------P~L~~~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 EEP------PLLPGHMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCC------CCCCcccC---cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 211 11111111 23467777789999999999999988764
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=289.05 Aligned_cols=253 Identities=21% Similarity=0.274 Sum_probs=192.6
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~~~ 455 (672)
+.||.|++|.||++... +++.+|+|.+..... ....+.+|++++.++ +|+||+++++++.+. ...++||||+++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 57999999999999975 467899998875432 345688999999998 899999999998654 367999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++|.+++..... ....+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 86 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 161 (287)
T cd06621 86 GSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG 161 (287)
T ss_pred CCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccccc
Confidence 999988764322 2334788999999999999999999998 9999999999999999999999999987543322
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...++..|+|||.+.+..++.++||||+|+++|||++|+.||...... ............... .... .......
T Consensus 162 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~-~~~~~~~--- 235 (287)
T cd06621 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVNMP-NPEL-KDEPGNG--- 235 (287)
T ss_pred cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHhcCC-chhh-ccCCCCC---
Confidence 234567899999999989999999999999999999999999865331 111111111111100 0000 0000000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1123457788889999999999999999983
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=289.65 Aligned_cols=243 Identities=23% Similarity=0.300 Sum_probs=188.1
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||.||+|... +++.||+|.+...... ...+..|..++....+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999964 4788999998654321 123445555555555899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP 535 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 535 (672)
++|.++++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.........
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF 153 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccccccC
Confidence 9999999643 24889999999999999999999998 999999999999999999999999998776555555
Q ss_pred CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHH
Q 005875 536 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 615 (672)
Q Consensus 536 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 615 (672)
.++..|+|||.+.+..++.++||||||+++|||++|..||......+. .......... .... ....
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~---~~~~-----~~~~ 219 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------FDNILSRRIN---WPEE-----VKEF 219 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcccC---CCCc-----cccc
Confidence 678889999999888899999999999999999999999975432211 1111110000 0000 0012
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 616 EMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 616 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
....+.+++.+||+.+|++||++.++.+.|
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 235577888899999999999776554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=285.35 Aligned_cols=241 Identities=20% Similarity=0.383 Sum_probs=194.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||++... +++.+++|.+..... ..+++.+|+++++++ +|+||+++++++...+..++||||+++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVMDYCEG 83 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEEecCCC
Confidence 467999999999999964 578899999864322 235788899999998 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++|.+++.... ...+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 84 GDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999987432 224789999999999999999999998 9999999999999999999999999987654322
Q ss_pred --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 534 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
...+++.|+|||++.+..++.++|+|||||++|||++|+.||..... ..............
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~----------- 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRGSYPP----------- 220 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcCCCCC-----------
Confidence 23467789999999988899999999999999999999999974321 11122221111100
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+.+++.+||+.+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011223457788889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=293.60 Aligned_cols=254 Identities=21% Similarity=0.316 Sum_probs=186.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||+|+.. +++.+++|+++.... ....+.+|++++.++ +|+||+++++++.+.+..++|+||+++
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVFEYCDQ 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEEecCCC
Confidence 357999999999999975 578899999865322 234677899999999 999999999999999999999999974
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
+|.+++.... ..+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 84 -~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 84 -DLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred -CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 7888775422 24899999999999999999999998 9999999999999999999999999987654322
Q ss_pred --CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh----cc--------
Q 005875 534 --TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE----EW-------- 598 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~-------- 598 (672)
...++..|+|||++.+. .++.++|||||||++|||+||+.|+......+ ............ .+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhccc
Confidence 23457789999998764 46899999999999999999999864322110 000000000000 00
Q ss_pred ccc--cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 599 TAE--VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 599 ~~~--~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... ..................+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 0000000000001123456678889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.55 Aligned_cols=249 Identities=21% Similarity=0.320 Sum_probs=186.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++.+|+||+++++++..+...+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 467999999999999965 478899999875432 2456788999999986699999999999999999999999864
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
++.++...........+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++......
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 544433211111123589999999999999999999975 5 999999999999999999999999998654332
Q ss_pred CCCCCCCcccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 533 ATPSRSAGYRAPEVIETR---KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.... .............. +.+..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~------~~~~~ 233 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDP------PILSN 233 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCCC------CcCCC
Confidence 223467789999999776 68899999999999999999999997432 11111111111100 00000
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.........+.+++.+||+.+|++|||++|++++
T Consensus 234 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 234 -SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001233457788889999999999999999884
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.65 Aligned_cols=240 Identities=19% Similarity=0.292 Sum_probs=182.9
Q ss_pred cccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHH--cCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 382 VLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRV--GQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l--~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
+||+|+||.||++... +++.+|+|.+...... ...+.+|..++..+ .+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 4788999988654321 22334444333332 379999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 99999998642 34899999999999999999999998 999999999999999999999999998654322
Q ss_pred CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
....++..|+|||.+.. ..++.++|||||||++|||++|..||........ ......... ....+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~------~~~~~---- 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLT------VNVEL---- 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH----HHHHHHhhc------CCcCC----
Confidence 23357889999999864 5688999999999999999999999975432221 111111000 00000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
.......+.+++.+|++.||++|| +++|++++
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 -PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 111234566777899999999999 59888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=284.19 Aligned_cols=241 Identities=21% Similarity=0.334 Sum_probs=191.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeC-CeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV~e~~~ 454 (672)
.+.||+|+||.||++... +++.+++|++..... ..+.+.+|+++++++ +|+|++++++.+... ...++||||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIVMGFCE 83 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEEecccC
Confidence 467999999999999965 467899999865432 234678888999888 899999999987644 45789999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+++|.+++.... ...+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 84 GGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999997532 234899999999999999999999998 999999999999999999999999998765332
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....+++.|+|||++.+..++.++||||||+++|||++|+.||..... .......... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~-~~~~--------- 221 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEG-KLPP--------- 221 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc-CCCC---------
Confidence 223467789999999999999999999999999999999999974321 1111111111 1100
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+.+++.+|++.+|++||++.|++++
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011233467788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=294.34 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=190.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++..+ +|+||+++++++..++..++||||+++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEEEecCCc
Confidence 367999999999999976 478899998865432 235678899999998 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++|.++.... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 85 TVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 9998877532 23899999999999999999999998 9999999999999999999999999987653322
Q ss_pred --CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC-CChhHHHH-------Hhhhhc-cccc
Q 005875 534 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-VDLPRWVQ-------SVVREE-WTAE 601 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~-~~~~~~~~-------~~~~~~-~~~~ 601 (672)
...++..|+|||++.+ ..++.++||||||+++|||++|++||......+. ..+..+.. ...... ....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 2335678999999875 4478899999999999999999999975432110 00000000 000000 0000
Q ss_pred cchhhhhccc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 602 VFDVELMRFQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 602 ~~d~~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+...... ........+.+++.+||+.+|++||+++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000 001223557788889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=290.73 Aligned_cols=240 Identities=24% Similarity=0.399 Sum_probs=194.5
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
+.||+|+||.||+|... +++.+++|++.......+.+.+|++++..+ +|+|++++++++...+..++|+||+++++|.
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence 57999999999999976 578899999876544456788999999998 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----CCC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----ATP 535 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~~~ 535 (672)
+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 104 ~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 176 (286)
T cd06614 104 DIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176 (286)
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence 9997532 25899999999999999999999988 999999999999999999999999987654332 223
Q ss_pred CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHH
Q 005875 536 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 615 (672)
Q Consensus 536 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 615 (672)
.++..|+|||++.+..++.++||||||+++|+|++|+.||....... ......... .. .......
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~--------~~~~~~~ 241 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFLITTKG-IP--------PLKNPEK 241 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-CC--------CCcchhh
Confidence 46678999999988889999999999999999999999997432211 111111110 00 0111111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 616 EMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 616 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
....+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 2345677888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=287.92 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=189.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---C--------hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---G--------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~--------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 447 (672)
.+.||+|+||.||+|... +++.+|+|.++.... . .+.+..|++++..+ +|+|++++++++...+..+
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccCCceE
Confidence 467999999999999864 578899998753211 0 13467788889888 8999999999999999999
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
+||||+++|+|.++++.. ..+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++++|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred EEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999743 34889999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCC------CCCCCCCcccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 528 LMNVP------ATPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 528 ~~~~~------~~~~~~~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
..... ....++..|+|||++.... ++.++|+||||+++||+++|..||......+ . ........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~-~~~~~~~~-~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----A-MFKLGNKR-S 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----H-HHHhhccc-c
Confidence 65322 1234677899999987654 7899999999999999999999996432110 0 11111000 0
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+.... .......+.+++.+||..+|++||+++|++++
T Consensus 230 ~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 01111100 01223567778889999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.65 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=190.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC------hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||.||+|... +++.|++|++...... ...+..|++++.++ +|+||+++++++.+.+..++||||
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINLVFEF 83 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEEEEcc
Confidence 357999999999999965 5789999999765332 23466788999998 899999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+ +|+|.+++.... ..+++..+..++.||++||+|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 84 M-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred c-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9 899999997432 24899999999999999999999998 999999999999999999999999998765433
Q ss_pred C----CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh---hhcc-----c
Q 005875 533 A----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEW-----T 599 (672)
Q Consensus 533 ~----~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~---~~~~-----~ 599 (672)
. ...+++.|+|||.+.+ ..++.++|||||||++|||++|.+||......+. +........ ...+ .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhhcccc
Confidence 2 2234667999998854 4578899999999999999999888875432111 000000000 0000 0
Q ss_pred cccchhhhhc----ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 600 AEVFDVELMR----FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 600 ~~~~d~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......... ..........+.+++.+||+.+|++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 00011224567788999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.25 Aligned_cols=253 Identities=19% Similarity=0.280 Sum_probs=188.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|... +++.+|+|+++..... .....+|+.++.++.+|+|++++++++.++ +..++||||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 357999999999999965 5788999998764322 233456888888886799999999999987 88999999997
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
|++.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||++.......
T Consensus 84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 58888876432 34899999999999999999999998 999999999999999 999999999987654322
Q ss_pred --CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc--------cccc
Q 005875 534 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW--------TAEV 602 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 602 (672)
...++..|+|||++.. ..++.++|||||||++|||++|+.||.+.+..+. ..+......... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhccccc
Confidence 2336778999997654 5578899999999999999999999976543221 111111110000 0000
Q ss_pred chhhhhc--c----cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 603 FDVELMR--F----QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 603 ~d~~~~~--~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.+..... . .........+.+++.+||+.+|++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000 0 0011234678889999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=286.95 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=194.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||.|+||+||+|... ++..+++|++..... ..+.+.+|++.++.+ +|+||+++++.+..++..++||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLVMPYLSGG 84 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence 467999999999999964 567899999865432 346788999999888 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC--
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-- 534 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 534 (672)
+|.++++.... ...+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 85 ~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 85 SLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred cHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999975321 234899999999999999999999998 99999999999999999999999999865543221
Q ss_pred ------CCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 535 ------PSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 535 ------~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
..++..|+|||++... .++.++|+|||||++|||++|+.||......+. .......... ..
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~------~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQNDPP------SL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcCCCC------Cc
Confidence 2367789999998776 789999999999999999999999975433211 1111111100 00
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
............+.+++.+||+.+|++||+++|++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000111233556788889999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.30 Aligned_cols=244 Identities=20% Similarity=0.296 Sum_probs=190.1
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||++.... ++.|++|.+..... ..+.+.+|++++..+ +||||+++++.+..++..++||||++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEEecCC
Confidence 3679999999999999754 67899998865432 234677888888888 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+++|.+++... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++++|||+++.....
T Consensus 85 g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 85 GGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999642 24889999999999999999999998 999999999999999999999999988642110
Q ss_pred -----------------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh
Q 005875 533 -----------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 595 (672)
Q Consensus 533 -----------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 595 (672)
....++..|+|||++....++.++|+||||+++|||++|..||.+....+ .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~~~~ 230 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVIS 230 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh
Confidence 01235667999999988889999999999999999999999997543221 1111111
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
... ..+. ........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 231 ~~~----~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDI----EWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccc----CCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 110 0000 000123456778889999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=293.66 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=194.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+++.. ++..+|+|++..... ....+.+|+++++.+ +|+|++++++++.+++..++||||+.
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 467999999999999964 578899998864322 124577899999998 89999999999999999999999997
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 534 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 534 (672)
+ ++.+.+... ...+++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 109 g-~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (317)
T cd06635 109 G-SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS 180 (317)
T ss_pred C-CHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCccc
Confidence 5 777777532 234899999999999999999999998 99999999999999999999999999887666556
Q ss_pred CCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 535 PSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 535 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
..++..|+|||++. ...++.++|||||||++|||++|+.||......+ ........... ..
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~~----------~~ 244 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNESP----------TL 244 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhccCC----------CC
Confidence 66888999999974 4568899999999999999999999987532111 11111111100 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
........+.+++.+||+.+|++||++.|+++++......
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 0112334567788899999999999999999977654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.98 Aligned_cols=255 Identities=21% Similarity=0.297 Sum_probs=189.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCe-----eEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----KLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lV~ 450 (672)
.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.++..+.+|+||+++++++...+. .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 467999999999999965 578899998765432 235678899999999778999999999987665 79999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-CCCeEEeecCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLM 529 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~ 529 (672)
||+++ +|.+++..........+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceec
Confidence 99986 8888886543322345899999999999999999999998 999999999999998 889999999998754
Q ss_pred CCCC----CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhc--ccccc
Q 005875 530 NVPA----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE--WTAEV 602 (672)
Q Consensus 530 ~~~~----~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 602 (672)
.... ...+++.|+|||++.+ ..++.++||||||+++|||++|..||.+....+ ....+.... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ------QLLHIFKLLGTPTEQV 235 (295)
T ss_pred CCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHHHhCCCChhh
Confidence 3321 2235678999998865 457899999999999999999999997643211 111111000 00000
Q ss_pred ch-----hh---hh--ccc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 603 FD-----VE---LM--RFQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 603 ~d-----~~---~~--~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+. .. .. ... ..+.....+.+++.+||+.+|++||+++|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 00 00 000 001223457788889999999999999999863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=284.07 Aligned_cols=240 Identities=23% Similarity=0.342 Sum_probs=190.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|... ++..|++|.+..... ..+.+.+|++++..+ +|+||+++++++.++...++||||
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEEEEEe
Confidence 367999999999999976 688999998865331 234678899999998 999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++++|.+++... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 84 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 84 VPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999743 24889999999999999999999998 999999999999999999999999998765332
Q ss_pred ---CCCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 533 ---ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
....++..|+|||.+.... ++.++|+||||+++|+|++|+.||...... .............. +
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~-~----- 223 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELPP-I----- 223 (258)
T ss_pred ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCCC-c-----
Confidence 2334677899999997766 899999999999999999999999754311 11111111000000 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.+|++||++.|++.+
T Consensus 224 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 ----PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 01122455677889999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.33 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=195.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||++... +++.+++|++..... ..+.+.+|+++++++ +||||+++++++..+...++++||++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEEEEecCCC
Confidence 467999999999999976 578899998876532 345688899999998 7999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--C
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--A 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--~ 533 (672)
+|.+++.... ..+++.....++.|++.|++|||+ .+ ++|+||||+||++++++.++|+|||.+...... .
T Consensus 85 ~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 85 SLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999997532 358899999999999999999999 77 999999999999999999999999998655322 1
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...++..|+|||++.+..++.++||||||+++|+|++|+.||...... ................. .. ..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~-~~---------~~ 226 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEPPP-RL---------PS 226 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCCCC-CC---------Ch
Confidence 245677899999999999999999999999999999999999754321 11112222222111100 00 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||..+|++|||+.|++.+
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1133457788889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=286.34 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=191.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||+|... +++.+++|.++.... ..+.+..|++++..+ +|+||+++++++...+..++|+||+++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEEecCCC
Confidence 467999999999999865 578899999876544 245688899999999 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC-
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT- 534 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~- 534 (672)
++|.+++... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 84 GTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999742 23788999999999999999999998 99999999999999999999999999876543221
Q ss_pred -------CCCCCcccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 535 -------PSRSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 535 -------~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
..++..|+|||++.+.. ++.++||||||+++||+++|+.||....... ........ .. .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~~-~~-----~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVGA-GH-----K 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHhc-CC-----C
Confidence 23567899999998766 8899999999999999999999997542110 01111110 00 0
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
+.... .......+.+++.+||+.+|++||++.|++.
T Consensus 225 ~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD---SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc---ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0112344567888999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=288.62 Aligned_cols=238 Identities=24% Similarity=0.396 Sum_probs=191.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||+|... ++..+|+|.+..... ..+.+.+|++++.++ +|+||+++++++..++..++||||++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 467999999999999864 578899998764432 235688899999998 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 88 SALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 99999863 23889999999999999999999998 9999999999999999999999999986553321
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...++..|+|||++.+..++.++|+|||||++|||++|..||....... ....+.... . ..+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-~-~~~--------- 221 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLIPKNN-P-PTL--------- 221 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHHhcCC-C-CCC---------
Confidence 2346778999999988888999999999999999999999997533211 111111110 0 000
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01223456778889999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.77 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=191.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||+|... +++.|++|+++.... ..+.+.+|+++++++ +|+||+++++++..++..++||||+++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~ 84 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLVFEYVER 84 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEEEecCCC
Confidence 467999999999999976 477899998875432 245788999999999 899999999999999999999999998
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
+.+..+... ...+++..+..++.||+.|++|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 85 TLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 777766542 223889999999999999999999998 9999999999999999999999999987655432
Q ss_pred ---CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh------------hc
Q 005875 534 ---TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR------------EE 597 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~------------~~ 597 (672)
...++..|+|||++.+. .++.++||||||+++|||++|+.||.+....+.. ........ ..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL---YLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHhhhcccCc
Confidence 23356779999999888 7899999999999999999999999754321110 00000000 00
Q ss_pred ccc-----ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 598 WTA-----EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 598 ~~~-----~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... ...+...............+.+++.+||..+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 00000000000011124667888899999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=325.16 Aligned_cols=250 Identities=16% Similarity=0.303 Sum_probs=189.5
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 453 (672)
.+.||+|+||+||+++... +..+|+|.+..... ....+..|+.++..+ +|||||+++++|... ...|+||||+
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~lyIVMEY~ 96 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFC 96 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence 4689999999999999764 56788888764432 235688899999999 999999999988653 4689999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCcccCCCCCCCEEecC---------------
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG----PKFTHGNIKASNVLINQ--------------- 514 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~----~~ivHrDLk~~NILl~~--------------- 514 (672)
++|+|.++|..... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 97 ~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 97 DAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 99999999974322 12358999999999999999999998542 34999999999999964
Q ss_pred --CCCeEEeecCCCCCCCCC---CCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChh
Q 005875 515 --DLDGCISDFGLTPLMNVP---ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP 587 (672)
Q Consensus 515 --~~~~kl~DfGla~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~ 587 (672)
.+.+||+|||++...... ....+++.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-----~~ 250 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-----FS 250 (1021)
T ss_pred CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-----HH
Confidence 345899999999765432 23457899999999854 4588999999999999999999999974321 11
Q ss_pred HHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHh
Q 005875 588 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEV 648 (672)
Q Consensus 588 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i 648 (672)
.... .+..... + ........+.+|+..||+.+|++||++.|++. .+..+
T Consensus 251 qli~-~lk~~p~-------l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 251 QLIS-ELKRGPD-------L----PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHH-HHhcCCC-------C----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 1111 1111100 0 00112345778888999999999999999995 44444
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=287.75 Aligned_cols=240 Identities=23% Similarity=0.391 Sum_probs=190.8
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc--ChhhHHHHHHHHHHHc--CCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|.. .+++.+++|.+..... ...++.+|+.+++++. .|||++++++++..+...++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 35799999999999996 4678899998865422 3456888999999884 49999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+++|.++++.. .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999998632 4899999999999999999999998 9999999999999999999999999987654332
Q ss_pred ---CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 534 ---TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
...++..|+|||.+.+. .++.++|||||||++|+|++|..||........ .... ..... +.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~~-~~~~~-----~~~~~ 224 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MMLI-PKSKP-----PRLED 224 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhcc-ccCCC-----CCCCc
Confidence 23467789999998654 468899999999999999999999975432211 1000 00000 00000
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.+|++||++.|++++
T Consensus 225 ----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 ----NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0123457788889999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=288.15 Aligned_cols=238 Identities=20% Similarity=0.309 Sum_probs=183.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc------ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 450 (672)
.+.||+|+||.||+|... .++.|++|++..... ....+.+|+.++..+ +|+||+++++++.+. ...+++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCEEEEEE
Confidence 467999999999999865 478899998864321 123577899999999 899999999998753 5678999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 86 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 86 EYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 999999999999642 23788999999999999999999988 9999999999999999999999999987543
Q ss_pred CC-------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 531 VP-------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 531 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~~----- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQPT----- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCCC-----
Confidence 21 1233677899999999888999999999999999999999999753211 11111111000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.+.. .......+.+++ +||..+|++||+++|+++
T Consensus 227 ~~~~-----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQL-----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCC-----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0100 011122344444 688899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.55 Aligned_cols=241 Identities=24% Similarity=0.353 Sum_probs=191.4
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|...+ ++.+|+|.+...... .+.+..|++++..+ +|+||+++++.+.+++..++||||+.
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEEEEecC
Confidence 3579999999999999764 788999998765322 34577889999988 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 85 GGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred CCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999987432 235899999999999999999999998 9999999999999999999999999876542211
Q ss_pred --------------------------------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 005875 534 --------------------------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 581 (672)
Q Consensus 534 --------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~ 581 (672)
...++..|+|||++.+..++.++||||||+++|||++|+.||.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 123567799999999888999999999999999999999999755422
Q ss_pred CCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 005875 582 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN----MDEVVR 643 (672)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~ 643 (672)
+. .......... ..........+.+++.+||+.+|++||+ ++|+++
T Consensus 239 ~~------~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ET------FSNILKKEVT----------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH------HHHHhcCCcc----------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 1111111100 0011113456777888999999999999 777766
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=284.48 Aligned_cols=242 Identities=25% Similarity=0.397 Sum_probs=196.4
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|++|.||++...+ ++.|++|++..... ....+..|++.+.++ +|+||+++++++..++..++||||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 3689999999999999775 88899999876543 356788999999999 7999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC-
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT- 534 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~- 534 (672)
+|.+++... ..+++..+..++.|++.|++|||+ .+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 85 ~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 85 SLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999743 348999999999999999999999 88 99999999999999999999999999876643322
Q ss_pred ---CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 535 ---PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 535 ---~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||......+.... ...+.... ... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~~~~~-~~~-~-------- 223 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAICDGP-PPS-L-------- 223 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH---HHHHhcCC-CCC-C--------
Confidence 2356789999999998899999999999999999999999976543111111 11111110 000 0
Q ss_pred ChHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 612 NIEE-EMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 612 ~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... ....+.+++.+||+.+|++||++.|++++
T Consensus 224 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 -PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011 33567778889999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=291.67 Aligned_cols=240 Identities=23% Similarity=0.356 Sum_probs=192.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||.||++... +++.|++|.+.... ...+.+.+|+.++..+ +||||+++++++...+..++|+||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence 467999999999999854 57889999986432 2345678899999888 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC----
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 533 (672)
|.+++... .+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 103 L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 103 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 99998632 3788999999999999999999998 9999999999999999999999999876543322
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+++.|+|||.+....++.++||||||+++||+++|+.||......+.... ..... .. .....
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~--~~-------~~~~~ 238 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--TP-------ELQNP 238 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC--CC-------CCCCc
Confidence 22466779999999888899999999999999999999999976543221110 00000 00 01111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.+|++||+++|++.+
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223456678889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=289.57 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=187.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+++++.+ +|+||+++++++.+++..++||||+.+
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~- 87 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLVFEYLDT- 87 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEEEecCCC-
Confidence 367999999999999975 5788999998654322 34567899999999 999999999999999999999999985
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++.... ..+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 88 ~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 88 DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 9999886433 24889999999999999999999998 999999999999999999999999998654322
Q ss_pred CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh----hhccc--------
Q 005875 533 ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV----REEWT-------- 599 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~-------- 599 (672)
....++..|+|||++.+ ..++.++||||+|+++|||++|+.||....... +......... .+.+.
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 12235677999999875 457899999999999999999999997543110 0000000000 00000
Q ss_pred ----cccc-hhhhh-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 600 ----AEVF-DVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 600 ----~~~~-d~~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.... ..... ..... .....+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRL-DRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCC-CCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000 00000 01145678888999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=284.19 Aligned_cols=238 Identities=20% Similarity=0.296 Sum_probs=191.2
Q ss_pred ccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 383 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 383 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
||.|+||.||+++... ++.+++|.+..... ..+.+.+|++++..+ +|+||+++++++.++...++||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 6999999999999764 78899999865432 235688899999998 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---CC
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---AT 534 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---~~ 534 (672)
|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 80 L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~ 151 (262)
T cd05572 80 LWTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151 (262)
T ss_pred HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence 99999743 23889999999999999999999988 999999999999999999999999998776543 22
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChH
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 614 (672)
..++..|+|||.+.+..++.++|+||||+++|||++|..||.....+ ............... ....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~----------~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNGKL----------EFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCCCC----------CCCc
Confidence 34677899999998888999999999999999999999999765421 112222221100000 0001
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 005875 615 EEMVQMLQIGMACVAKVPDMRPN-----MDEVVR 643 (672)
Q Consensus 615 ~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 643 (672)
.....+.+++.+||+.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11346778888999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=294.79 Aligned_cols=260 Identities=21% Similarity=0.311 Sum_probs=190.5
Q ss_pred hccccccCcEEEEEEEECC---CcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE---STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 450 (672)
.+.||+|+||.||+|.... ++.||+|.+.... ...+.+.+|++++..+ +||||+++++++.+. +..++||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceEEEEE
Confidence 3579999999999999754 6889999987633 1234677899999998 999999999999988 7899999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC----CCCeEEeecCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ----DLDGCISDFGLT 526 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~----~~~~kl~DfGla 526 (672)
||+++ ++.+++..........+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99975 6777665433323345899999999999999999999998 999999999999999 999999999998
Q ss_pred CCCCCCC-------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHH---HHhhh
Q 005875 527 PLMNVPA-------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV---QSVVR 595 (672)
Q Consensus 527 ~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~---~~~~~ 595 (672)
....... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+... ..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 7654322 2235678999998866 45789999999999999999999999866543311110000 00000
Q ss_pred -------hcc-----ccccch---hh-hhcc--cChH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 596 -------EEW-----TAEVFD---VE-LMRF--QNIE-------EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 596 -------~~~-----~~~~~d---~~-~~~~--~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+ ..+... .. .... .... .....+.+++.+|++.||++|||+.|++++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 000000 00 0000 0001 223457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=286.65 Aligned_cols=242 Identities=21% Similarity=0.356 Sum_probs=191.0
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc-------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||++.. .+++.+|+|.+..... ..+.+.+|+++++++ +|+||+++++++.+.+..++|||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEEEEEe
Confidence 46799999999999985 4578899998864331 134678899999998 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-CeEEeecCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMN 530 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~ 530 (672)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++ .++|+|||.+....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 84 WMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred ccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999642 24889999999999999999999998 99999999999998876 59999999986654
Q ss_pred CCC--------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 531 VPA--------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 531 ~~~--------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
... ...++..|+|||++.+..++.++||||+|+++|||++|..||........ ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~-- 230 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATTAP-- 230 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccCCCC--
Confidence 321 12356789999999888899999999999999999999999964332211 11111110000000
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.........+.+++.+|++.+|++||++.|+++
T Consensus 231 --------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 --------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011223356778888999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=288.70 Aligned_cols=254 Identities=20% Similarity=0.294 Sum_probs=185.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||+|... +++.|++|++...... ...+.+|++++..+ +|+||+++.+++..++..++||||+. +
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 367999999999999864 5789999998654322 24577899999998 89999999999999999999999996 6
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
++.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++.....
T Consensus 88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 88 DLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 7777665322 23788889999999999999999998 999999999999999999999999998754322
Q ss_pred CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh-------------hcc
Q 005875 533 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR-------------EEW 598 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-------------~~~ 598 (672)
....+++.|+|||++.+. .++.++|||||||++|||++|+.||....... ........... ..+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 123357789999998754 47889999999999999999999997543210 00000000000 000
Q ss_pred ccccc----hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 599 TAEVF----DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 599 ~~~~~----d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..... ................+.+++.+|++.||++|||++|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000 00000000000113456678889999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=289.82 Aligned_cols=239 Identities=21% Similarity=0.358 Sum_probs=191.2
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|++|.||++.. .+++.+++|++..... ..+.+.+|+.++..+ +|+||+++++++...+..++|+||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 36899999999999986 4678899998864432 244578888888888 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 533 (672)
|.+++.. ..+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||.+...... .
T Consensus 103 L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 103 LTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred HHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 9999874 23889999999999999999999998 999999999999999999999999987654322 2
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...++..|+|||.+.+..++.++|||||||++|||++|+.||...... ......... ... ... ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~-~~~-----~~~---~~ 238 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN-LPP-----KLK---NL 238 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc-CCC-----CCc---cc
Confidence 234678899999998888999999999999999999999999753221 111111111 000 000 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
......+.+++.+||+.+|++||++.|+++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 112345778888999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=286.94 Aligned_cols=240 Identities=21% Similarity=0.301 Sum_probs=187.0
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 383 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 383 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
||+|+||+||++... +++.+++|.+..... ....+..|++++..+ +||||+++++++...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999855 578899998865321 234567899999998 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---CC
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---AT 534 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---~~ 534 (672)
|.+++..... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||.+...... ..
T Consensus 80 L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 80 LKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred HHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence 9999975432 34899999999999999999999998 999999999999999999999999988655322 22
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChH
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 614 (672)
..++..|+|||++.+..++.++||||||+++|+|++|+.||......... .. .. ...... .. ....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~-~~----~~~~~~----~~---~~~~ 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EE-LK----RRTLEM----AV---EYPD 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HH-HH----hccccc----cc---cCCc
Confidence 34567899999998888999999999999999999999999754431110 00 00 000000 00 0001
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005875 615 EEMVQMLQIGMACVAKVPDMRP-----NMDEVVR 643 (672)
Q Consensus 615 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 643 (672)
.....+.+++.+||+.+|++|| ++.+++.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1234566788899999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=290.80 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=192.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||+|... +++.|++|++..... ....+.+|+.++.++ +|+||+++++++..+...++||||+ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~-~ 82 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVMEYM-P 82 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEeccc-C
Confidence 467999999999999965 578999999876532 245788999999999 8999999999999999999999999 9
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++|.+++.... ..+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 83 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 83 SDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99999986433 34899999999999999999999998 9999999999999999999999999987664432
Q ss_pred ---CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh-------------
Q 005875 534 ---TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE------------- 596 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------------- 596 (672)
...++..|+|||.+.+. .++.++||||+|+++|||++|.+||.+....+. ..........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcc
Confidence 23467789999998654 468899999999999999999888865432111 1111110000
Q ss_pred ccccccchhhh--hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 597 EWTAEVFDVEL--MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 597 ~~~~~~~d~~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.+....+.... .......+....+.+++.+|++.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0000001223667888889999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=285.94 Aligned_cols=239 Identities=19% Similarity=0.257 Sum_probs=185.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc------ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 450 (672)
.+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|+.++.++ +|+||+++++++.+. ...++||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCceEEEEE
Confidence 468999999999999975 478899998753221 124677899999999 999999999998764 4578999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++++|.+++... ..+++.....++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 86 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 86 EHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 999999999998632 23788899999999999999999998 9999999999999999999999999987543
Q ss_pred C-------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 531 V-------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 531 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
. .....++..|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~----- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------AIFKIATQPT----- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------HHHHHhcCCC-----
Confidence 2 112346778999999988889999999999999999999999997432110 0111111100
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. ..........+.+++.+|+. +|++||+++|++++
T Consensus 227 ~-----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 N-----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C-----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0 00112233456677778885 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=283.67 Aligned_cols=241 Identities=18% Similarity=0.383 Sum_probs=192.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||++... +++.+++|.+..... ....+.+|+++++++ +|+||+++++.+..++..++||||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEEecCCC
Confidence 467999999999999864 577899998865432 245688899999998 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-CeEEeecCCCCCCCCCC-
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~~- 533 (672)
++|.+++.... ...+++..+..++.+++.|++|||+.+ ++|+||+|+||++++++ .+||+|||.+.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 84 GTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999997532 234889999999999999999999998 99999999999998654 57999999987654332
Q ss_pred --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 534 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~~-~~~--------- 221 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSGTF-API--------- 221 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhcCC-CCC---------
Confidence 234677899999999888999999999999999999999999754321 11111111110 000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.+|++|||++|++++
T Consensus 222 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 -SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01123456788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=287.24 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=188.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
+.||+|+||.||+|+.. +++.|++|++..... ....+.+|++++.++ +||||+++++++.+++..++||||+. +
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 57999999999999975 578899998865432 234688899999999 99999999999999999999999996 5
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.+++.... ...+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 84 ~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 84 DLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred CHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 8988886433 234899999999999999999999998 9999999999999999999999999987554322
Q ss_pred -CCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh---cccc--ccc--h
Q 005875 534 -TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWTA--EVF--D 604 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~--~~~--d 604 (672)
...++..|+|||++.+.. ++.++||||||+++|||+||+.||......+ ...+........ .+.. ... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 223567899999887644 5889999999999999999999997543211 011100000000 0000 000 0
Q ss_pred hhhh--cccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 VELM--RFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~~~~--~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.... ..... ......+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 00000 0112345678889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=315.31 Aligned_cols=260 Identities=18% Similarity=0.250 Sum_probs=178.5
Q ss_pred hccccccCcEEEEEEEECCCc--EEEE------------------EEecccccChhhHHHHHHHHHHHcCCCceeceEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEEST--TVVV------------------KRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~--~vav------------------K~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~ 439 (672)
.+.||+|+||+||++..+... .++. |.+.........+++|++++.++ +|+||++++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 231 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEI 231 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCcCcEeEE
Confidence 468999999999998754211 1111 11111111234578899999999 99999999999
Q ss_pred EEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeE
Q 005875 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 519 (672)
Q Consensus 440 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 519 (672)
+...+..|+|+|++. ++|.+++...............+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 232 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 232 LRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999985 47777765332111222345677889999999999999998 99999999999999999999
Q ss_pred EeecCCCCCCCCCC-----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCC-CCCCCCCCCCChhHHHHHh
Q 005875 520 ISDFGLTPLMNVPA-----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP-LQSPTRDDMVDLPRWVQSV 593 (672)
Q Consensus 520 l~DfGla~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~p-f~~~~~~~~~~~~~~~~~~ 593 (672)
|+|||+++...... ...|+..|+|||++.+..++.++|||||||++|||++|..+ +..........+.+.....
T Consensus 308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~ 387 (501)
T PHA03210 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387 (501)
T ss_pred EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence 99999997654322 23578899999999999999999999999999999998764 4322211111111111100
Q ss_pred --hhhcccc---ccchh----hhh-cccChHH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 594 --VREEWTA---EVFDV----ELM-RFQNIEE------EMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 594 --~~~~~~~---~~~d~----~~~-~~~~~~~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+.... ..++. ... ....+.. ....+.+++.+|++.||++|||+.|++++
T Consensus 388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000 00000 000 0000011 11245677889999999999999999874
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=282.56 Aligned_cols=242 Identities=21% Similarity=0.350 Sum_probs=191.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEe--CCeeEEEEEecC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFA 454 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~~ 454 (672)
+.||.|+||.||++... +++.+++|.+..... ..+.+..|+++++.+ +|+||+++++++.. +...+++|||++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEEehhcc
Confidence 57999999999999864 567899998865432 234577889999998 99999999998764 346789999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-----SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-----~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
+++|.+++..... ....+++..++.++.|++.|++||| +.+ ++|+||||+||++++++.+||+|||++...
T Consensus 85 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 85 GGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred CCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999975432 2345899999999999999999999 655 999999999999999999999999998876
Q ss_pred CCCC----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 530 NVPA----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 530 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.... ...+++.|+|||++.+..++.++|+||||+++|+|++|+.||......+ ..... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~~---- 229 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ------LASKI-KEGKFRR---- 229 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH------HHHHH-hcCCCCC----
Confidence 5432 2356788999999998889999999999999999999999997543111 11111 1110000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+.+++.+|++.+|++||+++||+++
T Consensus 230 ------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 ------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011233567788889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=289.20 Aligned_cols=239 Identities=21% Similarity=0.371 Sum_probs=190.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+||+|+||.||++... ++..||+|++..... ....+.+|+.+++.+ +|+||+++++++...+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 57999999999999874 578899998754322 345688899999988 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC----C
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----T 534 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----~ 534 (672)
.+++.. ..+++.....++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 105 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 105 TDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 998753 23789999999999999999999998 9999999999999999999999999876543221 2
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChH
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 614 (672)
..++..|+|||++.+..++.++|+||||+++|||++|..||......+. .. ........ .. ....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~------~~-~~~~~~~~-----~~---~~~~ 240 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MK-MIRDNLPP-----KL---KNLH 240 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH-HHHhhCCc-----cc---CCcc
Confidence 3467889999999888899999999999999999999999975322111 11 11111100 00 0111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 615 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.....+.+++.+||+.+|.+||++.|++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 123345677889999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=279.64 Aligned_cols=242 Identities=26% Similarity=0.425 Sum_probs=195.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|++|.||++... ++..+++|++..... ....+.+|++++..+ +|+|++++++++..+...++++||+++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 367999999999999976 578899999876543 456788999999998 79999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---CC
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---AT 534 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---~~ 534 (672)
|.+++.... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||.+...... ..
T Consensus 84 L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 84 LKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred HHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 999987532 34899999999999999999999988 999999999999999999999999998776543 23
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChH
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 614 (672)
..++..|+|||++.+..++.++||||||+++|+|++|+.||......+ ....... ....... ...
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~~~~--------~~~ 221 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------ALFKIAT-NGPPGLR--------NPE 221 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHHh-cCCCCcC--------ccc
Confidence 456778999999998889999999999999999999999997543111 1111111 0000000 001
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 615 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.....+.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 113457788889999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=290.94 Aligned_cols=245 Identities=19% Similarity=0.352 Sum_probs=187.0
Q ss_pred HhccccccCcEEEEEEEECC-CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 379 SAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
..+.||+|+||+||+|..++ ++.||||.++.... ....+..|++++.+...|+||+++++++.++...++||||+.+
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 98 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST 98 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc
Confidence 35789999999999999875 78899999875432 2345666777777775699999999999999999999999854
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
++.+++.... ..+++..+..++.|++.||+|||+. + |+||||+|+||++++++.+||+|||++.......
T Consensus 99 -~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 99 -CLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred -CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 7777665322 2589999999999999999999974 6 9999999999999999999999999987654322
Q ss_pred --CCCCCCcccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 534 --TPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
...++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ............. ..
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~-~~----- 239 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEPP-SL----- 239 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCCC-CC-----
Confidence 223567899999997654 788999999999999999999999643211 1111111111100 00
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
.... .....+.+++.+||+.+|++||++++++++-
T Consensus 240 ~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 240 PPNE---GFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCC---CCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0000 1234567788899999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=281.07 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=198.6
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeC-CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV~ 450 (672)
..++-+|.||.||.|.+. +.+.|.+|.++..... -..+.+|.-.+..+ .|||+..+.+++.++ +..+.+|
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeeccCcceEEE
Confidence 346889999999999654 3456778877765432 23455555555555 799999999998654 5678999
Q ss_pred EecCCCchhhhhccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 451 DYFASGSLSTLLHGNRG---AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
.++.-|+|..|+...++ ...+.++..+...++.|++.||+|||..+ |||.||.++|++||+..++||+|=.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhcc
Confidence 99999999999984332 23455788899999999999999999998 9999999999999999999999999987
Q ss_pred CCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhcccc
Q 005875 528 LMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 600 (672)
Q Consensus 528 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (672)
..-.. ....+...||+||.+....|+.++|||||||+||||+| |+.||..-++.|+.. .+.+++
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-------ylkdGy-- 515 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-------YLKDGY-- 515 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-------HHhccc--
Confidence 65433 33445677999999999999999999999999999999 999998765554322 222322
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 601 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
+...+-++..+++.+|.-||..+|++||+++|++.-|.++..
T Consensus 516 --------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 516 --------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred --------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 233344677788999999999999999999999999988753
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=289.40 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=188.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 453 (672)
.+.||+|+||.||+|... +++.+++|.++..... ...+.+|++++.++ +||||+++++++... ...++||||+
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~lv~e~~ 88 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYMVMEYV 88 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEEEEehhc
Confidence 467999999999999976 4778999998754322 23467899999999 899999999999877 7899999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++ +|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~-~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 89 EH-DLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred Cc-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 75 9988886432 24899999999999999999999998 9999999999999999999999999987664432
Q ss_pred ----CCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC-hhHHHHHhhhhcc---------
Q 005875 534 ----TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-LPRWVQSVVREEW--------- 598 (672)
Q Consensus 534 ----~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~--------- 598 (672)
...+++.|+|||++.+.. ++.++|+||||+++|||++|..||......+... +...........|
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 233567899999987644 6889999999999999999999997543221100 0000000000000
Q ss_pred ----ccccchhhhhcccChHH--HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 599 ----TAEVFDVELMRFQNIEE--EMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 599 ----~~~~~d~~~~~~~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+ ...... ....+.+++.+||+.+|++|||++|++.+
T Consensus 241 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 241 KKKTFTKYPYNQL--RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccccccchhh--hccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000 000111 23456778889999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=284.61 Aligned_cols=239 Identities=19% Similarity=0.297 Sum_probs=183.0
Q ss_pred cccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHH--cCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 382 VLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRV--GQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l--~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.||+|+||.||++... +++.||+|.+...... ...+..|..++..+ ..||||+++.+++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 4789999988654321 12233444333332 379999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 99999988632 34899999999999999999999988 999999999999999999999999998754322
Q ss_pred CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
....++..|+|||++.+. .++.++||||+|+++|||++|+.||........... ...... .....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~------~~~~~---- 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MAVEL---- 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhc------cCCCC----
Confidence 234578889999999754 588999999999999999999999976532221111 000000 00000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR 643 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 643 (672)
.......+.+++.+|+..+|++|| ++.|+++
T Consensus 219 -~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 -PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 011234567778899999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=272.78 Aligned_cols=247 Identities=21% Similarity=0.301 Sum_probs=194.0
Q ss_pred HHhccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe----CCeeEEEEEe
Q 005875 378 ASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDY 452 (672)
Q Consensus 378 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~ 452 (672)
.+.++||-|-.|.|-.+..+. +..+|+|++.+. ...++|++..-....|||||..+++|++ ....++|||.
T Consensus 65 is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 65 ISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred ehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 345789999999999998664 667899988653 4457788877777789999999999865 3467899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC---CCCeEEeecCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLM 529 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~ 529 (672)
|+||.|.+.++... ...+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... |..+|++|||+|+..
T Consensus 141 meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 141 MEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred ccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccccccc
Confidence 99999999998543 456999999999999999999999998 999999999999974 567899999999876
Q ss_pred CC---CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhh
Q 005875 530 NV---PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606 (672)
Q Consensus 530 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 606 (672)
.. -.+++-||.|.|||++...+|+..+|+||+||++|-|+.|.+||....- ..+....+..+..... +..++
T Consensus 215 ~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gqy-~FP~p- 289 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQY-EFPEP- 289 (400)
T ss_pred CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccCc-cCCCh-
Confidence 53 3466789999999999999999999999999999999999999976532 1222222221111100 00111
Q ss_pred hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 607 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+...+...++|+.+++.+|++|.|+.|++++
T Consensus 290 -----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 290 -----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 113344556677779999999999999999875
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=291.21 Aligned_cols=256 Identities=21% Similarity=0.288 Sum_probs=184.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCC--------eeE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--------EKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~ 447 (672)
.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+++++++ +||||+++++++.... ..+
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 95 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNRYKGSFY 95 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccCCCceEE
Confidence 467999999999999975 5788999988644222 23456789999998 9999999999987654 349
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
+||||+.+ +|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 96 lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 96 LVFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred EEEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 99999975 7888776322 24899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCCC--------CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 528 LMNVPA--------TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 528 ~~~~~~--------~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
...... ...++..|+|||++.+. .++.++||||||+++|||++|..||.+.....................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 653321 12346679999988664 368899999999999999999999976543221111111000000000
Q ss_pred cccc-----chh-hhh--cccChH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 599 TAEV-----FDV-ELM--RFQNIE------EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 599 ~~~~-----~d~-~~~--~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.... .+. ... ...... .....+.+++.+||+.+|++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 000 000 000000 112345689999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=283.80 Aligned_cols=239 Identities=21% Similarity=0.289 Sum_probs=192.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||.|+||.||+|... +++.+++|.+..... ..+.+.+|+++++++ +||||+++++++.++...++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 468999999999999976 478899999875432 245788899999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 84 GGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred CCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999999643 34889999999999999999999998 999999999999999999999999998765433
Q ss_pred -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
....++..|+|||++.+..++.++|+||||+++|+|++|..||....... ..+....... .. ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~-~~----------~~ 220 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET-AD----------VL 220 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc-cc----------cc
Confidence 23346778999999998889999999999999999999999998654321 1111111111 00 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNM--DEVV 642 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl 642 (672)
........+.+++.+||+.||.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111223567788889999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.15 Aligned_cols=238 Identities=18% Similarity=0.242 Sum_probs=191.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||++... +++.+|+|.+..... ..+.+.+|++++.++ +||||+++++++.+++..++||||++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEEEecCC
Confidence 467999999999999975 478899999865422 235678899999999 79999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 85 ~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 156 (290)
T cd05580 85 GGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY 156 (290)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCC
Confidence 99999999743 34899999999999999999999988 9999999999999999999999999987764432
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ........... ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~---------~~~-- 219 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEKILEGKVR---------FPS-- 219 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCCcc---------CCc--
Confidence 3346788999999988888999999999999999999999997543111 11111111100 001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
.....+.+++.+||..+|++|+ +++|++++
T Consensus 220 -~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 220 -FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1124556778899999999999 77777753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.92 Aligned_cols=260 Identities=21% Similarity=0.277 Sum_probs=187.8
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccc---cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
++.+|.|+++.||++.. +++.||+|++.... ...+.+.+|++++..+ +|+||+++++++.+++..+++|||+++|
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCC
Confidence 44455556666666554 58899999987542 2345788999999998 8999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++..... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+......
T Consensus 85 ~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 85 SCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 99999975432 24888999999999999999999998 999999999999999999999999987544211
Q ss_pred -------CCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh----hhcc-
Q 005875 533 -------ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV----REEW- 598 (672)
Q Consensus 533 -------~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~----~~~~- 598 (672)
....++..|+|||++.. ..++.++|||||||++|||++|+.||........ ......... ....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCch
Confidence 12234567999999876 3578999999999999999999999975432110 000000000 0000
Q ss_pred -----ccc-----cchhhh---hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 005875 599 -----TAE-----VFDVEL---MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR 649 (672)
Q Consensus 599 -----~~~-----~~d~~~---~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~ 649 (672)
... ..+... ............+.+++.+||+.+|++|||++|+++ .++.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000 000000 000111122346778889999999999999999998 444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=285.45 Aligned_cols=258 Identities=22% Similarity=0.360 Sum_probs=190.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|++|.||+|+.. ++..||+|.++.... ....+.+|++++.++ +|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 367999999999999975 578899999875432 245677899999999 899999999999999999999999985
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++++|||++......
T Consensus 83 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 83 DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 88888864331 235899999999999999999999998 999999999999999999999999998754332
Q ss_pred CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC-hhHHHHHhhhhcc----ccccchhh
Q 005875 533 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-LPRWVQSVVREEW----TAEVFDVE 606 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~d~~ 606 (672)
....++..|++||++.+. .++.++|||||||++|||++|+.||.+....+... +...........+ ....+...
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 123457789999998654 56889999999999999999999998654322100 0000000000000 00000000
Q ss_pred hhc------ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 607 LMR------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 607 ~~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... ....+.....+.+++.+|++.+|++||+++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 00011223457788889999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=273.76 Aligned_cols=195 Identities=27% Similarity=0.445 Sum_probs=166.3
Q ss_pred hccccccCcEEEEEEEECC-----CcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEe-CCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-----STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lV~ 450 (672)
...||+|.||.||+|.-.+ ++.+|+|+++..... .....+|+..++.+ +||||+.+..++.. +...++++
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~~v~l~f 107 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSHDKKVWLLF 107 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhccCceEEEEe
Confidence 4679999999999996332 346899999865332 24578899999999 99999999999877 77899999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC----CCeEEeecCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLT 526 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~----~~~kl~DfGla 526 (672)
||.+. ||.+.++-.+.+....++......|+.||+.|+.|||++= |+||||||.|||+..+ |.|||+|||++
T Consensus 108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99987 9999998777666678999999999999999999999987 9999999999999877 99999999999
Q ss_pred CCCCCCCCC-------CCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005875 527 PLMNVPATP-------SRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 579 (672)
Q Consensus 527 ~~~~~~~~~-------~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~tg~~pf~~~~ 579 (672)
+.+..+-.+ ..|..|+|||.+.+.+ |+.+.||||.||++.||+|-++-|.+..
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 887654332 2477899999998765 7888999999999999999999887654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=288.16 Aligned_cols=244 Identities=13% Similarity=0.207 Sum_probs=171.3
Q ss_pred hccccccCcEEEEEEEECCC----cEEEEEEecccccC--hh-h---------HHHHHHHHHHHcCCCceeceEEEEEeC
Q 005875 380 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVVG--KR-D---------FEQQMEIVGRVGQHPNVVPLRAYYYSK 443 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~--~~-~---------~~~e~~~l~~l~~h~niv~l~~~~~~~ 443 (672)
.+.||+|+||+||+|...++ ..+++|+....... .+ . ...+...+..+ .|+|++++++++...
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYYGCGSFK 95 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEEEeeeEe
Confidence 46899999999999997654 34555543221111 00 0 01111222233 799999999987654
Q ss_pred C----eeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeE
Q 005875 444 D----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 519 (672)
Q Consensus 444 ~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 519 (672)
. ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++
T Consensus 96 ~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 96 RCRMYYRFILLEKLVE-NTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred cCCceEEEEEEehhcc-CHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEE
Confidence 4 34678887643 565665422 12577888999999999999999998 99999999999999999999
Q ss_pred EeecCCCCCCCCC-----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC-CChh
Q 005875 520 ISDFGLTPLMNVP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-VDLP 587 (672)
Q Consensus 520 l~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~-~~~~ 587 (672)
|+|||+|+..... ....+|+.|+|||+..+..++.++|||||||++|||++|+.||.+...... ....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 9999998754211 123478899999999999999999999999999999999999986532221 1100
Q ss_pred --HHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 588 --RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 588 --~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.+...+.. ... ........+.+++..|++.+|++||+++++++.++
T Consensus 247 ~~~~~~~~~~---------~~~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KCDFIKRLHE---------GKI----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHhhh---------hhh----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 01111110 000 11122356778888999999999999999998763
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=288.77 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=190.0
Q ss_pred ccccc--CcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 382 VLGKG--SYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 382 ~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.||+| +||+||+++.. .++.||+|++...... .+.+.+|+.++..+ +||||+++++++..++..++||||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecccC
Confidence 46666 99999999964 6899999998754322 24577788877777 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
|++.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+.....
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999987543 224889999999999999999999988 99999999999999999999999985432211
Q ss_pred -------CCCCCCCCcccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH-----------
Q 005875 532 -------PATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ----------- 591 (672)
Q Consensus 532 -------~~~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~----------- 591 (672)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||......+. +.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence 0111234569999999764 478999999999999999999999975432111 000000
Q ss_pred -----Hh----------------hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHh
Q 005875 592 -----SV----------------VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEV 648 (672)
Q Consensus 592 -----~~----------------~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i 648 (672)
.. ....+.....+... ...........+.+++.+||+.||++|||++|+++ .++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00 00000000000000 01111234567889999999999999999999987 56666
Q ss_pred hhc
Q 005875 649 RQS 651 (672)
Q Consensus 649 ~~~ 651 (672)
++.
T Consensus 315 ~~~ 317 (328)
T cd08226 315 KEQ 317 (328)
T ss_pred HHh
Confidence 554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=285.98 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=190.3
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc---cChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 453 (672)
.+.||+|+||.||+|...+ ++.+++|++.... .....+.+|++++..+ +|+|++++++++... +..++||||+
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEeccc
Confidence 3579999999999999764 7889999998653 1234678899999999 899999999999988 7899999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++ +|.+++.... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 83 DH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 75 8888886432 35899999999999999999999998 9999999999999999999999999987665432
Q ss_pred -----CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh----hcccc--c
Q 005875 534 -----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA--E 601 (672)
Q Consensus 534 -----~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~--~ 601 (672)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ........ ..+.. .
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchhhcccccc
Confidence 2234667999998765 45789999999999999999999999765422110 00000000 00000 0
Q ss_pred c-----chhhhhcc----cChHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 602 V-----FDVELMRF----QNIEE-EMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 602 ~-----~d~~~~~~----~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. ........ ..... +...+.+++.+||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 00000000 00011 24567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=279.26 Aligned_cols=241 Identities=21% Similarity=0.387 Sum_probs=192.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc---cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||++... ++..+|+|.+.... ...+.+.+|+++++.+ +|+||+++++.+..+...++|+||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEEecCCC
Confidence 467999999999999975 47889999886542 2345678899999998 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-CeEEeecCCCCCCCCCC-
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~~- 533 (672)
++|.+++.... ...+++..+..++.|++.|++|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 84 GDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999997533 224789999999999999999999998 99999999999999886 46999999987654332
Q ss_pred ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 534 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
...+++.|+|||++.+..++.++|+||||+++|||++|..||..... .++......... ...
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~~-------- 222 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQGYF-API-------- 222 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhcccC-CCC--------
Confidence 22467789999999888899999999999999999999999975321 122222221111 000
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.+|++|||++|++++
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01122457778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=291.01 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=187.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 453 (672)
.+.||+|+||.||+|... +++.||+|+++..... ...+.+|+.++.++ +|+||+++++++... +..++||||+
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEEEEEecC
Confidence 467999999999999975 4788999998644322 23456799999998 999999999998765 4679999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
.+ +|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 91 ~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 91 EQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred CC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 75 8888886432 34899999999999999999999998 9999999999999999999999999987664322
Q ss_pred ----CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh---ccc------
Q 005875 534 ----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWT------ 599 (672)
Q Consensus 534 ----~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~------ 599 (672)
...++..|+|||++.+ ..++.++||||+||++|||++|+.||...+..+... ........ ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD---LIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCChhhchhhhcc
Confidence 1224667999999865 457899999999999999999999997654322110 00000000 000
Q ss_pred --cccchhhhhcccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 600 --AEVFDVELMRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 600 --~~~~d~~~~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+.......... ......+.+++.+|++.||++|||++|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000000 1123456788889999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=287.85 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=191.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|+.. ++..+++|.+..... ...++.+|+++++.+ +|+|++++.+++..+...++||||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeEEEEEccC
Confidence 467999999999999965 467899998864321 124577899999998 99999999999999999999999996
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 534 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 534 (672)
|++.+++.... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 99 -~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (308)
T cd06634 99 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170 (308)
T ss_pred -CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCccc
Confidence 58877775322 24889999999999999999999998 99999999999999999999999999887665555
Q ss_pred CCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 535 PSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 535 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
..+++.|+|||++. ...++.++|||||||++|||++|+.||......+ ......... ....
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~~--------- 234 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE-SPAL--------- 234 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHhhcC-CCCc---------
Confidence 66788999999974 3567889999999999999999999986532111 111111100 0000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
........+.+++.+||+.+|++||++++++++-..+.
T Consensus 235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 01123345677888999999999999999998755444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=284.57 Aligned_cols=239 Identities=24% Similarity=0.376 Sum_probs=189.5
Q ss_pred ccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 383 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 383 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
||+|+||.||+++..+ ++.+++|.+..... ..+.+.+|++++.++ +|+||+++++.+..+...++||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999999875 88999999875432 245678888899998 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC----
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 533 (672)
|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 80 L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 80 LASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 999997432 4899999999999999999999998 9999999999999999999999999986543321
Q ss_pred --------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 534 --------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 534 --------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
...++..|+|||......++.++||||||+++||+++|+.||......+ .......... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~-----~- 219 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNILNGKI-----E- 219 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCCc-----C-
Confidence 1235677999999988889999999999999999999999997543221 1111111000 0
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
..........+.+++.+||+.+|++|||+.++.+.|+
T Consensus 220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 ----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000011355678888999999999999955555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=294.11 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=188.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccCh---------------hhHHHHHHHHHHHcCCCceeceEEEEEeC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK---------------RDFEQQMEIVGRVGQHPNVVPLRAYYYSK 443 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---------------~~~~~e~~~l~~l~~h~niv~l~~~~~~~ 443 (672)
.+.||+|+||+||+|... +++.||+|+++...... ..+.+|++++..+ +|+||+++++++..+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGLVDVYVEG 92 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeeeeEEEecC
Confidence 567999999999999965 58899999986543221 2467899999998 999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeec
Q 005875 444 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 523 (672)
Q Consensus 444 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~Df 523 (672)
+..++||||+. |+|.+++... ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCc
Confidence 99999999997 5899988632 24889999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCCCC------------------CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 005875 524 GLTPLMNVP------------------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 584 (672)
Q Consensus 524 Gla~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~ 584 (672)
|++...... ....++..|+|||++.+. .++.++|||||||++|||++|+.||.+....+.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~- 242 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ- 242 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 998655410 112246679999998764 468899999999999999999999986543221
Q ss_pred ChhHHHHHhhh----hccccccchhhhh-----ccc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 585 DLPRWVQSVVR----EEWTAEVFDVELM-----RFQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 585 ~~~~~~~~~~~----~~~~~~~~d~~~~-----~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......... ..|......+... ... ........+.+++.+|++.+|++||+++|++.+
T Consensus 243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 243 --LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred --HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 111111000 0010000000000 000 001123457788899999999999999999973
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.87 Aligned_cols=265 Identities=22% Similarity=0.336 Sum_probs=198.7
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC------eeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV~ 450 (672)
.+.||+|+||.||+|++ ..|+.||||.+..... ..+...+|+++++++ +|+|||+++++-++.. ...+||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccccceEEE
Confidence 45699999999999995 4688999999987543 456788999999999 7999999999876544 567999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec--CCC--CeEEeecCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDL--DGCISDFGLT 526 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~--~~~--~~kl~DfGla 526 (672)
|||.+|||...++... +...+++.+.+.++.+++.||.|||+++ |+||||||.||++- .+| .-||+|||.|
T Consensus 97 EyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred eecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999998654 3556999999999999999999999998 99999999999993 334 3599999999
Q ss_pred CCCCCCC---CCCCCCcccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccc--
Q 005875 527 PLMNVPA---TPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA-- 600 (672)
Q Consensus 527 ~~~~~~~---~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 600 (672)
+...... ...||..|.+||.+. .+.|+..+|.|||||++||++||..||..........-..|. ...++...
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~--~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH--IITKKPSGVA 249 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh--hhccCCCcee
Confidence 9887665 345899999999998 488899999999999999999999999754322111101111 11111100
Q ss_pred ----------ccchhhhhcccC-hHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHHhhhcC
Q 005875 601 ----------EVFDVELMRFQN-IEEEMVQMLQIGMACVAKVPDMRP--NMDEVVRMIEEVRQSD 652 (672)
Q Consensus 601 ----------~~~d~~~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RP--s~~evl~~L~~i~~~~ 652 (672)
-.+...++.... .......+-.....++..+|++|. ...+....+.+|.+..
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 001111111111 123334555666678888999998 7777777777776543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=278.13 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=194.4
Q ss_pred CCCCHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC
Q 005875 368 YNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD 444 (672)
Q Consensus 368 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 444 (672)
+.|+-++|+. ...||.|+||+|+|-.++ .|+..|||++..... +.+++..|.+..++-.+.||||+++|.+..++
T Consensus 59 ~~F~~~~Lqd--lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 59 HTFTSDNLQD--LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccccchHHH--HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 3444444432 256999999999999865 588899999976643 34568888888887779999999999999999
Q ss_pred eeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecC
Q 005875 445 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 524 (672)
Q Consensus 445 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 524 (672)
..|+.||+|+- ++..+-+.-.......+++.-.-.|....+.||.||.+.- +|||||+||+|||++..|.+|+||||
T Consensus 137 dcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 137 DCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred ceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeeccc
Confidence 99999999965 5554433222222345888888888889999999998754 69999999999999999999999999
Q ss_pred CCCCCCCCCC---CCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 525 LTPLMNVPAT---PSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 525 la~~~~~~~~---~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
++..+..+.. ..|-..|||||.+.. ..|+.++||||+|++|||+.||+.||..... +.+.+..+......
T Consensus 214 IcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdpp 288 (361)
T KOG1006|consen 214 ICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDPP 288 (361)
T ss_pred chHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCCC
Confidence 9877654322 235556999999953 3589999999999999999999999975431 22223333322221
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.-..+. ..-+....+.+++-.|+.+|-+.||...++.++
T Consensus 289 ~l~~~~------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDK------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcc------cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111111 112234567777779999999999999998763
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=286.76 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=189.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|++|+||+|... +++.|++|++..... ....+.+|++++..+ +|+|++++++++.+++..+++|||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEeccC-
Confidence 467999999999999965 688999999875432 235678899999999 89999999999999999999999995
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 82 ~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 82 LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 689999874331 34899999999999999999999988 9999999999999999999999999987553221
Q ss_pred --CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHh---hhhccccccchhh-
Q 005875 534 --TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV---VREEWTAEVFDVE- 606 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~d~~- 606 (672)
...++..|+|||++.+. .++.++||||||+++|||++|+.||......+. .....+.. ....+......+.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhh
Confidence 22346789999988664 468899999999999999999999975432110 01100000 0000000000000
Q ss_pred ---hhc--ccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 607 ---LMR--FQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 607 ---~~~--~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... ... .......+.+++.+|++.+|++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000 01112456788889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=288.70 Aligned_cols=262 Identities=22% Similarity=0.357 Sum_probs=190.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc---cChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 453 (672)
.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.++.++.+|+||+++++++... ...++||||+
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 567999999999999975 47789999886432 22345678999999987899999999998654 3679999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
+ ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 92 E-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred c-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 7 5999888632 4789999999999999999999998 9999999999999999999999999987553321
Q ss_pred ---------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChh-HHH-------HHhhh
Q 005875 534 ---------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-RWV-------QSVVR 595 (672)
Q Consensus 534 ---------~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~-~~~-------~~~~~ 595 (672)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+..... ... .....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 1236778999998865 45788999999999999999999999754322110000 000 00000
Q ss_pred hccccccch----hhhhc-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhc
Q 005875 596 EEWTAEVFD----VELMR-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQS 651 (672)
Q Consensus 596 ~~~~~~~~d----~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 651 (672)
........+ ..... ..........+.+++.+||+.+|++|||+.+++++ ++.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 000000000 00000 00001123567888899999999999999999985 5655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=275.58 Aligned_cols=241 Identities=26% Similarity=0.366 Sum_probs=195.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~ 453 (672)
.+.||+|++|.||+|... +++.|++|++..... ..+.+.+|+++++++ +|+||+++++.+... +..++|+||+
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 367999999999999976 678899999876542 356788899999999 899999999999988 8899999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++++|.+++.... .+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 84 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 84 SGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999997432 5899999999999999999999988 9999999999999999999999999987664432
Q ss_pred ------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 534 ------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 534 ------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
...++..|+|||.+.+..++.++||||||+++|+|++|..||.... +................
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~------ 224 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPE------ 224 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcC------
Confidence 2346778999999998889999999999999999999999997644 11111111110000000
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+.+++.+|++.+|++||++.|++++
T Consensus 225 ----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 ----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111224567778889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=292.12 Aligned_cols=238 Identities=21% Similarity=0.352 Sum_probs=195.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccCh---hhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|.|++|.++++. .+..||+|.+.+...+. +.+.+|++++..+ +|||||+++.+.......|+||||+.+
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEEEEEeccC
Confidence 467999999999999954 57899999998775432 3478899999999 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
|.+++++.+... ..+..+..++.|+..+++|||+++ |+|||||++||||+.+.++||+|||++..+...
T Consensus 140 ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 140 GELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred chhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccccc
Confidence 999999986442 555888899999999999999998 999999999999999999999999999887643
Q ss_pred CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
.+.+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-.+... +.+..+ ++...
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------rvl~gk---------~rIp~ 276 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------RVLRGK---------YRIPF 276 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------hheeee---------ecccc
Confidence 46789999999999999887 578999999999999999999999765433211 011111 11111
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
....+ .-+++++++-.+|.+|++++++.+.
T Consensus 277 ~ms~d---ce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 277 YMSCD---CEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeech---hHHHHHHhhccCccccCCHHHhhhh
Confidence 12222 2345668999999999999999874
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=296.09 Aligned_cols=256 Identities=20% Similarity=0.304 Sum_probs=188.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCC-----eeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lV~e 451 (672)
.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++.... ..++|+|
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccceEEEEeh
Confidence 468999999999999864 57889999986432 2235677899999999 8999999999876543 5799999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|+.+ +|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 89 LMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred hccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 9975 88887753 24899999999999999999999998 99999999999999999999999999866532
Q ss_pred CC-------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc---c
Q 005875 532 PA-------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT---A 600 (672)
Q Consensus 532 ~~-------~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~ 600 (672)
.. ...++..|+|||++.+ ..++.++||||+||++|||++|+.||.+..... .............. .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHH
Confidence 21 2346778999998754 568899999999999999999999997543211 01111111100000 0
Q ss_pred ccchhh-------hh--cccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005875 601 EVFDVE-------LM--RFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 649 (672)
Q Consensus 601 ~~~d~~-------~~--~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~ 649 (672)
.+.+.. .. .... .......+.+++.+||+.+|++|||+.|++++ ++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000 00 0000 01123557889999999999999999999996 66554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=281.44 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=190.9
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC---hhhHHHHHHHHHHHc--CCCceeceEEEEEeCCe-----eEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDE-----KLL 448 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~-----~~l 448 (672)
.+.||+|+||.||+|+.+. ++.+|+|+++..... ...+.+|++++.++. +|+|++++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 3579999999999999864 789999998744322 234667887777764 59999999999988776 899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 449 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
+|||+.+ +|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 84 ~~e~~~~-~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 84 VFEHVDQ-DLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred Eehhccc-CHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999975 89888864332 24899999999999999999999998 99999999999999999999999999877
Q ss_pred CCCCCC---CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh---hhcccccc
Q 005875 529 MNVPAT---PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWTAEV 602 (672)
Q Consensus 529 ~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 602 (672)
...... ..++..|+|||++.+..++.++|||||||++|||++|.+||......+. +.+...... ...+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcCCCc
Confidence 643322 2356779999999998999999999999999999999999976443221 111111000 00000000
Q ss_pred ------chhhhh-c-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 603 ------FDVELM-R-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 603 ------~d~~~~-~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+..... . .....+....+.+++.+||+.||++||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000 0 00112234566788999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=286.68 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=192.5
Q ss_pred CCHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCC
Q 005875 370 FDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD 444 (672)
Q Consensus 370 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 444 (672)
.+.+++. ...+.||+|+||+||+|+.. +++.|++|++...... ...+.+|++++..+ +|+|++++++++.+++
T Consensus 17 ~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 94 (313)
T cd06633 17 DDPEEIF-VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEH 94 (313)
T ss_pred CCHHHHh-hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCC
Confidence 3444542 22457999999999999964 5778999988643221 24577889999998 8999999999999999
Q ss_pred eeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecC
Q 005875 445 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 524 (672)
Q Consensus 445 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 524 (672)
..++||||+. |++.+++.... ..+++.++..++.|++.|++|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 95 ~~~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg 166 (313)
T cd06633 95 TAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG 166 (313)
T ss_pred EEEEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecC
Confidence 9999999996 57777775322 34899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccc
Q 005875 525 LTPLMNVPATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601 (672)
Q Consensus 525 la~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (672)
++..........++..|+|||++. ...++.++|||||||++|||++|..||....... ........... .
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~~-~ 239 (313)
T cd06633 167 SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNDSP-T 239 (313)
T ss_pred CCcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCCC-C
Confidence 987665555556788899999984 4567889999999999999999999997543211 11111111100 0
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 602 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. .......+.+++.+||+.+|++||++.+++.+
T Consensus 240 ~~---------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 LQ---------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CC---------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 01112346678889999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=285.39 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=192.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|++|.||++... +++.+++|.+...... ...+.+|+++++++ +|+||+++++++..++..++||||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEeccCC
Confidence 357999999999999965 5788999998765332 45678899999999 899999999999999999999999975
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++.+++.... ..+++..+..++.|++.|++|||+.+ |+|+||||+||++++++.++|+|||.+.......
T Consensus 83 -~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 83 -DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred -CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 8888886422 34899999999999999999999998 9999999999999999999999999986654432
Q ss_pred --CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh---ccccccch---
Q 005875 534 --TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWTAEVFD--- 604 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d--- 604 (672)
...++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+.. ......... .......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhcccchhhhh
Confidence 23356679999998776 7889999999999999999999999764422110 000000000 00000000
Q ss_pred ---hhhh--c----ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 ---VELM--R----FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ---~~~~--~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.... . ..........+.+++.+||+.||.+||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 0 00112234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=293.48 Aligned_cols=259 Identities=19% Similarity=0.307 Sum_probs=190.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc---cChhhHHHHHHHHHHHcCCCceeceEEEEEeC-----CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~ 450 (672)
.+.||+|+||+||+++.. +++.||+|.+.... .....+.+|+.++..+ +|+||+++++++... ...++||
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccCcEEEEE
Confidence 467999999999999964 57889999987532 2234567899999988 899999999988654 3479999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 89 e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 89 ELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred eCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 9996 6898888632 24899999999999999999999998 9999999999999999999999999987654
Q ss_pred CC----CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh---cccccc
Q 005875 531 VP----ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWTAEV 602 (672)
Q Consensus 531 ~~----~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 602 (672)
.. ....++..|+|||.+.. ..++.++|||||||++|||++|+.||.+....+.. ......... .....+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL---KLITELLGSPSEEDLGFI 236 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCChHHhhhc
Confidence 33 22346778999998865 46889999999999999999999999754321100 000000000 000000
Q ss_pred chhhh-------hc------ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhc
Q 005875 603 FDVEL-------MR------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQS 651 (672)
Q Consensus 603 ~d~~~-------~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 651 (672)
.+... .. ..........+.+++.+||+.+|++|||++|++++ ++.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 00000 00 00011233557788899999999999999999997 7666443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=292.80 Aligned_cols=252 Identities=21% Similarity=0.334 Sum_probs=187.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEe----CCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e 451 (672)
.+.||+|+||.||+|... +++.|++|++..... ....+.+|+.++.++ +|+||+++++++.. ....++|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCceEEEEEe
Confidence 357999999999999965 588999999875432 235677899999999 89999999988763 346799999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|+. |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 89 ~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 89 LME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred hhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 996 5899988632 23899999999999999999999998 99999999999999999999999999865432
Q ss_pred CC--------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh-------
Q 005875 532 PA--------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR------- 595 (672)
Q Consensus 532 ~~--------~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~------- 595 (672)
.. ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~~g~~~~~~~ 236 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSVLGSPSEEVL 236 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHHhCCChhHhh
Confidence 21 2346778999999865 45889999999999999999999999764321110 00000000
Q ss_pred ----hccccccchhh-hhcccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 596 ----EEWTAEVFDVE-LMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 596 ----~~~~~~~~d~~-~~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......++.. ...... .......+.+++.+||+.+|++||++++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 000000 01224567888889999999999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=271.88 Aligned_cols=237 Identities=23% Similarity=0.359 Sum_probs=189.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-Chhh---HHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRD---FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~---~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.++||+|.||+|-+++-+ .++.+|+|++++... .+++ ...|-+++... +||.+..+-..|+..+..+.||||.+
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCFVMeyan 251 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCFVMEYAN 251 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEEEEEEcc
Confidence 467999999999999955 578899999987643 3333 33466778777 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC----C
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----N 530 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~----~ 530 (672)
||.|.-++... ..+++.....+-..|+.||.|||+.+ ||+||||.+|.|+|.+|++||+|||+++.. .
T Consensus 252 GGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 252 GGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred CceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999998743 34888888889999999999999987 999999999999999999999999999753 3
Q ss_pred CCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 531 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 531 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
...+.+|||.|+|||++....|+.++|+|.+||+||||+.|+.||...+.+....+ +. -..++-.
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL------Il---------~ed~kFP 388 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL------IL---------MEDLKFP 388 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH------HH---------hhhccCC
Confidence 34577899999999999999999999999999999999999999986543322111 11 1111122
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR 643 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 643 (672)
..+..+++.++. -.+.+||.+|. .+.||.+
T Consensus 389 r~ls~eAktLLs---GLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 389 RTLSPEAKTLLS---GLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ccCCHHHHHHHH---HHhhcChHhhcCCCchhHHHHHh
Confidence 234455555544 78889999995 2555554
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=284.56 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=185.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|++|+||+|... +++.||+|++..... ..+.+.+|+++++++ +|+||+++++++.+++..++||||++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~- 84 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLVFEYLD- 84 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEEEeccc-
Confidence 357999999999999975 578899998865432 235678899999999 99999999999999999999999996
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-CCCeEEeecCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~~~-- 532 (672)
++|.+++.... ...+++.....++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||++......
T Consensus 85 ~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 85 LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 57887775332 223578888899999999999999998 999999999999985 557999999998754322
Q ss_pred --CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHHHHhhhhcccc--ccchhh
Q 005875 533 --ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-DLPRWVQSVVREEWTA--EVFDVE 606 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~d~~ 606 (672)
....+++.|+|||++.+. .++.++||||||+++|+|+||+.||......+.. ....+........|.. ...+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 223456789999998664 5788999999999999999999999754321110 0000000000000000 000000
Q ss_pred --hhc--ccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 607 --LMR--FQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 607 --~~~--~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
... ... .......+.+++.+|++.+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000 0112234677888999999999999999987
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=283.95 Aligned_cols=258 Identities=22% Similarity=0.380 Sum_probs=190.3
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|...+ ++.|++|++...... .....+|+..+.++.+|+||+++++++..++..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 4679999999999999764 678999998765432 2344568888888844999999999999999999999999 78
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence 9999887543 234899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCCCCcccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC-hh---------HHHHHhhhhcccccc
Q 005875 534 TPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-LP---------RWVQSVVREEWTAEV 602 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~-~~---------~~~~~~~~~~~~~~~ 602 (672)
...++..|+|||++. ...++.++|+||||+++|||++|+.||......+... .. .|.............
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 234577899999885 4457899999999999999999999997654322100 00 010000000000000
Q ss_pred chhhhhc--ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 603 FDVELMR--FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 603 ~d~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+...... ..........+.+++.+||+.+|++|||++|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00001113567889999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.14 Aligned_cols=253 Identities=22% Similarity=0.314 Sum_probs=187.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeC------CeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 449 (672)
.+.||+|+||.||+|... +++.||+|++..... ....+.+|++++.++ +|+||+++++++... ...++|
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 99 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEFQDVYLV 99 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccccCcEEEE
Confidence 467999999999999965 578999999865322 234567899999988 999999999998644 346999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||+.+ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 100 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 100 MELMDA-NLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred EeccCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 999964 88887752 1788899999999999999999998 999999999999999999999999999765
Q ss_pred CCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHHHHH-----
Q 005875 530 NVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV---------DLPRWVQS----- 592 (672)
Q Consensus 530 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~---------~~~~~~~~----- 592 (672)
.... ...++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+.. ....+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 4332 234677899999999999999999999999999999999999754321100 00000000
Q ss_pred --hhhhccc--c----ccchhhhh---cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 593 --VVREEWT--A----EVFDVELM---RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 593 --~~~~~~~--~----~~~d~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
....... . ..+..... ...........+.+++.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0 00000000 000011234456788999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=280.90 Aligned_cols=243 Identities=22% Similarity=0.353 Sum_probs=188.2
Q ss_pred hccccccCcEEEEEEEE----CCCcEEEEEEeccccc-----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.+.||+|+||.||+++. .++..||+|++..... ..+.+.+|++++.++.+|+||+++++++..+...++||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 36799999999999986 3678899999875321 23567889999999977999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++....
T Consensus 85 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 85 DYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999643 24788999999999999999999998 9999999999999999999999999987653
Q ss_pred CCC-----CCCCCCcccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 531 VPA-----TPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 531 ~~~-----~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
... ...++..|+|||.+... .++.++||||||+++|+|++|..||....... ..............
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~----- 229 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSEP----- 229 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccCC-----
Confidence 321 23467789999998753 46789999999999999999999997432211 11111111111100
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
.. .......+.+++.+|++.+|++|| ++++++.+
T Consensus 230 --~~-----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 --PY-----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --CC-----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00 011223566788899999999997 66777663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.28 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=190.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC------eeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 449 (672)
.+.||+|+||.||+|... +++.||+|++..... ....+.+|++++..+ +|+||+++++++.... ..++|
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCCceEEEE
Confidence 468999999999999964 588999999875422 234577899999998 9999999999987543 45899
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
+||+.. +|..+.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 99 ~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 99 MPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 999964 7766652 13889999999999999999999998 999999999999999999999999998765
Q ss_pred CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh-----------h
Q 005875 530 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR-----------E 596 (672)
Q Consensus 530 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-----------~ 596 (672)
.... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. ......... .
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHhcc
Confidence 4322 2345778999999876 4688999999999999999999999986432111 000000000 0
Q ss_pred ccccccchh-hhhcccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhcCCC
Q 005875 597 EWTAEVFDV-ELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQSDSE 654 (672)
Q Consensus 597 ~~~~~~~d~-~~~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~~~~ 654 (672)
......... ....... .......+.+++.+||+.||++||+++|++.+ ++.+++....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~ 309 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE 309 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc
Confidence 000000000 0000000 01123456788889999999999999999965 8887655443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=275.84 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=198.5
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCC-----ceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-----NVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-----niv~l~~~~~~~~~~~lV~e~~ 453 (672)
...+|+|.||.|-.+.... +..||+|+++....-.+...-|++++.++..+. -+|.+.++|.-.++.++|+|.+
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell 173 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL 173 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence 4679999999999998655 578999999877666677788999999885433 4788888999999999999988
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-------------------
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ------------------- 514 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~------------------- 514 (672)
|-++.+++..+. ..+++...+..|+.|++++++|||+.+ ++|.||||+|||+.+
T Consensus 174 -G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 174 -GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred -ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 449999998654 446889999999999999999999998 999999999999942
Q ss_pred -CCCeEEeecCCCCCCCCCC-CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC-------
Q 005875 515 -DLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD------- 585 (672)
Q Consensus 515 -~~~~kl~DfGla~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~------- 585 (672)
+..++|+|||.|+...... +...|..|+|||++.+-..+.++||||+||||+|+.||..-|+.....|.+.
T Consensus 247 ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG 326 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG 326 (415)
T ss_pred CCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC
Confidence 3457899999998876554 3456888999999999999999999999999999999999998655333211
Q ss_pred -hhHHHHH------hhhh---cccccc--------c---hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 586 -LPRWVQS------VVRE---EWTAEV--------F---DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 586 -~~~~~~~------~~~~---~~~~~~--------~---d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
++..+.. .+.. .|.... + .+.-......+.+...+++|+++|+..||.+|+|+.|++++
T Consensus 327 p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 327 PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 1111110 0000 000000 0 00001112335667889999999999999999999999874
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=281.32 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=192.2
Q ss_pred hccccccCcEEEEEEEEC----CCcEEEEEEeccccc-----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.+.||+|+||.||+++.. +++.||+|.++.... ..+.+.+|++++.++.+|+||+++++.+..+...++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 467999999999999843 467899999875321 23567889999999977999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++|+|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 85 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 85 DYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred ecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999998632 24889999999999999999999988 9999999999999999999999999987643
Q ss_pred CCC-----CCCCCCcccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 531 VPA-----TPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 531 ~~~-----~~~~~~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
... ...++..|+|||.+.+.. ++.++||||||+++|||++|..||....... ..............
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~----- 229 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSKP----- 229 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccCC-----
Confidence 322 123677899999987765 7889999999999999999999996432211 11111111111100
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
. .. ......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 230 --~--~~---~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 230 --P--FP---KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --C--CC---cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 00 11123456778899999999999998888877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=271.86 Aligned_cols=238 Identities=24% Similarity=0.436 Sum_probs=192.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|++|.||++... +++.+++|.+..... ..+.+.+|++++.++ +|+|++++++++.+++..+++|||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 467999999999999865 567899999976643 345688899999999 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC-
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT- 534 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~- 534 (672)
++|.+++... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 84 ~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 84 GSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999998743 34899999999999999999999998 99999999999999999999999999876654332
Q ss_pred ---CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 535 ---PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 535 ---~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
..++..|+|||...+..++.++||||+|+++|+|++|..||...... ... ....... ...+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~-~~~~~~~--~~~~-------- 219 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AAL-FRIVQDD--HPPL-------- 219 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHH-HHHhccC--CCCC--------
Confidence 34677899999998888899999999999999999999999754311 100 0111000 0000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.......+.+++.+||..+|++||++.|++.
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 -PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0112345667888999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=289.45 Aligned_cols=259 Identities=20% Similarity=0.329 Sum_probs=196.1
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC-----eeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lV~ 450 (672)
.+.||+|+||.||+|+..+ +..+++|++..... ..+.+.+|++++..+ +|+||+++.+++...+ ..++||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 83 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVT 83 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccceEEEe
Confidence 4679999999999999754 78899999876532 345788899999999 8999999999988775 789999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++ +|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 84 e~~~~-~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 84 ELMET-DLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred cchhh-hHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 99984 898888642 25899999999999999999999998 9999999999999999999999999987654
Q ss_pred CCC-------CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh----cc
Q 005875 531 VPA-------TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE----EW 598 (672)
Q Consensus 531 ~~~-------~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~ 598 (672)
... ...++..|+|||++.+. .++.++|+||||+++|+|++|+.||.+....+.. ......... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHh
Confidence 432 22356779999999887 7899999999999999999999999765432110 000000000 00
Q ss_pred -------ccccchh-hhhc----ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhc
Q 005875 599 -------TAEVFDV-ELMR----FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQS 651 (672)
Q Consensus 599 -------~~~~~d~-~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 651 (672)
....+.. .... ..........+.+++.+||+.+|++||++++++++ ++.+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000000 0000 00001123457788889999999999999999994 7766654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-34 Score=318.21 Aligned_cols=240 Identities=25% Similarity=0.345 Sum_probs=186.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc---cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.+||.|.||.||.|... +|...|+|-++-.. ..-+...+|+.++..+ +|||+|+++|+-.+.+..+|.||||++
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHHHHHHHHHhcc
Confidence 568999999999999954 46667888775432 2345678899999999 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
|+|.+.+...+ -.++.....+..|++.|++|||++| ||||||||.||+|+.+|.+|++|||.|.....+.
T Consensus 1319 GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1319 GSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred CcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 99999997432 2566677788899999999999999 9999999999999999999999999997765442
Q ss_pred ------CCCCCCcccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 534 ------TPSRSAGYRAPEVIETR---KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 534 ------~~~~~~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
...||+.|||||++.+. ....+.||||+|||+.||+||+.||...+.+ ..+ +..+. -..
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aI---My~V~-~gh------ 1458 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAI---MYHVA-AGH------ 1458 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHH---HhHHh-ccC------
Confidence 23589999999999653 4677899999999999999999999754321 000 00110 000
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+.++.....-.+++.+|+..||++|.++.|++++
T Consensus 1459 ----~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 ----KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 011111122333456669999999999999877765
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=271.73 Aligned_cols=243 Identities=20% Similarity=0.374 Sum_probs=195.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||++... ++..+++|++..... ..+.+.+|++++..+ +|+|++++.+.+..++..++|+||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEEEecCC
Confidence 357999999999999975 578899999876533 345688899999999 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++|.+++..... ....+++..+..++.+++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 84 GDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred CcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 999999975431 1245899999999999999999999998 9999999999999999999999999987654432
Q ss_pred --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 534 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
...+++.|+|||...+..++.++||||+|+++|+|++|+.||...... ........... ...
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~~--------- 223 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILKGQY-PPI--------- 223 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhcCCC-CCC---------
Confidence 234677899999999888999999999999999999999999754311 11221111110 000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||..+|++||++.|++++
T Consensus 224 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 -PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01223456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=275.24 Aligned_cols=243 Identities=24% Similarity=0.369 Sum_probs=194.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||++... +++.+++|.+..... ....+.+|+++++.+ +|+||+++.+++..+...++||||+++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEehhcCC
Confidence 467999999999999855 567899999875432 234677888999998 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++|.+++..... ....+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.+|++|||++.......
T Consensus 84 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 84 GDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK 159 (256)
T ss_pred CCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence 999999865321 2345899999999999999999999998 9999999999999999999999999987654332
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...++..|+|||.+.+..++.++|+||+|+++|||++|+.||......+ ...... ..... ...
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~----------~~~ 222 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------LRYKVQ-RGKYP----------PIP 222 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHh-cCCCC----------CCc
Confidence 2346778999999999889999999999999999999999997543211 111111 10000 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+|++.+|++||++.|++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2334567888889999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=283.25 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=185.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC----------e
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD----------E 445 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----------~ 445 (672)
.+.||+|+||.||+|..+ +++.|++|+++.... ....+.+|++++..+ +||||+++++++.+.. .
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 90 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDFKKDKGA 90 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhccccCCc
Confidence 468999999999999976 478899999865422 234677899999999 8999999999987654 7
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCC
Q 005875 446 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 525 (672)
Q Consensus 446 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 525 (672)
.++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred EEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccc
Confidence 8999999986 676766532 234899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCC-----CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc-
Q 005875 526 TPLMNVPA-----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW- 598 (672)
Q Consensus 526 a~~~~~~~-----~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 598 (672)
+....... ...++..|+|||.+.+ ..++.++|||||||++|||++|++||......+. ...+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~ 239 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISRLCGSPCP 239 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCh
Confidence 87654322 1224667999998864 4578899999999999999999999975432111 111111110000
Q ss_pred --ccccc--------hhhhhc----ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 599 --TAEVF--------DVELMR----FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 599 --~~~~~--------d~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+. +..... ..........+.+++.+||+.+|++||++++++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 000000 00001123457788889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=285.84 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=187.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEe-CCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||++... +++.||+|++..... ..+.+.+|++++..+ +||||+++.+++.. .+..++||||+
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 468999999999999855 688899998864322 245677899999999 89999999999875 45788999998
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+++|.++++. ..+++.....++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||++.......
T Consensus 93 ~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 163 (328)
T cd07856 93 GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMT 163 (328)
T ss_pred ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCcC
Confidence 5689888863 23788888899999999999999998 9999999999999999999999999987654332
Q ss_pred CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHHHhhhhccccccc
Q 005875 534 TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------LPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~ 603 (672)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||.......... ..++..............
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence 2345778999999866 568999999999999999999999997543211000 001111110000000000
Q ss_pred hhhhhcccChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRFQNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........... .....+.+++.+|++.+|++||+++|++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000011 123567788889999999999999999885
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=307.66 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=180.8
Q ss_pred CCCCHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeC-
Q 005875 368 YNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK- 443 (672)
Q Consensus 368 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~- 443 (672)
|.-|++++ ++||+||||.||+++.+ ||+.||||++.... .......+|+..+.++ +|||||+++..|.+.
T Consensus 477 Y~~DFEEL-----~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 477 YLNDFEEL-----ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVEST 550 (1351)
T ss_pred HhhhhHHH-----HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccC
Confidence 44566776 57999999999999976 89999999998664 2234678899999999 999999987653100
Q ss_pred --------------------------------------------------------------------------------
Q 005875 444 -------------------------------------------------------------------------------- 443 (672)
Q Consensus 444 -------------------------------------------------------------------------------- 443 (672)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred --------------------------------------CeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHH
Q 005875 444 --------------------------------------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 485 (672)
Q Consensus 444 --------------------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i 485 (672)
...||-||||+...+.++++.+.-. -......+++.+|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREI 706 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHH
Confidence 0136888999998888888754311 0356778999999
Q ss_pred HHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC----------------------CCCCCCCCCcccC
Q 005875 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----------------------VPATPSRSAGYRA 543 (672)
Q Consensus 486 a~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~----------------------~~~~~~~~~~y~a 543 (672)
+.||+|+|++| ||||||||.||+++++..|||+|||+|+... ......||.-|+|
T Consensus 707 lEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 707 LEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 99999999999 9999999999999999999999999997621 0112346777999
Q ss_pred cccccCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc-cChHHHHHH
Q 005875 544 PEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF-QNIEEEMVQ 619 (672)
Q Consensus 544 PE~~~~~~---~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~ 619 (672)
||++.+.. |+.|+|+||+|||++||+. ||.... |...+ ...+. +. .+... ....+.+..
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~i---L~~LR-~g--------~iP~~~~f~~~~~~~ 846 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASI---LTNLR-KG--------SIPEPADFFDPEHPE 846 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHH---HHhcc-cC--------CCCCCcccccccchH
Confidence 99997654 9999999999999999995 454321 11111 11111 11 11000 011223334
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 005875 620 MLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 620 l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
=.++|+++++.||.+|||+.|++.
T Consensus 847 e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 847 EASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHHhcCCCccCCCHHHHhh
Confidence 456778999999999999999986
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=283.99 Aligned_cols=255 Identities=21% Similarity=0.275 Sum_probs=184.1
Q ss_pred hccccccCcEEEEEEEECC---CcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeC----CeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK----DEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~----~~~~lV 449 (672)
.+.||+|+||.||++.... +..||+|++..... ..+.+.+|++++.++.+|+||+++++.+... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 4679999999999999653 67899998865322 2346778999999986799999999875432 356888
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
+||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 85 ~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 85 EELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred Eeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 89886 5898888632 34899999999999999999999998 999999999999999999999999998754
Q ss_pred CCC--------CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHH
Q 005875 530 NVP--------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------LPRWVQ 591 (672)
Q Consensus 530 ~~~--------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~---------~~~~~~ 591 (672)
... ....++..|+|||++.+ ..++.++||||+||++|+|++|+.||......+... ...+..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 321 12346788999998765 468899999999999999999999997543211100 000000
Q ss_pred HhhhhccccccchhhhhcccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 592 SVVREEWTAEVFDVELMRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 592 ~~~~~~~~~~~~d~~~~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
...................... ......+.+++.+|++.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000000000000 011346778888999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=287.21 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=190.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCC------eeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 449 (672)
.+.||+|+||.||++... ++..||+|++...... ...+.+|++++..+ +|+||+++++++..+. ..++|
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccccceEEEE
Confidence 467999999999999854 6788999998653222 34577899999999 9999999999987653 35899
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 99 ~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 99 MPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 9998 6799888852 23899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC-Ch--------hHHHHHhhhhcc
Q 005875 530 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-DL--------PRWVQSVVREEW 598 (672)
Q Consensus 530 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~-~~--------~~~~~~~~~~~~ 598 (672)
.... ...+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||......... .+ ..+...+....
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 247 (343)
T cd07880 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED- 247 (343)
T ss_pred ccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh-
Confidence 4332 2346788999999876 45788999999999999999999999754321100 00 00000000000
Q ss_pred ccccchhhhhccc------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhhcC
Q 005875 599 TAEVFDVELMRFQ------NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQSD 652 (672)
Q Consensus 599 ~~~~~d~~~~~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~~~~ 652 (672)
..... ....... ........+.+++.+|++.||++|||+.+++. .++.+....
T Consensus 248 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~ 308 (343)
T cd07880 248 AKNYV-KKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308 (343)
T ss_pred HHHHH-HhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence 00000 0000000 00112335778889999999999999999995 566654443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=287.17 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=184.5
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeC------CeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 449 (672)
.+.||+|+||.||+|.. .+++.||+|+++.... ..+.+.+|++++.++ +|+||+++++++... ...+++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 100 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV 100 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccccccccEEEE
Confidence 35799999999999985 4578899999875432 234577899999998 999999999988643 246788
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 101 ~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 101 THLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccc
Confidence 8876 7799888753 23899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh--hhccccccchh
Q 005875 530 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV--REEWTAEVFDV 605 (672)
Q Consensus 530 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~ 605 (672)
.... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... ....... .......+.+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK--LILRLVGTPGAELLKKISSE 248 (345)
T ss_pred cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHHHhhcccH
Confidence 4332 2346778999999866 567889999999999999999999997543211100 0000000 00000000000
Q ss_pred -------hhhc--ccChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 606 -------ELMR--FQNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 606 -------~~~~--~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.+.. ..... .....+.+++.+|++.||++||++.|++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 00000 113356788889999999999999999984
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=269.47 Aligned_cols=231 Identities=25% Similarity=0.334 Sum_probs=186.8
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 383 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 383 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
||+|+||.||++... +++.+++|.+..... ....+..|+++++.+ +|+||+++++.+..++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999976 478899999876533 234688899999988 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 533 (672)
|.+++.... .+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 80 L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (250)
T cd05123 80 LFSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151 (250)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence 999997432 4899999999999999999999988 999999999999999999999999998765432 2
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...++..|+|||...+...+.++|+||||+++||+++|..||..... ............ ...
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~---------~~~--- 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDPL---------RFP--- 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCCC---------CCC---
Confidence 33467789999999888889999999999999999999999975432 111111111100 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDE 640 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e 640 (672)
......+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111345677888999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=278.44 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=191.3
Q ss_pred ccccccCcEEEEEEEECC-CcEEEEEEecccc---cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 381 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
+.||+|+||.||+|+..+ ++.+++|.+.... ...+.+..|++++.++ +|+|++++++++.+.+..++||||++ +
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 569999999999999764 8889999987653 1235677899999988 89999999999999999999999998 5
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||++.......
T Consensus 83 ~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 83 DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 8999997532 34899999999999999999999998 9999999999999999999999999987654432
Q ss_pred -CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh----hccc--ccc--c
Q 005875 534 -TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWT--AEV--F 603 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~--~~~--~ 603 (672)
....+..|+|||.+.+. .++.++||||||+++|||++|+.||......+. ......... ..+. ... .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcccccc
Confidence 12245679999998776 789999999999999999999999976542211 000000000 0000 000 0
Q ss_pred hhhhhcc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+...... .........+.+++.+||+.+|++||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000 0011113467888999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=270.42 Aligned_cols=239 Identities=18% Similarity=0.254 Sum_probs=185.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc------cChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 450 (672)
.+.||+|+||.||+|... ++..|++|.+.... .....+++|++++.++ +|+||+++++++.+. ...++++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCEEEEEE
Confidence 468999999999999964 47889999875321 1124678899999999 899999999998764 4578999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++++|.+++... ..+++.....++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||+++...
T Consensus 86 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 86 EYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 999999999998632 23788999999999999999999998 9999999999999999999999999987543
Q ss_pred CC-------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 531 VP-------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 531 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
.. ....++..|+|||++.+..++.++|+|||||++|||++|+.||...... ..............
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~-- 229 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQPTKPM-- 229 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCCCCCC--
Confidence 21 1234677899999999888999999999999999999999999743211 11111111110000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+.+++.+|++ +|.+||++.+++.+
T Consensus 230 --------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 230 --------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --------CCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 011223456677779999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=280.27 Aligned_cols=238 Identities=21% Similarity=0.347 Sum_probs=190.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||++... +++.|++|++.... ...+.+.+|.+++.++.+|+||+++++++..++..++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 357999999999999975 68889999987532 1235677888999998449999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 86 ~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 86 NGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999997432 4899999999999999999999998 9999999999999999999999999987553322
Q ss_pred -----------------------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 005875 534 -----------------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV 590 (672)
Q Consensus 534 -----------------------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~ 590 (672)
...++..|+|||+.....++.++||||||++++++++|+.||....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~ 231 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------TF 231 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH------HH
Confidence 1124677999999988889999999999999999999999998554111 11
Q ss_pred HHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 005875 591 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNM----DEVVR 643 (672)
Q Consensus 591 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~ 643 (672)
.......+ .........+.+++.+||+.+|++||++ +|+++
T Consensus 232 ~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKILKLEY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHhcCC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11111100 0001123456788889999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=282.46 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=182.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC--------eeE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--------EKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~ 447 (672)
.+.||+|+||.||+|... +++.+++|++..... ....+.+|++++.++ +|+||+++++++.+.. ..+
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccccCceEE
Confidence 467999999999999965 578899998865432 134577899999998 9999999999875433 468
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
+||||+.+ ++...+... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++.
T Consensus 92 lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 92 MVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred EEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccch
Confidence 99999975 677766532 234899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCCCC---------------CCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh-hHHH
Q 005875 528 LMNVPAT---------------PSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL-PRWV 590 (672)
Q Consensus 528 ~~~~~~~---------------~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~-~~~~ 590 (672)
....... ..+++.|+|||.+.+ ..++.++|||||||++|||++|++||.+......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 5432211 123567999998865 4578999999999999999999999975433211000 0000
Q ss_pred HHhhhhcc-----ccc----c----chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 591 QSVVREEW-----TAE----V----FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 591 ~~~~~~~~-----~~~----~----~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+ ... . ....... ........+.+++.+|++.+|++|||+.|++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHH--HcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000 000 0 0000000 001112457788899999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=291.59 Aligned_cols=243 Identities=24% Similarity=0.398 Sum_probs=201.7
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe-----CCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-----KDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-----~~~~~lV~e~~ 453 (672)
.+.||.|.+|.||+++. ++++.+|+|++......+++.+.|.++++.+..|||++.++|+|.. ++..|+|||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC 103 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence 46899999999999994 5678899999887777788899999999999999999999999964 56899999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC--
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-- 531 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-- 531 (672)
.+|+..|++++.. ...+.|+.+..|+..++.|+++||... ++|||+|-.|||++.++.||+.|||++.....
T Consensus 104 ~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 104 GGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV 177 (953)
T ss_pred CCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence 9999999998776 344999999999999999999999987 99999999999999999999999999876543
Q ss_pred --CCCCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 532 --PATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 532 --~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
..+..|||.|||||++.. ..|+.++|+||+|++..||..|.+|+..+.+...+ -.+. .+. .
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------F~Ip-RNP-----P 245 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIP-RNP-----P 245 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------ccCC-CCC-----C
Confidence 345678999999999964 34778899999999999999999999765432210 0000 111 1
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
+ .....+.-.++|.++|..|+.+|-++||++.++++
T Consensus 246 P---kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 246 P---KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred c---cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1 12234566778889999999999999999988775
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=286.50 Aligned_cols=236 Identities=22% Similarity=0.312 Sum_probs=189.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
..+|.|+|+.|-.+... +++..+||++.+. ..+..+|+.++....+||||+++.+.+.++.+.|+|||++.++-+.
T Consensus 328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 328 EELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred cccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 45999999999998854 5678899998765 3455667778888889999999999999999999999999999988
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe-cCCCCeEEeecCCCCCCCCC-CCCCC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI-NQDLDGCISDFGLTPLMNVP-ATPSR 537 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl-~~~~~~kl~DfGla~~~~~~-~~~~~ 537 (672)
+.+...+ ....++..|+.+|+.++.|||++| ||||||||+|||+ ++.++++|+|||.++..... .+++-
T Consensus 405 ~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~ 475 (612)
T KOG0603|consen 405 RRIRSKP------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPAL 475 (612)
T ss_pred HHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchhhcccch
Confidence 8886433 333677889999999999999998 9999999999999 68999999999999887655 34466
Q ss_pred CCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHH
Q 005875 538 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 617 (672)
Q Consensus 538 ~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 617 (672)
|..|.|||++....|++++||||||++||+|++|+.||.....+ ..+ ...+.... + ...+++.+
T Consensus 476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei---~~~i~~~~-----~------s~~vS~~A 539 (612)
T KOG0603|consen 476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI---HTRIQMPK-----F------SECVSDEA 539 (612)
T ss_pred hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH---HHhhcCCc-----c------ccccCHHH
Confidence 78899999999999999999999999999999999999865433 111 01100000 0 02233444
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 618 VQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 618 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
+ +|+..|++.||.+||+|.|+..+=.-
T Consensus 540 K---dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 540 K---DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred H---HHHHHhccCChhhCcChhhhccCcch
Confidence 4 45559999999999999999885443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=271.39 Aligned_cols=242 Identities=24% Similarity=0.357 Sum_probs=186.1
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||++.... +..+++|.++.... ....+.+|+.++..+ +||||+++++++.+.+..++||||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCIITEY 83 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEEEEEe
Confidence 4679999999999998654 34455555543221 223466788888888 999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++++|.+++..... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++ +.++|+|||++......
T Consensus 84 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 84 CEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred CCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 999999998864332 2345899999999999999999999998 999999999999975 56999999998765332
Q ss_pred ----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 533 ----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 533 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ............ ...
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~~-~~~------- 224 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEGP-TPS------- 224 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcCC-CCC-------
Confidence 23346778999999988888999999999999999999999996432 111111111110 000
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+.+++.+||+.+|++||++.|++++
T Consensus 225 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 ---LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 012233567788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=284.18 Aligned_cols=255 Identities=24% Similarity=0.293 Sum_probs=183.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--------------
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-------------- 443 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-------------- 443 (672)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++..+ +||||+++++++...
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccccccccc
Confidence 467999999999999965 478899998865433 345678899999999 999999999776543
Q ss_pred CeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-CCCeEEee
Q 005875 444 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISD 522 (672)
Q Consensus 444 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~D 522 (672)
...++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+|++|
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 589888853 23889999999999999999999998 999999999999984 56789999
Q ss_pred cCCCCCCCCCC-------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh
Q 005875 523 FGLTPLMNVPA-------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 594 (672)
Q Consensus 523 fGla~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 594 (672)
||++....... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.. ........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~--~~~~~~~~ 236 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM--QLILESVP 236 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcC
Confidence 99987543211 1235677999998754 55788999999999999999999999754321110 00000000
Q ss_pred --hh--------ccccccchhhhhcccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHH
Q 005875 595 --RE--------EWTAEVFDVELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEE 647 (672)
Q Consensus 595 --~~--------~~~~~~~d~~~~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 647 (672)
.. ................ .......+.+++.+|++.||++|||+.|++. .++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 0000000000000000 0112245678888999999999999999996 4543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-33 Score=263.24 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=191.7
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccc--ccC-hhhHHHHHHHHHHHcCCCceeceEEEEEeC--------CeeE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEV--VVG-KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--------DEKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~ 447 (672)
..+||+|.||+||+|+.++ ++.||+|+.--. ..+ .....+|++++..+ +|+|++.+++.|... ...|
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcccccceee
Confidence 4679999999999999654 667787765321 112 34567899999999 999999999888542 2478
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
+||++|+. +|.-++.+.. ..++..++.+++.++..||.|+|... |+|||+|+.|+||+.+|.+||+|||+++
T Consensus 101 lVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 99999987 8888886432 34888999999999999999999987 9999999999999999999999999997
Q ss_pred CCCCCCCC--------CCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHH-HHhhhhc
Q 005875 528 LMNVPATP--------SRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV-QSVVREE 597 (672)
Q Consensus 528 ~~~~~~~~--------~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~ 597 (672)
....+... ..|..|++||.+.+ +.|+++.|||+.||++.||+||.+-+++.++...+.+++.. .++-.+-
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 66443221 23778999999876 45899999999999999999999999987766554433322 2222233
Q ss_pred ccc-------ccchhh-hh--cccChHHHHH------HHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 598 WTA-------EVFDVE-LM--RFQNIEEEMV------QMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 598 ~~~-------~~~d~~-~~--~~~~~~~~~~------~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
|.. ..+..+ +. ....+++..+ ...+++..++..||.+|+++++++.+
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 321 001000 10 1122333333 56778889999999999999998865
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-33 Score=276.04 Aligned_cols=231 Identities=25% Similarity=0.339 Sum_probs=184.2
Q ss_pred hccccccCcEEEEEEEECCC-cEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
..+||+|+||.|-++..+.+ ..+|||++++...- .+....|-+++....+-|.++++..+|+.-+..|.||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 36899999999999987653 45899999876431 22344566777777688999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
||+|--.++... .+.+..++.+|..||-||-+||++| |++||||..|||+|.+|++||+|||+++.--.
T Consensus 434 GGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 434 GGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred CchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 999988887432 3778889999999999999999999 99999999999999999999999999975422
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
..+.+|||.|+|||++....|+..+|+|||||+||||+.|++||++.++++.. +.+...+. .-.
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF------~aI~ehnv---------syP 570 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF------QAIMEHNV---------SYP 570 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHHHccC---------cCc
Confidence 34567999999999999999999999999999999999999999987665432 11111111 011
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCC
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRP 636 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RP 636 (672)
....++.+.+....+.+.|.+|.
T Consensus 571 ---KslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 571 ---KSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---ccccHHHHHHHHHHhhcCCcccc
Confidence 11223344555577788898884
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=287.54 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=186.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCe------eEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE------KLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lV 449 (672)
.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.+++.+ +|+||+++.+++...+. .++|
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccccccEEEE
Confidence 367999999999999976 467899998865322 234567799999988 99999999988876554 8999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
+||+ +++|.+++.. ..+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++...
T Consensus 99 ~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 99 THLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 9998 5699998863 24899999999999999999999998 999999999999999999999999998766
Q ss_pred CCC-CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC-h--------hHHHHHhhhhcc
Q 005875 530 NVP-ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-L--------PRWVQSVVREEW 598 (672)
Q Consensus 530 ~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~-~--------~~~~~~~~~~~~ 598 (672)
... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+... + ..+......+..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred cccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 433 23346778999999865 467889999999999999999999997543221100 0 000000000000
Q ss_pred ccccchh-hhhcccChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 599 TAEVFDV-ELMRFQNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 599 ~~~~~d~-~~~~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...... ......... .....+.+++.+|++.+|++|||+.|++++
T Consensus 249 -~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 249 -RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred -HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000 000000000 123567888999999999999999999873
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=266.57 Aligned_cols=219 Identities=17% Similarity=0.192 Sum_probs=171.6
Q ss_pred cCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchhhhhcc
Q 005875 386 GSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHG 464 (672)
Q Consensus 386 G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~ 464 (672)
|.||.||+++.. +++.+|+|++.... .+.+|...+... .||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999965 57889999986543 233344444444 699999999999999999999999999999999864
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-CCCCCCcccC
Q 005875 465 NRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRA 543 (672)
Q Consensus 465 ~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~a 543 (672)
. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+....... ...++..|+|
T Consensus 79 ~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~a 150 (237)
T cd05576 79 F-----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCA 150 (237)
T ss_pred h-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccC
Confidence 3 23899999999999999999999998 9999999999999999999999999876554322 2334667999
Q ss_pred cccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHH
Q 005875 544 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQI 623 (672)
Q Consensus 544 PE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l 623 (672)
||.+.+..++.++||||+|+++|||++|+.|+........ .. .. + .. . ......+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~--~~-~--~~--~---~~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------TH--TT-L--NI--P---EWVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cc--cc-c--CC--c---ccCCHHHHHH
Confidence 9999888899999999999999999999988753211000 00 00 0 00 0 1112356678
Q ss_pred HHHcccCCCCCCCCHH
Q 005875 624 GMACVAKVPDMRPNMD 639 (672)
Q Consensus 624 ~~~Cl~~dP~~RPs~~ 639 (672)
+.+|++.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 8899999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=301.79 Aligned_cols=139 Identities=24% Similarity=0.371 Sum_probs=122.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|... +++.||+|+++..... ...+..|+.++..+ +|+||+++++++...+..|+||||+.
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lVmEy~~ 87 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLVMEYLI 87 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEEEeCCC
Confidence 467999999999999976 5788999998754321 24677888888887 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
+++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999743 23788999999999999999999998 9999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=239.56 Aligned_cols=256 Identities=22% Similarity=0.346 Sum_probs=192.4
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
-++||+|.||+||+|+..+ +..||+|++.-...+ .....+|+-+++.+ +|.|||+++++...++..-+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhsdkkltlvfe~cdq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeHHHhhH
Confidence 3679999999999999654 677899988654322 34678899999999 999999999999999999999999976
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
+|..+....++ .++.+.+..++.|+.+|+.++|+++ +.|||+||.|.|++.+|..|++|||+++....+.
T Consensus 86 -dlkkyfdslng----~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 86 -DLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred -HHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 89888875544 3888999999999999999999998 9999999999999999999999999998776543
Q ss_pred --CCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH-Hhhhhccccc--cchhh
Q 005875 534 --TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ-SVVREEWTAE--VFDVE 606 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~d~~ 606 (672)
....|..|++|.++.+.+ |+...|+||.||++.|+.. |++-|.+.+.++....+-|.- ....+.|... ..|..
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 334688899999998755 7889999999999999987 666677766554432222221 1122333221 11111
Q ss_pred hh-ccc---ChHHHH----HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 607 LM-RFQ---NIEEEM----VQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 607 ~~-~~~---~~~~~~----~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. .+. ...... ..=.+++.+.+.-+|.+|.++++.+++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 10 000 011111 112456667788899999999988764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=299.75 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=193.2
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.++||+|+||.|..++.+. ++.||.|++.+.. .....|..|-++|..- +.+.|+.++-.|.++.+.|+|||||+
T Consensus 80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEEEEeccc
Confidence 5789999999999999765 6678999987743 2345677787887765 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
||||..++.+.. .+++..+..++..|+.||.-||+.| +|||||||+|||||..|++|++|||.+-.+..
T Consensus 159 GGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 159 GGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred CchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 999999997533 4999999999999999999999999 99999999999999999999999998866653
Q ss_pred --CCCCCCCCcccCccccc----C-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 532 --PATPSRSAGYRAPEVIE----T-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 532 --~~~~~~~~~y~aPE~~~----~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
....+|||-|.+||++. + +.|+..+|+||+||++|||+.|..||....- +.-..++......-.
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~KIm~hk~~l~--- 301 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYGKIMNHKESLS--- 301 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHHHHhchhhhcC---
Confidence 34567999999999994 3 5689999999999999999999999975432 222222222211100
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH-------HHHhhhcCCC
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN---MDEVVRM-------IEEVRQSDSE 654 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~-------L~~i~~~~~~ 654 (672)
++....++++++.+++ +.+. +|+.|.. ++++-.+ ...|++..++
T Consensus 302 --FP~~~~VSeeakdLI~---~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP 355 (1317)
T KOG0612|consen 302 --FPDETDVSEEAKDLIE---ALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP 355 (1317)
T ss_pred --CCcccccCHHHHHHHH---HHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence 0111123445554443 4443 6778877 8888764 3556655543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=268.82 Aligned_cols=245 Identities=21% Similarity=0.330 Sum_probs=184.7
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccCh--------hhHHHHHHHHHHHcCCCceeceEEEEEeC-CeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGK--------RDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~--------~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV 449 (672)
..+||+|||++||++.. .+.+.||||+-.-...++ +...+|..|.+.| .||.||++++|+.-+ +..+-|
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeeccccceee
Confidence 35799999999999984 556778898764333222 2345677888888 999999999999754 567899
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec---CCCCeEEeecCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLT 526 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~---~~~~~kl~DfGla 526 (672)
+|||+|.+|.-+|+..+ .+++.++..|+.||+.||.||.+.. |+|||-||||.|||+- .-|.+||+|||++
T Consensus 547 LEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 99999999999998544 4899999999999999999999984 8899999999999995 4588999999999
Q ss_pred CCCCCCCC-----------CCCCCcccCcccccC----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 005875 527 PLMNVPAT-----------PSRSAGYRAPEVIET----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ 591 (672)
Q Consensus 527 ~~~~~~~~-----------~~~~~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~ 591 (672)
+.+..... ..||.+|++||.+.- .+.+.|+||||.||++|.++.|+.||.......
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--------- 691 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--------- 691 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---------
Confidence 98864322 236888999998853 346889999999999999999999998643221
Q ss_pred HhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 592 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.++.++.....-...+.....+.. ....+|++|+++.-+.|....++..
T Consensus 692 dILqeNTIlkAtEVqFP~KPvVss---eAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 DILQENTILKATEVQFPPKPVVSS---EAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHhhhchhcceeccCCCCCccCH---HHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 112222111111111111112223 3445566999999999999888765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=239.77 Aligned_cols=197 Identities=25% Similarity=0.367 Sum_probs=163.2
Q ss_pred HHhccccccCcEEEEEEEE-CCCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 378 ASAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 378 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.....||+|+||.|-+-++ .+|+..|+|++.....+ .+....|+.+.++...+|.+|.++|.+.+....++.||.|+
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 3456799999999988885 45888999999866443 34567788888887789999999999999999999999996
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 534 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 534 (672)
. +|..+-+.--. ....+++...-+|+..+..||.|||++- .++|||+||+|||++.+|++|+||||.+..+..+..
T Consensus 129 t-Sldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 129 T-SLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred h-hHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 6 77665543222 2344899999999999999999999964 699999999999999999999999999987765432
Q ss_pred ---CCCCCcccCcccccC----CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 005875 535 ---PSRSAGYRAPEVIET----RKHSHKSDVYSFGVLLLEMLTGKAPLQSP 578 (672)
Q Consensus 535 ---~~~~~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~el~tg~~pf~~~ 578 (672)
..|-..|||||.+.. ..|+.|+||||+|+++.||.+++.||+..
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 234556999999853 46899999999999999999999999754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=270.59 Aligned_cols=250 Identities=19% Similarity=0.331 Sum_probs=193.9
Q ss_pred CCHHHHHHHH-hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC
Q 005875 370 FDLEDLLRAS-AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD 444 (672)
Q Consensus 370 ~~~~~l~~~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 444 (672)
.++..+.+.. .++||+|.||+||-|+++ .|+.||||++.+... .....++|+.|+..+ +||.||.+-..|+..+
T Consensus 558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~e 636 (888)
T KOG4236|consen 558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPE 636 (888)
T ss_pred hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCc
Confidence 3444555444 689999999999999964 689999999987653 345688999999999 9999999999999999
Q ss_pred eeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC---CCeEEe
Q 005875 445 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCIS 521 (672)
Q Consensus 445 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~---~~~kl~ 521 (672)
..++|||-+.|.-|.-.+... ...+++.....++.||+.||.|||.++ |+|+||||+|||+.+. -++|||
T Consensus 637 rvFVVMEKl~GDMLEMILSsE----kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSSE----KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred eEEEEehhhcchHHHHHHHhh----cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeec
Confidence 999999999664444444432 334898888999999999999999998 9999999999999754 368999
Q ss_pred ecCCCCCCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 522 DFGLTPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 522 DfGla~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
|||+|++..... .-.|||.|+|||++..+.|...-|+||.||++|--++|..||.... ++.+.++
T Consensus 710 DFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQIQ------- 777 (888)
T KOG4236|consen 710 DFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQIQ------- 777 (888)
T ss_pred cccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHhh-------
Confidence 999999887543 4468999999999999999999999999999999999999997432 1111111
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
...+-. ......+.....+++|...++..=++|-|.+..+.
T Consensus 778 -NAaFMy---Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 778 -NAAFMY---PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -cccccc---CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 000100 01112333445566666888888888888877655
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=285.86 Aligned_cols=252 Identities=19% Similarity=0.217 Sum_probs=160.6
Q ss_pred hccccccCcEEEEEEEECC-----CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEE------EEeCCeeEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-----STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY------YYSKDEKLL 448 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~------~~~~~~~~l 448 (672)
.+.||+|+||+||+|++.+ +..||+|++...... +....+ .+... .+.+++.++.. ...+...++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRA-CPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhh-chhhHHHHHHhhhcccccccCCceEE
Confidence 4789999999999999764 578999987643211 111111 11111 22223222221 235567899
Q ss_pred EEEecCCCchhhhhccCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec
Q 005875 449 VYDYFASGSLSTLLHGNRGA---------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN 513 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~ 513 (672)
||||+.+++|.++++..... .........+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~ 289 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFS 289 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEe
Confidence 99999999999998743210 0001123345679999999999999998 99999999999998
Q ss_pred C-CCCeEEeecCCCCCCCCC-----CCCCCCCcccCcccccCC----------------------CCCCccchhhHHHHH
Q 005875 514 Q-DLDGCISDFGLTPLMNVP-----ATPSRSAGYRAPEVIETR----------------------KHSHKSDVYSFGVLL 565 (672)
Q Consensus 514 ~-~~~~kl~DfGla~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwS~Gvvl 565 (672)
+ ++.+||+|||+|+..... ....+++.|+|||.+... .++.++|||||||++
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 6 579999999999765332 234578899999966322 234567999999999
Q ss_pred HHHHhCCCCCCCCCC-------CCCCChhHHHHHhhhhccccccchhhhh-cccChHHHHHHHHHHHHHcccCCCCCCCC
Q 005875 566 LEMLTGKAPLQSPTR-------DDMVDLPRWVQSVVREEWTAEVFDVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPN 637 (672)
Q Consensus 566 ~el~tg~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 637 (672)
|||+++..|+..... ....+...|....... ..+... .+...........+|+.+|++.||++|||
T Consensus 370 ~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 370 LQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 999997766542100 0001111221111000 000000 00000111223457888999999999999
Q ss_pred HHHHHHH
Q 005875 638 MDEVVRM 644 (672)
Q Consensus 638 ~~evl~~ 644 (672)
++|++++
T Consensus 444 a~e~L~H 450 (566)
T PLN03225 444 AKAALAH 450 (566)
T ss_pred HHHHhCC
Confidence 9999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=250.82 Aligned_cols=190 Identities=21% Similarity=0.373 Sum_probs=166.7
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccCh----hhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~----~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
..+||+|+|++|-.++++. .+.+|+|++++.-... +-.+.|-.+.....+||.+|-+..+|+.+...++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 4689999999999999765 5678999988764322 2355666777777799999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC----
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN---- 530 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~---- 530 (672)
||+|--+++..+ .++++.+..+...|..||.|||+.| |++||||..|+|+|..|.+|++|+|+++.--
T Consensus 335 ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 335 GGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred Ccceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 999988876433 4999999999999999999999999 9999999999999999999999999987542
Q ss_pred CCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 005875 531 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 577 (672)
Q Consensus 531 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~ 577 (672)
...+.+|||.|.|||++.+..|...+|+|++||+|+||+.|+.||+-
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 34567899999999999999999999999999999999999999984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=251.57 Aligned_cols=234 Identities=24% Similarity=0.358 Sum_probs=188.4
Q ss_pred CcEEEEEEEECC-CcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchhhhhc
Q 005875 387 SYGTAYKAVLEE-STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLH 463 (672)
Q Consensus 387 ~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~ 463 (672)
+||.||+|...+ ++.+++|++...... .+.+.+|++.++++ +|+||+++++++..+...++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999874 788999998765432 57889999999999 99999999999999999999999999999999987
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---CCCCCCCc
Q 005875 464 GNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---ATPSRSAG 540 (672)
Q Consensus 464 ~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---~~~~~~~~ 540 (672)
... .+++..+..++.+++.++.|||+.+ ++|+||+|+||++++++.++++|||.+...... ....++..
T Consensus 80 ~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T smart00220 80 KRG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE 151 (244)
T ss_pred hcc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence 432 2889999999999999999999998 999999999999999999999999998776543 23446778
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHH
Q 005875 541 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQM 620 (672)
Q Consensus 541 y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 620 (672)
|++||.+....++.++||||||+++|++++|..||...... ............... .........+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~---------~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-----LELFKKIGKPKPPFP---------PPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHhccCCCCc---------cccccCCHHH
Confidence 99999999888899999999999999999999999753111 111111111110000 0000023467
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 005875 621 LQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 621 ~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 77888999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=281.92 Aligned_cols=239 Identities=26% Similarity=0.440 Sum_probs=184.1
Q ss_pred hccccccCcEE-EEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGT-AYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+++|.|+-|+ ||+|.++ ++.||||++-... ..-..+|+..++.-.+|||||++++.-.++...||..|.|.. +|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL 589 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL 589 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence 56799999875 8999987 7899999986543 335678999998888899999999999999999999999965 99
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC---C--CCeEEeecCCCCCCCCC-
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---D--LDGCISDFGLTPLMNVP- 532 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~--~~~kl~DfGla~~~~~~- 532 (672)
.+++... ............+.+..|+++||++||+.+ ||||||||.||||+. + ..++|+|||+++.....
T Consensus 590 ~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 590 QDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999863 111111122455778899999999999988 999999999999976 3 46899999999887543
Q ss_pred ------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 ------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.+..||-||+|||++....-+.++||||+||++|+.++| .+||...-..+. .++..+....
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~---- 733 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLV---- 733 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCcccee----
Confidence 234578899999999998888899999999999999885 999975432211 1112221111
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
......++ ...+||.+|++++|..||++.+|+.
T Consensus 734 ---~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 ---HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11111222 5667888999999999999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-31 Score=272.71 Aligned_cols=240 Identities=19% Similarity=0.274 Sum_probs=193.7
Q ss_pred ccccccCcEEEEEEEECCCc-EEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLEEST-TVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~-~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
..||-|+||.|=+++.+... .+|+|++++... ..+....|-.+|... +.|.||+++-.|.+.+..|++||-|-|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhhhHHhhcC
Confidence 56999999999999976543 488888876643 123455677888888 799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
|.|...+++ +..++......++..+..|++|||+++ ||+|||||+|.++|.+|-+||.|||+|+......
T Consensus 505 GElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 505 GELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred chhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 999999974 334888888999999999999999998 9999999999999999999999999999887654
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
+.+|||.|.|||++..+.++.++|.||+|+++||+++|.+||.+.++....++ +++.- | ....
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~------ILkGi------d----~i~~ 640 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL------ILKGI------D----KIEF 640 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH------HHhhh------h----hhhc
Confidence 56799999999999999999999999999999999999999997654332211 11100 0 0011
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRMI 645 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L 645 (672)
+....+...+++++.++.+|.+|.- +.+|.++-
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 1223345567778999999999976 66666653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=268.34 Aligned_cols=194 Identities=25% Similarity=0.405 Sum_probs=164.3
Q ss_pred ccccccCcEEEEEEEECCC-cEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||-|+||+|++++..|+ ..+|.|.+.+... .....+.|.+|+... ..+.||+|+-.|.+++.+|+||||++|
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEEeccCC
Confidence 4699999999999996654 4578888876532 123467788899888 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC-----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----- 530 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~----- 530 (672)
||+-.+|-+. .-+.+.-+..++..+..|+++.|..| +|||||||+|||||.+|++||+||||++-+.
T Consensus 714 GDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 714 GDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999888642 23778888888999999999999999 9999999999999999999999999985321
Q ss_pred ----C-------------------------------------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHH
Q 005875 531 ----V-------------------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEML 569 (672)
Q Consensus 531 ----~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~ 569 (672)
. .....||+.|+|||++....|+..+|+||.||+||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 0 01123678899999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCC
Q 005875 570 TGKAPLQSPTRDDM 583 (672)
Q Consensus 570 tg~~pf~~~~~~~~ 583 (672)
.|++||...+..+.
T Consensus 866 ~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 866 VGQPPFLADTPGET 879 (1034)
T ss_pred hCCCCccCCCCCcc
Confidence 99999988776554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=271.60 Aligned_cols=250 Identities=21% Similarity=0.341 Sum_probs=170.0
Q ss_pred hccccccCcEEEEEEEE-----------------CCCcEEEEEEecccccC-h--------------hhHHHHHHHHHHH
Q 005875 380 AEVLGKGSYGTAYKAVL-----------------EESTTVVVKRLKEVVVG-K--------------RDFEQQMEIVGRV 427 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~-~--------------~~~~~e~~~l~~l 427 (672)
.++||+|+||+||+|.. .+++.||||+++..... . +....|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 46899999999999964 23567999998643221 1 2233466666777
Q ss_pred cCCCc-----eeceEEEEEe--------CCeeEEEEEecCCCchhhhhccCCCC-------------------CCCCCCH
Q 005875 428 GQHPN-----VVPLRAYYYS--------KDEKLLVYDYFASGSLSTLLHGNRGA-------------------GRTPLDW 475 (672)
Q Consensus 428 ~~h~n-----iv~l~~~~~~--------~~~~~lV~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~ 475 (672)
+|.+ +++++++|.. ++..++||||+++|+|.++++...+. ....+++
T Consensus 230 -~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 230 -KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred -hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 4443 4677787753 35689999999999999999753211 1123567
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC-----CCCCCcccCcccccCC
Q 005875 476 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-----PSRSAGYRAPEVIETR 550 (672)
Q Consensus 476 ~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~-----~~~~~~y~aPE~~~~~ 550 (672)
..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........ ...++.|+|||.+...
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 888999999999999999998 99999999999999999999999999876533221 1236789999988543
Q ss_pred C--------------------C--CCccchhhHHHHHHHHHhCCC-CCCCCCCCCC------CChhHHHHHhhhhccccc
Q 005875 551 K--------------------H--SHKSDVYSFGVLLLEMLTGKA-PLQSPTRDDM------VDLPRWVQSVVREEWTAE 601 (672)
Q Consensus 551 ~--------------------~--~~~~DvwS~Gvvl~el~tg~~-pf~~~~~~~~------~~~~~~~~~~~~~~~~~~ 601 (672)
. + ..+.||||+||+++||++|.. ||........ .++..|... ...
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~------~~~ 459 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY------KGQ 459 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh------ccc
Confidence 2 1 134799999999999999875 6653221110 011111110 000
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 005875 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVP---DMRPNMDEVVRM 644 (672)
Q Consensus 602 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~ 644 (672)
..+ +...........+++.+++..+| .+|+|++|++++
T Consensus 460 ~~~-----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KYD-----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCC-----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 011 11111223445666668888765 789999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-30 Score=244.52 Aligned_cols=256 Identities=17% Similarity=0.268 Sum_probs=188.7
Q ss_pred ccccccCcEEEEEEEE-CCCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeC-----CeeEEEEE
Q 005875 381 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVYD 451 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~e 451 (672)
+.||.|+||.||.+.+ ++|+.|+.|++..... ..+.+-+|++++... +|.|+...+++..-. ++.|+++|
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 5799999999999986 4689999999876543 356788899999888 999999998887543 25678899
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
.|.. +|...+- +.+.++...+.-++.||++||+|||+.+ |.||||||.|.|++.+..+||+|||+|+....
T Consensus 138 LmQS-DLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 138 LMQS-DLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHh-hhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 8855 7877774 3456888899999999999999999998 99999999999999999999999999987654
Q ss_pred CCCC-----CCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHH---------HHHhhhh
Q 005875 532 PATP-----SRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW---------VQSVVRE 596 (672)
Q Consensus 532 ~~~~-----~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~---------~~~~~~~ 596 (672)
.... ..|..|+|||++.+. .|+.++||||.||++.|++.++.-|+....-+.++++.. ++.....
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 4322 236679999999875 589999999999999999999999987665443332111 1111110
Q ss_pred ccc---c-ccchhhhh---cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 597 EWT---A-EVFDVELM---RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 597 ~~~---~-~~~d~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
... + ..-.+.+. ........-...+.+...++..||.+|.+.++.+.++.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000 0 00011111 01111111223345556889999999999999988654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=244.76 Aligned_cols=128 Identities=19% Similarity=0.226 Sum_probs=109.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCC-------CceeceEEEEEe----CCeeE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-------PNVVPLRAYYYS----KDEKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-------~niv~l~~~~~~----~~~~~ 447 (672)
.++||.|.|++||++... ..+.||+|+.+....-.+....|+++++++..+ .+||+|++.|.. +.+.+
T Consensus 83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVC 162 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVC 162 (590)
T ss_pred EEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEE
Confidence 578999999999999964 467899999988766667788899999988633 379999999974 46889
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec
Q 005875 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN 513 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~ 513 (672)
+|+|++ |.+|..+|.... .+.++...+.+|+.||+.||.|||+++ .|||.||||+|||+.
T Consensus 163 MVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 163 MVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred EEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 999998 669999997654 344999999999999999999999987 699999999999994
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=228.31 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=186.1
Q ss_pred hccccccCcEEEEEEE-ECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCC--eeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e~~~~g 456 (672)
.+++|+|-|++||.|. ..++..++||+++... ++.+.+|++++..+..||||+.++++..+.. ...+|+||+++.
T Consensus 43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~ 120 (338)
T KOG0668|consen 43 VRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT 120 (338)
T ss_pred HHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence 4679999999999998 4567789999998653 5678999999999988999999999998764 457999999998
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC-CCeEEeecCCCCCCCCCCCC
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVPATP 535 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~~~~~~ 535 (672)
+...+-. .++...+...+.++++||.|+|++| |+|||+||.|+|+|.. -.++++|+|+|.++......
T Consensus 121 Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 121 DFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred cHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 8876654 3778889999999999999999999 9999999999999965 57999999999887665443
Q ss_pred ---CCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCC-CCCCCCChhHHHHHhhhhcc---c---cccch
Q 005875 536 ---SRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSP-TRDDMVDLPRWVQSVVREEW---T---AEVFD 604 (672)
Q Consensus 536 ---~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~-~~~~~~~~~~~~~~~~~~~~---~---~~~~d 604 (672)
..+..|--||.+.. ..|+..-|+|||||++..|+..+.||-.. +..+ ++++.+.-...++. . .-..|
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D--QLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH--HHHHHHHHhChHHHHHHHHHHccCCC
Confidence 34566889999865 45788899999999999999999998532 2211 12221111110000 0 00011
Q ss_pred hhh------------hcccChH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 VEL------------MRFQNIE---EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~~~------------~~~~~~~---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+.. .++...+ -...+.++++.+.+.+|-.+|+|++|+..+
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111 0111100 112445677779999999999999999873
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=229.48 Aligned_cols=205 Identities=31% Similarity=0.527 Sum_probs=179.8
Q ss_pred ccccCcEEEEEEEECC-CcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 383 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 383 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
||+|++|.||++...+ ++.+++|++...... .+.+.+|++.+..+ +|++++++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999765 788999998765442 46789999999999 8999999999999989999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-CCCeEEeecCCCCCCCCC----CC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVP----AT 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~~~----~~ 534 (672)
+++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+...... ..
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 9997432 34889999999999999999999998 999999999999999 899999999998766543 22
Q ss_pred CCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..+...|++||.+... .++.++|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 3456779999999887 788999999999999998
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+.+++.+|++.+|++||+++++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356678889999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=252.08 Aligned_cols=190 Identities=23% Similarity=0.370 Sum_probs=162.5
Q ss_pred HhccccccCcEEEEEEEECC-CcEEEEEEecccccCh----h-----hHHHHHHHHHHHc--CCCceeceEEEEEeCCee
Q 005875 379 SAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGK----R-----DFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEK 446 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~----~-----~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~ 446 (672)
+.+.+|+|+||.|++|.++. ...|+||.+.+.+.-. + ..-.|+.||..+. .|+||++++++|++++..
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 35789999999999999765 5678899887654311 1 2446899999983 299999999999999999
Q ss_pred EEEEEec-CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCC
Q 005875 447 LLVYDYF-ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 525 (672)
Q Consensus 447 ~lV~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 525 (672)
||+||-. ++.+|.+++.. +..+++.++..|+.||+.|+++||++| |||||||-+|+.++.+|-+||+|||.
T Consensus 645 yl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred EEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 9999976 45699999974 334899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCCC--CCCCCCCcccCcccccCCCCCC-ccchhhHHHHHHHHHhCCCCCC
Q 005875 526 TPLMNVP--ATPSRSAGYRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPLQ 576 (672)
Q Consensus 526 a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~-~~DvwS~Gvvl~el~tg~~pf~ 576 (672)
|...... ....||.+|.|||++.+.+|-- .-||||+|+++|-++....||.
T Consensus 717 aa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 8765443 4567999999999999999854 4699999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=226.06 Aligned_cols=252 Identities=20% Similarity=0.307 Sum_probs=186.9
Q ss_pred HhccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEE-EEeCCeeEEEEEecCCC
Q 005875 379 SAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY-YYSKDEKLLVYDYFASG 456 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~-~~~~~~~~lV~e~~~~g 456 (672)
+.+.+|+|.||.+-+++++. .+.+++|.+.......++|.+|...--.|..|.||+.-+++ |+..+....++||++.|
T Consensus 28 I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~g 107 (378)
T KOG1345|consen 28 INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRG 107 (378)
T ss_pred HHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccc
Confidence 45789999999999999775 56789999988888889999999876677789999998765 55566777999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec--CCCCeEEeecCCCCCCCCCCC
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDLDGCISDFGLTPLMNVPAT 534 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~--~~~~~kl~DfGla~~~~~~~~ 534 (672)
+|.+.+.. ..+-+....+++.|++.|+.|||++. +||||||.+||||- +...+|+||||+.+..+....
T Consensus 108 dL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 108 DLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred hhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 99998864 23788889999999999999999998 99999999999993 335899999999876654332
Q ss_pred C-CCCCcccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 535 P-SRSAGYRAPEVIETR-----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 535 ~-~~~~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
. .....|-|||..... ...+.+|||.||+++|.++||+.||+.....+ ..+.+|.+-.-+.. .... .
T Consensus 179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w~~rk~--~~~P----~ 251 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQWLKRKN--PALP----K 251 (378)
T ss_pred hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHHhcccC--ccCc----h
Confidence 2 235569999987543 24667899999999999999999998543332 22333332211111 1110 1
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
.+..+. ..++++.++-+..+|++|-...++.++..+.+
T Consensus 252 ~F~~fs---~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 252 KFNPFS---EKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred hhcccC---HHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 122222 33445555888999999966666666555443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-28 Score=246.89 Aligned_cols=259 Identities=21% Similarity=0.265 Sum_probs=198.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHc-----CCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
....|+|-|++|.+|... .+..||||++.....-.+.=..|++++.+|. .--|+++++-.|...++.|||+|-+
T Consensus 437 ~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L 516 (752)
T KOG0670|consen 437 QGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL 516 (752)
T ss_pred EeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh
Confidence 346899999999999954 4789999999887666666778999999984 2348999999999999999999987
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC-CCeEEeecCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVP 532 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~~~ 532 (672)
.. +|.++|++... ...|....+..++.|+..||..|...+ |+|.||||.|||+++. ..+||||||.|......
T Consensus 517 sl-NLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 517 SL-NLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASEN 590 (752)
T ss_pred hc-hHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccc
Confidence 54 99999986542 234778889999999999999999988 9999999999999976 56799999999877654
Q ss_pred CCC--CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHH-----hhhhcc-ccccch
Q 005875 533 ATP--SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS-----VVREEW-TAEVFD 604 (672)
Q Consensus 533 ~~~--~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~d 604 (672)
..+ ..+..|.|||++.+..|+...|+||.||+|||+.||+..|.+.+..+++.+.-.+.. ++.... ...-||
T Consensus 591 eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD 670 (752)
T KOG0670|consen 591 EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFD 670 (752)
T ss_pred cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcc
Confidence 322 234569999999999999999999999999999999999999877766433211111 110000 000011
Q ss_pred h--------------------------------hhhccc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 V--------------------------------ELMRFQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~--------------------------------~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. .+...+ .-.....+|.+|+..|+..||++|.|..|++++
T Consensus 671 ~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 671 QDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred cccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 1 111111 112344668889999999999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=231.04 Aligned_cols=251 Identities=23% Similarity=0.324 Sum_probs=184.2
Q ss_pred ccccccCcEEEEEEEE-CCCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeC------CeeEEEE
Q 005875 381 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLVY 450 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV~ 450 (672)
+.+|.|.- .|..+.. -.++.||+|++..... ..++..+|...+..+ +|+||++++.+|.-. .+.|+||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHHHHhHHHHH
Confidence 46788877 5555553 3478899999876533 345677888888888 999999999998644 3579999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
|||.. +|...++. .++-.....|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+...
T Consensus 101 e~m~~-nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 101 ELMDA-NLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred Hhhhh-HHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccC
Confidence 99965 89888862 2777888999999999999999999 9999999999999999999999999998765
Q ss_pred CC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC----------------ChhHHHH
Q 005875 531 VP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------------DLPRWVQ 591 (672)
Q Consensus 531 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~----------------~~~~~~~ 591 (672)
.. .....+..|.|||++.+..|.+.+||||.||++.||++|+.-|.+...-+.. ++...++
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 43 2344677899999999988999999999999999999999999865322110 0001111
Q ss_pred Hhhh--hccccccchhhh-----h-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 592 SVVR--EEWTAEVFDVEL-----M-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 592 ~~~~--~~~~~~~~d~~~-----~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.... +++....+...+ . ..+...-......+++.+|+..+|++|.++++++++
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111 000000011000 0 001111223456778889999999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=221.64 Aligned_cols=190 Identities=29% Similarity=0.478 Sum_probs=166.2
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|++|+||++...+ ++.+++|.+..... ..+.+.+|++.+.++ +|+|++++++++......++++||++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEeccCCC
Confidence 3579999999999999875 78899999876543 356788899999999 9999999999999989999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++..... .+++.....++.+++.++.+||+.+ ++|+|+++.||+++.++.++|+|||.+......
T Consensus 83 ~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 83 DLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99999974331 1788999999999999999999998 999999999999999999999999998776543
Q ss_pred -CCCCCCCcccCcccc-cCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 005875 533 -ATPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 577 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~ 577 (672)
....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 233456779999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-27 Score=251.00 Aligned_cols=241 Identities=22% Similarity=0.347 Sum_probs=190.1
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
+.+|.|.||.|||++.. .+...|+|+++-.. ......++|+-+++.. +|+|||.++|.|...+..+++||||.+|+|
T Consensus 21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 57999999999999965 46778899887653 3345567788777777 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC----CCCC
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----VPAT 534 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~----~~~~ 534 (672)
.+.-+. ..++++.++..++....+|++|||+++ -+|||||-.||++++.|.+|++|||.+..+. ....
T Consensus 100 Qdiy~~-----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 100 QDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred cceeee-----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 998773 345899999999999999999999998 8999999999999999999999999886553 3445
Q ss_pred CCCCCcccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 535 PSRSAGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 535 ~~~~~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
..||+.|||||+. ..+.|..++|||+.|+...|+-.-.+|...........+ . ....+++. ...
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L------m-----TkS~~qpp--~lk 238 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL------M-----TKSGFQPP--TLK 238 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH------h-----hccCCCCC--ccc
Confidence 6799999999987 345689999999999999999888888643322111000 0 01111111 111
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
+.......|-++++.|+.++|.+||+++.++.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22334456777888999999999999987654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=224.79 Aligned_cols=187 Identities=28% Similarity=0.495 Sum_probs=159.0
Q ss_pred hccccccCcEEEEEEEEC----CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.++||+|.|++||++.+. ..+.||+|.+.... .......|++++..+..+.||+++.+++..++...+|+||++.
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H 119 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH 119 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence 568999999999999854 35679999886543 3466899999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-CCCeEEeecCCCCCC-----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLM----- 529 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~----- 529 (672)
.+..++... ++..++...+..+.+||+++|.+| ||||||||+|+|.+. .+.-.|.|||+|...
T Consensus 120 ~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 120 DRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred cCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 999888863 778899999999999999999999 999999999999986 467889999998511
Q ss_pred ------------CC----------------C---------------CCCCCCCcccCcccccC-CCCCCccchhhHHHHH
Q 005875 530 ------------NV----------------P---------------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLL 565 (672)
Q Consensus 530 ------------~~----------------~---------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl 565 (672)
.. + ....||+||+|||++.. ..-++++||||.||++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 00 0 01236899999999865 4568899999999999
Q ss_pred HHHHhCCCCCCCC
Q 005875 566 LEMLTGKAPLQSP 578 (672)
Q Consensus 566 ~el~tg~~pf~~~ 578 (672)
..+++++.||-..
T Consensus 269 Lslls~~~PFf~a 281 (418)
T KOG1167|consen 269 LSLLSRRYPFFKA 281 (418)
T ss_pred ehhhccccccccC
Confidence 9999999998643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=262.38 Aligned_cols=189 Identities=19% Similarity=0.220 Sum_probs=136.3
Q ss_pred CC-CceeceEEEE-------EeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 005875 429 QH-PNVVPLRAYY-------YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500 (672)
Q Consensus 429 ~h-~niv~l~~~~-------~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i 500 (672)
+| +||++++++| ...+..+.++||+ +++|.+++... ...+++.+++.++.||++||+|||+++ |
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 44 6888888877 2334567788887 55999999742 234899999999999999999999998 9
Q ss_pred ccCCCCCCCEEecC-------------------CCCeEEeecCCCCCCCCC--------------------CCCCCCCcc
Q 005875 501 THGNIKASNVLINQ-------------------DLDGCISDFGLTPLMNVP--------------------ATPSRSAGY 541 (672)
Q Consensus 501 vHrDLk~~NILl~~-------------------~~~~kl~DfGla~~~~~~--------------------~~~~~~~~y 541 (672)
+||||||+||||+. ++.+|++|||+++..... ....+|+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 445666777766532110 012357779
Q ss_pred cCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHH
Q 005875 542 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQML 621 (672)
Q Consensus 542 ~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~ 621 (672)
||||++.+..++.++|||||||++|||++|..|+.... ....... .. ...+.. ........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~-~~----~~~~~~------~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLR-HR----VLPPQI------LLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHH-Hh----hcChhh------hhcCHHHH
Confidence 99999999999999999999999999999988875321 0011000 00 011100 11123345
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 005875 622 QIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 622 ~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+++.+||+.+|.+||++.|++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 67789999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=207.70 Aligned_cols=170 Identities=20% Similarity=0.261 Sum_probs=127.5
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP 535 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 535 (672)
|+|.++++.. ...+++..+..++.||+.||+|||+.+ ||+|||++.++.+|+ ||++....... .
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~ 64 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-S 64 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-C
Confidence 6899999743 234999999999999999999999975 999999999999999 99987765433 3
Q ss_pred CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHH
Q 005875 536 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 615 (672)
Q Consensus 536 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 615 (672)
.+++.|||||++.+..++.++|||||||++|||+||+.||...... ............. . ++. .......
T Consensus 65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~~-~--~~~--~~~~~~~ 134 (176)
T smart00750 65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----SAILEILLNGMPA-D--DPR--DRSNLES 134 (176)
T ss_pred CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----cHHHHHHHHHhcc-C--Ccc--ccccHHH
Confidence 5789999999999999999999999999999999999999653221 1111111111000 0 000 0001111
Q ss_pred HH--HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 616 EM--VQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 616 ~~--~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.. ..+.+++.+||+.+|++||++.|+++++..+...
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 12 2578899999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=249.37 Aligned_cols=186 Identities=35% Similarity=0.637 Sum_probs=153.4
Q ss_pred ChhHHHHHHHHHHhCCCC--CCCCCCCCCCCCCCcceeeecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCC
Q 005875 64 LNSDRQALLDFADAVPHL--RKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSN 141 (672)
Q Consensus 64 ~~~~~~al~~~~~~~~~~--~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N 141 (672)
...|+.||++||+++.+. ...+|+...++| .|.||.|+. .++|+.|+|++++++|.+|+ .+..+++|++|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVC-LWQGITCNN-SSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC-cCcceecCC-CCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCC
Confidence 457999999999998533 345898666655 899999985 46999999999999999987 7999999999999999
Q ss_pred CcCCCCCCcCC-CCCCCcEEeeeccCCCCCCCCCcccccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC
Q 005875 142 VLTGGLPSEIT-SLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF 220 (672)
Q Consensus 142 ~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 220 (672)
+++|.+|..+. ++++|++|+|++|+++|.+|....++|++|+|++|.+++.+|..++++++|+.|+|++|.+.+.+|..
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 99999998765 99999999999999999888776678888888888888888888888888888888888887777764
Q ss_pred --CCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 221 --DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 221 --~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
.+++|++|+|++|++++.+|..++++++|+.+
T Consensus 184 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 217 (968)
T PLN00113 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI 217 (968)
T ss_pred hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEE
Confidence 67777777777777777777776666665543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-24 Score=203.20 Aligned_cols=246 Identities=23% Similarity=0.376 Sum_probs=182.7
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+|.+...|+.|+|++++ ..+++|+++-... ..++|..|.-.++-. .||||..++|.|....+..++..||+.|+
T Consensus 196 tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCCCCceEeeeeccchH
Confidence 357788899999999984 4566677754332 246788887777666 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCCCCC
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR 537 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 537 (672)
|+..++... ....+..++.+++.+||+|++|||+.. |-|.---|.+..+++|++.+++|. .+-+++.-.......
T Consensus 274 lynvlhe~t---~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfsfqe~gr~y 348 (448)
T KOG0195|consen 274 LYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVGRAY 348 (448)
T ss_pred HHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceeeeecccccc
Confidence 999998643 345778899999999999999999985 333344688999999999988874 122222222223334
Q ss_pred CCcccCcccccCCCC---CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChH
Q 005875 538 SAGYRAPEVIETRKH---SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614 (672)
Q Consensus 538 ~~~y~aPE~~~~~~~---~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 614 (672)
.|.||+||.+...+. -.++|+|||++++||+.|...||......+.- .++.-+... ..-.+
T Consensus 349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mkialeglr----------v~ipp 412 (448)
T KOG0195|consen 349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MKIALEGLR----------VHIPP 412 (448)
T ss_pred CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hhhhhcccc----------ccCCC
Confidence 678999999987654 35789999999999999999999876554421 011111110 01111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 615 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
.....+.+++.-|+.+||.+||.++.++-.||++.
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 22345567777999999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=202.79 Aligned_cols=152 Identities=19% Similarity=0.260 Sum_probs=117.3
Q ss_pred hccccccCcEEEEEEEEC--CCcEEEEEEeccccc------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|.+. +++.+|||++..... ..+.+.+|++++.++ +|+|++..+.. .+..++|||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~---~~~~~LVmE 98 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA---TGKDGLVRG 98 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE---cCCcEEEEE
Confidence 467999999999999865 466789998753311 134689999999999 89999863322 246799999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCC-CCCCEEecCCCCeEEeecCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNI-KASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDL-k~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
|+++++|... .. .. ...++.++++||+|||+.| |+|||| ||+|||++.++.+||+|||+|+...
T Consensus 99 ~~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 99 WTEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred ccCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 9999999632 10 11 1467889999999999998 999999 9999999999999999999998654
Q ss_pred CCC------------CCCCCCcccCcccccCC
Q 005875 531 VPA------------TPSRSAGYRAPEVIETR 550 (672)
Q Consensus 531 ~~~------------~~~~~~~y~aPE~~~~~ 550 (672)
... +..+++.|+|||++...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 322 12356679999998643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-20 Score=181.94 Aligned_cols=255 Identities=19% Similarity=0.209 Sum_probs=194.8
Q ss_pred HhccccccCcEEEEEEE-ECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 379 SAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+++||+|.||..+.|+ +-++..||||.= ...........|....+.|...+.|..++-+..++.+..+|+|++ |-+
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS 109 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS 109 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence 36899999999999999 456899999853 334445678889999999989999999998888888889999988 668
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC-----CCeEEeecCCCCCCCCC
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-----LDGCISDFGLTPLMNVP 532 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-----~~~kl~DfGla~~~~~~ 532 (672)
|.|+..-.. ..++...++.+|.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.+..+
T Consensus 110 LEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 110 LEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred HHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 888876433 23899999999999999999999998 9999999999999753 34789999999987665
Q ss_pred CC-----------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccc
Q 005875 533 AT-----------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601 (672)
Q Consensus 533 ~~-----------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (672)
.+ ..||..||+=.-..++.-+.+-|+=|+|-++++.+-|..||++...+... .-.+.+.+.....
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK----~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK----EKYEKIGETKRST 258 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH----HHHHHhccccccC
Confidence 43 23788899988888889999999999999999999999999987544321 1111122221111
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 602 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
-++. -..++++++...++.++ ..+-++-|..+-+...+.++....
T Consensus 259 ~i~~---Lc~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 259 PIEV---LCEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred CHHH---HHhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhc
Confidence 1111 12234566666666554 467778889888888777776543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-20 Score=192.12 Aligned_cols=253 Identities=19% Similarity=0.259 Sum_probs=186.0
Q ss_pred hccccccCcEEEEEEEECCC--cEEEEEEecccccC-hhhHHHHHHHHHHHcC---CCceeceEEEE-EeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEES--TTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQ---HPNVVPLRAYY-YSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~---h~niv~l~~~~-~~~~~~~lV~e~ 452 (672)
.+.||+|+||.||++...+. ..+|+|.-...... ...+..|..++..+.. -.++..+++.. ..+...++||+.
T Consensus 23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l 102 (322)
T KOG1164|consen 23 GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSL 102 (322)
T ss_pred eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEec
Confidence 57899999999999997654 36777776554322 2268889999888852 36888999888 477788999997
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC-----CCeEEeecCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-----LDGCISDFGLTP 527 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-----~~~kl~DfGla~ 527 (672)
+ |.+|.++..... ...++......++.|++.+|++||+.| ++||||||.|+++... ..+.+.|||+++
T Consensus 103 ~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 103 L-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred c-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 7 679999886443 345899999999999999999999999 9999999999999865 468999999998
Q ss_pred CCC---C-------C----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHh
Q 005875 528 LMN---V-------P----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 593 (672)
Q Consensus 528 ~~~---~-------~----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 593 (672)
... . . ....||..|.++....+...+.+.|+||++.++.|+..|..||......... ......
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~~~~ 252 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---SKFEKD 252 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---HHHHHH
Confidence 221 1 1 1123788899999999999999999999999999999999999765432211 001111
Q ss_pred hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 594 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
.... .... .....+.+.. ++...+-..+..++|....+...+++.....
T Consensus 253 ~~~~----~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKL----LTDR---FGDLKPEEFA---KILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhh----cccc---ccCCChHHHH---HHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1000 0000 0111223333 3333444589999999999999998887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-19 Score=189.91 Aligned_cols=253 Identities=27% Similarity=0.381 Sum_probs=188.7
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||.|+||.||++... ..+++|.+...... ...+.+|..++..+..|++++++.+.+......+++++|+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 357899999999999987 78899988765432 457888999999994344899999999777778999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-CeEEeecCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~-- 532 (672)
+++.+++...... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+......
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999777643211 24888999999999999999999998 99999999999999998 7999999998754332
Q ss_pred --------CCCCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccc
Q 005875 533 --------ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601 (672)
Q Consensus 533 --------~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (672)
....++..|+|||.+.+ ..+....|+||+|++++++++|..||...... ................
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP- 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-
Confidence 34457888999999987 57888999999999999999999997654321 0011111111111111
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 602 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........... ......+.+++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000000 1223456677789999999999999988775
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=219.19 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=173.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecc---cccChhh----HHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKE---VVVGKRD----FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~----~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
..++|.|++|.|+..... .....+.|.... ....... +..|.-+-..+ .|+|++..+..+.+....+-+||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhhhh
Confidence 568999999987777633 233333333221 1111111 22233333445 89999888877777666666699
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|+++ ||..++... ..+...++-.++.|+..|++|+|+.| |.|||+|++|++++.+|.+||+|||.+.....
T Consensus 402 ~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9999 999999743 24788888999999999999999999 99999999999999999999999999866543
Q ss_pred CC--------CCCCCCcccCcccccCCCCCCc-cchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 532 PA--------TPSRSAGYRAPEVIETRKHSHK-SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 532 ~~--------~~~~~~~y~aPE~~~~~~~~~~-~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
+. ...|+..|+|||++.+..|++. .||||.|+++..|.+|+.||......+... .........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~ 544 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQR 544 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhcccccc
Confidence 32 3457788999999999999875 799999999999999999998765544321 000000000
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
........-..........++.++++.+|.+|.|+++|++
T Consensus 545 -~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 -NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000000111233344567888999999999999999987
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8e-21 Score=215.38 Aligned_cols=149 Identities=29% Similarity=0.534 Sum_probs=103.5
Q ss_pred HHHHHHHHHHhhhhcccCChhHHHHHHHHHHhCCCCCCCCCCCCCCCCC----CcceeeecCC--C--CeEEEEEeCCCC
Q 005875 46 LFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQ----SWVGINCTQD--R--TRVFGLRLPGIG 117 (672)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~al~~~~~~~~~~~~~~w~~~~~~c~----~w~gv~C~~~--~--~~v~~l~l~~~~ 117 (672)
.++..+.++.+.+....+...|..||+++|.++.....++|++ ++|+ .|.||.|+.. . .+|+.|+|++|+
T Consensus 352 pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~ 429 (623)
T PLN03150 352 AIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQG 429 (623)
T ss_pred ceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCC
Confidence 3455555555555556667789999999999986554458964 3442 7999999632 1 258888888888
Q ss_pred ccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCc
Q 005875 118 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQ 195 (672)
Q Consensus 118 l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~ 195 (672)
+.|.+|+ .++.|++|+.|+|++|.|+|.+|..++.|++|+.|+|++|+|+|.+|..+. ++|+.|+|++|+|+|.+|.
T Consensus 430 L~g~ip~-~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 508 (623)
T PLN03150 430 LRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508 (623)
T ss_pred ccccCCH-HHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCCh
Confidence 8888887 688888888888888888888888888887777777777777665555443 3444444444444444444
Q ss_pred hh
Q 005875 196 SI 197 (672)
Q Consensus 196 ~~ 197 (672)
.+
T Consensus 509 ~l 510 (623)
T PLN03150 509 AL 510 (623)
T ss_pred HH
Confidence 43
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=177.30 Aligned_cols=138 Identities=14% Similarity=0.207 Sum_probs=106.5
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccC----------hhhH-----------------HHHHHHHHHHcCCCce
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG----------KRDF-----------------EQQMEIVGRVGQHPNV 433 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----------~~~~-----------------~~e~~~l~~l~~h~ni 433 (672)
+.||+|+||.||+|...+|+.||||+++..... ...| +.|++.+.++ .++++
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTAGI 81 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHCCC
Confidence 579999999999999888999999999754221 1122 3488888888 66666
Q ss_pred eceEEEEEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcccCCCCCCCEEe
Q 005875 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI-HSMGGPKFTHGNIKASNVLI 512 (672)
Q Consensus 434 v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivHrDLk~~NILl 512 (672)
.....+.. ...++||||++++++...... ...++......++.|++.+|.|+ |+.+ |+||||||+|||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 44333322 234899999999877654321 12488899999999999999999 6887 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCC
Q 005875 513 NQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 513 ~~~~~~kl~DfGla~~~~ 530 (672)
+ ++.++|+|||+|....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 5789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.8e-20 Score=173.97 Aligned_cols=182 Identities=16% Similarity=0.158 Sum_probs=139.7
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChh-----hHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR-----DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~-----~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
...|++|+||+||.+.. .+..++.+.+.......+ .+.+|++++.++.+|+++++++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35799999999997776 577788777765543222 578999999999777899999886 45799999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCC-CCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNI-KASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDL-k~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
|.+|...+.. ....++.|++.+++++|+.| |+|||| ||+|||++.++.++|+|||+|.......
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9998654320 11347789999999999999 999999 7999999999999999999997544322
Q ss_pred C-----------------CCCCCcccCcccccCC-CCC-CccchhhHHHHHHHHHhCCCCCCCCCCC
Q 005875 534 T-----------------PSRSAGYRAPEVIETR-KHS-HKSDVYSFGVLLLEMLTGKAPLQSPTRD 581 (672)
Q Consensus 534 ~-----------------~~~~~~y~aPE~~~~~-~~~-~~~DvwS~Gvvl~el~tg~~pf~~~~~~ 581 (672)
. ...++.|++|+...-. ..+ ...++++-|.-+|.++|+..+..+.++.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 1 0125556777654322 223 4668999999999999999998876543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.1e-20 Score=179.32 Aligned_cols=162 Identities=13% Similarity=0.185 Sum_probs=127.0
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhh----------HHHHHHHHHHHcCCCceeceEEEEEeC------
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD----------FEQQMEIVGRVGQHPNVVPLRAYYYSK------ 443 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~----------~~~e~~~l~~l~~h~niv~l~~~~~~~------ 443 (672)
.+++|.|+||.||+... +++.+|+|.+.......+. +++|+..+.++ .|++|....+++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~~~~~~~~ 113 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLLAERKTLR 113 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeeeccccccc
Confidence 46899999999999766 5778999999765433332 57888899999 999999999886643
Q ss_pred --CeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEe
Q 005875 444 --DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 521 (672)
Q Consensus 444 --~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 521 (672)
...++||||++|.+|.++.. ++. ....+++.++..+|+.| ++|||+||+||++++++ ++|+
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEE
Confidence 35789999999999988742 332 24568999999999998 99999999999999998 9999
Q ss_pred ecCCCCCCCCCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHH
Q 005875 522 DFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEM 568 (672)
Q Consensus 522 DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el 568 (672)
|||........... ..+.....+..++|+|+||+++.-.
T Consensus 177 Dfg~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 177 DLSGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred ECCCcccccchhhH--------HHHHHHhHhcccccccceeEeehHH
Confidence 99987655322111 1134455677899999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=209.82 Aligned_cols=238 Identities=23% Similarity=0.336 Sum_probs=174.5
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccc--cChhhHHHHHHHHH-HHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVV--VGKRDFEQQMEIVG-RVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~e~~~l~-~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+-||.+.|=+|.+|+.++|. |+||++.+.. ..-+.|.++++-++ .+.+|||++++.-+-..+...|+|-+|..+
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH- 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence 456999999999999998776 8899986553 34455665554333 445899999988777777778899898866
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|+|.+. .+..+...+.+.|+.|+..|+..+|..| |+|+|||.+||||+.-.-+.|+||..-+..-.+.
T Consensus 106 nLyDRlS-----TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 106 NLYDRLS-----TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred hhhhhhc-----cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 8999885 4556888999999999999999999999 9999999999999999999999998654432111
Q ss_pred --------CCCCCCcccCcccccCCC-----------CCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHh
Q 005875 534 --------TPSRSAGYRAPEVIETRK-----------HSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 593 (672)
Q Consensus 534 --------~~~~~~~y~aPE~~~~~~-----------~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 593 (672)
+..+...|.|||.+.... .+++.||||+||++.|+++ |++||.-. .....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---------QL~aY- 247 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---------QLLAY- 247 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---------HHHhH-
Confidence 222345699999885411 4678899999999999988 67777521 00000
Q ss_pred hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 594 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+++.. .+.+++ ..+.+++..|++.||++|.++++.++.
T Consensus 248 ----r~~~~~~~e~~-Le~Ied--~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 ----RSGNADDPEQL-LEKIED--VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ----hccCccCHHHH-HHhCcC--ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00001111110 000011 246678889999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-20 Score=201.40 Aligned_cols=186 Identities=29% Similarity=0.425 Sum_probs=159.1
Q ss_pred cccccCcEEEEEEE----ECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 382 VLGKGSYGTAYKAV----LEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+|+|.||.|++++ .+.+..++.|.+++.... +.....|..++..+.+||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 234666888887765431 22456677888888679999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 534 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 534 (672)
+|+|...+... ..+++.........++-++.++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99999888643 23667777778888999999999998 99999999999999999999999999988776666
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 577 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~ 577 (672)
.+|+..|||||++. .+..++|.||||++++||+||..||..
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 68999999999998 577899999999999999999999986
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.9e-19 Score=171.50 Aligned_cols=138 Identities=17% Similarity=0.245 Sum_probs=108.6
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccC---------------------------hhhHHHHHHHHHHHcCCCce
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---------------------------KRDFEQQMEIVGRVGQHPNV 433 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~~~~~~e~~~l~~l~~h~ni 433 (672)
+.||+|+||+||+|...+|+.||||++...... ...++.|.+.+.++ .|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhCCC
Confidence 579999999999999878999999998754211 11235678888888 78887
Q ss_pred eceEEEEEeCCeeEEEEEecCCCchhhh-hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEE
Q 005875 434 VPLRAYYYSKDEKLLVYDYFASGSLSTL-LHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVL 511 (672)
Q Consensus 434 v~l~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NIL 511 (672)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ .| |+||||||+||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 554444333 34899999998855433 321 237788899999999999999999 88 999999999999
Q ss_pred ecCCCCeEEeecCCCCCCCC
Q 005875 512 INQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 512 l~~~~~~kl~DfGla~~~~~ 531 (672)
++ ++.++|+|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 89999999999876643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.4e-19 Score=165.24 Aligned_cols=193 Identities=20% Similarity=0.261 Sum_probs=158.3
Q ss_pred hccccccCcEEEEEEE-ECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.++||.|+||.+|.|. ..+|.+||||.=.. .........|.++...+..-..|..+..+..+.....+|||.+ |-+|
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsL 97 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSL 97 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccH
Confidence 4689999999999999 56789999997443 3345667888999999977788888888988888999999988 6689
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC---CCeEEeecCCCCCCCCCC--
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DfGla~~~~~~~-- 533 (672)
.+++.-... .++....+-++-|++.-++|+|.++ ++||||||+|+|..-+ ..+.++|||+|+.+....
T Consensus 98 EdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 98 EDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred HHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 888864332 3888899999999999999999998 9999999999999754 457899999998764432
Q ss_pred ---------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 005875 534 ---------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 581 (672)
Q Consensus 534 ---------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~ 581 (672)
...||..|.+-....+..-+.+-|+=|+|.++...--|..||++....
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 223677787766666666778899999999999999999999986543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.8e-19 Score=189.88 Aligned_cols=211 Identities=21% Similarity=0.383 Sum_probs=159.3
Q ss_pred CCCceeceEEEEEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCC
Q 005875 429 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKAS 508 (672)
Q Consensus 429 ~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~ 508 (672)
.|.|+.+++|.+.++...++|.+|+..|+|.+.+... ...++|.-...+..+|++||+|+|... -..|+.+++.
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 7999999999999999999999999999999999752 334899999999999999999999864 2299999999
Q ss_pred CEEecCCCCeEEeecCCCCCCCCCCC------CCCCCcccCcccccCCC-------CCCccchhhHHHHHHHHHhCCCCC
Q 005875 509 NVLINQDLDGCISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRK-------HSHKSDVYSFGVLLLEMLTGKAPL 575 (672)
Q Consensus 509 NILl~~~~~~kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~-------~~~~~DvwS~Gvvl~el~tg~~pf 575 (672)
|+++|..+.+|++|||+......... .....-|.|||.+.... .+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999877643110 11123499999997642 356789999999999999999999
Q ss_pred CCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 576 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
......+.. .+.+..+.. .....+.+..... .+....+..++.+||..+|++||+++++-..++.+....
T Consensus 159 ~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 159 DLRNLVEDP--DEIILRVKK--GGSNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccCCh--HHHHHHHHh--cCCCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 864433221 111111111 1111122222111 122336788889999999999999999999999887654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=175.38 Aligned_cols=193 Identities=20% Similarity=0.290 Sum_probs=136.6
Q ss_pred cCCCceeceEEEEEeC---------------------------CeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHH
Q 005875 428 GQHPNVVPLRAYYYSK---------------------------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK 480 (672)
Q Consensus 428 ~~h~niv~l~~~~~~~---------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~ 480 (672)
.+|||||++++.|.+. ...|+||.-++. +|..++.... .+.....-
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~ 345 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRV 345 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHH
Confidence 4799999998887432 246899998865 9999997432 56667778
Q ss_pred HHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe--cCCCC--eEEeecCCCCCCCC----------CCCCCCCCcccCccc
Q 005875 481 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLI--NQDLD--GCISDFGLTPLMNV----------PATPSRSAGYRAPEV 546 (672)
Q Consensus 481 i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl--~~~~~--~kl~DfGla~~~~~----------~~~~~~~~~y~aPE~ 546 (672)
|+.|+++|+.|||++| |.|||+|++|||+ |+|+. +.|+|||++-.... .....|....||||+
T Consensus 346 ~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 8999999999999999 9999999999999 44443 57899997632211 112235566999999
Q ss_pred ccCCC------CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHH
Q 005875 547 IETRK------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQM 620 (672)
Q Consensus 547 ~~~~~------~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 620 (672)
..... ...|+|.|+.|-+.||+++...||....+.. ++...+ ++.... .-.+.+...+
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Y-----qe~qLP----------alp~~vpp~~ 486 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTY-----QESQLP----------ALPSRVPPVA 486 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhhh-----hhhhCC----------CCcccCChHH
Confidence 86433 2468999999999999999999998632211 111110 011110 0112334456
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 621 LQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 621 ~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.+++...++.||++|++.+-....|+
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 77888999999999999877766654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.5e-19 Score=176.40 Aligned_cols=230 Identities=18% Similarity=0.310 Sum_probs=139.6
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC----hhhHHHHHHHHHHHc---------CCCceeceEEEEEe---
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVG---------QHPNVVPLRAYYYS--- 442 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~---------~h~niv~l~~~~~~--- 442 (672)
++.||.|+++.||.+++.+ ++.+|+|++...... .+.+++|.-.+..+. .|-.++-.++...-
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4689999999999999875 678999988644321 234444443332211 12122222222211
Q ss_pred ------C--C------eeEEEEEecCCCchhhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCC
Q 005875 443 ------K--D------EKLLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 506 (672)
Q Consensus 443 ------~--~------~~~lV~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk 506 (672)
. . ..+++|+-+ .+||.+++..... .....+....++.+..|+++.+++||..| ++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccc
Confidence 1 1 235677777 4588877642111 01122445566778899999999999999 9999999
Q ss_pred CCCEEecCCCCeEEeecCCCCCCCCCCC-CCCCCcccCcccccCC--------CCCCccchhhHHHHHHHHHhCCCCCCC
Q 005875 507 ASNVLINQDLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETR--------KHSHKSDVYSFGVLLLEMLTGKAPLQS 577 (672)
Q Consensus 507 ~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~y~aPE~~~~~--------~~~~~~DvwS~Gvvl~el~tg~~pf~~ 577 (672)
|+|++++++|.+.|+||+.....+.... ...+..|.+||..... .++.+.|.|++|+++|.|+++..||..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999987655443222 2344679999977442 468899999999999999999999985
Q ss_pred CCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCC
Q 005875 578 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 635 (672)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 635 (672)
........ | .+..+.+....+.+||..+++.+|++|
T Consensus 253 ~~~~~~~~---~-------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSPEADPE---W-------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGGGSTSG---G-------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCcccccc---c-------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 53221110 0 112222344556667779999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=160.09 Aligned_cols=134 Identities=12% Similarity=0.126 Sum_probs=103.2
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeccc-ccChhhHHHHHHHHHHHc----CCCceeceEEEEEeCC---eeE-EEE
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEV-VVGKRDFEQQMEIVGRVG----QHPNVVPLRAYYYSKD---EKL-LVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~----~h~niv~l~~~~~~~~---~~~-lV~ 450 (672)
.+.||+|+||.||. +.+....+||++... ....+.+.+|+.++..+. .||||++++|+++++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36799999999996 443344478887653 224567899999999984 4899999999998874 333 789
Q ss_pred Ee--cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCcccCCCCCCCEEecC----CCCeEEeec
Q 005875 451 DY--FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV-AHIHSMGGPKFTHGNIKASNVLINQ----DLDGCISDF 523 (672)
Q Consensus 451 e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl-~~LH~~~~~~ivHrDLk~~NILl~~----~~~~kl~Df 523 (672)
|| +.+|+|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||
T Consensus 85 e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred cCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 99 5679999999642 25544 35677888777 9999998 999999999999974 347999995
Q ss_pred CCC
Q 005875 524 GLT 526 (672)
Q Consensus 524 Gla 526 (672)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.1e-16 Score=155.90 Aligned_cols=133 Identities=20% Similarity=0.367 Sum_probs=111.7
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccC---------hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
+.||+|++|.||+|.. .+..+++|+....... ...+.+|++++..+ .|+++.....++...+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEEE
Confidence 4689999999999987 5677889986543221 23567788889888 78888887777777788899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
|++|++|.+++... .. .+..++.+++.++.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998631 12 77889999999999999998 99999999999999 78999999998765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=154.43 Aligned_cols=130 Identities=21% Similarity=0.370 Sum_probs=104.9
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEeccccc---------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 382 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.||+|+||.||+|.+. +..+++|....... ....+.+|++++..+ +|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999954 67899998654321 124566799999988 677665555555666778999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
++|++|.+++.... . .++.+++.+|.++|+.+ ++|+|++|+||+++ ++.++++|||++...
T Consensus 79 ~~g~~l~~~~~~~~---------~---~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGN---------D---ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcH---------H---HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998875311 0 78999999999999998 99999999999999 899999999998663
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.7e-16 Score=156.08 Aligned_cols=139 Identities=15% Similarity=0.202 Sum_probs=106.3
Q ss_pred HhccccccCcEEEEEEE--ECCCcEEEEEEecccccC-------------------------hhhHHHHHHHHHHHcCC-
Q 005875 379 SAEVLGKGSYGTAYKAV--LEESTTVVVKRLKEVVVG-------------------------KRDFEQQMEIVGRVGQH- 430 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~~h- 430 (672)
..+.||+|+||.||+|. ..+++.||+|+++..... ...+++|++.+.++ .+
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-~~~ 110 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-YEA 110 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-Hhc
Confidence 35789999999999998 567899999998753210 01256788899888 43
Q ss_pred -CceeceEEEEEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCC
Q 005875 431 -PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASN 509 (672)
Q Consensus 431 -~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~N 509 (672)
..+.+++++ ...++||||+++++|...... ...........++.|++.++++||+.+ .|+||||||+|
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 233444432 235899999999888765421 122555667889999999999999986 59999999999
Q ss_pred EEecCCCCeEEeecCCCCCCC
Q 005875 510 VLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 510 ILl~~~~~~kl~DfGla~~~~ 530 (672)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=181.68 Aligned_cols=185 Identities=24% Similarity=0.336 Sum_probs=145.3
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHc--CCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|...+++.||+|+=+....++ |.--.+++.+|. --+-|..+...+.-.+..++|+||.+.|+
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt 780 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT 780 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence 45799999999999998889999999877655442 222233444441 12334444445555677889999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-------CCCeEEeecCCCCCCC
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-------DLDGCISDFGLTPLMN 530 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-------~~~~kl~DfGla~~~~ 530 (672)
|.+++... +.++|.-.+.+..|+++.+++||..+ |||+||||+|+||.. ...++|+|||.+-.+.
T Consensus 781 lld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 781 LLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred HHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999833 34899999999999999999999998 999999999999952 3458999999986553
Q ss_pred C---CC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 005875 531 V---PA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574 (672)
Q Consensus 531 ~---~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~p 574 (672)
. .. ...+|-.+-.+|...++..+.++|.|.++-+++-|+.|+..
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 2 21 12346678899999999999999999999999999998743
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=6e-16 Score=151.02 Aligned_cols=132 Identities=15% Similarity=0.174 Sum_probs=103.8
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC-----------------------hhhHHHHHHHHHHHcCCC--cee
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-----------------------KRDFEQQMEIVGRVGQHP--NVV 434 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------------~~~~~~e~~~l~~l~~h~--niv 434 (672)
.+.||+|+||.||++...+++.||||++...... ...+..|..++..+ .|+ .++
T Consensus 20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~v~ 98 (198)
T cd05144 20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEGFPVP 98 (198)
T ss_pred CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcCCCCC
Confidence 5789999999999999888999999987543210 11356677788887 565 444
Q ss_pred ceEEEEEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC
Q 005875 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 514 (672)
Q Consensus 435 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~ 514 (672)
..++ ....++||||+++++|...... .....++.+++.++.++|+.+ |+||||||+||++++
T Consensus 99 ~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~ 160 (198)
T cd05144 99 KPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDD 160 (198)
T ss_pred ceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcC
Confidence 4443 2456899999999998765421 234578899999999999988 999999999999999
Q ss_pred CCCeEEeecCCCCCCC
Q 005875 515 DLDGCISDFGLTPLMN 530 (672)
Q Consensus 515 ~~~~kl~DfGla~~~~ 530 (672)
++.++|+|||.+....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=5e-16 Score=174.45 Aligned_cols=132 Identities=20% Similarity=0.335 Sum_probs=107.6
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeccccc--------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|.+.+...++.++..+... ..+.+.+|++++..+ +|++++....++.+....++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeCCCCEEEEE
Confidence 468999999999999976544333222222111 124578899999999 89999988888877778899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|+++++|.+++. ....++.+++.++.|||+.+ ++||||||+|||+ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998874 34678999999999999998 9999999999999 6789999999998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-16 Score=178.49 Aligned_cols=197 Identities=24% Similarity=0.340 Sum_probs=133.7
Q ss_pred hccccccCcEEEEEEEECCC-cEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.++|-.|+||.||..+++.. +++|.|+-++. .+.+. ++... ..|.+| ||-
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~-----lilRn--ilt~a-~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQN-----LILRN--ILTFA-GNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccc-----hhhhc--ccccc-CCccee---------------------chh
Confidence 47889999999999998754 45666432221 11111 22222 344444 555
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-------
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV------- 531 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~------- 531 (672)
...++... .++.. ++.+++|+|+.+ |+|||+||+|.+|+.-|.+|++|||+.+....
T Consensus 139 ~tllk~~g-----~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 139 ATLLKNIG-----PLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhcccCC-----CCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 55554221 23322 267899999998 99999999999999999999999998754211
Q ss_pred ------------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 532 ------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 532 ------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
...-++|+.|.|||++....|+..+|+|++|+++||.+-|+.||.+.+.++.+. ..+.+...
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~visd~i~ 276 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVISDDIE 276 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hhhhhhcc
Confidence 112357999999999999999999999999999999999999999887665432 22222110
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCC
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 636 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 636 (672)
..+..+....+..+++.+.++.+|.+|-
T Consensus 277 ---------wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 277 ---------WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ---------ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 0011122223445566688889999984
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-16 Score=166.66 Aligned_cols=118 Identities=25% Similarity=0.353 Sum_probs=103.1
Q ss_pred eeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecC
Q 005875 445 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 524 (672)
Q Consensus 445 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 524 (672)
..|+.|+++.-.+|.+|+...+. ....++...+.++.|++.|+.| ++ .+|||+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 57899999999999999975442 3347788899999999999999 65 9999999999999999999999999
Q ss_pred CCCCCCCCC----------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh
Q 005875 525 LTPLMNVPA----------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 570 (672)
Q Consensus 525 la~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t 570 (672)
+........ ...+|..||+||.+.+..|+.|+||||+|++++|+++
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 987654332 3347888999999999999999999999999999997
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-15 Score=139.91 Aligned_cols=135 Identities=18% Similarity=0.168 Sum_probs=112.9
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCC-CceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-PNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..+.++ .++++++++...++..+++|||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 569999999999999865 7899998865433 56789999999999544 68999999888888899999999987765
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
.+ +......++.+++.+++++|....+.++|+|++|+||++++++.++++|||.+...
T Consensus 82 ~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 82 EV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 43 44566778999999999999864445999999999999999999999999987643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.4e-17 Score=145.05 Aligned_cols=144 Identities=31% Similarity=0.502 Sum_probs=129.5
Q ss_pred CCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--ccccee
Q 005875 105 RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182 (672)
Q Consensus 105 ~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L 182 (672)
...++.|.|++|.++ .+|+ .++.|.+|+.|++++|+++ .+|.++++|++|+.|+++-|++. .+|..|+ +.|+.|
T Consensus 32 ~s~ITrLtLSHNKl~-~vpp-nia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPP-NIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred hhhhhhhhcccCcee-ecCC-cHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 357889999999999 7787 6999999999999999999 89999999999999999999999 8999998 799999
Q ss_pred ecccccCcc-cCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 183 DLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 183 ~ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
||++|+++. .+|..|..++.|+.|+|++|.+.-.+|+. .+++|+.|.+..|.+- .+|..++.++.|+-++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelh 179 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELH 179 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHh
Confidence 999999974 58999999999999999999999777776 8999999999999998 7899988888776554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-14 Score=138.96 Aligned_cols=136 Identities=18% Similarity=0.227 Sum_probs=97.8
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccCh---hh----------------------HHHHHHHHHHHcCC-Ccee
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK---RD----------------------FEQQMEIVGRVGQH-PNVV 434 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~----------------------~~~e~~~l~~l~~h-~niv 434 (672)
+.||+|+||+||+|...+++.||||++....... .. ...|.+.+..+..+ -.+.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 5799999999999998889999999987542211 11 13455555555222 2344
Q ss_pred ceEEEEEeCCeeEEEEEecCCCchhh-hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEEe
Q 005875 435 PLRAYYYSKDEKLLVYDYFASGSLST-LLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLI 512 (672)
Q Consensus 435 ~l~~~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl 512 (672)
+.+++ ...++||||++++++.. .+.... .. .+...++.+++.++.++|. .+ |+||||||+||++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 45543 24689999999965432 121100 11 5678899999999999999 77 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCC
Q 005875 513 NQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 513 ~~~~~~kl~DfGla~~~~~ 531 (672)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 99999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.6e-14 Score=141.28 Aligned_cols=145 Identities=18% Similarity=0.236 Sum_probs=108.6
Q ss_pred CCCHHHHHHHHhcccc-ccCcEEEEEEEECCCcEEEEEEecccc--------------cChhhHHHHHHHHHHHcCCCce
Q 005875 369 NFDLEDLLRASAEVLG-KGSYGTAYKAVLEESTTVVVKRLKEVV--------------VGKRDFEQQMEIVGRVGQHPNV 433 (672)
Q Consensus 369 ~~~~~~l~~~~~~~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~~h~ni 433 (672)
.|+.+.. ...+..|| .|+.|+||.++.. +..+++|++.... .....+.+|++++..+ +|++|
T Consensus 26 ~~~~~~~-~~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi 102 (239)
T PRK01723 26 LFDPDFW-QQQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGL 102 (239)
T ss_pred hcCHHHH-hhcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCC
Confidence 3444333 23356798 8999999999886 6778888875311 1224577899999999 77664
Q ss_pred --eceEEEEEeCC----eeEEEEEecCC-CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCC
Q 005875 434 --VPLRAYYYSKD----EKLLVYDYFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 506 (672)
Q Consensus 434 --v~l~~~~~~~~----~~~lV~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk 506 (672)
++.+++...+. ..++||||+++ .+|.+++... .++.. .+.+++.++.+||+.| |+|||||
T Consensus 103 ~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlk 169 (239)
T PRK01723 103 PVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLN 169 (239)
T ss_pred CCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCC
Confidence 67777654332 23599999997 6898888531 24443 3568899999999999 9999999
Q ss_pred CCCEEecCCCCeEEeecCCCCCC
Q 005875 507 ASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 507 ~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|+|||++.++.++|+|||.+...
T Consensus 170 p~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 170 AHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred chhEEEcCCCCEEEEECCCcccC
Confidence 99999999999999999988664
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=7e-16 Score=138.41 Aligned_cols=136 Identities=30% Similarity=0.451 Sum_probs=122.6
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCC-CCCCCcc--cccceee
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG-KIPSSFS--PQLVVLD 183 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~--~~L~~L~ 183 (672)
.+..|++.+|++. .+|. .++.|++|+.|+++-|++. .+|..|+.++.|+.|||++|+++. .+|..|. +.|+-|+
T Consensus 57 nlevln~~nnqie-~lp~-~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly 133 (264)
T KOG0617|consen 57 NLEVLNLSNNQIE-ELPT-SISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY 133 (264)
T ss_pred hhhhhhcccchhh-hcCh-hhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence 4567899999998 7888 7999999999999999999 999999999999999999999974 6888877 8899999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFP 247 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~ 247 (672)
|++|.|. .+|..+++|++|+.|.+.+|.+-..+-+. .++.|+.|.+.+|+++ .+|+.++++.
T Consensus 134 l~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~ 196 (264)
T KOG0617|consen 134 LGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT-VLPPELANLD 196 (264)
T ss_pred hcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee-ecChhhhhhh
Confidence 9999999 99999999999999999999998444344 8999999999999999 8888877653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.9e-15 Score=164.78 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=175.7
Q ss_pred ccccccCcEEEEEEEECCC--cEEEEEEecccccCh---hhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLEES--TTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+|+.|-....... ..+++|.+....... .....|..+-..+.+|+|++.+++...+.+..+++++|.++
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 3489999999988876443 345555554432222 22333555555564599999999999999999999999999
Q ss_pred Cchhhhh-ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcccCCCCCCCEEecCCC-CeEEeecCCCCCCCC-
Q 005875 456 GSLSTLL-HGNRGAGRTPLDWETRVKILLGTARGVAHIH-SMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNV- 531 (672)
Q Consensus 456 g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~- 531 (672)
|++.+.+ +... ...+.......+.|+..++.|+| ..+ +.|||+||+|.+++..+ ..+++|||+|..+..
T Consensus 106 ~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 106 GSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccCCc----cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 9999888 4221 13566677789999999999999 777 99999999999999999 999999999987655
Q ss_pred CC------CCCC-CCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 532 PA------TPSR-SAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 532 ~~------~~~~-~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
.. ...| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+......+. ....|...... .
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~~~---~---- 250 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNKGR---F---- 250 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccccc---c----
Confidence 22 2346 88899999998854 46778999999999999999999986554432 11111111100 0
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
...... .-.....++..+++..+|++|.+.+++..
T Consensus 251 --~~~~~~---~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 --TQLPWN---SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --ccCccc---cCChhhhhcccccccCCchhccccccccc
Confidence 000111 11223455666888899999999888765
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.3e-15 Score=155.01 Aligned_cols=139 Identities=29% Similarity=0.391 Sum_probs=110.8
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCC----CCC----------
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG----KIP---------- 172 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g----~~p---------- 172 (672)
....|+|++|++. +||...+-+|+.|-+||||+|+|. .+|+.+..|..|++|+|++|.+.- .+|
T Consensus 127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence 4677999999988 899888999999999999999999 889999999999999999998752 233
Q ss_pred -----------CCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCC
Q 005875 173 -----------SSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGS 238 (672)
Q Consensus 173 -----------~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~ 238 (672)
.++. .+|..+|||.|+|. .+|+.+-++.+|+.|+||+|+|+..--.. ...+|+.|+||+|+|+ .
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~ 282 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-V 282 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-c
Confidence 2222 47889999999999 89999999999999999999988432222 5567777778877777 6
Q ss_pred CCcccCCCCCC
Q 005875 239 IPSSLQKFPNS 249 (672)
Q Consensus 239 ~p~~~~~~~~l 249 (672)
+|+.+.+++.|
T Consensus 283 LP~avcKL~kL 293 (1255)
T KOG0444|consen 283 LPDAVCKLTKL 293 (1255)
T ss_pred chHHHhhhHHH
Confidence 66666655544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.1e-14 Score=148.74 Aligned_cols=142 Identities=30% Similarity=0.305 Sum_probs=96.3
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
.+..|+|..|+++ .+..+.+.+|++|+.||||+|.|+..-++.|.-..+|++|+|++|+++..-+.+|. ..|++|+|
T Consensus 270 kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 270 KMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred ccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 4667888888888 45555788889999999999988878888888888899999999998865555554 56666666
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC-----CCCCCceEEeecCCCCCCCC-cccCCCCCCc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-----DIPKLRHLNLSYNGLKGSIP-SSLQKFPNSS 250 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-----~l~~L~~l~l~~N~l~g~~p-~~~~~~~~l~ 250 (672)
++|+++..-...|..+++|++|||++|.|++.+.+. .|++|+.|+|.+|++. .|| ..|..+.+|.
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE 419 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALE 419 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccc
Confidence 666666555555666666666666666666555432 4555555555555555 333 2344444433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.3e-12 Score=140.20 Aligned_cols=140 Identities=21% Similarity=0.312 Sum_probs=98.1
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccC-----------------------------------------hhhHHH
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-----------------------------------------KRDFEQ 419 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------------------------------~~~~~~ 419 (672)
+.||.|++|.||+|++++|+.||||+....... +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 579999999999999999999999998643210 002444
Q ss_pred HHHHHHHHc----CCCceeceEEEEEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 005875 420 QMEIVGRVG----QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR-GVAHIHS 494 (672)
Q Consensus 420 e~~~l~~l~----~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-gl~~LH~ 494 (672)
|...+.++. +++++.-..-+.......++||||++|++|.++...... .. ...+++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHHh
Confidence 554444442 234433222222234567999999999999887652211 12 23456666665 4678898
Q ss_pred cCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 495 ~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
.| ++|+|++|.||++++++.++++|||++....
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 88 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.2e-14 Score=144.75 Aligned_cols=137 Identities=32% Similarity=0.522 Sum_probs=114.5
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
+.+.+++.+|.+. .+|++.+. ++.|++||..+|-++ ++|++++.|.+|.-|||.+|++. .+| .|+ +.|.+|++
T Consensus 161 ~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~ 235 (565)
T KOG0472|consen 161 KLSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHV 235 (565)
T ss_pred HHHHhhccccchh-hCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHh
Confidence 3456677777777 55554444 888888888888887 89999999999999999999998 778 665 78999999
Q ss_pred ccccCcccCCchhh-hhccccceecCCccccCCCCC-C-CCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 185 SFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPN-F-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 185 s~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~-~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
+.|+|. .+|.+.. +|.+|..|||.+|++. ..|. . .+.+|++||+|+|.++ .+|.+++++ .|.|+
T Consensus 236 g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L 302 (565)
T KOG0472|consen 236 GENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFL 302 (565)
T ss_pred cccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeeh
Confidence 999999 8888776 8999999999999999 4555 3 8889999999999999 789999988 66655
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.8e-12 Score=128.04 Aligned_cols=198 Identities=21% Similarity=0.308 Sum_probs=137.7
Q ss_pred HHHHcCCCceeceEEEEEeCC-----eeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 005875 424 VGRVGQHPNVVPLRAYYYSKD-----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 498 (672)
Q Consensus 424 l~~l~~h~niv~l~~~~~~~~-----~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~ 498 (672)
+..+ .|.|||++..|+.+.+ ...++.|||..|++..+|++.+. ....+......+++.||..||.|||+.. |
T Consensus 121 llql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 121 LLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 3344 6999999999987654 45789999999999999986553 2344777888899999999999999975 8
Q ss_pred CcccCCCCCCCEEecCCCCeEEeecCCCCCC---C---C--CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh
Q 005875 499 KFTHGNIKASNVLINQDLDGCISDFGLTPLM---N---V--PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 570 (672)
Q Consensus 499 ~ivHrDLk~~NILl~~~~~~kl~DfGla~~~---~---~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t 570 (672)
+|+|+++..+-|++..+|-+|+.--.-.... . . .....+-++|.+||+=.....+.++|||+||....||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 8999999999999999998887421111000 0 0 011224578999998877778889999999999999988
Q ss_pred CCCCCC-CCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 571 GKAPLQ-SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 571 g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
+..--. +....+. .+....-++..+-. .-..++..|++..|..||+|++++.+.
T Consensus 278 lEiq~tnseS~~~~-----------ee~ia~~i~~len~----------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSESKVEV-----------EENIANVIIGLENG----------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCcceeeh-----------hhhhhhheeeccCc----------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 765422 1111110 00000011100000 012355699999999999999987653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=3e-13 Score=136.54 Aligned_cols=73 Identities=25% Similarity=0.361 Sum_probs=60.9
Q ss_pred eeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeec-cCC
Q 005875 98 GINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH-NNF 167 (672)
Q Consensus 98 gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~-N~l 167 (672)
-|.|+..+ ...+.|+|..|+++ .||+++|+.+.+|+.||||+|+|+-+-|..|.+|++|..|-+.+ |+|
T Consensus 50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLPPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI 128 (498)
T ss_pred eEEccCCCcccCcccCCCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence 46787532 35689999999999 89999999999999999999999988899999998887766655 787
Q ss_pred CCCCC
Q 005875 168 SGKIP 172 (672)
Q Consensus 168 ~g~~p 172 (672)
+ .+|
T Consensus 129 ~-~l~ 132 (498)
T KOG4237|consen 129 T-DLP 132 (498)
T ss_pred h-hhh
Confidence 7 444
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.1e-13 Score=145.51 Aligned_cols=145 Identities=26% Similarity=0.282 Sum_probs=119.3
Q ss_pred EEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccc
Q 005875 110 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 187 (672)
Q Consensus 110 ~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N 187 (672)
.|.|..|+++ .+.++.|-.|.++++|+|+.|+++..--.++.+|++|+.||||+|.+...-++++. ++|++|+||+|
T Consensus 249 nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N 327 (873)
T KOG4194|consen 249 NLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSN 327 (873)
T ss_pred hhhhhhcCcc-cccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccc
Confidence 3445556666 56667888999999999999999977778899999999999999999988777655 89999999999
Q ss_pred cCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcc---cC---CCCCCccccCC
Q 005875 188 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS---LQ---KFPNSSFVGNS 255 (672)
Q Consensus 188 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~---~~---~~~~l~~~~n~ 255 (672)
+|+...+.+|..|.+|+.|+|++|.++..-... .+++|+.|||++|.+++.|.+. |. .+++|.+-||.
T Consensus 328 ~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 328 RITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred ccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 999888889999999999999999999443332 8999999999999999888653 33 34445555654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-11 Score=117.30 Aligned_cols=131 Identities=15% Similarity=0.114 Sum_probs=97.1
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchhh
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLST 460 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~ 460 (672)
+.++.|.++.||+++.. ++.+++|...........++.|++++..+.+...+.+++.+. .+..++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 46889999999999976 678999987654433446788999988884443344555443 334689999999987754
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 461 LLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 461 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
.- . ....++.+++++++.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 1 11235678999999999986 12359999999999999 67899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.4e-13 Score=142.58 Aligned_cols=124 Identities=31% Similarity=0.462 Sum_probs=69.8
Q ss_pred EEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCc-CCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 108 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
++.|||++|.|. ..|. .+..-.++-+|+||+|+|. +||.. |.+|+.|-+||||+|++. .+|+.+. ..|++|+|
T Consensus 105 Lt~lDLShNqL~-EvP~-~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L 180 (1255)
T KOG0444|consen 105 LTILDLSHNQLR-EVPT-NLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL 180 (1255)
T ss_pred ceeeecchhhhh-hcch-hhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence 455666666665 4555 4555566666666666665 55533 455666666666666665 4454443 34555555
Q ss_pred ccccCc-------------------------ccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCC
Q 005875 185 SFNSFT-------------------------GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLK 236 (672)
Q Consensus 185 s~N~l~-------------------------~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~ 236 (672)
|+|-|. ..+|.++..|.+|..+|||.|+|. .+|+. .+++|+.|+||+|.++
T Consensus 181 s~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 181 SNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred CCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence 555322 135556666666666666666665 34442 5666666666666665
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.2e-13 Score=137.62 Aligned_cols=153 Identities=29% Similarity=0.461 Sum_probs=130.7
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
..+.+++.+|.++ ++|+ +++.+..++.|+.++|+++ .+|++++++.+|..|+.++|.+. .+|+.++ ..|+.|+.
T Consensus 69 ~l~vl~~~~n~l~-~lp~-aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~ 144 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPA-AIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDA 144 (565)
T ss_pred ceeEEEeccchhh-hCCH-HHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhc
Confidence 4678999999999 7888 7999999999999999999 99999999999999999999999 7777777 68999999
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCCCCccc---cCCCCCCC
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLCGP 260 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~---~n~~~~~~ 260 (672)
.+|+++ ..|..++++.+|..|++.+|++...+|.. +++.|++||.-+|-+. .+|+.++.+.+|..+ .|....-+
T Consensus 145 ~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP 222 (565)
T KOG0472|consen 145 TNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP 222 (565)
T ss_pred cccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC
Confidence 999999 89999999999999999999999777764 8899999999999888 889888888776533 34433334
Q ss_pred CCCCC
Q 005875 261 PLKAC 265 (672)
Q Consensus 261 ~l~~c 265 (672)
.+.+|
T Consensus 223 ef~gc 227 (565)
T KOG0472|consen 223 EFPGC 227 (565)
T ss_pred CCCcc
Confidence 44455
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.7e-11 Score=134.18 Aligned_cols=123 Identities=28% Similarity=0.512 Sum_probs=96.3
Q ss_pred EEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecccc
Q 005875 108 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFN 187 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N 187 (672)
.+.|++++++++ .+|. .+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+.++|+.|+|++|
T Consensus 180 ~~~L~L~~~~Lt-sLP~-~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~~L~~L~Ls~N 251 (754)
T PRK15370 180 KTELRLKILGLT-TIPA-CIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLPDTIQEMELSIN 251 (754)
T ss_pred ceEEEeCCCCcC-cCCc-ccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhhccccEEECcCC
Confidence 467888888888 5776 343 57999999999999 6777664 58999999999998 678888788999999999
Q ss_pred cCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCccc
Q 005875 188 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 243 (672)
Q Consensus 188 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~ 243 (672)
+|+ .+|..+. ++|+.|+|++|+|+. +|..-.++|+.|+|++|+|++ +|..+
T Consensus 252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~~sL~~L~Ls~N~Lt~-LP~~l 302 (754)
T PRK15370 252 RIT-ELPERLP--SALQSLDLFHNKISC-LPENLPEELRYLSVYDNSIRT-LPAHL 302 (754)
T ss_pred ccC-cCChhHh--CCCCEEECcCCccCc-cccccCCCCcEEECCCCcccc-Ccccc
Confidence 988 7777664 578899999999884 565444688888998888884 55443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-11 Score=140.40 Aligned_cols=88 Identities=42% Similarity=0.681 Sum_probs=74.3
Q ss_pred CCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecC
Q 005875 132 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 209 (672)
Q Consensus 132 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 209 (672)
.++.|+|++|.|+|.+|..|+.|++|+.|+|++|.|+|.+|..+. ++|+.|+|++|+|+|.+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 478899999999999999999999999999999999888887776 678888888888888888888888877777777
Q ss_pred CccccCCCCC
Q 005875 210 SNNLSGSIPN 219 (672)
Q Consensus 210 ~N~l~~~~p~ 219 (672)
+|+|+|.+|.
T Consensus 499 ~N~l~g~iP~ 508 (623)
T PLN03150 499 GNSLSGRVPA 508 (623)
T ss_pred CCcccccCCh
Confidence 7777777765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=7.5e-11 Score=129.89 Aligned_cols=140 Identities=17% Similarity=0.249 Sum_probs=89.1
Q ss_pred ccccccCcEEEEEEEECC-CcEEEEEEecccccC-----------------------------------------hhhHH
Q 005875 381 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG-----------------------------------------KRDFE 418 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-----------------------------------------~~~~~ 418 (672)
+.||+|++|+||+|++++ |+.||||+....... +-++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 999999999643100 01233
Q ss_pred HHHHHHHHHc---CCCceeceEEEEEe-CCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 005875 419 QQMEIVGRVG---QHPNVVPLRAYYYS-KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR-GVAHIH 493 (672)
Q Consensus 419 ~e~~~l~~l~---~h~niv~l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-gl~~LH 493 (672)
+|...+.++. .+.+.+.+-.++.+ ....++||||++|+.+.++-.-.. ...+... ++...+. -+..+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~----~g~d~~~---la~~~v~~~~~Qif 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA----AGTDMKL---LAERGVEVFFTQVF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh----cCCCHHH---HHHHHHHHHHHHHH
Confidence 4444333332 23333333333332 456789999999999987532111 0122111 2221111 123345
Q ss_pred hcCCCCcccCCCCCCCEEecCCC----CeEEeecCCCCCCC
Q 005875 494 SMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTPLMN 530 (672)
Q Consensus 494 ~~~~~~ivHrDLk~~NILl~~~~----~~kl~DfGla~~~~ 530 (672)
..| ++|+|+||.||+++.++ .++++|||++....
T Consensus 278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 567 99999999999999988 99999999986654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.4e-11 Score=129.30 Aligned_cols=239 Identities=18% Similarity=0.231 Sum_probs=170.3
Q ss_pred Hhccccc--cCcEEEEEEEE---CCCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 379 SAEVLGK--GSYGTAYKAVL---EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 379 ~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
+...+|+ |.+|.||.+.. .++..+|+|+-+.... ....-.+|....+.+..|+|.++....++..+..++-+
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 3567899 99999999986 3567788888554432 22344566666677778999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCcccCCCCCCCEEecCC-CCeEEeecCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR----GVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGL 525 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGl 525 (672)
|++. .+|..+.+.... .++.........+... |+.++|... ++|-|+||.||+...+ ...+++|||+
T Consensus 198 E~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 198 ELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred cccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 9885 688888764332 2566666677777777 999999987 9999999999999999 8899999998
Q ss_pred CCCCCCCC---------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh
Q 005875 526 TPLMNVPA---------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE 596 (672)
Q Consensus 526 a~~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 596 (672)
........ ...+..-|++||...+ .++...|+|++|.+..|..++..+...........+..+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------ 342 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------ 342 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc------
Confidence 76654332 1134556999998865 6788999999999999999987776432111111100000
Q ss_pred ccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 597 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 597 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
+..+ .++.-...+...+..+++.+|-.|++.+++..
T Consensus 343 ------ip~e-----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 ------IPLE-----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------Cchh-----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000 01111122333667899999999999888766
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.2e-12 Score=134.63 Aligned_cols=150 Identities=29% Similarity=0.478 Sum_probs=122.2
Q ss_pred EEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeeccc
Q 005875 109 FGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 186 (672)
Q Consensus 109 ~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~ 186 (672)
..+.|++|.+. .||+ .+++|..|++|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|..++ ..|..||.+.
T Consensus 101 e~liLy~n~~r-~ip~-~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~ 175 (722)
T KOG0532|consen 101 ESLILYHNCIR-TIPE-AICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSK 175 (722)
T ss_pred HHHHHHhccce-ecch-hhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhh
Confidence 34556666666 7777 7899999999999999998 8888888886 889999999998 7887776 7888999999
Q ss_pred ccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCccc--cCCCCCCCCCCC
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV--GNSLLCGPPLKA 264 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~--~n~~~~~~~l~~ 264 (672)
|++. .+|..+++|.+|+.|.+..|++...+++..--.|..||+|+|+++ .||-.|.+|+.|.++ .|+-+-.+|-..
T Consensus 176 nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAqI 253 (722)
T KOG0532|consen 176 NEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQI 253 (722)
T ss_pred hhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHHH
Confidence 9999 889999999999999999999997766665556889999999999 899999999998865 444444444333
Q ss_pred C
Q 005875 265 C 265 (672)
Q Consensus 265 c 265 (672)
|
T Consensus 254 C 254 (722)
T KOG0532|consen 254 C 254 (722)
T ss_pred H
Confidence 3
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.6e-10 Score=106.58 Aligned_cols=136 Identities=13% Similarity=0.161 Sum_probs=97.9
Q ss_pred ccccccCcEEEEEEEECC-------CcEEEEEEeccccc----------Ch-------------hhH----HHHHHHHHH
Q 005875 381 EVLGKGSYGTAYKAVLEE-------STTVVVKRLKEVVV----------GK-------------RDF----EQQMEIVGR 426 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~----------~~-------------~~~----~~e~~~l~~ 426 (672)
..||.|--+.||.|...+ +..+|||+.+.... +. +.+ ++|...+.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998553 47899998853211 00 112 267788888
Q ss_pred HcCC-CceeceEEEEEeCCeeEEEEEecCCCchhh-hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcccC
Q 005875 427 VGQH-PNVVPLRAYYYSKDEKLLVYDYFASGSLST-LLHGNRGAGRTPLDWETRVKILLGTARGVAHI-HSMGGPKFTHG 503 (672)
Q Consensus 427 l~~h-~niv~l~~~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivHr 503 (672)
+... -++...+++ ...++||||+.++.+.. .++. ..++..+...+..+++.+|..| |+.+ ++|+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 7543 566677765 56789999997754421 2221 1245556677889999999999 7887 9999
Q ss_pred CCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 504 NIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 504 DLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||++.||+++ ++.+.|+|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4689999999876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.9e-10 Score=109.55 Aligned_cols=142 Identities=19% Similarity=0.236 Sum_probs=109.3
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcC-CCceeceEEEEEeCC---eeEEEEEecC
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKD---EKLLVYDYFA 454 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~---~~~lV~e~~~ 454 (672)
+.||.|.++.||++...+|+.+++|....... ....+.+|.+++..+.+ +.++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987768899998765433 35678999999998844 245677777766532 5689999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-------------------------------------- 496 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-------------------------------------- 496 (672)
|.++.+.+.. ..++..+...++.++++++.+||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9988776531 13677778888888888888888531
Q ss_pred ---------------CCCcccCCCCCCCEEecC--CCCeEEeecCCCCC
Q 005875 497 ---------------GPKFTHGNIKASNVLINQ--DLDGCISDFGLTPL 528 (672)
Q Consensus 497 ---------------~~~ivHrDLk~~NILl~~--~~~~kl~DfGla~~ 528 (672)
...++|+|+.+.||++++ ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134789999999999998 56789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.3e-11 Score=136.77 Aligned_cols=147 Identities=32% Similarity=0.461 Sum_probs=115.1
Q ss_pred eEEEEEeCCCCccccCCcccc-------------------------CCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEe
Q 005875 107 RVFGLRLPGIGLVGPIPNNTL-------------------------GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLY 161 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~-------------------------~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 161 (672)
.+..|+|..|+|. .+|+..+ ..+..|+.|+|.+|.|+...-+.|.++++|+.|+
T Consensus 311 sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh 389 (1081)
T KOG0618|consen 311 SLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH 389 (1081)
T ss_pred eeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence 4667888877766 4554221 1345577888888888877766788899999999
Q ss_pred eeccCCCCCCCCCcc---cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCC
Q 005875 162 LQHNNFSGKIPSSFS---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 162 l~~N~l~g~~p~~~~---~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g 237 (672)
|++|++. .+|+... ..|++|+||+|+|+ .+|..+.++..|++|...+|+|. .+|+. .++.|+.+|+|.|+|+-
T Consensus 390 LsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 390 LSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred ecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccchhhh
Confidence 9999998 7887765 67999999999999 89999999999999999999999 55665 99999999999999974
Q ss_pred -CCCccc--CCCCCCccccCCCC
Q 005875 238 -SIPSSL--QKFPNSSFVGNSLL 257 (672)
Q Consensus 238 -~~p~~~--~~~~~l~~~~n~~~ 257 (672)
.+|... .+|..|.+.||.++
T Consensus 467 ~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 467 VTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhhhhhCCCcccceeeccCCccc
Confidence 344443 35566666777753
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-10 Score=132.90 Aligned_cols=118 Identities=31% Similarity=0.444 Sum_probs=73.2
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeeccc
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~ 186 (672)
.+..|+|++|+++ .+|. .+. .+|+.|+|++|++. .+|..+. ++|+.|+|++|+|+ .+|..+.++|+.|+|++
T Consensus 221 nL~~L~Ls~N~Lt-sLP~-~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~~sL~~L~Ls~ 292 (754)
T PRK15370 221 NIKTLYANSNQLT-SIPA-TLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLPEELRYLSVYD 292 (754)
T ss_pred CCCEEECCCCccc-cCCh-hhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccCCCCcEEECCC
Confidence 5677888888877 5665 232 46777777777777 6666553 46777777777777 56766666777777777
Q ss_pred ccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCC
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 236 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~ 236 (672)
|+|+ .+|..+. ++|+.|+|++|+|++ +|....++|+.|++++|.++
T Consensus 293 N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~Lt 338 (754)
T PRK15370 293 NSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLPPGLKTLEAGENALT 338 (754)
T ss_pred Cccc-cCcccch--hhHHHHHhcCCcccc-CCccccccceeccccCCccc
Confidence 7777 3454332 345556666666653 33322344555555555554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=2e-10 Score=130.93 Aligned_cols=109 Identities=28% Similarity=0.387 Sum_probs=69.4
Q ss_pred CCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecccccCcccCCchhhhhccccceecCCc
Q 005875 132 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 211 (672)
Q Consensus 132 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 211 (672)
+|++|+|++|+|+ .+|.. .++|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ +|.. .++|+.|++++|
T Consensus 343 ~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~-~LP~l-~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N 412 (788)
T PRK15387 343 GLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPAL-PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGN 412 (788)
T ss_pred ccceEecCCCccC-CCCCC---Ccccceehhhccccc-cCccc-ccccceEEecCCcccC-CCCc---ccCCCEEEccCC
Confidence 4455555555555 23332 123444455555554 24432 2467888888888883 5543 357888899999
Q ss_pred cccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 212 NLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 212 ~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
+|++ +|.. ..+|+.|+|++|+|+ .+|..+.++++|..++
T Consensus 413 ~Lss-IP~l-~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~Ld 451 (788)
T PRK15387 413 RLTS-LPML-PSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 451 (788)
T ss_pred cCCC-CCcc-hhhhhhhhhccCccc-ccChHHhhccCCCeEE
Confidence 8885 5543 457888999999998 7888888777766543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.9e-09 Score=115.58 Aligned_cols=162 Identities=18% Similarity=0.254 Sum_probs=120.5
Q ss_pred ECCCcEEEEEEecccccC-hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCC
Q 005875 396 LEESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 474 (672)
Q Consensus 396 ~~~~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~ 474 (672)
..++.+|.|+..+..... .....+.++.++.+ +||||++++..++.++..|+|+|-+. -|..++.. +.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~ 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LG 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hH
Confidence 345777877777654331 23355666777777 99999999999999999999999874 45566652 34
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCCCCC----CCcccCcccccCC
Q 005875 475 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETR 550 (672)
Q Consensus 475 ~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~----~~~y~aPE~~~~~ 550 (672)
.......+.||+.||.|||+.+ +++|++|.-..|++++.|..||++|-++........... --.|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence 5666778899999999999776 699999999999999999999999987754432221111 1136666655332
Q ss_pred CCCCccchhhHHHHHHHHHhCC
Q 005875 551 KHSHKSDVYSFGVLLLEMLTGK 572 (672)
Q Consensus 551 ~~~~~~DvwS~Gvvl~el~tg~ 572 (672)
. -..|.|-|||+++|++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 2 3469999999999999993
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.2e-09 Score=97.51 Aligned_cols=131 Identities=21% Similarity=0.334 Sum_probs=98.4
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEeccccc---------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 382 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+++|+-+.+|.+.+.+ ..+++|.-.+... ......+|+.++..+ .--.|..-.-+..+.+...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEEEE
Confidence 57899999999998764 3466665433322 123466788888887 433555455556677788899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
++|-.|.+.+... ...++..+-.-+.-||..| |+|+||.++||++..+. +.++|||++....
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9999999898632 2456677777788999999 99999999999998776 9999999987543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.6e-10 Score=126.75 Aligned_cols=71 Identities=31% Similarity=0.490 Sum_probs=44.1
Q ss_pred EEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecccccC
Q 005875 110 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 189 (672)
Q Consensus 110 ~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l 189 (672)
.|+|++++|+ .+|+ .+. .+|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|. +.++|+.|+|++|.|
T Consensus 205 ~LdLs~~~Lt-sLP~-~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~-lp~sL~~L~Ls~N~L 274 (788)
T PRK15387 205 VLNVGESGLT-TLPD-CLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPV-LPPGLLELSIFSNPL 274 (788)
T ss_pred EEEcCCCCCC-cCCc-chh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccC-cccccceeeccCCch
Confidence 4677777776 5776 343 36777777777777 45542 466777777777777 4453 234566666666655
Q ss_pred c
Q 005875 190 T 190 (672)
Q Consensus 190 ~ 190 (672)
+
T Consensus 275 ~ 275 (788)
T PRK15387 275 T 275 (788)
T ss_pred h
Confidence 5
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.5e-10 Score=108.86 Aligned_cols=124 Identities=27% Similarity=0.374 Sum_probs=47.1
Q ss_pred cCCCCCCcEEEccCCCcCCCCCCcCC-CCCCCcEEeeeccCCCCCCCC-CcccccceeecccccCcccCCchh-hhhccc
Q 005875 127 LGKLDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLSFNSFTGNIPQSI-QNLTQL 203 (672)
Q Consensus 127 ~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~-~~~~~L~~L~ls~N~l~~~~p~~~-~~l~~L 203 (672)
+.+..+++.|+|++|.|+ .+. .++ .+.+|+.|||++|.++. ++. ...++|++|+|++|+|+ .++..+ ..+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL 90 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence 566677888888888888 443 465 57888888888888883 332 12278888888888888 455555 468899
Q ss_pred cceecCCccccCCCCC---CCCCCCceEEeecCCCCCCCCc----ccCCCCCCccccCC
Q 005875 204 TGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNGLKGSIPS----SLQKFPNSSFVGNS 255 (672)
Q Consensus 204 ~~L~l~~N~l~~~~p~---~~l~~L~~l~l~~N~l~g~~p~----~~~~~~~l~~~~n~ 255 (672)
+.|+|++|+|...-.- ..+++|+.|+|.+|+++.. +. .+..+++|.+++..
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETTE
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCCE
Confidence 9999999988742211 2788999999999998843 32 35677888887743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.3e-10 Score=123.06 Aligned_cols=240 Identities=18% Similarity=0.202 Sum_probs=170.9
Q ss_pred ccccccCcEEEEEEEEC--CCcEEEEEEecccccCh---hhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
..||.|.|+.|+....+ ++..+++|.+.+..... ..-..|+.+...+..|.++++.+..|......|+--||+++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 57999999999998743 57788888877654432 22234666666676899999999888888888899999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC-CCeEEeecCCCCCCCCCC-
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~~~~- 533 (672)
+++...+. ....++...++++..|++.++.++|++. ++|+|+||+||++..+ +..++.|||.++.+....
T Consensus 351 ~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 351 GSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred cchhhhhH-----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceecc
Confidence 98876652 2334778889999999999999999987 9999999999999886 788999999987533222
Q ss_pred CCCCCCccc--CcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 534 TPSRSAGYR--APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 534 ~~~~~~~y~--aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
......+++ +++......+..++|+||||..+.|.+++..--+....- . .+.........
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~--------~----------~i~~~~~p~~~ 484 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS--------L----------TIRSGDTPNLP 484 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCcccccc--------e----------eeecccccCCC
Confidence 222333444 555556677889999999999999999987543321100 0 00000011111
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
. ...++..+...+...++..||.+.+...+.+-..
T Consensus 485 ~---~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 485 G---LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred c---hHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 1 1144555666788899999999998877665444
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.6e-11 Score=132.60 Aligned_cols=124 Identities=30% Similarity=0.409 Sum_probs=109.2
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCC-cCCCCCCCcEEeeeccCCCCCCCCCcc--ccccee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L 182 (672)
..+..|.+.+|.|+...=+ .+.+..+|+.|+|++|+|. .+|+ .+.++..|+.|+||+|+++ .+|.++. ..|++|
T Consensus 359 ~~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL 435 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTL 435 (1081)
T ss_pred HHHHHHHHhcCcccccchh-hhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHH
Confidence 3577888999999977666 6999999999999999999 7775 4899999999999999999 8888776 799999
Q ss_pred ecccccCcccCCchhhhhccccceecCCccccC-CCCCC-CCCCCceEEeecCC
Q 005875 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-SIPNF-DIPKLRHLNLSYNG 234 (672)
Q Consensus 183 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~-~l~~L~~l~l~~N~ 234 (672)
...+|+|. .+| .+..+++|+.+|++.|+|+- .+|.. ..++|++|||++|.
T Consensus 436 ~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 436 RAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred hhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 99999999 788 89999999999999999994 44544 44899999999997
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.8e-10 Score=106.94 Aligned_cols=118 Identities=34% Similarity=0.485 Sum_probs=50.5
Q ss_pred eEEEEEeCCCCccccCCccccC-CCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCc---cccccee
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLG-KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---SPQLVVL 182 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~---~~~L~~L 182 (672)
+...|+|.+|.++ .|. .++ .|++|+.|||++|.|+ .++ .+..|++|+.|++++|+++ .++..+ .++|++|
T Consensus 20 ~~~~L~L~~n~I~-~Ie--~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE--NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred ccccccccccccc-ccc--chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 5678999999988 554 366 6889999999999999 454 5888999999999999999 454433 2799999
Q ss_pred ecccccCcccCC-chhhhhccccceecCCccccCCCCCC------CCCCCceEEee
Q 005875 183 DLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNF------DIPKLRHLNLS 231 (672)
Q Consensus 183 ~ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~------~l~~L~~l~l~ 231 (672)
+|++|+|...-- ..+..+++|+.|+|.+|.++.. +.. .+|+|+.||-.
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETTE
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCCE
Confidence 999999985322 4678899999999999999844 442 78999998843
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.3e-09 Score=95.39 Aligned_cols=141 Identities=12% Similarity=0.265 Sum_probs=101.8
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccc---------cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVV---------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.++-+|+-+.|+++.+. |+...||.-.... ..+++..+|++.+.++ .--.|.--.-++.+...-.++||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeEEEE
Confidence 56889999999999987 5555555432221 1345678899998887 43355555555667777789999
Q ss_pred ecCC-CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC---eEEeecCCCC
Q 005875 452 YFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTP 527 (672)
Q Consensus 452 ~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DfGla~ 527 (672)
|+++ -++.+++...-.. +........++..|-..+.-||..+ |+|+||..+||++.+++. +.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 9987 4778887643211 1222333678888999999999998 999999999999976653 4799999976
Q ss_pred CC
Q 005875 528 LM 529 (672)
Q Consensus 528 ~~ 529 (672)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 54
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.4e-10 Score=128.80 Aligned_cols=234 Identities=21% Similarity=0.275 Sum_probs=152.6
Q ss_pred cccccCcEEEEEEEECC-CcEEEEEEeccc---cc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 382 VLGKGSYGTAYKAVLEE-STTVVVKRLKEV---VV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
-+-+|.++.++.++-.. +-..++|..... .. ..+....+-.+.... +||.++.....+......+++++|..++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcchhhHHhccC
Confidence 67788999888876332 211222222111 10 111122222222222 5677777666666677889999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----- 531 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----- 531 (672)
+|...++... ..+.+-.......+....+|||... +.|||++|.|.+...++..+++|||.......
T Consensus 890 ~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 890 DLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred CchhhhhcCC-----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999998543 2444444455666778899999875 89999999999999999999999984321100
Q ss_pred ------------------------------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 005875 532 ------------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 581 (672)
Q Consensus 532 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~ 581 (672)
.....+++.|.+||...+......+|+|+.|++++|.++|.+||...+..
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 01122577899999999999999999999999999999999999877655
Q ss_pred CCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 005875 582 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMD 639 (672)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 639 (672)
.... .+.. +.+ .......+......+++.+.+..+|.+|-.+.
T Consensus 1042 ~~f~------ni~~----~~~-----~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QIFE------NILN----RDI-----PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhh------cccc----CCC-----CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 4321 1111 111 11112222233444555577788888887765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.6e-09 Score=129.22 Aligned_cols=65 Identities=26% Similarity=0.279 Sum_probs=35.7
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCC
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 173 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~ 173 (672)
++..|+|++++..+.+|. ++.+++|+.|+|++|..-..+|..+++|++|+.|+|++|..-+.+|.
T Consensus 635 ~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~ 699 (1153)
T PLN03210 635 GLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT 699 (1153)
T ss_pred CCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC
Confidence 455566665544445553 55666666666666544445666666666666666655433334443
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.6e-10 Score=118.74 Aligned_cols=132 Identities=25% Similarity=0.265 Sum_probs=96.3
Q ss_pred CCeEEEEEeCCCCccccCCccccCCCCC---CcEEEccCCCcCC----CCCCcCCCC-CCCcEEeeeccCCCCCCCCCc-
Q 005875 105 RTRVFGLRLPGIGLVGPIPNNTLGKLDA---LEVLSLRSNVLTG----GLPSEITSL-PSLRYLYLQHNNFSGKIPSSF- 175 (672)
Q Consensus 105 ~~~v~~l~l~~~~l~g~~p~~~~~~l~~---L~~L~L~~N~l~g----~~p~~~~~l-~~L~~L~l~~N~l~g~~p~~~- 175 (672)
..+++.|+++++.+.+..+. .+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++..+..+
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred cCceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence 35788899999888765555 5655655 9999999998873 334456667 889999999999886433322
Q ss_pred ---c--cccceeecccccCccc----CCchhhhhccccceecCCccccCCCCC------CCCCCCceEEeecCCCCC
Q 005875 176 ---S--PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIPN------FDIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 176 ---~--~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~------~~l~~L~~l~l~~N~l~g 237 (672)
. ++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++.... ..+++|++|++++|.+++
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 2 4799999999998853 344555667899999999988743321 157889999999998875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.1e-07 Score=96.42 Aligned_cols=141 Identities=14% Similarity=0.143 Sum_probs=99.2
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeccccc------------ChhhHHHHHHHHHHHcC-CCceeceEEEEEe-----
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV------------GKRDFEQQMEIVGRVGQ-HPNVVPLRAYYYS----- 442 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~----- 442 (672)
+.+-.-....|++..+. |+.++||+...... ....+.+|...+.++.. .-.++..+++.+.
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 44444444456677664 67899997743321 11147788888877732 2234455666543
Q ss_pred CCeeEEEEEecCCC-chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-------
Q 005875 443 KDEKLLVYDYFASG-SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ------- 514 (672)
Q Consensus 443 ~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~------- 514 (672)
....++|||++++. +|.+++.... ....+...+..++.+++..+.-||..| |+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 23578999999986 8888875321 122456677889999999999999999 999999999999985
Q ss_pred CCCeEEeecCCCCC
Q 005875 515 DLDGCISDFGLTPL 528 (672)
Q Consensus 515 ~~~~kl~DfGla~~ 528 (672)
+..+.++||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46789999998754
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.2e-08 Score=122.46 Aligned_cols=144 Identities=24% Similarity=0.232 Sum_probs=107.0
Q ss_pred EEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCc-ccccceeeccc
Q 005875 108 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF-SPQLVVLDLSF 186 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~L~~L~ls~ 186 (672)
+..|.+.++.+. .+|. .+ .+.+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|.-- .++|+.|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~-~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPS-NF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCC-cC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecC
Confidence 455556666554 6665 34 5688889999998887 678888889999999998876656777522 27899999998
Q ss_pred ccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCCCCccccCC
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNS 255 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~n~ 255 (672)
|.....+|..+++|++|+.|++++|..-+.+|.. .+++|+.|+|++|...+.+|....++..|.+.+|.
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~ 736 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETA 736 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCCc
Confidence 8777788999999999999999987555566654 78888888888887766777665555555544443
|
syringae 6; Provisional |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.78 E-value=9.5e-11 Score=123.72 Aligned_cols=143 Identities=27% Similarity=0.413 Sum_probs=126.9
Q ss_pred EEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc-cccceeeccc
Q 005875 108 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLSF 186 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~~L~~L~ls~ 186 (672)
.+..||+.|.+. .+|. .++.+..|+.|.|.+|.+. .+|..+.+|..|++|||+.|+++ .+|..++ --|+.|-+++
T Consensus 77 t~~aDlsrNR~~-elp~-~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sN 152 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPE-EACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSN 152 (722)
T ss_pred hhhhhccccccc-cCch-HHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEec
Confidence 456789999988 8998 7999999999999999999 99999999999999999999999 7787766 5799999999
Q ss_pred ccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCC--CCccccCCC
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFP--NSSFVGNSL 256 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~--~l~~~~n~~ 256 (672)
|+++ .+|..++.+..|..||.+.|++...++.. .+.+|+.|++..|++. .+|+.+..|+ .|+|..|..
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNki 223 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKI 223 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCce
Confidence 9999 89999999999999999999999766665 9999999999999999 7787777665 566666653
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.77 E-value=7.4e-10 Score=108.33 Aligned_cols=122 Identities=24% Similarity=0.315 Sum_probs=92.3
Q ss_pred cCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecccccCcccCCchhhhhccccce
Q 005875 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGL 206 (672)
Q Consensus 127 ~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 206 (672)
+..-..|+.||||+|.|+ .+.++..-+++++.|++|+|.+...-.-.+.++|+.||||+|.++ .+...=.+|-+.+.|
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 445567899999999998 777788888999999999999984333233488999999999998 555555677888889
Q ss_pred ecCCccccCCCCCC-CCCCCceEEeecCCCCCCCC--cccCCCCCCccc
Q 005875 207 SLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIP--SSLQKFPNSSFV 252 (672)
Q Consensus 207 ~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p--~~~~~~~~l~~~ 252 (672)
.|+.|.|.. +... .+-+|..||+++|++. .+. ..+++++.|..+
T Consensus 358 ~La~N~iE~-LSGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l 404 (490)
T KOG1259|consen 358 KLAQNKIET-LSGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETL 404 (490)
T ss_pred ehhhhhHhh-hhhhHhhhhheeccccccchh-hHHHhcccccccHHHHH
Confidence 999998873 3333 7788899999999987 332 357777766543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.9e-10 Score=107.80 Aligned_cols=125 Identities=25% Similarity=0.333 Sum_probs=102.4
Q ss_pred EEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecc
Q 005875 108 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLS 185 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls 185 (672)
++.+||++|.++ .+.+ ++.-++.++.|+||+|+|. .+- .++.|++|+.||||+|.++ .+-++-. -+++.|.|+
T Consensus 286 LtelDLS~N~I~-~iDE-SvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDE-SVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhccccccchh-hhhh-hhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 567999999988 7776 7889999999999999998 444 4889999999999999998 4433322 589999999
Q ss_pred cccCcccCCchhhhhccccceecCCccccCCCC--CC-CCCCCceEEeecCCCCCCC
Q 005875 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP--NF-DIPKLRHLNLSYNGLKGSI 239 (672)
Q Consensus 186 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~-~l~~L~~l~l~~N~l~g~~ 239 (672)
.|.|.. + ..+++|-+|..||+++|+|...-. .. ++|-|++|.|.+|.+.+..
T Consensus 361 ~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 361 QNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 999872 2 458889999999999999984322 22 8899999999999999644
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.5e-08 Score=92.50 Aligned_cols=126 Identities=20% Similarity=0.285 Sum_probs=81.5
Q ss_pred EEEEEEECCCcEEEEEEecccccC---------------------------hhhHHHHHHHHHHHcCC-CceeceEEEEE
Q 005875 390 TAYKAVLEESTTVVVKRLKEVVVG---------------------------KRDFEQQMEIVGRVGQH-PNVVPLRAYYY 441 (672)
Q Consensus 390 ~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~~~~~~e~~~l~~l~~h-~niv~l~~~~~ 441 (672)
.||.|...++..+|+|+.+..... ....++|.+.|.++... -++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999988999999998532110 12356788888888433 3566776552
Q ss_pred eCCeeEEEEEecC--CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCcccCCCCCCCEEecCCCCe
Q 005875 442 SKDEKLLVYDYFA--SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDG 518 (672)
Q Consensus 442 ~~~~~~lV~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~-LH~~~~~~ivHrDLk~~NILl~~~~~~ 518 (672)
...+||||++ |..+..+... . ++......++.+++..+.. +|..| |+|+||.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 4579999998 5555444331 1 1133456677788776665 57887 9999999999999988 99
Q ss_pred EEeecCCCCCCC
Q 005875 519 CISDFGLTPLMN 530 (672)
Q Consensus 519 kl~DfGla~~~~ 530 (672)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999876544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2e-07 Score=96.00 Aligned_cols=263 Identities=14% Similarity=0.154 Sum_probs=153.6
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEE------Ee-CCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY------YS-KDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~------~~-~~~~~lV~e~ 452 (672)
+..||+|+-+.+|-.--- +..+.|++.......+ .+.+.++.....||-+-.-+.+- -+ +....++|..
T Consensus 16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchh--hchhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 567999999999865422 2234566654432211 22334444444566444312111 11 2225577777
Q ss_pred cCCCc-hhhhhcc-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 453 FASGS-LSTLLHG-NRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 453 ~~~g~-L~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
+.+.. ...+... .+..+.....|.-.++.+..+|.+.+.||..| .+-+|+.++|+|+++++.+.+.|-..-....
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeecc
Confidence 76642 2222221 12233455889999999999999999999999 8889999999999999999998754322221
Q ss_pred CC---CCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCCCCC------ChhHHHHHhhh
Q 005875 531 VP---ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMV------DLPRWVQSVVR 595 (672)
Q Consensus 531 ~~---~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg-~~pf~~~~~~~~~------~~~~~~~~~~~ 595 (672)
.. .-..+...|.+||.-. +-.-+...|-|.+||++++++.| ++||.+....... ++....-....
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~ 248 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYAS 248 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeech
Confidence 11 2245677899999754 33345678999999999998886 9999864221110 00000000000
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHHHhhhcC
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAK--VPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~L~~i~~~~ 652 (672)
+.....+-.+ ..-..+.....+..+..+|+.. .+.-|||++-.+..|.++.+.-
T Consensus 249 ~~~~g~~p~P---~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 249 DQRRGLKPPP---RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hccCCCCCCC---CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 0000000000 0111122223344444578754 4678999999988887776543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-08 Score=78.39 Aligned_cols=57 Identities=44% Similarity=0.588 Sum_probs=28.7
Q ss_pred ccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCC
Q 005875 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNG 234 (672)
Q Consensus 178 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~ 234 (672)
+|++|+|++|+|+...+..|.++++|+.|++++|+|+...|.. .+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 3455555555555333345555555555555555555443332 55555555555554
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.3e-07 Score=91.19 Aligned_cols=137 Identities=23% Similarity=0.263 Sum_probs=98.3
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeccccc-----------------------ChhhHHHHHHHHHHHcCC-C
Q 005875 376 LRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----------------------GKRDFEQQMEIVGRVGQH-P 431 (672)
Q Consensus 376 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------------------~~~~~~~e~~~l~~l~~h-~ 431 (672)
..+.++.||-|--+.||.|...++.+++||.-..... .....++|.++|.++..+ -
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3345789999999999999999999999996532110 112356788889888433 3
Q ss_pred ceeceEEEEEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEE
Q 005875 432 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVL 511 (672)
Q Consensus 432 niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NIL 511 (672)
.|.+.+++ +...+||||++|-.|...- ++.+..-.++..|+.-+...-..| +||+|+++-||+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIl 234 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNIL 234 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEE
Confidence 56666655 5678999999996665432 123334445555555555555677 999999999999
Q ss_pred ecCCCCeEEeecCCCCCC
Q 005875 512 INQDLDGCISDFGLTPLM 529 (672)
Q Consensus 512 l~~~~~~kl~DfGla~~~ 529 (672)
++++|.+.++||--+...
T Consensus 235 V~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 235 VTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred EecCCCEEEEeCcccccC
Confidence 999999999999765443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.2e-08 Score=110.85 Aligned_cols=139 Identities=31% Similarity=0.464 Sum_probs=78.1
Q ss_pred eEEEEEeCCCCccccCCccccCCCC-CCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCC--cccccceee
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLD-ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS--FSPQLVVLD 183 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~L~ 183 (672)
.++.+++.++.++ .+|+ ..+.+. +|+.|++++|.+. .+|..+..+++|+.|++++|+++ .+|.. ..++|+.|+
T Consensus 117 ~l~~L~l~~n~i~-~i~~-~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPP-LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred ceeEEecCCcccc-cCcc-ccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 3566666666666 5555 455553 6666666666666 55555666666666666666666 44444 235666666
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCC-CCCCCCCceEEeecCCCCCCCCcccCCCCCCcc
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP-NFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 251 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 251 (672)
+++|+++ .+|..++.+..|++|.+++|++.-.+. ...+.++..|.+++|++. .++..+++++++..
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~ 259 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLET 259 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhccccccce
Confidence 6666666 566555555556666666663222222 225555555555555554 22444444444333
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.66 E-value=9.7e-09 Score=111.42 Aligned_cols=140 Identities=32% Similarity=0.424 Sum_probs=116.7
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCC--cccccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS--FSPQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~L~l 184 (672)
.++.+++++|.+. .+|. .++.++.|+.|++++|.++ .+|...+.+++|+.|++++|+++ .+|.. ....|++|++
T Consensus 141 nL~~L~l~~N~i~-~l~~-~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~ 216 (394)
T COG4886 141 NLKELDLSDNKIE-SLPS-PLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216 (394)
T ss_pred hcccccccccchh-hhhh-hhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhh
Confidence 6889999999998 6764 6999999999999999999 88877779999999999999999 78876 4467999999
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCC-CCCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
++|++. .++..+.++.++..|.+.+|++...+-. ..+++|++|++++|.++ .++. ++.+.++..++
T Consensus 217 ~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~ 283 (394)
T COG4886 217 SNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELD 283 (394)
T ss_pred cCCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccc-cccc-ccccCccCEEe
Confidence 999765 6778899999999999999999853222 37888999999999999 4554 65555555443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.4e-08 Score=78.40 Aligned_cols=60 Identities=40% Similarity=0.536 Sum_probs=34.2
Q ss_pred CCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecccccCcccCCchhhhhccccceecCCc
Q 005875 132 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 211 (672)
Q Consensus 132 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 211 (672)
+|++|+|++|+|+..-+..|.++++|++|+|++|+++ ...|..|.++++|+.|++++|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~----------------------~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLT----------------------SIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSES----------------------EEETTTTTTSTTESEEEETSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccC----------------------ccCHHHHcCCCCCCEEeCcCC
Confidence 4566666666666333345555655555555555555 444455666666666666666
Q ss_pred cc
Q 005875 212 NL 213 (672)
Q Consensus 212 ~l 213 (672)
+|
T Consensus 60 ~l 61 (61)
T PF13855_consen 60 NL 61 (61)
T ss_dssp SB
T ss_pred cC
Confidence 54
|
... |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.5e-09 Score=111.19 Aligned_cols=146 Identities=27% Similarity=0.312 Sum_probs=102.7
Q ss_pred CeEEEEEeCCCCccc----cCCccccCCC-CCCcEEEccCCCcCCC----CCCcCCCCCCCcEEeeeccCCCCCCCCC--
Q 005875 106 TRVFGLRLPGIGLVG----PIPNNTLGKL-DALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSS-- 174 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g----~~p~~~~~~l-~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~-- 174 (672)
.++..|++++|.+++ .+.. .+..+ ++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.....
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~-~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~ 186 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAK-GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALA 186 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHH-HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHH
Confidence 458899999998873 2222 45666 8999999999999853 3445677889999999999998532222
Q ss_pred --cc--cccceeecccccCccc----CCchhhhhccccceecCCccccCCCCC-C------CCCCCceEEeecCCCCC--
Q 005875 175 --FS--PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIPN-F------DIPKLRHLNLSYNGLKG-- 237 (672)
Q Consensus 175 --~~--~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~-~------~l~~L~~l~l~~N~l~g-- 237 (672)
+. ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.... . ..+.|+.|++++|.++.
T Consensus 187 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~ 266 (319)
T cd00116 187 EGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDG 266 (319)
T ss_pred HHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHH
Confidence 22 5899999999998754 344566778899999999998852211 1 24789999999999872
Q ss_pred --CCCcccCCCCCCccc
Q 005875 238 --SIPSSLQKFPNSSFV 252 (672)
Q Consensus 238 --~~p~~~~~~~~l~~~ 252 (672)
.+...+..+++|.++
T Consensus 267 ~~~l~~~~~~~~~L~~l 283 (319)
T cd00116 267 AKDLAEVLAEKESLLEL 283 (319)
T ss_pred HHHHHHHHhcCCCccEE
Confidence 233344444444444
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.2e-09 Score=104.89 Aligned_cols=159 Identities=25% Similarity=0.323 Sum_probs=118.4
Q ss_pred ceeeecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc
Q 005875 97 VGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS 176 (672)
Q Consensus 97 ~gv~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 176 (672)
.+.+|++..+. .++-++.+|+ .+|.+ + -..-+.|+|..|+|+..-|..|+.+++|+.||||+|.|+-.-|+.|.
T Consensus 39 ~pC~Cs~~~g~--~VdCr~~GL~-eVP~~-L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~ 112 (498)
T KOG4237|consen 39 APCTCSDVEGG--IVDCRGKGLT-EVPAN-L--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFK 112 (498)
T ss_pred CCcccCCCCCc--eEEccCCCcc-cCccc-C--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhh
Confidence 34477764332 3455566666 55552 1 23467899999999966667899999999999999999988888886
Q ss_pred --ccc-ceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCc-ccCCCCCCc
Q 005875 177 --PQL-VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPS-SLQKFPNSS 250 (672)
Q Consensus 177 --~~L-~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~-~~~~~~~l~ 250 (672)
.+| +.+++++|+|+...-..|++|..|+.|.++-|++.-...+. .+++|..|.+-.|.+. .++. .|..+.+++
T Consensus 113 GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~ 191 (498)
T KOG4237|consen 113 GLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIK 191 (498)
T ss_pred hhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccc
Confidence 444 45556669999655568999999999999999999544443 8999999999999998 5555 676666655
Q ss_pred c---ccCCCCCCCCC
Q 005875 251 F---VGNSLLCGPPL 262 (672)
Q Consensus 251 ~---~~n~~~~~~~l 262 (672)
. .-|++.|.+.+
T Consensus 192 tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 192 TLHLAQNPFICDCNL 206 (498)
T ss_pred hHhhhcCcccccccc
Confidence 4 45666666544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.2e-06 Score=90.75 Aligned_cols=169 Identities=25% Similarity=0.348 Sum_probs=124.4
Q ss_pred EEEEEEE-ECCCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEe----CCeeEEEEEecCC-Cchhhh
Q 005875 389 GTAYKAV-LEESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFAS-GSLSTL 461 (672)
Q Consensus 389 g~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~~~~-g~L~~~ 461 (672)
.+.|++. ..||..|+.|++...+. .......-+++.+++ .|.|||++.+++.. +...++||+|+++ ++|.+.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 5789998 45788999999943221 122234456778888 99999999988863 4467899999987 477766
Q ss_pred hccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 462 LHGNRGA----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 462 l~~~~~~----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
-...... .....++...+.++.|+..||.++|+.| +.-+-|.+++|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5433221 2234778899999999999999999999 88899999999999999999988877655433
Q ss_pred CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 005875 532 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~p 574 (672)
... |-+.+ -.+-|.=.||.++.-|.||..-
T Consensus 446 d~~----------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11111 1346888999999999999643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.6e-06 Score=82.08 Aligned_cols=137 Identities=15% Similarity=0.179 Sum_probs=101.0
Q ss_pred ccccCcEEEEEEEECCCcEEEEEEeccc-------ccChhhHHHHHHHHHHHcC-CCceeceEEEEEe-C----CeeEEE
Q 005875 383 LGKGSYGTAYKAVLEESTTVVVKRLKEV-------VVGKRDFEQQMEIVGRVGQ-HPNVVPLRAYYYS-K----DEKLLV 449 (672)
Q Consensus 383 lG~G~fg~Vy~~~~~~~~~vavK~l~~~-------~~~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~-~----~~~~lV 449 (672)
-|+||-+.|+.-.+.+. .+.+|+-... ..+...|.+|...+..+.. .-.+.+.+ ++.. . ...+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 36789899999887644 6889887522 1256789999999888742 22344444 3321 1 245799
Q ss_pred EEecCC-CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC--eEEeecCCC
Q 005875 450 YDYFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--GCISDFGLT 526 (672)
Q Consensus 450 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~--~kl~DfGla 526 (672)
+|-+++ -+|.+++.... ..+.+...+..+..+++..++-||+.| +.|+|+.+.||+++.++. ++++||--+
T Consensus 104 Te~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 998764 48888875322 223577778899999999999999999 999999999999987777 899999755
Q ss_pred C
Q 005875 527 P 527 (672)
Q Consensus 527 ~ 527 (672)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 4
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.4e-06 Score=83.68 Aligned_cols=108 Identities=21% Similarity=0.289 Sum_probs=84.1
Q ss_pred hhhHHHHHHHHHHHcC-CCceeceEEEEEeCC----eeEEEEEecCCC-chhhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 005875 414 KRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKD----EKLLVYDYFASG-SLSTLLHGNRGAGRTPLDWETRVKILLGTAR 487 (672)
Q Consensus 414 ~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~----~~~lV~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 487 (672)
.....+|...+..+.. .-.+++.+++.+... ..++|+|++++. +|.+++.... ..+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 4467778887776632 344666777766532 458999999985 7999887422 1556677889999999
Q ss_pred HHHHHHhcCCCCcccCCCCCCCEEecCCC---CeEEeecCCCCCC
Q 005875 488 GVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLTPLM 529 (672)
Q Consensus 488 gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGla~~~ 529 (672)
.++-||+.| |+|+|+++.|||++.++ .+.++||+-++..
T Consensus 130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999 99999999999999887 8899999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.6e-06 Score=82.81 Aligned_cols=141 Identities=14% Similarity=0.171 Sum_probs=85.9
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCC-ceeceEEEEEeCCeeEEEEEecCCCc-h
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLRAYYYSKDEKLLVYDYFASGS-L 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~~~~~~~~~lV~e~~~~g~-L 458 (672)
..||+|..+.||+.. +..+++|.... .....+..+|.+++..+.... .+.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 468999999999842 44677787654 334566788999998885332 35777888877777889999999963 2
Q ss_pred hhhh---------------------ccCCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHhc-CCCCcccCCC
Q 005875 459 STLL---------------------HGNRGAGRTPLDWETRVKILL----------GTAR-GVAHIHSM-GGPKFTHGNI 505 (672)
Q Consensus 459 ~~~l---------------------~~~~~~~~~~l~~~~~~~i~~----------~ia~-gl~~LH~~-~~~~ivHrDL 505 (672)
...+ |..... ...+... ...+-. .+.. ...+|... ..+.++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 111000 0011100 000000 0011 12222211 1235789999
Q ss_pred CCCCEEecCCCCeEEeecCCCCC
Q 005875 506 KASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 506 k~~NILl~~~~~~kl~DfGla~~ 528 (672)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999988 99999987653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=9.1e-08 Score=104.61 Aligned_cols=146 Identities=23% Similarity=0.328 Sum_probs=96.8
Q ss_pred HHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC-------C------CCCCcccCccccc
Q 005875 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-------P------SRSAGYRAPEVIE 548 (672)
Q Consensus 482 ~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~-------~------~~~~~y~aPE~~~ 548 (672)
+.+++.|+.|+|... ++||++|.|++|.++..+..||+.|+.+.....+.. + .....|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345568999999864 799999999999999999999999997754432111 0 1234599999999
Q ss_pred CCCCCCccchhhHHHHHHHHH-hCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHc
Q 005875 549 TRKHSHKSDVYSFGVLLLEML-TGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMAC 627 (672)
Q Consensus 549 ~~~~~~~~DvwS~Gvvl~el~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C 627 (672)
....+.++|+||+||++|-+. .|+.-+............. .. .+. .......+...++.+=+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-----~~-------~~~--~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-----NL-------LNA--GAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-----cc-------ccc--ccccccccCcHHHHHHHHHH
Confidence 988899999999999999998 4555554432222111000 00 000 00001112233445555578
Q ss_pred ccCCCCCCCCHHHHHH
Q 005875 628 VAKVPDMRPNMDEVVR 643 (672)
Q Consensus 628 l~~dP~~RPs~~evl~ 643 (672)
+..++.-||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 8899999997777654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.2e-06 Score=94.26 Aligned_cols=149 Identities=19% Similarity=0.314 Sum_probs=95.3
Q ss_pred HHHHHHHHh-ccccccCcEEEEEEEECCCcEEEEEEecccccC-------------------------------------
Q 005875 372 LEDLLRASA-EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG------------------------------------- 413 (672)
Q Consensus 372 ~~~l~~~~~-~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------------------------------------- 413 (672)
.+++..... +.|+.++-|.||+|++++|+.||||+.......
T Consensus 121 iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 121 IEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 334444443 578899999999999999999999998532110
Q ss_pred ----hhhHHHHHHHHHHHc----CCCceeceEEEEEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHH
Q 005875 414 ----KRDFEQQMEIVGRVG----QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 485 (672)
Q Consensus 414 ----~~~~~~e~~~l~~l~----~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i 485 (672)
+-++.+|..-+.++. +.+++.----|++-.....++|||++|..+.+...... ..++... ++..+
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k~---ia~~~ 273 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRKE---LAELL 273 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHHH---HHHHH
Confidence 001233333333322 34444333333334567789999999998888743211 1244333 33333
Q ss_pred HHH-HHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 486 ARG-VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 486 a~g-l~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
+.+ +..+-..| +.|.|..|.||+++.+|.+.+.|||+.....
T Consensus 274 ~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 274 VRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 322 33344456 9999999999999999999999999986654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.7e-07 Score=96.70 Aligned_cols=130 Identities=28% Similarity=0.334 Sum_probs=63.9
Q ss_pred CeEEEEEeCCCCccccCCc-cccCCCCCCcEEEccCCCcCCCCCCcC-CCCCCCcEEeeeccCCCC--------------
Q 005875 106 TRVFGLRLPGIGLVGPIPN-NTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSG-------------- 169 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~-~~~~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~l~~N~l~g-------------- 169 (672)
..|..|||++|=+..--|- .....|++|+.|+|+.|+|.-..-... ..++.|+.|.|+.+.|+-
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 3566666666643311110 124456666666666666653222211 133444555555444441
Q ss_pred -------------CCCCCcccccceeecccccCcccCC--chhhhhccccceecCCccccC-CCCCC-------CCCCCc
Q 005875 170 -------------KIPSSFSPQLVVLDLSFNSFTGNIP--QSIQNLTQLTGLSLQSNNLSG-SIPNF-------DIPKLR 226 (672)
Q Consensus 170 -------------~~p~~~~~~L~~L~ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~-~~p~~-------~l~~L~ 226 (672)
..+..+...|++|||++|++- ..+ ...+.++.|+.|+++.+.+.. ..|+. .+++|+
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~ 304 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLE 304 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccce
Confidence 111112245666666666655 333 345566666666666666553 11211 456666
Q ss_pred eEEeecCCCC
Q 005875 227 HLNLSYNGLK 236 (672)
Q Consensus 227 ~l~l~~N~l~ 236 (672)
+|+++.|++.
T Consensus 305 ~L~i~~N~I~ 314 (505)
T KOG3207|consen 305 YLNISENNIR 314 (505)
T ss_pred eeecccCccc
Confidence 6666666664
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.1e-08 Score=111.13 Aligned_cols=122 Identities=32% Similarity=0.330 Sum_probs=98.4
Q ss_pred EEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCc--ccccceeecc
Q 005875 108 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF--SPQLVVLDLS 185 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~--~~~L~~L~ls 185 (672)
+...+.+.|.|+ .+.. ++.-|+.|++|||++|+++..- .+..|++|++|||+.|.+. .+|.-- +-.|+.|+|+
T Consensus 166 L~~a~fsyN~L~-~mD~-SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDE-SLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHH-HHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeec
Confidence 445566677776 4444 7889999999999999998443 7889999999999999999 666432 2469999999
Q ss_pred cccCcccCCchhhhhccccceecCCccccCCC---CCCCCCCCceEEeecCCCC
Q 005875 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI---PNFDIPKLRHLNLSYNGLK 236 (672)
Q Consensus 186 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~---p~~~l~~L~~l~l~~N~l~ 236 (672)
+|.++.. ..+.+|++|+.|||++|-|++.- |-+.|..|+.|+|.+|.+.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 9999832 35889999999999999998633 3447889999999999986
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.4e-05 Score=80.48 Aligned_cols=142 Identities=15% Similarity=0.156 Sum_probs=87.9
Q ss_pred ccccCc-EEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchhhh
Q 005875 383 LGKGSY-GTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTL 461 (672)
Q Consensus 383 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~ 461 (672)
|-.|.. ..||+.... +..+++|+..... ..+..+|++++..+..+--+.+++++....+..++|||+++|.++...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 789999865 4678888875543 446788999998886665566788887766678999999999777643
Q ss_pred h-------------------ccCCCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----cC
Q 005875 462 L-------------------HGNRGAGRTPLDW--ETRVKILL--------------------GTARGVAHIHS----MG 496 (672)
Q Consensus 462 l-------------------~~~~~~~~~~l~~--~~~~~i~~--------------------~ia~gl~~LH~----~~ 496 (672)
. |..... ...... ........ .+......|-. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVA-DCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcc-cCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 2 111100 001110 00000000 01111222211 11
Q ss_pred CCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 497 ~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
.+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 34589999999999999987788999987643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.5e-07 Score=80.94 Aligned_cols=112 Identities=21% Similarity=0.269 Sum_probs=62.3
Q ss_pred CCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeec
Q 005875 105 RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 184 (672)
Q Consensus 105 ~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~l 184 (672)
..+++.++|++|++. .+|+..-...+.++.|+|++|.|+ .+|.+++.++.|+.|+++.|.|.
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~---------------- 113 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN---------------- 113 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc----------------
Confidence 346666677777666 555533344456666666666666 66666666666666666666665
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS 242 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~ 242 (672)
..|..+..|.+|..|+..+|.+. .+|-. .-+.+-..++.+|.+.+.-|..
T Consensus 114 -------~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 114 -------AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred -------cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence 45555555666666666666554 33321 1122223334555555544443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.1e-07 Score=83.16 Aligned_cols=121 Identities=26% Similarity=0.357 Sum_probs=85.3
Q ss_pred cEEEccCCCcCCCCC---CcCCCCCCCcEEeeeccCCCCCCCCCcc---cccceeecccccCcccCCchhhhhcccccee
Q 005875 134 EVLSLRSNVLTGGLP---SEITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLS 207 (672)
Q Consensus 134 ~~L~L~~N~l~g~~p---~~~~~l~~L~~L~l~~N~l~g~~p~~~~---~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 207 (672)
..|||++..|- .++ ..+.....|+..+|++|.|. .+|..|. +.++.|+|++|.|+ .+|..+..++.|+.|+
T Consensus 30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 34455555443 333 23445556666777777777 5666665 47889999999999 8999999999999999
Q ss_pred cCCccccCCCCCC-CCCCCceEEeecCCCCCCCCccc--CCCCCCccccCCCCC
Q 005875 208 LQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSL--QKFPNSSFVGNSLLC 258 (672)
Q Consensus 208 l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~--~~~~~l~~~~n~~~~ 258 (672)
++.|.|...+-.. .|.+|-.||..+|.+. .||..+ ..++.+.-+||..+-
T Consensus 107 l~~N~l~~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~ 159 (177)
T KOG4579|consen 107 LRFNPLNAEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLG 159 (177)
T ss_pred cccCccccchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCccc
Confidence 9999999544333 7889999999999988 677542 233344445665443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.7e-05 Score=75.16 Aligned_cols=135 Identities=17% Similarity=0.248 Sum_probs=91.9
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEecccccCh----------hh---------------HHHHHHHHHHHc-CCCceec
Q 005875 382 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK----------RD---------------FEQQMEIVGRVG-QHPNVVP 435 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----------~~---------------~~~e~~~l~~l~-~h~niv~ 435 (672)
.|..|--+.||+|...++..+|||+++...... .. ...|..-|.++. .+-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 577788889999998889999999997542211 11 123444455543 2445555
Q ss_pred eEEEEEeCCeeEEEEEecCCCc-hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEEec
Q 005875 436 LRAYYYSKDEKLLVYDYFASGS-LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLIN 513 (672)
Q Consensus 436 l~~~~~~~~~~~lV~e~~~~g~-L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~ 513 (672)
-+++. +..|||||+.... -.-.|. ..++...+...+..++++.+.-|-. .+ +||+||+.-|||+.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~ 201 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH 201 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE
Confidence 55553 4569999996531 111111 1223333677778888888888876 55 99999999999999
Q ss_pred CCCCeEEeecCCCCCCC
Q 005875 514 QDLDGCISDFGLTPLMN 530 (672)
Q Consensus 514 ~~~~~kl~DfGla~~~~ 530 (672)
++.+.|+|||-|....
T Consensus 202 -~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 -DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CCeEEEEECccccccC
Confidence 8899999999876654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=9.3e-07 Score=95.68 Aligned_cols=179 Identities=21% Similarity=0.204 Sum_probs=129.0
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCc-eeceEEEEEeCCeeEEEEEecCCC-chh
Q 005875 382 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN-VVPLRAYYYSKDEKLLVYDYFASG-SLS 459 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lV~e~~~~g-~L~ 459 (672)
-.++|++++++|.+-...+....+.+... ....-+++++.++ +||| .+..++-++.++..+++++++.+| +..
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHc-cCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 46889999999988554554445544322 4456678889998 9999 777777777777889999999887 222
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---CCCC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---ATPS 536 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---~~~~ 536 (672)
..... ..-.+...+...+...-.++++|+|+.. -+||| ||+..+ +..+..||+....+... .+..
T Consensus 324 ~~~~~----se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 324 LEMTV----SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred ccCCh----hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcccccccCC
Confidence 11110 0111223334445555678899999864 58999 776655 77899999988766544 3445
Q ss_pred CCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 005875 537 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 577 (672)
Q Consensus 537 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~ 577 (672)
+++.|+|||+.....+..+.|+|+.|+-..+|.-|.+|-..
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 78889999999999999999999999988888888877543
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.2e-06 Score=60.90 Aligned_cols=37 Identities=43% Similarity=0.655 Sum_probs=31.5
Q ss_pred CCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCC
Q 005875 131 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS 168 (672)
Q Consensus 131 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 168 (672)
++|++|+|++|+|+ .+|+.|++|++|+.|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 47899999999999 78878999999999999999988
|
... |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=6.7e-05 Score=77.86 Aligned_cols=77 Identities=6% Similarity=0.060 Sum_probs=58.5
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCC--CceeceEEEEEeC---CeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH--PNVVPLRAYYYSK---DEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~---~~~~lV~e~~~ 454 (672)
.+.||.|..+.||+....++ .+++|..+. ......+..|.+.++.+.++ -.+.++++++... +..++|||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 35799999999999987655 466666433 22456899999999988654 4688899887643 56899999999
Q ss_pred CCch
Q 005875 455 SGSL 458 (672)
Q Consensus 455 ~g~L 458 (672)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8755
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.4e-05 Score=76.79 Aligned_cols=144 Identities=17% Similarity=0.227 Sum_probs=84.1
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCC-CceeceEEEEEeC---CeeEEEEEecCCC
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-PNVVPLRAYYYSK---DEKLLVYDYFASG 456 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~---~~~~lV~e~~~~g 456 (672)
+.++.|..+.||+....+ +.+++|..... ........|..++..+.++ ..+.+++.+.... ...+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468899999999999887 68999987654 3456778888888888544 2366777654332 3468999999998
Q ss_pred chhh----------------hh---ccCCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHhc
Q 005875 457 SLST----------------LL---HGNRGAGRTPLDWET---------RVKI------------LLGTAR-GVAHIHSM 495 (672)
Q Consensus 457 ~L~~----------------~l---~~~~~~~~~~l~~~~---------~~~i------------~~~ia~-gl~~LH~~ 495 (672)
.+.. .+ +... .......+.. .... ...+.. .++.+++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVP-PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSH-TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhccccc-ccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 8777 11 1110 0111111110 0000 111222 23333321
Q ss_pred ----CCCCcccCCCCCCCEEec-CCCCeEEeecCCCC
Q 005875 496 ----GGPKFTHGNIKASNVLIN-QDLDGCISDFGLTP 527 (672)
Q Consensus 496 ----~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla~ 527 (672)
....++|+|+.+.||+++ +++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 234599999999999999 55666799998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=5.4e-08 Score=105.76 Aligned_cols=125 Identities=33% Similarity=0.436 Sum_probs=94.8
Q ss_pred CCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCc-hhhhhcccccee
Q 005875 131 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQ-SIQNLTQLTGLS 207 (672)
Q Consensus 131 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~ 207 (672)
..|.+.+.+.|.|. .+..++.=++.|+.|||++|+|+.. . .+. +.|+.|||++|+|+ .+|. ....+. |+.|.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v-~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV-D-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh-H-HHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence 35778888999998 7777888899999999999999843 2 332 78999999999999 5554 445565 99999
Q ss_pred cCCccccCCCCCCCCCCCceEEeecCCCCCCCC----cccCCCCCCccccCCCCCCC
Q 005875 208 LQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP----SSLQKFPNSSFVGNSLLCGP 260 (672)
Q Consensus 208 l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p----~~~~~~~~l~~~~n~~~~~~ 260 (672)
|++|.++..---.+|.+|+.|||++|-|++.-- ..+..+..|..-||+..|.+
T Consensus 239 lrnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 239 LRNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ecccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 999999954444499999999999999886432 22334444555688877753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 672 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-42 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-21 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 2e-78
Identities = 106/291 (36%), Positives = 169/291 (58%), Gaps = 17/291 (5%)
Query: 370 FDLEDLLRA-----SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQME 422
F L +L A + +LG+G +G YK L + T V VKRLKE G+ F+ ++E
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 423 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 482
++ H N++ LR + + E+LLVY Y A+GS+++ L R + PLDW R +I
Sbjct: 80 MISMA-VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIA 137
Query: 483 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSRSAG 540
LG+ARG+A++H PK H ++KA+N+L++++ + + DFGL LM+ T + G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 541 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMVDLPRWVQSVVR 595
+ APE + T K S K+DV+ +GV+LLE++TG+ DD V L WV+ +++
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646
E+ + DV+L + +EE+ Q++Q+ + C P RP M EVVRM+E
Sbjct: 258 EKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 4e-68
Identities = 80/318 (25%), Positives = 144/318 (45%), Gaps = 26/318 (8%)
Query: 349 GSGVQEPEKNKLVFFEGCSYNFDLEDLLRA-----SAEVLGKGSYGTAYKAVLEESTTVV 403
+ + SY L DL A ++G G +G YK VL + V
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67
Query: 404 VKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL 462
+KR G +FE ++E + +HP++V L + ++E +L+Y Y +G+L L
Sbjct: 68 LKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 463 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 522
+G + WE R++I +G ARG+ ++H+ H ++K+ N+L++++ I+D
Sbjct: 127 YG-SDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITD 182
Query: 523 FGLTPLM----------NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 572
FG++ V T GY PE + + KSDVYSFGV+L E+L +
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTL----GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 573 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 632
+ + +MV+L W ++ D + + E + + + C+A
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVD-PNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 633 DMRPNMDEVVRMIEEVRQ 650
+ RP+M +V+ +E +
Sbjct: 298 EDRPSMGDVLWKLEYALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-66
Identities = 89/295 (30%), Positives = 144/295 (48%), Gaps = 25/295 (8%)
Query: 369 NFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----GKRDFEQQMEI 423
NFD E + +G+G +G YK + TTV VK+L +V K+ F+Q++++
Sbjct: 26 NFD-ERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKV 83
Query: 424 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 483
+ + QH N+V L + D+ LVY Y +GSL L G PL W R KI
Sbjct: 84 MAKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQ 140
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---PSRSAG 540
G A G+ +H H +IK++N+L+++ ISDFGL A SR G
Sbjct: 141 GAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVG 197
Query: 541 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 597
Y APE + + + KSD+YSFGV+LLE++TG + R+ L + + EE
Sbjct: 198 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV-DEHREPQ-LLLDIKEEIEDEE 254
Query: 598 WT-AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
T + D ++ + M + C+ + + RP++ +V ++++E+ S
Sbjct: 255 KTIEDYIDKKMNDAD--STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 9e-58
Identities = 67/319 (21%), Positives = 115/319 (36%), Gaps = 40/319 (12%)
Query: 367 SYNFDLEDLLRAS-----AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM 421
+ E+L S EV +G +G +KA L V VK E ++
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEYEV 69
Query: 422 EIVGRVGQHPNVVPLRAY----YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET 477
+ + +H N++ + L+ + GSLS L N + W
Sbjct: 70 YSLPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNE 122
Query: 478 RVKILLGTARGVAHIHSMGG-------PKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530
I ARG+A++H P +H +IK+ NVL+ +L CI+DFGL
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 531 VPATPSRS------AGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579
+ + Y APEV+E R + D+Y+ G++L E+ + P
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 580 RDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ-----NIEEEMVQMLQIGMACVAKVPDM 634
+ M+ + E EV + R M + + C +
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 635 RPNMDEVVRMIEEVRQSDS 653
R + V I ++++ +
Sbjct: 303 RLSAGCVGERITQMQRLTN 321
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-51
Identities = 69/191 (36%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 65 NSDRQALLDFADAVPHLRKL-NWSSTNPICQ-SWVGINCTQDR--TRVFGLRLPGIGLVG 120
D+QALL + + L +W T C +W+G+ C D RV L L G+ L
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 121 --PIPNNTLGKLDALEVLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 176
PIP++ L L L L + N L G +P I L L YLY+ H N SG IP S
Sbjct: 65 PYPIPSS-LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 177 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKL-RHLNLSY 232
LV LD S+N+ +G +P SI +L L G++ N +SG+IP+ KL + +S
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 233 NGLKGSIPSSL 243
N L G IP +
Sbjct: 184 NRLTGKIPPTF 194
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 45/151 (29%), Positives = 62/151 (41%), Gaps = 27/151 (17%)
Query: 118 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS 176
L G IP T L+ L + L N+L G S + + ++L N+ + + S
Sbjct: 186 LTGKIPP-TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243
Query: 177 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 236
L LDL N G +PQ + L L LN+S+N L
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLH----------------------SLNVSFNNLC 281
Query: 237 GSIPSS--LQKFPNSSFVGNSLLCGPPLKAC 265
G IP LQ+F S++ N LCG PL AC
Sbjct: 282 GEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-47
Identities = 72/297 (24%), Positives = 134/297 (45%), Gaps = 27/297 (9%)
Query: 371 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH 430
D +++ EV+G+G++G KA + V +K+++ ++ F ++ + RV H
Sbjct: 6 DYKEIEVE--EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQLSRV-NH 60
Query: 431 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
PN+V L + LV +Y GSL +LHG + L ++GVA
Sbjct: 61 PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVA 116
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR-SAGYRAPEVIE 548
++HSM H ++K N+L+ I DFG + T ++ SA + APEV E
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE 176
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608
+S K DV+S+G++L E++T + P D++ + V +
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVHNGTRPPLIK---- 227
Query: 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS-DSENRPSSEENKS 664
N+ + + ++ C +K P RP+M+E+V+++ + + + P +
Sbjct: 228 ---NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQH 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 49/297 (16%)
Query: 371 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLK-----EVVVGKRDFEQQMEIVG 425
D +L E++G G +G Y+A V VK + ++ + Q+ ++
Sbjct: 5 DFAELTLE--EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 426 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 485
+ +HPN++ LR + LV ++ G L+ +L G R + + V +
Sbjct: 62 ML-KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQI 114
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--------ISDFGL------TPLMNV 531
ARG+ ++H H ++K+SN+LI Q ++ I+DFGL T M+
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA 174
Query: 532 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ 591
+ APEVI S SDV+S+GVLL E+LTG+ P + D
Sbjct: 175 AGAY----AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----RGI-DGLAVAY 224
Query: 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648
V + L E ++++ C P RP+ ++ + +
Sbjct: 225 GVAMN-------KLALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 68/332 (20%), Positives = 117/332 (35%), Gaps = 50/332 (15%)
Query: 367 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGR 426
+ DL++L E++G+G YG YK L+E V VK +++F + I
Sbjct: 7 EPSLDLDNL--KLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFA--NRQNFINEKNIYRV 61
Query: 427 VG-QHPNVVPL-----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK 480
+H N+ R + E LLV +Y+ +GSL L DW + +
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCR 115
Query: 481 ILLGTARGVAHIHSM------GGPKFTHGNIKASNVLINQDLDGCISDFGL--------- 525
+ RG+A++H+ P +H ++ + NVL+ D ISDFGL
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 526 TPLMNVPATPSRSAG---YRAPEVIE-------TRKHSHKSDVYSFGVLLLEMLTGKAPL 575
G Y APEV+E + D+Y+ G++ E+ L
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 576 QSPTRDDMVDLP--RWVQSVVREEWTAEVFDVELMR------FQNIEEEMVQMLQIGMAC 627
+ V + E + E R ++ + + + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 628 VAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 659
+ + R + E+ N+ S
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 56/298 (18%), Positives = 127/298 (42%), Gaps = 43/298 (14%)
Query: 368 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRLK--------EVVVGKRDFE 418
++ + +GKG +G +K L + +VV +K L E++ ++F+
Sbjct: 14 PTLADNEIEYE--KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 419 QQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR 478
+++ I+ + HPN+V L + +V ++ G L L P+ W +
Sbjct: 72 REVFIMSNL-NHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVK 124
Query: 479 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-----ISDFGLTPLMNVPA 533
++++L A G+ ++ + P H ++++ N+ + + ++DFGL+
Sbjct: 125 LRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV 183
Query: 534 TPSR-SAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-RW 589
+ + + APE I ++ K+D YSF ++L +LTG+ P D+ ++
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF-----DEYSYGKIKF 238
Query: 590 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647
+ + E + + + + +++ C + P RP+ +V+ + E
Sbjct: 239 INMIREEGLRPTIPE-------DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 48/288 (16%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLR 437
E +G GS+GT ++A + V VK L E +F +++ I+ R+ +HPN+V
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFM 100
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+V +Y + GSL LLH + R LD R+ + A+G+ ++H+
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRN- 157
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVIETRKHS 553
P H N+K+ N+L+++ + DFGL+ L S+SA + APEV+ +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 554 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRWVQSVVREEWTAEVF 603
KSDVYSFGV+L E+ T + P + +V ++PR + V
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA-------- 269
Query: 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
++ C P RP+ ++ ++ + +S
Sbjct: 270 --AIIE----------------GCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 69/327 (21%), Positives = 123/327 (37%), Gaps = 55/327 (16%)
Query: 370 FDLEDLLRASAEVLGKGSYGTAYKAVLEEST-TVVVKRLKEV-VVGKRDFEQQMEIVGRV 427
F DL+ EVLGKG +G A K E+ +V+K L +R F ++++++ +
Sbjct: 7 FRPSDLIHG--EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 428 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 487
+HPNV+ Y + +Y G+L ++ W RV A
Sbjct: 65 -EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIAS 119
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 542
G+A++HSM H ++ + N L+ ++ + ++DFGL LM T
Sbjct: 120 GMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 543 -------------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW 589
APE+I R + K DV+SFG++L E++
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------------- 221
Query: 590 VQSVVREEWTAEVFDVELMRFQNIEEEMVQ-----MLQIGMACVAKVPDMRPNMDEVVRM 644
++ D L ++ I + C P+ RP+ ++
Sbjct: 222 -----DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276
Query: 645 IEEVRQSDSENRPSSEENKSKDSNVQT 671
+E +R + + P + + D
Sbjct: 277 LETLRMHLAGHLPLGPQLEQLDRGFWE 303
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 66/294 (22%), Positives = 118/294 (40%), Gaps = 45/294 (15%)
Query: 371 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK---RDFEQQMEIVGRV 427
D + L L + G +K + +VVK LK RDF ++ +
Sbjct: 8 DFKQLNFL--TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 428 GQHPNVVPLRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 485
HPNV+P+ S + + GSL +LH +D VK L
Sbjct: 65 -SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDM 120
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---TPSRSAGYR 542
ARG+A +H++ P + + +V+I++D+ IS + P P +
Sbjct: 121 ARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP----AWV 175
Query: 543 APEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 599
APE ++ + + +D++SF VLL E++T + P D+ V E
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF-----ADL-SNMEIGMKVALEG-- 227
Query: 600 AEVFDVELMRF---QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650
+R I + ++++I C+ + P RP D +V ++E+++
Sbjct: 228 --------LRPTIPPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-38
Identities = 50/145 (34%), Positives = 70/145 (48%), Gaps = 9/145 (6%)
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 170
L + G L G + L++L++ SN G +P L SL+YL L N F+G+
Sbjct: 228 LDISGNKLSGDFSRA-ISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGE 284
Query: 171 IPSSFS---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPK 224
IP S L LDLS N F G +P + + L L+L SNN SG +P +
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344
Query: 225 LRHLNLSYNGLKGSIPSSLQKFPNS 249
L+ L+LS+N G +P SL S
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSAS 369
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-38
Identities = 52/168 (30%), Positives = 69/168 (41%), Gaps = 27/168 (16%)
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 170
+ G T ++ L + N+L+G +P EI S+P L L L HN+ SG
Sbjct: 613 CNITSRVYGGHTSP-TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671
Query: 171 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHL 228
IP L +LDLS N G IPQ++ LT LT +
Sbjct: 672 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT----------------------EI 709
Query: 229 NLSYNGLKGSIPSS--LQKFPNSSFVGNSLLCGPPLKACFPVAPSPSP 274
+LS N L G IP + FP + F+ N LCG PL C P
Sbjct: 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-38
Identities = 51/135 (37%), Positives = 72/135 (53%), Gaps = 5/135 (3%)
Query: 118 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 176
L G IP++ LG L L L L N+L G +P E+ + +L L L N+ +G+IPS S
Sbjct: 430 LSGTIPSS-LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 177 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYN 233
L + LS N TG IP+ I L L L L +N+ SG+IP D L L+L+ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 234 GLKGSIPSSLQKFPN 248
G+IP+++ K
Sbjct: 549 LFNGTIPAAMFKQSG 563
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-37
Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 13/171 (7%)
Query: 79 PHLRKLNWSSTN---PICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNN--TLGKLDAL 133
L+ LN SS P S G+ L L + G L
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSG-GLKLNSLEV----LDLSANSISGANVVGWVLSDGCGEL 180
Query: 134 EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGN 192
+ L++ N ++G + ++ +L +L + NNFS IP L LD+S N +G+
Sbjct: 181 KHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGD 238
Query: 193 IPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 243
++I T+L L++ SN G IP + L++L+L+ N G IP L
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFL 289
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-37
Identities = 45/142 (31%), Positives = 60/142 (42%), Gaps = 6/142 (4%)
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 170
L + IP LG AL+ L + N L+G I++ L+ L + N F G
Sbjct: 205 LDVSSNNFSTGIP--FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262
Query: 171 IPSSFSPQLVVLDLSFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPN--FDIPKLRH 227
IP L L L+ N FTG IP + LTGL L N+ G++P L
Sbjct: 263 IPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322
Query: 228 LNLSYNGLKGSIP-SSLQKFPN 248
L LS N G +P +L K
Sbjct: 323 LALSSNNFSGELPMDTLLKMRG 344
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-36
Identities = 54/138 (39%), Positives = 72/138 (52%), Gaps = 8/138 (5%)
Query: 118 LVGPIPNNTLGKLDA-LEVLSLRSNVLTGGLPSEI--TSLPSLRYLYLQHNNFSGKIPSS 174
G +P +L L A L L L SN +G + + +L+ LYLQ+N F+GKIP +
Sbjct: 355 FSGELPE-SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 175 FS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNL 230
S +LV L LSFN +G IP S+ +L++L L L N L G IP + L L L
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 231 SYNGLKGSIPSSLQKFPN 248
+N L G IPS L N
Sbjct: 474 DFNDLTGEIPSGLSNCTN 491
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-36
Identities = 44/203 (21%), Positives = 72/203 (35%), Gaps = 32/203 (15%)
Query: 55 SLLPLAFADLNSDRQALLDFADAVPHLRKL-NWSSTNPICQSWVGINCTQDRTRVFGLRL 113
S L + L+ F D +P L +WSS C ++ G+ C +V + L
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTC--RDDKVTSIDL 57
Query: 114 PGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 173
L + S + SL L L+L +++ +G +
Sbjct: 58 SSKPLNVGF----------------------SAVSSSLLSLTGLESLFLSNSHINGSVSG 95
Query: 174 -SFSPQLVVLDLSFNSFTGNIP--QSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRH 227
S L LDLS NS +G + S+ + + L L++ SN L + L
Sbjct: 96 FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155
Query: 228 LNLSYNGLKGSIPSSLQKFPNSS 250
L+LS N + G+
Sbjct: 156 LDLSANSISGANVVGWVLSDGCG 178
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-34
Identities = 47/147 (31%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQHNNFSG 169
L + VGPIP L L + LSL N TG +P ++ + +L L L N+F G
Sbjct: 252 LNISSNQFVGPIPPLPLKSL---QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG 308
Query: 170 KIPSSFS--PQLVVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNFDI---P 223
+P F L L LS N+F+G +P ++ + L L L N SG +P
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368
Query: 224 KLRHLNLSYNGLKGSIPSSLQKFPNSS 250
L L+LS N G I +L + P ++
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQNPKNT 395
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-29
Identities = 31/135 (22%), Positives = 52/135 (38%), Gaps = 7/135 (5%)
Query: 118 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP 177
L G IP +G+L+ L +L L +N +G +P+E+ SL +L L N F+G IP++
Sbjct: 502 LTGEIPK-WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN--NLSGSIPN--FDIPKLRHLNLSYN 233
Q ++ N G I+N N G + N++
Sbjct: 561 QS--GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618
Query: 234 GLKGSIPSSLQKFPN 248
G + +
Sbjct: 619 VYGGHTSPTFDNNGS 633
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 63/302 (20%), Positives = 113/302 (37%), Gaps = 43/302 (14%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY- 439
+ +GKG YG + V VK E ++ + +H N++ A
Sbjct: 43 KQIGKGRYGEVWMGKWRG-EKVAVKVFFTTEEASWFRETEIYQTVLM-RHENILGFIAAD 100
Query: 440 ---YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM- 495
S + L+ DY +GSL L T LD ++ +K+ + G+ H+H+
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 496 ----GGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAG---YRA 543
G P H ++K+ N+L+ ++ CI+D GL + V P+ G Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 544 PEVIETRKH------SHKSDVYSFGVLLLEMLTGKAPLQSPTR-----DDMVDLPRWVQS 592
PEV++ + +D+YSFG++L E+ D+V
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV----PSDP 270
Query: 593 VVREEWTAEVFD---VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649
+ + +E + QM ++ C A P R V + + ++
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
Query: 650 QS 651
+S
Sbjct: 331 ES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 65/305 (21%), Positives = 116/305 (38%), Gaps = 45/305 (14%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-QHPNVVPLRA- 438
E +GKG +G ++ V VK +R + ++ EI V +H N++ A
Sbjct: 48 ESIGKGRFGEVWRGKWRG-EEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 439 ---YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
+ + LV DY GSL L+ R + E +K+ L TA G+AH+H
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 496 -----GGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAG---YR 542
G P H ++K+ N+L+ ++ CI+D GL + + P+ G Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 543 APEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR-----DDMVDLPRWVQ 591
APEV++ + ++D+Y+ G++ E+ + D+V
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV----PSD 274
Query: 592 SVVREEWTAEVFD---VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648
V E + E + M +I C R + + + ++
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
Query: 649 RQSDS 653
Q +
Sbjct: 335 SQQEG 339
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 61/309 (19%), Positives = 114/309 (36%), Gaps = 65/309 (21%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
E +GKG YG ++ + V VK E ++ + +H N++ A
Sbjct: 14 ECVGKGRYGEVWRGSWQG-ENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFIASD 71
Query: 441 YSKDEK----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM- 495
+ L+ Y GSL L T LD + ++I+L A G+AH+H
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 496 ----GGPKFTHGNIKASNVLINQDLDGCISDFGL-------TPLMNVPATPSR-SAGYRA 543
G P H ++K+ N+L+ ++ CI+D GL T ++V P + Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 544 PEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAPL---------------QSPTRDD 582
PEV++ + D+++FG++L E+ P+ +D
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 583 MVDLPRWVQSVVRE----EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNM 638
M + V + F + + ++++ C + P R
Sbjct: 246 MRKV------VCVDQQRPNIPNRWFSDPTLT------SLAKLMK---ECWYQNPSARLTA 290
Query: 639 DEVVRMIEE 647
+ + + +
Sbjct: 291 LRIKKTLTK 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 67/280 (23%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR---DFEQQMEIVGRVGQHPNVVPLR 437
+ +G GS+GT YK V VK L + F+ ++ ++ + +H N++
Sbjct: 30 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFM 86
Query: 438 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
Y S +L +V + SL LH + + + + I TARG+ ++H+
Sbjct: 87 GY--STAPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHAKS 140
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAPEVI--- 547
H ++K++N+ +++D I DFGL + + + + APEVI
Sbjct: 141 ---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 548 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607
++ +S +SDVY+FG++L E++TG+ P ++ + + ++ V R + ++ V
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYS-----NINNRDQIIEMVGRGSLSPDLSKVR- 251
Query: 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647
N + M +++ C+ K D RP+ ++ IEE
Sbjct: 252 ---SNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 53/309 (17%), Positives = 118/309 (38%), Gaps = 52/309 (16%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLR 437
E++GKG +G Y V ++ + + + F++++ + +H NVV
Sbjct: 39 ELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFM 95
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
S ++ +L +++ + LD +I +G+ ++H+
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA--- 148
Query: 498 PKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAG---------YRAPEVI 547
H ++K+ NV D I+DFGL + V R + APE+I
Sbjct: 149 KGILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 548 ETRK---------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 598
S SDV++ G + E+ + P ++ + ++ + + ++
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ---MGTGMKPN- 262
Query: 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS 658
+ + +E+ +L + C A + RP +++ M+E++ + + R S
Sbjct: 263 ---------LSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLEKLPKRNR--RLS 308
Query: 659 SEENKSKDS 667
+ K +
Sbjct: 309 HPGHFWKSA 317
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 61/271 (22%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 437
+G+GS+ T YK + E + V L++ + K + ++ + E + + QHPN+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 438 AYYYS---KDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+ S + +++ + SG+L T L + + + +G+ +H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 146
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPS--RSAGYRAPEVIET 549
+ P H ++K N+ I G I D GL L + + + APE+ E
Sbjct: 147 TRT-PPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 203
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609
K+ DVY+FG+ +LEM T + P + + R V S V+ +V E+
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261
Query: 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 640
IE C+ + D R ++ +
Sbjct: 262 I--IEG-----------CIRQNKDERYSIKD 279
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 33/155 (21%), Positives = 49/155 (31%), Gaps = 9/155 (5%)
Query: 118 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF-- 175
L + L L L + L SL L + N+F
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 176 -SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSY 232
L LDLS P + +L+ L L++ NN + L+ L+ S
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 233 NGLKGSIPSSLQKFPNS----SFVGNSLLCGPPLK 263
N + S LQ FP+S + N C +
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-29
Identities = 30/140 (21%), Positives = 51/140 (36%), Gaps = 5/140 (3%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
+ + + L+VL L + SL L L L N +FS L
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL-SGSIPNF--DIPKLRHLNLSYNGLK 236
L + I +L L L++ N + S +P + ++ L HL+LS N ++
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 237 GSIPSSLQKFPNSSFVGNSL 256
+ L+ + SL
Sbjct: 163 SIYCTDLRVLHQMPLLNLSL 182
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 24/121 (19%), Positives = 40/121 (33%), Gaps = 5/121 (4%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 190
+ L L N L S P L+ L L ++ L L L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 191 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG-SIPSSLQKFP 247
+ L+ L L NL+ + L+ LN+++N ++ +P
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 248 N 248
N
Sbjct: 150 N 150
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 10/156 (6%)
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 170
L++ G + +L L L L L P+ SL SL+ L + HNNF
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509
Query: 171 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNL-TQLTGLSLQSNNLSGSIPNFD----IP 223
+ L VLD S N + Q +Q+ + L L+L N+ + + + I
Sbjct: 510 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIK 569
Query: 224 KLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCG 259
R L + ++ + PS Q P S ++ C
Sbjct: 570 DQRQLLVEVERMECATPSDKQGMPVLSL---NITCQ 602
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-26
Identities = 34/144 (23%), Positives = 50/144 (34%), Gaps = 9/144 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF-SGKIPSSFS--PQ 178
+ L +L+ L L I L +L+ L + HN S K+P FS
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 179 LVVLDLSFNSFTGNIPQSIQNLTQLT----GLSLQSNNLSGSIPN-FDIPKLRHLNLSYN 233
L LDLS N ++ L Q+ L L N ++ P F +L L L N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 234 GLKGSIPS-SLQKFPNSSFVGNSL 256
++ +Q L
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVL 234
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-26
Identities = 28/132 (21%), Positives = 46/132 (34%), Gaps = 9/132 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
I + L L L L N + + L SL+ L N + L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 180 VVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLR----HLNLSY 232
L+++ N +P+ NLT L L L SN + + ++ L+LS
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 233 NGLKGSIPSSLQ 244
N + P + +
Sbjct: 187 NPMNFIQPGAFK 198
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 34/135 (25%), Positives = 51/135 (37%), Gaps = 11/135 (8%)
Query: 124 NNTLGKLDALEVLSLRS---NVLTGGLPSEITSLPSLRYLYLQHN--NFSGKIPSSFS-- 176
N G+ L++ SL+ GG LPSL +L L N +F G S
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 177 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYN 233
L LDLSFN + + L QL L Q +NL + L +L++S+
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 234 GLKGSIPSSLQKFPN 248
+ + +
Sbjct: 432 HTRVAFNGIFNGLSS 446
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 34/157 (21%), Positives = 50/157 (31%), Gaps = 26/157 (16%)
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 170
RL + + L + SL S + + + ++L L + F
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQF 319
Query: 171 IPSSFS---------------------PQLVVLDLSFN--SFTGNIPQSIQNLTQLTGLS 207
P L LDLS N SF G QS T L L
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 208 LQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSL 243
L N + NF + +L HL+ ++ LK S+
Sbjct: 380 LSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 28/156 (17%), Positives = 51/156 (32%), Gaps = 27/156 (17%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--- 177
+ N +G L L+ L++ N++ LP ++L +L +L L N +
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 178 ---QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS-----NNLSGSIPNF---DIPKLR 226
+ LDLS N P + + + L N S ++ + L
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEI------RLHKLTLRNNFDSLNVMKTCIQGLAGLE 228
Query: 227 HLNLSYNGLKGS------IPSSLQKFPNSSFVGNSL 256
L + S+L+ N + L
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-18
Identities = 29/142 (20%), Positives = 46/142 (32%), Gaps = 8/142 (5%)
Query: 112 RLPGIGLVGPIPNNTLGKLDALEVLSLRSNVL---TGGLPSEITSLPSLRYLYLQHNNFS 168
G + + L L L + R L + L ++ L
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
Query: 169 GKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHL 228
S++ L+L F +++L +LT S + N D+P L L
Sbjct: 296 RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA---FSEVDLPSLEFL 352
Query: 229 NLSYNGL--KGSIPSSLQKFPN 248
+LS NGL KG S +
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTS 374
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 30/146 (20%), Positives = 44/146 (30%), Gaps = 18/146 (12%)
Query: 120 GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRY----LYLQHNNFSGKIPSSF 175
+P L LE L L SN + +++ L + L L N + P +F
Sbjct: 139 FKLPE-YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 176 S-PQLVVLDLSFNSFTGNIPQ-SIQNLTQLTGLSLQSNNLSGSIPNFDIPK-----LRHL 228
+L L L N + N+ + IQ L L L K L +L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 229 NLSYNGLK------GSIPSSLQKFPN 248
+ L I N
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTN 283
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 21/100 (21%), Positives = 35/100 (35%), Gaps = 4/100 (4%)
Query: 151 ITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS 210
+ +P++ Y NF KIP + LDLSFN S + +L L L
Sbjct: 4 VEVVPNITYQ-CMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 211 NNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+ + L L L+ N ++ + +
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 27/147 (18%), Positives = 42/147 (28%), Gaps = 13/147 (8%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSG-----KIPSSF 175
I ++ L L+LR+N + + I L L L F K S
Sbjct: 192 IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 176 SPQLVVLDLSFNS------FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 229
L L + + +I LT ++ SL S + +HL
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 230 LSYNGLKGSIPSSLQKFPNSSFVGNSL 256
L L+ +F N
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKG 337
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 63/274 (22%), Positives = 102/274 (37%), Gaps = 41/274 (14%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVPL 436
LG GSYG +K E+ VKR G +D ++ +VGQHP V
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV-- 120
Query: 437 RAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHIH 493
+ + L + SL A L E +V L T +AH+H
Sbjct: 121 -RLEQAWEEGGILYLQTELCGPSLQQHCE----AWGASLP-EAQVWGYLRDTLLALAHLH 174
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETR 550
S G H ++K +N+ + + DFGL + G Y APE+++
Sbjct: 175 SQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-G 230
Query: 551 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610
+ +DV+S G+ +LE+ P + + Q + E+TA EL
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL---PHGGE--GWQQLRQGYLPPEFTAG-LSSELRSV 284
Query: 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644
+V ML+ P +R + ++ +
Sbjct: 285 ------LVMMLE-------PDPKLRATAEALLAL 305
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 55/302 (18%), Positives = 110/302 (36%), Gaps = 44/302 (14%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPLR 437
+ LG+G + LK ++ ++ ++ E + R+ HPN++ L
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYA--LKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 438 AYYYSKDEK----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
AY + L+ +F G+L + L + + +LLG RG+ IH
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------------- 540
+ + H ++K +N+L+ + + D G + SR A
Sbjct: 152 A---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 541 YRAPEVIETRKH---SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 597
YRAPE+ + H ++DV+S G +L M+ G+ P + V V+ +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-----VALAVQNQ 263
Query: 598 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRP 657
+ + + M+ P RP++ ++ +E ++
Sbjct: 264 LSIPQSPRHSSALWQL---LNSMMT-------VDPHQRPHIPLLLSQLEALQPPAPGQHT 313
Query: 658 SS 659
+
Sbjct: 314 TQ 315
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 67/326 (20%), Positives = 125/326 (38%), Gaps = 68/326 (20%)
Query: 381 EVLGKGSYGTAYKAVL---EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVP 435
+V+G+G++G KA + +KR+KE RDF ++E++ ++G HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR-----------VKILLG 484
L + L +Y G+L L +R P +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 485 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-YR- 542
ARG+ ++ +F H ++ A N+L+ ++ I+DFGL SR Y
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL----------SRGQEVYVK 197
Query: 543 -----------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 590
A E + ++ SDV+S+GVLL E+++ G P T ++ + +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---L 254
Query: 591 QSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646
R EV+D+ M Q C + P RP+ +++ +
Sbjct: 255 PQGYRLEKPLNCDDEVYDL--------------MRQ----CWREKPYERPSFAQILVSLN 296
Query: 647 EVRQSDSENRPSSEENKSKDSNVQTP 672
+ + ++ K + +
Sbjct: 297 RMLEERKTYVNTTLYEKFTYAGIDCS 322
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 63/285 (22%), Positives = 124/285 (43%), Gaps = 39/285 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+ LG G +G + A + T V VK +K + F + ++ + QH +V L A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVV 252
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
+K+ ++ ++ A GSL L + G + + A G+A I +
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 555
H +++A+N+L++ L I+DFGL ++ +R + APE I + K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 556 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 610
SDV+SFG+LL+E++T G+ P + +++ ++ R E E++++
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA---LERGYRMPRPENCPEELYNI----- 417
Query: 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 655
M++ C P+ RP + + ++++ +
Sbjct: 418 ---------MMR----CWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 39/291 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
LG+G +G + +T V +K LK + F Q+ +++ ++ +H +V L A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV 248
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
S++ +V +Y + GSL L G G L V + A G+A++ M +
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 555
H +++A+N+L+ ++L ++DFGL L+ +R + APE + + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 556 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 610
SDV+SFG+LL E+ T G+ P +++D V+ R E + D+
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYRMPCPPECPESLHDL----- 413
Query: 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 661
M Q C K P+ RP + + +E+ S E
Sbjct: 414 ---------MCQ----CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 451
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 381 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
LG G YG Y+ V + S TV VK LKE + +F ++ ++ + +HPN+V L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 284
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+ ++ ++ G+L L R R + + + + + ++
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSH 554
F H N+ A N L+ ++ ++DFGL+ LM + + + APE + K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 555 KSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMR 609
KSDV++FGVLL E+ T G +P + +L ++ R E +V+++
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRMERPEGCPEKVYEL---- 451
Query: 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653
M C P RP+ E+ + E + Q S
Sbjct: 452 ----------MRA----CWQWNPSDRPSFAEIHQAFETMFQESS 481
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 66/283 (23%), Positives = 122/283 (43%), Gaps = 39/283 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+ LG G +G + V VK +KE + + +F Q+ + + ++ HP +V
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVC 72
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
+ +V +Y ++G L L + L+ +++ G+A + S +F
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YR--APEVIETRKHSHK 555
H ++ A N L+++DL +SDFG+T + S + APEV K+S K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 556 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 610
SDV++FG+L+ E+ + GK P T ++V V R + ++ +
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK---VSQGHRLYRPHLASDTIYQI----- 237
Query: 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653
M C ++P+ RP +++ IE +R+ D
Sbjct: 238 ---------MYS----CWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 59/284 (20%), Positives = 115/284 (40%), Gaps = 41/284 (14%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+ LG G +G V +K +KE + + +F ++ +++ + H +V L
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC 88
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
+ ++ +Y A+G L L R + +++ + ++ S +F
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK---QF 141
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------APEVIETRKHSH 554
H ++ A N L+N +SDFGL+ + + S G + PEV+ K S
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 555 KSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMR 609
KSD+++FGVL+ E+ + GK P + T + + + +R + +V+ +
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IAQGLRLYRPHLASEKVYTI---- 253
Query: 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653
M C + D RP ++ I +V +S
Sbjct: 254 ----------MYS----CWHEKADERPTFKILLSNILDVMDEES 283
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVPL 436
E +G G +G+ +K V + +KR K+ + G D + +++ +GQH +VV
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV-- 74
Query: 437 RAYY--YSKDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 492
Y+ +++D+ +L+ +Y GSL+ + N E +K +LL RG+ +I
Sbjct: 75 -RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS-YFK-EAELKDLLLQVGRGLRYI 131
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGC-------------------ISDFGLTPLMNVPA 533
HSM H +IK SN+ I++ I D G ++ P
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 534 TPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ + A EV+ E H K+D+++ + ++ +
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 39/298 (13%)
Query: 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
LG G YG Y+ V + S TV VK LKE + +F ++ ++ + +HPN+V L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 77
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+ ++ ++ G+L L R R + + + + + ++
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSH 554
F H ++ A N L+ ++ ++DFGL+ LM + + + APE + K S
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 555 KSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMR 609
KSDV++FGVLL E+ T G +P + +L ++ R E +V+++
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRMERPEGCPEKVYEL---- 244
Query: 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDS 667
M C P RP+ E+ + E + Q S + +E + +
Sbjct: 245 ----------MRA----CWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT 288
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 65/315 (20%), Positives = 119/315 (37%), Gaps = 70/315 (22%)
Query: 381 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 433
LG+G +G + V VK LK + ++Q+++I+ + H ++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHI 95
Query: 434 VPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 491
+ + LV +Y GSL L + + + G+A+
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAY 149
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR--------- 542
+H+ + H ++ A NVL++ D I DFGL + P YR
Sbjct: 150 LHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-----PEGHEYYRVREDGDSPV 201
Query: 543 ---APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTR-DDMVDLPRWVQSVVR-- 595
APE ++ K + SDV+SFGV L E+LT + PT+ +++ + + +V+R
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 596 ------------EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
++ AEV+ + M C RP + ++
Sbjct: 262 ELLERGERLPRPDKCPAEVYHL--------------MKN----CWETEASFRPTFENLIP 303
Query: 644 MIEEVRQSDSENRPS 658
+++ V + PS
Sbjct: 304 ILKTVHEKYQGQAPS 318
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 31/138 (22%), Positives = 49/138 (35%), Gaps = 9/138 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----P 177
I NN K L L L N L+ L +L+ L L +N
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP-----NFDIPKLRHLNLSY 232
L L+LS N P + +L GL L + L S+ +R+L+LS
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231
Query: 233 NGLKGSIPSSLQKFPNSS 250
+ L + ++ ++
Sbjct: 232 SQLSTTSNTTFLGLKWTN 249
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-28
Identities = 36/133 (27%), Positives = 49/133 (36%), Gaps = 4/133 (3%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
+P + L L + N ++ P LP L+ L LQHN S +F+ L
Sbjct: 40 LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL 99
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKG 237
L L NS L L L N LS + + L+ L LS N ++
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 238 SIPSSLQKFPNSS 250
L F NSS
Sbjct: 160 LKSEELDIFANSS 172
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-26
Identities = 32/153 (20%), Positives = 51/153 (33%), Gaps = 16/153 (10%)
Query: 125 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS--------GKIPSSFS 176
+ L L +L L +N + + L L L LQHNN + G
Sbjct: 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLK 533
Query: 177 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSY 232
L +L+L N F + ++L +L + L NNL+ + + L+ LNL
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593
Query: 233 NGLKGSIPSSLQKFPNS----SFVGNSLLCGPP 261
N + + N C
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-26
Identities = 30/135 (22%), Positives = 45/135 (33%), Gaps = 6/135 (4%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
+ + T L L L SN + + +L L L HN S + L
Sbjct: 88 LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENL 147
Query: 180 VVLDLSFNSFTGNIPQSIQ--NLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGL 235
L LS N + + + L L L SN + P I +L L L+ L
Sbjct: 148 QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207
Query: 236 KGSIPSSLQKFPNSS 250
S+ L ++
Sbjct: 208 GPSLTEKLCLELANT 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-26
Identities = 37/146 (25%), Positives = 58/146 (39%), Gaps = 10/146 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEIT---SLPSLRYLYLQHNNFSGKIPSSFS-- 176
+ L L L + L L ++ + S+R L L ++ S ++F
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 177 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSY 232
L +LDLS+N+ S L QL L+ NN+ + + +R+LNL
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 233 NGLKGSIPS-SLQKFPNSSFVGNSLL 257
+ K SI SL K + SF L
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-26
Identities = 33/120 (27%), Positives = 48/120 (40%), Gaps = 4/120 (3%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 190
+ VL+L N L + T L L + N S P P L VL+L N +
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 191 GNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
++ T LT L L SN++ N L L+LS+NGL + + + N
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-26
Identities = 35/152 (23%), Positives = 52/152 (34%), Gaps = 14/152 (9%)
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG- 169
L L + + L+ + + L N + +PSL+ L L+
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469
Query: 170 -KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS--------GSIP 218
PS F L +LDLS N+ ++ L +L L LQ NNL+ G
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529
Query: 219 NF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
F + L LNL NG +
Sbjct: 530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-26
Identities = 29/136 (21%), Positives = 54/136 (39%), Gaps = 9/136 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS------F 175
I + + L LE L++ N + G + T L +L+YL L ++ S + ++
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379
Query: 176 SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSY 232
L +L+L+ N + + L L L L N + + + + + LSY
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 233 NGLKGSIPSSLQKFPN 248
N +S P+
Sbjct: 440 NKYLQLTRNSFALVPS 455
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-21
Identities = 51/227 (22%), Positives = 75/227 (33%), Gaps = 41/227 (18%)
Query: 53 IVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDR-TRVFGL 111
I P F + L L ++ + S C + T + L
Sbjct: 183 IKEFSPGCFHAI--------------GRLFGLFLNN-VQLGPSLTEKLCLELANTSIRNL 227
Query: 112 RLPGIGLVGPIPNNTLGKLD--ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 169
L L N T L L +L L N L LP L Y +L++NN
Sbjct: 228 SLSNSQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 170 KIPSSFS--PQLVVLDL---------SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 218
S + L+L S S S Q L L L+++ N++ G
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
Query: 219 NF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLK 263
N + L++L+LS + SL+ N +FV L PL
Sbjct: 347 NMFTGLINLKYLSLSNSFT------SLRTLTNETFVS---LAHSPLH 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-18
Identities = 22/95 (23%), Positives = 36/95 (37%), Gaps = 3/95 (3%)
Query: 156 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
S H + ++P + VL+L+ N + +QLT L + N +S
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 216 SIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
P +P L+ LNL +N L + N
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN 98
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-18
Identities = 28/138 (20%), Positives = 47/138 (34%), Gaps = 5/138 (3%)
Query: 123 PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLV 180
P L L L +L+L SN L L+ + L NN + S F+ L
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587
Query: 181 VLDLSFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 239
L+L N T + LT L ++ N + + + +N ++ +
Sbjct: 588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIA-WFVNWINETHTNIPELS 646
Query: 240 PSSLQKFPNSSFVGNSLL 257
L P + G +
Sbjct: 647 SHYLCNTP-PHYHGFPVR 663
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-15
Identities = 30/118 (25%), Positives = 44/118 (37%), Gaps = 8/118 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP---Q 178
IP L L+++ L N L S + SL+ L LQ N + F P
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 179 LVVLDLSFNSFTGNIP-----QSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLS 231
L LD+ FN F + N T L S+ L + P++ +R + S
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 47/287 (16%)
Query: 381 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLR 437
E +G+G++G + L ++T V VK +E + K F Q+ I+ + HPN+V L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLI 178
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
K +V + G T L L +T ++++ A G+ ++ S
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESK-- 232
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-------APEVIETR 550
H ++ A N L+ + ISDFG++ + S G R APE +
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 551 KHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE--- 606
++S +SDV+SFG+LL E + G +P P RE VE
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP-----------YPNLSNQQTREF-------VEKGG 332
Query: 607 -LMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
L + + + + M Q C A P RP+ + + ++ +R+
Sbjct: 333 RLPCPELCPDAVFRLMEQ----CWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 64/281 (22%), Positives = 123/281 (43%), Gaps = 39/281 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+ +G G +G + V +K ++E + + DF ++ E++ ++ HP +V L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC 72
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
+ LV ++ G LS L RG ET + + L G+A++
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA---CV 125
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 555
H ++ A N L+ ++ +SDFG+T + S + + +PEV ++S K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 556 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 610
SDV+SFGVL+ E+ + GK P ++ + ++V+ + + R + V+ +
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGFRLYKPRLASTHVYQI----- 237
Query: 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
M C + P+ RP ++R + E+ +S
Sbjct: 238 ---------MNH----CWRERPEDRPAFSRLLRQLAEIAES 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 58/313 (18%), Positives = 127/313 (40%), Gaps = 48/313 (15%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 435
+ +G+GS+G A E V +KE+ + + +++ E V +HPN+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYV--IKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
R + +V DY G L ++ +G + + + + H+H
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHDR 144
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-G---YRAPEVIETRK 551
K H +IK+ N+ + +D + DFG+ ++N +R+ G Y +PE+ E +
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA--EVFDVELMR 609
+++KSD+++ G +L E+ T K ++ M +L V ++ + + +L
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEA---GSMKNL---VLKIISGSFPPVSLHYSYDLRS 255
Query: 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR----------MIEEVRQSDSENRPSS 659
+ Q+ + + P RP+++ ++ + ++ +
Sbjct: 256 L------VSQLFK-------RNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTF 302
Query: 660 EENKSKDSNVQTP 672
+ S+ + P
Sbjct: 303 SKFGSQPIPAKRP 315
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-28
Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 39/291 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
LG+G +G + +T V +K LK + F Q+ +++ ++ +H +V L A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV 331
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
S++ +V +Y + GSL L G G L V + A G+A++ M +
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 555
H +++A+N+L+ ++L ++DFGL L+ +R + APE + + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 556 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 610
SDV+SFG+LL E+ T G+ P +++D V+ R E + D+
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYRMPCPPECPESLHDL----- 496
Query: 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 661
M Q C K P+ RP + + +E+ S E
Sbjct: 497 ---------MCQ----CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 534
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 61/298 (20%), Positives = 121/298 (40%), Gaps = 50/298 (16%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
E++G G +G +KA V +K V E++++ + ++ H N+V +
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYV--IKRVKYNNEKAEREVKALAKL-DHVNIVHYNGCW 73
Query: 441 YSKDEKL----------------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 484
D + ++ G+L + RG LD +++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQ 130
Query: 485 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---Y 541
+GV +IHS K + ++K SN+ + I DFGL + +RS G Y
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187
Query: 542 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601
+PE I ++ + + D+Y+ G++L E+L T + + +R+ ++
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVC-----DTAFETSKF----FTDLRDGIISD 238
Query: 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 659
+FD + + ++L K P+ RPN E++R + ++S +N +
Sbjct: 239 IFDKKEKTL------LQKLLS-------KKPEDRPNTSEILRTLTVWKKSPEKNERHT 283
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
E LG G +G + T V VK LK+ + F + ++ ++ QH +V L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVV 77
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
+++ ++ +Y +GSL L G L + + A G+A I +
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YR--APEVIETRKHSHK 555
H +++A+N+L++ L I+DFGL L+ +R + APE I + K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 556 SDVYSFGVLLLEMLT-GKAP 574
SDV+SFG+LL E++T G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 71/319 (22%), Positives = 123/319 (38%), Gaps = 63/319 (19%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 432
LG+GS+G Y+ V E T V +K + E + + +F + ++ +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHH 89
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTAR 487
VV L L++ + G L + L R P +++ A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 542
G+A++++ KF H ++ A N ++ +D I DFG+T + + YR
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY------ETDYYRKGGKG 200
Query: 543 -------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 594
+PE ++ + SDV+SFGV+L E+ T + P Q + + ++ V
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF---VMEGG 257
Query: 595 R----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650
+ +F ELMR C P MRP+ E++ I+E +
Sbjct: 258 LLDKPDNCPDMLF--ELMR----------------MCWQYNPKMRPSFLEIISSIKEEME 299
Query: 651 SDSENRP--SSEENKSKDS 667
SEENK +
Sbjct: 300 PGFREVSFYYSEENKLPEP 318
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 57/283 (20%), Positives = 108/283 (38%), Gaps = 45/283 (15%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 435
+G GSYG K + ++V KE+ G ++ +V V +HPN+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILV--WKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 436 LRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+ L V +Y G L++++ + LD E ++++ + H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKECH 128
Query: 494 SMGGPKFT--HGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRA 543
T H ++K +NV ++ + + DFGL ++N TP Y +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY----YMS 184
Query: 544 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA--E 601
PE + ++ KSD++S G LL E+ P + +L + ++
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA---FSQKEL---AGKIREGKFRRIPY 238
Query: 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644
+ EL + +ML RP+++E++
Sbjct: 239 RYSDELNEI------ITRMLN-------LKDYHRPSVEEILEN 268
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 58/295 (19%), Positives = 121/295 (41%), Gaps = 36/295 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-------KRDFEQQMEIVGRVGQHPNV 433
+ +G+G + Y+A V LK+V + + D ++++++ ++ HPNV
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVA--LKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNV 94
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+ A + +E +V + +G LS ++ + + + T K + + H+H
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSRS-AG---YRAPEVI 547
S + H +IK +NV I G + D GL + T + S G Y +PE I
Sbjct: 154 SR---RVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 548 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607
++ KSD++S G LL EM ++P ++ L + ++ ++ + EL
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEEN 662
+ + + P+ RP++ V + + + + + +
Sbjct: 268 RQL------VNMCIN-------PDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 64/313 (20%), Positives = 117/313 (37%), Gaps = 54/313 (17%)
Query: 381 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPNV 433
+VLG G +GT +K V V +K +++ + M +G + H ++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHI 77
Query: 434 VPLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
V L LV Y GSL + +RG L + + + A+G+
Sbjct: 78 VRL----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMY 129
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------AP 544
++ H N+ A NVL+ ++DFG+ L+ + + A
Sbjct: 130 YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 545 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 599
E I K++H+SDV+S+GV + E++T G P ++ DL ++ R + T
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL---LEKGERLAQPQICT 243
Query: 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 659
+V+ V M++ C ++RP E+ + +
Sbjct: 244 IDVYMV--------------MVK----CWMIDENIRPTFKELANEFTRMARDPPRYLVIK 285
Query: 660 EENKSKDSNVQTP 672
E+ + P
Sbjct: 286 RESGPGIAPGPEP 298
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 80/461 (17%), Positives = 156/461 (33%), Gaps = 87/461 (18%)
Query: 227 HLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACF--PVAPSPSPTYSPPPFIPR 284
+SY KG+ P+ L F + S K +A +P P
Sbjct: 247 EEGISYLTDKGANPTHLADFNQVQTIQYSNSEDKDRKGMLQLKIAGAPEP---------- 296
Query: 285 KQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKP 344
+ + + +A +I YC + + + +
Sbjct: 297 -------------LTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSI 343
Query: 345 KEEFGSGVQEPEKNKLVFFEGCSYN--FDLEDLLRASA--------------EVLGKGSY 388
+ + Q + + E Y D ED + +G+G +
Sbjct: 344 PKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQF 403
Query: 389 GTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 442
G ++ + + V +K K + F Q+ + + HP++V L +
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI-T 461
Query: 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 502
++ ++ + G L + L + LD + + + +A++ S +F H
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLESK---RFVH 514
Query: 503 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 557
+I A NVL++ + + DFGL+ M S G + APE I R+ + SD
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASD 574
Query: 558 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRFQN 612
V+ FGV + E+L G P Q +D++ +++ R ++ +
Sbjct: 575 VWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPTLYSL------- 624
Query: 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653
M + C A P RP E+ + + + +
Sbjct: 625 -------MTK----CWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 76/308 (24%), Positives = 121/308 (39%), Gaps = 60/308 (19%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 432
+ LG+G++G +A TV VK LKE R +++I+ +G H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 433 VVPLRAYYYSKDEKLLV-YDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVK 480
VV L L+V ++ G+LST L R + L E +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 481 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG 540
A+G+ + S K H ++ A N+L+++ I DFGL + +
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY------KDPD 203
Query: 541 YR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLP 587
Y APE I R ++ +SDV+SFGVLL E+ + G +P P +
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFC 261
Query: 588 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIE 646
R ++ R + EM Q ML C P RP E+V +
Sbjct: 262 RRLKEGTR-----------MRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLG 306
Query: 647 EVRQSDSE 654
+ Q++++
Sbjct: 307 NLLQANAQ 314
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 63/307 (20%), Positives = 110/307 (35%), Gaps = 68/307 (22%)
Query: 381 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 433
LG+G +G + V VK LK G D ++++EI+ + H N+
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENI 85
Query: 434 VPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 491
V + L+ ++ SGSL L N+ ++ + ++K + +G+ +
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDY 141
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR--------- 542
+ S ++ H ++ A NVL+ + I DFGLT + + Y
Sbjct: 142 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-----ETDKEYYTVKDDRDSPV 193
Query: 543 ---APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTR-DDMVDLPRWVQSVVR-- 595
APE + K SDV+SFGV L E+LT + M+ +V R
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253
Query: 596 ------------EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
EV+ + M + C P R + ++
Sbjct: 254 NTLKEGKRLPCPPNCPDEVYQL--------------MRK----CWEFQPSNRTSFQNLIE 295
Query: 644 MIEEVRQ 650
E + +
Sbjct: 296 GFEALLK 302
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 66/304 (21%), Positives = 126/304 (41%), Gaps = 60/304 (19%)
Query: 381 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKE-VVVGKRDFEQQMEIVGRVGQHPNVV 434
+ LGKG++G+ + V VK+L+ RDFE+++EI+ + QH N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIV 74
Query: 435 PLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
+ YS + L+ +Y GSL L ++ +D ++ +G+ ++
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL 130
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---------- 542
+ ++ H ++ N+L+ + I DFGLT ++ P ++
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-----PQDKEFFKVKEPGESPIF 182
Query: 543 --APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 600
APE + K S SDV+SFGV+L E+ T +SP + M + Q
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ------GQM 236
Query: 601 EVFDVELMRFQNIEE------------EMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEE 647
VF + + ++ E+ M + C + RP+ ++ +++
Sbjct: 237 IVFHL----IELLKNNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQ 288
Query: 648 VRQS 651
+R +
Sbjct: 289 IRDN 292
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 28/217 (12%), Positives = 75/217 (34%), Gaps = 26/217 (11%)
Query: 381 EVLGKGSYGTAYKAVLEESTT------VVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVV 434
+LG+G++ Y+A + V+K K + Q+ + +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
+ + ++ +LV + ++ G+L ++ + + + + + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 495 MGGPKFTHGNIKASNVLINQDLDG-----------CISDFGLTPLMNVPATPSR------ 537
HG+IK N ++ + D G + M + +
Sbjct: 191 CE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 538 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
++G++ E++ + +++ D + + ML G
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 57/295 (19%), Positives = 113/295 (38%), Gaps = 54/295 (18%)
Query: 381 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 433
+VLG G++GT YK + + V +K L+E ++ + ++ V +P+V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 79
Query: 434 VPLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
L L+ G L + ++ + + + + A+G+
Sbjct: 80 CRL----LGICLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMN 131
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------AP 544
++ + H ++ A NVL+ I+DFGL L+ + G + A
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 545 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 599
E I R ++H+SDV+S+GV + E++T G P ++ + ++ R T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICT 245
Query: 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654
+V+ + M + C D RP E++ ++ +
Sbjct: 246 IDVYMI--------------MRK----CWMIDADSRPKFRELIIEFSKMARDPQR 282
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 63/316 (19%), Positives = 108/316 (34%), Gaps = 67/316 (21%)
Query: 381 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE-VVVGKRDFEQQMEIVGRVGQHPNVV 434
LGKG++G+ V VK+L+ +RDF+++++I+ + +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIV 87
Query: 435 PLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
R Y + LV +Y SG L L +R LD + +G+ ++
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYL 143
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---------- 542
S + H ++ A N+L+ + I+DFGL L+ P Y
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL-----PLDKDYYVVREPGQSPIF 195
Query: 543 --APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVRE--- 596
APE + S +SDV+SFGV+L E+ T + +
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255
Query: 597 ------------EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644
AEV ++ M C A P RP+ +
Sbjct: 256 LLEEGQRLPAPPACPAEVHEL--------------MKL----CWAPSPQDRPSFSALGPQ 297
Query: 645 IEEVRQSDSENRPSSE 660
++ + +
Sbjct: 298 LDMLWSGSRGCETHAF 313
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 66/327 (20%), Positives = 122/327 (37%), Gaps = 60/327 (18%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVPL 436
VL +G + Y+A S LK ++ + + + + + ++ HPN+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYA--LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 437 RAYYYSKDEK-------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
+ E+ L+ G L L + R PL +T +KI T R V
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------- 540
H+H P H ++K N+L++ + DFG ++ S SA
Sbjct: 150 QHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 541 -------YRAPEVIETRKH---SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV 590
YR PE+I+ + K D+++ G +L + + P +
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----------K 258
Query: 591 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650
+V +++ D + F ++ + MLQ P+ R ++ EVV ++E+
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSL---IRAMLQ-------VNPEERLSIAEVVHQLQEIAA 308
Query: 651 SDSENRPS-----SEENKSKDSNVQTP 672
+ + N S E+N S +
Sbjct: 309 ARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 60/312 (19%), Positives = 115/312 (36%), Gaps = 76/312 (24%)
Query: 381 EVLGKGSYGTAYKAVL--------EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHP 431
E LG+G++ +K V T V++K L + F + ++ ++ H
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHK 72
Query: 432 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 491
++V DE +LV ++ GSL T L N+ ++ ++++ A +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHF 128
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGC--------ISDFGLTPLMNVPATPSRSAGYR- 542
+ HGN+ A N+L+ ++ D +SD G++ + +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL------PKDILQE 179
Query: 543 -----APEVIETRKH-SHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL--------- 586
PE IE K+ + +D +SFG L E+ + G PL + +
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239
Query: 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646
P+ AE+ ++ + C+ PD RP+ ++R +
Sbjct: 240 PKA----------AELANL--------------INN----CMDYEPDHRPSFRAIIRDLN 271
Query: 647 EVRQSDSENRPS 658
+ D R S
Sbjct: 272 SLFTPDLVPRGS 283
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 57/289 (19%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+ +GKG +G V VK +K + F + ++ ++ +H N+V L
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLGVI 83
Query: 441 YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+ L +V +Y A GSL L R GR+ L + +K L + ++
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYR------APEVIE 548
F H ++ A NVL+++D +SDFGL ++ + APE +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGL----------TKEASSTQDTGKLPVKWTAPEALR 187
Query: 549 TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVF 603
+K S KSDV+SFG+LL E+ + G+ P D+V V+ + + V+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCPPAVY 244
Query: 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652
+V M C MRP+ ++ +E ++ +
Sbjct: 245 EV--------------MKN----CWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 58/290 (20%), Positives = 114/290 (39%), Gaps = 46/290 (15%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 434
+G+G +G ++ + + V +K K + F Q+ + + HP++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIV 79
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
L +++ ++ + G L + L + LD + + + +A++ S
Sbjct: 80 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLES 134
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIET 549
+F H +I A NVL++ + + DFGL+ M S G + APE I
Sbjct: 135 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 550 RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFD 604
R+ + SDV+ FGV + E+L G P Q +D++ +++ R ++
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPTLYS 248
Query: 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654
+ M + C A P RP E+ + + + +
Sbjct: 249 L--------------MTK----CWAYDPSRRPRFTELKAQLSTILEEEKA 280
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 63/312 (20%), Positives = 114/312 (36%), Gaps = 67/312 (21%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPN 432
+ LG G++G +A + + TV VK LK + + +++++ +G H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT------- 485
+V L L++ +Y G L L R + ++
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 486 ------ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 539
A+G+A + S H ++ A N+L+ I DFGL + +
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK------NDS 199
Query: 540 GYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 586
Y APE I ++ +SDV+S+G+ L E+ + G +P P
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDSKF 257
Query: 587 PRWVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 642
+ ++ R E AE++D+ M C P RP ++V
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDI--------------MKT----CWDADPLKRPTFKQIV 299
Query: 643 RMIEEVRQSDSE 654
++IE+ +
Sbjct: 300 QLIEKQISESTN 311
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 67/291 (23%), Positives = 115/291 (39%), Gaps = 43/291 (14%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPNVV 434
EV+G+G +G Y L + VK L + + F + I+ HPNV+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 89
Query: 435 PLRAYYYSKDEKLL-VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
L + L V Y G L + + + L A+G+ ++
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKYLA 145
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYR------APE 545
S KF H ++ A N ++++ ++DFGL M + G + A E
Sbjct: 146 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604
++T+K + KSDV+SFGVLL E++T G P D+ + R
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRR--------- 250
Query: 605 VELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654
L++ + + + + ML+ C +MRP+ E+V I + +
Sbjct: 251 --LLQPEYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRISAIFSTFIG 295
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 67/304 (22%), Positives = 125/304 (41%), Gaps = 60/304 (19%)
Query: 381 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVV 434
+ LGKG++G+ + V VK+L+ RDFE+++EI+ + QH N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIV 105
Query: 435 PLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
+ YS + L+ +Y GSL L ++ +D ++ +G+ ++
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL 161
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---------- 542
+ ++ H ++ N+L+ + I DFGLT ++ P Y+
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-----PQDKEYYKVKEPGESPIF 213
Query: 543 --APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 600
APE + K S SDV+SFGV+L E+ T +SP + M + Q
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ------GQM 267
Query: 601 EVFDVELMRFQNIEE------------EMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEE 647
VF + + ++ E+ M + C + RP+ ++ +++
Sbjct: 268 IVFHL----IELLKNNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQ 319
Query: 648 VRQS 651
+R
Sbjct: 320 IRDQ 323
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 57/313 (18%), Positives = 117/313 (37%), Gaps = 54/313 (17%)
Query: 381 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 433
+VLG G++GT YK + + V +K L+E ++ + ++ V +P+V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 79
Query: 434 VPLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
L L+ G L + ++ + + + + A+G+
Sbjct: 80 CRL----LGICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMN 131
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------AP 544
++ + H ++ A NVL+ I+DFGL L+ + G + A
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 545 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 599
E I R ++H+SDV+S+GV + E++T G P ++ + ++ R T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICT 245
Query: 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 659
+V+ + M++ C D RP E++ ++ +
Sbjct: 246 IDVYMI--------------MVK----CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287
Query: 660 EENKSKDSNVQTP 672
+ + +
Sbjct: 288 GDERMHLPSPTDS 300
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 62/309 (20%), Positives = 111/309 (35%), Gaps = 37/309 (11%)
Query: 381 EVLGKG--SYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVP 435
V+GKG T A V V+R+ Q E+ V ++ HPN+VP
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 436 LRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
Y + D +L +V + A GS L+ ++ IL G + + +I
Sbjct: 91 ---YRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMN----VPATPSRSAG---Y 541
H MG + H ++KAS++LI+ D +S + V P S +
Sbjct: 145 HHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 542 RAPEVIETRKH--SHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMV----DLPRWVQSV 593
+PEV++ KSD+YS G+ E+ G P + T+ + +P + +
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261
Query: 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR-MIEEVRQSD 652
+ + + + + + +E+ Q +
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321
Query: 653 SENRPSSEE 661
+ RPS+
Sbjct: 322 PDARPSAST 330
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 75/328 (22%), Positives = 124/328 (37%), Gaps = 71/328 (21%)
Query: 381 EVLGKGSYGTAYKAVL--------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQH 430
+ LG+G++G A T V VK LK D +ME++ +G+H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 431 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRV 479
N++ L ++ +Y + G+L L R G L + V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 480 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 539
ARG+ ++ S K H ++ A NVL+ +D I+DFGL ++
Sbjct: 195 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH------HID 245
Query: 540 GYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 586
Y+ APE + R ++H+SDV+SFGVLL E+ T G +P +++ L
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 587 PRWVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 642
++ R T E++ +MR C VP RP ++V
Sbjct: 306 ---LKEGHRMDKPSNCTNELY--MMMR----------------DCWHAVPSQRPTFKQLV 344
Query: 643 RMIEEVRQSDSENRPS---SEENKSKDS 667
++ + S + D
Sbjct: 345 EDLDRIVALTSNQEMGYYHHHHHHDYDI 372
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 63/314 (20%), Positives = 105/314 (33%), Gaps = 66/314 (21%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 432
+VLG G++G A S V VK LKE + +++++ ++G H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT------- 485
+V L L+++Y G L L R K L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 486 -----------ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 534
A+G+ + H ++ A NVL+ I DFGL +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM---- 223
Query: 535 PSRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRD 581
+ Y APE + ++ KSDV+S+G+LL E+ + G P P
Sbjct: 224 --SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--YPGIP 279
Query: 582 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDE 640
+ + +Q+ + + + EE+ M C A RP+
Sbjct: 280 VDANFYKLIQNGFK-----------MDQPFYATEEIYIIMQS----CWAFDSRKRPSFPN 324
Query: 641 VVRMIEEVRQSDSE 654
+ + E
Sbjct: 325 LTSFLGCQLADAEE 338
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 62/309 (20%)
Query: 381 EVLGKGSYGTAYKAVL--------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQH 430
+ LG+G++G A +E+ TV VK LK+ D +ME++ +G+H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 431 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT----- 485
N++ L ++ +Y + G+L L R G RV T
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 486 ------ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 539
ARG+ ++ S K H ++ A NVL+ ++ I+DFGL +N
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN------NID 211
Query: 540 GYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 586
Y+ APE + R ++H+SDV+SFGVL+ E+ T G +P +++ L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMI 645
++ R + + N E+ M C VP RP ++V +
Sbjct: 272 ---LKEGHR-----------MDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 313
Query: 646 EEVRQSDSE 654
+ + +
Sbjct: 314 DRILTLTTN 322
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 47/286 (16%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+ +GKG +G V VK +K + F + ++ ++ +H N+V L
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLGVI 255
Query: 441 YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+ L +V +Y A GSL L R GR+ L + +K L + ++
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------APEVIETRKHS 553
F H ++ A NVL+++D +SDFGLT + S + APE + +K S
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFS 364
Query: 554 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELM 608
KSDV+SFG+LL E+ + G+ P D+V V+ + + V+DV
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCPPAVYDV--- 418
Query: 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654
M C RP ++ +E +R +
Sbjct: 419 -----------MKN----CWHLDAATRPTFLQLREQLEHIRTHELH 449
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 62/294 (21%), Positives = 115/294 (39%), Gaps = 52/294 (17%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 434
+LG+G +G Y+ V E V VK K+ + K F + I+ + HP++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIV 76
Query: 435 PLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 491
L ++ ++ + + G L L N+ + L T V L + +A+
Sbjct: 77 KL----IGIIEEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAY 128
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEV 546
+ S+ H +I N+L+ + DFGL+ + S + +PE
Sbjct: 129 LESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185
Query: 547 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAE 601
I R+ + SDV+ F V + E+L+ GK P D++ + ++ R +
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---LEKGDRLPKPDLCPPV 242
Query: 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 655
++ + M + C P RP E+V + +V Q + +
Sbjct: 243 LYTL--------------MTR----CWDYDPSDRPRFTELVCSLSDVYQMEKDI 278
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 47/297 (15%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 434
+++G G G L + V +K LK +RDF + I+G+ HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNII 113
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
L ++V +Y +GSL T L + G V +L G G+ ++
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSD 169
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAG---YR--APEVI 547
+G + H ++ A NVL++ +L +SDFGL+ ++ + A + + G R APE I
Sbjct: 170 LG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 548 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEV 602
R S SDV+SFGV++ E+L G+ P + T D++ V+ R +
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS---VEEGYRLPAPMGCPHAL 283
Query: 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 659
+ ML C K RP ++V +++ + +S R ++
Sbjct: 284 HQL--------------MLD----CWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 64/301 (21%), Positives = 120/301 (39%), Gaps = 55/301 (18%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNV 433
++LG+G +G+ + L S V VK +K +F + + HPNV
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNV 98
Query: 434 VPL-----RAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTAR 487
+ L + +++ + G L T L +R G + +T +K ++ A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 542
G+ ++ + F H ++ A N ++ D+ C++DFGL+ + YR
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIY------SGDYYRQGRIA 209
Query: 543 -------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 594
A E + R ++ KSDV++FGV + E+ T G P +M D +
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY---LLHGH 266
Query: 595 REEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653
R L + ++ +E+ + M C P RP + +E++ +S
Sbjct: 267 R-----------LKQPEDCLDELYEIMYS----CWRTDPLDRPTFSVLRLQLEKLLESLP 311
Query: 654 E 654
+
Sbjct: 312 D 312
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 68/310 (21%), Positives = 108/310 (34%), Gaps = 51/310 (16%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPN 432
LG G++G Y+ + V VK L EV + DF + I+ + H N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQN 94
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--RTPLDWETRVKILLGTARGVA 490
+V + ++ + A G L + L R + L + + A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDG---CISDFGLT-PLMNVPATPSRSAGYR---- 542
++ F H +I A N L+ G I DFG+ +
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 543 -APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 600
PE + K+D +SFGVLL E+ + G P S + ++++ V S R
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTSGGR----- 263
Query: 601 EVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS-------- 651
+ +N + + M Q C P+ RPN ++ IE Q
Sbjct: 264 ------MDPPKNCPGPVYRIMTQ----CWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
Query: 652 DSENRPSSEE 661
E P EE
Sbjct: 314 PIEYGPLVEE 323
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 40/219 (18%), Positives = 69/219 (31%), Gaps = 24/219 (10%)
Query: 53 IVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLR 112
+ +++DL + LR L+ S I S + + + L
Sbjct: 362 LSFSGCCSYSDLGT------------NSLRHLDLSFNGAIIMSANFMGLEELQH----LD 405
Query: 113 LPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP 172
L + L+ L L + L SL L + N+F
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
Query: 173 SSF---SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRH 227
S+ + L LDLS L +L L++ NNL + + L
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525
Query: 228 LNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLCGPPLK 263
L+ S+N ++ S + +F NS+ C +
Sbjct: 526 LDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQ 564
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 31/140 (22%), Positives = 49/140 (35%), Gaps = 5/140 (3%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
+ + + L+ L L + L L L L N P SFS L
Sbjct: 47 LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSL 106
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-SIPNF--DIPKLRHLNLSYNGLK 236
L I L L L++ N + +P + ++ L H++LSYN ++
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 237 GSIPSSLQKFPNSSFVGNSL 256
+ LQ + V SL
Sbjct: 167 TITVNDLQFLRENPQVNLSL 186
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 23/121 (19%), Positives = 41/121 (33%), Gaps = 5/121 (4%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 190
+ + L N L ++ L++L L ++ L L L+ N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 191 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG-SIPSSLQKFP 247
P S LT L L L+ + L+ LN+++N + +P+
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 248 N 248
N
Sbjct: 154 N 154
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-21
Identities = 31/145 (21%), Positives = 48/145 (33%), Gaps = 19/145 (13%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
I + L L L L N + P + L SL L + L
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 180 VVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH-------LNLS 231
L+++ N +P NLT L + L N + +I D+ LR L++S
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ-TITVNDLQFLRENPQVNLSLDMS 189
Query: 232 YNGLKGSIPSSLQKFPNSSFVGNSL 256
N + + +F G L
Sbjct: 190 LN--------PIDFIQDQAFQGIKL 206
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 32/130 (24%), Positives = 47/130 (36%), Gaps = 8/130 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG-KIPSSFS--PQ 178
+ L +LE L L I L +L+ L + HN K+P+ FS
Sbjct: 95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN 154
Query: 179 LVVLDLSFNSFTGNIPQSIQNLTQLTG----LSLQSNNLSGSIPN-FDIPKLRHLNLSYN 233
LV +DLS+N +Q L + L + N + F KL L L N
Sbjct: 155 LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN 214
Query: 234 GLKGSIPSSL 243
+I +
Sbjct: 215 FNSSNIMKTC 224
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 27/145 (18%), Positives = 45/145 (31%), Gaps = 10/145 (6%)
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 170
L++ G +N L L L L +L L+ L + HNN
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 171 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHL 228
S ++ L LD SFN + L +L +N+++ I L+ +
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICE-HQKFLQWV 570
Query: 229 NLSYNGLKG------SIPSSLQKFP 247
L + P +
Sbjct: 571 KEQKQFLVNVEQMTCATPVEMNTSL 595
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-17
Identities = 22/131 (16%), Positives = 39/131 (29%), Gaps = 5/131 (3%)
Query: 122 IPNNTLGKLDAL--EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 179
+ + L + + L + L ++ + L + +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKW 309
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 239
L + +L L L+L N S S +P L +L+LS N L S
Sbjct: 310 QSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSG 366
Query: 240 PSSLQKFPNSS 250
S +S
Sbjct: 367 CCSYSDLGTNS 377
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 23/106 (21%), Positives = 37/106 (34%), Gaps = 4/106 (3%)
Query: 145 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 204
G L I +P++ S K+P +DLSFN S N ++L
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQ 59
Query: 205 GLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
L L + + L +L L+ N ++ P S +
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS 105
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 36/151 (23%), Positives = 55/151 (36%), Gaps = 23/151 (15%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
+ K + LS+ L P+ LP L+ L L N S P L LDLS
Sbjct: 303 VPKHFKWQSLSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSR 359
Query: 187 NSFTGNIPQSIQNL--TQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSS- 242
N+ + + S +L L L L N NF + +L+HL+ ++ LK S
Sbjct: 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSA 419
Query: 243 ----------------LQKFPNSSFVGNSLL 257
+ + F+G + L
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 22/147 (14%), Positives = 36/147 (24%), Gaps = 16/147 (10%)
Query: 118 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLR----YLYLQHNNFSGKIPS 173
+ L L + L N + +++ L L + N
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQ 199
Query: 174 SFS-PQLVVLDLSFNSFTGNIPQ-SIQNLTQLTGLSLQSNNLSGSIPNFDIP-------- 223
+F +L L L N + NI + +QNL L L
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 224 --KLRHLNLSYNGLKGSIPSSLQKFPN 248
+ L+Y N
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLAN 286
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 61/316 (19%), Positives = 119/316 (37%), Gaps = 28/316 (8%)
Query: 360 LVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ 419
+ + +D + LG G+ G +K + S V+ ++L + + Q
Sbjct: 20 FLTQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ 77
Query: 420 -QMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET 477
E+ V P +V +YS E + ++ GSL +L + AGR P E
Sbjct: 78 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIP---EQ 131
Query: 478 RV-KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPA-- 533
+ K+ + +G+ ++ K H ++K SN+L+N + + DFG+ L++ A
Sbjct: 132 ILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 189
Query: 534 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD---MVDLP 587
T S Y +PE ++ +S +SD++S G+ L+EM G+ P+ P + M
Sbjct: 190 FVGTRS----YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245
Query: 588 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNM--DEVVRMI 645
+ + M + P + + E +
Sbjct: 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 305
Query: 646 EEVRQSDSENRPSSEE 661
+ + R ++
Sbjct: 306 NKCLIKNPAERADLKQ 321
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 67/313 (21%), Positives = 107/313 (34%), Gaps = 57/313 (18%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 432
LG G++G Y+ + V VK L EV + DF + I+ + H N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQN 135
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR--GAGRTPLDWETRVKILLGTARGVA 490
+V + ++ + A G L + L R + + L + + A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDG---CISDFGLT-PLMNVPATPSRSAGYR---- 542
++ F H +I A N L+ G I DFG+ +
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 543 -APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----E 596
PE + K+D +SFGVLL E+ + G P S + ++++ V S R +
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTSGGRMDPPK 309
Query: 597 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS----- 651
V+ +M C P+ RPN ++ IE Q
Sbjct: 310 NCPGPVY--RIMT----------------QCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351
Query: 652 ---DSENRPSSEE 661
E P EE
Sbjct: 352 TALPIEYGPLVEE 364
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 74/309 (23%), Positives = 135/309 (43%), Gaps = 54/309 (17%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 434
+V+G G +G L ++ +V +K LK +RDF + I+G+ HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
L ++V +Y +GSL + L + V +L G A G+ ++
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLSD 165
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAGYR------APEVI 547
MG + H ++ A N+LIN +L +SDFGL L + P + G + +PE I
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 548 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-------LPRWVQSVVREEWT 599
RK + SDV+S+G++L E+++ G+ P + D++ LP +
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP------PMDCP 276
Query: 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE-VRQSDSENRPS 658
A ++ + ML C K + RP +++V ++++ +R S +
Sbjct: 277 AALYQL--------------MLD----CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIIT 318
Query: 659 SEENKSKDS 667
S + +
Sbjct: 319 SAAARPSNL 327
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 65/308 (21%), Positives = 119/308 (38%), Gaps = 56/308 (18%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNV 433
+LGKG +G+ +A L V VK LK ++ +F ++ + HP+V
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHV 87
Query: 434 VPL------RAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTA 486
L +++ + G L L +R G L +T V+ ++ A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---- 542
G+ ++ S F H ++ A N ++ +D+ C++DFGL+ + YR
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIY------SGDYYRQGCA 198
Query: 543 --------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 593
A E + ++ SDV++FGV + E++T G+ P ++ + +
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY---LIGG 255
Query: 594 VREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652
R L + EE+ M Q C + P RP+ + +E +
Sbjct: 256 NR-----------LKQPPECMEEVYDLMYQ----CWSADPKQRPSFTCLRMELENILGHL 300
Query: 653 SENRPSSE 660
S S +
Sbjct: 301 SVLSTSQD 308
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 72/313 (23%), Positives = 128/313 (40%), Gaps = 70/313 (22%)
Query: 381 EVLGKGSYGTAYKAVL--------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQH 430
+ LG+G +G A +E+ TV VK LK+ D +ME++ +G+H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 431 PNVVPLRAYYY---SKDEKL-LVYDYFASGSLSTLLHGNR-----------GAGRTPLDW 475
N++ L ++D L ++ +Y + G+L L R + +
Sbjct: 147 KNIINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 476 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP 535
+ V ARG+ ++ S K H ++ A NVL+ ++ I+DFGL +N
Sbjct: 203 KDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN----- 254
Query: 536 SRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDD 582
Y+ APE + R ++H+SDV+SFGVL+ E+ T G +P ++
Sbjct: 255 -NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 583 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEV 641
+ L ++ R + + N E+ M C VP RP ++
Sbjct: 314 LFKL---LKEGHR-----------MDKPANCTNELYMMMRD----CWHAVPSQRPTFKQL 355
Query: 642 VRMIEEVRQSDSE 654
V ++ + +
Sbjct: 356 VEDLDRILTLTTN 368
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 61/291 (20%), Positives = 113/291 (38%), Gaps = 43/291 (14%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 434
V+GKG +G Y + +K L + + F ++ ++ + HPNV+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVL 85
Query: 435 PLRAYYYSKDE-KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
L + ++ Y G L + + + + L ARG+ ++
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR----NPTVKDLISFGLQVARGMEYLA 141
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYR------APE 545
KF H ++ A N ++++ ++DFGL + + + R A E
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604
++T + + KSDV+SFGVLL E+LT G P + D+ + R
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF---LAQGRR--------- 246
Query: 605 VELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654
L + + + + Q M Q C P +RP +V +E++ +
Sbjct: 247 --LPQPEYCPDSLYQVMQQ----CWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 65/310 (20%), Positives = 108/310 (34%), Gaps = 63/310 (20%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 432
+ LG G++G +A + V VK LK K +++I+ +GQH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR---------GAGRTPLDWETRVKILL 483
+V L L++ +Y G L L + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR- 542
A+G+A + S H ++ A NVL+ I DFGL + + Y
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIM------NDSNYIV 222
Query: 543 -----------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 590
APE I ++ +SDV+S+G+LL E+ + G P P + V
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--YPGILVNSKFYKLV 280
Query: 591 QSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646
+ + ++ +M+ AC A P RP ++ ++
Sbjct: 281 KDGYQMAQPAFAPKNIYS--IMQ----------------ACWALEPTHRPTFQQICSFLQ 322
Query: 647 EVRQSDSENR 656
E Q D R
Sbjct: 323 EQAQEDRRER 332
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 67/308 (21%), Positives = 120/308 (38%), Gaps = 65/308 (21%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNV 433
LG+G++G + A ++ V VK LKE ++DF+++ E++ + QH ++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHI 105
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR----------GAGRTPLDWETRVKILL 483
V L+V++Y G L+ L + PL + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR- 542
A G+ ++ + F H ++ N L+ Q L I DFG++ + + YR
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY------STDYYRV 216
Query: 543 -----------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 590
PE I RK + +SDV+SFGV+L E+ T GK P + + +D +
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC---I 273
Query: 591 QSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646
EV+ +MR C + P R ++ +V ++
Sbjct: 274 TQGRELERPRACPPEVY--AIMR----------------GCWQREPQQRHSIKDVHARLQ 315
Query: 647 EVRQSDSE 654
+ Q+
Sbjct: 316 ALAQAPPV 323
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 49/291 (16%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 434
EV+G+G +G Y L + VK L + F + I+ HPNV+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 153
Query: 435 PLRAYYYSKDEKLL-VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
L + L V Y G L + + + L A+G+ +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLA 209
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG-----YRAPE 545
S KF H ++ A N ++++ ++DFGL M + +++ + A E
Sbjct: 210 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA 600
++T+K + KSDV+SFGVLL E++T G P D+ + R E
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRRLLQPEYCPD 323
Query: 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
+++V ML+ C +MRP+ E+V I + +
Sbjct: 324 PLYEV--------------MLK----CWHPKAEMRPSFSELVSRISAIFST 356
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 69/303 (22%), Positives = 135/303 (44%), Gaps = 49/303 (16%)
Query: 381 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 433
+V+G G +G YK +L ++ V +K LK + DF + I+G+ H N+
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNI 108
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+ L +++ +Y +G+L L G V +L G A G+ ++
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLA 164
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAGYR------APEV 546
+M + H ++ A N+L+N +L +SDFGL+ L + P ++G + APE
Sbjct: 165 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 547 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAE 601
I RK + SDV+SFG+++ E++T G+ P + +++ + R + +
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---INDGFRLPTPMDCPSA 278
Query: 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE-VRQSDSENRPSSE 660
++ + M+Q C + RP ++V ++++ +R DS +
Sbjct: 279 IYQL--------------MMQ----CWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320
Query: 661 ENK 663
+ +
Sbjct: 321 DPR 323
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 25/149 (16%), Positives = 53/149 (35%), Gaps = 6/149 (4%)
Query: 113 LPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSGKI 171
+ + + ++++ + N L + + + + L L +N GK+
Sbjct: 288 GEQLKDDWQALAD-APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346
Query: 172 PS-SFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRH 227
P+ +L L+L++N T Q+ LS N L FD +
Sbjct: 347 PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSA 406
Query: 228 LNLSYNGLKGSIPSSLQKFPNSSFVGNSL 256
++ SYN + + + F G ++
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 21/190 (11%), Positives = 55/190 (28%), Gaps = 11/190 (5%)
Query: 71 LLDFADAVPHLRKLNWS--STNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLG 128
L + +++V + +D + + + I +
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS-SR 180
Query: 129 KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNS 188
+ SN +T + + L LR Y+ ++ F + + +
Sbjct: 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA---WENENSEYAQ 236
Query: 189 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKG--SIPSSLQ 244
NL LT + + + +P +P+++ +N++ N + Q
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296
Query: 245 KFPNSSFVGN 254
++
Sbjct: 297 ALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-25
Identities = 28/147 (19%), Positives = 49/147 (33%), Gaps = 21/147 (14%)
Query: 122 IPNNT-LGKLDALEVLSLRSNVLTG-------GLPSEITSLPSLRYLYLQHNNFSGKIPS 173
IPN + + + N + L ++ + L +N S
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451
Query: 174 SFS--PQLVVLDLSFNSFTG-------NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-- 222
FS L ++L N T + ++ +N LT + L+ N L+ +F
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATT 511
Query: 223 -PKLRHLNLSYNGLKGSIPSSLQKFPN 248
P L ++LSYN P+
Sbjct: 512 LPYLVGIDLSYNSFSK-FPTQPLNSST 537
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 31/138 (22%), Positives = 49/138 (35%), Gaps = 13/138 (9%)
Query: 124 NNTLGKLDALEVLSLRSNVLTGGLPSEI--TSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
N L + LR N LT L + T+LP L + L +N+FS P+ L
Sbjct: 481 NENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
Query: 180 VVL------DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 233
D N P+ I LT L + SN++ + P + L++ N
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDN 597
Query: 234 GLKGSIPSSLQKFPNSSF 251
S + + +
Sbjct: 598 PNISIDLSYVCPYIEAGM 615
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 34/154 (22%), Positives = 55/154 (35%), Gaps = 19/154 (12%)
Query: 118 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITS-LPSLRYLYLQHNNFSGKIPSSFS 176
L G +P G L L+L N +T +P+ + L HN IP+ F
Sbjct: 342 LEGKLP--AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-IPNIFD 397
Query: 177 ----PQLVVLDLSFNSFTG-------NIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIP 223
+ +D S+N + + ++ ++L +N +S
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 224 KLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 257
L +NL N L IP + K N +F LL
Sbjct: 458 PLSSINLMGNMLTE-IPKNSLKDENENFKNTYLL 490
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 26/143 (18%), Positives = 52/143 (36%), Gaps = 22/143 (15%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPS--EITSLPSLRYLYLQHNNFSGKIPSSFSP-- 177
IP N G + +E LS N L +P+ + S+ + + +N +F P
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 178 -------QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---------D 221
+ ++LS N + + + L+ ++L N L+ N +
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 222 IPKLRHLNLSYNGLKGSIPSSLQ 244
L ++L +N L + +
Sbjct: 487 TYLLTSIDLRFNKLT-KLSDDFR 508
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 19/152 (12%), Positives = 49/152 (32%), Gaps = 33/152 (21%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGG-------------------LPSEITSLPSLRYLYL 162
+ + +L L + ++ + +L L + +
Sbjct: 198 VSK-AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256
Query: 163 QHNNFSGKIPSSFS--PQLVVLDLSFNSFT--------GNIPQSIQNLTQLTGLSLQSNN 212
+ K+P+ P++ +++++ N ++ + + NN
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 213 L-SGSIPN--FDIPKLRHLNLSYNGLKGSIPS 241
L + + + KL L YN L+G +P+
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLPA 348
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-21
Identities = 19/139 (13%), Positives = 36/139 (25%), Gaps = 11/139 (7%)
Query: 120 GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQ- 178
G P +L + LSL +G +P I L L L L +
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
Query: 179 -----LVVLDLSFNSFTGNIPQSI--QNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLN 229
+ ++ + L + S+ SI K +
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 230 LSYNGLKGSIPSSLQKFPN 248
N + + ++ +
Sbjct: 190 QLSNNI-TFVSKAVMRLTK 207
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-18
Identities = 20/110 (18%), Positives = 32/110 (29%), Gaps = 9/110 (8%)
Query: 122 IPNNTLGKLDALEVLSLR------SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF 175
P L+ +R N P IT PSL L + N+ +
Sbjct: 528 FPTQ-PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585
Query: 176 SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKL 225
+P + VLD+ N + + L + I D +
Sbjct: 586 TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ-DIRGCDALDI 634
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-12
Identities = 15/92 (16%), Positives = 30/92 (32%), Gaps = 6/92 (6%)
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP------KLRHLNLS 231
++ L L +G +P +I LT+L L+L S+ + F
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 232 YNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLK 263
+ + + S + + + P K
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQK 173
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 32/228 (14%)
Query: 382 VLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVPL 436
LGKG +G Y A ++S ++ +K L + + K E Q+ EI + +HPN++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRL 74
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
Y++ L+ +Y G++ L + + + T + A +++ HS
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFD-EQRTA-TYITELANALSYCHSKR 129
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETR 550
H +IK N+L+ + I+DFG + V A SR + Y PE+IE R
Sbjct: 130 ---VIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 551 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 590
H K D++S GVL E L GK P ++ T + P +V
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 61/303 (20%), Positives = 116/303 (38%), Gaps = 57/303 (18%)
Query: 383 LGKGSYGTAYKAVL---EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
LG G++G+ + V ++ V +K LK+ + ++ +I+ ++ +P +V L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLI 76
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ +LV + G L L G R + ++L + G+ ++
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEKN- 130
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------------APE 545
F H ++ A NVL+ ISDFGL+ + + + Y APE
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKAL-----GADDSYYTARSAGKWPLKWYAPE 183
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA 600
I RK S +SDV+S+GV + E L+ G+ P + +++ ++ R E
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IEQGKRMECPPECPP 240
Query: 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSE 660
E++ + M C + RP+ V + + S +
Sbjct: 241 ELYAL--------------MSD----CWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 282
Query: 661 ENK 663
+
Sbjct: 283 HHH 285
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 43/210 (20%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKR-LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
+VLG G+ GT + ++ V VKR L E +++++++ +HPNV+
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCT 86
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+ + + + + +L + + L+ + +L T G+AH+HS+
Sbjct: 87 EKDRQFQYIAIEL-CAATLQEYVE-QKDFAHLGLE---PITLLQQTTSGLAHLHSLN--- 138
Query: 500 FTHGNIKASNVLI-----NQDLDGCISDFGL-------TPLMNVPATPSRSAGYRAPEVI 547
H ++K N+LI + + ISDFGL + + + G+ APE++
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 548 E---TRKHSHKSDVYSFGVLLLEMLTGKAP 574
++ D++S G + +++ +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 59/297 (19%), Positives = 109/297 (36%), Gaps = 62/297 (20%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVK--RLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
+ LG+G +G ++A + +K RL + + ++++ + ++ +HP +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIV--- 66
Query: 438 AYYYS------------KDEKLLVY---DYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 482
Y+ + K+ +Y +L ++G + + I
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIF 124
Query: 483 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----------TPLMNV 531
L A V +HS H ++K SN+ D + DFGL T L +
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 532 PATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586
PA + Y +PE I +SHK D++S G++L E+L P T+ + V
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS--TQMERVRT 236
Query: 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
+ VR +F + + + ML P RP ++
Sbjct: 237 ----LTDVRNLKFPPLFTQKYPCEYVM---VQDMLS-------PSPMERPEAINIIE 279
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 25/154 (16%), Positives = 58/154 (37%), Gaps = 9/154 (5%)
Query: 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN 166
+ + + PI ++ L + + +N +T + I L L+ +Y ++
Sbjct: 402 DLLQDAINRNPEMKPIKKDSRISLKDTQ-IGNLTNRITF-ISKAIQRLTKLQIIYFANSP 459
Query: 167 FSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPK 224
F+ + + + N S NL LT + L + +P+ +D+P+
Sbjct: 460 FTYDNIAVD---WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516
Query: 225 LRHLNLSYNGLKG--SIPSSLQKFPNSSFVGNSL 256
L+ LN++ N + + + + G +
Sbjct: 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 27/147 (18%), Positives = 48/147 (32%), Gaps = 18/147 (12%)
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG- 169
+ L L + L + LP + LP L+ L + N
Sbjct: 472 ANSDYAKQYENEEL-SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 170 --------KIPSSFS--PQLVVLDLSFNSFTGNIPQS--IQNLTQLTGLSLQSNNLSGSI 217
++ P++ + + +N+ P S +Q + +L L N + +
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HL 588
Query: 218 PNF-DIPKLRHLNLSYNGLKGSIPSSL 243
F KL L L YN ++ IP
Sbjct: 589 EAFGTNVKLTDLKLDYNQIE-EIPEDF 614
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 7e-23
Identities = 31/154 (20%), Positives = 51/154 (33%), Gaps = 18/154 (11%)
Query: 124 NNTLGKLDALEVLSLRSNVLTGGLPSEI--TSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
+ L + LR N LT L + T+LP L + + +N FS P+ QL
Sbjct: 721 DGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQL 778
Query: 180 VVLDLSF------NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 233
+ N P I L L + SN++ + P+L L+++ N
Sbjct: 779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADN 837
Query: 234 GLK-GSIPSSLQKFPNSSFV----GNSLLCGPPL 262
+ S +V + G
Sbjct: 838 PNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA 871
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 23/142 (16%), Positives = 49/142 (34%), Gaps = 22/142 (15%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPS--EITSLPSLRYLYLQHNNFSGKIPSSFSP-- 177
IP + D +E L N L +P+ S+ + + +N + +
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 178 -----QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN----------FDI 222
+ LS+N + + ++ + L +N ++ SIP +
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNT 727
Query: 223 PKLRHLNLSYNGLKGSIPSSLQ 244
L ++L +N L S+ +
Sbjct: 728 YLLTTIDLRFNKLT-SLSDDFR 748
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 7e-21
Identities = 26/144 (18%), Positives = 46/144 (31%), Gaps = 15/144 (10%)
Query: 126 TLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS----PQLV 180
G L L L N + +P + + L HN IP+ F+ +
Sbjct: 590 AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMG 647
Query: 181 VLDLSFNSFTGNIPQ-----SIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYN 233
+D S+N + ++L N + + + LS N
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 234 GLKGSIPSSLQKFPNSSFVGNSLL 257
+ SIP + K + ++ LL
Sbjct: 708 LM-TSIPENSLKPKDGNYKNTYLL 730
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 4e-20
Identities = 25/146 (17%), Positives = 47/146 (32%), Gaps = 21/146 (14%)
Query: 122 IPNNT-LGKLDALEVLSLRSNVLTGGLPSEITS------LPSLRYLYLQHNNFSGKIPSS 174
IPN + + + N + I+ + + L +N
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692
Query: 175 FS--PQLVVLDLSFNSFT-------GNIPQSIQNLTQLTGLSLQSNNLSG---SIPNFDI 222
F+ + + LS N T + +N LT + L+ N L+ +
Sbjct: 693 FATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTL 752
Query: 223 PKLRHLNLSYNGLKGSIPSSLQKFPN 248
P L ++++SYN S P+
Sbjct: 753 PYLSNMDVSYNCFS-SFPTQPLNSSQ 777
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-19
Identities = 23/136 (16%), Positives = 44/136 (32%), Gaps = 12/136 (8%)
Query: 125 NTLGKLDALEVLSLRSNVLTGGLPSE--ITSLPSLRYLYLQHNNFSGKIPSSFS--PQLV 180
+ +++ + N L P+ + + L L HN +F +L
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLT 598
Query: 181 VLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSYNGLK 236
L L +N IP+ Q+ GL N L F+ + ++ SYN +
Sbjct: 599 DLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG 657
Query: 237 GSIPSSLQKFPNSSFV 252
+ + +
Sbjct: 658 SEGRNISCSMDDYKGI 673
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 39/250 (15%), Positives = 69/250 (27%), Gaps = 69/250 (27%)
Query: 66 SDRQALLDFADAV-------------PHLRKLNWSSTNPICQ--SWVGINCTQDRTRVFG 110
D +AL +A+ + LNW+ + G++ + RV G
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDL-DNNGRVTG 327
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS--------------------- 149
L L G G G +P+ +G+L L+VLS ++ T
Sbjct: 328 LSLAGFGAKGRVPD-AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMH 386
Query: 150 ----EITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN------IPQSIQN 199
+ L L + + + + L I ++IQ
Sbjct: 387 YKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQR 446
Query: 200 LTQLTGLSLQSNNLSGSIPNFDI---------------------PKLRHLNLSYNGLKGS 238
LT+L + ++ + D L + L
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506
Query: 239 IPSSLQKFPN 248
+P L P
Sbjct: 507 LPDFLYDLPE 516
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 7e-13
Identities = 20/100 (20%), Positives = 36/100 (36%), Gaps = 10/100 (10%)
Query: 122 IPNNTLGKLDALEVLSLR------SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF 175
P L+ +R N + P+ IT+ PSL L + N+ K+
Sbjct: 768 FPT-QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL 825
Query: 176 SPQLVVLDLSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLS 214
+PQL +LD++ N ++ + L +
Sbjct: 826 TPQLYILDIADNPNISIDVTSVCPYIEAGM-YVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 12/95 (12%)
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH---------L 228
++ L L+ G +P +I LT+L LS +++ + S F +L +
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 229 NLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLK 263
+ Y + L S + +++ P +K
Sbjct: 384 RMHYKKMFLDYDQRLNL---SDLLQDAINRNPEMK 415
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 36/266 (13%), Positives = 83/266 (31%), Gaps = 54/266 (20%)
Query: 381 EVLGKGSYGTAYKAV---------------LEESTTVVVKRLKEVVVGKRDFEQ------ 419
VLG+ +A E + +K++KE V+ R
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 420 --------QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY-FASGSLSTLLH--GNRGA 468
+ + Q ++ +R + Y +L T + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 469 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528
L R+++ L R +A +H G H ++ +++++Q ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 529 MNVPATPSRSAGYRAPEVIETR-----------KHSHKSDVYSFGVLLLEMLTGKAPLQS 577
S S G+ PE+ R + D ++ G+++ + P+
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
Query: 578 PTRDDMV--------DLPRWVQSVVR 595
++P+ V++++
Sbjct: 316 DAALGGSEWIFRSCKNIPQPVRALLE 341
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 36/235 (15%)
Query: 382 VLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVPL 436
LGKG +G Y A +++ ++ +K L + + K E Q+ EI + +HPN++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRM 79
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
Y++ + L+ ++ G L L + GR + + + A + + H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFD-EQRSATFMEE-LADALHYCHERK 134
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRAPEVIE 548
H +IK N+L+ + I+DFG + P+ T Y PE+IE
Sbjct: 135 ---VIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMCGTLD----YLPPEMIE 185
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVR 595
+ H K D++ GVL E L G P SP+ + + P ++ +
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 67/303 (22%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPN 432
E LG+ +G YK L E++ V +K LK+ G + +F + + R QHPN
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR-LQHPN 73
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRVKI 481
VV L +++ Y + G L L ++ L+ V +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY 541
+ A G+ ++ S H ++ NVL+ L+ ISD GL + + Y
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY------AADYY 184
Query: 542 R------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR 588
+ APE I K S SD++S+GV+L E+ + G P + D+V++
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM-- 242
Query: 589 WVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644
+++ ++ A V+ + M++ C + P RP ++
Sbjct: 243 -IRNRQVLPCPDDCPAWVYAL--------------MIE----CWNEFPSRRPRFKDIHSR 283
Query: 645 IEE 647
+
Sbjct: 284 LRA 286
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 65/300 (21%), Positives = 125/300 (41%), Gaps = 54/300 (18%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNV 433
LG+G++G + A ++ V VK LK+ + ++DF+++ E++ + QH ++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHI 79
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR-----------VKIL 482
V D ++V++Y G L+ L + +D + R + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 483 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAGY 541
A G+ ++ S F H ++ N L+ +L I DFG++ + +
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 542 ---R--APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 595
R PE I RK + +SDV+SFGV+L E+ T GK P + ++++ +
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC---ITQGRV 253
Query: 596 ----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
EV+D +M C + P R N+ E+ +++ + ++
Sbjct: 254 LERPRVCPKEVYD--VML----------------GCWQREPQQRLNIKEIYKILHALGKA 295
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 61/275 (22%), Positives = 103/275 (37%), Gaps = 46/275 (16%)
Query: 326 GSNGVSKGKASSGGRSEKPKEEFGSGVQEP----------EKNKLVFFEGCSYNFDLEDL 375
GS VS G+A S K + +Q + + Y ++ +
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60
Query: 376 LRASAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNV 433
+G+GS+G ++ + VK V F + E+ P +
Sbjct: 61 THQ--PRVGRGSFGEVHRMKDKQTGFQCAVK-----KVRLEVFRVE-ELVACAGLSSPRI 112
Query: 434 VPLRAYY--YSKDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGV 489
VP Y + + ++ + GSL L+ + G P E R LG G+
Sbjct: 113 VP---LYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP---EDRALYYLGQALEGL 163
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFG----LTPLMNVPATPSRSA--G-- 540
++H+ HG++KA NVL++ D + DFG L P + + G
Sbjct: 164 EYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 541 -YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ APEV+ + K D++S ++L ML G P
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 35/298 (11%)
Query: 357 KNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKR 415
KL ++F EDL +G+G+YG+ K V + S ++ VKR++ V ++
Sbjct: 6 SGKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEK 62
Query: 416 DFEQ-QME--IVGRVGQHPNVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAG 469
+ +Q M+ +V R P +V +Y ++ + + + S
Sbjct: 63 EQKQLLMDLDVVMRSSDCPYIV---QFYGALFREGDCWICMELMS-TSFDKFYKYVYSVL 118
Query: 470 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529
+ E KI L T + + H+ K H +IK SN+L+++ + + DFG++ +
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 530 NVPATPSRSAG---YRAPEVIETRKH----SHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 582
+R AG Y APE I+ +SDV+S G+ L E+ TG+ P P +
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNS 234
Query: 583 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 640
+ D + VV+ + ++ + E F V C+ K RP E
Sbjct: 235 VFDQ---LTQVVKGD-PPQLSNSEEREFSPSFINFVN------LCLTKDESKRPKYKE 282
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKR--LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
E +GKGS+G +K + + VV +K L+E D +Q++ ++ + P V
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVT--- 83
Query: 438 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
YY Y KD KL ++ +Y GS LL PLD IL +G+ ++HS
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHS 137
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------AP 544
H +IKA+NVL+++ + ++DFG V + + R AP
Sbjct: 138 EK---KIHRDIKAANVLLSEHGEVKLADFG------VAGQLTDTQIKRNTFVGTPFWMAP 188
Query: 545 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
EVI+ + K+D++S G+ +E+ G+ P
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPH 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 437
EV+G G+ A + V +KR+ + + ++ EI HPN+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIV--- 76
Query: 438 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRT---PLDWETRVKILLGTARGVAH 491
+YY + ++L LV + GS+ ++ G LD T IL G+ +
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRS--AG---YR 542
+H G H ++KA N+L+ +D I+DFG L ++ R G +
Sbjct: 137 LHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 543 APEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPL 575
APEV+E + + K+D++SFG+ +E+ TG AP
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 31/213 (14%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPN 432
E LG GS+G + ++ +V VK LK V+ DF +++ + + H N
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRN 82
Query: 433 VVPLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
++ L Y +V + GSL L ++G T + + A G+
Sbjct: 83 LIRL----YGVVLTPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGM 134
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------- 542
++ S F H ++ A N+L+ I DFGL + +R
Sbjct: 135 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 543 APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
APE ++TR SH SD + FGV L EM T G+ P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 374 DLLRASAEVLGKGSYGTAYKAVL---EESTTVVVKRLKE---VVVGKRDFEQQMEIVGRV 427
LL + LG G++GT K + TV VK LK K + + ++ ++
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 428 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 487
+P +V + + +LV + G L+ L NR + + ++++ +
Sbjct: 76 -DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSM 128
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 542
G+ ++ F H ++ A NVL+ ISDFGL+ + + Y+
Sbjct: 129 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-----RADENYYKAQTHG 180
Query: 543 -------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
APE I K S KSDV+SFGVL+ E + G+ P
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 30/149 (20%), Positives = 46/149 (30%), Gaps = 9/149 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
I N T +L L L L + S L L L N ++ S L
Sbjct: 48 IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKAL 107
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKG 237
L + + N L L L SN++S F KL+ L+ N +
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 238 SIPSSLQKFPNSSFV-----GNSLLCGPP 261
+ ++ + GN + P
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDIAGIEP 196
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 36/155 (23%), Positives = 59/155 (38%), Gaps = 9/155 (5%)
Query: 118 LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 176
L + L L+VL+L ++L LP+L++L LQ N+F +
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 177 ----PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-FDIPKLRHLNLS 231
+L +L LSF + + +L + + L N L+ S K +LNL+
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLA 531
Query: 232 YNGLKGSIPSSLQKFPNSSFV---GNSLLCGPPLK 263
N + +PS L + N L C
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI 566
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 29/135 (21%), Positives = 51/135 (37%), Gaps = 8/135 (5%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSGKIPSSFS---- 176
+ + +L LS++ N L + + +L +LR L L H++ +
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375
Query: 177 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYN 233
L L+LS+N ++ + QL L L L ++ L+ LNLS++
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 234 GLKGSIPSSLQKFPN 248
L S P
Sbjct: 436 LLDISSEQLFDGLPA 450
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 21/120 (17%), Positives = 33/120 (27%), Gaps = 4/120 (3%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 190
E L NVL + + L +L +L L +F +L L L+ N
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 191 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
++ L L +S + L L L N +
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 30/136 (22%), Positives = 41/136 (30%), Gaps = 8/136 (5%)
Query: 121 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---SP 177
N L L L+ L+L N P L L L K S
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-----DIPKLRHLNLSY 232
L VL+LS + + Q L L L+LQ N+ + +L L LS+
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 233 NGLKGSIPSSLQKFPN 248
L +
Sbjct: 486 CDLSSIDQHAFTSLKM 501
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-21
Identities = 38/212 (17%), Positives = 65/212 (30%), Gaps = 21/212 (9%)
Query: 51 CVIVSLLPLAFADLNSDRQALLDF-----------ADAVPHLRKLNWSSTNPICQSWVGI 99
I L + L L+ A + LN+
Sbjct: 163 NAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGG-TQNLLVIFKG 221
Query: 100 NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDA--LEVLSLRSNVLTGGLPSEITSLPSL 157
++ + I L +E ++L+ + + L
Sbjct: 222 LKNSTIQSLWLGTFEDMDDED-ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGL 280
Query: 158 RYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
+ L L + S ++PS L L LS N F S N LT LS++ N
Sbjct: 281 QELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339
Query: 216 SIPNFDI---PKLRHLNLSYNGLKGSIPSSLQ 244
+ + LR L+LS++ ++ S +LQ
Sbjct: 340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-21
Identities = 30/141 (21%), Positives = 47/141 (33%), Gaps = 5/141 (3%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
+ L AL+ L ++ + + +L LYL N+ S +L
Sbjct: 96 MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKL 155
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ-SNNLSGSIPN--FDIPKLRHLNLSYNGLK 236
VLD N+ + + +L Q T LSL + N I FD + LN
Sbjct: 156 KVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNL 215
Query: 237 GSIPSSLQKFPNSSFVGNSLL 257
I L+ S +
Sbjct: 216 LVIFKGLKNSTIQSLWLGTFE 236
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 28/150 (18%), Positives = 48/150 (32%), Gaps = 12/150 (8%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
I +T L+ L L +N L + ++ +L++L+ S L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH-----LNLSYNG 234
L L N + +L L Q+N + + D+ L+ LNL+ N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGND 190
Query: 235 LKGSIPSSLQKFPNS---SFVGNSLLCGPP 261
+ I +F G L
Sbjct: 191 IA-GIEPGAFDSAVFQSLNFGGTQNLLVIF 219
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-19
Identities = 25/137 (18%), Positives = 38/137 (27%), Gaps = 9/137 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP---- 177
I L LE L L SN ++ + L+ L Q+N S
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP----NFDIPKLRHLNLSYN 233
+ L+L+ N G I + L+ I N I L
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 234 GLKGSIPSSLQKFPNSS 250
+ P+ + S
Sbjct: 239 DDEDISPAVFEGLCEMS 255
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-19
Identities = 21/131 (16%), Positives = 45/131 (34%), Gaps = 9/131 (6%)
Query: 126 TLGKLDALEVLSLRSNVLTGGLPSEI--TSLPSLRYLYLQHNNFSGKIPSSFSP----QL 179
+ L+ + + +++ SL + + P+ F +
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKG 237
++L + F + + L L L + +LS +P+ + L+ L LS N +
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315
Query: 238 SIPSSLQKFPN 248
S FP+
Sbjct: 316 LCQISASNFPS 326
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 32/145 (22%), Positives = 56/145 (38%), Gaps = 12/145 (8%)
Query: 121 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP-QL 179
N+L L LE+L L L+ TSL + ++ L HN + + S +
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG-- 237
+ L+L+ N + +P + L+Q ++L+ N L + N I L + L+
Sbjct: 526 IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN--IYFLEWYKENMQKLEDTE 583
Query: 238 ----SIPSSLQKFPNSSFVGNSLLC 258
P L+ +L C
Sbjct: 584 DTLCENPPLLR---GVRLSDVTLSC 605
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-14
Identities = 17/93 (18%), Positives = 31/93 (33%), Gaps = 3/93 (3%)
Query: 158 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 217
+ ++ + +IP + L+ SFN + L LT L L +
Sbjct: 15 KTYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 218 PNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+ +L L L+ N L ++L
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKA 106
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 2e-23
Identities = 39/317 (12%), Positives = 75/317 (23%), Gaps = 50/317 (15%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM--EI-------------- 423
E L G + E +K R +++
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 424 -----------VGRVGQHPNVVPLRAYY--YSKDEKLLVYDYFASGSLSTLLH--GNRGA 468
V P L Y+ LL+ AS L L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYV 186
Query: 469 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TP 527
R + R A++ S G HG+ N+ I D + D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 528 LMNVPATPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
+ S Y E + +H + + G+ + + P T
Sbjct: 244 VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
Query: 586 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM- 644
R V + + + + + ++ + R E +
Sbjct: 304 WKRPSLRVPGTD------SLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAMETP 354
Query: 645 -IEEVRQSDSENRPSSE 660
+++ S + + +
Sbjct: 355 EFLQLQNEISSSLSTGQ 371
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 3e-23
Identities = 32/265 (12%), Positives = 77/265 (29%), Gaps = 53/265 (20%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQME----------------- 422
VLG+ +A +E+ + V + +QM+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 423 -----------IVGRVGQHPNVVPLRAYYYSKDEKLLVYDY-FASGSLSTLLH--GNRGA 468
+ + Q ++ +R + Y +L T + +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 469 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528
L R+++ L R +A +H G H ++ +++++Q ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 529 MNVPATPSRSAGYRAPEVI----------ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 578
A G+ PE + D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 579 TRDDMV--------DLPRWVQSVVR 595
++P+ V++++
Sbjct: 321 AALGGSEWIFRSCKNIPQPVRALLE 345
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGK-RDFEQQMEIVGRVGQHPNVVPLRA 438
VLGKG+YG Y L + +K + E + +++ + + +H N+V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIV---Q 83
Query: 439 YY--YSKDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVA 490
Y +S++ + ++ + GSLS LL G + D E + IL G+
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK---DNEQTIGFYTKQIL----EGLK 136
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFG----LTPLMNVPATPSRSAGYRAP 544
++H H +IK NVLIN G + SDFG L + T + + Y AP
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
Query: 545 EVIE--TRKHSHKSDVYSFGVLLLEMLTGKAP 574
E+I+ R + +D++S G ++EM TGK P
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 373 EDLLRASAEVLGKGSYGTAYKAVLE---ESTTVVVKRLKE--VVVGKRDFEQQMEIVGRV 427
D L + LG G++G+ + V + V +K LK+ + ++ +I+ ++
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393
Query: 428 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 487
+P +V L + +LV + G L L G R + ++L +
Sbjct: 394 -DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSM 447
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--PATPSRSAG----- 540
G+ ++ F H N+ A NVL+ ISDFGL+ + +RSAG
Sbjct: 448 GMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 541 YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 574
+ APE I RK S +SDV+S+GV + E L+ G+ P
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 58/283 (20%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPL 436
LGKG + ++ ++ V K + + ++ K ++M EI + R H +VV
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
++ D +V + SL L + E R L G ++H
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEP-EAR-YYLRQIVLGCQYLHRNR 135
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRAPEVIE 548
H ++K N+ +N+DL+ I DFGL + TP+ Y APEV+
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----YIAPEVLS 188
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVREEWTA 600
+ HS + DV+S G ++ +L GK P ++ + +P+ + V
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA----- 243
Query: 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
L++ +MLQ P RP ++E++
Sbjct: 244 -----SLIQ---------KMLQ-------TDPTARPTINELLN 265
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 47/245 (19%), Positives = 102/245 (41%), Gaps = 28/245 (11%)
Query: 349 GSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLK 408
GS ++ + G Y ++ DL +G G+ G +K ++ V+ +
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQM 58
Query: 409 EVVVGKRDFEQ-QME--IVGRVGQHPNVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLL 462
K + ++ M+ +V + P +V + + + + + + + +
Sbjct: 59 RRSGNKEENKRILMDLDVVLKSHDCPYIV---QCFGTFITNTDVFIAMELMGTCAEKLKK 115
Query: 463 HGNRGAGRTPLDWETRV-KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 521
R G P E + K+ + + + ++ H ++K SN+L+++ +
Sbjct: 116 ---RMQGPIP---ERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLC 167
Query: 522 DFGLTPLMNVPATPSRSAG---YRAPEVIETRK-----HSHKSDVYSFGVLLLEMLTGKA 573
DFG++ + RSAG Y APE I+ + ++DV+S G+ L+E+ TG+
Sbjct: 168 DFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
Query: 574 PLQSP 578
P ++
Sbjct: 228 PYKNC 232
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 62/283 (21%), Positives = 111/283 (39%), Gaps = 58/283 (20%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPL 436
LGKG + ++ ++ V K + + ++ K ++M EI + R H +VV
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
++ D +V + SL L + + E R L G ++H
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALT-EPEAR-YYLRQIVLGCQYLHRNR 161
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRAPEVIE 548
H ++K N+ +N+DL+ I DFGL + TP+ Y APEV+
Sbjct: 162 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----YIAPEVLS 214
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVREEWTA 600
+ HS + DV+S G ++ +L GK P ++ + +P+ + V
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA----- 269
Query: 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
L++ +MLQ P RP ++E++
Sbjct: 270 -----SLIQ---------KMLQ-------TDPTARPTINELLN 291
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 59/282 (20%), Positives = 118/282 (41%), Gaps = 59/282 (20%)
Query: 383 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPLRA 438
LGKGS+ Y+A + V +K + + + K Q++ E+ + +HP+++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 439 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD-WETRVKILLGTARGVAHIHSMGG 497
Y+ + LV + +G ++ L P E R + G+ ++HS G
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEAR-HFMHQIITGMLYLHSHG- 132
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRAPEVIET 549
H ++ SN+L+ ++++ I+DFGL + +P TP+ Y +PE+
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN----YISPEIATR 186
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVREEWTAE 601
H +SDV+S G + +L G+ P + T + ++P ++ +
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK------ 240
Query: 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
+L+ Q+L+ + P R ++ V+
Sbjct: 241 ----DLIH---------QLLR-------RNPADRLSLSSVLD 262
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 76/313 (24%), Positives = 122/313 (38%), Gaps = 69/313 (22%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 432
+ LG+G +G KA TTV VK LKE RD + ++ +V HP+
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPH 87
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT------- 485
V+ L LL+ +Y GSL L +R G L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 486 ------------ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533
++G+ ++ M K H ++ A N+L+ + ISDFGL+ +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVY--- 201
Query: 534 TPSRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTR 580
Y A E + ++ +SDV+SFGVLL E++T G P
Sbjct: 202 ---EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 581 DDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMD 639
+ + +L +++ R + R N EEM + MLQ C + PD RP
Sbjct: 259 ERLFNL---LKTGHR-----------MERPDNCSEEMYRLMLQ----CWKQEPDKRPVFA 300
Query: 640 EVVRMIEEVRQSD 652
++ + +E++
Sbjct: 301 DISKDLEKMMVKR 313
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 68/323 (21%), Positives = 127/323 (39%), Gaps = 83/323 (25%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPN 432
+G+G++G ++A E T V VK LKE + DF+++ ++ +PN
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPN 111
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-------------------GAGRTPL 473
+V L L+++Y A G L+ L G PL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 474 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533
++ I A G+A++ KF H ++ N L+ +++ I+DFGL
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL-------- 220
Query: 534 TPSRSAG----YR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQ 576
SR+ Y+ PE I +++ +SDV+++GV+L E+ + G P
Sbjct: 221 --SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278
Query: 577 SPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 632
++++ V+ E E+++ LMR C +K+P
Sbjct: 279 GMAHEEVIYY---VRDGNILACPENCPLELYN--LMR----------------LCWSKLP 317
Query: 633 DMRPNMDEVVRMIEEVRQSDSEN 655
RP+ + R+++ + +
Sbjct: 318 ADRPSFCSIHRILQRMCERAEGT 340
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 437
E +G+G+ GT Y A+ + V ++++ + + E EI V R ++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIV--- 80
Query: 438 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
Y Y ++L +V +Y A GSL+ ++ T +D + + + +HS
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS 134
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMN----VPATPSRSAGY-RAPE 545
H +IK+ N+L+ D ++DFG +TP + + TP Y APE
Sbjct: 135 NQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP-----YWMAPE 186
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
V+ + + K D++S G++ +EM+ G+ P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 65/288 (22%), Positives = 108/288 (37%), Gaps = 39/288 (13%)
Query: 367 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQ-QME-- 422
S +DL LG+G+YG K S ++ VKR++ V ++ ++ M+
Sbjct: 1 SMEVKADDLEPI--MELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLD 57
Query: 423 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 482
I R P V + + + + + + P D KI
Sbjct: 58 ISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG--KIA 115
Query: 483 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-- 540
+ + + H+HS H ++K SNVLIN + DFG++ + AG
Sbjct: 116 VSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCK 173
Query: 541 -YRAPEVIETRKH----SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 595
Y APE I + S KSD++S G+ ++E+ + P D + ++ VV
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY-----DSWGTPFQQLKQVVE 228
Query: 596 EE---WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 640
E A+ F E + F + C+ K RP E
Sbjct: 229 EPSPQLPADKFSAEFVDFTS-------------QCLKKNSKERPTYPE 263
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 48/225 (21%), Positives = 86/225 (38%), Gaps = 38/225 (16%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKR-LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
++LG GS GT + V VKR L + +++++ HPNV+
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIRYYCS 77
Query: 440 YYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ + + + +L L+ + +L A GVAH+HS+
Sbjct: 78 ETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK- 135
Query: 498 PKFTHGNIKASNVLINQDLDGC-------------ISDFGL--------TPLMNVPATPS 536
H ++K N+L++ ISDFGL + PS
Sbjct: 136 --IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 537 RSAGYRAPEVIE-------TRKHSHKSDVYSFGVLLLEMLTGKAP 574
++G+RAPE++E R+ + D++S G + +L+
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 27/134 (20%), Positives = 47/134 (35%), Gaps = 7/134 (5%)
Query: 121 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---SP 177
+ + +L+ L L N + + S L L +L QH+N S
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 234
L+ LD+S L+ L L + N+ + F + L L+LS
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 235 LKGSIPSSLQKFPN 248
L+ P++ +
Sbjct: 482 LEQLSPTAFNSLSS 495
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 32/130 (24%), Positives = 48/130 (36%), Gaps = 8/130 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF-SGKIPSSFS--PQ 178
+ L +L+ L L I L +L+ L + HN S K+P FS
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 179 LVVLDLSFNSFTGNIPQSIQNLTQLTG----LSLQSNNLSGSIPN-FDIPKLRHLNLSYN 233
L LDLS N ++ L Q+ L L N ++ P F +L L L N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 234 GLKGSIPSSL 243
++ +
Sbjct: 211 FDSLNVMKTC 220
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 39/152 (25%), Positives = 60/152 (39%), Gaps = 14/152 (9%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEIT--SLPSLRYLYLQHNNFSGKIPSSFS--P 177
+ +N LG L+ LE L + + L + SL +L YL + H + F+
Sbjct: 388 MSSNFLG-LEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 178 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
L VL ++ NSF N I L LT L L L + F+ + L+ LN++ N
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASN 504
Query: 234 GLKGSIPSSLQKFPNSSFV---GNSLLCGPPL 262
LK + + + N C P
Sbjct: 505 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-18
Identities = 34/146 (23%), Positives = 49/146 (33%), Gaps = 21/146 (14%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 178
I + L L L L N + L + L SL+ L N +
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 179 LVVLDLSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH-------LNL 230
L L+++ N +P+ NLT L L L SN + SI D+ L L+L
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDL 184
Query: 231 SYNGLKGSIPSSLQKFPNSSFVGNSL 256
S N + +F L
Sbjct: 185 SLN--------PMNFIQPGAFKEIRL 202
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 24/121 (19%), Positives = 40/121 (33%), Gaps = 5/121 (4%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 190
+ L L N L S P L+ L L ++ L L L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 191 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLK-GSIPSSLQKFP 247
+ L+ L L NL+ + L+ LN+++N ++ +P
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 248 N 248
N
Sbjct: 150 N 150
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 29/140 (20%), Positives = 47/140 (33%), Gaps = 12/140 (8%)
Query: 121 PIPNNTLGKLDALEVLSLRSNVLTG---GLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP 177
+ L L L + R L + L ++ L S++
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG 237
L+L F +++L +LT SN + D+P L L+LS NGL
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLT---FTSNKGGNAFSEVDLPSLEFLDLSRNGL-- 359
Query: 238 SIPSSLQKFPNSSFVGNSLL 257
S + + S G + L
Sbjct: 360 ----SFKGCCSQSDFGTTSL 375
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 5/90 (5%)
Query: 162 LQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-- 219
NF KIP + LDLSFN S + +L L L + +I +
Sbjct: 14 CMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA 71
Query: 220 FD-IPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+ + L L L+ N ++ + +
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 25/156 (16%), Positives = 42/156 (26%), Gaps = 13/156 (8%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQ------HNNFSGKIPSS 174
I ++ L L+LR+N + + I L L L N S+
Sbjct: 192 IQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 175 FS--PQLVVLDLSFNS---FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 229
L + + + +I LT ++ SL S + +HL
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 230 LSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKAC 265
L L+ +F N
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 28/207 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRAY 439
E LG+GSYG+ YKA+ +E+ +V +K+V V E EI + + P+VV Y
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVA--IKQVPVESDLQEIIKEISIMQQCDSPHVV---KY 89
Query: 440 Y--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
Y Y K+ L +V +Y +GS+S ++ L + IL T +G+ ++H M
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK----TLTEDEIATILQSTLKGLEYLHFMR 145
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMN----VPATPSRSAGYRAPEVIE 548
H +IKA N+L+N + ++DFG LT M V TP + APEVI+
Sbjct: 146 K---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF----WMAPEVIQ 198
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPL 575
++ +D++S G+ +EM GK P
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 55/308 (17%), Positives = 111/308 (36%), Gaps = 55/308 (17%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPN--VVP 435
+ +G G ++ + E+ +K + + + ++ + ++ Q + ++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIR 92
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
L Y + +V + + L++ L + +D R V IH
Sbjct: 93 LYDYEITDQYIYMVMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 496 GGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR------SAGYRAPEVI 547
G H ++K +N LI DG + DFG+ M T + Y PE I
Sbjct: 147 G---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 548 E-----------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE 596
+ K S KSDV+S G +L M GK P Q + + L +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-NQISKLHAIIDPNHEI 259
Query: 597 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR---MIEEVRQSDS 653
E+ ++ + +L + L+ + P R ++ E++ + + +
Sbjct: 260 EF-PDIPEKDLQDV------LKCCLK-------RDPKQRISIPELLAHPYVQIQTHPVNQ 305
Query: 654 ENRPSSEE 661
+ ++EE
Sbjct: 306 MAKGTTEE 313
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 34/217 (15%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP---- 435
E++G G+YG YK ++ + +K + + + +Q++ ++ + H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 436 -LRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
++ D++L LV ++ +GS++ L+ +G L E I RG++H+H
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRGLSHLH 146
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------A 543
K H +IK NVL+ ++ + + DFG V A R+ G R A
Sbjct: 147 QH---KVIHRDIKGQNVLLTENAEVKLVDFG------VSAQLDRTVGRRNTFIGTPYWMA 197
Query: 544 PEVIETRKHS-----HKSDVYSFGVLLLEMLTGKAPL 575
PEVI ++ KSD++S G+ +EM G PL
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 47/224 (20%), Positives = 90/224 (40%), Gaps = 41/224 (18%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
VLG+G++G KA +S +K+++ ++ ++ + H VV A
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAA 70
Query: 440 YYSKDEKL-------------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 486
+ + + + +Y +G+L L+H + W +IL
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA-- 128
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--------- 537
+++IHS G H ++K N+ I++ + I DFGL ++ +
Sbjct: 129 --LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 538 ---------SAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTG 571
+A Y A EV++ H + K D+YS G++ EM+
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 31/151 (20%), Positives = 52/151 (34%), Gaps = 9/151 (5%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTG-GLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 180
+ + G ++ L L+ N + S +L +L LQ+N +L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLK 194
Query: 181 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGS 238
LDLS N + Q+ +T +SL++N L I L H +L NG
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 239 IPSSLQKFPN--SSFVGNSL--LCGPPLKAC 265
+ ++ L G + C
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 19/127 (14%), Positives = 38/127 (29%), Gaps = 6/127 (4%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 181
+ ++ L L N L+ +++ L L L N + L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRT 84
Query: 182 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPS 241
LDL+ N + + L +NN+S + +++ L+ N +
Sbjct: 85 LDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDL 138
Query: 242 SLQKFPN 248
Sbjct: 139 DEGCRSR 145
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 24/144 (16%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLT-----GGLP------------SEITSLPSLRYLYLQH 164
I L LE+L+L SNVL L E+ PS+ L+ +
Sbjct: 49 ISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAAN 108
Query: 165 NNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-- 222
NN S ++ S + L+ N T +++ L L+ N + ++ ++
Sbjct: 109 NNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAA 166
Query: 223 --PKLRHLNLSYNGLKGSIPSSLQ 244
L HLNL YN + + +
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 22/116 (18%), Positives = 47/116 (40%), Gaps = 8/116 (6%)
Query: 130 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 187
+ ++ + + L L S S +++ L L N S + + +L +L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 188 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 243
+++L+ L L L +N + + P + L+ + N + + S
Sbjct: 69 VLY-ETL-DLESLSTLRTLDLNNNYVQ-ELLVG--PSIETLHAANNNIS-RVSCSR 118
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 7/105 (6%)
Query: 146 GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 203
+ + + + ++ + S + LDLS N + + T+L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 204 TGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIP--SSLQK 245
L+L SN L + + LR L+L+ N ++ + S++
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLVGPSIET 103
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 17/104 (16%), Positives = 34/104 (32%), Gaps = 3/104 (2%)
Query: 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS-GKIPSSFSPQLVVLDL 184
+ +SLR+N L + + +L + L+ N F G + FS V +
Sbjct: 209 EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267
Query: 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHL 228
+ + + + + L +P +L L
Sbjct: 268 AKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIAL 310
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 63/309 (20%), Positives = 114/309 (36%), Gaps = 59/309 (19%)
Query: 381 EVLGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNV 433
+ LG G T Y A +L V +K + K + FE+++ ++ H N+
Sbjct: 17 DKLGGGGMSTVYLAEDTILNI--KVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNI 73
Query: 434 VPLRAYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 491
V + +++ LV +Y +LS + + PL +T + G+ H
Sbjct: 74 VSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKH 126
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPATPSR----SAGYRAPEV 546
H M H +IK N+LI+ + I DFG+ L T + + Y +PE
Sbjct: 127 AHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT---------RDDMVDLPRWVQSVVREE 597
+ +D+YS G++L EML G+ P T +D + ++ V+ + +
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 598 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDSENR 656
++ + K R + E+ + V + N
Sbjct: 244 L----------------SNVI------LRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281
Query: 657 PSSEENKSK 665
E +K K
Sbjct: 282 DVYELDKMK 290
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 4e-21
Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 3/114 (2%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L L L + +N +T S + +L +LR LYL +N S P + ++ L+L
Sbjct: 84 LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGA 141
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 240
N ++ + N+T L L++ + + P ++ L L+L+YN ++ P
Sbjct: 142 NHNLSDLS-PLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 28/123 (22%), Positives = 56/123 (45%), Gaps = 6/123 (4%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L +L + N +T + + ++ L L + +N + P + QL L++
Sbjct: 195 LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGT 252
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 245
N + +I ++++LT+L L++ SN +S I + + +L L L+ N L +
Sbjct: 253 NQIS-DIN-AVKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDMEVIGG 309
Query: 246 FPN 248
N
Sbjct: 310 LTN 312
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 24/114 (21%), Positives = 46/114 (40%), Gaps = 3/114 (2%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L + L+L +N S ++++ L YL + + P + L L L++
Sbjct: 128 LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNY 186
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 240
N P + +LT L + N ++ P ++ +L L + N + P
Sbjct: 187 NQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 30/124 (24%), Positives = 52/124 (41%), Gaps = 11/124 (8%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184
+ + L L + +N +T S + +L L +L + N S ++ +L +L++
Sbjct: 217 VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNV 272
Query: 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP-S 241
N + + NL+QL L L +N L + L L LS N + P +
Sbjct: 273 GSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA 330
Query: 242 SLQK 245
SL K
Sbjct: 331 SLSK 334
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 6/112 (5%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184
L L L L + +N ++ + + L L+ L + N S S + QL L L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294
Query: 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 236
+ N + I LT LT L L N+++ P + K+ + + +K
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 24/116 (20%), Positives = 42/116 (36%), Gaps = 6/116 (5%)
Query: 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185
L L+ +T L S+ L + + + L L+L+
Sbjct: 17 PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASIQGIEYLTNLEYLNLN 74
Query: 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIP 240
N T P + NL +LT L + +N ++ I + LR L L+ + + P
Sbjct: 75 GNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 21/100 (21%), Positives = 39/100 (39%), Gaps = 4/100 (4%)
Query: 149 SEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSL 208
L LQ + + + + L ++ +I I+ LT L L+L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73
Query: 209 QSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
N ++ P ++ KL +L + N + + S+LQ N
Sbjct: 74 NGNQITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTN 111
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 34/210 (16%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ--QMEI-VGRVGQHPNVVPLR 437
+G+GS G A + S V +K + + K+ + E+ + R QH NVV
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVA--VKMMDLRKQQRRELLFNEVVIMRDYQHFNVV--- 105
Query: 438 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
Y Y E+L ++ ++ G+L+ ++ + L+ E + + +A++H+
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHA 159
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMN----VPATPSRSAGY-RAPE 545
G H +IK+ ++L+ D +SDFG ++ + + TP Y APE
Sbjct: 160 QGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP-----YWMAPE 211
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
VI ++ + D++S G++++EM+ G+ P
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPY 241
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 2e-20
Identities = 28/125 (22%), Positives = 45/125 (36%), Gaps = 5/125 (4%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTG-GLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 180
+ + G ++ L L+ N + S +L +L LQ+N +L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLK 194
Query: 181 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGS 238
LDLS N + Q+ +T +SL++N L I L H +L NG
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 239 IPSSL 243
Sbjct: 253 TLRDF 257
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 4e-20
Identities = 19/127 (14%), Positives = 38/127 (29%), Gaps = 6/127 (4%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 181
+ ++ L L N L+ +++ L L L N + L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRT 84
Query: 182 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPS 241
LDL+ N + + L +NN+S + +++ L+ N +
Sbjct: 85 LDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDL 138
Query: 242 SLQKFPN 248
Sbjct: 139 DEGCRSR 145
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 1e-18
Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 24/144 (16%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLT-----GGLP------------SEITSLPSLRYLYLQH 164
I L LE+L+L SNVL L E+ PS+ L+ +
Sbjct: 49 ISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAAN 108
Query: 165 NNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-- 222
NN S ++ S + L+ N T +++ L L+ N + ++ ++
Sbjct: 109 NNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAA 166
Query: 223 --PKLRHLNLSYNGLKGSIPSSLQ 244
L HLNL YN + + +
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 22/116 (18%), Positives = 47/116 (40%), Gaps = 8/116 (6%)
Query: 130 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 187
+ ++ + + L L S S +++ L L N S + + +L +L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 188 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 243
+++L+ L L L +N + + P + L+ + N + + S
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG--PSIETLHAANNNIS-RVSCSR 118
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 7/105 (6%)
Query: 146 GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 203
+ + + + ++ + S + LDLS N + + T+L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 204 TGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIP--SSLQK 245
L+L SN L + + LR L+L+ N ++ + S++
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLVGPSIET 103
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 21/132 (15%), Positives = 41/132 (31%), Gaps = 3/132 (2%)
Query: 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS-GKIPSSFSPQLVVLDL 184
+ +SLR+N L + + +L + L+ N F G + FS V +
Sbjct: 209 EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267
Query: 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ 244
+ + Q+ + T T + +P +L L + L S +
Sbjct: 268 AKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSETE 326
Query: 245 KFPNSSFVGNSL 256
+
Sbjct: 327 RLECERENQARQ 338
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 16/158 (10%), Positives = 37/158 (23%), Gaps = 33/158 (20%)
Query: 125 NTLGKLDALEVLSLRSNVL-TGGLPSEITSLPSLRYLYLQ-------------------- 163
L LE LR N G L + ++ + Q
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 164 -HNNFSGKIPSSFSPQLVVLDLSFNSFT-------GNIPQSIQNLTQLTGLSLQSNNLSG 215
+P+ F+ +L+ L ++ + +N + +
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR- 349
Query: 216 SIPN---FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 250
++ + L L + + +
Sbjct: 350 TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELD 387
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 13/130 (10%), Positives = 27/130 (20%), Gaps = 9/130 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----- 176
+ + + + L +L+ + G
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN 334
Query: 177 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 235
+ +D + I Q L + L + N + H L
Sbjct: 335 QARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN---GRRAHAELDGTLQ 391
Query: 236 KGSIPSSLQK 245
+ LQ
Sbjct: 392 QAVGQIELQH 401
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 54/322 (16%), Positives = 111/322 (34%), Gaps = 77/322 (23%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPN--VVP 435
+ +G G ++ + E+ +K + + + ++ + ++ Q + ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIR 73
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
L Y + +V + + L++ L + +D R V IH
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLK-KKK----SIDPWERKSYWKNMLEAVHTIHQH 127
Query: 496 GGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR------SAGYRAPEVI 547
G H ++K +N LI DG + DFG+ M T + Y PE I
Sbjct: 128 G---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 548 E-----------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-----------RDDMVD 585
+ K S KSDV+S G +L M GK P Q + ++
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241
Query: 586 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR-- 643
P + ++ ++++ L+ + P R ++ E++
Sbjct: 242 FPDIPEKDLQ----------DVLK---------CCLK-------RDPKQRISIPELLAHP 275
Query: 644 -MIEEVRQSDSENRPSSEENKS 664
+ + + + ++EE K
Sbjct: 276 YVQIQTHPVNQMAKGTTEEMKY 297
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 59/258 (22%), Positives = 104/258 (40%), Gaps = 34/258 (13%)
Query: 331 SKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT 390
++ G P +++P+ +L F + F +G GS+G
Sbjct: 17 TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDL-------REIGHGSFGA 69
Query: 391 AYKAVLEESTTVV-VKRLKEVVVGKRDFEQ--QMEI-VGRVGQHPNVVPLRAYY--YSKD 444
Y A ++ VV +K++ + Q E+ + +HPN + Y Y ++
Sbjct: 70 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI---QYRGCYLRE 126
Query: 445 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 504
+ + GS S LL ++ PL + G +G+A++HS H +
Sbjct: 127 HTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRD 179
Query: 505 IKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHS---HKSD 557
+KA N+L+++ + DFG + P + TP + APEVI K D
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY----WMAPEVILAMDEGQYDGKVD 235
Query: 558 VYSFGVLLLEMLTGKAPL 575
V+S G+ +E+ K PL
Sbjct: 236 VWSLGITCIELAERKPPL 253
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 5e-20
Identities = 63/379 (16%), Positives = 131/379 (34%), Gaps = 67/379 (17%)
Query: 322 KKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEK---NKLVFFEGCSYNFDLEDLLRA 378
+G+ + A+ R + G+ + N+ + +G Y+
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL------- 61
Query: 379 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPN--V 433
+ +G G ++ + E+ +K + + + ++ + ++ Q + +
Sbjct: 62 --KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKI 118
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+ L Y + +V + + L++ L + +D R V IH
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKK----SIDPWERKSYWKNMLEAVHTIH 172
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR------SAGYRAPE 545
G H ++K +N LI DG + DFG+ M T + Y PE
Sbjct: 173 QHG---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 546 VIE-----------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 594
I+ K S KSDV+S G +L M GK P Q + + L +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-NQISKLHAIIDPNH 285
Query: 595 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR---MIEEVRQS 651
E+ ++ + +L + L+ + P R ++ E++ + +
Sbjct: 286 EIEF-PDIPEKDLQDV------LKCCLK-------RDPKQRISIPELLAHPYVQIQTHPV 331
Query: 652 DSENRPSSEENKSKDSNVQ 670
+ + ++EE K +
Sbjct: 332 NQMAKGTTEEMKYVLGQLV 350
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-20
Identities = 24/125 (19%), Positives = 54/125 (43%), Gaps = 7/125 (5%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184
+ ++ L++ + T + I+ L +L L + + + + S L +LD+
Sbjct: 62 IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSL 243
S ++ +I I L ++ + L N I +P+L+ LN+ ++G+ +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH-DY-RGI 177
Query: 244 QKFPN 248
+ FP
Sbjct: 178 EDFPK 182
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 26/109 (23%), Positives = 47/109 (43%), Gaps = 3/109 (2%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184
+ L LE L + +T ++ L SL L + H+ I + + P++ +DL
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 233
S+N +I ++ L +L L++Q + + D PKL L
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 28/125 (22%), Positives = 55/125 (44%), Gaps = 5/125 (4%)
Query: 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185
T ++++L ++L + +T + I +++ L + + + + P S L L +
Sbjct: 39 TEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIM 96
Query: 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSL 243
T + ++ LT LT L + + SI +PK+ ++LSYNG I L
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPL 155
Query: 244 QKFPN 248
+ P
Sbjct: 156 KTLPE 160
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-14
Identities = 19/91 (20%), Positives = 40/91 (43%), Gaps = 5/91 (5%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184
L L +L +L + + + ++I +LP + + L +N I P+L L++
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNI 166
Query: 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
F+ + + I++ +L L S + G
Sbjct: 167 QFDGVH-DY-RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 23/121 (19%), Positives = 45/121 (37%), Gaps = 7/121 (5%)
Query: 130 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 189
A L + + SL Y+ L + N + ++ + L ++
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHA 78
Query: 190 TGNIPQSIQNLTQLTGLSLQSNNLSGS-IPNFD-IPKLRHLNLSYNGLKGSIPSSLQKFP 247
T N I L+ L L + +++ IPN + L L++S++ SI + + P
Sbjct: 79 T-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 248 N 248
Sbjct: 137 K 137
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 10/97 (10%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 152 TSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 211
++ + L ++ + + + L + L+ + T ++ I+ + L++ +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMN-SLTYITLANINVT-DL-TGIEYAHNIKDLTINNI 76
Query: 212 NLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+ + P + L L + + +L +
Sbjct: 77 HATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTS 113
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 35/212 (16%)
Query: 381 EVLGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRDFEQQME----IVGRVGQHPNV 433
++G+G G Y+A V E V +K + E + F +M+ GR+ Q P+V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHV 96
Query: 434 VPLRAYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 491
VP+ + + + + + L+ +L + PL V I+ +
Sbjct: 97 VPI--HDFGEIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDA 149
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFG---------LTPLMNVPATPSRSAGYR 542
H+ G TH ++K N+L++ D + DFG LT L N T Y
Sbjct: 150 AHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLY----YM 202
Query: 543 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
APE ++++D+Y+ +L E LTG P
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 39/216 (18%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 437
LG G++G YKA +E+ + K ++ + + E +EI + HP +V
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYIV--- 79
Query: 438 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
Y D KL ++ ++ G++ ++ L + + +HS
Sbjct: 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHS 135
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------AP 544
H ++KA NVL+ + D ++DFG V A ++ R AP
Sbjct: 136 KR---IIHRDLKAGNVLMTLEGDIRLADFG------VSAKNLKTLQKRDSFIGTPYWMAP 186
Query: 545 EVIETRKHS-----HKSDVYSFGVLLLEMLTGKAPL 575
EV+ +K+D++S G+ L+EM + P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 41/120 (34%), Positives = 53/120 (44%), Gaps = 5/120 (4%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
LG L L+ LSL N L + SL +L L L +N S P S +L L L
Sbjct: 217 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGA 274
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP-SSLQK 245
N + P + LT LT L L N L P ++ L +L L +N + P SSL K
Sbjct: 275 NQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTK 332
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-18
Identities = 28/123 (22%), Positives = 50/123 (40%), Gaps = 6/123 (4%)
Query: 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185
+ LD + L + + L +L + +N + P +LV + ++
Sbjct: 41 SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMN 98
Query: 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 245
N P + NLT LTGL+L +N ++ P ++ L L LS N + S+L
Sbjct: 99 NNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSG 154
Query: 246 FPN 248
+
Sbjct: 155 LTS 157
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-18
Identities = 38/124 (30%), Positives = 52/124 (41%), Gaps = 6/124 (4%)
Query: 125 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 184
TL L L L L +N ++ + ++ L L L L N S P + L L+L
Sbjct: 237 GTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLEL 294
Query: 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ 244
+ N P I NL LT L+L NN+S P + KL+ L N + SSL
Sbjct: 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD--VSSLA 350
Query: 245 KFPN 248
N
Sbjct: 351 NLTN 354
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-18
Identities = 34/124 (27%), Positives = 51/124 (41%), Gaps = 7/124 (5%)
Query: 125 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 184
+ L L L L L SN ++ S ++ L SL+ L N + P + L LD+
Sbjct: 128 DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLANLTTLERLDI 184
Query: 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ 244
S N + + LT L L +N +S P + L L+L+ N LK +L
Sbjct: 185 SSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLA 240
Query: 245 KFPN 248
N
Sbjct: 241 SLTN 244
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-16
Identities = 30/123 (24%), Positives = 45/123 (36%), Gaps = 9/123 (7%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L +L+ LS + V + +L +L L + N S + L L +
Sbjct: 152 LSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATN 208
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQK 245
N + P + LT L LSL N L I + L L+L+ N + P L
Sbjct: 209 NQISDITP--LGILTNLDELSLNGNQLK-DIGTLASLTNLTDLDLANNQISNLAP--LSG 263
Query: 246 FPN 248
Sbjct: 264 LTK 266
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 7e-16
Identities = 23/115 (20%), Positives = 39/115 (33%), Gaps = 4/115 (3%)
Query: 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185
T L L +T T L + L + L ++ S
Sbjct: 19 TDTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFS 76
Query: 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 240
N T P ++NLT+L + + +N ++ P ++ L L L N + P
Sbjct: 77 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-15
Identities = 20/129 (15%), Positives = 45/129 (34%), Gaps = 3/129 (2%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
+ L L+ L +N ++ S + +L ++ +L HN S P + ++ L L+
Sbjct: 327 VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLND 384
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 246
++T N++ + + L D ++++N F
Sbjct: 385 QAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTF 443
Query: 247 PNSSFVGNS 255
+G
Sbjct: 444 SQPVTIGKG 452
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 4/100 (4%)
Query: 149 SEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSL 208
T+L L N + + + Q+ L ++ L LT ++
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINF 75
Query: 209 QSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+N L+ P ++ KL + ++ N + P L N
Sbjct: 76 SNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTN 113
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 34/133 (25%), Positives = 57/133 (42%), Gaps = 10/133 (7%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLT-GGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFSPQL 179
+ + L+ + V+ L +N L G+ + + L Y+ + N + IP P L
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL 194
Query: 180 VVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNGL 235
L L N T + S++ L L L L N++S ++ N + P LR L+L+ N L
Sbjct: 195 TELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKL 252
Query: 236 KGSIPSSLQKFPN 248
+P L
Sbjct: 253 V-KVPGGLADHKY 264
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 32/146 (21%), Positives = 53/146 (36%), Gaps = 18/146 (12%)
Query: 121 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS--P 177
I N + L + + +T +P + PSL L+L N + K+ + S
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLN 216
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGL 235
L L LSFNS + S+ N L L L +N L +P D ++ + L N
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN-- 273
Query: 236 KGSIPSSLQKFPNSSFVGNSLLCGPP 261
++ ++ F
Sbjct: 274 ------NISAIGSNDFCPPGYNTKKA 293
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 25/125 (20%), Positives = 46/125 (36%), Gaps = 15/125 (12%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
+ +L L+ L L L N ++ + + P LR L+L +N K+P + +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265
Query: 180 VVLDLSFNSFTGNIPQS-------IQNLTQLTGLSLQSNNLS-GSIPN---FDIPKLRHL 228
V+ L N+ + I + +G+SL SN + I + +
Sbjct: 266 QVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
Query: 229 NLSYN 233
L
Sbjct: 325 QLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 36/154 (23%), Positives = 64/154 (41%), Gaps = 37/154 (24%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
+P +T +L L++N +T + +L +L L L +N S P +F+ +L
Sbjct: 50 LPPDT-------ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 180 VVLDLSFNSFT---GNIPQSIQ------------------NLTQLTGLSLQSNNL-SGSI 217
L LS N +P+++Q L Q+ + L +N L S I
Sbjct: 103 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 162
Query: 218 PN--F-DIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
N F + KL ++ ++ + +IP L P+
Sbjct: 163 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPS 193
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 28/96 (29%), Positives = 37/96 (38%), Gaps = 8/96 (8%)
Query: 156 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
LR + K+P P +LDL N T +NL L L L +N +S
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS- 89
Query: 216 SIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPN 248
I F + KL L LS N LK +P +
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKT 122
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 34/218 (15%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRD-FEQQMEIVGRVGQHPNVVPLR 437
++LG+G+ ++ +++ + +K + D ++ E++ ++ H N+V L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLF 73
Query: 438 AYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
A + L+ ++ GSL T+L A P E +L G+ H+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFL-IVLRDVVGGMNHLREN 131
Query: 496 GGPKFTHGNIKASNVLINQDLDGC----ISDFGL-------TPLMNVPATPSRSAGYRAP 544
G H NIK N++ DG ++DFG +++ T Y P
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE----EYLHP 184
Query: 545 EVIE--------TRKHSHKSDVYSFGVLLLEMLTGKAP 574
++ E +K+ D++S GV TG P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 27/130 (20%), Positives = 47/130 (36%), Gaps = 10/130 (7%)
Query: 121 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--P 177
+ + +L+ L L N + + S L L +L QH+N S F
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 178 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYN 233
L+ LD+S I L+ L L + N+ + ++ L L+LS
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 234 GLKGSIPSSL 243
L+ + +
Sbjct: 186 QLE-QLSPTA 194
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 35/153 (22%), Positives = 55/153 (35%), Gaps = 15/153 (9%)
Query: 123 PNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS--PQ 178
+ L L L + + I L SL L + N+F F+
Sbjct: 118 EFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176
Query: 179 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNG 234
L LDLS + + +L+ L L++ NN S+ F + L+ L+ S N
Sbjct: 177 LTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNH 234
Query: 235 LKGSIPSSLQKFPNS----SFVGNSLLCGPPLK 263
+ S LQ FP+S + N C +
Sbjct: 235 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 267
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 32/119 (26%), Positives = 44/119 (36%), Gaps = 11/119 (9%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----PQLVVLDLSFNS 188
L L SN L L L L L N S K S S L LDLSFN
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 189 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI----PKLRHLNLSYNGLKGSIPSSL 243
+ + L QL L Q +NL + F + L +L++S+ + + +
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI 145
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 30/119 (25%), Positives = 46/119 (38%), Gaps = 8/119 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 178
N L +LEVL + N +I T L +L +L L P++F+
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200
Query: 179 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD--IPKLRHLNLSYN 233
L VL++S N+F + L L L N++ + L LNL+ N
Sbjct: 201 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 25/98 (25%), Positives = 42/98 (42%), Gaps = 8/98 (8%)
Query: 156 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLS 214
S + + +P+ L+L N ++P + LTQLT LSL SN LS
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 215 -GSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+ L++L+LS+NG+ ++ S+
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ 102
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 28/128 (21%), Positives = 52/128 (40%), Gaps = 17/128 (13%)
Query: 129 KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 186
L LRS L P + L L+++ + ++P + L L L+
Sbjct: 79 TQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-----------FDIPKLRHLNLSYNGL 235
N +P SI +L +L LS+++ +P + L+ L L + G+
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 236 KGSIPSSL 243
+ S+P+S+
Sbjct: 196 R-SLPASI 202
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 34/137 (24%), Positives = 56/137 (40%), Gaps = 16/137 (11%)
Query: 125 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-------- 176
+T+ + LE L+L N L LP+ I SL LR L ++ ++P +
Sbjct: 121 DTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 177 ---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLS 231
L L L + ++P SI NL L L ++++ LS ++ +PKL L+L
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLR 237
Query: 232 YNGLKGSIPSSLQKFPN 248
+ P
Sbjct: 238 GCTALRNYPPIFGGRAP 254
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 24/137 (17%), Positives = 53/137 (38%), Gaps = 17/137 (12%)
Query: 125 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182
+ +L L+ +++ + L LP + L L L N +P+S + +L L
Sbjct: 98 DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155
Query: 183 DLSFNSFTGNIPQSIQN---------LTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLS 231
+ +P+ + + L L L L+ + S+P ++ L+ L +
Sbjct: 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIR 214
Query: 232 YNGLKGSIPSSLQKFPN 248
+ L ++ ++ P
Sbjct: 215 NSPLS-ALGPAIHHLPK 230
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 28/128 (21%), Positives = 52/128 (40%), Gaps = 6/128 (4%)
Query: 125 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182
L L+ L L + LP+ I +L +L+ L ++++ S + + P+L L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 240
DL + N P L L L+ + ++P + +L L+L +P
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 241 SSLQKFPN 248
S + + P
Sbjct: 295 SLIAQLPA 302
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 20/134 (14%), Positives = 40/134 (29%), Gaps = 10/134 (7%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSL--PSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182
+ ++ + L + P L L+ + P L +
Sbjct: 52 QANSNNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM 109
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 240
+ +P ++Q L L+L N L ++P + +LR L++ +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
Query: 241 SSLQKFPNSSFVGN 254
L S
Sbjct: 168 EPLASTDASGEHQG 181
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 19/97 (19%), Positives = 30/97 (30%), Gaps = 2/97 (2%)
Query: 125 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182
+ L LE L LR P L+ L L+ + +P QL L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 219
DL +P I L + + + + +
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 19/137 (13%), Positives = 41/137 (29%), Gaps = 28/137 (20%)
Query: 132 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS----------------- 174
E L + + ++ + + + +S
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATA 72
Query: 175 ------FSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLR 226
P V L+L P L+ L +++ + L +P+ L
Sbjct: 73 DLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLE 130
Query: 227 HLNLSYNGLKGSIPSSL 243
L L+ N L+ ++P+S+
Sbjct: 131 TLTLARNPLR-ALPASI 146
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 9e-06
Identities = 19/120 (15%), Positives = 35/120 (29%), Gaps = 27/120 (22%)
Query: 154 LPSLRYLYLQHNNFSGKIPSSFS-------------------PQLVVLDLSFNSFTG--N 192
LY Q + S + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70
Query: 193 IPQSIQNLTQ--LTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+++ TQ L L+S L P+ F + L+H+ + GL +P ++Q+F
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 8e-19
Identities = 30/146 (20%), Positives = 50/146 (34%), Gaps = 11/146 (7%)
Query: 121 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 180
L L L L + N +P +R+L L + + L
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLE 434
Query: 181 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-PKLRHLNLSYNGLKGSI 239
VLD+S N+ + L +L L + N L ++P+ + P L + +S N LK
Sbjct: 435 VLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVP 489
Query: 240 PSSLQKFPNSSFV---GNSLLCGPPL 262
+ + + N C P
Sbjct: 490 DGIFDRLTSLQKIWLHTNPWDCSCPR 515
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 46/233 (19%), Positives = 81/233 (34%), Gaps = 33/233 (14%)
Query: 25 SSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFA--DAVPHLR 82
SS + + ++ S L L I+ L + F D + + + D V L
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281
Query: 83 KLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNV 142
K+ + L +P L + L+ ++ +++ ++
Sbjct: 282 KVETVTIR-------------------RLHIPQFYL-FYDLSTVYSLLEKVKRITVENSK 321
Query: 143 LTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-----PQLVVLDLSFNSFT--GNIPQ 195
+ S L SL +L L N + + + P L L LS N +
Sbjct: 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381
Query: 196 SIQNLTQLTGLSLQSNNLSGSIPNFDIP-KLRHLNLSYNGLK---GSIPSSLQ 244
+ L LT L + N + P K+R LNLS G++ IP +L+
Sbjct: 382 ILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLE 434
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-18
Identities = 33/134 (24%), Positives = 52/134 (38%), Gaps = 8/134 (5%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 178
I + L L+VL L+S+ + + + SL SL +L L N+ S S F
Sbjct: 41 IGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99
Query: 179 LVVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNFD---IPKLRHLNLSYNG 234
L L+L N + + NLT L L + + I D + L L +
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159
Query: 235 LKGSIPSSLQKFPN 248
L+ SL+ +
Sbjct: 160 LRNYQSQSLKSIRD 173
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 30/135 (22%), Positives = 48/135 (35%), Gaps = 10/135 (7%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSG-KIPSSFS--P 177
I + L +LE L L N L+ L S L SL+YL L N + + S F
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123
Query: 178 QLVVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSYN 233
L L + I LT L L +++ +L + + + + HL L +
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLS 182
Query: 234 GLKGSIPSSLQKFPN 248
+ +
Sbjct: 183 ESAFLLEIFADILSS 197
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 22/116 (18%), Positives = 42/116 (36%), Gaps = 7/116 (6%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 190
++ L L N +T ++ + +L+ L L+ + + +F L LDLS N +
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 191 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI----PKLRHLNLSYNGLKGSIPSS 242
L+ L L+L N ++ + L+ L + I
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 17/150 (11%), Positives = 42/150 (28%), Gaps = 14/150 (9%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
I L +L L +++ L + S+ + +L L + + + +
Sbjct: 139 IRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSV 198
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG------------SIPNFDIPKLRH 227
L+L + + + + + S ++ ++
Sbjct: 199 RYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEF 258
Query: 228 LNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 257
+ + NGL PS V +
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVTI 288
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 9e-12
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 153 SLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNN 212
S + + +F+ IPS + + LDLSFN T ++ L L L+S+
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 213 LSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSL 243
++ +I F + L HL+LS N L S+ SS
Sbjct: 62 IN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSW 93
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 21/149 (14%), Positives = 49/149 (32%), Gaps = 22/149 (14%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 181
+ +L + + L+L + L L S+RYL L+ N + S V
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222
Query: 182 LDLSFNSFTGN---------IPQSIQNLTQLTGLSLQSNNLSG-------------SIPN 219
+ +F G+ + + ++ + +L+ + L+G +
Sbjct: 223 SPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282
Query: 220 FDIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+ +R L++ L + +
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 17/144 (11%), Positives = 46/144 (31%), Gaps = 21/144 (14%)
Query: 123 PNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSG--------- 169
P ++ L+ R +VLT L + + L + +G
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSES 274
Query: 170 ----KIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-I 222
++ + + L + ++ L ++ ++++++ + +P +
Sbjct: 275 DVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHL 333
Query: 223 PKLRHLNLSYNGLKGSIPSSLQKF 246
L L+LS N + +
Sbjct: 334 KSLEFLDLSENLMVEEYLKNSACK 357
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 57/312 (18%), Positives = 108/312 (34%), Gaps = 74/312 (23%)
Query: 381 EVLGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRDFEQ--QME--IVGRVGQHPNV 433
E+LG G + A V VK L+ + F + E + HP +
Sbjct: 18 EILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAI 74
Query: 434 V----------PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 483
V P Y +V +Y +L ++H P+ + ++++
Sbjct: 75 VAVYDTGEAETPAGPLPY------IVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIA 123
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------ 537
+ + H G H ++K +N++I+ + DFG+ +
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 538 -SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT---------RDDMVDLP 587
+A Y +PE +SDVYS G +L E+LTG+ P + R+D +
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240
Query: 588 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIE 646
+ + +A++ + +V + +AK P+ R E+ +
Sbjct: 241 ARHEGL-----SADL------------DAVV------LKALAKNPENRYQTAAEMRADLV 277
Query: 647 EVRQSDSENRPS 658
V + P
Sbjct: 278 RVHNGEPPEAPK 289
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 60/213 (28%), Positives = 109/213 (51%), Gaps = 35/213 (16%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+V+G GS+G ++A L ES V +K+ V+ KR ++++I+ R+ +HPNVV L+A++
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKK---VLQDKRFKNRELQIM-RIVKHPNVVDLKAFF 101
Query: 441 YSKDEKL------LVYDYFASGSLSTLLH---GNRGAGRTPLDWETRVKILL-GTARGVA 490
YS +K LV +Y + ++ + + + +K+ + R +A
Sbjct: 102 YSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLA 155
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATP------SRSAGYRA 543
+IHS+G H +IK N+L++ + DFG + + P SR YRA
Sbjct: 156 YIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA-KILIAGEPNVSYICSRY--YRA 209
Query: 544 PEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 575
PE+I + + D++S G ++ E++ G+ PL
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQ-PL 241
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 89.0 bits (220), Expect = 2e-18
Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 23/219 (10%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRA 438
E LG G +G + + +++ V +K+ ++ + K +EI + + HPNVV R
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 439 YY------YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAH 491
D LL +Y G L L+ E ++ LL + + +
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK---EGPIRTLLSDISSALRY 136
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMNVPATPSRSA----GYRAP 544
+H H ++K N+++ I D G ++ Y AP
Sbjct: 137 LHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAP 192
Query: 545 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 583
E++E +K++ D +SFG L E +TG P +
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 50/241 (20%), Positives = 99/241 (41%), Gaps = 44/241 (18%)
Query: 382 VLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 436
+LG+GS+ T A ++ +K L K ++ + +++ R+ HP V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKL 95
Query: 437 RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVA 490
+ + DEKL Y +G L + R G ET + I+ +
Sbjct: 96 Y-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFD---ETCTRFYTAEIVSA----LE 144
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPATPSRS------AGYR 542
++H G H ++K N+L+ + D I+DFG +++ + +R+ A Y
Sbjct: 145 YLHGKG---IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 543 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVV 594
+PE++ + SD+++ G ++ +++ G P ++ + D P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 259
Query: 595 R 595
R
Sbjct: 260 R 260
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 28/152 (18%), Positives = 51/152 (33%), Gaps = 25/152 (16%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFSPQLV 180
+P L LS+ +N L + + + SL+ L L N + + S P L
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLF 189
Query: 181 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 240
++S+N + ++ + L N+++ + +L L L +N L
Sbjct: 190 HANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLT-DTA 242
Query: 241 S---------------SLQKFPNSSFVGNSLL 257
L+K FV L
Sbjct: 243 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 11/128 (8%)
Query: 125 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182
+TL A+E L N + + + L L LQHNN + + P LV +
Sbjct: 199 STLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEV 253
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 240
DLS+N + + +L L + +N L ++ + IP L+ L+LS+N L +
Sbjct: 254 DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 311
Query: 241 SSLQKFPN 248
+ +F
Sbjct: 312 RNQPQFDR 319
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 32/146 (21%), Positives = 55/146 (37%), Gaps = 24/146 (16%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLT----GGLPS------------EITSLPSLRYLYLQHN 165
I ++T +L+ L L SN LT +PS + ++ L HN
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN 215
Query: 166 NFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DI 222
+ + + + +L +L L N+ T + + N L + L N L I +
Sbjct: 216 SIN-VVRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKM 271
Query: 223 PKLRHLNLSYNGLKGSIPSSLQKFPN 248
+L L +S N L ++ Q P
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPT 296
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 30/121 (24%), Positives = 57/121 (47%), Gaps = 11/121 (9%)
Query: 130 LDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 186
L+ ++++ +++ + LP+ + S + L L +F+ + L + F
Sbjct: 44 LNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102
Query: 187 NSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSS 242
N+ +P + QN+ LT L L+ N+LS S+P + PKL L++S N L+ I
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 159
Query: 243 L 243
Sbjct: 160 T 160
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 25/125 (20%), Positives = 44/125 (35%), Gaps = 7/125 (5%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
I + K+ LE L + +N L L +P+L+ L L HN+ + + +L
Sbjct: 263 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 320
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 239
L L NS + + L L+L N+ + + + I
Sbjct: 321 ENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 377
Query: 240 PSSLQ 244
L+
Sbjct: 378 DYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 19/140 (13%), Positives = 41/140 (29%), Gaps = 16/140 (11%)
Query: 124 NNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVV 181
++ L + + E +L + + + +++ + Q+ +
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 73
Query: 182 LDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKG 237
L+L+ I + L + N + +P ++P L L L N
Sbjct: 74 LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN---- 127
Query: 238 SIPSSLQKFPNSSFVGNSLL 257
L P F L
Sbjct: 128 ----DLSSLPRGIFHNTPKL 143
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 51/231 (22%), Positives = 94/231 (40%), Gaps = 38/231 (16%)
Query: 376 LRASAEVLGKGSYGTAYKAVLEESTT------VVVKRLKEVVVGKRDFEQQMEIVGRVGQ 429
L + LG+GS+ K V + + ++ KR++ + ++++ +
Sbjct: 12 LDLKDKPLGEGSFSICRKCV-HKKSNQAFAVKIISKRMEA------NTQKEITALKLCEG 64
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGSLST--LLHGN---RGAGRTPLDWETRVKILLG 484
HPN+V L ++ + LV + G L + A ++ L+
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-------MRKLVS 117
Query: 485 TARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGC--ISDFGL----TPLMNVPATPSR 537
V+H+H +G H ++K N+L +++ + I DFG P TP
Sbjct: 118 ---AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171
Query: 538 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 588
+ Y APE++ + D++S GV+L ML+G+ P QS R
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 32/212 (15%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+V+G GS+G Y+A L +S +V +K+V+ KR ++++I+ ++ H N+V LR ++
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFF 116
Query: 441 YSKDEKL------LVYDYFASGSLSTLLHG---NRGAGRTPLDWETRVKILL-GTARGVA 490
YS EK LV DY + ++ + + L VK+ + R +A
Sbjct: 117 YSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLA 170
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGL--TPLMNVPATP---SRSAGYRAP 544
+IHS G H +IK N+L++ D + DFG + P SR YRAP
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--YRAP 225
Query: 545 EVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 575
E+I + DV+S G +L E+L G+ P+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 46/225 (20%), Positives = 79/225 (35%), Gaps = 43/225 (19%)
Query: 439 YYYSKDEKLLVY---DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
K+ +Y +L + NR + + I + A V +HS
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGL-------------TPLMNVPATPSRSAG-- 540
G H ++K SN+ D + DFGL M AT + G
Sbjct: 184 G---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 541 -YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 599
Y +PE I +SHK D++S G++L E+L T+ + V + + V ++
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF-----STQMERVRI---ITDVRNLKFP 292
Query: 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644
F + M+Q ++ P RP +++
Sbjct: 293 LL--------FTQKYPQEHMMVQ---DMLSPSPTERPEATDIIEN 326
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 22/216 (10%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPNVVPL 436
+ LG G+YG + + +K +++ V +++ ++ + HPN++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKL 101
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHSM 495
++ K LV + + G L + R + E +++ GV ++H
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELF-----DEIIHRMKFN-EVDAAVIIKQVLSGVTYLHKH 155
Query: 496 GGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRAPEVIET 549
H ++K N+L+ I DFGL+ + +A Y APEV+
Sbjct: 156 N---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR- 211
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
+K+ K DV+S GV+L +L G P T +++
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 3e-18
Identities = 40/237 (16%), Positives = 84/237 (35%), Gaps = 42/237 (17%)
Query: 381 EVLGKGSYGTAYKAV--LEESTTVVVKRLKEVVVGKRD------FEQQMEIVGRVGQHPN 432
+ G G Y A+ VV+K L D + + + V HP+
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVH----SGDAEAQAMAMAERQFLAEV-VHPS 140
Query: 433 VVPLRAYYYSKDEKL-------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 485
+V + + + + +V +Y SL L + LL
Sbjct: 141 IV--QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEI 191
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAGYRAP 544
++++HS+G + ++K N+++ ++ + D G +N + G++AP
Sbjct: 192 LPALSYLHSIG---LVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGYLYGTPGFQAP 246
Query: 545 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS------PTRDDMVDLPRWVQSVVR 595
E++ T + +D+Y+ G L + P D ++ ++R
Sbjct: 247 EIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLR 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 54/302 (17%), Positives = 110/302 (36%), Gaps = 39/302 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRD-FEQQMEIVGRVGQHPNVVPLR 437
++LG+G+ ++ +++ + +K + D ++ E++ ++ H N+V L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLF 73
Query: 438 AYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
A + L+ ++ GSL T+L A P E +L G+ H+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFL-IVLRDVVGGMNHLREN 131
Query: 496 GGPKFTHGNIKASNVLINQDLDGC----ISDFGLTPLMNVPATPSRSA----GYRAPEVI 547
G H NIK N++ DG ++DFG + S Y P++
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPDMY 187
Query: 548 ET--------RKHSHKSDVYSFGVLLLEMLTGKAP---LQSPTRDDMV-------DLPRW 589
E +K+ D++S GV TG P + P R+ V
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 590 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKV-PDMRPNMDEVVRMIEEV 648
+ V + E + ++ ++ + +L +A + + + D+ ++
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
Query: 649 RQ 650
Sbjct: 308 LH 309
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 42/222 (18%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV--VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 438
E +G GSY + + ++T + VK + + KRD +++EI+ R GQHPN++ L+
Sbjct: 28 EDIGVGSYSVCKRCI-HKATNMEFAVKIIDK---SKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 439 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETRVKILLGTARG 488
Y +V + G L LD E +L +
Sbjct: 84 VYDDGKYVYVVTELMKGGEL--------------LDKILRQKFFSEREAS-AVLFTITKT 128
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGC----ISDFGLTPLMNVP----ATPSRSAG 540
V ++H+ G H ++K SN+L + I DFG + TP +A
Sbjct: 129 VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 541 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 582
+ APEV+E + + D++S GVLL MLTG P + D
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-18
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRDFE---QQMEIVGRVGQHPNVVP 435
VLGKGS+G + + VK + K V K D E ++++++ ++ HPN++
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMK 90
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHS 494
L ++ K LV + + G L + R E ++ G+ ++H
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGELF-----DEIISRKRFS-EVDAARIIRQVLSGITYMHK 144
Query: 495 MGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRAPEVIE 548
H ++K N+L+ I DFGL+ +A Y APEV+
Sbjct: 145 NK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH 201
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
+ K DV+S GV+L +L+G P D++
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 37/154 (24%), Positives = 60/154 (38%), Gaps = 17/154 (11%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS--P 177
+ T L L L L L L + L +L+YLYLQ N +P +F
Sbjct: 96 VDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLG 153
Query: 178 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
L L L N + ++P+ + L L L L N ++ + F + +L L L N
Sbjct: 154 NLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFAN 211
Query: 234 GLKGSIPSS-LQKFPNSSFV---GNSLLCGPPLK 263
L ++P+ L ++ N +C +
Sbjct: 212 NLS-ALPTEALAPLRALQYLRLNDNPWVCDCRAR 244
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 25/115 (21%), Positives = 49/115 (42%), Gaps = 8/115 (6%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 190
+ + L N ++ + + +L L+L N + ++F+ L LDLS N+
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 191 GNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPS 241
++ + L +L L L L + F + L++L L N L+ ++P
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPD 146
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 24/102 (23%), Positives = 38/102 (37%), Gaps = 8/102 (7%)
Query: 147 LPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT 204
+P I + + ++L N S +SF L +L L N + L L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 205 GLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSL 243
L L N S+ F + +L L+L GL+ + L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL 124
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 18/86 (20%), Positives = 27/86 (31%), Gaps = 5/86 (5%)
Query: 160 LYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 219
+P + L N + S + LT L L SN L+ I
Sbjct: 16 TSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDA 73
Query: 220 ---FDIPKLRHLNLSYNGLKGSIPSS 242
+ L L+LS N S+ +
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPA 99
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 37/129 (28%), Positives = 57/129 (44%), Gaps = 8/129 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 178
I ++ L + N + LP + ++P L L L+ N+ S F P+
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 148
Query: 179 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG 237
L L +S N+ I Q T L L L SN L+ + IP L H N+SYN L
Sbjct: 149 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLST 206
Query: 238 -SIPSSLQK 245
+IP ++++
Sbjct: 207 LAIPIAVEE 215
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 3e-16
Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 11/128 (8%)
Query: 125 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182
+TL A+E L N + + + L L LQHNN + + P LV +
Sbjct: 205 STLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEV 259
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 240
DLS+N + + +L L + +N L ++ + IP L+ L+LS+N L +
Sbjct: 260 DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 317
Query: 241 SSLQKFPN 248
+ +F
Sbjct: 318 RNQPQFDR 325
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 3e-16
Identities = 33/146 (22%), Positives = 56/146 (38%), Gaps = 24/146 (16%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLT----GGLPS------------EITSLPSLRYLYLQHN 165
I ++T +L+ L L SN LT +PS + ++ L HN
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN 221
Query: 166 NFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-I 222
+ + + + +L +L L N+ T + + N L + L N L I F +
Sbjct: 222 SIN-VVRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKM 277
Query: 223 PKLRHLNLSYNGLKGSIPSSLQKFPN 248
+L L +S N L ++ Q P
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPT 302
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 5e-15
Identities = 30/121 (24%), Positives = 57/121 (47%), Gaps = 11/121 (9%)
Query: 130 LDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 186
L+ ++++ +++ + LP+ + S + L L +F+ + L + F
Sbjct: 50 LNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108
Query: 187 NSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSS 242
N+ +P + QN+ LT L L+ N+LS S+P + PKL L++S N L+ I
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 165
Query: 243 L 243
Sbjct: 166 T 166
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 26/126 (20%), Positives = 44/126 (34%), Gaps = 7/126 (5%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
I + K+ LE L + +N L L +P+L+ L L HN+ + + +L
Sbjct: 269 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 326
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 239
L L NS + S L L+L N+ + + + I
Sbjct: 327 ENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383
Query: 240 PSSLQK 245
L+
Sbjct: 384 DYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 19/140 (13%), Positives = 41/140 (29%), Gaps = 16/140 (11%)
Query: 124 NNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVV 181
++ L + + E +L + + + +++ + Q+ +
Sbjct: 20 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 79
Query: 182 LDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKG 237
L+L+ I + L + N + +P ++P L L L N
Sbjct: 80 LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN---- 133
Query: 238 SIPSSLQKFPNSSFVGNSLL 257
L P F L
Sbjct: 134 ----DLSSLPRGIFHNTPKL 149
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 28/129 (21%), Positives = 44/129 (34%), Gaps = 8/129 (6%)
Query: 124 NNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLD 183
N + L+VL L N L + L LYL HN+ + S L L
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLT 351
Query: 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 243
LS N + N +++ + ++ + I +L H K + L
Sbjct: 352 LSHNDWDCNSLRAL--FRNVARPAVDDADQHCKID----YQLEHGLCCKESDKPYLDRLL 405
Query: 244 QKFPNSSFV 252
Q +S V
Sbjct: 406 QYIALTSVV 414
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 30/132 (22%), Positives = 44/132 (33%), Gaps = 9/132 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 180
+P L + + + N L G L YL + + IP L
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPETLN 196
Query: 181 VLDLSFNSFTGNIPQ-SIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLK 236
L L N I + ++L L L N + I N +P LR L+L N L
Sbjct: 197 ELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS 254
Query: 237 GSIPSSLQKFPN 248
+P+ L
Sbjct: 255 -RVPAGLPDLKL 265
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 37/200 (18%), Positives = 61/200 (30%), Gaps = 43/200 (21%)
Query: 53 IVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVF-GL 111
I + F+ L ++ + NP+ S F GL
Sbjct: 135 IRKVPKGVFSGL--------------RNMNCIEMGG-NPLENSGF-------EPGAFDGL 172
Query: 112 RLPGIGLVG----PIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNN 166
+L + + IP + + L L L N + + E L L L HN
Sbjct: 173 KLNYLRISEAKLTGIPKDLP---ETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQ 228
Query: 167 FSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS--------GS 216
S S P L L L N + +P + +L L + L +NN++
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV 287
Query: 217 IPNFDIPKLRHLNLSYNGLK 236
++L N +
Sbjct: 288 GFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 24/126 (19%), Positives = 45/126 (35%), Gaps = 17/126 (13%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 178
I L + L L L N + + + + LP+LR L+L +N S ++P+
Sbjct: 208 IELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL 265
Query: 179 LVVLDLSFNSFTGNIPQSI-------QNLTQLTGLSLQSNNLS-GSIPN---FDIPKLRH 227
L V+ L N+ T + + G+SL +N + + +
Sbjct: 266 LQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324
Query: 228 LNLSYN 233
+
Sbjct: 325 IQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 44/213 (20%), Positives = 72/213 (33%), Gaps = 50/213 (23%)
Query: 67 DRQALLDFA-DAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVF--GLRLPGIGLVGP-- 121
D +A +P L L + + +C C V L L + P
Sbjct: 1 DEEASGAETTSGIPDLDSLP-PTYSAMCPF----GCHCHLRVVQCSDLGLKAV----PKE 51
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
I +T +L L++N ++ + L L L L +N S +FS +L
Sbjct: 52 ISPDT-------TLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 180 VVLDLSFNSFT---GNIPQSIQ------------------NLTQLTGLSLQSNNL-SGSI 217
L +S N N+P S+ L + + + N L +
Sbjct: 105 QKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGF 164
Query: 218 PN--FDIPKLRHLNLSYNGLKG---SIPSSLQK 245
FD KL +L +S L G +P +L +
Sbjct: 165 EPGAFDGLKLNYLRISEAKLTGIPKDLPETLNE 197
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 26/96 (27%), Positives = 38/96 (39%), Gaps = 8/96 (8%)
Query: 156 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
LR + +P SP +LDL N + + L L L L +N +S
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS- 91
Query: 216 SIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPN 248
I F + KL+ L +S N L IP +L +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSS 124
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 48/231 (20%), Positives = 87/231 (37%), Gaps = 41/231 (17%)
Query: 381 EVLGKGSYGTAYKAVLEES---------------TTVVVKRLKEVVVGKRDFEQQMEIVG 425
LG G+YG + K + + ++ ++
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 426 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGN---RGAGRTPLDWETRVK 480
+ HPN++ L + K LV +++ G L + A +K
Sbjct: 102 SLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-------MK 153
Query: 481 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLI-NQDLDGCI--SDFGLTPLM---NVPAT 534
+L G+ ++H H +IK N+L+ N++ I DFGL+
Sbjct: 154 QILS---GICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
+A Y APEV++ +K++ K DV+S GV++ +L G P D++
Sbjct: 208 RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-17
Identities = 30/137 (21%), Positives = 41/137 (29%), Gaps = 9/137 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKI--PSSFS--P 177
I L L +L L S+ + P L L L L S + F
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 178 QLVVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLS----GSIPNFDIPKLRHLNLSY 232
L LDLS N + S L L + SN + + L +L+
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 233 NGLKGSIPSSLQKFPNS 249
N L + K N
Sbjct: 184 NSLYSRVSVDWGKCMNP 200
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 32/137 (23%), Positives = 54/137 (39%), Gaps = 13/137 (9%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
+ + L L+VL+L N + L +L+ L L +N S+F P++
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKV 340
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 239
+DL N Q+ + L +L L L+ N L+ +I P + + LS N
Sbjct: 341 AYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFI--PSIPDIFLSGN------ 391
Query: 240 PSSLQKFPNSSFVGNSL 256
L P + N +
Sbjct: 392 --KLVTLPKINLTANLI 406
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 32/127 (25%), Positives = 46/127 (36%), Gaps = 8/127 (6%)
Query: 130 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKI-PSSFS--PQLVVLDLSF 186
L+ E L L N + S L L+ L L I +F P L +LDL
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI----PKLRHLNLSYNGLKG-SIPS 241
+ P + Q L L L L LS ++ L L+LS N ++ +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 242 SLQKFPN 248
S K +
Sbjct: 143 SFGKLNS 149
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 32/160 (20%), Positives = 52/160 (32%), Gaps = 19/160 (11%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGL--PSEITSLPSLRYLYLQHNNFSG-KIPSSFS-- 176
+ + L L L L L+ + +L +L L L N + SF
Sbjct: 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL 147
Query: 177 PQLVVLDLSFNSFTGNIPQSIQNLTQ--LTGLSLQSNNLSGSIP--------NFDIPKLR 226
L +D S N ++ L L+ SL +N+L + F L
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207
Query: 227 HLNLSYNGLKGSIPS----SLQKFPNSSFVGNSLLCGPPL 262
L++S NG I ++ K S + + G
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF 247
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 34/150 (22%), Positives = 49/150 (32%), Gaps = 8/150 (5%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 181
+ + L L+VL L N L P + L +LR L L N + + L +
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEI 530
Query: 182 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSI- 239
LD+S N P +L+ L + N I L H N++ G I
Sbjct: 531 LDISRNQLLAPNPDVFVSLSVLD---ITHNKFICECELSTFINWLNHTNVTIAGPPADIY 587
Query: 240 ---PSSLQKFPNSSFVGNSLLCGPPLKACF 266
P S S LK+
Sbjct: 588 CVYPDSFSGVSLFSLSTEGCDEEEVLKSLK 617
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 29/147 (19%), Positives = 54/147 (36%), Gaps = 16/147 (10%)
Query: 116 IGLVGPIPNNTLGKLD------ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 169
+ P N L LD +++ SN ++ + + +N
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254
Query: 170 KIPSSFSP----QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN---FD 221
++F+ + LDLS ++ + + L L L+L N ++ I + +
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYG 312
Query: 222 IPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+ L+ LNLSYN L S+ P
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPK 339
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 26/152 (17%), Positives = 55/152 (36%), Gaps = 26/152 (17%)
Query: 123 PNNTLGKLDALEVLSLRSNVLTGGLPSEITSL--PSLRYLYLQHNNFSGKIPSSFS---- 176
+ + GKL++L+ + SN + E+ L +L + L N+ ++ +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 177 ----PQLVVLDLSFNSFTGNIP------------QSIQNLTQLTGLSLQSNNLS----GS 216
L +LD+S N +T +I S+ + G +N+ +
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 217 IPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+RHL+LS+ + + +
Sbjct: 260 FAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 25/105 (23%), Positives = 37/105 (35%), Gaps = 13/105 (12%)
Query: 156 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
R + + N + ++P L LSFN S L QL L L S
Sbjct: 5 DGRIAFYRFCNLT-QVPQVL-NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 216 SIPN--F-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 257
+I F ++P LR L+L + + +F G L
Sbjct: 63 TIDKEAFRNLPNLRILDLGSS--------KIYFLHPDAFQGLFHL 99
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 27/114 (23%), Positives = 47/114 (41%), Gaps = 12/114 (10%)
Query: 130 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 189
+ VL++ + LT LP + + L + NN + +P+ P+L L++S N
Sbjct: 39 NNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALP-PELRTLEVSGNQL 93
Query: 190 TGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 243
T ++P L +L+ S +L L L + N L S+P
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPALPSG-----LCKLWIFGNQLT-SLPVLP 140
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 30/126 (23%), Positives = 48/126 (38%), Gaps = 17/126 (13%)
Query: 124 NNTLGKLDA----LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 179
N L L L+ LS+ N L LP+ L L+ +N + +P S L
Sbjct: 130 GNQLTSLPVLPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPMLPS-GL 183
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 239
L +S N ++P L +L + + +L L+ L +S N L S+
Sbjct: 184 QELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSG-----LKELIVSGNRLT-SL 236
Query: 240 PSSLQK 245
P +
Sbjct: 237 PVLPSE 242
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 31/119 (26%), Positives = 50/119 (42%), Gaps = 13/119 (10%)
Query: 130 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 189
L+ LS+ N L LP+ L L+ +N + +P+ S L L +S N
Sbjct: 180 PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLT-SLPALPS-GLKELIVSGNRL 233
Query: 190 TGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
T ++P L +L + N L+ S+P L L++ N L +P SL +
Sbjct: 234 T-SLPVLPSELKEL---MVSGNRLT-SLPML-PSGLLSLSVYRNQLT-RLPESLIHLSS 285
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 6/87 (6%)
Query: 170 KIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 229
K+ + + VL++ + T +P + +T L + NNL+ S+P P+LR L
Sbjct: 33 KMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPA-LPPELRTLE 87
Query: 230 LSYNGLKGSIPSSLQKFPNSSFVGNSL 256
+S N L S+P S N L
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPL 113
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 15/148 (10%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS--PQ 178
I + + +L L+VL + + +L L + H N + +P +
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVY 249
Query: 179 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNG 234
L L+LS+N + I S+ L +L + L L+ + + + LR LN+S N
Sbjct: 250 LRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQ 307
Query: 235 LKGSIP----SSLQKFPNSSFVGNSLLC 258
L ++ S+ N L C
Sbjct: 308 LT-TLEESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 33/142 (23%), Positives = 51/142 (35%), Gaps = 16/142 (11%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 178
+ L L L LRSN L +P + T L +L L + N + F
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129
Query: 179 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNGL 235
L L++ N ++ L L L+L+ NL+ SIP + L L L +
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHL-- 186
Query: 236 KGSIPSSLQKFPNSSFVGNSLL 257
++ + SF L
Sbjct: 187 ------NINAIRDYSFKRLYRL 202
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 32/131 (24%), Positives = 49/131 (37%), Gaps = 16/131 (12%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 190
+L L N + E S P L L L N S P +F+ L L L N
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93
Query: 191 GNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKF 246
IP + L+ LT L + N + + ++ D+ L+ L + N L
Sbjct: 94 -LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDN--------DLVYI 143
Query: 247 PNSSFVGNSLL 257
+ +F G + L
Sbjct: 144 SHRAFSGLNSL 154
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 23/106 (21%), Positives = 34/106 (32%), Gaps = 13/106 (12%)
Query: 155 PSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 214
R + F +P + +LDL N + L L L N +S
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69
Query: 215 GSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 257
++ ++ LR L L N L+ P F G S L
Sbjct: 70 -AVEPGAFNNLFNLRTLGLRSN--------RLKLIPLGVFTGLSNL 106
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 5e-17
Identities = 37/152 (24%), Positives = 60/152 (39%), Gaps = 14/152 (9%)
Query: 122 IPNNTLGKLDALEVLSL-RSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFSPQ 178
IP+ ++ +L L L L+ + L +LRYL L N +IP+ + +
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLSY-ISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIK 208
Query: 179 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGL 235
L LDLS N + P S Q L L L + + + I ++ L +NL++N L
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNL 267
Query: 236 KGSIP----SSLQKFPNSSFVGNSLLCGPPLK 263
+P + L N C +
Sbjct: 268 T-LLPHDLFTPLHHLERIHLHHNPWNCNCDIL 298
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 36/138 (26%), Positives = 53/138 (38%), Gaps = 22/138 (15%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
I NT +L+L N + + L L L L N+ +F+ L
Sbjct: 62 ISTNT-------RLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 180 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGL 235
L+L N T IP L++L L L++N + SIP++ IP LR L+L
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK- 171
Query: 236 KGSIPSSLQKFPNSSFVG 253
L +F G
Sbjct: 172 ------RLSYISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 6/90 (6%)
Query: 155 PSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 214
+ N ++P S +L+L N S ++L L L L N++
Sbjct: 43 NQFSKVICVRKNLR-EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101
Query: 215 GSIPN---FDIPKLRHLNLSYNGLKGSIPS 241
+I + L L L N L +IP+
Sbjct: 102 -TIEIGAFNGLANLNTLELFDNRLT-TIPN 129
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 72/288 (25%), Positives = 113/288 (39%), Gaps = 77/288 (26%)
Query: 339 GRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEE 398
G E KE G GV + + FE +R VLGKGS+G A ++E
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDNFE----------FIR----VLGKGSFGKVMLARVKE 46
Query: 399 STTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453
+ + VK L K+V++ D E M I+ HP + L + + D V ++
Sbjct: 47 TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFV 106
Query: 454 ASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKAS 508
G L + + R E R + I+ + +H G + ++K
Sbjct: 107 NGGDLMFHIQK---SRRFD---EARARFYAAEIISA----LMFLHDKG---IIYRDLKLD 153
Query: 509 NVLINQDLDG--CISDFGL----------------TPLMNVPATPSRSAGYRAPEVIETR 550
NVL+ D +G ++DFG+ TP Y APE+++
Sbjct: 154 NVLL--DHEGHCKLADFGMCKEGICNGVTTATFCGTP------------DYIAPEILQEM 199
Query: 551 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 590
+ D ++ GVLL EML G AP ++ DD+ V P W+
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 247
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 24/227 (10%)
Query: 371 DLEDLLRASAEVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQMEIVGRVG 428
+ D + S +VLG G G + T +K L + Q+++ +
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECF-HRRTGQKCALKLLYD----SPKARQEVDHHWQAS 79
Query: 429 QHPNVVPLRAYY----YSKDEKLLVYDYFASGSLSTLLHGNRGAGR-TPLDWETRVKILL 483
P++V + Y + K L++ + G L + + RG T + ++ +
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ-ERGDQAFTEREAAEIMRDIG 138
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLM--NVPATPSRS 538
+ +HS H ++K N+L +D ++DFG N TP +
Sbjct: 139 T---AIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 192
Query: 539 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
Y APEV+ K+ D++S GV++ +L G P S T +
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 35/128 (27%), Positives = 49/128 (38%), Gaps = 15/128 (11%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSF 186
L+VLS+ ++ P+L L L N G+ + P L VL L
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 187 NSFT---GNIPQSIQNLTQLTGLSLQSNNLSGSIP--NFDIP-KLRHLNLSYNGLK---G 237
G QL GL L N+L + + D P +L LNLS+ GLK
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK 270
Query: 238 SIPSSLQK 245
+P+ L
Sbjct: 271 GLPAKLSV 278
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 9/129 (6%)
Query: 116 IGLVGPIPNNTLGKLDALEVLSLRSNVLT---GGLPSEITSLPSLRYLYLQHNNFSGKIP 172
+G G I K L+VL+LR+ + G + + L+ L L HN+
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 173 SSF---SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 229
+ QL L+LSF +P+ + +L+ L L N L + ++P++ +L+
Sbjct: 246 APSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDRNPSPDELPQVGNLS 302
Query: 230 LSYNGLKGS 238
L N S
Sbjct: 303 LKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 33/181 (18%), Positives = 60/181 (33%), Gaps = 22/181 (12%)
Query: 107 RVFGLRLPGIGLVGPIPNNTLGKLDA--LEVLSLRSNVLTGGLPSEITSL--PSLRYLYL 162
+ L + + I L L L+ L+L + +TG P + P L L L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 163 QHN------NFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG- 215
++ + ++ P L VL ++ + ++ L+ L L N G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 216 -----SIPNFDIPKLRHLNLSYNGLK---GSIPSSLQKFPNSSFV---GNSLLCGPPLKA 264
++ P L+ L L G++ G + + NSL +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 265 C 265
C
Sbjct: 249 C 249
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 25/113 (22%), Positives = 35/113 (30%), Gaps = 3/113 (2%)
Query: 79 PHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSL 138
P L+ L + S V R ++ GL L L + L L+L
Sbjct: 201 PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260
Query: 139 RSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTG 191
L +P + L L L +N PQ+ L L N F
Sbjct: 261 SFTGLKQ-VPKGL--PAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 7e-17
Identities = 35/153 (22%), Positives = 58/153 (37%), Gaps = 16/153 (10%)
Query: 122 IPNNTLGKLDALEVLSL-RSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--P 177
IP+ ++ +L L L L + L +L+YL L N +P+ +
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEY-ISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLV 218
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNG 234
L L++S N F P S L+ L L + ++ +S I + L LNL++N
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNN 277
Query: 235 LKGSIPSS-LQKFPNSSFV---GNSLLCGPPLK 263
L S+P + N C +
Sbjct: 278 LS-SLPHDLFTPLRYLVELHLHHNPWNCDCDIL 309
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 30/126 (23%), Positives = 48/126 (38%), Gaps = 13/126 (10%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 190
L+L N + L L L L N+ +F+ L L+L N T
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136
Query: 191 GNIPQSIQNLTQLTGLSLQSNNLSGSIPN--F-DIPKLRHLNLSYNGLKGSIPSSLQKFP 247
+ + L++L L L++N + SIP+ F +P L L+L L+
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK-------KLEYIS 188
Query: 248 NSSFVG 253
+F G
Sbjct: 189 EGAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 19/90 (21%), Positives = 30/90 (33%), Gaps = 6/90 (6%)
Query: 155 PSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 214
+ S ++P L+L N+ + ++L L L L N++
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 215 GSIPN---FDIPKLRHLNLSYNGLKGSIPS 241
I + L L L N L IPS
Sbjct: 113 -QIEVGAFNGLASLNTLELFDNWLT-VIPS 140
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 7e-17
Identities = 71/284 (25%), Positives = 119/284 (41%), Gaps = 51/284 (17%)
Query: 333 GKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLED--LLRASAEVLGKGSYGT 390
+A G ++ P+E+ + + + + N G L D L VLGKGS+G
Sbjct: 307 ERAKIGQGTKAPEEKTANTISKFDNN------GNRDRMKLTDFNFLM----VLGKGSFGK 356
Query: 391 AYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDE 445
+ + + + VK L K+VV+ D E M ++ G+ P + L + + + D
Sbjct: 357 VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416
Query: 446 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKF 500
V +Y G L + GR E I +G + + S G
Sbjct: 417 LYFVMEYVNGGDLMYHIQQ---VGRFK---EPHAVFYAAEIAIG----LFFLQSKG---I 463
Query: 501 THGNIKASNVLINQDLDG--CISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRKHSH 554
+ ++K NV++ D +G I+DFG+ + T G Y APE+I + +
Sbjct: 464 IYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 521
Query: 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 590
D ++FGVLL EML G+AP + D++ V P+ +
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 565
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 56/248 (22%)
Query: 374 DLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRL-------KEVVVGKRDFEQQME--IV 424
+LL+ VLG+GS+G + ++ + ++L K + + +ME I+
Sbjct: 27 ELLK----VLGQGSFGKVFLV--KKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 425 GRVGQHPNVVPLRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK- 480
V HP +V L +Y+ + KL L+ D+ G L T L E VK
Sbjct: 81 VEV-NHPFIVKL---HYAFQTEGKLYLILDFLRGGDLFTRLSK---EVMFT---EEDVKF 130
Query: 481 ----ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPAT 534
+ L + H+HS+G + ++K N+L+ D +G ++DFGL+
Sbjct: 131 YLAELALA----LDHLHSLG---IIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEK 181
Query: 535 PSRS----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM------- 583
+ S Y APEV+ R H+ +D +SFGVL+ EMLTG P Q R +
Sbjct: 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241
Query: 584 -VDLPRWV 590
+ +P+++
Sbjct: 242 KLGMPQFL 249
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 56/250 (22%), Positives = 99/250 (39%), Gaps = 32/250 (12%)
Query: 341 SEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEEST 400
+ P +EF + + + E D R VLG+G +G + ++ +
Sbjct: 155 GQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFR----VLGRGGFGEVFACQMKATG 210
Query: 401 TV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455
+ K+L K+ + ++ ++ M +I+ +V +V L + +K + LV
Sbjct: 211 KLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNG 269
Query: 456 GSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKASNV 510
G + H P E R I+ G + H+H + ++K NV
Sbjct: 270 GDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQRN---IIYRDLKPENV 320
Query: 511 LINQDLDG--CISDFGLT-PLMNVPATPSRSAG---YRAPEVIETRKHSHKSDVYSFGVL 564
L+ D DG ISD GL L AG + APE++ ++ D ++ GV
Sbjct: 321 LL--DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 565 LLEMLTGKAP 574
L EM+ + P
Sbjct: 379 LYEMIAARGP 388
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 29/219 (13%)
Query: 382 VLGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 436
VLGKG +G + + + K+L K+ + ++ + +I+ +V VV L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSL 249
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAH 491
Y +KD LV G L ++ G+ E R I G +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYH---MGQAGFP-EARAVFYAAEICCG----LED 301
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPATPSRSAG---YRAPEV 546
+H + ++K N+L+ D G ISD GL + T G Y APEV
Sbjct: 302 LHRER---IVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
++ +++ D ++ G LL EM+ G++P Q + +
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 29/109 (26%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 129 KLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFN 187
++ +L+ L + N ++ + SL L + N + I P++ VLDL N
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSN 431
Query: 188 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
+IP+ + L L L++ SN L S+P+ FD + L+ + L N
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-15
Identities = 34/132 (25%), Positives = 54/132 (40%), Gaps = 6/132 (4%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS--GKIPSSFS--P 177
+ K+ L +N+LT + L L L LQ N KI +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 178 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 236
L LD+S NS + + + L L++ SN L+ +I P+++ L+L N +K
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434
Query: 237 GSIPSSLQKFPN 248
SIP + K
Sbjct: 435 -SIPKQVVKLEA 445
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 36/135 (26%), Positives = 57/135 (42%), Gaps = 12/135 (8%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS-- 176
G L LE L L+ N L + T + SL+ L + N+ S S
Sbjct: 339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT 398
Query: 177 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNG 234
L+ L++S N T I + + ++ L L SN + SIP + L+ LN++ N
Sbjct: 399 KSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ 455
Query: 235 LKGSIP-SSLQKFPN 248
LK S+P + +
Sbjct: 456 LK-SVPDGIFDRLTS 469
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 33/129 (25%), Positives = 49/129 (37%), Gaps = 17/129 (13%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
+ T +L++ N ++ S+I SL LR L + HN S F +L
Sbjct: 19 LSQKT-------TILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FD-IPKLRHLNLSYNGL 235
LDLS N I L L L N ++P F + +L+ L LS L
Sbjct: 72 EYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127
Query: 236 KGSIPSSLQ 244
+ S +
Sbjct: 128 EKSSVLPIA 136
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 8e-12
Identities = 34/197 (17%), Positives = 65/197 (32%), Gaps = 12/197 (6%)
Query: 56 LLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPG 115
+ + + S ++L P L L ++ S++ I T V+ +
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256
Query: 116 IGLVGPIPNNTLG----KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKI 171
+ L G + L AL + + S+V ++ +
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316
Query: 172 PSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN----FD-IPK 224
S + LD S N T + ++ +LT+L L LQ N L + +
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKS 375
Query: 225 LRHLNLSYNGLKGSIPS 241
L+ L++S N +
Sbjct: 376 LQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 19/83 (22%), Positives = 35/83 (42%), Gaps = 6/83 (7%)
Query: 162 LQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-- 219
N +P S + +L++S N + I +L++L L + N + +
Sbjct: 7 RSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISV 64
Query: 220 FD-IPKLRHLNLSYNGLKGSIPS 241
F +L +L+LS+N L I
Sbjct: 65 FKFNQELEYLDLSHNKLV-KISC 86
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 22/94 (23%), Positives = 37/94 (39%), Gaps = 7/94 (7%)
Query: 123 PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLV 180
+L L++ SN+LT + + P ++ L L N IP L
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQ 447
Query: 181 VLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNL 213
L+++ N ++P I LT L + L +N
Sbjct: 448 ELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 18/129 (13%), Positives = 36/129 (27%), Gaps = 8/129 (6%)
Query: 128 GKLDALEVLSLRSNVLTG-GLPSEITSLPSLRYLYLQHNNFSGKIPSSF---SPQLVVLD 183
L+ L L N + E ++ L++L L + + V+L
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 184 LSFNSFTGNIPQSIQNLTQLT-GLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSI 239
L P+ +Q+ + + +N I + + L N+
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206
Query: 240 PSSLQKFPN 248
L
Sbjct: 207 SYFLSILAK 215
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 21/135 (15%), Positives = 39/135 (28%), Gaps = 3/135 (2%)
Query: 123 PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVL 182
G + L+ L L + L I L + L + + K
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 242
L T I +++ T +L+ +N+ + K + L+ + S
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKC---VLEDNKCSYFLSILAKLQTNPKLS 223
Query: 243 LQKFPNSSFVGNSLL 257
N NS +
Sbjct: 224 NLTLNNIETTWNSFI 238
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 30/220 (13%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVPL 436
+LGKGS+G K + VK + + +D +++E++ ++ HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKL 86
Query: 437 RAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVAH 491
+V + + G L + A R +K + G+ +
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-------IKQVFS---GITY 136
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRAPE 545
+H H ++K N+L+ C I DFGL+ +A Y APE
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
V+ + K DV+S GV+L +L+G P D++
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 61/253 (24%)
Query: 374 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 428
+LR LG GS+G + + +K L KE+VV + E ++ V
Sbjct: 9 QILR----TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV- 63
Query: 429 QHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----IL 482
HP ++ + + +++ ++ DY G L +LL R + R P K +
Sbjct: 64 THPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFP---NPVAKFYAAEVC 116
Query: 483 LGTARGVAHIHSMGGPKFTHGNI-----KASNVLINQDLDG--CISDFGLTPLMNVPA-- 533
L + ++HS +I K N+L+ D +G I+DFG +
Sbjct: 117 LA----LEYLHSK--------DIIYRDLKPENILL--DKNGHIKITDFGFAKYVPDVTYT 162
Query: 534 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM------- 583
TP Y APEV+ T+ ++ D +SFG+L+ EML G P
Sbjct: 163 LCGTPD----YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218
Query: 584 -VDLPRWVQSVVR 595
+ P + V+
Sbjct: 219 ELRFPPFFNEDVK 231
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 36/130 (27%), Positives = 52/130 (40%), Gaps = 14/130 (10%)
Query: 128 GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLVVLDL 184
G L L L L N L LP +LP+L L + N + +P +L L L
Sbjct: 74 GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131
Query: 185 SFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIP 240
N +P + +L LSL +NNL+ +P + + L L L N L +IP
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188
Query: 241 SSLQKFPNSS 250
F +
Sbjct: 189 KGF--FGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 34/125 (27%), Positives = 51/125 (40%), Gaps = 13/125 (10%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 181
+P +T +L L N+L + + L L L + P L
Sbjct: 29 LPKDT-------TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 182 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGS 238
LDLS N ++P Q L LT L + N L+ S+P + +L+ L L N LK +
Sbjct: 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-T 138
Query: 239 IPSSL 243
+P L
Sbjct: 139 LPPGL 143
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 37/111 (33%), Positives = 48/111 (43%), Gaps = 9/111 (8%)
Query: 129 KLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLS 185
L AL VL + N LT LP L L+ LYL+ N P + P+L L L+
Sbjct: 98 TLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156
Query: 186 FNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYN 233
N+ T +P + L L L LQ N+L +IP F L L N
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 24/96 (25%), Positives = 40/96 (41%), Gaps = 4/96 (4%)
Query: 154 LPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL 213
+ S + N + +P +L LS N ++ T+LT L+L L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 214 SGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+ + +P L L+LS+N L+ S+P Q P
Sbjct: 68 T-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPA 101
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 42/225 (18%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
EVLG G++ + + T +K + K E ++ ++ ++ +H N+V L
Sbjct: 15 EVLGSGAFSEVFLVK-QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLE 72
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR--VKILLGT 485
Y S LV + G L D + ++ +L
Sbjct: 73 DIYESTTHYYLVMQLVSGGEL--------------FDRILERGVYTEKDASLVIQQVLS- 117
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM--NVPATPSRSAG 540
V ++H G H ++K N+L + I+DFGL+ + + +T + G
Sbjct: 118 --AVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPG 172
Query: 541 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
Y APEV+ + +S D +S GV+ +L G P T + +
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE 217
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 30/144 (20%), Positives = 48/144 (33%), Gaps = 8/144 (5%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 181
I + L L N +T +++ L L NN + K+ + + QL
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLDLNQNIQLTF 216
Query: 182 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPS 241
LD S N T I + LTQLT N L+ + + KL L+ L +
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLLEIDLT 272
Query: 242 SLQKFPNSSFVGNSLLCGPPLKAC 265
+ G + +
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHN 296
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 31/140 (22%), Positives = 52/140 (37%), Gaps = 7/140 (5%)
Query: 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185
+ +L L L ++ +T + I L L L NN + + S + L L
Sbjct: 37 SEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLDLSQNTNLTYLACD 93
Query: 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 245
N T N+ + LT+LT L+ +N L+ + P L +LN + N L S +
Sbjct: 94 SNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARNTLTEIDVSHNTQ 149
Query: 246 FPNSSFVGNSLLCGPPLKAC 265
N + +
Sbjct: 150 LTELDCHLNKKITKLDVTPQ 169
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 28/120 (23%), Positives = 47/120 (39%), Gaps = 9/120 (7%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
+ + L L+ N LT +++ L L N K+ + QL LD SF
Sbjct: 123 VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSF 179
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP-SSLQK 245
N T + + L L+ +NN++ + +L L+ S N L I + L +
Sbjct: 180 NKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSNKLT-EIDVTPLTQ 234
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 25/131 (19%), Positives = 44/131 (33%), Gaps = 6/131 (4%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L L ++T L L Q + ++ S +P+LV L L+
Sbjct: 271 LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELDLSQNPKLVYLYLNN 327
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 246
T + + + T+L LS + ++ IP L + + +L
Sbjct: 328 TELT-ELD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQTITMPKETLTNN 384
Query: 247 PNSSFVGNSLL 257
+ V LL
Sbjct: 385 SLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 25/136 (18%), Positives = 44/136 (32%), Gaps = 4/136 (2%)
Query: 121 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 180
N D + + L +L L +++ + L
Sbjct: 8 TQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLT 67
Query: 181 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 240
L + N+ T + + T LT L+ SN L+ ++ + KL +LN N L
Sbjct: 68 KLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTNKLTKLDV 123
Query: 241 SSLQKFPNSSFVGNSL 256
S + N+L
Sbjct: 124 SQNPLLTYLNCARNTL 139
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 19/135 (14%), Positives = 39/135 (28%), Gaps = 10/135 (7%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L + L L L + LT L ++ L+ L + + P L +
Sbjct: 314 LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAE 370
Query: 187 NSFTGNIPQSIQNLTQLTG------LSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 240
+P+ LT L N ++ + + +++ L P
Sbjct: 371 GQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429
Query: 241 SSLQKFPNSSFVGNS 255
+ F + +
Sbjct: 430 AVTYTFTSENGAIVG 444
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 63/253 (24%), Positives = 102/253 (40%), Gaps = 67/253 (26%)
Query: 374 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 428
+ L VLGKGS+G + + + + VK L K+VV+ D E M ++ G
Sbjct: 23 NFLM----VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 429 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 483
+ P + L + + + D V +Y G L + GR E I +
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFK---EPHAVFYAAEIAI 132
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGL---------------- 525
G + + S G + ++K NV++ D +G I+DFG+
Sbjct: 133 G----LFFLQSKG---IIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGVTTKTFCG 183
Query: 526 TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-- 583
TP Y APE+I + + D ++FGVLL EML G+AP + D++
Sbjct: 184 TP------------DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231
Query: 584 ------VDLPRWV 590
V P+ +
Sbjct: 232 SIMEHNVAYPKSM 244
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 32/216 (14%), Positives = 70/216 (32%), Gaps = 25/216 (11%)
Query: 382 VLGKGSYGTAYKA----------VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGR----- 426
L +G + E+S + + K + + +
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 427 -VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGN---RGAGRTPLDWETRVKIL 482
++ + + DE ++Y+Y + S+ + + I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 483 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAG 540
++IH+ H ++K SN+L++++ +SDFG + M +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYE 215
Query: 541 YRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAP 574
+ PE + K D++S G+ L M P
Sbjct: 216 FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 55/229 (24%), Positives = 99/229 (43%), Gaps = 35/229 (15%)
Query: 374 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 428
+ L+ +LGKG++G + + +K L KEV+V K + + ++
Sbjct: 151 EYLK----LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS- 205
Query: 429 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 483
+HP + L+ + + D V +Y G L L R + E R + I+
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS------RERVFSEDRARFYGAEIVS 259
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPL-MNVPATPSRSAG 540
+ ++HS + ++K N+++ D DG I+DFGL + AT G
Sbjct: 260 A----LDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGATMKTFCG 311
Query: 541 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586
Y APEV+E + D + GV++ EM+ G+ P + + + +L
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 37/130 (28%), Positives = 54/130 (41%), Gaps = 15/130 (11%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNF-SGKIPSSFS--P 177
+ L +L+ L L L + L +L+ L + HN S K+P FS
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 178 QLVVLDLSFNSFTGNIPQSI-QNLTQLTG----LSLQSNNLSGSIPN--FDIPKLRHLNL 230
L LDLS N +I + + L Q+ L L N ++ I F +L+ L L
Sbjct: 150 NLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELAL 207
Query: 231 SYNGLKGSIP 240
N LK S+P
Sbjct: 208 DTNQLK-SVP 216
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 8e-14
Identities = 28/127 (22%), Positives = 45/127 (35%), Gaps = 18/127 (14%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQ 178
+P +T + L L N L S P L+ L L I +
Sbjct: 26 LPFST-------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 179 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FDIP-KLRHLNLSYNG 234
L L L+ N ++ L+ L L NL+ S+ N L+ LN+++N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 235 LKGSIPS 241
++ S
Sbjct: 136 IQ-SFKL 141
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 16/124 (12%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEIT--SLPSLRYLYLQHNNFSGKIPS-SFS-- 176
+ N +G L L+ L++ N++ +L +L +L L N I
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVL 172
Query: 177 PQLVV----LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDI-PKLRHLN 229
Q+ + LDLS N I +L L+L +N L S+P+ FD L+ +
Sbjct: 173 HQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIW 230
Query: 230 LSYN 233
L N
Sbjct: 231 LHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 5/74 (6%)
Query: 171 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 227
IP + LDLSFN S + +L L L + +I + + + L
Sbjct: 22 IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLST 80
Query: 228 LNLSYNGLKGSIPS 241
L L+ N ++ S+
Sbjct: 81 LILTGNPIQ-SLAL 93
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 62/267 (23%), Positives = 110/267 (41%), Gaps = 45/267 (16%)
Query: 346 EEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAE------VLGKGSYGTAYKAVLEES 399
+E + EKN L + E +R E V+G+G++G L+ +
Sbjct: 39 DECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA 98
Query: 400 TTVV-VKRL-KEVVVGKRDFEQQME---IVGRVGQHPNVVPLRAYYYSKDEKL-LVYDYF 453
V +K L K ++ + + E ++ + L Y + D L LV DY+
Sbjct: 99 DKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLH-YAFQDDNNLYLVMDYY 156
Query: 454 ASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKAS 508
G L TLL ++ R P E + +++ + +H + + H +IK
Sbjct: 157 VGGDLLTLL--SKFEDRLP---EEMARFYLAEMVIA----IDSVHQLH---YVHRDIKPD 204
Query: 509 NVLINQDLDG--CISDFGL-TPLMNVPATPSRSA-G---YRAPEVIETRKHSHKS----- 556
N+L+ D++G ++DFG LM S A G Y +PE+++ +
Sbjct: 205 NILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPEC 262
Query: 557 DVYSFGVLLLEMLTGKAPLQSPTRDDM 583
D +S GV + EML G+ P + + +
Sbjct: 263 DWWSLGVCMYEMLYGETPFYAESLVET 289
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 53/246 (21%)
Query: 374 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 428
L + +LGKGS+G + A +++ +K L K+VV+ D E M ++
Sbjct: 20 ILHK----MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 429 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 483
+HP + + + +K+ V +Y G L + + +R I+L
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFD---LSRATFYAAEIIL 129
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPA-------- 533
G + +HS G + ++K N+L+ D DG I+DFG+ N+
Sbjct: 130 G----LQFLHSKG---IVYRDLKLDNILL--DKDGHIKIADFGMCKE-NMLGDAKTNTFC 179
Query: 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------V 584
TP Y APE++ +K++H D +SFGVLL EML G++P +++
Sbjct: 180 GTPD----YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235
Query: 585 DLPRWV 590
PRW+
Sbjct: 236 FYPRWL 241
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 5e-16
Identities = 51/275 (18%), Positives = 114/275 (41%), Gaps = 29/275 (10%)
Query: 321 KKKDNGSNGVSKGKASSGGRSE-KPKEEFGSGVQEPEKNKLVFFEGCSYN--FDLEDLLR 377
+K+ G + +GK G + + + + + + V + +D+
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIH---- 162
Query: 378 ASAEVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVV 434
E LG G++G ++ E +T K + K ++++ + + +HP +V
Sbjct: 163 ---EELGTGAFGVVHRVT-ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLV 217
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
L + +E +++Y++ + G L + + + ++ + G+ H+H
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCK---GLCHMHE 273
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSR----SAGYRAPEVIE 548
+ H ++K N++ + DFGLT ++ P + +A + APEV E
Sbjct: 274 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAE 329
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 583
+ + +D++S GVL +L+G +P D+
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 364
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 44/203 (21%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
E LG G++G ++ V E++T V K + + K + ++ I+ ++ HP ++ L
Sbjct: 57 EELGSGAFGVVHRCV-EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLH 114
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ K E +L+ ++ + G L + + + ++ G+ H+H
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACE---GLKHMHEHS- 169
Query: 498 PKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSR----SAGYRAPEVIETRK 551
H +IK N++ + DFGL +N P + +A + APE+++
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDREP 226
Query: 552 HSHKSDVYSFGVLLLEMLTGKAP 574
+D+++ GVL +L+G +P
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSP 249
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-16
Identities = 33/131 (25%), Positives = 53/131 (40%), Gaps = 21/131 (16%)
Query: 130 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 189
+LE + +N+L E+ +LP L +Y +N +P P L L++ N
Sbjct: 214 PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLP-PSLEALNVRDNYL 269
Query: 190 TGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---------------FDIPKLRHLNLSYNG 234
T ++P+ Q+LT L + LS PN P L LN+S N
Sbjct: 270 T-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 328
Query: 235 LKGSIPSSLQK 245
L +P+ +
Sbjct: 329 LI-ELPALPPR 338
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 33/116 (28%), Positives = 53/116 (45%), Gaps = 9/116 (7%)
Query: 130 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 189
+LE ++ +N L LP E+ +LP L +Y +N+ K+P L + N
Sbjct: 172 PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK-KLPDLPL-SLESIVAGNNIL 227
Query: 190 TGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 245
+P +QNL LT + +N L ++P+ P L LN+ N L +P Q
Sbjct: 228 E-ELP-ELQNLPFLTTIYADNNLLK-TLPDL-PPSLEALNVRDNYLT-DLPELPQS 278
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-15
Identities = 28/132 (21%), Positives = 50/132 (37%), Gaps = 13/132 (9%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 185
L L+++ + +N L LP PSL ++ +N ++P P L +
Sbjct: 149 LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE-ELPELQNLPFLTAIYAD 203
Query: 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQ 244
NS +P +L + +N L +P ++P L + N LK ++P
Sbjct: 204 NNSLK-KLPDLPLSLESIV---AGNNILE-ELPELQNLPFLTTIYADNNLLK-TLPDLPP 257
Query: 245 KFPNSSFVGNSL 256
+ N L
Sbjct: 258 SLEALNVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 24/135 (17%), Positives = 49/135 (36%), Gaps = 14/135 (10%)
Query: 128 GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFN 187
+LE L++ +N L LP+ P L L N+ + ++P L L + +N
Sbjct: 314 DLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-EVPELPQ-NLKQLHVEYN 367
Query: 188 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFP 247
P +++ L+ N+ +P L+ L++ N L+ P +
Sbjct: 368 PLR-EFPDIPESVE-----DLRMNSHLAEVPEL-PQNLKQLHVETNPLR-EFPDIPESVE 419
Query: 248 NSSFVGNSLLCGPPL 262
+ ++
Sbjct: 420 DLRMNSERVVDPYEF 434
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 25/154 (16%), Positives = 41/154 (26%), Gaps = 35/154 (22%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSL-------------PSLRYLYLQHNNFS 168
+P + + + P L L + S
Sbjct: 26 MPVE-AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 169 GKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--------- 219
+P P L L S NS T +P+ Q+L L + LS P
Sbjct: 85 -SLPELP-PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNN 141
Query: 220 --------FDIPKLRHLNLSYNGLKGSIPSSLQK 245
+ L+ +++ N LK +P
Sbjct: 142 QLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS 174
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 35/126 (27%), Positives = 50/126 (39%), Gaps = 17/126 (13%)
Query: 124 NNTLGKLDA----LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 179
NN L L LE L++R N LT LP SL L + S P L
Sbjct: 246 NNLLKTLPDLPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLS-----ELPPNL 299
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 239
L+ S N ++ +L +L ++ +N L +P P+L L S+N L +
Sbjct: 300 YYLNASSNEIR-SLCDLPPSLEEL---NVSNNKLI-ELPA-LPPRLERLIASFNHLA-EV 352
Query: 240 PSSLQK 245
P Q
Sbjct: 353 PELPQN 358
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 23/133 (17%), Positives = 44/133 (33%), Gaps = 24/133 (18%)
Query: 130 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------------- 176
L+ S+ LT +P E ++ S Y + + P
Sbjct: 10 NTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 177 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSY 232
Q L+L+ + ++P+ +L L N+L+ +P + L N +
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 233 NGLKGSIPSSLQK 245
L +P L+
Sbjct: 124 KALS-DLPPLLEY 135
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 14/111 (12%), Positives = 34/111 (30%), Gaps = 23/111 (20%)
Query: 124 NNTLGKLDA----LEVLSLRSNVLTGGLPSEITSL----------------PSLRYLYLQ 163
N L ++ L+ L + N L P S+ +L+ L+++
Sbjct: 346 FNHLAEVPELPQNLKQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVE 404
Query: 164 HNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 214
N + P + L ++ + + +L + ++
Sbjct: 405 TNPLR-EFPDIPE-SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 8e-16
Identities = 46/229 (20%), Positives = 93/229 (40%), Gaps = 45/229 (19%)
Query: 382 VLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQME---IVGRVGQHPNVVPL 436
V+G+G++ ++++ V +K + K ++ + + E ++ + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQL 126
Query: 437 RAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARG 488
+++ + L LV +Y+ G L TLL ++ R P + I++
Sbjct: 127 ---HFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIP---AEMARFYLAEIVMA---- 174
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGL-TPLMNVPATPSRSA-G---Y 541
+ +H +G + H +IK N+L+ D G ++DFG L S A G Y
Sbjct: 175 IDSVHRLG---YVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 542 RAPEVIETRKHSHKSDVY-------SFGVLLLEMLTGKAPLQSPTRDDM 583
+PE+++ + Y + GV EM G+ P + + +
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 67/283 (23%), Positives = 109/283 (38%), Gaps = 65/283 (22%)
Query: 342 EKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLED--LLRASAEVLGKGSYGTAYKAVLEES 399
K KE+F + P +N L+ ++ LG GS+G +ES
Sbjct: 20 AKAKEDFLKKWETPSQNTA----------QLDQFDRIK----TLGTGSFGRVMLVKHKES 65
Query: 400 TTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDEKLL--VYDY 452
+K L K+ VV + E + I+ V P +V L + KD L V +Y
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKL--EFSFKDNSNLYMVMEY 122
Query: 453 FASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKA 507
A G + + L R GR E + I+L ++HS+ + ++K
Sbjct: 123 VAGGEMFSHL---RRIGRFS---EPHARFYAAQIVLT----FEYLHSLD---LIYRDLKP 169
Query: 508 SNVLINQDLDG--CISDFGLTPLMNVPA-----TPSRSAGYRAPEVIETRKHSHKSDVYS 560
N+LI D G ++DFG + TP APE+I ++ ++ D ++
Sbjct: 170 ENLLI--DQQGYIQVTDFGFAKRVKGRTWTLCGTPE----ALAPEIILSKGYNKAVDWWA 223
Query: 561 FGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVR 595
GVL+ EM G P + + V P S ++
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 9e-16
Identities = 49/207 (23%), Positives = 85/207 (41%), Gaps = 28/207 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 438
+G+GS+G AV + + K++ K V F+Q++EI+ + HPN++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYE 73
Query: 439 YYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVAHIH 493
+ + LV + G L + A R +K +L VA+ H
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-------MKDVLS---AVAYCH 123
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRAPEVI 547
+ H ++K N L D + DFGL + T + Y +P+V+
Sbjct: 124 KLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180
Query: 548 ETRKHSHKSDVYSFGVLLLEMLTGKAP 574
E + + D +S GV++ +L G P
Sbjct: 181 E-GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 38/218 (17%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKR-LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 438
+ G+G++GT + + V +K+ +++ R+ Q M+ + + HPN+V L++
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVL-HHPNIVQLQS 86
Query: 439 YYYSKDEK-------LLVYDYFASGSLSTLLH---GNRGAGRTPLDWETRVKILL-GTAR 487
Y+Y+ E+ +V +Y + LH N + +K+ L R
Sbjct: 87 YFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPIL-IKVFLFQLIR 140
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVPATP------SRS 538
+ +H H +IK NVL+N+ L C DFG + P+ P SR
Sbjct: 141 SIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLC--DFGSAKKL-SPSEPNVAYICSRY 196
Query: 539 AGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 575
YRAPE+I +H + D++S G + EM+ G+ P+
Sbjct: 197 --YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 56/264 (21%), Positives = 103/264 (39%), Gaps = 43/264 (16%)
Query: 367 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQMEIV 424
S++ ED+ + +VLG+G++ + ++ VK + K+ + +++E++
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64
Query: 425 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRV 479
+ H NV+ L ++ +D LV++ GS+ + A V
Sbjct: 65 YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-------V 117
Query: 480 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGL----------T 526
+ + + +H+ G H ++K N+L NQ I DF L +
Sbjct: 118 QDVAS---ALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 527 PLMNVP-ATPSRSAGYRAPEVIETRKHSHKS-----DVYSFGVLLLEMLTGKAPLQSPTR 580
P+ TP SA Y APEV+E D++S GV+L +L+G P
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231
Query: 581 DDMVDLPRWVQSVVREEWTAEVFD 604
D W + +F+
Sbjct: 232 SD----CGWDRGEACPACQNMLFE 251
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 35/129 (27%), Positives = 58/129 (44%), Gaps = 15/129 (11%)
Query: 122 IPNNTLGKLDA--LEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS- 176
N T L+A ++ L + + L + + L L L N + KI +F
Sbjct: 264 PDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWG 321
Query: 177 -PQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLS 231
L+ L+LS N +I + +NL +L L L N++ ++ + F +P L+ L L
Sbjct: 322 LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALD 379
Query: 232 YNGLKGSIP 240
N LK S+P
Sbjct: 380 TNQLK-SVP 387
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 33/146 (22%), Positives = 58/146 (39%), Gaps = 10/146 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 177
+ + +L L+ L + + + L SL L L +N F ++ + F+
Sbjct: 45 LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLA 103
Query: 178 QLVVLDLSFNSFTG-NIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSY 232
L VL L+ + G + + + LT L L L+ NN+ P F + + L+L++
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163
Query: 233 NGLKGSIPSSLQKFPNSSFVGNSLLC 258
N +K L F F L
Sbjct: 164 NKVKSICEEDLLNFQGKHFTLLRLSS 189
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 30/147 (20%), Positives = 51/147 (34%), Gaps = 23/147 (15%)
Query: 119 VGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS- 176
V +P + + L N + + + L L++L ++ I + +F
Sbjct: 25 VPELPAHV-------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRG 77
Query: 177 -PQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNL-SGSIPN--FD-IPKLRHLNL 230
L++L L +N F + L L L+L NL + F + L L L
Sbjct: 78 LSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136
Query: 231 SYNGLKGSIPSSLQKFPNSSFVGNSLL 257
N +K I P S F+
Sbjct: 137 RDNNIK-KIQ------PASFFLNMRRF 156
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 39/139 (28%), Positives = 50/139 (35%), Gaps = 17/139 (12%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGG-LPSEI-TSLPSLRYLYLQHNNFSGKIPSSF---S 176
+ L LEVL+L L G L L SL L L+ NN P+SF
Sbjct: 94 LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM 153
Query: 177 PQLVVLDLSFNSFTGNIPQSIQNLT--QLTGLSLQSNNL---------SGSIPNFD-IPK 224
+ VLDL+FN + + N T L L S L N
Sbjct: 154 RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS 213
Query: 225 LRHLNLSYNGLKGSIPSSL 243
+ L+LS NG K S+
Sbjct: 214 ITTLDLSGNGFKESMAKRF 232
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 29/158 (18%), Positives = 47/158 (29%), Gaps = 48/158 (30%)
Query: 129 KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------------ 176
+L ++ + + L S+ L L N F + F
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 177 -----------------------------PQLVVLDLSFNSFTGNIPQSI-QNLTQLTGL 206
+ DLS + + +S+ + T L L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 207 SLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPS 241
+L N ++ I + F + L LNLS N L SI S
Sbjct: 305 TLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDS 340
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 13/47 (27%), Positives = 24/47 (51%), Gaps = 2/47 (4%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNF 167
+ + + L L+ L+L +N L +P I L SL+ ++L N +
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 49/227 (21%), Positives = 93/227 (40%), Gaps = 54/227 (23%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVK----------RLKEVVVGKRDFEQQMEIVGRVG 428
E+LG+G + + + T VK +EV + ++++I+ +V
Sbjct: 23 EILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 429 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR 478
HPN++ L+ Y + LV+D G L D+ ETR
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGEL--------------FDYLTEKVTLSEKETR 127
Query: 479 --VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPA 533
++ LL + +H + H ++K N+L++ D++ ++DFG + +
Sbjct: 128 KIMRALLE---VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181
Query: 534 TPSRSAGYRAPEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ Y APE+IE + + D++S GV++ +L G P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 33/223 (14%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRL--KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
LG G++G + S V+K + V E ++E++ + HPN++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIF 86
Query: 438 AYYYSKDEKLLVYDYFASGSL------STLLHGN---RGAGRTPLDWETRVKILLGTARG 488
+ +V + G L + +K ++
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL-------MKQMMN---A 136
Query: 489 VAHIHSMGGPKFTHGNIKASNVL-INQDLDGCI--SDFGLTPLM---NVPATPSRSAGYR 542
+A+ HS H ++K N+L + I DFGL L + +A Y
Sbjct: 137 LAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYM 193
Query: 543 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
APEV + R + K D++S GV++ +LTG P + +++
Sbjct: 194 APEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 35/294 (11%), Positives = 76/294 (25%), Gaps = 75/294 (25%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQME----IVGRVGQHPNVV 434
G ++A+ + + V + + V D Q+ + R+ P V
Sbjct: 37 IFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVA 94
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
+ +++ L+V ++ GSL + T ++ + A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAHR 147
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSH 554
G S V ++ D D ++ P A P
Sbjct: 148 AG---VALSIDHPSRVRVSIDGDVVLAYPATMP----DANP------------------- 181
Query: 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL-----------PRWVQSVVREEWTAEVF 603
+ D+ G L +L + PL + P + + + +A
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA- 240
Query: 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRP 657
V +R ++ ++++
Sbjct: 241 ---------------------ARSVQGDGGIRSA-STLLNLMQQATAVADRTEV 272
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 2e-15
Identities = 50/227 (22%), Positives = 96/227 (42%), Gaps = 38/227 (16%)
Query: 374 DLLRASAEVLGKGSYGTAYKAVLEESTTVV--VKRL-KEVVVGKRDFEQQM---EIVGRV 427
+ R ++G+G +G Y + T + +K L K+ + K+ + ++ V
Sbjct: 192 SVHR----IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 428 --GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK----- 480
G P +V + +++ D+ + D G L L G E ++
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFS---EADMRFYAAE 300
Query: 481 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPATPSR- 537
I+LG + H+H+ + ++K +N+L+ D G ISD GL + +
Sbjct: 301 IILG----LEHMHNRF---VVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASV 351
Query: 538 -SAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 582
+ GY APEV++ + +D +S G +L ++L G +P + D
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 64/289 (22%), Positives = 107/289 (37%), Gaps = 73/289 (25%)
Query: 327 SNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKG 386
N +G SG EK + L F+ LLR V+G+G
Sbjct: 18 ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFD----------LLR----VIGRG 63
Query: 387 SYGTAYKAVLEESTTV----VVKRLKEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAY 439
SY L+++ + VVK KE+V D + + + HP +V L +
Sbjct: 64 SYAKVLLVRLKKTDRIYAMRVVK--KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHS 494
+ ++ V +Y G L + H R + P E + I L + ++H
Sbjct: 122 FQTESRLFFVIEYVNGGDL--MFHMQR-QRKLP---EEHARFYSAEISLA----LNYLHE 171
Query: 495 MGGPKFTHGNIKASNVLINQDLDG--CISDFGL----------------TPLMNVPATPS 536
G + ++K NVL+ D +G ++D+G+ TP
Sbjct: 172 RG---IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP--------- 217
Query: 537 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
Y APE++ + D ++ GVL+ EM+ G++P D D
Sbjct: 218 ---NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 38/127 (29%), Positives = 56/127 (44%), Gaps = 13/127 (10%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 177
+P +L LE L + N L LP + L +L L L N +P F
Sbjct: 76 LPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLT 133
Query: 178 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
+L L L +N ++P+ + LT L L L +N L +P FD + +L+ L L N
Sbjct: 134 KLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNN 191
Query: 234 GLKGSIP 240
LK +P
Sbjct: 192 QLK-RVP 197
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 40/127 (31%), Positives = 56/127 (44%), Gaps = 18/127 (14%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQ 178
IP +T + L L+SN L+ L LR LYL N +P+ F
Sbjct: 35 IPADT-------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 179 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 234
L L ++ N +P + L L L L N L S+P FD + KL +L+L YN
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144
Query: 235 LKGSIPS 241
L+ S+P
Sbjct: 145 LQ-SLPK 150
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 21/74 (28%), Positives = 34/74 (45%), Gaps = 5/74 (6%)
Query: 171 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 227
IPS+ LDL N + ++ LT+L L L N L ++P F + L
Sbjct: 31 IPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLET 89
Query: 228 LNLSYNGLKGSIPS 241
L ++ N L+ ++P
Sbjct: 90 LWVTDNKLQ-ALPI 102
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 28/94 (29%), Positives = 38/94 (40%), Gaps = 6/94 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 178
+P L L LSL N L LP + L SL+ L L +N +F +
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE 182
Query: 179 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSN 211
L L L N +P+ +L +L L LQ N
Sbjct: 183 LKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 46/215 (21%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 381 EVLGKGSYGTAYKAVLEEST-------TVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHP 431
E LG G + K E+ST + ++ + V + + E+++ I+ +V H
Sbjct: 18 EELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHH 75
Query: 432 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVA 490
NV+ L Y ++ + +L+ + + G L + A + L E + GV
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELF-----DFLAQKESLS-EEEATSFIKQILDGVN 129
Query: 491 HIHSMGGPKFTHGNIKASNVLI-NQDLDGC---ISDFGL-------TPLMNVPATPSRSA 539
++H+ H ++K N+++ ++++ + DFGL N+ TP
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP---- 182
Query: 540 GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ APE++ ++D++S GV+ +L+G +P
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 75/352 (21%), Positives = 122/352 (34%), Gaps = 98/352 (27%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 432
+ LG+G++G +A TV VK LKE R +++I+ +G H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 433 VVPLRAYYYSKDEKLLV-YDYFASGSLSTLLHGNRGA------------------GRTPL 473
VV L L+V ++ G+LST L R G P+
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 474 DWETRVKILLGT----------ARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGC- 519
D + R+ + + + ++ + P+ + + LI Q G
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 520 --------------------------ISDFGLTPLMNVPATPSRSAGYR------APEVI 547
I DFGL + R R APE I
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267
Query: 548 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEV 602
R ++ +SDV+SFGVLL E+ + G +P P + R ++ R + T E+
Sbjct: 268 FDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDYTTPEM 325
Query: 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654
+ ML C P RP E+V + + Q++++
Sbjct: 326 YQT--------------MLD----CWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 374 DLLRASAEVLGKGSYGTAYKAVLEESTTV----VVKRLKEVVVGKRDFEQQM---EIVGR 426
DLLR V+G+GSY L+++ + VVK KE+V D + + +
Sbjct: 12 DLLR----VIGRGSYAKVLLVRLKKTDRIYAMKVVK--KELVNDDEDIDWVQTEKHVFEQ 65
Query: 427 VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----I 481
HP +V L + + ++ V +Y G L + H R + P E + I
Sbjct: 66 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLP---EEHARFYSAEI 119
Query: 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPA------ 533
L + ++H G + ++K NVL+ D +G ++D+G+ P
Sbjct: 120 SLA----LNYLHERG---IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGDTTSTF 170
Query: 534 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
TP+ Y APE++ + D ++ GVL+ EM+ G++P D D
Sbjct: 171 CGTPN----YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 29/132 (21%), Positives = 49/132 (37%), Gaps = 13/132 (9%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSE--ITSLPSLRYLYLQHNNFSGKIPS-SF--- 175
I + L +L L+ L + + L P + S L + N + IP +F
Sbjct: 96 IDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154
Query: 176 SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD--IPKLRHLNLS 231
+ + L L N FT ++ N T+L + L N I F L++S
Sbjct: 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213
Query: 232 YNGLKGSIPSSL 243
+ ++PS
Sbjct: 214 QTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 23/130 (17%), Positives = 42/130 (32%), Gaps = 12/130 (9%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 177
IP++ L + + + +V L S +L + ++ +++ I P
Sbjct: 46 IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP 105
Query: 178 QLVVLDLSFNSFTGNIPQ--SIQNLTQLTGLSLQSNNLSGSIPN--FD--IPKLRHLNLS 231
L L + P + + L + N SIP F + L L
Sbjct: 106 LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164
Query: 232 YNGLKGSIPS 241
NG S+
Sbjct: 165 NNGFT-SVQG 173
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 26/117 (22%), Positives = 50/117 (42%), Gaps = 17/117 (14%)
Query: 149 SEITSLP-SLRYLYLQHNNFSGKIPS-SFS--PQLVVLDLSFNSFTGNIPQSI-QNLTQL 203
I SLP S + L L + IPS +FS P + + +S + + NL+++
Sbjct: 24 QRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKV 82
Query: 204 TGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 257
T + +++ I +P L+ L + G L+ FP+ + V ++ +
Sbjct: 83 THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTG--------LKMFPDLTKVYSTDI 131
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 8/93 (8%)
Query: 122 IPNNTLGKLDA-LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSP-- 177
IP N L L L +N T + + L +YL N + I +F
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
Query: 178 -QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSL 208
+LD+S S T +P ++L +L +
Sbjct: 205 SGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 46/225 (20%), Positives = 93/225 (41%), Gaps = 56/225 (24%)
Query: 381 EVLGKGSYGTAYKAVLEEST-------TVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHP 431
E LG G + K E+ST + ++ + V + + E+++ I+ +V HP
Sbjct: 18 EELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHP 75
Query: 432 NVVPLRAYYYSKDEKLLVYDY------F----ASGSLSTLLHGNRGAGRTPLDWETRVKI 481
N++ L Y ++ + +L+ + F SLS E
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS----------------EEEATS 119
Query: 482 LLGT-ARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGC---ISDFGL-------TPLM 529
+ GV ++H+ H ++K N++ +++++ + DFGL
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 530 NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
N+ TP + APE++ ++D++S GV+ +L+G +P
Sbjct: 177 NIFGTP----EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 50/226 (22%), Positives = 77/226 (34%), Gaps = 51/226 (22%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQM-------EI-VGRVGQ 429
+ GSYG V E V +KR+ V R EI +
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 430 HPNVVPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL- 483
HPN++ L + KL LV + + T L R + ++ +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVIS-PQHIQYFMY 141
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 540
G+ +H G H ++ N+L+ + D I DF L +R
Sbjct: 142 HILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNL----------AREDTADA 188
Query: 541 ----------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 575
YRAPE++ K K D++S G ++ EM K L
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-AL 233
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 30/128 (23%), Positives = 47/128 (36%), Gaps = 11/128 (8%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS---P 177
I ++ L +LE L L N L+ L S L SL +L L N + +S
Sbjct: 91 IEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT 149
Query: 178 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
+L +L + I + LT L L + +++L S I + HL L
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMK 208
Query: 234 GLKGSIPS 241
+
Sbjct: 209 QHI-LLLE 215
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 35/225 (15%), Positives = 65/225 (28%), Gaps = 32/225 (14%)
Query: 53 IVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLR 112
+ +L F L L L NP ++ + T++ LR
Sbjct: 112 LSNLSSSWFKPL--------------SSLTFL-NLLGNPY-KTLGETSLFSHLTKLQILR 155
Query: 113 LPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP 172
+ + I L LE L + ++ L P + S+ ++ +L L +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215
Query: 173 SSFS--PQLVVLDLSFNSFTGNIPQSIQ--------NLTQLTGLSLQSNNLSGSIPNFD- 221
+ L+L + + + +L + +
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQ 275
Query: 222 IPKLRHLNLSYNGLKGSIPSS-LQKFPNSSFV---GNSLLCGPPL 262
I L L S N LK S+P + + + N C P
Sbjct: 276 ISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 31/115 (26%), Positives = 44/115 (38%), Gaps = 8/115 (6%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN 192
+ + S S + + IPS + + LDLS N T
Sbjct: 9 WVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLTEAVKSLDLSNNRIT-Y 66
Query: 193 IPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSL 243
I S Q L L L SN ++ +I F + L HL+LSYN L ++ SS
Sbjct: 67 ISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW 119
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 6e-15
Identities = 31/117 (26%), Positives = 52/117 (44%), Gaps = 6/117 (5%)
Query: 121 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP-SLRYLYLQHNNFSGKIPSSFSPQL 179
+ +LE L + N L + S+ L L N +G + P++
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKV 452
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
VLDL N +IP+ + +L L L++ SN L S+P+ FD + L+++ L N
Sbjct: 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 32/133 (24%), Positives = 50/133 (37%), Gaps = 8/133 (6%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP---- 177
I + L+ NV T + ++L L+ L LQ N
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNM 402
Query: 178 -QLVVLDLSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 235
L LD+S NS ++ + L+L SN L+GS+ PK++ L+L N +
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRI 462
Query: 236 KGSIPSSLQKFPN 248
SIP +
Sbjct: 463 M-SIPKDVTHLQA 474
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 33/121 (27%), Positives = 45/121 (37%), Gaps = 17/121 (14%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
+P T + LSL N ++ +I+ L LR L L HN F L
Sbjct: 50 LPPRT-------KALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDL 102
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FD-IPKLRHLNLSYNGL 235
LD+S N NI + L L L N+ +P F + KL L LS
Sbjct: 103 EYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 236 K 236
+
Sbjct: 159 R 159
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 31/126 (24%), Positives = 56/126 (44%), Gaps = 11/126 (8%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---S 176
L L+ L L+ N L + ++ SL L + N+ + +
Sbjct: 368 SVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427
Query: 177 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNG 234
++VL+LS N TG++ + + ++ L L +N + SIP + L+ LN++ N
Sbjct: 428 ESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484
Query: 235 LKGSIP 240
LK S+P
Sbjct: 485 LK-SVP 489
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 37/251 (14%), Positives = 78/251 (31%), Gaps = 21/251 (8%)
Query: 18 LGLHFCYSSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLP-LAFADLNSDRQALLDFAD 76
+ + L IP L + F + + + V+ L L +++ + +
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240
Query: 77 AV------PHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPI----PNNT 126
+ P L + + V + V L + + + I +
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS 300
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLD 183
L +L + +++ V + + + L ++ + I L+
Sbjct: 301 ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD-TPFIHMVCPPSPSSFTFLN 359
Query: 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-FDIP----KLRHLNLSYNGLKGS 238
+ N FT ++ Q L +L L LQ N L + + L L++S N L
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSH 418
Query: 239 IPSSLQKFPNS 249
+ S
Sbjct: 419 AYDRTCAWAES 429
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 22/90 (24%), Positives = 38/90 (42%), Gaps = 6/90 (6%)
Query: 156 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
+ + N + +P P+ L LS NS + I L++L L L N +
Sbjct: 32 LESMVDYSNRNLT-HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR- 89
Query: 216 SIPN--FD-IPKLRHLNLSYNGLKGSIPSS 242
S+ F L +L++S+N L+ +I
Sbjct: 90 SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC 118
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 7/83 (8%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 190
+ VL+L SN+LTG + + P ++ L L +N IP + L L+++ N
Sbjct: 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486
Query: 191 GNIPQSI-QNLTQLTGLSLQSNN 212
++P + LT L + L N
Sbjct: 487 -SVPDGVFDRLTSLQYIWLHDNP 508
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 41/202 (20%), Positives = 86/202 (42%), Gaps = 18/202 (8%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 438
E LG+G +G ++ V E S+ T + K +K + ++++ I+ H N++ L
Sbjct: 11 EDLGRGEFGIVHRCV-ETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHE 68
Query: 439 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 498
+ S +E ++++++ + + + + + V + + +HS
Sbjct: 69 SFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCE---ALQFLHSHN-- 122
Query: 499 KFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKH 552
H +I+ N++ I +FG + P R + Y APEV +
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 553 SHKSDVYSFGVLLLEMLTGKAP 574
S +D++S G L+ +L+G P
Sbjct: 181 STATDMWSLGTLVYVLLSGINP 202
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 6e-15
Identities = 53/218 (24%), Positives = 83/218 (38%), Gaps = 46/218 (21%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EIVG-RVGQHP 431
+ +G G+ G A V +K+L F+ Q E+V + H
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHK 121
Query: 432 NVVPLRAYYYSKDEKLLVYD-YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
N++ L + + D Y + L + LD E +L G+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIK 178
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---------- 540
H+HS G H ++K SN+++ D I DFGL +R+AG
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL----------ARTAGTSFMMTPYVV 225
Query: 541 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
YRAPEVI + D++S G ++ EM+ K L
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK-IL 262
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 36/123 (29%), Positives = 48/123 (39%), Gaps = 8/123 (6%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L + L L N L S I L S++ L L + P + L VL L
Sbjct: 81 LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 245
N T NI + LT L LS+ + +S + + KL L N + I S L
Sbjct: 139 NQIT-NIS-PLAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDNKIS-DI-SPLAS 193
Query: 246 FPN 248
PN
Sbjct: 194 LPN 196
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 24/123 (19%), Positives = 48/123 (39%), Gaps = 8/123 (6%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
+ L+ L L L+ N +T + + +L + L L N + + LDL+
Sbjct: 59 VQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTS 116
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 245
T P + L+ L L L N ++ +I + L++L++ + + + L
Sbjct: 117 TQITDVTP--LAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQVS-DL-TPLAN 171
Query: 246 FPN 248
Sbjct: 172 LSK 174
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 31/123 (25%), Positives = 49/123 (39%), Gaps = 6/123 (4%)
Query: 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185
T LD + LS +T + L +L L L+ N + P ++ L+LS
Sbjct: 36 TQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELS 93
Query: 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 245
N N+ +I L + L L S ++ P + L+ L L N + +I S L
Sbjct: 94 GNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQIT-NI-SPLAG 149
Query: 246 FPN 248
N
Sbjct: 150 LTN 152
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 29/123 (23%), Positives = 53/123 (43%), Gaps = 8/123 (6%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
+ L +++ L L S +T + + L +L+ LYL N + P + L L +
Sbjct: 103 IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGN 160
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQK 245
+ ++ + NL++LT L N +S I +P L ++L N + + S L
Sbjct: 161 AQVS-DLT-PLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQIS-DV-SPLAN 215
Query: 246 FPN 248
N
Sbjct: 216 TSN 218
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 28/128 (21%), Positives = 50/128 (39%), Gaps = 4/128 (3%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L L+VL L N +T S + L +L+YL + + S P + +L L
Sbjct: 125 LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 246
N + +I + +L L + L++N +S P + L + L+ +
Sbjct: 183 NKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQPVFYNNNL 240
Query: 247 PNSSFVGN 254
+ V
Sbjct: 241 VVPNVVKG 248
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 25/137 (18%), Positives = 48/137 (35%), Gaps = 15/137 (10%)
Query: 120 GPIPNNT-------LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP 172
G I T L ++ + +T L + L +
Sbjct: 1 GSITQPTAINVIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEG 58
Query: 173 SSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLS 231
+ L+ L+L N T ++ ++NLT++T L L N L ++ + ++ L+L+
Sbjct: 59 VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLT 115
Query: 232 YNGLKGSIPSSLQKFPN 248
+ P L N
Sbjct: 116 STQITDVTP--LAGLSN 130
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 24/107 (22%), Positives = 41/107 (38%), Gaps = 2/107 (1%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L L L N ++ S + SLP+L ++L++N S P + + L ++ L+
Sbjct: 169 LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 233
+ T NL + S D NL++N
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN 273
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 18/94 (19%), Positives = 38/94 (40%), Gaps = 7/94 (7%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L L + L++N ++ S + + +L + L + + P ++ LVV ++
Sbjct: 191 LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVK 247
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF 220
I T + S NL+ ++ +F
Sbjct: 248 G----PSGAPIAPATISDNGTYASPNLTWNLTSF 277
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 62/293 (21%), Positives = 107/293 (36%), Gaps = 72/293 (24%)
Query: 339 GRSEKPKEEFGSGVQEPE---KNKLVFFEGCSYNFDLED--LLRASAEVLGKGSYGTAYK 393
G S+ + E + P ++ + + D L+ V+GKGS+G
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLK----VIGKGSFGKVLL 56
Query: 394 AVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDEKLL 448
A + VK L K+ ++ K++ + M ++ + +HP +V L + + D+
Sbjct: 57 ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116
Query: 449 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHG 503
V DY G L L E R + I + ++HS+ +
Sbjct: 117 VLDYINGGELFYHLQR---ERCFL---EPRARFYAAEIASA----LGYLHSLN---IVYR 163
Query: 504 NIKASNVLINQDLDG--CISDFGL----------------TPLMNVPATPSRSAGYRAPE 545
++K N+L+ D G ++DFGL TP Y APE
Sbjct: 164 DLKPENILL--DSQGHIVLTDFGLCKENIEHNSTTSTFCGTP------------EYLAPE 209
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 590
V+ + + D + G +L EML G P S +M + L +
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI 262
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 57/241 (23%), Positives = 102/241 (42%), Gaps = 44/241 (18%)
Query: 374 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 428
D L+ +LGKG++G + + +K L KEV++ K + + ++
Sbjct: 8 DYLK----LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT- 62
Query: 429 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 483
+HP + L+ + + D V +Y G L H +R E R + I+
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFT---EERARFYGAEIVS 116
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPL-MNVPATPSRSAG 540
+ ++HS + +IK N+++ D DG I+DFGL ++ AT G
Sbjct: 117 A----LEYLHSRD---VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 541 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRW 589
Y APEV+E + D + GV++ EM+ G+ P + + + + PR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 227
Query: 590 V 590
+
Sbjct: 228 L 228
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 56/225 (24%)
Query: 381 EVLGKGSYGTAYKAVLEEST-------TVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHP 431
E LG G + K E+ST + +R K V + D E+++ I+ + QHP
Sbjct: 17 EELGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHP 74
Query: 432 NVVPLRAYYYSKDEKLLVYDY------F----ASGSLSTLLHGNRGAGRTPLDWETRVKI 481
NV+ L Y +K + +L+ + F SL+ E
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT----------------EEEATE 118
Query: 482 LLGT-ARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGC---ISDFGL-------TPLM 529
L GV ++HS+ H ++K N++ +++++ I DFGL
Sbjct: 119 FLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 530 NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
N+ TP + APE++ ++D++S GV+ +L+G +P
Sbjct: 176 NIFGTP----EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 42/222 (18%), Positives = 91/222 (40%), Gaps = 50/222 (22%)
Query: 381 EVLGKGSYGTAYKAVLEEST-------TVVVKRL--KEVVVGKRDFEQQMEIVGRVGQHP 431
E LG G + K ++ T + +RL V + + E+++ I+ + +HP
Sbjct: 11 EELGSGQFAIVRKCR-QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHP 68
Query: 432 NVVPLRAYYYSKDEKLLVYDY------F----ASGSLSTLLHGNRGAGRTPLDWETRVKI 481
N++ L + +K + +L+ + F SL+ E
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT----------------EDEATQ 112
Query: 482 LLGT-ARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGC---ISDFGLTPLMNVPATPS 536
L GV ++HS H ++K N++ +++++ + DFG+ +
Sbjct: 113 FLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEF 168
Query: 537 R----SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ + + APE++ ++D++S GV+ +L+G +P
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 26/211 (12%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQQ---------MEIVGRVGQ 429
+LGKG +GT + L + V +K + + V+G + VG G
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGS-LSTLLHGNRGAGRTPLDWETRVKILLGTARG 488
HP V+ L ++ +++ +LV + L + G +R
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEG-PSR-CFFGQVVAA 151
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLM--NVPATPSRSAGYRAP 544
+ H HS G H +IK N+LI+ GC + DFG L+ + Y P
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLR-RGCAKLIDFGSGALLHDEPYTDFDGTRVYSPP 207
Query: 545 EVIETRK-HSHKSDVYSFGVLLLEMLTGKAP 574
E I + H+ + V+S G+LL +M+ G P
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 32/210 (15%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGK--RDFEQQMEIVGRVGQHPNVVP 435
+LGKGS+G K + T VK + K K +++E++ ++ HPN++
Sbjct: 28 CMLGKGSFGEVLKCK-DRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMK 85
Query: 436 LRAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVA 490
L +V + + G L + A R +K + G+
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-------IKQVFS---GIT 135
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMN---VPATPSRSAGYRAP 544
++H H ++K N+L+ C I DFGL+ +A Y AP
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 545 EVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
EV+ + K DV+S GV+L +L+G P
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 67/291 (23%), Positives = 112/291 (38%), Gaps = 64/291 (21%)
Query: 321 KKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLED--LLRA 378
G+ G S G + K E + K+ +E+ LL+
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKV----------GIENFELLK- 60
Query: 379 SAEVLGKGSYGTAYKAVLEESTTVVVKRL-------KEVVVGK-RDFEQQM---EIVGRV 427
VLG G+YG + + + +L K +V K + E +++ +
Sbjct: 61 ---VLGTGAYGKVFLV--RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 428 GQHPNVVPLRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---- 480
Q P +V L +Y+ + KL L+ DY G L T L R E V+
Sbjct: 116 RQSPFLVTL---HYAFQTETKLHLILDYINGGELFTHL---SQRERFT---EHEVQIYVG 166
Query: 481 -ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLT-PLMNVPATPS 536
I+L + H+H +G + +IK N+L+ D +G ++DFGL+ + +
Sbjct: 167 EIVLA----LEHLHKLG---IIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERA 217
Query: 537 RS----AGYRAPEVIETRKHSHKSDV--YSFGVLLLEMLTGKAPLQSPTRD 581
Y AP+++ H V +S GVL+ E+LTG +P
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 61/248 (24%), Positives = 99/248 (39%), Gaps = 54/248 (21%)
Query: 374 DLLRASAEVLGKGSYGT---AYKAVLEESTTVV-VKRL-KEVVVGK-RDFEQQM---EIV 424
+LLR VLGKG YG K + + +K L K ++V +D I+
Sbjct: 20 ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 425 GRVGQHPNVVPLRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK- 480
V +HP +V L Y+ KL L+ +Y + G L L G E
Sbjct: 76 EEV-KHPFIVDL---IYAFQTGGKLYLILEYLSGGELFMQLER---EGIFM---EDTACF 125
Query: 481 ----ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPAT 534
I + + H+H G + ++K N+++ + G ++DFGL T
Sbjct: 126 YLAEISMA----LGHLHQKG---IIYRDLKPENIML--NHQGHVKLTDFGLCKESIHDGT 176
Query: 535 PSRS----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM------- 583
+ + Y APE++ H+ D +S G L+ +MLTG P R
Sbjct: 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
Query: 584 -VDLPRWV 590
++LP ++
Sbjct: 237 KLNLPPYL 244
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 46/258 (17%), Positives = 83/258 (32%), Gaps = 60/258 (23%)
Query: 381 EVLGKGSYGTAYKAVLEEST-------TVVVKRLKEVVVGKR-DFEQQMEIVGRVGQHPN 432
+G+GSYG A+ E T + +++++ + ++ ++ ++ HPN
Sbjct: 32 GAIGQGSYGVVRVAI-ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPN 89
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTAR--- 487
+ L Y + LV + G L L + G+ +D
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 488 ------------------------------GVAHIHSMGGPKFTHGNIKASNVLINQDLD 517
+ ++H+ G H +IK N L + +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKS 206
Query: 518 GC--ISDFGLTPLMNVPATPSR--------SAGYRAPEVIE--TRKHSHKSDVYSFGVLL 565
+ DFGL+ + + APEV+ + K D +S GVLL
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 566 LEMLTGKAPLQSPTRDDM 583
+L G P D
Sbjct: 267 HLLLMGAVPFPGVNDADT 284
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVK---------RLKEVVVGKRDFEQQMEIVGRVGQ 429
+ LG G+ G A E T V ++ + E ++EI+ ++
Sbjct: 141 KTLGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-N 198
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
HP ++ ++ ++ ++D +V + G L ++ G L T V
Sbjct: 199 HPCIIKIKNFFDAED-YYIVLELMEGGELF-----DKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRA 543
++H G H ++K NVL++ + C I+DFG + ++ ++ T + Y A
Sbjct: 253 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 544 PEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAP 574
PEV+ T ++ D +S GV+L L+G P
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 383 LGKGSYGTAYKAVLEESTT---VVVKRLKEVVVGKRDFEQQMEIVG-RVGQHPNVVPLR- 437
+G+G+YG YKA ++ +K+++ + EI R +HPNV+ L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQK 85
Query: 438 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDW---ETRVK-ILLGTARGVAHI 492
+ D K+ L++DY A L ++ +R + VK +L G+ ++
Sbjct: 86 VFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 493 HSMGGPKFTHGNIKASNVLINQDLD--GC--ISDFGLTPLMNVPATPSRSAG-------Y 541
H+ H ++K +N+L+ + G I+D G L N P P Y
Sbjct: 145 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 542 RAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
RAPE++ R ++ D+++ G + E+LT + P+
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 235
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 43/219 (19%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 371 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTV-----VVKRLKEVVVGKRDFEQQMEIVG 425
+ + +++ LG+G + + + +ST +K+ + + + ++ ++
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCI-SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83
Query: 426 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 485
P V+ L Y + E +L+ +Y A G + +L + D +K +L
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE- 142
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGCI--SDFGL-------TPLMNVPATP 535
GV ++H H ++K N+L + G I DFG+ L + TP
Sbjct: 143 --GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 536 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
Y APE++ + +D+++ G++ +LT +P
Sbjct: 198 ----EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 3e-14
Identities = 33/137 (24%), Positives = 58/137 (42%), Gaps = 17/137 (12%)
Query: 124 NNTLGKLDA----LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 179
N L L LE L N L+ LP SL++L + +N + +P + L
Sbjct: 89 QNALISLPELPASLEYLDACDNRLST-LPELP---ASLKHLDVDNNQLT-MLPELPA-LL 142
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 239
++ N T +P+ +L L S+++N L+ +P L L++S N L+ S+
Sbjct: 143 EYINADNNQLT-MLPELPTSLEVL---SVRNNQLT-FLPEL-PESLEALDVSTNLLE-SL 195
Query: 240 PSSLQKFPNSSFVGNSL 256
P+ + +S
Sbjct: 196 PAVPVRNHHSEETEIFF 212
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 33/166 (19%), Positives = 53/166 (31%), Gaps = 14/166 (8%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN 192
LE ++ +N LT LP TSL L +++N + +P L LD+S N +
Sbjct: 142 LEYINADNNQLTM-LPELPTSL---EVLSVRNNQLT-FLPELPE-SLEALDVSTNLLE-S 194
Query: 193 IPQSIQNLTQLT----GLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKF 246
+P + N ++ IP + + L N L I SL +
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253
Query: 247 PNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKL 292
+ P F KQS ++
Sbjct: 254 TAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 22/123 (17%), Positives = 38/123 (30%), Gaps = 7/123 (5%)
Query: 123 PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVL 182
P N L + S S N + Q L
Sbjct: 6 PINNNFSLSQNSFYNTISGTY-ADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 242
L+ + + ++P ++ Q+T L + N L S+P L +L+ N L ++P
Sbjct: 65 QLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPE-LPASLEYLDACDNRLS-TLPEL 118
Query: 243 LQK 245
Sbjct: 119 PAS 121
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 18/98 (18%), Positives = 29/98 (29%), Gaps = 5/98 (5%)
Query: 126 TLGKLDALE----VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 181
+ E R N +T +P I SL + L+ N S +I S S Q
Sbjct: 198 VPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256
Query: 182 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 219
D ++ QN + + +
Sbjct: 257 PDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 53/286 (18%), Positives = 104/286 (36%), Gaps = 60/286 (20%)
Query: 321 KKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASA 380
+ + K + F S E E + +D +
Sbjct: 47 DPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPK------- 99
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVKRLK---------EVVVGKRDFEQQMEIVGRVGQ 429
+V+G+G + V +T VK ++ ++ + ++ I+ +V
Sbjct: 100 DVIGRGVSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR- 478
HP+++ L Y S LV+D G L D+ ETR
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGEL--------------FDYLTEKVALSEKETRS 204
Query: 479 -VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPAT 534
++ LL V+ +H+ H ++K N+L++ ++ +SDFG + +
Sbjct: 205 IMRSLLE---AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE 258
Query: 535 PSRSAGYRAPEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAP 574
+ GY APE+++ + + D+++ GV+L +L G P
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 59/246 (23%), Positives = 105/246 (42%), Gaps = 42/246 (17%)
Query: 361 VFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV--VKRL-KEVVVGKRDF 417
VF E NFD ++LR +GKGS+G V + T + +K + K+ V + +
Sbjct: 5 VFDENEDVNFDHFEILR----AIGKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVERNEV 59
Query: 418 EQQM---EIVGRVGQHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPL 473
+I+ + +HP +V L Y + +E + +V D G L L +
Sbjct: 60 RNVFKELQIMQGL-EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFK- 113
Query: 474 DWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLT 526
E VK +++ + ++ + H ++K N+L+ D G I+DF +
Sbjct: 114 --EETVKLFICELVMA----LDYLQNQR---IIHRDMKPDNILL--DEHGHVHITDFNIA 162
Query: 527 PLMNVPATPSRSAG---YRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTR 580
++ + AG Y APE+ +RK +S D +S GV E+L G+ P +
Sbjct: 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222
Query: 581 DDMVDL 586
++
Sbjct: 223 TSSKEI 228
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 53/262 (20%), Positives = 101/262 (38%), Gaps = 40/262 (15%)
Query: 331 SKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT 390
A ++ P Q K+ L + + D + +++VLG G G
Sbjct: 23 PPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKN-----AIIDDYKVTSQVLGLGINGK 77
Query: 391 AYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY----YSKDE 445
+ + + +K L++ +++E+ R Q P++V + Y +
Sbjct: 78 VLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 446 KLLVYDYFASGSL--STLLHGN-----RGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 498
L+V + G L G+ R A +K + + ++HS+
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEI-------MKSIGEA---IQYLHSIN-- 181
Query: 499 KFTHGNIKASNVL-INQDLDGC--ISDFGL---TPLMNVPATPSRSAGYRAPEVIETRKH 552
H ++K N+L ++ + ++DFG T N TP + Y APEV+ K+
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
Query: 553 SHKSDVYSFGVLLLEMLTGKAP 574
D++S GV++ +L G P
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPP 262
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 38/211 (18%), Positives = 78/211 (36%), Gaps = 25/211 (11%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVV--------KRLKEVVVGKRDFEQQMEIVGRVGQHPN 432
EV+GKG + + + T K + D +++ I + HP+
Sbjct: 30 EVIGKGPFSVVRRCI-NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPH 87
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSL--STLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
+V L Y S +V+++ L + + G + ++ +L +
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE---ALR 144
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMNVPATPSR----SAGYRA 543
+ H H ++K VL+ + + FG+ + + + + A
Sbjct: 145 YCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 544 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
PEV++ + DV+ GV+L +L+G P
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 38/217 (17%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQQM--EI-VGRVGQHPNVVP 435
++LG+GSYG + + E VK L K+ + + E + EI + R +H NV+
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 436 LR--AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR------ 487
L Y K + +V +Y + +L D + + A
Sbjct: 71 LVDVLYNEEKQKMYMVMEY-CVCGMQEML-----------DSVPEKRFPVCQAHGYFCQL 118
Query: 488 --GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSA 539
G+ ++HS G H +IK N+L+ IS G+ ++ A T S
Sbjct: 119 IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 540 GYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAP 574
++ PE+ K D++S GV L + TG P
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 53/218 (24%), Positives = 83/218 (38%), Gaps = 46/218 (21%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQM-------EIVG-RVGQHP 431
+ +G G+ G A V +K+L F+ Q E+V + H
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHK 84
Query: 432 NVVPLRAYYYSKDEKLLVYD-YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
N++ L + + D Y + L + LD E +L G+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIK 141
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---------- 540
H+HS G H ++K SN+++ D I DFGL +R+AG
Sbjct: 142 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL----------ARTAGTSFMMTPYVV 188
Query: 541 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
YRAPEVI + D++S G ++ EM+ G L
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-VL 225
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-14
Identities = 29/126 (23%), Positives = 51/126 (40%), Gaps = 17/126 (13%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 178
IP T L L +N T + I LP LR + +N + +F
Sbjct: 30 IPQYT-------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 179 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 234
+ + L+ N N+ + + L L L L+SN ++ + N F + +R L+L N
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 235 LKGSIP 240
+ ++
Sbjct: 141 IT-TVA 145
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 28/130 (21%), Positives = 43/130 (33%), Gaps = 10/130 (7%)
Query: 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSG 169
LRL KL L ++ +N +T + + + L N
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLEN 95
Query: 170 KIPSSFS--PQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IP 223
F L L L N T + L+ + LSL N ++ ++ FD +
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLH 153
Query: 224 KLRHLNLSYN 233
L LNL N
Sbjct: 154 SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 17/77 (22%), Positives = 32/77 (41%), Gaps = 6/77 (7%)
Query: 171 IPSSFSPQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLR 226
IP L L+ N FT I + L QL ++ +N ++ I F+ +
Sbjct: 26 IPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVN 84
Query: 227 HLNLSYNGLKGSIPSSL 243
+ L+ N L+ ++ +
Sbjct: 85 EILLTSNRLE-NVQHKM 100
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 48/222 (21%), Positives = 84/222 (37%), Gaps = 32/222 (14%)
Query: 381 EVLGKGSYGTAYKAVLEESTTV-----VVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP 435
E LGKG++ + V + ++ K + E++ I + +HPN+V
Sbjct: 17 EELGKGAFSVVRRCV-KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVR 74
Query: 436 LRAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVA 490
L + L++D G L + A ++ +L V
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-------IQQILE---AVL 124
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDG---CISDFGLTPLMNVPATPSR----SAGYRA 543
H H MG H N+K N+L+ L G ++DFGL + + GY +
Sbjct: 125 HCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181
Query: 544 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
PEV+ + D+++ GV+L +L G P + +
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM------EI-VGRVGQHPNV 433
E LG G+Y T YK + + + V LKEV K D E+ EI + + +H N+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVA--LKEV---KLDSEEGTPSTAIREISLMKELKHENI 65
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLL-HGNRGAGRTPLDWETRVKILLGTARGVAHI 492
V L +++++ LV+++ + L + G L+ +G+A
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG-----YRAPE 545
H H ++K N+LIN+ G + DFGL +P + S+ YRAP+
Sbjct: 125 HENK---ILHRDLKPQNLLINK--RGQLKLGDFGLARAFGIP-VNTFSSEVVTLWYRAPD 178
Query: 546 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
V+ +R +S D++S G +L EM+TGK
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 47/208 (22%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
LG+G Y ++A+ + + VVVK LK V K+ +++++I+ + PN++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADI 99
Query: 440 YYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ LV+++ + L L + + + + HSMG
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG- 150
Query: 498 PKFTHGNIKASNVLINQDL-DGCISDFGL------TPLMNVPATPSRSAG--YRAPEVIE 548
H ++K NV+I+ + + D+GL NV R A ++ PE++
Sbjct: 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV-----RVASRYFKGPELLV 203
Query: 549 TRKHSHKS-DVYSFGVLLLEMLTGKAPL 575
+ S D++S G +L M+ K P
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 61/226 (26%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVG------------RVG 428
E +G+G+YG YKA + V +KR++ + + E G +
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR--------LDAEDE--GIPSTAIREISLLKEL 76
Query: 429 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TAR 487
HPN+V L +S+ LV+++ L +L N+ L ++++KI L R
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT----GLQ-DSQIKIYLYQLLR 130
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG----- 540
GVAH H H ++K N+LIN DG ++DFGL +R+ G
Sbjct: 131 GVAHCHQHR---ILHRDLKPQNLLINS--DGALKLADFGL----------ARAFGIPVRS 175
Query: 541 ---------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
YRAP+V+ ++K+S D++S G + EM+TGK
Sbjct: 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 49/210 (23%), Positives = 82/210 (39%), Gaps = 26/210 (12%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQQM------EI-VGRVGQHP 431
LG G++G + AV E++ VVVK + KE V+ E EI + +H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 432 NVVPLRAYYYSKDEKLLVYDYFASGS-LSTLL--HGNRGAGRTPLDWETRVKILLGTARG 488
N++ + + ++ LV + SG L + H LD I
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-------LDEPLASYIFRQLVSA 142
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPE 545
V ++ H +IK N++I +D + DFG + G Y APE
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE 199
Query: 546 VIETRK-HSHKSDVYSFGVLLLEMLTGKAP 574
V+ + +++S GV L ++ + P
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 64/266 (24%), Positives = 103/266 (38%), Gaps = 46/266 (17%)
Query: 346 EEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAE------VLGKGSYGTAYKAVLEES 399
+ KN F + LR AE V+G+G++G + +
Sbjct: 34 YDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST 93
Query: 400 TTVV-VKRL-KEVVVGKRDFEQQME---IVGRVGQHPNVVPLRAYYYSKDEKL-LVYDYF 453
V +K L K ++ + D E I+ P VV L Y + D L +V +Y
Sbjct: 94 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLF-YAFQDDRYLYMVMEYM 151
Query: 454 ASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKAS 508
G L L+ P E + ++L + IHSMG F H ++K
Sbjct: 152 PGGDLVNLMS----NYDVP---EKWARFYTAEVVLA----LDAIHSMG---FIHRDVKPD 197
Query: 509 NVLINQDLDG--CISDFGL-TPLMNVPATPSRSA-G---YRAPEVIETR----KHSHKSD 557
N+L+ D G ++DFG + +A G Y +PEV++++ + + D
Sbjct: 198 NMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 558 VYSFGVLLLEMLTGKAPLQSPTRDDM 583
+S GV L EML G P + +
Sbjct: 256 WWSVGVFLYEMLVGDTPFYADSLVGT 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 53/221 (23%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVP 435
E LGKG++ + V ++T K + + RDF+ ++ I ++ QHPN+V
Sbjct: 12 EELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVR 69
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR--VKILL 483
L + LV+D G L + + ++ +L
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGEL--------------FEDIVAREFYSEADASHCIQQIL 115
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGL-------TPLMNVPA 533
+A+ HS G H N+K N+L+ G ++DFGL
Sbjct: 116 E---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
TP GY +PEV++ +S D+++ GV+L +L G P
Sbjct: 170 TP----GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 46/152 (30%), Positives = 62/152 (40%), Gaps = 20/152 (13%)
Query: 123 PNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS--PQ 178
T +L L L L N L + SE +P+LRYL L N+ + FS
Sbjct: 56 AEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQA 113
Query: 179 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD----IPKLRHLNLS 231
L VL L N + ++ +++ QL L L N +S P +PKL L+LS
Sbjct: 114 LEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLS 171
Query: 232 YNGLKGSIPSSLQKFPNSSFV-----GNSLLC 258
N LK + LQK P N L C
Sbjct: 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 31/124 (25%), Positives = 46/124 (37%), Gaps = 15/124 (12%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS--P 177
I + + L L L SN L L + + L +L L L +N+ + +F
Sbjct: 79 ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMA 136
Query: 178 QLVVLDLSFNSFTGNIP----QSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNL 230
QL L LS N + P + L +L L L SN L +P +P L
Sbjct: 137 QLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGL 194
Query: 231 SYNG 234
+
Sbjct: 195 YLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 26/91 (28%), Positives = 37/91 (40%), Gaps = 13/91 (14%)
Query: 171 IPSSFSPQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLR 226
+P S +LDLS N+ + + LT L L L N+L+ I + F +P LR
Sbjct: 33 VPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLR 91
Query: 227 HLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 257
+L+LS N L F L
Sbjct: 92 YLDLSSN--------HLHTLDEFLFSDLQAL 114
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 28/100 (28%), Positives = 39/100 (39%), Gaps = 9/100 (9%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS---- 176
+ L ALEVL L +N + + + L+ LYL N S
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNK 161
Query: 177 -PQLVVLDLSFNSFTGNIPQSIQNLTQLT--GLSLQSNNL 213
P+L++LDLS N +Q L GL L +N L
Sbjct: 162 LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.1 bits (176), Expect = 3e-13
Identities = 40/124 (32%), Positives = 55/124 (44%), Gaps = 10/124 (8%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 185
L L L L L N + S + L L+ L L+HN S I PQL L L
Sbjct: 83 LTNLKNLGWLFLDENKIKD--LSSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLG 139
Query: 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQ 244
N T +I + LT+L LSL+ N +S I + KL++L LS N + + +L
Sbjct: 140 NNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS-DL-RALA 194
Query: 245 KFPN 248
N
Sbjct: 195 GLKN 198
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 1e-12
Identities = 26/124 (20%), Positives = 50/124 (40%), Gaps = 10/124 (8%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 185
+L+ +T L S+ + +++ + + P + L L+
Sbjct: 17 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLN 73
Query: 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQ 244
N T +I + + NL L L L N + + + D+ KL+ L+L +NG+ I + L
Sbjct: 74 GNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHNGIS-DI-NGLV 128
Query: 245 KFPN 248
P
Sbjct: 129 HLPQ 132
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 2e-12
Identities = 31/123 (25%), Positives = 49/123 (39%), Gaps = 8/123 (6%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
+ L + L L N LT +T+L +L +L+L N +L L L
Sbjct: 61 IQYLPNVTKLFLNGNKLTD--IKPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEH 118
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 245
N + +I + +L QL L L +N ++ I + KL L+L N + I L
Sbjct: 119 NGIS-DI-NGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DI-VPLAG 173
Query: 246 FPN 248
Sbjct: 174 LTK 176
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 30/122 (24%), Positives = 46/122 (37%), Gaps = 4/122 (3%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L L+ LSL N ++ + + LP L LYL +N + S +L L L
Sbjct: 105 LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLED 162
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 246
N + +I + LT+L L L N++S + L L L +
Sbjct: 163 NQIS-DIV-PLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNL 220
Query: 247 PN 248
Sbjct: 221 VV 222
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 24/130 (18%), Positives = 42/130 (32%), Gaps = 2/130 (1%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L +L L+ LSL N ++ + L L+ LYL N+ S + L VL+L
Sbjct: 149 LSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFS 206
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 246
NL + +L D N+ ++ + + S +
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFY 266
Query: 247 PNSSFVGNSL 256
+
Sbjct: 267 QPVTIGKAKA 276
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 48/223 (21%), Positives = 94/223 (42%), Gaps = 23/223 (10%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLRAY 439
+GKG++ A + V +K + + + ++ E+ + ++ HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
++ L+ +Y + G + L + GR E R V + H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAH---GRMKEK-EAR-SKFRQIVSAVQYCHQKR--- 134
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK-HSHK 555
H ++KA N+L++ D++ I+DFG + V G Y APE+ + +K +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 556 SDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 590
DV+S GV+L +++G P ++ +P ++
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 237
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
E+LG G +G +K E +T + K + + K + + ++ ++ ++ H N++ L
Sbjct: 95 EILGGGRFGQVHKCE-ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLY 152
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ SK++ +LV +Y G L + + T LD +K + G+ H+H M
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRII-DESYNLTELDTILFMKQICE---GIRHMHQMY- 207
Query: 498 PKFTHGNIKASNVL-INQDLDGC-ISDFGL-------TPLMNVPATPSRSAGYRAPEVIE 548
H ++K N+L +N+D I DFGL L TP + APEV+
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP----EFLAPEVVN 261
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAP 574
S +D++S GV+ +L+G +P
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 29/123 (23%), Positives = 47/123 (38%), Gaps = 9/123 (7%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
+ L+ L L N ++ S + L L L + N + S L L L
Sbjct: 59 MQFFTNLKELHLSHNQISD--LSPLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDN 115
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 245
N + S+ +L L LS+++N L SI + KL L+L N + + L +
Sbjct: 116 NELR-DT-DSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEIT-NT-GGLTR 170
Query: 246 FPN 248
Sbjct: 171 LKK 173
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 26/122 (21%), Positives = 42/122 (34%), Gaps = 7/122 (5%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L +L +T L ++ ++N F L L LS
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSH 72
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 246
N + ++ +++LT+L LS+ N L ++ L L L N L SL
Sbjct: 73 NQIS-DLS-PLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNEL--RDTDSLIHL 127
Query: 247 PN 248
N
Sbjct: 128 KN 129
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 17/87 (19%), Positives = 29/87 (33%), Gaps = 2/87 (2%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L LE+LS+R+N L + L L L L N + + ++ +DL+
Sbjct: 124 LIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTG 181
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNL 213
+ L +
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
LG+G+ Y+ + + ++ + V K+ ++ ++ R+ HPN++ L+ +
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIF 117
Query: 441 YSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVAHIHSM 495
+ E LV + G L + G R A VK +L VA++H
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-------VKQILE---AVAYLHEN 167
Query: 496 GGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIET 549
G H ++K N+L D I+DFGL+ ++ + T + GY APE++
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG 224
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 581
+ + D++S G++ +L G P D
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 49/223 (21%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQMEIVG------------- 425
+G+G+YG +KA ++ V +KR++ + E G
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVR--------VQTGEE--GMPLSTIREVAVLR 66
Query: 426 --RVGQHPNVVPLR----AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETR 478
+HPNVV L ++ KL LV+++ L+T L G
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPT----ET 121
Query: 479 VKILLG-TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATP 535
+K ++ RG+ +HS H ++K N+L+ G ++DFGL + +
Sbjct: 122 IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMAL 176
Query: 536 SRSAG---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
+ YRAPEV+ ++ D++S G + EM K PL
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-PL 218
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 30/125 (24%), Positives = 49/125 (39%), Gaps = 16/125 (12%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
+P + L N + P + LR + L +N S P +F L
Sbjct: 30 LPETI-------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 180 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGL 235
L L N T +P+S+ + L L L L +N ++ + F + L L+L N L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
Query: 236 KGSIP 240
+ +I
Sbjct: 141 Q-TIA 144
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 17/76 (22%), Positives = 31/76 (40%), Gaps = 5/76 (6%)
Query: 171 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 227
IP++ + + L N+ P + +L + L +N +S + F + L
Sbjct: 26 IPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNS 84
Query: 228 LNLSYNGLKGSIPSSL 243
L L N + +P SL
Sbjct: 85 LVLYGNKIT-ELPKSL 99
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 4/93 (4%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 178
+ + L +L L L N +T LP + L SL+ L L N + +F
Sbjct: 71 LAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN 129
Query: 179 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 211
L +L L N + L + + L N
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPL 436
+ LG G++G V VK L ++ + + + EI ++ +HP+++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHIH 493
+ + +V +Y + G L + + GR E R IL V + H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKH---GRVEEM-EARRLFQQILSA----VDYCH 128
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIETR 550
H ++K NVL++ ++ I+DFGL+ +M T S Y APEVI R
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185
Query: 551 K-HSHKSDVYSFGVLLLEMLTGKAP 574
+ D++S GV+L +L G P
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 7e-13
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 43/217 (19%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVG------------RVG 428
E +G+G+YG YKA T +K+++ E++ E G +
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR--------LEKEDE--GIPSTTIREISILKEL 57
Query: 429 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TAR 487
+H N+V L ++K +LV+++ L LL G L+ K L
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG----GLE-SVTAKSFLLQLLN 111
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG----- 540
G+A+ H H ++K N+LIN+ +G I+DFGL +P +
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINR--EGELKIADFGLARAFGIP-VRKYTHEIVTLW 165
Query: 541 YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
YRAP+V+ ++K+S D++S G + EM+ G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 34/218 (15%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM-------EI----VGRVGQ 429
+G G+YGT YKA S V LK V V E+ +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVA--LKSVRVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 430 HPNVVPLR----AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 484
HPNVV L ++ K+ LV+++ L T L G +K L+
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA----ETIKDLMR 127
Query: 485 -TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG- 540
RG+ +H+ H ++K N+L+ G ++DFGL + + +
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSG--GTVKLADFGLARIYSYQMALTPVVVT 182
Query: 541 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
YRAPEV+ ++ D++S G + EM K
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 27/130 (20%), Positives = 50/130 (38%), Gaps = 11/130 (8%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 177
I LE + + N + + +++ ++LP L + ++ N I F P
Sbjct: 45 IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLP 104
Query: 178 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD--IPKLRHLNLSY 232
L L +S ++P + Q L +Q N +I F + L L+
Sbjct: 105 NLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163
Query: 233 NGLKGSIPSS 242
NG++ I +S
Sbjct: 164 NGIQ-EIHNS 172
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 28/118 (23%), Positives = 48/118 (40%), Gaps = 11/118 (9%)
Query: 122 IPNNTLGKLDA-LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS--P 177
I N+ L +L L N + + + + L L L NN ++P+ F
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202
Query: 178 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYN 233
V+LD+S ++P +NL +L S NL +P + + L +L+Y
Sbjct: 203 GPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLK-KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 25/140 (17%), Positives = 46/140 (32%), Gaps = 24/140 (17%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQ 178
+P N L L + L + + N+ I + FS P+
Sbjct: 28 LPRNA-------IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 179 LVVLDLS-FNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYN 233
L + + N+ I QNL L L + + + +P+ + L++ N
Sbjct: 81 LHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138
Query: 234 GLKGSIPSSLQKFPNSSFVG 253
++ +SFVG
Sbjct: 139 -------INIHTIERNSFVG 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 17/105 (16%), Positives = 32/105 (30%), Gaps = 11/105 (10%)
Query: 156 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
S R Q + + +IPS + L + L + + N++
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 216 SIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 257
I F +PKL + + ++L +F L
Sbjct: 69 VIEADVFSNLPKLHEIRIEKA-------NNLLYINPEAFQNLPNL 106
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 46/229 (20%), Positives = 91/229 (39%), Gaps = 57/229 (24%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLK---EVVVGKRDF-E----QQMEIVGRVGQHP 431
+LG+G+YG A + + +V +K+++ + + R E + +H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-------KHE 69
Query: 432 NVVPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----I 481
N++ + R + ++ ++ + + L ++ L + ++
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ------MLS-DDHIQYFIYQT 121
Query: 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL----TPLMNVPATPSR 537
L R V +H H ++K SN+LIN + D + DFGL + P+
Sbjct: 122 L----RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 538 SAG----------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 575
YRAPEV+ T ++ DV+S G +L E+ + P+
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PI 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM------EI-VGRVGQHPNV 433
+ LG+G+Y T YK + + +V LKE+ + + E+ E+ + + +H N+
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVA--LKEI---RLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHI 492
V L +++ LV++Y L L ++ VK+ L RG+A+
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLD----DCGNIIN-MHNVKLFLFQLLRGLAYC 116
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG-----YRAPE 545
H K H ++K N+LIN+ G ++DFGL ++P T + YR P+
Sbjct: 117 HR---QKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIP-TKTYDNEVVTLWYRPPD 170
Query: 546 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
++ + +S + D++ G + EM TG+
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHP 431
+G G+YG+ A+ + S V +K+L F+ ++ E+ + + QH
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP------FQSEIFAKRAYRELLLLKHMQHE 83
Query: 432 NVVPLRAYYYSKDEKLLVYD-YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
NV+ L + YD Y + T L E ++ +G+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQK---IMGLKFSEEKIQYLVYQMLKGLK 140
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP---SRSAGYRAPEVI 547
+IHS G H ++K N+ +N+D + I DFGL + T +R YRAPEVI
Sbjct: 141 YIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW--YRAPEVI 195
Query: 548 ETRKHSHKS-DVYSFGVLLLEMLTGKAPL 575
+ H +++ D++S G ++ EMLTGK L
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGK-TL 223
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 50/226 (22%), Positives = 97/226 (42%), Gaps = 60/226 (26%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ-------------MEIVGRV 427
+ LG+G + T YKA + + +V +K++ +G R + E+
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVA--IKKIKLGHRSEAKDGINRTALREIKLLQEL---- 69
Query: 428 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TA 486
HPN++ L + K LV+D+ + L ++ N L + +K + T
Sbjct: 70 -SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL----VLT-PSHIKAYMLMTL 122
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG---- 540
+G+ ++H H ++K +N+L+++ +G ++DFGL ++S G
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDE--NGVLKLADFGL----------AKSFGSPNR 167
Query: 541 ----------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
YRAPE++ R + D+++ G +L E+L P
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV-PF 212
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 52/239 (21%), Positives = 88/239 (36%), Gaps = 54/239 (22%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+ LG GS+G + ES LK+V+ R ++++I+ +V H N++ L Y+
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFA--LKKVLQDPRYKNRELDIM-KVLDHVNIIKLVDYF 69
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR---------------------- 478
Y+ ++ N
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129
Query: 479 -------------VKILL-GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDF 523
+ I + R V IHS+G H +IK N+L+N + + DF
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 524 GLTPLMNVPATP------SRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 575
G + +P+ P SR YRAPE++ + D++S G + E++ GK PL
Sbjct: 187 GSAKKL-IPSEPSVAYICSRF--YRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PL 241
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVG------------RV 427
LG+G+YG YKA+ + V +KR++ E + E G +
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR--------LEHEEE--GVPGTAIREVSLLKE 89
Query: 428 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TA 486
QH N++ L++ + L+++Y A L + N + +K L
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKN-----PDVS-MRVIKSFLYQLI 142
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGC--ISDFGLTPLMNVPATPSRSAG- 540
GV HS + H ++K N+L++ I DFGL +P +
Sbjct: 143 NGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFTHEI 198
Query: 541 ----YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
YR PE++ +R +S D++S + EML
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 2e-12
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 52/221 (23%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ-------MEI-VGRVGQHPN 432
E +G+G+YGT +KA E+ +V LK V + D + + EI + + +H N
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVA--LKRV---RLDDDDEGVPSSALREICLLKELKHKN 62
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAH 491
+V L +S + LV+++ L G LD VK L +G+
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG----DLD-PEIVKSFLFQLLKGLGF 116
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG--------- 540
HS H ++K N+LIN+ +G +++FGL +R+ G
Sbjct: 117 CHSRN---VLHRDLKPQNLLINR--NGELKLANFGL----------ARAFGIPVRCYSAE 161
Query: 541 -----YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
YR P+V+ + +S D++S G + E+ PL
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 40/124 (32%), Positives = 55/124 (44%), Gaps = 10/124 (8%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 185
L L L L L N + S + L L+ L L+HN S I PQL L L
Sbjct: 86 LANLKNLGWLFLDENKVKD--LSSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLG 142
Query: 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQ 244
N T +I + LT+L LSL+ N +S I + KL++L LS N + + +L
Sbjct: 143 NNKIT-DI-TVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS-DL-RALA 197
Query: 245 KFPN 248
N
Sbjct: 198 GLKN 201
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 29/124 (23%), Positives = 56/124 (45%), Gaps = 8/124 (6%)
Query: 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185
T +L++++ + ++ + I LP++ L+L N + P + L L L
Sbjct: 41 TQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLD 98
Query: 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQ 244
N ++ S+++L +L LSL+ N +S I +P+L L L N + I + L
Sbjct: 99 ENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKIT-DI-TVLS 153
Query: 245 KFPN 248
+
Sbjct: 154 RLTK 157
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 26/123 (21%), Positives = 48/123 (39%), Gaps = 8/123 (6%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
+L+ +T L S+ + +++ + P + L L+
Sbjct: 20 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNG 77
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQK 245
N T +I + NL L L L N + + + D+ KL+ L+L +NG+ I + L
Sbjct: 78 NKLT-DIK-PLANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNGIS-DI-NGLVH 132
Query: 246 FPN 248
P
Sbjct: 133 LPQ 135
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 30/108 (27%), Positives = 46/108 (42%), Gaps = 6/108 (5%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L L+ LSL N ++ + + LP L LYL +N + S +L L L
Sbjct: 108 LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLED 165
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYN 233
N + +I + LT+L L L N++S + + L L L
Sbjct: 166 NQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 23/107 (21%), Positives = 37/107 (34%), Gaps = 2/107 (1%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L +L L+ LSL N ++ + L L+ LYL N+ S + L VL+L
Sbjct: 152 LSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFS 209
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 233
NL + +L D N+ ++
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 15/88 (17%), Positives = 30/88 (34%), Gaps = 2/88 (2%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L L+ L L N ++ + L +L L L K + S +V +
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 231
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLS 214
+ P+ I + +++ +
Sbjct: 232 TDGSLVTPEIISDDGDYEKPNVKWHLPE 259
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVP 435
E LGKG++ + V ++T K + + RDF+ ++ I ++ QHPN+V
Sbjct: 35 EELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVR 92
Query: 436 LRAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVA 490
L + LV+D G L + A ++ +L +A
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-------IQQILE---SIA 142
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGL-------TPLMNVPATPSRSAG 540
+ HS G H N+K N+L+ G ++DFGL TP G
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP----G 195
Query: 541 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
Y +PEV++ +S D+++ GV+L +L G P
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 47/218 (21%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHPN 432
++G+GSYG K +++ +V +K+ + +M EI + + +H N
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVA--IKKF---LESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
+V L K LV+++ + + + LD++ K L G+
Sbjct: 86 LVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------------ 540
HS H +IK N+L++Q + DFG +R+
Sbjct: 141 HSHN---IIHRDIKPENILVSQSGVVKLCDFGF----------ARTLAAPGEVYDDEVAT 187
Query: 541 --YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
YRAPE++ K+ DV++ G L+ EM G+ PL
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE-PL 224
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 52/274 (18%), Positives = 91/274 (33%), Gaps = 39/274 (14%)
Query: 335 ASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA 394
G P + + P K K + + +LG G +G+ Y
Sbjct: 14 LVPRGSHMAPCNDLHATKLAPGKEKEPLES----QYQVG-------PLLGSGGFGSVYSG 62
Query: 395 V-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGR--------VGQHPNVVPLRAYYYSKDE 445
+ + ++ V +K +++ + V V+ L ++ D
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 446 KLLVYDYFA-SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 504
+L+ + L + G + R V H H+ G H +
Sbjct: 123 FVLILERPEPVQDLFDFITER---GALQEE-LAR-SFFWQVLEAVRHCHNCG---VLHRD 174
Query: 505 IKASNVLINQDLDGC---ISDFGLTPLM--NVPATPSRSAGYRAPEVIETRK-HSHKSDV 558
IK N+LI DL+ + DFG L+ V + Y PE I + H + V
Sbjct: 175 IKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAV 232
Query: 559 YSFGVLLLEMLTGKAPLQSPTR--DDMVDLPRWV 590
+S G+LL +M+ G P + V + V
Sbjct: 233 WSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 51/230 (22%), Positives = 93/230 (40%), Gaps = 56/230 (24%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVG------------RV 427
+G+G++G +KA ++ V +K++ E + E G ++
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL--------MENEKE--GFPITALREIKILQL 72
Query: 428 GQHPNVVPLR-------AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 479
+H NVV L + Y + LV+D+ L+ LL + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLS----NVLVKFT-LSEI 126
Query: 480 K-ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPS 536
K ++ G+ +IH H ++KA+NVLI + DG ++DFGL ++ S
Sbjct: 127 KRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITR--DGVLKLADFGLARAFSLAK-NS 180
Query: 537 RSAG---------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
+ YR PE++ R + D++ G ++ EM T +Q
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 68.6 bits (167), Expect = 3e-12
Identities = 30/106 (28%), Positives = 43/106 (40%), Gaps = 12/106 (11%)
Query: 134 EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTG 191
VL L LT + + L + +L L HN +P + + L VL S N+
Sbjct: 444 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499
Query: 192 NIPQSIQNLTQLTGLSLQSNNLSGSIPNFD----IPKLRHLNLSYN 233
N+ + NL +L L L +N L P+L LNL N
Sbjct: 500 NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 2e-10
Identities = 26/128 (20%), Positives = 45/128 (35%), Gaps = 6/128 (4%)
Query: 125 NTLGKLDALEVL--SLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVL 182
+TL +D + + +R L+L H + + + L
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHL 468
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKG-SIP 240
DLS N +P ++ L L L N L ++ +P+L+ L L N L+ +
Sbjct: 469 DLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQQSAAI 526
Query: 241 SSLQKFPN 248
L P
Sbjct: 527 QPLVSCPR 534
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 42/239 (17%), Positives = 72/239 (30%), Gaps = 19/239 (7%)
Query: 1 MRGLASFPHVSRNIETLLGLHFCYSSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLPLA 60
+ S E L ++ + + P + + LL A
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRA 394
Query: 61 FADLNSDRQALLDFAD--AVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGL 118
L +++ L F+ AV +R + V L L L
Sbjct: 395 LDPLLYEKETLQYFSTLKAVDPMRAAYLD-DLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 119 VGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSP 177
+ + L +L + L L N L LP + +L L L N + + P
Sbjct: 454 TV-LCH--LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDGVANLP 508
Query: 178 QLVVLDLSFNSFTGNIP--QSIQNLTQLTGLSLQSNNLSGSIPNFD------IPKLRHL 228
+L L L N Q + + +L L+LQ N+L +P + +
Sbjct: 509 RLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVSSI 565
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 5e-12
Identities = 44/218 (20%), Positives = 81/218 (37%), Gaps = 47/218 (21%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHPN 432
+G+GSYG +K ++ +V +K+ + + EI + + +HPN
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVA--IKKF---LESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
+V L + K LV++Y + + + I T + V
Sbjct: 64 LVNLLEVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------------ 540
H H ++K N+LI + + DFG +R
Sbjct: 119 HKHN---CIHRDVKPENILITKHSVIKLCDFGF----------ARLLTGPSDYYDDEVAT 165
Query: 541 --YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
YR+PE++ ++ DV++ G + E+L+G PL
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV-PL 202
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGR------VGQHPNVVP 435
LG+G+YG AV V VK +V + E + + + H NVV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-----IVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHI 492
+ + + L +Y + G L + + P + + ++ GV ++
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEP-DAQRFFHQLMA----GVVYL 121
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEV 546
H +G TH +IK N+L+++ + ISDFGL + + Y APE+
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 547 IETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS 592
++ R+ H+ DV+S G++L ML G+ P P+ D + W +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEK 224
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 53/220 (24%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHP 431
+G G+YG+ A ++ V VK+L F+ + E+ + + +H
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHMKHE 88
Query: 432 NVVPLR-----AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 485
NV+ L A + + LV + L+ ++ L + ++
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ------KLTDDHVQFLIYQI 141
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----- 540
RG+ +IHS H ++K SN+ +N+D + I DFGL +R
Sbjct: 142 LRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL----------ARHTADEMTG 188
Query: 541 ------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKA 573
YRAPE++ H +++ D++S G ++ E+LTG+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 54/222 (24%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EIVG-RVGQHP 431
+ +G G+YG AV + V +K+L F+ ++ E+ + +H
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHMRHE 84
Query: 432 NVVPLRAYYYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 485
NV+ L + + LV + + L L+ L + ++
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE------KLGEDRIQFLVYQM 137
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----- 540
+G+ +IH+ G H ++K N+ +N+D + I DFGL +R A
Sbjct: 138 LKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL----------ARQADSEMTG 184
Query: 541 ------YRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 575
YRAPEVI + D++S G ++ EM+TGK L
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TL 225
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 65/238 (27%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EIV--GRVGQH 430
+ LGKG+YG +K++ + VV VK++ + F+ EI+ + H
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTDAQRTFREIMILTELSGH 68
Query: 431 PNVVPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 483
N+V L + +++ LV+DY + L ++ N L+ + ++
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN------ILE-PVHKQYVVYQLI- 119
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL----TPLMNVPATPSRSA 539
+ + ++HS G H ++K SN+L+N + ++DFGL + V S
Sbjct: 120 ---KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 540 G---------------------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 575
YRAPE++ K D++S G +L E+L GK P+
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PI 230
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 49/226 (21%), Positives = 91/226 (40%), Gaps = 55/226 (24%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGK--------RDFEQQMEIVGRVGQ 429
+ LG G+ G A E T V +K + K + E ++EI+ ++
Sbjct: 16 KTLGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-N 73
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR- 478
HP ++ ++ ++ ++D +V + G L D +
Sbjct: 74 HPCIIKIKNFFDAED-YYIVLELMEGGEL--------------FDKVVGNKRLKEATCKL 118
Query: 479 -VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NV 531
+L V ++H G H ++K NVL++ + C I+DFG + ++ ++
Sbjct: 119 YFYQMLL---AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 532 PATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAP 574
T + Y APEV+ T ++ D +S GV+L L+G P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGR------VGQHPNVVP 435
LG+G+YG AV V VK +V + E + + + H NVV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-----IVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHI 492
+ + + L +Y + G L + + P + + ++ GV ++
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEP-DAQRFFHQLMA----GVVYL 121
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEV 546
H +G TH +IK N+L+++ + ISDFGL + + Y APE+
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 547 IETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS 592
++ R+ H+ DV+S G++L ML G+ P P+ D + W +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEK 224
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 38/234 (16%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLRAY 439
+G G++G A V VK ++ G E Q EI R +HPN+V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR--------GVAH 491
+ ++ +Y + G L + AGR D AR GV++
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI---CNAGRFSED----------EARFFFQQLLSGVSY 131
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG---YRAPEV 546
HSM H ++K N L++ I DFG + + + P + G Y APEV
Sbjct: 132 CHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188
Query: 547 IETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 599
+ ++ +DV+S GV L ML G P + P ++ D + +Q ++ +++
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP--EEPRDYRKTIQRILSVKYS 240
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPL 436
E LG+GS+G A + V +K + ++++ + + EI ++ +HP+++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHIH 493
+ + ++V +Y A G L + R D E R I+ + + H
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYIVEK---KRMTED-EGRRFFQQII----CAIEYCH 125
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIETR 550
H ++K N+L++ +L+ I+DFGL+ +M N T S Y APEVI +
Sbjct: 126 RHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182
Query: 551 K-HSHKSDVYSFGVLLLEMLTGKAP 574
+ DV+S G++L ML G+ P
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 46/220 (20%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLK---EVVVGKRDF-E----QQMEIVGRVGQHP 431
+G+G+YG A + V +K++ +R E + +H
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-------RHE 85
Query: 432 NVVPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 486
N++ + RA + + + +V D + L LL L + L
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ------HLSNDHICYFLYQIL 138
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 540
RG+ +IHS H ++K SN+L+N D I DFGL V G
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA---RVADPDHDHTGFLTEYV 192
Query: 541 ----YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 575
YRAPE++ K KS D++S G +L EML+ + P+
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI 231
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPL 436
+ LG G++G V VK L ++ + + + EI ++ +HP+++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHIH 493
+ + +V +Y + G L + N GR E+R IL G V + H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKN---GRLDEK-ESRRLFQQILSG----VDYCH 133
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIETR 550
H ++K NVL++ ++ I+DFGL+ +M T S Y APEVI R
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 190
Query: 551 K-HSHKSDVYSFGVLLLEMLTGKAP 574
+ D++S GV+L +L G P
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLP 215
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-11
Identities = 29/115 (25%), Positives = 50/115 (43%), Gaps = 16/115 (13%)
Query: 127 LGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIP--SSFSPQLVVL 182
L L A + L+L +N + L + + +LR L L N KI + + L L
Sbjct: 44 LSTLKACKHLALSTNNIEKISSL----SGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD----IPKLRHLNLSYN 233
+S+N ++ I+ L L L + +N ++ + D + KL L L+ N
Sbjct: 99 WISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 30/130 (23%), Positives = 52/130 (40%), Gaps = 12/130 (9%)
Query: 125 NTLGKLDALEV-LSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVV 181
++ +A +V L + + + +++L + ++L L NN KI SS S L +
Sbjct: 18 KSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRI 74
Query: 182 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLK--GS 238
L L N I L L + N ++ S+ + + LR L +S N + G
Sbjct: 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKITNWGE 132
Query: 239 IPSSLQKFPN 248
I L
Sbjct: 133 I-DKLAALDK 141
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 40/209 (19%), Positives = 78/209 (37%), Gaps = 50/209 (23%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
+VLG G G + + + +K L++ +++E+ R Q P++V +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDV 79
Query: 440 Y----YSKDEKLLVYDYFASGSL--STLLHGN-----RGAGRTPLDWETRVKILLGTARG 488
Y + L+V + G L G+ R A +K +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-------MKSIGEA--- 129
Query: 489 VAHIHSMGGPKFTHGNIKASNVL-INQDLDGC--ISDFGLTPLMNVPATPSRSAGYRAPE 545
+ ++HS+ H ++K N+L ++ + ++DFG A E
Sbjct: 130 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------AKE 169
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAP 574
K+ D++S GV++ +L G P
Sbjct: 170 TTG-EKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 50/228 (21%), Positives = 87/228 (38%), Gaps = 45/228 (19%)
Query: 383 LGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQQMEIVGRVGQ----------- 429
+GKGSYG A ++T +K L K+ ++ + F ++ G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 430 --------------HPNVVPLRAYYY--SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPL 473
HPNVV L ++D +V++ G + + PL
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPL 134
Query: 474 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 532
+ +G+ ++H H +IK SN+L+ +D I+DFG++
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 533 ATPSRSAG---YRAPEVIETRKHSH---KSDVYSFGVLLLEMLTGKAP 574
A S + G + APE + + DV++ GV L + G+ P
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 28/218 (12%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI--------VGRVGQH 430
+V+GKGS+G KA + V +K ++ KR Q EI +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 431 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490
NV+ + + ++ + ++ S +L L+ N+ G L R K + +
Sbjct: 160 -NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGF-SLP-LVR-KFAHSILQCLD 214
Query: 491 HIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTPLMNVPATP---SRSAGYRAPE 545
+H + H ++K N+L+ Q I DFG + + SR YRAPE
Sbjct: 215 ALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--YRAPE 269
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 583
VI ++ D++S G +L E+LTG L D
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 51/247 (20%), Positives = 87/247 (35%), Gaps = 66/247 (26%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EI-VGRVGQHP 431
++G+GSYG Y A + + V +K++ + FE + EI + +
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------FEDLIDCKRILREITILNRLKSD 85
Query: 432 NVVPLRAYYYSKDEKL-----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----I 481
++ L D +V + S L L L E +K +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI-----FLT-EEHIKTILYNL 138
Query: 482 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL----------TPLMNV 531
L G IH G H ++K +N L+NQD + DFGL + ++
Sbjct: 139 L----LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 532 PATPSRSAG----------------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAP 574
YRAPE+I +++ KS D++S G + E+L
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
Query: 575 LQSPTRD 581
+ +
Sbjct: 252 HINDPTN 258
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 2e-10
Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 6/93 (6%)
Query: 148 PSEITSLPSLRYLYLQHNNFSGKIPS-SFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT 204
+ +L LY+++ + +L L + + P + +L+
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 205 GLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGL 235
L+L N L S+ L+ L LS N L
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 9/52 (17%), Positives = 22/52 (42%), Gaps = 4/52 (7%)
Query: 192 NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSYNGLKGSIP 240
+ + LT L +++ + D+ +LR+L + +GL+ +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA 72
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 21/110 (19%), Positives = 31/110 (28%), Gaps = 12/110 (10%)
Query: 93 CQSWVGINCTQDR-----------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSN 141
G+ CT+D + L + + + L L L L++ +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 142 VLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP-QLVVLDLSFNSFT 190
L P P L L L N + L L LS N
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 39/126 (30%), Positives = 57/126 (45%), Gaps = 18/126 (14%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV- 180
IP +T E L L+S L + L L +L L +N + + L
Sbjct: 33 IPADT-------EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 181 --VLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 234
L L+ N ++P + +LTQL L L N L S+P+ FD + KL+ L L+ N
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142
Query: 235 LKGSIP 240
L+ SIP
Sbjct: 143 LQ-SIP 147
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 39/120 (32%), Positives = 52/120 (43%), Gaps = 12/120 (10%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 177
+ L L L L +N L LP + L L LYL N +PS F
Sbjct: 74 LSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLT 131
Query: 178 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
+L L L+ N +IP LT L LSL +N L S+P+ FD + KL+ + L N
Sbjct: 132 KLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 22/74 (29%), Positives = 32/74 (43%), Gaps = 5/74 (6%)
Query: 171 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIP-KLRH 227
+PS LDL + + LT+LT L+L N L ++ FD +L
Sbjct: 29 VPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGT 87
Query: 228 LNLSYNGLKGSIPS 241
L L+ N L S+P
Sbjct: 88 LGLANNQLA-SLPL 100
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 51/226 (22%), Positives = 89/226 (39%), Gaps = 49/226 (21%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRL--KEVVVGKRDF-E----QQMEIVGRVGQHPN 432
+ LG G G + AV + V +K++ + K E +++ H N
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-------DHDN 69
Query: 433 VVPLRAYYYSKDEKL--------------LVYDYFASGSLSTLLHGNRGAGRTPLDWETR 478
+V + +L +V +Y + L+ +L PL E
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG------PLLEEHA 122
Query: 479 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMNVPATPSR 537
+ RG+ +IHS H ++K +N+ IN +DL I DFGL +M+ +
Sbjct: 123 RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 538 SAG-------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 575
YR+P ++ ++ D+++ G + EMLTGK L
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TL 224
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 50/225 (22%), Positives = 87/225 (38%), Gaps = 50/225 (22%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-------------VG 425
LG G + T + A + +T V +K ++ K E + EI
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 426 RVGQHPNVVPLRAYYYSKDEKL----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK- 480
+G + +++ L ++ K +V++ +L L+ G PL VK
Sbjct: 82 SMGAN-HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-IPLI---YVKQ 135
Query: 481 ----ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC------ISDFGLTPLMN 530
+LL G+ ++H G H +IK NVL+ I+D G +
Sbjct: 136 ISKQLLL----GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 531 VPATP---SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 572
T +R YR+PEV+ +D++S L+ E++TG
Sbjct: 190 EHYTNSIQTRE--YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 54/247 (21%), Positives = 89/247 (36%), Gaps = 61/247 (24%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHP 431
++G GSYG +A E V +K++ V FE + EI + H
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRV------FEDLIDCKRILREIAILNRLNHD 112
Query: 432 NVVPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 486
+VV + K ++L +V + S L L +L
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPV-----YLTELHIKTLLYNLL 166
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 540
GV ++HS G H ++K +N L+NQD + DFGL ++ P +
Sbjct: 167 VGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 541 -------------------------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAP 574
YRAPE+I +++ ++ DV+S G + E+L
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 575 LQSPTRD 581
+ D
Sbjct: 284 NVAYHAD 290
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 39/120 (32%), Positives = 57/120 (47%), Gaps = 13/120 (10%)
Query: 129 KLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFSPQLV---VLDL 184
+L L L L N L LP+ + L +L+ L L N +P +L L+L
Sbjct: 83 ELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNL 140
Query: 185 SFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIP 240
+ N ++P+ + LT LT L L N L S+P FD + +L+ L L N LK S+P
Sbjct: 141 AHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVP 197
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 42/120 (35%), Positives = 58/120 (48%), Gaps = 12/120 (10%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 177
+PN KL L+ L L N L LP + L +L YL L HN +P F
Sbjct: 100 LPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLT 157
Query: 178 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
L LDLS+N ++P+ + LTQL L L N L S+P+ FD + L+++ L N
Sbjct: 158 NLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 29/114 (25%), Positives = 46/114 (40%), Gaps = 15/114 (13%)
Query: 134 EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNI 193
+L+ +T ++ L S+ + +++ + P + L L N
Sbjct: 22 IKANLKKKSVTD-AVTQN-ELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKL---- 75
Query: 194 PQSI---QNLTQLTGLSLQSNNLSGSIPN--FDIP-KLRHLNLSYNGLKGSIPS 241
I + LT LT L L N L S+PN FD L+ L L N L+ S+P
Sbjct: 76 -HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPD 126
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 34/99 (34%), Positives = 45/99 (45%), Gaps = 13/99 (13%)
Query: 152 TSLPS-----LRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT 204
LP + LYL N F+ +P S L ++DLS N + QS N+TQL
Sbjct: 23 KVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 205 GLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIP 240
L L N L IP FD + LR L+L N + +P
Sbjct: 82 TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 36/118 (30%), Positives = 51/118 (43%), Gaps = 16/118 (13%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QL 179
IP + L L N T +P E+++ L + L +N S SFS QL
Sbjct: 29 IPRDV-------TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 180 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
+ L LS+N IP L L LSL N++S +P F+ + L HL + N
Sbjct: 81 LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 41/126 (32%), Positives = 57/126 (45%), Gaps = 18/126 (14%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV- 180
IP T L L +N L L SL LYL N +P+ +L
Sbjct: 26 IPAQT-------TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 181 --VLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 234
L+LS N ++P + LTQL L+L +N L S+P+ FD + +L+ L L N
Sbjct: 78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135
Query: 235 LKGSIP 240
LK S+P
Sbjct: 136 LK-SVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 28/74 (37%), Positives = 36/74 (48%), Gaps = 5/74 (6%)
Query: 171 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIP-KLRH 227
+P+ Q LDL NS LT LT L L N L S+PN F+ L +
Sbjct: 22 VPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTY 80
Query: 228 LNLSYNGLKGSIPS 241
LNLS N L+ S+P+
Sbjct: 81 LNLSTNQLQ-SLPN 93
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 58.0 bits (139), Expect = 3e-09
Identities = 37/244 (15%), Positives = 70/244 (28%), Gaps = 34/244 (13%)
Query: 31 PCIKQLLMKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSST- 89
L+ K L + + D + +++ + H L W
Sbjct: 91 EEGVNLMDKILKDKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDID 150
Query: 90 -NPICQSWVGINCTQDRTRVFG--LRLPGIGL-VGPIPNNTLGKLDALEVLSLRSNVLTG 145
SW+ D + V L + + + L+ L + S L
Sbjct: 151 FEEQEISWI---EQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPD 207
Query: 146 GLPSEITS--LPSLRYL--YLQHNNFSGK---------IPSSFSPQLVVLDLSFNSFTGN 192
+ +I LP+L L Y+ ++ P L L +
Sbjct: 208 SVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNV 267
Query: 193 IPQSI---QNLTQLTGLSLQSNNLS--------GSIPNFDIPKLRHLNLSYNGLKGSIPS 241
+ + L QL + + + L+ + L+ +N+ YN L +
Sbjct: 268 VVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKI--KHLKFINMKYNYLSDEMKK 325
Query: 242 SLQK 245
LQK
Sbjct: 326 ELQK 329
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 21/112 (18%), Positives = 34/112 (30%), Gaps = 8/112 (7%)
Query: 127 LGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 184
L LR + L + +L + N +L L +
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGA---TLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLV 71
Query: 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLS--GSIPNF-DIPKLRHLNLSYN 233
+ N Q L LT L L +N+L G + + L +L + N
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 23/108 (21%), Positives = 37/108 (34%), Gaps = 14/108 (12%)
Query: 149 SEITSLPSLRYLYLQHNNFSGKIP--SSFSPQLVVLDLSFNSFT--GNIPQSIQNLTQLT 204
++ T+ R L L+ I + Q +D S N P L +L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLK 67
Query: 205 GLSLQSNNLSGSIPNFD--IPKLRHLNLSYNGLK--GSIPSSLQKFPN 248
L + +N + D +P L L L+ N L G + L +
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKS 114
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 9e-04
Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 28/109 (25%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L L+ L + +N + +LP L L L +N+
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV----------------EL 103
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN------FDIPKLRHLN 229
+ +L LT L + N ++ + + + +P++R L+
Sbjct: 104 GDL-----DPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 146
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 26/102 (25%), Positives = 39/102 (38%), Gaps = 17/102 (16%)
Query: 152 TSLPS-----LRYLYLQHNNFSGKIPSS--FS--PQLVVLDLSFNSFTGNIPQSI-QNLT 201
+P L L N +I S F P LV L+L N T I + + +
Sbjct: 21 KEIPRDIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 202 QLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIP 240
+ L L N + I N F + +L+ LNL N + +
Sbjct: 79 HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 33/119 (27%), Positives = 47/119 (39%), Gaps = 16/119 (13%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 178
IP +T L L N L + LP L L L+ N +G P++F
Sbjct: 27 IPLHT-------TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 179 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
+ L L N I + L QL L+L N +S + F+ + L LNL+ N
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 50/385 (12%), Positives = 112/385 (29%), Gaps = 100/385 (25%)
Query: 347 EFGSGVQEPEKNKL--VFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA---------- 394
+F +G + + + VF + NFD +D+ +L K +
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67
Query: 395 --VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL----- 447
L +V++ E V+ + +++ M + + P+ + Y + ++L
Sbjct: 68 FWTLLSKQEEMVQKFVEEVL-RINYKFLMSPIKTEQRQPS--MMTRMYIEQRDRLYNDNQ 124
Query: 448 LVYDYFAS---------GSLSTL-------LHGNRGAGRTPLDWETRVKILLGTARGVAH 491
+ Y S +L L + G G+G+T + L
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWV--------ALDVCLSYKV 176
Query: 492 IHSMGGPKF--THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP-EVIE 548
M F N + ++ + + P N + S+ + I+
Sbjct: 177 QCKMDFKIFWLNLKNCNSPETVLEMLQKLL---YQIDP--NWTSRSDHSSNIKLRIHSIQ 231
Query: 549 TRK------HSHKS------DVYSFGVLLLEMLTGKAPLQSPTRDDMV--DLPRWVQSVV 594
+++ +V + + TR V L + +
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKA--WNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 595 REEWTAEVFD----VEL------MRFQNIEEEMVQM--LQIGMACVAKVPDM-------- 634
+ + L R Q++ E++ ++ + + D
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI-IAESIRDGLATWDNWK 348
Query: 635 RPNMDEVVRMIE---------EVRQ 650
N D++ +IE E R+
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRK 373
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 2e-07
Identities = 54/342 (15%), Positives = 103/342 (30%), Gaps = 110/342 (32%)
Query: 1 MRG-----LASFPHVSRNIETLLGLHF---------CYSSHLLIPCIKQLLMKFSSAAPL 46
+ G +A V + + + F C S ++ +++LL + P
Sbjct: 158 VLGSGKTWVAL--DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID---PN 212
Query: 47 FFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKL----NWSSTNPICQSWV----G 98
+ S + L ++S + L + P+ L N + +
Sbjct: 213 WTSRSDHSSNIKL---RIHSIQAELRRLLKSKPYENCLLVLLN------VQNAKAWNAFN 263
Query: 99 INC-----TQDRT---RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSE 150
++C T+ + + I L + TL + +L + LP E
Sbjct: 264 LSCKILLTTRFKQVTDFLSAATTTHISLDHH--SMTLTPDEVKSLLLKYLDCRPQDLPRE 321
Query: 151 ITSL-P--------SLR--------YLYLQHNNFSGKIPSSF---SP--------QLVVL 182
+ + P S+R + ++ + + I SS P +L V
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF 381
Query: 183 DLSFNSFTGNIPQSI--------------QNLTQLTGLSL---QSNNLSGSIPN--FDI- 222
S +IP + + +L SL Q + SIP+ ++
Sbjct: 382 PPSA-----HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK 436
Query: 223 PKLR-----HLNL--SYNGLKGSIPSSLQKFPNS----SFVG 253
KL H ++ YN K L S +G
Sbjct: 437 VKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG 478
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-08
Identities = 21/111 (18%), Positives = 41/111 (36%), Gaps = 8/111 (7%)
Query: 129 KLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLSF 186
++ L L ++ G L L +L + + I + +L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSD 73
Query: 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD----IPKLRHLNLSYN 233
N +G + + LT L+L N + + + + L+ L+L
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK-DLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-06
Identities = 32/108 (29%), Positives = 43/108 (39%), Gaps = 16/108 (14%)
Query: 148 PSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT--GNIPQSIQNLTQL 203
PS++ L L +N GK+ +L L T N+P L +L
Sbjct: 16 PSDVKEL----VLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKL 66
Query: 204 TGLSLQSNNLSGSIPNFD--IPKLRHLNLSYNGLKG-SIPSSLQKFPN 248
L L N +SG + P L HLNLS N +K S L+K N
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLEN 114
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 25/86 (29%), Positives = 34/86 (39%), Gaps = 9/86 (10%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN---FSGKIPSSFSPQLVVLD 183
L KL+ L+ L L N ++GGL P+L +L L N S P L LD
Sbjct: 60 LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119
Query: 184 LSFNSFTGN------IPQSIQNLTQL 203
L T + + + LT L
Sbjct: 120 LFNCEVTNLNDYRENVFKLLPQLTYL 145
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 26/110 (23%), Positives = 43/110 (39%), Gaps = 8/110 (7%)
Query: 130 LDALEVLSLRSNVLTGGLPSEITS-LPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLSFN 187
A+ L L + G +T+ +L +L L + + + P+L L+LS N
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSEN 81
Query: 188 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI----PKLRHLNLSYN 233
G + + L LT L+L N L I + L+ L+L
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 32/125 (25%), Positives = 45/125 (36%), Gaps = 16/125 (12%)
Query: 131 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNS 188
+++ L P+ + L L +N GKI + L L L
Sbjct: 6 SGMDMKRRIHLELRNRTPAAVREL----VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVG 60
Query: 189 FT--GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD--IPKLRHLNLSYNGLKG-SIPSSL 243
N+P L +L L L N + G + +P L HLNLS N LK S L
Sbjct: 61 LISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPL 116
Query: 244 QKFPN 248
+K
Sbjct: 117 KKLEC 121
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 7e-05
Identities = 28/86 (32%), Positives = 33/86 (38%), Gaps = 6/86 (6%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN---FSGKIPSSFSPQLVVLD 183
L KL L+ L L N + GGL LP+L +L L N S P L LD
Sbjct: 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126
Query: 184 LSFNSFT---GNIPQSIQNLTQLTGL 206
L T + L QLT L
Sbjct: 127 LFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 38/287 (13%), Positives = 90/287 (31%), Gaps = 93/287 (32%)
Query: 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHIHSMGGPKFTHGNIK 506
+V++ L + + PL VK I+ +G+ ++H+ H +IK
Sbjct: 122 MVFE-VLGHHLLKWIIKSNY-QGLPLPC---VKKIIQQVLQGLDYLHTKCR--IIHTDIK 174
Query: 507 ASNVLIN-------------------------------------------------QDLD 517
N+L++ + L
Sbjct: 175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK 234
Query: 518 GCISDFGL-TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576
I+D G + ++ YR+ EV+ ++ +D++S + E+ TG +
Sbjct: 235 VKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
Query: 577 -----SPTRDD-----MVDL-----PRWVQSVVREEWTAEVFD-------VELMRFQNIE 614
TRD+ +++L + + +++ E F + ++ +
Sbjct: 295 PHSGEEYTRDEDHIALIIELLGKVPRKLIV---AGKYSKEFFTKKGDLKHITKLKPWGLF 351
Query: 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 661
E +V+ + + + + + E R ++ E
Sbjct: 352 EVLVEKYEWS----------QEEAAGFTDFLLPMLELIPEKRATAAE 388
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 25/142 (17%), Positives = 43/142 (30%), Gaps = 23/142 (16%)
Query: 117 GLVGPIPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGK-- 170
L N L + N L G S L + + N +
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 171 ---IPSSFS--PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNN--------L 213
+ + +L VLDL N+FT + ++++ L L L +
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264
Query: 214 SGSIPNFDIPKLRHLNLSYNGL 235
+ + L+ L L YN +
Sbjct: 265 VDAFSKLENIGLQTLRLQYNEI 286
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 25/105 (23%), Positives = 35/105 (33%), Gaps = 17/105 (16%)
Query: 127 LGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGK--------IPSS 174
L L+VL L+ N T L + S P+LR L L S +
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271
Query: 175 FSPQLVVLDLSFNSFTGN----IPQSIQ-NLTQLTGLSLQSNNLS 214
+ L L L +N + + I + L L L N S
Sbjct: 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 22/142 (15%), Positives = 39/142 (27%), Gaps = 36/142 (25%)
Query: 127 LGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFS-------------- 168
L K L + L N L ++ L +LYL +N
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 169 -GKIPSSFSPQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNL---------- 213
+ +P L + N ++ Q+ L + + N +
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 214 SGSIPNFDIPKLRHLNLSYNGL 235
G +L+ L+L N
Sbjct: 210 EGLAYC---QELKVLDLQDNTF 228
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 28/154 (18%), Positives = 49/154 (31%), Gaps = 38/154 (24%)
Query: 133 LEVLSLRSNVLT--GG-----------LPSEITSLPSLRYLYLQHNNFSGK----IPSSF 175
LE L L +N L G + + + P LR + N +F
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 176 S--PQLVVLDLSFNSFT-----GNIPQSIQNLTQLTGLSLQSNN--------LSGSIPNF 220
L + + N + + + +L L LQ N L+ ++ ++
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243
Query: 221 DIPKLRHLNLSYNGLKG----SIPSSLQKFPNSS 250
P LR L L+ L ++ + K N
Sbjct: 244 --PNLRELGLNDCLLSARGAAAVVDAFSKLENIG 275
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 24/132 (18%), Positives = 46/132 (34%), Gaps = 32/132 (24%)
Query: 133 LEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGK----IPSSFS--PQLVVL 182
+E SL+ + +T + + + S++ + L N + + + + L +
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 183 DLSFNSFTGNIP-----------QSIQNLTQLTGLSLQSNN--------LSGSIPNFDIP 223
+ S FTG + Q++ +L + L N L +
Sbjct: 66 EFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH--T 122
Query: 224 KLRHLNLSYNGL 235
L HL L NGL
Sbjct: 123 PLEHLYLHNNGL 134
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 41/119 (34%), Positives = 54/119 (45%), Gaps = 11/119 (9%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 177
+ L L+ L L SN L LP + SL L L L N + +PS+ F
Sbjct: 55 LEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLV 112
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
L L + N T +P+ I+ LT LT L+L N L SIP+ FD + L H L N
Sbjct: 113 HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 23/74 (31%), Positives = 33/74 (44%), Gaps = 5/74 (6%)
Query: 171 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 227
+P+ +L L N T P +L L L L SN L ++P FD + +L
Sbjct: 34 VPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTV 92
Query: 228 LNLSYNGLKGSIPS 241
L+L N L +PS
Sbjct: 93 LDLGTNQLT-VLPS 105
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 47/220 (21%), Positives = 86/220 (39%), Gaps = 28/220 (12%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQ--MEI--------VGRVGQ 429
++GKGS+G KA E V +K ++ K+ F Q +E+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK----IIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
+ +V L+ ++ ++ LV++ S +L LL + K +
Sbjct: 116 Y-YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNT---NFRGVSLNLTRKFAQQMCTAL 170
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTPLMNVPATP---SRSAGYRAP 544
+ + H ++K N+L+ I DFG + + SR YR+P
Sbjct: 171 LFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--YRSP 227
Query: 545 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 584
EV+ + D++S G +L+EM TG+ D +
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM 267
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 33/118 (27%), Positives = 47/118 (39%), Gaps = 15/118 (12%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179
IP++ L L SN L L L L L N F +L
Sbjct: 26 IPSSA-------TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78
Query: 180 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
+L L N ++P + LTQL L+L +N L S+P+ FD + L+ + L N
Sbjct: 79 TILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 25/74 (33%), Positives = 35/74 (47%), Gaps = 5/74 (6%)
Query: 171 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 227
+P+ L+L N LTQLT LSL N + S+P+ FD + KL
Sbjct: 22 VPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTI 80
Query: 228 LNLSYNGLKGSIPS 241
L L N L+ S+P+
Sbjct: 81 LYLHENKLQ-SLPN 93
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 6e-06
Identities = 31/211 (14%), Positives = 60/211 (28%), Gaps = 49/211 (23%)
Query: 363 FEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK-------RLKEVVVGKR 415
F C L+ E +G+G +G ++ + + T V +K L K
Sbjct: 13 FSHCLPTEKLQRC-----EKIGEGVFGEVFQTIADH-TPVAIKIIAIEGPDLVNGSHQKT 66
Query: 416 DFEQQMEIV----------GRVGQHPNVVPLRAYYYSKDEK----LLVYDYFAS--GSLS 459
E EI+ + + L + + + L +D++ S GS +
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 460 TLLHGNRGA------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 501
+ T IL +A + +F
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFE 184
Query: 502 HGNIKASNVLINQDLDGCISDFGLTPLMNVP 532
H ++ NVL+ + + +P
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 23/118 (19%), Positives = 36/118 (30%), Gaps = 29/118 (24%)
Query: 132 ALEVLSLRSNVLT----GGLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSPQLV 180
L L + +T G L + + SL+ L L N + QL
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE 316
Query: 181 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGS 238
L + SFT + + + L N L L +S N L+ +
Sbjct: 317 SLWVKSCSFT---AACCSHFSSV----LAQN-----------RFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 23/117 (19%), Positives = 36/117 (30%), Gaps = 29/117 (24%)
Query: 133 LEVLSLRSNVLT----GGLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSPQLVV 181
LE L L L+ L S + + P + L + +N+ + + QL
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 182 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGS 238
L L T + ++L + S LR L L N L
Sbjct: 204 LKLESCGVT---SDNCRDL----CGIVASK-----------ASLRELALGSNKLGDV 242
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 24/127 (18%), Positives = 44/127 (34%), Gaps = 24/127 (18%)
Query: 133 LEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGK----IPSSFS--PQLVVLDLS 185
++ L ++ L+ + L + + L + I S+ P L L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 186 FNSFTGNIPQSI-----QNLTQLTGLSLQSNNLSGS---------IPNFDIPKLRHLNLS 231
N + ++ LSLQ+ L+G+ P L+ L+LS
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL---PTLQELHLS 121
Query: 232 YNGLKGS 238
N L +
Sbjct: 122 DNLLGDA 128
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 25/114 (21%), Positives = 44/114 (38%), Gaps = 29/114 (25%)
Query: 133 LEVLSLRSNVLT----GGLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSPQLVV 181
++ LSL++ LT G L S + +LP+L+ L+L N + +L
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146
Query: 182 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 235
L L + S + S + L L++ P + L +S N +
Sbjct: 147 LQLEYCSLS---AASCEPL----ASVLRAK-----------PDFKELTVSNNDI 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 24/115 (20%), Positives = 36/115 (31%), Gaps = 29/115 (25%)
Query: 132 ALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSPQLV 180
LE L ++S T S + L L + +N + L
Sbjct: 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR 373
Query: 181 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 235
VL L+ + S +L +L +N LR L+LS N L
Sbjct: 374 VLWLADCDVS---DSSCSSLAA----TLLAN-----------HSLRELDLSNNCL 410
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 34/227 (14%), Positives = 69/227 (30%), Gaps = 48/227 (21%)
Query: 381 EVLGKGSYGTAYKAV--LEESTTVVVKRLKEVVVGKRDFEQQ--MEI--------VGRVG 428
LG+G++G + + + V +K ++ + + +EI +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALK----IIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 429 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 488
+ V + ++ + ++ + L N PL R +
Sbjct: 81 KF-LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQP-YPLP-HVR-HMAYQLCHA 135
Query: 489 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------------- 535
+ +H + TH ++K N+L + + +
Sbjct: 136 LRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 536 ---------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 573
+R YR PEVI + DV+S G +L E G
Sbjct: 193 HEHHTTIVATRH--YRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 27/109 (24%), Positives = 38/109 (34%), Gaps = 27/109 (24%)
Query: 487 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP----------- 535
+ V +HS K TH ++K N+L Q + + P
Sbjct: 129 KSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 536 -----------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 573
+R YRAPEVI S DV+S G +L+E G
Sbjct: 186 YDDEHHSTLVSTRH--YRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 41/234 (17%), Positives = 71/234 (30%), Gaps = 58/234 (24%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQ----MEIVGRVGQHP---- 431
+G G++G ++ VK VV + + + +I+ ++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVK----VVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 432 NVVPLRAYYYSKD------EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 485
N+V + D E L SL ++ N E +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPL-------GPSLYEIITRN---NYNGFHIEDIKLYCIEI 146
Query: 486 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------- 537
+ + ++ M TH ++K N+L++ R
Sbjct: 147 LKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 538 ----SAG--------------YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 573
A YRAPEVI SD++SFG +L E+ TG
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 22/128 (17%), Positives = 41/128 (32%), Gaps = 25/128 (19%)
Query: 133 LEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---------PQL 179
+ L+L N L G L SL L+ +YL ++ ++
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286
Query: 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-----------SIPNFDIPK-LRH 227
+++D + + I NL + +L +I + +IP LR
Sbjct: 287 ILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRE 346
Query: 228 LNLSYNGL 235
+ L
Sbjct: 347 SIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 26/130 (20%), Positives = 43/130 (33%), Gaps = 29/130 (22%)
Query: 133 LEVLSLRSN--------VLTGGLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSP 177
+ L+LR N L L + ++ L L+ NN + K +S
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANV---NSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 178 QLVVLDLSFNSFTGNIPQSI-----QNLTQLTGLSLQSNNLSGSIPNF------DIPKLR 226
+ LDLS N + + L+L N L G + L+
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 227 HLNLSYNGLK 236
+ L Y+ +K
Sbjct: 257 TVYLDYDIVK 266
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 35/93 (37%), Positives = 43/93 (46%), Gaps = 13/93 (13%)
Query: 152 TSLPS-----LRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSI-QNLTQL 203
S+P+ + LYL N + P F QL LDL N T +P + LTQL
Sbjct: 22 ASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80
Query: 204 TGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
T LSL N L SIP FD + L H+ L N
Sbjct: 81 TQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 16/114 (14%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH----NNFSGKIPSSFSPQLVVLDLSFNS 188
L+ LSL L+ + + + +L L L + F+ + S +L L+LS+
Sbjct: 120 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 179
Query: 189 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD----------IPKLRHLNLSY 232
+ +Q ++ NLSG N P L HL+LS
Sbjct: 180 DFTE--KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 231
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 31/93 (33%), Positives = 42/93 (45%), Gaps = 13/93 (13%)
Query: 152 TSLPS-----LRYLYLQHNNFSGKIPSSFSP--QLVVLDLSFNSFTGNIPQSI-QNLTQL 203
S+P+ + L+L +N + P F L L + N T IP + LTQL
Sbjct: 25 ASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83
Query: 204 TGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 233
T L L N+L SIP FD + L H+ L N
Sbjct: 84 TQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 30/147 (20%), Positives = 46/147 (31%), Gaps = 16/147 (10%)
Query: 117 GLVGPIPNNTLGKLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQH-NNFSGK---I 171
G V P LE + L+ V+T L S + + L L FS
Sbjct: 91 GYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAA 150
Query: 172 PSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI--------- 222
++ L LDL + + + SL S N+S
Sbjct: 151 IAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT-SLVSLNISCLASEVSFSALERLVTR 209
Query: 223 -PKLRHLNLSYNGLKGSIPSSLQKFPN 248
P L+ L L+ + + LQ+ P
Sbjct: 210 CPNLKSLKLNRAVPLEKLATLLQRAPQ 236
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 672 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.91 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.86 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.83 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.75 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.74 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.73 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.73 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.72 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.72 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.69 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.69 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.69 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.69 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.69 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.68 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.67 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.67 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.67 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.67 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.67 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.67 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.66 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.66 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.66 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.65 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.65 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.65 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.65 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.65 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.65 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.64 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.64 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.63 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.63 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.62 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.62 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.61 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.61 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.61 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.61 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.61 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.6 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.59 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.59 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.59 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.58 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.58 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.58 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.58 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.58 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.57 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.57 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.57 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.57 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.56 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.56 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.56 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.56 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.55 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.54 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.53 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.53 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.52 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.52 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.52 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.51 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.51 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.51 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.51 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.5 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.49 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.49 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.48 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.47 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.45 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.43 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.43 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.42 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.42 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.41 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.41 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.4 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.39 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.38 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.37 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.36 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.35 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.35 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.32 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.31 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.29 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.23 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.23 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.22 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.22 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.03 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 99.03 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.82 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.79 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.73 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.72 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.48 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.46 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.45 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.41 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.18 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.17 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.1 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.05 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.0 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.0 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.89 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.71 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.54 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.52 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.28 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.24 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.21 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.2 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.19 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.03 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.87 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.63 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.47 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.32 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.23 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.23 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.12 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.08 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.08 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.8 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.72 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.45 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.07 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.46 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.52 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.34 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 89.15 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 84.15 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=435.09 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=202.2
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|++. +++.||||+++.... ..++|.+|++++.++ +|||||+++|+|.+++..++||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999865 367899999976532 346799999999999 999999999999999999999999
Q ss_pred cCCCchhhhhccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEee
Q 005875 453 FASGSLSTLLHGNRGA----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 522 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 522 (672)
|++|+|.++++..... ...+++|.+++.++.|||.||+|||+.+ ||||||||+||||++++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcc
Confidence 9999999999764321 2346999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhh
Q 005875 523 FGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 595 (672)
Q Consensus 523 fGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 595 (672)
||+|+..... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+ ....+..
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------~~~~i~~ 275 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------AIDCITQ 275 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH------HHHHHHH
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH------HHHHHHc
Confidence 9999865332 23457899999999999999999999999999999999 899998654222 1222211
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
. .... ........+.+|+.+||+.||++||||+||+++|+.+.+..
T Consensus 276 g-~~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 276 G-RELE----------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp T-CCCC----------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred C-CCCC----------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 1 1111 11123345778888999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=427.97 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=203.6
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|++. +++.||||+++.... ..++|.+|+.++.++ +|||||+++|+|.+++..++|||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~~~lV~E 109 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQPLSMIFS 109 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECCEEEEEEE
Confidence 467999999999999963 467899999976533 356899999999999 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEE
Q 005875 452 YFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 520 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl 520 (672)
||++|+|.++|+..... ....++|.+++.++.|||.||+|||+++ ||||||||+||||++++.+||
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEE
Confidence 99999999999754311 1235899999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCC------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHh
Q 005875 521 SDFGLTPLMNV------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 593 (672)
Q Consensus 521 ~DfGla~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 593 (672)
+|||+|+.... .....||+.|||||++.+..|+.++|||||||++|||+| |..||.+....+ ....+
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~------~~~~i 260 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------VVEMI 260 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH------HHHHH
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH------HHHHH
Confidence 99999976532 223457889999999999999999999999999999999 899998654322 11111
Q ss_pred hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 594 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
....... ...++...+.+++.+||+.||++||||+||+++|+.+.
T Consensus 261 -~~~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 261 -RNRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -HcCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1211111 11223456778888999999999999999999998653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=432.10 Aligned_cols=253 Identities=24% Similarity=0.440 Sum_probs=204.8
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|++. +++.||||+++.... ..++|.+|++++.++ +|||||+++|+|.+++..++||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEc
Confidence 578999999999999864 367899999976532 356799999999999 999999999999999999999999
Q ss_pred cCCCchhhhhccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecC
Q 005875 453 FASGSLSTLLHGNR--------GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 524 (672)
Q Consensus 453 ~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 524 (672)
|++|+|.++++... ......++|.+++.++.|||.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCS
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcc
Confidence 99999999997542 122346999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhc
Q 005875 525 LTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 597 (672)
Q Consensus 525 la~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 597 (672)
+|+..... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+ ....+....
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~------~~~~i~~~~ 247 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIECITQGR 247 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHHTC
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHcCC
Confidence 99754322 12347889999999999999999999999999999999 899998654322 122221111
Q ss_pred cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 598 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 598 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
... ........+.+++.+||+.||++|||++||.+.|+++.+..+
T Consensus 248 -~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 248 -VLQ----------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp -CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -CCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 111 111233457788889999999999999999999999986543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=419.86 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=198.2
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|++++ .||||+++..... .+.|.+|+++++++ +|||||+++|++. ++..++|||||++|
T Consensus 41 ~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~-~~~~~iVmEy~~gG 116 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMT-KDNLAIVTQWCEGS 116 (307)
T ss_dssp EEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEEECCSSC
T ss_pred eeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEE-CCeEEEEEEcCCCC
Confidence 5789999999999999763 5999998754433 35789999999999 9999999999885 45789999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----- 531 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----- 531 (672)
+|.++++..+ ..+++.+++.|+.|||.||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 117 sL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 117 SLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp BHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999997533 34999999999999999999999988 99999999999999999999999999986542
Q ss_pred -CCCCCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 532 -PATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
.....||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+....+ ............ +..
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~----p~~ 259 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYAS----PDL 259 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCCC----CCS
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCC----CCc
Confidence 123468999999999964 458999999999999999999999997643221 122222222111 111
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
. .....+...+.+++.+||+.||++||||+||++.|+.++..-
T Consensus 260 ~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 260 S--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp T--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred c--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 0 011123346777888999999999999999999999887543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=424.30 Aligned_cols=261 Identities=22% Similarity=0.305 Sum_probs=196.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCC----eeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD----EKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|++. |+.||||+++........++.|+..+.++ +|||||++++++.+++ ..|+||||+++
T Consensus 8 ~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 468999999999999985 88999999975432222233444444566 8999999999998764 57999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-----GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
|+|.++++.. .++|..+.+++.|++.||+|||+++ .++|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999743 3899999999999999999999861 2459999999999999999999999999997653
Q ss_pred CC--------CCCCCCCcccCcccccCC------CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC--------ChhH
Q 005875 531 VP--------ATPSRSAGYRAPEVIETR------KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV--------DLPR 588 (672)
Q Consensus 531 ~~--------~~~~~~~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~--------~~~~ 588 (672)
.. ....||+.|||||++.+. .++.++|||||||++|||+||..||......+.. ....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 32 124589999999999764 3678999999999999999999887644322110 0111
Q ss_pred HHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 589 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 589 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
.......+. ..++.+.......+....+.+++.+||+.||++||||.||++.|+++.+..
T Consensus 240 ~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 240 EMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 111111111 111221111122355677889999999999999999999999999998653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=419.68 Aligned_cols=240 Identities=20% Similarity=0.341 Sum_probs=199.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|+++++.+ +|||||+++++|.+++..|+|||||++|+
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 157 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGA 157 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEECCCTTEE
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 357999999999999976 58899999997543 3456789999999999 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 533 (672)
|.+++... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 158 L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 158 LTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 99999742 3999999999999999999999998 999999999999999999999999999865432 3
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
+..||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+ ....+. +..... . ...
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~-~~~~~~-----~---~~~ 293 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIR-DNLPPR-----L---KNL 293 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HSSCCC-----C---SCG
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHH-cCCCCC-----C---Ccc
Confidence 5679999999999999999999999999999999999999998643221 112221 111100 0 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+|+.+||+.||++|||++|++++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1223456677889999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=415.31 Aligned_cols=245 Identities=21% Similarity=0.243 Sum_probs=200.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.++||+|+||+||+|++. +++.||||+++.... ..+|++++..+ +|||||++++++.+++..|+||||+++|+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 467999999999999975 478999999975432 34689999998 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-CeEEeecCCCCCCCCC-----
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVP----- 532 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~----- 532 (672)
.++++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 138 ~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 138 GQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9999743 24999999999999999999999998 99999999999999998 6999999999765421
Q ss_pred ----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 533 ----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 533 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+.. ..+.........
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~i~~~~~~~~~------ 277 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LKIASEPPPIRE------ 277 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH------HHHHHSCCGGGG------
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHcCCCCchh------
Confidence 2246899999999999999999999999999999999999999876544321 112211111000
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
... .....+.+++.+||+.||++|||++|++++|....+..
T Consensus 278 ~~~---~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 278 IPP---SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp SCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cCc---cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 011 12345667778999999999999999999998887654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=422.16 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=206.2
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeC-CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV~ 450 (672)
.+.||+|+||+||+|++.. ++.||||+++.... ..+.|.+|++++.++.+|||||+++|+|.++ +..++||
T Consensus 69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~ 148 (353)
T 4ase_A 69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148 (353)
T ss_dssp EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence 5789999999999998643 35799999976533 2457899999999996679999999999764 5689999
Q ss_pred EecCCCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeE
Q 005875 451 DYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 519 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 519 (672)
|||++|+|.++|+..+. .....+++.+++.++.|||.||+|||+++ ||||||||+|||+++++.+|
T Consensus 149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEE
Confidence 99999999999975432 11345899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 005875 520 ISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQS 592 (672)
Q Consensus 520 l~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~ 592 (672)
|+|||+|+...... ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+ .+..
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~------~~~~ 299 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCR 299 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHH
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH------HHHH
Confidence 99999998764332 2246888999999999999999999999999999998 999998654322 2222
Q ss_pred hhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 593 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 593 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.+.+...... .+.....+.+++.+||+.||++|||++||+++|+.+.+...
T Consensus 300 ~i~~g~~~~~----------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 300 RLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp HHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHcCCCCCC----------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 2222221111 11223456788889999999999999999999999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=404.49 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=192.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEe----CCeeEEEEEe
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDY 452 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~ 452 (672)
+.||+|+||+||+|.+. ++..||+|++...... .+.|.+|+++++++ +|||||+++++|.+ ++..|+||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 56999999999999976 4788999999765433 35688999999999 99999999999875 3457999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-CCCeEEeecCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNV 531 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~~ 531 (672)
|++|+|.++++.. ..+++..+..++.||+.||+|||+++ ++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 111 ~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 111 MTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999743 34899999999999999999999985 56999999999999984 79999999999986543
Q ss_pred C--CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 532 P--ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 532 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
. .+..||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.... ......+ ........++
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~i-~~~~~~~~~~----- 252 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRV-TSGVKPASFD----- 252 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHH-TTTCCCGGGG-----
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHHH-HcCCCCCCCC-----
Confidence 3 24569999999999875 6999999999999999999999999753221 1111111 1111111111
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. ....+.+++.+||+.||++|||++|++++
T Consensus 253 -~~---~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 -KV---AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -GC---CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cc---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 11246678889999999999999999873
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=413.24 Aligned_cols=241 Identities=19% Similarity=0.374 Sum_probs=194.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|+.. +++.||||++...... .+.+.+|+++++++ +|||||++++++.+++..|+||||+++
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiVmEy~~g 107 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIVMDYCEG 107 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999975 5889999999765433 35688999999999 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
|+|.+++...+ ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 108 g~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 108 GDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred CcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999997543 234789999999999999999999998 999999999999999999999999999876532
Q ss_pred -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
.+..||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+. ......+....... . ..
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~~~-~-------~~ 247 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISGSFPP-V-------SL 247 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCCCC-C-------CT
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCCCCC-C-------Cc
Confidence 234589999999999999999999999999999999999999986432 22233333322210 0 01
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. ....+.+|+.+||+.||++|||++|++++
T Consensus 248 ~---~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 248 H---YSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp T---SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 22356677889999999999999999873
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=419.74 Aligned_cols=240 Identities=20% Similarity=0.339 Sum_probs=198.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+++++.+ +|||||+++++|.+++..|+|||||++|+
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 367999999999999975 588999999975533 456789999999999 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 533 (672)
|.++++.. .+++.++..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+..... .
T Consensus 235 L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 235 LTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred HHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 99999742 3899999999999999999999998 999999999999999999999999999765432 3
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
+..||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+ ....+. ..... .......+
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~-~~~~~-----~~~~~~~~ 373 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIR-DNLPP-----RLKNLHKV 373 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HSCCC-----CCSCTTSS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHH-cCCCC-----CCcccccC
Confidence 4568999999999999999999999999999999999999997643221 122211 11110 11111122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+.+|+.+||+.||++|||++|++++
T Consensus 374 ---s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 374 ---SPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp ---CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2356677789999999999999999884
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=403.91 Aligned_cols=237 Identities=18% Similarity=0.320 Sum_probs=197.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|++.+.. ...+.+.+|+++++++ +|||||++++++++++..|+||||++
T Consensus 37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 578999999999999975 57899999997542 2346789999999999 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 116 gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 116 NGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999743 24999999999999999999999998 99999999999999999999999999986532
Q ss_pred ---CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 532 ---PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 532 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
..+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+.. .....+...... +
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~~~~---~----- 253 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFAKIIKLEYD---F----- 253 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC---C-----
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCC---C-----
Confidence 23457999999999999999999999999999999999999999864322 222233222211 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
...+ ...+.+++.+||+.||++|||++|++.
T Consensus 254 -p~~~---s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 254 -PEKF---FPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -CTTC---CHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred -Cccc---CHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1112 234567788999999999999999754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=391.06 Aligned_cols=237 Identities=23% Similarity=0.360 Sum_probs=184.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|++.+... ..+.+.+|+++++++ +|||||++++++.+++..|+||||+
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~- 95 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMVIEYA- 95 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEeCC-
Confidence 468999999999999964 588999999975432 245689999999999 9999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 96 ~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 96 GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 67999998743 34999999999999999999999998 999999999999999999999999999876432
Q ss_pred -CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 -ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.+..||+.|||||++.+..| +.++||||+||++|||+||+.||.+.+. ......+...... + .
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~~~~~~---~------p 232 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNISNGVYT---L------P 232 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC---C------C
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCC---C------C
Confidence 34579999999999998886 5799999999999999999999975432 2222222222111 0 1
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+ ...+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~---s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 233 KFL---SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp TTS---CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCC---CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 112 2345677889999999999999999884
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=398.91 Aligned_cols=237 Identities=26% Similarity=0.393 Sum_probs=188.8
Q ss_pred hccccccCcEEEEEEEEC----CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|+.. .++.||+|++++... ....+.+|++++.++ +|||||++++++.+++..|+||||
T Consensus 29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEEEEECC
T ss_pred EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEEc
Confidence 478999999999999863 367899999975432 234688899999998 999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV- 531 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~- 531 (672)
++||+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 108 LRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp CTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999743 24999999999999999999999998 99999999999999999999999999976432
Q ss_pred ---CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 532 ---PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 532 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
..+..||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+..+ ....+......
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~~~--------- 244 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTMILKAKLG--------- 244 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC---------
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHHHHcCCCC---------
Confidence 234579999999999999999999999999999999999999998654222 22222222110
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVR 643 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 643 (672)
....+ ...+.+++.+||+.||++|||+ +|+++
T Consensus 245 ~p~~~---s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 MPQFL---SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCTTS---CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCcC---CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 01112 2345677789999999999984 56665
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=388.07 Aligned_cols=240 Identities=21% Similarity=0.362 Sum_probs=182.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC------------
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------------ 444 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------------ 444 (672)
.+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|+++++++ +|||||++++++.+.+
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~~~~~~ 88 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQPSSPKV 88 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC----------CE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccccCCCc
Confidence 468999999999999975 578999999865432 245688999999999 9999999999997654
Q ss_pred eeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecC
Q 005875 445 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 524 (672)
Q Consensus 445 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 524 (672)
..|+||||+++|+|.+++..... ....++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCC
T ss_pred EEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCc
Confidence 36899999999999999975431 233567788999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCC----------------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 005875 525 LTPLMNVP----------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 588 (672)
Q Consensus 525 la~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~ 588 (672)
+|+..... .+..||+.|||||++.+..|+.++|||||||++|||++ ||.... +...
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~ 235 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERVR 235 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHH
Confidence 99875432 12358999999999999999999999999999999996 775321 0001
Q ss_pred HHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 589 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 589 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......... +.+ ..........+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~-----~p~------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 TLTDVRNLK-----FPP------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHTTC-----CCH------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCC-----CCC------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111000 000 112233445678889999999999999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=381.43 Aligned_cols=187 Identities=23% Similarity=0.459 Sum_probs=163.6
Q ss_pred hccccccCcEEEEEEEEC----CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|+.+ .++.||+|++.... ....+.+|++++..+.+|||||++++++.+++..|+||||+++
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g 104 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH 104 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence 468999999999999853 35789999986543 3556889999999987899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC-CCeEEeecCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~~~-- 532 (672)
|+|.++++ .+++.++..++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 105 ~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 105 ESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred ccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 99999984 2899999999999999999999998 9999999999999877 79999999999644221
Q ss_pred ------------------------------CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 005875 533 ------------------------------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSP 578 (672)
Q Consensus 533 ------------------------------~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~ 578 (672)
.+..||+.|||||++.+. .|+.++||||+||++|||++|+.||...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 124589999999999775 4899999999999999999999999654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=381.03 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=191.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeC------CeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 449 (672)
.+.||+|+||+||+|+.. +++.||||+++..... .+.+.+|+++++.+ +|||||++++++... +..|+|
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~~~~iv 137 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVV 137 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCCEEEEE
Confidence 468999999999999975 5889999999765433 34577899999999 999999999997643 578999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
||||+ |+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 138 mE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 138 LDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeec
Confidence 99996 6899999743 35999999999999999999999998 999999999999999999999999999765
Q ss_pred CC--------CCCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc-
Q 005875 530 NV--------PATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT- 599 (672)
Q Consensus 530 ~~--------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 599 (672)
.. ..+..||+.|||||++.+. .++.++||||+||++|||++|++||.+.+..+. ...+......
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~------l~~I~~~~g~p 282 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ------LQLIMMVLGTP 282 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH------HHHHHHHHCCC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH------HHHHHHhcCCC
Confidence 32 2345789999999998875 468999999999999999999999987543221 1111110000
Q ss_pred -cccc--------h---hhhhc--ccChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 600 -AEVF--------D---VELMR--FQNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 600 -~~~~--------d---~~~~~--~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+ . ..+.. ..... .....+.+|+.+||+.||++|||++|++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0 00000 00000 112356778889999999999999999984
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=362.69 Aligned_cols=267 Identities=27% Similarity=0.520 Sum_probs=223.5
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|++.+++.||+|++..... ..+.+.+|++++..+ +||||+++++++.+++..++||||+++|+|
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYKYMENGNL 122 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence 367999999999999988899999999876533 346788999999888 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----- 533 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----- 533 (672)
.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 123 ~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 123 KRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp GGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999975432 2345899999999999999999999998 9999999999999999999999999987543221
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...+++.|+|||++.+..++.++||||||+++|||++|+.||......+......|..............++.... ..
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 277 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KI 277 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT-CS
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc-cc
Confidence 2236788999999998899999999999999999999999999877777777777765544444444444443322 22
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
..+....+.+++.+||+.||++|||++|++++|+.+.+..
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 3567788999999999999999999999999999987653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=389.81 Aligned_cols=242 Identities=18% Similarity=0.270 Sum_probs=191.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHc--CCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.++||+|+||+||+|+.. +++.||+|++.+... ......+|..++..+. +|||||+++++|.+++..|+||||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy 273 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 273 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence 468999999999999976 478999999975422 2233445544444332 799999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV- 531 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~- 531 (672)
++||+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+....
T Consensus 274 ~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 274 MNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp CCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999743 24999999999999999999999998 99999999999999999999999999987643
Q ss_pred -CCCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 532 -PATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
..+.+||+.|||||++.. ..|+.++||||+||++|||++|++||.+....+. ......+..... ..
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~~~~~---------~~ 413 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTMAV---------EL 413 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHHHCCC---------CC
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcCCCC---------CC
Confidence 345679999999999964 5799999999999999999999999976443321 111111111111 01
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 644 (672)
...++ ..+.+|+.+||+.||++|++ ++||+++
T Consensus 414 p~~~S---~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 414 PDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CTTSC---HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CccCC---HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11122 34567777999999999998 7888763
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=392.06 Aligned_cols=243 Identities=20% Similarity=0.392 Sum_probs=198.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|+.. +++.||+|++..... ..+.+.+|+++++.+ +|||||+++++|.+++..|+|||||++|+
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 468999999999999975 578999999876532 356788999999999 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC--CCeEEeecCCCCCCCCCC--
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD--LDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~--~~~kl~DfGla~~~~~~~-- 533 (672)
|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+......
T Consensus 241 L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 241 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp HHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred HHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999996432 34899999999999999999999998 9999999999999854 899999999998765433
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ ....+....+.. .. .....
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~~~i~~~~~~~---~~--~~~~~ 382 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDWNM---DD--SAFSG 382 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTCCCC---CS--GGGTT
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHhCCCCC---Cc--ccccC
Confidence 3468999999999999999999999999999999999999998654322 122222221110 00 01112
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
++ ..+.+|+.+||+.||++|||++|++++
T Consensus 383 ~s---~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 383 IS---EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22 345677789999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.73 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=201.8
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCC----eeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD----EKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|++. ++.||||++.........++.|+.++.++ +||||+++++++.+.. ..++||||+++
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 468999999999999987 78999999976544445566788888888 8999999999998754 36999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCcccCCCCCCCEEecCCCCeEEeecCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM----------GGPKFTHGNIKASNVLINQDLDGCISDFGL 525 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~----------~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 525 (672)
|+|.++++.. .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 107 g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 107 GSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999742 389999999999999999999998 7 99999999999999999999999999
Q ss_pred CCCCCCC------CCCCCCCcccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHH-----
Q 005875 526 TPLMNVP------ATPSRSAGYRAPEVIETR-----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW----- 589 (672)
Q Consensus 526 a~~~~~~------~~~~~~~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~----- 589 (672)
++..... ....+|+.|+|||++.+. .++.++|||||||++|||+||+.||.+............
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9654322 224578999999999863 456788999999999999999999987655443322111
Q ss_pred -----HHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 590 -----VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 590 -----~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
......... .+..............+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 258 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 258 SLEDMQEVVVHKKK-----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CHHHHHHHHTTSCC-----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccC-----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111111 111111111123456688999999999999999999999999999865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=360.65 Aligned_cols=278 Identities=38% Similarity=0.682 Sum_probs=223.2
Q ss_pred CCCHHHHHHHH-----hccccccCcEEEEEEEECCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEE
Q 005875 369 NFDLEDLLRAS-----AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYY 441 (672)
Q Consensus 369 ~~~~~~l~~~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 441 (672)
.|+..++.... .+.||+|+||+||+|+..+++.||||++..... ....+.+|++++..+ +||||+++++++.
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 97 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 97 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEEC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEe
Confidence 34555554433 468999999999999988899999999976532 334688999999888 8999999999999
Q ss_pred eCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEe
Q 005875 442 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 521 (672)
Q Consensus 442 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 521 (672)
+++..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+...++|+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999986543 34459999999999999999999999922239999999999999999999999
Q ss_pred ecCCCCCCCCC-----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC--CCCCCChhHHHHHhh
Q 005875 522 DFGLTPLMNVP-----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT--RDDMVDLPRWVQSVV 594 (672)
Q Consensus 522 DfGla~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~--~~~~~~~~~~~~~~~ 594 (672)
|||++...... ....+++.|+|||++.+..++.++||||||+++|||++|+.||.... .........|.....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999765432 22347899999999998889999999999999999999999996321 122334555665555
Q ss_pred hhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 595 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 595 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
.........+.... .....+....+.+++.+||+.||++|||++|++++|+...
T Consensus 257 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 55444444444332 2334677888999999999999999999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=353.95 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=196.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+.. ++.||||++...... .+.+.+|++++.++ +||||+++++++.+.+..++||||+++|
T Consensus 42 ~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred eeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCceEEEEecCCCC
Confidence 468999999999999874 788999998765433 24688899999999 8999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 196 (309)
T 3p86_A 120 SLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS 196 (309)
T ss_dssp BHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------------
T ss_pred cHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccccccc
Confidence 99999975321 123899999999999999999999985 45999999999999999999999999999765432
Q ss_pred CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 533 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ ............. .
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~~~~----------~ 260 (309)
T 3p86_A 197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKCKRLE----------I 260 (309)
T ss_dssp -----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSCCCCC----------C
T ss_pred ccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCCCC----------C
Confidence 23457899999999999999999999999999999999999997543221 1111110110000 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.......+.+++.+||+.||++|||++|+++.|+.+.+...
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 11122456778889999999999999999999999987643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=350.09 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=203.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|... +++.||+|++.... ...+.+.+|++++.++ +||||+++++++.+++..++||||+++|+
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGT 93 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence 478999999999999975 47889999886542 2346788999999999 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC----
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---- 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~---- 533 (672)
|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 94 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 94 LRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp HHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999997532 34899999999999999999999998 9999999999999999999999999997653221
Q ss_pred --------------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 534 --------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 534 --------------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
...||+.|+|||++.+..++.++||||||+++|||++|..||............ ..........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~- 244 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-NVRGFLDRYC- 244 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-CHHHHHHHTC-
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-hhhccccccC-
Confidence 345788999999999999999999999999999999999999764433221100 0000000000
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.......+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 245 -------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 245 -------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp -------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 01112346778889999999999999999999999986543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=359.12 Aligned_cols=254 Identities=25% Similarity=0.413 Sum_probs=204.4
Q ss_pred hccccccCcEEEEEEEEC--------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 449 (672)
.+.||+|+||+||+|+.. ++..||||+++.... ..+.+.+|++++.++.+||||+++++++.+++..++|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 578999999999999863 345699999976532 2356889999999987899999999999999999999
Q ss_pred EEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCe
Q 005875 450 YDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 518 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 518 (672)
|||+++|+|.+++...... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 242 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM 242 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCE
Confidence 9999999999999764321 1234899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 005875 519 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 591 (672)
Q Consensus 519 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~ 591 (672)
||+|||+++...... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+. ..
T Consensus 243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~------~~ 316 (370)
T 2psq_A 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------FK 316 (370)
T ss_dssp EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------HH
T ss_pred EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HH
Confidence 999999997554321 2234678999999999999999999999999999999 9999986543221 11
Q ss_pred HhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 592 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
......... ........+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 317 -~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 317 -LLKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp -HHHTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -HHhcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111111111 011223457778889999999999999999999999987654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=340.71 Aligned_cols=247 Identities=25% Similarity=0.440 Sum_probs=206.9
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|+..+++.||+|++.......+++.+|++++.++ +||||+++++++.+++..++||||+++|+|.
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 468999999999999998889999999988777778899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-----CCC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-----PAT 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-----~~~ 534 (672)
+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..... ...
T Consensus 94 ~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 94 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 9997533 34899999999999999999999998 99999999999999999999999999976543 223
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+ ....+... ... .. .
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~~~~-~~~--~~--------~ 229 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTG-FRL--YK--------P 229 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTT-CCC--CC--------C
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhcC-ccC--CC--------C
Confidence 445678999999998999999999999999999999 999997543221 11111111 000 00 0
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
......+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11224567788899999999999999999999999865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=347.28 Aligned_cols=240 Identities=23% Similarity=0.348 Sum_probs=196.9
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|.. .+++.||+|++.... ...+.+.+|+.++..+ +||||+++++++..++..++||||+++|+
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 36899999999999996 468899999987553 3456788999999998 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 533 (672)
|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...... .
T Consensus 104 L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 99999743 3899999999999999999999998 999999999999999999999999998765432 2
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+++.|+|||++.+..++.++|||||||++|||++|+.||...... ............ . ....
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~-~--------~~~~ 239 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-E--------LQNP 239 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-C--------CSCG
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-C--------CCCc
Confidence 345789999999999999999999999999999999999999754321 111111111110 0 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1223456778889999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.74 Aligned_cols=248 Identities=22% Similarity=0.360 Sum_probs=204.2
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|.+.++..||+|+++......+++.+|++++.++ +||||+++++++.+++..++||||+++|+|.
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence 468999999999999999888999999988777788899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-----CCC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-----PAT 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-----~~~ 534 (672)
+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..... ...
T Consensus 108 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (283)
T 3gen_A 108 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180 (283)
T ss_dssp HHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence 9997532 23899999999999999999999998 99999999999999999999999999976533 223
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+... ... . ..
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~-~~~--~--------~~ 243 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQG-LRL--Y--------RP 243 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTT-CCC--C--------CC
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHHHhcc-cCC--C--------CC
Confidence 345678999999998899999999999999999998 999997543211 11111111 000 0 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
......+.+++.+||+.+|++|||++|++++|+++.+.+
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 111245677888999999999999999999999998664
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=338.96 Aligned_cols=248 Identities=26% Similarity=0.425 Sum_probs=205.0
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|+..++..||+|+++......+++.+|++++.++ +||||+++++++.+++..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 468999999999999999888999999988777778899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----C
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 534 (672)
+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 92 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 92 NYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp HHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred HHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 9997532 24899999999999999999999998 9999999999999999999999999987654322 2
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ .......... ...+
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~---~~~~-------- 227 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGHR---LYRP-------- 227 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTCC---CCCC--------
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcCCC---CCCC--------
Confidence 335667999999998889999999999999999999 999997543211 1111111110 0000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
......+.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 111235677888999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=354.46 Aligned_cols=251 Identities=27% Similarity=0.450 Sum_probs=201.5
Q ss_pred hccccccCcEEEEEEEEC----CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||+||+|++. .+..||||+++.... ..+.+.+|++++.++ +||||+++++++.+++..++||||+
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCCEEEEECC
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCccEEEeeCC
Confidence 478999999999999974 345699999976432 245788999999999 8999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++|+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 133 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 133 ENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred CCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999997432 34899999999999999999999998 9999999999999999999999999997654322
Q ss_pred -------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 534 -------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 534 -------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
...+++.|+|||++.+..++.++||||||+++|||++ |..||......+ ....+.. ....
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~-~~~~----- 273 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISSVEE-GYRL----- 273 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHT-TCCC-----
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHc-CCCC-----
Confidence 1224567999999998899999999999999999999 999997543221 1111111 1100
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 655 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 655 (672)
.........+.+++.+||+.||++|||++|+++.|+.+.+.....
T Consensus 274 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 274 -----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred -----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 001122345778888999999999999999999999998776543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.70 Aligned_cols=270 Identities=29% Similarity=0.529 Sum_probs=213.2
Q ss_pred CCCHHHHHHHHh-----------ccccccCcEEEEEEEECCCcEEEEEEeccccc-----ChhhHHHHHHHHHHHcCCCc
Q 005875 369 NFDLEDLLRASA-----------EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPN 432 (672)
Q Consensus 369 ~~~~~~l~~~~~-----------~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~n 432 (672)
.|+.+++...+. +.||+|+||+||+|.. +++.||+|++..... ..+.+.+|++++..+ +|||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 91 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHEN 91 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTT
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCC
Confidence 466677766652 6799999999999997 478999999875421 245688999999999 9999
Q ss_pred eeceEEEEEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe
Q 005875 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 512 (672)
Q Consensus 433 iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl 512 (672)
|+++++++.+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999975332 345899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 005875 513 NQDLDGCISDFGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586 (672)
Q Consensus 513 ~~~~~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~ 586 (672)
+.++.+||+|||++...... ....+++.|+|||++.+ .++.++||||||+++|||++|..||......+...
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~- 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL- 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT-
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH-
Confidence 99999999999998765432 23457889999999875 58899999999999999999999998765443221
Q ss_pred hHHHHHhhhhcc-ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 587 PRWVQSVVREEW-TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 587 ~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
.+......... ....++... ..........+.+++.+||+.||++|||++|++++|+++.+
T Consensus 245 -~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 -DIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp -HHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred -HHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22221111110 111111111 11234566788899999999999999999999999999865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.70 Aligned_cols=251 Identities=23% Similarity=0.398 Sum_probs=193.7
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHH-cCCCceeceEEEEEeC----CeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV-GQHPNVVPLRAYYYSK----DEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~----~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+. +++.||||++... ....+..|.+++... .+||||+++++++... ...++||||++
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~ 89 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence 46899999999999998 5889999998653 245566777777663 2899999999997653 45789999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcccCCCCCCCEEecCCCCeEEeecCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH--------SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 526 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--------~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 526 (672)
+|+|.++++. ..+++..+..++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 90 MGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp TCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 9999999963 24899999999999999999999 766 999999999999999999999999998
Q ss_pred CCCCCC--------CCCCCCCcccCcccccCC------CCCCccchhhHHHHHHHHHhC----------CCCCCCCCCCC
Q 005875 527 PLMNVP--------ATPSRSAGYRAPEVIETR------KHSHKSDVYSFGVLLLEMLTG----------KAPLQSPTRDD 582 (672)
Q Consensus 527 ~~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~el~tg----------~~pf~~~~~~~ 582 (672)
+..... ....+|+.|+|||++.+. .++.++|||||||++|||++| +.||......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 654322 223688999999999876 455789999999999999999 78876543322
Q ss_pred CCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 583 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
.. . ................. ...........+.+++.+||+.||++|||++|+++.|+++
T Consensus 241 ~~-~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PS-F-EDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CC-H-HHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-h-hhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 11 1 11111111111111111 1111234567788999999999999999999999999976
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=345.70 Aligned_cols=253 Identities=15% Similarity=0.163 Sum_probs=204.0
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|++++..+.+||||+++++++..++..++||||+ +|+|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL 91 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence 46899999999999996 467889999987543 34578999999999989999999999999999999999999 9999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC-----eEEeecCCCCCCCCC-
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-----GCISDFGLTPLMNVP- 532 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~-----~kl~DfGla~~~~~~- 532 (672)
.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 92 EDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99997532 34999999999999999999999998 999999999999999887 999999999765332
Q ss_pred ----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 533 ----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 533 ----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.. .....+........
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~---~~~~~i~~~~~~~~- 240 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK---ERYQKIGDTKRATP- 240 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH---HHHHHHHHHHHHSC-
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH---HHHHHHHhhhccCC-
Confidence 2345789999999999999999999999999999999999999876433321 11111111110000
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
... ..... ..+.+++.+||+.||++||+++++.+.|+++.+..
T Consensus 241 -~~~--~~~~~----p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 241 -IEV--LCENF----PEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -HHH--HTTTC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -HHH--HhccC----hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 000 00111 16778888999999999999999999999987654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=344.43 Aligned_cols=239 Identities=21% Similarity=0.308 Sum_probs=196.1
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.++.++ +||||+++++++...+..++||||+++|+|
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 129 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEecCCCCCH
Confidence 47999999999999976 689999999875533 356788999999998 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----CC
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----AT 534 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 534 (672)
.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 130 ~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 130 TDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp HHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 999863 23899999999999999999999998 999999999999999999999999998765432 23
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChH
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 614 (672)
..+|+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+. ....... . ...
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------~~~~~~~-~~~~~~~-----~---~~~ 265 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRLR-DSPPPKL-----K---NSH 265 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSSCCCC-----T---TGG
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh-cCCCCCc-----C---ccc
Confidence 46889999999999999999999999999999999999999754321 1111111 1111000 0 001
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 615 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.....+.+++.+||+.||++|||++|++++
T Consensus 266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 266 KVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122356778889999999999999999885
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=356.53 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=207.0
Q ss_pred hccccccCcEEEEEEEEC--------CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 449 (672)
.+.||+|+||+||+|+.. ++..||+|+++..... .+.+.+|++++.++.+||||+++++++.+++..++|
T Consensus 74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 153 (382)
T 3tt0_A 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153 (382)
T ss_dssp EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence 468999999999999863 2357999999765332 356889999999998899999999999999999999
Q ss_pred EEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCe
Q 005875 450 YDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 518 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 518 (672)
|||+++|+|.+++...... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 230 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 230 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcE
Confidence 9999999999999764321 1235999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 005875 519 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 591 (672)
Q Consensus 519 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~ 591 (672)
||+|||+++...... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+ ...
T Consensus 231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~------~~~ 304 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFK 304 (382)
T ss_dssp EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHH
T ss_pred EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence 999999998664322 2235678999999999999999999999999999999 999997543221 111
Q ss_pred HhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCC
Q 005875 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 659 (672)
Q Consensus 592 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~s~ 659 (672)
. +........ .......+.+++.+||+.||++|||++|+++.|+.+.......+...
T Consensus 305 ~-~~~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 361 (382)
T 3tt0_A 305 L-LKEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY 361 (382)
T ss_dssp H-HHTTCCCCC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred H-HHcCCCCCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence 1 111111100 01123456778889999999999999999999999998776544433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.52 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=203.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|++...... .+.+.+|+.++.++ +||||+++++++.+++..++||||++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 94 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYYLVMEYIE 94 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEEEEEeCCC
Confidence 468999999999999965 5789999998654322 34678899999998 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 95 g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 95 GPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp SCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999743 24899999999999999999999998 9999999999999999999999999997654322
Q ss_pred ----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 534 ----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 534 ----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
...+++.|+|||++.+..++.++||||||+++|||++|+.||.+....+ ........... ......
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~----~~~~~~ 236 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDSVP----NVTTDV 236 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSCCC----CHHHHS
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhccCC----Ccchhc
Confidence 2347899999999999999999999999999999999999997643211 11111111110 000000
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhhcCCCCCCCCcccCC
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDSENRPSSEENKS 664 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~~~~~s~~~~~~ 664 (672)
.. .....+.+++.+||+.||++|| +++++.+.|+.+......++...+..+.
T Consensus 237 ~~---~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~ 289 (294)
T 4eqm_A 237 RK---DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKM 289 (294)
T ss_dssp CT---TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCCCC----
T ss_pred cc---CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcchhhhhcc
Confidence 11 1224567788899999999999 8999999999988776555544444433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.16 Aligned_cols=255 Identities=17% Similarity=0.193 Sum_probs=204.2
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|+. .+++.||+|++.... ..+.+.+|++++..+.+|+|++++++++.++...++||||+ +++|
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 92 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 92 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence 46899999999999996 568899999986543 34678899999999988999999999999999999999999 9999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC-----eEEeecCCCCCCCCC-
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-----GCISDFGLTPLMNVP- 532 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~-----~kl~DfGla~~~~~~- 532 (672)
.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||++......
T Consensus 93 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 93 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99997532 24899999999999999999999998 999999999999988776 999999999765432
Q ss_pred ----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 533 ----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 533 ----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
....+|+.|+|||++.+..++.++||||||+++|||++|+.||.+......... ...+.........
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~ 242 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK---YERIGEKKQSTPL 242 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH---HHHHHHHHHHSCH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH---HHHHHhhccCccH
Confidence 233578899999999999999999999999999999999999987543322111 1111111100000
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
... .. .....+.+++.+||+.||++||+++++++.|+++.+...
T Consensus 243 --~~~--~~---~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 243 --REL--CA---GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp --HHH--TT---TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --HHH--Hh---hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 000 00 123457788889999999999999999999999987643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=367.61 Aligned_cols=248 Identities=24% Similarity=0.440 Sum_probs=205.1
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|.+.++..||||+++......+.+.+|++++.++ +||||+++++++. ++..++||||+++|+|.
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 468999999999999998889999999987766778899999999999 9999999999986 66789999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-----CC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----AT 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-----~~ 534 (672)
++++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 271 ~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 271 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp HHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred HHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence 9997432 123889999999999999999999998 999999999999999999999999999865431 22
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||++....++.++|||||||++|||+| |+.||.+....+ ....+. ..... ...
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~-~~~~~----------~~~ 407 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALE-RGYRM----------PRP 407 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHH-HTCCC----------CCC
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-cCCCC----------CCC
Confidence 335678999999998899999999999999999999 999997643221 111111 11110 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
......+.+++.+||+.||++|||+++|++.|+++....
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 123346778888999999999999999999999887543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=345.47 Aligned_cols=238 Identities=19% Similarity=0.316 Sum_probs=196.1
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||+|+. .+++.||||++...... .+.+.+|+++++.+ +||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 98 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLIMEYASG 98 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEECCCC
Confidence 46899999999999997 56889999999765433 34577899999998 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 99 GEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp CBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 9999999643 24899999999999999999999998 999999999999999999999999999765432
Q ss_pred CCCCCCCcccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 ATPSRSAGYRAPEVIETRKHS-HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
....+|+.|+|||++.+..+. .++||||+||++|||++|+.||.+... ......+....... .
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~---------p- 234 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRGKYRI---------P- 234 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC---------C-
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC---------C-
Confidence 345689999999999888775 789999999999999999999976432 12222222211110 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.||++|||++|++++
T Consensus 235 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 --FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122346678889999999999999999885
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=344.80 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=196.2
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHH-cCCCceeceEEEEEeC----CeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV-GQHPNVVPLRAYYYSK----DEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~----~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. ++.||||++.... ...+..|.+++... .+||||+++++++... ...++||||++
T Consensus 42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 118 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE 118 (337)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCT
T ss_pred EeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccC
Confidence 578999999999999986 8899999986543 33445555555443 2899999999999887 67899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCcccCCCCCCCEEecCCCCeEEeecCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM--------GGPKFTHGNIKASNVLINQDLDGCISDFGLT 526 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~--------~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 526 (672)
+|+|.++++.. .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 119 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 119 NGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCc
Confidence 99999999743 389999999999999999999988 6 999999999999999999999999999
Q ss_pred CCCCCCC--------CCCCCCcccCcccccCCCCCCc------cchhhHHHHHHHHHhC----------CCCCCCCCCCC
Q 005875 527 PLMNVPA--------TPSRSAGYRAPEVIETRKHSHK------SDVYSFGVLLLEMLTG----------KAPLQSPTRDD 582 (672)
Q Consensus 527 ~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~------~DvwS~Gvvl~el~tg----------~~pf~~~~~~~ 582 (672)
....... ...+|+.|+|||++.+..+..+ +|||||||++|||+|| ..||......+
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 6553321 3457899999999988776665 9999999999999999 55554432222
Q ss_pred CCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 583 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
. . .............. +.........+....+.+++.+||+.||++|||++|++++|+.+.+...
T Consensus 270 ~-~-~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 270 P-S-YEDMREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp C-C-HHHHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred C-c-hhhhHHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 1 1 11111111111111 1111111123566778899999999999999999999999999987653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=358.98 Aligned_cols=246 Identities=25% Similarity=0.408 Sum_probs=202.1
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCC-eeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|.+. ++.||||+++... ..+.+.+|++++.++ +||||+++++++.+.+ ..++||||+++|+|
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 578999999999999986 6799999997654 457899999999999 9999999999988765 78999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-CCCC
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR 537 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~ 537 (672)
.++++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...+
T Consensus 275 ~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 348 (450)
T 1k9a_A 275 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 348 (450)
T ss_dssp HHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------CC
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCC
Confidence 99997532 234789999999999999999999998 9999999999999999999999999997554322 2345
Q ss_pred CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHH
Q 005875 538 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 616 (672)
Q Consensus 538 ~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 616 (672)
++.|+|||++.+..++.++|||||||++|||++ |+.||......+. . .. +....... .....
T Consensus 349 ~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~---~~-i~~~~~~~----------~p~~~ 411 (450)
T 1k9a_A 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V---PR-VEKGYKMD----------APDGC 411 (450)
T ss_dssp CTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---H---HH-HHTTCCCC----------CCTTC
T ss_pred CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---HH-HHcCCCCC----------CCCcC
Confidence 778999999999999999999999999999998 9999986544331 1 11 11111111 11123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 617 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 617 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
...+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 34677888899999999999999999999999765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=342.06 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=193.7
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+..+++.||+|++...... ...+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~- 103 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERCLTLVFEFMEK- 103 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSCEEEEEECCSE-
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCEEEEEEcCCCC-
Confidence 4689999999999999988999999999754332 35688999999999 999999999999999999999999985
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 104 DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 8888886433 34899999999999999999999998 999999999999999999999999999765432
Q ss_pred CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccccc---chh---
Q 005875 533 ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV---FDV--- 605 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~d~--- 605 (672)
....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.. ............... .+.
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhhhccchh
Confidence 23457889999999876 56899999999999999999999999876544321 111111111000000 000
Q ss_pred ---hhh--cccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 606 ---ELM--RFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 606 ---~~~--~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... .... .......+.+++.+||+.||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 0000 01122456788889999999999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=361.12 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=200.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|++. +++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+++..++||||+++|
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 578999999999999986 688999999875432 235688899999998 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.++++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 198 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 198 DFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp BHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999997432 24899999999999999999999998 9999999999999999999999999987643321
Q ss_pred ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 534 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
...+++.|+|||++.+..++.++|||||||++|||++ |..||......+ ............
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~-------- 335 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGRLP-------- 335 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCCCC--------
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC--------
Confidence 1123557999999998899999999999999999998 999997643221 111111111100
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
........+.+++.+||+.||++|||++|+++.|+++...
T Consensus 336 --~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 --CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0111234567888899999999999999999999999754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=335.52 Aligned_cols=245 Identities=25% Similarity=0.393 Sum_probs=189.1
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeccccc-----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|.+. ++.||||+++.... ..+.+.+|++++..+ +||||+++++++.+++..++||||++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCLVMEFAR 89 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CEEEEECCT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEEEEEcCC
Confidence 468999999999999986 78899999875432 235788999999998 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC--------CCCeEEeecCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--------DLDGCISDFGLT 526 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~--------~~~~kl~DfGla 526 (672)
+++|.+++.. ..+++..+..++.|++.||+|||+.+..+|+||||||+||+++. ++.+||+|||++
T Consensus 90 ~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 90 GGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp TEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred CCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 9999999963 24899999999999999999999987556899999999999986 778999999999
Q ss_pred CCCCCCC--CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 527 PLMNVPA--TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 527 ~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
....... ...+++.|+|||++.+..++.++||||||+++|||++|+.||.+..... .............
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~--- 234 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVAMNKLALP--- 234 (271)
T ss_dssp ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHTSCCCCC---
T ss_pred cccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhhcCCCCCC---
Confidence 7654332 3457889999999999899999999999999999999999997543211 1111111111100
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
........+.+++.+||+.||++|||++|++++|+++
T Consensus 235 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 235 -------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0112234577888899999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.53 Aligned_cols=241 Identities=21% Similarity=0.350 Sum_probs=196.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|+.. +++.||+|+++.... ..+.+.+|+.++..+ +||||+++++++.+.+..++|||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e 95 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENRTDVVLILE 95 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeCCEEEEEEE
Confidence 468999999999999976 578899999976532 235788999999999 89999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC----CeEEeecCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP 527 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DfGla~ 527 (672)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++.
T Consensus 96 ~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 96 LVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp CCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999642 34899999999999999999999998 99999999999998877 79999999997
Q ss_pred CCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 528 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 528 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
..... ....||+.|+|||++.+..++.++|||||||++|||++|..||.+....+ ....+...... ++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~i~~~~~~---~~ 238 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITAVSYD---FD 238 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTCCC---CC
T ss_pred EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCC---CC
Confidence 66443 34568999999999999999999999999999999999999997643221 11222111110 11
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.. .... ....+.+++.+||..||++|||++|+++
T Consensus 239 ~~--~~~~---~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 239 EE--FFSQ---TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HH--HHTT---SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ch--hccC---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 0111 1234667788999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=365.32 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=206.3
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|.+.+ +..||||+++......+++.+|++++.++ +||||+++++++.+++..++||||+++|+|
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~E~~~~g~L 303 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 303 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence 4689999999999999875 78899999987766778899999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----- 533 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----- 533 (672)
.++++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 304 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 304 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred HHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 99997533 234899999999999999999999998 9999999999999999999999999998654321
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...++..|+|||++.+..++.++|||||||++|||++ |..||.+....+. . ..+....... .
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~----~~~~~~~~~~----------~ 440 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y----ELLEKDYRME----------R 440 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H----HHHHTTCCCC----------C
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHcCCCCC----------C
Confidence 2234668999999998899999999999999999999 9999986543221 1 1111111111 1
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.......+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 112234567788899999999999999999999988644
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=348.05 Aligned_cols=245 Identities=19% Similarity=0.294 Sum_probs=194.5
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.++||+|+||+||+|+..+ ++.||+|++++.... .+.+..|..++.++.+||||+++++++.+++..++||||++
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 136 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence 4689999999999999764 678999999765322 34578899999888789999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 137 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 137 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 99999999743 24899999999999999999999998 99999999999999999999999999975322
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC--ChhHHHHHhhhhccccccchhhhh
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV--DLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .........+..... .
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------~ 280 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------R 280 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--------C
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--------C
Confidence 23456899999999999999999999999999999999999999754322211 111111111111100 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVR 643 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 643 (672)
... .....+.+++.+||+.||++||++ +|+++
T Consensus 281 ~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 281 IPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp CCT---TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred CCC---cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 011 122356677889999999999995 66665
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=344.78 Aligned_cols=243 Identities=21% Similarity=0.334 Sum_probs=198.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|... +++.+|+|.+.........+.+|++++..+ +||||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 467999999999999976 467899999876554556788999999998 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC--CCCeEEeecCCCCCCCCCC---
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--DLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~--~~~~kl~DfGla~~~~~~~--- 533 (672)
.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++.......
T Consensus 89 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 161 (321)
T 1tki_A 89 FERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence 99996432 34899999999999999999999998 999999999999997 7899999999998765432
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+++.|+|||++.+..++.++|||||||++|||++|..||.+.... .....+...... ++.. ...
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~---~~~~--~~~-- 228 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYT---FDEE--AFK-- 228 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC---CCHH--HHT--
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCCCC---CChh--hhc--
Confidence 234788999999999988999999999999999999999999764322 112222221111 0000 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.....+.+++.+||+.||++|||+.|++++
T Consensus 229 -~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 229 -EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 122456778889999999999999999984
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.32 Aligned_cols=247 Identities=25% Similarity=0.416 Sum_probs=206.0
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||.||+|...+++.||+|++.......+.+.+|++++.++ +||||+++++++.+++..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 468999999999999998888999999988776778899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-----CCC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-----PAT 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-----~~~ 534 (672)
+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..... ...
T Consensus 92 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 92 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp HHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 9997543 34899999999999999999999998 99999999999999999999999999876532 223
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+... .... . .
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i~~~-~~~~--~-----~--- 227 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG-FRLY--K-----P--- 227 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT-CCCC--C-----C---
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHHhcC-CcCC--C-----C---
Confidence 445678999999998889999999999999999999 89999754321 111111111 1000 0 0
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
......+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11224567788899999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=336.38 Aligned_cols=264 Identities=17% Similarity=0.253 Sum_probs=205.6
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCC--eeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+... ++.||||++.... ...+.+.+|++++.++ +||||+++++++...+ ..++||||++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEEEEEeCCC
Confidence 4689999999999999764 7899999997543 2356788999999999 8999999999998765 7799999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe----cCCCCeEEeecCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DfGla~~~~ 530 (672)
+|+|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 93 ~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp TCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999975432 233899999999999999999999998 9999999999999 788889999999997664
Q ss_pred CCC---CCCCCCcccCccccc--------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 531 VPA---TPSRSAGYRAPEVIE--------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 531 ~~~---~~~~~~~y~aPE~~~--------~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
... ...+++.|+|||++. +..++.++|||||||++|||++|+.||........ .......+......
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPS 245 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHHHHCCT
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHhcCCCc
Confidence 432 345788999999986 56789999999999999999999999975433221 11222222222111
Q ss_pred cc---c---------chhhhh-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 600 AE---V---------FDVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 600 ~~---~---------~d~~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.. . +..... ...........+.+++.+||+.||++|||++|++++..+..-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 00 0 000111 1122345566788899999999999999999999999876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=351.59 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=202.0
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCe-eEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-KLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-~~lV~ 450 (672)
.+.||+|+||.||+|++. +++.||||+++.... ..+.+.+|++++.++.+||||+++++++.+.+. .++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 568999999999999842 357899999976432 235688999999999889999999999987654 89999
Q ss_pred EecCCCchhhhhccCCCCC-------------------------------------------------------------
Q 005875 451 DYFASGSLSTLLHGNRGAG------------------------------------------------------------- 469 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~------------------------------------------------------------- 469 (672)
||+++|+|.++++......
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 9999999999997643210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC------CCCCCCcccC
Q 005875 470 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAGYRA 543 (672)
Q Consensus 470 ~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~a 543 (672)
...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...+|+.|+|
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 263 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence 122889999999999999999999998 9999999999999999999999999997653322 2335778999
Q ss_pred cccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHH
Q 005875 544 PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQ 622 (672)
Q Consensus 544 PE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~ 622 (672)
||++.+..++.++|||||||++|||+| |..||.+....+ .............. .......+.+
T Consensus 264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~----------~~~~~~~l~~ 327 (359)
T 3vhe_A 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA----------PDYTTPEMYQ 327 (359)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCC----------CTTCCHHHHH
T ss_pred hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCCC----------CCCCCHHHHH
Confidence 999999999999999999999999998 999997654322 11111111111110 0112235677
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 623 IGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 623 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
++.+||+.||++|||++|++++|+++.+..
T Consensus 328 li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 888999999999999999999999998653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=355.89 Aligned_cols=247 Identities=27% Similarity=0.503 Sum_probs=192.1
Q ss_pred hccccccCcEEEEEEEEC----CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||+||+|++. ++..||||+++.... ..+++.+|++++.++ +||||+++++++.+++..++||||+
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceEEEEeCC
Confidence 478999999999999865 467799999975432 245788999999999 9999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++|+|.++++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 129 ENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999997532 34899999999999999999999998 9999999999999999999999999997764322
Q ss_pred C-------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 534 T-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 534 ~-------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
. ..+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ .... +......
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~------~~~~-i~~~~~~----- 269 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIKA-VDEGYRL----- 269 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH------HHHH-HHTTEEC-----
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HHcCCCC-----
Confidence 1 123567999999999999999999999999999998 999997543221 1111 1111110
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.........+.+++.+||+.||++||+++|+++.|+.+...
T Consensus 270 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 270 -----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 01112334677888899999999999999999999999764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=343.56 Aligned_cols=241 Identities=22% Similarity=0.363 Sum_probs=192.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+.. +++.||+|++..... ..+.+.+|+.++..+ +||||+++++++.+++..++||||+++|
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 90 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG 90 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence 468999999999999976 678899999865432 246788999999998 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----- 531 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----- 531 (672)
+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999743 34899999999999999999999998 99999999999999999999999999975432
Q ss_pred -CCCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 532 -PATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
.....+++.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+. ..... ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~----~~~~~---~~----- 229 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTY---LN----- 229 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH----TTCTT---ST-----
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh----ccccc---CC-----
Confidence 124568899999999987775 7789999999999999999999976543211 011110 00000 00
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+.+++.+||+.||++|||++|++++
T Consensus 230 --~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011122455678889999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=339.15 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=196.7
Q ss_pred hccccccCcEEEEEEEE-----CCCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e 451 (672)
.+.||+|+||+||+|++ .+++.||||++..... ..+.+.+|++++.++ +||||+++++++... ...++|||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCceEEEEE
Confidence 46899999999999984 2578899999875432 235788999999999 899999999998653 56899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 94 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp CCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred eCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 999999999997543 24899999999999999999999998 99999999999999999999999999987643
Q ss_pred CC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC--------CCCC-hhHHHHHhhh
Q 005875 532 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD--------DMVD-LPRWVQSVVR 595 (672)
Q Consensus 532 ~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~--------~~~~-~~~~~~~~~~ 595 (672)
.. ...++..|+|||++.+..++.++||||||+++|||+||..|+...... .... ..........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 22 223456699999999999999999999999999999999998643110 0000 0000011111
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
... ...........+.+++.+||+.||++|||++|+++.|+++.+.-
T Consensus 247 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 247 NNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccC----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 110 01111223356778888999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.54 Aligned_cols=242 Identities=23% Similarity=0.380 Sum_probs=196.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|... +++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEE
Confidence 578999999999999976 478899999875432 246789999999999 89999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC----CeEEeecCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP 527 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DfGla~ 527 (672)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 95 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 95 LVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp CCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999642 34899999999999999999999998 99999999999999887 79999999997
Q ss_pred CCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 528 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 528 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
..... ....+|+.|+|||++.+..++.++|||||||++|||++|..||.+....+ ....+...... +.
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~---~~ 237 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAVNYE---FE 237 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHTCCC---CC
T ss_pred ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHHhcCCC---cC
Confidence 65432 23458899999999999999999999999999999999999997543211 11111111100 00
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. ... .....+.+++.+||+.||++|||++|++++
T Consensus 238 ~~--~~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DE--YFS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HH--HHT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cc--ccc---cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 001 112456678889999999999999999973
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.62 Aligned_cols=247 Identities=21% Similarity=0.340 Sum_probs=179.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|... +++.||||++... ....+.+|+.++..+.+||||+++++++.++...++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 367999999999999976 5788999998653 3467788999999996699999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC---CeEEeecCCCCCCCCC---
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGla~~~~~~--- 532 (672)
.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 94 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 94 FERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp HHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999753 34899999999999999999999998 99999999999998766 7999999999765432
Q ss_pred -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-DLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||......... ........+....... ... .
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~---~- 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--EGE---A- 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--CSH---H-
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--Ccc---c-
Confidence 2345688999999999999999999999999999999999999865433221 1122222222111110 000 0
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.||++|||++|++++
T Consensus 240 --~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 --WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp --HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred --ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 01123456778889999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=340.71 Aligned_cols=238 Identities=21% Similarity=0.278 Sum_probs=195.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|++++.. .....+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~E~~~ 88 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 468999999999999976 57899999997542 2345678899999988 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 89 GGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp TCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999743 24899999999999999999999998 99999999999999999999999999976432
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+...... ..
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~~---------~p 225 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEEIR---------FP 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC---------CC
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCC---------CC
Confidence 22345789999999999999999999999999999999999999754321 112222211110 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
.. ....+.+++.+||+.||++|| +++|++++
T Consensus 226 ~~---~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 RT---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TT---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CC---CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11 123466777899999999999 89999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=363.09 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=201.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|.+.++..||||+++......+.+.+|++++.++ +||||+++++++.+ +..++||||+++|+|.
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 468999999999999999888899999987666678899999999999 99999999999865 6789999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----C
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 534 (672)
++++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 267 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 267 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 9997432 134899999999999999999999998 9999999999999999999999999998654321 2
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ....+ ....... ..
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i-~~~~~~~----------~~ 403 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQV-ERGYRMP----------CP 403 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHH-HTTCCCC----------CC
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHH-HcCCCCC----------CC
Confidence 234678999999998899999999999999999999 999997643221 11111 1111100 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
......+.+++.+||+.||++|||++++++.|+++....
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 123345778888999999999999999999999987554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=348.32 Aligned_cols=245 Identities=19% Similarity=0.296 Sum_probs=190.0
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe----CCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~~~~ 455 (672)
+.||+|+||+||+|... +++.||||++.. ...+.+|++++.++.+||||+++++++.. .+..|+||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57999999999999976 478899999864 35678889888777799999999999876 5678999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC---CCCeEEeecCCCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~~ 532 (672)
|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 144 g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 144 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 99999997532 234899999999999999999999998 999999999999998 789999999999765432
Q ss_pred ---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 533 ---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+....... ..+ .
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~i~~~~~~~--~~~---~ 290 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQYEF--PNP---E 290 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS--HHHHHHHTCCCC--CTT---T
T ss_pred CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH--HHHHHHcCcccC--CCc---c
Confidence 244578999999999999999999999999999999999999986554332110 111111111100 000 0
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
. ......+.+++.+||+.||++|||++|++++-
T Consensus 291 ~---~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 291 W---SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp T---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred c---ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 1 11234567788899999999999999999853
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=344.95 Aligned_cols=246 Identities=22% Similarity=0.372 Sum_probs=194.3
Q ss_pred hccccccCcEEEEEEEECC-Cc----EEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|++.. ++ .||+|.+.... ...+.+.+|++++.++ +||||+++++++.++ ..++|+||
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~v~e~ 97 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS-SEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC-CeEEEEEe
Confidence 4689999999999999643 33 35888876443 2456789999999999 999999999999875 47899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999997543 34899999999999999999999998 999999999999999999999999998765432
Q ss_pred C------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
. ...+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+. ..........
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~~~~~~~----- 238 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGERL----- 238 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCCC-----
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-------HHHHHcCCCC-----
Confidence 2 2234678999999999999999999999999999999 9999986543321 1111111100
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.........+.+++.+||+.||++||++.|++++|+.+...
T Consensus 239 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 01112234577888899999999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.36 Aligned_cols=237 Identities=22% Similarity=0.327 Sum_probs=194.0
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|.. .+++.||+|++.... .....+.+|++++..+ +||||+++++++.+++..++||||+
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~- 91 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIVMVIEYA- 91 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEECC-
Confidence 46899999999999997 467899999986542 2245788999999988 8999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 92 ~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 92 GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 68999888642 24899999999999999999999998 999999999999999999999999999766443
Q ss_pred -CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 -ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....|++.|+|||++.+..+ +.++|||||||++|||++|+.||.+....+..... .... .
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-----------~~~~----~--- 225 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-----------NSCV----Y--- 225 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-----------CSSC----C---
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-----------HcCC----C---
Confidence 34568999999999988776 68999999999999999999999865433321100 0000 0
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.........+.+++.+||+.||++|||++|++++
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0001122346678889999999999999999984
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=354.42 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=200.6
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|++. +++.||||+++.... ....+.+|+.++.++ +||||+++++++.++...++|||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCEEEEE
Confidence 468999999999999953 356799999875432 234688899999999 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC---CeEEeecCCC
Q 005875 452 YFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLT 526 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGla 526 (672)
|+++|+|.+++...+. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a 231 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccc
Confidence 9999999999975432 12245899999999999999999999998 99999999999999555 5999999998
Q ss_pred CCCC------CCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 527 PLMN------VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 527 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
+... ......+++.|+|||++.+..++.++|||||||++|||++ |..||......+ ....+.... .
T Consensus 232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~------~~~~i~~~~-~ 304 (367)
T 3l9p_A 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFVTSGG-R 304 (367)
T ss_dssp HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTTC-C
T ss_pred cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCC-C
Confidence 6431 2222346788999999999999999999999999999998 999997643221 111111111 0
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
.. ........+.+++.+||+.||++|||++|++++|+.+.+..
T Consensus 305 ~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 305 MD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CC----------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 00 01122345678888999999999999999999999997654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.20 Aligned_cols=238 Identities=24% Similarity=0.328 Sum_probs=193.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|++++.. ...+.+.+|.+++..+.+||||+++++++.+.+..|+||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999976 47889999997542 2345677888899888789999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 108 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~ 179 (353)
T 3txo_A 108 GGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179 (353)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence 99999999743 24899999999999999999999998 99999999999999999999999999976432
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+...... ..
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~~---------~p 244 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDEVV---------YP 244 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC---------CC
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCC---------CC
Confidence 224468999999999999899999999999999999999999998653221 22222221110 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVR 643 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 643 (672)
......+.+++.+||+.||++||++ +|+++
T Consensus 245 ---~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 ---TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1122346677889999999999998 77776
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.33 Aligned_cols=255 Identities=17% Similarity=0.212 Sum_probs=192.7
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEecccccChhhHHHHHHHHHHHc--------------CCCceeceEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVGKRDFEQQMEIVGRVG--------------QHPNVVPLRAY 439 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~--------------~h~niv~l~~~ 439 (672)
.+.||+|+||+||+|.+.. ++.||||++.... ..+.+|++++.++. +|+||++++++
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 4689999999999999765 3679999986542 23444444444332 59999999999
Q ss_pred EEeC----CeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec--
Q 005875 440 YYSK----DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-- 513 (672)
Q Consensus 440 ~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-- 513 (672)
+... ...++||||+ +|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 9765 4579999999 999999997532 34999999999999999999999998 99999999999999
Q ss_pred CCCCeEEeecCCCCCCCCC-----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 005875 514 QDLDGCISDFGLTPLMNVP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 582 (672)
Q Consensus 514 ~~~~~kl~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~ 582 (672)
.++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999654321 22338899999999999999999999999999999999999998543221
Q ss_pred CCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 583 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
............ ......+..+. .. .....+.+++..||+.+|++||+++++++.|+++.+..
T Consensus 269 --~~~~~~~~~~~~-~~~~~~~~~~~-~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 269 --KYVRDSKIRYRE-NIASLMDKCFP-AA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp --HHHHHHHHHHHH-CHHHHHHHHSC-TT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --HHHHHHHHHhhh-hHHHHHHHhcc-cc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 111111111111 11111111110 01 12345677888999999999999999999999998654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.52 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=205.1
Q ss_pred hccccccCcEEEEEEEE------CCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|+. .+++.||+|+++.... ..+.+.+|++++.++.+||||+++++++.+++..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 107 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence 47899999999999985 2457899999975432 246788999999999889999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCe
Q 005875 452 YFASGSLSTLLHGNRGA-------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 518 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 518 (672)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT 184 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCE
Confidence 99999999999754321 1234899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 005875 519 CISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 591 (672)
Q Consensus 519 kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~ 591 (672)
||+|||++........ ..+++.|+|||++.+..++.++||||||+++|||+| |..||.+....+ ...
T Consensus 185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~ 258 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------KFY 258 (313)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH------HHH
T ss_pred EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh------HHH
Confidence 9999999977654322 224667999999999899999999999999999999 999997654321 111
Q ss_pred HhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 592 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.......... ........+.+++.+||+.||++|||++|++++|+++.....
T Consensus 259 ~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 259 KMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHhccCCCCC----------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1111111100 001123456778889999999999999999999999987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=326.83 Aligned_cols=254 Identities=17% Similarity=0.168 Sum_probs=198.3
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCcee-ceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVV-PLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv-~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|+. .+++.||+|++.... ..+.+.+|++++..+ +|++++ .+..+...++..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHH-TTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHh-hcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 46899999999999996 568899999986543 345789999999999 555544 4444446677889999999 899
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe---cCCCCeEEeecCCCCCCCCC--
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~~-- 532 (672)
|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++......
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999997432 24899999999999999999999998 9999999999999 48899999999999765432
Q ss_pred ---------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 533 ---------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 533 ---------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+.................
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 239 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI---- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch----
Confidence 2345788999999999999999999999999999999999999876544333322211111000000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
... .. .....+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 240 -~~~--~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 240 -EVL--CK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -HHH--TT---TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -HHH--Hh---hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 000 01 112457778889999999999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=343.75 Aligned_cols=244 Identities=20% Similarity=0.305 Sum_probs=190.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+++.. +++.||+|++.......+.+.+|+.+++.+ +||||+++++++.+.+..++||||+++|+|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 468999999999999976 678899999987666667889999999998 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC--eEEeecCCCCCCCC---CC
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--GCISDFGLTPLMNV---PA 533 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~--~kl~DfGla~~~~~---~~ 533 (672)
.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++.... ..
T Consensus 104 ~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 104 YERICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 9999642 24899999999999999999999998 999999999999988765 99999999874432 23
Q ss_pred CCCCCCcccCcccccCCCCCCc-cchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 TPSRSAGYRAPEVIETRKHSHK-SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~-~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...+|+.|+|||++.+..++.+ +|||||||++|||++|+.||.+..... ........+....... .....
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~-------~~~~~ 246 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKYSI-------PDDIR 246 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCCCC-------CTTSC
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCCCC-------CCcCC
Confidence 4558899999999988887665 899999999999999999998654322 2222222222211110 00001
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
....+.+++.+||+.||++|||++|++++
T Consensus 247 ---~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 247 ---ISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---CCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 12356678889999999999999999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=339.28 Aligned_cols=245 Identities=19% Similarity=0.292 Sum_probs=193.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|+++..... .+.+.+|..++.++.+||||+++++++.+++..++||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999976 4778999999765432 23467888888887789999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 94 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 99999999743 24899999999999999999999998 99999999999999999999999999975322
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC--ChhHHHHHhhhhccccccchhhhh
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV--DLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .........+..... .
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------~ 237 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------R 237 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--------C
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--------C
Confidence 23456899999999999999999999999999999999999999754322111 111111111111100 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVR 643 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 643 (672)
.. ......+.+++.+||+.||++||++ +|+++
T Consensus 238 ~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 238 IP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp CC---TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CC---CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 00 1122356677889999999999995 67765
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.78 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=200.5
Q ss_pred hccccccCcEEEEEEEE------CCCcEEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|+. .++..||+|++.... ...+.+.+|++++.++.+||||+++++++...+..++|||
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 129 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence 57899999999999996 235579999997543 2346789999999999889999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec
Q 005875 452 YFASGSLSTLLHGNRGA------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN 513 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~ 513 (672)
|+++|+|.+++...... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++
T Consensus 130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~ 206 (344)
T 1rjb_A 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVT 206 (344)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEc
Confidence 99999999999754321 0134799999999999999999999998 99999999999999
Q ss_pred CCCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCCh
Q 005875 514 QDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 586 (672)
Q Consensus 514 ~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~ 586 (672)
.++.+||+|||++....... ...+++.|+|||++.+..++.++||||||+++|||+| |..||.+....+
T Consensus 207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---- 282 (344)
T 1rjb_A 207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---- 282 (344)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----
T ss_pred CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH----
Confidence 99999999999997654332 1234678999999998899999999999999999998 999997654321
Q ss_pred hHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005875 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654 (672)
Q Consensus 587 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 654 (672)
.............. .......+.+++.+||+.||++|||+.|++++|+.+.....+
T Consensus 283 --~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 283 --NFYKLIQNGFKMDQ----------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp --HHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred --HHHHHHhcCCCCCC----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 11111211111100 011234567788899999999999999999999999876553
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.70 Aligned_cols=241 Identities=22% Similarity=0.307 Sum_probs=194.7
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+... ++.||+|++++.. ...+.+.+|+.++..+ +||||+++++++.+++..|+||||++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 4689999999999999764 7789999987532 2345688899999888 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.++++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 153 gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 153 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp TEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 99999999742 3899999999999999999999998 999999999999999999999999999765432
Q ss_pred ---CCCCCCCcccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 ---ATPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.+..||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.... .....+........
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~---- 293 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLT---- 293 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHCC----
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhcccccc----
Confidence 2567899999999997665 789999999999999999999999864322 12222222110000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM 644 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 644 (672)
......+ ...+.+++.+|++.+|++ ||+++|++++
T Consensus 294 -~p~~~~~---s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 294 -FPDDNDI---SKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -CCTTCCC---CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -CCCcccc---cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0011112 234566777999999988 9999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.76 Aligned_cols=193 Identities=21% Similarity=0.337 Sum_probs=169.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHc----CCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----QHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~----~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||||+++......+.+..|++++..+. +||||+++++++...+..++||||+
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~- 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL- 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-
Confidence 468999999999999974 5788999999765444567788999999884 4999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC--------------------
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-------------------- 514 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-------------------- 514 (672)
+++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 119 ~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 119 GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccccccccc
Confidence 899999997543 234899999999999999999999998 999999999999975
Q ss_pred -----CCCeEEeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005875 515 -----DLDGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579 (672)
Q Consensus 515 -----~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~ 579 (672)
++.+||+|||++...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 789999999999765443 34567899999999999999999999999999999999999998654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=330.76 Aligned_cols=247 Identities=22% Similarity=0.448 Sum_probs=194.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC--------hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.+.||+|+||+||+|+.. +++.||+|++...... .+.+.+|++++.++ +||||+++++++.+.. ++||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~--~lv~ 100 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNPP--RMVM 100 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTTT--EEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCCC--eEEE
Confidence 468999999999999974 6788999998654321 15688999999999 8999999999986544 7999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC-----eEEeecCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-----GCISDFGL 525 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~-----~kl~DfGl 525 (672)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++. +||+|||+
T Consensus 101 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 101 EFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp ECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred EecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 9999999999886432 34899999999999999999999985 45999999999999988876 99999999
Q ss_pred CCCCCCC-CCCCCCCcccCcccc--cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 526 TPLMNVP-ATPSRSAGYRAPEVI--ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 526 a~~~~~~-~~~~~~~~y~aPE~~--~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
++..... ....+++.|+|||++ ....++.++|||||||++|||++|+.||......+. ...............
T Consensus 176 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~ 251 (287)
T 4f0f_A 176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMIREEGLRPTI 251 (287)
T ss_dssp CBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHHHHSCCCCCC
T ss_pred cccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHHhccCCCCCC
Confidence 9765443 235678999999999 445678999999999999999999999976543221 111111111111111
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
.......+.+++.+||+.||++|||++|+++.|+++
T Consensus 252 ----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 252 ----------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ----------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 112234577888899999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.92 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=201.2
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||+|+..+ ++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCCceEEEEe
Confidence 4689999999999999753 47899999976432 245688999999999 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe
Q 005875 452 YFASGSLSTLLHGNRGA-------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 512 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl 512 (672)
|+++|+|.+++...... ....+++.++..++.||+.||+|||+.+ |+||||||+||++
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLV 207 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEE
Confidence 99999999999764321 1246899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCC------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 005875 513 NQDLDGCISDFGLTPLMNV------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 585 (672)
Q Consensus 513 ~~~~~~kl~DfGla~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~ 585 (672)
+.++.+||+|||++..... .....+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--- 284 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--- 284 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH---
Confidence 9999999999999865422 223446788999999998899999999999999999999 999997543211
Q ss_pred hhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 586 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
....+..... ... .......+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 285 ---~~~~~~~~~~-~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 285 ---VIYYVRDGNI-LAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp ---HHHHHHTTCC-CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred ---HHHHHhCCCc-CCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1111111111 000 0122345778888999999999999999999999998654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=351.34 Aligned_cols=242 Identities=20% Similarity=0.312 Sum_probs=194.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|... +++.+|+|++..... ..+.+.+|++++..+ +||||+++++++.+++..++||||+++
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTG 94 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence 578999999999999864 578899999876543 235688999999999 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec---CCCCeEEeecCCCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~---~~~~~kl~DfGla~~~~~~ 532 (672)
|+|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++......
T Consensus 95 g~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 95 GELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999998743 34899999999999999999999998 99999999999998 4688999999999766543
Q ss_pred C----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 533 A----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 533 ~----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
. ...||+.|+|||++.+..++.++||||+||++|||++|..||.+.... .....+....... .. .
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~--~~---~ 235 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQQIKAGAYDF--PS---P 235 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCCCC--CT---T
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhCCCCC--Cc---c
Confidence 2 346899999999999999999999999999999999999999764322 1122222111110 00 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.... ....+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~---~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 EWDT---VTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTT---SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccc---CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111 22356677889999999999999999983
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.68 Aligned_cols=239 Identities=21% Similarity=0.312 Sum_probs=187.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---------------------------ChhhHHHHHHHHHHHcCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------------------------GKRDFEQQMEIVGRVGQHP 431 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------------------------~~~~~~~e~~~l~~l~~h~ 431 (672)
.+.||+|+||+||+|+.. +++.||+|++..... ..+.+.+|++++.++ +||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 96 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL-DHP 96 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC-CCT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC-CCC
Confidence 468999999999999975 578899999865431 124688999999999 999
Q ss_pred ceeceEEEEEe--CCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCC
Q 005875 432 NVVPLRAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASN 509 (672)
Q Consensus 432 niv~l~~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~N 509 (672)
||+++++++.+ .+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 167 (298)
T 2zv2_A 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSN 167 (298)
T ss_dssp TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 99999999987 5678999999999999887642 34999999999999999999999998 9999999999
Q ss_pred EEecCCCCeEEeecCCCCCCCCC----CCCCCCCcccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 005875 510 VLINQDLDGCISDFGLTPLMNVP----ATPSRSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 582 (672)
Q Consensus 510 ILl~~~~~~kl~DfGla~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~ 582 (672)
||++.++.+||+|||++...... ....+++.|+|||++.+.. ++.++|||||||++|||++|+.||.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-- 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI-- 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH--
Confidence 99999999999999999765432 2346889999999998765 37789999999999999999999975321
Q ss_pred CCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 583 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+....... ..... ....+.+++.+||+.||++|||++|++++
T Consensus 246 ----~~~~~~~~~~~~~~-------~~~~~---~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 ----MCLHSKIKSQALEF-------PDQPD---IAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp ----HHHHHHHHHCCCCC-------CSSSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ----HHHHHHHhcccCCC-------CCccc---cCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 11111111111100 00111 22356778889999999999999999763
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=342.17 Aligned_cols=242 Identities=21% Similarity=0.333 Sum_probs=195.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|++++..+ +||||+++++++.+++..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g 112 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG 112 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 578999999999999975 5789999999765433 34678899999999 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC---CeEEeecCCCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLTPLMNVP 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGla~~~~~~ 532 (672)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++......
T Consensus 113 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 113 GELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999998642 34899999999999999999999998 99999999999998654 5999999999776543
Q ss_pred C---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 533 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 533 ~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
. ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+........ .+ .
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i~~~~~~~~--~~---~ 253 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAYDYP--SP---E 253 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCCC--TT---G
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCCC--cc---c
Confidence 2 346899999999999999999999999999999999999999764321 11222211111100 00 0
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. ......+.+++.+||+.||++|||++|++++
T Consensus 254 ~---~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 W---DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp G---GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c---cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 1122456678889999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=341.39 Aligned_cols=244 Identities=16% Similarity=0.299 Sum_probs=195.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc------cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|... +++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+++..++||||
T Consensus 29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~ 107 (351)
T 3c0i_A 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEF 107 (351)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEeC
Confidence 578999999999999975 57899999986432 1356789999999999 999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC---eEEeecCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTPLM 529 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DfGla~~~ 529 (672)
+++|+|.+++..... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 108 ~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 108 MDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp CSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred CCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999888764321 1234899999999999999999999998 999999999999987655 999999999766
Q ss_pred CCC----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 530 NVP----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 530 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+... .....+...... ..+
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~i~~~~~~---~~~ 253 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFEGIIKGKYK---MNP 253 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHHHHHHTCCC---CCH
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHHHHHcCCCC---CCc
Confidence 443 234589999999999999999999999999999999999999975321 111111111110 000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
. .... ....+.+++.+||+.||++|||+.|+++
T Consensus 254 ~--~~~~---~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 254 R--QWSH---ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp H--HHTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c--cccc---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0011 1245677888999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.68 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=192.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+..+++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~- 84 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEEEEecCC-
Confidence 468999999999999998899999999865432 235688999999998 899999999999999999999999986
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 85 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 85 DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 9999987432 34899999999999999999999998 999999999999999999999999998754322
Q ss_pred CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh----hccc----cccc
Q 005875 533 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWT----AEVF 603 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~----~~~~ 603 (672)
....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+. ......... ..+. ...+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhccccc
Confidence 234578899999999764 589999999999999999999999986432211 000101000 0000 0001
Q ss_pred hhhhhcc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
++..... .........+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111000 0001123456778889999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.45 Aligned_cols=246 Identities=23% Similarity=0.358 Sum_probs=194.6
Q ss_pred hccccccCcEEEEEEEECC-CcE----EEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STT----VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~----vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|++.. ++. |++|.+.... .....+.+|+.++.++ +||||+++++++. ++..++||||
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CCccEEEEEe
Confidence 4689999999999999653 333 7788775443 2335678899999998 9999999999885 5678999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.+++...+ ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 96 LPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp CTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred CCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999997542 24888999999999999999999998 999999999999999999999999999876433
Q ss_pred C------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
. ...++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+. .. ..........
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~~~~~--- 238 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PD----LLEKGERLAQ--- 238 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HH----HHHTTCBCCC---
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HH----HHHcCCCCCC---
Confidence 2 2235678999999999999999999999999999999 9999986543321 11 1111110000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.......+.+++.+||+.||++|||++|++++|+.+...
T Consensus 239 -------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 239 -------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 001122456788899999999999999999999998653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=342.02 Aligned_cols=238 Identities=22% Similarity=0.358 Sum_probs=194.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|+++... ...+.+..|.+++..+.+||||+++++++.+.+..++||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999976 47889999997642 2345677888888887799999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 102 GGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 99999999742 24899999999999999999999998 99999999999999999999999999976422
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+...... + .
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~~~---~------p 238 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDNPF---Y------P 238 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC---C------C
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHhCCCC---C------C
Confidence 234568999999999999999999999999999999999999997643221 12222111110 0 0
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVR 643 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 643 (672)
.. ....+.+++.+||+.||++||++. |+++
T Consensus 239 ~~---~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 239 RW---LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp TT---SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cc---cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11 123566778899999999999997 6654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=335.80 Aligned_cols=238 Identities=19% Similarity=0.280 Sum_probs=196.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+++.. +++.||+|++++.. ...+.+.+|..++..+ +||||+++++++.+.+..++||||++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~ 89 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIE 89 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEEEeCCC
Confidence 468999999999999975 58899999997542 2345677888898888 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-C
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-~ 533 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 90 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 90 GGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161 (318)
T ss_dssp SCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence 99999999753 24899999999999999999999998 999999999999999999999999999765433 3
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... ....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~---------~p~~- 225 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAELR---------FPPF- 225 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCCC---------CCTT-
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC---------CCCC-
Confidence 45689999999999999999999999999999999999999975432 1222222222110 0011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
....+.+++.+|++.||++|| +++|++++
T Consensus 226 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 226 --FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 123566777899999999999 89999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=326.13 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=198.9
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|++. ++.||+|+++..... .+.+.+|+.++.++ +||||+++++++.+. +..++||||++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTLITHWMP 92 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeEeeecccC
Confidence 468999999999999986 788999999765433 34688899998888 899999999999877 67899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 534 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 534 (672)
+|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.++|+|||++..... ..
T Consensus 93 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-~~ 167 (271)
T 3kmu_A 93 YGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-PG 167 (271)
T ss_dssp TCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-TT
T ss_pred CCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-cC
Confidence 999999998543 235899999999999999999999975 4599999999999999999999999988755432 34
Q ss_pred CCCCCcccCcccccCCCCCC---ccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 535 PSRSAGYRAPEVIETRKHSH---KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~---~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
..+|+.|+|||++.+..++. ++||||||+++|||++|+.||...... ...............
T Consensus 168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~--------- 232 (271)
T 3kmu_A 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLRPTI--------- 232 (271)
T ss_dssp CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCCCCC---------
T ss_pred ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCCCCC---------
Confidence 56789999999998766554 799999999999999999999754321 111122111111111
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
.......+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 233 -~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 233 -PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 01123456778889999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=363.46 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=204.9
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|.+.++..||||+++......++|.+|++++.++ +|+||+++++++.+ +..++||||+++|+|.
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred heecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 568999999999999999888899999987666678899999999999 99999999999865 6789999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-----CC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----AT 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-----~~ 534 (672)
++++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 350 ~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 423 (535)
T 2h8h_A 350 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423 (535)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence 9997432 124899999999999999999999998 999999999999999999999999999876431 22
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||++....++.++|||||||++|||++ |+.||.+....+ .... +....... ..
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~------~~~~-i~~~~~~~----------~~ 486 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQ-VERGYRMP----------CP 486 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH------HHHH-HHTTCCCC----------CC
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HHcCCCCC----------CC
Confidence 345678999999998899999999999999999999 999997643221 1111 11111110 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
......+.+++.+||+.||++|||+++|++.|+++....
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 122345778888999999999999999999999887543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=337.57 Aligned_cols=240 Identities=20% Similarity=0.345 Sum_probs=189.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCe-----------
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE----------- 445 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----------- 445 (672)
.+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+...
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~~~~ 89 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEEMDEIW 89 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence 468999999999999986 688999999975432 346788999999999 89999999999866442
Q ss_pred ----------------------------------------------eEEEEEecCCCchhhhhccCCCCCCCCCCHHHHH
Q 005875 446 ----------------------------------------------KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 479 (672)
Q Consensus 446 ----------------------------------------------~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~ 479 (672)
.++||||+++|+|.+++..... ....++..+.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~ 167 (332)
T 3qd2_B 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCL 167 (332)
T ss_dssp ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCHHHHH
T ss_pred hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhhHHHH
Confidence 7899999999999999985432 3346777899
Q ss_pred HHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----------------CCCCCCCcccC
Q 005875 480 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----------------ATPSRSAGYRA 543 (672)
Q Consensus 480 ~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----------------~~~~~~~~y~a 543 (672)
.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....+|+.|+|
T Consensus 168 ~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 99999999999999998 999999999999999999999999999765432 22357889999
Q ss_pred cccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHH
Q 005875 544 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQI 623 (672)
Q Consensus 544 PE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l 623 (672)
||++.+..++.++|||||||++|||++|..|+... ....... .... . ..........+.++
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~~-~~~~----~------~~~~~~~~~~~~~l 305 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITDV-RNLK----F------PLLFTQKYPQEHMM 305 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHHH-HTTC----C------CHHHHHHCHHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHHh-hccC----C------CcccccCChhHHHH
Confidence 99999999999999999999999999987765310 0000000 0000 0 00112333556788
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 005875 624 GMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 624 ~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+.+||+.||++|||++|++++
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCCCcCCCHHHHhhc
Confidence 899999999999999999873
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.17 Aligned_cols=254 Identities=23% Similarity=0.403 Sum_probs=190.3
Q ss_pred hccccccCcEEEEEEEECCCc----EEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCee------
Q 005875 380 AEVLGKGSYGTAYKAVLEEST----TVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK------ 446 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~----~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~------ 446 (672)
.+.||+|+||+||+|+...+. .||||+++.... ..+.+.+|++++.++ +||||+++++++...+..
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 106 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAKGRLPIP 106 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-------CE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccccccCCCcc
Confidence 578999999999999966433 799999876432 245788999999999 999999999999877655
Q ss_pred EEEEEecCCCchhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCC
Q 005875 447 LLVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 525 (672)
Q Consensus 447 ~lV~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 525 (672)
++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~ 183 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGL 183 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccc
Confidence 999999999999999964321 12235899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 526 TPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 526 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
++...... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+. .........
T Consensus 184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------~~~~~~~~~ 257 (323)
T 3qup_A 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI------YNYLIGGNR 257 (323)
T ss_dssp -----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHHHHTTCC
T ss_pred cccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH------HHHHhcCCC
Confidence 97654322 2235678999999999999999999999999999999 9999986543221 111111111
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 654 (672)
. .........+.+++.+||+.||++|||+.|+++.|+++.+....
T Consensus 258 ~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 258 L-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp C-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred C-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 0 01112234577888899999999999999999999999877653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=340.75 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=203.2
Q ss_pred hccccccCcEEEEEEEEC--------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 449 (672)
.+.||+|+||+||+|+.. ++..||+|+++.... ..+.+.+|++++.++.+||||+++++++.+++..++|
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 578999999999999863 467899999975432 2356889999999998899999999999999999999
Q ss_pred EEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCe
Q 005875 450 YDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 518 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 518 (672)
|||+++|+|.+++...... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM 196 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCE
Confidence 9999999999999864421 1234899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 005875 519 CISDFGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 591 (672)
Q Consensus 519 kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~ 591 (672)
||+|||++...... ....+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+ ...
T Consensus 197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~ 270 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LFK 270 (334)
T ss_dssp EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHH
T ss_pred EEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH------HHH
Confidence 99999999765432 22335678999999998889999999999999999999 999997543221 111
Q ss_pred HhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005875 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654 (672)
Q Consensus 592 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 654 (672)
. ........ ........+.+++.+||+.||++|||++|+++.|+.+......
T Consensus 271 ~-~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 271 L-LKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp H-HHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred H-HhcCCCCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1 11111100 0112234567788899999999999999999999999876553
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.28 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=201.8
Q ss_pred hccccccCcEEEEEEEE------CCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||+|.. .+++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCCceEEEEe
Confidence 47899999999999986 2347899999875432 235688899999998 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe
Q 005875 452 YFASGSLSTLLHGNRGA-------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 512 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl 512 (672)
|+++|+|.+++...... ....+++..+..++.||+.||+|||+.+ |+||||||+||++
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli 183 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILV 183 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEE
Confidence 99999999999764321 1234889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 005875 513 NQDLDGCISDFGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 585 (672)
Q Consensus 513 ~~~~~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~ 585 (672)
+.++.+||+|||++...... ....+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+.
T Consensus 184 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-- 261 (314)
T 2ivs_A 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL-- 261 (314)
T ss_dssp ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 99999999999999765332 22335678999999999889999999999999999999 9999986543221
Q ss_pred hhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 586 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
. .......... ........+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 262 -~----~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 262 -F----NLLKTGHRME----------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp -H----HHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -H----HHhhcCCcCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 1 1111111100 0112234567888899999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=330.28 Aligned_cols=249 Identities=26% Similarity=0.439 Sum_probs=203.5
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|...+++.||+|+++......+.+.+|++++..+ +||||+++++++. ++..++||||+++++|.
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 468999999999999998888999999987766778899999999999 9999999999986 45689999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----C
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 534 (672)
+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....... .
T Consensus 96 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T 1qpc_A 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (279)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence 9996432 124899999999999999999999998 9999999999999999999999999997654322 2
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..++..|+|||++.+..++.++||||||+++|||++ |+.||.+....+ ....+. ...... . .
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~-~~~~~~-------~---~ 232 (279)
T 1qpc_A 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLE-RGYRMV-------R---P 232 (279)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHH-TTCCCC-------C---C
T ss_pred CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHHh-cccCCC-------C---c
Confidence 335678999999998889999999999999999999 999997543211 111111 111100 0 0
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
......+.+++.+||+.||++|||++++++.|+++.....
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 1123456778889999999999999999999999986643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=333.33 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=195.4
Q ss_pred hccccccCcEEEEEEEECC-C-------cEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-S-------TTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.+.||+|+||+||+|+... + ..||+|++.... ...+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 91 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVCGDENILVQ 91 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECCTTCCEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEeCCCCEEEE
Confidence 4689999999999998653 2 469999986553 3356788999999999 8999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC--------eEEee
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--------GCISD 522 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~--------~kl~D 522 (672)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 92 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp ECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred ECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999997533 23899999999999999999999998 999999999999998887 99999
Q ss_pred cCCCCCCCCCCCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccc
Q 005875 523 FGLTPLMNVPATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601 (672)
Q Consensus 523 fGla~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (672)
||++..........+++.|+|||++.+ ..++.++||||||+++|||++|..|+..... ...... .......
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~~-~~~~~~~-- 236 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRKLQ-FYEDRHQ-- 236 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHH-HHHTTCC--
T ss_pred CcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHHHHH-HhhccCC--
Confidence 999876655444456888999999987 6789999999999999999996555432211 111111 1111000
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 602 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
. . . .....+.+++.+||+.||++|||++|++++|+++.....
T Consensus 237 ~-~------~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 237 L-P------A---PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp C-C------C---CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred C-C------C---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 0 0 0 011245678889999999999999999999999886543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.57 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=205.4
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|.+.+ +..||+|++.......+.+.+|++++.++ +||||+++++++.+++..++||||+++|+|
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 96 (288)
T 3kfa_A 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 96 (288)
T ss_dssp EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred EeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCEEEEEEcCCCCcH
Confidence 4689999999999999765 67899999987655567899999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC----
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---- 534 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 534 (672)
.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 170 (288)
T 3kfa_A 97 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170 (288)
T ss_dssp HHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred HHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence 99997543 345899999999999999999999998 99999999999999999999999999977653321
Q ss_pred -CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 535 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 535 -~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
..+++.|+|||++.+..++.++||||||+++|||++ |..||......+. .. ......... .
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~----~~~~~~~~~----------~ 233 (288)
T 3kfa_A 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YE----LLEKDYRME----------R 233 (288)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH----HHHTTCCCC----------C
T ss_pred CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHhccCCCC----------C
Confidence 224667999999998899999999999999999999 9999976543221 11 111111100 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
.......+.+++.+|++.||++|||++|+++.|+++.+..
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1112345778888999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=333.58 Aligned_cols=246 Identities=22% Similarity=0.372 Sum_probs=189.6
Q ss_pred hccccccCcEEEEEEEECC----CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||+||+|.+.. +..||+|+++.... ..+.+.+|+.++.++ +||||+++++++ .++..++||||+
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~~lv~e~~ 97 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI-TENPVWIIMELC 97 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEE-ccCccEEEEecC
Confidence 4689999999999999753 34699998875432 245688899999998 899999999998 456789999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 98 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999997432 34899999999999999999999998 9999999999999999999999999997764332
Q ss_pred -----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 534 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 534 -----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
...+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+. ...+...... .
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~------~~~i~~~~~~-~------ 237 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERL-P------ 237 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHHHHTTCCC-C------
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH------HHHHHcCCCC-C------
Confidence 2234678999999998899999999999999999997 9999986543321 1111111100 0
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
........+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 238 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 238 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0112234567788899999999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.01 Aligned_cols=254 Identities=17% Similarity=0.178 Sum_probs=197.3
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceec-eEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP-LRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~-l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|+. .+++.||+|++.... ..+.+.+|++++..+ +|++++. +..++..++..++||||+ +|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHH-TTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHh-cCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence 46899999999999996 567889999865543 335688999999999 5555554 445556777889999999 999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe---cCCCCeEEeecCCCCCCCCC--
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~~-- 532 (672)
|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++......
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp HHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999997432 24899999999999999999999998 9999999999999 78899999999999765432
Q ss_pred ---------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 533 ---------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 533 ---------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.+......................
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 239 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI---- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh----
Confidence 2345788999999999999999999999999999999999999876554443322211111000000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
. . .... ....+.+++.+||+.||++|||++|+++.|+++.+...
T Consensus 240 ~-~--~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 240 E-V--LCKG---YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp H-H--HTTT---SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred h-h--hhcc---CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0 0 0011 12457788889999999999999999999999987653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.52 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=196.2
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+. .+++.||||++...... .+.+.+|++++.++ +||||+++++++.+++..++||||++
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEEEEEecCC
Confidence 46799999999999996 46788999998754322 24678999999999 99999999999999999999999997
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 534 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 534 (672)
|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 138 -g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 209 (348)
T 1u5q_A 138 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209 (348)
T ss_dssp -EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence 58888875322 34899999999999999999999998 99999999999999999999999999988777667
Q ss_pred CCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 535 PSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 535 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
..+++.|+|||++. ...++.++|||||||++|||++|+.||..... ......+...... ... ..
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~~-~~~------~~ 276 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP-ALQ------SG 276 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCC-CCC------CT
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCC-CCC------CC
Confidence 78999999999984 56789999999999999999999999975432 1112222211111 000 01
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.....+.+++.+||+.||++|||++|++++-.
T Consensus 277 ---~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 277 ---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred ---CCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 11234667888999999999999999987543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=333.85 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=193.9
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|+.. ++.||+|++... ...+.+.+|++++.++ +||||+++++++. +..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRV-NHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHC-CCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcC-CCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 468999999999999986 688999998643 2356788999999999 9999999999876 4589999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC-eEEeecCCCCCCCCC-CCCCC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-GCISDFGLTPLMNVP-ATPSR 537 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~-~kl~DfGla~~~~~~-~~~~~ 537 (672)
++++.... ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++...... ....+
T Consensus 88 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~g 165 (307)
T 2eva_A 88 NVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKG 165 (307)
T ss_dssp HHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------C
T ss_pred HHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCC
Confidence 99975431 234788999999999999999999932223999999999999998887 799999999765433 23457
Q ss_pred CCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHH
Q 005875 538 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 617 (672)
Q Consensus 538 ~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 617 (672)
++.|+|||++.+..++.++||||||+++|||++|+.||....... .......... ..... .....
T Consensus 166 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~-~~~~~----------~~~~~ 230 (307)
T 2eva_A 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHNG-TRPPL----------IKNLP 230 (307)
T ss_dssp CTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHTT-CCCCC----------BTTCC
T ss_pred CCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhcC-CCCCc----------ccccC
Confidence 899999999999999999999999999999999999997543221 1111111111 00000 11122
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 618 VQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 618 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
..+.+++.+||+.||++|||++|+++.|+.+.+...
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 456778889999999999999999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=334.36 Aligned_cols=237 Identities=22% Similarity=0.292 Sum_probs=186.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccCh---hhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.++||+|+||+||+|+.. +++.||||++....... ..+..|+..+.++.+|+||+++++++.+++..++||||+ +
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~ 140 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence 468999999999999976 68899999987654332 344556666666668999999999999999999999999 6
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 141 ~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 141 PSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp CBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 69988886532 34999999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 533 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
....+|+.|+|||++.+ .++.++|||||||++|||++|..|+..... ...+ ... ...+...
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~~-~~~----~~~~~~~---- 274 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQL-RQG----YLPPEFT---- 274 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHHH-TTT----CCCHHHH----
T ss_pred cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHH-hcc----CCCcccc----
Confidence 23457899999999876 789999999999999999999777653210 0111 111 1111110
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.||++|||++|++++
T Consensus 275 -~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 275 -AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1123457788889999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.55 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=191.9
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
+.||+|+||+||+|... +++.||||++..... ..+.+.+|++++.++.+||||+++++++.+++..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 57999999999999954 688999999976533 3567889999999876899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC---eEEeecCCCCCCCCC---
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTPLMNVP--- 532 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DfGla~~~~~~--- 532 (672)
.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||++......
T Consensus 99 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 99 LSHIHKR-----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred HHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 9999743 24899999999999999999999998 999999999999998876 999999998754321
Q ss_pred --------CCCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh-----h---HHHH
Q 005875 533 --------ATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL-----P---RWVQ 591 (672)
Q Consensus 533 --------~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~-----~---~~~~ 591 (672)
....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.... . ....
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 12347889999999975 5588999999999999999999999987654331100 0 0000
Q ss_pred HhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 592 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+..... ..... ... .....+.+++.+||+.||++|||++|++++
T Consensus 251 ~~i~~~~~-~~~~~---~~~---~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 251 ESIQEGKY-EFPDK---DWA---HISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHCCC-CCCHH---HHT---TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhccCc-ccCch---hcc---cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00111000 00000 000 122456788889999999999999999884
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=350.30 Aligned_cols=244 Identities=17% Similarity=0.291 Sum_probs=194.2
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.++||+|+||+||+|+..+ ++.||+|++++.. .....+.+|..++..+ +||||+++++++.+++..++||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 4689999999999999875 6789999997532 2234588899999888 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 158 gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 158 GGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 999999997532 34999999999999999999999998 999999999999999999999999999765432
Q ss_pred ---CCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 533 ---ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.+....+ ....+...........
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERFQFPT 304 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTHHHHCCCCS
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------HHHhhhhccccccCCc
Confidence 2356899999999997 5678999999999999999999999998643222 1222221110000000
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM 644 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 644 (672)
..... ...+.+++.+|++.+|++ ||+++|++++
T Consensus 305 ----~~~~~---s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 305 ----QVTDV---SENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ----SCCCS---CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ----ccccC---CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00112 234566777999888888 9999999884
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.25 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=200.5
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHH-cCCCceeceEEEEEeCC----eeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV-GQHPNVVPLRAYYYSKD----EKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~~----~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. ++.||+|++... ....+.+|.+++..+ .+||||+++++++.... ..++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~ 123 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123 (342)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT
T ss_pred EeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC
Confidence 578999999999999985 889999998653 245677888888873 38999999999998876 7899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcccCCCCCCCEEecCCCCeEEeecCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH--------SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 526 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--------~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 526 (672)
+|+|.+++... .+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||++
T Consensus 124 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 124 HGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999999742 3899999999999999999999 666 999999999999999999999999998
Q ss_pred CCCCCC--------CCCCCCCcccCcccccCCC------CCCccchhhHHHHHHHHHhC----------CCCCCCCCCCC
Q 005875 527 PLMNVP--------ATPSRSAGYRAPEVIETRK------HSHKSDVYSFGVLLLEMLTG----------KAPLQSPTRDD 582 (672)
Q Consensus 527 ~~~~~~--------~~~~~~~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~el~tg----------~~pf~~~~~~~ 582 (672)
...... ....+++.|+|||++.+.. ++.++|||||||++|||+|| ..||......+
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 655432 2345788999999997753 34689999999999999999 67776543322
Q ss_pred CCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 583 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
. ....+.............. ......+....+.+++.+||+.||++|||++|++++|+++.+..
T Consensus 275 ~-~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 275 P-SVEEMRKVVCEQKLRPNIP-----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp C-CHHHHHHHHTTSCCCCCCC-----GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred c-cHHHHHHHHHHHHhCCCCc-----ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 1 1122222221111111111 00011355677889999999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=332.15 Aligned_cols=247 Identities=23% Similarity=0.355 Sum_probs=200.1
Q ss_pred ccccccCcEEEEEEEEC---CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||+||+|.+. ++..||+|+++.... ..+.+.+|++++..+ +||||+++++++ ..+..++||||+++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~ 93 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEALMLVMEMAGG 93 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence 47999999999999864 567899999976432 345688999999999 999999999999 55678999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 94 GPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999999643 234899999999999999999999998 9999999999999999999999999997654321
Q ss_pred -----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 534 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 534 -----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
...+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+.... ...
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~i~~~~-~~~------ 233 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGK-RME------ 233 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTC-CCC------
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHhcCC-cCC------
Confidence 2235678999999998889999999999999999998 999997644321 111111111 000
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
........+.+++.+||+.||++||++.|++++|+++.....
T Consensus 234 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 234 ----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp ----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 011223467778889999999999999999999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=339.28 Aligned_cols=239 Identities=24% Similarity=0.310 Sum_probs=194.7
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+... ++.||+|+++... ...+.+..|..++..+.+||||+++++++.+.+..|+||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 4689999999999999865 6789999997642 2345677888888877689999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 105 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 176 (353)
T 2i0e_A 105 GGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176 (353)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence 99999999743 24899999999999999999999998 99999999999999999999999999976422
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+...... ..
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~~~---------~p 241 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHNVA---------YP 241 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC---------CC
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHhCCCC---------CC
Confidence 23456899999999999999999999999999999999999999764321 122222221110 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 644 (672)
. .....+.+++.+||+.||++||+ ++|++++
T Consensus 242 ~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 242 K---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp T---TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred C---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 12235667788999999999995 5777764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=342.15 Aligned_cols=240 Identities=20% Similarity=0.303 Sum_probs=194.0
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+++... ++.||+|++.... ...+.+.+|++++..+ +|||||++++++.+.+..++||||++
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~ 98 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMVVDLLL 98 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 4689999999999999764 6789999986542 2345788899999999 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 99 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 99 GGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp TEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 99999999742 34899999999999999999999998 999999999999999999999999999765432
Q ss_pred -CCCCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 533 -ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ............
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~---~~~~~~~~~~~~---------- 237 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS---KEIVHTFETTVV---------- 237 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH---HHHHHHHHHCCC----------
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH---HHHHHHHhhccc----------
Confidence 34568999999999974 4589999999999999999999999976543321 111111111100
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPN-MDEVVR 643 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 643 (672)
.........+.+++.+||+.||++||+ ++++.+
T Consensus 238 --~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 --TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 001112345677888999999999998 777765
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.97 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=197.0
Q ss_pred hcccccc--CcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKG--SYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+| +||+||+|+.. +++.||||++...... .+.+.+|+++++.+ +|||||++++++.+++..++||||+
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 108 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFM 108 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEEEEEEEcc
Confidence 4689999 99999999976 5889999999765433 24577899999998 8999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC---
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--- 530 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~--- 530 (672)
++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+....
T Consensus 109 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 109 AYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp TTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred CCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 9999999997543 234899999999999999999999998 9999999999999999999999999874321
Q ss_pred --------CCCCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh-----
Q 005875 531 --------VPATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----- 595 (672)
Q Consensus 531 --------~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----- 595 (672)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.. .........
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDT 260 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-----------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCccccc
Confidence 1223457888999999987 67899999999999999999999999865433221 000000000
Q ss_pred -----hcc------------ccccch--------hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHh
Q 005875 596 -----EEW------------TAEVFD--------VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEV 648 (672)
Q Consensus 596 -----~~~------------~~~~~d--------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i 648 (672)
+.. ...... ...............+.+++.+||+.||++|||++|++++ ++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 000 000000 0000000111223457888999999999999999999975 5554
Q ss_pred h
Q 005875 649 R 649 (672)
Q Consensus 649 ~ 649 (672)
.
T Consensus 341 ~ 341 (389)
T 3gni_B 341 K 341 (389)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=366.13 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=198.9
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 382 VLGKGSYGTAYKAVLE---ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.||+|+||+||+|.+. ++..||||+++... ...+++.+|++++.++ +|||||++++++.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 6999999999999864 45679999998653 2457899999999999 99999999999976 5689999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC--
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-- 534 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 534 (672)
+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 421 ~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 421 PLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp BHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred cHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999999743 234899999999999999999999998 99999999999999999999999999987643221
Q ss_pred -----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 535 -----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 535 -----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
..+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+. ... +.......
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~------~~~-i~~~~~~~------- 559 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAF-IEQGKRME------- 559 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH------HHH-HHTTCCCC-------
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH------HHH-HHcCCCCC-------
Confidence 123578999999999999999999999999999998 9999986543221 111 11111110
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
........+.+++.+||+.+|++||+++++++.|+.+.....
T Consensus 560 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 560 ---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp ---CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 111233567788889999999999999999999999876543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=336.09 Aligned_cols=263 Identities=22% Similarity=0.340 Sum_probs=200.6
Q ss_pred hccccccCcEEEEEEEEC-----CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 450 (672)
.+.||+|+||+||++.+. +++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+. ...++||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTEEEEEE
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCceEEEEE
Confidence 468999999999998753 578899999976532 245688999999999 899999999999874 5779999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 115 e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 115 EYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp CCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred ecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999743 2899999999999999999999998 9999999999999999999999999997664
Q ss_pred CC-------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 531 VP-------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 531 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
.. ....+++.|+|||++.+..++.++||||||+++|||++|..||........ ....+..............
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence 32 223467779999999998899999999999999999999999874321100 0000000000000000000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 654 (672)
+... ...........+.+++.+||+.||++|||++|+++.|+.+.+....
T Consensus 265 ~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 265 ERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred hccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 0000 0111122335677888899999999999999999999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=337.89 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=192.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHH-HcCCCceeceEEEEEeC-----CeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGR-VGQHPNVVPLRAYYYSK-----DEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~-l~~h~niv~l~~~~~~~-----~~~~lV~e~~ 453 (672)
.+.||+|+||+||+|+. +++.||||++.... ...+..|.++... ..+|+||+++++.+... ...++||||+
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 46899999999999987 47899999986543 3444555544332 23899999999866532 2568999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCcccCCCCCCCEEecCCCCeEEeecC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM---------GGPKFTHGNIKASNVLINQDLDGCISDFG 524 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~---------~~~~ivHrDLk~~NILl~~~~~~kl~DfG 524 (672)
++|+|.+++.... .++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 95 ~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 95 PNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp TTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCT
T ss_pred CCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeecc
Confidence 9999999997432 58899999999999999999998 7 9999999999999999999999999
Q ss_pred CCCCCCCC------------CCCCCCCcccCcccccC-------CCCCCccchhhHHHHHHHHHhCCCCCCCCCC-CCCC
Q 005875 525 LTPLMNVP------------ATPSRSAGYRAPEVIET-------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR-DDMV 584 (672)
Q Consensus 525 la~~~~~~------------~~~~~~~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~-~~~~ 584 (672)
++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|..||..... .+..
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 99755321 13357889999999987 4567789999999999999999777643322 2211
Q ss_pred Chh----------HHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005875 585 DLP----------RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654 (672)
Q Consensus 585 ~~~----------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 654 (672)
... ...............+.. ...........+.+++.+||+.||++|||++|+++.|+++...-..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 110 011111111111111110 1111223556788899999999999999999999999999977655
Q ss_pred CCCC
Q 005875 655 NRPS 658 (672)
Q Consensus 655 ~~~s 658 (672)
++..
T Consensus 323 ~~~~ 326 (336)
T 3g2f_A 323 NKSV 326 (336)
T ss_dssp ----
T ss_pred cccC
Confidence 4433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.23 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=192.8
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc------ChhhHHHHHHHHHHHc--CCCceeceEEEEEeCC-----e
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKD-----E 445 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~-----~ 445 (672)
.+.||+|+||+||+|+. .+++.||+|++..... ....+.+|++++.++. +||||+++++++.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 46899999999999996 4578899999874322 1346778888887774 5999999999998765 4
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCC
Q 005875 446 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 525 (672)
Q Consensus 446 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 525 (672)
.++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred EEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 789999997 59999997543 233899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh----hhcc
Q 005875 526 TPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV----REEW 598 (672)
Q Consensus 526 a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~----~~~~ 598 (672)
+....... ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.. ....... ...+
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGLPPEDDW 243 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHHHCCCCTTTS
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChhhc
Confidence 98665433 234788999999999999999999999999999999999999765432211 1111110 0111
Q ss_pred ccccc--hhhhhc--ccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 599 TAEVF--DVELMR--FQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 599 ~~~~~--d~~~~~--~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..... ...... ... ..+....+.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 10000 000000 000 01123456778889999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=344.10 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=191.3
Q ss_pred hccccccCcEEEEEEEECC--C--cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEe-CCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEE--S--TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|++.+ + ..||+|.++.... ..+.+.+|+.++.++ +||||+++++++.+ ++..++||||
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeEEEEEC
Confidence 4689999999999998642 2 3589998875432 245788999999998 89999999998754 4578999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.++++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 173 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 173 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999997432 34889999999999999999999998 999999999999999999999999999765322
Q ss_pred --------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 533 --------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 533 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
....+++.|+|||++.+..++.++|||||||++|||+| |.+||......+. ... ...... . .
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~---~~~~~~-~--~ 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY---LLQGRR-L--L 316 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHH---HHTTCC-C--C
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHH---HHcCCC-C--C
Confidence 12235678999999999999999999999999999999 6778875543321 111 111110 0 0
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 654 (672)
. .......+.+++.+||+.||++|||++|+++.|+++......
T Consensus 317 ~--------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 317 Q--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred C--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 0 011224577888899999999999999999999999876553
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=331.10 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=196.5
Q ss_pred hccccccCcEEEEEEEECC-C---cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCee-EEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEE-S---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK-LLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~-~lV~e~ 452 (672)
.+.||+|+||+||+|++.+ + ..+|+|++..... ..+.+.+|++++..+ +||||+++++++.+.+.. ++||||
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEECC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCcEEEEec
Confidence 4789999999999998543 2 2699999875432 235688999999999 899999999999876655 999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV- 531 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~- 531 (672)
+.+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 105 ~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 105 MCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred ccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999753 234899999999999999999999998 99999999999999999999999999975432
Q ss_pred -------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCC-CCCCCCCCChhHHHHHhhhhccccccc
Q 005875 532 -------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ-SPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 532 -------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
.....+++.|+|||.+.+..++.++||||||+++|||++|..|+. .....+ +.. . ........
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~---~-~~~~~~~~-- 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTH---F-LAQGRRLP-- 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHH---H-HHTTCCCC--
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHH---H-hhcCCCCC--
Confidence 123345778999999999999999999999999999999655543 322111 111 1 11111000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
........+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 249 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 249 --------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred --------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 001122456788889999999999999999999999987754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.15 Aligned_cols=249 Identities=25% Similarity=0.473 Sum_probs=195.6
Q ss_pred hccccccCcEEEEEEEECCC-----cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEES-----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|....+ ..||+|+++.... ....+.+|++++.++ +||||+++++++.+.+..++||||
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCCcEEEEeC
Confidence 46899999999999986532 3599999875432 234688999999999 999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 128 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 128 MENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp CTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred CCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999997532 34899999999999999999999998 999999999999999999999999999765432
Q ss_pred C-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 533 A-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 533 ~-------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
. ...+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+. ......
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~~~~-~~~~~~--- 270 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAIN-DGFRLP--- 270 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHH-TTCCCC---
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHH-CCCcCC---
Confidence 1 1224667999999999999999999999999999999 999997543211 111111 111000
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
........+.+++.+||+.+|++||++.|+++.|+++.+...
T Consensus 271 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 271 -------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp -------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 011223456778889999999999999999999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=344.53 Aligned_cols=246 Identities=22% Similarity=0.354 Sum_probs=193.8
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
+.||+|+||.||+|... +++.||+|+++... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 57999999999999975 57899999987653 2456788999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe--cCCCCeEEeecCCCCCCCCC---C
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI--NQDLDGCISDFGLTPLMNVP---A 533 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl--~~~~~~kl~DfGla~~~~~~---~ 533 (672)
.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++..... .
T Consensus 174 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 174 FDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp HHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99886432 24899999999999999999999998 9999999999999 56788999999999766433 2
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+....+... . ......
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~~~--~---~~~~~~ 315 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWDLE--D---EEFQDI 315 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCSC--S---GGGTTS
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCCCC--h---hhhccC
Confidence 345889999999999999999999999999999999999999764321 22222222222110 0 011112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHh
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEV 648 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i 648 (672)
...+.+++.+||+.||++|||++|+++ .+++.
T Consensus 316 ---~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 316 ---SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ---CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 245677788999999999999999998 44443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=340.25 Aligned_cols=255 Identities=16% Similarity=0.231 Sum_probs=187.9
Q ss_pred hccccccCcEEEEEEEEC----CCcEEEEEEeccccc------------ChhhHHHHHHHHHHHcCCCceeceEEEEEe-
Q 005875 380 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV------------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS- 442 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~- 442 (672)
.+.||+|+||+||+|... .+..+|+|++..... ....+.+|+..+..+ +||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFYGSGLTE 120 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEEEEEEEE
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceeecccccc
Confidence 468999999999999976 467899999875421 122345566666666 89999999999988
Q ss_pred ---CCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC--C
Q 005875 443 ---KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL--D 517 (672)
Q Consensus 443 ---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~--~ 517 (672)
....++||||+ +++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTS
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCc
Confidence 67889999999 999999997432 5899999999999999999999998 99999999999999887 9
Q ss_pred eEEeecCCCCCCCCC-----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 005875 518 GCISDFGLTPLMNVP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586 (672)
Q Consensus 518 ~kl~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~ 586 (672)
+||+|||+++..... ....+++.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~ 269 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV--A 269 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--H
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--H
Confidence 999999999655321 233578899999999999999999999999999999999999964321110 0
Q ss_pred hHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 587 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.......... .. ................+.+++.+||+.||++|||++|+++.|+++...
T Consensus 270 ~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 270 VQTAKTNLLD----EL-PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp HHHHHHHHHH----TT-THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred HHHHHHhhcc----cc-cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 0111111100 00 000000000002234677788899999999999999999999987653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=331.98 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=195.8
Q ss_pred hccccccCcEEEEEEEE-----CCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~ 450 (672)
.+.||+|+||.||+|++ .+++.||+|++..... ..+.+.+|++++..+ +||||+++++++.+. ...++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---CCEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCceEEEEE
Confidence 46899999999999984 3578899999975432 346789999999999 899999999999876 6689999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 105 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 105 EFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp ECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999996432 34899999999999999999999998 9999999999999999999999999997654
Q ss_pred CC-------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC--------CCCCChhHHHHHhhh
Q 005875 531 VP-------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR--------DDMVDLPRWVQSVVR 595 (672)
Q Consensus 531 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~--------~~~~~~~~~~~~~~~ 595 (672)
.. ....++..|+|||++.+..++.++||||||+++|||++|..|+..... ...............
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 32 233467779999999998999999999999999999999998653210 000000000000000
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
... ...........+.+++.+||+.||++|||++|+++.|+++.
T Consensus 258 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000 00011122346778888999999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=333.56 Aligned_cols=238 Identities=22% Similarity=0.342 Sum_probs=187.5
Q ss_pred hccccccCcEEEEEEEE----CCCcEEEEEEeccccc-----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.+.||+|+||+||+++. .+++.||+|+++.... ....+.+|++++..+ +||||+++++++.+++..++||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcCCEEEEEE
Confidence 46899999999999997 4688999999976432 234577899999998 8999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 101 EYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred eCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999743 24889999999999999999999998 9999999999999999999999999987543
Q ss_pred C----CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhh
Q 005875 531 V----PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606 (672)
Q Consensus 531 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 606 (672)
. .....|++.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+......
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~------- 239 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKCKLN------- 239 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCCC-------
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCC-------
Confidence 2 22345889999999999999999999999999999999999999764321 112222211110
Q ss_pred hhcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 607 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
.. ......+.+++.+||+.||++|| +++|++++
T Consensus 240 --~p---~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 240 --LP---PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --CC---TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --CC---CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 00 11123566788899999999999 78888873
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=338.69 Aligned_cols=248 Identities=14% Similarity=0.213 Sum_probs=198.6
Q ss_pred hccccccCcEEEEEEE------ECCCcEEEEEEecccccChhhHHHHHHHHHHHc--CCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAV------LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|. ...++.||+|+++.. ...++..|++++.++. .|+||+++++++..++..++|||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e 147 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence 4689999999999994 446788999998754 3567888888888873 28999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-----------CCCeEE
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-----------DLDGCI 520 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-----------~~~~kl 520 (672)
|+++|+|.++++.........+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl 224 (365)
T 3e7e_A 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224 (365)
T ss_dssp CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEE
Confidence 999999999997543323455999999999999999999999998 999999999999998 899999
Q ss_pred eecCCCCCCC------CCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh
Q 005875 521 SDFGLTPLMN------VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 594 (672)
Q Consensus 521 ~DfGla~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 594 (672)
+|||+|+... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----------- 293 (365)
T 3e7e_A 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----------- 293 (365)
T ss_dssp CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----------
T ss_pred eeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----------
Confidence 9999996542 12244589999999999999999999999999999999999999964322110
Q ss_pred hhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHHhhhcCCC
Q 005875 595 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR-PNMDEVVRMIEEVRQSDSE 654 (672)
Q Consensus 595 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~i~~~~~~ 654 (672)
. ........ ...+ .+.+++..|++.+|.+| |+++++.+.|+++.+....
T Consensus 294 ----~---~~~~~~~~-~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 294 ----K---PEGLFRRL-PHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp ----E---ECSCCTTC-SSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred ----e---echhcccc-CcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 0 00000011 1122 34456669999999998 6789999999998877543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=339.10 Aligned_cols=243 Identities=24% Similarity=0.373 Sum_probs=192.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|... +++.||+|++.... ....+|++++.++.+||||+++++++.+++..++||||+++|+|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L 103 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTT---CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc---CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence 468999999999999976 47789999997543 34567888888887899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC----CCeEEeecCCCCCCCCC--
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~----~~~kl~DfGla~~~~~~-- 532 (672)
.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++.....
T Consensus 104 ~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 104 LDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp HHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 9999743 34899999999999999999999998 9999999999998543 34999999999765432
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....+|+.|+|||++.+..++.++|||||||++|||++|..||....... .......+........ . ...
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~~i~~~~~~~~--~---~~~ 247 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEEILARIGSGKFSLS--G---GYW 247 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HHHHHHHHHHCCCCCC--S---TTT
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HHHHHHHHccCCcccC--c---ccc
Confidence 24567899999999988889999999999999999999999998543221 1122222221111100 0 001
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. .....+.+++.+||+.||++|||++|++++
T Consensus 248 ~---~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 248 N---SVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp T---TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred c---cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 122356677789999999999999999984
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.68 Aligned_cols=248 Identities=27% Similarity=0.435 Sum_probs=188.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+..+ .||+|+++..... .+.+.+|++++.++ +||||+++++++ .....++||||++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 4689999999999998653 5999998765433 35688899999998 899999999965 556789999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 105 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 105 SLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999996432 34899999999999999999999998 999999999999999999999999998754321
Q ss_pred --CCCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 533 --ATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
....+++.|+|||++. +..++.++||||||+++|||++|+.||......+ ............. ..
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~----~~ 247 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSP----DL 247 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCC----CT
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCc----ch
Confidence 2235788999999986 5668889999999999999999999997543221 1111111111110 00
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
.. ........+.+++.+||+.+|++|||++|+++.|+++.+
T Consensus 248 ~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 SK--VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TS--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hh--ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 011223567788889999999999999999999998864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=342.13 Aligned_cols=265 Identities=16% Similarity=0.246 Sum_probs=206.6
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCC--eeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+... ++.||||++.... ...+.+.+|++++.++ +||||+++++++...+ ..++||||++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 92 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence 4689999999999999765 7899999997543 2356788999999999 8999999999998765 6799999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe----cCCCCeEEeecCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DfGla~~~~ 530 (672)
+|+|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 93 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp TEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999975432 233899999999999999999999998 9999999999999 778889999999997654
Q ss_pred CC---CCCCCCCcccCcccccC--------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 531 VP---ATPSRSAGYRAPEVIET--------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 531 ~~---~~~~~~~~y~aPE~~~~--------~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
.. ....+++.|+|||++.+ ..++.++|||||||++|||++|+.||........ .......+......
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPS 245 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHHSCCT
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhcCCCc
Confidence 33 23457899999999865 5678899999999999999999999975433221 11222222222111
Q ss_pred ccc------------chhhhhc-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 600 AEV------------FDVELMR-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 600 ~~~------------~d~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
... +...... ..........+.+++.+||+.||++||+++|+++.++++.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 000 0001111 1122455667788999999999999999999999999987653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=346.36 Aligned_cols=190 Identities=26% Similarity=0.433 Sum_probs=154.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCC--eeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e~~ 453 (672)
.+.||+|+||+||+|... +++.||+|++...... ...+.+|+.++..+.+||||+++++++..++ ..|+||||+
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 468999999999999965 5789999998754332 3457789999999966999999999998654 689999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC--
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-- 531 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-- 531 (672)
+ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 8 5999999742 3899999999999999999999998 99999999999999999999999999975422
Q ss_pred -----------------------CCCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005875 532 -----------------------PATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579 (672)
Q Consensus 532 -----------------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~ 579 (672)
.....+|+.|+|||++.+ ..++.++||||+||++|||++|++||.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112357889999999976 678999999999999999999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.92 Aligned_cols=242 Identities=21% Similarity=0.335 Sum_probs=182.1
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|+..+ ++.||+|+++... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 135 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLVLELVTGGEL 135 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC-CCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence 4689999999999999864 6789999987643 356688899999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC---CCCeEEeecCCCCCCCCC---
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~~--- 532 (672)
.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 136 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 207 (349)
T 2w4o_A 136 FDRIVEK-----GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207 (349)
T ss_dssp HHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccccc
Confidence 9999742 34899999999999999999999998 999999999999975 889999999999765433
Q ss_pred CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 533 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ .....+...... ...+ ..
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~~~~~--~~~~---~~-- 275 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILNCEYY--FISP---WW-- 275 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHTTCCC--CCTT---TT--
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHhCCCc--cCCc---hh--
Confidence 23457899999999999999999999999999999999999997543221 111112111110 0000 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.||++|||+.|++++
T Consensus 276 -~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 276 -DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123456778889999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=334.29 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=202.2
Q ss_pred hccccccCcEEEEEEEE------CCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC-eeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lV~ 450 (672)
.+.||+|+||+||+|+. .+++.||+|+++.... ..+.+.+|++++.++.+||||+++++++...+ ..++||
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~ 111 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence 57899999999999984 2457899999976533 23568899999999988999999999988755 489999
Q ss_pred EecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeE
Q 005875 451 DYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 519 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 519 (672)
||+++|+|.+++...... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEE
Confidence 999999999999754321 0223789999999999999999999998 99999999999999999999
Q ss_pred EeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 005875 520 ISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQS 592 (672)
Q Consensus 520 l~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~ 592 (672)
|+|||++....... ...+++.|+|||++.+..++.++||||||+++|||+| |..||.+....+ ....
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~ 262 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCR 262 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHH
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH------HHHH
Confidence 99999997654332 1235678999999999999999999999999999998 999997654322 1111
Q ss_pred hhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 593 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 593 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.......... .......+.+++.+||+.||++|||++|++++|+.+.+...
T Consensus 263 ~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 263 RLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HhccCccCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 1111111000 01122456778889999999999999999999999987643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.71 Aligned_cols=238 Identities=18% Similarity=0.199 Sum_probs=196.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+++..++||||++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 124 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 468999999999999976 57899999986542 2345678899999988 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-C
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-~ 533 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 125 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~ 196 (350)
T 1rdq_E 125 GGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp TCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence 99999999743 23899999999999999999999998 999999999999999999999999999766443 3
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+...... ..
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~~---------~p--- 258 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSGKVR---------FP--- 258 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC---------CC---
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHHHHcCCCC---------CC---
Confidence 456899999999999999999999999999999999999999754321 122222221110 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 644 (672)
......+.+++.+||+.||++||+ ++|++++
T Consensus 259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 112245677888999999999998 8888873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.60 Aligned_cols=254 Identities=23% Similarity=0.404 Sum_probs=200.7
Q ss_pred hccccccCcEEEEEEEECC-CcE--EEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STT--VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~--vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|+... +.. +++|+++... ...+.+.+|++++.++.+||||+++++++.+.+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 4689999999999999653 443 4899887532 2346788999999998789999999999999999999999999
Q ss_pred CCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeec
Q 005875 455 SGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 523 (672)
Q Consensus 455 ~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~Df 523 (672)
+|+|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Df 186 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 186 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEccc
Confidence 9999999975430 12345899999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 524 GLTPLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 524 Gla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
|+++..... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||.+....+ ....+. ....
T Consensus 187 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~~~~-~~~~ 259 (327)
T 1fvr_A 187 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLP-QGYR 259 (327)
T ss_dssp TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHGG-GTCC
T ss_pred CcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HHHHhh-cCCC
Confidence 998754321 22345778999999998889999999999999999998 999997543211 111111 1110
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.. ........+.+++.+||+.||++|||++|+++.|+++.+...
T Consensus 260 ~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 260 LE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp CC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 001122456778889999999999999999999999987764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=344.44 Aligned_cols=243 Identities=21% Similarity=0.381 Sum_probs=196.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|... +++.||+|++..... ....+.+|++++..+ +||||+++++++.+++..++||||+++|+
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence 468999999999999976 578899999875432 345688999999998 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC--CCCeEEeecCCCCCCCCCC--
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--DLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~--~~~~kl~DfGla~~~~~~~-- 533 (672)
|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++.......
T Consensus 135 L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 135 LFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp HHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 99999743 234899999999999999999999998 999999999999974 4779999999998765432
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...+|+.|+|||++.+..++.++|||||||++|||++|..||.+.... .....+....+.. +.. ..
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~~~~~~---~~~--~~-- 274 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDWEF---DED--AF-- 274 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCCCC---CSS--TT--
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCC---Ccc--cc--
Confidence 235789999999999999999999999999999999999999864321 1122222111110 000 01
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.||++|||++|++++
T Consensus 275 -~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 275 -SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1123456778889999999999999999974
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.89 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=194.9
Q ss_pred hccccccCcEEEEEEEECCC----cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEE-eCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYY-SKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~-~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|+..++ ..+|+|.+..... ..+.+.+|++++.++ +||||+++++++. .++..++||||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCCceEEEEeC
Confidence 46899999999999996432 2588998875432 235688999999999 8999999999865 45578999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 109 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 109 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999997432 34899999999999999999999998 999999999999999999999999999765332
Q ss_pred --------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 533 --------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 533 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
....+++.|+|||.+.+..++.++||||||+++|||++ |.+||......+. . ......... .
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~---~~~~~~~~~---~ 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---T---VYLLQGRRL---L 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---H---HHHHTTCCC---C
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---H---HHHhcCCCC---C
Confidence 22335678999999999999999999999999999999 5666654433221 1 111111100 0
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
. .......+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 253 ~--------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 253 Q--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred C--------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 01122357788889999999999999999999999987643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=337.59 Aligned_cols=240 Identities=20% Similarity=0.316 Sum_probs=190.1
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcC-CCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||++...+++.||||++...... .+.+.+|++++.++.+ ||||+++++++..++..++||| +.+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 4689999999999999888999999998755333 3568899999999954 6999999999999999999999 568
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 140 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 140 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 89999997532 4889999999999999999999998 99999999999995 589999999999876432
Q ss_pred ---CCCCCCCcccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 533 ---ATPSRSAGYRAPEVIET-----------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .......+.....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNH 285 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHCTTS
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhCccc
Confidence 23458999999999865 3688999999999999999999999975321 1112222221111
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.... ... ....+.+++.+||+.||++|||+.|++++
T Consensus 286 ~~~~-------~~~---~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 286 EIEF-------PDI---PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCC-------CCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCC-------Ccc---chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1000 001 12356778889999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=352.79 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=197.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 368999999999999975 58899999997542 2345678899999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 268 GGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp SCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 999999997543 234899999999999999999999998 999999999999999999999999999776443
Q ss_pred -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....... +.... .. + .
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~-i~~~~-~~-~------p- 409 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERL-VKEVP-EE-Y------S- 409 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHH-HHHCC-CC-C------C-
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHH-hhccc-cc-C------C-
Confidence 235689999999999998999999999999999999999999986543221 1111111 11110 00 0 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
......+.+++.+||+.||++|| +++|++++
T Consensus 410 --~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 410 --ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11223566777899999999999 78999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=326.45 Aligned_cols=239 Identities=22% Similarity=0.419 Sum_probs=176.1
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+. .+++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEEEecCC
Confidence 46899999999999997 4688999999865421 236788899999988 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 95 NGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp TEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999997432 34899999999999999999999998 999999999999999999999999998765432
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....+++.|+|||++.+..++.++||||||+++|||++|+.||......+... ...... . . ..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~----~---~--~~ 232 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVVLAD----Y---E--MP 232 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSSC----C---C--CC
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHhhcc----c---C--Cc
Confidence 23457889999999999889999999999999999999999998654332211 000000 0 0 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.||++|||++|++++
T Consensus 233 ---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 233 ---SFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ---TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---cccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1122356678889999999999999999873
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.47 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=191.8
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|+... ++.||+|++...... .+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLVFEYCDH 86 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEEEEeCCC
Confidence 4689999999999999764 789999998765433 34577899999999 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 87 ~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 87 TVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred chHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999988643 24899999999999999999999998 999999999999999999999999999765432
Q ss_pred -CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhH---------HHHHhhhhccccc
Q 005875 533 -ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR---------WVQSVVREEWTAE 601 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 601 (672)
....+++.|+|||++.+ ..++.++||||||+++|||++|+.||.+....+...... +........+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 23457888999999976 668999999999999999999999998654322111000 0000000000000
Q ss_pred cchhhhhcccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 602 VFDVELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 602 ~~d~~~~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+....... .......+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000 01223457788889999999999999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=336.26 Aligned_cols=246 Identities=22% Similarity=0.367 Sum_probs=192.3
Q ss_pred hccccccCcEEEEEEEECC-CcE----EEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STT----VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~----vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|++.. ++. |++|.+.... ...+.+.+|+.++.++ +||||+++++++..+. .++|+||
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-~~~v~~~ 97 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQL 97 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS-EEEEECC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC-ceEEEEe
Confidence 4689999999999999653 433 5777775432 2456789999999998 8999999999998754 7899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999997543 34899999999999999999999998 999999999999999999999999999765432
Q ss_pred C------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
. ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+. ...........
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~~~~~---- 239 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGERLP---- 239 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCCCC----
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCCCC----
Confidence 2 2234667999999999999999999999999999999 9999986543321 11111111000
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
........+.+++.+||+.||++|||++|+++.|+++...
T Consensus 240 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 240 ------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0111233567788899999999999999999999999743
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=332.16 Aligned_cols=241 Identities=21% Similarity=0.320 Sum_probs=188.7
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCC-CceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQH-PNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||++...+++.||||++...... .+.+.+|++++..+.+| +||+++++++.+++..++||| +.+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence 4689999999999999988999999998755433 25688899999999433 999999999999999999999 567
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 93 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 93 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 8999999753 34899999999999999999999998 99999999999997 6789999999998764322
Q ss_pred ----CCCCCCcccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 534 ----TPSRSAGYRAPEVIET-----------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 534 ----~~~~~~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNH 238 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTS
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHhcCCc
Confidence 3458999999999864 6788999999999999999999999974321 1111222211111
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
.... . ......+.+++.+||+.||++|||+.|++++-
T Consensus 239 ~~~~-------~---~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 239 EIEF-------P---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CCCC-------C---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccCC-------c---ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1100 0 01123567788899999999999999999853
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=363.48 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=196.6
Q ss_pred ccccccCcEEEEEEEEC---CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 381 EVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
+.||+|+||+||+|.+. .++.||||+++..... .+++.+|++++.++ +|||||++++++. .+..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-~~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE-AESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCCEEEEEEccC
Confidence 47999999999999753 3578999999865433 46789999999999 8999999999986 456889999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.++++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 453 ~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 453 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999999743 34899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhh
Q 005875 534 ------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606 (672)
Q Consensus 534 ------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 606 (672)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+ +...+........
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~---- 593 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGC---- 593 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCCC----
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC----
Confidence 1224677999999999999999999999999999998 999998654322 1111111111110
Q ss_pred hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 607 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.......+.+++.+||+.||++||+++++++.|+++...
T Consensus 594 ------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 594 ------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 112235677888899999999999999999999988643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.78 Aligned_cols=244 Identities=17% Similarity=0.288 Sum_probs=195.5
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
+.||+|+||+||+|... +++.||+|+++.... ....+.+|+.++..+.+||||+++++++.+.+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 78999999999999976 578999999976543 34678899999999978899999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC---CCCeEEeecCCCCCCCCC-
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~~- 532 (672)
+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++......
T Consensus 115 ~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 188 (327)
T 3lm5_A 115 EIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188 (327)
T ss_dssp EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence 9999986432 245899999999999999999999998 999999999999998 789999999999766443
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....+++.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+...... ...
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~--~~~------ 254 (327)
T 3lm5_A 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNISQVNVD--YSE------ 254 (327)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCC--CCT------
T ss_pred ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHHhcccc--cCc------
Confidence 23458899999999999999999999999999999999999997643221 11111111000 000
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.........+.+++.+||+.||++|||++|++++
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0011223456778889999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=345.61 Aligned_cols=243 Identities=16% Similarity=0.264 Sum_probs=192.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+++.. +++.||+|++++.. ...+.+.+|.+++..+ +||||+++++++.+++..|+||||++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 468999999999999975 58899999997532 1234588899999888 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 145 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 145 GGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp SCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999997432 24899999999999999999999998 9999999999999999999999999997654322
Q ss_pred ----CCCCCCcccCccccc-------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 534 ----TPSRSAGYRAPEVIE-------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 534 ----~~~~~~~y~aPE~~~-------~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
...||+.|+|||++. ...++.++|||||||++|||++|+.||.+....+ ....+.........
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------TYGKIVHYKEHLSL 291 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTHHHHCCC
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------HHHHHHhcccCcCC
Confidence 346899999999997 4568999999999999999999999997643221 12222211100000
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR---PNMDEVVRM 644 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~ 644 (672)
+.. ... ....+.+++.+||+ +|++| |+++|++++
T Consensus 292 --p~~--~~~---~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 --PLV--DEG---VPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --C------C---CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --Ccc--ccC---CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000 011 22356677779999 99998 689999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=325.97 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=189.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|+.. +++.||+|++...... .+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence 468999999999999975 4788999999755432 25678899999998 899999999999999999999999986
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
++.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 86 -~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 86 -DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp -EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred -CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 5655554322 34999999999999999999999998 999999999999999999999999999765432
Q ss_pred -CCCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh-------hcccccc-
Q 005875 533 -ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR-------EEWTAEV- 602 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~~- 602 (672)
....+|+.|+|||++.+.. ++.++|||||||++|||++|..||..... .......+.. +.+....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-----HHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-----HHHHHHHHHHHhCCCChhhhhhhcc
Confidence 2345788999999998766 79999999999999999998888643221 1111111111 0000000
Q ss_pred ---------chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 603 ---------FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 603 ---------~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.................+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000011223456678889999999999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.15 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=183.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEe--------CCeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--------KDEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--------~~~~~lV 449 (672)
.+.||+|+||+||+|+.. +++.||+|++..... ..+.+.+|+.++.++.+||||+++++++.. ....++|
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 112 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence 478999999999999975 578999998855432 345688999999999669999999999953 3347899
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||++ |+|.+++..... ...+++..+..++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 113 ~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 188 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188 (337)
T ss_dssp EECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCC
T ss_pred EEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceec
Confidence 99996 699998864221 234999999999999999999999975 45999999999999999999999999999776
Q ss_pred CCCC----------------CCCCCCcccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 005875 530 NVPA----------------TPSRSAGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV 590 (672)
Q Consensus 530 ~~~~----------------~~~~~~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~ 590 (672)
.... ...+++.|+|||++ .+..++.++|||||||++|||++|+.||.........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------ 262 (337)
T 3ll6_A 189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV------ 262 (337)
T ss_dssp SSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred cccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh------
Confidence 4321 23378889999998 5667889999999999999999999999754322211
Q ss_pred HHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005875 591 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654 (672)
Q Consensus 591 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 654 (672)
........ . ......+.+++.+||+.||++|||++|++++|+++.+....
T Consensus 263 ----~~~~~~~~-------~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 263 ----NGKYSIPP-------H---DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp -------CCCCT-------T---CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred ----cCcccCCc-------c---cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 00000000 0 01112356788899999999999999999999999876544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=335.71 Aligned_cols=257 Identities=21% Similarity=0.367 Sum_probs=186.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|... +++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+++..++||||++ |
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 87 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVFEFMD-N 87 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEEEecC-C
Confidence 467999999999999965 578899999875432 346788999999999 89999999999999999999999998 5
Q ss_pred chhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 457 SLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 457 ~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
+|.+++..... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCccc
Confidence 99998864321 12235899999999999999999999998 999999999999999999999999999765432
Q ss_pred -CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh----cccc----cc
Q 005875 533 -ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE----EWTA----EV 602 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~----~~ 602 (672)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.. ......... .+.. ..
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCGGGGGCTT
T ss_pred CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhhhhhhhhh
Confidence 23457889999999976 46899999999999999999999999865432211 111110000 0000 00
Q ss_pred chhhhh--cccCh---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 603 FDVELM--RFQNI---------EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 603 ~d~~~~--~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+.+... ..... ......+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000 00000 0122457788889999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.93 Aligned_cols=256 Identities=21% Similarity=0.337 Sum_probs=192.5
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCe----eEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE----KLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----~~lV~ 450 (672)
.+.||+|+||+||+|+. .+++.||+|+++..... ...+.+|++++.++ +||||+++++++..... .++||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~lv~ 95 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVM 95 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCcccEEEE
Confidence 46899999999999996 56788999999765332 23577888888888 89999999999876554 39999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++|+|.++++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 96 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 96 EYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp ECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 999999999999743 24899999999999999999999998 9999999999999999999999999997654
Q ss_pred CCC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 531 VPA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 531 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
... ...+++.|+|||++.+..++.++||||||+++|||++|+.||.+....+ ...........
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~---- 237 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI---- 237 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC----
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC----
Confidence 321 2347889999999999999999999999999999999999997543211 11111111110
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHHHHHhhhcCCCCCCC
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVRMIEEVRQSDSENRPS 658 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~L~~i~~~~~~~~~s 658 (672)
.+.. .... ....+.+++.+||+.||++||++. ++...+..+....+...+.
T Consensus 238 ~~~~-~~~~---~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~ 289 (311)
T 3ork_A 238 PPSA-RHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK 289 (311)
T ss_dssp CHHH-HSTT---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCC
T ss_pred Cccc-ccCC---CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCc
Confidence 0000 0111 224566788899999999999655 5555777666555443333
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.17 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=195.9
Q ss_pred hccccccCcEEEEEEEECC----CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||+||+|.+.+ +..||+|.+..... ..+.+.+|++++..+ +||||+++++++.+ +..++||||+
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCCEEEEecC
Confidence 4689999999999998643 23599999876432 346788999999999 99999999999764 5678999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 95 PYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp TTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred CCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999997432 34899999999999999999999998 9999999999999999999999999987654322
Q ss_pred -----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 534 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 534 -----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
...+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. . ... .......
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~---~~~-~~~~~~~------ 234 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---I---GVL-EKGDRLP------ 234 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---H---HHH-HHTCCCC------
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---H---HHH-hcCCCCC------
Confidence 2335678999999998899999999999999999998 9999975443221 1 111 1110000
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
........+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 235 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 ----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0011224567788899999999999999999999998765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.88 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=192.2
Q ss_pred hccccccCcEEEEEEEECC----CcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCe-----eE
Q 005875 380 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----KL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~ 447 (672)
.+.||+|+||+||+|+... +..||+|+++..... .+.+.+|+.++.++ +||||+++++++.+.+. .+
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC-------CEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccccCCcccE
Confidence 5689999999999998642 347999998755333 34688899999999 89999999999987653 49
Q ss_pred EEEEecCCCchhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCC
Q 005875 448 LVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 526 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 526 (672)
+||||+++|+|.+++..... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLS 194 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcc
Confidence 99999999999999853321 22345999999999999999999999998 999999999999999999999999999
Q ss_pred CCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 527 PLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 527 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
...... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+. ........ .
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~~~~~~-~ 267 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM------YDYLLHGH-R 267 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------HHHHHTTC-C
T ss_pred eecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHHcCC-C
Confidence 765432 12335678999999999999999999999999999999 8999976543221 11111111 0
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.. ........+.+++.+||+.||++|||+.|++++|+++.+..+
T Consensus 268 ~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 268 LK----------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp CC----------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CC----------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00 011223457788889999999999999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=324.05 Aligned_cols=251 Identities=20% Similarity=0.373 Sum_probs=200.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|+.. +++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 88 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKTDVVLILE 88 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCCeEEEEEe
Confidence 468999999999999976 588999999875432 256789999999999 89999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC----CeEEeecCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP 527 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DfGla~ 527 (672)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 89 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 89 LVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred ecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999642 24899999999999999999999998 99999999999999887 89999999997
Q ss_pred CCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 528 LMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 528 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
...... ...+++.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+...... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~---~~ 231 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTNISAVNYD---FD 231 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTCCC---CC
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHHhHhcccC---Cc
Confidence 654322 3457889999999999999999999999999999999999997643211 11111111100 00
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhhcCC
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQSDS 653 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~~~~~ 653 (672)
... .. .....+.+++.+||+.||++|||+.|+++ .++++.....
T Consensus 232 ~~~--~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 232 EEY--FS---NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp HHH--HT---TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred chh--cc---cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence 000 01 11245677888999999999999999998 5777765543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.48 Aligned_cols=242 Identities=21% Similarity=0.383 Sum_probs=196.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe----------------
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS---------------- 442 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~---------------- 442 (672)
.+.||+|+||.||+|+.. +++.||+|++... .+.+.+|++++.++ +||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECC---SGGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccccccccC
Confidence 478999999999999986 6889999998653 35678899999999 99999999999864
Q ss_pred CCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEee
Q 005875 443 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 522 (672)
Q Consensus 443 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 522 (672)
....++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred cceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECc
Confidence 345789999999999999997533 234899999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 523 FGLTPLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 523 fGla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
||++...... ....+++.|+|||++.+..++.++||||||+++|||++|..|+... ....... .....
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~~-~~~~~ 236 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTDL-RDGII 236 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHHH-HTTCC
T ss_pred chhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHHh-hcccc
Confidence 9998765433 2345788999999999999999999999999999999999887421 0111111 11111
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.. . ....+.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 237 ~~----------~---~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 237 SD----------I---FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp CT----------T---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred cc----------c---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11 1 12345678889999999999999999999999986654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=328.57 Aligned_cols=242 Identities=21% Similarity=0.342 Sum_probs=196.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||+|+.. +++.||+|+++.... ..+.+.+|++++..+ +||||+++++++.+++..++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEE
Confidence 578999999999999976 578899999875432 246789999999999 89999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC----CeEEeecCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP 527 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DfGla~ 527 (672)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 96 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 96 LVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp CCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999742 34899999999999999999999998 99999999999999888 79999999997
Q ss_pred CCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 528 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 528 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
..... ....+++.|+|||++.+..++.++||||||+++|||++|..||.+....+ ....+..... .++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~---~~~ 238 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITSVSY---DFD 238 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTCC---CCC
T ss_pred ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhccc---ccC
Confidence 65443 23457889999999999999999999999999999999999997543211 1111111110 011
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... .. .....+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~--~~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 239 EEF--FS---HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHH--HT---TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhh--hc---ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 110 01 112356778889999999999999999873
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=336.26 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=197.9
Q ss_pred hccccccCcEEEEEEEE-----CCCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEE--eCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYY--SKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~--~~~~~~lV~e 451 (672)
.+.||+|+||+||+|++ .+++.||||++..... ..+.+.+|++++.++ +||||+++++++. +....++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCceEEEEEe
Confidence 46899999999999984 3578899999876532 245688999999999 9999999999987 4456889999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 107 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 107 YLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred ecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999997532 24899999999999999999999998 99999999999999999999999999976543
Q ss_pred CC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC--------CCChhHHHHHhhhh
Q 005875 532 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD--------MVDLPRWVQSVVRE 596 (672)
Q Consensus 532 ~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~--------~~~~~~~~~~~~~~ 596 (672)
.. ...+++.|+|||++.+..++.++||||||+++|||++|+.||....... ..............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 22 2346777999999999889999999999999999999999986432110 00000011111111
Q ss_pred ccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 597 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 597 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.. ...........+.+++.+||+.||++|||++|++++|+.+.....
T Consensus 260 ~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 260 GQ----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred cc----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 10 001112233567788889999999999999999999999976654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=323.34 Aligned_cols=241 Identities=21% Similarity=0.325 Sum_probs=194.6
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|.... +..+|+|++.... ...+.+.+|++++.++ +||||+++++++.+++..++||||+++++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 4689999999999999765 5689999987653 3467899999999999 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe---cCCCCeEEeecCCCCCCCCC--
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~~-- 532 (672)
|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++......
T Consensus 93 L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 93 LFERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp HHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 99988643 24899999999999999999999998 9999999999999 78899999999998765432
Q ss_pred -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 533 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
....+++.|+|||++.+. ++.++||||||+++|||++|+.||......+ ....+...... .... ...
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~--~~~~---~~~ 232 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKIREGTFT--FPEK---DWL 232 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC--CCHH---HHT
T ss_pred hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCCCC--CCch---hhh
Confidence 244578899999998764 8999999999999999999999997643211 11111111110 0000 000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.....+.+++.+||+.||++|||+.|++++
T Consensus 233 ---~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 233 ---NVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ---TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123456778889999999999999999973
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.82 Aligned_cols=261 Identities=19% Similarity=0.317 Sum_probs=192.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+.. +++.||+|++...... ...+.+|++++.++ +||||+++++++.+++..++||||++ |
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLD-K 84 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEEecccc-c
Confidence 468999999999999976 5788999998754322 22456788999988 89999999999999999999999998 5
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 85 DLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 9999887532 34899999999999999999999998 9999999999999999999999999987654322
Q ss_pred -CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh----ccccccchhhh
Q 005875 534 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE----EWTAEVFDVEL 607 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~d~~~ 607 (672)
...+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. .......... .+.........
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhcchhh
Confidence 3356889999999876 5689999999999999999999999986543221 1111111110 00000000000
Q ss_pred h-------cccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhhcC
Q 005875 608 M-------RFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQSD 652 (672)
Q Consensus 608 ~-------~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~~~~ 652 (672)
. .... .......+.+++.+||+.||++|||++|+++ .+..+.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 0 0000 0112245678888999999999999999998 555554443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=327.07 Aligned_cols=255 Identities=20% Similarity=0.363 Sum_probs=194.0
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+++..++||||++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 46899999999999996 4688999999875322 235678899999999 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 116 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 116 AGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp SCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred CCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 9999999864221 1334899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 534 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 534 ---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
...+++.|+|||++.+..++.++||||||+++|||++|+.||.+... ............... ... .
T Consensus 192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~-~~~------~ 260 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCDYP-PLP------S 260 (310)
T ss_dssp -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTTCSC-CCC------T
T ss_pred cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhcccCC-CCc------c
Confidence 23578889999999999999999999999999999999999975432 111222221111111 000 0
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
......+.+++.+||+.||++|||++|+++.|+++.+...
T Consensus 261 ---~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 261 ---DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 1122356778889999999999999999999999987764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=343.95 Aligned_cols=254 Identities=19% Similarity=0.245 Sum_probs=201.4
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||.||+|+. .+++.||||++.... ....+.+|++++..+.+|+++..+..++...+..++||||+ +++|
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL 89 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 89 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence 46899999999999996 458899999876543 34568899999999966678888888888888999999999 9999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe---cCCCCeEEeecCCCCCCCCCC--
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~~~-- 533 (672)
.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 90 ~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 90 EDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99997432 24999999999999999999999998 9999999999999 688999999999997654322
Q ss_pred ---------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 534 ---------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 534 ---------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
...+++.|+|||++.+..++.++|||||||++|||++|+.||.+......... ...+...... ....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~---~~~i~~~~~~-~~~~ 238 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK---YEKISEKKVA-TSIE 238 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH---HHHHHHHHHH-SCHH
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH---HHHHhhcccc-ccHH
Confidence 34578899999999999999999999999999999999999987554332111 1111111110 0000
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
. + .. .....+.+++.+||+.+|++||++++|++.|+++....
T Consensus 239 ~-l--~~---~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 239 A-L--CR---GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp H-H--HT---TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H-H--hc---CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0 0 01 11246778888999999999999999999999996543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.48 Aligned_cols=244 Identities=24% Similarity=0.346 Sum_probs=194.9
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 382 VLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.||+|+||+||+|.+. .++.||||+++..... .+.+.+|++++..+ +||||+++++++ ..+..++||||+++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~ 101 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAESWMLVMEMAEL 101 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence 7999999999999642 3578999999765332 45788999999999 899999999999 56778999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 102 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 9999999753 24899999999999999999999998 9999999999999999999999999987654322
Q ss_pred -----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 534 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 534 -----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
...+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ............
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~------ 240 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG------ 240 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC------
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCC------
Confidence 1234678999999998889999999999999999999 999997643221 111111111100
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
........+.+++.+||+.||++||++.|+++.|+++....
T Consensus 241 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 241 ----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 01122345777888999999999999999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.45 Aligned_cols=250 Identities=20% Similarity=0.308 Sum_probs=192.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|++...... .+.+.+|+.++.++ +||||+++++++..++..++||||++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLYVDMRLIN 117 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEEEEEEecC
Confidence 468999999999999975 5788999998765332 25678899999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 118 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 118 GVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999743 24899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 534 ----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 534 ----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
...+++.|+|||++.+..++.++||||||+++|||++|+.||...... ........... .+. ..
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~----~~~-~~ 257 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP----RPS-TV 257 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC----CGG-GT
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC----Ccc-cc
Confidence 335788999999999999999999999999999999999999754211 11111111110 000 00
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhhcCC
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~ 653 (672)
. ......+.+++.+||+.||++|| +++++++.|+++.....
T Consensus 258 ~---~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 258 R---PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp S---TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred C---CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0 11223566788899999999999 99999999998876654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=337.74 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=201.7
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|.... ...||+|.+..... ..+.+.+|++++..+.+||||+++++++.+++..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 4789999999999999753 24799999876532 245688999999999789999999999999999999999
Q ss_pred ecCCCchhhhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEee
Q 005875 452 YFASGSLSTLLHGNRG---------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 522 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 522 (672)
|+++|+|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D 207 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGD 207 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCC
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECc
Confidence 9999999999964321 01234899999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhh
Q 005875 523 FGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 595 (672)
Q Consensus 523 fGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 595 (672)
||++....... ...+++.|+|||++.+..++.++||||||+++|||+| |..||.+....+ .......
T Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~ 281 (333)
T 2i1m_A 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------KFYKLVK 281 (333)
T ss_dssp CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------HHHHHHH
T ss_pred cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------HHHHHHh
Confidence 99997653322 2234668999999998899999999999999999999 999997643221 1111221
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
....... .......+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 282 ~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 282 DGYQMAQ----------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCC----------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1111100 0111245677888999999999999999999999987643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.14 Aligned_cols=194 Identities=23% Similarity=0.318 Sum_probs=169.2
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHc-----CCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||+||+|.... ++.||||++.......+.+.+|++++..+. +|+||+++++++...+..++||||+
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 181 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL 181 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc
Confidence 4689999999999998764 788999999765444567788888888774 5779999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC--eEEeecCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--GCISDFGLTPLMNV 531 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~--~kl~DfGla~~~~~ 531 (672)
. ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++.....
T Consensus 182 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 182 S-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp C-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred C-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 6 69999987543 234899999999999999999999998 999999999999999987 99999999976544
Q ss_pred C-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 005875 532 P-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR 580 (672)
Q Consensus 532 ~-~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~ 580 (672)
. ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 3 345688999999999999999999999999999999999999986543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.87 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=193.3
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeC-CeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+++.. ++.||+|+++... ..+.+.+|++++.++ +||||+++++++.+. +..++||||+++|+|
T Consensus 26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 478999999999999986 7899999987543 456788999999998 899999999997654 478999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-CCCC
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR 537 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~ 537 (672)
.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...+
T Consensus 103 ~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 176 (278)
T 1byg_A 103 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 176 (278)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------C
T ss_pred HHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccccCCCc
Confidence 99997432 123788999999999999999999998 9999999999999999999999999987654332 3346
Q ss_pred CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHH
Q 005875 538 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 616 (672)
Q Consensus 538 ~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 616 (672)
++.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+ ....... .....
T Consensus 177 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~------~~~~-~~~~~~~----------~~~~~ 239 (278)
T 1byg_A 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRV-EKGYKMD----------APDGC 239 (278)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH------HHHH-TTTCCCC----------CCTTC
T ss_pred cccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHH-hcCCCCC----------CcccC
Confidence 788999999998899999999999999999998 9999976432221 1111 1111100 01122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 617 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 617 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
...+.+++.+||+.||++|||+.|+++.|++++...
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 345677888999999999999999999999997653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=346.26 Aligned_cols=238 Identities=23% Similarity=0.360 Sum_probs=196.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~ 99 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPSDIFMVMEYVS 99 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 468999999999999976 68899999997542 2245688999999988 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 100 gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 100 GGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp SEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999999742 34899999999999999999999998 999999999999999999999999999766433
Q ss_pred -CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 -ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....|++.|+|||++.+..+ +.++|||||||++|||++|+.||.+... ......+...... ..
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~---------~p 236 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICDGIFY---------TP 236 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHTTCCC---------CC
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCcC---------CC
Confidence 34568999999999988776 6899999999999999999999975432 1222222221110 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. ....+.+++.+||+.||++|||++|++++
T Consensus 237 ~~---~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 237 QY---LNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp TT---CCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred cc---CCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11 12346778889999999999999999983
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=324.16 Aligned_cols=238 Identities=25% Similarity=0.384 Sum_probs=192.4
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|.... +..||+|++.... .....+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEEEEEecCC
Confidence 4689999999999999764 5689999986542 2345688899999988 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 93 LGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 99999999743 24899999999999999999999998 999999999999999999999999988655432
Q ss_pred CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 533 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
....+++.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+...... .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~------------~ 226 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVEFT------------F 226 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCC------------C
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HHHHHHhCCCC------------C
Confidence 23457889999999999999999999999999999999999997543211 11111111100 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01122356678889999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.37 Aligned_cols=243 Identities=22% Similarity=0.332 Sum_probs=190.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+++.. ++..+|+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++|
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 105 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGG 105 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeEEEEEEeCCCC
Confidence 578999999999999975 578899999876542 457789999999999 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe---cCCCCeEEeecCCCCCCCCC-
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVP- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~~- 532 (672)
+|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++......
T Consensus 106 ~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 106 ELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp BHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred cHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 99998854321 1234899999999999999999999998 9999999999999 45688999999999765432
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....+++.|+|||++. ..++.++||||||+++|||++|+.||.+....+ .............. ..
T Consensus 182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~------~~ 248 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYKEPNYAV------EC 248 (285)
T ss_dssp -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCC--------
T ss_pred cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccCCccccc------cc
Confidence 2345788999999986 468899999999999999999999997643211 11111111110000 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.. ....+.+++.+||+.||++|||++|+++
T Consensus 249 ~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 RP---LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Cc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01 1235667888999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=332.15 Aligned_cols=255 Identities=14% Similarity=0.168 Sum_probs=198.2
Q ss_pred hccccccCcEEEEEEEECC---------CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceec---------------
Q 005875 380 AEVLGKGSYGTAYKAVLEE---------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP--------------- 435 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~--------------- 435 (672)
.+.||+|+||+||+|+... ++.||+|++... +.+.+|++++.++ +||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHH-CCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHh-cccchhhhhhhhccCCccCccc
Confidence 4689999999999999764 788999998653 5788999999999 8999887
Q ss_pred eEEEEEe-CCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC
Q 005875 436 LRAYYYS-KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 514 (672)
Q Consensus 436 l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~ 514 (672)
+++++.. ++..++||||+ +|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDP 194 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEET
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcC
Confidence 6778876 67889999999 999999998542 234999999999999999999999998 999999999999999
Q ss_pred CC--CeEEeecCCCCCCCCC-----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 005875 515 DL--DGCISDFGLTPLMNVP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 581 (672)
Q Consensus 515 ~~--~~kl~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~ 581 (672)
++ .+||+|||+++..... ....+++.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 9999999999765321 2235788999999999999999999999999999999999999864321
Q ss_pred CCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 582 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
. ..+........ .. .....+... ..... ...+.+++.+||+.||++|||++|+++.|+++.+...
T Consensus 275 ~-~~~~~~~~~~~-~~-~~~~~~~~~-~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 275 T-EDIMKQKQKFV-DK-PGPFVGPCG-HWIRP---SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp H-HHHHHHHHHHH-HS-CCCEECTTS-CEECC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred H-HHHHHHHHhcc-CC-hhhhhhhcc-ccCCC---cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 1 01111111111 00 011111000 00111 2456777889999999999999999999999987653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=344.13 Aligned_cols=253 Identities=13% Similarity=0.045 Sum_probs=180.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHc-CCCceeceE-------EEEEeCC--
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVG-QHPNVVPLR-------AYYYSKD-- 444 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~-~h~niv~l~-------~~~~~~~-- 444 (672)
.+.||+|+||+||+|++. +++.||+|++..... ..+.+.+|++++..+. +||||++++ +++...+
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~ 146 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence 468999999999999975 678899999987543 2345677877777764 599988755 5554432
Q ss_pred ---------------eeEEEEEecCCCchhhhhccCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCcccC
Q 005875 445 ---------------EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR------VKILLGTARGVAHIHSMGGPKFTHG 503 (672)
Q Consensus 445 ---------------~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~gl~~LH~~~~~~ivHr 503 (672)
..++||||++ |+|.+++..... .+++..+ ..++.||+.||+|||+++ |+||
T Consensus 147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHr 218 (371)
T 3q60_A 147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHG 218 (371)
T ss_dssp SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccC
Confidence 3799999999 899999975321 2444555 678899999999999998 9999
Q ss_pred CCCCCCEEecCCCCeEEeecCCCCCCCCCC-CCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 005875 504 NIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR 580 (672)
Q Consensus 504 DLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~ 580 (672)
||||+|||++.++.+||+|||+++...... ...+++.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999999998765544 4456789999999987 6799999999999999999999999987643
Q ss_pred CCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 005875 581 DDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR 649 (672)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~ 649 (672)
......... ........ ........ .....+.+++.+||+.||++|||++|+++ .++++.
T Consensus 299 ~~~~~~~~~---~~~~~~~~---~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 299 GIKGSWKRP---SLRVPGTD---SLAFGSCT---PLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp TCTTCCCBC---CTTSCCCC---SCCCTTSS---CCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred ccccchhhh---hhhhcccc---ccchhhcc---CCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 321110000 00000000 00000111 22345677888999999999999999986 444443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=319.49 Aligned_cols=241 Identities=22% Similarity=0.363 Sum_probs=193.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|... +++.||+|++..... ..+.+.+|+.++..+ +||||+++++++.+++..++||||++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence 468999999999999976 578999999875432 246788999999988 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----- 531 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----- 531 (672)
+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999742 34899999999999999999999998 99999999999999999999999999875432
Q ss_pred -CCCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 532 -PATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
.....+++.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....+. ..... ..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~~---~~----- 229 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTY---LN----- 229 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH----TTCTT---ST-----
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh----hcccc---cC-----
Confidence 233457889999999987765 7789999999999999999999986543211 111111 10000 00
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+.+++.+||+.||++|||++|++++
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001122356678889999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=337.85 Aligned_cols=258 Identities=17% Similarity=0.255 Sum_probs=197.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHc-------CCCceeceEEEEE----eCCeeE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-------QHPNVVPLRAYYY----SKDEKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-------~h~niv~l~~~~~----~~~~~~ 447 (672)
.+.||+|+||+||+|+.. +++.||+|+++......+.+.+|++++..+. +|+||+++++++. +....+
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~ 121 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC 121 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEE
Confidence 468999999999999965 5778999999765444567889999999884 2889999999998 456789
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEecCCC----------
Q 005875 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDL---------- 516 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~---------- 516 (672)
+||||+ +|++.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 122 lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 122 MVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred EEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhh
Confidence 999999 556666654332 23489999999999999999999998 7 99999999999999775
Q ss_pred ---------------------------------------CeEEeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCcc
Q 005875 517 ---------------------------------------DGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKS 556 (672)
Q Consensus 517 ---------------------------------------~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~ 556 (672)
.+||+|||++...... ....+|+.|+|||++.+..++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 274 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence 7999999999765433 344689999999999999999999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh---h---------ccccccch------------------hh
Q 005875 557 DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---E---------EWTAEVFD------------------VE 606 (672)
Q Consensus 557 DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~---------~~~~~~~d------------------~~ 606 (672)
|||||||++|||++|+.||......+...-......+.. . .+....+. ..
T Consensus 275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (397)
T 1wak_A 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354 (397)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence 999999999999999999987655443221111111110 0 00000000 00
Q ss_pred hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 607 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+....+.+|+.+||+.||++|||++|++++
T Consensus 355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 01112235566788999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=321.49 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=195.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|... +++.||+|++...... .+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 89 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG 89 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence 468999999999999975 4788999999765433 34577899999999 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC---eEEeecCCCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTPLMNVP 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DfGla~~~~~~ 532 (672)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++......
T Consensus 90 ~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 90 GELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999888643 34899999999999999999999998 999999999999987665 999999999765443
Q ss_pred C---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 533 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 533 ~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
. ...+++.|+|||++.+..++.++||||||+++|||++|+.||...... .............. .+ .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~--~~---~ 230 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAYDYP--SP---E 230 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCCC--TT---T
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHHHhccccCC--ch---h
Confidence 3 345788999999999999999999999999999999999999754321 11111111111100 00 0
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. .....+.+++.+||+.||++|||++|++++
T Consensus 231 ~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 231 WD---TVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TT---TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hc---ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11 122356678889999999999999999984
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=335.19 Aligned_cols=244 Identities=21% Similarity=0.339 Sum_probs=194.4
Q ss_pred hccccccCcEEEEEEEE----CCCcEEEEEEecccc-----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL----EESTTVVVKRLKEVV-----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.+.||+|+||+||+++. .+++.||||+++... ...+.+.+|++++..+.+||||+++++++..++..++||
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence 47899999999999997 368899999987542 234567789999999978999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 139 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 139 DYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp CCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 999999999999743 24899999999999999999999998 9999999999999999999999999987543
Q ss_pred CC-----CCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 531 VP-----ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 531 ~~-----~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
.. ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..............
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~---- 284 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSEPP---- 284 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCCCC----
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccCCC----
Confidence 21 22357899999999985 3478999999999999999999999986543321 11222222111100
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRMI 645 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 645 (672)
........+.+++.+||+.||++|| +++|++++.
T Consensus 285 --------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 285 --------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0111223566788899999999999 999998854
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=322.23 Aligned_cols=241 Identities=21% Similarity=0.323 Sum_probs=193.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|... +++.||+|+++.... ....+.+|+..+..+.+||||+++++++.+++..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 468999999999999976 688999999876432 2456778888888887899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC-------------------C
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-------------------L 516 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-------------------~ 516 (672)
|+|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.+ .
T Consensus 96 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 96 GSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CC
T ss_pred CcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 999999975321 1234899999999999999999999998 9999999999999844 4
Q ss_pred CeEEeecCCCCCCCCCCCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh
Q 005875 517 DGCISDFGLTPLMNVPATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 595 (672)
Q Consensus 517 ~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 595 (672)
.+||+|||.+..........+++.|+|||++.+. .++.++|||||||++|||++|.+++.... . ...+.
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~-~~~~~- 241 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--------Q-WHEIR- 241 (289)
T ss_dssp CEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--------H-HHHHH-
T ss_pred EEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--------H-HHHHH-
Confidence 7999999999888777777799999999999876 56689999999999999999998764321 0 11111
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
....... .. .....+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~-------~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 242 QGRLPRI-------PQ---VLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp TTCCCCC-------SS---CCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cCCCCCC-------Cc---ccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111000 01 112356778889999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=347.95 Aligned_cols=244 Identities=20% Similarity=0.297 Sum_probs=196.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
+.||+|+||+||+|+.. +++.||+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..|+||||+++
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 56999999999999975 58899999997543 2345688899999998 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
|+|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 270 g~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 270 GDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp CBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 999999975432 2345999999999999999999999998 9999999999999999999999999997654332
Q ss_pred --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 534 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ........+...... ...
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~~~---------~p~ 414 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQAVT---------YPD 414 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCCCC---------CCT
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhcccC---------CCc
Confidence 3468999999999999999999999999999999999999998654221 112222222211110 001
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVR 643 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 643 (672)
.....+.+++.+||+.||++||++ +|+++
T Consensus 415 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 415 ---KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 122355677789999999999975 66765
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=344.87 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=186.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeC------CeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 449 (672)
.+.||+|+||+||+|... +++.||||++...... .+.+.+|+.++..+ +||||+++++++... ...|+|
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccCCeEEEE
Confidence 468999999999999965 4788999999765332 35677899999998 999999999999654 356999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||+++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 146 ~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 146 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred EeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 999986 56666642 2889999999999999999999998 999999999999999999999999999876
Q ss_pred CCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC-h--------hHH-------H
Q 005875 530 NVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-L--------PRW-------V 590 (672)
Q Consensus 530 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~-~--------~~~-------~ 590 (672)
... ....+|+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+... + ..+ .
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 543 23468999999999999999999999999999999999999998654221100 0 000 0
Q ss_pred HHhhhhccc-ccc-----chhhhhcc--cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 591 QSVVREEWT-AEV-----FDVELMRF--QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 591 ~~~~~~~~~-~~~-----~d~~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......... ... +....... .........+.+|+.+||+.||++|||++|++++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 000 00000000 0011224567889999999999999999999984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=330.49 Aligned_cols=255 Identities=20% Similarity=0.362 Sum_probs=196.0
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEe----CCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~~ 453 (672)
.+.||+|+||.||+++. .+++.||+|++.... ...+.+.+|++++..+ +||||+++++++.. ....++||||+
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 46899999999999997 568899999886532 2346788999999998 99999999999873 34778999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++|+|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 113 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 113 KRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp TTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 99999999975322 1345899999999999999999999998 9999999999999999999999999986543211
Q ss_pred -------------CCCCCCcccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhc
Q 005875 534 -------------TPSRSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 597 (672)
Q Consensus 534 -------------~~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 597 (672)
...+++.|+|||++.+.. ++.++||||||+++|||++|+.||........ ..... ....
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~----~~~~ 263 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA----VQNQ 263 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH----HHCC
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH----hhcc
Confidence 123588899999997654 68899999999999999999999963211110 11000 0000
Q ss_pred cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 005875 598 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654 (672)
Q Consensus 598 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 654 (672)
.. ..........+.+++.+||+.||++|||++|++++|+.+....+.
T Consensus 264 ~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 264 LS----------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred CC----------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 00 000011234577788899999999999999999999998765543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.83 Aligned_cols=234 Identities=21% Similarity=0.275 Sum_probs=182.2
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+... ++.||+|++++.... ...+..|..++.+..+||||+++++++.+.+..|+||||++
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 122 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence 4789999999999999764 678999999765432 23345555553333389999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 123 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 123 GGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 99999999743 24889999999999999999999998 99999999999999999999999999975322
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.+.... .....+...... ..
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~~~---------~~ 259 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKPLQ---------LK 259 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHHSCCC---------CC
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhcccC---------CC
Confidence 23456899999999999999999999999999999999999999754321 122222221110 01
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMD 639 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 639 (672)
... ...+.+++.+||+.||++||++.
T Consensus 260 ~~~---~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 260 PNI---TNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp SSS---CHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCC---CHHHHHHHHHHcccCHHhCCCCC
Confidence 112 23456777899999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=331.13 Aligned_cols=232 Identities=22% Similarity=0.311 Sum_probs=192.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 449 (672)
.+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999964 578899999976532 234677899999999 999999999999999999999
Q ss_pred EEecCCC-chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 450 YDYFASG-SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 450 ~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
|||+.+| +|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 108 ~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 9999777 999999743 24899999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCC---CCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 529 MNVPA---TPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 529 ~~~~~---~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
..... ...+|+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .. ...
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~~-----~~~ 242 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------EA-----AIH 242 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------TT-----CCC
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------hh-----ccC
Confidence 65433 2357899999999988877 788999999999999999999997422100 00 000
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.... ....+.+++.+||+.||++|||++|++++
T Consensus 243 ----~~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 243 ----PPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----CSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----CCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 12346778889999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.34 Aligned_cols=244 Identities=13% Similarity=0.166 Sum_probs=185.4
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc----ChhhHHHHHHHHHHHc--CCCceeceE-------EEEEeCCe
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVG--QHPNVVPLR-------AYYYSKDE 445 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~--~h~niv~l~-------~~~~~~~~ 445 (672)
.+.||+|+||+||+|+. .+++.||||++..... ..+.+.+|++++..+. +|||||+++ +++.+.+.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 46899999999999996 4588999999974322 2356888986555443 799999998 77765542
Q ss_pred -----------------eEEEEEecCCCchhhhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCC
Q 005875 446 -----------------KLLVYDYFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 506 (672)
Q Consensus 446 -----------------~~lV~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk 506 (672)
.++||||+ +|+|.+++...... ....+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDik 233 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR 233 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 78999999 67999999753211 1122446888899999999999999998 9999999
Q ss_pred CCCEEecCCCCeEEeecCCCCCCCCCC-CCCCCCcccCcccccCC-----------CCCCccchhhHHHHHHHHHhCCCC
Q 005875 507 ASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVIETR-----------KHSHKSDVYSFGVLLLEMLTGKAP 574 (672)
Q Consensus 507 ~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~aPE~~~~~-----------~~~~~~DvwS~Gvvl~el~tg~~p 574 (672)
|+|||++.++.+||+|||+++...... ...| +.|+|||++.+. .++.++|||||||++|||++|+.|
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~P 312 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCC
T ss_pred HHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999998654332 3446 899999999887 899999999999999999999999
Q ss_pred CCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhh
Q 005875 575 LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQ 650 (672)
Q Consensus 575 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~~ 650 (672)
|.+....+..... . ...... ...+.+++.+||+.||++|||+.|+++ .++++.+
T Consensus 313 f~~~~~~~~~~~~---------------~----~~~~~~---~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 313 ITKDAALGGSEWI---------------F----RSCKNI---PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp C------CCSGGG---------------G----SSCCCC---CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred Ccccccccchhhh---------------h----hhccCC---CHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 9765433321100 0 000111 235667888999999999999999997 4555543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=332.88 Aligned_cols=251 Identities=20% Similarity=0.269 Sum_probs=192.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc------cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|... +++.||+|++.... ...+.+.+|++++.++ +||||+++++++.+++..++||||
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCCeEEEEEeC
Confidence 578999999999999975 56789999986542 2235788999999999 899999999999999999999999
Q ss_pred cCCCchhhhhccCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005875 453 FASGSLSTLLHGNRGA-----------------------------------GRTPLDWETRVKILLGTARGVAHIHSMGG 497 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~ 497 (672)
+++|+|.+++...... ....+++..+..++.||+.||+|||+.+
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~- 188 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG- 188 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence 9999999998521110 0112456778899999999999999998
Q ss_pred CCcccCCCCCCCEEecCCC--CeEEeecCCCCCCCC--------CCCCCCCCcccCcccccC--CCCCCccchhhHHHHH
Q 005875 498 PKFTHGNIKASNVLINQDL--DGCISDFGLTPLMNV--------PATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLL 565 (672)
Q Consensus 498 ~~ivHrDLk~~NILl~~~~--~~kl~DfGla~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl 565 (672)
|+||||||+||+++.++ .+||+|||++..... .....+++.|+|||++.+ ..++.++|||||||++
T Consensus 189 --ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 266 (345)
T 3hko_A 189 --ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266 (345)
T ss_dssp --EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred --ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence 99999999999998776 899999999975422 123457889999999975 6789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--
Q 005875 566 LEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR-- 643 (672)
Q Consensus 566 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~-- 643 (672)
|||++|+.||.+....+ ............. .+ .. ......+.+++.+||+.||++|||+.|+++
T Consensus 267 ~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~--~~---~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 267 HLLLMGAVPFPGVNDAD------TISQVLNKKLCFE--NP---NY---NVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHSSCSSCCSSHHH------HHHHHHHCCCCTT--SG---GG---GGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHCCCCCCCCChHH------HHHHHHhcccccC--Cc---cc---ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 99999999997543221 1122221111100 00 00 112345677888999999999999999998
Q ss_pred HHHHh
Q 005875 644 MIEEV 648 (672)
Q Consensus 644 ~L~~i 648 (672)
.++++
T Consensus 333 ~~~~~ 337 (345)
T 3hko_A 333 WISQF 337 (345)
T ss_dssp HHHTT
T ss_pred hhccC
Confidence 34443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=329.73 Aligned_cols=254 Identities=19% Similarity=0.294 Sum_probs=196.8
Q ss_pred hccccccCcEEEEEEEE--CCCcEEEEEEecccccChhhHHHHHHHHHHHcCC------CceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL--EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH------PNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h------~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|.. .+++.||+|+++......+.+.+|++++..+ +| ++++++++++.+.+..++|||
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 46899999999999986 3578899999976544456788899998887 44 459999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-----------------
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ----------------- 514 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~----------------- 514 (672)
|+ +++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 98 ~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 98 LL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred CC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99 889999997543 235899999999999999999999998 999999999999987
Q ss_pred --CCCeEEeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 005875 515 --DLDGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ 591 (672)
Q Consensus 515 --~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~ 591 (672)
++.+||+|||++...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+... ...
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~~~ 247 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA---MME 247 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH---HHH
T ss_pred ccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHH
Confidence 678999999999765443 34468899999999999999999999999999999999999998654322111 111
Q ss_pred Hhhhh---c-----cccccc---------------------hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 005875 592 SVVRE---E-----WTAEVF---------------------DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 642 (672)
Q Consensus 592 ~~~~~---~-----~~~~~~---------------------d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 642 (672)
..... . .....+ .+..............+.+++.+||+.||++|||++|++
T Consensus 248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327 (339)
T ss_dssp HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence 11000 0 000000 000000111234456788999999999999999999998
Q ss_pred HH
Q 005875 643 RM 644 (672)
Q Consensus 643 ~~ 644 (672)
++
T Consensus 328 ~h 329 (339)
T 1z57_A 328 KH 329 (339)
T ss_dssp TS
T ss_pred cC
Confidence 74
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=346.16 Aligned_cols=237 Identities=20% Similarity=0.277 Sum_probs=187.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|+.. +++.||+|+++.... ....+.+|+.++..+ +||||+++++++.+.+..++||||++
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 478999999999999965 578999999975421 234566788888887 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~-- 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....
T Consensus 232 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 232 GGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp SCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 99999999743 248999999999999999999998 77 99999999999999999999999999976432
Q ss_pred --CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 532 --PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 532 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...... .
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~~---------~ 368 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEEIR---------F 368 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC---------C
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC---------C
Confidence 23456899999999999999999999999999999999999999754321 112222211110 0
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR 643 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 643 (672)
. ......+.+++.+||+.||++|| +++|+++
T Consensus 369 p---~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 P---RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp C---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C---ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 11123567788899999999999 9999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.37 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=184.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 449 (672)
.+.||+|+||+||+|... +++.||+|++..... ....+.+|++++.++ +||||+++++++. .+..++|
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-~~~~~lv 217 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD-AEDYYIV 217 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE-SSEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCceEEE
Confidence 468999999999999975 468999999875421 123588999999999 9999999999975 4568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC---CeEEeecCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLT 526 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DfGla 526 (672)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 218 ~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 218 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccc
Confidence 9999999999998643 34899999999999999999999998 99999999999997544 5999999999
Q ss_pred CCCCCCC---CCCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccc
Q 005875 527 PLMNVPA---TPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 600 (672)
Q Consensus 527 ~~~~~~~---~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (672)
+...... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.... ......
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i----~~~~~~ 363 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI----TSGKYN 363 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH----HTTCCC
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH----hcCCCC
Confidence 8765432 3457899999999853 5678899999999999999999999976433221 11111 111000
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 601 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. .+. .. ......+.+++.+||+.||++|||++|++++
T Consensus 364 -~-~~~--~~---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 364 -F-IPE--VW---AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -C-CHH--HH---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -C-Cch--hh---cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 000 00 1123456778889999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.19 Aligned_cols=250 Identities=21% Similarity=0.297 Sum_probs=191.7
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe--CCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+. .+++.||+|+++.. ..+.+.+|++++.++.+||||+++++++.+ ....++||||++++
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 118 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 118 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence 46899999999999986 46789999998743 357789999999999669999999999988 56789999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-CeEEeecCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~--- 532 (672)
+|.++++. +++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 119 ~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 119 DFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp CHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred hHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 99999852 889999999999999999999998 99999999999999777 8999999999765432
Q ss_pred CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccccc-------ch
Q 005875 533 ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV-------FD 604 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~d 604 (672)
....+++.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+..... ........+. .+
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~-~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAK-VLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHH-HHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHH-hcCCchhhhHHHHhccccc
Confidence 23457888999999977 678999999999999999999999996432210 00000000 0000000000 00
Q ss_pred hh---------------hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 VE---------------LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~~---------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+. .............+.+++.+||+.||++|||++|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 00000111123567788889999999999999999873
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=336.35 Aligned_cols=251 Identities=20% Similarity=0.347 Sum_probs=188.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCC------eeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 449 (672)
.+.||+|+||.||+|... +++.||||++...... .+.+.+|++++..+ +||||+++++++...+ ..++|
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv 108 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLV 108 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccccCceEEEE
Confidence 467999999999999974 5889999998654332 35678899999999 8999999999997653 45999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 109 ~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 109 MPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp EECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 9999 7899999974 23899999999999999999999998 999999999999999999999999999876
Q ss_pred CCC-CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhc------cccc
Q 005875 530 NVP-ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE------WTAE 601 (672)
Q Consensus 530 ~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~ 601 (672)
... ....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+. ...+.... ....
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ------LKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHHHCCCCHHHHHT
T ss_pred ccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHhcCCCCHHHHHH
Confidence 543 23467899999999977 6799999999999999999999999986542211 11111000 0000
Q ss_pred c---------------chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005875 602 V---------------FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 649 (672)
Q Consensus 602 ~---------------~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~ 649 (672)
+ ....+. .........+.+++.+||+.||++|||++|++++ ++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhHHHHHHHHhCCCCCCCCHH--HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 000000 0011223456778889999999999999999984 54443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=331.99 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=190.9
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeC--------CeeE
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--------DEKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~ 447 (672)
.+.||+|+||+||+|+. .+++.||+|++..... ....+.+|++++..+ +||||+++++++... +..+
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 100 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIY 100 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC--------CEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccccCCceEE
Confidence 46899999999999997 4678999999865432 234678999999999 899999999999873 4689
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
+||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 101 lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 101 LVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 99999986 7777776432 24899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCC--------CCCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh--
Q 005875 528 LMNV--------PATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE-- 596 (672)
Q Consensus 528 ~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-- 596 (672)
.... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+... ........
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA---LISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCC
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCC
Confidence 5432 123346888999999876 457999999999999999999999998654322111 11111000
Q ss_pred -ccccccchh--------hhhcccChHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 597 -EWTAEVFDV--------ELMRFQNIEEE------MVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 597 -~~~~~~~d~--------~~~~~~~~~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......... .........+. ...+.+++.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000000 00001111111 2347789999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=345.42 Aligned_cols=189 Identities=27% Similarity=0.417 Sum_probs=149.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeC-----CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~ 450 (672)
.+.||+|+||+||+|+.. +++.||||++...... .+.+.+|++++..+ +||||+++++++... ...|+||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 136 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVL 136 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCceEEEEE
Confidence 468999999999999965 5789999999764332 35688899999999 999999999999543 5689999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+. |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 137 EIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9984 6999998742 34999999999999999999999998 9999999999999999999999999997654
Q ss_pred CC-------------------------------CCCCCCCcccCcccc-cCCCCCCccchhhHHHHHHHHHh--------
Q 005875 531 VP-------------------------------ATPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLT-------- 570 (672)
Q Consensus 531 ~~-------------------------------~~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~el~t-------- 570 (672)
.. ....+|+.|+|||++ .+..++.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 21 123468889999986 56679999999999999999999
Q ss_pred ---CCCCCCCC
Q 005875 571 ---GKAPLQSP 578 (672)
Q Consensus 571 ---g~~pf~~~ 578 (672)
|+++|.+.
T Consensus 288 ~~~~~p~f~g~ 298 (458)
T 3rp9_A 288 HADRGPLFPGS 298 (458)
T ss_dssp GGGCCCSCC--
T ss_pred cccccccCCCC
Confidence 66666554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=330.18 Aligned_cols=242 Identities=19% Similarity=0.362 Sum_probs=193.8
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccccC---------hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
+.||+|+||.||+|... +++.||||++...... .+.+.+|+.++.++.+||||+++++++......++||
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 179 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence 78999999999999986 6889999998654321 2457789999999878999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+|||++....
T Consensus 180 e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 180 DLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999742 24899999999999999999999998 9999999999999999999999999987654
Q ss_pred CC---CCCCCCCcccCcccccC------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccc
Q 005875 531 VP---ATPSRSAGYRAPEVIET------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601 (672)
Q Consensus 531 ~~---~~~~~~~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (672)
.. ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.......
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~~~- 324 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------LMLRMIMEGQYQF- 324 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCC-
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCC-
Confidence 32 23468899999999863 35888999999999999999999999754211 1111111111100
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 602 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+. .. .....+.+++.+||+.||++|||++|++++
T Consensus 325 -~~~~---~~---~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 325 -SSPE---WD---DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -CHHH---HS---SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCcc---cc---cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 01 112356778889999999999999999873
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.49 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=191.8
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|+... ++.||+|++...... .+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 4689999999999999764 788999998655433 34577899999999 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC---
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~--- 532 (672)
++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 109 ~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 109 TILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred chHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 9999887632 24899999999999999999999998 999999999999999999999999999765432
Q ss_pred -CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC-hh-------HHHHHhhhhc-cccc
Q 005875 533 -ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-LP-------RWVQSVVREE-WTAE 601 (672)
Q Consensus 533 -~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~-~~-------~~~~~~~~~~-~~~~ 601 (672)
....+++.|+|||++.+. .++.++|||||||++|||++|+.||.+....+... +. .......... ....
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 234578899999999875 68999999999999999999999998654322100 00 0000000000 0000
Q ss_pred cchhhhhcccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 602 VFDVELMRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 602 ~~d~~~~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+........ ......+.+++.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000000 1123567788889999999999999999873
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=329.40 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=199.8
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|... .++.||+|++..... ....+.+|++++..+ +||||+++++++.+++..++|||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEccCCccEEEEE
Confidence 468999999999999864 367899999875432 234688899999998 89999999999999999999999
Q ss_pred ecCCCchhhhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCC
Q 005875 452 YFASGSLSTLLHGNRG-----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 526 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla 526 (672)
|+++|+|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~ 185 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 185 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccc
Confidence 9999999999974321 11234789999999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 527 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 527 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
....... ...+++.|+|||++.+..++.++||||||+++|||++ |..||...... .....+......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~~~ 259 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVMEGGLL 259 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHHHHHHTTCCC
T ss_pred cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------HHHHHHHcCCcC
Confidence 7653221 2234678999999998899999999999999999999 89999754321 111111111110
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
. ........+.+++.+||+.||++|||+.|++++|+++...
T Consensus 260 -~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 260 -D----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp -C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 0 0112234567788899999999999999999999988543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.77 Aligned_cols=195 Identities=22% Similarity=0.406 Sum_probs=153.4
Q ss_pred hccccccCcEEEEEEEEC---CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe--CCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~~ 454 (672)
+++||+|+||+||+|+.. +++.||+|++..... ...+.+|++++.++ +||||+++++++.. +...++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 568999999999999976 467899999975432 45688999999999 89999999999965 568899999997
Q ss_pred CCchhhhhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe----cCCCCeEEeecCCC
Q 005875 455 SGSLSTLLHGNRG----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLT 526 (672)
Q Consensus 455 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DfGla 526 (672)
+ +|.+++..... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 5 88887753211 11234899999999999999999999998 9999999999999 77899999999999
Q ss_pred CCCCCC-------CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 005875 527 PLMNVP-------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTR 580 (672)
Q Consensus 527 ~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~ 580 (672)
+..... ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 865432 234578999999999874 589999999999999999999999986543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=317.11 Aligned_cols=238 Identities=22% Similarity=0.325 Sum_probs=194.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 97 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAP 97 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence 468999999999999976 46789999986532 2346788999999999 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC--C
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--P 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--~ 532 (672)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..... .
T Consensus 98 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 98 RGELYKELQKHG-----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 999999997432 4899999999999999999999998 99999999999999999999999999865543 2
Q ss_pred CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 533 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
....+++.|+|||++.+..++.++||||||+++|||++|+.||...... .....+...... ...
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~---------~~~- 233 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIVNVDLK---------FPP- 233 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCCC---------CCT-
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHhccccC---------CCC-
Confidence 3445788999999999999999999999999999999999999754321 111111111100 001
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.....+.+++.+||+.||++|||++|++++
T Consensus 234 --~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 234 --FLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --TSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --cCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 112356678889999999999999999983
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=329.66 Aligned_cols=258 Identities=19% Similarity=0.280 Sum_probs=194.3
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccChhhHHHHHHHHHHHc----------CCCceeceEEEEEeCC----
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----------QHPNVVPLRAYYYSKD---- 444 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~----------~h~niv~l~~~~~~~~---- 444 (672)
.+.||+|+||+||+|+. .+++.||||++.......+.+.+|++++.++. .|+||+++++++...+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 103 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 103 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCc
Confidence 46899999999999996 45788999999765445567888999988873 2899999999998654
Q ss_pred eeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEec------CCCC
Q 005875 445 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLIN------QDLD 517 (672)
Q Consensus 445 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~------~~~~ 517 (672)
..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++ ..+.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 104 HVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEE
T ss_pred eEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcce
Confidence 688999999 889999997543 23489999999999999999999998 8 99999999999994 4457
Q ss_pred eEEeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh-
Q 005875 518 GCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR- 595 (672)
Q Consensus 518 ~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~- 595 (672)
+||+|||++...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.................+..
T Consensus 177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (373)
T 1q8y_A 177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256 (373)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred EEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHh
Confidence 999999999766543 344688999999999999999999999999999999999999986543322211111111110
Q ss_pred --hc---------cc----------ccc--------chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 596 --EE---------WT----------AEV--------FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 596 --~~---------~~----------~~~--------~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. +. ..+ .+...............+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 00 00 000 000001112234566788899999999999999999999983
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.74 Aligned_cols=243 Identities=23% Similarity=0.385 Sum_probs=190.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe------CCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS------KDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lV~e~ 452 (672)
.+.||+|+||.||+|+.. +++.||+|++.......+.+.+|+.++.++.+||||+++++++.. .+..++||||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 108 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence 468999999999999974 678999999976666677899999999999789999999999987 4678999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 109 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 109 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp CTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred CCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 99999999997543 234899999999999999999999998 999999999999999999999999998765432
Q ss_pred ----CCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 533 ----ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 533 ----~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
....+++.|+|||++. +..++.++|||||||++|||++|..||...... .......... .....
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~~ 255 (326)
T 2x7f_A 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPRNP-APRLK 255 (326)
T ss_dssp --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CCCCS
T ss_pred ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhcCc-cccCC
Confidence 2345788999999997 566889999999999999999999999754321 1111111111 00000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... ....+.+++.+||+.||++||+++|++++
T Consensus 256 ------~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 256 ------SKK---WSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ------CSC---SCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ------ccc---cCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 011 12356778889999999999999999883
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.03 Aligned_cols=242 Identities=21% Similarity=0.352 Sum_probs=193.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+++.. +++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 578999999999999975 588999999976532 345688999999999 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe---cCCCCeEEeecCCCCCCCCCC-
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~~~- 533 (672)
|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++.......
T Consensus 93 L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 93 LFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp HHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 99998643 24899999999999999999999998 9999999999999 788999999999987654322
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...+++.|+|||++.+..++.++||||||+++|||++|+.||...... .....+...... +... ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~---~~~~--~~-- 231 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKEGYYE---FESP--FW-- 231 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHCCCC---CCTT--TT--
T ss_pred ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCC---CCcc--cc--
Confidence 123788999999999999999999999999999999999999754321 111111111110 0000 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.||++|||++|++++
T Consensus 232 -~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 232 -DDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1122456778889999999999999999984
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=328.79 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=197.7
Q ss_pred hccccccCcEEEEEEEE-----CCCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC--eeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lV~e 451 (672)
.+.||+|+||.||+|++ .+++.||+|++..... ..+.+.+|++++.++ +||||+++++++...+ ..++|||
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCceEEEEE
Confidence 46899999999999984 3578899999876432 245788999999999 8999999999987654 6799999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 125 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred CCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999997543 34899999999999999999999998 99999999999999999999999999976543
Q ss_pred CC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC--------CCCCC-hhHHHHHhhh
Q 005875 532 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR--------DDMVD-LPRWVQSVVR 595 (672)
Q Consensus 532 ~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~--------~~~~~-~~~~~~~~~~ 595 (672)
.. ...++..|+|||++.+..++.++||||||+++|||+||..||..... ..... ..........
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 22 23356679999999988899999999999999999999999863210 00000 0000001111
Q ss_pred hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 596 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.... ..........+.+++.+||+.||++|||+.|+++.|+++++.
T Consensus 278 ~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 278 NNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1000 001112234677888899999999999999999999998764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=316.74 Aligned_cols=242 Identities=24% Similarity=0.385 Sum_probs=190.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEe----CCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e 451 (672)
.+.||+|+||+||+|... ++..||+|++...... .+.+.+|++++..+ +||||+++++++.. +...++|||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e 109 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceEEEEEE
Confidence 357999999999999975 4678999998765433 34678899999998 89999999999875 345799999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec-CCCCeEEeecCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMN 530 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla~~~~ 530 (672)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||||+||+++ +++.+||+|||++....
T Consensus 110 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 110 LMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred ecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999743 34899999999999999999999975 4599999999999998 78999999999997654
Q ss_pred CCC--CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 531 VPA--TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 531 ~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
... ...+++.|+|||++.+ .++.++||||||+++|||++|+.||...... ........ .......++
T Consensus 184 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~~~~~~~---- 252 (290)
T 1t4h_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVT-SGVKPASFD---- 252 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHT-TTCCCGGGG----
T ss_pred ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHh-ccCCccccC----
Confidence 332 3457889999998874 5899999999999999999999999753321 11111111 111111111
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.||++|||++|++++
T Consensus 253 -----~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 253 -----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0112356788889999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=331.06 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=190.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC------hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|+.. +++.||+|++...... .+.+.+|++++..+ +||||+++++++.+.+..++||||
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCceEEEEEc
Confidence 468999999999999975 4789999998753221 24678899999999 899999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 94 MET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred CCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 986 8988886432 34888999999999999999999998 999999999999999999999999999876432
Q ss_pred ----CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh---hhccccccch
Q 005875 533 ----ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWTAEVFD 604 (672)
Q Consensus 533 ----~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~d 604 (672)
....+|+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+. +........ .+.|......
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSSSTTSS
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCChhhhhhhccC
Confidence 234578899999999764 588999999999999999999999976532211 001011000 0011000000
Q ss_pred hhh---hccc--C----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 VEL---MRFQ--N----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~~~---~~~~--~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
+.. .... . .......+.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0000 0 01123567788889999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.78 Aligned_cols=191 Identities=21% Similarity=0.381 Sum_probs=166.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|... +++.||+|++..... ..+.+.+|++++..+ +||||+++++++.+++..++||||+++|
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 116 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 116 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEEEECCCCC
Confidence 468999999999999976 578899999876432 235688899999988 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC--CCC
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--VPA 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~--~~~ 533 (672)
+|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++.... ...
T Consensus 117 ~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 188 (360)
T 3eqc_A 117 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188 (360)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999997432 489999999999999999999986 7 9999999999999999999999999986442 223
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~ 579 (672)
...+++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4568899999999999999999999999999999999999997643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=341.99 Aligned_cols=241 Identities=21% Similarity=0.343 Sum_probs=194.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc---cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|+.. +++.||||++.... .....+.+|++++.++ +||||+++++++.+....++||||+++
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 105 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTG 105 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence 578999999999999975 57899999986542 3456788999999999 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec---CCCCeEEeecCCCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~---~~~~~kl~DfGla~~~~~~ 532 (672)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 106 ~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 106 GELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999988643 24899999999999999999999998 99999999999995 4567999999999766433
Q ss_pred ---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 533 ---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
....+|+.|+|||++.+ .++.++||||+||++|||++|+.||.+....+ ....+......... ..
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~~~~-----~~ 245 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGKYAFDL-----PQ 245 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCCSCS-----GG
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCCCC-----cc
Confidence 23458899999999976 58999999999999999999999997643221 12222211111100 01
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. .....+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~---~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 WR---TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GG---GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cC---CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 122356678889999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.11 Aligned_cols=195 Identities=22% Similarity=0.302 Sum_probs=165.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCc-----eeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN-----VVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-----iv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||+||+|+.. +++.||||+++........+..|+.++..+.+|++ |+++++++...+..++||||+
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 138 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML 138 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC
Confidence 468999999999999976 46789999997654445667788888888855664 999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec--CCCCeEEeecCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~--~~~~~kl~DfGla~~~~~ 531 (672)
+ |+|.+++.... ...+++..+..++.|++.||+|||.+. .+|+||||||+|||++ .++.+||+|||++.....
T Consensus 139 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 139 S-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp C-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred C-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 6 59999997543 234899999999999999999999521 2399999999999995 478899999999977654
Q ss_pred C-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005875 532 P-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579 (672)
Q Consensus 532 ~-~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~ 579 (672)
. ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 214 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3 34568899999999999999999999999999999999999998654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.73 Aligned_cols=240 Identities=24% Similarity=0.374 Sum_probs=196.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|... +++.||+|++.... ...+.+.+|+.++..+ +||||+++++++.+++..++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 468999999999999965 57889999987553 2346789999999998 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 106 ~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 106 SALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 99999963 24899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 533 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
....+++.|+|||++.+..++.++||||||+++|||++|+.||...... ..... ......... ..
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~-------~~- 241 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFL-IPKNNPPTL-------EG- 241 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSCCCCC-------CS-
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHH-hhcCCCCCC-------cc-
Confidence 2345788999999999999999999999999999999999999754321 11111 111111000 01
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 646 (672)
.....+.+++.+||+.||++|||++|++++..
T Consensus 242 --~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 242 --NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp --SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred --ccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 11234677888999999999999999998644
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=356.71 Aligned_cols=238 Identities=24% Similarity=0.314 Sum_probs=195.1
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+... ++.||||++++.. ...+.+..|..++..+.+||||+++++++.+.+..|+||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 4689999999999999764 6789999997542 2345677888888888789999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC---
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--- 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~--- 531 (672)
+|+|.++++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 426 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 426 GGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 99999999743 24899999999999999999999998 99999999999999999999999999975322
Q ss_pred -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 532 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.. .....+...... ..
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~---------~p 562 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHNVA---------YP 562 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHSSCCC---------CC
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHHhCCCC---------CC
Confidence 23456899999999999999999999999999999999999999864322 222222222110 01
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVR 643 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 643 (672)
. .....+.+|+.+||+.||++||++ +||++
T Consensus 563 ~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 K---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp T---TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred c---cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 122456677789999999999997 77765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=321.82 Aligned_cols=240 Identities=25% Similarity=0.407 Sum_probs=191.6
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||.||+|.... ++.||+|++.... ..+.+.+|++++..+ +||||+++++++..++..++||||+++|+|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 4689999999999999764 7899999987543 456788999999998 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----CC
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----AT 534 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 534 (672)
.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 112 ~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 112 SDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp HHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence 9998632 234899999999999999999999998 999999999999999999999999998665432 23
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChH
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 614 (672)
..+++.|+|||++.+..++.++||||||+++|||++|+.||...... ...... ........ ....
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~~--------~~~~ 249 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMI-PTNPPPTF--------RKPE 249 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHH-HHSCCCCC--------SSGG
T ss_pred cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHH-hcCCCccc--------CCcc
Confidence 45788999999999999999999999999999999999999753311 111111 11110000 0011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 615 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.....+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 12345678888999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=343.50 Aligned_cols=241 Identities=22% Similarity=0.354 Sum_probs=191.4
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc--------------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--------------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD 444 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 444 (672)
.+.||+|+||+||+|+... ++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+++
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 119 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKK 119 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCC
Confidence 4689999999999999764 67899999875432 245688999999999 8999999999999999
Q ss_pred eeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC---CeEEe
Q 005875 445 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCIS 521 (672)
Q Consensus 445 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~---~~kl~ 521 (672)
..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999998643 24899999999999999999999998 99999999999999876 69999
Q ss_pred ecCCCCCCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 522 DFGLTPLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 522 DfGla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
|||++...... ....+|+.|+|||++.+ .++.++||||+||++|+|++|..||.+....+ ....+.....
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~ 264 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------IIKKVEKGKY 264 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC
Confidence 99999766443 34568999999999874 68999999999999999999999998654221 1222211111
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. + ...... ....+.+++.+||+.||++|||++|++++
T Consensus 265 ~~---~--~~~~~~---~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 YF---D--FNDWKN---ISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CC---C--HHHHTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC---C--ccccCC---CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 10 0 001111 12456778889999999999999999984
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.88 Aligned_cols=238 Identities=21% Similarity=0.349 Sum_probs=194.3
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+++..+ ++.+|+|++..... ..+.+.+|+.++..+ +||||+++++++.+++..++||||++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEEEEecCC
Confidence 4689999999999999764 67899999875432 235678899999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 99 RRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp TCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999998642 24899999999999999999999998 999999999999999999999999998765422
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....+++.|+|||++.+..++.++||||||+++|||++|+.||...... ............ ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---------~~ 235 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNEYS---------IP 235 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCCC---------CC
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhhccCC---------Cc
Confidence 2345788999999999989999999999999999999999999754321 111111111100 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.||++|||++|++++
T Consensus 236 ---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 ---KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1112356678889999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=317.32 Aligned_cols=238 Identities=21% Similarity=0.335 Sum_probs=188.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPTDFFMVMEYVS 94 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCeEEEEEeccC
Confidence 468999999999999976 68899999986542 2345788999999998 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 95 GGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp SCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred CCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 99999999743 24899999999999999999999998 9999999999999999999999999987764432
Q ss_pred --CCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 534 --TPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
...+++.|+|||++.+..+ +.++||||||+++|||++|+.||..... ......+...... . .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~---~------~ 231 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKKIRGGVFY---I------P 231 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---C------C
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCccc---C------c
Confidence 3457888999999988765 5899999999999999999999975321 1111111111100 0 0
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.||++|||++|++++
T Consensus 232 ---~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 ---EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1112356778889999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.50 Aligned_cols=241 Identities=23% Similarity=0.383 Sum_probs=195.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+.
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 109 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYT 109 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 578999999999999976 67899999986542 2456788999999999 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe---cCCCCeEEeecCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DfGla~~~~~ 531 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 110 ~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 110 GGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp SCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999998743 34899999999999999999999998 9999999999999 5678999999999876554
Q ss_pred CC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 532 PA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 532 ~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
.. ...+|+.|+|||++.+ .++.++||||+||++|||++|+.||.+....+ ....+......... .
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~~~~-----~ 249 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKKVEKGKYTFEL-----P 249 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCS-----G
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCCCCCC-----c
Confidence 33 2357899999999976 68999999999999999999999998653221 12222221111110 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... .....+.+++.+||+.||++|||++|++++
T Consensus 250 ~~~---~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 250 QWK---KVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp GGG---GSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 111 122456678889999999999999999984
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.92 Aligned_cols=243 Identities=24% Similarity=0.312 Sum_probs=191.5
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+||+|+||+||+|... +++.||+|.+..... ..+.+.+|+.++..+ +||||+++++++.+.+..++||||+++++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 47999999999999964 577899999876533 346788999999998 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-CCCeEEeecCCCCCCCC----CC
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNV----PA 533 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~~~~----~~ 533 (672)
.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++..... ..
T Consensus 107 ~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 107 SALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp HHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred HHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 999975432 234678999999999999999999998 999999999999988 89999999999876543 22
Q ss_pred CCCCCCcccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 534 TPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
...+++.|+|||++.+.. ++.++||||||+++|||++|+.||......+ ...............
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~--------- 247 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFKVHPEI--------- 247 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHCCCCCC---------
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhccccccccc---------
Confidence 345788999999997643 7899999999999999999999996432111 000000000000000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......+.+++.+||+.||++|||++|++++
T Consensus 248 -~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 -PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01123456778889999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=325.52 Aligned_cols=249 Identities=25% Similarity=0.361 Sum_probs=188.0
Q ss_pred hccccccCcEEEEEEEEC--CCc--EEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE--EST--TVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~--~~~--~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|++. +++ .||+|+++.... ..+.+.+|++++.++ +||||+++++++..+. .++|||
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-CEEEEE
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-ceeeEe
Confidence 468999999999999853 233 589998875432 235688999999999 8999999999997654 889999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 101 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 101 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred cccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999997532 24899999999999999999999998 99999999999999999999999999876543
Q ss_pred CC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 532 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 532 ~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
.. ...++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.......
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~--- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERL--- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCC---
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCCC---
Confidence 22 2335678999999998889999999999999999999 99999754321 1122221111110
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.........+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 245 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 245 -------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred -------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 0011223457788889999999999999999999999876543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.33 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=196.4
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|++. ++..||||++..... ...++.+|+.++.++ +||||+++++++.+++..++|||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCCCcEEEEe
Confidence 468999999999999842 466899999965422 345688899999999 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC---CCCeEEeecCCC
Q 005875 452 YFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLT 526 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla 526 (672)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++. +..+||+|||++
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~ 190 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccc
Confidence 99999999999765321 1245899999999999999999999998 999999999999994 446999999988
Q ss_pred CCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 527 PLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 527 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
...... ....+++.|+|||++.+..++.++||||||+++|||+| |..||......+ ....+.... .
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~-~ 263 (327)
T 2yfx_A 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFVTSGG-R 263 (327)
T ss_dssp HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTTC-C
T ss_pred cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------HHHHHhcCC-C
Confidence 643221 22345778999999998899999999999999999998 999997543211 111111111 0
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
.. ........+.+++.+||+.||++||+++|++++|+.+.+..
T Consensus 264 ~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 264 MD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CC----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 00 00112245677888999999999999999999999987654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=342.42 Aligned_cols=245 Identities=21% Similarity=0.356 Sum_probs=191.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc---cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|+.. ++..||+|++.... .....+.+|++++..+ +||||+++++++.+....++||||+++
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 120 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKG 120 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 578999999999999976 57889999987653 2356788999999998 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC---CCeEEeecCCCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLMNVP 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DfGla~~~~~~ 532 (672)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++......
T Consensus 121 g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 121 GELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999988643 24899999999999999999999998 9999999999999764 55999999999765433
Q ss_pred ---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 533 ---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
....+|+.|+|||++. ..++.++||||+||++|||++|..||.+....+ ....+........ .+ .
T Consensus 193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~~~--~~---~ 260 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKVEKGKYTFD--SP---E 260 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCCCC--SG---G
T ss_pred ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCCC--ch---h
Confidence 3456899999999986 469999999999999999999999998654221 1222221111100 00 1
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHh
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEV 648 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i 648 (672)
... ....+.+++.+||+.||++|||+.|++++ +++.
T Consensus 261 ~~~---~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 261 WKN---VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp GTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ccc---CCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 111 22346677889999999999999999974 5544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.77 Aligned_cols=238 Identities=21% Similarity=0.350 Sum_probs=194.3
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+++..+ ++.+|+|++..... ..+.+.+|+.++..+ +|+||+++++++.+.+..++||||++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEecCC
Confidence 4689999999999999764 67899999875432 235678899999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 125 ~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 125 RRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp TCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 99999998642 24899999999999999999999998 999999999999999999999999999765422
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....+++.|+|||++.+..++.++||||||+++|||++|+.||...... .....+...... ..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~---------~~ 261 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNEYS---------IP 261 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC---------CC
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHhcCCCC---------CC
Confidence 2345788999999999989999999999999999999999999754321 111111111110 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. .....+.+++.+||+.||++|||++|++++
T Consensus 262 ~---~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 262 K---HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred c---cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 112346678889999999999999999984
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=330.33 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=184.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|+.. +++.||+|+++..... .+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAEN 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEEEEEecCCC
Confidence 468999999999999965 5788999999754332 34577899999999 999999999999999999999999985
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec-----CCCCeEEeecCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-----QDLDGCISDFGLTPLMN 530 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-----~~~~~kl~DfGla~~~~ 530 (672)
+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++....
T Consensus 118 -~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 118 -DLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp -EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred -CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999997533 3899999999999999999999998 99999999999994 45569999999987554
Q ss_pred CC----CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh---hcccc--
Q 005875 531 VP----ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---EEWTA-- 600 (672)
Q Consensus 531 ~~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~-- 600 (672)
.. ....+++.|+|||++.+. .++.++|||||||++|||++|+.||.+....+. +......... ..+..
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSTTGG
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCchhhhhhhh
Confidence 22 234568899999999874 489999999999999999999999976432211 0000000000 00000
Q ss_pred --ccchhhhh--cccChHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 601 --EVFDVELM--RFQNIEE-----EMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 601 --~~~d~~~~--~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
..+..... ....... ....+.+++.+||+.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000 0000111 1245678888999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=325.17 Aligned_cols=245 Identities=19% Similarity=0.283 Sum_probs=168.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe----CCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~~~ 454 (672)
.++||+|+||+||+|... +++.||+|++... ....+|+....+..+||||+++++++.. +...++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 357999999999999976 5889999998653 3344555554555599999999999976 445799999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC---CCCeEEeecCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNV 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~ 531 (672)
+|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++.....
T Consensus 110 gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 110 GGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp TEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 999999998543 235999999999999999999999998 999999999999986 45599999999976543
Q ss_pred C--CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 532 P--ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 532 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
. ....+++.|+|||++.+..++.++||||||+++|||++|+.||............ ......... .... ..
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~--~~~~---~~ 256 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--KRRIRLGQY--GFPN---PE 256 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCCT---TT
T ss_pred cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--HHhhhcccc--ccCc---hh
Confidence 2 2345788999999998888999999999999999999999999765433221100 000000000 0000 00
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. ......+.+++.+||+.||++|||++|++++
T Consensus 257 ~---~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 257 W---SEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp S---TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred h---ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 1223456778889999999999999999983
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=321.36 Aligned_cols=242 Identities=21% Similarity=0.337 Sum_probs=189.5
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|+... ++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+++..++||||+++++
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence 4679999999999999864 7889999987553 3456788999999998 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC----CCCC
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPA 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~----~~~~ 533 (672)
|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++... ....
T Consensus 103 l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 103 VDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 999986422 24899999999999999999999998 999999999999999999999999987432 1223
Q ss_pred CCCCCCcccCcccc-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 534 TPSRSAGYRAPEVI-----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 534 ~~~~~~~y~aPE~~-----~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
...+++.|+|||++ ....++.++||||||+++|||++|+.||...... ............. ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~-~~----- 243 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSDPPT-LL----- 243 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCCC-CS-----
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccCCcc-cC-----
Confidence 45688899999998 4667899999999999999999999999754321 1111211111110 00
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
........+.+++.+||+.||++|||++|++++
T Consensus 244 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 244 ---TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ---SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ---CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 011122456778889999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=325.44 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=185.6
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC------------hhhHHHHHHHHHHHcCCCceeceEEEEEeC----
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG------------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK---- 443 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~---- 443 (672)
.+.||+|+||.||+|...+++.||||++...... .+.+.+|++++.++ +||||+++++++...
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 105 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPA 105 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEEECCTTT
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeEEeccCCC
Confidence 4689999999999999888999999998654321 15688999999999 899999999998653
Q ss_pred -CeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEee
Q 005875 444 -DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 522 (672)
Q Consensus 444 -~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~D 522 (672)
...++||||++ |+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 106 MHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred cceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEe
Confidence 35799999998 5888888743 234899999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCCCC---CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 523 FGLTPLMNVP---ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 523 fGla~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
||++...... ....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. ...+.....
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~------~~~i~~~~~ 251 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ------LNKIVEVVG 251 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHHHC
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHHcC
Confidence 9999754332 23457888999999877 6789999999999999999999999986532211 111110000
Q ss_pred c---c-----------ccchhhhhc--ccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 599 T---A-----------EVFDVELMR--FQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 599 ~---~-----------~~~d~~~~~--~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. . ......... ... .......+.+++.+||+.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0 0 000000000 000 01123457788889999999999999999983
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.92 Aligned_cols=187 Identities=26% Similarity=0.400 Sum_probs=158.9
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeC-----CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~ 450 (672)
.+.||+|+||+||+|+... ++.||||++...... .+.+.+|++++..+ +||||+++++++... +..|+||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 109 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVL 109 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcCCeEEEEE
Confidence 4689999999999999754 678999999765332 35688999999999 899999999999776 5689999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||++ |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 110 e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 110 EIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp ECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred ecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 9987 5999999742 34899999999999999999999998 9999999999999999999999999997653
Q ss_pred CC--------------------------CCCCCCCcccCcccc-cCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 005875 531 VP--------------------------ATPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576 (672)
Q Consensus 531 ~~--------------------------~~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~el~tg~~pf~ 576 (672)
.. ....+|+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 22 334578999999986 56679999999999999999998655554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=316.75 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=178.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccCh--hhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+.. +++.||+|+++...... .....|...+.+..+||||+++++++.+++..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~- 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT- 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-
Confidence 468999999999999974 67889999997653322 23333444433444899999999999999999999999985
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
+|.+++..... ....+++..+..++.|++.||+|||++ + |+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 91 SLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred chHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 88777753211 123599999999999999999999998 8 9999999999999999999999999997654332
Q ss_pred -CCCCCCcccCcccc----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 534 -TPSRSAGYRAPEVI----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 534 -~~~~~~~y~aPE~~----~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
...+++.|+|||++ .+..++.++||||||+++|||++|+.||...... .............. ..
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~-~~----- 235 (290)
T 3fme_A 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPSPQ-LP----- 235 (290)
T ss_dssp ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCCCC-CC-----
T ss_pred cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCCCC-cc-----
Confidence 23578899999996 5667889999999999999999999999743211 11111111111110 00
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHh
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEV 648 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i 648 (672)
.......+.+++.+||+.||++|||++|+++ .++..
T Consensus 236 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 236 ----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ----cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 0112345678888999999999999999998 44443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.53 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=184.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCC------eeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 449 (672)
.+.||+|+||+||+|... +++.||||++...... .+.+.+|+.++..+ +||||+++++++...+ ..++|
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~lv 108 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIV 108 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccccceEEE
Confidence 468999999999999965 5788999999764332 34677899999998 9999999999997665 67999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||+++ +|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 109 ~e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 109 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred EEcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 999975 78888852 2889999999999999999999998 999999999999999999999999999766
Q ss_pred CCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHH-------
Q 005875 530 NVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------LPRWV------- 590 (672)
Q Consensus 530 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~---------~~~~~------- 590 (672)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+....+... .+.+.
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 433 23457889999999999999999999999999999999999998654211100 00000
Q ss_pred HHhhhhccc--cccchhhhh---cc---cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 591 QSVVREEWT--AEVFDVELM---RF---QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 591 ~~~~~~~~~--~~~~d~~~~---~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......... ...+..... .. .........+.+++.+||+.||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 000000000 00 0012234568889999999999999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=333.39 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=175.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeC------CeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 449 (672)
.+.||+|+||.||+|... +++.||||++...... .+.+.+|++++..+ +||||+++++++... ...++|
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~~lv 112 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV 112 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccccCCeEEEE
Confidence 468999999999999964 5788999998754332 35677899999999 899999999999754 567999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 ~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 113 THLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp EECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 9999 6899998863 24999999999999999999999998 999999999999999999999999999775
Q ss_pred CCC-CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh---ccccccch
Q 005875 530 NVP-ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWTAEVFD 604 (672)
Q Consensus 530 ~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d 604 (672)
... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. .......... .....+..
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHTTCCC
T ss_pred cccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHHhhh
Confidence 443 23467899999999977 6789999999999999999999999986542211 1111111000 00000000
Q ss_pred h-------hhhc--ccChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 V-------ELMR--FQNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~-------~~~~--~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
. .+.. ..... .....+.+|+.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0000 00001 112456788889999999999999999984
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.47 Aligned_cols=249 Identities=20% Similarity=0.306 Sum_probs=193.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEe--CCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~ 453 (672)
.+.||+|+||+||+++.. +++.||+|++...... .+.+.+|++++.++ +||||+++++++.+ ....++||||+
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~ 89 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYC 89 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEEEEEeCC
Confidence 468999999999999976 5788999999754332 35688899999999 89999999998864 56789999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
++|+|.+++..... ....+++..+..++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~ 168 (279)
T 2w5a_A 90 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168 (279)
T ss_dssp TTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC--
T ss_pred CCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecc
Confidence 99999999975332 2334899999999999999999999976 23499999999999999999999999999876543
Q ss_pred CC----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 532 PA----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 532 ~~----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
.. ...+++.|+|||++.+..++.++||||||+++|||++|+.||...... .....+. .......
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~-~~~~~~~----- 236 (279)
T 2w5a_A 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIR-EGKFRRI----- 236 (279)
T ss_dssp -CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HTCCCCC-----
T ss_pred ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHHHHHh-hcccccC-----
Confidence 32 124688899999999989999999999999999999999999754321 1111111 1111110
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
.......+.+++.+||+.||++|||++|+++++..
T Consensus 237 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 237 -----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 01122456778889999999999999999987653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=317.80 Aligned_cols=242 Identities=19% Similarity=0.351 Sum_probs=193.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 448 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 448 (672)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++.++.+||||+++++++..++..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 468999999999999976 578899999865421 134577899999999669999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 449 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 102 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999742 24899999999999999999999998 99999999999999999999999999876
Q ss_pred CCCC---CCCCCCCcccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 529 MNVP---ATPSRSAGYRAPEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 529 ~~~~---~~~~~~~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
.... ....+++.|+|||++. ...++.++||||||+++|||++|..||...... .....+......
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~ 247 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMIMSGNYQ 247 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------HHHHHHhcCCcc
Confidence 5432 2345788999999985 456889999999999999999999999754321 111111111111
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.. .+ ........+.+++.+||+.||++|||++|+++
T Consensus 248 ~~--~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 248 FG--SP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CC--TT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cC--cc------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00 00 01122345778888999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=317.39 Aligned_cols=241 Identities=23% Similarity=0.381 Sum_probs=187.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 449 (672)
.+.||+|+||.||+|... +++.||||++..... ....+.+|++++.++ +||||+++++++..++ .++|
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~lv 92 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIV 92 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESSS-EEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCCc-eEEE
Confidence 578999999999999975 468899999865421 124588999999999 9999999999987654 8999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC---eEEeecCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLT 526 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DfGla 526 (672)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||++
T Consensus 93 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 93 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred EecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 9999999999998642 34899999999999999999999998 999999999999987665 999999999
Q ss_pred CCCCCCC---CCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccc
Q 005875 527 PLMNVPA---TPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 600 (672)
Q Consensus 527 ~~~~~~~---~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (672)
....... ...+++.|+|||++. ...++.++|||||||++|||++|..||....... .+..... .... .
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~---~~~~-~ 238 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT---SGKY-N 238 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH---HTCC-C
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH---hCcc-c
Confidence 7764332 224788999999974 5678899999999999999999999997654322 1111111 1100 0
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 601 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
..+.. . ......+.+++.+||+.||++|||++|+++
T Consensus 239 --~~~~~--~---~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 --FIPEV--W---AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --CCHHH--H---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cCchh--h---hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 0 112345678888999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=320.42 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=192.2
Q ss_pred hccccccCcEEEEEEEE--CCCcEEEEEEeccccc---ChhhHHHHHHHHHHHc--CCCceeceEEEEE-----eCCeeE
Q 005875 380 AEVLGKGSYGTAYKAVL--EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVG--QHPNVVPLRAYYY-----SKDEKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~-----~~~~~~ 447 (672)
.+.||+|+||+||+|+. .+++.||+|+++.... ....+.+|+.++..+. +||||+++++++. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 46899999999999997 3578899999875432 2346778888887765 7999999999987 456789
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
+||||++ |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 96 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 9999998 69999997543 234899999999999999999999998 9999999999999999999999999997
Q ss_pred CCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh----hhcccc
Q 005875 528 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV----REEWTA 600 (672)
Q Consensus 528 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~ 600 (672)
..... ....+++.|+|||++.+..++.++||||||+++|||++|+.||.+....+. ........ ...+..
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCGGGSCT
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCcccCcc
Confidence 65432 234578899999999999999999999999999999999999986542211 11110000 011110
Q ss_pred ccchhh--hh------cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 601 EVFDVE--LM------RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 601 ~~~d~~--~~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
....+. .. ...........+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00 00000112345667888999999999999999996
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=327.17 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=190.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeC-----CeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~e 451 (672)
.+.||+|+||+||+|... +++.||+|++..... ..+.+.+|++++.++ +||||+++++++... ...++|||
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~e 110 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQD 110 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccceEEEEEc
Confidence 468999999999999965 567899999875332 235688999999999 899999999999765 36899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 111 ~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 111 LME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 997 4999998642 3899999999999999999999998 99999999999999999999999999976542
Q ss_pred C-------CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc---c
Q 005875 532 P-------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT---A 600 (672)
Q Consensus 532 ~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~ 600 (672)
. ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.. ............ .
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDLN 257 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH---HHHHHHHCSCCHHHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH---HHHHHHhCCCCHHHHH
Confidence 2 23467899999998754 45899999999999999999999999865433321 111111000000 0
Q ss_pred ccchh-------hhh--cccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 601 EVFDV-------ELM--RFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 601 ~~~d~-------~~~--~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+. ... ..... ......+.+++.+||+.||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000 00000 1122457788889999999999999999983
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=325.05 Aligned_cols=253 Identities=17% Similarity=0.282 Sum_probs=192.9
Q ss_pred hccccccCcEEEEEEEECC-C-cEEEEEEecccccChhhHHHHHHHHHHHcCCCc------eeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE-S-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN------VVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~-~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n------iv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|.... + +.||+|+++......+.+.+|++++..+ +|++ ++.+++++...+..++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 4689999999999999753 3 6899999976544456788899999888 4444 9999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe-------------------
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI------------------- 512 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl------------------- 512 (672)
|+ ++++.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 103 ~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 103 LL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred cc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccc
Confidence 99 567777765432 234899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 005875 513 NQDLDGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ 591 (672)
Q Consensus 513 ~~~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~ 591 (672)
+.++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~ 252 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL---VMME 252 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHH
T ss_pred cCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH
Confidence 66889999999999765443 3446889999999999999999999999999999999999999865432211 1111
Q ss_pred Hhhhh---cc-----cccc-------chh--------------hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 005875 592 SVVRE---EW-----TAEV-------FDV--------------ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 642 (672)
Q Consensus 592 ~~~~~---~~-----~~~~-------~d~--------------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 642 (672)
..... .+ .... ++. ..............+.+++.+||+.||++|||++|++
T Consensus 253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 11000 00 0000 000 0000011123455788999999999999999999998
Q ss_pred H
Q 005875 643 R 643 (672)
Q Consensus 643 ~ 643 (672)
+
T Consensus 333 ~ 333 (355)
T 2eu9_A 333 L 333 (355)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=335.67 Aligned_cols=245 Identities=23% Similarity=0.363 Sum_probs=183.8
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||.+...+++.||||++.... .+.+.+|++++.++.+||||+++++++.+++..++||||++ |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 36799999999987777779999999986532 35678899999887789999999999999999999999996 6999
Q ss_pred hhhccCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC-------------CCeEEeecC
Q 005875 460 TLLHGNRGAGR--TPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-------------LDGCISDFG 524 (672)
Q Consensus 460 ~~l~~~~~~~~--~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-------------~~~kl~DfG 524 (672)
+++........ ...++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 99975432111 11133456789999999999999998 9999999999999754 489999999
Q ss_pred CCCCCCCCC--------CCCCCCcccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhH
Q 005875 525 LTPLMNVPA--------TPSRSAGYRAPEVIET-------RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR 588 (672)
Q Consensus 525 la~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~ 588 (672)
+++...... ...+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------ 247 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------ 247 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH------
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH------
Confidence 997664322 2357899999999975 668999999999999999999 999996432111
Q ss_pred HHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 589 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 589 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
..+.......... ...........+.+++.+||+.||++|||+.|+++
T Consensus 248 --~~i~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --SNIIRGIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHTCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHhcCCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111111110000 01112344567788899999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=324.88 Aligned_cols=252 Identities=16% Similarity=0.253 Sum_probs=195.7
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccCh------------------hhHHHHHHHHHHHcCCCceeceEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK------------------RDFEQQMEIVGRVGQHPNVVPLRAYYY 441 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~------------------~~~~~e~~~l~~l~~h~niv~l~~~~~ 441 (672)
.+.||+|+||.||+|.. +++.||+|++....... +.+.+|++++.++ +||||+++++++.
T Consensus 36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 113 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLTCEGIIT 113 (348)
T ss_dssp EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBCCCSEEEE
T ss_pred EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcceEEEEEe
Confidence 46899999999999999 89999999997543221 7789999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCchhhh------hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEEecC
Q 005875 442 SKDEKLLVYDYFASGSLSTL------LHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQ 514 (672)
Q Consensus 442 ~~~~~~lV~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~ 514 (672)
+.+..++||||+++|+|.++ +... ....+++..+..++.|++.||+|||+ .+ |+||||||+||+++.
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK 187 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence 99999999999999999999 5432 13459999999999999999999999 87 999999999999999
Q ss_pred CCCeEEeecCCCCCCCCC--CCCCCCCcccCcccccCC-CCCC-ccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 005875 515 DLDGCISDFGLTPLMNVP--ATPSRSAGYRAPEVIETR-KHSH-KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV 590 (672)
Q Consensus 515 ~~~~kl~DfGla~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~-~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~ 590 (672)
++.+||+|||++...... ....+++.|+|||++.+. .++. ++||||||+++|||++|..||...... ....
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~ 262 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-----VELF 262 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----HHHH
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHH
Confidence 999999999999765332 344578899999999887 5666 999999999999999999999865431 1111
Q ss_pred HHhhhhcccccc----chhhhhc---ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 591 QSVVREEWTAEV----FDVELMR---FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 591 ~~~~~~~~~~~~----~d~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..+......... +...... ..........+.+++.+||+.||++|||++|++++
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111110000 0000000 00001223456788889999999999999999873
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=329.53 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=188.8
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCe------eEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE------KLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lV~e~~ 453 (672)
.+.||+|+||+||+|+..++..+|+|++.... ....+|++++..+ +||||+++++++..... .++||||+
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~---~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCT---TSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCc---chHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 46899999999999999888889999886532 2334689999998 99999999999976543 78999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec-CCCCeEEeecCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla~~~~~~ 532 (672)
+++.+........ ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 121 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 121 PETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp SEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred CccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 8754443332111 1234899999999999999999999998 99999999999999 7999999999999765332
Q ss_pred ---CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHh----------hhhcc
Q 005875 533 ---ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV----------VREEW 598 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~----------~~~~~ 598 (672)
....+++.|+|||++.+. .++.++|||||||++|||++|+.||.+....+. +....... ....+
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhChhh
Confidence 234578899999998765 589999999999999999999999986542221 11111000 00000
Q ss_pred ccccchhhhhcccChH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 005875 599 TAEVFDVELMRFQNIE-----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQ 650 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~ 650 (672)
....+. .. ...... .....+.+++.+||+.||++|||+.|++++ ++++..
T Consensus 274 ~~~~~~-~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 274 MEHKFP-QI-RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp SSSCCC-CC-CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhccc-cc-cCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 000000 00 000000 123467788889999999999999999984 555543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.41 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=178.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|... +++.||+|++.... ...+++.+|++++.++ +||||+++++++..++..++||||+++|
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 98 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLVMKLLSGG 98 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcEEEehhccCC
Confidence 468999999999999954 57899999886542 2345677888888888 8999999999999999999999999999
Q ss_pred chhhhhccCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-
Q 005875 457 SLSTLLHGNR---GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 532 (672)
Q Consensus 457 ~L~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~- 532 (672)
+|.+++.... ......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence 9999986321 112345899999999999999999999998 999999999999999999999999988654321
Q ss_pred --------CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 533 --------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 533 --------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+. .......... ..
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~-~~- 247 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLTLQNDPP-SL- 247 (303)
T ss_dssp ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHTSSCC-CT-
T ss_pred CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHHhccCCC-cc-
Confidence 22357889999999976 5689999999999999999999999976432211 1111111100 00
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
................+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000000011122456778889999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.48 Aligned_cols=263 Identities=20% Similarity=0.289 Sum_probs=182.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCe-------eEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-------KLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-------~~lV~e 451 (672)
.+.||+|+||+||+|+.. +++.||||++...........++++.+..+ +||||+++++++..... .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccceeEEEEee
Confidence 467999999999999975 578999999876555556677788888888 99999999999976443 789999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCcccCCCCCCCEEecC-CCCeEEeecCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH--SMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPL 528 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--~~~~~~ivHrDLk~~NILl~~-~~~~kl~DfGla~~ 528 (672)
|++++ |.+.+.... .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+||+|||++..
T Consensus 107 ~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 107 YVPDT-LHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp CCSCB-HHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred ccccc-HHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 99874 444332111 12334889999999999999999999 877 999999999999997 89999999999987
Q ss_pred CCCCC---CCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHH-----------h
Q 005875 529 MNVPA---TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS-----------V 593 (672)
Q Consensus 529 ~~~~~---~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~-----------~ 593 (672)
..... ...+++.|+|||++.+.. ++.++|||||||++|||++|+.||.+....+.. ...... .
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp CCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHH
T ss_pred cCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHHHHcCCCCHHHHHhc
Confidence 65432 345788999999986654 899999999999999999999999865432211 011100 0
Q ss_pred hhhccccccchh-----hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 005875 594 VREEWTAEVFDV-----ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQ 650 (672)
Q Consensus 594 ~~~~~~~~~~d~-----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~ 650 (672)
..........+. ..............+.+++.+||+.||++|||+.|++++ ++++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 000000000000 000000011134567888889999999999999999984 555543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=333.90 Aligned_cols=259 Identities=25% Similarity=0.347 Sum_probs=187.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeC----C--eeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK----D--EKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~----~--~~~lV~e~ 452 (672)
.+.||+|+||+||+|++. +++.||||++... .....+|++++..+ +||||+++++++... + ..++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC---TTSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccc---chhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 468999999999999986 4889999998653 23345799999998 999999999998642 1 35799999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC-CCeEEeecCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNV 531 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~~~~ 531 (672)
+++ ++.+.+..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 135 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 135 VPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 986 66665542111 1345999999999999999999999998 9999999999999965 5689999999976533
Q ss_pred C---CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh---hcc---ccc
Q 005875 532 P---ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---EEW---TAE 601 (672)
Q Consensus 532 ~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~~---~~~ 601 (672)
. ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+. +......... +.+ ...
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHHHHHCSC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhChh
Confidence 2 234678999999999764 789999999999999999999999986542211 1111110000 000 000
Q ss_pred cchhhhhc--ccCh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 005875 602 VFDVELMR--FQNI-----EEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR 649 (672)
Q Consensus 602 ~~d~~~~~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~ 649 (672)
..+..+.. .... ......+.+|+.+||+.||++|||+.|+++ .++++.
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 00000000 0000 111246778888999999999999999997 344443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=322.78 Aligned_cols=246 Identities=20% Similarity=0.324 Sum_probs=189.3
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+..+ .+|+|+++.... ..+.+.+|+.++.++ +||||+++++++.+.+..++||||++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceEEEeecccCC
Confidence 4689999999999999864 499999875432 235677889999888 8999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----- 531 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----- 531 (672)
+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++ ++.+||+|||++.....
T Consensus 115 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 115 TLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp EHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 999999743 234899999999999999999999998 99999999999998 68999999999865431
Q ss_pred ----CCCCCCCCcccCcccccC---------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 532 ----PATPSRSAGYRAPEVIET---------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 532 ----~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
.....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ....... ..
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~-~~ 259 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------IIWQMGT-GM 259 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------HHHHHHT-TC
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHhcc-CC
Confidence 112336788999999874 347889999999999999999999997543211 1111111 11
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
...... . .....+.+++.+||+.||++|||++|+++.|+++....
T Consensus 260 ~~~~~~------~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 260 KPNLSQ------I---GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCCCCC------S---SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCc------C---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 111100 0 11234667888999999999999999999999998664
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=352.06 Aligned_cols=246 Identities=22% Similarity=0.360 Sum_probs=196.6
Q ss_pred hccccccCcEEEEEEEECC----CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||+||+|.+.. +..||+|+++.... ..+.+.+|+.++.++ +||||+++++++. ++..++||||+
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~lv~E~~ 472 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELC 472 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-cCceEEEEEcC
Confidence 5689999999999999743 45689998875432 235788999999999 9999999999984 56789999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++|+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 473 ~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 473 TLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp TTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999997432 34899999999999999999999998 9999999999999999999999999998764432
Q ss_pred C-----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 534 T-----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 534 ~-----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
. ..+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+ ....+..... ..
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~~~~i~~~~~-~~------ 612 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGER-LP------ 612 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHHTCC-CC------
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHcCCC-CC------
Confidence 1 234678999999998899999999999999999997 999997643221 1111111110 00
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
........+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 613 ----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 613 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0112234567888899999999999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=327.04 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=190.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCee------EEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK------LLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~------~lV 449 (672)
.+.||+|+||+||+|... +++.||+|++...... .+.+.+|+.++..+ +||||+++++++...+.. ++|
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCcccceeEEEE
Confidence 468999999999999965 5788999999765433 35678899999999 899999999999877654 999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||+. |+|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 126 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 126 MPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp EECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred Ecccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99998 588888742 2899999999999999999999998 999999999999999999999999999766
Q ss_pred CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh------ccccc
Q 005875 530 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE------EWTAE 601 (672)
Q Consensus 530 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~ 601 (672)
.... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. ...+... .....
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 195 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ------LTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHHHCCCCHHHHTT
T ss_pred ccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHHHhCCCcHHHHHH
Confidence 5433 3467899999999987 6789999999999999999999999986532211 1111100 00000
Q ss_pred cchh-------hhh--cccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005875 602 VFDV-------ELM--RFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 649 (672)
Q Consensus 602 ~~d~-------~~~--~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~ 649 (672)
..+. ... ..... ......+.+++.+||+.||++|||++|++++ ++.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 0000 000 00000 1123567788889999999999999999984 44443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.77 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=189.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCe------eEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE------KLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lV 449 (672)
.+.||+|+||+||+|... +++.||||++...... .+.+.+|+.++..+ +||||+++++++...+. .++|
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 107 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLV 107 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccceeEEEE
Confidence 467999999999999975 5789999999765433 34678899999998 89999999999987654 4999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||++ |+|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 108 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 108 MPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp EECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred ecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 99997 588888742 3899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh---hccccccch
Q 005875 530 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---EEWTAEVFD 604 (672)
Q Consensus 530 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d 604 (672)
.... ...+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. ......... ..+.....+
T Consensus 177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHHTTCSC
T ss_pred CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHHHhh
Confidence 4432 3457889999999877 6789999999999999999999999986542211 000000000 000000000
Q ss_pred h-------hh-----hc-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005875 605 V-------EL-----MR-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 649 (672)
Q Consensus 605 ~-------~~-----~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~ 649 (672)
. .. .. ..........+.+++.+||+.||++|||++|++++ ++.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0 00 00 00011233567788889999999999999999974 44443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=327.62 Aligned_cols=258 Identities=22% Similarity=0.329 Sum_probs=188.6
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeC---------------
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--------------- 443 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------------- 443 (672)
.+.||+|+||+||+|+. .+++.||+|++.... ....+|+++++.+ +||||+++++++...
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTC-CCTTBCCEEEEEEEC---------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHc-CCCCccchhheeeecCcccccccccccccc
Confidence 46899999999999996 468899999986542 3345789999988 999999999998543
Q ss_pred -----------------------CeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 005875 444 -----------------------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500 (672)
Q Consensus 444 -----------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i 500 (672)
...++||||+++ +|.+.+..... ....+++..+..++.||+.||+|||+.+ |
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i 162 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLG---I 162 (383)
T ss_dssp ----------------------CCEEEEEECCCSE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred cccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCc---C
Confidence 337899999984 87777653211 1235999999999999999999999998 9
Q ss_pred ccCCCCCCCEEec-CCCCeEEeecCCCCCCCCC---CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCC
Q 005875 501 THGNIKASNVLIN-QDLDGCISDFGLTPLMNVP---ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPL 575 (672)
Q Consensus 501 vHrDLk~~NILl~-~~~~~kl~DfGla~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf 575 (672)
+||||||+|||++ .++.+||+|||+++..... ....+++.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 242 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence 9999999999998 6889999999999765332 344578899999998765 4899999999999999999999999
Q ss_pred CCCCCCCCCChhHHHHHhhhhc-----------ccc----ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 005875 576 QSPTRDDMVDLPRWVQSVVREE-----------WTA----EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 640 (672)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~----~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 640 (672)
.+....+. +.... ...... +.. ........ ..........+.+++.+||+.||++|||+.|
T Consensus 243 ~~~~~~~~--~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 243 SGETSIDQ--LVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR-KILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp CCSSHHHH--HHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHH-HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCChHHH--HHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHH-hhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 86543221 11111 000000 000 00000000 0000112345778888999999999999999
Q ss_pred HHH--HHHHhhh
Q 005875 641 VVR--MIEEVRQ 650 (672)
Q Consensus 641 vl~--~L~~i~~ 650 (672)
+++ .++++..
T Consensus 319 ~l~hp~f~~~~~ 330 (383)
T 3eb0_A 319 AMAHPFFDHLRN 330 (383)
T ss_dssp HHTSGGGHHHHH
T ss_pred HhcCHHHHHHHh
Confidence 997 4565544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=312.41 Aligned_cols=241 Identities=20% Similarity=0.304 Sum_probs=188.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcC-CCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||++...+++.||+|++...... .+.+.+|++++.++.+ |+||+++++++.+++..++||| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 4689999999999999988999999999754332 3568889999999954 7999999999999999999999 668
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++ +.+||+|||++.......
T Consensus 112 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 112 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 8999999753 24899999999999999999999998 999999999999964 899999999998654322
Q ss_pred ----CCCCCCcccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 534 ----TPSRSAGYRAPEVIET-----------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 534 ----~~~~~~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
...+++.|+|||++.+ ..++.++||||||+++|||++|+.||..... .............
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~ 257 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNH 257 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTS
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHhccc
Confidence 2357889999999875 4688899999999999999999999975321 1111222211111
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 645 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 645 (672)
.... ... ....+.+++.+||+.||++|||++|++++-
T Consensus 258 ~~~~-------~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 258 EIEF-------PDI---PEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CCCC-------CCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccCC-------ccc---chHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1100 001 123567788899999999999999999853
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=319.37 Aligned_cols=251 Identities=20% Similarity=0.266 Sum_probs=188.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeC-----CeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~e 451 (672)
.+.||+|+||+||+|+.. +++.||||++..... ....+.+|++++.++ +||||+++++++..+ ...++|||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccceEEEEEe
Confidence 468999999999999976 578899999864322 234677899999999 899999999998764 57899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|+. |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 95 LMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 997 599999874 23899999999999999999999998 99999999999999999999999999976542
Q ss_pred C--------------CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh
Q 005875 532 P--------------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE 596 (672)
Q Consensus 532 ~--------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 596 (672)
. ....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~ 241 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFGIIGT 241 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCC
Confidence 1 12356888999998754 6789999999999999999999999986532110 0000000000
Q ss_pred cc----ccccchhh-------hhc--ccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 597 EW----TAEVFDVE-------LMR--FQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 597 ~~----~~~~~d~~-------~~~--~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. ........ ... ... .......+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000000 000 000 01123456788889999999999999999983
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=309.99 Aligned_cols=241 Identities=21% Similarity=0.334 Sum_probs=192.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|+.. +++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTG 105 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEEEEEEccCC
Confidence 578999999999999976 578999999875432 356788999999999 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC---CCeEEeecCCCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLMNVP 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DfGla~~~~~~ 532 (672)
++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.+ +.+||+|||++......
T Consensus 106 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 106 GELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999988643 24899999999999999999999998 9999999999999764 46999999998766443
Q ss_pred CCC---CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 533 ATP---SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 533 ~~~---~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
... .+++.|+|||++.+ .++.++||||||+++|||++|+.||...... .....+........ ...
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~-----~~~ 245 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYAFD-----LPQ 245 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCC-----SGG
T ss_pred CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCCCC-----chh
Confidence 222 25677999999876 4899999999999999999999999764321 11122111111100 001
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... ....+.+++.+||+.||++|||++|++++
T Consensus 246 ~~~---~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 246 WRT---ISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp GTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhh---cCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 111 22456778889999999999999999983
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.99 Aligned_cols=239 Identities=21% Similarity=0.335 Sum_probs=187.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc-----cChhhHHHHHHHHHHHcCCCceeceEEEEE--eCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYY--SKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~--~~~~~~lV~e 451 (672)
.+.||+|+||.||++... +++.||+|+++... ...+.+.+|++++.++ +||||+++++++. +.+..++|||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e 88 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQKMYMVME 88 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---CEEEEEE
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCeEEEEeh
Confidence 468999999999999975 57889999997542 2246788999999999 8999999999985 3457899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|++++ |.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 89 YCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp CCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred hccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99886 767765432 235899999999999999999999998 99999999999999999999999999876532
Q ss_pred C------CCCCCCCcccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 532 P------ATPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 532 ~------~~~~~~~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
. ....+++.|+|||++.+.. ++.++||||||+++|||++|+.||..... ......+......
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~~~~---- 231 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENIGKGSYA---- 231 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC----
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHHhcCCCC----
Confidence 1 2345788999999997644 37799999999999999999999975421 1112221111110
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. ......+.+++.+||+.||++|||++|++++
T Consensus 232 -----~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 -----IP---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----CC---SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----CC---CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 1122356678889999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=321.95 Aligned_cols=248 Identities=22% Similarity=0.308 Sum_probs=181.8
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEE--------------eC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYY--------------SK 443 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~--------------~~ 443 (672)
.+.||+|+||+||+|.... ++.||+|++..... ..+.+.+|++++.++ +||||+++++++. +.
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccccccccc
Confidence 4689999999999999875 78899999865432 245688999999999 9999999999873 34
Q ss_pred CeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec-CCCCeEEee
Q 005875 444 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISD 522 (672)
Q Consensus 444 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~D 522 (672)
...++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++.+||+|
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECC
T ss_pred CceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEcc
Confidence 67899999998 599999963 24899999999999999999999998 99999999999997 567999999
Q ss_pred cCCCCCCCCCC-------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhh
Q 005875 523 FGLTPLMNVPA-------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 594 (672)
Q Consensus 523 fGla~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 594 (672)
||++....... ...++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+ ....+.
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~~~ 238 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE------QMQLIL 238 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHHH
Confidence 99998654321 1235778999998865 678999999999999999999999998654211 111111
Q ss_pred hhccc------cc-------cchhhhhcc-cCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 595 REEWT------AE-------VFDVELMRF-QNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 595 ~~~~~------~~-------~~d~~~~~~-~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..... .+ ......... ... ......+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 10000 00 000000000 000 1123457788889999999999999999884
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=309.79 Aligned_cols=241 Identities=21% Similarity=0.357 Sum_probs=184.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe-------------CCe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-------------KDE 445 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-------------~~~ 445 (672)
.+.||+|+||+||+|+.. +++.||+|++.......+.+.+|++++.++ +||||+++++++.+ .+.
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 468999999999999975 688999999976544456788999999998 89999999999865 346
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCC
Q 005875 446 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 525 (672)
Q Consensus 446 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 525 (672)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcc
Confidence 789999999999999997432 34788999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCC------------------CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 005875 526 TPLMNVP------------------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 586 (672)
Q Consensus 526 a~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~ 586 (672)
+...... ....+++.|+|||++.+. .++.++|||||||++|||++ ||.... +.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-----~~ 234 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-----ER 234 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----hH
Confidence 8765421 123467889999999764 68999999999999999998 553210 00
Q ss_pred hHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 587 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+..... .+.+. ........+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~---~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILKKLRSVSI---EFPPD-----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHSTTC---CCCTT-----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHhcccccc---ccCcc-----ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111111000 00000 011223456778889999999999999999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=315.98 Aligned_cols=248 Identities=21% Similarity=0.342 Sum_probs=170.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||.||+|... +++.||||++...... ...+..|+..+.+..+||||+++++++.+++..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 467999999999999975 5788999999764322 234555666444444899999999999999999999999986
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
+|.+++..........+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++.......
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 182 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccccccc
Confidence 887777532111234589999999999999999999998 8 9999999999999999999999999997664332
Q ss_pred -CCCCCCcccCcccc----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 534 -TPSRSAGYRAPEVI----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 534 -~~~~~~~y~aPE~~----~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
...+++.|+|||++ .+..++.++||||||+++|||++|+.||........ ......... ...... .
T Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~-~~~~~~---~ 253 (327)
T 3aln_A 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVVKGD-PPQLSN---S 253 (327)
T ss_dssp -----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCSC-CCCCCC---C
T ss_pred ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHhcCC-CCCCCC---c
Confidence 23578889999999 456789999999999999999999999975432100 000000000 000000 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
... .....+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 254 EER---EFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SSC---CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccc---cCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 001 12245677888999999999999999988
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=327.91 Aligned_cols=239 Identities=21% Similarity=0.350 Sum_probs=180.6
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||.....+++.||||++.... ...+.+|++++..+.+|||||++++++.+.+..++||||++ |+|.
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~ 105 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence 36899999999766666678999999986532 23467899999988789999999999999999999999996 5999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-----CCCeEEeecCCCCCCCCC--
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-----DLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-----~~~~kl~DfGla~~~~~~-- 532 (672)
+++..... ...+..+..++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++.....
T Consensus 106 ~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 106 EYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp HHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred HHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 99975432 2444556789999999999999998 999999999999953 335789999999765432
Q ss_pred -----CCCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 533 -----ATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 533 -----~~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
....||+.|+|||++. ...++.++|||||||++|||++ |..||...... ....... .......
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~-~~~~~~~ 250 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLG-ACSLDCL 250 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTT-CCCCTTS
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhc-cCCcccc
Confidence 2345899999999997 4567889999999999999999 99999643211 1111111 1100000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
.........+.+++.+||+.||++|||++|+++
T Consensus 251 -------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 251 -------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 011123345677888999999999999999995
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.65 Aligned_cols=233 Identities=21% Similarity=0.390 Sum_probs=189.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-------ChhhHHHHHHHHHHHc-CCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVG-QHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.+.||+|+||+||+|... +++.||||++..... ..+.+.+|++++.++. .|+||+++++++.+++..++||
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 468999999999999964 578899999976532 2256778999999995 3799999999999999999999
Q ss_pred EecCC-CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec-CCCCeEEeecCCCCC
Q 005875 451 DYFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPL 528 (672)
Q Consensus 451 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla~~ 528 (672)
||+.+ ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++.+||+|||++..
T Consensus 128 e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 128 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 99986 8999999742 34899999999999999999999998 99999999999999 789999999999876
Q ss_pred CCCC--CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 529 MNVP--ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 529 ~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.... ....+++.|+|||++.+..+ +.++||||||+++|||++|+.||.... ....... .+
T Consensus 200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~~~---~~-- 262 (320)
T 3a99_A 200 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV---FF-- 262 (320)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC---CC--
T ss_pred cccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhcccc---cc--
Confidence 5433 23457889999999987665 678999999999999999999996421 0000000 00
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.... ...+.+++.+||+.||++|||++|++++
T Consensus 263 ----~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 263 ----RQRV---SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----SSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----cccC---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111 2356678889999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.84 Aligned_cols=241 Identities=18% Similarity=0.316 Sum_probs=169.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccCh--hhHHHHHH-HHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK--RDFEQQME-IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~e~~-~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||.||+|+.. +++.||||++....... .++..|.. ++..+ +||||+++++++.+++..++||||+ +
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecc-C
Confidence 468999999999999975 58899999997653322 23333443 44444 9999999999999999999999999 4
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+.+..+.... ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++.......
T Consensus 108 ~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 108 TCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 4555555422 23489999999999999999999995 7 9999999999999999999999999987654322
Q ss_pred --CCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhh
Q 005875 534 --TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 606 (672)
...+++.|+|||++. ...++.++||||||+++|||++|+.||...... ..............
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~------ 249 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEPPL------ 249 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCCCC------
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCCCC------
Confidence 335788999999994 456889999999999999999999999753211 11122222211110
Q ss_pred hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 607 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
...... ....+.+++.+||+.||++||+++|+++
T Consensus 250 ~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 LPGHMG---FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCSSSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccCC---CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000011 1235667888999999999999999988
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=312.88 Aligned_cols=233 Identities=23% Similarity=0.381 Sum_probs=184.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-------ChhhHHHHHHHHHHHc---CCCceeceEEEEEeCCeeEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVG---QHPNVVPLRAYYYSKDEKLL 448 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~---~h~niv~l~~~~~~~~~~~l 448 (672)
.+.||+|+||.||+|+.. +++.||+|++..... ....+.+|+.++.++. +|+||+++++++...+..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 478999999999999864 578999999975432 2234667888888885 79999999999999999999
Q ss_pred EEEe-cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec-CCCCeEEeecCCC
Q 005875 449 VYDY-FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLT 526 (672)
Q Consensus 449 V~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla 526 (672)
|||| +.+++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++ .++.+||+|||++
T Consensus 116 v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp EEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred EEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 9999 7899999999742 24899999999999999999999998 99999999999999 8899999999998
Q ss_pred CCCCCC--CCCCCCCcccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 527 PLMNVP--ATPSRSAGYRAPEVIETRKHS-HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 527 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
...... ....+++.|+|||++.+..+. .++||||||+++|||++|+.||.... .......
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~~----- 250 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EILEAEL----- 250 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHTCC-----
T ss_pred hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HHhhhcc-----
Confidence 765433 234578899999999876664 58999999999999999999996421 0010000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... ......+.+++.+||+.||++|||++|++++
T Consensus 251 ----~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 ----HFP---AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----CCC---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CCc---ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 1122356778889999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=299.42 Aligned_cols=228 Identities=12% Similarity=0.111 Sum_probs=178.1
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccCh----hhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~----~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||.||+|+... ++.||+|++....... +.+.+|++++.++ +||||+++++++.+++..|+||||++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 114 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGGLVVAEWIR 114 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcEEEEEEecC
Confidence 3689999999999999765 7899999998654432 5688899999888 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 534 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 534 (672)
+++|.++++.. ....++.+++.|++.||+|||+.+ |+||||||+|||++.++.+||+++|
T Consensus 115 g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 115 GGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred CCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999531 355678899999999999999998 9999999999999999999998553
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChH
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 614 (672)
|++ .++.++|||||||++|||+||+.||.+....+..... ...... ....+. .....
T Consensus 175 ------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~----~~~~~~-~~~~~-- 231 (286)
T 3uqc_A 175 ------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAG----QPIEPA-DIDRD-- 231 (286)
T ss_dssp ------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTTS----CBCCHH-HHCTT--
T ss_pred ------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhcc----CCCChh-hcccC--
Confidence 333 3688999999999999999999999876544321100 000000 000000 00111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 615 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
....+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 232 -~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 232 -IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp -SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred -CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 22346778889999999999 99999999999987654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.89 Aligned_cols=226 Identities=18% Similarity=0.288 Sum_probs=174.8
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe----CCeeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~~~~ 455 (672)
+.||+|+||.||+|... +++.||+|+++. ...+.+|++++.++.+||||+++++++.. +...++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 57999999999999974 578999999864 35678899888777799999999999987 6678999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC---CCCeEEeecCCCCCCCCC
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~~ 532 (672)
|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 100 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 100 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp CBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 99999997543 235899999999999999999999998 999999999999998 7899999999986432
Q ss_pred CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 533 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
+..++.++|||||||++|||++|+.||......+.... .................
T Consensus 172 ----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~-- 226 (299)
T 3m2w_A 172 ----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------MKTRIRMGQYEFPNPEW-- 226 (299)
T ss_dssp ----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-------SCCSSCTTCCSSCHHHH--
T ss_pred ----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-------HHHHHhhccccCCchhc--
Confidence 24577899999999999999999999976543221100 00000000000000000
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.||++|||++|++++
T Consensus 227 -~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 227 -SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -ccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1123456778889999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=338.12 Aligned_cols=233 Identities=18% Similarity=0.266 Sum_probs=188.5
Q ss_pred hccccccCcEEEEEEEEC--CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCe-----eEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----KLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lV~ 450 (672)
.+.||+|+||+||+|.+. +++.||||++..... ....+.+|++++.++ +||||+++++++...+. .|+||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~lv~ 163 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDPVGYIVM 163 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCceeEEEE
Confidence 468999999999999975 578999999865422 234678899999998 89999999999987765 69999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++++|.+++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ .+||+|||+++...
T Consensus 164 E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 164 EYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp ECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 99999999988752 4899999999999999999999998 9999999999999986 89999999998877
Q ss_pred CCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 531 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 531 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
......||++|+|||++.+. ++.++|||||||++|||++|..||.+........ .
T Consensus 233 ~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~------------------------~ 287 (681)
T 2pzi_A 233 SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE------------------------D 287 (681)
T ss_dssp CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCT------------------------T
T ss_pred cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccccc------------------------c
Confidence 66667799999999999765 4889999999999999999999987532211100 0
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHHhh
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPN-MDEVVRMIEEVR 649 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~i~ 649 (672)
.........+.+++.+||+.||++||+ ++++...|..+.
T Consensus 288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 001112345778888999999999995 667777776654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=331.12 Aligned_cols=262 Identities=19% Similarity=0.287 Sum_probs=196.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEe------CCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS------KDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lV~ 450 (672)
.+.||+|+||+||+|... +++.||||++..... ..+.+.+|++++.++ +||||+++++++.. ++..++||
T Consensus 19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCeEEEEE
Confidence 478999999999999974 578899999875422 245688899999999 99999999999765 56779999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCC---eEEeecCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTP 527 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DfGla~ 527 (672)
||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++.
T Consensus 98 Ey~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp ECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 99999999999985432 234888999999999999999999998 999999999999997765 8999999998
Q ss_pred CCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh---------
Q 005875 528 LMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR--------- 595 (672)
Q Consensus 528 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--------- 595 (672)
...... ...+++.|+|||++.+..++.++||||||+++|||++|..||...... ..|......
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------CCSC
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchhhhhh
Confidence 765432 345788999999999999999999999999999999999999753110 001000000
Q ss_pred hccccc-cchhhhhcc-cChHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHHhhhcC
Q 005875 596 EEWTAE-VFDVELMRF-QNIEEEMVQMLQIGMACVAKVPDMRPNMDE-----VVRMIEEVRQSD 652 (672)
Q Consensus 596 ~~~~~~-~~d~~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e-----vl~~L~~i~~~~ 652 (672)
+..... .+....... .........+.+++.+||+.||++|||++| ..+.++++.+..
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 000000 000000000 111234466788888999999999999988 567777776554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.03 Aligned_cols=236 Identities=12% Similarity=0.124 Sum_probs=171.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc----ChhhHHHHHHHHHHHcCC-Ccee---------c---------
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQH-PNVV---------P--------- 435 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h-~niv---------~--------- 435 (672)
.+.||+|+||+||+|++. +++.||||++..... ..+.+.+|+.++..+ +| +|.. .
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhhcccCC
Confidence 468999999999999954 688999999873322 246788898888877 44 3211 1
Q ss_pred ---eEEEEEe-----CCeeEEEEEecCCCchhhhhccCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCC
Q 005875 436 ---LRAYYYS-----KDEKLLVYDYFASGSLSTLLHGNR--GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNI 505 (672)
Q Consensus 436 ---l~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDL 505 (672)
++.++.. ....+++|+++ +++|.+++.... ......+++..+..++.||+.||+|||+++ |+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence 1111111 12346677655 679999884211 011234788899999999999999999998 999999
Q ss_pred CCCCEEecCCCCeEEeecCCCCCCCCC-CCCCCCCcccCcccc----------cCCCCCCccchhhHHHHHHHHHhCCCC
Q 005875 506 KASNVLINQDLDGCISDFGLTPLMNVP-ATPSRSAGYRAPEVI----------ETRKHSHKSDVYSFGVLLLEMLTGKAP 574 (672)
Q Consensus 506 k~~NILl~~~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~----------~~~~~~~~~DvwS~Gvvl~el~tg~~p 574 (672)
||+|||++.++.+||+|||+++..... ....| +.|+|||++ .+..++.++|||||||++|||++|+.|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999998765443 23456 899999999 556688999999999999999999999
Q ss_pred CCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 575 LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 575 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
|......+... ..+.....++ ..+.+++.+||+.||++||++.|+++
T Consensus 317 f~~~~~~~~~~-------------------~~~~~~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 317 NTDDAALGGSE-------------------WIFRSCKNIP---QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCTTGGGSCSG-------------------GGGSSCCCCC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcchhhhHH-------------------HHHhhcccCC---HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 98654332211 0010111122 45677888999999999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=295.73 Aligned_cols=238 Identities=13% Similarity=0.173 Sum_probs=180.4
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEeccccc---------ChhhHHHHHHHHHHHc--------CCCceeceEEEE
Q 005875 378 ASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVG--------QHPNVVPLRAYY 440 (672)
Q Consensus 378 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~--------~h~niv~l~~~~ 440 (672)
...+.||+|+||+||+|+. +++.||||++..... ..+.+.+|+.+++.+. +||||+++.+++
T Consensus 23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 3468999999999999998 579999999975432 1267889999999885 488888887765
Q ss_pred E------------------------------eCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 005875 441 Y------------------------------SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 490 (672)
Q Consensus 441 ~------------------------------~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~ 490 (672)
. .++..++||||+++|++.+.+.+ ..+++..+..++.||+.||+
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHHH
Confidence 3 26789999999999987777642 23899999999999999999
Q ss_pred HHH-hcCCCCcccCCCCCCCEEecCCC--------------------CeEEeecCCCCCCCCCCCCCCCCcccCcccccC
Q 005875 491 HIH-SMGGPKFTHGNIKASNVLINQDL--------------------DGCISDFGLTPLMNVPATPSRSAGYRAPEVIET 549 (672)
Q Consensus 491 ~LH-~~~~~~ivHrDLk~~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~ 549 (672)
||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||++.+
T Consensus 176 ~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCC
T ss_pred HHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcC
Confidence 999 888 99999999999999887 8999999999876543 3468999999999987
Q ss_pred CCCCCccchhhHHHH-HHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcc
Q 005875 550 RKHSHKSDVYSFGVL-LLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACV 628 (672)
Q Consensus 550 ~~~~~~~DvwS~Gvv-l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl 628 (672)
.. +.++||||++++ .+++++|..||... .|................. ............+.+++.+||
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKMLKQMTFKTK-CNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHHHHTCCCSSC-CCSHHHHHHHHHHHHHHHHGG
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhhhhhhccCcc-cchhhhhhcCHHHHHHHHHHh
Confidence 66 889999998777 78889999998521 1211111100000000000 000112345567888999999
Q ss_pred cCCCCCCCCHHHHH
Q 005875 629 AKVPDMRPNMDEVV 642 (672)
Q Consensus 629 ~~dP~~RPs~~evl 642 (672)
+.| |++|++
T Consensus 321 ~~d-----sa~e~l 329 (336)
T 2vuw_A 321 NFS-----SATDLL 329 (336)
T ss_dssp GSS-----SHHHHH
T ss_pred ccC-----CHHHHH
Confidence 976 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=280.14 Aligned_cols=181 Identities=17% Similarity=0.105 Sum_probs=127.3
Q ss_pred cccccCcEEEEEEE-ECCCcEEEEEEeccccc-----------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEE
Q 005875 382 VLGKGSYGTAYKAV-LEESTTVVVKRLKEVVV-----------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~-----------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 449 (672)
..+.|++|.+..++ .--|..+++|++..... ..++|.+|++++.++..|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666654 33478899999965421 2346899999999998899999999999999999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||++||+|.+++... .+++.. +|+.||+.||+|+|++| ||||||||+|||++++|.+||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999999743 236553 58899999999999999 999999999999999999999999999876
Q ss_pred CCCCC----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 005875 530 NVPAT----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574 (672)
Q Consensus 530 ~~~~~----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~p 574 (672)
..... ..||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 54332 237889999999976 467789999999998887665444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=246.03 Aligned_cols=188 Identities=36% Similarity=0.675 Sum_probs=169.6
Q ss_pred cCChhHHHHHHHHHHhCCCCC-CCCCCCCCCCCCC--cceeeecCCC--CeEEEEEeCCCCccc--cCCccccCCCCCCc
Q 005875 62 ADLNSDRQALLDFADAVPHLR-KLNWSSTNPICQS--WVGINCTQDR--TRVFGLRLPGIGLVG--PIPNNTLGKLDALE 134 (672)
Q Consensus 62 ~~~~~~~~al~~~~~~~~~~~-~~~w~~~~~~c~~--w~gv~C~~~~--~~v~~l~l~~~~l~g--~~p~~~~~~l~~L~ 134 (672)
.|.+.|+.||++||+++.+.. ..+|+.+.++| . |.||.|+... ++|+.|+|+++++.| .+|+ .++++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C-~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTT-TTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCC-cCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCC
Confidence 467789999999999996543 34898766666 5 9999998654 799999999999999 8998 899999999
Q ss_pred EEEccC-CCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCc
Q 005875 135 VLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 211 (672)
Q Consensus 135 ~L~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 211 (672)
+|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|. ++|++|+|++|+|++.+|..|+++++|+.|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 999999999999999999999999999999999887 89999999999999999999999999999999999
Q ss_pred cccCCCCCC--CCC-CCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 212 NLSGSIPNF--DIP-KLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 212 ~l~~~~p~~--~l~-~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
+++|.+|.. .++ +|+.|+|++|+++|.+|..+..++ |..+
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L 202 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV 202 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEE
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEE
Confidence 999988874 776 999999999999999999888775 5544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=251.27 Aligned_cols=177 Identities=16% Similarity=0.210 Sum_probs=144.2
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC---------hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.+.||+|+||+||+|... ++.+++|+....... .+.+.+|++++.++ +||||+++..++...+..++||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccEEEE
Confidence 568999999999999654 678888886543221 23478999999999 9999997777777888889999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++|+|.++++. +..++.|++.||+|||+++ |+||||||+|||++. .+||+|||+++...
T Consensus 419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 99999999999963 4579999999999999998 999999999999999 99999999998775
Q ss_pred CCC-----------CCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCC
Q 005875 531 VPA-----------TPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQ 576 (672)
Q Consensus 531 ~~~-----------~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~el~tg~~pf~ 576 (672)
... ...+|+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 431 2347889999999987 668888999999999999888887774
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=254.96 Aligned_cols=189 Identities=24% Similarity=0.350 Sum_probs=157.6
Q ss_pred cccCChhHHHHHHHHHHhCCCC-CCCCCCCCCCCCCCcceeeecCCCCeEEEEEeCCCCcccc---CCc-----------
Q 005875 60 AFADLNSDRQALLDFADAVPHL-RKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGP---IPN----------- 124 (672)
Q Consensus 60 ~~~~~~~~~~al~~~~~~~~~~-~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~---~p~----------- 124 (672)
+..+.+.|++||++||+++.++ ...+|+.+.+|| .|.||+|+ .++|+.|+|+++++.|. +|+
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C-~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG-GSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc-CCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 3445678999999999998544 344898666655 89999998 58999999999999987 543
Q ss_pred -----------cccCCCCCCcEEEccCCCcCCCCCC--cCCCCCCCcEEeeeccCCCCCCCCCcc---cccceeeccccc
Q 005875 125 -----------NTLGKLDALEVLSLRSNVLTGGLPS--EITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLDLSFNS 188 (672)
Q Consensus 125 -----------~~~~~l~~L~~L~L~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~~~---~~L~~L~ls~N~ 188 (672)
..++.+++|++|||++|.++|.+|. .++++++|++|+|++|.+++.+|..+. ++|++|+|++|+
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 3688999999999999999999998 999999999999999999999998762 789999999999
Q ss_pred CcccCCch---hhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 189 FTGNIPQS---IQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 189 l~~~~p~~---~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
|++..|.. +.++++|+.|+|++|.+++.+|...+++|++|+|++|.+++.+|. ++++++|+.+
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L 228 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHL 228 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEE
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEE
Confidence 99988877 788888888888888888877777788888888888888877776 7777766654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-24 Score=248.92 Aligned_cols=184 Identities=26% Similarity=0.458 Sum_probs=161.8
Q ss_pred hhHHHHHHHHHHhCCCCCC----------CCCCCCCCCCCCc---ceeeecCCCCeEEEEEeCCCCccccCCccccCCCC
Q 005875 65 NSDRQALLDFADAVPHLRK----------LNWSSTNPICQSW---VGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLD 131 (672)
Q Consensus 65 ~~~~~al~~~~~~~~~~~~----------~~w~~~~~~c~~w---~gv~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~ 131 (672)
..|+.||.++++++..... .+|+.+.++| .| .||.|+.. ++|++|+|+++++.|.+|+ .+++|+
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~-~l~~L~ 105 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPD-AIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-GTTCCTTEEECTT-CCEEEEECTTSCCEEEECG-GGGGCT
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-cccCCCCeEEcCC-CCEEEEEecCcccCCcCCh-HHhcCc
Confidence 4699999999999854321 2698776666 89 99999865 8999999999999999998 899999
Q ss_pred CCcEEEccCCC---------------------------------------------------------------------
Q 005875 132 ALEVLSLRSNV--------------------------------------------------------------------- 142 (672)
Q Consensus 132 ~L~~L~L~~N~--------------------------------------------------------------------- 142 (672)
+|++|+|++|.
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~ 185 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence 99999999884
Q ss_pred ---------cCCCCCCcCCCCCCCcEEeeeccCCCCC-----------------CCCCcc----cccceeecccccCccc
Q 005875 143 ---------LTGGLPSEITSLPSLRYLYLQHNNFSGK-----------------IPSSFS----PQLVVLDLSFNSFTGN 192 (672)
Q Consensus 143 ---------l~g~~p~~~~~l~~L~~L~l~~N~l~g~-----------------~p~~~~----~~L~~L~ls~N~l~~~ 192 (672)
|+| +|.+|+++++|++|+|++|+|+|. +|..+. ++|++|+|++|+++|.
T Consensus 186 l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~ 264 (636)
T 4eco_A 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264 (636)
T ss_dssp TTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSS
T ss_pred hhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCcc
Confidence 445 899999999999999999999986 898876 7899999999999999
Q ss_pred CCchhhhhccccceecCCcc-ccC-CCCCC--CC------CCCceEEeecCCCCCCCCc--ccCCCCCCcccc
Q 005875 193 IPQSIQNLTQLTGLSLQSNN-LSG-SIPNF--DI------PKLRHLNLSYNGLKGSIPS--SLQKFPNSSFVG 253 (672)
Q Consensus 193 ~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~--~l------~~L~~l~l~~N~l~g~~p~--~~~~~~~l~~~~ 253 (672)
+|..|+++++|+.|+|++|+ ++| .+|.. .+ ++|+.|+|++|+++ .+|. .++++++|..+.
T Consensus 265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~ 336 (636)
T 4eco_A 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLE 336 (636)
T ss_dssp CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEE
T ss_pred ChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEe
Confidence 99999999999999999998 998 77763 44 89999999999999 8998 898888887664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=253.32 Aligned_cols=185 Identities=26% Similarity=0.470 Sum_probs=162.1
Q ss_pred CChhHHHHHHHHHHhCCCCCCCCCCCCC-----CC-CCCc------------ceeeecCCCCeEEEEEeCCCCccccCCc
Q 005875 63 DLNSDRQALLDFADAVPHLRKLNWSSTN-----PI-CQSW------------VGINCTQDRTRVFGLRLPGIGLVGPIPN 124 (672)
Q Consensus 63 ~~~~~~~al~~~~~~~~~~~~~~w~~~~-----~~-c~~w------------~gv~C~~~~~~v~~l~l~~~~l~g~~p~ 124 (672)
+...|+.||++||+++... +|+.++ ++ ||+| .||.|+. .+||+.|+|+++++.|.+|+
T Consensus 266 ~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECG
T ss_pred cchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCch
Confidence 3457999999999999654 786554 34 2599 9999986 58999999999999999998
Q ss_pred cccCCCCCCcEEEc-cCCCcCCC---------------------------------------------------------
Q 005875 125 NTLGKLDALEVLSL-RSNVLTGG--------------------------------------------------------- 146 (672)
Q Consensus 125 ~~~~~l~~L~~L~L-~~N~l~g~--------------------------------------------------------- 146 (672)
.|++|++|++|+| ++|.++|.
T Consensus 342 -~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 342 -AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp -GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred -HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 8999999999999 77766554
Q ss_pred -------------------CCCcCCCCCCCcEEeeeccCCCC-----------------CCCCCcc----cccceeeccc
Q 005875 147 -------------------LPSEITSLPSLRYLYLQHNNFSG-----------------KIPSSFS----PQLVVLDLSF 186 (672)
Q Consensus 147 -------------------~p~~~~~l~~L~~L~l~~N~l~g-----------------~~p~~~~----~~L~~L~ls~ 186 (672)
+|..|++|++|+.|+|++|+|+| .+|..++ ++|++|+|++
T Consensus 421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~ 500 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred cccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence 88899999999999999999998 4898875 7999999999
Q ss_pred ccCcccCCchhhhhccccceecCCcc-ccC-CCCCC---------CCCCCceEEeecCCCCCCCCc--ccCCCCCCcccc
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNN-LSG-SIPNF---------DIPKLRHLNLSYNGLKGSIPS--SLQKFPNSSFVG 253 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~---------~l~~L~~l~l~~N~l~g~~p~--~~~~~~~l~~~~ 253 (672)
|++.|.+|..|++|++|+.|+|++|+ |+| .+|.. .+++|+.|+|++|+++ .+|. .++++++|..+.
T Consensus 501 N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~ 579 (876)
T 4ecn_A 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLD 579 (876)
T ss_dssp CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEE
T ss_pred CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEE
Confidence 99999999999999999999999998 998 77742 4569999999999999 8998 898888887654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-22 Score=210.97 Aligned_cols=186 Identities=18% Similarity=0.316 Sum_probs=149.8
Q ss_pred ccCChhHHHHHHHHHHhCC-CCC--CCCCC----CCCCCCCCcceeeecC--------CCCeEEEEEeCCCCccccCCcc
Q 005875 61 FADLNSDRQALLDFADAVP-HLR--KLNWS----STNPICQSWVGINCTQ--------DRTRVFGLRLPGIGLVGPIPNN 125 (672)
Q Consensus 61 ~~~~~~~~~al~~~~~~~~-~~~--~~~w~----~~~~~c~~w~gv~C~~--------~~~~v~~l~l~~~~l~g~~p~~ 125 (672)
..+..+++.||++||.++. +.. ..+|. ...++| .|.|+.|.. ...+|+.|+|++|++. .+|+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~-~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~- 98 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE-TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD- 98 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC-CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS-
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc-ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh-
Confidence 3466789999999999772 222 23783 334455 899999952 3468999999999998 8888
Q ss_pred ccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhh----
Q 005875 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQN---- 199 (672)
Q Consensus 126 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~---- 199 (672)
.++++++|++|+|++|.|+ .+|..++++++|++|+|++|+++ .+|..+. ++|++|+|++|++.+.+|..++.
T Consensus 99 ~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~ 176 (328)
T 4fcg_A 99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176 (328)
T ss_dssp CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-C
T ss_pred hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccch
Confidence 6888999999999999999 89999999999999999999999 7888776 78999999998888888887765
Q ss_pred -----hccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 200 -----LTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 200 -----l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
+++|+.|+|++|+|+ .+|.. .+++|+.|+|++|++++ +|..++++++|..+.
T Consensus 177 ~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~ 235 (328)
T 4fcg_A 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD 235 (328)
T ss_dssp CCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEE
T ss_pred hhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEE
Confidence 888999999999888 56653 78888888888888884 666777777776553
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.5e-22 Score=234.79 Aligned_cols=161 Identities=35% Similarity=0.632 Sum_probs=122.7
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcC-----------------------------------
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI----------------------------------- 151 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~----------------------------------- 151 (672)
.+..|+|++|.++|.+|. .++.+++|+.|+|++|.++|.+|..+
T Consensus 515 ~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (768)
T 3rgz_A 515 NLAILKLSNNSFSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNL 593 (768)
T ss_dssp TCCEEECCSSCCEEECCG-GGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEE
T ss_pred CCCEEECCCCcccCcCCH-HHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccc
Confidence 455666666666666666 56677777777777776666665433
Q ss_pred -----------------------------------CCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCC
Q 005875 152 -----------------------------------TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIP 194 (672)
Q Consensus 152 -----------------------------------~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p 194 (672)
+++++|+.|||++|+++|.+|..++ ++|+.|+|++|+|+|.+|
T Consensus 594 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip 673 (768)
T 3rgz_A 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP 673 (768)
T ss_dssp EECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred cccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCC
Confidence 2345677777777777777777776 678888888888888888
Q ss_pred chhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcc--cCCCCCCccccCCCCCCCCCCCCCCC
Q 005875 195 QSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS--LQKFPNSSFVGNSLLCGPPLKACFPV 268 (672)
Q Consensus 195 ~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~--~~~~~~l~~~~n~~~~~~~l~~c~~~ 268 (672)
..|++|++|+.|+|++|+|+|.+|.. .+++|++|||++|+|+|.||.. +..++.+.|.||+++||.|+..|.+.
T Consensus 674 ~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~ 751 (768)
T 3rgz_A 674 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 751 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSC
T ss_pred hHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCC
Confidence 88888888888888888888888875 7888888888888888888864 66777888999999999988888543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.6e-22 Score=202.14 Aligned_cols=150 Identities=19% Similarity=0.241 Sum_probs=118.9
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeccccc-------------------ChhhHHHHHHHHHHHcCCCceeceEEEEE
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-------------------GKRDFEQQMEIVGRVGQHPNVVPLRAYYY 441 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 441 (672)
+.||+|+||.||+|...+++.||+|.++.... ....+.+|++++.++. | +++.+++.
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~---~-~~v~~~~~ 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ---G-LAVPKVYA 171 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT---T-SSSCCEEE
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc---C-CCcCeEEe
Confidence 78999999999999997789999999864321 1345789999999994 4 56666554
Q ss_pred eCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEe
Q 005875 442 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 521 (672)
Q Consensus 442 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~ 521 (672)
. +..++||||+++|+|.+ +.. .....++.|++.||+|||+.+ |+||||||+|||++ ++.+||+
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEEC
T ss_pred c-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEE
Confidence 3 56699999999999998 531 124469999999999999998 99999999999999 9999999
Q ss_pred ecCCCCCCCCCCCCCCCCcccCcccccC----------CCCCCccchhh
Q 005875 522 DFGLTPLMNVPATPSRSAGYRAPEVIET----------RKHSHKSDVYS 560 (672)
Q Consensus 522 DfGla~~~~~~~~~~~~~~y~aPE~~~~----------~~~~~~~DvwS 560 (672)
|||+|... ..|+|||++.. ..+...+|+|.
T Consensus 235 DFG~a~~~---------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 235 DFPQSVEV---------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CCTTCEET---------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred ECCCCeEC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99998643 34789998854 34555666664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4.3e-20 Score=185.91 Aligned_cols=151 Identities=25% Similarity=0.258 Sum_probs=127.3
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
.+..|+|++|++.+..+. .|+++++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..|. ++|++|+|
T Consensus 36 ~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDA-TFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TCCEEECTTSCCCCCCTT-TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEccCCCcCccCHh-HhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 467899999999865554 799999999999999999988888899999999999999999976666665 79999999
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCccc---cCCCCC
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLC 258 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~---~n~~~~ 258 (672)
++|+|++..+..|.++++|+.|+|++|+|++.++.. .+++|+.|+|++|++++..+..+.++++|..+ +|+.-|
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 999999777777899999999999999999777743 78999999999999998777778777766544 555544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.80 E-value=2.4e-20 Score=194.22 Aligned_cols=142 Identities=27% Similarity=0.420 Sum_probs=73.5
Q ss_pred EEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--c-c------
Q 005875 108 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--P-Q------ 178 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~-~------ 178 (672)
+..|+|++|++++.+|. .++++++|++|+|++|.+++.+|..|.++++|++|+|++|+++|.+|..+. + +
T Consensus 103 L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L 181 (313)
T 1ogq_A 103 LHYLYITHTNVSGAIPD-FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181 (313)
T ss_dssp CSEEEEEEECCEEECCG-GGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEEC
T ss_pred CCEEECcCCeeCCcCCH-HHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEEC
Confidence 44455555555555554 455555555555555555555555555555555555555555544444433 1 3
Q ss_pred -----------------cceeecccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCC
Q 005875 179 -----------------LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIP 240 (672)
Q Consensus 179 -----------------L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p 240 (672)
|++|+|++|+|++.+|..|.++++|+.|+|++|++++.+|.. .+++|++|+|++|+++|.+|
T Consensus 182 ~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 261 (313)
T 1ogq_A 182 SRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP 261 (313)
T ss_dssp CSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCC
T ss_pred cCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCC
Confidence 445555555555555555555555555555555555544443 44555555555555555555
Q ss_pred cccCCCCCCc
Q 005875 241 SSLQKFPNSS 250 (672)
Q Consensus 241 ~~~~~~~~l~ 250 (672)
..+.++++|.
T Consensus 262 ~~l~~l~~L~ 271 (313)
T 1ogq_A 262 QGLTQLKFLH 271 (313)
T ss_dssp GGGGGCTTCC
T ss_pred hHHhcCcCCC
Confidence 5555444443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.1e-19 Score=177.04 Aligned_cols=146 Identities=27% Similarity=0.371 Sum_probs=76.4
Q ss_pred CCCCCCCCCCcceeeecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeecc
Q 005875 86 WSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 165 (672)
Q Consensus 86 w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 165 (672)
|......| +|.+|.|+... +. .+|. .+ .++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 12 ~~~~~~~C-s~~~v~c~~~~------------l~-~ip~-~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N 74 (229)
T 3e6j_A 12 ACPSQCSC-SGTTVDCRSKR------------HA-SVPA-GI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN 74 (229)
T ss_dssp CCCTTCEE-ETTEEECTTSC------------CS-SCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCCCCEE-eCCEeEccCCC------------cC-ccCC-CC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCC
Confidence 44455556 89999997532 21 3443 12 145555555555555555555555555555555555
Q ss_pred CCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCc
Q 005875 166 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPS 241 (672)
Q Consensus 166 ~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~ 241 (672)
+|++..+..|. ++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|.. .+++|+.|+|++|+|++..+.
T Consensus 75 ~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~ 153 (229)
T 3e6j_A 75 QLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG 153 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred CCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHH
Confidence 55433223332 45555555555555444444555555555555555555 33332 555555555555555544444
Q ss_pred ccCCCCCC
Q 005875 242 SLQKFPNS 249 (672)
Q Consensus 242 ~~~~~~~l 249 (672)
.|.++++|
T Consensus 154 ~~~~l~~L 161 (229)
T 3e6j_A 154 AFDRLSSL 161 (229)
T ss_dssp TTTTCTTC
T ss_pred HHhCCCCC
Confidence 44444433
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.5e-18 Score=169.37 Aligned_cols=146 Identities=26% Similarity=0.282 Sum_probs=113.2
Q ss_pred CCcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeec
Q 005875 94 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 164 (672)
Q Consensus 94 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 164 (672)
|.|.+|.|+... .+++.|+|++|++++ +++..++.+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 7 C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 7 CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKS-LPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCc-CChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 489999997532 257788888888884 5554678888888888888888866666678888888888888
Q ss_pred cCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCC
Q 005875 165 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 240 (672)
Q Consensus 165 N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p 240 (672)
|++++..+..|. ++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|.+.+..|
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 888865555554 68888888888888776777888888888888888888766653 67888888888887775443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.3e-19 Score=173.67 Aligned_cols=146 Identities=20% Similarity=0.248 Sum_probs=96.0
Q ss_pred EEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCC-CcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeeccc
Q 005875 110 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 186 (672)
Q Consensus 110 ~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~ 186 (672)
.+++++++++ .+|. .+. ..+++|+|++|+|++..| ..|.++++|++|+|++|++++..|..|. ++|++|+|++
T Consensus 15 ~l~~s~n~l~-~iP~-~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLN-KIPE-HIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCS-SCCS-CCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCcc-cCcc-CCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 4556666665 4665 232 345677777777775544 3366777777777777777765555555 6777777777
Q ss_pred ccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCcc---ccCCCCCC
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF---VGNSLLCG 259 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~---~~n~~~~~ 259 (672)
|+|++..|..|.++++|++|+|++|+|++..|.. .+++|+.|+|++|++++..|..|..+++|.. .+|++.|.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 7777666666777777777777777777666653 6677777777777777766766666655543 35555554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.6e-18 Score=174.82 Aligned_cols=146 Identities=25% Similarity=0.286 Sum_probs=104.7
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
.++.|+|++|++++ +++..|+++++|++|+|++|.|+...+..|.++++|++|+|++|++++..+..|. ++|++|+|
T Consensus 38 ~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 38 DTKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TCSEEECCSSCCSC-CCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCEEECcCCCCCe-eCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 35677777777774 4444677888888888888888754445567788888888888888755554444 67888888
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
++|+|++..|..|+++++|+.|+|++|+|++..+.. .+++|+.|+|++|++++..+..|.++++|..++
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 187 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLK 187 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEE
Confidence 888888777777778888888888888887655542 677888888888888766666677666666543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-18 Score=169.04 Aligned_cols=145 Identities=23% Similarity=0.302 Sum_probs=95.6
Q ss_pred EEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeeccccc
Q 005875 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNS 188 (672)
Q Consensus 111 l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~ 188 (672)
+++++++++ .+|. .+. ++|+.|+|++|+|++..|..|.++++|++|+|++|++++..|..|. ++|++|+|++|+
T Consensus 16 v~c~~~~l~-~iP~-~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 16 VDCRGKGLT-EIPT-NLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EECTTSCCS-SCCS-SCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEcCCCCcC-cCCC-ccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 334445555 4555 232 5677777777777765556677777777777777777766666665 677777777777
Q ss_pred CcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCc---cccCCCCCC
Q 005875 189 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLLCG 259 (672)
Q Consensus 189 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~---~~~n~~~~~ 259 (672)
|++..+..|.++++|+.|+|++|+|++..|.. .+++|+.|+|++|++++..+..|..+++|. ..+|++.|.
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 77555555677777777777777777666653 667777777777777766665566555544 345665554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=6.7e-18 Score=166.31 Aligned_cols=143 Identities=22% Similarity=0.229 Sum_probs=127.0
Q ss_pred CCcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeec
Q 005875 94 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 164 (672)
Q Consensus 94 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 164 (672)
|.|..|.|.... ..++.|+|++|++++ +++..|..+++|++|+|++|.|++..|..|.++++|++|+|++
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~-i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCC-cCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 479999997532 368999999999995 5555899999999999999999988899999999999999999
Q ss_pred cCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCC
Q 005875 165 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 165 N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g 237 (672)
|+|++..+..|. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|++..
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 999955444454 89999999999999999999999999999999999999887763 79999999999999974
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.8e-18 Score=167.31 Aligned_cols=147 Identities=20% Similarity=0.193 Sum_probs=131.8
Q ss_pred CCcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeec
Q 005875 94 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 164 (672)
Q Consensus 94 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 164 (672)
|.|..+.|+... ..++.|+|++|++++..|.+.|+.+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 479999997532 24678999999999876766799999999999999999988888999999999999999
Q ss_pred cCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCC
Q 005875 165 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 240 (672)
Q Consensus 165 N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p 240 (672)
|++++..|..|. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|.. .+++|+.|+|++|.+++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999988777776 89999999999999999999999999999999999999987864 89999999999999987544
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-18 Score=173.28 Aligned_cols=132 Identities=14% Similarity=0.160 Sum_probs=101.9
Q ss_pred hccccccCcEEEEEEEE-CCCcE--EEEEEecccccC-------------------------hhhHHHHHHHHHHHcCCC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTT--VVVKRLKEVVVG-------------------------KRDFEQQMEIVGRVGQHP 431 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~~h~ 431 (672)
.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+.++.++ .|+
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 130 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA-KEA 130 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-HHT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-HhC
Confidence 36799999999999998 67888 999987543211 12578899999998 666
Q ss_pred ce--eceEEEEEeCCeeEEEEEecCC-C----chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcccC
Q 005875 432 NV--VPLRAYYYSKDEKLLVYDYFAS-G----SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-SMGGPKFTHG 503 (672)
Q Consensus 432 ni--v~l~~~~~~~~~~~lV~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-~~~~~~ivHr 503 (672)
++ +..+++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 53 444432 367899999942 4 66665431 224467789999999999999 888 9999
Q ss_pred CCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 504 NIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 504 DLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
||||+|||+++ .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-17 Score=170.13 Aligned_cols=151 Identities=26% Similarity=0.307 Sum_probs=132.1
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
..+..|+|++|.+.+ ++ .++.+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|. ++|++|+
T Consensus 63 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp TTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 468899999999986 43 699999999999999999988888899999999999999999977776665 7999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCccc---cCCCCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLC 258 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~---~n~~~~ 258 (672)
|++|+|++..|..++++++|+.|+|++|++++.++.. .+++|+.|+|++|++++..|..+.++++|..+ +|+..|
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 9999999888888999999999999999999877764 79999999999999998888778877776654 565554
Q ss_pred C
Q 005875 259 G 259 (672)
Q Consensus 259 ~ 259 (672)
.
T Consensus 220 ~ 220 (272)
T 3rfs_A 220 T 220 (272)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.1e-17 Score=168.10 Aligned_cols=154 Identities=24% Similarity=0.278 Sum_probs=133.1
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
.++..|+|++|.++ .+|+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|. ++|++|+
T Consensus 61 ~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp TTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 46889999999998 67776789999999999999999977777889999999999999999987777765 8999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCc---cccCCCCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLLC 258 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~---~~~n~~~~ 258 (672)
|++|+|++..+..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|++++..+..+..+++|. +.+|++.|
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 9999999777777999999999999999999877753 789999999999999976666677666655 55777666
Q ss_pred CC
Q 005875 259 GP 260 (672)
Q Consensus 259 ~~ 260 (672)
.+
T Consensus 220 ~c 221 (270)
T 2o6q_A 220 TC 221 (270)
T ss_dssp SS
T ss_pred CC
Confidence 43
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.5e-18 Score=179.03 Aligned_cols=144 Identities=26% Similarity=0.393 Sum_probs=126.6
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCc----------
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---------- 175 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~---------- 175 (672)
.++..|+|++|+++ .+|. .++.+++|++|+|++|.|+ .+|..|+++++|++|+|++|++.+.+|..+
T Consensus 104 ~~L~~L~L~~n~l~-~lp~-~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPD-TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp TTCSEEEEESSCCC-CCCS-CGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCEEECCCCCcc-chhH-HHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 35788999999999 8887 7899999999999999999 889999999999999999999999999877
Q ss_pred -ccccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 176 -SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 176 -~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
.++|++|+|++|+|+ .+|..++++++|+.|+|++|++++.++.. .+++|+.|+|++|++.+.+|..++++++|..+.
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 259 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEE
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEE
Confidence 478999999999999 88888999999999999999999755554 788999999999999999999888888877664
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-17 Score=163.39 Aligned_cols=133 Identities=27% Similarity=0.231 Sum_probs=118.6
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
..++.|+|++|++++..|. .|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|. ++|++|+
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 118 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPG-VFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF 118 (229)
T ss_dssp TTCSEEECCSSCCCCCCTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEEcCCCccCccCHH-HhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEe
Confidence 5688999999999976666 899999999999999999866667789999999999999999976666665 8999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 240 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p 240 (672)
|++|+|+ .+|..+.++++|+.|+|++|+|++..+.. .+++|+.|+|++|.+++..+
T Consensus 119 Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 119 MCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred ccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999999 88999999999999999999999777653 78999999999999986543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.2e-18 Score=181.89 Aligned_cols=167 Identities=28% Similarity=0.260 Sum_probs=140.3
Q ss_pred CCcceeeecCCC---------CeEEEEEeCCCCccccCCccccC-CCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeee
Q 005875 94 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLG-KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQ 163 (672)
Q Consensus 94 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 163 (672)
|.|..+.|.... ..++.|+|++|++++..+ ..+. .+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~-~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRA-EWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECT-TSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccCh-hhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 478889997532 246789999999996444 4777 99999999999999998778889999999999999
Q ss_pred ccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC-----CCCCCceEEeecCCCC
Q 005875 164 HNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-----DIPKLRHLNLSYNGLK 236 (672)
Q Consensus 164 ~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-----~l~~L~~l~l~~N~l~ 236 (672)
+|+|++..+..|. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 9999976666665 89999999999999988999999999999999999999755542 5899999999999999
Q ss_pred CCCCcccCCCC-----CCccccCCCCCCCC
Q 005875 237 GSIPSSLQKFP-----NSSFVGNSLLCGPP 261 (672)
Q Consensus 237 g~~p~~~~~~~-----~l~~~~n~~~~~~~ 261 (672)
+..+..+..++ .|...+|++.|.+.
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 65556666664 46777899888754
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.9e-17 Score=169.75 Aligned_cols=144 Identities=23% Similarity=0.197 Sum_probs=73.1
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCC-cCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNV-LTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
++..|+|++|.+.+..|. .|+.+++|++|+|++|. +++..|..|.++++|++|+|++|++++..|..+. ++|++|+
T Consensus 57 ~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 135 (285)
T 1ozn_A 57 NLTILWLHSNVLARIDAA-AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (285)
T ss_dssp TCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEECCCCccceeCHh-hcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence 345555555555543333 45555555555555554 4433345555555555555555555544444443 4555555
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCcc
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 251 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 251 (672)
|++|+|++..+..|+++++|+.|+|++|++++..+.. .+++|+.|+|++|++++..|..+.++++|..
T Consensus 136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 205 (285)
T 1ozn_A 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205 (285)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccE
Confidence 5555555444444555555555555555555433321 4455555555555555544555544444443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.70 E-value=7.1e-17 Score=165.98 Aligned_cols=142 Identities=30% Similarity=0.312 Sum_probs=86.9
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
.++.|+|++|.+++..|. .|..+++|++|+|++|.|++. |.. +.+++|++|+|++|+++ .+|..+. ++|++|+|
T Consensus 32 ~l~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLA-TLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TCCEEECTTSCCSEEEGG-GGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCEEEcCCCcCCccCHH-HhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 466777777777654444 677777777777777777633 322 56666666666666666 5555443 56666666
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
++|+|++..|..|.++++|+.|+|++|+|++.++.. .+++|+.|+|++|++++..+..|.++++|..+
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 177 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEE
Confidence 666666555566666666666666666666554442 56666666666666664434444555554433
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=8.7e-18 Score=161.80 Aligned_cols=127 Identities=27% Similarity=0.318 Sum_probs=111.7
Q ss_pred EEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCC-cCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeeccc
Q 005875 110 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 186 (672)
Q Consensus 110 ~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~ 186 (672)
.++++++++. .+|. .+.. +|++|+|++|+|++..|. .|+++++|++|+|++|+|++..|..|. ++|++|+|++
T Consensus 12 ~l~~s~~~l~-~ip~-~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPR-DIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EEECTTSCCS-SCCS-CCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EEEcCCCCcC-cCcc-CCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 4667777775 7887 4443 899999999999976664 489999999999999999998898887 7999999999
Q ss_pred ccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCC
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 240 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p 240 (672)
|+|++..|..|.++++|+.|+|++|+|++.+|.. .+++|++|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 9999999989999999999999999999988874 89999999999999998765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.4e-17 Score=170.82 Aligned_cols=156 Identities=24% Similarity=0.298 Sum_probs=96.5
Q ss_pred CCcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCC--CCCCcCCCCCCCcEEee
Q 005875 94 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG--GLPSEITSLPSLRYLYL 162 (672)
Q Consensus 94 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~l 162 (672)
|.|.+|.|+... ..++.|+|++|+++ .+|+..|+++++|++|+|++|.++. .+|..+.++++|++|+|
T Consensus 7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 589999998632 36889999999998 6787678999999999999999873 23455555666666666
Q ss_pred eccCCCCCCCCCcc--cccceeecccccCcccCC-chhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCC
Q 005875 163 QHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 163 ~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g 237 (672)
++|.++ .+|..+. ++|++|+|++|++++..+ ..+.++++|+.|++++|.+++.+|.. .+++|+.|+|++|.+++
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 666665 3444333 455555555555554333 34555555555555555555444432 44555555555555544
Q ss_pred -CCCcccCCCCCCcc
Q 005875 238 -SIPSSLQKFPNSSF 251 (672)
Q Consensus 238 -~~p~~~~~~~~l~~ 251 (672)
.+|..+.++++|..
T Consensus 165 ~~~~~~~~~l~~L~~ 179 (306)
T 2z66_A 165 NFLPDIFTELRNLTF 179 (306)
T ss_dssp GEECSCCTTCTTCCE
T ss_pred ccchhHHhhCcCCCE
Confidence 34444444444443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=7.3e-17 Score=165.36 Aligned_cols=147 Identities=24% Similarity=0.233 Sum_probs=127.2
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccC-CCCCCCCCcc--ccccee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN-FSGKIPSSFS--PQLVVL 182 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~--~~L~~L 182 (672)
..++.|+|++|++++ +++..|+.+++|++|+|++|.+++..|..|.++++|++|+|++|. +++..|..+. ++|++|
T Consensus 32 ~~l~~L~l~~n~i~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCc-cCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 368899999999986 444479999999999999999998889999999999999999997 7766577776 799999
Q ss_pred ecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 183 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
+|++|++++..|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|++++..+..+.++++|..++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 183 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEE
Confidence 99999999888999999999999999999999777653 789999999999999976666788887776553
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-17 Score=190.29 Aligned_cols=153 Identities=20% Similarity=0.218 Sum_probs=129.2
Q ss_pred ceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCC
Q 005875 97 VGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF 167 (672)
Q Consensus 97 ~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 167 (672)
..|.|.... ..++.|+|++|.|+ .+|+..|.++++|++|||++|+|++..|..|.+|++|++|+|++|+|
T Consensus 34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l 112 (635)
T 4g8a_A 34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 112 (635)
T ss_dssp TEEECTTSCCSSCCSSSCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CEEECCCCCcCccCCCCCcCCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcC
Confidence 357786422 36889999999999 56665899999999999999999977778899999999999999999
Q ss_pred CCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCC-CCCC--CCCCCceEEeecCCCCCCCCcc
Q 005875 168 SGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS-IPNF--DIPKLRHLNLSYNGLKGSIPSS 242 (672)
Q Consensus 168 ~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~--~l~~L~~l~l~~N~l~g~~p~~ 242 (672)
++..|..|. ++|++|+|++|+|++..+..|++|++|+.|+|++|++++. +|.. .+++|++|+|++|++++..|..
T Consensus 113 ~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 192 (635)
T 4g8a_A 113 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 192 (635)
T ss_dssp CEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence 966666666 7999999999999987777899999999999999999864 4553 7899999999999999888887
Q ss_pred cCCCCCCc
Q 005875 243 LQKFPNSS 250 (672)
Q Consensus 243 ~~~~~~l~ 250 (672)
+..+.++.
T Consensus 193 l~~L~~l~ 200 (635)
T 4g8a_A 193 LRVLHQMP 200 (635)
T ss_dssp GHHHHTCT
T ss_pred ccchhhhh
Confidence 76655443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.69 E-value=2e-16 Score=159.00 Aligned_cols=154 Identities=24% Similarity=0.318 Sum_probs=135.4
Q ss_pred CCCcceeeecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCC
Q 005875 93 CQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP 172 (672)
Q Consensus 93 c~~w~gv~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 172 (672)
|..|.|+.|... ...+++++++++ .+|. .+. ++|+.|+|++|++++..|..|.++++|++|+|++|++++..|
T Consensus 4 Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~-~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 4 CETVTGCTCNEG---KKEVDCQGKSLD-SVPS-GIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp CHHHHSSEEEGG---GTEEECTTCCCS-SCCS-CCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred CCCCCceEcCCC---CeEEecCCCCcc-ccCC-CCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 558999999642 346899999998 7887 344 689999999999999888899999999999999999998888
Q ss_pred CCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCC
Q 005875 173 SSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 248 (672)
Q Consensus 173 ~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~ 248 (672)
..|. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|++++..+..|+++++
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 156 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence 7776 89999999999999888889999999999999999999777763 7999999999999999777778888888
Q ss_pred Ccccc
Q 005875 249 SSFVG 253 (672)
Q Consensus 249 l~~~~ 253 (672)
|..++
T Consensus 157 L~~L~ 161 (251)
T 3m19_A 157 LQTLS 161 (251)
T ss_dssp CCEEE
T ss_pred CCEEE
Confidence 87664
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=8.4e-17 Score=154.88 Aligned_cols=126 Identities=26% Similarity=0.278 Sum_probs=110.2
Q ss_pred CCcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeec
Q 005875 94 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 164 (672)
Q Consensus 94 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 164 (672)
|.|..+.|+... ..++.|+|++|.+.+..+.+.++.+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 479999997532 36789999999998655544589999999999999999998899999999999999999
Q ss_pred cCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCC
Q 005875 165 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 219 (672)
Q Consensus 165 N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 219 (672)
|+|++..|..|. ++|++|+|++|+|++.+|..|..+++|+.|+|++|.+++..+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 999988887775 8999999999999999999999999999999999999987653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.6e-16 Score=152.30 Aligned_cols=153 Identities=24% Similarity=0.300 Sum_probs=126.4
Q ss_pred eeeecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc-
Q 005875 98 GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 176 (672)
Q Consensus 98 gv~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~- 176 (672)
+..|.. +.++.++++++ .+|.. ..++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.
T Consensus 4 ~C~C~~-----~~v~c~~~~l~-~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 74 (208)
T 2o6s_A 4 RCSCSG-----TTVECYSQGRT-SVPTG---IPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNK 74 (208)
T ss_dssp TCEEET-----TEEECCSSCCS-SCCSC---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred CCEECC-----CEEEecCCCcc-CCCCC---CCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCC
Confidence 456643 46788899887 67752 356899999999999977777789999999999999999966555555
Q ss_pred -cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCcc--
Q 005875 177 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF-- 251 (672)
Q Consensus 177 -~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~-- 251 (672)
++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|++++..+..+.++++|..
T Consensus 75 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 154 (208)
T 2o6s_A 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154 (208)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEE
Confidence 89999999999999777778899999999999999999877763 7999999999999999777766777776654
Q ss_pred -ccCCCCCC
Q 005875 252 -VGNSLLCG 259 (672)
Q Consensus 252 -~~n~~~~~ 259 (672)
.+|+..|.
T Consensus 155 l~~N~~~~~ 163 (208)
T 2o6s_A 155 LHDNPWDCT 163 (208)
T ss_dssp CCSCCBCCC
T ss_pred ecCCCeecC
Confidence 46665543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.5e-17 Score=186.84 Aligned_cols=156 Identities=23% Similarity=0.238 Sum_probs=136.3
Q ss_pred CcceeeecCC-----------CCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeee
Q 005875 95 SWVGINCTQD-----------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQ 163 (672)
Q Consensus 95 ~w~gv~C~~~-----------~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 163 (672)
.|.|+ |+.. ..+++.|+|++|++++..|. .|+++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHG-DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSS-TTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCce-EECCCCccccccccCCCCccEEECcCCccCccChh-hhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 79998 8632 13689999999999976665 79999999999999999998888999999999999999
Q ss_pred ccCCCCCCCCCcc--cccceeecccccCcc-cCCchhhhhccccceecCCccccCCCCC--C-CCCCCceEEeecCCCCC
Q 005875 164 HNNFSGKIPSSFS--PQLVVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPN--F-DIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 164 ~N~l~g~~p~~~~--~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~-~l~~L~~l~l~~N~l~g 237 (672)
+|++++..|..|. ++|++|+|++|+|++ .+|..++++++|+.|++++|++.+.+|. + .+++|++|++++|++++
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 162 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc
Confidence 9999987776676 799999999999997 4678999999999999999996666663 2 88999999999999999
Q ss_pred CCCcccCCCCCCccc
Q 005875 238 SIPSSLQKFPNSSFV 252 (672)
Q Consensus 238 ~~p~~~~~~~~l~~~ 252 (672)
.+|..++++++|..+
T Consensus 163 ~~~~~l~~l~~L~~L 177 (549)
T 2z81_A 163 YQSQSLKSIRDIHHL 177 (549)
T ss_dssp ECTTTTTTCSEEEEE
T ss_pred cChhhhhccccCceE
Confidence 999999888776544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=6.1e-17 Score=167.72 Aligned_cols=140 Identities=23% Similarity=0.227 Sum_probs=79.1
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCC-CCCCCcc--cccceee
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG-KIPSSFS--PQLVVLD 183 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~--~~L~~L~ 183 (672)
.+..|++++|.+.+..+...+..+++|++|+|++|.+++..|..+.++++|++|+|++|.+++ .+|..+. ++|++|+
T Consensus 102 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 181 (306)
T 2z66_A 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181 (306)
T ss_dssp TCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEE
Confidence 345555555555543332345556666666666666655555555666666666666666654 3444444 4566666
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKF 246 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~ 246 (672)
|++|+|++..|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|++++..|..+..+
T Consensus 182 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCC
T ss_pred CCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhh
Confidence 6666666555556666666666666666665544321 45566666666666665555555544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.4e-16 Score=160.43 Aligned_cols=134 Identities=30% Similarity=0.341 Sum_probs=120.5
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
.++..|+|++|.+++. ++..++.+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+. ++|++|+
T Consensus 85 ~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSL-PNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp TTCCEEECTTSCCCCC-CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCcc-ChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 4688999999999954 444799999999999999999988888899999999999999999977776665 8999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 240 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p 240 (672)
|++|+|++..|..|+++++|+.|+|++|++++.+|.. .+++|+.|+|++|.+++..|
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 9999999888888999999999999999999988864 89999999999999987655
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=2.2e-16 Score=160.96 Aligned_cols=153 Identities=24% Similarity=0.254 Sum_probs=96.6
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCC-CCCCCcc--cccceee
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG-KIPSSFS--PQLVVLD 183 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~--~~L~~L~ 183 (672)
++..|+|++|.+.+..+. .+.++++|++|+|++|.+++..+..++++++|++|+|++|++++ .+|..+. ++|++|+
T Consensus 77 ~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~ 155 (276)
T 2z62_A 77 HLSTLILTGNPIQSLALG-AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155 (276)
T ss_dssp TCCEEECTTCCCCEECTT-TTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEE
T ss_pred CCCEEECCCCccCccChh-hhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEE
Confidence 455666666666644333 56666666666666666665555556666666666666666664 2455555 5666666
Q ss_pred cccccCcccCCchhhhhcccc----ceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCCCCc---cccCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLT----GLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNS 255 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~----~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~---~~~n~ 255 (672)
|++|+|++..+..+..+++|+ .|++++|.+++..+.. ...+|+.|+|++|++++..+..+.++++|. +.+|+
T Consensus 156 Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 235 (276)
T 2z62_A 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 235 (276)
T ss_dssp CCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSC
T ss_pred CCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCc
Confidence 666666666566666666666 5666666666555543 455788888888888866555566666554 45666
Q ss_pred CCCCC
Q 005875 256 LLCGP 260 (672)
Q Consensus 256 ~~~~~ 260 (672)
..|.+
T Consensus 236 ~~c~c 240 (276)
T 2z62_A 236 WDCSC 240 (276)
T ss_dssp BCCCT
T ss_pred ccccC
Confidence 66543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.2e-17 Score=173.53 Aligned_cols=165 Identities=25% Similarity=0.243 Sum_probs=128.7
Q ss_pred CCCCCCCCCCcceeeecCC-----------CCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCC
Q 005875 86 WSSTNPICQSWVGINCTQD-----------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSL 154 (672)
Q Consensus 86 w~~~~~~c~~w~gv~C~~~-----------~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l 154 (672)
|......| .|.|+ |+.. ...++.|+|++|++++ +|+..++++++|++|+|++|++++..|..|.++
T Consensus 23 ~~~~~~~C-~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 99 (353)
T 2z80_A 23 SNQASLSC-DRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSL 99 (353)
T ss_dssp ----CCEE-CTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred CCccCCCC-CCCeE-eeCCCCCcccccccccccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCC
Confidence 44334445 79887 6521 1368899999999985 555579999999999999999998878889999
Q ss_pred CCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCC-chhhhhccccceecCCcc-ccCCCCCC--CCCCCceE
Q 005875 155 PSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNN-LSGSIPNF--DIPKLRHL 228 (672)
Q Consensus 155 ~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~-l~~~~p~~--~l~~L~~l 228 (672)
++|++|+|++|++++..+..+. ++|++|+|++|+|++..+ ..+.++++|+.|++++|+ +.+..|.. .+++|+.|
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L 179 (353)
T 2z80_A 100 GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL 179 (353)
T ss_dssp TTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE
T ss_pred CCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEE
Confidence 9999999999999954443354 789999999999994433 478999999999999995 66554543 78899999
Q ss_pred EeecCCCCCCCCcccCCCCCCcccc
Q 005875 229 NLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 229 ~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
++++|++++..|..+.++++|..+.
T Consensus 180 ~l~~n~l~~~~~~~l~~l~~L~~L~ 204 (353)
T 2z80_A 180 EIDASDLQSYEPKSLKSIQNVSHLI 204 (353)
T ss_dssp EEEETTCCEECTTTTTTCSEEEEEE
T ss_pred ECCCCCcCccCHHHHhccccCCeec
Confidence 9999999988898888888776653
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=7.3e-17 Score=176.67 Aligned_cols=151 Identities=24% Similarity=0.335 Sum_probs=133.3
Q ss_pred Ccce--eeecCCC--------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCC-CcCCCCCCCcEEeee
Q 005875 95 SWVG--INCTQDR--------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQ 163 (672)
Q Consensus 95 ~w~g--v~C~~~~--------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~l~ 163 (672)
.|.+ |.|+... .+++.|+|++|.+.+..|. .|+++++|++|+|++|.+.+.+| ..|.++++|++|+|+
T Consensus 9 ~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 9 SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNET-SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTT-TTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChh-HhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence 4554 8887543 4689999999999976666 89999999999999999987774 679999999999999
Q ss_pred ccCCCCCCCCCcc--cccceeecccccCcccCCch--hhhhccccceecCCccccCCCCC--C-CCCCCceEEeecCCCC
Q 005875 164 HNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQS--IQNLTQLTGLSLQSNNLSGSIPN--F-DIPKLRHLNLSYNGLK 236 (672)
Q Consensus 164 ~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p~--~-~l~~L~~l~l~~N~l~ 236 (672)
+|++++..|..|. ++|++|+|++|++++.+|.. |+++++|+.|+|++|++++..|. . .+++|++|+|++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 167 (455)
T 3v47_A 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167 (455)
T ss_dssp TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence 9999988898887 89999999999999876665 99999999999999999998886 2 8999999999999999
Q ss_pred CCCCcccCCC
Q 005875 237 GSIPSSLQKF 246 (672)
Q Consensus 237 g~~p~~~~~~ 246 (672)
+..|..+.++
T Consensus 168 ~~~~~~l~~l 177 (455)
T 3v47_A 168 SICEEDLLNF 177 (455)
T ss_dssp CCCTTTSGGG
T ss_pred ccChhhhhcc
Confidence 9989888766
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.67 E-value=7.2e-17 Score=183.14 Aligned_cols=170 Identities=19% Similarity=0.164 Sum_probs=136.0
Q ss_pred CCCCCCCCCCCC---cceeeecCC----------------CCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcC
Q 005875 84 LNWSSTNPICQS---WVGINCTQD----------------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT 144 (672)
Q Consensus 84 ~~w~~~~~~c~~---w~gv~C~~~----------------~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~ 144 (672)
.+|.++.+||.. |.++.|+.. -..+..++++++.+. .+|+..++.+++|++|+|++|.|+
T Consensus 10 ~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~ 88 (597)
T 3oja_B 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE 88 (597)
T ss_dssp -CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCC
T ss_pred cCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCC
Confidence 378776666654 655555410 023466788888876 677767899999999999999999
Q ss_pred CCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--
Q 005875 145 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-- 220 (672)
Q Consensus 145 g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-- 220 (672)
+..|..|+++++|++|+|++|.+++..|..|. ++|++|+|++|+|++..+..|+++++|+.|+|++|.|++.+|..
T Consensus 89 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 168 (597)
T 3oja_B 89 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 168 (597)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTT
T ss_pred CCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhh
Confidence 88888999999999999999999988777776 89999999999999666666899999999999999999988864
Q ss_pred CCCCCceEEeecCCCCCCCCcccCCCCCCccccC
Q 005875 221 DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGN 254 (672)
Q Consensus 221 ~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~n 254 (672)
.+++|+.|+|++|.+++..+..+.++..|...+|
T Consensus 169 ~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 169 ATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp TCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred cCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 8999999999999999765455555555444444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=175.71 Aligned_cols=158 Identities=22% Similarity=0.207 Sum_probs=136.8
Q ss_pred CcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeecc
Q 005875 95 SWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 165 (672)
Q Consensus 95 ~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 165 (672)
.|..|.|.... ..+..|+|++|++++..|. .|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQD-EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTT-TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHh-HccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 47889997532 3578999999999976555 8999999999999999999888999999999999999999
Q ss_pred CCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCc
Q 005875 166 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPS 241 (672)
Q Consensus 166 ~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~ 241 (672)
++++..+..|. ++|++|+|++|++++..|..|.++++|+.|+|++|++++..|.. .+++|+.|+|++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 99965555555 89999999999999999999999999999999999999877754 889999999999999976666
Q ss_pred ccCCCCCCcccc
Q 005875 242 SLQKFPNSSFVG 253 (672)
Q Consensus 242 ~~~~~~~l~~~~ 253 (672)
.+.++++|..+.
T Consensus 171 ~l~~l~~L~~L~ 182 (477)
T 2id5_A 171 ALSHLHGLIVLR 182 (477)
T ss_dssp HHTTCTTCCEEE
T ss_pred HhcccCCCcEEe
Confidence 677777776553
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.9e-16 Score=162.73 Aligned_cols=149 Identities=28% Similarity=0.315 Sum_probs=115.5
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
.++..|+|++|.+++ ++. .+.+++|++|+|++|+|+ .+|..+.++++|++|+|++|++++..|..|. ++|++|+
T Consensus 55 ~~L~~L~L~~n~l~~-~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~ 130 (290)
T 1p9a_G 55 TRLTQLNLDRAELTK-LQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (290)
T ss_dssp TTCCEEECTTSCCCE-EEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCc-ccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence 467788888888874 444 378888888888888888 7788888888888888888888866666665 6888888
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCc---cccCCCCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLLC 258 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~---~~~n~~~~ 258 (672)
|++|+|++..+..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|+++ .+|..+..+.+|. ..+|++.|
T Consensus 131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 8888888777777888888888888888888655543 6888888888888888 6777666555544 45677666
Q ss_pred C
Q 005875 259 G 259 (672)
Q Consensus 259 ~ 259 (672)
.
T Consensus 210 ~ 210 (290)
T 1p9a_G 210 N 210 (290)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.9e-16 Score=148.87 Aligned_cols=131 Identities=26% Similarity=0.303 Sum_probs=109.8
Q ss_pred CCcceeeecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCC
Q 005875 94 QSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 173 (672)
Q Consensus 94 ~~w~gv~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~ 173 (672)
|+|.++.|+. +++. .+|. .+ .++|++|+|++|++++..+..|.++++|++|+|++|++++..+.
T Consensus 7 C~~~~l~~~~------------~~l~-~~p~-~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (177)
T 2o6r_A 7 CSGTEIRCNS------------KGLT-SVPT-GI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG 70 (177)
T ss_dssp EETTEEECCS------------SCCS-SCCT-TC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred eCCCEEEecC------------CCCc-cCCC-CC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChh
Confidence 3677777754 4444 4664 22 37899999999999977777789999999999999999966666
Q ss_pred Ccc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCC
Q 005875 174 SFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 240 (672)
Q Consensus 174 ~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p 240 (672)
.|. ++|++|+|++|+|++..+..+.++++|+.|+|++|+|++.++.. .+++|++|+|++|++++..|
T Consensus 71 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 71 VFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred HccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 555 79999999999999888888999999999999999999776653 68999999999999997665
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.1e-16 Score=173.08 Aligned_cols=156 Identities=22% Similarity=0.215 Sum_probs=113.9
Q ss_pred CcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeecc
Q 005875 95 SWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 165 (672)
Q Consensus 95 ~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 165 (672)
.|..|.|.... ..++.|+|++|++++..|. .|+++++|++|+|++|.|++..|..|.++++|++|+|++|
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQAD-TFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTT-TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHH-HcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 46788887532 3688999999999976565 8999999999999999999888899999999999999999
Q ss_pred CCCCCCCCCcc--cccceeecccccCcccCCchhhhhcc-------------------------ccceecCCccccCCCC
Q 005875 166 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQ-------------------------LTGLSLQSNNLSGSIP 218 (672)
Q Consensus 166 ~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~-------------------------L~~L~l~~N~l~~~~p 218 (672)
++++..+..|. ++|++|+|++|+|++..+..|.++++ |+.|+|++|+|++. |
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~ 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c
Confidence 99966555565 78999999999988655545555444 44555555555433 2
Q ss_pred CC-CCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 219 NF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 219 ~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
.. .+++|+.|+|++|++++..|..|.++++|..+
T Consensus 213 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 247 (452)
T 3zyi_A 213 NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247 (452)
T ss_dssp CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEE
T ss_pred cccccccccEEECcCCcCcccCcccccCccCCCEE
Confidence 22 55566666666666665556566655555443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.66 E-value=8.6e-17 Score=172.59 Aligned_cols=169 Identities=20% Similarity=0.183 Sum_probs=129.7
Q ss_pred CCCCCCCCCCCcceeeecCC-------------------CCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCC
Q 005875 85 NWSSTNPICQSWVGINCTQD-------------------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG 145 (672)
Q Consensus 85 ~w~~~~~~c~~w~gv~C~~~-------------------~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g 145 (672)
+|....+||+.|.+..|... -..+..+++.++.+. .+|+..+..+++|++|+|++|.+++
T Consensus 5 ~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~ 83 (390)
T 3o6n_A 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE 83 (390)
T ss_dssp --CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCE
T ss_pred CCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccc
Confidence 68776677766555544211 034567888888877 6887678999999999999999997
Q ss_pred CCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--C
Q 005875 146 GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--D 221 (672)
Q Consensus 146 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~ 221 (672)
..|..|.++++|++|+|++|++++..|..|. ++|++|+|++|+|+...+..|+++++|+.|+|++|++++..|.. .
T Consensus 84 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 163 (390)
T 3o6n_A 84 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 163 (390)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSS
T ss_pred cChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccC
Confidence 7778999999999999999999988777776 79999999999999554555799999999999999999887763 8
Q ss_pred CCCCceEEeecCCCCCCCCcccCCCCCCccccC
Q 005875 222 IPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGN 254 (672)
Q Consensus 222 l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~n 254 (672)
+++|+.|++++|++++.-...+.++..+...+|
T Consensus 164 l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 164 TTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp CTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred CCCCCEEECCCCcCCccccccccccceeecccc
Confidence 899999999999999654344444444444443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.8e-16 Score=187.14 Aligned_cols=86 Identities=30% Similarity=0.334 Sum_probs=64.0
Q ss_pred cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCccccCCC
Q 005875 177 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSL 256 (672)
Q Consensus 177 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~n~~ 256 (672)
++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.+|....++|+.|+|++|++++.+|..+.++..+.+.+|++
T Consensus 480 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~ 559 (844)
T 3j0a_A 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKF 559 (844)
T ss_dssp CCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECC
T ss_pred ccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCc
Confidence 35566666666666666666777777777777777777665554347788888888888888888888888888999999
Q ss_pred CCCCCC
Q 005875 257 LCGPPL 262 (672)
Q Consensus 257 ~~~~~l 262 (672)
.|.+++
T Consensus 560 ~C~c~~ 565 (844)
T 3j0a_A 560 ICECEL 565 (844)
T ss_dssp CCSSSC
T ss_pred cccccc
Confidence 997654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=174.79 Aligned_cols=130 Identities=22% Similarity=0.254 Sum_probs=115.0
Q ss_pred CCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceec
Q 005875 131 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSL 208 (672)
Q Consensus 131 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 208 (672)
++|++|+|++|.+++.+|..|+++++|+.|+|++|++++..|..|. ++|++|+|++|+|++..|..|+++++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 6899999999999999999999999999999999999988888886 89999999999999888999999999999999
Q ss_pred CCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCc---cccCCCCCCC
Q 005875 209 QSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLLCGP 260 (672)
Q Consensus 209 ~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~---~~~n~~~~~~ 260 (672)
++|++++..|.. .+++|++|+|++|++++..+..+..+++|. ..+|+..|.+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence 999999887764 899999999999999976666677777665 4466665544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.65 E-value=4e-17 Score=186.54 Aligned_cols=132 Identities=17% Similarity=0.314 Sum_probs=119.0
Q ss_pred CccccCCccccCCCCCCcEEEccCCCcCCC-----------------CCCcCC--CCCCCcEEeeeccCCCCCCCCCcc-
Q 005875 117 GLVGPIPNNTLGKLDALEVLSLRSNVLTGG-----------------LPSEIT--SLPSLRYLYLQHNNFSGKIPSSFS- 176 (672)
Q Consensus 117 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~-----------------~p~~~~--~l~~L~~L~l~~N~l~g~~p~~~~- 176 (672)
+++| +|+ .++++++|++|+|++|.|+|. +|..++ ++++|++|+|++|++.|.+|..+.
T Consensus 194 ~l~~-ip~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 271 (636)
T 4eco_A 194 NITF-VSK-AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271 (636)
T ss_dssp EEEE-ECG-GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT
T ss_pred CCcc-CCH-HHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhc
Confidence 4556 887 799999999999999999986 999999 999999999999999999999887
Q ss_pred -cccceeeccccc-Ccc-cCCchhhhh------ccccceecCCccccCCCCC--C--CCCCCceEEeecCCCCCCCCccc
Q 005875 177 -PQLVVLDLSFNS-FTG-NIPQSIQNL------TQLTGLSLQSNNLSGSIPN--F--DIPKLRHLNLSYNGLKGSIPSSL 243 (672)
Q Consensus 177 -~~L~~L~ls~N~-l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~--~l~~L~~l~l~~N~l~g~~p~~~ 243 (672)
++|++|+|++|+ |+| .+|..++++ ++|+.|+|++|+++ .+|. . .+++|+.|+|++|+++|.+| .+
T Consensus 272 l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~ 349 (636)
T 4eco_A 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF 349 (636)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC
T ss_pred CCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh
Confidence 799999999998 999 899999988 99999999999999 7776 3 89999999999999999999 88
Q ss_pred CCCCCCccc
Q 005875 244 QKFPNSSFV 252 (672)
Q Consensus 244 ~~~~~l~~~ 252 (672)
+++++|..+
T Consensus 350 ~~l~~L~~L 358 (636)
T 4eco_A 350 GSEIKLASL 358 (636)
T ss_dssp EEEEEESEE
T ss_pred CCCCCCCEE
Confidence 777766654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=161.98 Aligned_cols=143 Identities=21% Similarity=0.192 Sum_probs=121.8
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
.++.|+|++|++++..+. .|+++++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|. ++|++|++
T Consensus 29 ~l~~L~ls~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSY-SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEECTT-TTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCcccccCHh-HhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 588999999999865444 799999999999999999977777899999999999999999977777776 79999999
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCC-CCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS-IPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 250 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~ 250 (672)
++|++++..+..++++++|+.|+|++|++++. +|.. .+++|+.|+|++|++++..+..+..+.++.
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 176 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcc
Confidence 99999987777899999999999999999873 4653 789999999999999977777666555443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.5e-16 Score=180.90 Aligned_cols=152 Identities=20% Similarity=0.229 Sum_probs=133.1
Q ss_pred ceeeecCC---------CCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCC
Q 005875 97 VGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF 167 (672)
Q Consensus 97 ~gv~C~~~---------~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 167 (672)
..|.|... ..+++.|+|++|.+++..+. .|+++++|++|+|++|.+++..|..|+++++|++|+|++|++
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l 92 (606)
T 3vq2_A 14 ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSY-SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92 (606)
T ss_dssp TEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTT-TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChh-hccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence 35777642 24689999999999966555 799999999999999999988899999999999999999999
Q ss_pred CCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccC-CCCCC--CCCCCceEEeecCCCCCCCCcc
Q 005875 168 SGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-SIPNF--DIPKLRHLNLSYNGLKGSIPSS 242 (672)
Q Consensus 168 ~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~--~l~~L~~l~l~~N~l~g~~p~~ 242 (672)
++..|..|. ++|++|+|++|++++..|..|+++++|++|+|++|.+++ .+|.. .+++|++|+|++|++++..|..
T Consensus 93 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~ 172 (606)
T 3vq2_A 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172 (606)
T ss_dssp CCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTT
T ss_pred cccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhh
Confidence 988898887 899999999999998888899999999999999999986 56764 8999999999999999888887
Q ss_pred cCCCCCC
Q 005875 243 LQKFPNS 249 (672)
Q Consensus 243 ~~~~~~l 249 (672)
++.+.+|
T Consensus 173 ~~~l~~L 179 (606)
T 3vq2_A 173 LQFLREN 179 (606)
T ss_dssp THHHHHC
T ss_pred hhhhhcc
Confidence 7765544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.7e-16 Score=149.06 Aligned_cols=133 Identities=26% Similarity=0.258 Sum_probs=109.4
Q ss_pred CeEEEEEeCCCCcc-ccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--ccccee
Q 005875 106 TRVFGLRLPGIGLV-GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182 (672)
Q Consensus 106 ~~v~~l~l~~~~l~-g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L 182 (672)
..++.|+|++|+++ +.+|. .+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+. ++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 46788999999988 78887 688899999999999999865 6788999999999999999977776664 789999
Q ss_pred ecccccCcccC-CchhhhhccccceecCCccccCCCC----CC-CCCCCceEEeecCCCCCCCCcc
Q 005875 183 DLSFNSFTGNI-PQSIQNLTQLTGLSLQSNNLSGSIP----NF-DIPKLRHLNLSYNGLKGSIPSS 242 (672)
Q Consensus 183 ~ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p----~~-~l~~L~~l~l~~N~l~g~~p~~ 242 (672)
+|++|+|++.. +..+.++++|+.|+|++|.+++..+ .. .+++|++|++++|.+. .+|+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 99999998642 2788889999999999999987766 22 7889999999999887 45543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.65 E-value=4.3e-16 Score=170.58 Aligned_cols=155 Identities=23% Similarity=0.196 Sum_probs=105.0
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCC------------
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS------------ 174 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~------------ 174 (672)
++..|+|++|++++..|. .|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..
T Consensus 100 ~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 178 (452)
T 3zyi_A 100 HLEVLQLGRNSIRQIEVG-AFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDL 178 (452)
T ss_dssp TCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCccCCcChh-hccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeC
Confidence 455666666666543333 5666666666666666665444444555555555555555554222211
Q ss_pred -----------------------------------cc--cccceeecccccCcccCCchhhhhccccceecCCccccCCC
Q 005875 175 -----------------------------------FS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 217 (672)
Q Consensus 175 -----------------------------------~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (672)
+. ++|++|+|++|+|++..|..|.++++|+.|+|++|++++..
T Consensus 179 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 258 (452)
T 3zyi_A 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258 (452)
T ss_dssp CCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEEC
T ss_pred CCCCCccccChhhccCCCCCCEEECCCCcccccccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceEC
Confidence 11 46777788888888878888999999999999999998877
Q ss_pred CCC--CCCCCceEEeecCCCCCCCCcccCCCCCC---ccccCCCCCCCCC
Q 005875 218 PNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNS---SFVGNSLLCGPPL 262 (672)
Q Consensus 218 p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l---~~~~n~~~~~~~l 262 (672)
|.. .+++|+.|+|++|++++..+..+..+++| .+.+|++.|.+.+
T Consensus 259 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred HHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 764 78999999999999997777667666655 4568888887653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.9e-17 Score=187.33 Aligned_cols=178 Identities=20% Similarity=0.278 Sum_probs=110.5
Q ss_pred CChhHHHHHHHHHHhCC---CCCCCCCCCCCCCCCCcceeeecCCCCeEEEEEeCCC------------------Cccc-
Q 005875 63 DLNSDRQALLDFADAVP---HLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGI------------------GLVG- 120 (672)
Q Consensus 63 ~~~~~~~al~~~~~~~~---~~~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~------------------~l~g- 120 (672)
..+.++.+|+++..+.. ......|......+.+|.++.++. .+++.|+|.++ .+.+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~ 206 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEANQALLQHKKLSQYSIDED 206 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcchhhHhhcCccCcccccCc
Confidence 34567889999987662 122235655555555898887765 34555554333 3322
Q ss_pred -------cCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcc
Q 005875 121 -------PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTG 191 (672)
Q Consensus 121 -------~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~ 191 (672)
.++++.+..+.+|+.|+|++|.|. .+|..+.++++|++|+|++|+|+ .+|..|. ++|++|+|++|+|+
T Consensus 207 ~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 207 DDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 133446888899999999999998 78888889999999999999999 8888776 78999999999999
Q ss_pred cCCchhhhhccccceecCCccccCCCCC-C-CCCCCceEEeecCCCCCCCCcccCCC
Q 005875 192 NIPQSIQNLTQLTGLSLQSNNLSGSIPN-F-DIPKLRHLNLSYNGLKGSIPSSLQKF 246 (672)
Q Consensus 192 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~-~l~~L~~l~l~~N~l~g~~p~~~~~~ 246 (672)
.+|..|++|++|+.|+|++|.|+ .+|. + .+++|+.|+|++|.|+|.+|..+..+
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 339 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEK 339 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHH
T ss_pred ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhc
Confidence 78999999999999999999997 5554 3 88899999999999998888776543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=5.6e-16 Score=162.30 Aligned_cols=145 Identities=20% Similarity=0.255 Sum_probs=119.3
Q ss_pred CCcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeec
Q 005875 94 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 164 (672)
Q Consensus 94 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 164 (672)
|.|..+.|+... ..++.|+|++|++++. ++..|+++++|++|+|++|.+++..|..|+++++|++|+|++
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEI-KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCB-CTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEe-ChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 479999997521 3578899999999964 444799999999999999999988899999999999999999
Q ss_pred cCCCCCCCCCcccccceeecccccCcccCCchhhhhccccceecCCccccC--CCCCC--CCCCCceEEeecCCCCCCCC
Q 005875 165 NNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG--SIPNF--DIPKLRHLNLSYNGLKGSIP 240 (672)
Q Consensus 165 N~l~g~~p~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~--~l~~L~~l~l~~N~l~g~~p 240 (672)
|+++ .+|..+.++|++|++++|++++..+..|.++++|+.|++++|.++. ..+.. .+++|+.|++++|.++. +|
T Consensus 110 n~l~-~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~ 187 (330)
T 1xku_A 110 NQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IP 187 (330)
T ss_dssp SCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CC
T ss_pred CcCC-ccChhhcccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CC
Confidence 9999 7888888899999999999997777778888888888888888863 44432 56777777777777663 44
Q ss_pred c
Q 005875 241 S 241 (672)
Q Consensus 241 ~ 241 (672)
.
T Consensus 188 ~ 188 (330)
T 1xku_A 188 Q 188 (330)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.4e-16 Score=181.05 Aligned_cols=143 Identities=24% Similarity=0.208 Sum_probs=75.1
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCC-CcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
++..|+|++|.+.+ +|. .+..+++|+.|+|++|.+++..| ..+.++++|++|++++|++++.+|..+. ++|++|+
T Consensus 377 ~L~~L~L~~n~l~~-~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 454 (606)
T 3vq2_A 377 SLRHLDLSFNGAII-MSA-NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLK 454 (606)
T ss_dssp CCCEEECCSCSEEE-ECC-CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred cccEeECCCCcccc-chh-hccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEE
Confidence 44555666665553 443 45555555555555555555544 4455555555555555555555554443 4555555
Q ss_pred cccccCcc-cCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCcc
Q 005875 184 LSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 251 (672)
Q Consensus 184 ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 251 (672)
|++|++++ .+|..|+++++|+.|+|++|++++.+|.. .+++|+.|+|++|++++.+|..+.++++|..
T Consensus 455 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 525 (606)
T 3vq2_A 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525 (606)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCE
T ss_pred CCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCE
Confidence 55555554 24555555555555555555555544432 4555555555555555544555554444443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.1e-16 Score=179.58 Aligned_cols=154 Identities=19% Similarity=0.108 Sum_probs=137.3
Q ss_pred cceeeecCC---------CCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccC
Q 005875 96 WVGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN 166 (672)
Q Consensus 96 w~gv~C~~~---------~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 166 (672)
+..+.|... ...++.|+|++|.+++..|. .|+++++|++|+|++|.+++..|..|+++++|++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNT-TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTT-TSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChh-HhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 556888652 24689999999999966565 89999999999999999998889999999999999999999
Q ss_pred CCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCC-CCCC-CCCCCceEEeecCCCCCCCCcc
Q 005875 167 FSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS-IPNF-DIPKLRHLNLSYNGLKGSIPSS 242 (672)
Q Consensus 167 l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~-~l~~L~~l~l~~N~l~g~~p~~ 242 (672)
+++..|..|. ++|++|+|++|+|++..|..++++++|++|+|++|++++. +|.. .+++|+.|+|++|.+++..|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 9988898887 8999999999999987788999999999999999999984 4554 8999999999999999888888
Q ss_pred cCCCCCCc
Q 005875 243 LQKFPNSS 250 (672)
Q Consensus 243 ~~~~~~l~ 250 (672)
++.+++|.
T Consensus 173 ~~~l~~L~ 180 (606)
T 3t6q_A 173 MSSLQQAT 180 (606)
T ss_dssp HHTTTTCC
T ss_pred hhhhcccc
Confidence 88888776
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.63 E-value=7.7e-16 Score=161.39 Aligned_cols=157 Identities=21% Similarity=0.267 Sum_probs=128.3
Q ss_pred CCcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeec
Q 005875 94 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 164 (672)
Q Consensus 94 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 164 (672)
|.|..+.|+... ..++.|+|++|++.+..|. .|+++++|++|+|++|.+++..|..|+++++|++|+|++
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKD-DFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHh-HhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 479999997532 3678999999999865554 899999999999999999988899999999999999999
Q ss_pred cCCCCCCCCCcccccceeecccccCcccCCchhhhhccccceecCCccccC--CCCCC--CCCCCceEEeecCCCCCCCC
Q 005875 165 NNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG--SIPNF--DIPKLRHLNLSYNGLKGSIP 240 (672)
Q Consensus 165 N~l~g~~p~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~--~l~~L~~l~l~~N~l~g~~p 240 (672)
|+++ .+|..+.++|++|+|++|+|++..+..|.++++|+.|++++|.++. ..|.. .+ +|+.|++++|++++ +|
T Consensus 112 n~l~-~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~ 188 (332)
T 2ft3_A 112 NHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IP 188 (332)
T ss_dssp SCCC-SCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CC
T ss_pred CcCC-ccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cC
Confidence 9999 7888888999999999999997777789999999999999999963 44443 34 77788888887774 45
Q ss_pred ccc-CCCCCCccccC
Q 005875 241 SSL-QKFPNSSFVGN 254 (672)
Q Consensus 241 ~~~-~~~~~l~~~~n 254 (672)
..+ .++..|...+|
T Consensus 189 ~~~~~~L~~L~l~~n 203 (332)
T 2ft3_A 189 KDLPETLNELHLDHN 203 (332)
T ss_dssp SSSCSSCSCCBCCSS
T ss_pred ccccCCCCEEECCCC
Confidence 433 34455554444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=8.7e-16 Score=167.58 Aligned_cols=155 Identities=26% Similarity=0.275 Sum_probs=115.7
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcC-------------------------CCCCCCcEE
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-------------------------TSLPSLRYL 160 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~-------------------------~~l~~L~~L 160 (672)
.++..|+|++|+++ .+|++.|..+++|++|+|++|.|++..+..| .++++|++|
T Consensus 112 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L 190 (440)
T 3zyj_A 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190 (440)
T ss_dssp SSCCEEECCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEE
T ss_pred ccCCEEECCCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCee
Confidence 46778888888887 4555578888888888888887774444344 445555555
Q ss_pred eeeccCCCCCCCCCcc-cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCC
Q 005875 161 YLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 161 ~l~~N~l~g~~p~~~~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g 237 (672)
+|++|+++ .+|.... ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|++++
T Consensus 191 ~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 191 NLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269 (440)
T ss_dssp ECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred cCCCCcCc-cccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence 55555555 3343111 67888999999999888899999999999999999999877764 88999999999999997
Q ss_pred CCCcccCCCCCC---ccccCCCCCCCCC
Q 005875 238 SIPSSLQKFPNS---SFVGNSLLCGPPL 262 (672)
Q Consensus 238 ~~p~~~~~~~~l---~~~~n~~~~~~~l 262 (672)
..+..|..+++| ...+|++.|.+.+
T Consensus 270 ~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 270 LPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred cChhHhccccCCCEEEcCCCCccCCCCc
Confidence 777777766655 4568888887643
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-16 Score=157.26 Aligned_cols=142 Identities=16% Similarity=0.187 Sum_probs=112.3
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCC-cCCCCCCcCCCCCCCcEEeeec-cCCCCCCCCCcc--cccce
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNV-LTGGLPSEITSLPSLRYLYLQH-NNFSGKIPSSFS--PQLVV 181 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~--~~L~~ 181 (672)
..++.|+|++|++++ +|+..|+.+++|++|+|++|. +++..+..|.++++|++|+|++ |++++..|..|. ++|++
T Consensus 31 ~~l~~L~l~~n~l~~-i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 31 PSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp TTCCEEEEESCCCSE-ECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CcccEEEEeCCcceE-ECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 368889999999984 555579999999999999997 8855566889999999999998 999966556665 78999
Q ss_pred eecccccCcccCCchhhhhcccc---ceecCCc-cccCCCCCC--CCCCCc-eEEeecCCCCCCCCcccCCCCCCcc
Q 005875 182 LDLSFNSFTGNIPQSIQNLTQLT---GLSLQSN-NLSGSIPNF--DIPKLR-HLNLSYNGLKGSIPSSLQKFPNSSF 251 (672)
Q Consensus 182 L~ls~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~~--~l~~L~-~l~l~~N~l~g~~p~~~~~~~~l~~ 251 (672)
|+|++|+|++ +|. |.++++|+ .|++++| ++++..+.. .+++|+ .|++++|+++ .+|......++|..
T Consensus 110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~ 183 (239)
T 2xwt_C 110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183 (239)
T ss_dssp EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEE
T ss_pred EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCE
Confidence 9999999986 676 88888888 9999999 888666653 788888 9999999988 56654332244443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=146.50 Aligned_cols=123 Identities=30% Similarity=0.379 Sum_probs=108.4
Q ss_pred EEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccc
Q 005875 110 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 187 (672)
Q Consensus 110 ~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N 187 (672)
.++++++++. .+|.+ + ..+|++|+|++|.|+ .+|..|.++++|+.|+|++|++++..|..|. ++|++|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~~-~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKG-I--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCSC-C--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCCC-C--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 4667777877 78863 4 368999999999999 8889999999999999999999987777776 89999999999
Q ss_pred cCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCC
Q 005875 188 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 188 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g 237 (672)
+|++..|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 999888889999999999999999999766653 78999999999999874
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-16 Score=176.15 Aligned_cols=135 Identities=19% Similarity=0.137 Sum_probs=71.5
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc---cccceee
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLD 183 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~---~~L~~L~ 183 (672)
.+..|+|++|.+++..+. .+++|+.|+|++|.|++..|..++++++|++|+|++|.+++.+|..+. ++|++|+
T Consensus 100 ~L~~L~L~~N~l~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 100 SIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TCCEEECCSSCCCCEEEC----CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CcCEEECcCCcCCCCCcc----ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 344555555555543221 245555556666655555555555555556666666655555555443 4555555
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPN 248 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~ 248 (672)
|++|.|++..+ +..+++|+.|+|++|.|++.+|.+ .+++|+.|+|++|.|++ +|..+..+++
T Consensus 176 Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~ 238 (487)
T 3oja_A 176 LQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQN 238 (487)
T ss_dssp CTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTT
T ss_pred cCCCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCC
Confidence 55555554422 223555555555555555544443 45555555555555553 4444444433
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-16 Score=165.38 Aligned_cols=144 Identities=22% Similarity=0.257 Sum_probs=80.1
Q ss_pred eEEEEEeCCCCccccCCcccc-CCCCCCcEEEccCCCcCCCCCCcCCCC-----CCCcEEeeeccCCCCCCCCCcc--cc
Q 005875 107 RVFGLRLPGIGLVGPIPNNTL-GKLDALEVLSLRSNVLTGGLPSEITSL-----PSLRYLYLQHNNFSGKIPSSFS--PQ 178 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~-~~l~~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~--~~ 178 (672)
++..|+|++|+++|.+|...+ +.+++|++|+|++|++++. |..++++ ++|++|+|++|++++..|..|. ++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 455666666666666665321 6666666666666666655 5555555 6666666666666655555554 56
Q ss_pred cceeecccccCccc--CCchh--hhhccccceecCCccccCC--CCC-C--CCCCCceEEeecCCCCCCCC-cccCCCCC
Q 005875 179 LVVLDLSFNSFTGN--IPQSI--QNLTQLTGLSLQSNNLSGS--IPN-F--DIPKLRHLNLSYNGLKGSIP-SSLQKFPN 248 (672)
Q Consensus 179 L~~L~ls~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~~--~p~-~--~l~~L~~l~l~~N~l~g~~p-~~~~~~~~ 248 (672)
|++|+|++|+++|. +|..+ +++++|+.|+|++|+|++. ++. . .+++|+.|+|++|++++.+| ..+..+++
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 254 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTT
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCC
Confidence 66666666666554 23333 5566666666666666531 111 1 45566666666666665554 23333444
Q ss_pred Ccc
Q 005875 249 SSF 251 (672)
Q Consensus 249 l~~ 251 (672)
|+.
T Consensus 255 L~~ 257 (312)
T 1wwl_A 255 LNS 257 (312)
T ss_dssp CCE
T ss_pred CCE
Confidence 433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.61 E-value=2e-16 Score=184.84 Aligned_cols=144 Identities=22% Similarity=0.355 Sum_probs=131.5
Q ss_pred CeEEEEEeCCCCccc-----------------cCCccccC--CCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccC
Q 005875 106 TRVFGLRLPGIGLVG-----------------PIPNNTLG--KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN 166 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g-----------------~~p~~~~~--~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 166 (672)
.++..|+|++|.++| .+|+ .++ +|++|++|+|++|++.|.+|..|++|++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~-~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE-ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCCh-hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 468899999999998 4998 677 99999999999999999999999999999999999998
Q ss_pred -CCC-CCCCCcc--c-------ccceeecccccCcccCCc--hhhhhccccceecCCccccCCCCCC-CCCCCceEEeec
Q 005875 167 -FSG-KIPSSFS--P-------QLVVLDLSFNSFTGNIPQ--SIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSY 232 (672)
Q Consensus 167 -l~g-~~p~~~~--~-------~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~ 232 (672)
++| .+|..+. + +|++|+|++|+|+ .+|. .|+++++|+.|+|++|+|+ .+|.+ .+++|+.|+|++
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY 604 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCS
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcC
Confidence 998 8998765 3 8999999999999 8999 9999999999999999999 77765 889999999999
Q ss_pred CCCCCCCCcccCCCCC-Ccccc
Q 005875 233 NGLKGSIPSSLQKFPN-SSFVG 253 (672)
Q Consensus 233 N~l~g~~p~~~~~~~~-l~~~~ 253 (672)
|+++ .+|..+.++++ |..+.
T Consensus 605 N~l~-~lp~~l~~l~~~L~~L~ 625 (876)
T 4ecn_A 605 NQIE-EIPEDFCAFTDQVEGLG 625 (876)
T ss_dssp SCCS-CCCTTSCEECTTCCEEE
T ss_pred Cccc-cchHHHhhccccCCEEE
Confidence 9999 89998888777 76553
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.4e-16 Score=182.45 Aligned_cols=149 Identities=21% Similarity=0.235 Sum_probs=127.8
Q ss_pred CcceeeecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCC-CCcCCCCCCCcEEeeeccCCCCCCCC
Q 005875 95 SWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGL-PSEITSLPSLRYLYLQHNNFSGKIPS 173 (672)
Q Consensus 95 ~w~gv~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~ 173 (672)
+|..|.+ ...+++.|+|++|.+++..|. .|+++++|++|+|++|.+.+.+ |..|.+|++|++|+|++|++++..|.
T Consensus 15 ~L~~vP~--lp~~l~~LdLs~N~i~~i~~~-~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 15 NLTQVPQ--VLNTTERLLLSFNYIRTVTAS-SFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CSSCCCS--SCTTCCEEEEESCCCCEECSS-SCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCC--CCCCcCEEECCCCcCCccChh-HCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 5666665 345788999999999876665 7999999999999999877777 77899999999999999999988898
Q ss_pred Ccc--cccceeecccccCcccCCch--hhhhccccceecCCccccCCCCC--C-CCCCCceEEeecCCCCCCCCcccCCC
Q 005875 174 SFS--PQLVVLDLSFNSFTGNIPQS--IQNLTQLTGLSLQSNNLSGSIPN--F-DIPKLRHLNLSYNGLKGSIPSSLQKF 246 (672)
Q Consensus 174 ~~~--~~L~~L~ls~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p~--~-~l~~L~~l~l~~N~l~g~~p~~~~~~ 246 (672)
.|. ++|++|+|++|++++.+|.. |++|++|+.|+|++|.+++..+. + .+++|++|+|++|.+++..|..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 887 79999999999999877766 89999999999999999987664 2 89999999999999998888877544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.61 E-value=8.2e-16 Score=171.78 Aligned_cols=150 Identities=25% Similarity=0.362 Sum_probs=122.9
Q ss_pred CCCCCCCCCC----Cccee-eecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcE
Q 005875 85 NWSSTNPICQ----SWVGI-NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRY 159 (672)
Q Consensus 85 ~w~~~~~~c~----~w~gv-~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~ 159 (672)
+|..+..+|. .|.|+ .|.. .+++.|+|++|++++ +|. .+ +++|++|+|++|+|+ .+| ..+++|++
T Consensus 35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~-~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~ 104 (571)
T 3cvr_A 35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPD-NL--PPQITVLEITQNALI-SLP---ELPASLEY 104 (571)
T ss_dssp HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCS-CC--CTTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCH-hH--cCCCCEEECcCCCCc-ccc---cccCCCCE
Confidence 5665556663 49999 7864 468899999999996 887 34 388999999999999 788 56899999
Q ss_pred EeeeccCCCCCCCCCcccccceeecccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCC
Q 005875 160 LYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 239 (672)
Q Consensus 160 L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~ 239 (672)
|+|++|+|++ +|. +..+|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +
T Consensus 105 L~Ls~N~l~~-ip~-l~~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~L~~-l 175 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPASLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE-LPTSLEVLSVRNNQLTF-L 175 (571)
T ss_dssp EECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-C
T ss_pred EEccCCCCCC-cch-hhcCCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC-cCCCcCEEECCCCCCCC-c
Confidence 9999999997 888 77899999999999997 776 68999999999999997 555 78899999999999997 7
Q ss_pred CcccC-CCCCCccccC
Q 005875 240 PSSLQ-KFPNSSFVGN 254 (672)
Q Consensus 240 p~~~~-~~~~l~~~~n 254 (672)
|. |. ++..|...+|
T Consensus 176 p~-l~~~L~~L~Ls~N 190 (571)
T 3cvr_A 176 PE-LPESLEALDVSTN 190 (571)
T ss_dssp CC-CCTTCCEEECCSS
T ss_pred ch-hhCCCCEEECcCC
Confidence 77 54 3333334444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.61 E-value=9.5e-16 Score=148.06 Aligned_cols=139 Identities=19% Similarity=0.342 Sum_probs=118.2
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
+++.|++++|++. .+| .+..+++|++|+|++|.++ .+..+.++++|++|+|++|++++..|..+. ++|++|+|
T Consensus 45 ~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp TCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 5788999999998 677 4899999999999999775 334799999999999999999987888877 79999999
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
++|++++..|..++++++|+.|+|++|.+.+.+|.. .+++|+.|++++|++++ ++ .+..+++|..+
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L 186 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQL 186 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEE
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEE
Confidence 999999989999999999999999999833455554 89999999999999996 44 56666666554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=4.7e-16 Score=176.78 Aligned_cols=143 Identities=24% Similarity=0.229 Sum_probs=108.0
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCc-CCCCCCCcEEeeeccCCCCCCCCCcc--ccccee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L 182 (672)
.++..|++++|.+.+..|. .++.+++|++|+|++|.+++..|.. +.++++|+.|+|++|.+++..|..+. ++|++|
T Consensus 376 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 454 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKTE-AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454 (606)
T ss_dssp TTCCEEECCSCSCEEECTT-TTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCcCCcCCHH-HhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEE
Confidence 4677788888888766665 6888888888888888887776644 77888888888888888877777665 678888
Q ss_pred ecccccCccc---CCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCC
Q 005875 183 DLSFNSFTGN---IPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNS 249 (672)
Q Consensus 183 ~ls~N~l~~~---~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l 249 (672)
+|++|+|++. .+..+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|++++..|..+.+++.|
T Consensus 455 ~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 526 (606)
T 3t6q_A 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI 526 (606)
T ss_dssp ECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC
T ss_pred ECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc
Confidence 8888887762 3356777888888888888887776653 67778888888888877777777777766
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3.4e-16 Score=143.86 Aligned_cols=122 Identities=26% Similarity=0.281 Sum_probs=79.5
Q ss_pred eEEEEEeCCCCcc-ccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 107 RVFGLRLPGIGLV-GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 107 ~v~~l~l~~~~l~-g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
+++.|++++|+++ +.+|. .++.+++|++|+|++|.+++. ..++++++|++|+|++|++++.+|..+. ++|++|+
T Consensus 18 ~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred cCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 4566777777776 66665 567777777777777777654 5566777777777777777765665543 5677777
Q ss_pred cccccCccc-CCchhhhhccccceecCCccccCCCC---C-C-CCCCCceEEee
Q 005875 184 LSFNSFTGN-IPQSIQNLTQLTGLSLQSNNLSGSIP---N-F-DIPKLRHLNLS 231 (672)
Q Consensus 184 ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p---~-~-~l~~L~~l~l~ 231 (672)
|++|+|++. .|..++++++|+.|++++|++++..+ . . .+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 777777652 33666667777777777777765544 1 1 56666666654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.5e-15 Score=171.13 Aligned_cols=151 Identities=23% Similarity=0.322 Sum_probs=126.5
Q ss_pred CCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCC--CCCCcCCCCCCCcEEeeeccCCCCCCCCCcc---ccc
Q 005875 105 RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG--GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---PQL 179 (672)
Q Consensus 105 ~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~---~~L 179 (672)
-..++.|+|++|.+++.+|. .++.+++|++|+|++|++++ .+|..+.++++|++|+|++|++++.+|.... ++|
T Consensus 352 l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQ-GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTT-TCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCceEEECCCCccccchhh-hhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 35788999999999988887 79999999999999999996 4467799999999999999999987776533 799
Q ss_pred ceeecccccCcccCCchhhhhccccceecCCccccCCCCC-C-CCCCCceEEeecCCCCCCCCcc-cCCCCCCc---ccc
Q 005875 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-F-DIPKLRHLNLSYNGLKGSIPSS-LQKFPNSS---FVG 253 (672)
Q Consensus 180 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~-~l~~L~~l~l~~N~l~g~~p~~-~~~~~~l~---~~~ 253 (672)
++|+|++|+|++.+|..+. ++|+.|+|++|+|+ .+|. . .+++|+.|+|++|+++ .+|.. +..+++|. ..+
T Consensus 431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~ 506 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHD 506 (562)
T ss_dssp CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCS
T ss_pred CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecC
Confidence 9999999999988887765 78999999999999 4554 3 8899999999999999 56665 77766655 456
Q ss_pred CCCCCCC
Q 005875 254 NSLLCGP 260 (672)
Q Consensus 254 n~~~~~~ 260 (672)
|++.|.+
T Consensus 507 N~~~c~c 513 (562)
T 3a79_B 507 NPWDCTC 513 (562)
T ss_dssp CCBCCCH
T ss_pred CCcCCCc
Confidence 7776653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=4.5e-16 Score=161.59 Aligned_cols=148 Identities=22% Similarity=0.214 Sum_probs=108.7
Q ss_pred CeEEEEEeCCCCccccCCc---cccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCC--CC-CCc-c--
Q 005875 106 TRVFGLRLPGIGLVGPIPN---NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK--IP-SSF-S-- 176 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~---~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p-~~~-~-- 176 (672)
..+..|+|++|.+.+..+. ..+..+++|++|+|++|.+++..|..|+++++|++|+|++|++.+. ++ ..+ .
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 4677888999988876652 2456788999999999999888888888999999999999988752 22 221 2
Q ss_pred cccceeecccccCcccCCc----hhhhhccccceecCCccccCCCCCC--C---CCCCceEEeecCCCCCCCCcccC-CC
Q 005875 177 PQLVVLDLSFNSFTGNIPQ----SIQNLTQLTGLSLQSNNLSGSIPNF--D---IPKLRHLNLSYNGLKGSIPSSLQ-KF 246 (672)
Q Consensus 177 ~~L~~L~ls~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~~p~~--~---l~~L~~l~l~~N~l~g~~p~~~~-~~ 246 (672)
++|++|+|++|+|+ .+|. .++++++|+.|+|++|+|++..|.. . +++|++|+|++|+++ .+|..+. ++
T Consensus 197 ~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L 274 (310)
T 4glp_A 197 PAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKL 274 (310)
T ss_dssp CCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCC
T ss_pred CCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCC
Confidence 68889999999887 3333 3577888999999999988876642 3 368889999999888 6676653 34
Q ss_pred CCCccccCC
Q 005875 247 PNSSFVGNS 255 (672)
Q Consensus 247 ~~l~~~~n~ 255 (672)
..|...+|.
T Consensus 275 ~~L~Ls~N~ 283 (310)
T 4glp_A 275 RVLDLSSNR 283 (310)
T ss_dssp SCEECCSCC
T ss_pred CEEECCCCc
Confidence 444444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.60 E-value=7e-16 Score=170.38 Aligned_cols=97 Identities=21% Similarity=0.216 Sum_probs=58.6
Q ss_pred CCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhh-hhccccceecCCccccCCCCCCCCCCCceEEee
Q 005875 155 PSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLS 231 (672)
Q Consensus 155 ~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~ 231 (672)
++|+.|+|++|.+++..|..+. ++|++|+|++|+|++.+|..+. ++++|+.|+|++|.|++..+...+++|+.|+|+
T Consensus 120 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls 199 (487)
T 3oja_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLS 199 (487)
T ss_dssp SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECC
T ss_pred CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECC
Confidence 4445555555555555454443 5666666666666666666654 566666666666666665444466777777777
Q ss_pred cCCCCCCCCcccCCCCCCccc
Q 005875 232 YNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 232 ~N~l~g~~p~~~~~~~~l~~~ 252 (672)
+|.+++ +|..+..+++|..+
T Consensus 200 ~N~l~~-~~~~~~~l~~L~~L 219 (487)
T 3oja_A 200 SNKLAF-MGPEFQSAAGVTWI 219 (487)
T ss_dssp SSCCCE-ECGGGGGGTTCSEE
T ss_pred CCCCCC-CCHhHcCCCCccEE
Confidence 777775 34446555555544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.2e-15 Score=158.44 Aligned_cols=130 Identities=12% Similarity=0.135 Sum_probs=94.7
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC---------------hhh--------HHHHHHHHHHHcCCCcee--
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---------------KRD--------FEQQMEIVGRVGQHPNVV-- 434 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------~~~--------~~~e~~~l~~l~~h~niv-- 434 (672)
.+.||+|+||.||+|...+|+.||||+++..... ... ...|...+.++ .+.++.
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~gv~vp 178 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEGFPVP 178 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTTCSCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcCCCCC
Confidence 5689999999999999999999999987643110 001 12355556665 333322
Q ss_pred ceEEEEEeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC
Q 005875 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 514 (672)
Q Consensus 435 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~ 514 (672)
..++. ...++||||+++++|.++.. . .....++.|++.+|.|||+.| ||||||||.|||+++
T Consensus 179 ~p~~~----~~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 179 EPIAQ----SRHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp CEEEE----ETTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred eeeec----cCceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 22222 23479999999999876643 1 123568899999999999998 999999999999998
Q ss_pred CCC----------eEEeecCCCCC
Q 005875 515 DLD----------GCISDFGLTPL 528 (672)
Q Consensus 515 ~~~----------~kl~DfGla~~ 528 (672)
++. +.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 773 88999997644
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.6e-15 Score=172.92 Aligned_cols=155 Identities=22% Similarity=0.236 Sum_probs=135.1
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCC-CCCCCCcc--cccceee
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS-GKIPSSFS--PQLVVLD 183 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~~~--~~L~~L~ 183 (672)
.+..+++.+++.....+...+..+.+|+.++++.|.+++..|..+..+++|+.|+|++|++. +.+|..|. ++|++|+
T Consensus 421 ~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~ 500 (635)
T 4g8a_A 421 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 500 (635)
T ss_dssp TCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred cccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEE
Confidence 45667777787777777778899999999999999999999999999999999999999854 45677776 7999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCC-CCC---ccccCCCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKF-PNS---SFVGNSLL 257 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~-~~l---~~~~n~~~ 257 (672)
|++|+|++..|..|.+|++|+.|+|++|+|++.+|.. .+++|+.|+|++|+|++..|..+..+ ++| ...+|++.
T Consensus 501 Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 501 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred CCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 9999999999999999999999999999999887764 89999999999999999999988766 344 56689988
Q ss_pred CCCC
Q 005875 258 CGPP 261 (672)
Q Consensus 258 ~~~~ 261 (672)
|.+.
T Consensus 581 C~C~ 584 (635)
T 4g8a_A 581 CTCE 584 (635)
T ss_dssp CSGG
T ss_pred ccCC
Confidence 8754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=2.2e-15 Score=157.74 Aligned_cols=144 Identities=25% Similarity=0.357 Sum_probs=124.8
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcC--CCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~--g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~l 184 (672)
.+..|++++|.+.+ +++..+.++++|++|+|++|.++ |..|..+.++++|++|++++|+++ .+|..+.++|++|+|
T Consensus 122 ~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~L~~L~l 199 (330)
T 1xku_A 122 TLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHL 199 (330)
T ss_dssp TCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCCTTCSEEEC
T ss_pred cccEEECCCCcccc-cCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCccccccCCEEEC
Confidence 46677777777774 44446889999999999999996 367888999999999999999998 578887799999999
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
++|++++..|..|.++++|+.|+|++|.+++..+.. .+++|+.|+|++|+++ .+|..+..+++|..+.
T Consensus 200 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~ 269 (330)
T 1xku_A 200 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269 (330)
T ss_dssp TTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEE
Confidence 999999988999999999999999999999877754 8899999999999999 8898888888877654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.5e-15 Score=175.06 Aligned_cols=149 Identities=26% Similarity=0.289 Sum_probs=127.4
Q ss_pred CcceeeecCC---------CCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeecc
Q 005875 95 SWVGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 165 (672)
Q Consensus 95 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 165 (672)
.+..|.|+.. ..+++.|+|++|++++ +|+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 5 ~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 5 SHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp BSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred ECCeeECCCCCccccccccCCCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 4566677642 2468899999999996 55547999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCc
Q 005875 166 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPS 241 (672)
Q Consensus 166 ~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~ 241 (672)
++++..+..|. ++|++|+|++|++++..|..|+++++|+.|+|++|.+++.+|.. .+++|++|+|++|.+++..|.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99965555566 89999999999999888889999999999999999999888764 899999999999999987776
Q ss_pred ccC
Q 005875 242 SLQ 244 (672)
Q Consensus 242 ~~~ 244 (672)
.+.
T Consensus 164 ~~~ 166 (680)
T 1ziw_A 164 ELD 166 (680)
T ss_dssp HHG
T ss_pred Hhh
Confidence 543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.2e-15 Score=141.40 Aligned_cols=124 Identities=22% Similarity=0.286 Sum_probs=108.7
Q ss_pred CCCCCCcEEEccCCCcC-CCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhcccc
Q 005875 128 GKLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT 204 (672)
Q Consensus 128 ~~l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 204 (672)
...++|+.|+|++|.++ |.+|..+..+++|++|+|++|.+++. ..+. ++|++|+|++|+|++.+|..+.++++|+
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 34578999999999998 89999999999999999999999976 5554 7999999999999988999999999999
Q ss_pred ceecCCccccCCC--CCC-CCCCCceEEeecCCCCCCCC---cccCCCCCCcccc
Q 005875 205 GLSLQSNNLSGSI--PNF-DIPKLRHLNLSYNGLKGSIP---SSLQKFPNSSFVG 253 (672)
Q Consensus 205 ~L~l~~N~l~~~~--p~~-~l~~L~~l~l~~N~l~g~~p---~~~~~~~~l~~~~ 253 (672)
.|+|++|+|++.. +.. .+++|+.|++++|.+++..+ ..+..+++|.+++
T Consensus 99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~ 153 (168)
T 2ell_A 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153 (168)
T ss_dssp EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEET
T ss_pred EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEec
Confidence 9999999999754 233 89999999999999996655 4788888887765
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.7e-15 Score=168.79 Aligned_cols=149 Identities=27% Similarity=0.376 Sum_probs=118.0
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCC--CCCCcCCCCCCCcEEeeeccCCCCCCCCC-cc--cccc
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG--GLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLV 180 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~--~~L~ 180 (672)
..++.|+|++|.+++.+|. .++.+++|++|+|++|++++ .+|..++++++|++|+|++|++++.+|.. +. ++|+
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFE-NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCEEECCSSCCCTTTTT-TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CcccEEEeECCccChhhhh-hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 4677888999988887877 78889999999999999886 56777888899999999999998767765 33 7889
Q ss_pred eeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcc-cCCCCCCc---cccC
Q 005875 181 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS-LQKFPNSS---FVGN 254 (672)
Q Consensus 181 ~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~-~~~~~~l~---~~~n 254 (672)
+|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|.. .+++|+.|+|++|+++ .+|.. +.++++|. ..+|
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N 478 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSS
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCC
Confidence 999999999888877665 78889999999988 55542 7888999999999988 56654 66666654 4466
Q ss_pred CCCCC
Q 005875 255 SLLCG 259 (672)
Q Consensus 255 ~~~~~ 259 (672)
+..|.
T Consensus 479 ~~~c~ 483 (520)
T 2z7x_B 479 PWDCS 483 (520)
T ss_dssp CBCCC
T ss_pred CCccc
Confidence 66554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=8e-16 Score=141.38 Aligned_cols=123 Identities=17% Similarity=0.258 Sum_probs=108.1
Q ss_pred CCCCCcEEEccCCCcC-CCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccc
Q 005875 129 KLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTG 205 (672)
Q Consensus 129 ~l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 205 (672)
..++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+. ++|++|+|++|+|++.+|..+.++++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 4578999999999998 89999999999999999999999976 4554 79999999999999889999999999999
Q ss_pred eecCCccccCCC--CCC-CCCCCceEEeecCCCCCCCC---cccCCCCCCcccc
Q 005875 206 LSLQSNNLSGSI--PNF-DIPKLRHLNLSYNGLKGSIP---SSLQKFPNSSFVG 253 (672)
Q Consensus 206 L~l~~N~l~~~~--p~~-~l~~L~~l~l~~N~l~g~~p---~~~~~~~~l~~~~ 253 (672)
|++++|++++.. +.. .+++|++|++++|++++..+ ..+..+++|..++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~ 146 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEET
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCccccc
Confidence 999999999743 333 89999999999999997665 4788888887765
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.6e-15 Score=170.27 Aligned_cols=108 Identities=24% Similarity=0.264 Sum_probs=79.9
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
.+..|+|++|.+.+..|. .|+.+++|++|+|++|.|++..|..|+++++|++|+|++|.+++..+..|. ++|++|+|
T Consensus 76 ~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTY-AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCSEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCcEEECCCCCCCCCChH-HhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 566778888877755444 677888888888888888777777777888888888888887744444343 67888888
Q ss_pred ccccCcccCCchhhhhccccceecCCccccC
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 215 (672)
++|.|++..|..|+++++|+.|+|++|.|++
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 8888877777777777778888777777765
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.8e-15 Score=166.83 Aligned_cols=147 Identities=20% Similarity=0.155 Sum_probs=130.3
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
.++..|+|++|.+++..|. .|+++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|. ++|++|+
T Consensus 56 ~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPG-AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp TTCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCEeChh-hhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 4688999999999976666 899999999999999999966666789999999999999999988888876 7999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCC--CCCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
|++|++++..|..|.++++|+.|+|++|++++..+. ..+++|+.|+|++|.+++..+..|.++++|..+.
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 206 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEE
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceee
Confidence 999999999999999999999999999999976654 2889999999999999988888888888777654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=4.7e-16 Score=161.64 Aligned_cols=146 Identities=27% Similarity=0.298 Sum_probs=119.1
Q ss_pred CeEEEEEeCCCCccccCCccccCCC-----CCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCC--CCCCc--c
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKL-----DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK--IPSSF--S 176 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l-----~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~~--~ 176 (672)
..++.|+|++|.+++. |+ .++.+ ++|++|+|++|+|++..|..|+++++|++|+|++|++.|. +|..+ .
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~-~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DA-WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp CCCSEEEEESCBCSSS-SS-HHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCccEEEccCCCCcch-hH-HHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 4688999999999977 65 68777 9999999999999988889999999999999999999875 23333 2
Q ss_pred --cccceeecccccCcc--cCC-chhhhhccccceecCCccccCCCCC--C-CCCCCceEEeecCCCCCCCCcccC-CCC
Q 005875 177 --PQLVVLDLSFNSFTG--NIP-QSIQNLTQLTGLSLQSNNLSGSIPN--F-DIPKLRHLNLSYNGLKGSIPSSLQ-KFP 247 (672)
Q Consensus 177 --~~L~~L~ls~N~l~~--~~p-~~~~~l~~L~~L~l~~N~l~~~~p~--~-~l~~L~~l~l~~N~l~g~~p~~~~-~~~ 247 (672)
++|++|+|++|+|++ .++ ..+.++++|+.|+|++|+|++.+|. . .+++|+.|+|++|+++ .+|..+. ++.
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~L~ 277 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLS 277 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCCSEEE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhccCCce
Confidence 799999999999993 233 3456889999999999999997753 2 6799999999999999 8888776 333
Q ss_pred CCccccC
Q 005875 248 NSSFVGN 254 (672)
Q Consensus 248 ~l~~~~n 254 (672)
.|...+|
T Consensus 278 ~L~Ls~N 284 (312)
T 1wwl_A 278 VLDLSYN 284 (312)
T ss_dssp EEECCSS
T ss_pred EEECCCC
Confidence 3444444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.8e-15 Score=157.09 Aligned_cols=143 Identities=23% Similarity=0.359 Sum_probs=111.2
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcC--CCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~--g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~l 184 (672)
.+..|++++|.+. .+|+..++.+++|++|+|++|.++ +..|..+..+ +|++|++++|++++ +|..+.++|++|+|
T Consensus 124 ~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~~~L~~L~l 200 (332)
T 2ft3_A 124 SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLPETLNELHL 200 (332)
T ss_dssp TCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSCSSCSCCBC
T ss_pred cCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCccccCCCCEEEC
Confidence 4556666666666 344445677777777777777774 3556666666 77777777777773 67666788999999
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
++|++++..|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|+++ .+|..+.++++|..++
T Consensus 201 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~ 270 (332)
T 2ft3_A 201 DHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270 (332)
T ss_dssp CSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEE
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEE
Confidence 999999888889999999999999999999877753 7899999999999999 8888888888777654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.5e-15 Score=169.21 Aligned_cols=151 Identities=25% Similarity=0.294 Sum_probs=108.5
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCC-CcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
.+..|++++|.+.+ +|+ .++.+++|++|+|++|.+++..| ..+.++++|++|+|++|.+++.+|..+. ++|++|+
T Consensus 374 ~L~~L~l~~n~l~~-~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 451 (570)
T 2z63_A 374 SLKYLDLSFNGVIT-MSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451 (570)
T ss_dssp CCCEEECCSCSEEE-EEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred ccCEEECCCCcccc-ccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEE
Confidence 45566666666663 344 37777777777777777776655 4577788888888888888777776665 6788888
Q ss_pred cccccCc-ccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCcc---ccCCCC
Q 005875 184 LSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF---VGNSLL 257 (672)
Q Consensus 184 ls~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~---~~n~~~ 257 (672)
|++|+++ +.+|..+..+++|+.|+|++|++++..|.. .+++|+.|+|++|++++..|..+.++++|.. .+|+..
T Consensus 452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 531 (570)
T 2z63_A 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531 (570)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCccc
Confidence 8888887 567778888888888888888888776653 6778888888888888777766766666543 455554
Q ss_pred CC
Q 005875 258 CG 259 (672)
Q Consensus 258 ~~ 259 (672)
|.
T Consensus 532 ~~ 533 (570)
T 2z63_A 532 CS 533 (570)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.8e-15 Score=161.64 Aligned_cols=141 Identities=22% Similarity=0.203 Sum_probs=96.6
Q ss_pred CcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeecc
Q 005875 95 SWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 165 (672)
Q Consensus 95 ~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 165 (672)
.|..|.|.... ..+..|+|++|++.+..+. .|.++++|++|+|++|.|++..|..|.++++|++|+|++|
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVN-SFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTT-TTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHH-HhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 46788887532 3467899999998865544 7899999999999999998777788889999999999999
Q ss_pred CCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC---CCCCCceEEeecCCCC
Q 005875 166 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLK 236 (672)
Q Consensus 166 ~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~l~~L~~l~l~~N~l~ 236 (672)
++++..+..|. ++|++|+|++|+|++..+..|.++++|+.|+|++|+..+.++.. .+++|+.|+|++|+++
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence 99865555565 68888888888887655555555555555555553333233321 3444444444444443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.57 E-value=8.4e-15 Score=155.40 Aligned_cols=148 Identities=25% Similarity=0.244 Sum_probs=122.7
Q ss_pred ceeeecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCC-CCCCCcEEeeeccCCCCCCCCCc
Q 005875 97 VGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQHNNFSGKIPSSF 175 (672)
Q Consensus 97 ~gv~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~ 175 (672)
....|.. ..+++++++|. .+|. .+. ..|+.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..|
T Consensus 14 ~~C~C~~-----~~l~c~~~~l~-~iP~-~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~ 84 (361)
T 2xot_A 14 ANCLCAS-----NILSCSKQQLP-NVPQ-SLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF 84 (361)
T ss_dssp TTCEEET-----TEEECCSSCCS-SCCS-SCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTT
T ss_pred CCCEECC-----CEEEeCCCCcC-ccCc-cCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhc
Confidence 5677764 25899999998 5887 343 4689999999999977777787 99999999999999997777777
Q ss_pred c--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCccc---CCCCC
Q 005875 176 S--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSL---QKFPN 248 (672)
Q Consensus 176 ~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~---~~~~~ 248 (672)
. ++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|.. .+++|+.|+|++|+|++..+..| .++++
T Consensus 85 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~ 164 (361)
T 2xot_A 85 VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPK 164 (361)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTT
T ss_pred cCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCc
Confidence 6 79999999999999888889999999999999999999877764 89999999999999996433444 45666
Q ss_pred Ccccc
Q 005875 249 SSFVG 253 (672)
Q Consensus 249 l~~~~ 253 (672)
|..++
T Consensus 165 L~~L~ 169 (361)
T 2xot_A 165 LMLLD 169 (361)
T ss_dssp CCEEE
T ss_pred CCEEE
Confidence 66543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=5.4e-15 Score=170.38 Aligned_cols=151 Identities=23% Similarity=0.268 Sum_probs=102.4
Q ss_pred EEEeCCCCcc--ccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCC--------Ccc--c
Q 005875 110 GLRLPGIGLV--GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS--------SFS--P 177 (672)
Q Consensus 110 ~l~l~~~~l~--g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--------~~~--~ 177 (672)
.|++.+|.+. +.+|. .++.+++|++|+|++|+|++..|..|.++++|++|+|++|++++..+. .|. +
T Consensus 458 ~L~l~~n~l~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~ 536 (680)
T 1ziw_A 458 RLMLRRVALKNVDSSPS-PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536 (680)
T ss_dssp EEECTTSCCBCTTCSSC-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCT
T ss_pred cchhccccccccccCCc-ccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCC
Confidence 3444444333 34454 577777777777777777766666677777777777777777743211 122 6
Q ss_pred ccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcc----cCCCCCCcc
Q 005875 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS----LQKFPNSSF 251 (672)
Q Consensus 178 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~----~~~~~~l~~ 251 (672)
+|++|+|++|+|+...+..|.++++|+.|+|++|+|++.++.. .+++|+.|+|++|++++..|.. +.++..+.+
T Consensus 537 ~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l 616 (680)
T 1ziw_A 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDM 616 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEEC
T ss_pred CCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEc
Confidence 7888888888888444446788888888888888888655553 6788888888888888766653 345556667
Q ss_pred ccCCCCCCCC
Q 005875 252 VGNSLLCGPP 261 (672)
Q Consensus 252 ~~n~~~~~~~ 261 (672)
.+|++.|.++
T Consensus 617 ~~N~~~c~c~ 626 (680)
T 1ziw_A 617 RFNPFDCTCE 626 (680)
T ss_dssp TTCCCCBCCC
T ss_pred cCCCcccCCc
Confidence 7888887654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.4e-15 Score=149.08 Aligned_cols=137 Identities=20% Similarity=0.242 Sum_probs=114.8
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecc
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls 185 (672)
..+..|++++|+++ .+| .++.+++|++|+|++|+|++..| +.++++|++|+|++|++++ +|....++|++|+|+
T Consensus 41 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~~~L~~L~L~ 114 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPSACLSRLFLD 114 (263)
T ss_dssp TTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCCSSCCEEECC
T ss_pred CcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccccCcccEEEcc
Confidence 35778999999988 566 58999999999999999996555 9999999999999999996 444333899999999
Q ss_pred cccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 186 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
+|+|++ +| .+.++++|+.|+|++|+|++..+-..+++|+.|+|++|++++. ..+.++++|..+
T Consensus 115 ~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L 177 (263)
T 1xeu_A 115 NNELRD-TD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWI 177 (263)
T ss_dssp SSCCSB-SG-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEE
T ss_pred CCccCC-Ch-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch--HHhccCCCCCEE
Confidence 999996 33 6999999999999999999764333899999999999999976 667777776654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=4e-15 Score=166.91 Aligned_cols=148 Identities=22% Similarity=0.268 Sum_probs=112.9
Q ss_pred CeEEEEEeCCCCccccCC-ccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeec
Q 005875 106 TRVFGLRLPGIGLVGPIP-NNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 184 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p-~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~l 184 (672)
..++.|+|++|.+++..+ ...++.+++|++|+|++|+|+ .+|..+..+++|++|+|++|+++ .+|..+.++|++|+|
T Consensus 361 ~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~L 438 (549)
T 2z81_A 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDV 438 (549)
T ss_dssp TTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEEC
T ss_pred ccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhcCCceEEEC
Confidence 346667777777664221 124777888888888888887 67777888888888888888887 566666678888888
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCCCCc---cccCCCCCCC
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLLCGP 260 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~---~~~n~~~~~~ 260 (672)
++|+|++.+ .++++|+.|+|++|+|+ .+|.. .+++|+.|+|++|++++.+|..+.++++|. ..+|++.|.+
T Consensus 439 s~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 439 SNNNLDSFS----LFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp CSSCCSCCC----CCCTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred CCCChhhhc----ccCChhcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 888888643 47889999999999999 56654 789999999999999998888777766654 5577776653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=6.7e-15 Score=141.62 Aligned_cols=120 Identities=21% Similarity=0.268 Sum_probs=108.0
Q ss_pred CCcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeec
Q 005875 94 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 164 (672)
Q Consensus 94 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 164 (672)
|.|..+.|+... ..++.|+|++|.++ .+|. .|..+++|++|+|++|.|++..|..|.++++|++|+|++
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~-~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPK-ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCG-GGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHH-HhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 478889997532 36889999999998 7886 899999999999999999988888999999999999999
Q ss_pred cCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccC
Q 005875 165 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215 (672)
Q Consensus 165 N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 215 (672)
|+|++..|..|. ++|++|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 999988777776 899999999999997777789999999999999999985
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-15 Score=157.64 Aligned_cols=146 Identities=21% Similarity=0.227 Sum_probs=122.0
Q ss_pred eEEEEEeCCCCccccCCcccc--CCCCCCcEEEccCCCcCCCCC----CcCCCCCCCcEEeeeccCCCCCCCCCcc--cc
Q 005875 107 RVFGLRLPGIGLVGPIPNNTL--GKLDALEVLSLRSNVLTGGLP----SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQ 178 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~--~~l~~L~~L~L~~N~l~g~~p----~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~ 178 (672)
++..|+|++|++.+.+|. .+ +.+++|++|+|++|.+++..| ..+..+++|++|+|++|++++..|..|. ++
T Consensus 92 ~L~~L~l~~n~l~~~~~~-~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPP-LPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp CCCEEEEESCCCBSCCCC-CSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred ceeEEEeeCCEeccchhh-hhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 488999999999999998 56 999999999999999998766 4456899999999999999988888876 89
Q ss_pred cceeecccccCccc--C--CchhhhhccccceecCCccccCCCCC-----CCCCCCceEEeecCCCCCCCCcccCCC---
Q 005875 179 LVVLDLSFNSFTGN--I--PQSIQNLTQLTGLSLQSNNLSGSIPN-----FDIPKLRHLNLSYNGLKGSIPSSLQKF--- 246 (672)
Q Consensus 179 L~~L~ls~N~l~~~--~--p~~~~~l~~L~~L~l~~N~l~~~~p~-----~~l~~L~~l~l~~N~l~g~~p~~~~~~--- 246 (672)
|++|+|++|++++. + +..++++++|++|+|++|+|+...+. ..+++|++|+|++|++++..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 99999999998863 3 23357899999999999999743321 167999999999999999889887766
Q ss_pred CCCcccc
Q 005875 247 PNSSFVG 253 (672)
Q Consensus 247 ~~l~~~~ 253 (672)
++|..++
T Consensus 251 ~~L~~L~ 257 (310)
T 4glp_A 251 SALNSLN 257 (310)
T ss_dssp TTCCCEE
T ss_pred CcCCEEE
Confidence 4555543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.56 E-value=3e-15 Score=149.12 Aligned_cols=144 Identities=19% Similarity=0.235 Sum_probs=122.5
Q ss_pred CeEEEEEeCCCC-ccccCCccccCCCCCCcEEEccC-CCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccc-
Q 005875 106 TRVFGLRLPGIG-LVGPIPNNTLGKLDALEVLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLV- 180 (672)
Q Consensus 106 ~~v~~l~l~~~~-l~g~~p~~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~- 180 (672)
.++..|+|++|. ++ .+++..|+++++|++|+|++ |+|++..|..|.++++|++|+|++|++++ +|. +. ++|+
T Consensus 55 ~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp TTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 468899999997 66 67766899999999999999 99997667789999999999999999996 776 54 6777
Q ss_pred --eeecccc-cCcccCCchhhhhcccc-ceecCCccccCCCCCC--CCCCCceEEeecCC-CCCCCCcccCCC-CCCccc
Q 005875 181 --VLDLSFN-SFTGNIPQSIQNLTQLT-GLSLQSNNLSGSIPNF--DIPKLRHLNLSYNG-LKGSIPSSLQKF-PNSSFV 252 (672)
Q Consensus 181 --~L~ls~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~-l~g~~p~~~~~~-~~l~~~ 252 (672)
+|+|++| ++++..+..|.++++|+ .|++++|+++ .+|.. ..++|+.|+|++|+ +++..+..|..+ ++|..+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L 210 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEE
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEE
Confidence 9999999 99987778899999999 9999999999 55543 45889999999995 986666778887 777765
Q ss_pred c
Q 005875 253 G 253 (672)
Q Consensus 253 ~ 253 (672)
+
T Consensus 211 ~ 211 (239)
T 2xwt_C 211 D 211 (239)
T ss_dssp E
T ss_pred E
Confidence 4
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.55 E-value=4.7e-15 Score=143.16 Aligned_cols=128 Identities=23% Similarity=0.327 Sum_probs=108.8
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
.++..|++++|.+. .++ .+..+++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..+. ++|++|+
T Consensus 66 ~~L~~L~l~~n~~~--~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp TTCSEEEEESCCCS--CCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCEEEccCCCCC--cch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 36889999999665 333 699999999999999999988899999999999999999999987787776 7999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g 237 (672)
|++|++.+.+| .+.++++|+.|++++|++++..+-..+++|+.|++++|++.+
T Consensus 143 L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 143 LSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred ccCCCCccccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 99999333666 799999999999999999975533489999999999999874
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.3e-14 Score=155.62 Aligned_cols=107 Identities=25% Similarity=0.320 Sum_probs=70.6
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCC-cc--cccceee
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLVVLD 183 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~--~~L~~L~ 183 (672)
++..|+|++|.+.+..+ ..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|.. |. ++|++|+
T Consensus 70 ~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 70 QVELLNLNDLQIEEIDT-YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred cCcEEECCCCcccccCh-hhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 45667777777664333 36777777777777777777666666777777777777777776 34433 33 5677777
Q ss_pred cccccCcccCCchhhhhccccceecCCccccC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 215 (672)
|++|+|++..|..|+++++|+.|++++|++++
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 77777776666667777777777777776664
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.2e-14 Score=163.70 Aligned_cols=136 Identities=22% Similarity=0.248 Sum_probs=125.7
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCC-CCCCCCcc--ccccee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS-GKIPSSFS--PQLVVL 182 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~~~--~~L~~L 182 (672)
..+..|++++|.+.+..|...+..+++|++|+|++|.+++..|..+.++++|+.|+|++|+++ +.+|..+. ++|++|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 357789999999998877667999999999999999999999999999999999999999998 68898876 899999
Q ss_pred ecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCc
Q 005875 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPS 241 (672)
Q Consensus 183 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~ 241 (672)
+|++|++++..|..|.++++|+.|+|++|++++.+|.. .+++|+.|++++|++++..|.
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 99999999999999999999999999999999988764 899999999999999988774
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.6e-15 Score=157.98 Aligned_cols=136 Identities=19% Similarity=0.142 Sum_probs=72.5
Q ss_pred EEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc---cccceeec
Q 005875 108 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLDL 184 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~---~~L~~L~l 184 (672)
+..|++++|.+++..+ ..+++|++|+|++|++++..|..++.+++|++|+|++|.+++..|..+. ++|++|+|
T Consensus 101 L~~L~l~~n~l~~~~~----~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 176 (317)
T 3o53_A 101 IETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (317)
T ss_dssp CCEEECCSSCCSEEEE----CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred cCEEECCCCccCCcCc----cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEEC
Confidence 4445555555543222 1245566666666666655555556666666666666666655444443 45666666
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCCCCc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 250 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~ 250 (672)
++|+|++. |. ...+++|+.|+|++|+|++.++.+ .+++|+.|+|++|+++ .+|..+..+++|.
T Consensus 177 ~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~ 240 (317)
T 3o53_A 177 QYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240 (317)
T ss_dssp TTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCC
T ss_pred CCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCC
Confidence 66666543 21 223555666666666665544433 5555666666666665 3455554444443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.4e-15 Score=155.48 Aligned_cols=143 Identities=22% Similarity=0.208 Sum_probs=91.5
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCC-c---------------CCCCCCCcEEeeeccCCCC
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-E---------------ITSLPSLRYLYLQHNNFSG 169 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~-~---------------~~~l~~L~~L~l~~N~l~g 169 (672)
.++..|+|++|.+++..| ++.+++|++|+|++|.|++..+. . ...+++|+.|+|++|++++
T Consensus 58 ~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~ 134 (317)
T 3o53_A 58 TKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (317)
T ss_dssp TTCCEEECTTSCCEEEEE---ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCCS
T ss_pred CcCCEEECCCCcCCcchh---hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCCC
Confidence 467788888888876442 78888888888888877642210 0 1123455666666666665
Q ss_pred CCCCCcc--cccceeecccccCcccCCchhh-hhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCC
Q 005875 170 KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 246 (672)
Q Consensus 170 ~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~ 246 (672)
..|..+. ++|++|+|++|+|++..|..+. ++++|+.|+|++|+|++..+...+++|+.|+|++|++++ +|..+..+
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l 213 (317)
T 3o53_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF-MGPEFQSA 213 (317)
T ss_dssp GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE-ECGGGGGG
T ss_pred ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCc-chhhhccc
Confidence 5454553 5677777777777766666553 567777777777777755444467777777777777774 44456666
Q ss_pred CCCccc
Q 005875 247 PNSSFV 252 (672)
Q Consensus 247 ~~l~~~ 252 (672)
++|..+
T Consensus 214 ~~L~~L 219 (317)
T 3o53_A 214 AGVTWI 219 (317)
T ss_dssp TTCSEE
T ss_pred CcccEE
Confidence 665554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.52 E-value=2e-14 Score=161.81 Aligned_cols=139 Identities=27% Similarity=0.245 Sum_probs=116.8
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecc
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls 185 (672)
.+++.|+|++|.+++..| +.|+++++|++|+|++|+|++..|..|.++++|++|+|++|+++ .+|..-.++|++|+|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~l~~L~~L~Ls 129 (562)
T 3a79_B 52 PRTKALSLSQNSISELRM-PDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLRHLDLS 129 (562)
T ss_dssp TTCCEEECCSSCCCCCCG-GGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSCCCTTCSEEECC
T ss_pred CCcCEEECCCCCccccCh-hhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCccccccCCEEECC
Confidence 468899999999985444 48999999999999999999888889999999999999999998 6777644899999999
Q ss_pred cccCcc-cCCchhhhhccccceecCCccccCCCCCCCCCCC--ceEEeecCCC--CCCCCcccCCCC
Q 005875 186 FNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKL--RHLNLSYNGL--KGSIPSSLQKFP 247 (672)
Q Consensus 186 ~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L--~~l~l~~N~l--~g~~p~~~~~~~ 247 (672)
+|+|++ .+|..|+++++|+.|+|++|++++. ....+++| +.|+|++|.+ ++..|..+..+.
T Consensus 130 ~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~ 195 (562)
T 3a79_B 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL-DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195 (562)
T ss_dssp SSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT-TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECC
T ss_pred CCCccccCchHhhcccCcccEEecCCCccccC-chhhhhhceeeEEEeecccccccccCcccccccC
Confidence 999997 4578999999999999999999862 22255555 9999999999 888888887765
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.52 E-value=2.3e-14 Score=151.30 Aligned_cols=95 Identities=21% Similarity=0.241 Sum_probs=61.3
Q ss_pred CCcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCC-cCCCCCCCcE-Eee
Q 005875 94 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EITSLPSLRY-LYL 162 (672)
Q Consensus 94 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~-L~l 162 (672)
|+|..|.|++.. ..++.|+|++|+|+ .||++.|++|++|++|+|++|++.+.+|. .|.++++|+. +++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 589999997532 35789999999998 78877899999999999999998665553 3445444332 333
Q ss_pred eccCCCCCCCCCcc--cccceeecccccC
Q 005875 163 QHNNFSGKIPSSFS--PQLVVLDLSFNSF 189 (672)
Q Consensus 163 ~~N~l~g~~p~~~~--~~L~~L~ls~N~l 189 (672)
+.|++++..|..|. ++|++|++++|+|
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l 116 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGI 116 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECC
T ss_pred cCCcccccCchhhhhcccccccccccccc
Confidence 44444433333332 3344444444433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=8.7e-15 Score=163.10 Aligned_cols=139 Identities=27% Similarity=0.282 Sum_probs=121.7
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecc
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls 185 (672)
.+++.|+|++|++++..|. .|+.+++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|..-.++|++|+|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~l~~L~~L~L~ 98 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTS-DILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLKHLDLS 98 (520)
T ss_dssp TTCSEEECCSSCCCCCCHH-HHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECCCCCCCSEEECC
T ss_pred ccccEEECCCCcccccChh-hccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCccccCCccEEecc
Confidence 4788999999999965554 7999999999999999999888999999999999999999999 6777644899999999
Q ss_pred cccCcc-cCCchhhhhccccceecCCccccCCCCCCCCCCC--ceEEeecCCC--CCCCCcccCCCC
Q 005875 186 FNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKL--RHLNLSYNGL--KGSIPSSLQKFP 247 (672)
Q Consensus 186 ~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L--~~l~l~~N~l--~g~~p~~~~~~~ 247 (672)
+|+|++ .+|..|+++++|+.|+|++|++++. .-..+++| +.|++++|.+ ++..|..+..+.
T Consensus 99 ~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~ 164 (520)
T 2z7x_B 99 FNAFDALPICKEFGNMSQLKFLGLSTTHLEKS-SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164 (520)
T ss_dssp SSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG-GGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred CCccccccchhhhccCCcceEEEecCcccchh-hccccccceeeEEEeecccccccccccccccccc
Confidence 999997 5889999999999999999999862 22366777 9999999999 888888888765
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=8e-17 Score=155.78 Aligned_cols=142 Identities=25% Similarity=0.333 Sum_probs=119.2
Q ss_pred eEEEEEeCCCCccccCCc-----cccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--ccc
Q 005875 107 RVFGLRLPGIGLVGPIPN-----NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 179 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~-----~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L 179 (672)
+++.+++.++.+.|.+|. ..++.+++|++|+|++|.|++ +| .+.++++|++|+|++|+++ .+|..+. ++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 445556666666666653 258999999999999999996 78 8999999999999999999 6787665 799
Q ss_pred ceeecccccCcccCCchhhhhccccceecCCccccCCCC--C-CCCCCCceEEeecCCCCCCCCcc----------cCCC
Q 005875 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP--N-FDIPKLRHLNLSYNGLKGSIPSS----------LQKF 246 (672)
Q Consensus 180 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~-~~l~~L~~l~l~~N~l~g~~p~~----------~~~~ 246 (672)
++|+|++|+|++ +| .+.++++|+.|+|++|++++..+ . ..+++|++|++++|++++.+|.. +.++
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l 173 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhC
Confidence 999999999996 55 79999999999999999996443 2 38999999999999999877653 7788
Q ss_pred CCCcccc
Q 005875 247 PNSSFVG 253 (672)
Q Consensus 247 ~~l~~~~ 253 (672)
++|..++
T Consensus 174 ~~L~~Ld 180 (198)
T 1ds9_A 174 PNLKKLD 180 (198)
T ss_dssp SSCSEEC
T ss_pred CCcEEEC
Confidence 8888776
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.51 E-value=3.4e-14 Score=145.94 Aligned_cols=136 Identities=32% Similarity=0.400 Sum_probs=104.4
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
.+++.|+|++|++++ +++ ++.+++|++|+|++|.+++ +| .+.++++|++|+|++|++++. + .+. ++|++|+
T Consensus 68 ~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~-~l~~l~~L~~L~ 140 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-N-GLVHLPQLESLY 140 (291)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-G-GGGGCTTCCEEE
T ss_pred CCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-h-hhcCCCCCCEEE
Confidence 457788888888875 443 8888888888888888885 44 488888888888888888853 3 333 7888888
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
|++|+|++. ..+.++++|+.|+|++|++++..|-..+++|+.|+|++|.+++ +| .+.++++|..+
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L 205 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVL 205 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEE
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence 888888864 5788888888888888888877664578888888888888885 44 36666666554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.3e-15 Score=176.08 Aligned_cols=137 Identities=27% Similarity=0.308 Sum_probs=119.1
Q ss_pred CCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--ccccee
Q 005875 105 RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182 (672)
Q Consensus 105 ~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L 182 (672)
...+..|+|++|.+. .+|+ .+..|++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|. ++|++|
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISA-NIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCG-GGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred CCCCcEEECCCCCCC-CCCh-hhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 356889999999998 8988 5779999999999999999 99999999999999999999999 8899987 799999
Q ss_pred ecccccCcccCCchhhhhccccceecCCccccCCCCCC--CC-CCCceEEeecCCCCCCCCcccCCC
Q 005875 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DI-PKLRHLNLSYNGLKGSIPSSLQKF 246 (672)
Q Consensus 183 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l-~~L~~l~l~~N~l~g~~p~~~~~~ 246 (672)
+|++|.|+ .+|..|++|++|+.|+|++|.|+|.+|.. .+ ..+..|+|++|.++|.+|..+..+
T Consensus 299 ~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l 364 (727)
T 4b8c_D 299 YFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFI 364 (727)
T ss_dssp ECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----
T ss_pred ECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccccee
Confidence 99999998 88999999999999999999999988864 11 122357899999999999877654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.2e-14 Score=160.87 Aligned_cols=117 Identities=25% Similarity=0.263 Sum_probs=98.9
Q ss_pred EEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecc
Q 005875 108 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLS 185 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls 185 (672)
+..|+|++|++++ +|. ++.|++|+.|+|++|.|+ .+|..|++|++|+.|+|++|+|++ +| .+. ++|++|+|+
T Consensus 443 L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp CSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred ceEEEecCCCCCC-CcC--ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 5668899998885 664 889999999999999998 888889999999999999999986 67 555 789999999
Q ss_pred cccCcccC-CchhhhhccccceecCCccccCCCCCC-----CCCCCceEEe
Q 005875 186 FNSFTGNI-PQSIQNLTQLTGLSLQSNNLSGSIPNF-----DIPKLRHLNL 230 (672)
Q Consensus 186 ~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~-----~l~~L~~l~l 230 (672)
+|+|++.. |..|++|++|+.|+|++|+|++.+|.. .+++|+.|++
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999776 888999999999999999998877754 4788888864
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.7e-14 Score=149.90 Aligned_cols=149 Identities=23% Similarity=0.250 Sum_probs=124.0
Q ss_pred ceeeecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc
Q 005875 97 VGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS 176 (672)
Q Consensus 97 ~gv~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 176 (672)
..+.|... .+ .++++++++ .+|. .+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.
T Consensus 26 ~~~~C~~~--~~--c~~~~~~l~-~iP~-~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (353)
T 2z80_A 26 ASLSCDRN--GI--CKGSSGSLN-SIPS-GLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFS 97 (353)
T ss_dssp -CCEECTT--SE--EECCSTTCS-SCCT-TCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred cCCCCCCC--eE--eeCCCCCcc-cccc-ccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcC
Confidence 45677653 23 789999998 7887 343 5899999999999976666899999999999999999988788787
Q ss_pred --cccceeecccccCcccCCchhhhhccccceecCCccccCCCC-C-C-CCCCCceEEeecCC-CCCCCCcccCCCCCCc
Q 005875 177 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP-N-F-DIPKLRHLNLSYNG-LKGSIPSSLQKFPNSS 250 (672)
Q Consensus 177 --~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~-~-~l~~L~~l~l~~N~-l~g~~p~~~~~~~~l~ 250 (672)
++|++|+|++|+|++..+..|+++++|++|+|++|++++..+ . + .+++|++|++++|+ +++..|..+.++++|.
T Consensus 98 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~ 177 (353)
T 2z80_A 98 SLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE 177 (353)
T ss_dssp TCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEE
T ss_pred CCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCC
Confidence 899999999999996555569999999999999999996555 2 3 89999999999995 6666677888888877
Q ss_pred ccc
Q 005875 251 FVG 253 (672)
Q Consensus 251 ~~~ 253 (672)
.++
T Consensus 178 ~L~ 180 (353)
T 2z80_A 178 ELE 180 (353)
T ss_dssp EEE
T ss_pred EEE
Confidence 654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.49 E-value=5.1e-14 Score=144.65 Aligned_cols=136 Identities=22% Similarity=0.321 Sum_probs=116.5
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
.+++.|+++++++. .++ .++.+++|++|+|++|++++..| +.++++|++|+|++|++++ +|. +. ++|++|+
T Consensus 46 ~~L~~L~l~~~~i~-~~~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 118 (291)
T 1h6t_A 46 NSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLS 118 (291)
T ss_dssp HTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEE
T ss_pred CcccEEEccCCCcc-cCh--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEE
Confidence 35788999999988 455 48999999999999999997555 9999999999999999996 443 44 8999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
|++|+|++. +.+.++++|+.|+|++|++++. +.. .+++|+.|+|++|++++..| +..+++|..++
T Consensus 119 L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~ 184 (291)
T 1h6t_A 119 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184 (291)
T ss_dssp CTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred CCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEE
Confidence 999999964 5799999999999999999976 443 89999999999999997655 77888777654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.49 E-value=5e-14 Score=145.98 Aligned_cols=136 Identities=27% Similarity=0.380 Sum_probs=94.5
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
.++..|+|++|.+.+ +++ +..+++|++|+|++|.+++ +| .+.++++|++|+|++|++++. |. +. ++|++|+
T Consensus 63 ~~L~~L~L~~n~i~~-~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLY 135 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCC-Chh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEE
Confidence 356778888887774 443 7778888888888888774 33 577788888888888887753 32 33 6788888
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
|++|++++..+ ++++++|+.|+|++|++++..+-..+++|+.|+|++|++++..+ +..+++|..+
T Consensus 136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L 200 (308)
T 1h6u_A 136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEV 200 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred CCCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChh--hcCCCCCCEE
Confidence 88888775443 77777788888888877765553477777888888887775433 5555555443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.48 E-value=7e-14 Score=144.88 Aligned_cols=136 Identities=25% Similarity=0.388 Sum_probs=75.1
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeeccc
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~ 186 (672)
++..|+|++|.+.+ ++ .++.+++|++|+|++|++++ +|. +.++++|++|+|++|++++..+-.-.++|++|+|++
T Consensus 86 ~L~~L~L~~n~l~~-~~--~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~ 160 (308)
T 1h6u_A 86 KITELELSGNPLKN-VS--AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGN 160 (308)
T ss_dssp SCCEEECCSCCCSC-CG--GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCS
T ss_pred CCCEEEccCCcCCC-ch--hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCccccCCCCccEEEccC
Confidence 45566666666553 32 36666666666666666664 232 566666666666666666433311115566666666
Q ss_pred ccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCcc
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 251 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 251 (672)
|++++..+ +.++++|+.|+|++|++++..+-..+++|++|+|++|++++..| +.++++|..
T Consensus 161 n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~ 221 (308)
T 1h6u_A 161 AQVSDLTP--LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221 (308)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCE
T ss_pred CcCCCChh--hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCcccc--ccCCCCCCE
Confidence 66664322 56666666666666666654443355666666666666664332 444444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=130.13 Aligned_cols=104 Identities=25% Similarity=0.273 Sum_probs=76.0
Q ss_pred EEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccc
Q 005875 110 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 187 (672)
Q Consensus 110 ~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N 187 (672)
.+++++|+++ .+|. .+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|. ++|++|+|++|
T Consensus 13 ~l~~s~n~l~-~ip~-~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 13 TVDCSGKSLA-SVPT-GI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EEECTTSCCS-SCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCc-cC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 5677777777 5776 34 37888999999999988888888888888888888888865554443 56777777777
Q ss_pred cCcccCCchhhhhccccceecCCccccCCC
Q 005875 188 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 217 (672)
Q Consensus 188 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (672)
+|++..|..|.++++|+.|+|++|.++...
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 777655556667777776666666666443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.48 E-value=1e-13 Score=154.74 Aligned_cols=117 Identities=28% Similarity=0.427 Sum_probs=72.0
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeeccc
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~ 186 (672)
+++.|+|++|+++ .+| +.+++|++|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. ..++|++|+|++
T Consensus 81 ~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~ 149 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE-LPALLEYINADN 149 (571)
T ss_dssp TCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC-CCTTCCEEECCS
T ss_pred CCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC-cCccccEEeCCC
Confidence 4666777777766 565 345667777777777765 665 544 66666666666665 555 446666666666
Q ss_pred ccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCc
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPS 241 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~ 241 (672)
|+|++ +|. .+++|+.|+|++|+|++ +|.+. ++|+.|+|++|+|+ .+|.
T Consensus 150 N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~l~-~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 150 NQLTM-LPE---LPTSLEVLSVRNNQLTF-LPELP-ESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCC-TTCCEEECCSSCCS-SCCC
T ss_pred CccCc-CCC---cCCCcCEEECCCCCCCC-cchhh-CCCCEEECcCCCCC-chhh
Confidence 66664 444 45566666666666665 33333 56666666666666 4454
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.48 E-value=7.2e-14 Score=132.27 Aligned_cols=112 Identities=27% Similarity=0.313 Sum_probs=99.3
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
..++.|++++|++++ +|+..++.+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..+. ++|++|+
T Consensus 28 ~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 106 (177)
T 2o6r_A 28 SSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA 106 (177)
T ss_dssp TTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEEeCCCcccE-eCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence 468899999999985 5555789999999999999999977777789999999999999999977666665 7999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 218 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 218 (672)
|++|+|++..+..+.++++|+.|+|++|.+++..|
T Consensus 107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99999997766678999999999999999998766
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=1.3e-13 Score=129.75 Aligned_cols=104 Identities=29% Similarity=0.334 Sum_probs=93.6
Q ss_pred CcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCC
Q 005875 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS 210 (672)
Q Consensus 133 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 210 (672)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|. ++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 578999999999 6887774 8999999999999988888886 8999999999999987777889999999999999
Q ss_pred ccccCCCCCC--CCCCCceEEeecCCCCCCC
Q 005875 211 NNLSGSIPNF--DIPKLRHLNLSYNGLKGSI 239 (672)
Q Consensus 211 N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~ 239 (672)
|+|++..+.. .+++|+.|+|++|+++...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 9999877763 8999999999999998543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.47 E-value=9.3e-14 Score=156.74 Aligned_cols=137 Identities=32% Similarity=0.383 Sum_probs=116.0
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
..+..|+|++|.+.+ +++ ++.|++|+.|+|++|.|++ +| .+..|++|+.|+|++|++++. | .+. ++|+.|+
T Consensus 65 ~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~~L~ 137 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTD-IKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI-N-GLVHLPQLESLY 137 (605)
T ss_dssp TTCCEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC-G-GGGGCTTCSEEE
T ss_pred CCCCEEEeeCCCCCC-Chh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC-c-cccCCCccCEEE
Confidence 468899999999986 443 8999999999999999985 44 799999999999999999963 3 343 8999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
|++|+|++. ..|..|++|+.|+|++|+|++.+|...+++|+.|+|++|+|++. +.+..+++|..+.
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~ 203 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLE 203 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEE
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCC--hHHccCCCCCEEE
Confidence 999999965 67999999999999999999888855899999999999999963 3577777776553
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=5.2e-14 Score=133.18 Aligned_cols=124 Identities=23% Similarity=0.286 Sum_probs=84.8
Q ss_pred eEEEEEeCCCCccccCCccccCCCC-CCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLD-ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
.++.|+|++|+++ .+|. +..+. +|++|+|++|.|++. ..|+++++|++|+|++|++++..|..+. ++|++|+
T Consensus 20 ~L~~L~l~~n~l~-~i~~--~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 20 RDRELDLRGYKIP-VIEN--LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp SCEEEECTTSCCC-SCCC--GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CceEEEeeCCCCc-hhHH--hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 4677788887777 4543 44444 788888888887754 5677778888888888887743323223 6778888
Q ss_pred cccccCcccCCc--hhhhhccccceecCCccccCCCCC----C-CCCCCceEEeecCCCC
Q 005875 184 LSFNSFTGNIPQ--SIQNLTQLTGLSLQSNNLSGSIPN----F-DIPKLRHLNLSYNGLK 236 (672)
Q Consensus 184 ls~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~----~-~l~~L~~l~l~~N~l~ 236 (672)
|++|+|+ .+|. .+.++++|+.|++++|.++...+. . .+++|+.||+++|...
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 8888775 4555 677777788888888877743332 2 6777777777777654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.1e-13 Score=128.78 Aligned_cols=104 Identities=25% Similarity=0.284 Sum_probs=76.6
Q ss_pred EEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeeccc
Q 005875 109 FGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 186 (672)
Q Consensus 109 ~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~ 186 (672)
+.++++++++. .+|. .+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|. ++|++|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~-~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPA-GIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCC-CcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 46788888885 7887 343 8889999999999988888888999998888888888864444443 6777777777
Q ss_pred ccCcccCCchhhhhccccceecCCccccCC
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGS 216 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 216 (672)
|+|++..+..|.++++|+.|+|++|.+...
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 777755444566676676666666666643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.3e-13 Score=128.50 Aligned_cols=101 Identities=26% Similarity=0.348 Sum_probs=91.7
Q ss_pred cEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCc
Q 005875 134 EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 211 (672)
Q Consensus 134 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 211 (672)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|. ++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 78999999997 8898775 8999999999999988888886 89999999999999776677899999999999999
Q ss_pred cccCCCCC-C-CCCCCceEEeecCCCCC
Q 005875 212 NLSGSIPN-F-DIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 212 ~l~~~~p~-~-~l~~L~~l~l~~N~l~g 237 (672)
+|++.++. + .+++|++|+|++|++..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 99987776 3 79999999999999984
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.4e-14 Score=158.43 Aligned_cols=134 Identities=22% Similarity=0.232 Sum_probs=67.8
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCC-------------cEEeeeccCCCCCCC
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL-------------RYLYLQHNNFSGKIP 172 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L-------------~~L~l~~N~l~g~~p 172 (672)
.++..+++++|++ |.+|+ .+++|++|++|+|++|.++|.+|.+++++++| ++|++++|.+++ +|
T Consensus 11 ~~L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp 87 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LP 87 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CC
T ss_pred ccchhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CC
Confidence 4677888888888 78888 68999999999999998888888888887764 777777777774 34
Q ss_pred CCcccccceeecccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCcc
Q 005875 173 SSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 251 (672)
Q Consensus 173 ~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 251 (672)
. +.++|++|+|++|++++ +|..+ ++|+.|++++|++++. |.. .++|++|++++|++++ +| .++++++|..
T Consensus 88 ~-~~~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~~l-~~~-~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~ 157 (454)
T 1jl5_A 88 E-LPPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKAL-SDL-PPLLEYLGVSNNQLEK-LP-ELQNSSFLKI 157 (454)
T ss_dssp S-CCTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSCC-CSC-CTTCCEEECCSSCCSS-CC-CCTTCTTCCE
T ss_pred C-CcCCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccCcc-cCC-CCCCCEEECcCCCCCC-Cc-ccCCCCCCCE
Confidence 3 34567777777777765 55432 4455555555555531 111 1345555555555553 44 3444444443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.43 E-value=2.1e-13 Score=149.81 Aligned_cols=138 Identities=33% Similarity=0.356 Sum_probs=99.5
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecc
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls 185 (672)
..+..|++++|.+.+ ++ .+..+++|++|+|++|.+++..| +.++++|+.|+|++|.+++..|-.-.++|++|+|+
T Consensus 221 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~ 295 (466)
T 1o6v_A 221 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN 295 (466)
T ss_dssp TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred CCCCEEECCCCCccc-ch--hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccccccCCCccCeEEcC
Confidence 357778888888774 33 57788888888888888886655 77888888888888888865442222678888888
Q ss_pred cccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 186 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
+|++++..| ++.+++|+.|+|++|++++..|...+++|+.|++++|++++. ..+.++++|..+
T Consensus 296 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 358 (466)
T 1o6v_A 296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWL 358 (466)
T ss_dssp SSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEE
T ss_pred CCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc--hhhccCCCCCEE
Confidence 888876544 777788888888888887776655777778888888777764 356666666554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=1.1e-13 Score=155.10 Aligned_cols=104 Identities=31% Similarity=0.330 Sum_probs=79.4
Q ss_pred CCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecC
Q 005875 132 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 209 (672)
Q Consensus 132 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 209 (672)
.|+.|+|++|.|++ +|. |++|++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +| .|++|++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 46678888888874 665 788888888888888888 7777776 678888888888885 56 78888888888888
Q ss_pred CccccCCC-CCC--CCCCCceEEeecCCCCCCCC
Q 005875 210 SNNLSGSI-PNF--DIPKLRHLNLSYNGLKGSIP 240 (672)
Q Consensus 210 ~N~l~~~~-p~~--~l~~L~~l~l~~N~l~g~~p 240 (672)
+|+|++.+ |.. .+++|+.|+|++|+|++.+|
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 88888775 543 77888888888888876554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.42 E-value=1.2e-13 Score=130.67 Aligned_cols=122 Identities=17% Similarity=0.159 Sum_probs=102.7
Q ss_pred ccCCCCCCcEEEccCCCcCCCCCCcCCCCC-CCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhcc
Q 005875 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLP-SLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQ 202 (672)
Q Consensus 126 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~ 202 (672)
.+.++.+|+.|+|++|+++ .+|. +..+. +|++|+|++|.+++. ..+. ++|++|+|++|+|++..|..+.++++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4778999999999999999 5564 55555 999999999999965 4554 79999999999999765566799999
Q ss_pred ccceecCCccccCCCCC---C-CCCCCceEEeecCCCCCCCCcc----cCCCCCCcccc
Q 005875 203 LTGLSLQSNNLSGSIPN---F-DIPKLRHLNLSYNGLKGSIPSS----LQKFPNSSFVG 253 (672)
Q Consensus 203 L~~L~l~~N~l~~~~p~---~-~l~~L~~l~l~~N~l~g~~p~~----~~~~~~l~~~~ 253 (672)
|+.|+|++|+|+. +|. . .+++|+.|++++|.++ .+|.. +..+++|.+++
T Consensus 90 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld 146 (176)
T 1a9n_A 90 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 146 (176)
T ss_dssp CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred CCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeC
Confidence 9999999999975 443 3 8899999999999998 56764 78888887776
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1.9e-13 Score=154.24 Aligned_cols=136 Identities=24% Similarity=0.344 Sum_probs=116.5
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
.++..|+|+++++. .+| .++.|++|+.|+|++|.|++..| +.+|++|+.|+|++|.|++ +| .+. ++|+.|+
T Consensus 43 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~ 115 (605)
T 1m9s_A 43 NSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLS 115 (605)
T ss_dssp TTCCCCBCTTCCCC-CCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEE
T ss_pred CCCCEEECcCCCCC-CCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEE
Confidence 35677899999987 455 49999999999999999997665 9999999999999999996 44 444 8999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
|++|+|++ + +.+.+|++|+.|+|++|+|++. +.. .+++|+.|+|++|++++..| +..+++|..++
T Consensus 116 Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 181 (605)
T 1m9s_A 116 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 181 (605)
T ss_dssp CTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred ecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEE
Confidence 99999996 3 4699999999999999999976 443 89999999999999998766 77777776653
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.41 E-value=8.1e-13 Score=144.40 Aligned_cols=132 Identities=25% Similarity=0.381 Sum_probs=103.4
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeeccc
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~ 186 (672)
.++.|++++|.+++ +|. + .++|++|+|++|++++ +| +|+++++|++|++++|++++ +|..+ .+|++|+|++
T Consensus 112 ~L~~L~l~~n~l~~-l~~--~--~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~-~~L~~L~L~~ 182 (454)
T 1jl5_A 112 SLKSLLVDNNNLKA-LSD--L--PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP-PSLEFIAAGN 182 (454)
T ss_dssp TCCEEECCSSCCSC-CCS--C--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC-TTCCEEECCS
T ss_pred CCcEEECCCCccCc-ccC--C--CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc-ccccEEECcC
Confidence 45666666666663 332 1 1689999999999985 78 59999999999999999995 66554 5899999999
Q ss_pred ccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
|++++ +| .++++++|+.|++++|++++ +|.. .++|+.|++++|.++ .+|. ++++++|..+.
T Consensus 183 n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~-~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~ 243 (454)
T 1jl5_A 183 NQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL-PLSLESIVAGNNILE-ELPE-LQNLPFLTTIY 243 (454)
T ss_dssp SCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC-CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC-cCcccEEECcCCcCC-cccc-cCCCCCCCEEE
Confidence 99996 66 68999999999999999987 4433 368999999999998 6774 77777776654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.41 E-value=3.8e-13 Score=147.12 Aligned_cols=123 Identities=23% Similarity=0.159 Sum_probs=79.4
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeeccc
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~ 186 (672)
.+..|++++|...+.+ .++.+++|++|+|++|+|++ +| ++.+++|+.|++++|++++. +-.-.++|++|+|++
T Consensus 149 ~L~~L~l~~n~~~~~~---~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~ 221 (457)
T 3bz5_A 149 QLTELDCHLNKKITKL---DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCSS 221 (457)
T ss_dssp TCCEEECTTCSCCCCC---CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECCS
T ss_pred cCCEEECCCCCccccc---ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECcC
Confidence 5667777777666666 26677777777777777775 45 67777777777777777754 311126777777777
Q ss_pred ccCcccCCchhhhhccccceecCCccccCCCCCCCCC----------CCceEEeecCCCCCCCC
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP----------KLRHLNLSYNGLKGSIP 240 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~----------~L~~l~l~~N~l~g~~p 240 (672)
|+|++ +| ++.+++|+.|++++|+|++..+. .++ +|+.|++++|.+.|.+|
T Consensus 222 N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~-~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 222 NKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS-TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp SCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT-TCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred Ccccc-cC--ccccCCCCEEEeeCCcCCCcCHH-HCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence 77775 55 67777777777777777764432 222 34444555555555554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.2e-13 Score=153.96 Aligned_cols=152 Identities=26% Similarity=0.351 Sum_probs=105.8
Q ss_pred CCCCCCCCCCCcceeeec------CCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCc
Q 005875 85 NWSSTNPICQSWVGINCT------QDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLR 158 (672)
Q Consensus 85 ~w~~~~~~c~~w~gv~C~------~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 158 (672)
.|....++| .|.|..|. .....++.|++++++++ .+|. .+. ++|++|+|++|+|+ .+|. .+++|+
T Consensus 14 ~W~~~~~~~-~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~-~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~ 84 (622)
T 3g06_A 14 AWRRAAPAE-ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPD-CLP--AHITTLVIPDNNLT-SLPA---LPPELR 84 (622)
T ss_dssp HHHHTCCGG-GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCS-CCC--TTCSEEEECSCCCS-CCCC---CCTTCC
T ss_pred HHHhcCCcc-hhccccccCcccccccCCCCcEEEecCCCcC-ccCh-hhC--CCCcEEEecCCCCC-CCCC---cCCCCC
Confidence 576555555 78664221 11134778999999988 7887 444 78999999999988 6675 578888
Q ss_pred EEeeeccCCCCCCCCCcccccceeecccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCC
Q 005875 159 YLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGS 238 (672)
Q Consensus 159 ~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~ 238 (672)
+|+|++|+|+ .+|. ..++|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|++++
T Consensus 85 ~L~Ls~N~l~-~lp~-~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~-~l~~L~~L~Ls~N~l~~- 155 (622)
T 3g06_A 85 TLEVSGNQLT-SLPV-LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPV-LPPGLQELSVSDNQLAS- 155 (622)
T ss_dssp EEEECSCCCS-CCCC-CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-
T ss_pred EEEcCCCcCC-cCCC-CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCC-CCCCCCEEECcCCcCCC-
Confidence 9999999888 5666 44788888888888884 454 56777888888888875 333 34777777887777774
Q ss_pred CCcccCCCCCCccccC
Q 005875 239 IPSSLQKFPNSSFVGN 254 (672)
Q Consensus 239 ~p~~~~~~~~l~~~~n 254 (672)
+|..+.++..|...+|
T Consensus 156 l~~~~~~L~~L~L~~N 171 (622)
T 3g06_A 156 LPALPSELCKLWAYNN 171 (622)
T ss_dssp CCCCCTTCCEEECCSS
T ss_pred cCCccCCCCEEECCCC
Confidence 4555555544444333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.39 E-value=5.1e-13 Score=140.55 Aligned_cols=139 Identities=22% Similarity=0.298 Sum_probs=95.8
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecc
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls 185 (672)
..+..|++++|.+.+ +++ +..+++|+.|++++|.+++..+ +..+++|+.|+|++|++++..+-.-.++|++|+|+
T Consensus 177 ~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~ 251 (347)
T 4fmz_A 177 TDLYSLSLNYNQIED-ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIG 251 (347)
T ss_dssp TTCSEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCEEEccCCcccc-ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECC
Confidence 357778888888774 443 7777778888888887775544 77777777788877777754441122677777777
Q ss_pred cccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 186 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
+|++++. +.+..+++|+.|++++|++++. |.. .+++|+.|+|++|++++..|..++++++|..+
T Consensus 252 ~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 252 TNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp SSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred CCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 7777753 4577777777777777777754 333 67777777777777777666666666666544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.38 E-value=8.8e-13 Score=144.82 Aligned_cols=137 Identities=29% Similarity=0.338 Sum_probs=104.2
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecc
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls 185 (672)
..+..|++++|.+.+..| ++.+++|+.|+|++|.+++. + .+..+++|+.|+|++|.+++..|-.-.++|++|+|+
T Consensus 199 ~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~ 273 (466)
T 1o6v_A 199 TNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKDI-G-TLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLG 273 (466)
T ss_dssp TTCSEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred CCCCEEEecCCccccccc---ccccCCCCEEECCCCCcccc-h-hhhcCCCCCEEECCCCccccchhhhcCCCCCEEECC
Confidence 457788888888876443 67788888888888888853 3 578888888888888888876652223788888888
Q ss_pred cccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCcc
Q 005875 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 251 (672)
Q Consensus 186 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 251 (672)
+|++++..| +..+++|+.|+|++|++++..|...+++|+.|+|++|++++..| +..+++|..
T Consensus 274 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 335 (466)
T 1o6v_A 274 ANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 335 (466)
T ss_dssp SSCCCCCGG--GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCE
T ss_pred CCccCcccc--ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchh--hccCccCCE
Confidence 888886544 78888888888888888876665578888888888888887665 455555543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=6.2e-13 Score=140.06 Aligned_cols=106 Identities=27% Similarity=0.379 Sum_probs=77.4
Q ss_pred CCcceeeecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccC-CCcCCCCCCcCCCCCCCcEEeeeccCCCCCCC
Q 005875 94 QSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP 172 (672)
Q Consensus 94 ~~w~gv~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 172 (672)
|.|.+|.|++. |+|+ .+|. |..+++|+.|+|++ |.|++..|..|++|++|+.|+|++|+|++..|
T Consensus 8 C~~~~v~~~~~-----------n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 73 (347)
T 2ifg_A 8 HGSSGLRCTRD-----------GALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (347)
T ss_dssp SSSSCEECCSS-----------CCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred ccCCEEEcCCC-----------CCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCH
Confidence 46777777531 1566 4776 88899999999996 99997777889999998888888888887666
Q ss_pred CCcc--cccceeecccccCcccCCchhhhhccccceecCCcccc
Q 005875 173 SSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 214 (672)
Q Consensus 173 ~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 214 (672)
..|. ++|++|+|++|+|++..|..|..++ |+.|+|++|.|.
T Consensus 74 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp TGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred HHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 6655 6777777777777755444455444 666666666665
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.37 E-value=9.3e-13 Score=133.09 Aligned_cols=123 Identities=24% Similarity=0.292 Sum_probs=105.3
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
..+..|+|++|.+++ +++ ++.+++|++|+|++|+|++ +|. +.. ++|+.|+|++|++++. | .+. ++|++|+
T Consensus 63 ~~L~~L~L~~N~i~~-~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILS 134 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEE
T ss_pred CCCCEEECCCCccCC-Chh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEE
Confidence 468899999999985 554 9999999999999999995 554 333 9999999999999964 4 344 8999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCC
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGS 238 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~ 238 (672)
|++|+|++. | .+..+++|+.|+|++|++++...-..+++|+.|++++|.+++.
T Consensus 135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBCTTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCCcCCCC-h-HHccCCCCCEEECCCCcCcchHHhccCCCCCEEeCCCCcccCC
Confidence 999999964 4 7999999999999999999872223899999999999999865
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.7e-12 Score=140.41 Aligned_cols=133 Identities=23% Similarity=0.221 Sum_probs=99.5
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecc
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 185 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls 185 (672)
..+..|+|++|.+++ +| ++.+++|++|+|++|+|++ +| ++++++|++|++++|+..+.++-.-.++|++|+|+
T Consensus 106 ~~L~~L~L~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls 178 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTK-LD---VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCS 178 (457)
T ss_dssp TTCCEEECCSSCCSC-CC---CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECC
T ss_pred CcCCEEECCCCcCCe-ec---CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcccccccccCCcCCEEECC
Confidence 467889999998886 43 7888999999999999986 34 78888888888888876666643333778888888
Q ss_pred cccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 186 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
+|+|++ +| ++.+++|+.|++++|++++. +-..+++|+.|+|++|++++ +| ++.+++|..+
T Consensus 179 ~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L 238 (457)
T 3bz5_A 179 FNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYF 238 (457)
T ss_dssp SSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEE
T ss_pred CCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECcCCcccc-cC--ccccCCCCEE
Confidence 888885 45 77778888888888888764 44477778888888888876 55 5566655543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.8e-14 Score=151.05 Aligned_cols=147 Identities=23% Similarity=0.295 Sum_probs=99.0
Q ss_pred CeEEEEEeCCCCcccc-CCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeecc-CCCCC-CCCCcc--cccc
Q 005875 106 TRVFGLRLPGIGLVGP-IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN-NFSGK-IPSSFS--PQLV 180 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~-~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~--~~L~ 180 (672)
.++..|+|++|.+++. +|. .+..+++|++|+|++|.+++..|..++++++|++|+|++| .+++. +|..+. ++|+
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHG-ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp BCCCEEECTTCEECHHHHHH-HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCEEEccCCCcCHHHHHH-HHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 4566777777776654 555 5777777777777777777777777777777777777777 56642 343333 6777
Q ss_pred eeecccc-cCccc-CCchhhhhc-cccceecCCc--ccc-CCCCCC--CCCCCceEEeecCC-CCCCCCcccCCCCCCcc
Q 005875 181 VLDLSFN-SFTGN-IPQSIQNLT-QLTGLSLQSN--NLS-GSIPNF--DIPKLRHLNLSYNG-LKGSIPSSLQKFPNSSF 251 (672)
Q Consensus 181 ~L~ls~N-~l~~~-~p~~~~~l~-~L~~L~l~~N--~l~-~~~p~~--~l~~L~~l~l~~N~-l~g~~p~~~~~~~~l~~ 251 (672)
+|+|++| ++++. ++..+.+++ +|+.|+|++| .++ +.+|.. .+++|+.|+|++|. +++..+..+.++++|..
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~ 251 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 251 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCE
Confidence 7777777 77754 566677777 7777777777 344 333332 67777888888777 66666666666666665
Q ss_pred cc
Q 005875 252 VG 253 (672)
Q Consensus 252 ~~ 253 (672)
++
T Consensus 252 L~ 253 (336)
T 2ast_B 252 LS 253 (336)
T ss_dssp EE
T ss_pred ee
Confidence 54
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.35 E-value=8.3e-13 Score=138.93 Aligned_cols=137 Identities=21% Similarity=0.271 Sum_probs=114.8
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
..+..+++++|.+.+. ++ +..+++|++|+|++|.+++..+ +..+++|++|+|++|.+++. + .+. ++|++|+
T Consensus 199 ~~L~~L~l~~n~l~~~-~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~ 271 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDI-TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-N-AVKDLTKLKMLN 271 (347)
T ss_dssp TTCCEEECCSSCCCCC-GG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred CccceeecccCCCCCC-ch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC-h-hHhcCCCcCEEE
Confidence 4678899999998854 32 8899999999999999996544 99999999999999999964 3 333 8999999
Q ss_pred cccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 184 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
|++|++++. +.+..+++|+.|+|++|++++..|.. .+++|+.|+|++|++++..| +..+++|..++
T Consensus 272 l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 339 (347)
T 4fmz_A 272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSAD 339 (347)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEES
T ss_pred ccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceee
Confidence 999999964 46899999999999999999887764 89999999999999997766 66666665543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.32 E-value=3.6e-14 Score=148.62 Aligned_cols=145 Identities=19% Similarity=0.268 Sum_probs=117.7
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCC-CCCcCCCCCCCcEEeeeccCCCCCCCCCcc--ccccee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 182 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L 182 (672)
..+..+++++|.+.+..+. +..+++|++|+|++|.+++. +|..+.++++|++|+|++|.+++..|..+. ++|++|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 4577888999988877664 67899999999999999876 888889999999999999999877777665 789999
Q ss_pred ecccc-cCccc-CCchhhhhccccceecCCc-cccCC-CCCC--CCC-CCceEEeecC--CCC-CCCCcccCCCCCCccc
Q 005875 183 DLSFN-SFTGN-IPQSIQNLTQLTGLSLQSN-NLSGS-IPNF--DIP-KLRHLNLSYN--GLK-GSIPSSLQKFPNSSFV 252 (672)
Q Consensus 183 ~ls~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~--~l~-~L~~l~l~~N--~l~-g~~p~~~~~~~~l~~~ 252 (672)
+|++| .+++. +|..+.++++|+.|+|++| .+++. ++.. .++ +|++|+|++| .++ +.+|..+.++++|..+
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L 227 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 227 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEE
Confidence 99999 78863 7778899999999999999 88864 4442 778 9999999999 565 4566666666666554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.31 E-value=5.9e-12 Score=142.27 Aligned_cols=132 Identities=27% Similarity=0.344 Sum_probs=71.8
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCc---CCCC--------------CCCcEEeeeccCCCC
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSE---ITSL--------------PSLRYLYLQHNNFSG 169 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~---~~~l--------------~~L~~L~l~~N~l~g 169 (672)
.+..|+|++|++++ +|. .+++|++|+|++|+|++ +|.. +..| ++|+.|+|++|++++
T Consensus 122 ~L~~L~L~~N~l~~-lp~----~l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~ 195 (622)
T 3g06_A 122 GLCKLWIFGNQLTS-LPV----LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS 195 (622)
T ss_dssp TCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC
T ss_pred CcCEEECCCCCCCc-CCC----CCCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC
Confidence 45566666666653 554 13666666666666663 2222 2222 666777777777764
Q ss_pred CCCCCc-------------------ccccceeecccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEe
Q 005875 170 KIPSSF-------------------SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNL 230 (672)
Q Consensus 170 ~~p~~~-------------------~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l 230 (672)
+|..+ .++|++|+|++|+|++ +| ..+++|+.|+|++|+|++ +|. .+++|+.|+|
T Consensus 196 -l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~-~~~~L~~L~L 268 (622)
T 3g06_A 196 -LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM-LPSGLLSLSV 268 (622)
T ss_dssp -CCCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCTTCCEEEC
T ss_pred -CCCccchhhEEECcCCcccccCCCCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc-ccccCcEEeC
Confidence 34322 1345555555555553 34 234555666666666653 333 4556666666
Q ss_pred ecCCCCCCCCcccCCCCCCccc
Q 005875 231 SYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 231 ~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
++|+|+ .+|..+.++++|..+
T Consensus 269 s~N~L~-~lp~~l~~l~~L~~L 289 (622)
T 3g06_A 269 YRNQLT-RLPESLIHLSSETTV 289 (622)
T ss_dssp CSSCCC-SCCGGGGGSCTTCEE
T ss_pred CCCCCC-cCCHHHhhccccCEE
Confidence 666666 556656555555443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.29 E-value=6.9e-14 Score=149.67 Aligned_cols=148 Identities=20% Similarity=0.300 Sum_probs=93.8
Q ss_pred CeEEEEEeCCC---CccccCCccc------cCCCCCCcEEEccCCCcCC----CCCCcCCCCCCCcEEeeeccCCCCCCC
Q 005875 106 TRVFGLRLPGI---GLVGPIPNNT------LGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIP 172 (672)
Q Consensus 106 ~~v~~l~l~~~---~l~g~~p~~~------~~~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~~p 172 (672)
.++..|+|++| .+.+.+|.+. +..+++|++|+|++|.|++ .+|..+.++++|++|+|++|.+++..+
T Consensus 60 ~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~ 139 (386)
T 2ca6_A 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 139 (386)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence 34666777664 4555555421 3667777777777777776 466667777777777777777764333
Q ss_pred CCcc---------------cccceeecccccCc-ccCC---chhhhhccccceecCCcccc--C---CCC-CC-CCCCCc
Q 005875 173 SSFS---------------PQLVVLDLSFNSFT-GNIP---QSIQNLTQLTGLSLQSNNLS--G---SIP-NF-DIPKLR 226 (672)
Q Consensus 173 ~~~~---------------~~L~~L~ls~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p-~~-~l~~L~ 226 (672)
..+. ++|++|+|++|+|+ +.+| ..+.++++|+.|+|++|+|+ | .+| .. .+++|+
T Consensus 140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~ 219 (386)
T 2ca6_A 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219 (386)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCcc
Confidence 3332 46777777777776 4444 45667777777777777776 2 233 22 567777
Q ss_pred eEEeecCCCC----CCCCcccCCCCCCcccc
Q 005875 227 HLNLSYNGLK----GSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 227 ~l~l~~N~l~----g~~p~~~~~~~~l~~~~ 253 (672)
.|+|++|.++ +.+|..+.++++|..++
T Consensus 220 ~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~ 250 (386)
T 2ca6_A 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELG 250 (386)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred EEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence 7777777775 55666666666655543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=4.2e-12 Score=133.63 Aligned_cols=102 Identities=20% Similarity=0.168 Sum_probs=90.5
Q ss_pred cEEEccCC-CcCCCCCCcCCCCCCCcEEeeec-cCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecC
Q 005875 134 EVLSLRSN-VLTGGLPSEITSLPSLRYLYLQH-NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 209 (672)
Q Consensus 134 ~~L~L~~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 209 (672)
..+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|. ++|++|+|++|+|++..|..|++|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35688988 899 6898 99999999999996 999987777776 899999999999999999999999999999999
Q ss_pred CccccCCCCCC-CCCCCceEEeecCCCCC
Q 005875 210 SNNLSGSIPNF-DIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 210 ~N~l~~~~p~~-~l~~L~~l~l~~N~l~g 237 (672)
+|+|++.++.. ...+|+.|+|++|.|..
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccC
Confidence 99999877664 43449999999999984
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=2.7e-11 Score=122.10 Aligned_cols=136 Identities=17% Similarity=0.113 Sum_probs=107.6
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
..+|.|+++.||++... ++.+++|+..... .....+.+|.+++..+.++..+.++++++.+.+..|+||||++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 35677788999999855 6789999986532 234579999999999966888999999999888999999999999998
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG------------------------------------------- 496 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------------------------------------------- 496 (672)
+.+.. ......++.+++.+++.||+..
T Consensus 99 ~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 76421 1123467889999999999811
Q ss_pred -------------CCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 497 -------------GPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 497 -------------~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
.+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876666799998764
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.23 E-value=3.5e-13 Score=144.16 Aligned_cols=148 Identities=20% Similarity=0.277 Sum_probs=116.2
Q ss_pred CeEEEEEeCCCCccccCCc---cccCCCCCCcEEEccCC---CcCCCCCCcC-------CCCCCCcEEeeeccCCCC---
Q 005875 106 TRVFGLRLPGIGLVGPIPN---NTLGKLDALEVLSLRSN---VLTGGLPSEI-------TSLPSLRYLYLQHNNFSG--- 169 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~---~~~~~l~~L~~L~L~~N---~l~g~~p~~~-------~~l~~L~~L~l~~N~l~g--- 169 (672)
.+++.|+|++|++.+..+. ..+..+++|++|+|++| ++++.+|..+ .++++|++|+|++|.+++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 4588999999998875332 14779999999999995 5667777666 789999999999999997
Q ss_pred -CCCCCcc--cccceeecccccCcccCCchh----hhh---------ccccceecCCcccc-CCCCC----C-CCCCCce
Q 005875 170 -KIPSSFS--PQLVVLDLSFNSFTGNIPQSI----QNL---------TQLTGLSLQSNNLS-GSIPN----F-DIPKLRH 227 (672)
Q Consensus 170 -~~p~~~~--~~L~~L~ls~N~l~~~~p~~~----~~l---------~~L~~L~l~~N~l~-~~~p~----~-~l~~L~~ 227 (672)
.+|..+. ++|++|+|++|.|++..+..+ ..+ ++|+.|+|++|+++ +.+|. . .+++|+.
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 191 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence 4665655 799999999999986555444 444 89999999999998 45553 1 6789999
Q ss_pred EEeecCCCC--C---CCCcccCCCCCCcccc
Q 005875 228 LNLSYNGLK--G---SIPSSLQKFPNSSFVG 253 (672)
Q Consensus 228 l~l~~N~l~--g---~~p~~~~~~~~l~~~~ 253 (672)
|+|++|+++ | .+|..+.++++|..+.
T Consensus 192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~ 222 (386)
T 2ca6_A 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLD 222 (386)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCEEE
T ss_pred EECcCCCCCHhHHHHHHHHHhhcCCCccEEE
Confidence 999999998 3 3454677777776654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.23 E-value=4.3e-13 Score=142.19 Aligned_cols=133 Identities=24% Similarity=0.287 Sum_probs=70.4
Q ss_pred EEEEEeCCCCccccCCc---cccCCCC-CCcEEEccCCCcCCCCCCcCCCC-----CCCcEEeeeccCCCCCCCCCcc--
Q 005875 108 VFGLRLPGIGLVGPIPN---NTLGKLD-ALEVLSLRSNVLTGGLPSEITSL-----PSLRYLYLQHNNFSGKIPSSFS-- 176 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~---~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~-- 176 (672)
++.|+|++|.+++.-+. ..+..++ +|++|+|++|.|++..+..|..+ ++|++|+|++|++++..+..+.
T Consensus 24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence 55666666665533320 2455555 56666666666665555555443 5666666666666554443221
Q ss_pred -----cccceeecccccCcccCCchhhhh-----ccccceecCCccccCCCCC----C--CCC-CCceEEeecCCCCCCC
Q 005875 177 -----PQLVVLDLSFNSFTGNIPQSIQNL-----TQLTGLSLQSNNLSGSIPN----F--DIP-KLRHLNLSYNGLKGSI 239 (672)
Q Consensus 177 -----~~L~~L~ls~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~----~--~l~-~L~~l~l~~N~l~g~~ 239 (672)
++|++|+|++|+|++..+..+... ++|+.|+|++|+|++..+. . .++ +|++|+|++|++++..
T Consensus 104 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~ 183 (362)
T 3goz_A 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKN 183 (362)
T ss_dssp HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSC
T ss_pred HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhh
Confidence 356666666666665544444331 4566666666666532221 0 222 5666666666665444
Q ss_pred C
Q 005875 240 P 240 (672)
Q Consensus 240 p 240 (672)
+
T Consensus 184 ~ 184 (362)
T 3goz_A 184 C 184 (362)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.2e-12 Score=138.84 Aligned_cols=129 Identities=20% Similarity=0.145 Sum_probs=109.5
Q ss_pred EEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCC----CcCCCCC-CCcEEeeeccCCCCCCCCCcc-------cc
Q 005875 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP----SEITSLP-SLRYLYLQHNNFSGKIPSSFS-------PQ 178 (672)
Q Consensus 111 l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p----~~~~~l~-~L~~L~l~~N~l~g~~p~~~~-------~~ 178 (672)
.+|+.++++|.+|. .+....+|++|+|++|.|++..+ ..+.+++ +|++|+|++|++++..+..+. ++
T Consensus 3 ~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57889999999987 67777789999999999997666 6788898 999999999999987776553 58
Q ss_pred cceeecccccCcccCCchhhhh-----ccccceecCCccccCCCCCC------C-CCCCceEEeecCCCCCCCC
Q 005875 179 LVVLDLSFNSFTGNIPQSIQNL-----TQLTGLSLQSNNLSGSIPNF------D-IPKLRHLNLSYNGLKGSIP 240 (672)
Q Consensus 179 L~~L~ls~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~------~-l~~L~~l~l~~N~l~g~~p 240 (672)
|++|+|++|+|++..+..+... ++|+.|+|++|+|++..+.. . .++|++|+|++|.+++.-+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 155 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSS 155 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHH
Confidence 9999999999998888876665 89999999999998766532 3 3699999999999996443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.22 E-value=7.8e-14 Score=134.66 Aligned_cols=123 Identities=20% Similarity=0.231 Sum_probs=105.8
Q ss_pred cCCCCCCcEEEccCCCcCCCCCC------cCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhh
Q 005875 127 LGKLDALEVLSLRSNVLTGGLPS------EITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ 198 (672)
Q Consensus 127 ~~~l~~L~~L~L~~N~l~g~~p~------~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~ 198 (672)
+.....++.++|+.|.|+|.+|. .+.++++|++|+|++|++++ +| .+. ++|++|+|++|+|+ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 55677889999999999999887 89999999999999999996 77 665 89999999999999 7899999
Q ss_pred hhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCC-cccCCCCCCcccc
Q 005875 199 NLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIP-SSLQKFPNSSFVG 253 (672)
Q Consensus 199 ~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p-~~~~~~~~l~~~~ 253 (672)
.+++|+.|+|++|++++ +|.. .+++|+.|+|++|++++..+ ..+.++++|..+.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~ 146 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL 146 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HHHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEE
T ss_pred cCCcCCEEECcCCcCCc-CCccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEE
Confidence 99999999999999997 4444 78899999999999995332 4677777776553
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.14 E-value=8.2e-11 Score=123.96 Aligned_cols=140 Identities=15% Similarity=0.115 Sum_probs=107.1
Q ss_pred eeecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCc-c-
Q 005875 99 INCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF-S- 176 (672)
Q Consensus 99 v~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~- 176 (672)
..|+.. .++.++++|+ .+|. .+ .++|++|+|++|+|+..-+..|.+|++|++|+|++|++.+.+|... .
T Consensus 7 C~C~~~-----~v~C~~~~Lt-~iP~-~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~ 77 (350)
T 4ay9_X 7 CHCSNR-----VFLCQESKVT-EIPS-DL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN 77 (350)
T ss_dssp SEEETT-----EEEEESTTCC-SCCT-TC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCS
T ss_pred cEeeCC-----EEEecCCCCC-ccCc-Cc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhc
Confidence 567642 3677889998 7887 34 4689999999999994444579999999999999999988888654 3
Q ss_pred -cccc-eeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeec-CCCCCCCCcccCCCC
Q 005875 177 -PQLV-VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSY-NGLKGSIPSSLQKFP 247 (672)
Q Consensus 177 -~~L~-~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~-N~l~g~~p~~~~~~~ 247 (672)
++|+ .+++++|+|++..|..|.++++|+.|++++|+|++..+.. ...++..|++.+ |++....+..|..+.
T Consensus 78 L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~ 153 (350)
T 4ay9_X 78 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153 (350)
T ss_dssp CTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred chhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc
Confidence 4444 5788889999888999999999999999999999766653 555677788866 445533334455443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=4e-10 Score=112.98 Aligned_cols=131 Identities=11% Similarity=0.085 Sum_probs=98.9
Q ss_pred ccc-ccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCc-eeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 382 VLG-KGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN-VVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 382 ~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.++ .|..+.||++...+++.+++|..... ....+.+|++++..+.+|.- +.+++++...++..++||||++|.++.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 344 45569999998777788999987653 34568899999999855522 566888888877889999999998884
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG------------------------------------------- 496 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------------------------------------------- 496 (672)
... .+ ...++.+++..++.||+..
T Consensus 104 --~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 104 --SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp --TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred --cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 211 11 2256777888888888643
Q ss_pred ------------CCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 497 ------------GPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 497 ------------~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
.+.++|+|++|.||++++++.+.|+|||.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999864
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.07 E-value=1.5e-12 Score=142.42 Aligned_cols=147 Identities=20% Similarity=0.092 Sum_probs=113.9
Q ss_pred CeEEEEEeCCCCcccc----CCccccCCCCCCcEEEccCCCcCCC----CCCcCCCCCCCcEEeeeccCCCCCCCCCcc-
Q 005875 106 TRVFGLRLPGIGLVGP----IPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 176 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~----~p~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~- 176 (672)
..+..|+|++|.+.+. +.+..+..+++|++|+|++|.+++. +|..+.++++|++|+|++|.+++..+..+.
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 4678899999988753 2222344689999999999999864 677788899999999999998755444333
Q ss_pred ------cccceeecccccCccc----CCchhhhhccccceecCCccccCCCCCC-------CCCCCceEEeecCCCCC--
Q 005875 177 ------PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIPNF-------DIPKLRHLNLSYNGLKG-- 237 (672)
Q Consensus 177 ------~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~-------~l~~L~~l~l~~N~l~g-- 237 (672)
++|++|+|++|.+++. +|..+.++++|+.|+|++|++++..+.. ..++|+.|+|++|.+++
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~ 386 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 386 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence 4899999999999876 6777888899999999999988654321 26789999999999986
Q ss_pred --CCCcccCCCCCCccc
Q 005875 238 --SIPSSLQKFPNSSFV 252 (672)
Q Consensus 238 --~~p~~~~~~~~l~~~ 252 (672)
.+|..+.++++|..+
T Consensus 387 ~~~l~~~l~~~~~L~~L 403 (461)
T 1z7x_W 387 CSSLAATLLANHSLREL 403 (461)
T ss_dssp HHHHHHHHHHCCCCCEE
T ss_pred HHHHHHHHHhCCCccEE
Confidence 777777666666554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.03 E-value=1.7e-12 Score=142.02 Aligned_cols=136 Identities=20% Similarity=0.214 Sum_probs=107.2
Q ss_pred CeEEEEEeCCCCcccc----CCccccCCCCCCcEEEccCCCcCCCC-----CCcCCCCCCCcEEeeeccCCCCC----CC
Q 005875 106 TRVFGLRLPGIGLVGP----IPNNTLGKLDALEVLSLRSNVLTGGL-----PSEITSLPSLRYLYLQHNNFSGK----IP 172 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~----~p~~~~~~l~~L~~L~L~~N~l~g~~-----p~~~~~l~~L~~L~l~~N~l~g~----~p 172 (672)
.++..|+|++|++++. ++. .+..+++|++|+|++|.+++.- +..+..+++|++|+|++|.+++. +|
T Consensus 199 ~~L~~L~L~~n~l~~~~~~~l~~-~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 277 (461)
T 1z7x_W 199 CQLEALKLESCGVTSDNCRDLCG-IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277 (461)
T ss_dssp CCCCEEECTTSCCBTTHHHHHHH-HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred CCceEEEccCCCCcHHHHHHHHH-HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence 3788999999998863 555 6888999999999999987532 33344689999999999999854 45
Q ss_pred CCcc--cccceeecccccCcccCCchhhhh-----ccccceecCCccccCC----CCCC--CCCCCceEEeecCCCCCCC
Q 005875 173 SSFS--PQLVVLDLSFNSFTGNIPQSIQNL-----TQLTGLSLQSNNLSGS----IPNF--DIPKLRHLNLSYNGLKGSI 239 (672)
Q Consensus 173 ~~~~--~~L~~L~ls~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~----~p~~--~l~~L~~l~l~~N~l~g~~ 239 (672)
..+. ++|++|+|++|.|++..+..+... ++|+.|+|++|.+++. ++.. .+++|+.|+|++|.+++..
T Consensus 278 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence 5554 789999999999987766666654 6999999999999865 2332 6789999999999998654
Q ss_pred Ccc
Q 005875 240 PSS 242 (672)
Q Consensus 240 p~~ 242 (672)
+..
T Consensus 358 ~~~ 360 (461)
T 1z7x_W 358 VRE 360 (461)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=99.03 E-value=9e-13 Score=132.10 Aligned_cols=158 Identities=20% Similarity=0.195 Sum_probs=115.4
Q ss_pred CcceeeecCCCCeEEEEEeCC---CCccccCCccccCCCCCCcEEEccCCCcCCCCCC-cCCCCCCCcE--EeeeccCCC
Q 005875 95 SWVGINCTQDRTRVFGLRLPG---IGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EITSLPSLRY--LYLQHNNFS 168 (672)
Q Consensus 95 ~w~gv~C~~~~~~v~~l~l~~---~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~--L~l~~N~l~ 168 (672)
.|.|+.|+..+.+|+.+...+ ..+.|.++++.+..|+. .|...+|..++.++- .+...+.|.. ++++.|+..
T Consensus 79 ~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 79 AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 799999998766776666655 45667777655555554 456666777766653 2666666766 788888654
Q ss_pred CCCCCCc------ccccceeecccccCcc--cCCchhhhhccccceecCCccccCCCCCCCCC--CCceEEeecCCCCCC
Q 005875 169 GKIPSSF------SPQLVVLDLSFNSFTG--NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP--KLRHLNLSYNGLKGS 238 (672)
Q Consensus 169 g~~p~~~------~~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~--~L~~l~l~~N~l~g~ 238 (672)
.++..+ .++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.-.-..+. +|+.|+|++|.+++.
T Consensus 157 -~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~ 235 (267)
T 3rw6_A 157 -CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDT 235 (267)
T ss_dssp -HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGG
T ss_pred -HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCccc
Confidence 333322 1689999999999998 66788899999999999999999752212233 999999999999988
Q ss_pred CCc-------ccCCCCCCccccCC
Q 005875 239 IPS-------SLQKFPNSSFVGNS 255 (672)
Q Consensus 239 ~p~-------~~~~~~~l~~~~n~ 255 (672)
+|. .+..+++|..++..
T Consensus 236 ~~~~~~y~~~il~~~P~L~~LDg~ 259 (267)
T 3rw6_A 236 FRDQSTYISAIRERFPKLLRLDGH 259 (267)
T ss_dssp CSSHHHHHHHHHHHCTTCCEESSC
T ss_pred cCcchhHHHHHHHHCcccCeECCc
Confidence 873 36788888888753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.8e-09 Score=113.98 Aligned_cols=140 Identities=15% Similarity=0.223 Sum_probs=105.4
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEec--ccc--cChhhHHHHHHHHHHHcC-CCceeceEEEEEeC---CeeEEEEEe
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLK--EVV--VGKRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSK---DEKLLVYDY 452 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~--~~~--~~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~---~~~~lV~e~ 452 (672)
+.++.|.++.||+....+ ..+++|+.. ... .....+.+|..++..+.. +..++++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 468889999999998764 678888775 322 234578899999999853 45688899988766 347999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG------------------------------------ 496 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------------------------------------ 496 (672)
++|..+.+.. ...++..++..++.+++..|+.||+..
T Consensus 123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9998775422 123778888999999999999999731
Q ss_pred -------------------CCCcccCCCCCCCEEecCCCC--eEEeecCCCCC
Q 005875 497 -------------------GPKFTHGNIKASNVLINQDLD--GCISDFGLTPL 528 (672)
Q Consensus 497 -------------------~~~ivHrDLk~~NILl~~~~~--~kl~DfGla~~ 528 (672)
.+.++|+|+++.||++++++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245899999999999998764 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=1.7e-09 Score=111.49 Aligned_cols=182 Identities=18% Similarity=0.247 Sum_probs=120.9
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCc--eeceEEEEEeCC---eeEEEEEecCC
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN--VVPLRAYYYSKD---EKLLVYDYFAS 455 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n--iv~l~~~~~~~~---~~~lV~e~~~~ 455 (672)
+.++.|.+..||+.. ..+++|+.... .....+.+|.+++..+..+.. +.+.+......+ ..|+|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 358899999999864 56888875432 234678899999988854433 344554443332 34799999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--------------------------------------- 496 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--------------------------------------- 496 (672)
.++.+... ..++..++..++.+++..++.||+..
T Consensus 101 ~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 88875432 12677788888888888888888621
Q ss_pred ----------------CCCcccCCCCCCCEEecC--CCCeEEeecCCCCCCCCCCC----CC----CCC--------cc-
Q 005875 497 ----------------GPKFTHGNIKASNVLINQ--DLDGCISDFGLTPLMNVPAT----PS----RSA--------GY- 541 (672)
Q Consensus 497 ----------------~~~ivHrDLk~~NILl~~--~~~~kl~DfGla~~~~~~~~----~~----~~~--------~y- 541 (672)
.+.++|+|+++.||++++ ...+.|+||+.+........ .. ..+ .|
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 134799999999999998 45678999998765322110 00 000 01
Q ss_pred -cC-cccccCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 005875 542 -RA-PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 576 (672)
Q Consensus 542 -~a-PE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~ 576 (672)
.. |+.... .....+.|+++.++|.+.+|..+|-
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 111111 1122589999999999999987763
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.82 E-value=7.3e-11 Score=125.24 Aligned_cols=133 Identities=17% Similarity=0.183 Sum_probs=95.6
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcC-----CCCCCCcEEeeeccCCCCC----CCCCcc
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-----TSLPSLRYLYLQHNNFSGK----IPSSFS 176 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~-----~~l~~L~~L~l~~N~l~g~----~p~~~~ 176 (672)
..++.|+|++|.++..-.......+.+|+.|+|++|.|+..-...+ ...++|+.|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 4789999999988643333233456789999999999975433333 3567899999999998742 222222
Q ss_pred --cccceeecccccCccc----CCchhhhhccccceecCCccccCCCC----CC--CCCCCceEEeecCCCCCC
Q 005875 177 --PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIP----NF--DIPKLRHLNLSYNGLKGS 238 (672)
Q Consensus 177 --~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p----~~--~l~~L~~l~l~~N~l~g~ 238 (672)
++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+..-. .. ..++|++|+|++|.++..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 6799999999998853 45667788899999999999874221 11 457899999999988743
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.79 E-value=7.9e-09 Score=107.70 Aligned_cols=141 Identities=18% Similarity=0.205 Sum_probs=90.4
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCC----CCCCCCCc-------
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF----SGKIPSSF------- 175 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l----~g~~p~~~------- 175 (672)
.++.|+|++ +++ .|++.+|.++++|+.|+|++|.+...-+..|.++.+|..|.++.+.. ...-+..|
T Consensus 102 ~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~ 179 (329)
T 3sb4_A 102 TLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE 179 (329)
T ss_dssp TCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred CCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence 466777777 666 57777788888888888888877644445566665555555444211 00000000
Q ss_pred ---------------------------------------------ccccceeecccccCcccCCchhhhhccccceecCC
Q 005875 176 ---------------------------------------------SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS 210 (672)
Q Consensus 176 ---------------------------------------------~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 210 (672)
.++|+.|+|++|+++...+.+|.+|++|+.|+|.+
T Consensus 180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence 24788888888888866666788888888888888
Q ss_pred ccccCCCCC-C--CCCCCc-eEEeecCCCCCCCCcccCCCCCCccc
Q 005875 211 NNLSGSIPN-F--DIPKLR-HLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 211 N~l~~~~p~-~--~l~~L~-~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
| ++ .++. . ++++|+ .++|.+ +++..-+..|.++++|..+
T Consensus 260 n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 260 N-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp T-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred c-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 7 55 3443 2 777787 888877 6664445677777776655
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.73 E-value=6.5e-09 Score=108.32 Aligned_cols=131 Identities=13% Similarity=0.165 Sum_probs=93.5
Q ss_pred cCCccccCC--------CCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccC-
Q 005875 121 PIPNNTLGK--------LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSF- 189 (672)
Q Consensus 121 ~~p~~~~~~--------l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l- 189 (672)
.||+..|.+ +++|+.|+|.+ +++..-+..|.+|++|+.|+|++|.++...+..|. .++..+.++.+..
T Consensus 83 ~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~ 161 (329)
T 3sb4_A 83 FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAY 161 (329)
T ss_dssp EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHH
T ss_pred ccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhh
Confidence 567778888 99999999999 88855557799999999999999999855555565 3455555444211
Q ss_pred -----------c--------------ccCCch---------------------------h-hhhccccceecCCccccCC
Q 005875 190 -----------T--------------GNIPQS---------------------------I-QNLTQLTGLSLQSNNLSGS 216 (672)
Q Consensus 190 -----------~--------------~~~p~~---------------------------~-~~l~~L~~L~l~~N~l~~~ 216 (672)
. +.+|.. + ..+++|+.|+|++|+++..
T Consensus 162 ~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I 241 (329)
T 3sb4_A 162 RFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTI 241 (329)
T ss_dssp HTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEE
T ss_pred hccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCccee
Confidence 0 001110 0 1378999999999999844
Q ss_pred CCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCc-ccc
Q 005875 217 IPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS-FVG 253 (672)
Q Consensus 217 ~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~-~~~ 253 (672)
.+.. .+++|+.|+|.+| ++..-+..|.++++|. .+.
T Consensus 242 ~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~ 280 (329)
T 3sb4_A 242 PDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLE 280 (329)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred cHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEE
Confidence 3332 8999999999998 7744456788888887 443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.72 E-value=5.1e-11 Score=126.44 Aligned_cols=145 Identities=22% Similarity=0.246 Sum_probs=103.4
Q ss_pred eEEEEEeCCCCccccCCccccC-----CCCCCcEEEccCCCcCCCCCCcC-CCCCCCcEEeeeccCCCCCCCCCcc----
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLG-----KLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS---- 176 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~-----~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~l~~N~l~g~~p~~~~---- 176 (672)
.+..|+|++|.++..-.. .+. ...+|++|+|++|.|+..-...+ ..+++|+.|+|++|.++......+.
T Consensus 73 ~L~~L~Ls~n~l~~~~~~-~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCT-VVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TCCEEECTTSCCCHHHHH-HHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hCCEEEecCCCCCHHHHH-HHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 467899999988743222 232 23799999999999975433333 3567899999999999854333332
Q ss_pred ---cccceeecccccCcc----cCCchhhhhccccceecCCccccCCC----CC--CCCCCCceEEeecCCCCCC----C
Q 005875 177 ---PQLVVLDLSFNSFTG----NIPQSIQNLTQLTGLSLQSNNLSGSI----PN--FDIPKLRHLNLSYNGLKGS----I 239 (672)
Q Consensus 177 ---~~L~~L~ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~----p~--~~l~~L~~l~l~~N~l~g~----~ 239 (672)
++|++|+|++|+|+. .++..+..+++|+.|+|++|.|+..- +. ...++|+.|+|++|.++.. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 679999999999985 35566788999999999999998422 21 1567899999999999752 3
Q ss_pred CcccCCCCCCccc
Q 005875 240 PSSLQKFPNSSFV 252 (672)
Q Consensus 240 p~~~~~~~~l~~~ 252 (672)
+..+...++|..+
T Consensus 232 ~~~L~~~~~L~~L 244 (372)
T 3un9_A 232 ARAAREHPSLELL 244 (372)
T ss_dssp HHHHHHCSSCCEE
T ss_pred HHHHHhCCCCCEE
Confidence 3334334444444
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.54 E-value=1.7e-09 Score=122.02 Aligned_cols=109 Identities=15% Similarity=0.101 Sum_probs=54.2
Q ss_pred CCCCCCcEEEccCCCcCCCCCCcCCC-CCCCcEEeee----ccCCCCC-----CCCCcc--cccceeecccc--cCcccC
Q 005875 128 GKLDALEVLSLRSNVLTGGLPSEITS-LPSLRYLYLQ----HNNFSGK-----IPSSFS--PQLVVLDLSFN--SFTGNI 193 (672)
Q Consensus 128 ~~l~~L~~L~L~~N~l~g~~p~~~~~-l~~L~~L~l~----~N~l~g~-----~p~~~~--~~L~~L~ls~N--~l~~~~ 193 (672)
..+++|++|+|+.|.+++..+..++. +++|+.|+|+ .|++++. ++..+. ++|+.|+|++| .+++..
T Consensus 375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~ 454 (592)
T 3ogk_B 375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454 (592)
T ss_dssp HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence 34566666666666666555545544 5666666664 4555532 111111 45555555532 245444
Q ss_pred Cchhhh-hccccceecCCccccC-CCCC--CCCCCCceEEeecCCCC
Q 005875 194 PQSIQN-LTQLTGLSLQSNNLSG-SIPN--FDIPKLRHLNLSYNGLK 236 (672)
Q Consensus 194 p~~~~~-l~~L~~L~l~~N~l~~-~~p~--~~l~~L~~l~l~~N~l~ 236 (672)
+..++. +++|+.|+|++|++++ .++. ..+++|+.|+|++|.++
T Consensus 455 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp HHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred HHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence 444433 5555555555555543 1222 14455555555555554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=8.7e-07 Score=89.18 Aligned_cols=135 Identities=16% Similarity=0.166 Sum_probs=97.6
Q ss_pred cccccCcE-EEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 382 VLGKGSYG-TAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 382 ~lG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+..|..| .||+.... ++..+++|+-... ...++.+|...+..+..+--+.++++++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34446554 68988754 4567888876543 24568889999998866666888999999999999999999998887
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG------------------------------------------- 496 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------------------------------------------- 496 (672)
+..... ......+..+++..++.||...
T Consensus 109 ~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 109 QVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 665321 1223345556666666666421
Q ss_pred ------------CCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 497 ------------GPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 497 ------------~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
.+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137899999999999988777899998764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.46 E-value=4.9e-09 Score=99.63 Aligned_cols=111 Identities=14% Similarity=0.193 Sum_probs=79.7
Q ss_pred ccCCCCCCcEEEccCC-CcCCC----CCCcCCCCCCCcEEeeeccCCCCCCCCCcc------cccceeecccccCccc--
Q 005875 126 TLGKLDALEVLSLRSN-VLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGN-- 192 (672)
Q Consensus 126 ~~~~l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~------~~L~~L~ls~N~l~~~-- 192 (672)
.+...++|++|+|++| .|... +...+...++|++|+|++|.+...-...+. ++|++|+|++|+|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 5677888888999888 87632 344566778889999999988742222222 5788999999988854
Q ss_pred --CCchhhhhccccceec--CCccccCCCC----CC--CCCCCceEEeecCCCC
Q 005875 193 --IPQSIQNLTQLTGLSL--QSNNLSGSIP----NF--DIPKLRHLNLSYNGLK 236 (672)
Q Consensus 193 --~p~~~~~l~~L~~L~l--~~N~l~~~~p----~~--~l~~L~~l~l~~N~l~ 236 (672)
+...+...++|+.|+| ++|.|...-. .. ..++|++|+|++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4566777788999999 7888874221 11 4578999999988875
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.41 E-value=1.3e-07 Score=94.62 Aligned_cols=75 Identities=28% Similarity=0.467 Sum_probs=42.3
Q ss_pred CCCCCcEEeeeccCCCC--CCCCCcc--cccceeecccccCcccCCchhhhhc--cccceecCCccccCCCCCC------
Q 005875 153 SLPSLRYLYLQHNNFSG--KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLT--QLTGLSLQSNNLSGSIPNF------ 220 (672)
Q Consensus 153 ~l~~L~~L~l~~N~l~g--~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~~------ 220 (672)
++++|+.|+|++|+|++ .+|..+. ++|+.|+|++|+|++. ..+..++ +|+.|+|++|.+++.+|..
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 45566666666666665 3333322 5666666666666643 3344444 6666666666666655531
Q ss_pred ---CCCCCceEE
Q 005875 221 ---DIPKLRHLN 229 (672)
Q Consensus 221 ---~l~~L~~l~ 229 (672)
.+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 456666665
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.1e-08 Score=115.43 Aligned_cols=141 Identities=16% Similarity=0.109 Sum_probs=89.9
Q ss_pred eEEEEEeCCCC-ccc-cCCccccCCCCCCcEEEccCCCcCCC----CCCcCCCCCCCcEEeeeccCCCCCCCCCcc----
Q 005875 107 RVFGLRLPGIG-LVG-PIPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS---- 176 (672)
Q Consensus 107 ~v~~l~l~~~~-l~g-~~p~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~---- 176 (672)
++..|+|+++. ++. .++. ...++++|++|+|++|.+++. ++..+.++++|+.|+|++|.+++.-+..+.
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~ 217 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLS-IVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR 217 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHH-HHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHH-HHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh
Confidence 37788888775 211 1221 334778899999999988765 444556788899999999988743333322
Q ss_pred --cccceeecccccCcccCCchhhhhccccceecCCccccC---CCCC--CCCCCCceEEeecCCCCCCCCcccCCCCCC
Q 005875 177 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG---SIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPNS 249 (672)
Q Consensus 177 --~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~---~~p~--~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l 249 (672)
++|++|+|++|.+++ +|..+.++++|+.|+++++.... ..+. ..+++|+.|+++++. .+.+|..+..+++|
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L 295 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQI 295 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGC
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCC
Confidence 688999999988885 77888888888888887533221 1111 145566666666643 22455544444444
Q ss_pred c
Q 005875 250 S 250 (672)
Q Consensus 250 ~ 250 (672)
.
T Consensus 296 ~ 296 (592)
T 3ogk_B 296 R 296 (592)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=4.8e-06 Score=85.57 Aligned_cols=136 Identities=18% Similarity=0.197 Sum_probs=94.4
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCC--ceeceEEEEE-eCCeeEEEEEecCCCc
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP--NVVPLRAYYY-SKDEKLLVYDYFASGS 457 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~--niv~l~~~~~-~~~~~~lV~e~~~~g~ 457 (672)
+.++.|....||+. ++.+++|+-.. ......+.+|.+++..+.+|- .+.+.+.+.. ..+..++||||++|..
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45788888999988 56788887432 222457889999999995542 3566777764 3456789999999988
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG----------------------------------------- 496 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~----------------------------------------- 496 (672)
+.+.... .++..+...++.+++..|+.||+..
T Consensus 100 l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 100 LGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred Cchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8763211 1445555566666666666666422
Q ss_pred ----------------CCCcccCCCCCCCEEecC---CCCe-EEeecCCCCC
Q 005875 497 ----------------GPKFTHGNIKASNVLINQ---DLDG-CISDFGLTPL 528 (672)
Q Consensus 497 ----------------~~~ivHrDLk~~NILl~~---~~~~-kl~DfGla~~ 528 (672)
.+.++|+|+++.||++++ ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 234699999999999998 4554 7999997643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=1.7e-06 Score=90.82 Aligned_cols=80 Identities=14% Similarity=0.139 Sum_probs=57.7
Q ss_pred ccc-cccCcEEEEEEEEC-------CCcEEEEEEecccc---c-ChhhHHHHHHHHHHHcCC--CceeceEEEEEeC---
Q 005875 381 EVL-GKGSYGTAYKAVLE-------ESTTVVVKRLKEVV---V-GKRDFEQQMEIVGRVGQH--PNVVPLRAYYYSK--- 443 (672)
Q Consensus 381 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~-~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~--- 443 (672)
+.| +.|....+|+.... +++.+++|+..... . ....+.+|..++..+..+ -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999998764 25678888765432 1 235788999999888655 3577788887655
Q ss_pred CeeEEEEEecCCCchhh
Q 005875 444 DEKLLVYDYFASGSLST 460 (672)
Q Consensus 444 ~~~~lV~e~~~~g~L~~ 460 (672)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.18 E-value=4e-08 Score=110.76 Aligned_cols=61 Identities=16% Similarity=0.218 Sum_probs=25.3
Q ss_pred EEEEEeCCCCccccCCccccC-CCCCCcEEEccCC-CcCCC-CCCcCCCCCCCcEEeeeccCCCC
Q 005875 108 VFGLRLPGIGLVGPIPNNTLG-KLDALEVLSLRSN-VLTGG-LPSEITSLPSLRYLYLQHNNFSG 169 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~-~l~~L~~L~L~~N-~l~g~-~p~~~~~l~~L~~L~l~~N~l~g 169 (672)
++.|+|+++.+++..+. .+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++
T Consensus 107 L~~L~L~~~~~~~~~~~-~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~ 170 (594)
T 2p1m_B 107 LEEIRLKRMVVTDDCLE-LIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDD 170 (594)
T ss_dssp CCEEEEESCBCCHHHHH-HHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEEC
T ss_pred CCeEEeeCcEEcHHHHH-HHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCC
Confidence 44444444444433332 222 3444555555444 33211 22222344445555555544443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.17 E-value=2.3e-08 Score=112.69 Aligned_cols=107 Identities=18% Similarity=0.108 Sum_probs=63.2
Q ss_pred CCCCCcEEEccCCCcCCCCCCcCC-CCCCCcEEeee--c----cCCCCCCCC--C----c--ccccceeecccccCcccC
Q 005875 129 KLDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQ--H----NNFSGKIPS--S----F--SPQLVVLDLSFNSFTGNI 193 (672)
Q Consensus 129 ~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~l~--~----N~l~g~~p~--~----~--~~~L~~L~ls~N~l~~~~ 193 (672)
.+++|++|+++.|.+++..+..+. ++++|+.|+|+ + |.+++ .|. . + .++|+.|+|++ .+++..
T Consensus 370 ~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~ 447 (594)
T 2p1m_B 370 GCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKV 447 (594)
T ss_dssp HCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC-CCTHHHHHHHHHHCTTCCEEECCS-SCCHHH
T ss_pred hchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC-CchhhHHHHHHhhCCCccEEeecC-cccHHH
Confidence 366777777777777655554444 46777777777 3 44442 111 1 1 15677777765 566555
Q ss_pred Cchhhh-hccccceecCCccccCCCCCC---CCCCCceEEeecCCCCC
Q 005875 194 PQSIQN-LTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 194 p~~~~~-l~~L~~L~l~~N~l~~~~p~~---~l~~L~~l~l~~N~l~g 237 (672)
+..++. +++|+.|+|++|.+++..+.. .+++|+.|+|++|.+++
T Consensus 448 ~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp HHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred HHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 555554 666777777777765432221 46677777777777643
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.10 E-value=1.5e-07 Score=89.30 Aligned_cols=108 Identities=16% Similarity=0.209 Sum_probs=82.2
Q ss_pred CeEEEEEeCCC-Ccccc----CCccccCCCCCCcEEEccCCCcCCC----CCCcCCCCCCCcEEeeeccCCCCC----CC
Q 005875 106 TRVFGLRLPGI-GLVGP----IPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGK----IP 172 (672)
Q Consensus 106 ~~v~~l~l~~~-~l~g~----~p~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p 172 (672)
..++.|+|++| ++... +.. .+...++|++|+|++|.|+.. +...+...++|++|+|++|.|+.. +.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~-~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHH-HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 46888999998 76532 222 567789999999999999742 344556668999999999999853 22
Q ss_pred CCcc--cccceeec--ccccCccc----CCchhhhhccccceecCCcccc
Q 005875 173 SSFS--PQLVVLDL--SFNSFTGN----IPQSIQNLTQLTGLSLQSNNLS 214 (672)
Q Consensus 173 ~~~~--~~L~~L~l--s~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 214 (672)
..+. ++|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2333 68999999 88999864 4456666789999999999985
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.05 E-value=1.1e-06 Score=92.48 Aligned_cols=126 Identities=21% Similarity=0.255 Sum_probs=62.9
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCC--CCCCCcEEeeec--cCCCCC---------CCC
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEIT--SLPSLRYLYLQH--NNFSGK---------IPS 173 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~l~~L~~L~l~~--N~l~g~---------~p~ 173 (672)
++..|+|.++.- -.+++ +. +++|+.|+|..+.++......+. .+++|+.|+|+. |...|. +..
T Consensus 173 ~L~~L~L~g~~~-l~l~~--~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~ 248 (362)
T 2ra8_A 173 LLNNLKIKGTNN-LSIGK--KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248 (362)
T ss_dssp TCCEEEEECCBT-CBCCS--CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred CCcEEEEeCCCC-ceecc--cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence 455666655421 12332 22 56666666666665432222232 566666666643 221111 000
Q ss_pred CcccccceeecccccCcccCCchhh---hhccccceecCCccccCC----CCCC--CCCCCceEEeecCCCC
Q 005875 174 SFSPQLVVLDLSFNSFTGNIPQSIQ---NLTQLTGLSLQSNNLSGS----IPNF--DIPKLRHLNLSYNGLK 236 (672)
Q Consensus 174 ~~~~~L~~L~ls~N~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~----~p~~--~l~~L~~l~l~~N~l~ 236 (672)
.-.++|+.|+|++|.+++..+..+. .+++|+.|+|+.|.|++. ++.. .+++|+.|+|++|.++
T Consensus 249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 1125666666666666654443333 356666666666666542 2211 4566666666666655
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.00 E-value=1.6e-05 Score=84.76 Aligned_cols=135 Identities=16% Similarity=0.145 Sum_probs=69.6
Q ss_pred EEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc-cccceeeccc
Q 005875 108 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLSF 186 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~~L~~L~ls~ 186 (672)
++.+.|+++ +. .|+..+|.+ .+|+.++|.+ .++..-+..|.+|++|+.++|++|+++..-...|. .+|+.+.|.+
T Consensus 137 L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~ 212 (401)
T 4fdw_A 137 IAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPV 212 (401)
T ss_dssp CSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCT
T ss_pred ccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeCC
Confidence 555556544 33 455555655 3566666664 55533345566666666666666666632222333 5666666663
Q ss_pred ccCcccCCchhhhhccccceecCCccccCCCCC--CCCCCCceEEeecCCCCCCCCcccCCCCCCc
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 250 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~ 250 (672)
| ++..-..+|.+|++|+.|+|.+| ++ .++. +.-.+|+.+.| .|.++..-+..|.++++|.
T Consensus 213 ~-l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~~~L~~i~l-p~~i~~I~~~aF~~c~~L~ 274 (401)
T 4fdw_A 213 T-LKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEAFRESGITTVKL-PNGVTNIASRAFYYCPELA 274 (401)
T ss_dssp T-CCEECTTTTTTCTTCCCEECCTT-CC-EECTTTTTTCCCSEEEE-ETTCCEECTTTTTTCTTCC
T ss_pred c-hheehhhHhhCCCCCCEEecCCC-cc-CccccccccCCccEEEe-CCCccEEChhHhhCCCCCC
Confidence 3 55445556666666666666654 22 2222 12245555555 2333322233444444443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.00 E-value=9.4e-06 Score=86.62 Aligned_cols=123 Identities=15% Similarity=0.184 Sum_probs=72.1
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
.++.+.|++ ++. .|+...|.++.+|+.++|++|+++ .+|......++|+.+.|..| ++..-...|. ++|+.++|
T Consensus 158 ~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l 233 (401)
T 4fdw_A 158 TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEI 233 (401)
T ss_dssp CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEEC
T ss_pred CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEec
Confidence 467777775 455 566668888888888888888887 55544333577777777744 5533333343 56777777
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCC
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLK 236 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~ 236 (672)
.+| ++..-..+|.+ .+|+.+.| .|.++...+.. .+++|+.+++.+|.+.
T Consensus 234 ~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 234 PEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp CTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred CCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 654 44333445555 55666666 33343211211 5556666666655543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=7.7e-05 Score=79.42 Aligned_cols=74 Identities=12% Similarity=0.194 Sum_probs=50.0
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccc--------cChhhHHHHHHHHHHHcCC-Cc-eeceEEEEEeCCeeEEE
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--------VGKRDFEQQMEIVGRVGQH-PN-VVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~e~~~l~~l~~h-~n-iv~l~~~~~~~~~~~lV 449 (672)
+.+|.|.++.||++... +++.+++|...... ...+.+..|.+++..+..+ +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999754 46789999765321 1234567888888887543 33 4455543 45567899
Q ss_pred EEecCCC
Q 005875 450 YDYFASG 456 (672)
Q Consensus 450 ~e~~~~g 456 (672)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.87 E-value=5.1e-05 Score=78.72 Aligned_cols=142 Identities=15% Similarity=0.226 Sum_probs=79.9
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCC-CceeceEE------EEEeCCeeEEEEEecC
Q 005875 382 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-PNVVPLRA------YYYSKDEKLLVYDYFA 454 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~------~~~~~~~~~lV~e~~~ 454 (672)
.|+.|..+.||+....++ .+++|+... ...+...|..++..+.++ -.+.+++. +....+..++||||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 466677889999987654 588888765 234455566666555321 12344433 1234667899999999
Q ss_pred CCchh--------------hhhccCC-C---C-CC----CCCCHHHH-------------------------------HH
Q 005875 455 SGSLS--------------TLLHGNR-G---A-GR----TPLDWETR-------------------------------VK 480 (672)
Q Consensus 455 ~g~L~--------------~~l~~~~-~---~-~~----~~l~~~~~-------------------------------~~ 480 (672)
|..+. ..+|... . . .. ..-.|... ..
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 1111110 0 0 00 01123211 01
Q ss_pred HHHHHHHHHHHHHh--------c--CCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 481 ILLGTARGVAHIHS--------M--GGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 481 i~~~ia~gl~~LH~--------~--~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
+...+..++++|++ . ..+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11123345666653 1 23459999999999999888899999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=8.1e-05 Score=76.33 Aligned_cols=140 Identities=18% Similarity=0.169 Sum_probs=92.0
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCC--CceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH--PNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
+.|+.|.+..+|+.... ++.+++|+.... ....+..|.+.+..+..+ ..+++++++....+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 35788999999999864 678888886543 256788999998888543 6788899998888889999999998754
Q ss_pred hh-----------hhccCCC-C--C--------------CCCCCHHHHH---HHHH----------------HHHHH-HH
Q 005875 459 ST-----------LLHGNRG-A--G--------------RTPLDWETRV---KILL----------------GTARG-VA 490 (672)
Q Consensus 459 ~~-----------~l~~~~~-~--~--------------~~~l~~~~~~---~i~~----------------~ia~g-l~ 490 (672)
.. .+|.... . + .-.-+|.... ++.. .+..- ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 21 2232211 0 0 0012454321 1111 11111 12
Q ss_pred HHHh-cCCCCcccCCCCCCCEEecCCCCeEEeecC
Q 005875 491 HIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFG 524 (672)
Q Consensus 491 ~LH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DfG 524 (672)
.|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3321 2246799999999999999887 8899974
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.71 E-value=4.4e-06 Score=87.74 Aligned_cols=127 Identities=19% Similarity=0.286 Sum_probs=85.3
Q ss_pred CeEEEEEeCCCCccccCCcccc--CCCCCCcEEEccC--CCcCCC-----CCCcC--CCCCCCcEEeeeccCCCCCCCCC
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTL--GKLDALEVLSLRS--NVLTGG-----LPSEI--TSLPSLRYLYLQHNNFSGKIPSS 174 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~--~~l~~L~~L~L~~--N~l~g~-----~p~~~--~~l~~L~~L~l~~N~l~g~~p~~ 174 (672)
.++..|+|..+++....-. .+ ..+++|++|+|+. |...|. +-..+ ..+++|++|+|++|.+.+..+..
T Consensus 193 ~~L~~L~L~~~~l~~~~l~-~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 193 PNLKSLEIISGGLPDSVVE-DILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp TTCSEEEEECSBCCHHHHH-HHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCcEEEEecCCCChHHHH-HHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 3577788877766532221 23 3789999999964 222221 11122 35899999999999987543322
Q ss_pred c-----ccccceeecccccCccc----CCchhhhhccccceecCCccccCCCCCCCCCC--CceEEeecCC
Q 005875 175 F-----SPQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPK--LRHLNLSYNG 234 (672)
Q Consensus 175 ~-----~~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~--L~~l~l~~N~ 234 (672)
+ .++|++|+|+.|.|++. ++..+.++++|+.|+|++|.|+...-. .+.. ...+++++|+
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~-~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKK-ELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHH-HHHHHCCSEEECCSBC
T ss_pred HHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHH-HHHHHcCCEEEecCCc
Confidence 2 37899999999999974 556667899999999999988742111 1111 3568888877
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.0004 Score=70.32 Aligned_cols=73 Identities=15% Similarity=0.183 Sum_probs=54.4
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCC--ceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHP--NVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~--niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
+.+|.|..+.||+.+..+|+.+++|+-..... ....|+.|...++.+.+.. .+++++++. ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 46899999999999999999999998654432 2456889999999885432 345555542 3478999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00046 Score=73.96 Aligned_cols=73 Identities=12% Similarity=0.089 Sum_probs=44.8
Q ss_pred CCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCCCC-----CCCcccCcccccCCC---CCCccchhhHHHHHHHHH
Q 005875 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-----RSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEML 569 (672)
Q Consensus 498 ~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~~-----~~~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~el~ 569 (672)
+.++|+|+++.|||+++++ ++|+||+.+.......... -...|.+|+...... .....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4599999999999999876 9999999875432110000 011255555543211 112344557777778777
Q ss_pred hC
Q 005875 570 TG 571 (672)
Q Consensus 570 tg 571 (672)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0001 Score=65.16 Aligned_cols=57 Identities=19% Similarity=0.251 Sum_probs=44.6
Q ss_pred cEEeeeccCCC-CCCCCCcccccceeecccccCcccCCchhhhhccccceecCCcccc
Q 005875 158 RYLYLQHNNFS-GKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 214 (672)
Q Consensus 158 ~~L~l~~N~l~-g~~p~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 214 (672)
..++.+++.++ ..+|..+.++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36777777776 4677778788899999999998666667788888888888888764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00071 Score=68.92 Aligned_cols=71 Identities=6% Similarity=-0.011 Sum_probs=45.8
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec-CCCch
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF-ASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~-~~g~L 458 (672)
+.|+.|....+|+. ..+++|+.........+..+|..++..+..+.-..+++++ +.+.-++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 46888999999999 5688888765322223456788888777544333556554 344567899999 55444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0012 Score=67.97 Aligned_cols=144 Identities=15% Similarity=0.111 Sum_probs=83.1
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCC-ceeceEEE-----EEeCCeeEEEEEecCC
Q 005875 382 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLRAY-----YYSKDEKLLVYDYFAS 455 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~-----~~~~~~~~lV~e~~~~ 455 (672)
.++ |....||+....+|+.+++|...........+..|..++..+..+. .+++++.. ...++..++||||++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 355 7778999988777778999998644445667778888888775432 24444432 2234566889999988
Q ss_pred Cchhh-----------h---hccC----CCCCCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc---
Q 005875 456 GSLST-----------L---LHGN----RGAGRTPLDWETR----VKI---------------LLGTARGVAHIHSM--- 495 (672)
Q Consensus 456 g~L~~-----------~---l~~~----~~~~~~~l~~~~~----~~i---------------~~~ia~gl~~LH~~--- 495 (672)
..+.. . +|.. ........++... ..+ ...+...++.+...
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 54321 0 1110 0000111222211 001 01111223333221
Q ss_pred -CCCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 496 -GGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 496 -~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
..+.++|+|+++.||+++ + .+.|+||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 223489999999999999 4 899999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0011 Score=69.80 Aligned_cols=142 Identities=15% Similarity=0.196 Sum_probs=84.2
Q ss_pred cccccCcEEEEEEEEC--------CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 382 VLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+..|....+|+.... +++.+++|+.-..........+|.+++..+..+.-..++++++.+ .+||||+
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i 132 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYI 132 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEe
Confidence 4666777889999864 246788888644333456677899999888666555777776543 3899999
Q ss_pred CCCchhhh-----------------hccCCCCCCCCCC--HHHHHHHHHHHHH-------------------HHHHH---
Q 005875 454 ASGSLSTL-----------------LHGNRGAGRTPLD--WETRVKILLGTAR-------------------GVAHI--- 492 (672)
Q Consensus 454 ~~g~L~~~-----------------l~~~~~~~~~~l~--~~~~~~i~~~ia~-------------------gl~~L--- 492 (672)
+|..+..- +|...-....... +.+..++..++.. .+..|
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 98655311 1111111111122 3444444443321 23333
Q ss_pred -HhcC-CCCcccCCCCCCCEEecCC----CCeEEeecCCCC
Q 005875 493 -HSMG-GPKFTHGNIKASNVLINQD----LDGCISDFGLTP 527 (672)
Q Consensus 493 -H~~~-~~~ivHrDLk~~NILl~~~----~~~kl~DfGla~ 527 (672)
...+ ...++|+|+.+.||+++++ +.+.++||..+.
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2222 2348999999999999877 789999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0016 Score=70.35 Aligned_cols=74 Identities=7% Similarity=0.050 Sum_probs=49.2
Q ss_pred ccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 381 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
+.|+.|-...+|+....+ +..+++|+........-+..+|..++..+..+.-..++++.+. + .+||||++|-++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 457778889999999875 4678888764432222234688899998865554567777762 2 359999987554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.21 E-value=8.6e-05 Score=68.86 Aligned_cols=81 Identities=9% Similarity=0.063 Sum_probs=50.9
Q ss_pred CCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccC-CCCCCCCCcc------cccceeeccccc-CcccCCchhhhhcc
Q 005875 131 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN-FSGKIPSSFS------PQLVVLDLSFNS-FTGNIPQSIQNLTQ 202 (672)
Q Consensus 131 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~------~~L~~L~ls~N~-l~~~~p~~~~~l~~ 202 (672)
-.|+.|||+++.++..--..+.++++|+.|+|+++. ++..-=..+. ++|++|+|+++. ||..-=..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 368888888887764433456788888888888874 5532111111 357777777763 66433344556666
Q ss_pred ccceecCCc
Q 005875 203 LTGLSLQSN 211 (672)
Q Consensus 203 L~~L~l~~N 211 (672)
|+.|+|++.
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 666666665
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00081 Score=72.22 Aligned_cols=73 Identities=12% Similarity=0.104 Sum_probs=50.7
Q ss_pred ccccccCcEEEEEEEECC--------CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 381 EVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
+.|+.|....||++...+ ++.+++|+.... .....+..|..++..+..+.-..++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 457778889999998753 467888887432 1125566788888888655545677776532 389999
Q ss_pred cCCCch
Q 005875 453 FASGSL 458 (672)
Q Consensus 453 ~~~g~L 458 (672)
++|-++
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 987444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0026 Score=65.16 Aligned_cols=145 Identities=10% Similarity=0.096 Sum_probs=80.3
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCC-ceeceEEE------EEeCCeeEEEEEec
Q 005875 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLRAY------YYSKDEKLLVYDYF 453 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~------~~~~~~~~lV~e~~ 453 (672)
+.|+.|....+|+....++ .+++|..... ....++..|..++..+..+. .+.+++.. ....+..+++|+|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3467788889999987655 6788887652 23456677888887775432 13333321 12345678999999
Q ss_pred CCCchhh--------------hhccC-CCCCC---CCC---CHHHHHH------------HHHHHHHHHHHHHhc----C
Q 005875 454 ASGSLST--------------LLHGN-RGAGR---TPL---DWETRVK------------ILLGTARGVAHIHSM----G 496 (672)
Q Consensus 454 ~~g~L~~--------------~l~~~-~~~~~---~~l---~~~~~~~------------i~~~ia~gl~~LH~~----~ 496 (672)
+|..+.. .+|.. .+-.. ... .|..... +...+...++++++. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 9865321 11111 00000 001 1222110 001133445555532 1
Q ss_pred CCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 497 ~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
.+.++|+|+.+.||+++++..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2348999999999999987666899998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0013 Score=68.02 Aligned_cols=143 Identities=15% Similarity=0.092 Sum_probs=74.0
Q ss_pred cccccCcEE-EEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCC-ceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 382 VLGKGSYGT-AYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 382 ~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.|+.|+... +|+....+++.+++|...... ..++..|+.++..+..+. .+.+++.+.. +.-+++||++.+..+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcchH
Confidence 455554444 667765446677777543321 145566777777775442 3556666532 2237899999776665
Q ss_pred hhhccCC---------------------CCCCCCCCHHHHH-------H-------------HHHHHHHHHHHHH---hc
Q 005875 460 TLLHGNR---------------------GAGRTPLDWETRV-------K-------------ILLGTARGVAHIH---SM 495 (672)
Q Consensus 460 ~~l~~~~---------------------~~~~~~l~~~~~~-------~-------------i~~~ia~gl~~LH---~~ 495 (672)
+++.... ......++..... . ....+...++.+. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 4442210 0001112211100 0 0001112222331 11
Q ss_pred CCCCcccCCCCCCCEEecCC----CCeEEeecCCCCC
Q 005875 496 GGPKFTHGNIKASNVLINQD----LDGCISDFGLTPL 528 (672)
Q Consensus 496 ~~~~ivHrDLk~~NILl~~~----~~~kl~DfGla~~ 528 (672)
..+.++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 23459999999999999875 6789999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0017 Score=68.22 Aligned_cols=74 Identities=12% Similarity=0.112 Sum_probs=45.7
Q ss_pred ccccccCcEEEEEEEECC---------CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 381 EVLGKGSYGTAYKAVLEE---------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
+.++.|....+|+....+ ++.+++|+.........+...|.+++..+..+.-+.++++.. . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 357778888999998764 267888876543221123567888888875554355676554 2 368999
Q ss_pred ecCCCch
Q 005875 452 YFASGSL 458 (672)
Q Consensus 452 ~~~~g~L 458 (672)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.87 E-value=9.2e-05 Score=70.00 Aligned_cols=85 Identities=13% Similarity=0.140 Sum_probs=52.3
Q ss_pred cCCCCCCcEEEccCC-CcCC----CCCCcCCCCCCCcEEeeeccCCCCCCCCCcc------cccceeecccccCccc---
Q 005875 127 LGKLDALEVLSLRSN-VLTG----GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGN--- 192 (672)
Q Consensus 127 ~~~l~~L~~L~L~~N-~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~------~~L~~L~ls~N~l~~~--- 192 (672)
+.+-+.|++|+|++| .|.. .+-+.+..=+.|+.|+|++|++...--..+. +.|+.|+|++|+|+..
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 445567888888875 6652 1233445556788888888877643333333 5678888888887743
Q ss_pred -CCchhhhhccccceecCCc
Q 005875 193 -IPQSIQNLTQLTGLSLQSN 211 (672)
Q Consensus 193 -~p~~~~~l~~L~~L~l~~N 211 (672)
+-.++..-+.|+.|+|++|
T Consensus 117 ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCC
Confidence 2233444455777777654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0077 Score=62.33 Aligned_cols=69 Identities=16% Similarity=0.140 Sum_probs=44.2
Q ss_pred cccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCC--CceeceEEE------EEeCCeeEEEEEecCC
Q 005875 384 GKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH--PNVVPLRAY------YYSKDEKLLVYDYFAS 455 (672)
Q Consensus 384 G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h--~niv~l~~~------~~~~~~~~lV~e~~~~ 455 (672)
|.|....||+....++ .+++|+...... ..|..++..+.++ +++++.+.. ....+..++||+|++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4444679999987766 899998765431 3556666655332 224454432 2335677899999998
Q ss_pred Cch
Q 005875 456 GSL 458 (672)
Q Consensus 456 g~L 458 (672)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.47 E-value=0.00095 Score=61.79 Aligned_cols=80 Identities=10% Similarity=0.035 Sum_probs=56.8
Q ss_pred CCCcEEeeeccCCCCCCCCCcc--cccceeeccccc-CcccCCchhhhh----ccccceecCCcc-ccC--CCCCCCCCC
Q 005875 155 PSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNS-FTGNIPQSIQNL----TQLTGLSLQSNN-LSG--SIPNFDIPK 224 (672)
Q Consensus 155 ~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~--~~p~~~l~~ 224 (672)
-+|+.|||+++.++..--..+. ++|+.|+|+++. |+..-=..++.+ ++|+.|+|+++. ++. ...-..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 4799999999998743222332 789999999985 775444445553 479999999974 662 111126899
Q ss_pred CceEEeecCC
Q 005875 225 LRHLNLSYNG 234 (672)
Q Consensus 225 L~~l~l~~N~ 234 (672)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0061 Score=64.96 Aligned_cols=73 Identities=7% Similarity=0.070 Sum_probs=49.8
Q ss_pred cccccCcEEEEEEEECC--------CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 382 VLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+..|-...+|+....+ ++.+++|+........-+..+|..++..+..+.-..++++.+ . -+.||||+
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~efI 152 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEFI 152 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEECC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEEe
Confidence 45567778899998763 577888886543322334578888888886555556677643 2 37899999
Q ss_pred CCCch
Q 005875 454 ASGSL 458 (672)
Q Consensus 454 ~~g~L 458 (672)
+|..|
T Consensus 153 ~G~~l 157 (424)
T 3mes_A 153 DGEPL 157 (424)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.27 E-value=0.00034 Score=66.04 Aligned_cols=109 Identities=14% Similarity=0.209 Sum_probs=72.1
Q ss_pred CCeEEEEEeCCC-Cccc----cCCccccCCCCCCcEEEccCCCcCCC----CCCcCCCCCCCcEEeeeccCCCCCCCCCc
Q 005875 105 RTRVFGLRLPGI-GLVG----PIPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSF 175 (672)
Q Consensus 105 ~~~v~~l~l~~~-~l~g----~~p~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 175 (672)
...++.|+|+++ ++.. .+-+ .+..=+.|+.|+|++|.|... +-..+..=+.|+.|+|++|.|+..--..+
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~-aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHH-HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 356788888875 5432 1222 466678899999999999733 22233345789999999999984322222
Q ss_pred c------cccceeecccc---cCccc----CCchhhhhccccceecCCcccc
Q 005875 176 S------PQLVVLDLSFN---SFTGN----IPQSIQNLTQLTGLSLQSNNLS 214 (672)
Q Consensus 176 ~------~~L~~L~ls~N---~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 214 (672)
. +.|++|+|++| .|... +-..+..-+.|+.|+++.|.+.
T Consensus 119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 2 57999999876 34432 3445666677888888777643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.23 E-value=0.039 Score=52.39 Aligned_cols=102 Identities=12% Similarity=0.066 Sum_probs=66.4
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCCCC
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS 536 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 536 (672)
+|.+.|... ..+++++++..++.|.+.+|.-+-.... + ..+=+.|..|++..+|.|.+.+ ..+. .
T Consensus 34 SL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------~ 98 (229)
T 2yle_A 34 SLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------A 98 (229)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------c
Confidence 788888753 3469999999999999998877632111 1 1233456899999999998764 1111 1
Q ss_pred CCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 005875 537 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 574 (672)
Q Consensus 537 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~p 574 (672)
....+.|||... ...+.+.=|||+|+++|..+.-..|
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 122367888764 3456788999999999998864444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0065 Score=53.34 Aligned_cols=56 Identities=27% Similarity=0.260 Sum_probs=40.2
Q ss_pred EEEeCCCCcc-ccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCC
Q 005875 110 GLRLPGIGLV-GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS 168 (672)
Q Consensus 110 ~l~l~~~~l~-g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 168 (672)
.++.++++|+ ..+|.+ --.+|++|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~---lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTA---FPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSC---CCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCC---CCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5677777776 456652 2246888999999998544556778888888888888765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.012 Score=62.10 Aligned_cols=134 Identities=16% Similarity=0.133 Sum_probs=64.3
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
.+..+.++..- . .+....+.....|+.+.+..|..+ .-...|.++.+|+.+.+..+.+.. ..|. .+|+.+.+
T Consensus 231 ~l~~i~ip~~~-~-~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~---~~F~~~~~L~~i~l 304 (394)
T 4fs7_A 231 GVKNIIIPDSF-T-ELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE---KTFYGCSSLTEVKL 304 (394)
T ss_dssp CCCEEEECTTC-C-EECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT---TTTTTCTTCCEEEE
T ss_pred CCceEEECCCc-e-ecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc---cccccccccccccc
Confidence 34555555432 2 344446777777777777766443 333445556666655555443211 1111 45555555
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCC--C-CCCCCceEEeecCCCCCCCCcccCCCCCCc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--F-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 250 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~ 250 (672)
.+| ++..-..+|.++++|+.++|.++ ++ .++. + ++.+|+.++|..| ++..-...|.++++|.
T Consensus 305 ~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~ 369 (394)
T 4fs7_A 305 LDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLK 369 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCC
T ss_pred ccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCC
Confidence 433 44333445555555555555433 33 2222 1 4555555555444 3322223444444443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0078 Score=63.65 Aligned_cols=109 Identities=16% Similarity=0.230 Sum_probs=75.8
Q ss_pred CCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhh
Q 005875 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQN 199 (672)
Q Consensus 122 ~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~ 199 (672)
+...+|.+...|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-...|. .+|+.++|..| ++..-..+|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 44457888888888888766543 444568888888888886 445523233443 68888888765 66455678888
Q ss_pred hccccceecCCccccCCCCC---CCCCCCceEEeecCCC
Q 005875 200 LTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNGL 235 (672)
Q Consensus 200 l~~L~~L~l~~N~l~~~~p~---~~l~~L~~l~l~~N~l 235 (672)
|.+|+.+.|..| ++ .+.. .++++|+.+++.+|..
T Consensus 333 C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 333 CEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp CTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred CCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence 889998888655 44 3443 2788888888887754
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.019 Score=60.24 Aligned_cols=123 Identities=14% Similarity=0.095 Sum_probs=77.7
Q ss_pred ccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccc
Q 005875 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 203 (672)
Q Consensus 126 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L 203 (672)
.+....+|+.+.+..+ +...-...+.++.+|+.+.+..+ ++..-...|. .+|+.+.+..+ ++..-...|.+|++|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 5667778888887655 44234456778888888888765 4422223333 56788877644 554455677888888
Q ss_pred cceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCccc
Q 005875 204 TGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 204 ~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~ 252 (672)
+.+.+.+|.++..-... ++.+|+.+.|..| ++..-...|.++++|..+
T Consensus 289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i 338 (379)
T 4h09_A 289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTI 338 (379)
T ss_dssp CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCC
T ss_pred ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEE
Confidence 88888877776322222 7788888888654 442223456666666544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.72 E-value=0.013 Score=61.91 Aligned_cols=114 Identities=14% Similarity=0.196 Sum_probs=71.6
Q ss_pred CCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecC
Q 005875 132 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 209 (672)
Q Consensus 132 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 209 (672)
.+..+.+. +.+...-...|.++++|+.+.+.++..+ .-...|. ++|+.+.+. +.++..-..+|.+|.+|+.+.|.
T Consensus 243 ~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp 319 (394)
T 4gt6_A 243 EDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIP 319 (394)
T ss_dssp CCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECC
T ss_pred ccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeC
Confidence 34444443 2333233456788888888888766543 2233333 678888885 55664556678888888888887
Q ss_pred CccccCCCCC--C-CCCCCceEEeecCCCCCCCC-cccCCCCCCccc
Q 005875 210 SNNLSGSIPN--F-DIPKLRHLNLSYNGLKGSIP-SSLQKFPNSSFV 252 (672)
Q Consensus 210 ~N~l~~~~p~--~-~l~~L~~l~l~~N~l~g~~p-~~~~~~~~l~~~ 252 (672)
.| ++ .+.. + ++.+|+.+.|..+ ++ .|. ..|.++++|.-+
T Consensus 320 ~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i 362 (394)
T 4gt6_A 320 EG-IT-QILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNI 362 (394)
T ss_dssp TT-CC-EECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEE
T ss_pred Cc-cc-EehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEE
Confidence 65 44 3333 2 7788888888654 55 443 567777776543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.45 E-value=0.03 Score=59.08 Aligned_cols=43 Identities=7% Similarity=0.035 Sum_probs=24.3
Q ss_pred CCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeecc
Q 005875 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 165 (672)
Q Consensus 122 ~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 165 (672)
|...+|.++++|+.+.|.. .++..-...|.++++|+.++|.+|
T Consensus 62 Ig~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~ 104 (394)
T 4fs7_A 62 IGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS 104 (394)
T ss_dssp ECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT
T ss_pred hHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC
Confidence 4444566666666666653 355222345666666666666544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.07 E-value=0.07 Score=55.75 Aligned_cols=82 Identities=15% Similarity=0.210 Sum_probs=40.1
Q ss_pred ccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCC-Ccc--cccceeecccccCcccCCchhhhhcc
Q 005875 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS--PQLVVLDLSFNSFTGNIPQSIQNLTQ 202 (672)
Q Consensus 126 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~ 202 (672)
.+.+...|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++ .++. .|. ++|+.+++.+|.++..-+.+|.+|.+
T Consensus 235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~ 311 (379)
T 4h09_A 235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVK 311 (379)
T ss_dssp TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTT
T ss_pred cccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCC
Confidence 4555555555555443 33222344555555555555433 33 2222 222 45555555555555444445555555
Q ss_pred ccceecCC
Q 005875 203 LTGLSLQS 210 (672)
Q Consensus 203 L~~L~l~~ 210 (672)
|+.+.|..
T Consensus 312 L~~i~lp~ 319 (379)
T 4h09_A 312 LSSVTLPT 319 (379)
T ss_dssp CCEEECCT
T ss_pred CCEEEcCc
Confidence 55555543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.46 E-value=0.51 Score=49.70 Aligned_cols=29 Identities=21% Similarity=0.462 Sum_probs=24.3
Q ss_pred cccCCCCCCCEEe------cCCCCeEEeecCCCCC
Q 005875 500 FTHGNIKASNVLI------NQDLDGCISDFGLTPL 528 (672)
Q Consensus 500 ivHrDLk~~NILl------~~~~~~kl~DfGla~~ 528 (672)
++|+|+.+.|||+ +++..+.++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999987643
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.52 E-value=0.1 Score=35.61 Aligned_cols=31 Identities=29% Similarity=0.254 Sum_probs=16.8
Q ss_pred ceeeeeeechhHHHHHHHHHhhhhhccccCC
Q 005875 295 GAIIAIAVGGSAVLLLVALVILCYCLKKKDN 325 (672)
Q Consensus 295 ~~ii~ivv~~~~~~llv~~~i~~~~~~rk~~ 325 (672)
..|++.++++++++++++++++++.+||+++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 3455566666665555555555555555443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.34 E-value=0.085 Score=35.94 Aligned_cols=32 Identities=28% Similarity=0.389 Sum_probs=18.1
Q ss_pred ceeeeeeechhHHHHHHHHHhhhhhccccCCC
Q 005875 295 GAIIAIAVGGSAVLLLVALVILCYCLKKKDNG 326 (672)
Q Consensus 295 ~~ii~ivv~~~~~~llv~~~i~~~~~~rk~~~ 326 (672)
..|++.+++++++++++++.++++.+||++++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 44666666666665555555555555554443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=89.15 E-value=0.065 Score=35.46 Aligned_cols=31 Identities=19% Similarity=0.163 Sum_probs=20.3
Q ss_pred ccccceeeeeeechhHHHHHHHHHhhhhhcc
Q 005875 291 KLGLGAIIAIAVGGSAVLLLVALVILCYCLK 321 (672)
Q Consensus 291 ~~~~~~ii~ivv~~~~~~llv~~~i~~~~~~ 321 (672)
..+.++|.+++++.++.+++++.+++++++|
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 3456778888888777666665555555544
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=84.15 E-value=0.22 Score=33.87 Aligned_cols=29 Identities=17% Similarity=0.370 Sum_probs=14.2
Q ss_pred eeeeeeechhHHHHHHHHHhhhhhccccCC
Q 005875 296 AIIAIAVGGSAVLLLVALVILCYCLKKKDN 325 (672)
Q Consensus 296 ~ii~ivv~~~~~~llv~~~i~~~~~~rk~~ 325 (672)
.|+++++| +++++++++.+++|.+||+.+
T Consensus 13 ~Ia~~vVG-vll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 13 SIISAVVG-ILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHH-HHHHHHHHHHHHHHHHHHCSC
T ss_pred chHHHHHH-HHHHHHHHHHHHhheehhhhh
Confidence 35555555 444444444444555555443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 672 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-11 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-54
Identities = 69/276 (25%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
E LG G +G + T V VK LK+ + F + ++ ++ QH +V L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYA-V 76
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
+++ ++ +Y +GSL L G L + + A G+A I +
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---Y 130
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVIETRKHSHK 555
H +++A+N+L++ L I+DFGL L+ +R + APE I + K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 556 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 615
SDV+SFG+LL E++T + P +Q++ R ++R N E
Sbjct: 191 SDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLER--------GYRMVRPDNCPE 237
Query: 616 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
E+ Q++ C + P+ RP D + ++E+ +
Sbjct: 238 ELYQLM---RLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-53
Identities = 64/283 (22%), Positives = 127/283 (44%), Gaps = 35/283 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLR 437
+ +G GS+GT YK V VK L + F+ ++ ++ + +H N++
Sbjct: 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFM 70
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
Y + + +V + SL LH + + I TA+G+ ++H+
Sbjct: 71 GYS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 551
H ++K++N+ +++DL I DFGL + + + + S + APEVI +
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 552 ---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608
+S +SDVY+FG++L E++TG+ P + ++ + +V + +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFMVGRGYLSPDLS---K 233
Query: 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
N + M +++ C+ K D RP +++ IE + +S
Sbjct: 234 VRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIELLARS 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 6e-53
Identities = 62/277 (22%), Positives = 120/277 (43%), Gaps = 31/277 (11%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+ +G G +G + V +K ++E + + DF ++ E++ ++ HP +V L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC 69
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
+ LV+++ G LS L R ET + + L G+A++
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIETRKHSHK 555
H ++ A N L+ ++ +SDFG+T + S + +PEV ++S K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 556 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614
SDV+SFGVL+ E+ + GK P ++ + ++V+ + + +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST------------- 229
Query: 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
+ QI C + P+ RP ++R + E+ +S
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-52
Identities = 58/300 (19%), Positives = 109/300 (36%), Gaps = 35/300 (11%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
E +GKG +G ++ V VK E ++ + +H N++ A
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAAD 66
Query: 441 YSKDEKL----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-- 494
+ LV DY GSL L+ R + E +K+ L TA G+AH+H
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 495 ---MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA--------GYRA 543
G P H ++K+ N+L+ ++ CI+D GL + A Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 544 PEVIETRKH------SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM----VDLPRWVQSV 593
PEV++ + ++D+Y+ G++ E+ + + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653
+R+ + + E + M +I C R + + + ++ Q +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 4e-51
Identities = 63/272 (23%), Positives = 113/272 (41%), Gaps = 27/272 (9%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+ +GKG +G V VK +K + F + ++ ++ +H N+V L
Sbjct: 13 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLGVI 69
Query: 441 YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+ L +V +Y A GSL L GR+ L + +K L + ++
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 123
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLTPLMN-VPATPSRSAGYRAPEVIETRKHSHKSDV 558
F H ++ A NVL+++D +SDFGLT + T + APE + +K S KSDV
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 559 YSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMV 618
+SFG+LL E+ + R + D+ V+ + + +
Sbjct: 184 WSFGILLWEIYSFGRVPYP--RIPLKDVVPRVEKGYKMD-----------APDGCPPAVY 230
Query: 619 QMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650
+++ C MRP+ ++ +E ++
Sbjct: 231 EVM---KNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-51
Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 31/274 (11%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
+ LG G +G V +K +KE + + +F ++ +++ + H +V L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC 68
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
+ ++ +Y A+G L L R + +++ + ++ S F
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIETRKHSHK 555
H ++ A N L+N +SDFGL+ + S + PEV+ K S K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 556 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614
SD+++FGVL+ E+ + GK P + T + + + R +E
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE------------- 228
Query: 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648
++ I +C + D RP ++ I +V
Sbjct: 229 ----KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 6e-50
Identities = 64/302 (21%), Positives = 117/302 (38%), Gaps = 46/302 (15%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPN 432
+ LG G++G +A + + TV VK LK + + +++++ +G H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA-------------GRTPLDWETRV 479
+V L L++ +Y G L L R + LD E +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 480 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS- 538
A+G+A + S H ++ A N+L+ I DFGL + +
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 539 -----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 593
+ APE I ++ +SDV+S+G+ L E+ + + + + +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFYKM 260
Query: 594 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653
++E + R + E +M I C P RP ++V++IE+ S+S
Sbjct: 261 IKEGF----------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI-SES 309
Query: 654 EN 655
N
Sbjct: 310 TN 311
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-48
Identities = 48/291 (16%), Positives = 114/291 (39%), Gaps = 18/291 (6%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLR 437
LG G+ G +K + S + K + + + ++++++ P +V
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFY 70
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+YS E + ++ GSL +L + + K+ + +G+ ++
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIETRKHSHK 555
H ++K SN+L+N + + DFG++ + ++ + + Y +PE ++ +S +
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 556 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV--FDVELMRFQNI 613
SD++S G+ L+EM G+ P+ P ++ + E L +
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 614 EEEMVQMLQIGMACVAKVPDMRPNM---DEVVRMIEEVRQSDSENRPSSEE 661
+ + ++ V + P P+ E + + + R ++
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-48
Identities = 59/310 (19%), Positives = 127/310 (40%), Gaps = 38/310 (12%)
Query: 381 EVLGKGSYGTAYKAVLEES---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVP 435
+V+G+G++G KA +++ +KR+KE RDF ++E++ ++G HPN++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGN-----------RGAGRTPLDWETRVKILLG 484
L + L +Y G+L L + + + L + +
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 485 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---Y 541
ARG+ ++ F H ++ A N+L+ ++ I+DFGL+ V + +
Sbjct: 136 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192
Query: 542 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601
A E + ++ SDV+S+GVLL E+++ P + + +
Sbjct: 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGM--TCAELYEKLPQ------ 241
Query: 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 661
L + N ++E+ ++ C + P RP+ +++ + + + ++
Sbjct: 242 --GYRLEKPLNCDDEVYDLM---RQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 296
Query: 662 NKSKDSNVQT 671
K + +
Sbjct: 297 EKFTYAGIDC 306
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-48
Identities = 66/286 (23%), Positives = 122/286 (42%), Gaps = 30/286 (10%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 440
LG+G +G + +T V +K LK + F Q+ +++ ++ +H +V L A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYA-V 80
Query: 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 500
S++ +V +Y + GSL L G G L V + A G+A++ M +
Sbjct: 81 VSEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---Y 134
Query: 501 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVIETRKHSHK 555
H +++A+N+L+ ++L ++DFGL L+ +R + APE + + K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 556 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 615
SDV+SFG+LL E+ T ++ V+ R E +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVERGYRMPCPPECPE----------- 241
Query: 616 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS-DSENRPSSE 660
+ + C K P+ RP + + +E+ S + + +P
Sbjct: 242 ---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (427), Expect = 5e-48
Identities = 65/290 (22%), Positives = 129/290 (44%), Gaps = 41/290 (14%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVV 434
+V+G G +G L + V +K LK +RDF + I+G+ HPNV+
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVI 90
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
L +++ ++ +GSL + L N G V +L G A G+ ++
Sbjct: 91 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLAD 146
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---------SAGYRAPE 545
M + H ++ A N+L+N +L +SDFGL+ + + + APE
Sbjct: 147 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604
I+ RK + SDV+S+G+++ E+++ G+ P T D+++ + +++
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-------IEQDY------ 250
Query: 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 654
R + + Q+ + C K + RP ++V ++++ ++ +
Sbjct: 251 ----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (418), Expect = 9e-47
Identities = 64/279 (22%), Positives = 119/279 (42%), Gaps = 29/279 (10%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
LG G YG Y+ V ++ TV VK LKE + +F ++ ++ + +HPN+V L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 81
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+ ++ ++ G+L L R + + + + + ++
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN--- 135
Query: 500 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-----AGYRAPEVIETRKHSH 554
F H ++ A N L+ ++ ++DFGL+ LM + + + APE + K S
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614
KSDV++FGVLL E+ T +DL + + + ++ R + E
Sbjct: 196 KSDVWAFGVLLWEIATYGMSP-----YPGIDLSQVYELLEKD-----------YRMERPE 239
Query: 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653
++ ++ AC P RP+ E+ + E + Q S
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 9e-47
Identities = 65/329 (19%), Positives = 116/329 (35%), Gaps = 56/329 (17%)
Query: 355 PEKNKLVFFEGCSYNFDLEDLLRAS----AEVLGKGSYGTAYKAVLEES------TTVVV 404
N+ + + Y +DL+ +VLG G++G A V V
Sbjct: 13 SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 72
Query: 405 KRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL 462
K LKE + +++++ ++G H N+V L L+++Y G L L
Sbjct: 73 KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 132
Query: 463 HGNRG------------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 504
R L +E + A+G+ + H +
Sbjct: 133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189
Query: 505 IKASNVLINQDLDGCISDFGLTPLMN------VPATPSRSAGYRAPEVIETRKHSHKSDV 558
+ A NVL+ I DFGL + V + APE + ++ KSDV
Sbjct: 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249
Query: 559 YSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 617
+S+G+LL E+ + G P P + + +Q+ + + EE+
Sbjct: 250 WSYGILLWEIFSLGVNPY--PGIPVDANFYKLIQNGFKMDQP-----------FYATEEI 296
Query: 618 VQMLQIGMACVAKVPDMRPNMDEVVRMIE 646
++Q +C A RP+ + +
Sbjct: 297 YIIMQ---SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (417), Expect = 1e-46
Identities = 61/304 (20%), Positives = 124/304 (40%), Gaps = 55/304 (18%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPN 432
+G+G++G ++A E T V VK LKE + DF+++ ++ +PN
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPN 77
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG-------------------AGRTPL 473
+V L L+++Y A G L+ L G PL
Sbjct: 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 474 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--- 530
++ I A G+A++ F H ++ N L+ +++ I+DFGL+ +
Sbjct: 138 SCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 531 ---VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 586
+ + PE I +++ +SDV+++GV+L E+ + G P ++++
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 254
Query: 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 646
V D ++ E +++ + C +K+P RP+ + R+++
Sbjct: 255 ---------------VRDGNILAC--PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
Query: 647 EVRQ 650
+ +
Sbjct: 298 RMCE 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-46
Identities = 64/286 (22%), Positives = 115/286 (40%), Gaps = 39/286 (13%)
Query: 381 EVLGKGSYGTAYKAVLEESTT----VVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPNVV 434
EV+G+G +G Y L ++ VK L + + F + I+ HPNV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 91
Query: 435 PLRAYYYSKDEK-LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
L + L+V Y G L + + + L A+G+ +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLA 147
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--------SAGYRAPE 545
S F H ++ A N ++++ ++DFGL M S + A E
Sbjct: 148 SKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605
++T+K + KSDV+SFGVLL E++T AP P D + +++
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDV--NTFDITVYLLQGR-------- 251
Query: 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
L++ + + + ++ + C +MRP+ E+V I + +
Sbjct: 252 RLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-46
Identities = 62/294 (21%), Positives = 126/294 (42%), Gaps = 38/294 (12%)
Query: 381 EVLGKGSYGTAYKAVLEEST-----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNV 433
+V+G G +G YK +L+ S+ V +K LK + DF + I+G+ H N+
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNI 71
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+ L +++ +Y +G+L L G V +L G A G+ ++
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLA 127
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-------GYRAPEV 546
+M + H ++ A N+L+N +L +SDFGL+ ++ + + + APE
Sbjct: 128 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606
I RK + SDV+SFG+++ E++T ++ + + R
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGER--PYWELSNHEVMKAINDGFRLPT-------- 234
Query: 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSE 660
+ + Q+ M C + RP ++V +++++ ++ + ++
Sbjct: 235 ------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-45
Identities = 61/300 (20%), Positives = 119/300 (39%), Gaps = 45/300 (15%)
Query: 369 NFDLEDLLRASAEVLGKGSYGTAYKAVL---EESTTVVVKRLKEVV--VGKRDFEQQMEI 423
N + D+ LG G++G+ + V ++ V +K LK+ + ++ +I
Sbjct: 9 NLLIADI------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 424 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 483
+ ++ +P +V L + + +LV + G L L G R + ++L
Sbjct: 63 MHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLH 116
Query: 484 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------ 537
+ G+ ++ F H ++ A NVL+ ISDFGL+ + +
Sbjct: 117 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 538 -SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 595
+ APE I RK S +SDV+S+GV + E L+ G+ P + +++ +++ R
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGKR 230
Query: 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 655
E E ++ + C + RP+ V + + S +
Sbjct: 231 MECPPECPP--------------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-45
Identities = 51/276 (18%), Positives = 114/276 (41%), Gaps = 33/276 (11%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPL 436
+G GSYG K + +V K L + K+ ++ ++ + +HPN+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRY 68
Query: 437 RAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
+ L V +Y G L++++ R LD E ++++ + H
Sbjct: 69 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHR 127
Query: 495 MG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIE 548
G H ++K +NV ++ + + DFGL ++N + +++ Y +PE +
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608
++ KSD++S G LL E+ P + ++ ++ ++ + +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------------KIREGKFR 232
Query: 609 RF-QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
R +E+ +++ + RP+++E++
Sbjct: 233 RIPYRYSDELNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 5e-45
Identities = 61/298 (20%), Positives = 121/298 (40%), Gaps = 40/298 (13%)
Query: 354 EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVV 412
+P+ +L F + F +G GS+G Y A + S V +K++
Sbjct: 1 DPDVAELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK 53
Query: 413 GK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA 468
+D +++ + ++ +HPN + R Y + LV +Y + L +
Sbjct: 54 QSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-- 110
Query: 469 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528
PL + G +G+A++HS H ++KA N+L+++ + DFG +
Sbjct: 111 ---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 529 MNVPATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 585
M + + + APEVI ++ K DV+S G+ +E+ K PL +
Sbjct: 165 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-- 222
Query: 586 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
+ + + E A ++ + E + +C+ K+P RP + +++
Sbjct: 223 ----LYHIAQNESPA-------LQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-44
Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 32/269 (11%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPL 436
LGKG +G Y A ++S + +K L + + K E Q+ E+ + +HPN++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
Y++ L+ +Y G++ L D + + A +++ HS
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR 126
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--SAGYRAPEVIETRKHSH 554
H +IK N+L+ + I+DFG + + + Y PE+IE R H
Sbjct: 127 ---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183
Query: 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614
K D++S GVL E L GK P ++ T + V+ + T D+
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL--------- 234
Query: 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
+ ++L+ P RP + EV+
Sbjct: 235 --ISRLLK-------HNPSQRPMLREVLE 254
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 160 bits (405), Expect = 2e-44
Identities = 55/297 (18%), Positives = 121/297 (40%), Gaps = 32/297 (10%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 438
E LG G++G ++ + K + K ++++ + + +HP +V L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHD 90
Query: 439 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 498
+ +E +++Y++ + G L + + + V+ + +G+ H+H
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 499 KFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVP---ATPSRSAGYRAPEVIETRKHS 553
+ H ++K N++ + DFGLT ++ + +A + APEV E +
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 554 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613
+ +D++S GVL +L+G +P D+ +++V +W ++ F I
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWN-----MDDSAFSGI 252
Query: 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR---MIEEVRQSDSENRPSSEENKSKDS 667
E+ ++ + P+ R + + + + PSS K +DS
Sbjct: 253 SEDGKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 7e-44
Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 34/274 (12%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRD---FEQQMEIVGRVGQHPNVVPL 436
+G+GS+ T YK + E+T V L++ + K + F+++ E++ + QHPN+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRF 73
Query: 437 RAYYYS----KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
+ S K +LV + SG+L T L + + + +G+ +
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFL 128
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR--SAGYRAPEVIET 549
H+ P H ++K N+ I I D GL L + + + APE+ E
Sbjct: 129 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 186
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609
K+ DVY+FG+ +LEM T + P + + R V S V+ +V E+
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244
Query: 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
C+ + D R ++ +++
Sbjct: 245 I-------------IEGCIRQNKDERYSIKDLLN 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 65/285 (22%), Positives = 111/285 (38%), Gaps = 41/285 (14%)
Query: 381 EVLGKGSYGTAYKAVLEEST----TVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPN 432
E LG GS+G + + + +V VK LK V+ + DF +++ + + H N
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRN 72
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
++ L + K+ V + GSL L ++G T + + A G+ ++
Sbjct: 73 LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYL 127
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------SAGYRAPE 545
S F H ++ A N+L+ I DFGL + + APE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604
++TR SH SD + FGV L EM T G+ P ++ + +E
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------IDKEGE------ 232
Query: 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649
R E+ + + + C A P+ RP + + E +
Sbjct: 233 ----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 41/280 (14%)
Query: 382 VLGKGSYGTAYKAVLEESTT---VVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVP 435
LG G++GT K + V VK LK K + + ++ ++ +P +V
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVR 72
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
+ + +LV + G L+ L NR + + ++++ + G+ ++
Sbjct: 73 MIGICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES 126
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------SAGYRAPEVIE 548
F H ++ A NVL+ ISDFGL+ + + + APE I
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 549 TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607
K S KSDV+SFGVL+ E + G+ P + ++ + ++ R
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---LEKGERMGCP-------- 232
Query: 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647
EM ++ C + RP V +
Sbjct: 233 ---AGCPREMYDLM---NLCWTYDVENRPGFAAVELRLRN 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-43
Identities = 58/292 (19%), Positives = 119/292 (40%), Gaps = 35/292 (11%)
Query: 363 FEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQ 420
+E + + + ED LG G++G YKA +E++ + K + + D+ +
Sbjct: 1 YEHVTRDLNPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 59
Query: 421 MEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK 480
++I+ HPN+V L +Y ++ ++ ++ A G++ ++ PL
Sbjct: 60 IDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQV 114
Query: 481 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-- 538
+ T + ++H H ++KA N+L D D ++DFG++ S
Sbjct: 115 VCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
Query: 539 --AGYRAPEVI-----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ 591
+ APEV+ + R + +K+DV+S G+ L+EM + P + +
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LL 225
Query: 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
+ + E L + L+ C+ K D R ++++
Sbjct: 226 KIAKSEP------PTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 6e-43
Identities = 67/296 (22%), Positives = 121/296 (40%), Gaps = 48/296 (16%)
Query: 381 EVLGKGSYGTAYKAVLEES--------TTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQH 430
+ LG+G++G A T V VK LK K D +ME++ +G+H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 431 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRV 479
N++ L ++ +Y + G+L L R G L + V
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 480 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS- 538
ARG+ ++ S H ++ A NVL+ +D I+DFGL ++ ++
Sbjct: 139 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 539 -----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQS 592
+ APE + R ++H+SDV+SFGVLL E+ T G +P +++ + ++
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---KLLKE 252
Query: 593 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648
R + + + ++ + C VP RP ++V ++ +
Sbjct: 253 GHRMDKPSNCTN--------------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 6e-42
Identities = 70/299 (23%), Positives = 117/299 (39%), Gaps = 44/299 (14%)
Query: 381 EVLGKGSYGTAYKAVLEES------TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPN 432
+ LG+G++G +A TV VK LKE R +++I+ +G H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 433 VVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVK 480
VV L L ++ ++ G+LST L R + L E +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 481 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA- 539
A+G+ + S H ++ A N+L+++ I DFGL + R
Sbjct: 139 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 540 -----GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 594
+ APE I R ++ +SDV+SFGVLL E+ + A V + +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDEEFCRRL 250
Query: 595 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653
+E R + + +M Q + C P RP E+V + + Q+++
Sbjct: 251 KEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 299
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 1e-41
Identities = 53/269 (19%), Positives = 111/269 (41%), Gaps = 31/269 (11%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 438
E +G+G+ GT Y A+ + V ++++ + K ++ ++ ++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLD 84
Query: 439 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 498
Y DE +V +Y A GSL+ ++ T +D + + + +HS
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 499 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKHSH 554
H +IK+ N+L+ D ++DFG + + + + APEV+ + +
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614
K D++S G++ +EM+ G+ P + + L + EL + +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNGT------PELQNPEKLS 243
Query: 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
L C+ + R + E+++
Sbjct: 244 AIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 152 bits (385), Expect = 2e-41
Identities = 57/296 (19%), Positives = 119/296 (40%), Gaps = 31/296 (10%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 438
E LG G++G ++ V + + V K + + K + ++ I+ ++ HP ++ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHD 93
Query: 439 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 498
+ K E +L+ ++ + G L + + + + G+ H+H
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHS-- 147
Query: 499 KFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHS 553
H +IK N++ I DFGL +N + + APE+++
Sbjct: 148 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 554 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613
+D+++ GVL +L+G +P + +Q+V R +W FD + F ++
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWE---FDEDA--FSSV 255
Query: 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQSDSENRPSSEENKSKDS 667
E ++ + K P R + + + ++ + + PSS NK +
Sbjct: 256 SPEAKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-41
Identities = 58/284 (20%), Positives = 112/284 (39%), Gaps = 38/284 (13%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVV 434
+G+G +G ++ + + V +K K + F Q+ + + HP++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIV 71
Query: 435 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 494
L +++ ++ + G L + L + LD + + + +A++ S
Sbjct: 72 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLES 126
Query: 495 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIET 549
F H +I A NVL++ + + DFGL+ M S G + APE I
Sbjct: 127 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 550 RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608
R+ + SDV+ FGV + E+L G P Q +D++ +++ R
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGERLPM---------- 230
Query: 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652
N + ++ C A P RP E+ + + + +
Sbjct: 231 -PPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTILEEE 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 60/273 (21%), Positives = 114/273 (41%), Gaps = 34/273 (12%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRL--KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
+ LG+G+YG AV + V VK + K V + ++++ I + H NVV
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFY 69
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ + + L +Y + G L + + G + + GV ++H +G
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIG- 123
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 551
TH +IK N+L+++ + ISDFGL + + Y APE+++ R+
Sbjct: 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 552 -HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610
H+ DV+S G++L ML G+ P P+ D + W + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEKKTYLN-----------PW 229
Query: 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
+ I+ + +L + + P R + ++ +
Sbjct: 230 KKIDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-40
Identities = 51/301 (16%), Positives = 124/301 (41%), Gaps = 31/301 (10%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
E LG+G +G ++ V S T + K +K + ++++ I+ +H N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHES 69
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+ S +E ++++++ + + ++ + L+ V + + +HS
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHN--- 122
Query: 500 FTHGNIKASNVLINQDLDG--CISDFGLTPLMNVP---ATPSRSAGYRAPEVIETRKHSH 554
H +I+ N++ I +FG + + Y APEV + S
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614
+D++S G L+ +L+G P + T + +++++ E+T FD E F+ I
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYT---FDEEA--FKEIS 231
Query: 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVR---MIEEVRQSDSENRPSSEENKSKDSNVQT 671
E + + + K R E ++ + +++ + ++ + + + + ++
Sbjct: 232 IEAMDFVD---RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
Query: 672 P 672
Sbjct: 289 D 289
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-40
Identities = 57/298 (19%), Positives = 113/298 (37%), Gaps = 41/298 (13%)
Query: 381 EVLGKGSYGTAYKAVLEES-----TTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 433
+VLG G++GT YK + V +K L+E K ++ + ++ V +P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 73
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
L L+ G L + ++ + + + + A+G+ ++
Sbjct: 74 CRLL-GICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLE 128
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAPEVI 547
H ++ A NVL+ I+DFGL L+ + G + A E I
Sbjct: 129 DRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 548 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606
R ++H+SDV+S+GV + E++T G P ++ + +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------------- 230
Query: 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKS 664
R + + I + C D RP E++ ++ + D + + ++
Sbjct: 231 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR-DPQRYLVIQGDER 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 63/303 (20%), Positives = 113/303 (37%), Gaps = 41/303 (13%)
Query: 381 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPN 432
LG+GS+G Y+ V E T V +K + E + +F + ++ +
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHH 84
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----RTPLDWETRVKILLGTAR 487
VV L L++ + G L + L R A P +++ A
Sbjct: 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 488 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGY 541
G+A++++ F H ++ A N ++ +D I DFG+T + + +
Sbjct: 145 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 542 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 601
+PE ++ + SDV+SFGV+L E+ T + R+V +
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFVMEGGLLDKPDN 259
Query: 602 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS--S 659
D + ++ C P MRP+ E++ I+E + S
Sbjct: 260 CPD--------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 305
Query: 660 EEN 662
EEN
Sbjct: 306 EEN 308
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-39
Identities = 57/306 (18%), Positives = 120/306 (39%), Gaps = 36/306 (11%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
+VLG G G + + + +K L++ +++E+ R Q P++V +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDV 73
Query: 440 YYSKDEK----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
Y + L+V + G L + + G +I+ + ++HS+
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 496 GGPKFTHGNIKASNVLINQDLDG---CISDFG---LTPLMNVPATPSRSAGYRAPEVIET 549
H ++K N+L ++DFG T N TP + Y APEV+
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609
K+ D++S GV++ +L G P S + + + +++ +R ++
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYS---NHGLAISPGMKTRIRMGQ----YEFPNPE 240
Query: 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV-----VRMIEEVRQSDSENRPSSEENKS 664
+ + EE+ +++ + P R + E + +V Q+ +E+K
Sbjct: 241 WSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 665 KDSNVQ 670
+ +V+
Sbjct: 298 RWEDVK 303
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 142 bits (360), Expect = 6e-39
Identities = 51/281 (18%), Positives = 107/281 (38%), Gaps = 42/281 (14%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLK----------EVVVGKRDFEQQMEIVGRVGQ 429
E+LG+G + + + + VK + EV + ++++I+ +V
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
HPN++ L+ Y + LV+D G L L L + KI+ +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVI 123
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEV 546
+H + H ++K N+L++ D++ ++DFG + ++ G Y APE+
Sbjct: 124 CALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 547 IET------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 600
IE + + D++S GV++ +L G P + M+ +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-----------RMIMS 229
Query: 601 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 641
+ + + + + ++ + P R +E
Sbjct: 230 GNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 6e-38
Identities = 44/272 (16%), Positives = 106/272 (38%), Gaps = 38/272 (13%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 435
++LG+GS+ T A L S +K L++ + K + ++ +++ R+ HP V
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVK 72
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
L + ++ Y +G L + D + ++H
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG- 126
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS------AGYRAPEVIET 549
H ++K N+L+N+D+ I+DFG +++ + +R+ A Y +PE++
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609
+ SD+++ G ++ +++ G P ++ + ++ +E
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ---------------KIIKLEYDF 229
Query: 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 641
+ + +++ + R +E+
Sbjct: 230 PEKFFPKARDLVE---KLLVLDATKRLGCEEM 258
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-36
Identities = 58/272 (21%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 435
++LGKGS+G + A +++ +K LK+ VV D + ++ +HP +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
+ + +K+ V +Y G L + D G+ +HS
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK 122
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRK 551
G + ++K N+L+++D I+DFG+ + + + Y APE++ +K
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611
++H D +SFGVLL EML G++P +++ R E D+
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL------ 233
Query: 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
+V++ + P+ R + +R
Sbjct: 234 -----LVKLFV-------REPEKRLGVRGDIR 253
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (345), Expect = 1e-36
Identities = 51/269 (18%), Positives = 110/269 (40%), Gaps = 26/269 (9%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRD-FEQQMEIVGRVGQHPNVVPLR 437
+VLG G++ A + + V +K + K+ + GK E ++ ++ ++ +HPN+V L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALD 73
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
Y S L+ + G L + +++ V ++H +G
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHSH 554
+++D ISDFGL+ + + + S + G Y APEV+ + +S
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614
D +S GV+ +L G P + + +++ E ++ + + +I
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQILKAE-----YEFDSPYWDDIS 237
Query: 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
+ ++ + K P+ R ++ ++
Sbjct: 238 DSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 132 bits (333), Expect = 3e-35
Identities = 54/286 (18%), Positives = 108/286 (37%), Gaps = 40/286 (13%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVP 435
E+LG G + A L V VK L+ + F ++ + + HP +V
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVA 71
Query: 436 LRAYYYSKDEKL----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 491
+ ++ +V +Y +L ++H P+ + ++++ + +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNF 126
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------SAGYRAP 544
H G H ++K +N++I+ + DFG+ + +A Y +P
Sbjct: 127 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 545 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604
E +SDVYS G +L E+LTG+ P + + VRE+
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP---- 233
Query: 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVR 649
R + + ++ ++ + +AK P+ R E+ + V
Sbjct: 234 -PSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 132 bits (333), Expect = 4e-35
Identities = 43/288 (14%), Positives = 80/288 (27%), Gaps = 36/288 (12%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
+G+GS+G ++ L + V +K + + + + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
+LV D L R +T V IH
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKS--- 121
Query: 500 FTHGNIKASNVLINQDLDG-----CISDFGLTPLMNVPATPSR-----------SAGYRA 543
+ +IK N LI + + DFG+ P T +A Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 544 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603
R+ S + D+ + G + + L G P Q + + E+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
EE + + D P+ D + + +V +
Sbjct: 242 A-------GFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 8e-35
Identities = 66/287 (22%), Positives = 111/287 (38%), Gaps = 38/287 (13%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
+V+G GS+G Y+A L +S V +K++ + KR ++++I+ ++ H N+V LR +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKL-DHCNIVRLRYF 81
Query: 440 YYSKDEK------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+YS EK LV DY H +R + L + R +A+IH
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLM---NVPATPSRSAGYRAP-EVIE 548
S G H +IK N+L++ D + DFG + + S YRAP +
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 549 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV------ 602
++ DV+S G +L E+L G+ + D + V E E+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 603 --------FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 641
+ E + + + P R E
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEA 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (328), Expect = 2e-34
Identities = 45/283 (15%), Positives = 86/283 (30%), Gaps = 34/283 (12%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
+G GS+G Y + V +K V + +I + Q +P +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMM-QGGVGIPTIRW 70
Query: 440 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 499
++ + ++ SL L + +T + + + +IHS
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKN--- 123
Query: 500 FTHGNIKASNVLINQDLDG---CISDFGLTPLMNVPATPSR-----------SAGYRAPE 545
F H ++K N L+ G I DFGL T +A Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605
+ S + D+ S G +L+ G P Q ++
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-------YERISEKKMSTP 236
Query: 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648
+ + E L C + D +P+ + ++ +
Sbjct: 237 IEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 130 bits (328), Expect = 8e-34
Identities = 50/281 (17%), Positives = 106/281 (37%), Gaps = 37/281 (13%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQ-------MEIVGRVGQHPN 432
++G+G +G Y ++ +K L + + + E + +V G P
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV-STGDCPF 68
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
+V + +++ D+ + D G L L + G+ H+
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHM 123
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIET- 549
H+ + ++K +N+L+++ ISD GL P + GY APEV++
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609
+ +D +S G +L ++L G +P + D ++ R ++ E
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----------- 229
Query: 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650
+ E+ +L+ + + + R R +EV++
Sbjct: 230 -DSFSPELRSLLE---GLLQRDVNRRLGCLG--RGAQEVKE 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-33
Identities = 58/278 (20%), Positives = 109/278 (39%), Gaps = 38/278 (13%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLK-------EVVVGKRDFEQQMEIVGRVGQHPN 432
E LG G + K + + K +K V + D E+++ I+ + QHPN
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPN 74
Query: 433 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 492
V+ L Y +K + +L+ + A G L L L E + L GV ++
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYL 129
Query: 493 HSMGGPKFTHGNIKASNVLINQDLDG----CISDFGLTPLMNVPATPSRSAG---YRAPE 545
HS+ + H ++K N+++ I DFGL ++ G + APE
Sbjct: 130 HSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 546 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605
++ ++D++S GV+ +L+G +P T+ + + V +E+
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY------- 239
Query: 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
F N ++ + K P R + + ++
Sbjct: 240 ----FSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 128 bits (321), Expect = 1e-33
Identities = 59/285 (20%), Positives = 113/285 (39%), Gaps = 34/285 (11%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRL---KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 437
E +G+G+YG YKA T +K++ KE +++ I+ + +H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLY 66
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
++K +LV+++ L L+ T LL G+A+ H
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIE-TRKH 552
H ++K N+LIN++ + I+DFGL +P YRAP+V+ ++K+
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 553 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR--- 609
S D++S G + EM+ G + D + + + V ++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 610 -----------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
+ ++E + +L + P+ R + +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 8e-33
Identities = 58/300 (19%), Positives = 111/300 (37%), Gaps = 32/300 (10%)
Query: 381 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQMEIVG-----RVGQHPNV 433
+G+G+YG +KA ++ V +KR++ + + V +HPNV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 434 VPLRAYYYS----KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
V L ++ KL + L+T L G + ET ++ RG+
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQLLRGL 129
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEV 546
+HS H ++K N+L+ ++DFGL + + + YRAPEV
Sbjct: 130 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186
Query: 547 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606
+ ++ D++S G + EM K + + D + V + EE +
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 607 LMRFQNIEEEMVQMLQIGMA---------CVAKVPDMRPNMDEVVRM--IEEVRQSDSEN 655
F + + ++ + C+ P R + + +++ + EN
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC-KEN 305
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 6e-32
Identities = 54/321 (16%), Positives = 116/321 (36%), Gaps = 46/321 (14%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLR 437
+G+G+YG A + V +K++ + ++++I+ R +H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGIN 72
Query: 438 AYYYSKD----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+ + + + + L LL L + L RG+ +IH
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIH 126
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGL-------TPLMNVPATPSRSAGYRAPEV 546
S H ++K SN+L+N D I DFGL + YRAPE+
Sbjct: 127 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 547 IET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605
+ + ++ D++S G +L EML+ + D ++ + +E + ++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 606 ELMR----------------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEE 647
+ F N + + + +L + P R +++ + +E+
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALAHPYLEQ 300
Query: 648 VRQSDSENRPSSEENKSKDSN 668
E + + +
Sbjct: 301 YYDPSDEPIAEAPFKFDMELD 321
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-31
Identities = 52/276 (18%), Positives = 99/276 (35%), Gaps = 44/276 (15%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLK-------EVVVGKRDFEQQMEIVGRV-GQHP 431
+LG G +G+ Y + + ++ V +K ++ + ++ ++ +V
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 432 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 491
V+ L ++ D +L+ + RG L E V H
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR--SAGYRAPEVIE 548
H+ G H +IK N+LI+ + + DFG L+ + Y PE I
Sbjct: 126 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 549 TRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607
+ H + V+S G+LL +M+ G P + E+ ++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQV 221
Query: 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643
Q + E +++ C+A P RP +E+
Sbjct: 222 FFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 51/289 (17%), Positives = 113/289 (39%), Gaps = 37/289 (12%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGK------RDFEQQMEIVGRVGQHPNV 433
+ LG+G + T YKA + + V +K++K + R ++++++ + HPN+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNI 62
Query: 434 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+ L + K LV+D+ + + + L +L T +G+ ++H
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH 117
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIET 549
H ++K +N+L++++ ++DFGL P + YRAPE++
Sbjct: 118 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 550 RK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-------------DLPRWVQSVVR 595
+ + D+++ G +L E+L L + D + P
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 596 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644
+ + F ++++ ++Q P R + ++M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (302), Expect = 1e-30
Identities = 51/275 (18%), Positives = 106/275 (38%), Gaps = 33/275 (12%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQME---IVGRVGQHPNVVPL 436
LG GS+G + + +K LK+ +V + + ++ + HP ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
+ + ++ DY G L +LL ++ + ++HS
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPATPSRSAGYRAPEVIETRKHSHK 555
+ ++K N+L++++ I+DFG + +V T + Y APEV+ T+ ++
Sbjct: 125 ---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 556 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 615
D +SFG+L+ EML G P + ++ + EL E
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYE---------------KILNAELRFPPFFNE 226
Query: 616 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650
++ +L + + R + E+V+
Sbjct: 227 DVKDLLS---RLITRDLSQRLGNLQ--NGTEDVKN 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 54/284 (19%), Positives = 110/284 (38%), Gaps = 34/284 (11%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPL 436
E +G+G+YG YKA + + V +K+++ + +++ ++ + HPN+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKL 66
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
+++++ LV+++ + + L +G+A HS
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVI-ETRK 551
+ H ++K N+LIN + ++DFGL VP YRAPE++ +
Sbjct: 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR-- 609
+S D++S G + EM+T +A + D + E V + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 610 ------------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 641
++E+ +L + P+ R +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 7e-30
Identities = 62/316 (19%), Positives = 120/316 (37%), Gaps = 35/316 (11%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPL 436
+ +G G+YG AV + V +K+L + + +++ ++ + +H NV+ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGL 82
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
+ + D++ G L + ++ +G+ +IH+ G
Sbjct: 83 LDVFTPDETLDDFTDFYLVMPFMGTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAG 141
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPEVI-ETRKHSH 554
H ++K N+ +N+D + I DFGL + T YRAPEVI +++
Sbjct: 142 ---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR----- 609
D++S G ++ EM+TGK + D + V E+ + E
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 610 -----------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQSDSENR 656
N V +L+ + + R E + E + D+E+
Sbjct: 259 PELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEALAHPYFESLH--DTEDE 313
Query: 657 PSSEE-NKSKDSNVQT 671
P ++ + S D +T
Sbjct: 314 PQVQKYDDSFDDVDRT 329
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (290), Expect = 8e-29
Identities = 53/278 (19%), Positives = 104/278 (37%), Gaps = 19/278 (6%)
Query: 334 KASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYK 393
A+ G ++ +EF + +E K + D D ++ LG GS+G
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----TLGTGSFGRVML 59
Query: 394 AVLEES-TTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 448
+ES +K L + V K + I+ V P +V L + +
Sbjct: 60 VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118
Query: 449 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKAS 508
V +Y A G + + L ++HS+ + ++K
Sbjct: 119 VMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 509 NVLINQDLDGCISDFGL-TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLE 567
N+LI+Q ++DFG + T + APE+I ++ ++ D ++ GVL+ E
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 568 MLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605
M G P + + + + +++++ D+
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (288), Expect = 9e-29
Identities = 50/289 (17%), Positives = 117/289 (40%), Gaps = 22/289 (7%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 439
LG+G Y ++A+ + + VVVK LK V K+ +++++I+ + PN++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADI 98
Query: 440 YYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ LV+++ + L L + + + + HSMG
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG- 149
Query: 498 PKFTHGNIKASNVLI-NQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEV-IETRKH 552
H ++K NV+I ++ + D+GL + + ++ PE+ ++ + +
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 553 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612
+ D++S G +L M+ K P D+ L R + + E+ + +
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPF-FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 661
+ + + + + E + ++++ + D ++R ++ E
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 52/279 (18%), Positives = 104/279 (37%), Gaps = 38/279 (13%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 435
++LGKG++G + + +K L++ V+ +D + ++ +HP +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTA 69
Query: 436 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 495
L+ + + D V +Y G L L R E + ++HS
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR 124
Query: 496 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRK 551
+ +IK N+++++D I+DFGL + + Y APEV+E
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611
+ D + GV++ EM+ G+ P + + + +L + + E +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL------ 235
Query: 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650
+ +L+ K P R +EV +
Sbjct: 236 -----LAGLLK-------KDPKQRLGGGP--SDAKEVME 260
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-27
Identities = 56/284 (19%), Positives = 112/284 (39%), Gaps = 30/284 (10%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPL 436
E +G+G+YGT +KA E+ V +KR++ + +++ ++ + +H N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRL 66
Query: 437 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 496
+S + LV+++ N LD E L +G+ HS
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 497 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----RSAGYRAPEVIETRK- 551
H ++K N+LIN++ + +++FGL +P + YR P+V+ K
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 552 HSHKSDVYSFGVLLLEMLTGKAPL-QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610
+S D++S G + E+ PL DD + + EE + + +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 611 QNIEEEMVQMLQIG-----------MACVAKVPDMRPNMDEVVR 643
+ ++ + + P R + +E ++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 2e-26
Identities = 56/286 (19%), Positives = 108/286 (37%), Gaps = 40/286 (13%)
Query: 381 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGKRD-----FEQQMEIVGRVGQHP 431
+VLG G+YG + + +K LK+ + ++ + +++ + Q P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 432 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 491
+V L + ++ + L+ DY G L T L R + + H
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEH 144
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-----AGYRAPEV 546
+H +G + +IK N+L++ + ++DFGL+ T Y AP++
Sbjct: 145 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 547 IET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604
+ H D +S GVL+ E+LTG +P + + E + +
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-----------SQAEISRRILK 250
Query: 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650
E Q + ++Q + K P R R +E+++
Sbjct: 251 SEPPYPQEMSALAKDLIQ---RLLMKDPKKRLGCGP--RDADEIKE 291
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 4e-26
Identities = 54/297 (18%), Positives = 112/297 (37%), Gaps = 27/297 (9%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLK---EVVVGKRDFEQQMEIVGRVGQHPNVVPL 436
+G+G++G +KA ++ V +K++ E ++++I+ + +H NVV L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNL 74
Query: 437 RAYYYSKDEKLLVYD---YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 493
+K Y L G +++ G+ +IH
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134
Query: 494 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--------SAGYRAPE 545
H ++KA+NVLI +D ++DFGL ++ + YR PE
Sbjct: 135 RNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 546 VIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604
++ + + D++ G ++ EM T +Q T + L + + E V +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 661
EL + + + ++ + + P D + +++ D R S++
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYAL---DLIDKLL----VLDPAQRIDSDD 301
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 53/293 (18%), Positives = 119/293 (40%), Gaps = 31/293 (10%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLK---EVVVGKRDFEQQMEIVGRVGQHPNVVPL 436
+G G+YG+ A + V VK+L + ++ + +++ ++ + +H NV+ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGL 82
Query: 437 RAYYYSKD-----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 491
+ + + + L+ ++ + L + ++ RG+ +
Sbjct: 83 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKY 136
Query: 492 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVI-ET 549
IHS H ++K SN+ +N+D + I DFGL + + YRAPE++
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 193
Query: 550 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609
++ D++S G ++ E+LTG+ D + L + EL++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG---------TPGAELLK 244
Query: 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVRMIEEVRQSDSENRPSSEE 661
+ E + + ++ + V ++E++ DS+ R ++ +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 2e-23
Identities = 55/323 (17%), Positives = 108/323 (33%), Gaps = 44/323 (13%)
Query: 381 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 437
+ +G G+ G A V +K+L + ++ E+ + + H N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 438 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 497
+ + D + L + + LD E +L G+ H+HS
Sbjct: 83 NVFTPQKTLEEFQDVYLVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA-- 138
Query: 498 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHSH 554
H ++K SN+++ D I DFGL + YRAPEVI +
Sbjct: 139 -GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 555 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------------------------LP 587
D++S G ++ EM+ K D + P
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257
Query: 588 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR---M 644
++ + + +F + + + +L + P R ++D+ ++ +
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAKRISVDDALQHPYI 314
Query: 645 IEEVRQSDSENRPSSEENKSKDS 667
++ E P +K D
Sbjct: 315 NVWYDPAEVEAPPPQIYDKQLDE 337
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.0 bits (245), Expect = 5e-23
Identities = 51/310 (16%), Positives = 98/310 (31%), Gaps = 33/310 (10%)
Query: 381 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ---------- 429
LG G + T + A + +T V +K ++ V E +++++ RV
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
+++ L ++ K + LL + + +I G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVPATPSRSA------GYR 542
++H G H +IK NVL+ D + + L N YR
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 543 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-----------LPRWVQ 591
+PEV+ +D++S L+ E++TG + L
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651
++R F +NI + L+ + K E+ + + Q
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA--KEISDFLSPMLQL 314
Query: 652 DSENRPSSEE 661
D R +
Sbjct: 315 DPRKRADAGG 324
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.9 bits (206), Expect = 7e-18
Identities = 41/180 (22%), Positives = 62/180 (34%), Gaps = 25/180 (13%)
Query: 74 FADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDAL 133
+D P N + I T + L L + P L L L
Sbjct: 209 ISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP---LSGLTKL 265
Query: 134 EVLSLRSNVLTGGLP--------------------SEITSLPSLRYLYLQHNNFSGKIPS 173
L L +N ++ P S I++L +L YL L NN S P
Sbjct: 266 TELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV 325
Query: 174 SFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 233
S +L L + N + S+ NLT + LS N +S P ++ ++ L L+
Sbjct: 326 SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.0 bits (188), Expect = 1e-15
Identities = 42/156 (26%), Positives = 58/156 (37%), Gaps = 27/156 (17%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN 192
L+ LSL N L + SL +L L L +N S P S +L L L N +
Sbjct: 221 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNI 278
Query: 193 IP--------------------QSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSY 232
P I NL LT L+L NN+S P + KL+ L +
Sbjct: 279 SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFAN 338
Query: 233 NGLKGSIPSSLQKFPNSSFV---GNSLLCGPPLKAC 265
N + SSL N +++ N + PL
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISDLTPLANL 372
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 62.7 bits (151), Expect = 5e-11
Identities = 25/88 (28%), Positives = 35/88 (39%), Gaps = 2/88 (2%)
Query: 153 SLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNN 212
L +L L +N S P L L L+ N ++ +LT LT L L +N
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252
Query: 213 LSGSIPNFDIPKLRHLNLSYNGLKGSIP 240
+S P + KL L L N + P
Sbjct: 253 ISNLAPLSGLTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 16/82 (19%), Positives = 33/82 (40%), Gaps = 2/82 (2%)
Query: 152 TSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 211
T+L L N + + + Q+ L +I ++ L LT ++ +N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNN 76
Query: 212 NLSGSIPNFDIPKLRHLNLSYN 233
L+ P ++ KL + ++ N
Sbjct: 77 QLTDITPLKNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 4e-04
Identities = 24/111 (21%), Positives = 38/111 (34%), Gaps = 2/111 (1%)
Query: 151 ITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS 210
+ +L +L L + N S + L L + N + P I T L LSL
Sbjct: 171 LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNG 228
Query: 211 NNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPP 261
N L + L L+L+ N + P S +G + +
Sbjct: 229 NQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNIS 279
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 15/70 (21%), Positives = 28/70 (40%), Gaps = 5/70 (7%)
Query: 199 NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNS 255
L + L N++ ++ D+ ++ L G+K SI ++ N + + N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQ 77
Query: 256 LLCGPPLKAC 265
L PLK
Sbjct: 78 LTDITPLKNL 87
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.1 bits (188), Expect = 5e-16
Identities = 27/83 (32%), Positives = 35/83 (42%), Gaps = 20/83 (24%)
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 242
DL N G +PQ + L L L++ NNL G IP +
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG--------------------GN 289
Query: 243 LQKFPNSSFVGNSLLCGPPLKAC 265
LQ+F S++ N LCG PL AC
Sbjct: 290 LQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 59/162 (36%), Positives = 82/162 (50%), Gaps = 8/162 (4%)
Query: 66 SDRQALLDFADAVPHLRKL-NWSSTNPICQ-SWVGINCTQD--RTRVFGLRLPGIGLVGP 121
D+QALL + + L +W T C +W+G+ C D RV L L G+ L P
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 122 IP-NNTLGKLDALEVLSLRSNV-LTGGLPSEITSLPSLRYLYLQHNNFSGKIP--SSFSP 177
P ++L L L L + L G +P I L L YLY+ H N SG IP S
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 219
LV LD S+N+ +G +P SI +L L G++ N +SG+IP+
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 18/58 (31%), Positives = 26/58 (44%), Gaps = 1/58 (1%)
Query: 138 LRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGNIP 194
LR+N + G LP +T L L L + NN G+IP + + V + N P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.4 bits (116), Expect = 6e-07
Identities = 16/88 (18%), Positives = 27/88 (30%), Gaps = 2/88 (2%)
Query: 85 NWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT 144
+ + GL L + G +P L +L L L++ N L
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ-GLTQLKFLHSLNVSFNNLC 281
Query: 145 GGLPSEITSLPSLRYLYLQHNNFSGKIP 172
G +P + +L +N P
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (153), Expect = 1e-11
Identities = 35/168 (20%), Positives = 60/168 (35%), Gaps = 4/168 (2%)
Query: 80 HLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLR 139
L +L+ + +G + + L L L +P++T L L L L
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLH 161
Query: 140 SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QLVVLDLSFNSFTGNIPQSI 197
N ++ L SL L L N + P +F +L+ L L N+ + +++
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221
Query: 198 QNLTQLTGLSLQSNNLSGSIPNFDIPK-LRHLNLSYNGLKGSIPSSLQ 244
L L L L N + L+ S + + S+P L
Sbjct: 222 APLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (133), Expect = 4e-09
Identities = 43/220 (19%), Positives = 67/220 (30%), Gaps = 36/220 (16%)
Query: 75 ADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALE 134
A + R L + + + + L L + + T L L
Sbjct: 49 AASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH 108
Query: 135 VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF--SPQLVVLDLSFNSFTGN 192
L L L P L +L+YLYLQ N +F L L L N +
Sbjct: 109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168
Query: 193 IPQSIQNLTQLTGLSLQSNNLSGSIPNF--------------------------DIPKLR 226
++ + L L L L N ++ P+ + L+
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228
Query: 227 HLNLSYNGLKGSIP-----SSLQKFPNSSFVGNSLLCGPP 261
+L L+ N + LQKF SS + + C P
Sbjct: 229 YLRLNDNPWVCDCRARPLWAWLQKFRGSS---SEVPCSLP 265
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (93), Expect = 4e-04
Identities = 27/156 (17%), Positives = 47/156 (30%), Gaps = 36/156 (23%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKI---------- 171
IP + + + L N ++ + + +L L+L N +
Sbjct: 30 IPAAS-------QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 172 ---------------PSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 214
P++F +L L L P + L L L LQ N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 215 GSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+ D+ L HL L N + + + +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 0.002
Identities = 6/34 (17%), Positives = 10/34 (29%)
Query: 171 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 204
+P + L N + S + LT
Sbjct: 26 VPVGIPAASQRIFLHGNRISHVPAASFRACRNLT 59
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 64.1 bits (154), Expect = 2e-11
Identities = 24/94 (25%), Positives = 40/94 (42%), Gaps = 8/94 (8%)
Query: 138 LRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSI 197
N + + S PSL L + +N ++P+ P+L L SFN +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP-PRLERLIASFNHLA-EVPELP 323
Query: 198 QNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLS 231
QNL Q L ++ N L P+ + L ++
Sbjct: 324 QNLKQ---LHVEYNPLR-EFPDI-PESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.9 bits (138), Expect = 1e-09
Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 8/89 (8%)
Query: 159 YLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 218
YL ++ + P L L++S N +P L + L N+L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVP 320
Query: 219 NFDIPKLRHLNLSYNGLKG--SIPSSLQK 245
L+ L++ YN L+ IP S++
Sbjct: 321 EL-PQNLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.6 bits (132), Expect = 8e-09
Identities = 19/73 (26%), Positives = 35/73 (47%), Gaps = 8/73 (10%)
Query: 130 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 189
+LE L++ +N L LP+ P L L N+ + ++P L L + +N
Sbjct: 283 PPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPELP-QNLKQLHVEYNPL 336
Query: 190 TG--NIPQSIQNL 200
+IP+S+++L
Sbjct: 337 REFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 4e-06
Identities = 18/79 (22%), Positives = 28/79 (35%), Gaps = 3/79 (3%)
Query: 184 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 243
N+ + I L L++ +N L +P P+L L S+N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL-PPRLERLIASFNHLA-EVPELP 323
Query: 244 QKFPNSSFVGNSLLCGPPL 262
Q N L P +
Sbjct: 324 QNLKQLHVEYNPLREFPDI 342
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 14/60 (23%), Positives = 26/60 (43%), Gaps = 6/60 (10%)
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG 237
Q L+L+ + ++P+ +L L N+L+ +P L+ L + N LK
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPEL-PQSLKSLLVDNNNLKA 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 3e-04
Identities = 17/56 (30%), Positives = 22/56 (39%), Gaps = 3/56 (5%)
Query: 201 TQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSL 256
Q L L + LS S+P P L L S N L +P Q + N+L
Sbjct: 38 RQAHELELNNLGLS-SLPEL-PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 90
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 13/59 (22%), Positives = 21/59 (35%), Gaps = 6/59 (10%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTG 191
L L + L+ LP P L L N+ + ++P L L + N+
Sbjct: 40 AHELELNNLGLSS-LPELP---PHLESLVASCNSLT-ELPELPQ-SLKSLLVDNNNLKA 92
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.3 bits (148), Expect = 2e-11
Identities = 34/203 (16%), Positives = 62/203 (30%), Gaps = 33/203 (16%)
Query: 381 EVLGKGSYGTAYKAVLEESTTVVVKRLK-----------EVVVGKRDFEQQMEIVGRVGQ 429
+++G+G + E+ VVK K + G F R +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN-E 64
Query: 430 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 489
+ L+ K Y + + L L+ + + ++L V
Sbjct: 65 FRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD---EVLDMILEEV 116
Query: 490 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY--RAPEVI 547
A + HG++ NVL+ + I DF + V R I
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQS----VEVGEEGWREILERDVRNI 168
Query: 548 ET---RKHSHKSDVYSFGVLLLE 567
T R + + D+ S +L+
Sbjct: 169 ITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.1 bits (152), Expect = 2e-11
Identities = 56/284 (19%), Positives = 95/284 (33%), Gaps = 25/284 (8%)
Query: 2 RGLASFP-HVSRNIETLLGLHFCYSSHLLIPCIKQLLMKFSSAAPLFFPLCVIVSLLPLA 60
GL P + + L L + + K L + L I + P A
Sbjct: 20 LGLEKVPKDLPPDTALLD-LQNNKITEIKDGDFKNL----KNLHTLILINNKISKISPGA 74
Query: 61 FADLNS------DRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLP 114
FA L + L + + +P + N I + + ++ V L
Sbjct: 75 FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134
Query: 115 GIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS 174
+ G + L + + +T +P + PSL L+L N + +S
Sbjct: 135 PLKSSGIENG-AFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAAS 190
Query: 175 FS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-FDIPKLRHLNLS 231
L L LSFNS + S+ N L L L +N L D ++ + L
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250
Query: 232 YNGLKGSIPSSLQKFPNSSFVGNSL----LCGPPLKACFPVAPS 271
N + +I S+ P + S L P++ + + PS
Sbjct: 251 NNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ-YWEIQPS 292
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 62.0 bits (149), Expect = 5e-11
Identities = 29/106 (27%), Positives = 40/106 (37%), Gaps = 4/106 (3%)
Query: 156 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
LR + K+P P +LDL N T +NL L L L +N +S
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 216 SIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCG 259
P + KL L LS N LK +P + K V + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITK 114
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.4 bits (144), Expect = 3e-10
Identities = 14/108 (12%), Positives = 28/108 (25%), Gaps = 7/108 (6%)
Query: 133 LEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLS 185
++ L ++ L+ + L + + L + S P L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 233
N + Q +Q +L + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL 111
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 3e-08
Identities = 21/93 (22%), Positives = 29/93 (31%), Gaps = 15/93 (16%)
Query: 155 PSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGNIPQSI-----QNLTQL 203
LR L+L + S SS + L LDLS N + Q L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 204 TGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 236
L L S + + L+ L L+
Sbjct: 429 EQLVLYDIYWSEEMEDR----LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 5e-08
Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 14/93 (15%)
Query: 156 SLRYLYLQHNNFSGKIPSSFSP---QLVVLDLSFNSFTG----NIPQSIQNLTQLTGLSL 208
++ L +Q S + P Q V+ L T +I +++ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 209 QSNNLSGSIPNF-------DIPKLRHLNLSYNG 234
+SN L + K++ L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 6e-08
Identities = 18/90 (20%), Positives = 29/90 (32%), Gaps = 15/90 (16%)
Query: 133 LEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-------PQLVV 181
L VL L ++ L + + + SLR L L +N L
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 182 LDLSFNSFTGNIPQSIQNL----TQLTGLS 207
L L ++ + +Q L L +S
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 6e-07
Identities = 15/77 (19%), Positives = 25/77 (32%), Gaps = 7/77 (9%)
Query: 176 SPQLVVLDLSFNSFTGN-IPQSIQNLTQLTGLSLQSNNLSG----SIPNF--DIPKLRHL 228
S + LD+ + + + L Q + L L+ I + P L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 229 NLSYNGLKGSIPSSLQK 245
NL N L + +
Sbjct: 61 NLRSNELGDVGVHCVLQ 77
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.3 bits (130), Expect = 1e-09
Identities = 28/120 (23%), Positives = 43/120 (35%), Gaps = 9/120 (7%)
Query: 135 VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIP 194
VL L LT + L + +L L HN P+ + + L +
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 195 QSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSYN---GLKGSIPSSLQKFPN 248
+ NL +L L L +N L S + P+L LNL N +G + P+
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 3e-08
Identities = 24/109 (22%), Positives = 39/109 (35%), Gaps = 9/109 (8%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186
L +L + L L N L P+ + +L L L N + P+L L L
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQELLLCN 74
Query: 187 NSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNFD------IPKLRHL 228
N Q + + +L L+LQ N+L +P + +
Sbjct: 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 6e-07
Identities = 23/94 (24%), Positives = 36/94 (38%), Gaps = 6/94 (6%)
Query: 158 RYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
R L+L H + + + + LDLS N P ++ L L L N L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 216 SIPNFDIPKLRHLNLSYNGLKG-SIPSSLQKFPN 248
++P+L+ L L N L+ + L P
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 91
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.003
Identities = 19/126 (15%), Positives = 37/126 (29%), Gaps = 13/126 (10%)
Query: 63 DLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPI 122
L +L + + + L+ S N + + + + + G
Sbjct: 4 HLAHKDLTVLCHLEQLLLVTHLDLSH-NRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 123 PNNTLGKLDALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSGKIP-----SSFS 176
L +L L +N L + S P L L LQ N+ + +
Sbjct: 63 NLPRLQELL------LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 177 PQLVVL 182
P + +
Sbjct: 117 PSVSSI 122
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 2e-08
Identities = 16/78 (20%), Positives = 30/78 (38%), Gaps = 1/78 (1%)
Query: 150 EITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 209
E++ + S + N + +P +L LS N ++ T+LT L+L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 210 SNNLSGSIPNFDIPKLRH 227
L+ + +P L
Sbjct: 64 RAELTKLQVDGTLPVLGT 81
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 12/54 (22%), Positives = 24/54 (44%), Gaps = 3/54 (5%)
Query: 196 SIQNLTQLTGLSLQSNNLSGSIPNFDIPK-LRHLNLSYNGLKGSIPSSLQKFPN 248
+ + ++ NL+ ++P D+PK L+LS N L ++L +
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPP-DLPKDTTILHLSENLLYTFSLATLMPYTR 56
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 8e-04
Identities = 15/51 (29%), Positives = 20/51 (39%), Gaps = 3/51 (5%)
Query: 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYN 233
+ N+ T + L L L LQ N+L +IP F L L N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 9e-04
Identities = 12/46 (26%), Positives = 20/46 (43%), Gaps = 1/46 (2%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF 167
+P L L+ L+ L L+ N L +P L + +L N +
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (85), Expect = 0.004
Identities = 17/87 (19%), Positives = 28/87 (32%), Gaps = 6/87 (6%)
Query: 141 NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGN-----IP 194
N LT + L +L L LQ N+ F L L N + N
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFR 217
Query: 195 QSIQNLTQLTGLSLQSNNLSGSIPNFD 221
+ +Q+ + + Q ++ N
Sbjct: 218 RWLQDNAENVYVWKQGVDVKAMTSNVA 244
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 6e-08
Identities = 21/98 (21%), Positives = 36/98 (36%), Gaps = 5/98 (5%)
Query: 136 LSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP-QLVVLDLSFNSFTGN-I 193
L L L + + S + + + FSP ++ +DLS + + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 194 PQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLN 229
+ ++L LSL+ LS I N L LN
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 8/69 (11%), Positives = 30/69 (43%), Gaps = 3/69 (4%)
Query: 182 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP-NFDIPKLRHLNLSYNGLKG-SI 239
LDL+ + ++ + + + + + + +F +++H++LS + ++ ++
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 240 PSSLQKFPN 248
L +
Sbjct: 64 HGILSQCSK 72
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (112), Expect = 6e-07
Identities = 28/116 (24%), Positives = 42/116 (36%), Gaps = 14/116 (12%)
Query: 127 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----PQLVVL 182
L + VL+ RS++ L ++P L L L +N S P L +L
Sbjct: 38 LVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD---------IPKLRHLN 229
+LS N +L L L N+LS + + PKL L+
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 16/64 (25%), Positives = 29/64 (45%), Gaps = 2/64 (3%)
Query: 122 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 181
L L L L N ++ S + SLP+L ++L++N S P + + L +
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLANTSNLFI 221
Query: 182 LDLS 185
+ L+
Sbjct: 222 VTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 4e-06
Identities = 16/73 (21%), Positives = 30/73 (41%), Gaps = 2/73 (2%)
Query: 159 YLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 218
YL + + S P + +L L N + P + +L L + L++N +S P
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
Query: 219 NFDIPKLRHLNLS 231
+ L + L+
Sbjct: 213 LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 15/64 (23%), Positives = 27/64 (42%), Gaps = 3/64 (4%)
Query: 148 PSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLS 207
+ + +L L L N S P + P L+ + L N + P + N + L ++
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 208 LQSN 211
L +N
Sbjct: 224 L-TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 11/59 (18%), Positives = 24/59 (40%), Gaps = 4/59 (6%)
Query: 178 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGL 235
+ + ++ T + Q+ +L +T LS ++ +I + L L L N +
Sbjct: 20 NAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 5e-04
Identities = 8/50 (16%), Positives = 21/50 (42%), Gaps = 2/50 (4%)
Query: 199 NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
L ++ +N++ ++ D+ + L+ G+ +I +Q N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TI-EGVQYLNN 64
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 15/52 (28%), Positives = 23/52 (44%), Gaps = 2/52 (3%)
Query: 197 IQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
+ NL++LT L N +S P +P L ++L N + P L N
Sbjct: 169 LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSN 218
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 1e-05
Identities = 17/98 (17%), Positives = 37/98 (37%), Gaps = 11/98 (11%)
Query: 145 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 204
G L SE ++P+ + F+ + + +L S T + Q+ L +
Sbjct: 1 GPLGSETITVPTPIKQIFSDDAFA---------ETIKDNLKKKSVTDAVTQN--ELNSID 49
Query: 205 GLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 242
+ ++++ +P + L L+ N L P +
Sbjct: 50 QIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLA 87
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 7e-04
Identities = 14/79 (17%), Positives = 27/79 (34%), Gaps = 5/79 (6%)
Query: 121 PIPNNTLGKLDALE---VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP 177
P P + DA +L+ +T L S+ + +++ + P
Sbjct: 11 PTPIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGIQYLP 68
Query: 178 QLVVLDLSFNSFTGNIPQS 196
+ L L+ N T P +
Sbjct: 69 NVTKLFLNGNKLTDIKPLA 87
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 4e-05
Identities = 13/83 (15%), Positives = 27/83 (32%), Gaps = 15/83 (18%)
Query: 159 YLYLQHNNFSGKIPSSFS--------PQLVVLDLSFNSFTGNIPQSI-----QNLTQLTG 205
L L S + ++ L L L +N + +++ + + L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 206 LSLQSNNLSGSIPNFDIPKLRHL 228
L L N S + ++R +
Sbjct: 307 LELNGNRFSEEDDV--VDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 7e-05
Identities = 13/64 (20%), Positives = 24/64 (37%), Gaps = 9/64 (14%)
Query: 153 SLPSLRYLYLQHNNFSGKIPSSFS-------PQLVVLDLSFNSFT--GNIPQSIQNLTQL 203
L+ L LQ+N + P L+ L+L+ N F+ ++ I+ +
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFST 330
Query: 204 TGLS 207
G
Sbjct: 331 RGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 5e-04
Identities = 13/89 (14%), Positives = 26/89 (29%), Gaps = 5/89 (5%)
Query: 85 NWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT 144
+ + + L G + + + L+ L L+ N +
Sbjct: 227 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286
Query: 145 GGLPSEITS-----LPSLRYLYLQHNNFS 168
+ + +P L +L L N FS
Sbjct: 287 LDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.001
Identities = 14/91 (15%), Positives = 30/91 (32%), Gaps = 10/91 (10%)
Query: 133 LEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVL 182
+E SL+ + +T + + + S++ + L N + S L +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 183 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL 213
+ S + + L L L+ L
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.5 bits (98), Expect = 5e-05
Identities = 23/106 (21%), Positives = 38/106 (35%), Gaps = 3/106 (2%)
Query: 159 YLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS 216
L L N F QL L+L N + +P S ++L LT L+L SN + +
Sbjct: 82 ELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141
Query: 217 IPNFDIPKL-RHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPP 261
+ R +L+ + PS ++ + C
Sbjct: 142 CHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSE 187
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 7e-05
Identities = 21/122 (17%), Positives = 33/122 (27%), Gaps = 7/122 (5%)
Query: 133 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN 192
L LR + + + +L + N +L L ++ N
Sbjct: 20 DRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRI 78
Query: 193 IPQSIQNLTQLTGLSL---QSNNLSGSIPNFDIPKLRHLNLS---YNGLKGSIPSSLQKF 246
Q L LT L L L P + L +L + K + K
Sbjct: 79 GEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKV 138
Query: 247 PN 248
P
Sbjct: 139 PQ 140
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 2e-04
Identities = 17/115 (14%), Positives = 31/115 (26%), Gaps = 5/115 (4%)
Query: 149 SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGL 206
++ T+ R L L+ I + + Q +D S N L +L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68
Query: 207 SLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPP 261
+ +N + D L L + + + P
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 10/65 (15%), Positives = 19/65 (29%), Gaps = 1/65 (1%)
Query: 156 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 215
S R Q + + +IPS + L + L + + N++
Sbjct: 9 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 216 SIPNF 220
I
Sbjct: 68 VIEAD 72
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 3e-04
Identities = 14/67 (20%), Positives = 22/67 (32%), Gaps = 5/67 (7%)
Query: 157 LRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 214
+NN F V+LD+S ++NL +L S NL
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
Query: 215 GSIPNFD 221
+P +
Sbjct: 237 -KLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 8e-04
Identities = 8/54 (14%), Positives = 18/54 (33%), Gaps = 3/54 (5%)
Query: 120 GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 173
+PN+ +L + + + +L LR + K+P+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 11/84 (13%), Positives = 26/84 (30%), Gaps = 3/84 (3%)
Query: 159 YLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 218
+L + + + N+ + L + + S+P
Sbjct: 159 WLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLP 217
Query: 219 NFDIPKLRHLN-LSYNGLKGSIPS 241
++ + L+ L S LK +P+
Sbjct: 218 SYGLENLKKLRARSTYNLK-KLPT 240
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 10/50 (20%), Positives = 21/50 (42%), Gaps = 2/50 (4%)
Query: 199 NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 248
L + L N++ ++ D+ ++ L G+K SI ++ N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNN 63
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 4/62 (6%)
Query: 177 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGL 235
+ + L + T + Q+ +L Q+T L + SI + + L +N S N L
Sbjct: 18 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQL 74
Query: 236 KG 237
Sbjct: 75 TD 76
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 4e-04
Identities = 32/164 (19%), Positives = 52/164 (31%), Gaps = 21/164 (12%)
Query: 93 CQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEIT 152
G+ CT+D ++ L + L L + + L
Sbjct: 7 PHGSSGLRCTRDGAL-------------DSLHH-LPGAENLTELYIENQQHLQHLELRDL 52
Query: 153 S-LPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 209
L LR L + + P +F P+L L+LSFN+ ++ L L L
Sbjct: 53 RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLS 111
Query: 210 SNNLSGSIPNFDIPKL---RHLNLSYNGLKGSIPSSLQKFPNSS 250
N L S + + + L+ L PN+S
Sbjct: 112 GNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.003
Identities = 16/88 (18%), Positives = 33/88 (37%), Gaps = 5/88 (5%)
Query: 172 PSSFSPQ-LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRH 227
P + P L + + + + LT L +++ + D+ +LR+
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 228 LNLSYNGLKGSIPSSLQKFPNSSFVGNS 255
L + +GL+ P + P S + S
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLS 88
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 672 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.66 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.66 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.61 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.59 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.58 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.58 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.43 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.41 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.38 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.38 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.33 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.32 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.32 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.3 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.3 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.25 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.2 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.14 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.99 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.95 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.81 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.61 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.33 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.32 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.18 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.14 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.08 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.02 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.92 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.88 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.47 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.84 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.43 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.77 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.04 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=408.28 Aligned_cols=247 Identities=24% Similarity=0.415 Sum_probs=198.6
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|++.+++.||||+++......++|.+|++++.++ +|||||+++|+|.+++..++||||+++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 467999999999999999888999999987777788999999999999 9999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----C
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 534 (672)
+++.... ..+++..+..++.|||.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 89 ~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 89 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred HHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9987532 34899999999999999999999998 9999999999999999999999999997664322 2
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..+|+.|+|||++.+..|+.++|||||||++|||+|+ .+||..... ......+. ...... .+
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~~~i~-~~~~~~--~p-------- 224 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDIS-TGFRLY--KP-------- 224 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHHHHHH-HTCCCC--CC--------
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HHHHHHHH-hcCCCC--Cc--------
Confidence 3468889999999999999999999999999999995 555543221 11122111 111110 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
......+.+++.+||+.||++||||+||+++|+++.+.
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11234567888899999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-49 Score=398.39 Aligned_cols=250 Identities=27% Similarity=0.409 Sum_probs=196.8
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+++ ..||||+++..... .+.|.+|++++.++ +|||||++++++. ++..++||||+++|
T Consensus 13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~-~~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST-APQLAIVTQWCEGS 88 (276)
T ss_dssp CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEEECCCEE
T ss_pred EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEe-ccEEEEEEecCCCC
Confidence 468999999999999875 35999998754332 35788999999999 9999999999875 45689999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
+|.++++..+ ..+++..+..++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 89 SLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999997533 34999999999999999999999998 999999999999999999999999999765432
Q ss_pred --CCCCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 533 --ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
....||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+....+ ............. ..
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~p----~~ 231 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSP----DL 231 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCCC----CG
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCC----cc
Confidence 23457899999999964 357899999999999999999999998643221 1112222211111 00
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
.. ........+.+++.+||+.||++|||++|++++|+.+.+.-
T Consensus 232 ~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 232 SK--VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp GG--SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred hh--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 00 01122345677888999999999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=395.74 Aligned_cols=244 Identities=22% Similarity=0.351 Sum_probs=205.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|++++++.||||+++.....+++|.+|++++.++ +||||++++|+|.+++..++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 468999999999999998888999999988777788999999999999 9999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----C
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-----~ 534 (672)
+++.... ..+++..+.+++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 88 ~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 88 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp HHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred Hhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9976433 34899999999999999999999998 9999999999999999999999999997654322 2
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+ ....+ ....... .+
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~~~i-~~~~~~~--~p-------- 223 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHI-AQGLRLY--RP-------- 223 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHH-HTTCCCC--CC--------
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH------HHHHH-HhCCCCC--Cc--------
Confidence 346788999999999999999999999999999998 899998654322 11112 1211111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
......+.+++.+||+.||++|||++|++++|.+|
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12224677888899999999999999999999754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=395.84 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=201.0
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchh
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 459 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 459 (672)
.+.||+|+||+||+|++++++.||||+++......+.|.+|++++.++ +|||||+++|++. ++..++||||+++|+|.
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeec-cCCeEEEEEeCCCCcHH
Confidence 467999999999999999888999999987777788899999999999 9999999999875 45679999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-----CC
Q 005875 460 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----AT 534 (672)
Q Consensus 460 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-----~~ 534 (672)
+++.... ...+++..+++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+..... ..
T Consensus 96 ~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (272)
T d1qpca_ 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (272)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccccccc
Confidence 9886433 224899999999999999999999998 999999999999999999999999999876432 23
Q ss_pred CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChH
Q 005875 535 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 614 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 614 (672)
..+++.|+|||++.+..++.++|||||||++|||+||..|+..... .......+. ....... . .
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~~~~~~~i~-~~~~~~~-------p---~ 233 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPEVIQNLE-RGYRMVR-------P---D 233 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHH-TTCCCCC-------C---T
T ss_pred cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH-hcCCCCC-------c---c
Confidence 4578889999999999999999999999999999996555432211 111111111 1111110 1 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 615 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 615 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
.....+.+++.+||+.||++||||+||++.|+++-.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 123456778889999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-48 Score=398.79 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=205.0
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|++.+ ++.||||+++......+++.+|++++.++ +|||||+++++|.+++..++||||+++|+|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 100 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 100 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEEEeecccCcch
Confidence 4689999999999999764 77899999987766778899999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC----
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---- 534 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 534 (672)
.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 101 ~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 101 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred HHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 99997533 345899999999999999999999998 99999999999999999999999999987654322
Q ss_pred -CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 535 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 535 -~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
..+++.|+|||++.+..|+.++|||||||++|||++|..||..... ... ....+........ .
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~~-~~~~i~~~~~~~~-------~--- 238 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQ-VYELLEKDYRMER-------P--- 238 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHH-HHHHHHTTCCCCC-------C---
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HHH-HHHHHhcCCCCCC-------C---
Confidence 2257789999999999999999999999999999997777643221 111 1122222211111 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
......+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12234567888899999999999999999999988654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-48 Score=399.86 Aligned_cols=247 Identities=26% Similarity=0.480 Sum_probs=193.9
Q ss_pred hccccccCcEEEEEEEECCC----cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.++||+|+||+||+|++... ..||||++..... ..++|.+|+++++++ +|||||+++|++.+++..++||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEec
Confidence 46899999999999997532 2588898865433 245789999999999 9999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++|+|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 110 ~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 110 ENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp TTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999987533 34899999999999999999999998 9999999999999999999999999998654321
Q ss_pred ---------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 534 ---------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 534 ---------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
...+|+.|||||++.+..++.++|||||||++|||+| |+.||.+....+ ....+.. .....
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~------~~~~i~~-~~~~~-- 253 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD------VINAIEQ-DYRLP-- 253 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHT-TCCCC--
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH------HHHHHHc-CCCCC--
Confidence 1235778999999999999999999999999999998 899998654221 1111111 11110
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
...+....+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 254 --------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 254 --------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1112334577888899999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=392.92 Aligned_cols=240 Identities=22% Similarity=0.337 Sum_probs=192.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+++++++ +|||||++++++.+++..|+||||+++|
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEEEeccCCC
Confidence 468999999999999975 578999999875432 345789999999999 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----- 531 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----- 531 (672)
+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 89 ~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 89 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999742 34999999999999999999999998 99999999999999999999999999976532
Q ss_pred -CCCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 532 -PATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 532 -~~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
.....||+.|||||++.+..+ +.++||||+||++|||+||+.||........ ............. .
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----~~~~~~~~~~~~~-------~ 228 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKEKKTYLN-------P 228 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-----HHHHHHTTCTTST-------T
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcCCCCCC-------c
Confidence 234568999999999988776 5789999999999999999999976442211 0111111100000 0
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
. ......+.+++.+||+.||++|||++|+++
T Consensus 229 ~---~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 W---KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp G---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c---ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 111234567788999999999999999876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=395.96 Aligned_cols=240 Identities=22% Similarity=0.340 Sum_probs=197.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|+.. +++.||||+++... ...+.+.+|+++++++ +|||||++++++.+++..|+||||+++|+
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 103 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence 367999999999999964 58899999987553 3456799999999998 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----C
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~----~ 533 (672)
|.+++... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 104 L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 99988642 3899999999999999999999998 999999999999999999999999999765432 3
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.... ............. . ...
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~-~--------~~~ 239 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPE-L--------QNP 239 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCC-C--------SSG
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCCC-C--------CCc
Confidence 445899999999999999999999999999999999999999754321 1122222211110 0 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122456677889999999999999999873
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=388.70 Aligned_cols=237 Identities=26% Similarity=0.391 Sum_probs=197.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|++.... ...+.+.+|+++++++ +|||||++++++.+++..++||||++
T Consensus 11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEEEeecC
Confidence 578999999999999975 57889999986432 2356788999999999 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 90 ~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 90 LGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred CCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 99999999743 24999999999999999999999998 9999999999999999999999999998765432
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+ ....+...... ....
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~~---------~p~~ 226 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVEFT---------FPDF 226 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTCCC---------CCTT
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCC---------CCcc
Confidence 3458999999999999999999999999999999999999997643221 12222211110 0111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
. ...+.+++.+||+.||++|||++|+++
T Consensus 227 ~---s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 V---TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C---CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1 234667778999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=391.39 Aligned_cols=244 Identities=24% Similarity=0.366 Sum_probs=198.3
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 382 VLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 382 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.||+|+||+||+|.+. ++..||||+++.... ..++|.+|++++.++ +|||||+++|++.+ +..|+||||+++|
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~~lvmE~~~~g 93 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGG 93 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeEEEEEEeCCCC
Confidence 4999999999999864 345799999975432 246789999999999 99999999999864 5689999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~--- 533 (672)
+|.+++...+ ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 94 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 94 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred cHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999986432 35999999999999999999999998 9999999999999999999999999997654321
Q ss_pred ----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 534 ----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 534 ----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
...+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+ .... +........
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~------~~~~-i~~~~~~~~------ 233 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAF-IEQGKRMEC------ 233 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHH-HHTTCCCCC------
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH------HHHH-HHcCCCCCC------
Confidence 2346788999999999999999999999999999998 999998654322 1111 112111111
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.......+.+++.+||+.||++|||+.+|.+.|+.+...
T Consensus 234 ----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 234 ----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 112234567888899999999999999999999988654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=394.32 Aligned_cols=242 Identities=21% Similarity=0.330 Sum_probs=197.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|+.. +++.||||+++... ...+.+.+|+++++++ +|||||++++++.+++..++||||+++|+
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lvmEy~~~g~ 95 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGA 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence 467999999999999975 57889999987643 3346789999999999 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----CC
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----PA 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~----~~ 533 (672)
|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.... ..
T Consensus 96 L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 96 VDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 999976432 34999999999999999999999998 99999999999999999999999999975532 23
Q ss_pred CCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 534 TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
...||+.|+|||++. +..|+.++|||||||++|||+||+.||.+....+. ...+....... .
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~~~~~-~------ 235 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSEPPT-L------ 235 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHSCCCC-C------
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCCC-C------
Confidence 567899999999984 45688999999999999999999999986543321 12222221110 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.........+.+++.+||+.||++|||++|++++
T Consensus 236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111223456778889999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=390.81 Aligned_cols=242 Identities=24% Similarity=0.356 Sum_probs=194.0
Q ss_pred ccccccCcEEEEEEEECC---CcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 381 EVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
+.||+|+||+||+|.+.+ ++.||||+++....+ .+++.+|++++.++ +|||||+++++|.+ +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc-CCEEEEEEcCC
Confidence 469999999999998643 357999999754332 35789999999999 99999999999864 56789999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~- 533 (672)
+|+|.++++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 91 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999999743 34999999999999999999999998 9999999999999999999999999997654321
Q ss_pred ------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhh
Q 005875 534 ------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 606 (672)
Q Consensus 534 ------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 606 (672)
...+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+ +...+........
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~~~---- 231 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGC---- 231 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCCC----
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCCCCC----
Confidence 2347889999999999999999999999999999998 899998653221 1111211111111
Q ss_pred hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 005875 607 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 649 (672)
Q Consensus 607 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 649 (672)
.......+.+++.+||+.||++|||++||++.|+...
T Consensus 232 ------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 232 ------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1122345677888999999999999999999888764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=399.12 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=199.2
Q ss_pred hccccccCcEEEEEEEECCC------cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEES------TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~------~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|++... ..||+|++..... ....+.+|+.++.++.+|||||++++++.+.+..++|||
T Consensus 42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (325)
T d1rjba_ 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121 (325)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence 57899999999999996532 2589999865432 345788999999999889999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec
Q 005875 452 YFASGSLSTLLHGNRGA------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN 513 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~ 513 (672)
|+++|+|.++++..+.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVT 198 (325)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccc
Confidence 99999999999754321 1234899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCCh
Q 005875 514 QDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 586 (672)
Q Consensus 514 ~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~ 586 (672)
.++.+||+|||+|+...... +..+|+.|||||++.+..++.++|||||||++|||+| |+.||.+....+
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~---- 274 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---- 274 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----
T ss_pred cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999998764432 2235888999999999999999999999999999998 899998654332
Q ss_pred hHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005875 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 647 (672)
Q Consensus 587 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 647 (672)
....++........ .......+.+|+.+||+.||++|||++||+++|..
T Consensus 275 --~~~~~~~~~~~~~~----------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 275 --NFYKLIQNGFKMDQ----------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp --HHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHhcCCCCCC----------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 12222222221111 11223457788889999999999999999999964
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=388.07 Aligned_cols=248 Identities=24% Similarity=0.439 Sum_probs=194.7
Q ss_pred hccccccCcEEEEEEEECCC-----cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEES-----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.++||+|+||+||+|.++++ ..||||++..... ...+|.+|++++.++ +|||||+++|++.+.+..++||||
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCceEEEEEe
Confidence 46899999999999997643 3699999865433 234688999999999 999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+.+|++.+++.... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 91 MENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp CTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred cccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999886433 34999999999999999999999998 999999999999999999999999999875432
Q ss_pred C-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 A-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ~-------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
. ...+|+.|+|||++.+..++.++|||||||++|||++|..|+...... ..... .+.+.....
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~~~~-~i~~~~~~~---- 233 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMK-AINDGFRLP---- 233 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHH-HHHTTCCCC----
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HHHHH-HHhccCCCC----
Confidence 1 234678899999999999999999999999999999976665432211 11111 111111111
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
........+.+++.+||+.||++||||.||++.|+.+.+.
T Consensus 234 ------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 234 ------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1112334577888899999999999999999999998865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-47 Score=382.87 Aligned_cols=241 Identities=24% Similarity=0.390 Sum_probs=191.4
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEe----CCeeEEEEEe
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDY 452 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~ 452 (672)
+.||+|+||+||+|++. +++.||+|++...... .+.+.+|+++++++ +|||||++++++.+ +...++||||
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 56999999999999976 4778999998765433 34688999999999 89999999999875 3457899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec-CCCCeEEeecCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DfGla~~~~~ 531 (672)
+++|+|.+++... ..+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 94 ~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 94 MTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999743 34899999999999999999999975 5699999999999996 578999999999976543
Q ss_pred C--CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 532 P--ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 532 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
. ....||+.|||||++.+ .++.++|||||||++|||++|+.||.+.... ......+. .......++
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~~~~i~-~~~~~~~~~----- 235 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVT-SGVKPASFD----- 235 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHT-TTCCCGGGG-----
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHHHHHHH-cCCCCcccC-----
Confidence 3 24568999999999875 5999999999999999999999999753211 11111111 111111111
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. ....+.+++.+||+.||++|||++|++++
T Consensus 236 -~~---~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 -KV---AIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -GC---CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cc---CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11 12346678889999999999999999863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=389.10 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=200.2
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 379 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
..+.||+|+||+||+|++++++.||||+++......+.|.+|+.+++++ +|||||+++|++. ++..++||||+++|+|
T Consensus 21 i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l 98 (285)
T d1fmka3 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 98 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEe-cCCeEEEEEecCCCch
Confidence 3578999999999999999888999999987777788899999999999 9999999999985 5668999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-----
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----- 533 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~----- 533 (672)
.+++.... ...++|.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 99 ~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 99 LDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp HHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred hhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 99886432 234899999999999999999999998 9999999999999999999999999997654322
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+++.|+|||++.+..++.++|||||||++|||++|..|+...... ......+.. ...... .
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~~~~~i~~-~~~~~~-------~--- 236 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVER-GYRMPC-------P--- 236 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHT-TCCCCC-------C---
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHHHh-cCCCCC-------C---
Confidence 244788999999999999999999999999999999976665432211 111111111 111111 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
......+.+++.+||+.||++|||+++|+++|++.....
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 122345677888999999999999999999999877554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=398.44 Aligned_cols=191 Identities=21% Similarity=0.386 Sum_probs=168.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+.. +++.||+|+++..... .+.+.+|+.+++++ +|||||+++++|.++++.++||||+++|
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 367999999999999975 5788999998754322 45788999999998 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC--CCC
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--VPA 533 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~--~~~ 533 (672)
+|.+++.+. ..+++..+..++.|++.||+|||++ + |+||||||+|||+++++.+||+|||+|+... ...
T Consensus 90 ~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 161 (322)
T d1s9ja_ 90 SLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 161 (322)
T ss_dssp EHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred cHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCccc
Confidence 999999743 2489999999999999999999974 7 9999999999999999999999999997653 234
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 579 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~ 579 (672)
+..||+.|+|||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 5679999999999999999999999999999999999999998654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=389.72 Aligned_cols=246 Identities=20% Similarity=0.329 Sum_probs=186.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEe--CCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lV~e~~ 453 (672)
.+.||+|+||+||+|+.. +++.||+|++...... .+.+.+|++++.++ +|||||++++++.+ ++..|+||||+
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ivmEy~ 87 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYC 87 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEEEEECC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence 368999999999999975 5788999999765443 34578899999998 99999999999865 45679999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
++|+|.+++..... ....+++..+..++.||+.||+|||+++ ..+|+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 88 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp TTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 99999999864321 1335999999999999999999999875 23599999999999999999999999999976543
Q ss_pred C----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 532 P----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 532 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
. ....||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+ ....+..... ..+
T Consensus 167 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~~~i~~~~~-~~~----- 234 (269)
T d2java1 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGKF-RRI----- 234 (269)
T ss_dssp ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCC-CCC-----
T ss_pred CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------HHHHHHcCCC-CCC-----
Confidence 2 23568999999999999999999999999999999999999997643221 1222221111 111
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
... ....+.+++.+||+.||++|||++|++++
T Consensus 235 --~~~---~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 --PYR---YSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --CTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --Ccc---cCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 011 22356677889999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-47 Score=391.51 Aligned_cols=239 Identities=23% Similarity=0.356 Sum_probs=196.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||||++...... .+.+.+|+++++++ +|||||++++++.+++..|+||||++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~ 98 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL 98 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEEEEEecC
Confidence 467999999999999965 5778999998765332 24688899999999 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 534 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~~ 534 (672)
+|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 99 ~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (309)
T d1u5ra_ 99 GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170 (309)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred CCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence 99998776532 34999999999999999999999998 99999999999999999999999999998877778
Q ss_pred CCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhccc
Q 005875 535 PSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 611 (672)
Q Consensus 535 ~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 611 (672)
..||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.... .....+...... .... .
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~~~-~~~~------~ 237 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP-ALQS------G 237 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCC-CCSC------T
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCC-CCCC------C
Confidence 889999999999864 45899999999999999999999999754321 112222221111 0100 1
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 612 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 612 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
. ....+.+++.+||+.||++|||++|+++
T Consensus 238 ~---~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 H---WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp T---SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C---CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 1235667788999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-46 Score=387.25 Aligned_cols=242 Identities=21% Similarity=0.371 Sum_probs=183.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+.. +++.||||++..... ....+.+|++++.++ +|||||++++++.+++..|+||||+++|
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 468999999999999976 578899999975532 245678899999999 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec---CCCCeEEeecCCCCCCCCC-
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVP- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~---~~~~~kl~DfGla~~~~~~- 532 (672)
+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+.....
T Consensus 93 ~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 93 ELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp BHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999743 34999999999999999999999998 99999999999995 5789999999999866433
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
.+..||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+ ....+........ ....
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~~~~-----~~~~ 233 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAEYEFD-----SPYW 233 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTTCCCCC-----TTTT
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhccCCCCC-----Cccc
Confidence 24568999999999999999999999999999999999999997543221 1222222211100 0011
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. ....+.+++.+||+.||++|||++|++++
T Consensus 234 ~~---~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 234 DD---ISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TT---SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cC---CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11 22356677889999999999999999884
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=381.57 Aligned_cols=246 Identities=26% Similarity=0.414 Sum_probs=193.6
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe-CCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||.||+|+++ ++.||||++++. ...+.+.+|+++++++ +||||++++|++.+ ++..++||||+++|+|
T Consensus 12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 578999999999999986 778999999764 3457799999999999 99999999999865 4568999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC-CCCC
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR 537 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~ 537 (672)
.++++... ...+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++...... ...+
T Consensus 89 ~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~ 162 (262)
T d1byga_ 89 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162 (262)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------C
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCCccccc
Confidence 99996432 224899999999999999999999988 9999999999999999999999999998754433 3456
Q ss_pred CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccChHHH
Q 005875 538 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 616 (672)
Q Consensus 538 ~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 616 (672)
+..|+|||++.+..++.++|||||||++|||+| |++||......+ +..++ ........ ....
T Consensus 163 ~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i----~~~~~~~~----------~~~~ 225 (262)
T d1byga_ 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGYKMDA----------PDGC 225 (262)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHH----TTTCCCCC----------CTTC
T ss_pred cccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCCCCCC----------CccC
Confidence 788999999999999999999999999999998 688887543332 22211 11111111 1112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 617 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 617 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
...+.+++.+||+.||++||||.|++++|++++..
T Consensus 226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 24567788899999999999999999999998753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=387.79 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=196.1
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccChhhHHHHHHHH--HHHcCCCceeceEEEEEeCC----eeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIV--GRVGQHPNVVPLRAYYYSKD----EKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l--~~l~~h~niv~l~~~~~~~~----~~~lV~e~~ 453 (672)
.+.||+|+||+||+|++. |+.||||+++... .+++..|.+++ ..+ +|||||++++++.+++ ..++||||+
T Consensus 8 ~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 467999999999999975 7899999986543 33444454443 455 8999999999998754 578999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-----GPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
++|+|.++++.. .++|..+.+++.|+|.||+|+|+.. .++|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 84 EHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999743 3899999999999999999999741 23599999999999999999999999999976
Q ss_pred CCCC--------CCCCCCCcccCcccccCCC------CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC--------Ch
Q 005875 529 MNVP--------ATPSRSAGYRAPEVIETRK------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV--------DL 586 (672)
Q Consensus 529 ~~~~--------~~~~~~~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~--------~~ 586 (672)
.... ....||+.|+|||++.+.. ++.++|||||||++|||+||..||......+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 5322 2345899999999987643 567899999999999999999988643322211 01
Q ss_pred hHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 587 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 587 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
........... ..++.........+....+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 238 ~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 238 VEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 11122111111 111111111122345567888999999999999999999999999998664
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=383.88 Aligned_cols=238 Identities=18% Similarity=0.315 Sum_probs=196.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|++++.++ +||||+++++++.+++..|+||||++
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEEEEccC
Confidence 478999999999999975 57899999987532 2345789999999999 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 92 gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 92 NGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999998743 34999999999999999999999998 999999999999999999999999999865422
Q ss_pred ----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 533 ----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 533 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+ ....+...... +
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~~---~----- 229 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKIIKLEYD---F----- 229 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTCCC---C-----
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHHHcCCCC---C-----
Confidence 23468999999999999999999999999999999999999998643221 12222222111 0
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.... ...+.+++.+||+.||++|||++|++++
T Consensus 230 -p~~~---s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 -PEKF---FPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -CTTC---CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -CccC---CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 0111 2346678889999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=381.73 Aligned_cols=242 Identities=23% Similarity=0.380 Sum_probs=197.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-------ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|+++++++ +|||||++++++.+++..|+|||
T Consensus 15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E 93 (293)
T d1jksa_ 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILE 93 (293)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999975 578999999865422 246789999999999 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC----CeEEeecCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP 527 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DfGla~ 527 (672)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+|++|||+|.
T Consensus 94 ~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 94 LVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999743 24999999999999999999999998 99999999999999876 49999999997
Q ss_pred CCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 528 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 528 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+ ....+...... +.
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~~---~~ 236 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAVNYE---FE 236 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTCCC---CC
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHHhcCCC---CC
Confidence 76433 34567889999999999999999999999999999999999998654222 11121111110 00
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. ... .....+.+++.+||+.||++|||++|++++
T Consensus 237 ~~--~~~---~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 DE--YFS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HH--HHT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ch--hcC---CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 001 122456678889999999999999999873
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=382.64 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=193.5
Q ss_pred hccccccCcEEEEEEEECC------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC-eeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lV~ 450 (672)
.+.||+|+||+||+|++.. ++.||||+++.... ..+.+.+|..++.++.+|+|||.+++++.+++ ..++||
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 5789999999999999642 35799999875432 24567788888999888999999999987654 679999
Q ss_pred EecCCCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeE
Q 005875 451 DYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 519 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~k 519 (672)
||+++|+|.++++.... .....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEE
Confidence 99999999999975432 11334899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHH
Q 005875 520 ISDFGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQS 592 (672)
Q Consensus 520 l~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg-~~pf~~~~~~~~~~~~~~~~~ 592 (672)
|+|||+|+..... ....||+.|+|||++.+..++.++|||||||++|||+|| .+||.+....+ ....
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~------~~~~ 248 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCR 248 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHH
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH------HHHH
Confidence 9999999765332 123578899999999999999999999999999999997 55776543221 2222
Q ss_pred hhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 593 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 593 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
.+.+....... ......+.+++.+||+.||++|||++|++++|+++.+..
T Consensus 249 ~~~~~~~~~~~----------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 249 RLKEGTRMRAP----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp HHHHTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCC----------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 22222221111 112345778888999999999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.9e-46 Score=391.42 Aligned_cols=243 Identities=19% Similarity=0.375 Sum_probs=198.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|++++.++ +|||||++++++.+++..|+||||+++|+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 478999999999999975 578999999976533 346688999999999 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC--CCCeEEeecCCCCCCCCCC--
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--DLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~--~~~~kl~DfGla~~~~~~~-- 533 (672)
|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+......
T Consensus 110 L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 110 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp HHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999996432 34999999999999999999999998 999999999999964 6789999999998765433
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...||+.|||||++.+..++.++||||+||++|||++|+.||.+.+.. .....+....+... .. ...
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~---~~--~~~- 250 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDWNMD---DS--AFS- 250 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCSC---CG--GGG-
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCC---cc--ccc-
Confidence 346899999999999999999999999999999999999999765322 22222222222110 00 011
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.....+.+++.+||+.||++|||++|++++
T Consensus 251 --~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 --GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112356677889999999999999999885
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=376.27 Aligned_cols=246 Identities=22% Similarity=0.363 Sum_probs=191.1
Q ss_pred hccccccCcEEEEEEEECC----CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 380 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
.+.||+|+||+||+|++.. +..||||+++.... ..+.+.+|+++++++ +|||||++++++. ++..++||||+
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCeEEEEEEec
Confidence 5789999999999998753 34688988865433 245688999999999 9999999999985 56789999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 533 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~ 533 (672)
++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+|+......
T Consensus 90 ~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 90 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred cCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999876433 34899999999999999999999998 9999999999999999999999999998754322
Q ss_pred -----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhh
Q 005875 534 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 607 (672)
Q Consensus 534 -----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 607 (672)
...+|+.|+|||++.+..++.++|||||||++|||+| |.+||.+....+. ...+. .......
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~------~~~i~-~~~~~~~----- 230 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIE-NGERLPM----- 230 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHHHH-TTCCCCC-----
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH------HHHHH-cCCCCCC-----
Confidence 2346788999999999999999999999999999998 8999986654331 11111 1111111
Q ss_pred hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 608 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 608 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
. ......+.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 231 --~---~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 231 --P---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --C---CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1 11234567788899999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=380.21 Aligned_cols=254 Identities=23% Similarity=0.398 Sum_probs=201.3
Q ss_pred hccccccCcEEEEEEEECCC-c--EEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLEES-T--TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~-~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+++++ . .||||+++.... ..+++.+|++++.++.+|||||++++++.+++..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 57899999999999997643 3 477888764432 356799999999998779999999999999999999999999
Q ss_pred CCchhhhhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeec
Q 005875 455 SGSLSTLLHGNR-----------GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 523 (672)
Q Consensus 455 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~Df 523 (672)
+|+|.++++... ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccc
Confidence 999999997542 122345999999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 524 GLTPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 524 Gla~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
|+++...... ...+|..|+|||.+.+..++.++|||||||++|||++|. +||.+.+..+ ....+. +...
T Consensus 172 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~------~~~~i~-~~~~ 244 (309)
T d1fvra_ 172 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLP-QGYR 244 (309)
T ss_dssp TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHGG-GTCC
T ss_pred cccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH------HHHHHH-hcCC
Confidence 9997654322 334788999999999999999999999999999999976 4676443221 122221 1111
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 653 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 653 (672)
.. .. ......+.+++.+||+.||++||||+||+++|+++.+...
T Consensus 245 ~~-------~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 245 LE-------KP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp CC-------CC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CC-------CC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 11 01 1123456778889999999999999999999999987654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=383.88 Aligned_cols=245 Identities=22% Similarity=0.372 Sum_probs=195.9
Q ss_pred hccccccCcEEEEEEEECC-Cc----EEEEEEecccc--cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.++||+|+||+||+|++.. ++ .||+|+++... ...+++.+|++++.++ +|||||+++|+|.++ ..++++||
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~~~~v~e~ 91 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL 91 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEEEEEEC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-CeeEEEEe
Confidence 3689999999999999753 33 58899887543 2456799999999999 999999999999764 56788999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 92 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp CTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred ccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999887533 35999999999999999999999998 999999999999999999999999999765432
Q ss_pred C------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 533 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 533 ~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
. ...+|+.|+|||++.+..++.++|||||||++|||+| |..||.+....+. ...+.......
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-------~~~i~~~~~~~---- 233 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGERLP---- 233 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-------HHHHHHTCCCC----
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCCCC----
Confidence 2 2246889999999999999999999999999999999 7899876543321 11111111110
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
..+.....+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 234 ------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 234 ------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 111223456788889999999999999999999998864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-45 Score=381.09 Aligned_cols=250 Identities=24% Similarity=0.411 Sum_probs=200.3
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEecccccC--hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|+++ +++.||||+++..... .++|.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeeccCCceEEEEE
Confidence 468999999999999964 3468999998754332 45789999999999 99999999999999999999999
Q ss_pred ecCCCchhhhhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEe
Q 005875 452 YFASGSLSTLLHGNRG-------------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 512 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl 512 (672)
|+++|+|.++++.... .....+++..++.++.|++.||+|||+++ |+||||||+|||+
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILl 173 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLV 173 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEE
Confidence 9999999999964321 12234899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecCCCCCCCC------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCCCCCCCCCCC
Q 005875 513 NQDLDGCISDFGLTPLMNV------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVD 585 (672)
Q Consensus 513 ~~~~~~kl~DfGla~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~-~pf~~~~~~~~~~ 585 (672)
+.++.+||+|||+|+.... .....+++.|+|||++.+..|+.++|||||||++|||++|. +||.+....+
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e--- 250 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--- 250 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH---
Confidence 9999999999999865422 12345678899999999999999999999999999999985 5776543222
Q ss_pred hhHHHHHhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 005875 586 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 650 (672)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 650 (672)
....+ .+...... . ......+.+|+.+||+.+|++||||.||+++|++|.+
T Consensus 251 ---~~~~v-~~~~~~~~-------p---~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 251 ---VIYYV-RDGNILAC-------P---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp ---HHHHH-HTTCCCCC-------C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---HHHHH-HcCCCCCC-------C---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 12222 12111111 1 1223457788889999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.5e-46 Score=389.17 Aligned_cols=243 Identities=21% Similarity=0.378 Sum_probs=197.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCc
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 457 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 457 (672)
.+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|+++++++ +|||||++++++.+++..|+||||+++|+
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence 468999999999999974 588999999876532 345688999999999 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEec--CCCCeEEeecCCCCCCCCCC--
Q 005875 458 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 458 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~--~~~~~kl~DfGla~~~~~~~-- 533 (672)
|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+......
T Consensus 113 L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 113 LFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp HHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 99887642 234999999999999999999999998 99999999999998 67899999999998765433
Q ss_pred -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccC
Q 005875 534 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 612 (672)
Q Consensus 534 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 612 (672)
...+|+.|+|||++.+..++.++||||+||++|||+||+.||.+....+ ....+....... .. ...
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~~---~~--~~~-- 252 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCDWEF---DE--DAF-- 252 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHCCCCC---CS--STT--
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCC---Cc--ccc--
Confidence 3468899999999999999999999999999999999999997643221 122222211110 00 001
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 613 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 613 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
......+.+|+.+||+.||++|||++|++++
T Consensus 253 -~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 253 -SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122356678889999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=375.24 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=197.0
Q ss_pred hccccccCcEEEEEEEECCC----cEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeC-CeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lV~e~ 452 (672)
.++||+|+||+||+|++.++ ..||||+++.... ..++|.+|++++.++ +||||++++|++.+. ...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEEEE
Confidence 46799999999999997543 2589999875332 236799999999999 899999999998764 578999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.++++... ...++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999987532 34788999999999999999999998 999999999999999999999999999865432
Q ss_pred C--------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 533 A--------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 533 ~--------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
. ...+|+.|+|||.+.+..++.++||||||+++|||+||+.||...... .++..+ +.... ... .
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~---i~~g~-~~~--~ 255 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY---LLQGR-RLL--Q 255 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HHTTC-CCC--C
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHH---HHcCC-CCC--C
Confidence 1 234678899999999999999999999999999999988887643221 111111 11111 110 0
Q ss_pred hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 605 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 605 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.......+.+++.+||+.||++||||.||+++|+.+.+.
T Consensus 256 --------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 256 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 011224567888899999999999999999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=380.01 Aligned_cols=245 Identities=19% Similarity=0.305 Sum_probs=193.1
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEe----CCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+. .+++.||||++++ ...+.+|++++.++.+|||||+++++|++ +...|+|||||+
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 35799999999999997 4578999999864 35678899988877789999999999876 356899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC---CCCeEEeecCCCCCCCC
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNV 531 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~ 531 (672)
||+|.+++.... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+....
T Consensus 93 gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 93 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp SEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccC
Confidence 999999997532 235999999999999999999999998 999999999999986 56799999999976543
Q ss_pred C---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhh
Q 005875 532 P---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 608 (672)
Q Consensus 532 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 608 (672)
. ....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+....+.... ... .......+..
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~----~i~~~~~~~~-- 237 (335)
T d2ozaa1 167 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKT----RIRMGQYEFP-- 237 (335)
T ss_dssp CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCSCSSSCC--
T ss_pred CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHH----HHhcCCCCCC--
Confidence 2 345689999999999999999999999999999999999999986543332110 000 0000000000
Q ss_pred cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 609 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 609 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..........+.+|+.+||+.||++|||++|++++
T Consensus 238 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 238 -NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00011233567788889999999999999999884
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=377.91 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=198.6
Q ss_pred hccccccCcEEEEEEEECC--------CcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV 449 (672)
.+.||+|+||.||+|+... +..||||+++.... ...++.+|...+.++.+|||||+++++|.+++..++|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 5789999999999998542 24699999976543 2367888999999998899999999999999999999
Q ss_pred EEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCe
Q 005875 450 YDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 518 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 518 (672)
|||+++|+|.+++...... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCe
Confidence 9999999999999754321 1345899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 005875 519 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 591 (672)
Q Consensus 519 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~ 591 (672)
||+|||+++...... ...+++.|+|||.+.+..|+.++|||||||++|||++ |.+||.+....+ +.
T Consensus 175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-------~~ 247 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LF 247 (299)
T ss_dssp EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HH
T ss_pred EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-------HH
Confidence 999999998664322 2346788999999999999999999999999999998 688887544221 11
Q ss_pred HhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 592 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
..+........ .. .....+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 248 ~~i~~~~~~~~-------p~---~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 248 KLLKEGHRMDK-------PS---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHTTCCCCC-------CS---SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCC-------Cc---cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 12222211111 11 1224577888899999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=375.62 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=202.5
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||.||+|++. .++.||||+++.... ....+.+|+.++..+.+|||||++++++.+++..++|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 578999999999999852 356899999976432 345688999999999789999999999999999999999
Q ss_pred ecCCCchhhhhccCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCe
Q 005875 452 YFASGSLSTLLHGNRG-------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 518 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~ 518 (672)
|+++|+|.++++.... .....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcc
Confidence 9999999999975432 12335899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 005875 519 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 591 (672)
Q Consensus 519 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~ 591 (672)
|++|||+++...... ...+|+.|+|||++.+..++.++|||||||++|||+| |.+||......+ .+.
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~------~~~ 258 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------KFY 258 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH------HHH
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence 999999998765432 2346788999999999999999999999999999999 555555433221 122
Q ss_pred HhhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 592 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 592 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.++........ .+.....+.+|+.+||+.||++||||+||+++|+++...
T Consensus 259 ~~i~~~~~~~~----------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 KMIKEGFRMLS----------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHTCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCC----------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 22222211111 112234577888899999999999999999999987654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=375.13 Aligned_cols=244 Identities=25% Similarity=0.355 Sum_probs=188.0
Q ss_pred hccccccCcEEEEEEEECC--C--cEEEEEEeccccc----ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEE--S--TTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD 451 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e 451 (672)
.+.||+|+||+||+|++.. + ..||||+++.... ..++|.+|++++.++ +|||||+++|++.+ +..++|||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~~lv~e 90 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPMKMVTE 90 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cchheeee
Confidence 3679999999999998642 2 3689999875432 135789999999999 99999999999965 56789999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC
Q 005875 452 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 531 (672)
Q Consensus 452 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~ 531 (672)
|+++|++.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 91 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999998886432 34999999999999999999999998 99999999999999999999999999987643
Q ss_pred CC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 532 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 532 ~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
.. ...++..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+ ....+.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~~~~~~- 236 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGERLPR- 236 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCCCCC-
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhCCCCCCC-
Confidence 32 2335678999999999999999999999999999998 899997553322 22222222211111
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 648 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 648 (672)
.......+.+++.+||+.||++||||+||.+.|++.
T Consensus 237 ---------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 237 ---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112224577888899999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=375.77 Aligned_cols=238 Identities=21% Similarity=0.286 Sum_probs=196.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||+|++++.. ...+.+.+|+++++++ +||||+++++++.+++..|+||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv~ey~~ 88 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccceeccC
Confidence 468999999999999974 68899999997542 2346688999999998 89999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 89 gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 89 GGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp TCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999997533 4899999999999999999999998 999999999999999999999999999865432
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+ ....+...... ..
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~i~~~~~~---------~p 225 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEEIR---------FP 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC---------CC
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHHHhcCCCC---------CC
Confidence 23458999999999999999999999999999999999999998654322 12222211110 01
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 644 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 644 (672)
..+ ...+.+++.+||+.||++||+ ++|++++
T Consensus 226 ~~~---s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 226 RTL---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTS---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ccC---CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 112 234567778999999999995 8888874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-44 Score=374.89 Aligned_cols=238 Identities=20% Similarity=0.302 Sum_probs=197.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||||++++.. ...+.+.+|+.+++++ +|||||++++++.+++..|+||||++
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeEeeecC
Confidence 478999999999999975 58899999997542 2346788999999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-C
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-~ 533 (672)
+|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 88 gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~ 159 (316)
T d1fota_ 88 GGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159 (316)
T ss_dssp SCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred Cccccccccccc-----cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccccc
Confidence 999999987433 4788999999999999999999998 999999999999999999999999999876543 3
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
+..||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+.. .....+...... + ....
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~~~~---~------p~~~ 224 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNAELR---F------PPFF 224 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHCCCC---C------CTTS
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHcCCCC---C------CCCC
Confidence 466899999999999999999999999999999999999999864322 222222222111 0 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 644 (672)
...+.+++.+||+.||++|+ |++|++++
T Consensus 225 ---s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 225 ---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 23466777899999999996 89999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-44 Score=365.28 Aligned_cols=243 Identities=20% Similarity=0.359 Sum_probs=195.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC----------hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 448 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 448 (672)
.+.||+|+||+||+|+.. +++.||||+++..... .+.+.+|+.++.++..||||+++++++.+++..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 478999999999999974 6789999998754321 13577899999999669999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCC
Q 005875 449 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 528 (672)
Q Consensus 449 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~ 528 (672)
||||+++|+|.++++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 vmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999743 24999999999999999999999998 99999999999999999999999999976
Q ss_pred CCCC---CCCCCCCcccCcccccC------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccc
Q 005875 529 MNVP---ATPSRSAGYRAPEVIET------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 599 (672)
Q Consensus 529 ~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 599 (672)
.... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ ....+......
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~~~~i~~~~~~ 233 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIMSGNYQ 233 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCC
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH------HHHHHHhCCCC
Confidence 6542 33557899999999853 347889999999999999999999998653211 11222222211
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 600 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 600 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.. .+ . .......+.+++.+||+.||++|||++|++++
T Consensus 234 ~~--~~---~---~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 FG--SP---E---WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CC--TT---T---GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CC--Cc---c---cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 00 1 11222456777889999999999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=375.37 Aligned_cols=243 Identities=21% Similarity=0.338 Sum_probs=198.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|... +++.||||+++........+.+|++++..+ +|||||++++++.+++..|+||||+++|+|
T Consensus 10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L 88 (321)
T d1tkia_ 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence 468999999999999976 577899999987655556788999999998 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC--CCeEEeecCCCCCCCCCC---
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD--LDGCISDFGLTPLMNVPA--- 533 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~--~~~kl~DfGla~~~~~~~--- 533 (672)
.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 89 ~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 89 FERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 99997432 24899999999999999999999998 9999999999999854 589999999998765432
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...+++.|+|||.+.+..|+.++||||+||++|||++|+.||.+.+..+ ....+...... ++.. ....+
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~~~~---~~~~--~~~~~ 230 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYT---FDEE--AFKEI 230 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCC---CCHH--HHTTS
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC---CChh--hccCC
Confidence 3347889999999999999999999999999999999999998654221 12222222111 0100 01111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...+.+++.+||+.||++|||++|++++
T Consensus 231 ---s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 231 ---SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2345677889999999999999999983
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=373.50 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=190.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEecccccC------hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEec
Q 005875 381 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 453 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~ 453 (672)
++||+|+||+||+|+.. +++.||||+++..... .+.+.+|++++.++ +|||||++++++.+++..|+||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhhhh
Confidence 67999999999999975 5789999998654321 24688999999999 9999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-
Q 005875 454 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 532 (672)
Q Consensus 454 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~- 532 (672)
.++++..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 ~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 99888777653 234888999999999999999999998 999999999999999999999999999766432
Q ss_pred ---CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh----hccccccc-
Q 005875 533 ---ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVF- 603 (672)
Q Consensus 533 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~- 603 (672)
....+|+.|+|||++.+. .|+.++|||||||++|||+||..||.+....+.. ........ +.+.....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhcc
Confidence 234588999999998654 5799999999999999999999999865432211 11111100 00000000
Q ss_pred --hhhhhcc--cCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 --DVELMRF--QNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 --d~~~~~~--~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
....... ... ......+.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000 000 1112457788889999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.6e-44 Score=364.80 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=194.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC----hhhHHHHHHHHHHHcCCCceeceEEEEEeCCe----eEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE----KLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----~~lV~ 450 (672)
.+.||+|+||+||+|+.. +++.||||+++..... .+.+.+|+++++.+ +|||||++++++...+. .|+||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~~~~lvm 90 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVM 90 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCceEEEEE
Confidence 468999999999999964 6889999999765332 24688999999998 99999999999987543 78999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++..+++|||.+....
T Consensus 91 E~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 91 EYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp ECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred ECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhc
Confidence 999999999988643 34999999999999999999999998 9999999999999999999999999876543
Q ss_pred C-------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 531 V-------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 531 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.. .............
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP--- 233 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC---
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCC---
Confidence 2 22345899999999999999999999999999999999999999764322 2222222222111
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhh
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVR 649 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~ 649 (672)
+. .....+ ...+.+++.+||+.||++|| |++|+++.|..+.
T Consensus 234 -~~-~~~~~~---s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -PS-ARHEGL---SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -GG-GTSSSC---CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -Cc-hhccCC---CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00 011122 23566777799999999999 8999999998775
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=375.26 Aligned_cols=238 Identities=22% Similarity=0.355 Sum_probs=193.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|+.. +++.||||++++.. ...+.+..|+.++.+..+|||||++++++.+++..|+||||++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 468999999999999975 57889999997532 2345677787777755599999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC--
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-- 532 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-- 532 (672)
+|+|.++++... .+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 87 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999997432 4899999999999999999999998 999999999999999999999999999765432
Q ss_pred --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcc
Q 005875 533 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 610 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 610 (672)
....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+ ....+...... ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~~~---------~p 223 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDNPF---------YP 223 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC---------CC
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCC---------CC
Confidence 23468999999999999999999999999999999999999998654222 11111111110 00
Q ss_pred cChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 005875 611 QNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVR 643 (672)
Q Consensus 611 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 643 (672)
..+ ...+.+|+.+||+.||++||++. |+++
T Consensus 224 ~~~---s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 RWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ccC---CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 112 23466778899999999999995 7764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-44 Score=374.64 Aligned_cols=237 Identities=18% Similarity=0.203 Sum_probs=196.9
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 454 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~ 454 (672)
.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|+++++.+ +|||||++++++.+.+..++||||+.
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccccccccccccccc
Confidence 468999999999999975 58899999986432 2345688999999998 99999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC-C
Q 005875 455 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A 533 (672)
Q Consensus 455 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~-~ 533 (672)
+|+|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+..... .
T Consensus 125 ~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 125 GGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp TCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred ccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 99999999743 24899999999999999999999998 999999999999999999999999999876543 3
Q ss_pred CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhcccCh
Q 005875 534 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 613 (672)
Q Consensus 534 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 613 (672)
...||+.|||||++.+..++.++|||||||++|||+||+.||.+.+. ......+...... ..
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~~---------~p--- 258 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKVR---------FP--- 258 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------CC---
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcCCCC---------CC---
Confidence 45689999999999999999999999999999999999999976432 1122222221110 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005875 614 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR 643 (672)
Q Consensus 614 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 643 (672)
......+.+++.+||+.||++|+ |++|+++
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11223566788899999999994 8999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-43 Score=373.97 Aligned_cols=242 Identities=18% Similarity=0.250 Sum_probs=190.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccc----cChhhHHHHHHHHHHHc--CCCceeceEEEEEeCCeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
.+.||+|+||+||+|+.. +++.||||++.... .....+.+|..++..+. +|||||++++++.+++..|+||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 468999999999999975 58899999986432 22344555655544442 699999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 532 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~ 532 (672)
+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 89 MNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp CCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred cCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999743 34889999999999999999999998 999999999999999999999999999866443
Q ss_pred --CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchhhhhc
Q 005875 533 --ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 609 (672)
Q Consensus 533 --~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 609 (672)
....||+.|+|||++.. ..|+.++|||||||++|||+||+.||.+....+. ............ ..
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~~~~~~~---------~~ 228 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTMAV---------EL 228 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHHHSSSCCC---------CC
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcccCCC---------CC
Confidence 34568999999999974 5689999999999999999999999986543321 111111111000 00
Q ss_pred ccChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 005875 610 FQNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM 644 (672)
Q Consensus 610 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 644 (672)
...+ ...+.+++.+||+.||++||| ++|++++
T Consensus 229 ~~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 229 PDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CSSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCC---CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1112 234667788999999999999 6888763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=369.19 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=201.8
Q ss_pred HhccccccCcEEEEEEEEC------CCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 379 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 379 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
..+.||+|+||+||+|.++ +++.||||+++.... ....+.+|++++.++ +|||||++++++..++..++||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecCCceeEEE
Confidence 3578999999999999864 246899999975432 234588999999999 8999999999999999999999
Q ss_pred EecCCCchhhhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCC
Q 005875 451 DYFASGSLSTLLHGNRG-----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 525 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGl 525 (672)
||+++|+|.+++...+. .....+++..+.+++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeeccc
Confidence 99999999999864321 12334789999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 526 TPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 526 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
|+...... ...+++.|+|||.+.+..++.++||||||+++|||+||. .||.+... ......+....
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~~i~~~~- 252 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFVMEGG- 252 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHHHHTTC-
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhCC-
Confidence 98654322 234688899999999999999999999999999999985 67765432 22222222211
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 599 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 599 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.... .......+.+++.+||+.+|++|||++||+++|++..+.
T Consensus 253 ~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 253 LLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp CCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1111 111234677888899999999999999999999887654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=363.96 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=189.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|+++++++ +|||||++++++.+++..|+||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEEEeecCC
Confidence 368999999999999974 588999999965432 246788999999998 999999999999999999999999976
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC----
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---- 531 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~---- 531 (672)
+.+...... . ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~~~~~~~~-~---~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 86 DLKKFMDAS-A---LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EHHHHHHHT-T---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred chhhhhhhh-c---ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 544433332 2 234999999999999999999999998 99999999999999999999999999866543
Q ss_pred CCCCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh--hcccccc-----c
Q 005875 532 PATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR--EEWTAEV-----F 603 (672)
Q Consensus 532 ~~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----~ 603 (672)
.....+|+.|+|||.+.... ++.++||||+||++|||++|+.||.+.+..+. +......... +...... .
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhcccccccccc
Confidence 22346889999999987665 47899999999999999999999976532211 0000000000 0000000 0
Q ss_pred hhhhh--cccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVELM--RFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~~--~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
..... ..... ......+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 00000 1112456778889999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=358.64 Aligned_cols=233 Identities=21% Similarity=0.393 Sum_probs=188.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc-------ChhhHHHHHHHHHHHc-CCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVG-QHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.+.||+|+||+||+|+.. +++.||||++..... ....+.+|+.+++++. .|||||++++++.+++..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 468999999999999975 578999999875432 1234678999999984 3999999999999999999999
Q ss_pred EecCC-CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCC-CCeEEeecCCCCC
Q 005875 451 DYFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPL 528 (672)
Q Consensus 451 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DfGla~~ 528 (672)
||+.+ +++.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 89 e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccccee
Confidence 99976 6788887642 34999999999999999999999998 9999999999999854 7999999999976
Q ss_pred CCCC--CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccchh
Q 005875 529 MNVP--ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 605 (672)
Q Consensus 529 ~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 605 (672)
.... .+..||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... .+..... .+
T Consensus 161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~---~~-- 223 (273)
T d1xwsa_ 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV---FF-- 223 (273)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC---CC--
T ss_pred cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhccc---CC--
Confidence 5433 34568999999999987765 567899999999999999999997421 1111110 00
Q ss_pred hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 606 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 606 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
...++ ..+.+++.+||+.||++|||++|++++
T Consensus 224 ----~~~~s---~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 224 ----RQRVS---SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----SSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCCCC---HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11122 345677789999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5e-43 Score=358.90 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=192.7
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|++++++.||||+++.... ..+.+.+|+.+++++ +|||||++++++.+++..+++|||+.++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~~e~~~~~ 85 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQD 85 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEEEEeehhh
Confidence 367999999999999999999999999965432 246789999999999 8999999999999999999999999987
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCC----
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~---- 532 (672)
.+..+... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||.+......
T Consensus 86 ~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 86 LKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp HHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred hHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 77777653 234999999999999999999999998 999999999999999999999999998665432
Q ss_pred CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhh---hccc----cccch
Q 005875 533 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---EEWT----AEVFD 604 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~----~~~~d 604 (672)
....+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+.. ......... ..+. ....+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH--HHHHHhhCCCChhhccchhhhhhcc
Confidence 234578889999999764 4689999999999999999999999765322110 000000000 0000 00000
Q ss_pred hhhh------cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 605 VELM------RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 605 ~~~~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.... ...........+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 000111122456788889999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=359.14 Aligned_cols=258 Identities=20% Similarity=0.260 Sum_probs=190.1
Q ss_pred hccccccCcEEEEEEEEC-C-CcEEEEEEeccccc---ChhhHHHHHHHHHHHc--CCCceeceEEEEEe-----CCeeE
Q 005875 380 AEVLGKGSYGTAYKAVLE-E-STTVVVKRLKEVVV---GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYS-----KDEKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~-----~~~~~ 447 (672)
.+.||+|+||+||+|+.. + ++.||||+++.... ....+.+|+.+++.+. +||||++++++|.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 468999999999999974 3 45689999875432 2346778888887764 79999999999863 24678
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
++|||+++|++....... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 999999998776555432 234899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCC---CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChh-HHHHHhhhhccccccc
Q 005875 528 LMNV---PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-RWVQSVVREEWTAEVF 603 (672)
Q Consensus 528 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 603 (672)
.... .....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+..... ..........+.....
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 244 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence 6543 23566899999999999999999999999999999999999999865432211100 0000000001100000
Q ss_pred hhhh--------hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 604 DVEL--------MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 604 d~~~--------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.... ............+.+|+.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0000011122345677889999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-41 Score=347.03 Aligned_cols=252 Identities=17% Similarity=0.162 Sum_probs=190.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|++. +++.||||++.... ..+++..|++++..+.+|++|+.+.+++.+++..++||||+. |++
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l 89 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSL 89 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBH
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cch
Confidence 468999999999999974 57899999876543 345688999999999555556666777778888999999995 466
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC---CCCeEEeecCCCCCCCCC---
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DfGla~~~~~~--- 532 (672)
.+.+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+.....
T Consensus 90 ~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 90 EDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred hhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 6655432 234999999999999999999999998 999999999999864 557999999999765432
Q ss_pred --------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChh-HHHHHhhhhccccccc
Q 005875 533 --------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-RWVQSVVREEWTAEVF 603 (672)
Q Consensus 533 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 603 (672)
....||+.|+|||++.+..++.++|||||||++|||+||+.||......+..... .+........
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~------ 236 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------ 236 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC------
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC------
Confidence 2335899999999999999999999999999999999999999876544332211 1111100000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 651 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 651 (672)
.+. .... ....+.+++.+||+.+|++||+++++.+.|+.+...
T Consensus 237 ~~~--~~~~---~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 237 IEV--LCKG---YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHH--HTTT---SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhH--hccC---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 000 0011 224567778899999999999999999999987543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.9e-41 Score=344.23 Aligned_cols=254 Identities=17% Similarity=0.179 Sum_probs=200.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCch
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 458 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 458 (672)
.+.||+|+||+||+|++. +++.||||++... .....+.+|++++..+.+|+|++.+++++.++...++||||+ +|+|
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l 87 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 87 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCH
Confidence 468999999999999975 5788999987654 334568889999999977799999999999999999999999 6799
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecC-----CCCeEEeecCCCCCCCC--
Q 005875 459 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-----DLDGCISDFGLTPLMNV-- 531 (672)
Q Consensus 459 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~-----~~~~kl~DfGla~~~~~-- 531 (672)
.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+....
T Consensus 88 ~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 88 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 99887533 24899999999999999999999998 999999999999974 57899999999976532
Q ss_pred ---------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcccccc
Q 005875 532 ---------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 602 (672)
Q Consensus 532 ---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (672)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.+......... ...+........
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~---~~~i~~~~~~~~- 236 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK---YERIGEKKQSTP- 236 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH---HHHHHHHHHHSC-
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH---HHHHHhccCCCC-
Confidence 1234589999999999999999999999999999999999999986554332111 111111110000
Q ss_pred chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 005875 603 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 652 (672)
Q Consensus 603 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 652 (672)
-..+ ...+ ...+.+++..|++.+|++||+++.+.+.|+++.+..
T Consensus 237 -~~~l--~~~~---p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 237 -LREL--CAGF---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp -HHHH--TTTS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -hHHh--cCCC---CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 0000 0111 235677778999999999999999999999987554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=350.04 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=187.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeccccc---ChhhHHHHHHHHHHHcCCCceeceEEEEEe--------CCeeE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--------KDEKL 447 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--------~~~~~ 447 (672)
.+.||+|+||+||+|+.. +++.||||++..... ..+++.+|+++++.+ +||||+++++++.. ++..+
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC----------CEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccccCceEE
Confidence 468999999999999974 688999999865432 245688999999999 99999999999865 34578
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 448 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 448 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
+||||+.++.+..+... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 94 iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp EEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 99999998877666542 234889999999999999999999998 9999999999999999999999999996
Q ss_pred CCCC--------CCCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhcc
Q 005875 528 LMNV--------PATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 598 (672)
Q Consensus 528 ~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 598 (672)
.... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+................
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 5432 2234578999999998765 689999999999999999999999976432221111000000000000
Q ss_pred cccc--------chhhhhcccChHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 599 TAEV--------FDVELMRFQNIEEE------MVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 599 ~~~~--------~d~~~~~~~~~~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.... ............+. ...+++|+.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000 00000001111111 2356788999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=357.16 Aligned_cols=260 Identities=25% Similarity=0.319 Sum_probs=188.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeC------CeeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV~e~ 452 (672)
.++||+|+||+||+|+.. +++.||||+++... ....+|+++++++ +||||++++++|... ...++||||
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECccc---hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 368999999999999975 58899999987543 3345799999998 999999999998643 246899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-CeEEeecCCCCCCCC
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNV 531 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~ 531 (672)
+++|.+..+.+... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 101 ~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 101 VPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp CSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred cCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 98765444332111 2335999999999999999999999998 99999999999999875 899999999976543
Q ss_pred ---CCCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh-h--------HHHHHhhhhcc
Q 005875 532 ---PATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL-P--------RWVQSVVREEW 598 (672)
Q Consensus 532 ---~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~-~--------~~~~~~~~~~~ 598 (672)
..+..+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.... . .+..... ...
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~-~~~ 254 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN-PNY 254 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC-C--
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc-cch
Confidence 234567889999998865 5689999999999999999999999976543221100 0 0000000 000
Q ss_pred ccccc----hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 005875 599 TAEVF----DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQ 650 (672)
Q Consensus 599 ~~~~~----d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~ 650 (672)
....+ ...... .........+.+|+.+||+.||++|||++|++++ ++++..
T Consensus 255 ~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp -CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhccccccccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 00000 000000 0001123456778889999999999999999974 666654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=355.88 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=188.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCC------eeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lV 449 (672)
.+.||+|+||+||+|... +++.||||+++..... .+.+.+|+++++.+ +|||||+++++|...+ +.++|
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccccceEEEE
Confidence 367999999999999975 5888999999765433 34678899999998 9999999999997654 46999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||+ +++|..+.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|+..
T Consensus 102 ~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp EECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred Eecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence 9999 56888877632 3999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCC-CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh----cc-----
Q 005875 530 NVPA-TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE----EW----- 598 (672)
Q Consensus 530 ~~~~-~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~----- 598 (672)
.... ...+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+.............. ..
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T d1cm8a_ 172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251 (346)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence 5443 35688999999998764 5689999999999999999999999865422211000000000000 00
Q ss_pred ------ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 005875 599 ------TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQ 650 (672)
Q Consensus 599 ------~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~ 650 (672)
........+ ..........+.+|+.+||+.||++|||++|++++ ++++..
T Consensus 252 ~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 252 KNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhhhccCCcccccch--HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 000000000 00011122356778889999999999999999985 666543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-40 Score=346.99 Aligned_cols=249 Identities=20% Similarity=0.294 Sum_probs=189.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeC--CeeEEEEEecCCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFASG 456 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lV~e~~~~g 456 (672)
.+.||+|+||+||+|+.. +++.||||+++.. ..+.+.+|++++..+.+||||+++++++... ...++||||+++|
T Consensus 40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~ 117 (328)
T d3bqca1 40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence 478999999999999974 5788999998753 3567889999999996799999999999854 4689999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCC-CeEEeecCCCCCCCCC---
Q 005875 457 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVP--- 532 (672)
Q Consensus 457 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DfGla~~~~~~--- 532 (672)
+|..+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 118 ~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 118 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp BGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred cHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence 9987653 3899999999999999999999998 99999999999998765 5899999999766433
Q ss_pred CCCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhh------------ccc
Q 005875 533 ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE------------EWT 599 (672)
Q Consensus 533 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------------~~~ 599 (672)
....+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||....... +........... ...
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhhhhhhhcccccC
Confidence 3445788999999987654 7999999999999999999999997543211 000000000000 000
Q ss_pred c---ccc-------hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005875 600 A---EVF-------DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 643 (672)
Q Consensus 600 ~---~~~-------d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 643 (672)
. ... ................+.+|+.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000 0000001111122345778888999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-41 Score=352.45 Aligned_cols=260 Identities=20% Similarity=0.274 Sum_probs=187.9
Q ss_pred hccccccCcEEEEEEEE-CCCcEEEEEEeccccc--ChhhHHHHHHHHHHHcCCCceeceEEEEEeCC----eeEEEEEe
Q 005875 380 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD----EKLLVYDY 452 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lV~e~ 452 (672)
.+.||+|+||+||+|+. .+++.||||++..... ..+.+.+|++++..+ +||||+++++++.... ..+++++|
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccceEEEEEe
Confidence 46899999999999986 4688999999975432 235678899999999 9999999999997653 33556677
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCC-
Q 005875 453 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV- 531 (672)
Q Consensus 453 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~- 531 (672)
+.+|+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 92 ~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 92 LMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred ecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 7899999999742 3999999999999999999999998 99999999999999999999999999865432
Q ss_pred ------CCCCCCCCcccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch
Q 005875 532 ------PATPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 604 (672)
Q Consensus 532 ------~~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 604 (672)
.....+++.|+|||++. +..++.++||||+||++|||++|+.||.+....+......................
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 23345788999999985 45678899999999999999999999976543221100000000000000000000
Q ss_pred -------hhhh--cccChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 005875 605 -------VELM--RFQNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR 649 (672)
Q Consensus 605 -------~~~~--~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~ 649 (672)
.... ...... .....+.+++.+||+.||++|||++|++++ +++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0000 000000 111356788889999999999999999985 55443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=345.34 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=192.3
Q ss_pred hccccccCcEEEEEEEEC----CCcEEEEEEecccc-----cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVV-----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~ 450 (672)
.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++.++.+||||+++++++.+....++||
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~ 108 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence 478999999999999852 37889999986542 234568899999999966689999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 109 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred ecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999997543 3788999999999999999999998 9999999999999999999999999987653
Q ss_pred C-----CCCCCCCCcccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccc
Q 005875 531 V-----PATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 603 (672)
Q Consensus 531 ~-----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (672)
. .....+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+... ...........
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~~~~~~----- 253 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKSEP----- 253 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHCCC-----
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcccCCC-----
Confidence 2 2234578899999999754 46789999999999999999999998765443211 11111111000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005875 604 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR 643 (672)
Q Consensus 604 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 643 (672)
.........+.+++.+||++||++|| |++|+++
T Consensus 254 -------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 -------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 00112334667788899999999999 4889887
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-40 Score=335.54 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=192.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCC
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 455 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~ 455 (672)
.+.||+|+||+||+|+.. +++.||||+++..... ...+.+|+.+++.+ +||||+++++++.+.+..++|+|++.+
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEeeeccc
Confidence 368999999999999975 5788999999755332 35688999999998 999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCCCCC--
Q 005875 456 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-- 533 (672)
Q Consensus 456 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~~~~-- 533 (672)
+++..+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 86 ~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 86 DLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred cccccccccc-----cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9998888643 34889999999999999999999998 9999999999999999999999999997765432
Q ss_pred --CCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhc-------cc----
Q 005875 534 --TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE-------WT---- 599 (672)
Q Consensus 534 --~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~---- 599 (672)
...+++.|+|||++.... ++.++||||+||++|||++|+.||..... .......+.... +.
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-----HHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC-----HHHHHHHHHhhcCCCChhhhhhhhh
Confidence 233567799999987665 68999999999999999999999753221 111111111100 00
Q ss_pred ------cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 600 ------AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 600 ------~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
....................+.+|+.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000001111223456778889999999999999999873
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-40 Score=344.71 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=183.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccCh---hhHHHHHHHHHHHcCCCceeceEEEEEeC------CeeEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV 449 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lV 449 (672)
.++||+|+||+||+|++. +++.||||+++...... ..+.+|+.++.++ +|||||+++++|... ...|+|
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCceeEEE
Confidence 368999999999999976 58899999997654432 4578899999998 899999999999643 578999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCC
Q 005875 450 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 529 (672)
Q Consensus 450 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~ 529 (672)
|||+.++.+. .+. ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+|++|||+++..
T Consensus 101 ~Ey~~~~l~~-~~~-------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 101 MELMDANLCQ-VIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EECCSEEHHH-HHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EeccchHHHH-hhh-------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcc
Confidence 9999775554 443 13899999999999999999999998 999999999999999999999999998765
Q ss_pred CCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC----------------hhHHH
Q 005875 530 NVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD----------------LPRWV 590 (672)
Q Consensus 530 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~----------------~~~~~ 590 (672)
... ....+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...... .....
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 443 23457889999999999999999999999999999999999997654221100 00000
Q ss_pred HHhhhhcccc-c-----cchhhhhc--ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005875 591 QSVVREEWTA-E-----VFDVELMR--FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 644 (672)
Q Consensus 591 ~~~~~~~~~~-~-----~~d~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 644 (672)
.......... . .+...... ..........+.+|+.+|++.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0001110000 0 00000000 00112345668889999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=347.60 Aligned_cols=260 Identities=19% Similarity=0.271 Sum_probs=188.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccC---hhhHHHHHHHHHHHcCCCceeceEEEEEeC-----CeeEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY 450 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lV~ 450 (672)
.+.||+|+||+||+|+.. +++.||||++.....+ .+.+.+|++++.++ +|||||++++++... ...+++|
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccCceEEEE
Confidence 468999999999999964 6889999999765433 34678899999999 999999999998643 3456778
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEEeecCCCCCCC
Q 005875 451 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 530 (672)
Q Consensus 451 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl~DfGla~~~~ 530 (672)
+|+.+|+|.++++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++....
T Consensus 102 ~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 102 THLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp EECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccC
Confidence 88899999999963 23999999999999999999999998 9999999999999999999999999987654
Q ss_pred CC-CCCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHhhhhccccccch----
Q 005875 531 VP-ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD---- 604 (672)
Q Consensus 531 ~~-~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---- 604 (672)
.. .+..+++.|+|||+..+.. ++.++||||+||++|||++|+.||.+.+.........................
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 33 3445778899999877654 68899999999999999999999986542211100000000000000000000
Q ss_pred ---hhhhc--ccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 005875 605 ---VELMR--FQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR 649 (672)
Q Consensus 605 ---~~~~~--~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~ 649 (672)
..... .... ......+.+|+.+||+.||++|||++|+++ .+++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00000 0000 011235677888999999999999999998 455543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-36 Score=316.07 Aligned_cols=268 Identities=18% Similarity=0.230 Sum_probs=190.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEecccccChhhHHHHHHHHHHHc----------CCCceeceEEEEEeC--Cee
Q 005875 380 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----------QHPNVVPLRAYYYSK--DEK 446 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~----------~h~niv~l~~~~~~~--~~~ 446 (672)
.++||+|+||+||+|+.. +++.||||+++......+.+.+|+++++.+. .|+||+++++++... ...
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~ 97 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 97 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence 478999999999999974 6889999999865444567788888887763 368999999988653 456
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCCEEecCCCC------eE
Q 005875 447 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLD------GC 519 (672)
Q Consensus 447 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivHrDLk~~NILl~~~~~------~k 519 (672)
+++|+++..+.......... ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++. ++
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 98 HVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp EEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred eeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceee
Confidence 67777765554332222111 23458899999999999999999998 66 999999999999987654 89
Q ss_pred EeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHh---hh
Q 005875 520 ISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV---VR 595 (672)
Q Consensus 520 l~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~---~~ 595 (672)
++|||.+...... ....+|+.|+|||++.+..++.++||||+||+++||++|+.||.................. +.
T Consensus 173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg 252 (362)
T d1q8ya_ 173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252 (362)
T ss_dssp ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence 9999998765433 3456899999999999999999999999999999999999999865433222111111100 00
Q ss_pred h---c------ccc----------cc--------chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HH
Q 005875 596 E---E------WTA----------EV--------FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IE 646 (672)
Q Consensus 596 ~---~------~~~----------~~--------~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~ 646 (672)
. . ... .+ .+...............+.+|+.+|++.||++|||++|++++ ++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332 (362)
T ss_dssp SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccC
Confidence 0 0 000 00 000001222345667788999999999999999999999985 66
Q ss_pred HhhhcC
Q 005875 647 EVRQSD 652 (672)
Q Consensus 647 ~i~~~~ 652 (672)
+.....
T Consensus 333 ~~~~~~ 338 (362)
T d1q8ya_ 333 DTLGME 338 (362)
T ss_dssp TCTTCT
T ss_pred CCCCcc
Confidence 554333
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=7.2e-31 Score=271.56 Aligned_cols=203 Identities=38% Similarity=0.696 Sum_probs=150.3
Q ss_pred cCChhHHHHHHHHHHhCCCCCC-CCCCCCCCCCC-CcceeeecCCC--CeEEEEEeCCCCccc--cCCccccCCCCCCcE
Q 005875 62 ADLNSDRQALLDFADAVPHLRK-LNWSSTNPICQ-SWVGINCTQDR--TRVFGLRLPGIGLVG--PIPNNTLGKLDALEV 135 (672)
Q Consensus 62 ~~~~~~~~al~~~~~~~~~~~~-~~w~~~~~~c~-~w~gv~C~~~~--~~v~~l~l~~~~l~g--~~p~~~~~~l~~L~~ 135 (672)
.|.++|++||++||+++.++.. .+|..+++||. +|.||+|+..+ .||+.|+|++++++| .+|+ .+++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~~ 80 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCccccc
Confidence 3678999999999999966544 48987778774 69999998743 489999999999998 5787 8999999999
Q ss_pred EEccC-CCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--------------------------cccceeeccccc
Q 005875 136 LSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--------------------------PQLVVLDLSFNS 188 (672)
Q Consensus 136 L~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--------------------------~~L~~L~ls~N~ 188 (672)
|+|++ |+++|.+|.+|++|++|++|+|++|++++..|..+. ++|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 999999999999999999999999999876654332 234444444444
Q ss_pred CcccCCch-----------------------------------------------------------------------h
Q 005875 189 FTGNIPQS-----------------------------------------------------------------------I 197 (672)
Q Consensus 189 l~~~~p~~-----------------------------------------------------------------------~ 197 (672)
++|.+|.. +
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~ 240 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 44333322 2
Q ss_pred hhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcc--cCCCCCCccccCCCCCCCCCCCC
Q 005875 198 QNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS--LQKFPNSSFVGNSLLCGPPLKAC 265 (672)
Q Consensus 198 ~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~--~~~~~~l~~~~n~~~~~~~l~~c 265 (672)
+.+++|+.|+|++|+|+|.+|.. .+++|++|+|++|+|+|.+|+. +.++..+.+.+|+.+||.|++.|
T Consensus 241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence 33455666666666666666653 6677777777777777777742 23344445667777787777666
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.8e-22 Score=192.25 Aligned_cols=159 Identities=18% Similarity=0.160 Sum_probs=116.0
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEecccccC-------------------hhhHHHHHHHHHHHcCCCceeceEEEE
Q 005875 380 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-------------------KRDFEQQMEIVGRVGQHPNVVPLRAYY 440 (672)
Q Consensus 380 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------------------~~~~~~e~~~l~~l~~h~niv~l~~~~ 440 (672)
++.||+|+||+||+|...+|+.||||+++..... ......|...+.++ .|.+++..+++.
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~~~~~ 83 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCEEEEE
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceEEEec
Confidence 5789999999999999988999999987532110 11234566777777 899999887653
Q ss_pred EeCCeeEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCCEEecCCCCeEE
Q 005875 441 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 520 (672)
Q Consensus 441 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivHrDLk~~NILl~~~~~~kl 520 (672)
..+++|||+++..+.+ ++......++.|++.+++|||+.+ |+||||||+|||+++++ ++|
T Consensus 84 ----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp ----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEE
T ss_pred ----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEE
Confidence 3479999998866543 223345678999999999999998 99999999999999655 899
Q ss_pred eecCCCCCCCCCCCCCCCCcccCc------ccccCCCCCCccchhhHHHH
Q 005875 521 SDFGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVL 564 (672)
Q Consensus 521 ~DfGla~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~~DvwS~Gvv 564 (672)
+|||.|.....+.. ..|... |. ..+.|+.++|+||..--
T Consensus 144 iDFG~a~~~~~~~~----~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGW----REILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTH----HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCc----HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 99999866543211 112111 11 13567889999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=1.1e-18 Score=165.80 Aligned_cols=124 Identities=27% Similarity=0.332 Sum_probs=96.4
Q ss_pred EEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCC-CCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccc
Q 005875 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGL-PSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 187 (672)
Q Consensus 111 l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N 187 (672)
++.++++|+ .+|.+ +. +++++|+|++|.|++.+ +..|.++++|+.|+|++|++++..+..|. ++|++|+|++|
T Consensus 13 v~Cs~~~L~-~iP~~-lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EECTTSCCS-SCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEeCCCcC-ccCCC-CC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 455566777 67763 32 67888888888887655 45568888888888888888877777765 78888888888
Q ss_pred cCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCC
Q 005875 188 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGS 238 (672)
Q Consensus 188 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~ 238 (672)
+|++..|..|.++++|+.|+|++|+|++..|.. .+++|++|+|++|.+...
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 888777778888888888888888888776664 788888888888888743
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=1.9e-16 Score=158.20 Aligned_cols=149 Identities=29% Similarity=0.264 Sum_probs=103.8
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--c-------
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--P------- 177 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~------- 177 (672)
.++.|+|++|.++ .+|++.|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|++++. |..+. +
T Consensus 32 ~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 32 DTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDV 107 (266)
T ss_dssp TCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCC-CcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccccc-ccccccccccccccc
Confidence 4778888888887 455557888888888888888887 555 357788888888888888743 33332 3
Q ss_pred -----------------ccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCC
Q 005875 178 -----------------QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGS 238 (672)
Q Consensus 178 -----------------~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~ 238 (672)
+|++|++++|.+++..+..+..+++|+.|++++|+|++..+.. .+++|++|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 4555555666666555556667777777777777777666653 6778888888888887 6
Q ss_pred CCcccCCCCCCc---cccCCCCCCC
Q 005875 239 IPSSLQKFPNSS---FVGNSLLCGP 260 (672)
Q Consensus 239 ~p~~~~~~~~l~---~~~n~~~~~~ 260 (672)
+|+.+..+++|. ..||++.|.+
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cChhHCCCCCCCEEEecCCCCCCCc
Confidence 777666555544 4467776653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.66 E-value=1.8e-16 Score=150.31 Aligned_cols=165 Identities=24% Similarity=0.259 Sum_probs=137.8
Q ss_pred CcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeecc
Q 005875 95 SWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 165 (672)
Q Consensus 95 ~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 165 (672)
+|..|.|++.. ..++.|+|++|.+++.++...|+.+++|++|+|++|.+.+..+..|..+++|++|+|++|
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred cCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 79999998532 367899999999998888878999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcc
Q 005875 166 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSS 242 (672)
Q Consensus 166 ~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~ 242 (672)
+|++..|..|. ++|++|+|++|+|++..|..|..+++|++|+|++|.+....+.. -...|+.+.+..|.+....|..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~ 168 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK 168 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChh
Confidence 99977777776 89999999999999888899999999999999999998655432 2234666778888888778877
Q ss_pred cCCCCCCccccCCCCCC
Q 005875 243 LQKFPNSSFVGNSLLCG 259 (672)
Q Consensus 243 ~~~~~~l~~~~n~~~~~ 259 (672)
+.++.-++...|..-|.
T Consensus 169 l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 169 VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp TTTSBGGGSCTTTCCCC
T ss_pred hcCCEeeecCHhhCcCC
Confidence 77665444445554453
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.1e-15 Score=152.62 Aligned_cols=145 Identities=23% Similarity=0.238 Sum_probs=109.1
Q ss_pred eecCCCCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCccccc
Q 005875 100 NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 179 (672)
Q Consensus 100 ~C~~~~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L 179 (672)
.|... ....+++.++++|+ .+|+ .+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+..-+....++|
T Consensus 5 ~~~~~-~~~~~v~C~~~~L~-~iP~-~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~~~l~~L 79 (266)
T d1p9ag_ 5 EVSKV-ASHLEVNCDKRNLT-ALPP-DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVL 79 (266)
T ss_dssp EEECS-TTCCEEECTTSCCS-SCCS-CCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTC
T ss_pred EEccc-CCCeEEEccCCCCC-eeCc-CcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccccccccccc
Confidence 45543 23455688899998 6887 343 5799999999999966667899999999999999999943333344899
Q ss_pred ceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCc
Q 005875 180 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 250 (672)
Q Consensus 180 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~ 250 (672)
++|+|++|+|+ .+|..+.++++|+.|++++|.+.+..+.. .+.+|+.|++++|.+++..+..+..++++.
T Consensus 80 ~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~ 151 (266)
T d1p9ag_ 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE 151 (266)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred ccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccch
Confidence 99999999999 56778899999999999999888655543 566666666666666654444445454444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=1.8e-15 Score=152.47 Aligned_cols=153 Identities=24% Similarity=0.294 Sum_probs=129.2
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
.+..+....++....+++..|.++++|++|+|++|.+.+..+..+..+++|+.+++++|++++..+..|. ++|+.|+|
T Consensus 81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhccc
Confidence 3445555544444466666899999999999999999977788899999999999999999976666675 78999999
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCccc---cCCCCCC
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLCG 259 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~---~n~~~~~ 259 (672)
++|+|++..|..|.++++|+.|++++|++++..|.. .+++|++|++++|++++..|..|+++++|.++ +|++-|.
T Consensus 161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 999999888999999999999999999999888875 88999999999999998888888887776654 7777664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.58 E-value=3.8e-15 Score=151.62 Aligned_cols=157 Identities=25% Similarity=0.335 Sum_probs=124.5
Q ss_pred CCcceeeecCC---------CCeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeec
Q 005875 94 QSWVGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH 164 (672)
Q Consensus 94 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 164 (672)
|.|.+|.|++. ...++.|+|++|+++ .+|+..|.++++|++|++++|.+....|..|.++++|+.|++++
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 48999999753 135788999999998 67776899999999999999999987788999999999999999
Q ss_pred cCCCCCCCCCcc--------------------------------------------------------------------
Q 005875 165 NNFSGKIPSSFS-------------------------------------------------------------------- 176 (672)
Q Consensus 165 N~l~g~~p~~~~-------------------------------------------------------------------- 176 (672)
|+++ .+|..+.
T Consensus 89 n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~ 167 (305)
T d1xkua_ 89 NQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ 167 (305)
T ss_dssp SCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS
T ss_pred CccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCc
Confidence 9987 3443221
Q ss_pred ---cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCcc
Q 005875 177 ---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 251 (672)
Q Consensus 177 ---~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 251 (672)
++|+.|++++|.+++..+..|.+++.++.|++++|.+++..+.. .+++|+.|+|++|+|+ .+|..|.++++|+.
T Consensus 168 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~ 246 (305)
T d1xkua_ 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 246 (305)
T ss_dssp SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCE
T ss_pred ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCE
Confidence 23556666666666667777888888888888888888766654 6788888888888888 67878888877776
Q ss_pred cc
Q 005875 252 VG 253 (672)
Q Consensus 252 ~~ 253 (672)
+.
T Consensus 247 L~ 248 (305)
T d1xkua_ 247 VY 248 (305)
T ss_dssp EE
T ss_pred EE
Confidence 53
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=4.4e-15 Score=149.59 Aligned_cols=157 Identities=23% Similarity=0.242 Sum_probs=120.5
Q ss_pred cceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCC-------------------
Q 005875 96 WVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGL------------------- 147 (672)
Q Consensus 96 w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~------------------- 147 (672)
|.-|.|++.+ ..++.|+|++|+++ .+|+..|.++++|++|++++|+|.+..
T Consensus 13 ~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 13 KVTTSCPQQGLQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp SCEEECCSSCCSSCCTTCCTTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred CeEEEcCCCCCCccCCCCCCCCCEEECcCCcCC-CCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 5567887522 24578999999998 677778999999999999999875322
Q ss_pred ------CCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCC
Q 005875 148 ------PSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 219 (672)
Q Consensus 148 ------p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 219 (672)
|..|.++++|++|++++|.+.+..+..+. ++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 45567778888888888888755555554 6788888888888876677788888888888888888866665
Q ss_pred C--CCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 220 F--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 220 ~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
. .+++|+.+++++|++++..|..|.+++++..++
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 3 778888888888888877788888777776554
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.52 E-value=3.7e-15 Score=152.32 Aligned_cols=119 Identities=30% Similarity=0.544 Sum_probs=111.8
Q ss_pred CCCcEEEccCCCcCC--CCCCcCCCCCCCcEEeeec-cCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccc
Q 005875 131 DALEVLSLRSNVLTG--GLPSEITSLPSLRYLYLQH-NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTG 205 (672)
Q Consensus 131 ~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 205 (672)
.+++.|+|++|+++| .+|++|++|++|++|+|++ |+++|.+|..|+ ++|++|+|++|+|++..|..+.++.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 468999999999998 5899999999999999997 899999999998 79999999999999999999999999999
Q ss_pred eecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCC
Q 005875 206 LSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNS 249 (672)
Q Consensus 206 L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l 249 (672)
+++++|.+.+.+|.. .++.|+.+++++|.++|.+|..+..+..+
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l 175 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT
T ss_pred cccccccccccCchhhccCcccceeecccccccccccccccccccc
Confidence 999999999999875 89999999999999999999999888765
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=6.9e-14 Score=121.88 Aligned_cols=99 Identities=27% Similarity=0.328 Sum_probs=65.6
Q ss_pred EEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeeccccc
Q 005875 111 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNS 188 (672)
Q Consensus 111 l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~ 188 (672)
|+|++|+++ .++ .++.+++|++|+|++|.|+ .+|+.++.+++|+.|++++|+|++ +|+ +. ++|++|++++|+
T Consensus 3 L~Ls~n~l~-~l~--~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~-~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 3 LHLAHKDLT-VLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNR 76 (124)
T ss_dssp EECTTSCCS-SCC--CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSC
T ss_pred EEcCCCCCC-CCc--ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cCc-cccccccCeEECCCCc
Confidence 677777776 454 3677777777777777776 566667777777777777777773 342 33 567777777777
Q ss_pred CcccC-CchhhhhccccceecCCccccC
Q 005875 189 FTGNI-PQSIQNLTQLTGLSLQSNNLSG 215 (672)
Q Consensus 189 l~~~~-p~~~~~l~~L~~L~l~~N~l~~ 215 (672)
|+... ...++.+++|+.|++++|+++.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 76432 2456666777777777777663
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=5.7e-14 Score=122.44 Aligned_cols=99 Identities=32% Similarity=0.368 Sum_probs=86.4
Q ss_pred cEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccccceecCCc
Q 005875 134 EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 211 (672)
Q Consensus 134 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 211 (672)
++|||++|+|+ .+| .+.++++|++|++++|+|+ .+|..+. ++|+.|++++|+|++ +| .++++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 58999999999 666 4999999999999999999 6787776 799999999999994 55 5999999999999999
Q ss_pred cccCCCCC---CCCCCCceEEeecCCCCC
Q 005875 212 NLSGSIPN---FDIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 212 ~l~~~~p~---~~l~~L~~l~l~~N~l~g 237 (672)
+|+..... ..+++|+.|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 99954432 278999999999999974
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=3.2e-14 Score=130.33 Aligned_cols=124 Identities=19% Similarity=0.135 Sum_probs=94.8
Q ss_pred ccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccc
Q 005875 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 203 (672)
Q Consensus 126 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L 203 (672)
.+.+...|++|||++|+|+ .+|..+..+++|+.|+|++|+++ .++. |. ++|++|+|++|+|+...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECC-CCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccCC-cccCcchhhhhcccccccCCCcccccccccc
Confidence 3667788888999999888 56766678888999999999888 4443 33 788899999999886656667788899
Q ss_pred cceecCCccccCCCC--C-CCCCCCceEEeecCCCCCCCCc----ccCCCCCCcccc
Q 005875 204 TGLSLQSNNLSGSIP--N-FDIPKLRHLNLSYNGLKGSIPS----SLQKFPNSSFVG 253 (672)
Q Consensus 204 ~~L~l~~N~l~~~~p--~-~~l~~L~~l~l~~N~l~g~~p~----~~~~~~~l~~~~ 253 (672)
+.|+|++|+|+.... . ..+++|++|++++|.++ ..|. .+..+++|.+++
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 999999998874321 2 27888999999999887 3443 467778887776
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.43 E-value=2e-13 Score=130.82 Aligned_cols=136 Identities=33% Similarity=0.414 Sum_probs=101.3
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
+++.|+|++|.+++ +++ ++.+++|++|++++|+|++ +| .+.++++|+.|++++|.+.. ++. +. ++|+.+++
T Consensus 69 ~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~~~-l~~l~~l~~l~~ 141 (210)
T d1h6ta2 69 NVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-ING-LVHLPQLESLYL 141 (210)
T ss_dssp TCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-CGG-GGGCTTCCEEEC
T ss_pred CCCEEeCCCccccC-ccc--cccCccccccccccccccc-cc-cccccccccccccccccccc-ccc-cccccccccccc
Confidence 57788888888874 443 6788888888888888873 55 47788888888888888763 332 22 67888888
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
++|.+++ +..+.++++|+.+++++|++++..+-..+++|+.|+|++|+++ .+| .+.++++|+++.
T Consensus 142 ~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~ 206 (210)
T d1h6ta2 142 GNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLE 206 (210)
T ss_dssp CSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEE
T ss_pred ccccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEE
Confidence 8888874 3457788888888888888886555457888888888888887 455 577777777654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.41 E-value=2.8e-13 Score=128.61 Aligned_cols=122 Identities=24% Similarity=0.328 Sum_probs=55.2
Q ss_pred EEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecccc
Q 005875 108 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFN 187 (672)
Q Consensus 108 v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N 187 (672)
++.|+|++|.+++ +++ ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+....+-.-.++|+.|++++|
T Consensus 64 L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n 138 (199)
T d2omxa2 64 LTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 138 (199)
T ss_dssp CCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred cCcCccccccccC-ccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccccccchhhhhHHhhhhhh
Confidence 4444455444442 221 444445555555554444 222 24444555555555444443221111144555555555
Q ss_pred cCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCC
Q 005875 188 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 236 (672)
Q Consensus 188 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~ 236 (672)
++.. +| .+..+++|+.|++++|++++..+-..+++|+.|++++|+++
T Consensus 139 ~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 139 TISD-IS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVS 185 (199)
T ss_dssp CCCC-CG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred hhcc-cc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCC
Confidence 5542 22 34455555555555555554333234555555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.38 E-value=5.5e-13 Score=126.46 Aligned_cols=137 Identities=25% Similarity=0.316 Sum_probs=112.6
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCC-Ccccccceeecc
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 185 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~~L~~L~ls 185 (672)
+++.|+++++++. .++ .+..+++|++|+|++|+|++..| ++++++|++|++++|.+.. +|. .-.++|+.|+++
T Consensus 41 ~l~~L~l~~~~i~-~l~--~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 41 QVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLF 114 (199)
T ss_dssp TCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCC-Ccc--ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cccccccccccccccc
Confidence 5778999999988 454 48999999999999999996544 9999999999999999984 442 222899999999
Q ss_pred cccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 186 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
+|.+... ..+..+++|+.|++++|++....+-..+++|+.|++++|++++. + .++++++|..+.
T Consensus 115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ 178 (199)
T d2omxa2 115 NNQITDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLD 178 (199)
T ss_dssp SSCCCCC--GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred ccccccc--cccchhhhhHHhhhhhhhhcccccccccccccccccccccccCC-c-cccCCCCCCEEE
Confidence 9999854 34889999999999999998543334899999999999999964 3 477777776654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=2.9e-13 Score=123.82 Aligned_cols=119 Identities=24% Similarity=0.324 Sum_probs=99.0
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
.++..|+|++|+++ .++. .+..+++|+.|||++|.|+ .++ .|..+++|++|+|++|+++...+..+. ++|+.|+
T Consensus 18 ~~lr~L~L~~n~I~-~i~~-~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 93 (162)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CcCcEEECCCCCCC-ccCc-cccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccce
Confidence 35788999999998 6775 6788999999999999999 564 589999999999999999954333333 7999999
Q ss_pred cccccCcccCC--chhhhhccccceecCCccccCCCCC------CCCCCCceEEe
Q 005875 184 LSFNSFTGNIP--QSIQNLTQLTGLSLQSNNLSGSIPN------FDIPKLRHLNL 230 (672)
Q Consensus 184 ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~------~~l~~L~~l~l 230 (672)
|++|+|+. ++ ..+..+++|+.|++++|.++. .|. ..+++|+.||-
T Consensus 94 L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 94 LTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETT
T ss_pred eccccccc-cccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeCC
Confidence 99999984 44 468899999999999999984 443 16899999873
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.33 E-value=1.6e-12 Score=124.24 Aligned_cols=136 Identities=22% Similarity=0.285 Sum_probs=112.8
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeec
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 184 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l 184 (672)
.++.|+++++++.. ++ .+..+++|++|+|++|+|++. + .+++|++|++|++++|++++ +|. +. ++|+.|++
T Consensus 47 ~L~~L~l~~~~i~~-l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~~-l~~l~~L~~L~l 119 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSL 119 (210)
T ss_dssp TCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEEC
T ss_pred CccEEECcCCCCCC-ch--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-ccc-cccccccccccc
Confidence 47789999999884 54 388999999999999999964 4 37899999999999999995 453 33 89999999
Q ss_pred ccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCcccc
Q 005875 185 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG 253 (672)
Q Consensus 185 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~ 253 (672)
++|.++. + ..+.++++|+.+++++|.+++..+...+++|+.+++++|++++ ++ .+.++++|..++
T Consensus 120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~ 184 (210)
T d1h6ta2 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLY 184 (210)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEE
T ss_pred ccccccc-c-ccccccccccccccccccccccccccccccccccccccccccc-cc-cccCCCCCCEEE
Confidence 9999983 3 4689999999999999999976555589999999999999996 43 377777776543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.32 E-value=1.6e-12 Score=125.90 Aligned_cols=138 Identities=23% Similarity=0.334 Sum_probs=85.7
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc---------
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--------- 176 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--------- 176 (672)
.++..|++++|.+++ ++ .+..+++|++|++++|.++ .++ .+.++++|+.|++++|...+..+-...
T Consensus 63 ~~L~~L~ls~n~i~~-~~--~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 63 NNLIGLELKDNQITD-LA--PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp TTCCEEECCSSCCCC-CG--GGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCcEeecCCceeec-cc--ccccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhch
Confidence 357778888888774 33 2778888888888888877 444 477888888888888887754332221
Q ss_pred -------------cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCccc
Q 005875 177 -------------PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 243 (672)
Q Consensus 177 -------------~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~ 243 (672)
++|+.|++++|++++.. .++++++|+.|+|++|++++..+-..+++|++|+|++|++++ +| .+
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt~-i~-~l 213 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISD-VS-PL 213 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCB-CG-GG
T ss_pred hhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCCC-Cc-cc
Confidence 34666666666665322 256666666666666666643222356666666666666663 33 24
Q ss_pred CCCCCCccc
Q 005875 244 QKFPNSSFV 252 (672)
Q Consensus 244 ~~~~~l~~~ 252 (672)
+++++|.++
T Consensus 214 ~~l~~L~~L 222 (227)
T d1h6ua2 214 ANTSNLFIV 222 (227)
T ss_dssp TTCTTCCEE
T ss_pred ccCCCCCEE
Confidence 555555443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=2.9e-12 Score=125.13 Aligned_cols=159 Identities=18% Similarity=0.150 Sum_probs=98.7
Q ss_pred CcceeeecCCC---------CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCC-cCC------------
Q 005875 95 SWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EIT------------ 152 (672)
Q Consensus 95 ~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~------------ 152 (672)
.+..|.|.... ..++.|+|++|.++ .+|+..|.++++|++|+|++|.+...+|. .|.
T Consensus 9 ~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 9 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp CSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred cCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 67888887421 25788999999987 67776789999999999999987654432 233
Q ss_pred -------------CCCCCcEEeeeccCCCCCCCCCcc----------------------------cccceeecccccCcc
Q 005875 153 -------------SLPSLRYLYLQHNNFSGKIPSSFS----------------------------PQLVVLDLSFNSFTG 191 (672)
Q Consensus 153 -------------~l~~L~~L~l~~N~l~g~~p~~~~----------------------------~~L~~L~ls~N~l~~ 191 (672)
++++|+.|++++|.+....+..+. ..++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 455566666666666532221110 134556666666663
Q ss_pred cCCchhhhhcccc-ceecCCccccCCCCCC--CCCCCceEEeecCCCCCCCCcccCCCCCCccccCC
Q 005875 192 NIPQSIQNLTQLT-GLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNS 255 (672)
Q Consensus 192 ~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~~~n~ 255 (672)
++....+..++. .+++++|+|+...+.. .+++|+.|+|++|+++...+..|.++++|+.+++.
T Consensus 168 -i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 168 -IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp -ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred -cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 333333334433 3345666666433332 67788888888888874444557777777766644
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.30 E-value=1.7e-14 Score=136.83 Aligned_cols=124 Identities=25% Similarity=0.330 Sum_probs=102.2
Q ss_pred ccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccc
Q 005875 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 203 (672)
Q Consensus 126 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L 203 (672)
.++.|++|++|+|++|+|+ .++ .|.+|++|+.|+|++|+++ .+|..+. ++|++|++++|+|+. + +.+.++++|
T Consensus 43 sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L 117 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNL 117 (198)
T ss_dssp HHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHS
T ss_pred HHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccc
Confidence 6899999999999999999 565 5999999999999999998 6665443 689999999999995 4 458999999
Q ss_pred cceecCCccccCCCC--C-CCCCCCceEEeecCCCCCCCCcc----------cCCCCCCccccC
Q 005875 204 TGLSLQSNNLSGSIP--N-FDIPKLRHLNLSYNGLKGSIPSS----------LQKFPNSSFVGN 254 (672)
Q Consensus 204 ~~L~l~~N~l~~~~p--~-~~l~~L~~l~l~~N~l~g~~p~~----------~~~~~~l~~~~n 254 (672)
+.|+|++|+|+.... . ..+++|+.|+|++|++....+.. +.++++|..++.
T Consensus 118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD~ 181 (198)
T d1m9la_ 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLDG 181 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEESS
T ss_pred cccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeCC
Confidence 999999999985422 2 38999999999999987544432 456778877763
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.30 E-value=3.6e-12 Score=129.10 Aligned_cols=109 Identities=25% Similarity=0.322 Sum_probs=77.7
Q ss_pred ccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCcccCCchhhhhccc
Q 005875 126 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 203 (672)
Q Consensus 126 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L 203 (672)
.+..+++|+.+++++|.++ .+|..+ +++|+.|++++|..++..+..|. +.+++|++++|.+++..|..+.++++|
T Consensus 145 ~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L 221 (305)
T d1xkua_ 145 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221 (305)
T ss_dssp GGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred ccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccc
Confidence 5677777777777777776 555443 56777777777777776666665 567777777777777777777777777
Q ss_pred cceecCCccccCCCCCC-CCCCCceEEeecCCCCC
Q 005875 204 TGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 204 ~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g 237 (672)
++|+|++|+|+..++.. .+++|+.|+|++|+++.
T Consensus 222 ~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 222 RELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp CEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCC
T ss_pred eeeecccccccccccccccccCCCEEECCCCccCc
Confidence 77777777777432333 67777777777777773
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.25 E-value=5.9e-12 Score=131.40 Aligned_cols=137 Identities=26% Similarity=0.345 Sum_probs=94.5
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc---------
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--------- 176 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--------- 176 (672)
.++..+++++|.++. ++ .+..+++|+.|++++|.+++..| ++.+++|+.|++++|++++..|-.-.
T Consensus 219 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~ 293 (384)
T d2omza2 219 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN 293 (384)
T ss_dssp TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred CCCCEEECCCCCCCC-cc--hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccc
Confidence 457788999998874 43 58889999999999999986554 88889999999999998865432111
Q ss_pred -------------cccceeecccccCcccCCchhhhhccccceecCCccccCCCCCC-CCCCCceEEeecCCCCCCCCcc
Q 005875 177 -------------PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSS 242 (672)
Q Consensus 177 -------------~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~ 242 (672)
++|+.|+|++|+|++.. .+..+++|++|+|++|+|++ ++.. .+++|++|+|++|++++..|
T Consensus 294 ~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~-- 368 (384)
T d2omza2 294 ENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP-- 368 (384)
T ss_dssp SSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG--
T ss_pred ccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh--
Confidence 45667777777776543 26667777777777777764 3333 66677777777777765433
Q ss_pred cCCCCCCccc
Q 005875 243 LQKFPNSSFV 252 (672)
Q Consensus 243 ~~~~~~l~~~ 252 (672)
+.++++|+.+
T Consensus 369 l~~l~~L~~L 378 (384)
T d2omza2 369 LANLTRITQL 378 (384)
T ss_dssp GTTCTTCSEE
T ss_pred hccCCCCCEe
Confidence 5555555443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=8.8e-12 Score=112.96 Aligned_cols=73 Identities=25% Similarity=0.317 Sum_probs=46.1
Q ss_pred CCccccCCccccCCCCCCcEEEccCC-CcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceeecccccCc
Q 005875 116 IGLVGPIPNNTLGKLDALEVLSLRSN-VLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 190 (672)
Q Consensus 116 ~~l~g~~p~~~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~ 190 (672)
+++. .+|. .+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|..|. ++|++|+|++|+|+
T Consensus 18 ~~~~-~~p~-~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 18 DGAL-DSLH-HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp SCCC-TTTT-TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCc-cCcc-cccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc
Confidence 3444 4455 5777888888888765 47744456678888887777777777744344443 45555555555555
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.20 E-value=2.1e-11 Score=110.34 Aligned_cols=106 Identities=17% Similarity=0.102 Sum_probs=88.8
Q ss_pred CCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccC-CCCCCCCCcc--cccceeecccccCcccCCchhhhhccccce
Q 005875 130 LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN-FSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGL 206 (672)
Q Consensus 130 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 206 (672)
....+.++.+++++. .+|..+.++++|+.|+|++|+ ++..-+..|. ++|+.|+|++|+|+...|.+|..+++|+.|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 344556888998888 678889999999999998764 8854455565 799999999999998888999999999999
Q ss_pred ecCCccccCCCCCC-CCCCCceEEeecCCCC
Q 005875 207 SLQSNNLSGSIPNF-DIPKLRHLNLSYNGLK 236 (672)
Q Consensus 207 ~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~ 236 (672)
+|++|+|+...+.. ...+|+.|+|++|.+.
T Consensus 86 ~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred eccCCCCcccChhhhccccccccccCCCccc
Confidence 99999999555543 5568999999999985
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.14 E-value=3.6e-11 Score=125.23 Aligned_cols=140 Identities=31% Similarity=0.370 Sum_probs=105.0
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeeccc
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~ 186 (672)
....++++++.+++..| +...++|+.|++++|.++. +| .+..+++|+.|++++|++++..|-...++|++|++++
T Consensus 198 ~~~~l~l~~n~i~~~~~---~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~ 272 (384)
T d2omza2 198 NLESLIATNNQISDITP---LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGA 272 (384)
T ss_dssp TCSEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred ccceeeccCCccCCCCc---ccccCCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCCcccccccCCEeeccC
Confidence 46788999999986443 5678899999999999984 44 6889999999999999999876655558999999999
Q ss_pred ccCcccCC--------------------chhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCC
Q 005875 187 NSFTGNIP--------------------QSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 246 (672)
Q Consensus 187 N~l~~~~p--------------------~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~ 246 (672)
|++++..| ..+..+++++.|++++|++++..+-..+++|+.|+|++|++++ +| .++++
T Consensus 273 ~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~-~l~~l 350 (384)
T d2omza2 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VS-SLANL 350 (384)
T ss_dssp SCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CG-GGGGC
T ss_pred cccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-Ch-hHcCC
Confidence 99986432 2355566677777777777765443467777777777777764 33 46666
Q ss_pred CCCcccc
Q 005875 247 PNSSFVG 253 (672)
Q Consensus 247 ~~l~~~~ 253 (672)
++|+.++
T Consensus 351 ~~L~~L~ 357 (384)
T d2omza2 351 TNINWLS 357 (384)
T ss_dssp TTCCEEE
T ss_pred CCCCEEE
Confidence 6666553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.99 E-value=1.7e-12 Score=122.73 Aligned_cols=118 Identities=23% Similarity=0.307 Sum_probs=97.9
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcc--cccceee
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD 183 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ 183 (672)
..+..|+|++|+++ .++ .+..|++|++|+|++|.|+ .+|..+..+++|++|++++|+++. ++. +. ++|+.|+
T Consensus 48 ~~L~~L~Ls~n~I~-~i~--~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~-~~~l~~L~~L~ 121 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSG-IEKLVNLRVLY 121 (198)
T ss_dssp TTCCEEECSEEEES-CCC--CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHH-HHHHHHSSEEE
T ss_pred cccceeECcccCCC-Ccc--cccCCccccChhhcccccc-cccccccccccccccccccccccc-ccc-ccccccccccc
Confidence 36789999999998 565 4999999999999999998 677666677899999999999994 332 33 7999999
Q ss_pred cccccCcccCC-chhhhhccccceecCCccccCCCCCC------------CCCCCceEE
Q 005875 184 LSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNF------------DIPKLRHLN 229 (672)
Q Consensus 184 ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~------------~l~~L~~l~ 229 (672)
|++|+|+.... ..+.++++|+.|+|++|.+....+.. .+++|+.||
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 99999994322 47899999999999999998655542 478999887
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.95 E-value=7.9e-10 Score=106.43 Aligned_cols=121 Identities=23% Similarity=0.337 Sum_probs=86.2
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCC--------------------CCcCCCCCCCcEEeeeccC
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGL--------------------PSEITSLPSLRYLYLQHNN 166 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~--------------------p~~~~~l~~L~~L~l~~N~ 166 (672)
.+..++++++.++ .++ .++.+++|+.|++++|...+.. ...+.++++|+.|++++|.
T Consensus 86 ~l~~l~~~~n~~~-~i~--~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~ 162 (227)
T d1h6ua2 86 KITELELSGNPLK-NVS--AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQ 162 (227)
T ss_dssp SCCEEECCSCCCS-CCG--GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccccccccc-ccc--cccccccccccccccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccc
Confidence 3445555555544 333 2555566666666555544321 1235678889999999999
Q ss_pred CCCCCCCCcccccceeecccccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeec
Q 005875 167 FSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSY 232 (672)
Q Consensus 167 l~g~~p~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~ 232 (672)
+++..+-.-.++|++|+|++|++++ +| .++++++|+.|+|++|+|++..|-..+++|+.|+|++
T Consensus 163 ~~~~~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 163 VSDLTPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226 (227)
T ss_dssp CCCCGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEE
T ss_pred cccchhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcccccCCCCCEEEeeC
Confidence 9865442222899999999999995 44 3899999999999999999765555899999999984
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.89 E-value=2.4e-09 Score=103.86 Aligned_cols=133 Identities=16% Similarity=0.123 Sum_probs=101.6
Q ss_pred EEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCC-cc--cccceeecc-
Q 005875 110 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLVVLDLS- 185 (672)
Q Consensus 110 ~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~--~~L~~L~ls- 185 (672)
.++.++.+++ .+|++ + .+++++|+|++|+|+...+..|.++++|++|+|++|.+...+|.. |. +++++|++.
T Consensus 12 ~i~c~~~~l~-~iP~~-l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp EEEEESCSCS-SCCSC-S--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred EEEEeCCCCC-CcCCC-C--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 4677788888 88873 3 257999999999999544557999999999999999998777654 43 788888876
Q ss_pred cccCcccCCchhhhhccccceecCCccccCCCCCC---CCCCCceEEeecCCCCCCCCcccCCC
Q 005875 186 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKF 246 (672)
Q Consensus 186 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~l~~L~~l~l~~N~l~g~~p~~~~~~ 246 (672)
.|+++...+..|.++++|+.|++++|++....+.. .+..|..+..+++.+...-+..+.++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~ 151 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 151 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccc
Confidence 47888888889999999999999999998654433 34555556666777764444455444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.82 E-value=9.3e-09 Score=104.87 Aligned_cols=127 Identities=28% Similarity=0.401 Sum_probs=97.1
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeeccc
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 186 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~ 186 (672)
+++.|+|++++++ .+|+ . +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. +.+.|++|+|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~-~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-lp~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPE-L---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-LPPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCS-C---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-CCTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCC-C---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-hccccccccccc
Confidence 4668999999998 6886 2 578999999999999 888654 57889999999998 5553 557899999999
Q ss_pred ccCcccCCchhhhhccccceecCCccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCc
Q 005875 187 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 250 (672)
Q Consensus 187 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~ 250 (672)
|.|+ .+|. ++++++|+.|++++|.++...+. ...+..+.+.++.... +..+..++.+.
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~--~~~l~~l~~~~~~~~~--~~~l~~l~~l~ 165 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL--PPSLEFIAAGNNQLEE--LPELQNLPFLT 165 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCSS--CCCCTTCTTCC
T ss_pred cccc-cccc-hhhhccceeeccccccccccccc--cccccchhhccccccc--cccccccccce
Confidence 9998 5664 68899999999999999855443 4667788887766653 23344444433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.81 E-value=1.5e-08 Score=103.34 Aligned_cols=110 Identities=20% Similarity=0.206 Sum_probs=82.6
Q ss_pred CCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeeccCCCCCCCCCcccccceeecccccCcccCCchhhhhccccceecCC
Q 005875 131 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS 210 (672)
Q Consensus 131 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 210 (672)
.+|++|||++|+|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .+.|++|++++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~-~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP-QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC-TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch-hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 35889999999998 68864 568899999999998 778654 58999999999988 44432 14589999999
Q ss_pred ccccCCCCCCCCCCCceEEeecCCCCCCCCcccCCCCCCcc
Q 005875 211 NNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF 251 (672)
Q Consensus 211 N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 251 (672)
|.+....+...+++|+.|++++|.++ ..|..+..+..+..
T Consensus 108 n~l~~lp~~~~l~~L~~L~l~~~~~~-~~~~~~~~l~~l~~ 147 (353)
T d1jl5a_ 108 NQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAA 147 (353)
T ss_dssp SCCSSCCCCTTCTTCCEEECCSSCCS-CCCCCCTTCCEEEC
T ss_pred cccccccchhhhccceeecccccccc-ccccccccccchhh
Confidence 99985433347899999999999887 44444444544433
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=1e-09 Score=109.58 Aligned_cols=148 Identities=23% Similarity=0.270 Sum_probs=91.1
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCCCCCCcCCCCCCCcEEeeecc-CCCCCCCCCc---ccccce
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN-NFSGKIPSSF---SPQLVV 181 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~---~~~L~~ 181 (672)
.++..|||+++.+........+..+++|++|+|+++.+++..+..++.+++|+.|+|+++ .++...-..+ .++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 467888998887765433336788899999999999888877888888899999999884 5552110111 167888
Q ss_pred eecccc-cCccc-CCchhhhh-ccccceecCCc--cccCC-CCCC--CCCCCceEEeecC-CCCCCCCcccCCCCCCccc
Q 005875 182 LDLSFN-SFTGN-IPQSIQNL-TQLTGLSLQSN--NLSGS-IPNF--DIPKLRHLNLSYN-GLKGSIPSSLQKFPNSSFV 252 (672)
Q Consensus 182 L~ls~N-~l~~~-~p~~~~~l-~~L~~L~l~~N--~l~~~-~p~~--~l~~L~~l~l~~N-~l~g~~p~~~~~~~~l~~~ 252 (672)
|+|+++ +++.. ++..+..+ ++|+.|++++. .++.. +... .+++|++|+|++| .+++.....+.++++|+.+
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 888874 45421 22233333 46666666643 23211 1111 4566666776664 3555555556666665554
Q ss_pred c
Q 005875 253 G 253 (672)
Q Consensus 253 ~ 253 (672)
.
T Consensus 206 ~ 206 (284)
T d2astb2 206 S 206 (284)
T ss_dssp E
T ss_pred E
Confidence 3
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.33 E-value=1.4e-08 Score=91.88 Aligned_cols=79 Identities=25% Similarity=0.296 Sum_probs=48.3
Q ss_pred cccceeecccccCccc--CCchhhhhccccceecCCccccCCCCC--CCCCCCceEEeecCCCCCCCCcc-------cCC
Q 005875 177 PQLVVLDLSFNSFTGN--IPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSS-------LQK 245 (672)
Q Consensus 177 ~~L~~L~ls~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~l~~L~~l~l~~N~l~g~~p~~-------~~~ 245 (672)
++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+...+. ....+|+.|++++|+++...... +..
T Consensus 65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~ 144 (162)
T d1koha1 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144 (162)
T ss_dssp TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTT
T ss_pred CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHH
Confidence 4666667777766643 234566777777777777777743221 14456777777777777554422 456
Q ss_pred CCCCccccCC
Q 005875 246 FPNSSFVGNS 255 (672)
Q Consensus 246 ~~~l~~~~n~ 255 (672)
+++|..+++.
T Consensus 145 ~P~L~~LDg~ 154 (162)
T d1koha1 145 FPKLLRLDGH 154 (162)
T ss_dssp STTCCEETTE
T ss_pred CCCCCEECcC
Confidence 6777766643
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.32 E-value=3.5e-08 Score=98.04 Aligned_cols=147 Identities=24% Similarity=0.287 Sum_probs=97.1
Q ss_pred CeEEEEEeCCCCccccCCccccCCCCCCcEEEccC-CCcCCC-CCCcCCCCCCCcEEeeecc-CCCCC-CCCCc---ccc
Q 005875 106 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRS-NVLTGG-LPSEITSLPSLRYLYLQHN-NFSGK-IPSSF---SPQ 178 (672)
Q Consensus 106 ~~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~-N~l~g~-~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~---~~~ 178 (672)
.++..|+|.++.+.+..+. .++.+++|++|+|++ +.++.. +..-..++++|+.|+|+++ .++.. ++..+ .++
T Consensus 71 ~~L~~L~L~~~~l~~~~~~-~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~ 149 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVN-TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 149 (284)
T ss_dssp CCCSEEECTTCBCCHHHHH-HHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCcccccccccCCCcHHHH-HHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence 3577888888888766666 688888999999988 466522 2222456788999999884 44421 11111 257
Q ss_pred cceeecccc--cCccc-CCchhhhhccccceecCCc-cccCCCCCC--CCCCCceEEeec-CCCCCCCCcccCCCCCCcc
Q 005875 179 LVVLDLSFN--SFTGN-IPQSIQNLTQLTGLSLQSN-NLSGSIPNF--DIPKLRHLNLSY-NGLKGSIPSSLQKFPNSSF 251 (672)
Q Consensus 179 L~~L~ls~N--~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~~p~~--~l~~L~~l~l~~-N~l~g~~p~~~~~~~~l~~ 251 (672)
|+.|++++. .++.. +...+.++++|+.|+|++| .+++..... .+++|++|+|++ +.++......++++++|..
T Consensus 150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~ 229 (284)
T d2astb2 150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229 (284)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCE
Confidence 888888863 45432 3334467788888888875 466443332 778888888888 4576655566777777766
Q ss_pred cc
Q 005875 252 VG 253 (672)
Q Consensus 252 ~~ 253 (672)
++
T Consensus 230 L~ 231 (284)
T d2astb2 230 LQ 231 (284)
T ss_dssp EE
T ss_pred Ee
Confidence 64
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=2.4e-06 Score=82.95 Aligned_cols=132 Identities=17% Similarity=0.161 Sum_probs=93.0
Q ss_pred ccC-cEEEEEEEECCCcEEEEEEecccc-cChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEecCCCchhhhh
Q 005875 385 KGS-YGTAYKAVLEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL 462 (672)
Q Consensus 385 ~G~-fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l 462 (672)
+|+ .+.||+... +++.+++|+..... .....+.+|...+..+..+--+.+++.+..+++..++||++++|.++.+..
T Consensus 23 ~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 23 EGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 344 468999874 45667888876543 344568889999888866666788899888888999999999998886654
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 005875 463 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG---------------------------------------------- 496 (672)
Q Consensus 463 ~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~---------------------------------------------- 496 (672)
... .....++.++++.++.||+..
T Consensus 102 ~~~----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (263)
T d1j7la_ 102 EDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp TTC----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHH
T ss_pred ccc----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHH
Confidence 211 112234445555555555321
Q ss_pred ----------CCCcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 497 ----------GPKFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 497 ----------~~~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
.+.++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1127899999999999987767799998764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=4.3e-08 Score=88.63 Aligned_cols=79 Identities=28% Similarity=0.301 Sum_probs=44.1
Q ss_pred CCCCCCCcEEeeeccCCCCCCC--CCcc--cccceeecccccCcccCCchhhhhccccceecCCccccCCCCC-------
Q 005875 151 ITSLPSLRYLYLQHNNFSGKIP--SSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN------- 219 (672)
Q Consensus 151 ~~~l~~L~~L~l~~N~l~g~~p--~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~------- 219 (672)
+..+++|++|+|++|+++..-+ ..+. ++|+.|+|++|+|+...+-.+....+|+.|++++|.++.....
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 3455666666666666663211 1121 5666666666666633332333444567777777777655442
Q ss_pred --CCCCCCceEE
Q 005875 220 --FDIPKLRHLN 229 (672)
Q Consensus 220 --~~l~~L~~l~ 229 (672)
..+|+|+.||
T Consensus 141 i~~~~P~L~~LD 152 (162)
T d1koha1 141 IRERFPKLLRLD 152 (162)
T ss_dssp HHTTSTTCCEET
T ss_pred HHHHCCCCCEEC
Confidence 1467777665
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.14 E-value=4.2e-08 Score=103.56 Aligned_cols=108 Identities=22% Similarity=0.266 Sum_probs=54.4
Q ss_pred eEEEEEeCCCCccccCCccccCCCCCCcEEEccCCCcCC----CCCCcCCCCCCCcEEeeeccCCCCC----CCCCcc--
Q 005875 107 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGK----IPSSFS-- 176 (672)
Q Consensus 107 ~v~~l~l~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~-- 176 (672)
.+.+||++++++++.-=...+..+++|+.|+|++|+|+. .+...+..+++|+.|||++|.++.. +...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 456666666666542101134455666666666666651 2333445566666666666665411 111111
Q ss_pred -cccceeecccccCccc----CCchhhhhccccceecCCcccc
Q 005875 177 -PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLS 214 (672)
Q Consensus 177 -~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 214 (672)
.+|++|+|++|+++.. ++..+..+++|++|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 2466666666665532 3334445555555555555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.08 E-value=5.1e-08 Score=99.59 Aligned_cols=85 Identities=24% Similarity=0.284 Sum_probs=38.6
Q ss_pred CCCCcEEEccCCCcCCC----CCCcCCCCCCCcEEeeeccCCCCC-----CCCCcc--cccceeecccccCccc----CC
Q 005875 130 LDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGK-----IPSSFS--PQLVVLDLSFNSFTGN----IP 194 (672)
Q Consensus 130 l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~-----~p~~~~--~~L~~L~ls~N~l~~~----~p 194 (672)
...|+.|++++|.++.. +...+...++|+.|+|++|+++.. +...+. ++|+.|+|++|.|+.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 34455555555554411 122233445555555555555421 111111 4455555555555422 23
Q ss_pred chhhhhccccceecCCcccc
Q 005875 195 QSIQNLTQLTGLSLQSNNLS 214 (672)
Q Consensus 195 ~~~~~l~~L~~L~l~~N~l~ 214 (672)
..+..+++|+.|+|++|.|+
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCC
T ss_pred ccccccccchhhhhhcCccC
Confidence 33445555555555555554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.02 E-value=1.2e-05 Score=77.43 Aligned_cols=76 Identities=7% Similarity=0.056 Sum_probs=55.7
Q ss_pred ccccCc-EEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCC-CceeceEEEEEeCCeeEEEEEecCCCchhh
Q 005875 383 LGKGSY-GTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-PNVVPLRAYYYSKDEKLLVYDYFASGSLST 460 (672)
Q Consensus 383 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lV~e~~~~g~L~~ 460 (672)
+..|.. +.||+....++..+++|...... ..++..|...++.+..+ -.+.+++++..+++..++||+|++|-++.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 444543 68999998878888888765432 34678888888877543 336778888888888999999998866543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.92 E-value=1.9e-07 Score=98.41 Aligned_cols=106 Identities=25% Similarity=0.358 Sum_probs=77.8
Q ss_pred CCcEEEccCCCcCCCC-CCcCCCCCCCcEEeeeccCCCC----CCCCCcc--cccceeecccccCccc----CCchhh-h
Q 005875 132 ALEVLSLRSNVLTGGL-PSEITSLPSLRYLYLQHNNFSG----KIPSSFS--PQLVVLDLSFNSFTGN----IPQSIQ-N 199 (672)
Q Consensus 132 ~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~--~~L~~L~ls~N~l~~~----~p~~~~-~ 199 (672)
+|+.||++.|++++.. ..-+..+++|++|+|++|.++. .++..+. ++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6899999999998532 3345678999999999999872 1222222 7899999999999732 222222 2
Q ss_pred hccccceecCCccccCC----CCC--CCCCCCceEEeecCCCCC
Q 005875 200 LTQLTGLSLQSNNLSGS----IPN--FDIPKLRHLNLSYNGLKG 237 (672)
Q Consensus 200 l~~L~~L~l~~N~l~~~----~p~--~~l~~L~~l~l~~N~l~g 237 (672)
..+|+.|+|++|+++.. ++. ..+++|++|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35799999999999753 222 268899999999999863
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.88 E-value=2.8e-07 Score=93.87 Aligned_cols=110 Identities=19% Similarity=0.251 Sum_probs=61.9
Q ss_pred cCCCCCCcEEEccCCCcCCC----CCCcCCCCCCCcEEeeeccCCCCCCCCCc---------------ccccceeecccc
Q 005875 127 LGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSF---------------SPQLVVLDLSFN 187 (672)
Q Consensus 127 ~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~---------------~~~L~~L~ls~N 187 (672)
+...++|++|+|++|.++.. +...+...++|+.|++++|.++......+ .+.|+.|++++|
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 45566777777777776643 23334456677777777776642111111 035667777777
Q ss_pred cCccc----CCchhhhhccccceecCCccccCC-----CCC-C-CCCCCceEEeecCCCC
Q 005875 188 SFTGN----IPQSIQNLTQLTGLSLQSNNLSGS-----IPN-F-DIPKLRHLNLSYNGLK 236 (672)
Q Consensus 188 ~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~-----~p~-~-~l~~L~~l~l~~N~l~ 236 (672)
+++.. +...+..++.|+.|+|++|+++.. +.. . ..++|+.|+|++|.++
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred cccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence 66522 333455566677777777766521 111 1 4566777777777664
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.47 E-value=8.7e-06 Score=73.31 Aligned_cols=106 Identities=13% Similarity=0.124 Sum_probs=60.5
Q ss_pred CCCCCCcEEEccC-CCcCCC----CCCcCCCCCCCcEEeeeccCCCCCCCCCcc------cccceeecccccCccc----
Q 005875 128 GKLDALEVLSLRS-NVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGN---- 192 (672)
Q Consensus 128 ~~l~~L~~L~L~~-N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~------~~L~~L~ls~N~l~~~---- 192 (672)
.+.++|++|+|++ |.++.. +-..+...++|+.|+|++|.+.......+. +.|++|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 3456677777776 345421 223455666777777777777632222222 5677777777777643
Q ss_pred CCchhhhhccccceecCCccccCCCC-------CC--CCCCCceEEeecC
Q 005875 193 IPQSIQNLTQLTGLSLQSNNLSGSIP-------NF--DIPKLRHLNLSYN 233 (672)
Q Consensus 193 ~p~~~~~l~~L~~L~l~~N~l~~~~p-------~~--~l~~L~~l~l~~N 233 (672)
+-..+...+.|++|+|++|.+...-. .. .-++|+.|+++.+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 22345555667777777776552111 00 3456677776554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.47 E-value=0.00027 Score=72.52 Aligned_cols=76 Identities=12% Similarity=0.159 Sum_probs=49.5
Q ss_pred ccccccCcEEEEEEEECC-CcEEEEEEecccc--------cChhhHHHHHHHHHHHcCC--CceeceEEEEEeCCeeEEE
Q 005875 381 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV--------VGKRDFEQQMEIVGRVGQH--PNVVPLRAYYYSKDEKLLV 449 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--------~~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~~~~~lV 449 (672)
+.||.|....||+....+ ++.++||.-.... ....+...|.+.+..+..+ ..+++++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 5678888653211 1223456688888877554 335555544 56677899
Q ss_pred EEecCCCch
Q 005875 450 YDYFASGSL 458 (672)
Q Consensus 450 ~e~~~~g~L 458 (672)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.15 E-value=2e-05 Score=70.86 Aligned_cols=107 Identities=14% Similarity=0.184 Sum_probs=72.8
Q ss_pred CeEEEEEeCCCC-cccc----CCccccCCCCCCcEEEccCCCcCCC----CCCcCCCCCCCcEEeeeccCCCCCCCCCcc
Q 005875 106 TRVFGLRLPGIG-LVGP----IPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS 176 (672)
Q Consensus 106 ~~v~~l~l~~~~-l~g~----~p~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 176 (672)
..++.|+|++++ +... +-. .+..-+.|++|+|++|.+... +-..+...+.|+.|+|++|.++...-..+.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~-~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHH-HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 467888887643 3321 112 466778899999999988632 223345568899999999998843222222
Q ss_pred ------cccceeecccccCccc-------CCchhhhhccccceecCCccc
Q 005875 177 ------PQLVVLDLSFNSFTGN-------IPQSIQNLTQLTGLSLQSNNL 213 (672)
Q Consensus 177 ------~~L~~L~ls~N~l~~~-------~p~~~~~l~~L~~L~l~~N~l 213 (672)
++|++|+|++|++... +...+...+.|+.|+++.+..
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 6799999999876532 445666778899999887654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.87 E-value=0.0046 Score=61.16 Aligned_cols=68 Identities=10% Similarity=0.044 Sum_probs=47.9
Q ss_pred EEEEEEEECCCcEEEEEEecccccChhhHHHHHHHHHHHcCCC-ceeceE-----EEEEeCCeeEEEEEecCCC
Q 005875 389 GTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLR-----AYYYSKDEKLLVYDYFASG 456 (672)
Q Consensus 389 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~-----~~~~~~~~~~lV~e~~~~g 456 (672)
-.||+++.++|+.+++|+........+++..|...+..|..+. -++..+ ..+..++..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 4799999999999999998766666778888998888875331 111111 1223456678899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.84 E-value=0.002 Score=65.85 Aligned_cols=73 Identities=12% Similarity=0.076 Sum_probs=51.1
Q ss_pred ccccccCcEEEEEEEECCC--------cEEEEEEecccccChhhHHHHHHHHHHHcCCCceeceEEEEEeCCeeEEEEEe
Q 005875 381 EVLGKGSYGTAYKAVLEES--------TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 452 (672)
Q Consensus 381 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lV~e~ 452 (672)
+.|+-|-.-.+|++...++ ..|++++.- ......+..+|..+++.+..+.-..++++++. -.+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 4577788889999987543 446666554 33344567788889888877765667887763 2689999
Q ss_pred cCCCch
Q 005875 453 FASGSL 458 (672)
Q Consensus 453 ~~~g~L 458 (672)
++|-.+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.43 E-value=0.00011 Score=65.64 Aligned_cols=107 Identities=16% Similarity=0.222 Sum_probs=55.7
Q ss_pred CCCCCCcEEEccC-CCcCCC----CCCcCCCCCCCcEEeeeccCCCCCCCCCcc------cccceeecccccCccc----
Q 005875 128 GKLDALEVLSLRS-NVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGN---- 192 (672)
Q Consensus 128 ~~l~~L~~L~L~~-N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~------~~L~~L~ls~N~l~~~---- 192 (672)
.+.++|++|+|++ |.++.. +-..+...++|+.|+|++|.++...-..+. ++|+.|++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456677777765 445421 223344566677777777766532222221 5677777777766532
Q ss_pred CCchhhhhccccceec--CCccccCC----CCCC--CCCCCceEEeecCC
Q 005875 193 IPQSIQNLTQLTGLSL--QSNNLSGS----IPNF--DIPKLRHLNLSYNG 234 (672)
Q Consensus 193 ~p~~~~~l~~L~~L~l--~~N~l~~~----~p~~--~l~~L~~l~l~~N~ 234 (672)
+-..+...++|+.++| ++|.+... +... ..++|+.|+++.|.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 2244555666665433 44555321 1111 45667777766554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.77 E-value=0.0011 Score=58.72 Aligned_cols=108 Identities=15% Similarity=0.158 Sum_probs=73.5
Q ss_pred CeEEEEEeCCC-Ccccc----CCccccCCCCCCcEEEccCCCcCCC----CCCcCCCCCCCcEEeeeccCCCCCCCCCcc
Q 005875 106 TRVFGLRLPGI-GLVGP----IPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS 176 (672)
Q Consensus 106 ~~v~~l~l~~~-~l~g~----~p~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 176 (672)
..++.|+|+++ .++.. +-. .+...++|++|+|++|.++.. +-..+...++|+.|++++|.++...-..+.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~-al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHH-HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 46777888763 34311 112 466889999999999998743 223345678999999999998743222221
Q ss_pred ------cccce--eecccccCcc----cCCchhhhhccccceecCCcccc
Q 005875 177 ------PQLVV--LDLSFNSFTG----NIPQSIQNLTQLTGLSLQSNNLS 214 (672)
Q Consensus 177 ------~~L~~--L~ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 214 (672)
++|+. |++++|.+.. .+...+...++|+.|+++.|...
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 57876 4556778864 35567778999999999887653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.04 E-value=0.086 Score=51.06 Aligned_cols=29 Identities=21% Similarity=0.204 Sum_probs=26.0
Q ss_pred CcccCCCCCCCEEecCCCCeEEeecCCCC
Q 005875 499 KFTHGNIKASNVLINQDLDGCISDFGLTP 527 (672)
Q Consensus 499 ~ivHrDLk~~NILl~~~~~~kl~DfGla~ 527 (672)
.+||+|+.+.||+++.+...-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 48999999999999998877899999764
|